The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
region.types | default |
differential.permutations | 0 |
differential.comparison.columns | lineage, karyotype, sex |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment | yes |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (t-test or limma depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
ectoderm vs. non.ectoderm (based on lineage) | 35094 |
ectoderm, mesoderm vs. non.ectoderm, mesoderm (based on lineage) | 47551 |
endoderm vs. non.endoderm (based on lineage) | 28524 |
epithelial vs. non.epithelial (based on lineage) | 155229 |
extraembryonic mesoderm, trophectoderm vs. non.extraembryonic mesoderm, trophectoderm (based on lineage) | 75671 |
inner cell mass vs. non.inner cell mass (based on lineage) | 79546 |
mesoderm vs. non.mesoderm (based on lineage) | 47347 |
cancer vs. normal (based on karyotype) | 136749 |
B vs. non.B (based on sex) | 58957 |
F vs. non.F (based on sex) | 18041 |
M vs. non.M (based on sex) | 30798 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling | genes | promoters | cpgislands | |
ectoderm vs. non.ectoderm (based on lineage) | 2611 | 2306 | 2048 | 2338 |
ectoderm, mesoderm vs. non.ectoderm, mesoderm (based on lineage) | 2727 | 389 | 340 | 299 |
endoderm vs. non.endoderm (based on lineage) | 6969 | 891 | 664 | 972 |
epithelial vs. non.epithelial (based on lineage) | 15569 | 2245 | 1484 | 785 |
extraembryonic mesoderm, trophectoderm vs. non.extraembryonic mesoderm, trophectoderm (based on lineage) | 3240 | 800 | 600 | 723 |
inner cell mass vs. non.inner cell mass (based on lineage) | 7348 | 1354 | 1667 | 2570 |
mesoderm vs. non.mesoderm (based on lineage) | 4997 | 1935 | 3186 | 1492 |
cancer vs. normal (based on karyotype) | 10160 | 5776 | 4309 | 5114 |
B vs. non.B (based on sex) | 5272 | 688 | 487 | 261 |
F vs. non.F (based on sex) | 3422 | 77 | 163 | 213 |
M vs. non.M (based on sex) | 1837 | 41 | 0 | 139 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling | genes | promoters | cpgislands | |
ectoderm vs. non.ectoderm (based on lineage) | csv | csv | csv | csv |
ectoderm, mesoderm vs. non.ectoderm, mesoderm (based on lineage) | csv | csv | csv | csv |
endoderm vs. non.endoderm (based on lineage) | csv | csv | csv | csv |
epithelial vs. non.epithelial (based on lineage) | csv | csv | csv | csv |
extraembryonic mesoderm, trophectoderm vs. non.extraembryonic mesoderm, trophectoderm (based on lineage) | csv | csv | csv | csv |
inner cell mass vs. non.inner cell mass (based on lineage) | csv | csv | csv | csv |
mesoderm vs. non.mesoderm (based on lineage) | csv | csv | csv | csv |
cancer vs. normal (based on karyotype) | csv | csv | csv | csv |
B vs. non.B (based on sex) | csv | csv | csv | csv |
F vs. non.F (based on sex) | csv | csv | csv | csv |
M vs. non.M (based on sex) | csv | csv | csv | csv |
Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006968 | 0.0034 | 25.9012 | 0.0871 | 2 | 38 | cellular defense response |
GO:0002249 | 0.0069 | 225.3929 | 0.0069 | 1 | 3 | lymphocyte anergy |
GO:0002667 | 0.0069 | 225.3929 | 0.0069 | 1 | 3 | regulation of T cell anergy |
GO:0006420 | 0.0069 | 225.3929 | 0.0069 | 1 | 3 | arginyl-tRNA aminoacylation |
GO:0070268 | 0.0069 | 225.3929 | 0.0069 | 1 | 3 | cornification |
GO:0006533 | 0.0091 | 150.25 | 0.0092 | 1 | 4 | aspartate catabolic process |
GO:0048539 | 0.0091 | 150.25 | 0.0092 | 1 | 4 | bone marrow development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048568 | 0 | 9.7558 | 1.5875 | 12 | 379 | embryonic organ development |
GO:0048704 | 0 | 19.0213 | 0.377 | 6 | 90 | embryonic skeletal system morphogenesis |
GO:0043009 | 0 | 6.5114 | 2.3206 | 12 | 554 | chordate embryonic development |
GO:0001501 | 0 | 7.5399 | 1.621 | 10 | 387 | skeletal system development |
GO:0007389 | 0 | 7.3196 | 1.6671 | 10 | 398 | pattern specification process |
GO:0061029 | 0 | 94.44 | 0.0461 | 3 | 11 | eyelid development in camera-type eye |
GO:0009952 | 0 | 10.3254 | 0.7959 | 7 | 190 | anterior/posterior pattern specification |
GO:0048729 | 0 | 6.042 | 1.998 | 10 | 477 | tissue morphogenesis |
GO:0048485 | 1e-04 | 44.4106 | 0.0838 | 3 | 20 | sympathetic nervous system development |
GO:0002088 | 1e-04 | 18.966 | 0.2429 | 4 | 58 | lens development in camera-type eye |
GO:0009887 | 1e-04 | 4.9271 | 2.4535 | 10 | 627 | organ morphogenesis |
GO:0072175 | 1e-04 | 11.5109 | 0.4943 | 5 | 118 | epithelial tube formation |
GO:0003180 | 2e-04 | 164.6667 | 0.0209 | 2 | 5 | aortic valve morphogenesis |
GO:0001654 | 2e-04 | 6.7202 | 1.198 | 7 | 286 | eye development |
GO:0032501 | 3e-04 | 2.7417 | 20.9855 | 34 | 5010 | multicellular organismal process |
GO:0035108 | 3e-04 | 9.6906 | 0.5822 | 5 | 139 | limb morphogenesis |
GO:0035239 | 3e-04 | 6.0731 | 1.3194 | 7 | 315 | tube morphogenesis |
GO:0016331 | 3e-04 | 9.3383 | 0.6032 | 5 | 144 | morphogenesis of embryonic epithelium |
GO:2000679 | 5e-04 | 82.3137 | 0.0335 | 2 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0048736 | 5e-04 | 8.5307 | 0.6576 | 5 | 157 | appendage development |
GO:0001841 | 7e-04 | 10.8606 | 0.4105 | 4 | 98 | neural tube formation |
GO:0001709 | 8e-04 | 18.84 | 0.1801 | 3 | 43 | cell fate determination |
GO:0001649 | 8e-04 | 7.6621 | 0.7288 | 5 | 174 | osteoblast differentiation |
GO:0043518 | 9e-04 | 54.8627 | 0.0461 | 2 | 11 | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0060900 | 9e-04 | 54.8627 | 0.0461 | 2 | 11 | embryonic camera-type eye formation |
GO:0060429 | 9e-04 | 3.5138 | 3.707 | 11 | 885 | epithelium development |
GO:0001764 | 0.0016 | 8.815 | 0.5014 | 4 | 122 | neuron migration |
GO:0035113 | 0.0016 | 8.7096 | 0.5068 | 4 | 121 | embryonic appendage morphogenesis |
GO:0050789 | 0.0018 | 2.6901 | 32.647 | 43 | 7794 | regulation of biological process |
GO:0042733 | 0.0019 | 13.44 | 0.2471 | 3 | 59 | embryonic digit morphogenesis |
GO:0048812 | 0.0022 | 3.8729 | 2.3499 | 8 | 561 | neuron projection morphogenesis |
GO:0060231 | 0.0022 | 32.902 | 0.0712 | 2 | 17 | mesenchymal to epithelial transition |
GO:0060713 | 0.0022 | 32.902 | 0.0712 | 2 | 17 | labyrinthine layer morphogenesis |
GO:0042471 | 0.0023 | 32.5417 | 0.0716 | 2 | 18 | ear morphogenesis |
GO:0000902 | 0.0025 | 3.0714 | 4.1929 | 11 | 1001 | cell morphogenesis |
GO:2000027 | 0.0026 | 7.652 | 0.5739 | 4 | 137 | regulation of organ morphogenesis |
GO:0051101 | 0.0029 | 11.5708 | 0.2848 | 3 | 68 | regulation of DNA binding |
GO:0022008 | 0.0033 | 2.8273 | 5.0013 | 12 | 1194 | neurogenesis |
GO:0018345 | 0.0038 | 24.6667 | 0.0922 | 2 | 22 | protein palmitoylation |
GO:0045909 | 0.0038 | 24.6667 | 0.0922 | 2 | 22 | positive regulation of vasodilation |
GO:0046320 | 0.0038 | 24.6667 | 0.0922 | 2 | 22 | regulation of fatty acid oxidation |
GO:0009889 | 0.0038 | 2.2231 | 13.6301 | 23 | 3254 | regulation of biosynthetic process |
GO:0003294 | 0.0042 | Inf | 0.0042 | 1 | 1 | atrial ventricular junction remodeling |
GO:0010232 | 0.0042 | Inf | 0.0042 | 1 | 1 | vascular transport |
GO:0010652 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of cell communication by chemical coupling |
GO:0018009 | 0.0042 | Inf | 0.0042 | 1 | 1 | N-terminal peptidyl-L-cysteine N-palmitoylation |
GO:0021852 | 0.0042 | Inf | 0.0042 | 1 | 1 | pyramidal neuron migration |
GO:0035332 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of hippo signaling |
GO:0035732 | 0.0042 | Inf | 0.0042 | 1 | 1 | nitric oxide storage |
GO:0035898 | 0.0042 | Inf | 0.0042 | 1 | 1 | parathyroid hormone secretion |
GO:0048698 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of collateral sprouting in absence of injury |
GO:0060156 | 0.0042 | Inf | 0.0042 | 1 | 1 | milk ejection |
GO:2000607 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of cell proliferation involved in mesonephros development |
GO:2000703 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
GO:2000734 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
GO:2000802 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:2001111 | 0.0042 | Inf | 0.0042 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
GO:0045664 | 0.0043 | 4.3035 | 1.5456 | 6 | 369 | regulation of neuron differentiation |
GO:0010629 | 0.0045 | 2.9769 | 3.8662 | 10 | 923 | negative regulation of gene expression |
GO:0001843 | 0.0047 | 9.6323 | 0.3393 | 3 | 81 | neural tube closure |
GO:0032720 | 0.0049 | 21.4442 | 0.1047 | 2 | 25 | negative regulation of tumor necrosis factor production |
GO:0048589 | 0.0049 | 4.9439 | 1.11 | 5 | 265 | developmental growth |
GO:0035282 | 0.0052 | 9.2733 | 0.3519 | 3 | 84 | segmentation |
GO:0031111 | 0.0052 | 20.549 | 0.1089 | 2 | 26 | negative regulation of microtubule polymerization or depolymerization |
GO:0042127 | 0.0054 | 2.7518 | 4.6327 | 11 | 1106 | regulation of cell proliferation |
GO:0051960 | 0.0058 | 3.5782 | 2.1823 | 7 | 521 | regulation of nervous system development |
GO:0032502 | 0.0059 | 2.2122 | 14.3534 | 23 | 3774 | developmental process |
GO:0007507 | 0.0064 | 3.9445 | 1.6797 | 6 | 401 | heart development |
GO:0007140 | 0.0065 | 18.2614 | 0.1215 | 2 | 29 | male meiosis |
GO:0009954 | 0.0065 | 18.2614 | 0.1215 | 2 | 29 | proximal/distal pattern formation |
GO:0042472 | 0.0065 | 8.5309 | 0.3812 | 3 | 91 | inner ear morphogenesis |
GO:0050905 | 0.0065 | 8.5309 | 0.3812 | 3 | 91 | neuromuscular process |
GO:0045597 | 0.0066 | 3.4792 | 2.241 | 7 | 535 | positive regulation of cell differentiation |
GO:0034113 | 0.0069 | 17.6078 | 0.1257 | 2 | 30 | heterotypic cell-cell adhesion |
GO:0048048 | 0.0074 | 16.9993 | 0.1299 | 2 | 31 | embryonic eye morphogenesis |
GO:2001141 | 0.0075 | 2.128 | 11.7829 | 20 | 2813 | regulation of RNA biosynthetic process |
GO:0048667 | 0.0077 | 3.3789 | 2.3038 | 7 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0006357 | 0.0078 | 2.5032 | 5.5752 | 12 | 1331 | regulation of transcription from RNA polymerase II promoter |
GO:0031099 | 0.008 | 7.8979 | 0.4105 | 3 | 98 | regeneration |
GO:0002011 | 0.0081 | 16.2168 | 0.1356 | 2 | 33 | morphogenesis of an epithelial sheet |
GO:0021569 | 0.0082 | 247.0196 | 0.0082 | 1 | 2 | rhombomere 3 development |
GO:0051241 | 0.0082 | 4.345 | 1.2566 | 5 | 300 | negative regulation of multicellular organismal process |
GO:0042060 | 0.0083 | 3.3277 | 2.3373 | 7 | 558 | wound healing |
GO:0051093 | 0.0083 | 3.3277 | 2.3373 | 7 | 558 | negative regulation of developmental process |
GO:0003366 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
GO:0006601 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | creatine biosynthetic process |
GO:0021568 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | rhombomere 2 development |
GO:0021658 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | rhombomere 3 morphogenesis |
GO:0046618 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | drug export |
GO:0060995 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | cell-cell signaling involved in kidney development |
GO:0061290 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | canonical Wnt signaling pathway involved in metanephric kidney development |
GO:0061386 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | closure of optic fissure |
GO:0071639 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | positive regulation of monocyte chemotactic protein-1 production |
GO:1900625 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | positive regulation of monocyte aggregation |
GO:2000276 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | negative regulation of oxidative phosphorylation uncoupler activity |
GO:2000664 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | positive regulation of interleukin-5 secretion |
GO:2000667 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | positive regulation of interleukin-13 secretion |
GO:2000683 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | regulation of cellular response to X-ray |
GO:2000793 | 0.0084 | 242.2885 | 0.0084 | 1 | 2 | cell proliferation involved in heart valve development |
GO:0072676 | 0.0084 | 15.9001 | 0.1382 | 2 | 33 | lymphocyte migration |
GO:0080090 | 0.0087 | 2.0021 | 19.0503 | 28 | 4548 | regulation of primary metabolic process |
GO:0042180 | 0.0087 | 5.3319 | 0.8126 | 4 | 194 | cellular ketone metabolic process |
GO:0003008 | 0.0087 | 2.5586 | 4.9469 | 11 | 1181 | system process |
GO:0001738 | 0.0089 | 15.402 | 0.1424 | 2 | 34 | morphogenesis of a polarized epithelium |
GO:0009953 | 0.0091 | 7.5 | 0.4314 | 3 | 103 | dorsal/ventral pattern formation |
GO:0007159 | 0.0099 | 14.4937 | 0.1508 | 2 | 36 | leukocyte cell-cell adhesion |
GO:0043124 | 0.0099 | 14.4937 | 0.1508 | 2 | 36 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:1901796 | 0.0099 | 14.4937 | 0.1508 | 2 | 36 | regulation of signal transduction by p53 class mediator |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001501 | 2e-04 | 6.6272 | 1.254 | 7 | 387 | skeletal system development |
GO:0046330 | 4e-04 | 23.0765 | 0.1491 | 3 | 46 | positive regulation of JNK cascade |
GO:0007423 | 5e-04 | 5.7909 | 1.4257 | 7 | 440 | sensory organ development |
GO:0009887 | 6e-04 | 4.4546 | 2.4562 | 9 | 758 | organ morphogenesis |
GO:0007605 | 7e-04 | 11.3495 | 0.3986 | 4 | 123 | sensory perception of sound |
GO:0090263 | 7e-04 | 19.0688 | 0.1782 | 3 | 55 | positive regulation of canonical Wnt signaling pathway |
GO:0070304 | 8e-04 | 18.7075 | 0.1815 | 3 | 56 | positive regulation of stress-activated protein kinase signaling cascade |
GO:0032735 | 0.001 | 49.7002 | 0.0486 | 2 | 15 | positive regulation of interleukin-12 production |
GO:0042730 | 0.0012 | 46.1465 | 0.0518 | 2 | 16 | fibrinolysis |
GO:0048568 | 0.0013 | 5.625 | 1.2281 | 6 | 379 | embryonic organ development |
GO:0001502 | 0.0017 | 37.994 | 0.0616 | 2 | 19 | cartilage condensation |
GO:0048839 | 0.0018 | 8.5214 | 0.5249 | 4 | 162 | inner ear development |
GO:0070328 | 0.0021 | 33.9892 | 0.068 | 2 | 21 | triglyceride homeostasis |
GO:0008344 | 0.0021 | 13.0222 | 0.256 | 3 | 79 | adult locomotory behavior |
GO:0055088 | 0.0023 | 12.6862 | 0.2625 | 3 | 81 | lipid homeostasis |
GO:0051130 | 0.0026 | 4.2691 | 1.9096 | 7 | 604 | positive regulation of cellular component organization |
GO:0032355 | 0.0028 | 11.7744 | 0.2819 | 3 | 87 | response to estradiol |
GO:0050794 | 0.0028 | 2.9015 | 24.0984 | 33 | 7437 | regulation of cellular process |
GO:0032964 | 0.0029 | 28.0691 | 0.081 | 2 | 25 | collagen biosynthetic process |
GO:0048704 | 0.0031 | 11.3657 | 0.2916 | 3 | 90 | embryonic skeletal system morphogenesis |
GO:0001958 | 0.0032 | 26.8974 | 0.0842 | 2 | 26 | endochondral ossification |
GO:0002920 | 0.0032 | 26.8974 | 0.0842 | 2 | 26 | regulation of humoral immune response |
GO:0002408 | 0.0032 | Inf | 0.0032 | 1 | 1 | myeloid dendritic cell chemotaxis |
GO:0007634 | 0.0032 | Inf | 0.0032 | 1 | 1 | optokinetic behavior |
GO:0010902 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of very-low-density lipoprotein particle remodeling |
GO:0019836 | 0.0032 | Inf | 0.0032 | 1 | 1 | hemolysis by symbiont of host erythrocytes |
GO:0021560 | 0.0032 | Inf | 0.0032 | 1 | 1 | abducens nerve development |
GO:0021599 | 0.0032 | Inf | 0.0032 | 1 | 1 | abducens nerve formation |
GO:0030844 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of intermediate filament depolymerization |
GO:0035659 | 0.0032 | Inf | 0.0032 | 1 | 1 | Wnt signaling pathway involved in wound healing, spreading of epidermal cells |
GO:0038115 | 0.0032 | Inf | 0.0032 | 1 | 1 | chemokine (C-C motif) ligand 19 signaling pathway |
GO:0038116 | 0.0032 | Inf | 0.0032 | 1 | 1 | chemokine (C-C motif) ligand 21 signaling pathway |
GO:0044179 | 0.0032 | Inf | 0.0032 | 1 | 1 | hemolysis in other organism |
GO:0045108 | 0.0032 | Inf | 0.0032 | 1 | 1 | regulation of intermediate filament polymerization or depolymerization |
GO:0051801 | 0.0032 | Inf | 0.0032 | 1 | 1 | cytolysis in other organism involved in symbiotic interaction |
GO:0097022 | 0.0032 | Inf | 0.0032 | 1 | 1 | lymphocyte migration into lymph node |
GO:2000522 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of immunological synapse formation |
GO:2000525 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of T cell costimulation |
GO:2000526 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
GO:2000547 | 0.0032 | Inf | 0.0032 | 1 | 1 | regulation of dendritic cell dendrite assembly |
GO:1900047 | 0.0034 | 25.8195 | 0.0875 | 2 | 27 | negative regulation of hemostasis |
GO:0030111 | 0.0034 | 7.106 | 0.6254 | 4 | 193 | regulation of Wnt signaling pathway |
GO:0010557 | 0.0035 | 3.1726 | 3.8042 | 10 | 1174 | positive regulation of macromolecule biosynthetic process |
GO:0051239 | 0.0035 | 2.7961 | 5.8618 | 13 | 1809 | regulation of multicellular organismal process |
GO:0050819 | 0.0039 | 23.9031 | 0.094 | 2 | 29 | negative regulation of coagulation |
GO:0035115 | 0.0045 | 22.2511 | 0.1005 | 2 | 31 | embryonic forelimb morphogenesis |
GO:0009628 | 0.0046 | 3.4771 | 2.6895 | 8 | 830 | response to abiotic stimulus |
GO:0040011 | 0.0046 | 3.0425 | 3.95 | 10 | 1219 | locomotion |
GO:0007166 | 0.0047 | 2.5566 | 7.5727 | 15 | 2337 | cell surface receptor signaling pathway |
GO:0060325 | 0.0048 | 21.5077 | 0.1037 | 2 | 32 | face morphogenesis |
GO:0031960 | 0.0051 | 9.4038 | 0.35 | 3 | 108 | response to corticosteroid |
GO:0042471 | 0.0052 | 9.3143 | 0.3532 | 3 | 109 | ear morphogenesis |
GO:0031328 | 0.0054 | 2.9663 | 4.0407 | 10 | 1247 | positive regulation of cellular biosynthetic process |
GO:0050789 | 0.0062 | 11.2015 | 0.4108 | 3 | 263 | regulation of biological process |
GO:0035137 | 0.0064 | 18.4278 | 0.1199 | 2 | 37 | hindlimb morphogenesis |
GO:2000179 | 0.0064 | 18.4278 | 0.1199 | 2 | 37 | positive regulation of neural precursor cell proliferation |
GO:0010260 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | organ senescence |
GO:0014834 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
GO:0019086 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | late viral transcription |
GO:0034059 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | response to anoxia |
GO:0034371 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | chylomicron remodeling |
GO:0060697 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | positive regulation of phospholipid catabolic process |
GO:0060876 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | semicircular canal formation |
GO:0070172 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | positive regulation of tooth mineralization |
GO:0072610 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | interleukin-12 secretion |
GO:2000253 | 0.0065 | 315.275 | 0.0065 | 1 | 2 | positive regulation of feeding behavior |
GO:0035113 | 0.007 | 8.3591 | 0.3921 | 3 | 121 | embryonic appendage morphogenesis |
GO:0009605 | 0.0071 | 2.7204 | 4.8897 | 11 | 1509 | response to external stimulus |
GO:0070542 | 0.0074 | 16.969 | 0.1296 | 2 | 40 | response to fatty acid |
GO:0050795 | 0.0076 | 8.0824 | 0.405 | 3 | 125 | regulation of behavior |
GO:0002673 | 0.0078 | 16.5325 | 0.1329 | 2 | 41 | regulation of acute inflammatory response |
GO:0010628 | 0.0079 | 2.9463 | 3.5903 | 9 | 1108 | positive regulation of gene expression |
GO:0030902 | 0.0087 | 7.6998 | 0.4245 | 3 | 131 | hindbrain development |
GO:0071229 | 0.0087 | 7.6998 | 0.4245 | 3 | 131 | cellular response to acid chemical |
GO:1903034 | 0.0088 | 5.3676 | 0.8198 | 4 | 253 | regulation of response to wounding |
GO:0007389 | 0.0089 | 4.3183 | 1.2897 | 5 | 398 | pattern specification process |
GO:0010171 | 0.0093 | 14.9899 | 0.1458 | 2 | 45 | body morphogenesis |
GO:0000432 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO:0001768 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | establishment of T cell polarity |
GO:0001907 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | killing by symbiont of host cells |
GO:0002885 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | positive regulation of hypersensitivity |
GO:0010898 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | positive regulation of triglyceride catabolic process |
GO:0010916 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | negative regulation of very-low-density lipoprotein particle clearance |
GO:0021570 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | rhombomere 4 development |
GO:0021754 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | facial nucleus development |
GO:0031133 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | regulation of axon diameter |
GO:0060066 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | oviduct development |
GO:0060166 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | olfactory pit development |
GO:0060279 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | positive regulation of ovulation |
GO:0071464 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | cellular response to hydrostatic pressure |
GO:0097029 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | mature dendritic cell differentiation |
GO:2000507 | 0.0097 | 157.625 | 0.0097 | 1 | 3 | positive regulation of energy homeostasis |
GO:0006928 | 0.0098 | 2.6978 | 4.3971 | 10 | 1357 | cellular component movement |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006750 | 0.0014 | 44.014 | 0.0555 | 2 | 13 | glutathione biosynthetic process |
GO:0019370 | 0.0016 | 40.3429 | 0.0597 | 2 | 14 | leukotriene biosynthetic process |
GO:1901687 | 0.0029 | 28.4661 | 0.0811 | 2 | 19 | glutathione derivative biosynthetic process |
GO:1901071 | 0.0032 | 26.8825 | 0.0854 | 2 | 20 | glucosamine-containing compound metabolic process |
GO:0043043 | 0.0036 | 25.4656 | 0.0896 | 2 | 21 | peptide biosynthetic process |
GO:0001913 | 0.0039 | 24.1904 | 0.0939 | 2 | 22 | T cell mediated cytotoxicity |
GO:0006751 | 0.0043 | Inf | 0.0043 | 1 | 1 | glutathione catabolic process |
GO:0042489 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of odontogenesis of dentin-containing tooth |
GO:1990166 | 0.0043 | Inf | 0.0043 | 1 | 1 | protein localization to site of double-strand break |
GO:2000568 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of memory T cell activation |
GO:0006045 | 0.0085 | 237.6981 | 0.0085 | 1 | 2 | N-acetylglucosamine biosynthetic process |
GO:0035552 | 0.0085 | 237.6981 | 0.0085 | 1 | 2 | oxidative single-stranded DNA demethylation |
GO:0071799 | 0.0085 | 237.6981 | 0.0085 | 1 | 2 | cellular response to prostaglandin D stimulus |
GO:0042267 | 0.0087 | 15.5931 | 0.1408 | 2 | 33 | natural killer cell mediated cytotoxicity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032514 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of protein phosphatase type 2B activity |
GO:0042697 | 0.0034 | Inf | 0.0034 | 1 | 1 | menopause |
GO:1990166 | 0.0034 | Inf | 0.0034 | 1 | 1 | protein localization to site of double-strand break |
GO:0007308 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | P granule organization |
GO:0034970 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | histone H3-R2 methylation |
GO:0051533 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | positive regulation of NFAT protein import into nucleus |
GO:0061051 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:1902261 | 0.0068 | 300.2143 | 0.0068 | 1 | 2 | positive regulation of delayed rectifier potassium channel activity |
GO:0006584 | 0.0085 | 15.7236 | 0.1393 | 2 | 41 | catecholamine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007617 | 1e-04 | 41.8868 | 0.0885 | 3 | 20 | mating behavior |
GO:0002125 | 1e-04 | 233.2407 | 0.0177 | 2 | 4 | maternal aggressive behavior |
GO:0042713 | 2e-04 | 155.4815 | 0.0221 | 2 | 5 | sperm ejaculation |
GO:0019098 | 2e-04 | 28.4649 | 0.1239 | 3 | 28 | reproductive behavior |
GO:0045924 | 4e-04 | 93.2741 | 0.031 | 2 | 7 | regulation of female receptivity |
GO:0001101 | 6e-04 | 6.51 | 1.0356 | 6 | 234 | response to acid chemical |
GO:0033993 | 7e-04 | 4.2427 | 2.4475 | 9 | 553 | response to lipid |
GO:0035815 | 8e-04 | 58.2824 | 0.0443 | 2 | 10 | positive regulation of renal sodium excretion |
GO:0043084 | 8e-04 | 58.2824 | 0.0443 | 2 | 10 | penile erection |
GO:0042711 | 0.001 | 51.8025 | 0.0487 | 2 | 11 | maternal behavior |
GO:0031960 | 0.0013 | 9.2404 | 0.478 | 4 | 108 | response to corticosteroid |
GO:0007625 | 0.0017 | 38.8426 | 0.062 | 2 | 14 | grooming behavior |
GO:0006590 | 0.0019 | 35.8519 | 0.0664 | 2 | 15 | thyroid hormone generation |
GO:0034694 | 0.0022 | 33.2884 | 0.0708 | 2 | 16 | response to prostaglandin |
GO:0032892 | 0.0028 | 29.1227 | 0.0797 | 2 | 18 | positive regulation of organic acid transport |
GO:0044062 | 0.0028 | 29.1227 | 0.0797 | 2 | 18 | regulation of excretion |
GO:0051412 | 0.0028 | 29.1227 | 0.0797 | 2 | 18 | response to corticosterone |
GO:0007275 | 0.0028 | 2.1973 | 16.7119 | 27 | 3776 | multicellular organismal development |
GO:0033057 | 0.0031 | 27.4074 | 0.0841 | 2 | 19 | multicellular organismal reproductive behavior |
GO:0042445 | 0.0033 | 7.1009 | 0.6152 | 4 | 139 | hormone metabolic process |
GO:0051954 | 0.0035 | 25.8827 | 0.0885 | 2 | 20 | positive regulation of amine transport |
GO:0046717 | 0.0036 | 10.5858 | 0.3098 | 3 | 70 | acid secretion |
GO:0018958 | 0.0041 | 10.1296 | 0.3231 | 3 | 73 | phenol-containing compound metabolic process |
GO:0009651 | 0.0042 | 23.2907 | 0.0974 | 2 | 22 | response to salt stress |
GO:0060450 | 0.0044 | Inf | 0.0044 | 1 | 1 | positive regulation of hindgut contraction |
GO:0030431 | 0.0046 | 22.1799 | 0.1018 | 2 | 23 | sleep |
GO:0051591 | 0.0048 | 9.579 | 0.3408 | 3 | 77 | response to cAMP |
GO:0001975 | 0.005 | 21.17 | 0.1062 | 2 | 24 | response to amphetamine |
GO:0021513 | 0.0054 | 20.248 | 0.1106 | 2 | 25 | spinal cord dorsal/ventral patterning |
GO:0031069 | 0.0054 | 20.248 | 0.1106 | 2 | 25 | hair follicle morphogenesis |
GO:0007204 | 0.0055 | 6.0951 | 0.7126 | 4 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0021510 | 0.0067 | 8.4319 | 0.385 | 3 | 87 | spinal cord development |
GO:0006820 | 0.0071 | 3.8372 | 1.7172 | 6 | 388 | anion transport |
GO:0006775 | 0.0072 | 17.2428 | 0.1283 | 2 | 29 | fat-soluble vitamin metabolic process |
GO:0045777 | 0.0072 | 17.2428 | 0.1283 | 2 | 29 | positive regulation of blood pressure |
GO:0048665 | 0.0077 | 16.6257 | 0.1328 | 2 | 30 | neuron fate specification |
GO:0055078 | 0.0082 | 16.0511 | 0.1372 | 2 | 31 | sodium ion homeostasis |
GO:0001992 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | regulation of systemic arterial blood pressure by vasopressin |
GO:0010701 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | positive regulation of norepinephrine secretion |
GO:0018879 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | biphenyl metabolic process |
GO:0018894 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | dibenzo-p-dioxin metabolic process |
GO:0033595 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | response to genistein |
GO:0042412 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | taurine biosynthetic process |
GO:0046618 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | drug export |
GO:0050756 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | fractalkine metabolic process |
GO:0060014 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | granulosa cell differentiation |
GO:0060465 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | pharynx development |
GO:0060992 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | response to fungicide |
GO:0071799 | 0.0088 | 229.0182 | 0.0089 | 1 | 2 | cellular response to prostaglandin D stimulus |
GO:0006805 | 0.0095 | 7.3709 | 0.4382 | 3 | 99 | xenobiotic metabolic process |
GO:0015718 | 0.0095 | 7.3709 | 0.4382 | 3 | 99 | monocarboxylic acid transport |
GO:0031644 | 0.0099 | 14.5428 | 0.1505 | 2 | 34 | regulation of neurological system process |
GO:0035176 | 0.0099 | 14.5428 | 0.1505 | 2 | 34 | social behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 6.5544 | 1.8244 | 10 | 398 | pattern specification process |
GO:0001502 | 1e-04 | 42.883 | 0.0871 | 3 | 19 | cartilage condensation |
GO:0021516 | 1e-04 | 36.1033 | 0.1008 | 3 | 22 | dorsal spinal cord development |
GO:0009952 | 2e-04 | 7.7828 | 0.8709 | 6 | 190 | anterior/posterior pattern specification |
GO:0055123 | 3e-04 | 9.5659 | 0.5867 | 5 | 128 | digestive system development |
GO:0009888 | 3e-04 | 3.4379 | 5.0706 | 14 | 1215 | tissue development |
GO:0001501 | 4e-04 | 5.1572 | 1.774 | 8 | 387 | skeletal system development |
GO:0031326 | 4e-04 | 2.5539 | 14.806 | 27 | 3230 | regulation of cellular biosynthetic process |
GO:0032501 | 4e-04 | 2.5072 | 22.9653 | 36 | 5010 | multicellular organismal process |
GO:0006355 | 7e-04 | 2.5165 | 12.757 | 24 | 2783 | regulation of transcription, DNA-templated |
GO:0007275 | 8e-04 | 2.6395 | 13.2308 | 24 | 3378 | multicellular organismal development |
GO:0050793 | 0.001 | 2.8093 | 6.9675 | 16 | 1520 | regulation of developmental process |
GO:0007420 | 0.001 | 3.9696 | 2.5945 | 9 | 566 | brain development |
GO:0009887 | 0.001 | 4.3974 | 2.0896 | 8 | 498 | organ morphogenesis |
GO:0048562 | 0.0012 | 5.6061 | 1.1918 | 6 | 260 | embryonic organ morphogenesis |
GO:0051252 | 0.0012 | 2.3995 | 13.2337 | 24 | 2887 | regulation of RNA metabolic process |
GO:0021537 | 0.0014 | 6.6187 | 0.8343 | 5 | 182 | telencephalon development |
GO:0043583 | 0.0015 | 6.5437 | 0.8434 | 5 | 184 | ear development |
GO:0061448 | 0.0017 | 6.4144 | 0.8606 | 5 | 191 | connective tissue development |
GO:0032774 | 0.0017 | 2.3316 | 13.5271 | 24 | 2951 | RNA biosynthetic process |
GO:0008283 | 0.0017 | 2.7258 | 6.6191 | 15 | 1444 | cell proliferation |
GO:2000310 | 0.0018 | 37.4494 | 0.0642 | 2 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0048546 | 0.0019 | 13.416 | 0.2475 | 3 | 54 | digestive tract morphogenesis |
GO:0030326 | 0.0023 | 7.9 | 0.5547 | 4 | 121 | embryonic limb morphogenesis |
GO:0051239 | 0.0024 | 2.4996 | 8.2923 | 17 | 1809 | regulation of multicellular organismal process |
GO:0051960 | 0.0024 | 3.7683 | 2.3882 | 8 | 521 | regulation of nervous system development |
GO:2000378 | 0.0027 | 29.9524 | 0.0779 | 2 | 17 | negative regulation of reactive oxygen species metabolic process |
GO:0018130 | 0.0032 | 2.1756 | 15.026 | 25 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0.0032 | 2.1756 | 15.026 | 25 | 3278 | aromatic compound biosynthetic process |
GO:0060602 | 0.0034 | 26.4244 | 0.0871 | 2 | 19 | branch elongation of an epithelium |
GO:0010556 | 0.0035 | 2.1769 | 14.2467 | 24 | 3108 | regulation of macromolecule biosynthetic process |
GO:0035107 | 0.0037 | 6.8368 | 0.6372 | 4 | 139 | appendage morphogenesis |
GO:0048869 | 0.0038 | 2.1783 | 13.4858 | 23 | 2942 | cellular developmental process |
GO:0044271 | 0.004 | 2.1338 | 15.2414 | 25 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0010823 | 0.0041 | 23.6391 | 0.0963 | 2 | 21 | negative regulation of mitochondrion organization |
GO:2001222 | 0.0045 | 22.4554 | 0.1008 | 2 | 22 | regulation of neuron migration |
GO:0048598 | 0.0045 | 5.0421 | 1.0909 | 5 | 260 | embryonic morphogenesis |
GO:0000433 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
GO:0006147 | 0.0046 | Inf | 0.0046 | 1 | 1 | guanine catabolic process |
GO:0010730 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0035523 | 0.0046 | Inf | 0.0046 | 1 | 1 | protein K29-linked deubiquitination |
GO:0035565 | 0.0046 | Inf | 0.0046 | 1 | 1 | regulation of pronephros size |
GO:0051460 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of corticotropin secretion |
GO:0061228 | 0.0046 | Inf | 0.0046 | 1 | 1 | mesonephric nephron morphogenesis |
GO:0061296 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
GO:1900011 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
GO:1902078 | 0.0046 | Inf | 0.0046 | 1 | 1 | positive regulation of lateral motor column neuron migration |
GO:1902905 | 0.0046 | Inf | 0.0046 | 1 | 1 | positive regulation of fibril organization |
GO:1990167 | 0.0046 | Inf | 0.0046 | 1 | 1 | protein K27-linked deubiquitination |
GO:1990168 | 0.0046 | Inf | 0.0046 | 1 | 1 | protein K33-linked deubiquitination |
GO:2000057 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
GO:2000570 | 0.0046 | Inf | 0.0046 | 1 | 1 | positive regulation of T-helper 2 cell activation |
GO:2000971 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of detection of glucose |
GO:2000976 | 0.0046 | Inf | 0.0046 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose |
GO:1901362 | 0.0048 | 2.0975 | 15.434 | 25 | 3367 | organic cyclic compound biosynthetic process |
GO:0045596 | 0.0049 | 3.6789 | 2.1086 | 7 | 460 | negative regulation of cell differentiation |
GO:0060173 | 0.0058 | 6.0237 | 0.7197 | 4 | 157 | limb development |
GO:0021871 | 0.0058 | 19.5217 | 0.1146 | 2 | 25 | forebrain regionalization |
GO:0051171 | 0.006 | 2.038 | 16.5754 | 26 | 3616 | regulation of nitrogen compound metabolic process |
GO:0060561 | 0.0063 | 18.7068 | 0.1192 | 2 | 26 | apoptotic process involved in morphogenesis |
GO:0021511 | 0.0067 | 17.9571 | 0.1238 | 2 | 27 | spinal cord patterning |
GO:0048589 | 0.0072 | 4.4757 | 1.2147 | 5 | 265 | developmental growth |
GO:0010470 | 0.0077 | 16.6243 | 0.1329 | 2 | 29 | regulation of gastrulation |
GO:0002009 | 0.0079 | 3.7394 | 1.7556 | 6 | 383 | morphogenesis of an epithelium |
GO:0042472 | 0.0083 | 7.7523 | 0.4171 | 3 | 91 | inner ear morphogenesis |
GO:0021772 | 0.0088 | 15.4754 | 0.1421 | 2 | 31 | olfactory bulb development |
GO:0009082 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | branched-chain amino acid biosynthetic process |
GO:0009590 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | detection of gravity |
GO:0009609 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | response to symbiotic bacterium |
GO:0038188 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | cholecystokinin signaling pathway |
GO:0039020 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | pronephric nephron tubule development |
GO:0045013 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | carbon catabolite repression of transcription |
GO:0060741 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | prostate gland stromal morphogenesis |
GO:0061017 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | hepatoblast differentiation |
GO:0071314 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | cellular response to cocaine |
GO:0072181 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | mesonephric duct formation |
GO:1900273 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | positive regulation of long-term synaptic potentiation |
GO:1903426 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | regulation of reactive oxygen species biosynthetic process |
GO:2000382 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | positive regulation of mesoderm development |
GO:2000969 | 0.0091 | 220.9474 | 0.0092 | 1 | 2 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0032502 | 0.0095 | 2.2264 | 10.6113 | 18 | 2813 | developmental process |
GO:0007399 | 0.0099 | 2.525 | 5.0486 | 11 | 1225 | nervous system development |
GO:0042743 | 0.01 | 14.4747 | 0.1513 | 2 | 33 | hydrogen peroxide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 0 | Inf | 0.0063 | 2 | 2 | oocyte construction |
GO:0007314 | 0 | Inf | 0.0063 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0 | Inf | 0.0063 | 2 | 2 | P granule organization |
GO:0007028 | 1e-04 | 165.9079 | 0.019 | 2 | 6 | cytoplasm organization |
GO:0007350 | 9e-04 | 55.2675 | 0.0443 | 2 | 14 | blastoderm segmentation |
GO:0008595 | 9e-04 | 55.2675 | 0.0443 | 2 | 14 | anterior/posterior axis specification, embryo |
GO:0043046 | 0.001 | 51.0121 | 0.0474 | 2 | 15 | DNA methylation involved in gamete generation |
GO:0042026 | 0.0016 | 38.9969 | 0.0601 | 2 | 19 | protein refolding |
GO:0007292 | 0.0018 | 13.9282 | 0.2403 | 3 | 76 | female gamete generation |
GO:0009798 | 0.0018 | 13.9282 | 0.2403 | 3 | 76 | axis specification |
GO:0009952 | 0.003 | 7.4235 | 0.6006 | 4 | 190 | anterior/posterior pattern specification |
GO:0048698 | 0.0032 | Inf | 0.0032 | 1 | 1 | negative regulation of collateral sprouting in absence of injury |
GO:0070370 | 0.0032 | Inf | 0.0032 | 1 | 1 | cellular heat acclimation |
GO:0009994 | 0.0051 | 20.6924 | 0.1075 | 2 | 34 | oocyte differentiation |
GO:0048566 | 0.0057 | 19.4721 | 0.1138 | 2 | 36 | embryonic digestive tract development |
GO:0009992 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | cellular water homeostasis |
GO:0034970 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | histone H3-R2 methylation |
GO:0060748 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | tertiary branching involved in mammary gland duct morphogenesis |
GO:0097168 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | mesenchymal stem cell proliferation |
GO:1902732 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | positive regulation of chondrocyte proliferation |
GO:0006986 | 0.0071 | 8.3015 | 0.3952 | 3 | 125 | response to unfolded protein |
GO:0030099 | 0.0084 | 5.4502 | 0.8093 | 4 | 256 | myeloid cell differentiation |
GO:0006305 | 0.0089 | 15.3856 | 0.1423 | 2 | 45 | DNA alkylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000717 | 0.0026 | Inf | 0.0026 | 1 | 1 | nucleotide-excision repair, DNA duplex unwinding |
GO:0010625 | 0.0026 | Inf | 0.0026 | 1 | 1 | positive regulation of Schwann cell proliferation |
GO:1901585 | 0.0026 | Inf | 0.0026 | 1 | 1 | regulation of acid-sensing ion channel activity |
GO:0046618 | 0.0052 | 394.3438 | 0.0052 | 1 | 2 | drug export |
GO:0014717 | 0.0078 | 197.1562 | 0.0078 | 1 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0043932 | 0.0078 | 197.1562 | 0.0078 | 1 | 3 | ossification involved in bone remodeling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045132 | 0 | 60.2775 | 0.0626 | 3 | 22 | meiotic chromosome segregation |
GO:0007135 | 1e-04 | 185.4853 | 0.0171 | 2 | 6 | meiosis II |
GO:0045880 | 0.0023 | 32.2097 | 0.0711 | 2 | 25 | positive regulation of smoothened signaling pathway |
GO:0007129 | 0.0026 | 29.6282 | 0.0768 | 2 | 27 | synapsis |
GO:0007131 | 0.0027 | 29.3473 | 0.0775 | 2 | 28 | reciprocal meiotic recombination |
GO:0032526 | 0.0028 | 11.7338 | 0.2845 | 3 | 100 | response to retinoic acid |
GO:0002879 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of acute inflammatory response to non-antigenic stimulus |
GO:0033315 | 0.0028 | Inf | 0.0028 | 1 | 1 | meiotic DNA replication checkpoint |
GO:0042843 | 0.0028 | Inf | 0.0028 | 1 | 1 | D-xylose catabolic process |
GO:0070947 | 0.0028 | Inf | 0.0028 | 1 | 1 | neutrophil mediated killing of fungus |
GO:2000266 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of blood coagulation, intrinsic pathway |
GO:0061458 | 0.0032 | 5.6364 | 1.0129 | 5 | 356 | reproductive system development |
GO:0032677 | 0.0047 | 21.7699 | 0.1024 | 2 | 36 | regulation of interleukin-8 production |
GO:0044707 | 0.0048 | 2.5225 | 13.8418 | 22 | 4865 | single-multicellular organism process |
GO:0006954 | 0.0052 | 4.9906 | 1.1381 | 5 | 400 | inflammatory response |
GO:0006968 | 0.0052 | 20.5572 | 0.1081 | 2 | 38 | cellular defense response |
GO:0002232 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | leukocyte chemotaxis involved in inflammatory response |
GO:0002752 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | cell surface pattern recognition receptor signaling pathway |
GO:0007066 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | female meiosis sister chromatid cohesion |
GO:0010845 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
GO:0018879 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | biphenyl metabolic process |
GO:0018894 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | dibenzo-p-dioxin metabolic process |
GO:0030150 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | protein import into mitochondrial matrix |
GO:0033595 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | response to genistein |
GO:0042138 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | meiotic DNA double-strand break formation |
GO:0045079 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | negative regulation of chemokine biosynthetic process |
GO:0045416 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | positive regulation of interleukin-8 biosynthetic process |
GO:0045918 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | negative regulation of cytolysis |
GO:0050756 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | fractalkine metabolic process |
GO:0060014 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | granulosa cell differentiation |
GO:0060992 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | response to fungicide |
GO:1901993 | 0.0057 | 360.4571 | 0.0057 | 1 | 2 | regulation of meiotic cell cycle phase transition |
GO:0032642 | 0.006 | 18.9713 | 0.1167 | 2 | 41 | regulation of chemokine production |
GO:0001541 | 0.0069 | 17.612 | 0.1252 | 2 | 44 | ovarian follicle development |
GO:0000280 | 0.0078 | 4.4955 | 1.2576 | 5 | 442 | nuclear division |
GO:0051321 | 0.0081 | 7.9515 | 0.415 | 3 | 150 | meiotic cell cycle |
GO:0051177 | 0.0083 | 185.5 | 0.0083 | 1 | 3 | meiotic sister chromatid cohesion |
GO:0001878 | 0.0085 | 180.2143 | 0.0085 | 1 | 3 | response to yeast |
GO:0006311 | 0.0085 | 180.2143 | 0.0085 | 1 | 3 | meiotic gene conversion |
GO:0010032 | 0.0085 | 180.2143 | 0.0085 | 1 | 3 | meiotic chromosome condensation |
GO:0018963 | 0.0085 | 180.2143 | 0.0085 | 1 | 3 | phthalate metabolic process |
GO:0033313 | 0.0085 | 180.2143 | 0.0085 | 1 | 3 | meiotic cell cycle checkpoint |
GO:0002700 | 0.0092 | 15.0876 | 0.1451 | 2 | 51 | regulation of production of molecular mediator of immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045944 | 0 | 6.6212 | 2.8528 | 14 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0044707 | 0 | 4.3339 | 18.4557 | 35 | 4865 | single-multicellular organism process |
GO:0045665 | 0 | 31.0688 | 0.1973 | 5 | 52 | negative regulation of neuron differentiation |
GO:0010628 | 0 | 5.2715 | 4.2033 | 16 | 1108 | positive regulation of gene expression |
GO:1902680 | 0 | 5.0866 | 3.9795 | 15 | 1049 | positive regulation of RNA biosynthetic process |
GO:0009891 | 0 | 4.5541 | 4.7913 | 16 | 1263 | positive regulation of biosynthetic process |
GO:0021893 | 0 | Inf | 0.0076 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0045935 | 0 | 4.3887 | 4.5447 | 15 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0045685 | 0 | 25.3737 | 0.1859 | 4 | 49 | regulation of glial cell differentiation |
GO:0023057 | 0 | 4.9253 | 3.0766 | 12 | 811 | negative regulation of signaling |
GO:0010648 | 0 | 4.9057 | 3.088 | 12 | 814 | negative regulation of cell communication |
GO:0007420 | 0 | 5.7029 | 2.1472 | 10 | 566 | brain development |
GO:0021882 | 0 | 548 | 0.0114 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021895 | 0 | 52.4542 | 0.0721 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0050789 | 1e-04 | 4.3822 | 29.5671 | 42 | 7794 | regulation of biological process |
GO:0002089 | 1e-04 | 44.1614 | 0.0835 | 3 | 22 | lens morphogenesis in camera-type eye |
GO:0021872 | 1e-04 | 20.0128 | 0.2314 | 4 | 61 | forebrain generation of neurons |
GO:0048522 | 1e-04 | 3.4954 | 8.3689 | 19 | 2583 | positive regulation of cellular process |
GO:0045595 | 2e-04 | 3.8926 | 4.2147 | 13 | 1111 | regulation of cell differentiation |
GO:0048665 | 2e-04 | 31.0568 | 0.1138 | 3 | 30 | neuron fate specification |
GO:0006355 | 2e-04 | 3.0169 | 10.5575 | 22 | 2783 | regulation of transcription, DNA-templated |
GO:0051093 | 2e-04 | 5.0677 | 2.1168 | 9 | 558 | negative regulation of developmental process |
GO:0014014 | 2e-04 | 29.9452 | 0.1176 | 3 | 31 | negative regulation of gliogenesis |
GO:0034654 | 2e-04 | 2.9452 | 12.2115 | 24 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0007423 | 2e-04 | 5.6356 | 1.6692 | 8 | 440 | sensory organ development |
GO:0071310 | 3e-04 | 3.4405 | 5.6372 | 15 | 1486 | cellular response to organic substance |
GO:2000026 | 3e-04 | 3.7319 | 4.3778 | 13 | 1154 | regulation of multicellular organismal development |
GO:0050767 | 3e-04 | 5.3285 | 1.7602 | 8 | 464 | regulation of neurogenesis |
GO:0021510 | 3e-04 | 13.7152 | 0.33 | 4 | 87 | spinal cord development |
GO:0051252 | 4e-04 | 2.8766 | 10.952 | 22 | 2887 | regulation of RNA metabolic process |
GO:0043010 | 4e-04 | 7.1771 | 0.956 | 6 | 252 | camera-type eye development |
GO:0002118 | 4e-04 | 91.2971 | 0.0303 | 2 | 8 | aggressive behavior |
GO:0008284 | 4e-04 | 4.5614 | 2.3368 | 9 | 616 | positive regulation of cell proliferation |
GO:0003002 | 5e-04 | 12.2155 | 0.3711 | 4 | 110 | regionalization |
GO:0007166 | 5e-04 | 2.9076 | 8.8656 | 19 | 2337 | cell surface receptor signaling pathway |
GO:0002087 | 6e-04 | 68.462 | 0.0379 | 2 | 10 | regulation of respiratory gaseous exchange by neurological system process |
GO:0021877 | 6e-04 | 68.462 | 0.0379 | 2 | 10 | forebrain neuron fate commitment |
GO:0031326 | 7e-04 | 2.696 | 12.2532 | 23 | 3230 | regulation of cellular biosynthetic process |
GO:0009966 | 7e-04 | 2.9269 | 7.6099 | 17 | 2006 | regulation of signal transduction |
GO:0048715 | 8e-04 | 60.8502 | 0.0417 | 2 | 11 | negative regulation of oligodendrocyte differentiation |
GO:0097154 | 8e-04 | 60.8502 | 0.0417 | 2 | 11 | GABAergic neuron differentiation |
GO:0021766 | 8e-04 | 18.2014 | 0.1859 | 3 | 49 | hippocampus development |
GO:0045165 | 8e-04 | 7.5901 | 0.7443 | 5 | 209 | cell fate commitment |
GO:0010556 | 0.001 | 2.61 | 11.7904 | 22 | 3108 | regulation of macromolecule biosynthetic process |
GO:0048368 | 0.0011 | 49.7787 | 0.0493 | 2 | 13 | lateral mesoderm development |
GO:0001764 | 0.0012 | 9.5386 | 0.4666 | 4 | 123 | neuron migration |
GO:0051716 | 0.0012 | 2.5198 | 18.1484 | 29 | 4784 | cellular response to stimulus |
GO:0044057 | 0.0014 | 5.4668 | 1.2405 | 6 | 327 | regulation of system process |
GO:0060581 | 0.0014 | 42.1137 | 0.0569 | 2 | 15 | cell fate commitment involved in pattern specification |
GO:0007399 | 0.0015 | 2.8554 | 6.6236 | 15 | 1746 | nervous system development |
GO:0001525 | 0.0015 | 5.4149 | 1.2519 | 6 | 330 | angiogenesis |
GO:0009790 | 0.0016 | 3.5149 | 3.3687 | 10 | 888 | embryo development |
GO:0070848 | 0.0016 | 4.1168 | 2.2458 | 8 | 592 | response to growth factor |
GO:0003215 | 0.0016 | 39.1025 | 0.0607 | 2 | 16 | cardiac right ventricle morphogenesis |
GO:0001568 | 0.0017 | 4.5384 | 1.7602 | 7 | 464 | blood vessel development |
GO:0021514 | 0.0018 | 36.4928 | 0.0645 | 2 | 17 | ventral spinal cord interneuron differentiation |
GO:0048585 | 0.0021 | 3.6366 | 2.9164 | 9 | 814 | negative regulation of response to stimulus |
GO:0021954 | 0.0021 | 13.0635 | 0.2542 | 3 | 67 | central nervous system neuron development |
GO:0032892 | 0.0021 | 34.2092 | 0.0683 | 2 | 18 | positive regulation of organic acid transport |
GO:0043576 | 0.0021 | 34.2092 | 0.0683 | 2 | 18 | regulation of respiratory gaseous exchange |
GO:0034110 | 0.0023 | 32.1944 | 0.0721 | 2 | 19 | regulation of homotypic cell-cell adhesion |
GO:0071346 | 0.0024 | 12.2912 | 0.2693 | 3 | 71 | cellular response to interferon-gamma |
GO:0021544 | 0.0026 | 30.4034 | 0.0759 | 2 | 20 | subpallium development |
GO:0045746 | 0.0026 | 30.4034 | 0.0759 | 2 | 20 | negative regulation of Notch signaling pathway |
GO:0048562 | 0.0029 | 5.6316 | 0.9863 | 5 | 260 | embryonic organ morphogenesis |
GO:0010594 | 0.0031 | 11.2892 | 0.2921 | 3 | 77 | regulation of endothelial cell migration |
GO:0003016 | 0.0031 | 27.3587 | 0.0835 | 2 | 22 | respiratory system process |
GO:0051171 | 0.0035 | 2.3076 | 13.7175 | 23 | 3616 | regulation of nitrogen compound metabolic process |
GO:0070661 | 0.0038 | 6.854 | 0.6411 | 4 | 169 | leukocyte proliferation |
GO:0001827 | 0.0038 | Inf | 0.0038 | 1 | 1 | inner cell mass cell fate commitment |
GO:0002646 | 0.0038 | Inf | 0.0038 | 1 | 1 | regulation of central tolerance induction |
GO:0002897 | 0.0038 | Inf | 0.0038 | 1 | 1 | positive regulation of central B cell tolerance induction |
GO:0003327 | 0.0038 | Inf | 0.0038 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0021723 | 0.0038 | Inf | 0.0038 | 1 | 1 | medullary reticular formation development |
GO:0021764 | 0.0038 | Inf | 0.0038 | 1 | 1 | amygdala development |
GO:0030322 | 0.0038 | Inf | 0.0038 | 1 | 1 | stabilization of membrane potential |
GO:0034972 | 0.0038 | Inf | 0.0038 | 1 | 1 | histone H3-R26 methylation |
GO:0035922 | 0.0038 | Inf | 0.0038 | 1 | 1 | foramen ovale closure |
GO:0036306 | 0.0038 | Inf | 0.0038 | 1 | 1 | embryonic heart tube elongation |
GO:0048894 | 0.0038 | Inf | 0.0038 | 1 | 1 | efferent axon development in a lateral line nerve |
GO:0048925 | 0.0038 | Inf | 0.0038 | 1 | 1 | lateral line system development |
GO:0051308 | 0.0038 | Inf | 0.0038 | 1 | 1 | male meiosis chromosome separation |
GO:0051466 | 0.0038 | Inf | 0.0038 | 1 | 1 | positive regulation of corticotropin-releasing hormone secretion |
GO:0060580 | 0.0038 | Inf | 0.0038 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0061452 | 0.0038 | Inf | 0.0038 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
GO:0072016 | 0.0038 | Inf | 0.0038 | 1 | 1 | glomerular parietal epithelial cell development |
GO:1901003 | 0.0038 | Inf | 0.0038 | 1 | 1 | negative regulation of fermentation |
GO:1901248 | 0.0038 | Inf | 0.0038 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
GO:1901751 | 0.0038 | Inf | 0.0038 | 1 | 1 | leukotriene A4 metabolic process |
GO:2001306 | 0.0038 | Inf | 0.0038 | 1 | 1 | lipoxin B4 biosynthetic process |
GO:0021513 | 0.004 | 23.7845 | 0.0948 | 2 | 25 | spinal cord dorsal/ventral patterning |
GO:0042129 | 0.0042 | 10.0578 | 0.3262 | 3 | 86 | regulation of T cell proliferation |
GO:0009887 | 0.0043 | 5.1913 | 1.0869 | 5 | 341 | organ morphogenesis |
GO:0050852 | 0.0046 | 9.7047 | 0.3376 | 3 | 89 | T cell receptor signaling pathway |
GO:0002042 | 0.0047 | 21.8783 | 0.1024 | 2 | 27 | cell migration involved in sprouting angiogenesis |
GO:0032729 | 0.0047 | 21.8783 | 0.1024 | 2 | 27 | positive regulation of interferon-gamma production |
GO:0090288 | 0.0052 | 9.2704 | 0.3528 | 3 | 93 | negative regulation of cellular response to growth factor stimulus |
GO:0009888 | 0.0053 | 2.6765 | 5.3413 | 12 | 1408 | tissue development |
GO:0009954 | 0.0054 | 20.2544 | 0.11 | 2 | 29 | proximal/distal pattern formation |
GO:0051094 | 0.0056 | 3.3014 | 2.7617 | 8 | 728 | positive regulation of developmental process |
GO:0009952 | 0.0057 | 6.0699 | 0.7208 | 4 | 190 | anterior/posterior pattern specification |
GO:0048705 | 0.0057 | 6.0699 | 0.7208 | 4 | 190 | skeletal system morphogenesis |
GO:0090101 | 0.0059 | 8.873 | 0.368 | 3 | 97 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0021772 | 0.0061 | 18.8546 | 0.1176 | 2 | 31 | olfactory bulb development |
GO:0060191 | 0.0064 | 8.5966 | 0.3794 | 3 | 100 | regulation of lipase activity |
GO:0050865 | 0.0066 | 4.6118 | 1.195 | 5 | 315 | regulation of cell activation |
GO:0048870 | 0.0069 | 2.9693 | 3.4825 | 9 | 918 | cell motility |
GO:0021522 | 0.0069 | 17.6353 | 0.1252 | 2 | 33 | spinal cord motor neuron differentiation |
GO:0035176 | 0.0073 | 17.0829 | 0.129 | 2 | 34 | social behavior |
GO:0080090 | 0.0074 | 2.1125 | 17.2531 | 26 | 4548 | regulation of primary metabolic process |
GO:0061061 | 0.0075 | 3.8235 | 1.745 | 6 | 460 | muscle structure development |
GO:0001992 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | regulation of systemic arterial blood pressure by vasopressin |
GO:0002635 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | negative regulation of germinal center formation |
GO:0002661 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | regulation of B cell tolerance induction |
GO:0002713 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | negative regulation of B cell mediated immunity |
GO:0002924 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0003193 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | pulmonary valve formation |
GO:0003326 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | pancreatic PP cell fate commitment |
GO:0021934 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | hindbrain tangential cell migration |
GO:0030150 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | protein import into mitochondrial matrix |
GO:0033693 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | neurofilament bundle assembly |
GO:0060577 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | pulmonary vein morphogenesis |
GO:0071812 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | positive regulation of fever generation by positive regulation of prostaglandin secretion |
GO:0071848 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling |
GO:2000824 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | negative regulation of androgen receptor activity |
GO:2001206 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | positive regulation of osteoclast development |
GO:2001303 | 0.0076 | 268.1702 | 0.0076 | 1 | 2 | lipoxin A4 biosynthetic process |
GO:0042476 | 0.0077 | 8.0135 | 0.4059 | 3 | 107 | odontogenesis |
GO:0045934 | 0.0078 | 2.9038 | 3.5546 | 9 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0032502 | 0.008 | 2.4248 | 9.8328 | 17 | 3251 | developmental process |
GO:0051047 | 0.0082 | 5.4449 | 0.8004 | 4 | 211 | positive regulation of secretion |
GO:0000187 | 0.009 | 7.5727 | 0.4287 | 3 | 113 | activation of MAPK activity |
GO:1901576 | 0.009 | 2.0672 | 17.4921 | 26 | 4611 | organic substance biosynthetic process |
GO:0046456 | 0.0091 | 15.18 | 0.1442 | 2 | 38 | icosanoid biosynthetic process |
GO:0045087 | 0.0093 | 3.2726 | 2.3975 | 7 | 632 | innate immune response |
GO:0021545 | 0.0095 | 14.7685 | 0.1479 | 2 | 39 | cranial nerve development |
GO:0032370 | 0.0095 | 14.7685 | 0.1479 | 2 | 39 | positive regulation of lipid transport |
GO:0009719 | 0.0096 | 2.662 | 4.3398 | 10 | 1144 | response to endogenous stimulus |
GO:0001667 | 0.0097 | 5.1898 | 0.8384 | 4 | 221 | ameboidal cell migration |
GO:0023052 | 0.0097 | 2.0548 | 16.6386 | 25 | 4386 | signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070328 | 1e-04 | 44.6277 | 0.083 | 3 | 21 | triglyceride homeostasis |
GO:0034384 | 3e-04 | 104.9833 | 0.0277 | 2 | 7 | high-density lipoprotein particle clearance |
GO:0033700 | 4e-04 | 87.4792 | 0.0316 | 2 | 8 | phospholipid efflux |
GO:0010804 | 5e-04 | 74.9762 | 0.0356 | 2 | 9 | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO:0055091 | 5e-04 | 74.9762 | 0.0356 | 2 | 9 | phospholipid homeostasis |
GO:0032692 | 8e-04 | 58.3056 | 0.0435 | 2 | 11 | negative regulation of interleukin-1 production |
GO:0043691 | 8e-04 | 58.3056 | 0.0435 | 2 | 11 | reverse cholesterol transport |
GO:0042632 | 0.0012 | 16.0251 | 0.2094 | 3 | 53 | cholesterol homeostasis |
GO:0034367 | 0.002 | 34.9667 | 0.0672 | 2 | 17 | macromolecular complex remodeling |
GO:0034369 | 0.002 | 34.9667 | 0.0672 | 2 | 17 | plasma lipoprotein particle remodeling |
GO:0042158 | 0.0022 | 12.7052 | 0.2608 | 3 | 66 | lipoprotein biosynthetic process |
GO:0019433 | 0.0025 | 30.848 | 0.0751 | 2 | 19 | triglyceride catabolic process |
GO:1901687 | 0.0025 | 30.848 | 0.0751 | 2 | 19 | glutathione derivative biosynthetic process |
GO:0046461 | 0.0028 | 29.1319 | 0.079 | 2 | 20 | neutral lipid catabolic process |
GO:0010902 | 0.004 | Inf | 0.004 | 1 | 1 | positive regulation of very-low-density lipoprotein particle remodeling |
GO:0010903 | 0.004 | Inf | 0.004 | 1 | 1 | negative regulation of very-low-density lipoprotein particle remodeling |
GO:0021767 | 0.004 | Inf | 0.004 | 1 | 1 | mammillary body development |
GO:0035732 | 0.004 | Inf | 0.004 | 1 | 1 | nitric oxide storage |
GO:0060354 | 0.004 | Inf | 0.004 | 1 | 1 | negative regulation of cell adhesion molecule production |
GO:0061374 | 0.004 | Inf | 0.004 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.004 | Inf | 0.004 | 1 | 1 | cell migration in diencephalon |
GO:0045834 | 0.0044 | 9.8676 | 0.3319 | 3 | 84 | positive regulation of lipid metabolic process |
GO:0001775 | 0.0045 | 3.4194 | 2.6594 | 8 | 673 | cell activation |
GO:0071825 | 0.005 | 20.9633 | 0.1067 | 2 | 27 | protein-lipid complex subunit organization |
GO:0009954 | 0.0058 | 19.4074 | 0.1146 | 2 | 29 | proximal/distal pattern formation |
GO:0032374 | 0.0062 | 18.7128 | 0.1185 | 2 | 30 | regulation of cholesterol transport |
GO:0046503 | 0.0062 | 18.7128 | 0.1185 | 2 | 30 | glycerolipid catabolic process |
GO:0032651 | 0.0066 | 18.0661 | 0.1225 | 2 | 31 | regulation of interleukin-1 beta production |
GO:0006805 | 0.007 | 8.3158 | 0.3912 | 3 | 99 | xenobiotic metabolic process |
GO:0033344 | 0.007 | 17.4625 | 0.1265 | 2 | 32 | cholesterol efflux |
GO:0060761 | 0.007 | 17.4625 | 0.1265 | 2 | 32 | negative regulation of response to cytokine stimulus |
GO:0032956 | 0.0072 | 5.6508 | 0.7706 | 4 | 195 | regulation of actin cytoskeleton organization |
GO:0050776 | 0.0077 | 3.3929 | 2.3078 | 7 | 584 | regulation of immune response |
GO:0002740 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | negative regulation of cytokine secretion involved in immune response |
GO:0018916 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | nitrobenzene metabolic process |
GO:0021893 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0034371 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | chylomicron remodeling |
GO:0035697 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | CD8-positive, alpha-beta T cell extravasation |
GO:0046618 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | drug export |
GO:0050713 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | negative regulation of interleukin-1 beta secretion |
GO:0060545 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | positive regulation of necroptotic process |
GO:0060697 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | positive regulation of phospholipid catabolic process |
GO:0061379 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | inferior colliculus development |
GO:0070458 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | cellular detoxification of nitrogen compound |
GO:2000407 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | regulation of T cell extravasation |
GO:2000452 | 0.0079 | 257.1837 | 0.0079 | 1 | 2 | regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation |
GO:2000379 | 0.0079 | 16.3685 | 0.1344 | 2 | 34 | positive regulation of reactive oxygen species metabolic process |
GO:0009410 | 0.0082 | 7.8229 | 0.4149 | 3 | 105 | response to xenobiotic stimulus |
GO:0006749 | 0.0084 | 15.8712 | 0.1383 | 2 | 35 | glutathione metabolic process |
GO:0048513 | 0.0087 | 2.2025 | 9.5076 | 17 | 2406 | organ development |
GO:0006869 | 0.0097 | 5.1819 | 0.8377 | 4 | 212 | lipid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048705 | 1e-04 | 10.388 | 0.6757 | 6 | 190 | skeletal system morphogenesis |
GO:0071223 | 1e-04 | 195.4264 | 0.0178 | 2 | 5 | cellular response to lipoteichoic acid |
GO:0048701 | 4e-04 | 23.6278 | 0.1458 | 3 | 41 | embryonic cranial skeleton morphogenesis |
GO:0007389 | 5e-04 | 5.7558 | 1.4155 | 7 | 398 | pattern specification process |
GO:0009952 | 5e-04 | 8.3939 | 0.6757 | 5 | 190 | anterior/posterior pattern specification |
GO:0040034 | 7e-04 | 65.1111 | 0.0391 | 2 | 11 | regulation of development, heterochronic |
GO:0048706 | 8e-04 | 10.6923 | 0.4197 | 4 | 118 | embryonic skeletal system development |
GO:0045165 | 0.0012 | 7.0062 | 0.8038 | 5 | 226 | cell fate commitment |
GO:0071622 | 0.0016 | 39.0481 | 0.0605 | 2 | 17 | regulation of granulocyte chemotaxis |
GO:0048568 | 0.0021 | 5.0464 | 1.3479 | 6 | 379 | embryonic organ development |
GO:0048598 | 0.0022 | 4.3431 | 1.8494 | 7 | 520 | embryonic morphogenesis |
GO:0048520 | 0.0023 | 12.6127 | 0.2632 | 3 | 74 | positive regulation of behavior |
GO:0002089 | 0.0027 | 29.2744 | 0.0782 | 2 | 22 | lens morphogenesis in camera-type eye |
GO:0030431 | 0.003 | 27.8782 | 0.0818 | 2 | 23 | sleep |
GO:0048512 | 0.0032 | 26.6089 | 0.0854 | 2 | 24 | circadian behavior |
GO:0001662 | 0.0035 | 25.4499 | 0.0889 | 2 | 25 | behavioral fear response |
GO:0008045 | 0.0035 | 25.4499 | 0.0889 | 2 | 25 | motor neuron axon guidance |
GO:0032760 | 0.0035 | 25.4499 | 0.0889 | 2 | 25 | positive regulation of tumor necrosis factor production |
GO:0007634 | 0.0036 | Inf | 0.0036 | 1 | 1 | optokinetic behavior |
GO:0010085 | 0.0036 | Inf | 0.0036 | 1 | 1 | polarity specification of proximal/distal axis |
GO:0021560 | 0.0036 | Inf | 0.0036 | 1 | 1 | abducens nerve development |
GO:0021599 | 0.0036 | Inf | 0.0036 | 1 | 1 | abducens nerve formation |
GO:0021764 | 0.0036 | Inf | 0.0036 | 1 | 1 | amygdala development |
GO:0042502 | 0.0036 | Inf | 0.0036 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
GO:0048321 | 0.0036 | Inf | 0.0036 | 1 | 1 | axial mesodermal cell differentiation |
GO:0048327 | 0.0036 | Inf | 0.0036 | 1 | 1 | axial mesodermal cell fate specification |
GO:0060802 | 0.0036 | Inf | 0.0036 | 1 | 1 | epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification |
GO:0090010 | 0.0036 | Inf | 0.0036 | 1 | 1 | transforming growth factor beta receptor signaling pathway involved in primitive streak formation |
GO:0007423 | 0.0044 | 4.3155 | 1.5648 | 6 | 440 | sensory organ development |
GO:0009953 | 0.0058 | 8.9343 | 0.3663 | 3 | 103 | dorsal/ventral pattern formation |
GO:0002690 | 0.0061 | 18.8702 | 0.1174 | 2 | 33 | positive regulation of leukocyte chemotaxis |
GO:0042471 | 0.0068 | 8.4245 | 0.3877 | 3 | 109 | ear morphogenesis |
GO:0021569 | 0.0069 | 293.1628 | 0.007 | 1 | 2 | rhombomere 3 development |
GO:0002085 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | inhibition of neuroepithelial cell differentiation |
GO:0002232 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | leukocyte chemotaxis involved in inflammatory response |
GO:0015920 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | lipopolysaccharide transport |
GO:0019483 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | beta-alanine biosynthetic process |
GO:0021568 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | rhombomere 2 development |
GO:0021658 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | rhombomere 3 morphogenesis |
GO:0046010 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0050666 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | regulation of homocysteine metabolic process |
GO:0060265 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | positive regulation of respiratory burst involved in inflammatory response |
GO:0060460 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | left lung morphogenesis |
GO:0060876 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | semicircular canal formation |
GO:0071799 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | cellular response to prostaglandin D stimulus |
GO:1900224 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:1901164 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | negative regulation of trophoblast cell migration |
GO:1901383 | 0.0071 | 286.5227 | 0.0071 | 1 | 2 | negative regulation of chorionic trophoblast cell proliferation |
GO:0030326 | 0.009 | 7.5605 | 0.4303 | 3 | 121 | embryonic limb morphogenesis |
GO:0006952 | 0.01 | 2.8013 | 3.7058 | 9 | 1042 | defense response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 0 | Inf | 0.0058 | 2 | 2 | oocyte construction |
GO:0007314 | 0 | Inf | 0.0058 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0 | Inf | 0.0058 | 2 | 2 | P granule organization |
GO:0007028 | 1e-04 | 180.1714 | 0.0175 | 2 | 6 | cytoplasm organization |
GO:0007350 | 7e-04 | 60.019 | 0.0409 | 2 | 14 | blastoderm segmentation |
GO:0008595 | 7e-04 | 60.019 | 0.0409 | 2 | 14 | anterior/posterior axis specification, embryo |
GO:0043046 | 9e-04 | 55.3978 | 0.0439 | 2 | 15 | DNA methylation involved in gamete generation |
GO:0042026 | 0.0014 | 42.3496 | 0.0556 | 2 | 19 | protein refolding |
GO:0009798 | 0.0014 | 15.1608 | 0.2222 | 3 | 76 | axis specification |
GO:0009952 | 0.0022 | 8.1004 | 0.5556 | 4 | 190 | anterior/posterior pattern specification |
GO:0048698 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of collateral sprouting in absence of injury |
GO:0070370 | 0.0029 | Inf | 0.0029 | 1 | 1 | cellular heat acclimation |
GO:0009994 | 0.0044 | 22.4714 | 0.0994 | 2 | 34 | oocyte differentiation |
GO:0048566 | 0.0049 | 21.1462 | 0.1053 | 2 | 36 | embryonic digestive tract development |
GO:0006986 | 0.0057 | 9.0362 | 0.3655 | 3 | 125 | response to unfolded protein |
GO:0009992 | 0.0058 | 350.4167 | 0.0058 | 1 | 2 | cellular water homeostasis |
GO:0034970 | 0.0058 | 350.4167 | 0.0058 | 1 | 2 | histone H3-R2 methylation |
GO:0097168 | 0.0058 | 350.4167 | 0.0058 | 1 | 2 | mesenchymal stem cell proliferation |
GO:1902732 | 0.0058 | 350.4167 | 0.0058 | 1 | 2 | positive regulation of chondrocyte proliferation |
GO:0030099 | 0.0064 | 5.9471 | 0.7486 | 4 | 256 | myeloid cell differentiation |
GO:0006305 | 0.0076 | 16.7083 | 0.1316 | 2 | 45 | DNA alkylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001501 | 1e-04 | 5.7026 | 1.8351 | 9 | 387 | skeletal system development |
GO:0001502 | 1e-04 | 41.3717 | 0.0901 | 3 | 19 | cartilage condensation |
GO:0007389 | 1e-04 | 5.5364 | 1.8873 | 9 | 398 | pattern specification process |
GO:0032502 | 1e-04 | 2.7029 | 20.5422 | 35 | 4332 | developmental process |
GO:0021516 | 1e-04 | 34.831 | 0.1043 | 3 | 22 | dorsal spinal cord development |
GO:2000026 | 2e-04 | 3.3521 | 5.4722 | 15 | 1154 | regulation of multicellular organismal development |
GO:0009952 | 3e-04 | 7.4934 | 0.901 | 6 | 190 | anterior/posterior pattern specification |
GO:0007399 | 3e-04 | 2.9157 | 8.2795 | 19 | 1746 | nervous system development |
GO:0035107 | 5e-04 | 8.4525 | 0.6591 | 5 | 139 | appendage morphogenesis |
GO:0009790 | 8e-04 | 3.3439 | 4.2109 | 12 | 888 | embryo development |
GO:0031326 | 8e-04 | 2.3986 | 15.3165 | 27 | 3230 | regulation of cellular biosynthetic process |
GO:0060173 | 9e-04 | 7.4408 | 0.7445 | 5 | 157 | limb development |
GO:0006355 | 0.0012 | 2.3762 | 13.1969 | 24 | 2783 | regulation of transcription, DNA-templated |
GO:0009888 | 0.0013 | 4.2449 | 2.1777 | 8 | 523 | tissue development |
GO:0048562 | 0.0014 | 5.3976 | 1.2329 | 6 | 260 | embryonic organ morphogenesis |
GO:2000310 | 0.0019 | 36.1523 | 0.0664 | 2 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0051252 | 0.0021 | 2.2657 | 13.69 | 24 | 2887 | regulation of RNA metabolic process |
GO:0048546 | 0.0021 | 12.9432 | 0.2561 | 3 | 54 | digestive tract morphogenesis |
GO:0044707 | 0.0023 | 2.3067 | 18.5897 | 29 | 4467 | single-multicellular organism process |
GO:0030326 | 0.0026 | 7.6166 | 0.5738 | 4 | 121 | embryonic limb morphogenesis |
GO:0060429 | 0.0027 | 3.0101 | 4.1966 | 11 | 885 | epithelium development |
GO:0030154 | 0.0028 | 2.2291 | 13.1305 | 23 | 2769 | cell differentiation |
GO:0032774 | 0.0029 | 2.2016 | 13.9935 | 24 | 2951 | RNA biosynthetic process |
GO:2000378 | 0.0029 | 28.9149 | 0.0806 | 2 | 17 | negative regulation of reactive oxygen species metabolic process |
GO:0044271 | 0.0031 | 2.1543 | 15.767 | 26 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0048565 | 0.0031 | 11.1828 | 0.2941 | 3 | 65 | digestive tract development |
GO:0060602 | 0.0036 | 25.5091 | 0.0901 | 2 | 19 | branch elongation of an epithelium |
GO:0010823 | 0.0044 | 22.8203 | 0.0996 | 2 | 21 | negative regulation of mitochondrion organization |
GO:0006147 | 0.0047 | Inf | 0.0047 | 1 | 1 | guanine catabolic process |
GO:0010730 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0035523 | 0.0047 | Inf | 0.0047 | 1 | 1 | protein K29-linked deubiquitination |
GO:0035565 | 0.0047 | Inf | 0.0047 | 1 | 1 | regulation of pronephros size |
GO:0048789 | 0.0047 | Inf | 0.0047 | 1 | 1 | cytoskeletal matrix organization at active zone |
GO:0051460 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of corticotropin secretion |
GO:0061228 | 0.0047 | Inf | 0.0047 | 1 | 1 | mesonephric nephron morphogenesis |
GO:0061296 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis |
GO:0097115 | 0.0047 | Inf | 0.0047 | 1 | 1 | neurexin clustering |
GO:1900011 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
GO:1902905 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of fibril organization |
GO:1990167 | 0.0047 | Inf | 0.0047 | 1 | 1 | protein K27-linked deubiquitination |
GO:1990168 | 0.0047 | Inf | 0.0047 | 1 | 1 | protein K33-linked deubiquitination |
GO:2000057 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
GO:2000119 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of sodium-dependent phosphate transport |
GO:2000302 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of synaptic vesicle exocytosis |
GO:2000570 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of T-helper 2 cell activation |
GO:0007420 | 0.005 | 3.3182 | 2.6839 | 8 | 566 | brain development |
GO:0042127 | 0.0051 | 2.6277 | 5.2446 | 12 | 1106 | regulation of cell proliferation |
GO:0018130 | 0.0055 | 2.0509 | 15.5441 | 25 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0.0055 | 2.0509 | 15.5441 | 25 | 3278 | aromatic compound biosynthetic process |
GO:0009887 | 0.0056 | 3.5939 | 2.1699 | 7 | 498 | organ morphogenesis |
GO:0010556 | 0.0058 | 2.0556 | 14.738 | 24 | 3108 | regulation of macromolecule biosynthetic process |
GO:0021871 | 0.0062 | 18.8456 | 0.1185 | 2 | 25 | forebrain regionalization |
GO:0060561 | 0.0067 | 18.0589 | 0.1233 | 2 | 26 | apoptotic process involved in morphogenesis |
GO:0044706 | 0.0071 | 5.6579 | 0.7635 | 4 | 161 | multi-multicellular organism process |
GO:0048732 | 0.0073 | 3.8083 | 1.7213 | 6 | 363 | gland development |
GO:1901362 | 0.008 | 1.9772 | 15.9662 | 25 | 3367 | organic cyclic compound biosynthetic process |
GO:0048589 | 0.0083 | 4.3122 | 1.2566 | 5 | 265 | developmental growth |
GO:0007566 | 0.0088 | 15.4741 | 0.1423 | 2 | 30 | embryo implantation |
GO:0042472 | 0.0092 | 7.4791 | 0.4315 | 3 | 91 | inner ear morphogenesis |
GO:0021772 | 0.0094 | 14.9394 | 0.147 | 2 | 31 | olfactory bulb development |
GO:0009082 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | branched-chain amino acid biosynthetic process |
GO:0009590 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | detection of gravity |
GO:0009609 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | response to symbiotic bacterium |
GO:0034441 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | plasma lipoprotein particle oxidation |
GO:0038188 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | cholecystokinin signaling pathway |
GO:0039020 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | pronephric nephron tubule development |
GO:0060741 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | prostate gland stromal morphogenesis |
GO:0061017 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | hepatoblast differentiation |
GO:0071314 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | cellular response to cocaine |
GO:0072181 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | mesonephric duct formation |
GO:1900244 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | positive regulation of synaptic vesicle endocytosis |
GO:1902174 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | positive regulation of keratinocyte apoptotic process |
GO:1903426 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | regulation of reactive oxygen species biosynthetic process |
GO:2000382 | 0.0095 | 213.4237 | 0.0095 | 1 | 2 | positive regulation of mesoderm development |
GO:0007166 | 0.0096 | 2.0542 | 11.082 | 19 | 2337 | cell surface receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017127 | 6e-04 | 73.2381 | 0.0364 | 2 | 9 | cholesterol transporter activity |
GO:0005319 | 0.0026 | 12.0255 | 0.2751 | 3 | 68 | lipid transporter activity |
GO:0008028 | 0.0032 | 26.9561 | 0.0849 | 2 | 21 | monocarboxylic acid transmembrane transporter activity |
GO:0008508 | 0.004 | Inf | 0.004 | 1 | 1 | bile acid:sodium symporter activity |
GO:0031771 | 0.004 | Inf | 0.004 | 1 | 1 | type 1 hypocretin receptor binding |
GO:0031772 | 0.004 | Inf | 0.004 | 1 | 1 | type 2 hypocretin receptor binding |
GO:0032038 | 0.004 | Inf | 0.004 | 1 | 1 | myosin II heavy chain binding |
GO:0042931 | 0.004 | Inf | 0.004 | 1 | 1 | enterobactin transporter activity |
GO:0070653 | 0.004 | Inf | 0.004 | 1 | 1 | high-density lipoprotein particle receptor binding |
GO:0005215 | 0.005 | 2.9361 | 3.9479 | 10 | 976 | transporter activity |
GO:0005102 | 0.0059 | 2.8683 | 4.0328 | 10 | 997 | receptor binding |
GO:0015081 | 0.0068 | 8.3857 | 0.3883 | 3 | 96 | sodium ion transmembrane transporter activity |
GO:0015293 | 0.0079 | 7.9546 | 0.4085 | 3 | 101 | symporter activity |
GO:0008281 | 0.0081 | 251.2245 | 0.0081 | 1 | 2 | sulfonylurea receptor activity |
GO:0016492 | 0.0081 | 251.2245 | 0.0081 | 1 | 2 | G-protein coupled neurotensin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019807 | 0.0021 | Inf | 0.0021 | 1 | 1 | aspartoacylase activity |
GO:0008138 | 0.003 | 27.6982 | 0.082 | 2 | 39 | protein tyrosine/serine/threonine phosphatase activity |
GO:0016314 | 0.0042 | 493.36 | 0.0042 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity |
GO:0030109 | 0.0042 | 493.36 | 0.0042 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0004814 | 0.0063 | 246.66 | 0.0063 | 1 | 3 | arginine-tRNA ligase activity |
GO:0031849 | 0.0063 | 246.66 | 0.0063 | 1 | 3 | olfactory receptor binding |
GO:0033743 | 0.0063 | 246.66 | 0.0063 | 1 | 3 | peptide-methionine (R)-S-oxide reductase activity |
GO:0004197 | 0.0072 | 17.339 | 0.1283 | 2 | 61 | cysteine-type endopeptidase activity |
GO:0016874 | 0.0075 | 5.8309 | 0.793 | 4 | 377 | ligase activity |
GO:0004872 | 0.0077 | 4.0382 | 1.8068 | 6 | 859 | receptor activity |
GO:0034618 | 0.0084 | 164.4267 | 0.0084 | 1 | 4 | arginine binding |
GO:0047760 | 0.0084 | 164.4267 | 0.0084 | 1 | 4 | butyrate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004982 | 0 | Inf | 0.0061 | 2 | 2 | N-formyl peptide receptor activity |
GO:0001653 | 0.0026 | 12.0552 | 0.2767 | 3 | 90 | peptide receptor activity |
GO:0035757 | 0.0031 | Inf | 0.0031 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0031 | Inf | 0.0031 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0031 | Inf | 0.0031 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0031 | Inf | 0.0031 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0060230 | 0.0031 | Inf | 0.0031 | 1 | 1 | lipoprotein lipase activator activity |
GO:0005109 | 0.0043 | 22.7648 | 0.0984 | 2 | 32 | frizzled binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003840 | 1e-04 | 182.3852 | 0.019 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0004506 | 0.0038 | Inf | 0.0038 | 1 | 1 | squalene monooxygenase activity |
GO:0008761 | 0.0038 | Inf | 0.0038 | 1 | 1 | UDP-N-acetylglucosamine 2-epimerase activity |
GO:0009384 | 0.0038 | Inf | 0.0038 | 1 | 1 | N-acylmannosamine kinase activity |
GO:0018455 | 0.0038 | Inf | 0.0038 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0001785 | 0.0076 | 267.6739 | 0.0076 | 1 | 2 | prostaglandin J receptor activity |
GO:0004956 | 0.0076 | 267.6739 | 0.0076 | 1 | 2 | prostaglandin D receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004096 | 0.0035 | Inf | 0.0035 | 1 | 1 | catalase activity |
GO:0035755 | 0.0035 | Inf | 0.0035 | 1 | 1 | cardiolipin hydrolase activity |
GO:0047894 | 0.0035 | Inf | 0.0035 | 1 | 1 | flavonol 3-sulfotransferase activity |
GO:0070611 | 0.0035 | Inf | 0.0035 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0035 | Inf | 0.0035 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GO:0022839 | 0.0052 | 20.6712 | 0.1078 | 2 | 31 | ion gated channel activity |
GO:0003854 | 0.0069 | 293.2619 | 0.007 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0004062 | 0.0069 | 293.2619 | 0.007 | 1 | 2 | aryl sulfotransferase activity |
GO:0004609 | 0.0069 | 293.2619 | 0.007 | 1 | 2 | phosphatidylserine decarboxylase activity |
GO:0005153 | 0.0069 | 293.2619 | 0.007 | 1 | 2 | interleukin-8 receptor binding |
GO:0050294 | 0.0069 | 293.2619 | 0.007 | 1 | 2 | steroid sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 136.7556 | 0.0463 | 4 | 13 | olfactory receptor activity |
GO:0038023 | 6e-04 | 4.3801 | 2.4632 | 9 | 692 | signaling receptor activity |
GO:0004930 | 7e-04 | 6.3646 | 1.0855 | 6 | 312 | G-protein coupled receptor activity |
GO:0004522 | 0.0036 | Inf | 0.0036 | 1 | 1 | pancreatic ribonuclease activity |
GO:0004631 | 0.0036 | Inf | 0.0036 | 1 | 1 | phosphomevalonate kinase activity |
GO:0017064 | 0.0036 | Inf | 0.0036 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0031721 | 0.0036 | Inf | 0.0036 | 1 | 1 | hemoglobin alpha binding |
GO:0033798 | 0.0036 | Inf | 0.0036 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0060089 | 0.0058 | 3.0803 | 3.4101 | 9 | 958 | molecular transducer activity |
GO:0004800 | 0.0071 | 286.4186 | 0.0071 | 1 | 2 | thyroxine 5'-deiodinase activity |
GO:0005171 | 0.0071 | 286.4186 | 0.0071 | 1 | 2 | hepatocyte growth factor receptor binding |
GO:0008502 | 0.0071 | 286.4186 | 0.0071 | 1 | 2 | melatonin receptor activity |
GO:0034485 | 0.0071 | 286.4186 | 0.0071 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0.001 | 4.0485 | 2.6134 | 9 | 673 | sequence-specific DNA binding |
GO:0005506 | 0.0013 | 9.2371 | 0.4815 | 4 | 124 | iron ion binding |
GO:0004031 | 0.0039 | Inf | 0.0039 | 1 | 1 | aldehyde oxidase activity |
GO:0005324 | 0.0039 | Inf | 0.0039 | 1 | 1 | long-chain fatty acid transporter activity |
GO:0008386 | 0.0039 | Inf | 0.0039 | 1 | 1 | cholesterol monooxygenase (side-chain-cleaving) activity |
GO:0017172 | 0.0039 | Inf | 0.0039 | 1 | 1 | cysteine dioxygenase activity |
GO:0031855 | 0.0039 | Inf | 0.0039 | 1 | 1 | oxytocin receptor binding |
GO:0035594 | 0.0039 | Inf | 0.0039 | 1 | 1 | ganglioside binding |
GO:2001069 | 0.0039 | Inf | 0.0039 | 1 | 1 | glycogen binding |
GO:0017046 | 0.0042 | 23.2325 | 0.0971 | 2 | 25 | peptide hormone binding |
GO:0001785 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | prostaglandin J receptor activity |
GO:0004854 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | xanthine dehydrogenase activity |
GO:0004956 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | prostaglandin D receptor activity |
GO:0005185 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | neurohypophyseal hormone activity |
GO:0005275 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | amine transmembrane transporter activity |
GO:0015111 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | iodide transmembrane transporter activity |
GO:0031894 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | V1A vasopressin receptor binding |
GO:0070538 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | oleic acid binding |
GO:0008289 | 0.0088 | 3.6894 | 1.8057 | 6 | 465 | lipid binding |
GO:0033293 | 0.01 | 14.4254 | 0.1514 | 2 | 39 | monocarboxylic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 2e-04 | 112.0727 | 0.0231 | 2 | 13 | olfactory receptor activity |
GO:0004963 | 0.0018 | Inf | 0.0018 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0019807 | 0.0018 | Inf | 0.0018 | 1 | 1 | aspartoacylase activity |
GO:0004930 | 0.0021 | 8.6229 | 0.5589 | 4 | 314 | G-protein coupled receptor activity |
GO:0004872 | 0.0031 | 5.0495 | 1.5288 | 6 | 859 | receptor activity |
GO:0004167 | 0.0036 | 587.5238 | 0.0036 | 1 | 2 | dopachrome isomerase activity |
GO:0004998 | 0.0036 | 587.5238 | 0.0036 | 1 | 2 | transferrin receptor activity |
GO:0038191 | 0.0036 | 587.5238 | 0.0036 | 1 | 2 | neuropilin binding |
GO:0070009 | 0.0036 | 587.5238 | 0.0036 | 1 | 2 | serine-type aminopeptidase activity |
GO:0019166 | 0.0053 | 293.7381 | 0.0053 | 1 | 3 | trans-2-enoyl-CoA reductase (NADPH) activity |
GO:0004366 | 0.0071 | 195.8095 | 0.0071 | 1 | 4 | glycerol-3-phosphate O-acyltransferase activity |
GO:0004046 | 0.0089 | 146.8452 | 0.0089 | 1 | 5 | aminoacylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004531 | 0.0032 | Inf | 0.0032 | 1 | 1 | deoxyribonuclease II activity |
GO:0035755 | 0.0032 | Inf | 0.0032 | 1 | 1 | cardiolipin hydrolase activity |
GO:0070611 | 0.0032 | Inf | 0.0032 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0032 | Inf | 0.0032 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GO:0005153 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | interleukin-8 receptor binding |
GO:0019834 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | phospholipase A2 inhibitor activity |
GO:0035241 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | protein-arginine omega-N monomethyltransferase activity |
GO:0070915 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | lysophosphatidic acid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 4e-04 | 86.1678 | 0.0294 | 2 | 13 | olfactory receptor activity |
GO:0038023 | 7e-04 | 5.6681 | 1.5675 | 7 | 692 | signaling receptor activity |
GO:0004522 | 0.0023 | Inf | 0.0023 | 1 | 1 | pancreatic ribonuclease activity |
GO:0019807 | 0.0023 | Inf | 0.0023 | 1 | 1 | aspartoacylase activity |
GO:0035755 | 0.0023 | Inf | 0.0023 | 1 | 1 | cardiolipin hydrolase activity |
GO:0005171 | 0.0045 | 456.7407 | 0.0045 | 1 | 2 | hepatocyte growth factor receptor binding |
GO:0016314 | 0.0045 | 456.7407 | 0.0045 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity |
GO:0030109 | 0.0045 | 456.7407 | 0.0045 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0060089 | 0.0046 | 3.9895 | 2.1701 | 7 | 958 | molecular transducer activity |
GO:0003823 | 0.0048 | 21.4843 | 0.1042 | 2 | 46 | antigen binding |
GO:0004930 | 0.0052 | 6.464 | 0.7113 | 4 | 314 | G-protein coupled receptor activity |
GO:0005134 | 0.0068 | 228.3519 | 0.0068 | 1 | 3 | interleukin-2 receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004031 | 0.0023 | Inf | 0.0023 | 1 | 1 | aldehyde oxidase activity |
GO:0019958 | 0.0023 | Inf | 0.0023 | 1 | 1 | C-X-C chemokine binding |
GO:0001632 | 0.0045 | 456.7407 | 0.0045 | 1 | 2 | leukotriene B4 receptor activity |
GO:0004854 | 0.0045 | 456.7407 | 0.0045 | 1 | 2 | xanthine dehydrogenase activity |
GO:0004459 | 0.0068 | 228.3519 | 0.0068 | 1 | 3 | L-lactate dehydrogenase activity |
GO:0032564 | 0.0068 | 228.3519 | 0.0068 | 1 | 3 | dATP binding |
GO:0016494 | 0.009 | 152.2222 | 0.0091 | 1 | 4 | C-X-C chemokine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004888 | 0.0025 | 3.7889 | 2.4221 | 8 | 611 | transmembrane signaling receptor activity |
GO:0004411 | 0.004 | Inf | 0.004 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0008613 | 0.004 | Inf | 0.004 | 1 | 1 | diuretic hormone activity |
GO:0008892 | 0.004 | Inf | 0.004 | 1 | 1 | guanine deaminase activity |
GO:0017064 | 0.004 | Inf | 0.004 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0017174 | 0.004 | Inf | 0.004 | 1 | 1 | glycine N-methyltransferase activity |
GO:0031721 | 0.004 | Inf | 0.004 | 1 | 1 | hemoglobin alpha binding |
GO:0070524 | 0.004 | Inf | 0.004 | 1 | 1 | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO:0003845 | 0.0079 | 256.4792 | 0.0079 | 1 | 2 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity |
GO:0008502 | 0.0079 | 256.4792 | 0.0079 | 1 | 2 | melatonin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005179 | 5e-04 | 21.9107 | 0.158 | 3 | 63 | hormone activity |
GO:0017046 | 0.0018 | 36.9025 | 0.0627 | 2 | 25 | peptide hormone binding |
GO:0004871 | 0.002 | 4.1666 | 2.4026 | 8 | 958 | signal transducer activity |
GO:0001616 | 0.0025 | Inf | 0.0025 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0004930 | 0.0064 | 6.0437 | 0.7526 | 4 | 310 | G-protein coupled receptor activity |
GO:0008426 | 0.0075 | 205.4667 | 0.0075 | 1 | 3 | protein kinase C inhibitor activity |
GO:0019834 | 0.0075 | 205.4667 | 0.0075 | 1 | 3 | phospholipase A2 inhibitor activity |
GO:0051431 | 0.0075 | 205.4667 | 0.0075 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0070699 | 0.0075 | 205.4667 | 0.0075 | 1 | 3 | type II activin receptor binding |
GO:0016520 | 0.01 | 136.9667 | 0.01 | 1 | 4 | growth hormone-releasing hormone receptor activity |
GO:0030280 | 0.01 | 136.9667 | 0.01 | 1 | 4 | structural constituent of epidermis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008201 | 0.0022 | 12.9376 | 0.2621 | 3 | 108 | heparin binding |
GO:0008386 | 0.0024 | Inf | 0.0024 | 1 | 1 | cholesterol monooxygenase (side-chain-cleaving) activity |
GO:0010844 | 0.0024 | Inf | 0.0024 | 1 | 1 | recombination hotspot binding |
GO:0047837 | 0.0024 | Inf | 0.0024 | 1 | 1 | D-xylose 1-dehydrogenase (NADP+) activity |
GO:0001632 | 0.0048 | 425.1724 | 0.0049 | 1 | 2 | leukotriene B4 receptor activity |
GO:0008746 | 0.0048 | 425.1724 | 0.0049 | 1 | 2 | NAD(P)+ transhydrogenase activity |
GO:0047006 | 0.0048 | 425.1724 | 0.0049 | 1 | 2 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
GO:0048248 | 0.0048 | 425.1724 | 0.0049 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0008017 | 0.0053 | 9.4035 | 0.3568 | 3 | 147 | microtubule binding |
GO:0004867 | 0.0065 | 18.2783 | 0.1213 | 2 | 50 | serine-type endopeptidase inhibitor activity |
GO:0032795 | 0.0073 | 212.569 | 0.0073 | 1 | 3 | heterotrimeric G-protein binding |
GO:0047035 | 0.0097 | 141.7011 | 0.0097 | 1 | 4 | testosterone dehydrogenase (NAD+) activity |
GO:0047115 | 0.0097 | 141.7011 | 0.0097 | 1 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0055102 | 8e-04 | 59.4396 | 0.0427 | 2 | 11 | lipase inhibitor activity |
GO:0004364 | 0.0011 | 48.6245 | 0.0505 | 2 | 13 | glutathione transferase activity |
GO:0005319 | 0.0023 | 12.5621 | 0.2641 | 3 | 68 | lipid transporter activity |
GO:0005324 | 0.0039 | Inf | 0.0039 | 1 | 1 | long-chain fatty acid transporter activity |
GO:0035730 | 0.0039 | Inf | 0.0039 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0039 | Inf | 0.0039 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0060230 | 0.0039 | Inf | 0.0039 | 1 | 1 | lipoprotein lipase activator activity |
GO:0070026 | 0.0039 | Inf | 0.0039 | 1 | 1 | nitric oxide binding |
GO:0070653 | 0.0039 | Inf | 0.0039 | 1 | 1 | high-density lipoprotein particle receptor binding |
GO:0043565 | 0.004 | 3.5032 | 2.6134 | 8 | 673 | sequence-specific DNA binding |
GO:0001632 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | leukotriene B4 receptor activity |
GO:0001730 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | 2'-5'-oligoadenylate synthetase activity |
GO:0005275 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | amine transmembrane transporter activity |
GO:0034987 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | immunoglobulin receptor binding |
GO:0050062 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | long-chain-fatty-acyl-CoA reductase activity |
GO:0070538 | 0.0078 | 261.9574 | 0.0078 | 1 | 2 | oleic acid binding |
GO:0008289 | 0.0088 | 3.6894 | 1.8057 | 6 | 465 | lipid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004531 | 0.0031 | Inf | 0.0031 | 1 | 1 | deoxyribonuclease II activity |
GO:0035755 | 0.0031 | Inf | 0.0031 | 1 | 1 | cardiolipin hydrolase activity |
GO:0070611 | 0.0031 | Inf | 0.0031 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0031 | Inf | 0.0031 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GO:0005153 | 0.0061 | 333.027 | 0.0061 | 1 | 2 | interleukin-8 receptor binding |
GO:0016934 | 0.0061 | 333.027 | 0.0061 | 1 | 2 | extracellular-glycine-gated chloride channel activity |
GO:0019834 | 0.0092 | 166.5 | 0.0092 | 1 | 3 | phospholipase A2 inhibitor activity |
GO:0022824 | 0.0092 | 166.5 | 0.0092 | 1 | 3 | transmitter-gated ion channel activity |
GO:0035241 | 0.0092 | 166.5 | 0.0092 | 1 | 3 | protein-arginine omega-N monomethyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 2e-04 | 4.2992 | 3.0489 | 11 | 673 | sequence-specific DNA binding |
GO:0042277 | 4e-04 | 9.1817 | 0.6116 | 5 | 135 | peptide binding |
GO:0003700 | 0.0025 | 3.0537 | 4.1815 | 11 | 923 | sequence-specific DNA binding transcription factor activity |
GO:0042813 | 0.0029 | 28.4468 | 0.0815 | 2 | 18 | Wnt-activated receptor activity |
GO:0005104 | 0.0033 | 26.7712 | 0.0861 | 2 | 19 | fibroblast growth factor receptor binding |
GO:0008508 | 0.0045 | Inf | 0.0045 | 1 | 1 | bile acid:sodium symporter activity |
GO:0008609 | 0.0045 | Inf | 0.0045 | 1 | 1 | alkylglycerone-phosphate synthase activity |
GO:0008892 | 0.0045 | Inf | 0.0045 | 1 | 1 | guanine deaminase activity |
GO:0015054 | 0.0045 | Inf | 0.0045 | 1 | 1 | gastrin receptor activity |
GO:0031741 | 0.0045 | Inf | 0.0045 | 1 | 1 | type B gastrin/cholecystokinin receptor binding |
GO:0017147 | 0.0061 | 18.9522 | 0.1178 | 2 | 26 | Wnt-protein binding |
GO:0030165 | 0.0071 | 8.2352 | 0.3941 | 3 | 87 | PDZ domain binding |
GO:0004951 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | cholecystokinin receptor activity |
GO:0008502 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | melatonin receptor activity |
GO:0047066 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | phospholipid-hydroperoxide glutathione peroxidase activity |
GO:0051424 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | corticotropin-releasing hormone binding |
GO:0052654 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | L-leucine transaminase activity |
GO:0052655 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | L-valine transaminase activity |
GO:0052656 | 0.009 | 223.7091 | 0.0091 | 1 | 2 | L-isoleucine transaminase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0090038 | 0.002 | Inf | 0.002 | 1 | 1 | negative regulation of protein kinase C signaling |
GO:0097254 | 0.002 | Inf | 0.002 | 1 | 1 | renal tubular secretion |
GO:2000312 | 0.002 | Inf | 0.002 | 1 | 1 | regulation of kainate selective glutamate receptor activity |
GO:0006122 | 0.0039 | 533.6842 | 0.0039 | 1 | 2 | mitochondrial electron transport, ubiquinol to cytochrome c |
GO:0015742 | 0.0039 | 533.6842 | 0.0039 | 1 | 2 | alpha-ketoglutarate transport |
GO:0031427 | 0.0059 | 266.8158 | 0.0059 | 1 | 3 | response to methotrexate |
GO:0034115 | 0.0059 | 266.8158 | 0.0059 | 1 | 3 | negative regulation of heterotypic cell-cell adhesion |
GO:1902600 | 0.0065 | 18.6685 | 0.122 | 2 | 62 | hydrogen ion transmembrane transport |
GO:0019731 | 0.0079 | 177.8596 | 0.0079 | 1 | 4 | antibacterial humoral response |
GO:0043252 | 0.0079 | 177.8596 | 0.0079 | 1 | 4 | sodium-independent organic anion transport |
GO:0050861 | 0.0079 | 177.8596 | 0.0079 | 1 | 4 | positive regulation of B cell receptor signaling pathway |
GO:0070586 | 0.0079 | 177.8596 | 0.0079 | 1 | 4 | cell-cell adhesion involved in gastrulation |
GO:0030041 | 0.0094 | 15.3242 | 0.1476 | 2 | 75 | actin filament polymerization |
GO:0002227 | 0.0098 | 133.3816 | 0.0098 | 1 | 5 | innate immune response in mucosa |
GO:0030091 | 0.0098 | 133.3816 | 0.0098 | 1 | 5 | protein repair |
GO:0050718 | 0.0098 | 133.3816 | 0.0098 | 1 | 5 | positive regulation of interleukin-1 beta secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 1e-04 | 19.3722 | 0.2446 | 4 | 71 | embryonic skeletal system morphogenesis |
GO:1900274 | 7e-04 | 19.6836 | 0.1757 | 3 | 51 | regulation of phospholipase C activity |
GO:0010518 | 0.001 | 17.4861 | 0.1963 | 3 | 57 | positive regulation of phospholipase activity |
GO:0042060 | 0.0025 | 4.9917 | 1.4088 | 6 | 409 | wound healing |
GO:0045773 | 0.0025 | 30.6242 | 0.0758 | 2 | 22 | positive regulation of axon extension |
GO:0060191 | 0.0027 | 12.0769 | 0.279 | 3 | 81 | regulation of lipase activity |
GO:0010848 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of chromatin disassembly |
GO:0015728 | 0.0034 | Inf | 0.0034 | 1 | 1 | mevalonate transport |
GO:0018101 | 0.0034 | Inf | 0.0034 | 1 | 1 | protein citrullination |
GO:0035879 | 0.0034 | Inf | 0.0034 | 1 | 1 | plasma membrane lactate transport |
GO:0036413 | 0.0034 | Inf | 0.0034 | 1 | 1 | histone H3-R26 citrullination |
GO:0051388 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of neurotrophin TRK receptor signaling pathway |
GO:0051780 | 0.0034 | Inf | 0.0034 | 1 | 1 | behavioral response to nutrient |
GO:0060262 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of N-terminal protein palmitoylation |
GO:1901624 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of lymphocyte chemotaxis |
GO:1903059 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of protein lipidation |
GO:0006833 | 0.0041 | 23.5431 | 0.0964 | 2 | 28 | water transport |
GO:0030239 | 0.0041 | 23.5431 | 0.0964 | 2 | 28 | myofibril assembly |
GO:0001501 | 0.0044 | 5.2252 | 1.0954 | 5 | 318 | skeletal system development |
GO:0038179 | 0.0057 | 6.183 | 0.7268 | 4 | 211 | neurotrophin signaling pathway |
GO:0015727 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | lactate transport |
GO:0015840 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | urea transport |
GO:0021570 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | rhombomere 4 development |
GO:0035790 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | platelet-derived growth factor receptor-alpha signaling pathway |
GO:0038091 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0072275 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | metanephric glomerulus morphogenesis |
GO:0072277 | 0.0069 | 297.7941 | 0.0069 | 1 | 2 | metanephric glomerular capillary formation |
GO:0007202 | 0.0095 | 14.9076 | 0.1481 | 2 | 43 | activation of phospholipase C activity |
GO:0061387 | 0.0095 | 14.9076 | 0.1481 | 2 | 43 | regulation of extent of cell growth |
GO:0048857 | 0.01 | 14.5512 | 0.1516 | 2 | 44 | neural nucleus development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043903 | 0.0011 | 9.9291 | 0.456 | 4 | 113 | regulation of symbiosis, encompassing mutualism through parasitism |
GO:0001878 | 0.004 | Inf | 0.004 | 1 | 1 | response to yeast |
GO:0032023 | 0.004 | Inf | 0.004 | 1 | 1 | trypsinogen activation |
GO:0034120 | 0.004 | Inf | 0.004 | 1 | 1 | positive regulation of erythrocyte aggregation |
GO:0042697 | 0.004 | Inf | 0.004 | 1 | 1 | menopause |
GO:0070947 | 0.004 | Inf | 0.004 | 1 | 1 | neutrophil mediated killing of fungus |
GO:2000287 | 0.004 | Inf | 0.004 | 1 | 1 | positive regulation of myotome development |
GO:0009411 | 0.0056 | 9.1044 | 0.3632 | 3 | 90 | response to UV |
GO:0043123 | 0.0062 | 8.7982 | 0.3753 | 3 | 93 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0045069 | 0.0073 | 17.2479 | 0.1291 | 2 | 32 | regulation of viral genome replication |
GO:0006284 | 0.0077 | 16.6898 | 0.1332 | 2 | 33 | base-excision repair |
GO:0002317 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | plasma cell differentiation |
GO:0034970 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | histone H3-R2 methylation |
GO:0045079 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | negative regulation of chemokine biosynthetic process |
GO:0045416 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | positive regulation of interleukin-8 biosynthetic process |
GO:0098609 | 0.0086 | 7.7539 | 0.4237 | 3 | 105 | cell-cell adhesion |
GO:0006986 | 0.0098 | 7.3879 | 0.4439 | 3 | 110 | response to unfolded protein |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 3e-04 | 93.7407 | 0.0285 | 2 | 10 | keratinization |
GO:0032940 | 5e-04 | 5.9907 | 1.4784 | 7 | 518 | secretion by cell |
GO:0010712 | 0.0013 | 44.0741 | 0.0542 | 2 | 19 | regulation of collagen metabolic process |
GO:0009913 | 0.002 | 13.4785 | 0.254 | 3 | 89 | epidermal cell differentiation |
GO:0043588 | 0.0027 | 7.7867 | 0.5936 | 4 | 208 | skin development |
GO:0009593 | 0.0028 | 28.792 | 0.0799 | 2 | 28 | detection of chemical stimulus |
GO:0001300 | 0.0029 | Inf | 0.0029 | 1 | 1 | chronological cell aging |
GO:0036273 | 0.0029 | Inf | 0.0029 | 1 | 1 | response to statin |
GO:0090287 | 0.0049 | 9.7088 | 0.3482 | 3 | 122 | regulation of cellular response to growth factor stimulus |
GO:0060032 | 0.0057 | 361.8214 | 0.0057 | 1 | 2 | notochord regression |
GO:0070483 | 0.0057 | 361.8214 | 0.0057 | 1 | 2 | detection of hypoxia |
GO:1900042 | 0.0057 | 361.8214 | 0.0057 | 1 | 2 | positive regulation of interleukin-2 secretion |
GO:0003273 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | cell migration involved in endocardial cushion formation |
GO:0007418 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | ventral midline development |
GO:0021938 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation |
GO:0022009 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | central nervous system vasculogenesis |
GO:0032966 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | negative regulation of collagen biosynthetic process |
GO:0045345 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | positive regulation of MHC class I biosynthetic process |
GO:0045348 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | positive regulation of MHC class II biosynthetic process |
GO:2000680 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | regulation of rubidium ion transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060290 | 1e-04 | 305.8182 | 0.0201 | 2 | 3 | transdifferentiation |
GO:0032501 | 2e-04 | 2.48 | 25.9258 | 41 | 3874 | multicellular organismal process |
GO:0030325 | 2e-04 | 33.2275 | 0.1138 | 3 | 17 | adrenal gland development |
GO:0048468 | 2e-04 | 2.9078 | 8.5995 | 20 | 1285 | cell development |
GO:0042107 | 4e-04 | 13.359 | 0.3413 | 4 | 51 | cytokine metabolic process |
GO:0017148 | 6e-04 | 11.8396 | 0.3815 | 4 | 57 | negative regulation of translation |
GO:0009653 | 6e-04 | 2.6547 | 9.4588 | 20 | 1508 | anatomical structure morphogenesis |
GO:0043583 | 6e-04 | 6.3292 | 1.0574 | 6 | 158 | ear development |
GO:0016358 | 6e-04 | 8.0119 | 0.696 | 5 | 104 | dendrite development |
GO:0030855 | 6e-04 | 4.209 | 2.4226 | 9 | 362 | epithelial cell differentiation |
GO:0072239 | 7e-04 | 76.4318 | 0.0402 | 2 | 6 | metanephric glomerulus vasculature development |
GO:0071711 | 9e-04 | 61.1394 | 0.0468 | 2 | 7 | basement membrane organization |
GO:0072203 | 9e-04 | 61.1394 | 0.0468 | 2 | 7 | cell proliferation involved in metanephros development |
GO:0043066 | 0.001 | 3.6521 | 3.1119 | 10 | 465 | negative regulation of apoptotic process |
GO:0009790 | 0.0011 | 3.0496 | 4.9456 | 13 | 739 | embryo development |
GO:0032836 | 0.0012 | 50.9444 | 0.0535 | 2 | 8 | glomerular basement membrane development |
GO:0060548 | 0.0017 | 3.379 | 3.3461 | 10 | 500 | negative regulation of cell death |
GO:0042472 | 0.0019 | 8.3483 | 0.5287 | 4 | 79 | inner ear morphogenesis |
GO:0072075 | 0.0019 | 38.2008 | 0.0669 | 2 | 10 | metanephric mesenchyme development |
GO:1902931 | 0.0019 | 38.2008 | 0.0669 | 2 | 10 | negative regulation of alcohol biosynthetic process |
GO:1902176 | 0.0023 | 33.9529 | 0.0736 | 2 | 11 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO:0030030 | 0.0026 | 2.7308 | 5.4676 | 13 | 817 | cell projection organization |
GO:0007275 | 0.0027 | 2.3094 | 12.4433 | 22 | 2149 | multicellular organismal development |
GO:0048699 | 0.0027 | 2.6226 | 6.1703 | 14 | 922 | generation of neurons |
GO:0048667 | 0.0029 | 3.3466 | 3.0048 | 9 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0001655 | 0.0033 | 4.5105 | 1.4589 | 6 | 218 | urogenital system development |
GO:0042035 | 0.0033 | 11.0451 | 0.3012 | 3 | 45 | regulation of cytokine biosynthetic process |
GO:0048812 | 0.0034 | 3.2537 | 3.0851 | 9 | 461 | neuron projection morphogenesis |
GO:0048562 | 0.0034 | 4.4674 | 1.4723 | 6 | 220 | embryonic organ morphogenesis |
GO:0019218 | 0.0035 | 10.7871 | 0.3078 | 3 | 46 | regulation of steroid metabolic process |
GO:0042490 | 0.0035 | 10.7871 | 0.3078 | 3 | 46 | mechanoreceptor differentiation |
GO:0010894 | 0.0038 | 25.4571 | 0.0937 | 2 | 14 | negative regulation of steroid biosynthetic process |
GO:0048565 | 0.0041 | 6.6483 | 0.6558 | 4 | 98 | digestive tract development |
GO:0033273 | 0.0042 | 10.0806 | 0.3279 | 3 | 49 | response to vitamin |
GO:0007399 | 0.0043 | 2.254 | 9.4227 | 18 | 1408 | nervous system development |
GO:1902883 | 0.0044 | 23.4965 | 0.1004 | 2 | 15 | negative regulation of response to oxidative stress |
GO:0043067 | 0.0049 | 2.5216 | 5.8758 | 13 | 878 | regulation of programmed cell death |
GO:0045843 | 0.005 | 21.816 | 0.1071 | 2 | 16 | negative regulation of striated muscle tissue development |
GO:0060560 | 0.0053 | 6.1832 | 0.7027 | 4 | 105 | developmental growth involved in morphogenesis |
GO:0048675 | 0.0053 | 9.2705 | 0.3547 | 3 | 53 | axon extension |
GO:0032101 | 0.0053 | 3.5975 | 2.1348 | 7 | 319 | regulation of response to external stimulus |
GO:0031323 | 0.0053 | 1.9191 | 25.203 | 36 | 3766 | regulation of cellular metabolic process |
GO:0050793 | 0.0054 | 2.2867 | 8.1177 | 16 | 1213 | regulation of developmental process |
GO:0040007 | 0.0056 | 2.8279 | 3.9484 | 10 | 590 | growth |
GO:2000112 | 0.0056 | 1.9727 | 17.0853 | 27 | 2553 | regulation of cellular macromolecule biosynthetic process |
GO:0003309 | 0.0056 | 20.3596 | 0.1138 | 2 | 17 | type B pancreatic cell differentiation |
GO:0036342 | 0.0056 | 20.3596 | 0.1138 | 2 | 17 | post-anal tail morphogenesis |
GO:1902042 | 0.0056 | 20.3596 | 0.1138 | 2 | 17 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0061564 | 0.0057 | 3.231 | 2.7304 | 8 | 408 | axon development |
GO:0009888 | 0.0057 | 2.3281 | 7.4217 | 15 | 1109 | tissue development |
GO:0035108 | 0.006 | 5.9452 | 0.7295 | 4 | 109 | limb morphogenesis |
GO:0016265 | 0.0061 | 2.2077 | 8.9743 | 17 | 1341 | death |
GO:0009889 | 0.0063 | 1.9402 | 18.0959 | 28 | 2704 | regulation of biosynthetic process |
GO:0032990 | 0.0063 | 2.772 | 4.022 | 10 | 601 | cell part morphogenesis |
GO:2000027 | 0.0064 | 5.8329 | 0.7428 | 4 | 111 | regulation of organ morphogenesis |
GO:0007389 | 0.0064 | 3.46 | 2.2151 | 7 | 331 | pattern specification process |
GO:0072166 | 0.0066 | Inf | 0.0066 | 1 | 1 | posterior mesonephric tubule development |
GO:0007356 | 0.0067 | Inf | 0.0067 | 1 | 1 | thorax and anterior abdomen determination |
GO:0010610 | 0.0067 | Inf | 0.0067 | 1 | 1 | regulation of mRNA stability involved in response to stress |
GO:0010730 | 0.0067 | Inf | 0.0067 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0014076 | 0.0067 | Inf | 0.0067 | 1 | 1 | response to fluoxetine |
GO:0021509 | 0.0067 | Inf | 0.0067 | 1 | 1 | roof plate formation |
GO:0048304 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of isotype switching to IgG isotypes |
GO:0048389 | 0.0067 | Inf | 0.0067 | 1 | 1 | intermediate mesoderm development |
GO:0061090 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of sequestering of zinc ion |
GO:0061227 | 0.0067 | Inf | 0.0067 | 1 | 1 | pattern specification involved in mesonephros development |
GO:0070105 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of interleukin-6-mediated signaling pathway |
GO:0070593 | 0.0067 | Inf | 0.0067 | 1 | 1 | dendrite self-avoidance |
GO:0071673 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of smooth muscle cell chemotaxis |
GO:0072168 | 0.0067 | Inf | 0.0067 | 1 | 1 | specification of anterior mesonephric tubule identity |
GO:0072169 | 0.0067 | Inf | 0.0067 | 1 | 1 | specification of posterior mesonephric tubule identity |
GO:0072183 | 0.0067 | Inf | 0.0067 | 1 | 1 | negative regulation of nephron tubule epithelial cell differentiation |
GO:0072184 | 0.0067 | Inf | 0.0067 | 1 | 1 | renal vesicle progenitor cell differentiation |
GO:0072259 | 0.0067 | Inf | 0.0067 | 1 | 1 | metanephric interstitial fibroblast development |
GO:0072302 | 0.0067 | Inf | 0.0067 | 1 | 1 | negative regulation of metanephric glomerular mesangial cell proliferation |
GO:0072347 | 0.0067 | Inf | 0.0067 | 1 | 1 | response to anesthetic |
GO:0097484 | 0.0067 | Inf | 0.0067 | 1 | 1 | dendrite extension |
GO:1902905 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of fibril organization |
GO:2000057 | 0.0067 | Inf | 0.0067 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
GO:2000570 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of T-helper 2 cell activation |
GO:2001051 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of tendon cell differentiation |
GO:2001076 | 0.0067 | Inf | 0.0067 | 1 | 1 | positive regulation of metanephric ureteric bud development |
GO:0001822 | 0.007 | 4.498 | 1.2046 | 5 | 180 | kidney development |
GO:0072207 | 0.0078 | 16.9613 | 0.1338 | 2 | 20 | metanephric epithelium development |
GO:2001234 | 0.0082 | 5.4228 | 0.7964 | 4 | 119 | negative regulation of apoptotic signaling pathway |
GO:0016331 | 0.0084 | 5.3755 | 0.8031 | 4 | 120 | morphogenesis of embryonic epithelium |
GO:0010823 | 0.0085 | 16.067 | 0.1405 | 2 | 21 | negative regulation of mitochondrion organization |
GO:0035116 | 0.0085 | 16.067 | 0.1405 | 2 | 21 | embryonic hindlimb morphogenesis |
GO:0051239 | 0.0088 | 2.1152 | 9.3089 | 17 | 1391 | regulation of multicellular organismal process |
GO:0009954 | 0.0094 | 15.2621 | 0.1472 | 2 | 22 | proximal/distal pattern formation |
GO:1903201 | 0.0094 | 15.2621 | 0.1472 | 2 | 22 | regulation of oxidative stress-induced cell death |
GO:2000243 | 0.0094 | 15.2621 | 0.1472 | 2 | 22 | positive regulation of reproductive process |
GO:0048736 | 0.0097 | 5.1508 | 0.8365 | 4 | 125 | appendage development |
GO:0010468 | 0.0097 | 1.8598 | 18.658 | 28 | 2788 | regulation of gene expression |
GO:0097285 | 0.0098 | 3.5478 | 1.8337 | 6 | 274 | cell-type specific apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002675 | 0.0012 | 47.7683 | 0.053 | 2 | 11 | positive regulation of acute inflammatory response |
GO:0042119 | 0.0023 | 33.0573 | 0.0723 | 2 | 15 | neutrophil activation |
GO:0042026 | 0.0026 | 30.693 | 0.0772 | 2 | 16 | protein refolding |
GO:2000026 | 0.0036 | 2.9485 | 4.4125 | 11 | 915 | regulation of multicellular organismal development |
GO:0001809 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of type IV hypersensitivity |
GO:0007231 | 0.0048 | Inf | 0.0048 | 1 | 1 | osmosensory signaling pathway |
GO:0010513 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of phosphatidylinositol biosynthetic process |
GO:0030103 | 0.0048 | Inf | 0.0048 | 1 | 1 | vasopressin secretion |
GO:0032672 | 0.0048 | Inf | 0.0048 | 1 | 1 | regulation of interleukin-3 production |
GO:0043622 | 0.0048 | Inf | 0.0048 | 1 | 1 | cortical microtubule organization |
GO:0045401 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of interleukin-3 biosynthetic process |
GO:0045425 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process |
GO:0046373 | 0.0048 | Inf | 0.0048 | 1 | 1 | L-arabinose metabolic process |
GO:0070370 | 0.0048 | Inf | 0.0048 | 1 | 1 | cellular heat acclimation |
GO:0071226 | 0.0048 | Inf | 0.0048 | 1 | 1 | cellular response to molecule of fungal origin |
GO:0072719 | 0.0048 | Inf | 0.0048 | 1 | 1 | cellular response to cisplatin |
GO:1902732 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of chondrocyte proliferation |
GO:2000368 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of acrosomal vesicle exocytosis |
GO:2000386 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of ovarian follicle development |
GO:2000388 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of antral ovarian follicle growth |
GO:0035036 | 0.0054 | 20.4478 | 0.1109 | 2 | 23 | sperm-egg recognition |
GO:0048333 | 0.0054 | 20.4478 | 0.1109 | 2 | 23 | mesodermal cell differentiation |
GO:0007159 | 0.0064 | 18.666 | 0.1206 | 2 | 25 | leukocyte cell-cell adhesion |
GO:0030593 | 0.0069 | 17.8865 | 0.1254 | 2 | 26 | neutrophil chemotaxis |
GO:0045921 | 0.0069 | 17.8865 | 0.1254 | 2 | 26 | positive regulation of exocytosis |
GO:0050900 | 0.0069 | 5.7478 | 0.7619 | 4 | 158 | leukocyte migration |
GO:0071478 | 0.0076 | 8.0765 | 0.4051 | 3 | 84 | cellular response to radiation |
GO:0048566 | 0.0079 | 16.5074 | 0.135 | 2 | 28 | embryonic digestive tract development |
GO:0009994 | 0.0091 | 15.3252 | 0.1447 | 2 | 30 | oocyte differentiation |
GO:0070509 | 0.0091 | 15.3252 | 0.1447 | 2 | 30 | calcium ion import |
GO:0002351 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | serotonin production involved in inflammatory response |
GO:0002554 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | serotonin secretion by platelet |
GO:0002883 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | regulation of hypersensitivity |
GO:0007308 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0010710 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | regulation of collagen catabolic process |
GO:0030719 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | P granule organization |
GO:0035803 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | egg coat formation |
GO:0043366 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | beta selection |
GO:0071421 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | manganese ion transmembrane transport |
GO:0097168 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | mesenchymal stem cell proliferation |
GO:2000360 | 0.0096 | 210.6458 | 0.0096 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:0033627 | 0.0097 | 14.7953 | 0.1495 | 2 | 31 | cell adhesion mediated by integrin |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010269 | 1e-04 | 449.4667 | 0.0139 | 2 | 3 | response to selenium ion |
GO:0007266 | 1e-04 | 19.5078 | 0.2405 | 4 | 52 | Rho protein signal transduction |
GO:0006642 | 1e-04 | 224.7111 | 0.0185 | 2 | 4 | triglyceride mobilization |
GO:0006639 | 2e-04 | 14.8409 | 0.3099 | 4 | 67 | acylglycerol metabolic process |
GO:0009410 | 3e-04 | 13.7428 | 0.333 | 4 | 72 | response to xenobiotic stimulus |
GO:0042632 | 6e-04 | 20.8285 | 0.1665 | 3 | 36 | cholesterol homeostasis |
GO:0034383 | 7e-04 | 64.1714 | 0.0416 | 2 | 9 | low-density lipoprotein particle clearance |
GO:0044282 | 0.0014 | 6.8008 | 0.828 | 5 | 179 | small molecule catabolic process |
GO:0040017 | 0.0018 | 6.3197 | 0.8881 | 5 | 192 | positive regulation of locomotion |
GO:0006796 | 0.0019 | 2.5117 | 11.4806 | 21 | 2482 | phosphate-containing compound metabolic process |
GO:0055088 | 0.0024 | 12.4698 | 0.2683 | 3 | 58 | lipid homeostasis |
GO:0003158 | 0.0028 | 11.8213 | 0.2822 | 3 | 61 | endothelium development |
GO:0006805 | 0.0038 | 10.5409 | 0.3145 | 3 | 68 | xenobiotic metabolic process |
GO:0009611 | 0.004 | 3.5129 | 2.618 | 8 | 566 | response to wounding |
GO:0010823 | 0.0042 | 23.614 | 0.0971 | 2 | 21 | negative regulation of mitochondrion organization |
GO:0033344 | 0.0042 | 23.614 | 0.0971 | 2 | 21 | cholesterol efflux |
GO:0046395 | 0.0042 | 6.6756 | 0.6615 | 4 | 143 | carboxylic acid catabolic process |
GO:0009791 | 0.0044 | 9.9259 | 0.333 | 3 | 72 | post-embryonic development |
GO:0065008 | 0.0045 | 2.4106 | 8.9828 | 17 | 1942 | regulation of biological quality |
GO:0010124 | 0.0046 | Inf | 0.0046 | 1 | 1 | phenylacetate catabolic process |
GO:0010730 | 0.0046 | Inf | 0.0046 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0035623 | 0.0046 | Inf | 0.0046 | 1 | 1 | renal glucose absorption |
GO:0046226 | 0.0046 | Inf | 0.0046 | 1 | 1 | coumarin catabolic process |
GO:0060468 | 0.0046 | Inf | 0.0046 | 1 | 1 | prevention of polyspermy |
GO:0070593 | 0.0046 | Inf | 0.0046 | 1 | 1 | dendrite self-avoidance |
GO:0071673 | 0.0046 | Inf | 0.0046 | 1 | 1 | positive regulation of smooth muscle cell chemotaxis |
GO:1900128 | 0.0046 | Inf | 0.0046 | 1 | 1 | regulation of G-protein activated inward rectifier potassium channel activity |
GO:1902905 | 0.0046 | Inf | 0.0046 | 1 | 1 | positive regulation of fibril organization |
GO:0048870 | 0.0048 | 3.1609 | 3.3026 | 9 | 714 | cell motility |
GO:0051128 | 0.0055 | 2.6725 | 5.3749 | 12 | 1162 | regulation of cellular component organization |
GO:0010883 | 0.0063 | 18.6852 | 0.1203 | 2 | 26 | regulation of lipid storage |
GO:0070542 | 0.0068 | 17.936 | 0.1249 | 2 | 27 | response to fatty acid |
GO:0051179 | 0.0069 | 2.1517 | 15.3891 | 24 | 3327 | localization |
GO:0009749 | 0.0073 | 8.2401 | 0.3978 | 3 | 86 | response to glucose |
GO:0035094 | 0.0073 | 17.2444 | 0.1295 | 2 | 28 | response to nicotine |
GO:0042743 | 0.0073 | 17.2444 | 0.1295 | 2 | 28 | hydrogen peroxide metabolic process |
GO:0010876 | 0.0077 | 5.5747 | 0.7863 | 4 | 170 | lipid localization |
GO:0097006 | 0.0079 | 16.6041 | 0.1341 | 2 | 29 | regulation of plasma lipoprotein particle levels |
GO:0001885 | 0.0084 | 16.0095 | 0.1388 | 2 | 30 | endothelial cell development |
GO:0030335 | 0.0089 | 5.3453 | 0.8187 | 4 | 177 | positive regulation of cell migration |
GO:0034284 | 0.009 | 7.5939 | 0.4302 | 3 | 93 | response to monosaccharide |
GO:0009609 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | response to symbiotic bacterium |
GO:0010157 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | response to chlorate |
GO:0010260 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | organ senescence |
GO:0032803 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | regulation of low-density lipoprotein particle receptor catabolic process |
GO:1903426 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | regulation of reactive oxygen species biosynthetic process |
GO:2000360 | 0.0092 | 219.8478 | 0.0093 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:0051270 | 0.0095 | 3.6391 | 1.8363 | 6 | 397 | regulation of cellular component movement |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006968 | 0.0014 | 41.6214 | 0.0571 | 2 | 20 | cellular defense response |
GO:0035825 | 0.0021 | 34.0404 | 0.0685 | 2 | 24 | reciprocal DNA recombination |
GO:0001207 | 0.0029 | Inf | 0.0029 | 1 | 1 | histone displacement |
GO:0002378 | 0.0029 | Inf | 0.0029 | 1 | 1 | immunoglobulin biosynthetic process |
GO:0051039 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of transcription during meiosis |
GO:0051321 | 0.0056 | 9.2372 | 0.3653 | 3 | 128 | meiotic cell cycle |
GO:0010845 | 0.0057 | 361.8214 | 0.0057 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
GO:0045918 | 0.0057 | 361.8214 | 0.0057 | 1 | 2 | negative regulation of cytolysis |
GO:0007127 | 0.0073 | 17.2393 | 0.1296 | 2 | 47 | meiosis I |
GO:0007283 | 0.008 | 5.6714 | 0.8048 | 4 | 282 | spermatogenesis |
GO:0006311 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | meiotic gene conversion |
GO:0007597 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | blood coagulation, intrinsic pathway |
GO:0018242 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | protein O-linked glycosylation via serine |
GO:0045347 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | negative regulation of MHC class II biosynthetic process |
GO:0046951 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | ketone body biosynthetic process |
GO:0051024 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | positive regulation of immunoglobulin secretion |
GO:0071670 | 0.0085 | 180.8929 | 0.0086 | 1 | 3 | smooth muscle cell chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048598 | 0 | 7.8207 | 1.8493 | 11 | 437 | embryonic morphogenesis |
GO:0030326 | 0 | 18.4828 | 0.3978 | 6 | 94 | embryonic limb morphogenesis |
GO:0035107 | 0 | 15.7675 | 0.4613 | 6 | 109 | appendage morphogenesis |
GO:0060173 | 0 | 13.6257 | 0.529 | 6 | 125 | limb development |
GO:0048705 | 0 | 10.8496 | 0.6559 | 6 | 155 | skeletal system morphogenesis |
GO:0035295 | 5e-04 | 5.0879 | 1.8747 | 8 | 443 | tube development |
GO:0046620 | 0.0013 | 15.7344 | 0.2158 | 3 | 51 | regulation of organ growth |
GO:0010656 | 0.0023 | 32.8553 | 0.0719 | 2 | 17 | negative regulation of muscle cell apoptotic process |
GO:0060706 | 0.0023 | 32.8553 | 0.0719 | 2 | 17 | cell differentiation involved in embryonic placenta development |
GO:0040007 | 0.0029 | 3.7451 | 2.4968 | 8 | 590 | growth |
GO:0030307 | 0.0032 | 11.2511 | 0.2962 | 3 | 70 | positive regulation of cell growth |
GO:0060021 | 0.0032 | 11.2511 | 0.2962 | 3 | 70 | palate development |
GO:0051308 | 0.0042 | Inf | 0.0042 | 1 | 1 | male meiosis chromosome separation |
GO:0061185 | 0.0042 | Inf | 0.0042 | 1 | 1 | negative regulation of dermatome development |
GO:1901751 | 0.0042 | Inf | 0.0042 | 1 | 1 | leukotriene A4 metabolic process |
GO:2001303 | 0.0042 | Inf | 0.0042 | 1 | 1 | lipoxin A4 biosynthetic process |
GO:2001306 | 0.0042 | Inf | 0.0042 | 1 | 1 | lipoxin B4 biosynthetic process |
GO:0007156 | 0.0043 | 10.043 | 0.3301 | 3 | 78 | homophilic cell adhesion |
GO:0010950 | 0.0053 | 9.2935 | 0.3555 | 3 | 84 | positive regulation of endopeptidase activity |
GO:0001841 | 0.0055 | 9.1793 | 0.3597 | 3 | 85 | neural tube formation |
GO:0048731 | 0.0065 | 2.2939 | 11.0663 | 19 | 2615 | system development |
GO:1901362 | 0.0071 | 2.2515 | 12.0143 | 20 | 2839 | organic cyclic compound biosynthetic process |
GO:0030178 | 0.0079 | 7.9979 | 0.4105 | 3 | 97 | negative regulation of Wnt signaling pathway |
GO:1902041 | 0.008 | 16.4033 | 0.1354 | 2 | 32 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0060348 | 0.0081 | 7.9129 | 0.4147 | 3 | 98 | bone development |
GO:0012502 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | induction of programmed cell death |
GO:0051901 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | positive regulation of mitochondrial depolarization |
GO:0052330 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction |
GO:0052501 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction |
GO:0060139 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | positive regulation of apoptotic process by virus |
GO:0060465 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | pharynx development |
GO:0061056 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | sclerotome development |
GO:0061370 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | testosterone biosynthetic process |
GO:2000035 | 0.0084 | 240.881 | 0.0085 | 1 | 2 | regulation of stem cell division |
GO:0048538 | 0.0085 | 15.8725 | 0.1397 | 2 | 33 | thymus development |
GO:0044707 | 0.0088 | 2.1651 | 15.878 | 24 | 3752 | single-multicellular organism process |
GO:0072175 | 0.0093 | 7.5135 | 0.4359 | 3 | 103 | epithelial tube formation |
GO:0048568 | 0.0097 | 4.2191 | 1.3161 | 5 | 311 | embryonic organ development |
GO:0046328 | 0.0098 | 7.3647 | 0.4443 | 3 | 105 | regulation of JNK cascade |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 751.6296 | 0.0054 | 2 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 4e-04 | 86.5299 | 0.0303 | 2 | 28 | detection of chemical stimulus |
GO:0050906 | 7e-04 | 64.2222 | 0.0401 | 2 | 37 | detection of stimulus involved in sensory perception |
GO:0007606 | 8e-04 | 59.1345 | 0.0433 | 2 | 40 | sensory perception of chemical stimulus |
GO:0071420 | 0.0054 | 253.65 | 0.0054 | 1 | 5 | cellular response to histamine |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045472 | 0 | 532.6316 | 0.0118 | 2 | 3 | response to ether |
GO:0032370 | 2e-04 | 34.1115 | 0.1063 | 3 | 27 | positive regulation of lipid transport |
GO:0007156 | 2e-04 | 15.0856 | 0.3071 | 4 | 78 | homophilic cell adhesion |
GO:0030326 | 5e-04 | 12.384 | 0.37 | 4 | 94 | embryonic limb morphogenesis |
GO:0035107 | 9e-04 | 10.5989 | 0.4291 | 4 | 109 | appendage morphogenesis |
GO:0015874 | 0.001 | 53.2158 | 0.0472 | 2 | 12 | norepinephrine transport |
GO:0030431 | 0.0013 | 44.3377 | 0.0551 | 2 | 14 | sleep |
GO:0060173 | 0.0014 | 9.1827 | 0.4921 | 4 | 125 | limb development |
GO:0050801 | 0.0016 | 5.3876 | 1.2873 | 6 | 327 | ion homeostasis |
GO:0007586 | 0.0017 | 14.0676 | 0.2401 | 3 | 61 | digestion |
GO:0010656 | 0.002 | 35.4596 | 0.0669 | 2 | 17 | negative regulation of muscle cell apoptotic process |
GO:0019748 | 0.002 | 35.4596 | 0.0669 | 2 | 17 | secondary metabolic process |
GO:0042755 | 0.0027 | 29.5409 | 0.0787 | 2 | 20 | eating behavior |
GO:0044058 | 0.0027 | 29.5409 | 0.0787 | 2 | 20 | regulation of digestive system process |
GO:0050433 | 0.0033 | 26.5816 | 0.0866 | 2 | 22 | regulation of catecholamine secretion |
GO:0010124 | 0.0039 | Inf | 0.0039 | 1 | 1 | phenylacetate catabolic process |
GO:0010841 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0033494 | 0.0039 | Inf | 0.0039 | 1 | 1 | ferulate metabolic process |
GO:0042322 | 0.0039 | Inf | 0.0039 | 1 | 1 | negative regulation of circadian sleep/wake cycle, REM sleep |
GO:0046226 | 0.0039 | Inf | 0.0039 | 1 | 1 | coumarin catabolic process |
GO:0060450 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of hindgut contraction |
GO:1901751 | 0.0039 | Inf | 0.0039 | 1 | 1 | leukotriene A4 metabolic process |
GO:2000763 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
GO:2000764 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
GO:2000854 | 0.0039 | Inf | 0.0039 | 1 | 1 | positive regulation of corticosterone secretion |
GO:2001260 | 0.0039 | Inf | 0.0039 | 1 | 1 | regulation of semaphorin-plexin signaling pathway |
GO:2001303 | 0.0039 | Inf | 0.0039 | 1 | 1 | lipoxin A4 biosynthetic process |
GO:2001306 | 0.0039 | Inf | 0.0039 | 1 | 1 | lipoxin B4 biosynthetic process |
GO:0045776 | 0.005 | 21.2547 | 0.1063 | 2 | 27 | negative regulation of blood pressure |
GO:0048514 | 0.0067 | 4.6447 | 1.2085 | 5 | 307 | blood vessel morphogenesis |
GO:0072358 | 0.0071 | 3.5086 | 2.299 | 7 | 584 | cardiovascular system development |
GO:0055082 | 0.0073 | 4.5515 | 1.2322 | 5 | 313 | cellular chemical homeostasis |
GO:0001501 | 0.0078 | 4.4765 | 1.2518 | 5 | 318 | skeletal system development |
GO:0015850 | 0.0078 | 8.0439 | 0.4094 | 3 | 104 | organic hydroxy compound transport |
GO:0003253 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0006210 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | thymine catabolic process |
GO:0006212 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | uracil catabolic process |
GO:0010701 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | positive regulation of norepinephrine secretion |
GO:0015889 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | cobalamin transport |
GO:0019482 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | beta-alanine metabolic process |
GO:0033685 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | negative regulation of luteinizing hormone secretion |
GO:0035811 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | negative regulation of urine volume |
GO:0035902 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | response to immobilization stress |
GO:0051901 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | positive regulation of mitochondrial depolarization |
GO:0061032 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | visceral serous pericardium development |
GO:0061325 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | cell proliferation involved in outflow tract morphogenesis |
GO:0070093 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | negative regulation of glucagon secretion |
GO:0071314 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | cellular response to cocaine |
GO:1903365 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | regulation of fear response |
GO:2000987 | 0.0079 | 259.4872 | 0.0079 | 1 | 2 | positive regulation of behavioral fear response |
GO:0019752 | 0.0089 | 3.3541 | 2.3974 | 7 | 609 | carboxylic acid metabolic process |
GO:0010463 | 0.0092 | 15.1669 | 0.1457 | 2 | 37 | mesenchymal cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002675 | 0.0011 | 51.0404 | 0.0498 | 2 | 11 | positive regulation of acute inflammatory response |
GO:0032633 | 0.0018 | 38.2689 | 0.0634 | 2 | 14 | interleukin-4 production |
GO:0042026 | 0.0023 | 32.7955 | 0.0724 | 2 | 16 | protein refolding |
GO:0001809 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of type IV hypersensitivity |
GO:0007231 | 0.0045 | Inf | 0.0045 | 1 | 1 | osmosensory signaling pathway |
GO:0010513 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of phosphatidylinositol biosynthetic process |
GO:0030103 | 0.0045 | Inf | 0.0045 | 1 | 1 | vasopressin secretion |
GO:0043622 | 0.0045 | Inf | 0.0045 | 1 | 1 | cortical microtubule organization |
GO:0046373 | 0.0045 | Inf | 0.0045 | 1 | 1 | L-arabinose metabolic process |
GO:0070370 | 0.0045 | Inf | 0.0045 | 1 | 1 | cellular heat acclimation |
GO:0072719 | 0.0045 | Inf | 0.0045 | 1 | 1 | cellular response to cisplatin |
GO:1902732 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of chondrocyte proliferation |
GO:2000368 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of acrosomal vesicle exocytosis |
GO:2000386 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of ovarian follicle development |
GO:2000388 | 0.0045 | Inf | 0.0045 | 1 | 1 | positive regulation of antral ovarian follicle growth |
GO:0035036 | 0.0048 | 21.8485 | 0.1041 | 2 | 23 | sperm-egg recognition |
GO:0048333 | 0.0048 | 21.8485 | 0.1041 | 2 | 23 | mesodermal cell differentiation |
GO:0071478 | 0.0064 | 8.6425 | 0.3803 | 3 | 84 | cellular response to radiation |
GO:2000026 | 0.0068 | 2.8269 | 4.1423 | 10 | 915 | regulation of multicellular organismal development |
GO:0048566 | 0.007 | 17.6381 | 0.1268 | 2 | 28 | embryonic digestive tract development |
GO:0009994 | 0.008 | 16.375 | 0.1358 | 2 | 30 | oocyte differentiation |
GO:0070509 | 0.008 | 16.375 | 0.1358 | 2 | 30 | calcium ion import |
GO:0032103 | 0.009 | 7.6009 | 0.4301 | 3 | 95 | positive regulation of response to external stimulus |
GO:0002883 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | regulation of hypersensitivity |
GO:0007308 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | oocyte construction |
GO:0007314 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0010710 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | regulation of collagen catabolic process |
GO:0030719 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | P granule organization |
GO:0035803 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | egg coat formation |
GO:0071421 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | manganese ion transmembrane transport |
GO:0097168 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | mesenchymal stem cell proliferation |
GO:1900042 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | positive regulation of interleukin-2 secretion |
GO:2000360 | 0.009 | 224.7556 | 0.0091 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.7453 | 25.5445 | 42 | 3874 | multicellular organismal process |
GO:0048468 | 0 | 3.1892 | 8.4731 | 21 | 1285 | cell development |
GO:0060290 | 1e-04 | 310.5538 | 0.0198 | 2 | 3 | transdifferentiation |
GO:0030325 | 2e-04 | 33.75 | 0.1121 | 3 | 17 | adrenal gland development |
GO:0042107 | 3e-04 | 13.5724 | 0.3363 | 4 | 51 | cytokine metabolic process |
GO:0017148 | 5e-04 | 12.0288 | 0.3758 | 4 | 57 | negative regulation of translation |
GO:0043583 | 6e-04 | 6.4336 | 1.0418 | 6 | 158 | ear development |
GO:0016358 | 6e-04 | 8.1419 | 0.6858 | 5 | 104 | dendrite development |
GO:0072239 | 6e-04 | 77.6154 | 0.0396 | 2 | 6 | metanephric glomerulus vasculature development |
GO:0048699 | 8e-04 | 2.9218 | 6.0795 | 15 | 922 | generation of neurons |
GO:0032502 | 8e-04 | 2.6096 | 12.3645 | 23 | 2213 | developmental process |
GO:0043066 | 9e-04 | 3.7166 | 3.0661 | 10 | 465 | negative regulation of apoptotic process |
GO:0071711 | 9e-04 | 62.0862 | 0.0462 | 2 | 7 | basement membrane organization |
GO:0072203 | 9e-04 | 62.0862 | 0.0462 | 2 | 7 | cell proliferation involved in metanephros development |
GO:0009790 | 9e-04 | 3.1064 | 4.8728 | 13 | 739 | embryo development |
GO:0032836 | 0.0012 | 51.7333 | 0.0528 | 2 | 8 | glomerular basement membrane development |
GO:0060548 | 0.0015 | 3.4386 | 3.2969 | 10 | 500 | negative regulation of cell death |
GO:0042472 | 0.0018 | 8.4817 | 0.5209 | 4 | 79 | inner ear morphogenesis |
GO:0050793 | 0.0018 | 2.5295 | 7.9983 | 17 | 1213 | regulation of developmental process |
GO:0031323 | 0.0018 | 2.1052 | 24.8324 | 37 | 3766 | regulation of cellular metabolic process |
GO:0072075 | 0.0019 | 38.7923 | 0.0659 | 2 | 10 | metanephric mesenchyme development |
GO:1902931 | 0.0019 | 38.7923 | 0.0659 | 2 | 10 | negative regulation of alcohol biosynthetic process |
GO:2000112 | 0.002 | 2.1521 | 16.8341 | 28 | 2553 | regulation of cellular macromolecule biosynthetic process |
GO:1902176 | 0.0023 | 34.4786 | 0.0725 | 2 | 11 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO:0009889 | 0.0023 | 2.1166 | 17.8297 | 29 | 2704 | regulation of biosynthetic process |
GO:0030030 | 0.0023 | 2.7817 | 5.3872 | 13 | 817 | cell projection organization |
GO:0009887 | 0.0024 | 3.7736 | 2.3808 | 8 | 388 | organ morphogenesis |
GO:0048667 | 0.0026 | 3.4046 | 2.9606 | 9 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0048812 | 0.0031 | 3.3101 | 3.0398 | 9 | 461 | neuron projection morphogenesis |
GO:0051239 | 0.0031 | 2.3333 | 9.172 | 18 | 1391 | regulation of multicellular organismal process |
GO:0042035 | 0.0032 | 11.2188 | 0.2967 | 3 | 45 | regulation of cytokine biosynthetic process |
GO:0048562 | 0.0032 | 4.5411 | 1.4506 | 6 | 220 | embryonic organ morphogenesis |
GO:0019218 | 0.0034 | 10.9568 | 0.3033 | 3 | 46 | regulation of steroid metabolic process |
GO:0042490 | 0.0034 | 10.9568 | 0.3033 | 3 | 46 | mechanoreceptor differentiation |
GO:0010648 | 0.0035 | 2.8728 | 4.3322 | 11 | 657 | negative regulation of cell communication |
GO:0010894 | 0.0037 | 25.8513 | 0.0923 | 2 | 14 | negative regulation of steroid biosynthetic process |
GO:0010468 | 0.0037 | 2.0289 | 18.3836 | 29 | 2788 | regulation of gene expression |
GO:0048731 | 0.0038 | 2.1158 | 15.0693 | 25 | 2423 | system development |
GO:0045664 | 0.0039 | 3.8219 | 2.0177 | 7 | 306 | regulation of neuron differentiation |
GO:0048565 | 0.0039 | 6.7545 | 0.6462 | 4 | 98 | digestive tract development |
GO:0033273 | 0.0041 | 10.2391 | 0.3231 | 3 | 49 | response to vitamin |
GO:1902883 | 0.0043 | 23.8604 | 0.0989 | 2 | 15 | negative regulation of response to oxidative stress |
GO:0043067 | 0.0043 | 2.5686 | 5.7894 | 13 | 878 | regulation of programmed cell death |
GO:0007275 | 0.0047 | 5.1566 | 1.1143 | 5 | 236 | multicellular organismal development |
GO:0045843 | 0.0048 | 22.1538 | 0.1055 | 2 | 16 | negative regulation of striated muscle tissue development |
GO:0032101 | 0.0049 | 3.6578 | 2.1034 | 7 | 319 | regulation of response to external stimulus |
GO:0009059 | 0.0049 | 1.9563 | 21.4102 | 32 | 3247 | macromolecule biosynthetic process |
GO:0009888 | 0.005 | 2.3731 | 7.3126 | 15 | 1109 | tissue development |
GO:0040007 | 0.005 | 2.8778 | 3.8904 | 10 | 590 | growth |
GO:0060560 | 0.005 | 6.2819 | 0.6924 | 4 | 105 | developmental growth involved in morphogenesis |
GO:0048675 | 0.0051 | 9.4162 | 0.3495 | 3 | 53 | axon extension |
GO:0061564 | 0.0052 | 3.2861 | 2.6903 | 8 | 408 | axon development |
GO:0003309 | 0.0055 | 20.6749 | 0.1121 | 2 | 17 | type B pancreatic cell differentiation |
GO:0036342 | 0.0055 | 20.6749 | 0.1121 | 2 | 17 | post-anal tail morphogenesis |
GO:1902042 | 0.0055 | 20.6749 | 0.1121 | 2 | 17 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0032990 | 0.0057 | 2.821 | 3.9629 | 10 | 601 | cell part morphogenesis |
GO:0035108 | 0.0057 | 6.0402 | 0.7187 | 4 | 109 | limb morphogenesis |
GO:0030855 | 0.0058 | 3.5411 | 2.1735 | 7 | 339 | epithelial cell differentiation |
GO:0007389 | 0.0059 | 3.518 | 2.1826 | 7 | 331 | pattern specification process |
GO:0051960 | 0.0064 | 3.1624 | 2.7892 | 8 | 423 | regulation of nervous system development |
GO:0072166 | 0.0065 | Inf | 0.0065 | 1 | 1 | posterior mesonephric tubule development |
GO:0007356 | 0.0066 | Inf | 0.0066 | 1 | 1 | thorax and anterior abdomen determination |
GO:0010610 | 0.0066 | Inf | 0.0066 | 1 | 1 | regulation of mRNA stability involved in response to stress |
GO:0010730 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0014076 | 0.0066 | Inf | 0.0066 | 1 | 1 | response to fluoxetine |
GO:0021509 | 0.0066 | Inf | 0.0066 | 1 | 1 | roof plate formation |
GO:0048304 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of isotype switching to IgG isotypes |
GO:0048389 | 0.0066 | Inf | 0.0066 | 1 | 1 | intermediate mesoderm development |
GO:0061227 | 0.0066 | Inf | 0.0066 | 1 | 1 | pattern specification involved in mesonephros development |
GO:0070105 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of interleukin-6-mediated signaling pathway |
GO:0070593 | 0.0066 | Inf | 0.0066 | 1 | 1 | dendrite self-avoidance |
GO:0071673 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of smooth muscle cell chemotaxis |
GO:0072168 | 0.0066 | Inf | 0.0066 | 1 | 1 | specification of anterior mesonephric tubule identity |
GO:0072169 | 0.0066 | Inf | 0.0066 | 1 | 1 | specification of posterior mesonephric tubule identity |
GO:0072183 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of nephron tubule epithelial cell differentiation |
GO:0072184 | 0.0066 | Inf | 0.0066 | 1 | 1 | renal vesicle progenitor cell differentiation |
GO:0072259 | 0.0066 | Inf | 0.0066 | 1 | 1 | metanephric interstitial fibroblast development |
GO:0072302 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of metanephric glomerular mesangial cell proliferation |
GO:0072347 | 0.0066 | Inf | 0.0066 | 1 | 1 | response to anesthetic |
GO:0097484 | 0.0066 | Inf | 0.0066 | 1 | 1 | dendrite extension |
GO:1902905 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of fibril organization |
GO:2000057 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis |
GO:2000570 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of T-helper 2 cell activation |
GO:2001051 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of tendon cell differentiation |
GO:2001076 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of metanephric ureteric bud development |
GO:0080090 | 0.0069 | 1.8861 | 24.661 | 35 | 3740 | regulation of primary metabolic process |
GO:0072207 | 0.0075 | 17.2239 | 0.1319 | 2 | 20 | metanephric epithelium development |
GO:2001234 | 0.0078 | 5.5095 | 0.7847 | 4 | 119 | negative regulation of apoptotic signaling pathway |
GO:0016331 | 0.008 | 5.4614 | 0.7913 | 4 | 120 | morphogenesis of embryonic epithelium |
GO:0010823 | 0.0083 | 16.3158 | 0.1385 | 2 | 21 | negative regulation of mitochondrion organization |
GO:0035116 | 0.0083 | 16.3158 | 0.1385 | 2 | 21 | embryonic hindlimb morphogenesis |
GO:0072001 | 0.0086 | 4.2725 | 1.266 | 5 | 192 | renal system development |
GO:0009954 | 0.0091 | 15.4985 | 0.1451 | 2 | 22 | proximal/distal pattern formation |
GO:1903201 | 0.0091 | 15.4985 | 0.1451 | 2 | 22 | regulation of oxidative stress-induced cell death |
GO:2000243 | 0.0091 | 15.4985 | 0.1451 | 2 | 22 | positive regulation of reproductive process |
GO:0097285 | 0.0092 | 3.6063 | 1.8067 | 6 | 274 | cell-type specific apoptotic process |
GO:0048736 | 0.0092 | 5.2331 | 0.8242 | 4 | 125 | appendage development |
GO:0007411 | 0.0093 | 3.5925 | 1.8133 | 6 | 275 | axon guidance |
GO:0044249 | 0.0095 | 1.8324 | 25.1093 | 35 | 3808 | cellular biosynthetic process |
GO:0072006 | 0.0097 | 7.3462 | 0.4418 | 3 | 67 | nephron development |
GO:0003156 | 0.0099 | 14.759 | 0.1517 | 2 | 23 | regulation of organ formation |
GO:0035115 | 0.0099 | 14.759 | 0.1517 | 2 | 23 | embryonic forelimb morphogenesis |
GO:0035850 | 0.0099 | 14.759 | 0.1517 | 2 | 23 | epithelial cell differentiation involved in kidney development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008270 | 0.0031 | 5.2365 | 1.5475 | 6 | 810 | zinc ion binding |
GO:0015347 | 0.0038 | 551.3889 | 0.0038 | 1 | 2 | sodium-independent organic anion transmembrane transporter activity |
GO:0031404 | 0.0038 | 551.3889 | 0.0038 | 1 | 2 | chloride ion binding |
GO:0032090 | 0.0038 | 551.3889 | 0.0038 | 1 | 2 | Pyrin domain binding |
GO:0008900 | 0.0057 | 275.6667 | 0.0057 | 1 | 3 | hydrogen:potassium-exchanging ATPase activity |
GO:0033743 | 0.0057 | 275.6667 | 0.0057 | 1 | 3 | peptide-methionine (R)-S-oxide reductase activity |
GO:0051371 | 0.0057 | 275.6667 | 0.0057 | 1 | 3 | muscle alpha-actinin binding |
GO:0008121 | 0.0095 | 137.8056 | 0.0096 | 1 | 5 | ubiquinol-cytochrome-c reductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046983 | 0.0028 | 3.4705 | 3.0616 | 9 | 692 | protein dimerization activity |
GO:0001596 | 0.0044 | Inf | 0.0044 | 1 | 1 | angiotensin type I receptor activity |
GO:0004485 | 0.0044 | Inf | 0.0044 | 1 | 1 | methylcrotonoyl-CoA carboxylase activity |
GO:0004945 | 0.0044 | Inf | 0.0044 | 1 | 1 | angiotensin type II receptor activity |
GO:0005152 | 0.0044 | Inf | 0.0044 | 1 | 1 | interleukin-1 receptor antagonist activity |
GO:0015130 | 0.0044 | Inf | 0.0044 | 1 | 1 | mevalonate transmembrane transporter activity |
GO:0017172 | 0.0044 | Inf | 0.0044 | 1 | 1 | cysteine dioxygenase activity |
GO:0035730 | 0.0044 | Inf | 0.0044 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0044 | Inf | 0.0044 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0047915 | 0.0044 | Inf | 0.0044 | 1 | 1 | ganglioside galactosyltransferase activity |
GO:0070026 | 0.0044 | Inf | 0.0044 | 1 | 1 | nitric oxide binding |
GO:0070888 | 0.0067 | 18.0861 | 0.1239 | 2 | 28 | E-box binding |
GO:0005052 | 0.0088 | 230.2326 | 0.0088 | 1 | 2 | peroxisome matrix targeting signal-1 binding |
GO:0005134 | 0.0088 | 230.2326 | 0.0088 | 1 | 2 | interleukin-2 receptor binding |
GO:0031711 | 0.0088 | 230.2326 | 0.0088 | 1 | 2 | bradykinin receptor binding |
GO:0033872 | 0.0088 | 230.2326 | 0.0088 | 1 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004668 | 0.0032 | Inf | 0.0032 | 1 | 1 | protein-arginine deiminase activity |
GO:0005018 | 0.0032 | Inf | 0.0032 | 1 | 1 | platelet-derived growth factor alpha-receptor activity |
GO:0005163 | 0.0032 | Inf | 0.0032 | 1 | 1 | nerve growth factor receptor binding |
GO:0015130 | 0.0032 | Inf | 0.0032 | 1 | 1 | mevalonate transmembrane transporter activity |
GO:0004565 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | beta-galactosidase activity |
GO:0008321 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | Ral guanyl-nucleotide exchange factor activity |
GO:0033829 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
GO:0038085 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | vascular endothelial growth factor binding |
GO:0050508 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity |
GO:1990459 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | transferrin receptor binding |
GO:1990460 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | leptin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 1e-04 | 17.2684 | 0.2703 | 4 | 64 | serine-type endopeptidase activity |
GO:0017171 | 3e-04 | 13.9815 | 0.3294 | 4 | 78 | serine hydrolase activity |
GO:0070011 | 0.0021 | 5.1065 | 1.3472 | 6 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0004096 | 0.0042 | Inf | 0.0042 | 1 | 1 | catalase activity |
GO:0008725 | 0.0042 | Inf | 0.0042 | 1 | 1 | DNA-3-methyladenine glycosylase activity |
GO:0043916 | 0.0042 | Inf | 0.0042 | 1 | 1 | DNA-7-methylguanine glycosylase activity |
GO:0052821 | 0.0042 | Inf | 0.0042 | 1 | 1 | DNA-7-methyladenine glycosylase activity |
GO:0052822 | 0.0042 | Inf | 0.0042 | 1 | 1 | DNA-3-methylguanine glycosylase activity |
GO:0070611 | 0.0042 | Inf | 0.0042 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0042 | Inf | 0.0042 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GO:0003854 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0004062 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | aryl sulfotransferase activity |
GO:0005153 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | interleukin-8 receptor binding |
GO:0016936 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | galactoside binding |
GO:0030395 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | lactose binding |
GO:0035241 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | protein-arginine omega-N monomethyltransferase activity |
GO:0044020 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | histone methyltransferase activity (H4-R3 specific) |
GO:0047894 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | flavonol 3-sulfotransferase activity |
GO:0050294 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | steroid sulfotransferase activity |
GO:0070492 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | oligosaccharide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 6e-04 | 4.9852 | 1.9346 | 8 | 481 | signaling receptor activity |
GO:0005003 | 0.0012 | 47.3397 | 0.0523 | 2 | 13 | ephrin receptor activity |
GO:0019199 | 0.0023 | 12.6667 | 0.2655 | 3 | 66 | transmembrane receptor protein kinase activity |
GO:0001641 | 0.004 | Inf | 0.004 | 1 | 1 | group II metabotropic glutamate receptor activity |
GO:0017020 | 0.004 | Inf | 0.004 | 1 | 1 | myosin phosphatase regulator activity |
GO:0017064 | 0.004 | Inf | 0.004 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0017124 | 0.0049 | 9.5949 | 0.3459 | 3 | 86 | SH3 domain binding |
GO:0060089 | 0.0055 | 3.3702 | 2.7833 | 8 | 692 | molecular transducer activity |
GO:0048306 | 0.0072 | 17.3246 | 0.1287 | 2 | 32 | calcium-dependent protein binding |
GO:0005006 | 0.008 | 253.9487 | 0.008 | 1 | 2 | epidermal growth factor-activated receptor activity |
GO:0008502 | 0.008 | 253.9487 | 0.008 | 1 | 2 | melatonin receptor activity |
GO:0034485 | 0.008 | 253.9487 | 0.008 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GO:0048408 | 0.008 | 253.9487 | 0.008 | 1 | 2 | epidermal growth factor binding |
GO:0004713 | 0.0087 | 7.7161 | 0.4263 | 3 | 106 | protein tyrosine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008198 | 6e-04 | 70.7143 | 0.0372 | 2 | 10 | ferrous iron binding |
GO:0016701 | 0.0012 | 47.1238 | 0.0521 | 2 | 14 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0009055 | 0.0017 | 14.2435 | 0.2381 | 3 | 64 | electron carrier activity |
GO:0000334 | 0.0037 | Inf | 0.0037 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0004031 | 0.0037 | Inf | 0.0037 | 1 | 1 | aldehyde oxidase activity |
GO:0004854 | 0.0037 | Inf | 0.0037 | 1 | 1 | xanthine dehydrogenase activity |
GO:0008116 | 0.0037 | Inf | 0.0037 | 1 | 1 | prostaglandin-I synthase activity |
GO:0017172 | 0.0037 | Inf | 0.0037 | 1 | 1 | cysteine dioxygenase activity |
GO:0035594 | 0.0037 | Inf | 0.0037 | 1 | 1 | ganglioside binding |
GO:0061627 | 0.0037 | Inf | 0.0037 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
GO:0008374 | 0.0041 | 23.5333 | 0.0967 | 2 | 26 | O-acyltransferase activity |
GO:0003846 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | 2-acylglycerol O-acyltransferase activity |
GO:0004966 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | galanin receptor activity |
GO:0008898 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | S-adenosylmethionine-homocysteine S-methyltransferase activity |
GO:0042923 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | neuropeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008107 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | galactoside 2-alpha-L-fucosyltransferase activity |
GO:0005534 | 0.0084 | 183.6111 | 0.0084 | 1 | 3 | galactose binding |
GO:0050220 | 0.0084 | 183.6111 | 0.0084 | 1 | 3 | prostaglandin-E synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048027 | 4e-04 | 104.5185 | 0.0327 | 2 | 5 | mRNA 5'-UTR binding |
GO:0008083 | 0.0031 | 7.2139 | 0.6078 | 4 | 93 | growth factor activity |
GO:0005169 | 0.0065 | Inf | 0.0065 | 1 | 1 | neurotrophin TRKB receptor binding |
GO:0005307 | 0.0065 | Inf | 0.0065 | 1 | 1 | choline:sodium symporter activity |
GO:0008609 | 0.0065 | Inf | 0.0065 | 1 | 1 | alkylglycerone-phosphate synthase activity |
GO:0003700 | 0.0095 | 2.4869 | 4.9608 | 11 | 759 | sequence-specific DNA binding transcription factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001618 | 0.0028 | 29.283 | 0.0803 | 2 | 17 | virus receptor activity |
GO:0005034 | 0.0047 | Inf | 0.0047 | 1 | 1 | osmosensor activity |
GO:0046556 | 0.0047 | Inf | 0.0047 | 1 | 1 | alpha-L-arabinofuranosidase activity |
GO:0004867 | 0.0087 | 15.6667 | 0.1418 | 2 | 30 | serine-type endopeptidase inhibitor activity |
GO:0005153 | 0.0094 | 215.1522 | 0.0095 | 1 | 2 | interleukin-8 receptor binding |
GO:0005384 | 0.0094 | 215.1522 | 0.0095 | 1 | 2 | manganese ion transmembrane transporter activity |
GO:0032190 | 0.0094 | 215.1522 | 0.0095 | 1 | 2 | acrosin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017020 | 0.0028 | Inf | 0.0028 | 1 | 1 | myosin phosphatase regulator activity |
GO:0030884 | 0.0028 | Inf | 0.0028 | 1 | 1 | exogenous lipid antigen binding |
GO:0072545 | 0.0028 | Inf | 0.0028 | 1 | 1 | tyrosine binding |
GO:0004831 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | tyrosine-tRNA ligase activity |
GO:0005153 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | interleukin-8 receptor binding |
GO:0016907 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | G-protein coupled acetylcholine receptor activity |
GO:0030881 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | beta-2-microglobulin binding |
GO:0034485 | 0.0056 | 367.2593 | 0.0056 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GO:0004689 | 0.0084 | 183.6111 | 0.0084 | 1 | 3 | phosphorylase kinase activity |
GO:0052659 | 0.0084 | 183.6111 | 0.0084 | 1 | 3 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 0.0037 | Inf | 0.0037 | 1 | 1 | leukotriene B4 receptor activity |
GO:0003875 | 0.0037 | Inf | 0.0037 | 1 | 1 | ADP-ribosylarginine hydrolase activity |
GO:0004031 | 0.0037 | Inf | 0.0037 | 1 | 1 | aldehyde oxidase activity |
GO:0004854 | 0.0037 | Inf | 0.0037 | 1 | 1 | xanthine dehydrogenase activity |
GO:0019958 | 0.0037 | Inf | 0.0037 | 1 | 1 | C-X-C chemokine binding |
GO:0033041 | 0.0037 | Inf | 0.0037 | 1 | 1 | sweet taste receptor activity |
GO:0035755 | 0.0037 | Inf | 0.0037 | 1 | 1 | cardiolipin hydrolase activity |
GO:0004459 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | L-lactate dehydrogenase activity |
GO:0005094 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | Rho GDP-dissociation inhibitor activity |
GO:0031781 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | type 4 melanocortin receptor binding |
GO:0050682 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | AF-2 domain binding |
GO:0070996 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | type 1 melanocortin receptor binding |
GO:0071253 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | connexin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 0 | Inf | 0.0099 | 2 | 2 | aryldialkylphosphatase activity |
GO:0004064 | 1e-04 | 210.5106 | 0.0197 | 2 | 4 | arylesterase activity |
GO:0008430 | 0.001 | 52.5957 | 0.0493 | 2 | 10 | selenium binding |
GO:0050750 | 0.001 | 52.5957 | 0.0493 | 2 | 10 | low-density lipoprotein particle receptor binding |
GO:0008083 | 0.0011 | 9.7948 | 0.4582 | 4 | 93 | growth factor activity |
GO:0005543 | 0.0026 | 5.805 | 0.9608 | 5 | 195 | phospholipid binding |
GO:0004411 | 0.0049 | Inf | 0.0049 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0009032 | 0.0049 | Inf | 0.0049 | 1 | 1 | thymidine phosphorylase activity |
GO:0016154 | 0.0049 | Inf | 0.0049 | 1 | 1 | pyrimidine-nucleoside phosphorylase activity |
GO:0017064 | 0.0049 | Inf | 0.0049 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0017174 | 0.0049 | Inf | 0.0049 | 1 | 1 | glycine N-methyltransferase activity |
GO:0018733 | 0.0049 | Inf | 0.0049 | 1 | 1 | 3,4-dihydrocoumarin hydrolase activity |
GO:0047747 | 0.0049 | Inf | 0.0049 | 1 | 1 | cholate-CoA ligase activity |
GO:0047856 | 0.0049 | Inf | 0.0049 | 1 | 1 | dihydrocoumarin hydrolase activity |
GO:0070002 | 0.0049 | Inf | 0.0049 | 1 | 1 | glutamic-type peptidase activity |
GO:0004030 | 0.0098 | 206.1458 | 0.0099 | 1 | 2 | aldehyde dehydrogenase [NAD(P)+] activity |
GO:0008502 | 0.0098 | 206.1458 | 0.0099 | 1 | 2 | melatonin receptor activity |
GO:0032051 | 0.0098 | 206.1458 | 0.0099 | 1 | 2 | clathrin light chain binding |
GO:0034189 | 0.0098 | 206.1458 | 0.0099 | 1 | 2 | very-low-density lipoprotein particle binding |
GO:0047066 | 0.0098 | 206.1458 | 0.0099 | 1 | 2 | phospholipid-hydroperoxide glutathione peroxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005506 | 0.0027 | 12.1047 | 0.2799 | 3 | 87 | iron ion binding |
GO:0001616 | 0.0032 | Inf | 0.0032 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0004052 | 0.0032 | Inf | 0.0032 | 1 | 1 | arachidonate 12-lipoxygenase activity |
GO:0031854 | 0.0032 | Inf | 0.0032 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0047977 | 0.0032 | Inf | 0.0032 | 1 | 1 | hepoxilin-epoxide hydrolase activity |
GO:0005094 | 0.0064 | 319.7419 | 0.0064 | 1 | 2 | Rho GDP-dissociation inhibitor activity |
GO:0015433 | 0.0064 | 319.7419 | 0.0064 | 1 | 2 | peptide antigen-transporting ATPase activity |
GO:0016165 | 0.0064 | 319.7419 | 0.0064 | 1 | 2 | linoleate 13S-lipoxygenase activity |
GO:0046979 | 0.0064 | 319.7419 | 0.0064 | 1 | 2 | TAP2 binding |
GO:0051120 | 0.0064 | 319.7419 | 0.0064 | 1 | 2 | hepoxilin A3 synthase activity |
GO:0008426 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | protein kinase C inhibitor activity |
GO:0016493 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | C-C chemokine receptor activity |
GO:0046978 | 0.0096 | 159.8548 | 0.0097 | 1 | 3 | TAP1 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010844 | 0.0024 | Inf | 0.0024 | 1 | 1 | recombination hotspot binding |
GO:0047747 | 0.0024 | Inf | 0.0024 | 1 | 1 | cholate-CoA ligase activity |
GO:0048248 | 0.0024 | Inf | 0.0024 | 1 | 1 | CXCR3 chemokine receptor binding |
GO:0001733 | 0.0072 | 215.6304 | 0.0072 | 1 | 3 | galactosylceramide sulfotransferase activity |
GO:0015245 | 0.0072 | 215.6304 | 0.0072 | 1 | 3 | fatty acid transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0.0019 | 4.0323 | 2.3397 | 8 | 554 | sequence-specific DNA binding |
GO:0004052 | 0.0042 | Inf | 0.0042 | 1 | 1 | arachidonate 12-lipoxygenase activity |
GO:0010577 | 0.0042 | Inf | 0.0042 | 1 | 1 | metalloenzyme activator activity |
GO:0032395 | 0.0042 | Inf | 0.0042 | 1 | 1 | MHC class II receptor activity |
GO:0047977 | 0.0042 | Inf | 0.0042 | 1 | 1 | hepoxilin-epoxide hydrolase activity |
GO:0016165 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | linoleate 13S-lipoxygenase activity |
GO:0050682 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | AF-2 domain binding |
GO:0050698 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | proteoglycan sulfotransferase activity |
GO:0051120 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | hepoxilin A3 synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 827.6667 | 0.005 | 2 | 5 | olfactory receptor activity |
GO:0022851 | 0.001 | Inf | 0.001 | 1 | 1 | GABA-gated chloride ion channel activity |
GO:0004609 | 0.002 | 1103.7778 | 0.002 | 1 | 2 | phosphatidylserine decarboxylase activity |
GO:0008900 | 0.003 | 551.8333 | 0.003 | 1 | 3 | hydrogen:potassium-exchanging ATPase activity |
GO:0022835 | 0.003 | 551.8333 | 0.003 | 1 | 3 | transmitter-gated channel activity |
GO:0004890 | 0.005 | 275.8611 | 0.005 | 1 | 5 | GABA-A receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 0 | Inf | 0.0076 | 2 | 2 | aryldialkylphosphatase activity |
GO:0005184 | 0 | 79.3797 | 0.0521 | 3 | 14 | neuropeptide hormone activity |
GO:0004064 | 1e-04 | 275.1389 | 0.0153 | 2 | 4 | arylesterase activity |
GO:0002058 | 0.0038 | Inf | 0.0038 | 1 | 1 | uracil binding |
GO:0002059 | 0.0038 | Inf | 0.0038 | 1 | 1 | thymine binding |
GO:0004042 | 0.0038 | Inf | 0.0038 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
GO:0004052 | 0.0038 | Inf | 0.0038 | 1 | 1 | arachidonate 12-lipoxygenase activity |
GO:0005185 | 0.0038 | Inf | 0.0038 | 1 | 1 | neurohypophyseal hormone activity |
GO:0017045 | 0.0038 | Inf | 0.0038 | 1 | 1 | corticotropin-releasing hormone activity |
GO:0018733 | 0.0038 | Inf | 0.0038 | 1 | 1 | 3,4-dihydrocoumarin hydrolase activity |
GO:0031855 | 0.0038 | Inf | 0.0038 | 1 | 1 | oxytocin receptor binding |
GO:0047856 | 0.0038 | Inf | 0.0038 | 1 | 1 | dihydrocoumarin hydrolase activity |
GO:0047977 | 0.0038 | Inf | 0.0038 | 1 | 1 | hepoxilin-epoxide hydrolase activity |
GO:0005509 | 0.0039 | 4.5033 | 1.536 | 6 | 402 | calcium ion binding |
GO:0003847 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO:0004067 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | asparaginase activity |
GO:0004157 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | dihydropyrimidinase activity |
GO:0016165 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | linoleate 13S-lipoxygenase activity |
GO:0050682 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | AF-2 domain binding |
GO:0051120 | 0.0076 | 267.7297 | 0.0076 | 1 | 2 | hepoxilin A3 synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001618 | 0.0026 | 30.6512 | 0.0769 | 2 | 17 | virus receptor activity |
GO:0005034 | 0.0045 | Inf | 0.0045 | 1 | 1 | osmosensor activity |
GO:0046556 | 0.0045 | Inf | 0.0045 | 1 | 1 | alpha-L-arabinofuranosidase activity |
GO:0004035 | 0.009 | 224.9773 | 0.009 | 1 | 2 | alkaline phosphatase activity |
GO:0005153 | 0.009 | 224.9773 | 0.009 | 1 | 2 | interleukin-8 receptor binding |
GO:0005384 | 0.009 | 224.9773 | 0.009 | 1 | 2 | manganese ion transmembrane transporter activity |
GO:0016934 | 0.009 | 224.9773 | 0.009 | 1 | 2 | extracellular-glycine-gated chloride channel activity |
GO:0032190 | 0.009 | 224.9773 | 0.009 | 1 | 2 | acrosin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048027 | 4e-04 | 107.9672 | 0.0317 | 2 | 5 | mRNA 5'-UTR binding |
GO:0044212 | 0.0023 | 3.8034 | 2.3566 | 8 | 372 | transcription regulatory region DNA binding |
GO:0001067 | 0.0025 | 3.7499 | 2.3882 | 8 | 377 | regulatory region nucleic acid binding |
GO:0008083 | 0.0028 | 7.4599 | 0.5891 | 4 | 93 | growth factor activity |
GO:0005169 | 0.0063 | Inf | 0.0063 | 1 | 1 | neurotrophin TRKB receptor binding |
GO:0008609 | 0.0063 | Inf | 0.0063 | 1 | 1 | alkylglycerone-phosphate synthase activity |
GO:0003700 | 0.0075 | 2.5831 | 4.8081 | 11 | 759 | sequence-specific DNA binding transcription factor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002125 | 0 | Inf | 0.0885 | 4 | 4 | maternal aggressive behavior |
GO:0051970 | 0 | Inf | 0.0664 | 3 | 3 | negative regulation of transmission of nerve impulse |
GO:0007200 | 0 | 8.2413 | 1.1507 | 8 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0007218 | 0 | 5.9927 | 1.9031 | 10 | 86 | neuropeptide signaling pathway |
GO:0032849 | 0 | 133.9928 | 0.0885 | 3 | 4 | positive regulation of cellular pH reduction |
GO:0050801 | 1e-04 | 2.5071 | 10.4007 | 24 | 470 | ion homeostasis |
GO:0007267 | 1e-04 | 3.6571 | 3.8906 | 13 | 185 | cell-cell signaling |
GO:0007625 | 2e-04 | 17.9174 | 0.3098 | 4 | 14 | grooming behavior |
GO:0044705 | 2e-04 | 10.6944 | 0.5754 | 5 | 26 | multi-organism reproductive behavior |
GO:2000026 | 2e-04 | 1.8918 | 25.537 | 44 | 1154 | regulation of multicellular organismal development |
GO:2000824 | 5e-04 | Inf | 0.0443 | 2 | 2 | negative regulation of androgen receptor activity |
GO:0060180 | 6e-04 | 26.7899 | 0.177 | 3 | 8 | female mating behavior |
GO:0071236 | 6e-04 | 26.7899 | 0.177 | 3 | 8 | cellular response to antibiotic |
GO:0007263 | 6e-04 | 12.794 | 0.3983 | 4 | 18 | nitric oxide mediated signal transduction |
GO:0032892 | 6e-04 | 12.794 | 0.3983 | 4 | 18 | positive regulation of organic acid transport |
GO:0060429 | 6e-04 | 1.9366 | 19.5843 | 35 | 885 | epithelium development |
GO:0042220 | 6e-04 | 8.3138 | 0.7081 | 5 | 32 | response to cocaine |
GO:0006694 | 8e-04 | 3.9953 | 2.4563 | 9 | 111 | steroid biosynthetic process |
GO:0007204 | 9e-04 | 3.3322 | 3.5628 | 11 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0007618 | 0.0011 | 7.2387 | 0.7966 | 5 | 36 | mating |
GO:0043269 | 0.0011 | 2.2907 | 9.3385 | 20 | 422 | regulation of ion transport |
GO:0043084 | 0.0011 | 19.1325 | 0.2213 | 3 | 10 | penile erection |
GO:0006970 | 0.0012 | 5.6227 | 1.195 | 6 | 54 | response to osmotic stress |
GO:0043627 | 0.0013 | 3.4085 | 3.1645 | 10 | 143 | response to estrogen |
GO:0055082 | 0.0013 | 2.2616 | 9.4491 | 20 | 427 | cellular chemical homeostasis |
GO:0007610 | 0.0014 | 2.1163 | 11.6178 | 23 | 525 | behavior |
GO:0045666 | 0.0014 | 4.5723 | 1.6818 | 7 | 76 | positive regulation of neuron differentiation |
GO:0014049 | 0.0014 | 89.0072 | 0.0664 | 2 | 3 | positive regulation of glutamate secretion |
GO:0031394 | 0.0014 | 89.0072 | 0.0664 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0097211 | 0.0014 | 89.0072 | 0.0664 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0042711 | 0.0016 | 16.7396 | 0.2434 | 3 | 11 | maternal behavior |
GO:0015672 | 0.0016 | 2.3326 | 8.232 | 18 | 372 | monovalent inorganic cation transport |
GO:0044058 | 0.0018 | 8.9514 | 0.5311 | 4 | 24 | regulation of digestive system process |
GO:0030003 | 0.0018 | 2.3737 | 7.6346 | 17 | 345 | cellular cation homeostasis |
GO:0055074 | 0.0019 | 15.3258 | 0.2581 | 3 | 12 | calcium ion homeostasis |
GO:0030001 | 0.0019 | 2.0006 | 13.3439 | 25 | 603 | metal ion transport |
GO:0045851 | 0.0021 | 8.5245 | 0.5532 | 4 | 25 | pH reduction |
GO:0051216 | 0.0021 | 3.1676 | 3.3858 | 10 | 153 | cartilage development |
GO:1901654 | 0.0022 | 4.2044 | 1.8146 | 7 | 82 | response to ketone |
GO:0009790 | 0.0023 | 1.7998 | 19.6507 | 33 | 888 | embryo development |
GO:0007399 | 0.0024 | 1.5803 | 38.6375 | 56 | 1746 | nervous system development |
GO:0009952 | 0.0025 | 2.9044 | 4.0446 | 11 | 184 | anterior/posterior pattern specification |
GO:0071248 | 0.0026 | 4.0946 | 1.8588 | 7 | 84 | cellular response to metal ion |
GO:0006874 | 0.0026 | 2.6169 | 5.2889 | 13 | 239 | cellular calcium ion homeostasis |
GO:0009887 | 0.0026 | 2.0848 | 10.7291 | 21 | 498 | organ morphogenesis |
GO:0003084 | 0.0026 | 13.3895 | 0.2877 | 3 | 13 | positive regulation of systemic arterial blood pressure |
GO:0030890 | 0.0028 | 7.782 | 0.5975 | 4 | 27 | positive regulation of B cell proliferation |
GO:0007621 | 0.0028 | 44.5 | 0.0885 | 2 | 4 | negative regulation of female receptivity |
GO:2001279 | 0.0028 | 44.5 | 0.0885 | 2 | 4 | regulation of unsaturated fatty acid biosynthetic process |
GO:0044707 | 0.0032 | 1.4367 | 87.8563 | 109 | 4194 | single-multicellular organism process |
GO:0021542 | 0.0033 | 12.1713 | 0.3098 | 3 | 14 | dentate gyrus development |
GO:2000310 | 0.0033 | 12.1713 | 0.3098 | 3 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0032502 | 0.0033 | 1.4103 | 95.8634 | 118 | 4332 | developmental process |
GO:0007389 | 0.0033 | 2.1683 | 8.8074 | 18 | 398 | pattern specification process |
GO:0050864 | 0.0036 | 4.4198 | 1.4827 | 6 | 67 | regulation of B cell activation |
GO:0044060 | 0.0036 | 7.1583 | 0.6417 | 4 | 29 | regulation of endocrine process |
GO:0007268 | 0.004 | 1.8808 | 14.1184 | 25 | 638 | synaptic transmission |
GO:0070374 | 0.0045 | 3.6634 | 2.058 | 7 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0045165 | 0.0045 | 2.5441 | 5.0012 | 12 | 226 | cell fate commitment |
GO:0055078 | 0.0046 | 6.6269 | 0.686 | 4 | 31 | sodium ion homeostasis |
GO:0008611 | 0.0047 | 29.6643 | 0.1106 | 2 | 5 | ether lipid biosynthetic process |
GO:0042713 | 0.0047 | 29.6643 | 0.1106 | 2 | 5 | sperm ejaculation |
GO:0071374 | 0.0047 | 29.6643 | 0.1106 | 2 | 5 | cellular response to parathyroid hormone stimulus |
GO:1901503 | 0.0047 | 29.6643 | 0.1106 | 2 | 5 | ether biosynthetic process |
GO:2001199 | 0.0047 | 29.6643 | 0.1106 | 2 | 5 | negative regulation of dendritic cell differentiation |
GO:0034694 | 0.0048 | 10.2971 | 0.3541 | 3 | 16 | response to prostaglandin |
GO:0035813 | 0.0048 | 10.2971 | 0.3541 | 3 | 16 | regulation of renal sodium excretion |
GO:0003044 | 0.0052 | 6.3898 | 0.7081 | 4 | 32 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0007205 | 0.0052 | 6.3898 | 0.7081 | 4 | 32 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0051453 | 0.0052 | 6.3898 | 0.7081 | 4 | 32 | regulation of intracellular pH |
GO:0002700 | 0.0052 | 4.8723 | 1.1286 | 5 | 51 | regulation of production of molecular mediator of immune response |
GO:0048562 | 0.0053 | 2.3903 | 5.7536 | 13 | 260 | embryonic organ morphogenesis |
GO:0007166 | 0.0056 | 1.457 | 51.7158 | 69 | 2337 | cell surface receptor signaling pathway |
GO:0051048 | 0.0057 | 3.1628 | 2.6998 | 8 | 122 | negative regulation of secretion |
GO:0033993 | 0.0057 | 1.9017 | 12.2374 | 22 | 553 | response to lipid |
GO:0034367 | 0.0058 | 9.5609 | 0.3762 | 3 | 17 | macromolecular complex remodeling |
GO:0034369 | 0.0058 | 9.5609 | 0.3762 | 3 | 17 | plasma lipoprotein particle remodeling |
GO:0030901 | 0.0058 | 6.1689 | 0.7303 | 4 | 33 | midbrain development |
GO:0006820 | 0.0058 | 2.0911 | 8.5861 | 17 | 388 | anion transport |
GO:0055085 | 0.0061 | 1.6535 | 22.5496 | 35 | 1019 | transmembrane transport |
GO:0023061 | 0.0064 | 2.181 | 7.2584 | 15 | 328 | signal release |
GO:0031644 | 0.0065 | 5.9628 | 0.7524 | 4 | 34 | regulation of neurological system process |
GO:0035176 | 0.0065 | 5.9628 | 0.7524 | 4 | 34 | social behavior |
GO:0009888 | 0.0065 | 1.9474 | 10.8884 | 20 | 523 | tissue development |
GO:0002739 | 0.0069 | 22.2464 | 0.1328 | 2 | 6 | regulation of cytokine secretion involved in immune response |
GO:0021797 | 0.0069 | 22.2464 | 0.1328 | 2 | 6 | forebrain anterior/posterior pattern specification |
GO:0042756 | 0.0069 | 22.2464 | 0.1328 | 2 | 6 | drinking behavior |
GO:0072567 | 0.0069 | 22.2464 | 0.1328 | 2 | 6 | chemokine (C-X-C motif) ligand 2 production |
GO:0051241 | 0.007 | 2.2243 | 6.6387 | 14 | 300 | negative regulation of multicellular organismal process |
GO:0007188 | 0.0075 | 3.3139 | 2.2572 | 7 | 102 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0042592 | 0.0075 | 1.6163 | 23.7003 | 36 | 1071 | homeostatic process |
GO:0042221 | 0.0075 | 1.414 | 59.6159 | 77 | 2694 | response to chemical |
GO:0034612 | 0.0079 | 3.2791 | 2.2793 | 7 | 103 | response to tumor necrosis factor |
GO:0015833 | 0.0079 | 2.4639 | 4.7135 | 11 | 213 | peptide transport |
GO:0034122 | 0.008 | 8.3644 | 0.4205 | 3 | 19 | negative regulation of toll-like receptor signaling pathway |
GO:0048016 | 0.008 | 8.3644 | 0.4205 | 3 | 19 | inositol phosphate-mediated signaling |
GO:0001776 | 0.0084 | 4.308 | 1.2614 | 5 | 57 | leukocyte homeostasis |
GO:0003208 | 0.0084 | 4.308 | 1.2614 | 5 | 57 | cardiac ventricle morphogenesis |
GO:0036342 | 0.0092 | 7.8717 | 0.4426 | 3 | 20 | post-anal tail morphogenesis |
GO:0051954 | 0.0092 | 7.8717 | 0.4426 | 3 | 20 | positive regulation of amine transport |
GO:0003310 | 0.0095 | 17.7957 | 0.1549 | 2 | 7 | pancreatic A cell differentiation |
GO:0032308 | 0.0095 | 17.7957 | 0.1549 | 2 | 7 | positive regulation of prostaglandin secretion |
GO:0033504 | 0.0095 | 17.7957 | 0.1549 | 2 | 7 | floor plate development |
GO:0042538 | 0.0095 | 17.7957 | 0.1549 | 2 | 7 | hyperosmotic salinity response |
GO:0033209 | 0.0096 | 5.2596 | 0.8409 | 4 | 38 | tumor necrosis factor-mediated signaling pathway |
GO:0007588 | 0.0097 | 4.1478 | 1.3056 | 5 | 59 | excretion |
GO:0008284 | 0.01 | 1.7778 | 13.6315 | 23 | 616 | positive regulation of cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 64.8052 | 0.1757 | 6 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 12.3274 | 0.8784 | 9 | 65 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 12.7137 | 0.7568 | 8 | 56 | detection of chemical stimulus |
GO:0007606 | 0 | 8.6912 | 0.919 | 7 | 68 | sensory perception of chemical stimulus |
GO:0050877 | 3e-04 | 2.5079 | 9.6764 | 22 | 716 | neurological system process |
GO:0006813 | 0.0015 | 3.9549 | 2.1758 | 8 | 161 | potassium ion transport |
GO:0071805 | 0.0017 | 4.3604 | 1.7299 | 7 | 128 | potassium ion transmembrane transport |
GO:0031424 | 0.0027 | 12.3651 | 0.2838 | 3 | 21 | keratinization |
GO:0098655 | 0.0034 | 2.3633 | 6.7978 | 15 | 503 | cation transmembrane transport |
GO:0043252 | 0.0048 | 24.6075 | 0.1081 | 2 | 8 | sodium-independent organic anion transport |
GO:0055085 | 0.0052 | 1.8849 | 13.7714 | 24 | 1019 | transmembrane transport |
GO:2000107 | 0.0075 | 8.2374 | 0.4054 | 3 | 30 | negative regulation of leukocyte apoptotic process |
GO:0032836 | 0.0076 | 18.4527 | 0.1351 | 2 | 10 | glomerular basement membrane development |
GO:0042428 | 0.0076 | 18.4527 | 0.1351 | 2 | 10 | serotonin metabolic process |
GO:0032963 | 0.0085 | 4.2422 | 1.2569 | 5 | 93 | collagen metabolic process |
GO:0002709 | 0.009 | 7.6681 | 0.4325 | 3 | 32 | regulation of T cell mediated immunity |
GO:0007210 | 0.0092 | 16.4011 | 0.1487 | 2 | 11 | serotonin receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048568 | 0 | 4.8861 | 5.9453 | 25 | 299 | embryonic organ development |
GO:0001501 | 0 | 4.118 | 7.8299 | 28 | 387 | skeletal system development |
GO:0043009 | 0 | 3.7067 | 7.962 | 26 | 403 | chordate embryonic development |
GO:0009952 | 0 | 5.7746 | 2.9772 | 15 | 149 | anterior/posterior pattern specification |
GO:0032502 | 0 | 1.8875 | 87.6466 | 126 | 4332 | developmental process |
GO:0007389 | 0 | 3.4887 | 8.0525 | 25 | 398 | pattern specification process |
GO:0048701 | 0 | 12.086 | 0.8295 | 8 | 41 | embryonic cranial skeleton morphogenesis |
GO:0048598 | 0 | 3.1862 | 8.3857 | 24 | 430 | embryonic morphogenesis |
GO:2000679 | 0 | 49.1786 | 0.1619 | 4 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0060231 | 0 | 20.5594 | 0.344 | 5 | 17 | mesenchymal to epithelial transition |
GO:0045944 | 0 | 2.4035 | 15.2147 | 33 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009887 | 0 | 2.8007 | 9.443 | 24 | 483 | organ morphogenesis |
GO:0048485 | 0 | 16.4436 | 0.4046 | 5 | 20 | sympathetic nervous system development |
GO:0097503 | 0 | 16.4436 | 0.4046 | 5 | 20 | sialylation |
GO:0048704 | 0 | 8.5214 | 0.9635 | 7 | 49 | embryonic skeletal system morphogenesis |
GO:0021543 | 1e-04 | 6.86 | 1.3343 | 8 | 67 | pallium development |
GO:0048863 | 1e-04 | 3.269 | 5.6853 | 17 | 281 | stem cell differentiation |
GO:0000904 | 1e-04 | 2.334 | 14.6078 | 31 | 722 | cell morphogenesis involved in differentiation |
GO:0051252 | 1e-04 | 1.7022 | 58.4108 | 85 | 2887 | regulation of RNA metabolic process |
GO:0048729 | 1e-04 | 2.5967 | 9.6508 | 23 | 477 | tissue morphogenesis |
GO:0006355 | 1e-04 | 1.6917 | 56.3066 | 82 | 2783 | regulation of transcription, DNA-templated |
GO:0035107 | 1e-04 | 4.3035 | 2.8123 | 11 | 139 | appendage morphogenesis |
GO:0010556 | 1e-04 | 1.6555 | 62.8822 | 89 | 3108 | regulation of macromolecule biosynthetic process |
GO:2000026 | 2e-04 | 2.0018 | 22.078 | 40 | 1109 | regulation of multicellular organismal development |
GO:0045596 | 2e-04 | 2.567 | 9.3069 | 22 | 460 | negative regulation of cell differentiation |
GO:0048731 | 2e-04 | 1.7148 | 49.8337 | 73 | 2737 | system development |
GO:0031326 | 2e-04 | 1.6266 | 65.3505 | 91 | 3230 | regulation of cellular biosynthetic process |
GO:0061005 | 2e-04 | 8.0173 | 0.87 | 6 | 43 | cell differentiation involved in kidney development |
GO:0044707 | 2e-04 | 1.6343 | 76.6555 | 102 | 4194 | single-multicellular organism process |
GO:0003357 | 3e-04 | 36.7381 | 0.1416 | 3 | 7 | noradrenergic neuron differentiation |
GO:0032000 | 3e-04 | 36.7381 | 0.1416 | 3 | 7 | positive regulation of fatty acid beta-oxidation |
GO:0001656 | 3e-04 | 5.1613 | 1.7198 | 8 | 85 | metanephros development |
GO:0061180 | 3e-04 | 5.9807 | 1.3151 | 7 | 65 | mammary gland epithelium development |
GO:0060173 | 3e-04 | 3.7674 | 3.1765 | 11 | 157 | limb development |
GO:0048663 | 4e-04 | 5.6852 | 1.3758 | 7 | 68 | neuron fate commitment |
GO:0048870 | 4e-04 | 1.9946 | 18.5733 | 34 | 918 | cell motility |
GO:0010628 | 4e-04 | 1.9045 | 22.4175 | 39 | 1108 | positive regulation of gene expression |
GO:0009891 | 4e-04 | 1.8495 | 25.5535 | 43 | 1263 | positive regulation of biosynthetic process |
GO:0065007 | 6e-04 | 1.5884 | 165.4804 | 190 | 8179 | biological regulation |
GO:0006688 | 6e-04 | 24.6733 | 0.1808 | 3 | 9 | glycosphingolipid biosynthetic process |
GO:0032989 | 7e-04 | 1.8784 | 21.4463 | 37 | 1060 | cellular component morphogenesis |
GO:0045923 | 7e-04 | 11.5593 | 0.4249 | 4 | 21 | positive regulation of fatty acid metabolic process |
GO:0014033 | 8e-04 | 6.048 | 1.1128 | 6 | 55 | neural crest cell differentiation |
GO:0001708 | 9e-04 | 5.0228 | 1.5377 | 7 | 76 | cell fate specification |
GO:0046320 | 9e-04 | 10.9162 | 0.4451 | 4 | 22 | regulation of fatty acid oxidation |
GO:0060562 | 0.0011 | 2.9154 | 4.7832 | 13 | 240 | epithelial tube morphogenesis |
GO:0060485 | 0.0011 | 3.2486 | 3.6418 | 11 | 180 | mesenchyme development |
GO:0050896 | 0.0011 | 1.4853 | 119.29 | 144 | 5896 | response to stimulus |
GO:0048732 | 0.0012 | 2.4774 | 7.3443 | 17 | 363 | gland development |
GO:1902680 | 0.0012 | 1.8389 | 21.2237 | 36 | 1049 | positive regulation of RNA biosynthetic process |
GO:0061029 | 0.0012 | 18.3631 | 0.2226 | 3 | 11 | eyelid development in camera-type eye |
GO:0001705 | 0.0012 | 97.6063 | 0.0607 | 2 | 3 | ectoderm formation |
GO:0003253 | 0.0012 | 97.6063 | 0.0607 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0014031 | 0.0012 | 3.7278 | 2.61 | 9 | 129 | mesenchymal cell development |
GO:0072091 | 0.0013 | 4.6187 | 1.6591 | 7 | 82 | regulation of stem cell proliferation |
GO:0071333 | 0.0014 | 5.3856 | 1.2342 | 6 | 61 | cellular response to glucose stimulus |
GO:0040017 | 0.0015 | 2.7929 | 4.9772 | 13 | 246 | positive regulation of locomotion |
GO:0045725 | 0.0016 | 16.3215 | 0.2428 | 3 | 12 | positive regulation of glycogen biosynthetic process |
GO:0072182 | 0.0016 | 16.3215 | 0.2428 | 3 | 12 | regulation of nephron tubule epithelial cell differentiation |
GO:0007409 | 0.0016 | 2.2226 | 9.6186 | 20 | 479 | axonogenesis |
GO:0071326 | 0.0018 | 5.1058 | 1.2949 | 6 | 64 | cellular response to monosaccharide stimulus |
GO:0021953 | 0.0019 | 3.2317 | 3.3181 | 10 | 164 | central nervous system neuron differentiation |
GO:0034654 | 0.002 | 1.4958 | 65.128 | 86 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0072283 | 0.002 | 14.6881 | 0.263 | 3 | 13 | metanephric renal vesicle morphogenesis |
GO:0090183 | 0.0021 | 6.1539 | 0.9105 | 5 | 45 | regulation of kidney development |
GO:0050794 | 0.0022 | 1.4898 | 136.2509 | 158 | 7054 | regulation of cellular process |
GO:0002064 | 0.0022 | 3.1489 | 3.399 | 10 | 168 | epithelial cell development |
GO:0001960 | 0.0023 | 8.1832 | 0.5665 | 4 | 28 | negative regulation of cytokine-mediated signaling pathway |
GO:0046189 | 0.0023 | 8.1832 | 0.5665 | 4 | 28 | phenol-containing compound biosynthetic process |
GO:0022603 | 0.0023 | 2.0024 | 12.8071 | 24 | 633 | regulation of anatomical structure morphogenesis |
GO:0007412 | 0.0024 | 48.7992 | 0.0809 | 2 | 4 | axon target recognition |
GO:0021569 | 0.0024 | 48.7992 | 0.0809 | 2 | 4 | rhombomere 3 development |
GO:0042738 | 0.0024 | 48.7992 | 0.0809 | 2 | 4 | exogenous drug catabolic process |
GO:0060708 | 0.0024 | 48.7992 | 0.0809 | 2 | 4 | spongiotrophoblast differentiation |
GO:0048858 | 0.0024 | 1.9388 | 14.3447 | 26 | 709 | cell projection morphogenesis |
GO:0009746 | 0.0024 | 3.6705 | 2.347 | 8 | 116 | response to hexose |
GO:0051101 | 0.0025 | 4.7748 | 1.3758 | 6 | 68 | regulation of DNA binding |
GO:0007420 | 0.0026 | 2.2253 | 8.6152 | 18 | 435 | brain development |
GO:0009954 | 0.0026 | 7.8552 | 0.5867 | 4 | 29 | proximal/distal pattern formation |
GO:0080090 | 0.0026 | 1.4418 | 92.0168 | 114 | 4548 | regulation of primary metabolic process |
GO:0031175 | 0.0029 | 1.9121 | 14.5268 | 26 | 718 | neuron projection development |
GO:0061053 | 0.0029 | 4.6249 | 1.4163 | 6 | 70 | somite development |
GO:1901576 | 0.003 | 1.4333 | 93.2914 | 115 | 4611 | organic substance biosynthetic process |
GO:0021766 | 0.003 | 5.5926 | 0.9914 | 5 | 49 | hippocampus development |
GO:0050679 | 0.003 | 3.5383 | 2.4279 | 8 | 120 | positive regulation of epithelial cell proliferation |
GO:0060065 | 0.0031 | 12.2381 | 0.3035 | 3 | 15 | uterus development |
GO:0046879 | 0.0032 | 2.6605 | 4.7951 | 12 | 237 | hormone secretion |
GO:0007423 | 0.0034 | 3.1775 | 3.026 | 9 | 154 | sensory organ development |
GO:0045935 | 0.0035 | 1.6886 | 24.2384 | 38 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0001764 | 0.0035 | 3.4452 | 2.4886 | 8 | 123 | neuron migration |
GO:0051272 | 0.0036 | 2.6249 | 4.8558 | 12 | 240 | positive regulation of cellular component movement |
GO:0021915 | 0.0036 | 3.1446 | 3.0551 | 9 | 151 | neural tube development |
GO:0034645 | 0.0039 | 1.4351 | 75.8916 | 96 | 3751 | cellular macromolecule biosynthetic process |
GO:0021885 | 0.0039 | 5.2344 | 1.0521 | 5 | 52 | forebrain cell migration |
GO:0003180 | 0.0039 | 32.5302 | 0.1012 | 2 | 5 | aortic valve morphogenesis |
GO:0030718 | 0.0039 | 32.5302 | 0.1012 | 2 | 5 | germ-line stem cell maintenance |
GO:0042421 | 0.0039 | 32.5302 | 0.1012 | 2 | 5 | norepinephrine biosynthetic process |
GO:0071637 | 0.0039 | 32.5302 | 0.1012 | 2 | 5 | regulation of monocyte chemotactic protein-1 production |
GO:0061138 | 0.0041 | 2.8723 | 3.7025 | 10 | 183 | morphogenesis of a branching epithelium |
GO:0003156 | 0.0042 | 6.7696 | 0.6677 | 4 | 33 | regulation of organ formation |
GO:0050994 | 0.0042 | 6.7696 | 0.6677 | 4 | 33 | regulation of lipid catabolic process |
GO:0090287 | 0.0045 | 3.0364 | 3.1562 | 9 | 156 | regulation of cellular response to growth factor stimulus |
GO:0072001 | 0.0045 | 2.5452 | 4.9974 | 12 | 247 | renal system development |
GO:0060713 | 0.0045 | 10.4881 | 0.344 | 3 | 17 | labyrinthine layer morphogenesis |
GO:0071773 | 0.0045 | 10.4881 | 0.344 | 3 | 17 | cellular response to BMP stimulus |
GO:0072087 | 0.0045 | 10.4881 | 0.344 | 3 | 17 | renal vesicle development |
GO:0008284 | 0.0046 | 2.0539 | 9.8147 | 19 | 496 | positive regulation of cell proliferation |
GO:0035148 | 0.0049 | 3.2456 | 2.6302 | 8 | 130 | tube formation |
GO:0003007 | 0.0051 | 2.7747 | 3.8239 | 10 | 189 | heart morphogenesis |
GO:0030902 | 0.0051 | 3.219 | 2.6504 | 8 | 131 | hindbrain development |
GO:0007398 | 0.0052 | 9.8653 | 0.3614 | 3 | 18 | ectoderm development |
GO:0002053 | 0.0052 | 6.3318 | 0.7081 | 4 | 35 | positive regulation of mesenchymal cell proliferation |
GO:0001667 | 0.0054 | 2.6056 | 4.4714 | 11 | 221 | ameboidal cell migration |
GO:0001654 | 0.0055 | 2.3759 | 5.7865 | 13 | 286 | eye development |
GO:0001892 | 0.0056 | 3.9966 | 1.6186 | 6 | 80 | embryonic placenta development |
GO:0048839 | 0.0057 | 2.9159 | 3.2776 | 9 | 162 | inner ear development |
GO:0008343 | 0.0058 | 24.3957 | 0.1214 | 2 | 6 | adult feeding behavior |
GO:0021869 | 0.0058 | 24.3957 | 0.1214 | 2 | 6 | forebrain ventricular zone progenitor cell division |
GO:0021937 | 0.0058 | 24.3957 | 0.1214 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0035860 | 0.0058 | 24.3957 | 0.1214 | 2 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
GO:0061308 | 0.0058 | 24.3957 | 0.1214 | 2 | 6 | cardiac neural crest cell development involved in heart development |
GO:0051171 | 0.0059 | 1.4125 | 73.1602 | 92 | 3616 | regulation of nitrogen compound metabolic process |
GO:0055088 | 0.0059 | 3.943 | 1.6388 | 6 | 81 | lipid homeostasis |
GO:0042476 | 0.006 | 3.457 | 2.1649 | 7 | 107 | odontogenesis |
GO:0010720 | 0.0061 | 2.6982 | 3.9251 | 10 | 194 | positive regulation of cell development |
GO:0002088 | 0.0062 | 4.6396 | 1.1735 | 5 | 58 | lens development in camera-type eye |
GO:0002052 | 0.0062 | 9.1756 | 0.3844 | 3 | 19 | positive regulation of neuroblast proliferation |
GO:0042474 | 0.0062 | 9.1756 | 0.3844 | 3 | 19 | middle ear morphogenesis |
GO:0060021 | 0.0063 | 3.8908 | 1.6591 | 6 | 82 | palate development |
GO:0050767 | 0.0063 | 2.0266 | 9.3878 | 18 | 464 | regulation of neurogenesis |
GO:0042246 | 0.0064 | 5.9471 | 0.7486 | 4 | 37 | tissue regeneration |
GO:0042733 | 0.0067 | 4.5533 | 1.1937 | 5 | 59 | embryonic digit morphogenesis |
GO:0060675 | 0.0067 | 4.5533 | 1.1937 | 5 | 59 | ureteric bud morphogenesis |
GO:0030335 | 0.0068 | 2.5201 | 4.613 | 11 | 228 | positive regulation of cell migration |
GO:0043066 | 0.0069 | 1.8995 | 11.6943 | 21 | 578 | negative regulation of apoptotic process |
GO:0009743 | 0.007 | 3.0439 | 2.7921 | 8 | 138 | response to carbohydrate |
GO:0019933 | 0.007 | 5.7717 | 0.7688 | 4 | 38 | cAMP-mediated signaling |
GO:0021795 | 0.007 | 5.7717 | 0.7688 | 4 | 38 | cerebral cortex cell migration |
GO:0035282 | 0.0071 | 3.7905 | 1.6995 | 6 | 84 | segmentation |
GO:0040007 | 0.0071 | 1.7922 | 14.7899 | 25 | 731 | growth |
GO:0030182 | 0.0072 | 1.7528 | 16.3897 | 27 | 844 | neuron differentiation |
GO:0032369 | 0.0072 | 8.6352 | 0.4046 | 3 | 20 | negative regulation of lipid transport |
GO:0060397 | 0.0072 | 8.6352 | 0.4046 | 3 | 20 | JAK-STAT cascade involved in growth hormone signaling pathway |
GO:0009968 | 0.0076 | 1.7825 | 14.8705 | 25 | 745 | negative regulation of signal transduction |
GO:0030326 | 0.0078 | 4.381 | 1.2357 | 5 | 62 | embryonic limb morphogenesis |
GO:0045597 | 0.0079 | 2.1935 | 6.733 | 14 | 341 | positive regulation of cell differentiation |
GO:0032970 | 0.0079 | 2.4623 | 4.7141 | 11 | 233 | regulation of actin filament-based process |
GO:0001574 | 0.008 | 19.515 | 0.1416 | 2 | 7 | ganglioside biosynthetic process |
GO:0042761 | 0.008 | 19.515 | 0.1416 | 2 | 7 | very long-chain fatty acid biosynthetic process |
GO:0048608 | 0.008 | 2.1875 | 6.7464 | 14 | 337 | reproductive structure development |
GO:0060548 | 0.0081 | 1.8421 | 12.625 | 22 | 624 | negative regulation of cell death |
GO:0051241 | 0.0081 | 2.2574 | 6.0697 | 13 | 300 | negative regulation of multicellular organismal process |
GO:0048557 | 0.0083 | 8.1548 | 0.4249 | 3 | 21 | embryonic digestive tract morphogenesis |
GO:0070328 | 0.0083 | 8.1548 | 0.4249 | 3 | 21 | triglyceride homeostasis |
GO:0021510 | 0.0083 | 3.6492 | 1.7602 | 6 | 87 | spinal cord development |
GO:0022008 | 0.0085 | 1.7863 | 14.2538 | 24 | 730 | neurogenesis |
GO:0048519 | 0.0091 | 1.4231 | 55.8076 | 72 | 2837 | negative regulation of biological process |
GO:0009948 | 0.0092 | 5.3024 | 0.8295 | 4 | 41 | anterior/posterior axis specification |
GO:0042471 | 0.0093 | 3.5561 | 1.8023 | 6 | 90 | ear morphogenesis |
GO:0003016 | 0.0095 | 7.725 | 0.4451 | 3 | 22 | respiratory system process |
GO:0042755 | 0.0095 | 7.725 | 0.4451 | 3 | 22 | eating behavior |
GO:0016055 | 0.0095 | 2.21 | 6.1911 | 13 | 306 | Wnt signaling pathway |
GO:0001838 | 0.0096 | 3.1402 | 2.3672 | 7 | 117 | embryonic epithelial tube formation |
GO:0006665 | 0.0096 | 3.1402 | 2.3672 | 7 | 117 | sphingolipid metabolic process |
GO:0006664 | 0.0098 | 3.518 | 1.8209 | 6 | 90 | glycolipid metabolic process |
GO:0022414 | 0.0099 | 1.6699 | 18.4114 | 29 | 910 | reproductive process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 7.2824 | 1.5791 | 10 | 90 | embryonic skeletal system morphogenesis |
GO:0001501 | 0 | 3.2546 | 6.79 | 20 | 387 | skeletal system development |
GO:0048568 | 1e-04 | 2.9501 | 6.6496 | 18 | 379 | embryonic organ development |
GO:0035115 | 2e-04 | 10.9934 | 0.5439 | 5 | 31 | embryonic forelimb morphogenesis |
GO:0021612 | 3e-04 | 34.0438 | 0.1404 | 3 | 8 | facial nerve structural organization |
GO:0009887 | 4e-04 | 2.2161 | 13.2993 | 27 | 758 | organ morphogenesis |
GO:0021602 | 4e-04 | 13.3988 | 0.3685 | 4 | 21 | cranial nerve morphogenesis |
GO:0002062 | 5e-04 | 5.4368 | 1.4212 | 7 | 81 | chondrocyte differentiation |
GO:0021561 | 6e-04 | 24.3131 | 0.1755 | 3 | 10 | facial nerve development |
GO:0007267 | 6e-04 | 1.9989 | 17.5102 | 32 | 998 | cell-cell signaling |
GO:0007389 | 7e-04 | 2.6228 | 6.983 | 17 | 398 | pattern specification process |
GO:0001101 | 9e-04 | 3.1426 | 4.1056 | 12 | 234 | response to acid chemical |
GO:0021570 | 9e-04 | 113 | 0.0526 | 2 | 3 | rhombomere 4 development |
GO:0021754 | 9e-04 | 113 | 0.0526 | 2 | 3 | facial nucleus development |
GO:0035113 | 0.0013 | 4.0751 | 2.123 | 8 | 121 | embryonic appendage morphogenesis |
GO:0035116 | 0.0016 | 9.1053 | 0.5088 | 4 | 29 | embryonic hindlimb morphogenesis |
GO:0048532 | 0.0017 | 15.467 | 0.2456 | 3 | 14 | anatomical structure arrangement |
GO:0021571 | 0.0018 | 56.4955 | 0.0702 | 2 | 4 | rhombomere 5 development |
GO:0071805 | 0.0019 | 3.8352 | 2.2458 | 8 | 128 | potassium ion transmembrane transport |
GO:0009952 | 0.0019 | 3.2104 | 3.3336 | 10 | 190 | anterior/posterior pattern specification |
GO:0006813 | 0.0021 | 3.4134 | 2.8248 | 9 | 161 | potassium ion transport |
GO:0061448 | 0.0022 | 3.157 | 3.3862 | 10 | 193 | connective tissue development |
GO:0008038 | 0.0023 | 8.1278 | 0.5614 | 4 | 32 | neuron recognition |
GO:0032501 | 0.0024 | 1.482 | 87.9017 | 109 | 5010 | multicellular organismal process |
GO:1902667 | 0.0025 | 13.0854 | 0.2807 | 3 | 16 | regulation of axon guidance |
GO:0042391 | 0.0029 | 2.5768 | 5.3688 | 13 | 306 | regulation of membrane potential |
GO:0021825 | 0.003 | 37.6606 | 0.0877 | 2 | 5 | substrate-dependent cerebral cortex tangential migration |
GO:0035108 | 0.0031 | 3.51 | 2.4388 | 8 | 139 | limb morphogenesis |
GO:0072358 | 0.0031 | 1.9571 | 13.1414 | 24 | 749 | cardiovascular system development |
GO:0071300 | 0.0034 | 5.3813 | 1.0176 | 5 | 58 | cellular response to retinoic acid |
GO:0048486 | 0.0036 | 11.3388 | 0.3158 | 3 | 18 | parasympathetic nervous system development |
GO:1902284 | 0.0036 | 11.3388 | 0.3158 | 3 | 18 | neuron projection extension involved in neuron projection guidance |
GO:0003376 | 0.0044 | 28.2432 | 0.1053 | 2 | 6 | sphingosine-1-phosphate signaling pathway |
GO:0038171 | 0.0044 | 28.2432 | 0.1053 | 2 | 6 | cannabinoid signaling pathway |
GO:0071230 | 0.0047 | 6.4986 | 0.6843 | 4 | 39 | cellular response to amino acid stimulus |
GO:0050771 | 0.0056 | 6.1463 | 0.7194 | 4 | 41 | negative regulation of axonogenesis |
GO:0070374 | 0.0059 | 3.9413 | 1.6317 | 6 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0021675 | 0.006 | 4.6725 | 1.158 | 5 | 66 | nerve development |
GO:0002922 | 0.0061 | 22.5927 | 0.1228 | 2 | 7 | positive regulation of humoral immune response |
GO:0061303 | 0.0061 | 22.5927 | 0.1228 | 2 | 7 | cornea development in camera-type eye |
GO:0050795 | 0.0065 | 3.3974 | 2.1932 | 7 | 125 | regulation of behavior |
GO:0048736 | 0.0065 | 3.0815 | 2.7546 | 8 | 157 | appendage development |
GO:0055085 | 0.0065 | 1.7365 | 17.8786 | 29 | 1019 | transmembrane transport |
GO:0048871 | 0.0075 | 2.7817 | 3.4213 | 9 | 195 | multicellular organismal homeostasis |
GO:0048843 | 0.008 | 18.8258 | 0.1404 | 2 | 8 | negative regulation of axon extension involved in axon guidance |
GO:0051917 | 0.008 | 18.8258 | 0.1404 | 2 | 8 | regulation of fibrinolysis |
GO:0061333 | 0.0082 | 8.0952 | 0.4211 | 3 | 24 | renal tubule morphogenesis |
GO:0048598 | 0.0086 | 2.1696 | 6.8134 | 14 | 399 | embryonic morphogenesis |
GO:0006811 | 0.0094 | 1.6554 | 20.0191 | 31 | 1141 | ion transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 1e-04 | 2.7878 | 7.9323 | 20 | 601 | G-protein coupled receptor signaling pathway |
GO:0007308 | 2e-04 | Inf | 0.0264 | 2 | 2 | oocyte construction |
GO:0007314 | 2e-04 | Inf | 0.0264 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 2e-04 | Inf | 0.0264 | 2 | 2 | P granule organization |
GO:0032467 | 3e-04 | 14.5662 | 0.33 | 4 | 25 | positive regulation of cytokinesis |
GO:0060259 | 3e-04 | 28.532 | 0.1452 | 3 | 11 | regulation of feeding behavior |
GO:0007283 | 5e-04 | 3.1788 | 4.4347 | 13 | 336 | spermatogenesis |
GO:0007276 | 0.0016 | 2.6682 | 5.6489 | 14 | 428 | gamete generation |
GO:0007028 | 0.0025 | 37.8242 | 0.0792 | 2 | 6 | cytoplasm organization |
GO:1902186 | 0.0025 | 12.6707 | 0.2772 | 3 | 21 | regulation of viral release from host cell |
GO:0032504 | 0.0038 | 2.2693 | 7.5627 | 16 | 573 | multicellular organism reproduction |
GO:0030317 | 0.0042 | 10.3636 | 0.33 | 3 | 25 | sperm motility |
GO:0006952 | 0.0051 | 1.8907 | 13.7528 | 24 | 1042 | defense response |
GO:0030818 | 0.0052 | 9.4985 | 0.3564 | 3 | 27 | negative regulation of cAMP biosynthetic process |
GO:0030809 | 0.0071 | 8.4411 | 0.396 | 3 | 30 | negative regulation of nucleotide biosynthetic process |
GO:0045026 | 0.0073 | 18.9061 | 0.132 | 2 | 10 | plasma membrane fusion |
GO:0030800 | 0.0085 | 7.8577 | 0.4224 | 3 | 32 | negative regulation of cyclic nucleotide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 79.4162 | 0.1952 | 7 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0070830 | 0 | 12.5072 | 0.6757 | 7 | 45 | tight junction assembly |
GO:0009593 | 0 | 9.6909 | 0.8409 | 7 | 56 | detection of chemical stimulus |
GO:0023052 | 0 | 1.8246 | 65.8611 | 93 | 4386 | signaling |
GO:0045591 | 0 | 99.9545 | 0.0751 | 3 | 5 | positive regulation of regulatory T cell differentiation |
GO:0050906 | 1e-04 | 8.1812 | 0.9761 | 7 | 65 | detection of stimulus involved in sensory perception |
GO:0032689 | 1e-04 | 24.3441 | 0.2252 | 4 | 15 | negative regulation of interferon-gamma production |
GO:0007606 | 1e-04 | 7.7769 | 1.0211 | 7 | 68 | sensory perception of chemical stimulus |
GO:0002718 | 1e-04 | 12.4484 | 0.4805 | 5 | 32 | regulation of cytokine production involved in immune response |
GO:0034329 | 1e-04 | 4.1935 | 2.8681 | 11 | 191 | cell junction assembly |
GO:0050868 | 2e-04 | 8.4341 | 0.8109 | 6 | 54 | negative regulation of T cell activation |
GO:0007165 | 2e-04 | 1.7367 | 59.0287 | 83 | 3931 | signal transduction |
GO:0006968 | 2e-04 | 10.1802 | 0.5706 | 5 | 38 | cellular defense response |
GO:0032613 | 3e-04 | 14.0849 | 0.3454 | 4 | 23 | interleukin-10 production |
GO:0002695 | 4e-04 | 5.7054 | 1.3515 | 7 | 90 | negative regulation of leukocyte activation |
GO:0050877 | 5e-04 | 2.3391 | 10.7516 | 23 | 716 | neurological system process |
GO:0002774 | 7e-04 | 132.5745 | 0.045 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007207 | 7e-04 | 132.5745 | 0.045 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0002443 | 0.001 | 3.8478 | 2.5227 | 9 | 168 | leukocyte mediated immunity |
GO:0006955 | 0.0013 | 2.0259 | 14.5507 | 27 | 969 | immune response |
GO:0002765 | 0.0013 | 66.2819 | 0.0601 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0002682 | 0.0013 | 2.0806 | 13.0791 | 25 | 871 | regulation of immune system process |
GO:0042267 | 0.0014 | 9.2206 | 0.4955 | 4 | 33 | natural killer cell mediated cytotoxicity |
GO:0050896 | 0.0015 | 1.6202 | 68.7351 | 88 | 4927 | response to stimulus |
GO:0009595 | 0.0016 | 15.364 | 0.2403 | 3 | 16 | detection of biotic stimulus |
GO:0002440 | 0.0016 | 5.1777 | 1.2614 | 6 | 84 | production of molecular mediator of immune response |
GO:1902106 | 0.0017 | 6.3284 | 0.8709 | 5 | 58 | negative regulation of leukocyte differentiation |
GO:0030104 | 0.0018 | 8.6243 | 0.5256 | 4 | 35 | water homeostasis |
GO:0001906 | 0.0019 | 6.2107 | 0.886 | 5 | 59 | cell killing |
GO:0044707 | 0.0019 | 1.5452 | 73.0538 | 93 | 4865 | single-multicellular organism process |
GO:0045216 | 0.002 | 3.4514 | 2.793 | 9 | 186 | cell-cell junction organization |
GO:0019373 | 0.0022 | 44.1844 | 0.0751 | 2 | 5 | epoxygenase P450 pathway |
GO:2001179 | 0.0022 | 44.1844 | 0.0751 | 2 | 5 | regulation of interleukin-10 secretion |
GO:0051239 | 0.0023 | 1.7178 | 27.1643 | 42 | 1809 | regulation of multicellular organismal process |
GO:0010837 | 0.0023 | 13.3134 | 0.2703 | 3 | 18 | regulation of keratinocyte proliferation |
GO:0033561 | 0.0023 | 13.3134 | 0.2703 | 3 | 18 | regulation of water loss via skin |
GO:0002664 | 0.0032 | 33.1356 | 0.0901 | 2 | 6 | regulation of T cell tolerance induction |
GO:2000668 | 0.0032 | 33.1356 | 0.0901 | 2 | 6 | regulation of dendritic cell apoptotic process |
GO:0007186 | 0.0041 | 2.1325 | 9.0247 | 18 | 601 | G-protein coupled receptor signaling pathway |
GO:0046645 | 0.0045 | 26.5064 | 0.1051 | 2 | 7 | positive regulation of gamma-delta T cell activation |
GO:2001198 | 0.0045 | 26.5064 | 0.1051 | 2 | 7 | regulation of dendritic cell differentiation |
GO:0002573 | 0.0048 | 3.6009 | 2.0722 | 7 | 138 | myeloid leukocyte differentiation |
GO:0050663 | 0.0048 | 4.9054 | 1.1002 | 5 | 74 | cytokine secretion |
GO:0030857 | 0.0053 | 9.505 | 0.3604 | 3 | 24 | negative regulation of epithelial cell differentiation |
GO:0072643 | 0.0059 | 22.0869 | 0.1201 | 2 | 8 | interferon-gamma secretion |
GO:0019228 | 0.0067 | 4.5248 | 1.1863 | 5 | 79 | neuronal action potential |
GO:0015671 | 0.0075 | 18.9301 | 0.1351 | 2 | 9 | oxygen transport |
GO:0043116 | 0.0075 | 18.9301 | 0.1351 | 2 | 9 | negative regulation of vascular permeability |
GO:0060576 | 0.0075 | 18.9301 | 0.1351 | 2 | 9 | intestinal epithelial cell development |
GO:0007155 | 0.0076 | 1.8398 | 13.3794 | 23 | 891 | cell adhesion |
GO:0007171 | 0.0093 | 16.5625 | 0.1502 | 2 | 10 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0032695 | 0.0093 | 16.5625 | 0.1502 | 2 | 10 | negative regulation of interleukin-12 production |
GO:0035313 | 0.0093 | 16.5625 | 0.1502 | 2 | 10 | wound healing, spreading of epidermal cells |
GO:0042129 | 0.0095 | 4.1315 | 1.2914 | 5 | 86 | regulation of T cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.0998 | 104.0291 | 152 | 4849 | multicellular organismal process |
GO:0007389 | 0 | 3.9469 | 8.7445 | 30 | 398 | pattern specification process |
GO:0045944 | 0 | 3.0108 | 16.5222 | 43 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006355 | 0 | 1.997 | 61.1455 | 99 | 2783 | regulation of transcription, DNA-templated |
GO:0051954 | 0 | 24.5626 | 0.4394 | 7 | 20 | positive regulation of amine transport |
GO:0002125 | 0 | Inf | 0.0879 | 4 | 4 | maternal aggressive behavior |
GO:2000026 | 0 | 2.3537 | 25.3546 | 52 | 1154 | regulation of multicellular organismal development |
GO:0009891 | 0 | 2.28 | 27.7495 | 55 | 1263 | positive regulation of biosynthetic process |
GO:0051252 | 0 | 1.9018 | 63.4305 | 99 | 2887 | regulation of RNA metabolic process |
GO:0001662 | 0 | 17.7325 | 0.5493 | 7 | 25 | behavioral fear response |
GO:0018130 | 0 | 1.8448 | 72.0212 | 108 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0 | 1.8448 | 72.0212 | 108 | 3278 | aromatic compound biosynthetic process |
GO:1901362 | 0 | 1.833 | 73.9766 | 110 | 3367 | organic cyclic compound biosynthetic process |
GO:0021953 | 0 | 8.2517 | 1.4407 | 10 | 67 | central nervous system neuron differentiation |
GO:0031326 | 0 | 1.849 | 67.5 | 102 | 3141 | regulation of cellular biosynthetic process |
GO:0019098 | 0 | 15.1956 | 0.6152 | 7 | 28 | reproductive behavior |
GO:0042711 | 0 | 37.7564 | 0.2417 | 5 | 11 | maternal behavior |
GO:0044271 | 0 | 1.8085 | 73.0538 | 108 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0045935 | 0 | 2.1993 | 26.3213 | 51 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0048665 | 0 | 13.872 | 0.6591 | 7 | 30 | neuron fate specification |
GO:0010556 | 0 | 1.8063 | 68.2861 | 102 | 3108 | regulation of macromolecule biosynthetic process |
GO:0010628 | 0 | 2.2277 | 24.344 | 48 | 1108 | positive regulation of gene expression |
GO:1902680 | 0 | 2.248 | 23.0477 | 46 | 1049 | positive regulation of RNA biosynthetic process |
GO:0033555 | 0 | 8.4162 | 1.2743 | 9 | 58 | multicellular organismal response to stress |
GO:0048562 | 0 | 3.6935 | 5.7125 | 19 | 260 | embryonic organ morphogenesis |
GO:0051171 | 0 | 1.7612 | 79.4474 | 114 | 3616 | regulation of nitrogen compound metabolic process |
GO:0065007 | 0 | 1.9628 | 114.0526 | 145 | 5673 | biological regulation |
GO:0001654 | 0 | 3.5289 | 6.2837 | 20 | 286 | eye development |
GO:0007586 | 0 | 6.253 | 2.0213 | 11 | 92 | digestion |
GO:0021542 | 0 | 25.1648 | 0.3076 | 5 | 14 | dentate gyrus development |
GO:0051094 | 0 | 2.428 | 15.9949 | 35 | 728 | positive regulation of developmental process |
GO:0044058 | 0 | 15.1434 | 0.5273 | 6 | 24 | regulation of digestive system process |
GO:0033993 | 0 | 2.634 | 12.15 | 29 | 553 | response to lipid |
GO:0007218 | 0 | 6.0384 | 1.8895 | 10 | 86 | neuropeptide signaling pathway |
GO:0021515 | 0 | 8.1185 | 1.1645 | 8 | 53 | cell differentiation in spinal cord |
GO:0046717 | 0 | 6.754 | 1.538 | 9 | 70 | acid secretion |
GO:0007187 | 0 | 4.7676 | 2.8123 | 12 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0009725 | 0 | 2.3891 | 14.7426 | 32 | 671 | response to hormone |
GO:0032502 | 0 | 1.7927 | 58.5412 | 86 | 3017 | developmental process |
GO:0050877 | 0 | 2.3791 | 14.8085 | 32 | 682 | neurological system process |
GO:0007263 | 0 | 17.4162 | 0.3955 | 5 | 18 | nitric oxide mediated signal transduction |
GO:0032892 | 0 | 17.4162 | 0.3955 | 5 | 18 | positive regulation of organic acid transport |
GO:0045666 | 0 | 6.1461 | 1.6698 | 9 | 76 | positive regulation of neuron differentiation |
GO:0021913 | 0 | 134.9891 | 0.0879 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0060455 | 0 | 134.9891 | 0.0879 | 3 | 4 | negative regulation of gastric acid secretion |
GO:0021543 | 0 | 4.8143 | 2.5486 | 11 | 116 | pallium development |
GO:0021517 | 1e-04 | 8.386 | 0.9887 | 7 | 45 | ventral spinal cord development |
GO:0060573 | 1e-04 | 25.7935 | 0.2417 | 4 | 11 | cell fate specification involved in pattern specification |
GO:0009790 | 1e-04 | 2.9909 | 6.9435 | 19 | 328 | embryo development |
GO:0035176 | 1e-04 | 9.7272 | 0.747 | 6 | 34 | social behavior |
GO:0050767 | 1e-04 | 2.563 | 10.1946 | 24 | 464 | regulation of neurogenesis |
GO:0042755 | 1e-04 | 13.3139 | 0.4834 | 5 | 22 | eating behavior |
GO:0042713 | 1e-04 | 67.4891 | 0.1099 | 3 | 5 | sperm ejaculation |
GO:0060406 | 1e-04 | 67.4891 | 0.1099 | 3 | 5 | positive regulation of penile erection |
GO:2001199 | 1e-04 | 67.4891 | 0.1099 | 3 | 5 | negative regulation of dendritic cell differentiation |
GO:0048663 | 1e-04 | 9.2981 | 0.773 | 6 | 36 | neuron fate commitment |
GO:0043270 | 1e-04 | 4.3539 | 2.7903 | 11 | 127 | positive regulation of ion transport |
GO:0021761 | 1e-04 | 7.1748 | 1.1278 | 7 | 52 | limbic system development |
GO:0045665 | 1e-04 | 7.0775 | 1.1425 | 7 | 52 | negative regulation of neuron differentiation |
GO:0001975 | 1e-04 | 11.9105 | 0.5273 | 5 | 24 | response to amphetamine |
GO:0007625 | 2e-04 | 18.0511 | 0.3076 | 4 | 14 | grooming behavior |
GO:0071542 | 2e-04 | 18.0511 | 0.3076 | 4 | 14 | dopaminergic neuron differentiation |
GO:2000252 | 2e-04 | 44.9891 | 0.1318 | 3 | 6 | negative regulation of feeding behavior |
GO:0030817 | 2e-04 | 5.5259 | 1.6259 | 8 | 74 | regulation of cAMP biosynthetic process |
GO:0060041 | 2e-04 | 4.3603 | 2.5267 | 10 | 115 | retina development in camera-type eye |
GO:0007204 | 2e-04 | 3.7017 | 3.5373 | 12 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0060579 | 3e-04 | 16.4088 | 0.3296 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:0021511 | 3e-04 | 10.2839 | 0.5932 | 5 | 27 | spinal cord patterning |
GO:0021549 | 3e-04 | 5.2844 | 1.6918 | 8 | 77 | cerebellum development |
GO:0051046 | 3e-04 | 2.4401 | 9.7332 | 22 | 443 | regulation of secretion |
GO:0003357 | 3e-04 | 33.7391 | 0.1538 | 3 | 7 | noradrenergic neuron differentiation |
GO:0021798 | 3e-04 | 33.7391 | 0.1538 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0071372 | 3e-04 | 33.7391 | 0.1538 | 3 | 7 | cellular response to follicle-stimulating hormone stimulus |
GO:0052652 | 3e-04 | 4.5164 | 2.1971 | 9 | 100 | cyclic purine nucleotide metabolic process |
GO:0048646 | 4e-04 | 1.9957 | 19.0709 | 35 | 868 | anatomical structure formation involved in morphogenesis |
GO:0045165 | 4e-04 | 4.0436 | 2.7021 | 10 | 129 | cell fate commitment |
GO:0044699 | 4e-04 | 1.8196 | 223.7534 | 245 | 10184 | single-organism process |
GO:0007267 | 5e-04 | 2.138 | 14.1882 | 28 | 670 | cell-cell signaling |
GO:0080090 | 5e-04 | 1.5132 | 99.9244 | 127 | 4548 | regulation of primary metabolic process |
GO:0010701 | 5e-04 | Inf | 0.0439 | 2 | 2 | positive regulation of norepinephrine secretion |
GO:0060014 | 5e-04 | Inf | 0.0439 | 2 | 2 | granulosa cell differentiation |
GO:0030902 | 5e-04 | 4.2915 | 2.3 | 9 | 106 | hindbrain development |
GO:0060180 | 5e-04 | 26.9891 | 0.1758 | 3 | 8 | female mating behavior |
GO:0071705 | 6e-04 | 2.2041 | 12.2159 | 25 | 556 | nitrogen compound transport |
GO:0042220 | 6e-04 | 8.3761 | 0.7031 | 5 | 32 | response to cocaine |
GO:0031960 | 6e-04 | 4.1487 | 2.3729 | 9 | 108 | response to corticosteroid |
GO:0021854 | 7e-04 | 12.0292 | 0.4175 | 4 | 19 | hypothalamus development |
GO:0019233 | 7e-04 | 5.2143 | 1.494 | 7 | 68 | sensory perception of pain |
GO:0030901 | 7e-04 | 8.0763 | 0.725 | 5 | 33 | midbrain development |
GO:0009952 | 7e-04 | 3.2238 | 4.0155 | 12 | 184 | anterior/posterior pattern specification |
GO:0030808 | 7e-04 | 4.4971 | 1.9554 | 8 | 89 | regulation of nucleotide biosynthetic process |
GO:0060429 | 8e-04 | 1.963 | 17.6174 | 32 | 815 | epithelium development |
GO:0015711 | 8e-04 | 2.6672 | 6.4375 | 16 | 293 | organic anion transport |
GO:0009914 | 8e-04 | 2.8767 | 5.2291 | 14 | 238 | hormone transport |
GO:0006874 | 8e-04 | 2.8636 | 5.2511 | 14 | 239 | cellular calcium ion homeostasis |
GO:0048485 | 8e-04 | 11.2765 | 0.4394 | 4 | 20 | sympathetic nervous system development |
GO:0034645 | 9e-04 | 1.4992 | 82.4135 | 107 | 3751 | cellular macromolecule biosynthetic process |
GO:0007275 | 9e-04 | 1.707 | 36.7683 | 55 | 2037 | multicellular organismal development |
GO:0023061 | 9e-04 | 2.5266 | 7.2065 | 17 | 328 | signal release |
GO:0014070 | 0.001 | 2.1492 | 11.9834 | 24 | 554 | response to organic cyclic compound |
GO:0023019 | 0.001 | 10.6123 | 0.4614 | 4 | 21 | signal transduction involved in regulation of gene expression |
GO:0048505 | 0.0011 | 19.2748 | 0.2197 | 3 | 10 | regulation of timing of cell differentiation |
GO:0048706 | 0.0012 | 3.765 | 2.5926 | 9 | 118 | embryonic skeletal system development |
GO:0043627 | 0.0012 | 3.4345 | 3.1419 | 10 | 143 | response to estrogen |
GO:0048565 | 0.0012 | 3.7305 | 2.6146 | 9 | 119 | digestive tract development |
GO:0007626 | 0.0014 | 3.1452 | 3.7571 | 11 | 171 | locomotory behavior |
GO:0003285 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | septum secundum development |
GO:0014049 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | positive regulation of glutamate secretion |
GO:0021912 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0031394 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0051970 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:0055014 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | atrial cardiac muscle cell development |
GO:0097211 | 0.0014 | 89.6667 | 0.0659 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0048513 | 0.0014 | 1.7892 | 23.9625 | 39 | 1272 | organ development |
GO:0060341 | 0.0014 | 1.9185 | 16.7859 | 30 | 764 | regulation of cellular localization |
GO:0030431 | 0.0015 | 9.4937 | 0.5053 | 4 | 23 | sleep |
GO:0019953 | 0.0015 | 2.1113 | 11.6447 | 23 | 530 | sexual reproduction |
GO:0030799 | 0.0015 | 3.9997 | 2.1751 | 8 | 99 | regulation of cyclic nucleotide metabolic process |
GO:0048593 | 0.0015 | 3.9997 | 2.1751 | 8 | 99 | camera-type eye morphogenesis |
GO:0097154 | 0.0015 | 16.8641 | 0.2417 | 3 | 11 | GABAergic neuron differentiation |
GO:0001764 | 0.0016 | 3.5984 | 2.7024 | 9 | 123 | neuron migration |
GO:0050801 | 0.0016 | 2.1704 | 10.3264 | 21 | 470 | ion homeostasis |
GO:0002088 | 0.0017 | 5.2275 | 1.2743 | 6 | 58 | lens development in camera-type eye |
GO:0031018 | 0.0017 | 6.5024 | 0.873 | 5 | 40 | endocrine pancreas development |
GO:0009953 | 0.0017 | 4.4283 | 1.7292 | 7 | 80 | dorsal/ventral pattern formation |
GO:0055074 | 0.0018 | 15.5057 | 0.2552 | 3 | 12 | calcium ion homeostasis |
GO:0010001 | 0.0018 | 3.2375 | 3.3176 | 10 | 151 | glial cell differentiation |
GO:0046887 | 0.0019 | 4.3529 | 1.7577 | 7 | 80 | positive regulation of hormone secretion |
GO:0007617 | 0.0019 | 15.1483 | 0.261 | 3 | 12 | mating behavior |
GO:0008306 | 0.002 | 5.0331 | 1.3183 | 6 | 60 | associative learning |
GO:0021533 | 0.002 | 8.5881 | 0.5493 | 4 | 25 | cell differentiation in hindbrain |
GO:0048468 | 0.0021 | 1.6444 | 31.7343 | 48 | 1472 | cell development |
GO:0002065 | 0.0023 | 4.1801 | 1.8236 | 7 | 83 | columnar/cuboidal epithelial cell differentiation |
GO:0001709 | 0.0024 | 5.9461 | 0.9448 | 5 | 43 | cell fate determination |
GO:0009887 | 0.0025 | 2.232 | 8.5902 | 18 | 413 | organ morphogenesis |
GO:0042053 | 0.0025 | 13.4891 | 0.2856 | 3 | 13 | regulation of dopamine metabolic process |
GO:0051937 | 0.0027 | 5.7932 | 0.9667 | 5 | 44 | catecholamine transport |
GO:0022008 | 0.0027 | 1.9004 | 15.2121 | 27 | 730 | neurogenesis |
GO:0002118 | 0.0027 | 45.489 | 0.0866 | 2 | 4 | aggressive behavior |
GO:0007621 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | negative regulation of female receptivity |
GO:0032849 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0060137 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | maternal process involved in parturition |
GO:0060206 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | estrous cycle phase |
GO:0060278 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | regulation of ovulation |
GO:2001279 | 0.0028 | 44.8297 | 0.0879 | 2 | 4 | regulation of unsaturated fatty acid biosynthetic process |
GO:0044706 | 0.0029 | 3.0207 | 3.5373 | 10 | 161 | multi-multicellular organism process |
GO:0001707 | 0.003 | 4.6047 | 1.4281 | 6 | 65 | mesoderm formation |
GO:0007166 | 0.003 | 1.5005 | 51.3464 | 70 | 2337 | cell surface receptor signaling pathway |
GO:0030803 | 0.0031 | 7.5128 | 0.6152 | 4 | 28 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0009605 | 0.0031 | 1.5997 | 33.1544 | 49 | 1509 | response to external stimulus |
GO:0051705 | 0.0032 | 7.4105 | 0.6207 | 4 | 29 | multi-organism behavior |
GO:0046390 | 0.0032 | 2.807 | 4.1745 | 11 | 190 | ribose phosphate biosynthetic process |
GO:0032941 | 0.0032 | 4.5276 | 1.4501 | 6 | 66 | secretion by tissue |
GO:0065008 | 0.0033 | 1.483 | 55.0595 | 74 | 2506 | regulation of biological quality |
GO:0008584 | 0.0034 | 3.8723 | 1.9554 | 7 | 89 | male gonad development |
GO:0021954 | 0.0035 | 4.453 | 1.4721 | 6 | 67 | central nervous system neuron development |
GO:0010470 | 0.0035 | 7.2117 | 0.6372 | 4 | 29 | regulation of gastrulation |
GO:0045777 | 0.0035 | 7.2117 | 0.6372 | 4 | 29 | positive regulation of blood pressure |
GO:0045933 | 0.0035 | 7.2117 | 0.6372 | 4 | 29 | positive regulation of muscle contraction |
GO:0048863 | 0.0037 | 2.4048 | 6.1739 | 14 | 281 | stem cell differentiation |
GO:0030510 | 0.0038 | 7.0188 | 0.6515 | 4 | 30 | regulation of BMP signaling pathway |
GO:0051955 | 0.0039 | 11.2391 | 0.3296 | 3 | 15 | regulation of amino acid transport |
GO:0045596 | 0.004 | 2.3874 | 6.2186 | 14 | 293 | negative regulation of cell differentiation |
GO:1900372 | 0.004 | 6.9337 | 0.6591 | 4 | 30 | negative regulation of purine nucleotide biosynthetic process |
GO:0030003 | 0.004 | 2.236 | 7.58 | 16 | 345 | cellular cation homeostasis |
GO:0007193 | 0.0043 | 5.1328 | 1.0766 | 5 | 49 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0022029 | 0.0043 | 5.1328 | 1.0766 | 5 | 49 | telencephalon cell migration |
GO:0061053 | 0.0043 | 4.2432 | 1.538 | 6 | 70 | somite development |
GO:0014014 | 0.0045 | 6.6764 | 0.6811 | 4 | 31 | negative regulation of gliogenesis |
GO:0030815 | 0.0045 | 6.6764 | 0.6811 | 4 | 31 | negative regulation of cAMP metabolic process |
GO:0055078 | 0.0045 | 6.6764 | 0.6811 | 4 | 31 | sodium ion homeostasis |
GO:0060986 | 0.0045 | 6.6764 | 0.6811 | 4 | 31 | endocrine hormone secretion |
GO:0043084 | 0.0045 | 30.2076 | 0.1087 | 2 | 5 | penile erection |
GO:0021778 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0035881 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | amacrine cell differentiation |
GO:0051459 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | regulation of corticotropin secretion |
GO:0051891 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0060023 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | soft palate development |
GO:2000609 | 0.0046 | 29.8841 | 0.1099 | 2 | 5 | regulation of thyroid hormone generation |
GO:0007589 | 0.0046 | 4.1776 | 1.5599 | 6 | 71 | body fluid secretion |
GO:0008284 | 0.0047 | 1.8807 | 13.5342 | 24 | 616 | positive regulation of cell proliferation |
GO:0035813 | 0.0048 | 10.3737 | 0.3515 | 3 | 16 | regulation of renal sodium excretion |
GO:2001258 | 0.0048 | 10.3737 | 0.3515 | 3 | 16 | negative regulation of cation channel activity |
GO:0048522 | 0.0048 | 1.4762 | 52.5184 | 70 | 2527 | positive regulation of cellular process |
GO:0007270 | 0.005 | 3.2442 | 2.6365 | 8 | 120 | neuron-neuron synaptic transmission |
GO:0034284 | 0.005 | 3.2442 | 2.6365 | 8 | 120 | response to monosaccharide |
GO:0048869 | 0.0051 | 1.6576 | 24.9222 | 38 | 1280 | cellular developmental process |
GO:0001706 | 0.0051 | 4.9088 | 1.1205 | 5 | 51 | endoderm formation |
GO:0021879 | 0.0051 | 4.9088 | 1.1205 | 5 | 51 | forebrain neuron differentiation |
GO:0050885 | 0.0051 | 4.9088 | 1.1205 | 5 | 51 | neuromuscular process controlling balance |
GO:0008015 | 0.0052 | 2.2345 | 7.0967 | 15 | 323 | blood circulation |
GO:0000122 | 0.0055 | 1.9093 | 12.1939 | 22 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0023057 | 0.0056 | 1.7476 | 17.6291 | 29 | 808 | negative regulation of signaling |
GO:0032924 | 0.0057 | 6.215 | 0.725 | 4 | 33 | activin receptor signaling pathway |
GO:0048536 | 0.0057 | 6.215 | 0.725 | 4 | 33 | spleen development |
GO:0009950 | 0.0057 | 9.6319 | 0.3735 | 3 | 17 | dorsal/ventral axis specification |
GO:0030878 | 0.0057 | 9.6319 | 0.3735 | 3 | 17 | thyroid gland development |
GO:0042403 | 0.0057 | 9.6319 | 0.3735 | 3 | 17 | thyroid hormone metabolic process |
GO:0007611 | 0.0058 | 2.7277 | 3.8889 | 10 | 177 | learning or memory |
GO:0009152 | 0.0058 | 2.7277 | 3.8889 | 10 | 177 | purine ribonucleotide biosynthetic process |
GO:0010648 | 0.0059 | 1.7404 | 17.6945 | 29 | 811 | negative regulation of cell communication |
GO:0009792 | 0.006 | 1.8945 | 12.2818 | 22 | 559 | embryo development ending in birth or egg hatching |
GO:0015718 | 0.0061 | 3.4486 | 2.1751 | 7 | 99 | monocarboxylic acid transport |
GO:0031644 | 0.0063 | 6.0073 | 0.747 | 4 | 34 | regulation of neurological system process |
GO:0055082 | 0.0063 | 2.0255 | 9.3816 | 18 | 427 | cellular chemical homeostasis |
GO:0001710 | 0.0067 | 8.9891 | 0.3955 | 3 | 18 | mesodermal cell fate commitment |
GO:0043576 | 0.0067 | 8.9891 | 0.3955 | 3 | 18 | regulation of respiratory gaseous exchange |
GO:0051412 | 0.0067 | 8.9891 | 0.3955 | 3 | 18 | response to corticosterone |
GO:0051051 | 0.0068 | 2.2336 | 6.6133 | 14 | 301 | negative regulation of transport |
GO:0021523 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | somatic motor neuron differentiation |
GO:0021797 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | forebrain anterior/posterior pattern specification |
GO:0042756 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | drinking behavior |
GO:0060022 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | hard palate development |
GO:1900107 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | regulation of nodal signaling pathway |
GO:2000675 | 0.0068 | 22.4112 | 0.1318 | 2 | 6 | negative regulation of type B pancreatic cell apoptotic process |
GO:0050794 | 0.0069 | 1.4747 | 75.4995 | 92 | 3998 | regulation of cellular process |
GO:0030514 | 0.007 | 5.813 | 0.769 | 4 | 35 | negative regulation of BMP signaling pathway |
GO:0031279 | 0.007 | 4.5147 | 1.2084 | 5 | 55 | regulation of cyclase activity |
GO:0048609 | 0.0075 | 1.8834 | 11.7718 | 21 | 547 | multicellular organismal reproductive process |
GO:0015833 | 0.0075 | 2.4827 | 4.6798 | 11 | 213 | peptide transport |
GO:0010721 | 0.0076 | 3.0007 | 2.8343 | 8 | 129 | negative regulation of cell development |
GO:0007417 | 0.0078 | 2.9873 | 2.8441 | 8 | 141 | central nervous system development |
GO:0019228 | 0.0078 | 3.7174 | 1.7357 | 6 | 79 | neuronal action potential |
GO:0007420 | 0.0078 | 2.0254 | 8.8522 | 17 | 421 | brain development |
GO:0002052 | 0.0078 | 8.4266 | 0.4175 | 3 | 19 | positive regulation of neuroblast proliferation |
GO:0007530 | 0.0078 | 8.4266 | 0.4175 | 3 | 19 | sex determination |
GO:0021895 | 0.0078 | 8.4266 | 0.4175 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0033574 | 0.0078 | 8.4266 | 0.4175 | 3 | 19 | response to testosterone |
GO:0023052 | 0.0079 | 1.3592 | 96.3651 | 116 | 4386 | signaling |
GO:0045934 | 0.0084 | 1.6487 | 20.5869 | 32 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0050807 | 0.0088 | 4.2581 | 1.2743 | 5 | 58 | regulation of synapse organization |
GO:0051924 | 0.0091 | 2.9037 | 2.9222 | 8 | 133 | regulation of calcium ion transport |
GO:0001953 | 0.0091 | 7.9303 | 0.4394 | 3 | 20 | negative regulation of cell-matrix adhesion |
GO:0007194 | 0.0091 | 7.9303 | 0.4394 | 3 | 20 | negative regulation of adenylate cyclase activity |
GO:2000241 | 0.0091 | 4.209 | 1.2874 | 5 | 59 | regulation of reproductive process |
GO:0072091 | 0.0093 | 3.5698 | 1.8016 | 6 | 82 | regulation of stem cell proliferation |
GO:0048705 | 0.0093 | 2.528 | 4.1745 | 10 | 190 | skeletal system morphogenesis |
GO:0048585 | 0.0093 | 1.6475 | 19.9278 | 31 | 907 | negative regulation of response to stimulus |
GO:0003310 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | pancreatic A cell differentiation |
GO:0015816 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | glycine transport |
GO:0021796 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | cerebral cortex regionalization |
GO:0022601 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | menstrual cycle phase |
GO:0031017 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | exocrine pancreas development |
GO:0032308 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | positive regulation of prostaglandin secretion |
GO:0033504 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | floor plate development |
GO:0042538 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | hyperosmotic salinity response |
GO:0060158 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0061303 | 0.0094 | 17.9275 | 0.1538 | 2 | 7 | cornea development in camera-type eye |
GO:0002793 | 0.0094 | 4.1789 | 1.2963 | 5 | 59 | positive regulation of peptide secretion |
GO:0007588 | 0.0094 | 4.1789 | 1.2963 | 5 | 59 | excretion |
GO:0051339 | 0.0094 | 4.1789 | 1.2963 | 5 | 59 | regulation of lyase activity |
GO:0032774 | 0.0099 | 1.4861 | 38.0436 | 52 | 1903 | RNA biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.4187 | 115.2225 | 177 | 5010 | multicellular organismal process |
GO:0007417 | 0 | 3.744 | 17.1799 | 53 | 747 | central nervous system development |
GO:0007389 | 0 | 4.9415 | 8.728 | 36 | 383 | pattern specification process |
GO:0007423 | 0 | 4.3227 | 10.1193 | 37 | 440 | sensory organ development |
GO:0006355 | 0 | 2.2702 | 64.0048 | 112 | 2783 | regulation of transcription, DNA-templated |
GO:2000026 | 0 | 2.9067 | 22.9142 | 56 | 1017 | regulation of multicellular organismal development |
GO:0051252 | 0 | 2.1616 | 66.3967 | 112 | 2887 | regulation of RNA metabolic process |
GO:0045944 | 0 | 3.0998 | 17.2949 | 46 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0045666 | 0 | 10.0268 | 1.7479 | 14 | 76 | positive regulation of neuron differentiation |
GO:1902680 | 0 | 2.6653 | 24.1254 | 55 | 1049 | positive regulation of RNA biosynthetic process |
GO:0010556 | 0 | 2.0454 | 71.4793 | 115 | 3108 | regulation of macromolecule biosynthetic process |
GO:0010628 | 0 | 2.5619 | 25.4823 | 56 | 1108 | positive regulation of gene expression |
GO:1901362 | 0 | 1.9989 | 77.4359 | 121 | 3367 | organic cyclic compound biosynthetic process |
GO:0018130 | 0 | 1.9862 | 75.3891 | 118 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0 | 1.9862 | 75.3891 | 118 | 3278 | aromatic compound biosynthetic process |
GO:0031326 | 0 | 2.1741 | 49.1497 | 86 | 2239 | regulation of cellular biosynthetic process |
GO:0050767 | 0 | 3.412 | 10.6713 | 32 | 464 | regulation of neurogenesis |
GO:0044271 | 0 | 1.9759 | 76.47 | 119 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0048562 | 0 | 4.3906 | 5.9796 | 23 | 260 | embryonic organ morphogenesis |
GO:0045935 | 0 | 2.3955 | 27.5522 | 57 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0046903 | 0 | 2.7354 | 17.4789 | 42 | 760 | secretion |
GO:0051094 | 0 | 2.8027 | 16.2266 | 40 | 712 | positive regulation of developmental process |
GO:0021516 | 0 | 110.2768 | 0.1579 | 5 | 7 | dorsal spinal cord development |
GO:0042472 | 0 | 7.3645 | 2.0929 | 13 | 91 | inner ear morphogenesis |
GO:0009891 | 0 | 2.3048 | 29.0471 | 58 | 1263 | positive regulation of biosynthetic process |
GO:0048869 | 0 | 1.931 | 64.8309 | 102 | 2899 | cellular developmental process |
GO:0021542 | 0 | 32.5105 | 0.322 | 6 | 14 | dentate gyrus development |
GO:0051171 | 0 | 1.8322 | 83.1626 | 122 | 3616 | regulation of nitrogen compound metabolic process |
GO:0021527 | 0 | 28.8959 | 0.345 | 6 | 15 | spinal cord association neuron differentiation |
GO:0030901 | 0 | 13.95 | 0.759 | 8 | 33 | midbrain development |
GO:0009887 | 0 | 3.7525 | 6.5892 | 22 | 322 | organ morphogenesis |
GO:0021537 | 0 | 4.5864 | 4.1857 | 17 | 182 | telencephalon development |
GO:0007275 | 0 | 2.0512 | 45.273 | 75 | 2425 | multicellular organismal development |
GO:0001501 | 0 | 3.1155 | 8.9004 | 25 | 387 | skeletal system development |
GO:0048729 | 0 | 2.9865 | 9.6461 | 26 | 425 | tissue morphogenesis |
GO:0022008 | 0 | 2.5259 | 15.5115 | 35 | 730 | neurogenesis |
GO:0007548 | 0 | 3.8915 | 4.8527 | 17 | 211 | sex differentiation |
GO:0009953 | 0 | 6.5157 | 1.7727 | 10 | 78 | dorsal/ventral pattern formation |
GO:0009952 | 0 | 4.2177 | 3.9603 | 15 | 175 | anterior/posterior pattern specification |
GO:2000310 | 0 | 23.9957 | 0.322 | 5 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0010453 | 0 | 13.6765 | 0.575 | 6 | 25 | regulation of cell fate commitment |
GO:0060537 | 0 | 3.2079 | 6.8536 | 20 | 298 | muscle tissue development |
GO:0022414 | 0 | 2.169 | 20.9286 | 41 | 910 | reproductive process |
GO:0001709 | 0 | 9.5629 | 0.8911 | 7 | 39 | cell fate determination |
GO:0060429 | 0 | 2.3006 | 16.2797 | 34 | 732 | epithelium development |
GO:0034645 | 0 | 1.6388 | 86.2674 | 118 | 3751 | cellular macromolecule biosynthetic process |
GO:0061448 | 0 | 3.7201 | 4.4387 | 15 | 193 | connective tissue development |
GO:0060042 | 0 | 8.681 | 0.9659 | 7 | 42 | retina morphogenesis in camera-type eye |
GO:0050877 | 0 | 2.2657 | 16.4669 | 34 | 716 | neurological system process |
GO:0008284 | 1e-04 | 2.4168 | 13.1257 | 29 | 579 | positive regulation of cell proliferation |
GO:0007517 | 1e-04 | 3.0363 | 6.8306 | 19 | 297 | muscle organ development |
GO:0060173 | 1e-04 | 3.9677 | 3.6108 | 13 | 157 | limb development |
GO:0043010 | 1e-04 | 3.2017 | 5.7956 | 17 | 252 | camera-type eye development |
GO:0001655 | 1e-04 | 9.308 | 0.7758 | 6 | 35 | urogenital system development |
GO:0007565 | 2e-04 | 4.1838 | 2.8978 | 11 | 126 | female pregnancy |
GO:0007270 | 2e-04 | 5.0865 | 1.9785 | 9 | 87 | neuron-neuron synaptic transmission |
GO:0015812 | 2e-04 | 19.1297 | 0.299 | 4 | 13 | gamma-aminobutyric acid transport |
GO:0048598 | 2e-04 | 3.0916 | 5.6225 | 16 | 260 | embryonic morphogenesis |
GO:0048667 | 2e-04 | 2.3151 | 12.6492 | 27 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0045665 | 2e-04 | 6.7464 | 1.1959 | 7 | 52 | negative regulation of neuron differentiation |
GO:0048663 | 2e-04 | 8.3312 | 0.8519 | 6 | 38 | neuron fate commitment |
GO:0021915 | 2e-04 | 3.7822 | 3.4728 | 12 | 151 | neural tube development |
GO:0072001 | 2e-04 | 3.0554 | 5.6806 | 16 | 247 | renal system development |
GO:0007610 | 2e-04 | 2.9293 | 6.2923 | 17 | 284 | behavior |
GO:0080090 | 2e-04 | 1.5368 | 104.5972 | 134 | 4548 | regulation of primary metabolic process |
GO:0009792 | 2e-04 | 2.2742 | 12.8562 | 27 | 559 | embryo development ending in birth or egg hatching |
GO:0021533 | 2e-04 | 10.7885 | 0.575 | 5 | 25 | cell differentiation in hindbrain |
GO:0021797 | 2e-04 | 42.9132 | 0.138 | 3 | 6 | forebrain anterior/posterior pattern specification |
GO:0048852 | 2e-04 | 42.9132 | 0.138 | 3 | 6 | diencephalon morphogenesis |
GO:0097120 | 2e-04 | 42.9132 | 0.138 | 3 | 6 | receptor localization to synapse |
GO:0031018 | 3e-04 | 7.7121 | 0.911 | 6 | 40 | endocrine pancreas development |
GO:0050810 | 3e-04 | 7.6334 | 0.9199 | 6 | 40 | regulation of steroid biosynthetic process |
GO:0007411 | 3e-04 | 2.6456 | 7.7505 | 19 | 337 | axon guidance |
GO:0048608 | 3e-04 | 3.3739 | 4.1856 | 13 | 186 | reproductive structure development |
GO:0021983 | 3e-04 | 9.9012 | 0.6152 | 5 | 27 | pituitary gland development |
GO:0048646 | 3e-04 | 1.9818 | 19.7404 | 36 | 864 | anatomical structure formation involved in morphogenesis |
GO:0048732 | 4e-04 | 2.6868 | 7.2253 | 18 | 322 | gland development |
GO:0035107 | 4e-04 | 3.7549 | 3.1968 | 11 | 139 | appendage morphogenesis |
GO:0060079 | 4e-04 | 9.4692 | 0.6381 | 5 | 28 | regulation of excitatory postsynaptic membrane potential |
GO:0003310 | 4e-04 | 32.1823 | 0.161 | 3 | 7 | pancreatic A cell differentiation |
GO:0021796 | 4e-04 | 32.1823 | 0.161 | 3 | 7 | cerebral cortex regionalization |
GO:0022601 | 4e-04 | 32.1823 | 0.161 | 3 | 7 | menstrual cycle phase |
GO:0015833 | 4e-04 | 3.0891 | 4.8987 | 14 | 213 | peptide transport |
GO:0007267 | 4e-04 | 3.4153 | 3.8125 | 12 | 185 | cell-cell signaling |
GO:0010470 | 5e-04 | 8.9875 | 0.667 | 5 | 29 | regulation of gastrulation |
GO:0030326 | 5e-04 | 3.9277 | 2.7828 | 10 | 121 | embryonic limb morphogenesis |
GO:0046928 | 5e-04 | 6.8277 | 1.0119 | 6 | 44 | regulation of neurotransmitter secretion |
GO:0021514 | 5e-04 | 13.2393 | 0.391 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0030539 | 5e-04 | 13.2393 | 0.391 | 4 | 17 | male genitalia development |
GO:0001764 | 5e-04 | 3.8576 | 2.8288 | 10 | 123 | neuron migration |
GO:0048812 | 5e-04 | 2.1689 | 12.9022 | 26 | 561 | neuron projection morphogenesis |
GO:0007626 | 6e-04 | 3.301 | 3.9327 | 12 | 171 | locomotory behavior |
GO:0007215 | 6e-04 | 5.3209 | 1.4719 | 7 | 64 | glutamate receptor signaling pathway |
GO:0021879 | 7e-04 | 6.3702 | 1.0738 | 6 | 47 | forebrain neuron differentiation |
GO:0030902 | 7e-04 | 4.1016 | 2.4007 | 9 | 106 | hindbrain development |
GO:0007166 | 7e-04 | 1.5891 | 51.2775 | 73 | 2273 | cell surface receptor signaling pathway |
GO:0072358 | 8e-04 | 2.7744 | 5.8143 | 15 | 261 | cardiovascular system development |
GO:0007218 | 8e-04 | 4.4519 | 1.9779 | 8 | 86 | neuropeptide signaling pathway |
GO:0001502 | 8e-04 | 11.4722 | 0.437 | 4 | 19 | cartilage condensation |
GO:0009888 | 9e-04 | 3.1571 | 4.1031 | 12 | 207 | tissue development |
GO:0065007 | 9e-04 | 1.5311 | 175.4648 | 200 | 7967 | biological regulation |
GO:0048839 | 0.001 | 4.932 | 1.5712 | 7 | 71 | inner ear development |
GO:0006935 | 0.001 | 2.1414 | 12.0052 | 24 | 522 | chemotaxis |
GO:0051954 | 0.001 | 10.7544 | 0.46 | 4 | 20 | positive regulation of amine transport |
GO:0060850 | 0.001 | 10.7544 | 0.46 | 4 | 20 | regulation of transcription involved in cell fate commitment |
GO:0009749 | 0.0011 | 3.7985 | 2.5758 | 9 | 112 | response to glucose |
GO:0002068 | 0.0012 | 10.1209 | 0.483 | 4 | 21 | glandular epithelial cell development |
GO:0023019 | 0.0012 | 10.1209 | 0.483 | 4 | 21 | signal transduction involved in regulation of gene expression |
GO:0043403 | 0.0012 | 10.1209 | 0.483 | 4 | 21 | skeletal muscle tissue regeneration |
GO:0032774 | 0.0013 | 1.6427 | 38.6995 | 57 | 1903 | RNA biosynthetic process |
GO:0051967 | 0.0013 | 18.3854 | 0.23 | 3 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:0061564 | 0.0013 | 2.1337 | 11.5222 | 23 | 501 | axon development |
GO:0044699 | 0.0013 | 1.6813 | 234.2167 | 254 | 10184 | single-organism process |
GO:0007492 | 0.0013 | 4.663 | 1.6559 | 7 | 72 | endoderm development |
GO:0051963 | 0.0013 | 6.9541 | 0.8279 | 5 | 36 | regulation of synapse assembly |
GO:0050794 | 0.0013 | 1.5143 | 129.8962 | 153 | 6326 | regulation of cellular process |
GO:0048738 | 0.0014 | 3.3719 | 3.1987 | 10 | 140 | cardiac muscle tissue development |
GO:0090304 | 0.0015 | 1.4534 | 90.8211 | 115 | 3949 | nucleic acid metabolic process |
GO:0001754 | 0.0015 | 6.7362 | 0.8509 | 5 | 37 | eye photoreceptor cell differentiation |
GO:2000179 | 0.0015 | 6.7362 | 0.8509 | 5 | 37 | positive regulation of neural precursor cell proliferation |
GO:0050804 | 0.0015 | 3.1112 | 3.7973 | 11 | 168 | regulation of synaptic transmission |
GO:0045595 | 0.0015 | 2.0101 | 13.8785 | 26 | 643 | regulation of cell differentiation |
GO:0021902 | 0.0016 | 85.5433 | 0.069 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030910 | 0.0016 | 85.5433 | 0.069 | 2 | 3 | olfactory placode formation |
GO:0042335 | 0.0016 | 85.5433 | 0.069 | 2 | 3 | cuticle development |
GO:0071698 | 0.0016 | 85.5433 | 0.069 | 2 | 3 | olfactory placode development |
GO:2000195 | 0.0016 | 85.5433 | 0.069 | 2 | 3 | negative regulation of female gonad development |
GO:0002791 | 0.0017 | 3.0739 | 3.8407 | 11 | 167 | regulation of peptide secretion |
GO:0048565 | 0.0017 | 3.5547 | 2.7368 | 9 | 119 | digestive tract development |
GO:0030111 | 0.0017 | 2.8946 | 4.4387 | 12 | 193 | regulation of Wnt signaling pathway |
GO:0006662 | 0.0017 | 16.0859 | 0.253 | 3 | 11 | glycerol ether metabolic process |
GO:0021521 | 0.0017 | 16.0859 | 0.253 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0021903 | 0.0017 | 16.0859 | 0.253 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0097154 | 0.0017 | 16.0859 | 0.253 | 3 | 11 | GABAergic neuron differentiation |
GO:0002064 | 0.0017 | 3.054 | 3.8637 | 11 | 168 | epithelial cell development |
GO:0034284 | 0.0018 | 3.5224 | 2.7598 | 9 | 120 | response to monosaccharide |
GO:0071705 | 0.0018 | 2.0372 | 12.5682 | 24 | 550 | nitrogen compound transport |
GO:0030858 | 0.0019 | 6.339 | 0.8969 | 5 | 39 | positive regulation of epithelial cell differentiation |
GO:0048638 | 0.0019 | 3.4907 | 2.7828 | 9 | 121 | regulation of developmental growth |
GO:0035987 | 0.0021 | 6.1573 | 0.9199 | 5 | 40 | endodermal cell differentiation |
GO:0035051 | 0.0021 | 3.7702 | 2.2998 | 8 | 100 | cardiocyte differentiation |
GO:0071383 | 0.0021 | 3.7702 | 2.2998 | 8 | 100 | cellular response to steroid hormone stimulus |
GO:0032946 | 0.0022 | 4.2073 | 1.8169 | 7 | 79 | positive regulation of mononuclear cell proliferation |
GO:0000122 | 0.0023 | 2.0028 | 12.7642 | 24 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0045596 | 0.0023 | 2.1985 | 9.1955 | 19 | 408 | negative regulation of cell differentiation |
GO:0021513 | 0.0024 | 8.1905 | 0.575 | 4 | 25 | spinal cord dorsal/ventral patterning |
GO:0030030 | 0.0024 | 1.738 | 22.8375 | 37 | 993 | cell projection organization |
GO:0048864 | 0.0024 | 2.642 | 5.2437 | 13 | 228 | stem cell development |
GO:0030534 | 0.0025 | 3.3402 | 2.8978 | 9 | 126 | adult behavior |
GO:0007269 | 0.0027 | 4.7112 | 1.4014 | 6 | 62 | neurotransmitter secretion |
GO:0050803 | 0.0027 | 4.7108 | 1.4029 | 6 | 61 | regulation of synapse structure and activity |
GO:0000902 | 0.0027 | 1.7223 | 23.0215 | 37 | 1001 | cell morphogenesis |
GO:0048665 | 0.0028 | 13.0813 | 0.2942 | 3 | 13 | neuron fate specification |
GO:0009719 | 0.0028 | 1.674 | 26.3103 | 41 | 1144 | response to endogenous stimulus |
GO:0021520 | 0.0029 | 12.8667 | 0.299 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0001714 | 0.003 | 43.0592 | 0.0914 | 2 | 4 | endodermal cell fate specification |
GO:0003163 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | sinoatrial node development |
GO:0010269 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | response to selenium ion |
GO:0014054 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0042660 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | positive regulation of cell fate specification |
GO:0042663 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0042816 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | vitamin B6 metabolic process |
GO:0060214 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | endocardium formation |
GO:0060591 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | chondroblast differentiation |
GO:0060913 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | cardiac cell fate determination |
GO:2000977 | 0.0031 | 42.7682 | 0.092 | 2 | 4 | regulation of forebrain neuron differentiation |
GO:0032729 | 0.0032 | 7.477 | 0.621 | 4 | 27 | positive regulation of interferon-gamma production |
GO:0048666 | 0.0033 | 2.4458 | 6.0858 | 14 | 279 | neuron development |
GO:0007268 | 0.0033 | 2.2863 | 7.4317 | 16 | 344 | synaptic transmission |
GO:0061138 | 0.0034 | 2.7843 | 4.2087 | 11 | 183 | morphogenesis of a branching epithelium |
GO:0009914 | 0.0035 | 2.5225 | 5.4736 | 13 | 238 | hormone transport |
GO:0021517 | 0.0035 | 7.2585 | 0.636 | 4 | 28 | ventral spinal cord development |
GO:0090090 | 0.0036 | 3.8323 | 1.9779 | 7 | 86 | negative regulation of canonical Wnt signaling pathway |
GO:0021984 | 0.0036 | 11.696 | 0.322 | 3 | 14 | adenohypophysis development |
GO:0051968 | 0.0036 | 11.696 | 0.322 | 3 | 14 | positive regulation of synaptic transmission, glutamatergic |
GO:0031016 | 0.0037 | 7.0786 | 0.6487 | 4 | 29 | pancreas development |
GO:0032355 | 0.0039 | 3.7841 | 2.0009 | 7 | 87 | response to estradiol |
GO:0045471 | 0.0039 | 3.7841 | 2.0009 | 7 | 87 | response to ethanol |
GO:0060562 | 0.0039 | 2.3113 | 6.8766 | 15 | 299 | epithelial tube morphogenesis |
GO:0035019 | 0.0039 | 5.2537 | 1.0579 | 5 | 46 | somatic stem cell maintenance |
GO:0045446 | 0.004 | 4.3165 | 1.5179 | 6 | 66 | endothelial cell differentiation |
GO:0023061 | 0.0041 | 2.5806 | 4.9365 | 12 | 222 | signal release |
GO:0009653 | 0.0042 | 1.9677 | 11.9787 | 22 | 642 | anatomical structure morphogenesis |
GO:0030182 | 0.0043 | 3.7036 | 2.034 | 7 | 101 | neuron differentiation |
GO:2000027 | 0.0044 | 3.0504 | 3.1508 | 9 | 137 | regulation of organ morphogenesis |
GO:0021781 | 0.0045 | 10.7205 | 0.345 | 3 | 15 | glial cell fate commitment |
GO:0042693 | 0.0045 | 10.7205 | 0.345 | 3 | 15 | muscle cell fate commitment |
GO:0060581 | 0.0045 | 10.7205 | 0.345 | 3 | 15 | cell fate commitment involved in pattern specification |
GO:0072112 | 0.0045 | 10.7205 | 0.345 | 3 | 15 | glomerular visceral epithelial cell differentiation |
GO:2000463 | 0.0045 | 10.7205 | 0.345 | 3 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0007155 | 0.0045 | 1.715 | 20.4917 | 33 | 891 | cell adhesion |
GO:0035265 | 0.0046 | 3.6464 | 2.0699 | 7 | 90 | organ growth |
GO:0021696 | 0.0047 | 6.6127 | 0.69 | 4 | 30 | cerebellar cortex morphogenesis |
GO:0060795 | 0.0047 | 6.6127 | 0.69 | 4 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0030900 | 0.0047 | 3.0099 | 3.1878 | 9 | 145 | forebrain development |
GO:0001826 | 0.005 | 28.5098 | 0.115 | 2 | 5 | inner cell mass cell differentiation |
GO:0008611 | 0.005 | 28.5098 | 0.115 | 2 | 5 | ether lipid biosynthetic process |
GO:0035881 | 0.005 | 28.5098 | 0.115 | 2 | 5 | amacrine cell differentiation |
GO:0060290 | 0.005 | 28.5098 | 0.115 | 2 | 5 | transdifferentiation |
GO:0060297 | 0.005 | 28.5098 | 0.115 | 2 | 5 | regulation of sarcomere organization |
GO:0060421 | 0.005 | 28.5098 | 0.115 | 2 | 5 | positive regulation of heart growth |
GO:0090031 | 0.005 | 28.5098 | 0.115 | 2 | 5 | positive regulation of steroid hormone biosynthetic process |
GO:0097114 | 0.005 | 28.5098 | 0.115 | 2 | 5 | N-methyl-D-aspartate receptor clustering |
GO:1901503 | 0.005 | 28.5098 | 0.115 | 2 | 5 | ether biosynthetic process |
GO:2000727 | 0.005 | 28.5098 | 0.115 | 2 | 5 | positive regulation of cardiac muscle cell differentiation |
GO:0008406 | 0.0051 | 2.7845 | 3.8178 | 10 | 166 | gonad development |
GO:0007586 | 0.0052 | 3.56 | 2.1159 | 7 | 92 | digestion |
GO:0048854 | 0.0053 | 6.3673 | 0.713 | 4 | 31 | brain morphogenesis |
GO:0060441 | 0.0053 | 6.3673 | 0.713 | 4 | 31 | epithelial tube branching involved in lung morphogenesis |
GO:0060512 | 0.0053 | 6.3673 | 0.713 | 4 | 31 | prostate gland morphogenesis |
GO:0060999 | 0.0054 | 9.895 | 0.368 | 3 | 16 | positive regulation of dendritic spine development |
GO:0072148 | 0.0054 | 9.895 | 0.368 | 3 | 16 | epithelial cell fate commitment |
GO:0048592 | 0.0055 | 3.5307 | 2.1309 | 7 | 94 | eye morphogenesis |
GO:0048513 | 0.0056 | 1.7331 | 19.3408 | 31 | 1085 | organ development |
GO:0048545 | 0.0057 | 2.585 | 4.5089 | 11 | 200 | response to steroid hormone |
GO:0000578 | 0.0059 | 6.1394 | 0.736 | 4 | 32 | embryonic axis specification |
GO:0030073 | 0.006 | 2.714 | 3.9097 | 10 | 170 | insulin secretion |
GO:0050673 | 0.006 | 2.3519 | 5.8416 | 13 | 254 | epithelial cell proliferation |
GO:0007519 | 0.0061 | 2.8905 | 3.3118 | 9 | 144 | skeletal muscle tissue development |
GO:0051049 | 0.0061 | 1.5913 | 27.5062 | 41 | 1196 | regulation of transport |
GO:0042102 | 0.0062 | 4.6808 | 1.1729 | 5 | 51 | positive regulation of T cell proliferation |
GO:0046883 | 0.0064 | 2.544 | 4.5767 | 11 | 199 | regulation of hormone secretion |
GO:0060914 | 0.0064 | 9.1875 | 0.391 | 3 | 17 | heart formation |
GO:0001678 | 0.0066 | 3.8633 | 1.6789 | 6 | 73 | cellular glucose homeostasis |
GO:0035094 | 0.0066 | 5.9272 | 0.759 | 4 | 33 | response to nicotine |
GO:0035850 | 0.0066 | 5.9272 | 0.759 | 4 | 33 | epithelial cell differentiation involved in kidney development |
GO:0051932 | 0.0066 | 5.9272 | 0.759 | 4 | 33 | synaptic transmission, GABAergic |
GO:0021885 | 0.0067 | 4.5808 | 1.1959 | 5 | 52 | forebrain cell migration |
GO:0060415 | 0.0067 | 4.5808 | 1.1959 | 5 | 52 | muscle tissue morphogenesis |
GO:0048520 | 0.007 | 3.8062 | 1.7019 | 6 | 74 | positive regulation of behavior |
GO:0031327 | 0.0072 | 1.6312 | 22.7915 | 35 | 991 | negative regulation of cellular biosynthetic process |
GO:0032502 | 0.0072 | 1.549 | 36.0293 | 50 | 2068 | developmental process |
GO:0010033 | 0.0072 | 1.4613 | 45.0771 | 61 | 1960 | response to organic substance |
GO:0015870 | 0.0074 | 21.3806 | 0.138 | 2 | 6 | acetylcholine transport |
GO:0051450 | 0.0074 | 21.3806 | 0.138 | 2 | 6 | myoblast proliferation |
GO:0060527 | 0.0074 | 21.3806 | 0.138 | 2 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0060534 | 0.0074 | 21.3806 | 0.138 | 2 | 6 | trachea cartilage development |
GO:2000252 | 0.0074 | 21.3806 | 0.138 | 2 | 6 | negative regulation of feeding behavior |
GO:0007263 | 0.0076 | 8.5743 | 0.414 | 3 | 18 | nitric oxide mediated signal transduction |
GO:0007271 | 0.0076 | 8.5743 | 0.414 | 3 | 18 | synaptic transmission, cholinergic |
GO:0072010 | 0.0076 | 8.5743 | 0.414 | 3 | 18 | glomerular epithelium development |
GO:2000311 | 0.0076 | 8.5743 | 0.414 | 3 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0021766 | 0.0076 | 5.6586 | 0.7892 | 4 | 35 | hippocampus development |
GO:0009605 | 0.0077 | 1.5119 | 34.7047 | 49 | 1509 | response to external stimulus |
GO:0007611 | 0.0078 | 2.5987 | 4.0707 | 10 | 177 | learning or memory |
GO:0040011 | 0.0084 | 1.557 | 28.0352 | 41 | 1219 | locomotion |
GO:0021549 | 0.0085 | 3.6445 | 1.7709 | 6 | 77 | cerebellum development |
GO:0022898 | 0.0086 | 2.9332 | 2.8978 | 8 | 126 | regulation of transmembrane transporter activity |
GO:0070663 | 0.0086 | 2.9332 | 2.8978 | 8 | 126 | regulation of leukocyte proliferation |
GO:0021871 | 0.0086 | 8.1204 | 0.4327 | 3 | 19 | forebrain regionalization |
GO:0044057 | 0.0088 | 2.099 | 7.5205 | 15 | 327 | regulation of system process |
GO:0007530 | 0.0089 | 8.0378 | 0.437 | 3 | 19 | sex determination |
GO:0055012 | 0.0089 | 8.0378 | 0.437 | 3 | 19 | ventricular cardiac muscle cell differentiation |
GO:0001944 | 0.0091 | 1.8756 | 11.2233 | 20 | 488 | vasculature development |
GO:0043271 | 0.0091 | 4.2201 | 1.2879 | 5 | 56 | negative regulation of ion transport |
GO:0090277 | 0.0091 | 4.2201 | 1.2879 | 5 | 56 | positive regulation of peptide hormone secretion |
GO:0008202 | 0.0094 | 2.4012 | 4.8297 | 11 | 210 | steroid metabolic process |
GO:0071805 | 0.0094 | 2.8839 | 2.9438 | 8 | 128 | potassium ion transmembrane transport |
GO:0034765 | 0.0095 | 2.2114 | 6.1866 | 13 | 269 | regulation of ion transmembrane transport |
GO:0061351 | 0.0095 | 3.5499 | 1.8131 | 6 | 80 | neural precursor cell proliferation |
GO:0032990 | 0.0095 | 1.7039 | 16.7199 | 27 | 727 | cell part morphogenesis |
GO:0030282 | 0.0096 | 3.5441 | 1.8169 | 6 | 79 | bone mineralization |
GO:0050773 | 0.0096 | 3.5441 | 1.8169 | 6 | 79 | regulation of dendrite development |
GO:0003151 | 0.0098 | 4.1386 | 1.3109 | 5 | 57 | outflow tract morphogenesis |
GO:0003208 | 0.0098 | 4.1386 | 1.3109 | 5 | 57 | cardiac ventricle morphogenesis |
GO:0035136 | 0.01 | 5.2071 | 0.8509 | 4 | 37 | forelimb morphogenesis |
GO:0035137 | 0.01 | 5.2071 | 0.8509 | 4 | 37 | hindlimb morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007028 | 1e-04 | 54.9602 | 0.1086 | 3 | 6 | cytoplasm organization |
GO:0007308 | 3e-04 | Inf | 0.0362 | 2 | 2 | oocyte construction |
GO:0007314 | 3e-04 | Inf | 0.0362 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 3e-04 | Inf | 0.0362 | 2 | 2 | P granule organization |
GO:0001806 | 0.001 | 109.4537 | 0.0543 | 2 | 3 | type IV hypersensitivity |
GO:0045785 | 0.0012 | 3.7239 | 2.6062 | 9 | 144 | positive regulation of cell adhesion |
GO:0007186 | 0.0013 | 2.1742 | 10.8772 | 22 | 601 | G-protein coupled receptor signaling pathway |
GO:0007606 | 0.0014 | 5.3647 | 1.2307 | 6 | 68 | sensory perception of chemical stimulus |
GO:0050911 | 0.0015 | 16.4788 | 0.2353 | 3 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0072164 | 0.0015 | 4.5237 | 1.6832 | 7 | 93 | mesonephric tubule development |
GO:0031338 | 0.0018 | 14.9795 | 0.2534 | 3 | 14 | regulation of vesicle fusion |
GO:0033599 | 0.0018 | 14.9795 | 0.2534 | 3 | 14 | regulation of mammary gland epithelial cell proliferation |
GO:0097267 | 0.0019 | 54.7225 | 0.0724 | 2 | 4 | omega-hydroxylase P450 pathway |
GO:1903034 | 0.0022 | 2.7955 | 4.5789 | 12 | 253 | regulation of response to wounding |
GO:0002675 | 0.0023 | 13.7301 | 0.2715 | 3 | 15 | positive regulation of acute inflammatory response |
GO:0019373 | 0.0031 | 36.4787 | 0.0905 | 2 | 5 | epoxygenase P450 pathway |
GO:0071675 | 0.0031 | 36.4787 | 0.0905 | 2 | 5 | regulation of mononuclear cell migration |
GO:0023052 | 0.0041 | 1.4454 | 79.3799 | 99 | 4386 | signaling |
GO:1902533 | 0.0042 | 2.035 | 10.4609 | 20 | 578 | positive regulation of intracellular signal transduction |
GO:0060675 | 0.0042 | 5.1133 | 1.0678 | 5 | 59 | ureteric bud morphogenesis |
GO:0045765 | 0.0043 | 3.3201 | 2.57 | 8 | 142 | regulation of angiogenesis |
GO:0034333 | 0.0045 | 5.0199 | 1.0859 | 5 | 60 | adherens junction assembly |
GO:0009838 | 0.0047 | 27.3568 | 0.1086 | 2 | 6 | abscission |
GO:0034112 | 0.0047 | 27.3568 | 0.1086 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
GO:1903037 | 0.0047 | 27.3568 | 0.1086 | 2 | 6 | regulation of leukocyte cell-cell adhesion |
GO:0010573 | 0.0061 | 9.149 | 0.3801 | 3 | 21 | vascular endothelial growth factor production |
GO:0006954 | 0.0062 | 2.1918 | 7.2394 | 15 | 400 | inflammatory response |
GO:0050906 | 0.0064 | 4.5997 | 1.1764 | 5 | 65 | detection of stimulus involved in sensory perception |
GO:0061180 | 0.0064 | 4.5997 | 1.1764 | 5 | 65 | mammary gland epithelium development |
GO:0001765 | 0.0065 | 21.8837 | 0.1267 | 2 | 7 | membrane raft assembly |
GO:0032753 | 0.0065 | 21.8837 | 0.1267 | 2 | 7 | positive regulation of interleukin-4 production |
GO:0023056 | 0.0068 | 1.746 | 17.1212 | 28 | 946 | positive regulation of signaling |
GO:0007165 | 0.0069 | 1.42 | 71.1451 | 89 | 3931 | signal transduction |
GO:2000026 | 0.0069 | 1.683 | 20.3845 | 32 | 1140 | regulation of multicellular organismal development |
GO:0010647 | 0.0073 | 1.7338 | 17.2297 | 28 | 952 | positive regulation of cell communication |
GO:0090287 | 0.0075 | 3.0026 | 2.8234 | 8 | 156 | regulation of cellular response to growth factor stimulus |
GO:0007044 | 0.0077 | 4.3796 | 1.2307 | 5 | 68 | cell-substrate junction assembly |
GO:0061217 | 0.0079 | 8.2327 | 0.4163 | 3 | 23 | regulation of mesonephros development |
GO:1901888 | 0.0081 | 5.504 | 0.7963 | 4 | 44 | regulation of cell junction assembly |
GO:2000145 | 0.0085 | 2.0556 | 8.2167 | 16 | 454 | regulation of cell motility |
GO:0030335 | 0.0086 | 2.5567 | 4.1265 | 10 | 228 | positive regulation of cell migration |
GO:0010810 | 0.0086 | 3.2061 | 2.3166 | 7 | 128 | regulation of cell-substrate adhesion |
GO:0001676 | 0.0087 | 4.2442 | 1.2669 | 5 | 70 | long-chain fatty acid metabolic process |
GO:0007162 | 0.0087 | 3.6066 | 1.7737 | 6 | 98 | negative regulation of cell adhesion |
GO:0048589 | 0.0089 | 2.4176 | 4.7961 | 11 | 265 | developmental growth |
GO:0002711 | 0.0089 | 7.8401 | 0.4344 | 3 | 24 | positive regulation of T cell mediated immunity |
GO:0070528 | 0.0089 | 7.8401 | 0.4344 | 3 | 24 | protein kinase C signaling |
GO:0044255 | 0.0092 | 1.7964 | 13.5739 | 23 | 750 | cellular lipid metabolic process |
GO:0032103 | 0.0094 | 3.1534 | 2.3528 | 7 | 130 | positive regulation of response to external stimulus |
GO:0072073 | 0.0094 | 3.1534 | 2.3528 | 7 | 130 | kidney epithelium development |
GO:0007160 | 0.01 | 2.8467 | 2.9681 | 8 | 164 | cell-matrix adhesion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 293.3803 | 0.1562 | 10 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 17.9823 | 0.7808 | 11 | 65 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 19.0677 | 0.6727 | 10 | 56 | detection of chemical stimulus |
GO:0007606 | 0 | 15.1081 | 0.8169 | 10 | 68 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 2.8791 | 8.6013 | 22 | 716 | neurological system process |
GO:0007186 | 1e-04 | 3.0516 | 6.9538 | 19 | 590 | G-protein coupled receptor signaling pathway |
GO:0007308 | 1e-04 | Inf | 0.024 | 2 | 2 | oocyte construction |
GO:0007314 | 1e-04 | Inf | 0.024 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 1e-04 | Inf | 0.024 | 2 | 2 | P granule organization |
GO:0007210 | 3e-04 | 31.4421 | 0.1321 | 3 | 11 | serotonin receptor signaling pathway |
GO:0002774 | 4e-04 | 166.6667 | 0.036 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007350 | 6e-04 | 22.8615 | 0.1682 | 3 | 14 | blastoderm segmentation |
GO:0008595 | 6e-04 | 22.8615 | 0.1682 | 3 | 14 | anterior/posterior axis specification, embryo |
GO:0032689 | 7e-04 | 20.9547 | 0.1802 | 3 | 15 | negative regulation of interferon-gamma production |
GO:0002765 | 8e-04 | 83.3267 | 0.0481 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0002664 | 0.0021 | 41.6567 | 0.0721 | 2 | 6 | regulation of T cell tolerance induction |
GO:0007028 | 0.0021 | 41.6567 | 0.0721 | 2 | 6 | cytoplasm organization |
GO:0051883 | 0.0029 | 33.3227 | 0.0841 | 2 | 7 | killing of cells in other organism involved in symbiotic interaction |
GO:2001198 | 0.0029 | 33.3227 | 0.0841 | 2 | 7 | regulation of dendritic cell differentiation |
GO:0072643 | 0.0038 | 27.7667 | 0.0961 | 2 | 8 | interferon-gamma secretion |
GO:0007155 | 0.0049 | 2.0231 | 10.7035 | 20 | 891 | cell adhesion |
GO:0007586 | 0.005 | 4.8534 | 1.1052 | 5 | 92 | digestion |
GO:0034113 | 0.0054 | 9.302 | 0.3604 | 3 | 30 | heterotypic cell-cell adhesion |
GO:0001906 | 0.0055 | 6.116 | 0.7088 | 4 | 59 | cell killing |
GO:0002718 | 0.0065 | 8.6591 | 0.3844 | 3 | 32 | regulation of cytokine production involved in immune response |
GO:0042445 | 0.0066 | 3.8216 | 1.6698 | 6 | 139 | hormone metabolic process |
GO:0044707 | 0.0066 | 1.5322 | 55.8579 | 71 | 4773 | single-multicellular organism process |
GO:0002507 | 0.0073 | 18.5067 | 0.1321 | 2 | 11 | tolerance induction |
GO:0044364 | 0.0073 | 18.5067 | 0.1321 | 2 | 11 | disruption of cells of other organism |
GO:0044110 | 0.0087 | 16.6547 | 0.1442 | 2 | 12 | growth involved in symbiotic interaction |
GO:0044117 | 0.0087 | 16.6547 | 0.1442 | 2 | 12 | growth of symbiont in host |
GO:0046541 | 0.0087 | 16.6547 | 0.1442 | 2 | 12 | saliva secretion |
GO:0050714 | 0.0095 | 5.1709 | 0.8289 | 4 | 69 | positive regulation of protein secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070474 | 3e-04 | 32.8229 | 0.1454 | 3 | 8 | positive regulation of uterine smooth muscle contraction |
GO:0010701 | 3e-04 | Inf | 0.0364 | 2 | 2 | positive regulation of norepinephrine secretion |
GO:0051343 | 0.001 | 108.9649 | 0.0545 | 2 | 3 | positive regulation of cyclic-nucleotide phosphodiesterase activity |
GO:0050908 | 0.0012 | 18.2291 | 0.2181 | 3 | 12 | detection of light stimulus involved in visual perception |
GO:0010043 | 0.0013 | 9.5421 | 0.4908 | 4 | 27 | response to zinc ion |
GO:0008217 | 0.0019 | 3.8232 | 2.254 | 8 | 124 | regulation of blood pressure |
GO:0006564 | 0.0019 | 54.4781 | 0.0727 | 2 | 4 | L-serine biosynthetic process |
GO:0042816 | 0.0019 | 54.4781 | 0.0727 | 2 | 4 | vitamin B6 metabolic process |
GO:0060455 | 0.0019 | 54.4781 | 0.0727 | 2 | 4 | negative regulation of gastric acid secretion |
GO:0072378 | 0.0023 | 13.6685 | 0.2727 | 3 | 15 | blood coagulation, fibrin clot formation |
GO:0007204 | 0.0027 | 3.2877 | 2.9266 | 9 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0007186 | 0.0032 | 2.0517 | 10.9247 | 21 | 601 | G-protein coupled receptor signaling pathway |
GO:0042713 | 0.0032 | 36.3158 | 0.0909 | 2 | 5 | sperm ejaculation |
GO:0060406 | 0.0032 | 36.3158 | 0.0909 | 2 | 5 | positive regulation of penile erection |
GO:0006936 | 0.0034 | 2.7861 | 4.199 | 11 | 231 | muscle contraction |
GO:0042026 | 0.0046 | 10.2481 | 0.3454 | 3 | 19 | protein refolding |
GO:0060252 | 0.0047 | 27.2346 | 0.1091 | 2 | 6 | positive regulation of glial cell proliferation |
GO:1901380 | 0.0047 | 27.2346 | 0.1091 | 2 | 6 | negative regulation of potassium ion transmembrane transport |
GO:0090257 | 0.0059 | 3.139 | 2.7084 | 8 | 149 | regulation of muscle system process |
GO:0072525 | 0.0062 | 9.1079 | 0.3817 | 3 | 21 | pyridine-containing compound biosynthetic process |
GO:0051001 | 0.0065 | 21.786 | 0.1272 | 2 | 7 | negative regulation of nitric-oxide synthase activity |
GO:0003009 | 0.0071 | 8.6279 | 0.3999 | 3 | 22 | skeletal muscle contraction |
GO:2000021 | 0.0075 | 3.3016 | 2.254 | 7 | 124 | regulation of ion homeostasis |
GO:0033059 | 0.0075 | 5.6201 | 0.7816 | 4 | 43 | cellular pigmentation |
GO:0019674 | 0.008 | 8.1958 | 0.4181 | 3 | 23 | NAD metabolic process |
GO:0060856 | 0.0086 | 18.1535 | 0.1454 | 2 | 8 | establishment of blood-brain barrier |
GO:0046717 | 0.0088 | 4.225 | 1.2724 | 5 | 70 | acid secretion |
GO:0006940 | 0.0088 | 5.3451 | 0.818 | 4 | 45 | regulation of smooth muscle contraction |
GO:0001975 | 0.0091 | 7.8049 | 0.4363 | 3 | 24 | response to amphetamine |
GO:0044058 | 0.0091 | 7.8049 | 0.4363 | 3 | 24 | regulation of digestive system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070830 | 0 | 12.2886 | 0.8038 | 8 | 45 | tight junction assembly |
GO:0050891 | 0 | 13.5295 | 0.5537 | 6 | 31 | multicellular organismal water homeostasis |
GO:0044707 | 1e-04 | 1.6979 | 85.5139 | 114 | 4844 | single-multicellular organism process |
GO:0061028 | 4e-04 | 13.9764 | 0.3572 | 4 | 20 | establishment of endothelial barrier |
GO:0050896 | 6e-04 | 1.5644 | 105.3107 | 130 | 5896 | response to stimulus |
GO:0034329 | 6e-04 | 3.4811 | 3.4115 | 11 | 191 | cell junction assembly |
GO:0060561 | 0.0011 | 10.1597 | 0.4644 | 4 | 26 | apoptotic process involved in morphogenesis |
GO:0050808 | 0.0011 | 3.7763 | 2.572 | 9 | 144 | synapse organization |
GO:0007155 | 0.0012 | 1.975 | 15.9145 | 29 | 891 | cell adhesion |
GO:0007165 | 0.0012 | 1.5359 | 70.2131 | 92 | 3931 | signal transduction |
GO:0070293 | 0.0014 | 16.7045 | 0.2322 | 3 | 13 | renal absorption |
GO:0023052 | 0.0018 | 1.5434 | 63.9484 | 84 | 3748 | signaling |
GO:0042663 | 0.0019 | 55.4688 | 0.0714 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0045216 | 0.0019 | 3.2226 | 3.3222 | 10 | 186 | cell-cell junction organization |
GO:0061436 | 0.0022 | 13.9182 | 0.2679 | 3 | 15 | establishment of skin barrier |
GO:0007186 | 0.0026 | 2.0924 | 10.7347 | 21 | 601 | G-protein coupled receptor signaling pathway |
GO:0048878 | 0.0029 | 2.0008 | 12.3065 | 23 | 689 | chemical homeostasis |
GO:0032611 | 0.003 | 7.4456 | 0.6073 | 4 | 34 | interleukin-1 beta production |
GO:0051712 | 0.0031 | 36.9762 | 0.0893 | 2 | 5 | positive regulation of killing of cells of other organism |
GO:0071681 | 0.0031 | 36.9762 | 0.0893 | 2 | 5 | cellular response to indole-3-methanol |
GO:0048525 | 0.0032 | 5.4902 | 1.0002 | 5 | 56 | negative regulation of viral process |
GO:2000378 | 0.0032 | 11.9279 | 0.3036 | 3 | 17 | negative regulation of reactive oxygen species metabolic process |
GO:0071356 | 0.0044 | 4.2092 | 1.5361 | 6 | 86 | cellular response to tumor necrosis factor |
GO:0006570 | 0.0045 | 27.7299 | 0.1072 | 2 | 6 | tyrosine metabolic process |
GO:0030011 | 0.0045 | 27.7299 | 0.1072 | 2 | 6 | maintenance of cell polarity |
GO:0060261 | 0.0045 | 27.7299 | 0.1072 | 2 | 6 | positive regulation of transcription initiation from RNA polymerase II promoter |
GO:0090239 | 0.0045 | 27.7299 | 0.1072 | 2 | 6 | regulation of histone H4 acetylation |
GO:0050877 | 0.0046 | 1.9184 | 12.7887 | 23 | 716 | neurological system process |
GO:0007268 | 0.0051 | 1.9608 | 11.3956 | 21 | 638 | synaptic transmission |
GO:0016338 | 0.0051 | 9.8206 | 0.3572 | 3 | 20 | calcium-independent cell-cell adhesion |
GO:0016337 | 0.0052 | 2.4965 | 5.0905 | 12 | 285 | single organismal cell-cell adhesion |
GO:0031424 | 0.0059 | 9.2743 | 0.3751 | 3 | 21 | keratinization |
GO:0045446 | 0.0064 | 4.5865 | 1.1789 | 5 | 66 | endothelial cell differentiation |
GO:0016339 | 0.0067 | 8.7855 | 0.393 | 3 | 22 | calcium-dependent cell-cell adhesion |
GO:0008217 | 0.0068 | 3.363 | 2.2148 | 7 | 124 | regulation of blood pressure |
GO:0048731 | 0.007 | 1.4421 | 59.0676 | 76 | 3307 | system development |
GO:0001817 | 0.0075 | 2.2072 | 6.698 | 14 | 375 | regulation of cytokine production |
GO:0032613 | 0.0076 | 8.3455 | 0.4108 | 3 | 23 | interleukin-10 production |
GO:0035235 | 0.0076 | 8.3455 | 0.4108 | 3 | 23 | ionotropic glutamate receptor signaling pathway |
GO:0035249 | 0.0077 | 4.3704 | 1.2324 | 5 | 69 | synaptic transmission, glutamatergic |
GO:0072643 | 0.0083 | 18.4836 | 0.1429 | 2 | 8 | interferon-gamma secretion |
GO:0050715 | 0.0083 | 5.4432 | 0.8038 | 4 | 45 | positive regulation of cytokine secretion |
GO:0051702 | 0.0086 | 7.9475 | 0.4287 | 3 | 24 | interaction with symbiont |
GO:0098655 | 0.0089 | 1.9985 | 8.9843 | 17 | 503 | cation transmembrane transport |
GO:0030308 | 0.0091 | 3.1713 | 2.3398 | 7 | 131 | negative regulation of cell growth |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042246 | 0 | 11.8946 | 0.6082 | 6 | 37 | tissue regeneration |
GO:0043415 | 0 | 91.0463 | 0.0822 | 3 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0040008 | 2e-04 | 2.7347 | 7.9893 | 20 | 486 | regulation of growth |
GO:0033993 | 2e-04 | 3.2859 | 4.6339 | 14 | 293 | response to lipid |
GO:0045137 | 5e-04 | 3.9025 | 2.7782 | 10 | 169 | development of primary sexual characteristics |
GO:0046661 | 5e-04 | 4.793 | 1.8247 | 8 | 111 | male sex differentiation |
GO:0010862 | 5e-04 | 12.8235 | 0.3781 | 4 | 23 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0030307 | 5e-04 | 5.4514 | 1.4137 | 7 | 86 | positive regulation of cell growth |
GO:2000026 | 6e-04 | 1.9758 | 18.9704 | 34 | 1154 | regulation of multicellular organismal development |
GO:0008584 | 6e-04 | 5.2506 | 1.4631 | 7 | 89 | male gonad development |
GO:0072506 | 7e-04 | 22.7506 | 0.1808 | 3 | 11 | trivalent inorganic anion homeostasis |
GO:0007586 | 8e-04 | 5.0641 | 1.5124 | 7 | 92 | digestion |
GO:0007207 | 8e-04 | 120.8155 | 0.0493 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0014717 | 8e-04 | 120.8155 | 0.0493 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0030309 | 8e-04 | 120.8155 | 0.0493 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0032729 | 9e-04 | 10.5899 | 0.4438 | 4 | 27 | positive regulation of interferon-gamma production |
GO:0030155 | 9e-04 | 2.9613 | 4.7179 | 13 | 287 | regulation of cell adhesion |
GO:1903034 | 0.001 | 3.1003 | 4.159 | 12 | 253 | regulation of response to wounding |
GO:0003084 | 0.0011 | 18.1976 | 0.2137 | 3 | 13 | positive regulation of systemic arterial blood pressure |
GO:0032095 | 0.0011 | 18.1976 | 0.2137 | 3 | 13 | regulation of response to food |
GO:0071396 | 0.0012 | 3.0111 | 4.2741 | 12 | 260 | cellular response to lipid |
GO:0097305 | 0.0013 | 3.1613 | 3.7316 | 11 | 227 | response to alcohol |
GO:0051051 | 0.0014 | 2.8141 | 4.9481 | 13 | 301 | negative regulation of transport |
GO:0051240 | 0.0016 | 2.3463 | 8.2358 | 18 | 501 | positive regulation of multicellular organismal process |
GO:0050891 | 0.0016 | 9.0182 | 0.5096 | 4 | 31 | multicellular organismal water homeostasis |
GO:0060986 | 0.0016 | 9.0182 | 0.5096 | 4 | 31 | endocrine hormone secretion |
GO:0007621 | 0.0016 | 60.4029 | 0.0658 | 2 | 4 | negative regulation of female receptivity |
GO:0060278 | 0.0016 | 60.4029 | 0.0658 | 2 | 4 | regulation of ovulation |
GO:0014070 | 0.0016 | 2.2327 | 9.6331 | 20 | 586 | response to organic cyclic compound |
GO:0061436 | 0.0017 | 15.1622 | 0.2466 | 3 | 15 | establishment of skin barrier |
GO:0007205 | 0.0018 | 8.6954 | 0.526 | 4 | 32 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0022414 | 0.002 | 1.9532 | 14.9593 | 27 | 910 | reproductive process |
GO:0048608 | 0.0021 | 2.5849 | 5.7865 | 14 | 352 | reproductive structure development |
GO:0007186 | 0.0022 | 2.216 | 9.1971 | 19 | 569 | G-protein coupled receptor signaling pathway |
GO:0043627 | 0.0025 | 3.6474 | 2.3507 | 8 | 143 | response to estrogen |
GO:0010812 | 0.0025 | 7.852 | 0.5754 | 4 | 35 | negative regulation of cell-substrate adhesion |
GO:0071773 | 0.0025 | 12.9941 | 0.2795 | 3 | 17 | cellular response to BMP stimulus |
GO:0006954 | 0.0025 | 2.4346 | 6.5755 | 15 | 400 | inflammatory response |
GO:0008627 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | intrinsic apoptotic signaling pathway in response to osmotic stress |
GO:0014719 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | skeletal muscle satellite cell activation |
GO:0046884 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | follicle-stimulating hormone secretion |
GO:0051901 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | positive regulation of mitochondrial depolarization |
GO:0060040 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | retinal bipolar neuron differentiation |
GO:1901723 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | negative regulation of cell proliferation involved in kidney development |
GO:2000609 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | regulation of thyroid hormone generation |
GO:2001023 | 0.0026 | 40.2654 | 0.0822 | 2 | 5 | regulation of response to drug |
GO:0044057 | 0.003 | 2.5756 | 5.3755 | 13 | 327 | regulation of system process |
GO:0043010 | 0.003 | 2.8276 | 4.1426 | 11 | 252 | camera-type eye development |
GO:0045597 | 0.0032 | 2.3044 | 7.4085 | 16 | 459 | positive regulation of cell differentiation |
GO:0046456 | 0.0034 | 7.1574 | 0.6247 | 4 | 38 | icosanoid biosynthetic process |
GO:0065007 | 0.0036 | 1.5316 | 134.4529 | 153 | 8179 | biological regulation |
GO:0060341 | 0.0036 | 1.9637 | 12.5592 | 23 | 764 | regulation of cellular localization |
GO:0031638 | 0.0036 | 4.3709 | 1.4795 | 6 | 90 | zymogen activation |
GO:0001816 | 0.0037 | 2.3343 | 6.8385 | 15 | 416 | cytokine production |
GO:0006950 | 0.0037 | 1.5456 | 44.3025 | 61 | 2695 | response to stress |
GO:0030643 | 0.0039 | 30.1966 | 0.0986 | 2 | 6 | cellular phosphate ion homeostasis |
GO:0035860 | 0.0039 | 30.1966 | 0.0986 | 2 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
GO:0060017 | 0.0039 | 30.1966 | 0.0986 | 2 | 6 | parathyroid gland development |
GO:1902476 | 0.004 | 5.1707 | 1.0521 | 5 | 64 | chloride transmembrane transport |
GO:0043269 | 0.0042 | 2.2988 | 6.9372 | 15 | 422 | regulation of ion transport |
GO:0050767 | 0.0042 | 2.2316 | 7.6276 | 16 | 464 | regulation of neurogenesis |
GO:0001516 | 0.0047 | 10.1033 | 0.3452 | 3 | 21 | prostaglandin biosynthetic process |
GO:0072132 | 0.0047 | 10.1033 | 0.3452 | 3 | 21 | mesenchyme morphogenesis |
GO:0007565 | 0.0048 | 3.6073 | 2.0713 | 7 | 126 | female pregnancy |
GO:0008544 | 0.0049 | 2.7935 | 3.7974 | 10 | 231 | epidermis development |
GO:0007204 | 0.0051 | 3.2136 | 2.6466 | 8 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0007044 | 0.0052 | 4.8409 | 1.1178 | 5 | 68 | cell-substrate junction assembly |
GO:0032722 | 0.0061 | 9.0915 | 0.3781 | 3 | 23 | positive regulation of chemokine production |
GO:0061217 | 0.0061 | 9.0915 | 0.3781 | 3 | 23 | regulation of mesonephros development |
GO:0070830 | 0.0062 | 5.9321 | 0.7397 | 4 | 45 | tight junction assembly |
GO:0044707 | 0.0063 | 1.476 | 63.3556 | 80 | 4124 | single-multicellular organism process |
GO:0015698 | 0.0064 | 3.8614 | 1.6603 | 6 | 101 | inorganic anion transport |
GO:0051222 | 0.0068 | 3.0519 | 2.7782 | 8 | 169 | positive regulation of protein transport |
GO:0030857 | 0.0069 | 8.6578 | 0.3945 | 3 | 24 | negative regulation of epithelial cell differentiation |
GO:0070528 | 0.0069 | 8.6578 | 0.3945 | 3 | 24 | protein kinase C signaling |
GO:0002579 | 0.0071 | 20.1278 | 0.1315 | 2 | 8 | positive regulation of antigen processing and presentation |
GO:0032099 | 0.0071 | 20.1278 | 0.1315 | 2 | 8 | negative regulation of appetite |
GO:0045603 | 0.0071 | 20.1278 | 0.1315 | 2 | 8 | positive regulation of endothelial cell differentiation |
GO:0060180 | 0.0071 | 20.1278 | 0.1315 | 2 | 8 | female mating behavior |
GO:0050877 | 0.0072 | 1.8986 | 11.7702 | 21 | 716 | neurological system process |
GO:0006636 | 0.0073 | 5.6553 | 0.7726 | 4 | 47 | unsaturated fatty acid biosynthetic process |
GO:0007612 | 0.0073 | 3.7423 | 1.7096 | 6 | 104 | learning |
GO:0032101 | 0.0075 | 2.1458 | 7.3975 | 15 | 450 | regulation of response to external stimulus |
GO:0001836 | 0.0078 | 5.5263 | 0.7891 | 4 | 48 | release of cytochrome c from mitochondria |
GO:0044087 | 0.0079 | 2.1957 | 6.7399 | 14 | 410 | regulation of cellular component biogenesis |
GO:0044708 | 0.0079 | 2.3576 | 5.3755 | 12 | 327 | single-organism behavior |
GO:0009617 | 0.008 | 2.5904 | 4.0768 | 10 | 248 | response to bacterium |
GO:0042127 | 0.008 | 1.7101 | 18.1813 | 29 | 1106 | regulation of cell proliferation |
GO:0051047 | 0.0082 | 2.7411 | 3.4686 | 9 | 211 | positive regulation of secretion |
GO:0045666 | 0.0082 | 4.2927 | 1.2493 | 5 | 76 | positive regulation of neuron differentiation |
GO:0098656 | 0.0084 | 3.2239 | 2.3014 | 7 | 140 | anion transmembrane transport |
GO:0040012 | 0.0084 | 2.0594 | 8.2194 | 16 | 500 | regulation of locomotion |
GO:0006692 | 0.0086 | 7.9037 | 0.4274 | 3 | 26 | prostanoid metabolic process |
GO:0032755 | 0.0086 | 7.9037 | 0.4274 | 3 | 26 | positive regulation of interleukin-6 production |
GO:0034330 | 0.0089 | 2.7003 | 3.5179 | 9 | 214 | cell junction organization |
GO:0032656 | 0.009 | 17.251 | 0.1479 | 2 | 9 | regulation of interleukin-13 production |
GO:0042541 | 0.009 | 17.251 | 0.1479 | 2 | 9 | hemoglobin biosynthetic process |
GO:2000484 | 0.009 | 17.251 | 0.1479 | 2 | 9 | positive regulation of interleukin-8 secretion |
GO:2001054 | 0.009 | 17.251 | 0.1479 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
GO:0045445 | 0.0091 | 5.2852 | 0.8219 | 4 | 50 | myoblast differentiation |
GO:0010632 | 0.0092 | 3.5592 | 1.7918 | 6 | 109 | regulation of epithelial cell migration |
GO:0050673 | 0.0093 | 2.5255 | 4.1755 | 10 | 254 | epithelial cell proliferation |
GO:0048878 | 0.0097 | 1.8726 | 11.3263 | 20 | 689 | chemical homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045132 | 0 | 18.8554 | 0.346 | 5 | 22 | meiotic chromosome segregation |
GO:0007129 | 1e-04 | 14.5642 | 0.4246 | 5 | 27 | synapsis |
GO:0007131 | 3e-04 | 14.312 | 0.3427 | 4 | 22 | reciprocal meiotic recombination |
GO:0007597 | 6e-04 | 23.8125 | 0.173 | 3 | 11 | blood coagulation, intrinsic pathway |
GO:0030277 | 6e-04 | 23.8125 | 0.173 | 3 | 11 | maintenance of gastrointestinal epithelium |
GO:0051321 | 7e-04 | 4.0493 | 2.4063 | 9 | 153 | meiotic cell cycle |
GO:0046642 | 7e-04 | 126.4264 | 0.0472 | 2 | 3 | negative regulation of alpha-beta T cell proliferation |
GO:0071805 | 9e-04 | 4.3051 | 2.0131 | 8 | 128 | potassium ion transmembrane transport |
GO:0007140 | 0.001 | 10.1982 | 0.4561 | 4 | 29 | male meiosis |
GO:0002700 | 0.0012 | 6.952 | 0.8021 | 5 | 51 | regulation of production of molecular mediator of immune response |
GO:0098660 | 0.002 | 2.3556 | 7.7379 | 17 | 492 | inorganic ion transmembrane transport |
GO:0051177 | 0.0024 | 42.1354 | 0.0786 | 2 | 5 | meiotic sister chromatid cohesion |
GO:0098655 | 0.0025 | 2.3002 | 7.9109 | 17 | 503 | cation transmembrane transport |
GO:0007135 | 0.0035 | 31.599 | 0.0944 | 2 | 6 | meiosis II |
GO:0007144 | 0.0035 | 31.599 | 0.0944 | 2 | 6 | female meiosis I |
GO:0006813 | 0.0039 | 3.3675 | 2.5321 | 8 | 161 | potassium ion transport |
GO:0031295 | 0.0062 | 5.9206 | 0.7392 | 4 | 47 | T cell costimulation |
GO:0000712 | 0.0065 | 21.0626 | 0.1258 | 2 | 8 | resolution of meiotic recombination intermediates |
GO:0006957 | 0.0065 | 21.0626 | 0.1258 | 2 | 8 | complement activation, alternative pathway |
GO:0050755 | 0.0065 | 21.0626 | 0.1258 | 2 | 8 | chemokine metabolic process |
GO:0043414 | 0.0069 | 3.0447 | 2.7838 | 8 | 177 | macromolecule methylation |
GO:0048285 | 0.0071 | 2.1597 | 7.3605 | 15 | 468 | organelle fission |
GO:0002252 | 0.0073 | 2.2174 | 6.6842 | 14 | 425 | immune effector process |
GO:0050907 | 0.0076 | 8.2726 | 0.4089 | 3 | 26 | detection of chemical stimulus involved in sensory perception |
GO:0002438 | 0.0082 | 18.0522 | 0.1415 | 2 | 9 | acute inflammatory response to antigenic stimulus |
GO:0002719 | 0.0082 | 18.0522 | 0.1415 | 2 | 9 | negative regulation of cytokine production involved in immune response |
GO:0060263 | 0.0082 | 18.0522 | 0.1415 | 2 | 9 | regulation of respiratory burst |
GO:0050863 | 0.0095 | 2.8723 | 2.941 | 8 | 187 | regulation of T cell activation |
GO:0002682 | 0.01 | 1.7886 | 13.6986 | 23 | 871 | regulation of immune system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007423 | 0 | 6.2598 | 8.937 | 44 | 440 | sensory organ development |
GO:0045944 | 0 | 4.6835 | 15.2742 | 56 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006355 | 0 | 2.9529 | 56.5266 | 115 | 2783 | regulation of transcription, DNA-templated |
GO:0051252 | 0 | 2.8117 | 58.639 | 115 | 2887 | regulation of RNA metabolic process |
GO:0010556 | 0 | 2.7139 | 63.1278 | 119 | 3108 | regulation of macromolecule biosynthetic process |
GO:1902680 | 0 | 3.5936 | 21.3066 | 61 | 1049 | positive regulation of RNA biosynthetic process |
GO:1901362 | 0 | 2.6314 | 68.3884 | 124 | 3367 | organic cyclic compound biosynthetic process |
GO:0010628 | 0 | 3.45 | 22.505 | 62 | 1108 | positive regulation of gene expression |
GO:0009891 | 0 | 3.2329 | 25.6533 | 66 | 1263 | positive regulation of biosynthetic process |
GO:0018130 | 0 | 2.5623 | 66.5807 | 120 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0 | 2.5623 | 66.5807 | 120 | 3278 | aromatic compound biosynthetic process |
GO:0044271 | 0 | 2.5525 | 67.5354 | 121 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0045935 | 0 | 3.1515 | 24.333 | 62 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0035107 | 0 | 8.7062 | 2.8233 | 20 | 139 | appendage morphogenesis |
GO:0007389 | 0 | 6.7152 | 4.2922 | 24 | 231 | pattern specification process |
GO:0043009 | 0 | 4.3242 | 9.8855 | 36 | 494 | chordate embryonic development |
GO:0051171 | 0 | 2.3396 | 73.446 | 123 | 3616 | regulation of nitrogen compound metabolic process |
GO:0060173 | 0 | 7.5512 | 3.1889 | 20 | 157 | limb development |
GO:0010629 | 0 | 3.1882 | 18.7474 | 50 | 923 | negative regulation of gene expression |
GO:0000122 | 0 | 3.8565 | 11.2728 | 37 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0021510 | 0 | 10.6095 | 1.7671 | 15 | 87 | spinal cord development |
GO:1902679 | 0 | 3.26 | 16.7163 | 46 | 823 | negative regulation of RNA biosynthetic process |
GO:0045934 | 0 | 3.0529 | 19.0318 | 49 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0045165 | 0 | 6.8238 | 3.2928 | 19 | 170 | cell fate commitment |
GO:0050767 | 0 | 3.9388 | 9.4245 | 32 | 464 | regulation of neurogenesis |
GO:0060562 | 0 | 4.7673 | 6.0731 | 25 | 299 | epithelial tube morphogenesis |
GO:2000113 | 0 | 2.9947 | 18.4631 | 47 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0032502 | 0 | 2.284 | 65.5822 | 107 | 3604 | developmental process |
GO:0048562 | 0 | 11.5752 | 1.2874 | 12 | 71 | embryonic organ morphogenesis |
GO:0045665 | 0 | 13.4746 | 1.0562 | 11 | 52 | negative regulation of neuron differentiation |
GO:0080090 | 0 | 2.0667 | 92.3762 | 137 | 4548 | regulation of primary metabolic process |
GO:0072359 | 0 | 3.0385 | 15.2132 | 40 | 749 | circulatory system development |
GO:0090304 | 0 | 2.0235 | 80.2097 | 122 | 3949 | nucleic acid metabolic process |
GO:0065007 | 0 | 2.2407 | 166.1268 | 206 | 8179 | biological regulation |
GO:0048704 | 0 | 13.0547 | 0.9791 | 10 | 49 | embryonic skeletal system morphogenesis |
GO:0045666 | 0 | 9.4378 | 1.5437 | 12 | 76 | positive regulation of neuron differentiation |
GO:0031326 | 0 | 2.3208 | 39.3582 | 72 | 2239 | regulation of cellular biosynthetic process |
GO:0007420 | 0 | 3.7662 | 8.179 | 27 | 421 | brain development |
GO:0001947 | 0 | 11.9086 | 1.0562 | 10 | 52 | heart looping |
GO:0009954 | 0 | 18.9329 | 0.589 | 8 | 29 | proximal/distal pattern formation |
GO:2000026 | 0 | 2.7187 | 18.7778 | 44 | 963 | regulation of multicellular organismal development |
GO:0035115 | 0 | 17.2837 | 0.6297 | 8 | 31 | embryonic forelimb morphogenesis |
GO:0021761 | 0 | 9.1935 | 1.4421 | 11 | 71 | limbic system development |
GO:0009892 | 0 | 2.2832 | 31.442 | 61 | 1548 | negative regulation of metabolic process |
GO:0060581 | 0 | 32.9004 | 0.3047 | 6 | 15 | cell fate commitment involved in pattern specification |
GO:0021872 | 0 | 9.8 | 1.239 | 10 | 61 | forebrain generation of neurons |
GO:0021514 | 0 | 26.9142 | 0.3453 | 6 | 17 | ventral spinal cord interneuron differentiation |
GO:0001764 | 0 | 5.9507 | 2.4983 | 13 | 123 | neuron migration |
GO:0009952 | 0 | 6.2023 | 2.2117 | 12 | 114 | anterior/posterior pattern specification |
GO:0042472 | 0 | 6.8839 | 1.8483 | 11 | 91 | inner ear morphogenesis |
GO:0035148 | 0 | 5.5915 | 2.6405 | 13 | 130 | tube formation |
GO:0021797 | 0 | 97.9763 | 0.1219 | 4 | 6 | forebrain anterior/posterior pattern specification |
GO:0030902 | 0 | 5.5437 | 2.6608 | 13 | 131 | hindbrain development |
GO:0009799 | 0 | 6.6335 | 1.9093 | 11 | 94 | specification of symmetry |
GO:0044707 | 0 | 1.913 | 73.4128 | 105 | 4412 | single-multicellular organism process |
GO:0009887 | 0 | 3.4779 | 6.7469 | 21 | 391 | organ morphogenesis |
GO:0021543 | 0 | 5.789 | 2.3561 | 12 | 116 | pallium development |
GO:0060485 | 0 | 5.2848 | 2.7749 | 13 | 140 | mesenchyme development |
GO:0048565 | 0 | 5.6253 | 2.4171 | 12 | 119 | digestive tract development |
GO:2000543 | 0 | 65.3123 | 0.1422 | 4 | 7 | positive regulation of gastrulation |
GO:0021542 | 0 | 27.3082 | 0.2844 | 5 | 14 | dentate gyrus development |
GO:0060021 | 0 | 6.9298 | 1.6655 | 10 | 82 | palate development |
GO:0001944 | 0 | 2.9074 | 9.912 | 26 | 488 | vasculature development |
GO:0051094 | 0 | 2.5731 | 13.8618 | 32 | 703 | positive regulation of developmental process |
GO:0021513 | 0 | 15.5718 | 0.5078 | 6 | 25 | spinal cord dorsal/ventral patterning |
GO:0048793 | 0 | 48.9802 | 0.1625 | 4 | 8 | pronephros development |
GO:0010721 | 0 | 5.1403 | 2.6202 | 12 | 129 | negative regulation of cell development |
GO:0009953 | 0 | 7.1824 | 1.4458 | 9 | 73 | dorsal/ventral pattern formation |
GO:0048664 | 0 | 39.181 | 0.1828 | 4 | 9 | neuron fate determination |
GO:0003230 | 0 | 12.8595 | 0.589 | 6 | 29 | cardiac atrium development |
GO:0000904 | 0 | 2.4128 | 14.6648 | 32 | 722 | cell morphogenesis involved in differentiation |
GO:0003281 | 0 | 9.3528 | 0.8937 | 7 | 44 | ventricular septum development |
GO:0048665 | 0 | 17.8947 | 0.3787 | 5 | 19 | neuron fate specification |
GO:0043010 | 0 | 4.6351 | 2.8731 | 12 | 149 | camera-type eye development |
GO:0021913 | 0 | 146.3976 | 0.0812 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0007368 | 0 | 6.2607 | 1.6331 | 9 | 81 | determination of left/right symmetry |
GO:0035050 | 1e-04 | 6.8893 | 1.3304 | 8 | 66 | embryonic heart tube development |
GO:0048557 | 1e-04 | 15.3522 | 0.4265 | 5 | 21 | embryonic digestive tract morphogenesis |
GO:0014031 | 1e-04 | 4.6527 | 2.6202 | 11 | 129 | mesenchymal cell development |
GO:0001501 | 1e-04 | 3.5528 | 4.6238 | 15 | 234 | skeletal system development |
GO:0003215 | 1e-04 | 24.6733 | 0.2419 | 4 | 12 | cardiac right ventricle morphogenesis |
GO:0051891 | 1e-04 | 73.1929 | 0.1016 | 3 | 5 | positive regulation of cardioblast differentiation |
GO:0007399 | 1e-04 | 2.6663 | 9.538 | 23 | 552 | nervous system development |
GO:0023057 | 1e-04 | 2.2 | 16.4725 | 33 | 811 | negative regulation of signaling |
GO:0048935 | 1e-04 | 21.7602 | 0.264 | 4 | 13 | peripheral nervous system neuron development |
GO:0060413 | 1e-04 | 21.7602 | 0.264 | 4 | 13 | atrial septum morphogenesis |
GO:0045686 | 1e-04 | 12.925 | 0.4875 | 5 | 24 | negative regulation of glial cell differentiation |
GO:0034645 | 1e-04 | 1.7596 | 50.8327 | 75 | 2843 | cellular macromolecule biosynthetic process |
GO:0010648 | 1e-04 | 2.191 | 16.5335 | 33 | 814 | negative regulation of cell communication |
GO:0045995 | 1e-04 | 5.2561 | 1.9093 | 9 | 94 | regulation of embryonic development |
GO:0021871 | 1e-04 | 19.8859 | 0.2802 | 4 | 14 | forebrain regionalization |
GO:0009798 | 1e-04 | 5.8247 | 1.5437 | 8 | 76 | axis specification |
GO:0021983 | 2e-04 | 8.4423 | 0.8328 | 6 | 41 | pituitary gland development |
GO:0001841 | 2e-04 | 5.0183 | 1.9905 | 9 | 98 | neural tube formation |
GO:0048585 | 2e-04 | 2.0835 | 18.4224 | 35 | 907 | negative regulation of response to stimulus |
GO:0042733 | 2e-04 | 6.6468 | 1.1984 | 7 | 59 | embryonic digit morphogenesis |
GO:0072498 | 2e-04 | 17.8009 | 0.3047 | 4 | 15 | embryonic skeletal joint development |
GO:0032989 | 2e-04 | 1.9931 | 21.5301 | 39 | 1060 | cellular component morphogenesis |
GO:2000177 | 2e-04 | 10.9067 | 0.5571 | 5 | 28 | regulation of neural precursor cell proliferation |
GO:0001824 | 2e-04 | 6.5208 | 1.2187 | 7 | 60 | blastocyst development |
GO:0061061 | 3e-04 | 3.6553 | 3.5738 | 12 | 182 | muscle structure development |
GO:0035116 | 3e-04 | 10.2282 | 0.589 | 5 | 29 | embryonic hindlimb morphogenesis |
GO:0003357 | 3e-04 | 36.5906 | 0.1422 | 3 | 7 | noradrenergic neuron differentiation |
GO:0021796 | 3e-04 | 36.5906 | 0.1422 | 3 | 7 | cerebral cortex regionalization |
GO:0033504 | 3e-04 | 36.5906 | 0.1422 | 3 | 7 | floor plate development |
GO:0002065 | 3e-04 | 5.2781 | 1.6858 | 8 | 83 | columnar/cuboidal epithelial cell differentiation |
GO:0003231 | 3e-04 | 7.5732 | 0.912 | 6 | 46 | cardiac ventricle development |
GO:0021522 | 3e-04 | 9.896 | 0.6047 | 5 | 30 | spinal cord motor neuron differentiation |
GO:0007166 | 3e-04 | 1.6725 | 47.4677 | 70 | 2337 | cell surface receptor signaling pathway |
GO:0072087 | 3e-04 | 15.0599 | 0.3453 | 4 | 17 | renal vesicle development |
GO:0035295 | 3e-04 | 3.0126 | 5.3871 | 15 | 288 | tube development |
GO:0021772 | 4e-04 | 9.4399 | 0.6297 | 5 | 31 | olfactory bulb development |
GO:0044057 | 4e-04 | 2.7616 | 6.6418 | 17 | 327 | regulation of system process |
GO:0071495 | 4e-04 | 2.0505 | 16.9803 | 32 | 836 | cellular response to endogenous stimulus |
GO:0003207 | 4e-04 | Inf | 0.0399 | 2 | 2 | cardiac chamber formation |
GO:0051705 | 4e-04 | 5.7568 | 1.3609 | 7 | 67 | multi-organism behavior |
GO:0003171 | 4e-04 | 13.9831 | 0.3656 | 4 | 18 | atrioventricular valve development |
GO:0060045 | 4e-04 | 13.9831 | 0.3656 | 4 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:0035137 | 4e-04 | 29.8 | 0.1597 | 3 | 8 | hindlimb morphogenesis |
GO:0003218 | 4e-04 | Inf | 0.0406 | 2 | 2 | cardiac left ventricle formation |
GO:0003326 | 4e-04 | Inf | 0.0406 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 4e-04 | Inf | 0.0406 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0021893 | 4e-04 | Inf | 0.0406 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0060014 | 4e-04 | Inf | 0.0406 | 2 | 2 | granulosa cell differentiation |
GO:0060460 | 4e-04 | Inf | 0.0406 | 2 | 2 | left lung morphogenesis |
GO:0060577 | 4e-04 | Inf | 0.0406 | 2 | 2 | pulmonary vein morphogenesis |
GO:0045595 | 4e-04 | 2.3032 | 11.3345 | 24 | 621 | regulation of cell differentiation |
GO:0001525 | 4e-04 | 2.7344 | 6.7028 | 17 | 330 | angiogenesis |
GO:0055021 | 4e-04 | 9.0895 | 0.65 | 5 | 32 | regulation of cardiac muscle tissue growth |
GO:0022008 | 4e-04 | 2.1843 | 13.4753 | 27 | 730 | neurogenesis |
GO:0001838 | 5e-04 | 13.4339 | 0.3753 | 4 | 19 | embryonic epithelial tube formation |
GO:0021953 | 5e-04 | 4.8369 | 1.8194 | 8 | 95 | central nervous system neuron differentiation |
GO:0030901 | 5e-04 | 8.7642 | 0.6703 | 5 | 33 | midbrain development |
GO:0021895 | 5e-04 | 13.0498 | 0.3859 | 4 | 19 | cerebral cortex neuron differentiation |
GO:0009743 | 5e-04 | 3.8803 | 2.803 | 10 | 138 | response to carbohydrate |
GO:0007267 | 5e-04 | 1.9361 | 20.2708 | 36 | 998 | cell-cell signaling |
GO:0048863 | 6e-04 | 8.4399 | 0.6876 | 5 | 36 | stem cell differentiation |
GO:0072028 | 6e-04 | 8.4613 | 0.6906 | 5 | 34 | nephron morphogenesis |
GO:0048593 | 6e-04 | 6.4676 | 1.0468 | 6 | 53 | camera-type eye morphogenesis |
GO:0060429 | 6e-04 | 2.4365 | 8.8707 | 20 | 483 | epithelium development |
GO:0001829 | 6e-04 | 12.2332 | 0.4062 | 4 | 20 | trophectodermal cell differentiation |
GO:0007617 | 6e-04 | 12.2332 | 0.4062 | 4 | 20 | mating behavior |
GO:0010656 | 6e-04 | 12.2332 | 0.4062 | 4 | 20 | negative regulation of muscle cell apoptotic process |
GO:0048485 | 6e-04 | 12.2332 | 0.4062 | 4 | 20 | sympathetic nervous system development |
GO:0072048 | 6e-04 | 24.3898 | 0.1828 | 3 | 9 | renal system pattern specification |
GO:0090009 | 6e-04 | 24.3898 | 0.1828 | 3 | 9 | primitive streak formation |
GO:0001655 | 7e-04 | 2.8157 | 5.7278 | 15 | 282 | urogenital system development |
GO:0048514 | 7e-04 | 8.0553 | 0.717 | 5 | 37 | blood vessel morphogenesis |
GO:0007507 | 7e-04 | 3.2332 | 4.0016 | 12 | 206 | heart development |
GO:0030324 | 7e-04 | 3.4414 | 3.4529 | 11 | 170 | lung development |
GO:0007409 | 7e-04 | 2.3388 | 9.6565 | 21 | 479 | axonogenesis |
GO:0001823 | 7e-04 | 4.4936 | 1.9499 | 8 | 96 | mesonephros development |
GO:0023019 | 8e-04 | 11.5127 | 0.4265 | 4 | 21 | signal transduction involved in regulation of gene expression |
GO:0048598 | 8e-04 | 3.1927 | 4.0492 | 12 | 234 | embryonic morphogenesis |
GO:0032774 | 8e-04 | 1.8701 | 23.435 | 39 | 1443 | RNA biosynthetic process |
GO:0014033 | 8e-04 | 6.0234 | 1.1171 | 6 | 55 | neural crest cell differentiation |
GO:0060322 | 8e-04 | 6.0234 | 1.1171 | 6 | 55 | head development |
GO:0021877 | 9e-04 | 20.9038 | 0.2031 | 3 | 10 | forebrain neuron fate commitment |
GO:0030002 | 9e-04 | 20.9038 | 0.2031 | 3 | 10 | cellular anion homeostasis |
GO:0048505 | 9e-04 | 20.9038 | 0.2031 | 3 | 10 | regulation of timing of cell differentiation |
GO:0002089 | 9e-04 | 10.8722 | 0.4469 | 4 | 22 | lens morphogenesis in camera-type eye |
GO:2000677 | 9e-04 | 10.8722 | 0.4469 | 4 | 22 | regulation of transcription regulatory region DNA binding |
GO:0003229 | 0.001 | 7.4333 | 0.7718 | 5 | 38 | ventricular cardiac muscle tissue development |
GO:0035051 | 0.001 | 4.2968 | 2.0311 | 8 | 100 | cardiocyte differentiation |
GO:0048644 | 0.001 | 5.7863 | 1.1577 | 6 | 57 | muscle organ morphogenesis |
GO:0072210 | 0.001 | 10.4118 | 0.4623 | 4 | 23 | metanephric nephron development |
GO:0048589 | 0.001 | 2.7877 | 5.3825 | 14 | 265 | developmental growth |
GO:0060538 | 0.0011 | 3.4938 | 3.0873 | 10 | 152 | skeletal muscle organ development |
GO:0021545 | 0.0011 | 7.2141 | 0.7921 | 5 | 39 | cranial nerve development |
GO:0030858 | 0.0011 | 7.2141 | 0.7921 | 5 | 39 | positive regulation of epithelial cell differentiation |
GO:0048522 | 0.0011 | 1.6176 | 46.4453 | 66 | 2530 | positive regulation of cellular process |
GO:0014706 | 0.0011 | 3.2406 | 3.6501 | 11 | 184 | striated muscle tissue development |
GO:0051216 | 0.0011 | 3.469 | 3.1076 | 10 | 153 | cartilage development |
GO:0046887 | 0.0012 | 4.7266 | 1.6249 | 7 | 80 | positive regulation of hormone secretion |
GO:0003161 | 0.0012 | 18.2894 | 0.2234 | 3 | 11 | cardiac conduction system development |
GO:0021903 | 0.0012 | 18.2894 | 0.2234 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0072506 | 0.0012 | 18.2894 | 0.2234 | 3 | 11 | trivalent inorganic anion homeostasis |
GO:0097154 | 0.0012 | 18.2894 | 0.2234 | 3 | 11 | GABAergic neuron differentiation |
GO:0035282 | 0.0012 | 9.9363 | 0.4803 | 4 | 24 | segmentation |
GO:0002074 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | extraocular skeletal muscle development |
GO:0003253 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0003285 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | septum secundum development |
GO:0003350 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | pulmonary myocardium development |
GO:0014707 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0021524 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | visceral motor neuron differentiation |
GO:0021882 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021912 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035054 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0036023 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0097211 | 0.0012 | 97.2157 | 0.0609 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0048858 | 0.0012 | 2.0163 | 14.4008 | 27 | 709 | cell projection morphogenesis |
GO:0009888 | 0.0013 | 2.3992 | 8.0876 | 18 | 469 | tissue development |
GO:0001843 | 0.0013 | 4.6624 | 1.6452 | 7 | 81 | neural tube closure |
GO:0048869 | 0.0013 | 1.9416 | 17.6705 | 31 | 1077 | cellular developmental process |
GO:0030509 | 0.0013 | 4.0737 | 2.1327 | 8 | 105 | BMP signaling pathway |
GO:0048701 | 0.0014 | 6.8122 | 0.8328 | 5 | 41 | embryonic cranial skeleton morphogenesis |
GO:0021537 | 0.0014 | 5.3874 | 1.2315 | 6 | 63 | telencephalon development |
GO:0014855 | 0.0015 | 6.6275 | 0.8531 | 5 | 42 | striated muscle cell proliferation |
GO:0060766 | 0.0016 | 16.2559 | 0.2437 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
GO:0072182 | 0.0016 | 16.2559 | 0.2437 | 3 | 12 | regulation of nephron tubule epithelial cell differentiation |
GO:0042692 | 0.0017 | 2.6476 | 5.6466 | 14 | 278 | muscle cell differentiation |
GO:0048596 | 0.0017 | 8.8926 | 0.5281 | 4 | 26 | embryonic camera-type eye morphogenesis |
GO:0072089 | 0.0018 | 5.1193 | 1.2905 | 6 | 65 | stem cell proliferation |
GO:0007218 | 0.0018 | 4.3655 | 1.7468 | 7 | 86 | neuropeptide signaling pathway |
GO:0009790 | 0.0018 | 2.6204 | 5.7223 | 14 | 343 | embryo development |
GO:0048870 | 0.0019 | 1.8476 | 18.6459 | 32 | 918 | cell motility |
GO:0031018 | 0.0019 | 8.5955 | 0.5429 | 4 | 27 | endocrine pancreas development |
GO:0021884 | 0.002 | 8.5052 | 0.5484 | 4 | 27 | forebrain neuron development |
GO:0048368 | 0.002 | 14.6291 | 0.264 | 3 | 13 | lateral mesoderm development |
GO:0072283 | 0.002 | 14.6291 | 0.264 | 3 | 13 | metanephric renal vesicle morphogenesis |
GO:0010720 | 0.0021 | 2.9842 | 3.9404 | 11 | 194 | positive regulation of cell development |
GO:0061326 | 0.0021 | 6.129 | 0.914 | 5 | 45 | renal tubule development |
GO:2000736 | 0.0022 | 4.2048 | 1.8077 | 7 | 89 | regulation of stem cell differentiation |
GO:0055008 | 0.0023 | 5.979 | 0.9343 | 5 | 46 | cardiac muscle tissue morphogenesis |
GO:0003197 | 0.0023 | 8.1502 | 0.5687 | 4 | 28 | endocardial cushion development |
GO:0010092 | 0.0023 | 8.1502 | 0.5687 | 4 | 28 | specification of organ identity |
GO:0019098 | 0.0023 | 8.1502 | 0.5687 | 4 | 28 | reproductive behavior |
GO:0002125 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | maternal aggressive behavior |
GO:0003166 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | bundle of His development |
GO:0003219 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | cardiac right ventricle formation |
GO:0007412 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | axon target recognition |
GO:0007621 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | negative regulation of female receptivity |
GO:0019896 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | axon transport of mitochondrion |
GO:0061031 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | endodermal digestive tract morphogenesis |
GO:0061325 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0072268 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | pattern specification involved in metanephros development |
GO:0072278 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0097476 | 0.0024 | 48.6039 | 0.0812 | 2 | 4 | spinal cord motor neuron migration |
GO:0048709 | 0.0025 | 4.7554 | 1.3812 | 6 | 68 | oligodendrocyte differentiation |
GO:0003148 | 0.0026 | 13.2981 | 0.2844 | 3 | 14 | outflow tract septum morphogenesis |
GO:0007512 | 0.0026 | 13.2981 | 0.2844 | 3 | 14 | adult heart development |
GO:0070374 | 0.0028 | 4.0079 | 1.889 | 7 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0072164 | 0.0028 | 4.0079 | 1.889 | 7 | 93 | mesonephric tubule development |
GO:0044708 | 0.0028 | 2.4007 | 6.6418 | 15 | 327 | single-organism behavior |
GO:0001570 | 0.0029 | 4.6061 | 1.4218 | 6 | 70 | vasculogenesis |
GO:0021527 | 0.0031 | 12.189 | 0.3047 | 3 | 15 | spinal cord association neuron differentiation |
GO:0008284 | 0.0032 | 2.0886 | 10.1974 | 20 | 525 | positive regulation of cell proliferation |
GO:0048545 | 0.0033 | 2.4395 | 6.0934 | 14 | 300 | response to steroid hormone |
GO:0048864 | 0.0033 | 3.8795 | 1.9446 | 7 | 99 | stem cell development |
GO:0090101 | 0.0036 | 3.8285 | 1.9702 | 7 | 97 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0042471 | 0.0036 | 34.0332 | 0.0968 | 2 | 5 | ear morphogenesis |
GO:0001706 | 0.0036 | 5.3269 | 1.0359 | 5 | 51 | endoderm formation |
GO:0060419 | 0.0036 | 5.3269 | 1.0359 | 5 | 51 | heart growth |
GO:0060039 | 0.0038 | 11.2505 | 0.325 | 3 | 16 | pericardium development |
GO:0072224 | 0.0038 | 11.2505 | 0.325 | 3 | 16 | metanephric glomerulus development |
GO:0071310 | 0.0038 | 1.6137 | 30.1827 | 45 | 1486 | cellular response to organic substance |
GO:0045596 | 0.0038 | 2.4922 | 5.538 | 13 | 293 | negative regulation of cell differentiation |
GO:0003211 | 0.0039 | 32.7804 | 0.1004 | 2 | 5 | cardiac ventricle formation |
GO:0007548 | 0.0039 | 2.7267 | 4.2857 | 11 | 211 | sex differentiation |
GO:0001826 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | inner cell mass cell differentiation |
GO:0003278 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | apoptotic process involved in heart morphogenesis |
GO:0021778 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0021855 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | hypothalamus cell migration |
GO:0030718 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | germ-line stem cell maintenance |
GO:0035881 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | amacrine cell differentiation |
GO:0072081 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | specification of nephron tubule identity |
GO:0072162 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | metanephric mesenchymal cell differentiation |
GO:1900094 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry |
GO:1900164 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:2000851 | 0.0039 | 32.4 | 0.1016 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0021885 | 0.004 | 5.2132 | 1.0562 | 5 | 52 | forebrain cell migration |
GO:0007600 | 0.004 | 2.1806 | 8.2667 | 17 | 407 | sensory perception |
GO:0016202 | 0.004 | 3.7447 | 2.0108 | 7 | 99 | regulation of striated muscle tissue development |
GO:0030326 | 0.004 | 6.858 | 0.6575 | 4 | 34 | embryonic limb morphogenesis |
GO:0035850 | 0.0043 | 6.7423 | 0.6703 | 4 | 33 | epithelial cell differentiation involved in kidney development |
GO:0051932 | 0.0043 | 6.7423 | 0.6703 | 4 | 33 | synaptic transmission, GABAergic |
GO:0042475 | 0.0044 | 4.2092 | 1.5437 | 6 | 76 | odontogenesis of dentin-containing tooth |
GO:0001709 | 0.0045 | 6.619 | 0.6803 | 4 | 34 | cell fate determination |
GO:0010842 | 0.0046 | 10.446 | 0.3453 | 3 | 17 | retina layer formation |
GO:0030878 | 0.0046 | 10.446 | 0.3453 | 3 | 17 | thyroid gland development |
GO:0021549 | 0.0047 | 4.1496 | 1.564 | 6 | 77 | cerebellum development |
GO:0002009 | 0.0049 | 4.0994 | 1.5775 | 6 | 84 | morphogenesis of an epithelium |
GO:0001658 | 0.0051 | 4.8992 | 1.1171 | 5 | 55 | branching involved in ureteric bud morphogenesis |
GO:0060840 | 0.0051 | 4.8992 | 1.1171 | 5 | 55 | artery development |
GO:0042493 | 0.0051 | 2.3151 | 6.3981 | 14 | 315 | response to drug |
GO:0048609 | 0.0052 | 1.9537 | 11.3947 | 21 | 561 | multicellular organismal reproductive process |
GO:2000179 | 0.0052 | 9.8526 | 0.3619 | 3 | 18 | positive regulation of neural precursor cell proliferation |
GO:0051412 | 0.0054 | 9.7488 | 0.3656 | 3 | 18 | response to corticosterone |
GO:0009058 | 0.0055 | 1.489 | 57.2279 | 74 | 3413 | biosynthetic process |
GO:0035136 | 0.0055 | 25.0385 | 0.1184 | 2 | 6 | forelimb morphogenesis |
GO:0001667 | 0.0055 | 2.5948 | 4.4888 | 11 | 221 | ameboidal cell migration |
GO:0010459 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | negative regulation of heart rate |
GO:0021960 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | anterior commissure morphogenesis |
GO:0030643 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | cellular phosphate ion homeostasis |
GO:0035502 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | metanephric part of ureteric bud development |
GO:0045760 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | positive regulation of action potential |
GO:0048852 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | diencephalon morphogenesis |
GO:0061308 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | cardiac neural crest cell development involved in heart development |
GO:0072284 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:2000252 | 0.0058 | 24.298 | 0.1219 | 2 | 6 | negative regulation of feeding behavior |
GO:0031175 | 0.006 | 1.8198 | 14.5836 | 25 | 718 | neuron projection development |
GO:0061458 | 0.0062 | 2.1912 | 7.2309 | 15 | 356 | reproductive system development |
GO:0002052 | 0.0063 | 9.1388 | 0.3859 | 3 | 19 | positive regulation of neuroblast proliferation |
GO:0007530 | 0.0063 | 9.1388 | 0.3859 | 3 | 19 | sex determination |
GO:0042474 | 0.0063 | 9.1388 | 0.3859 | 3 | 19 | middle ear morphogenesis |
GO:0033555 | 0.0063 | 4.6208 | 1.1781 | 5 | 58 | multicellular organismal response to stress |
GO:0001754 | 0.0065 | 5.9231 | 0.7515 | 4 | 37 | eye photoreceptor cell differentiation |
GO:0043392 | 0.0065 | 5.9231 | 0.7515 | 4 | 37 | negative regulation of DNA binding |
GO:0002793 | 0.0068 | 4.5348 | 1.1984 | 5 | 59 | positive regulation of peptide secretion |
GO:0008406 | 0.0068 | 2.829 | 3.3717 | 9 | 166 | gonad development |
GO:2000027 | 0.0068 | 3.0552 | 2.7827 | 8 | 137 | regulation of organ morphogenesis |
GO:0003309 | 0.0073 | 8.6005 | 0.4062 | 3 | 20 | type B pancreatic cell differentiation |
GO:0031290 | 0.0073 | 8.6005 | 0.4062 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0045823 | 0.0073 | 8.6005 | 0.4062 | 3 | 20 | positive regulation of heart contraction |
GO:0072078 | 0.0073 | 8.6005 | 0.4062 | 3 | 20 | nephron tubule morphogenesis |
GO:0001756 | 0.0073 | 4.452 | 1.2187 | 5 | 60 | somitogenesis |
GO:0031327 | 0.0073 | 4.4355 | 1.2174 | 5 | 68 | negative regulation of cellular biosynthetic process |
GO:0003151 | 0.0073 | 5.6903 | 0.7778 | 4 | 39 | outflow tract morphogenesis |
GO:0090087 | 0.0076 | 2.7753 | 3.4326 | 9 | 169 | regulation of peptide transport |
GO:0022414 | 0.0077 | 2.2017 | 6.7166 | 14 | 344 | reproductive process |
GO:0014014 | 0.0078 | 19.7952 | 0.1397 | 2 | 7 | negative regulation of gliogenesis |
GO:0071320 | 0.0078 | 5.5837 | 0.7921 | 4 | 39 | cellular response to cAMP |
GO:0021521 | 0.0079 | 19.6667 | 0.1406 | 2 | 7 | ventral spinal cord interneuron specification |
GO:0003206 | 0.0079 | 3.6912 | 1.7404 | 6 | 88 | cardiac chamber morphogenesis |
GO:0003263 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | cardioblast proliferation |
GO:0021798 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | forebrain dorsal/ventral pattern formation |
GO:0046549 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | retinal cone cell development |
GO:0046877 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | regulation of saliva secretion |
GO:0048318 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | axial mesoderm development |
GO:0048755 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | branching morphogenesis of a nerve |
GO:0051957 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | positive regulation of amino acid transport |
GO:0061072 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | iris morphogenesis |
GO:0061303 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | cornea development in camera-type eye |
GO:0071372 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | cellular response to follicle-stimulating hormone stimulus |
GO:2001012 | 0.0081 | 19.4369 | 0.1422 | 2 | 7 | mesenchymal cell differentiation involved in renal system development |
GO:0003407 | 0.0081 | 8.2413 | 0.4206 | 3 | 21 | neural retina development |
GO:0050794 | 0.0082 | 1.5255 | 61.4052 | 76 | 4024 | regulation of cellular process |
GO:0002068 | 0.0084 | 8.122 | 0.4265 | 3 | 21 | glandular epithelial cell development |
GO:0035909 | 0.0084 | 8.122 | 0.4265 | 3 | 21 | aorta morphogenesis |
GO:0060972 | 0.0084 | 8.122 | 0.4265 | 3 | 21 | left/right pattern formation |
GO:0072132 | 0.0084 | 8.122 | 0.4265 | 3 | 21 | mesenchyme morphogenesis |
GO:0045778 | 0.0086 | 5.4282 | 0.8125 | 4 | 40 | positive regulation of ossification |
GO:0030178 | 0.0086 | 3.2158 | 2.3155 | 7 | 114 | negative regulation of Wnt signaling pathway |
GO:0008589 | 0.009 | 4.2207 | 1.2796 | 5 | 63 | regulation of smoothened signaling pathway |
GO:0097485 | 0.009 | 2.1534 | 6.8449 | 14 | 337 | neuron projection guidance |
GO:0009746 | 0.0094 | 3.1563 | 2.3561 | 7 | 116 | response to hexose |
GO:0009914 | 0.0094 | 2.3971 | 4.8341 | 11 | 238 | hormone transport |
GO:0045909 | 0.0096 | 7.6939 | 0.4469 | 3 | 22 | positive regulation of vasodilation |
GO:0042221 | 0.0097 | 1.4456 | 46.855 | 62 | 2379 | response to chemical |
GO:2000648 | 0.0098 | 5.1966 | 0.8444 | 4 | 42 | positive regulation of stem cell proliferation |
GO:0048468 | 0.0099 | 1.8403 | 12.1227 | 21 | 684 | cell development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.8015 | 91.8253 | 127 | 4437 | multicellular organismal process |
GO:0070663 | 0 | 5.4279 | 2.7186 | 13 | 126 | regulation of leukocyte proliferation |
GO:0007389 | 0 | 3.0941 | 8.5872 | 24 | 398 | pattern specification process |
GO:0007618 | 0 | 11.2078 | 0.7767 | 7 | 36 | mating |
GO:0050670 | 0 | 5.2244 | 2.5891 | 12 | 120 | regulation of lymphocyte proliferation |
GO:0002125 | 0 | 137.5444 | 0.0863 | 3 | 4 | maternal aggressive behavior |
GO:0032946 | 0 | 5.9951 | 1.7045 | 9 | 79 | positive regulation of mononuclear cell proliferation |
GO:0051954 | 1e-04 | 15.3794 | 0.4315 | 5 | 20 | positive regulation of amine transport |
GO:0009952 | 1e-04 | 3.7482 | 4.0994 | 14 | 190 | anterior/posterior pattern specification |
GO:0060406 | 1e-04 | 68.7667 | 0.1079 | 3 | 5 | positive regulation of penile erection |
GO:0021761 | 1e-04 | 5.9021 | 1.5319 | 8 | 71 | limbic system development |
GO:0051960 | 2e-04 | 2.4153 | 11.241 | 25 | 521 | regulation of nervous system development |
GO:0021542 | 2e-04 | 18.3941 | 0.3021 | 4 | 14 | dentate gyrus development |
GO:0044705 | 2e-04 | 10.9799 | 0.561 | 5 | 26 | multi-organism reproductive behavior |
GO:0051239 | 3e-04 | 1.8153 | 31.2721 | 51 | 1509 | regulation of multicellular organismal process |
GO:0051241 | 3e-04 | 2.8386 | 6.4728 | 17 | 300 | negative regulation of multicellular organismal process |
GO:0001960 | 3e-04 | 10.0235 | 0.6041 | 5 | 28 | negative regulation of cytokine-mediated signaling pathway |
GO:0048598 | 4e-04 | 2.3094 | 11.2195 | 24 | 520 | embryonic morphogenesis |
GO:0042403 | 4e-04 | 14.1458 | 0.3668 | 4 | 17 | thyroid hormone metabolic process |
GO:0045664 | 4e-04 | 2.5711 | 7.9615 | 19 | 369 | regulation of neuron differentiation |
GO:0010901 | 5e-04 | Inf | 0.0432 | 2 | 2 | regulation of very-low-density lipoprotein particle remodeling |
GO:0032892 | 5e-04 | 13.1344 | 0.3884 | 4 | 18 | positive regulation of organic acid transport |
GO:0044062 | 5e-04 | 13.1344 | 0.3884 | 4 | 18 | regulation of excretion |
GO:0003139 | 5e-04 | 27.5 | 0.1726 | 3 | 8 | secondary heart field specification |
GO:0045723 | 5e-04 | 27.5 | 0.1726 | 3 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0060180 | 5e-04 | 27.5 | 0.1726 | 3 | 8 | female mating behavior |
GO:0002694 | 5e-04 | 2.761 | 6.2354 | 16 | 289 | regulation of leukocyte activation |
GO:0048870 | 7e-04 | 1.9148 | 19.8067 | 35 | 918 | cell motility |
GO:0050863 | 7e-04 | 3.2066 | 4.0347 | 12 | 187 | regulation of T cell activation |
GO:0035176 | 8e-04 | 7.9458 | 0.7336 | 5 | 34 | social behavior |
GO:0048664 | 8e-04 | 22.9148 | 0.1942 | 3 | 9 | neuron fate determination |
GO:0021953 | 9e-04 | 3.3552 | 3.5384 | 11 | 164 | central nervous system neuron differentiation |
GO:0021543 | 9e-04 | 3.9103 | 2.5028 | 9 | 116 | pallium development |
GO:0002520 | 9e-04 | 2.0849 | 13.3986 | 26 | 621 | immune system development |
GO:0035815 | 0.0011 | 19.6397 | 0.2158 | 3 | 10 | positive regulation of renal sodium excretion |
GO:0045060 | 0.0011 | 19.6397 | 0.2158 | 3 | 10 | negative thymic T cell selection |
GO:0007275 | 0.0011 | 1.5277 | 68.635 | 91 | 3378 | multicellular organismal development |
GO:0060759 | 0.0011 | 4.7647 | 1.6182 | 7 | 75 | regulation of response to cytokine stimulus |
GO:0060284 | 0.0012 | 2.081 | 12.8808 | 25 | 597 | regulation of cell development |
GO:0051048 | 0.0013 | 3.7008 | 2.6323 | 9 | 122 | negative regulation of secretion |
GO:0006805 | 0.0013 | 4.0768 | 2.136 | 8 | 99 | xenobiotic metabolic process |
GO:0065007 | 0.0013 | 1.5112 | 176.4694 | 200 | 8179 | biological regulation |
GO:0050710 | 0.0014 | 9.674 | 0.4962 | 4 | 23 | negative regulation of cytokine secretion |
GO:0014049 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | positive regulation of glutamate secretion |
GO:0031394 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0042414 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | epinephrine metabolic process |
GO:0051970 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:0051251 | 0.0014 | 3.1468 | 3.7542 | 11 | 174 | positive regulation of lymphocyte activation |
GO:0050793 | 0.0014 | 1.849 | 19.9065 | 34 | 959 | regulation of developmental process |
GO:0042711 | 0.0014 | 17.1833 | 0.2373 | 3 | 11 | maternal behavior |
GO:0071222 | 0.0016 | 4.4985 | 1.7045 | 7 | 79 | cellular response to lipopolysaccharide |
GO:0048663 | 0.0016 | 5.2834 | 1.2599 | 6 | 59 | neuron fate commitment |
GO:0051155 | 0.0016 | 9.1896 | 0.5178 | 4 | 24 | positive regulation of striated muscle cell differentiation |
GO:0002237 | 0.0017 | 3.0519 | 3.8621 | 11 | 179 | response to molecule of bacterial origin |
GO:0009712 | 0.0018 | 6.3972 | 0.8846 | 5 | 41 | catechol-containing compound metabolic process |
GO:0001501 | 0.0019 | 2.2977 | 8.3499 | 18 | 387 | skeletal system development |
GO:0003013 | 0.0019 | 2.432 | 7.0122 | 16 | 325 | circulatory system process |
GO:0009410 | 0.0019 | 3.8228 | 2.2655 | 8 | 105 | response to xenobiotic stimulus |
GO:0032680 | 0.002 | 5.0358 | 1.3161 | 6 | 61 | regulation of tumor necrosis factor production |
GO:0050900 | 0.002 | 2.8295 | 4.5296 | 12 | 212 | leukocyte migration |
GO:1901700 | 0.0022 | 1.765 | 21.9427 | 36 | 1017 | response to oxygen-containing compound |
GO:0045597 | 0.0022 | 2.116 | 10.5775 | 21 | 496 | positive regulation of cell differentiation |
GO:0048545 | 0.0022 | 2.4674 | 6.4728 | 15 | 300 | response to steroid hormone |
GO:0033077 | 0.0023 | 4.8583 | 1.3593 | 6 | 63 | T cell differentiation in thymus |
GO:0048368 | 0.0024 | 13.7444 | 0.2805 | 3 | 13 | lateral mesoderm development |
GO:2000380 | 0.0024 | 13.7444 | 0.2805 | 3 | 13 | regulation of mesoderm development |
GO:0030098 | 0.0025 | 2.7579 | 4.6388 | 12 | 215 | lymphocyte differentiation |
GO:0071706 | 0.0025 | 4.7741 | 1.3809 | 6 | 64 | tumor necrosis factor superfamily cytokine production |
GO:0030890 | 0.0025 | 7.989 | 0.5825 | 4 | 27 | positive regulation of B cell proliferation |
GO:0071356 | 0.0025 | 4.0976 | 1.8555 | 7 | 86 | cellular response to tumor necrosis factor |
GO:0033993 | 0.0026 | 2.621 | 5.2841 | 13 | 253 | response to lipid |
GO:0007621 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | negative regulation of female receptivity |
GO:0010936 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | negative regulation of macrophage cytokine production |
GO:0032849 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0042738 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | exogenous drug catabolic process |
GO:0070235 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | regulation of activation-induced cell death of T cells |
GO:2001279 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | regulation of unsaturated fatty acid biosynthetic process |
GO:0010092 | 0.0029 | 7.6555 | 0.6041 | 4 | 28 | specification of organ identity |
GO:0007625 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | grooming behavior |
GO:0010803 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | regulation of tumor necrosis factor-mediated signaling pathway |
GO:0032504 | 0.0031 | 1.9788 | 12.363 | 23 | 573 | multicellular organism reproduction |
GO:0050867 | 0.0033 | 2.7983 | 4.1857 | 11 | 194 | positive regulation of cell activation |
GO:0048704 | 0.0033 | 3.8989 | 1.9418 | 7 | 90 | embryonic skeletal system morphogenesis |
GO:2001141 | 0.0035 | 1.4631 | 60.693 | 80 | 2813 | regulation of RNA biosynthetic process |
GO:0048568 | 0.0036 | 2.2046 | 8.1773 | 17 | 379 | embryonic organ development |
GO:0050714 | 0.0037 | 4.3934 | 1.4887 | 6 | 69 | positive regulation of protein secretion |
GO:0048869 | 0.0037 | 1.4625 | 60.843 | 80 | 2866 | cellular developmental process |
GO:0051955 | 0.0037 | 11.4519 | 0.3236 | 3 | 15 | regulation of amino acid transport |
GO:0061082 | 0.0037 | 11.4519 | 0.3236 | 3 | 15 | myeloid leukocyte cytokine production |
GO:0048699 | 0.0038 | 1.6766 | 24.3161 | 38 | 1127 | generation of neurons |
GO:0046717 | 0.0039 | 4.3244 | 1.5103 | 6 | 70 | acid secretion |
GO:0061053 | 0.0039 | 4.3244 | 1.5103 | 6 | 70 | somite development |
GO:0045995 | 0.0042 | 3.7184 | 2.0281 | 7 | 94 | regulation of embryonic development |
GO:0019748 | 0.0042 | 6.8032 | 0.6689 | 4 | 31 | secondary metabolic process |
GO:0055078 | 0.0042 | 6.8032 | 0.6689 | 4 | 31 | sodium ion homeostasis |
GO:0048523 | 0.0043 | 1.4474 | 62.0307 | 81 | 2875 | negative regulation of cellular process |
GO:0002260 | 0.0043 | 5.114 | 1.0788 | 5 | 50 | lymphocyte homeostasis |
GO:0043084 | 0.0044 | 30.7836 | 0.1067 | 2 | 5 | penile erection |
GO:0043009 | 0.0044 | 1.952 | 11.9531 | 22 | 554 | chordate embryonic development |
GO:0042113 | 0.0044 | 3.0465 | 3.1501 | 9 | 146 | B cell activation |
GO:0009888 | 0.0044 | 1.5953 | 30.3789 | 45 | 1408 | tissue development |
GO:0042713 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | sperm ejaculation |
GO:0071374 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | cellular response to parathyroid hormone stimulus |
GO:1900094 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry |
GO:1900164 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:2000609 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | regulation of thyroid hormone generation |
GO:0030097 | 0.0044 | 1.9482 | 11.9746 | 22 | 555 | hemopoiesis |
GO:0002686 | 0.0045 | 10.5701 | 0.3452 | 3 | 16 | negative regulation of leukocyte migration |
GO:0015711 | 0.0046 | 2.3445 | 6.3217 | 14 | 293 | organic anion transport |
GO:0042102 | 0.0047 | 5.0024 | 1.1004 | 5 | 51 | positive regulation of T cell proliferation |
GO:0051093 | 0.0047 | 1.9368 | 12.0394 | 22 | 558 | negative regulation of developmental process |
GO:0002718 | 0.0047 | 6.5597 | 0.6904 | 4 | 32 | regulation of cytokine production involved in immune response |
GO:0042130 | 0.0047 | 6.5597 | 0.6904 | 4 | 32 | negative regulation of T cell proliferation |
GO:0015850 | 0.0048 | 3.0022 | 3.1932 | 9 | 148 | organic hydroxy compound transport |
GO:0032940 | 0.0049 | 1.8492 | 14.348 | 25 | 665 | secretion by cell |
GO:0009891 | 0.0051 | 1.6137 | 27.2504 | 41 | 1263 | positive regulation of biosynthetic process |
GO:0071216 | 0.0053 | 3.5538 | 2.1144 | 7 | 98 | cellular response to biotic stimulus |
GO:1901362 | 0.0053 | 1.4131 | 72.6461 | 92 | 3367 | organic cyclic compound biosynthetic process |
GO:0048536 | 0.0053 | 6.333 | 0.712 | 4 | 33 | spleen development |
GO:0060914 | 0.0054 | 9.8143 | 0.3668 | 3 | 17 | heart formation |
GO:0008217 | 0.0054 | 3.1917 | 2.6754 | 8 | 124 | regulation of blood pressure |
GO:0015718 | 0.0056 | 3.5149 | 2.136 | 7 | 99 | monocarboxylic acid transport |
GO:0031644 | 0.0059 | 6.1214 | 0.7336 | 4 | 34 | regulation of neurological system process |
GO:0001708 | 0.0059 | 3.9518 | 1.6398 | 6 | 76 | cell fate specification |
GO:0006954 | 0.0061 | 2.0801 | 8.6304 | 17 | 400 | inflammatory response |
GO:0045581 | 0.0064 | 9.1593 | 0.3884 | 3 | 18 | negative regulation of T cell differentiation |
GO:0051412 | 0.0064 | 9.1593 | 0.3884 | 3 | 18 | response to corticosterone |
GO:0045944 | 0.0064 | 1.7644 | 16.2251 | 27 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0014033 | 0.0065 | 4.6007 | 1.1867 | 5 | 55 | neural crest cell differentiation |
GO:0071347 | 0.0066 | 5.9235 | 0.7552 | 4 | 35 | cellular response to interleukin-1 |
GO:0002645 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | positive regulation of tolerance induction |
GO:0034370 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | triglyceride-rich lipoprotein particle remodeling |
GO:0044597 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | daunorubicin metabolic process |
GO:0044598 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | doxorubicin metabolic process |
GO:0090197 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | positive regulation of chemokine secretion |
GO:0048585 | 0.0073 | 1.6823 | 19.5694 | 31 | 907 | negative regulation of response to stimulus |
GO:0008284 | 0.0074 | 1.8287 | 13.2908 | 23 | 616 | positive regulation of cell proliferation |
GO:0043368 | 0.0075 | 8.5861 | 0.4099 | 3 | 19 | positive T cell selection |
GO:0030902 | 0.0075 | 3.0083 | 2.8264 | 8 | 131 | hindbrain development |
GO:0003208 | 0.0076 | 4.4231 | 1.2298 | 5 | 57 | cardiac ventricle morphogenesis |
GO:0048863 | 0.0081 | 2.2597 | 6.0628 | 13 | 281 | stem cell differentiation |
GO:0033555 | 0.0081 | 4.3393 | 1.2514 | 5 | 58 | multicellular organismal response to stress |
GO:1902106 | 0.0081 | 4.3393 | 1.2514 | 5 | 58 | negative regulation of leukocyte differentiation |
GO:0048667 | 0.0082 | 1.8669 | 11.8668 | 21 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0007204 | 0.0082 | 2.7425 | 3.4737 | 9 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0010628 | 0.0085 | 1.6023 | 23.9061 | 36 | 1108 | positive regulation of gene expression |
GO:0002697 | 0.0085 | 2.5627 | 4.121 | 10 | 191 | regulation of immune effector process |
GO:0001667 | 0.0086 | 2.4331 | 4.7683 | 11 | 221 | ameboidal cell migration |
GO:0002931 | 0.0086 | 8.0804 | 0.4315 | 3 | 20 | response to ischemia |
GO:0007194 | 0.0086 | 8.0804 | 0.4315 | 3 | 20 | negative regulation of adenylate cyclase activity |
GO:0043589 | 0.0088 | 5.3995 | 0.8199 | 4 | 38 | skin morphogenesis |
GO:0048538 | 0.0088 | 5.3995 | 0.8199 | 4 | 38 | thymus development |
GO:0045892 | 0.009 | 1.6973 | 17.4549 | 28 | 809 | negative regulation of transcription, DNA-templated |
GO:0016198 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | axon choice point recognition |
GO:0034384 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | high-density lipoprotein particle clearance |
GO:0042538 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | hyperosmotic salinity response |
GO:0042180 | 0.0095 | 2.5203 | 4.1857 | 10 | 194 | cellular ketone metabolic process |
GO:0002440 | 0.0095 | 3.5442 | 1.8124 | 6 | 84 | production of molecular mediator of immune response |
GO:0030858 | 0.0096 | 5.2448 | 0.8415 | 4 | 39 | positive regulation of epithelial cell differentiation |
GO:0032945 | 0.0096 | 5.2448 | 0.8415 | 4 | 39 | negative regulation of mononuclear cell proliferation |
GO:0060047 | 0.0097 | 2.867 | 2.9559 | 8 | 137 | heart contraction |
GO:0046006 | 0.0099 | 7.6309 | 0.4531 | 3 | 21 | regulation of activated T cell proliferation |
GO:0046457 | 0.0099 | 7.6309 | 0.4531 | 3 | 21 | prostanoid biosynthetic process |
GO:0070328 | 0.0099 | 7.6309 | 0.4531 | 3 | 21 | triglyceride homeostasis |
GO:0072678 | 0.0099 | 7.6309 | 0.4531 | 3 | 21 | T cell migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 14.3454 | 2.6107 | 27 | 121 | homophilic cell adhesion |
GO:0007155 | 0 | 2.6162 | 19.2241 | 44 | 891 | cell adhesion |
GO:0045944 | 0 | 2.7785 | 15.9651 | 39 | 745 | positive regulation of transcription from RNA polymerase II promoter |
GO:0010628 | 0 | 2.3994 | 23.9061 | 50 | 1108 | positive regulation of gene expression |
GO:0009891 | 0 | 2.2239 | 27.2504 | 53 | 1263 | positive regulation of biosynthetic process |
GO:0060173 | 0 | 5.0106 | 3.3874 | 15 | 157 | limb development |
GO:0032501 | 0 | 1.7764 | 108.0953 | 146 | 5010 | multicellular organismal process |
GO:1902680 | 0 | 2.2986 | 22.6331 | 46 | 1049 | positive regulation of RNA biosynthetic process |
GO:0045666 | 0 | 7.0941 | 1.6398 | 10 | 76 | positive regulation of neuron differentiation |
GO:0006355 | 0 | 1.7994 | 60.0458 | 91 | 2783 | regulation of transcription, DNA-templated |
GO:0009952 | 0 | 5.1045 | 2.6414 | 12 | 125 | anterior/posterior pattern specification |
GO:0045723 | 0 | 46.0074 | 0.1726 | 4 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0031326 | 0 | 1.7361 | 69.6902 | 101 | 3230 | regulation of cellular biosynthetic process |
GO:0045935 | 0 | 2.0832 | 25.8479 | 48 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0090009 | 0 | 36.803 | 0.1942 | 4 | 9 | primitive streak formation |
GO:0051252 | 0 | 1.7139 | 62.2897 | 91 | 2887 | regulation of RNA metabolic process |
GO:0002125 | 0 | 137.5444 | 0.0863 | 3 | 4 | maternal aggressive behavior |
GO:2000026 | 1e-04 | 2.0767 | 22.4508 | 42 | 1060 | regulation of multicellular organismal development |
GO:0048704 | 1e-04 | 7.8557 | 1.0412 | 7 | 49 | embryonic skeletal system morphogenesis |
GO:0001501 | 1e-04 | 2.7354 | 8.3499 | 21 | 387 | skeletal system development |
GO:0032502 | 1e-04 | 1.5919 | 93.4668 | 123 | 4332 | developmental process |
GO:0035137 | 1e-04 | 8.9518 | 0.7983 | 6 | 37 | hindlimb morphogenesis |
GO:0048663 | 1e-04 | 8.8882 | 0.8008 | 6 | 38 | neuron fate commitment |
GO:0003084 | 1e-04 | 20.4395 | 0.2805 | 4 | 13 | positive regulation of systemic arterial blood pressure |
GO:0021513 | 2e-04 | 11.5299 | 0.5394 | 5 | 25 | spinal cord dorsal/ventral patterning |
GO:0035136 | 2e-04 | 46.6075 | 0.1274 | 3 | 6 | forelimb morphogenesis |
GO:0050767 | 2e-04 | 2.4907 | 10.0112 | 23 | 464 | regulation of neurogenesis |
GO:0034654 | 2e-04 | 1.6077 | 69.4529 | 96 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0010556 | 2e-04 | 1.6048 | 67.0579 | 93 | 3108 | regulation of macromolecule biosynthetic process |
GO:0060581 | 2e-04 | 16.7205 | 0.3236 | 4 | 15 | cell fate commitment involved in pattern specification |
GO:0035113 | 3e-04 | 4.2027 | 2.6107 | 10 | 121 | embryonic appendage morphogenesis |
GO:2000543 | 3e-04 | 34.3778 | 0.151 | 3 | 7 | positive regulation of gastrulation |
GO:0009954 | 4e-04 | 9.6051 | 0.6257 | 5 | 29 | proximal/distal pattern formation |
GO:0008284 | 4e-04 | 2.1972 | 13.2908 | 27 | 616 | positive regulation of cell proliferation |
GO:0021514 | 4e-04 | 14.1458 | 0.3668 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0007186 | 5e-04 | 2.3706 | 10.0076 | 22 | 473 | G-protein coupled receptor signaling pathway |
GO:0010901 | 5e-04 | Inf | 0.0432 | 2 | 2 | regulation of very-low-density lipoprotein particle remodeling |
GO:0035115 | 5e-04 | 8.8648 | 0.6689 | 5 | 31 | embryonic forelimb morphogenesis |
GO:0050891 | 5e-04 | 8.8648 | 0.6689 | 5 | 31 | multicellular organismal water homeostasis |
GO:0055078 | 5e-04 | 8.8648 | 0.6689 | 5 | 31 | sodium ion homeostasis |
GO:0032892 | 5e-04 | 13.1344 | 0.3884 | 4 | 18 | positive regulation of organic acid transport |
GO:0044062 | 5e-04 | 13.1344 | 0.3884 | 4 | 18 | regulation of excretion |
GO:0060180 | 5e-04 | 27.5 | 0.1726 | 3 | 8 | female mating behavior |
GO:0009790 | 6e-04 | 2.0476 | 15.8607 | 30 | 752 | embryo development |
GO:0048665 | 6e-04 | 12.388 | 0.4058 | 4 | 19 | neuron fate specification |
GO:0031644 | 8e-04 | 7.9458 | 0.7336 | 5 | 34 | regulation of neurological system process |
GO:0048645 | 8e-04 | 6.1598 | 1.1004 | 6 | 51 | organ formation |
GO:0051954 | 8e-04 | 11.4907 | 0.4315 | 4 | 20 | positive regulation of amine transport |
GO:0021761 | 8e-04 | 5.0641 | 1.5319 | 7 | 71 | limbic system development |
GO:0045665 | 8e-04 | 6.0254 | 1.1219 | 6 | 52 | negative regulation of neuron differentiation |
GO:0030002 | 0.0011 | 19.6397 | 0.2158 | 3 | 10 | cellular anion homeostasis |
GO:0035815 | 0.0011 | 19.6397 | 0.2158 | 3 | 10 | positive regulation of renal sodium excretion |
GO:0043084 | 0.0011 | 19.6397 | 0.2158 | 3 | 10 | penile erection |
GO:0007626 | 0.0012 | 3.2066 | 3.6895 | 11 | 171 | locomotory behavior |
GO:0006579 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | amino-acid betaine catabolic process |
GO:0014049 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | positive regulation of glutamate secretion |
GO:0019482 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | beta-alanine metabolic process |
GO:0021530 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0031394 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0051970 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:0072180 | 0.0014 | 91.3579 | 0.0647 | 2 | 3 | mesonephric duct morphogenesis |
GO:0048468 | 0.0014 | 1.6831 | 31.1466 | 48 | 1472 | cell development |
GO:0014061 | 0.0014 | 17.1833 | 0.2373 | 3 | 11 | regulation of norepinephrine secretion |
GO:0021521 | 0.0014 | 17.1833 | 0.2373 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0042711 | 0.0014 | 17.1833 | 0.2373 | 3 | 11 | maternal behavior |
GO:0070471 | 0.0014 | 17.1833 | 0.2373 | 3 | 11 | uterine smooth muscle contraction |
GO:0009887 | 0.0015 | 2.2446 | 9.5422 | 20 | 478 | organ morphogenesis |
GO:0001523 | 0.0015 | 5.3276 | 1.2514 | 6 | 58 | retinoid metabolic process |
GO:0033555 | 0.0015 | 5.3276 | 1.2514 | 6 | 58 | multicellular organismal response to stress |
GO:0021953 | 0.0016 | 3.5696 | 2.7194 | 9 | 129 | central nervous system neuron differentiation |
GO:0045165 | 0.0016 | 3.2911 | 3.2642 | 10 | 158 | cell fate commitment |
GO:0003002 | 0.0017 | 3.8878 | 2.2267 | 8 | 110 | regionalization |
GO:0048701 | 0.0018 | 6.3972 | 0.8846 | 5 | 41 | embryonic cranial skeleton morphogenesis |
GO:0055123 | 0.0018 | 3.5125 | 2.7617 | 9 | 128 | digestive system development |
GO:0060485 | 0.0018 | 3.0336 | 3.8837 | 11 | 180 | mesenchyme development |
GO:0001662 | 0.0019 | 8.7513 | 0.5394 | 4 | 25 | behavioral fear response |
GO:0051171 | 0.0022 | 1.4573 | 78.0185 | 100 | 3616 | regulation of nitrogen compound metabolic process |
GO:0008589 | 0.0023 | 4.8583 | 1.3593 | 6 | 63 | regulation of smoothened signaling pathway |
GO:0003214 | 0.0024 | 13.7444 | 0.2805 | 3 | 13 | cardiac left ventricle morphogenesis |
GO:0007621 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | negative regulation of female receptivity |
GO:0021569 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | rhombomere 3 development |
GO:0032849 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0050955 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | thermoception |
GO:0072268 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | pattern specification involved in metanephros development |
GO:0090185 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | negative regulation of kidney development |
GO:2001279 | 0.0027 | 45.6753 | 0.0863 | 2 | 4 | regulation of unsaturated fatty acid biosynthetic process |
GO:0019229 | 0.0027 | 5.7556 | 0.9709 | 5 | 45 | regulation of vasoconstriction |
GO:0048562 | 0.0029 | 3.0234 | 3.5318 | 10 | 170 | embryonic organ morphogenesis |
GO:0050801 | 0.003 | 2.0957 | 10.1407 | 20 | 470 | ion homeostasis |
GO:0007625 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | grooming behavior |
GO:0015874 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | norepinephrine transport |
GO:0021542 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | dentate gyrus development |
GO:0071542 | 0.003 | 12.4939 | 0.3021 | 3 | 14 | dopaminergic neuron differentiation |
GO:0003014 | 0.0032 | 4.5382 | 1.4456 | 6 | 67 | renal system process |
GO:0007389 | 0.0032 | 4.5216 | 1.4448 | 6 | 73 | pattern specification process |
GO:0016053 | 0.0033 | 2.54 | 5.4371 | 13 | 252 | organic acid biosynthetic process |
GO:0035270 | 0.0033 | 3.4879 | 2.4642 | 8 | 115 | endocrine system development |
GO:0006721 | 0.0034 | 4.4647 | 1.4672 | 6 | 68 | terpenoid metabolic process |
GO:0045597 | 0.0036 | 2.1014 | 9.5982 | 19 | 459 | positive regulation of cell differentiation |
GO:0006555 | 0.0037 | 11.4519 | 0.3236 | 3 | 15 | methionine metabolic process |
GO:0061436 | 0.0037 | 11.4519 | 0.3236 | 3 | 15 | establishment of skin barrier |
GO:0001838 | 0.0038 | 3.3986 | 2.5244 | 8 | 117 | embryonic epithelial tube formation |
GO:0007193 | 0.004 | 5.2307 | 1.0572 | 5 | 49 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0045685 | 0.004 | 5.2307 | 1.0572 | 5 | 49 | regulation of glial cell differentiation |
GO:0045995 | 0.0042 | 3.7184 | 2.0281 | 7 | 94 | regulation of embryonic development |
GO:0014014 | 0.0042 | 6.8032 | 0.6689 | 4 | 31 | negative regulation of gliogenesis |
GO:0055062 | 0.0044 | 30.6642 | 0.1071 | 2 | 5 | phosphate ion homeostasis |
GO:0010873 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | positive regulation of cholesterol esterification |
GO:0021779 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | glial cell fate specification |
GO:0042713 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | sperm ejaculation |
GO:0051901 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | positive regulation of mitochondrial depolarization |
GO:0071223 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | cellular response to lipoteichoic acid |
GO:0072081 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | specification of nephron tubule identity |
GO:0072172 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | mesonephric tubule formation |
GO:1900094 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry |
GO:1900164 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:2001199 | 0.0044 | 30.4477 | 0.1079 | 2 | 5 | negative regulation of dendritic cell differentiation |
GO:0043009 | 0.0045 | 2.0163 | 10.5131 | 20 | 494 | chordate embryonic development |
GO:0050892 | 0.0045 | 10.5701 | 0.3452 | 3 | 16 | intestinal absorption |
GO:0051930 | 0.0045 | 10.5701 | 0.3452 | 3 | 16 | regulation of sensory perception of pain |
GO:0006935 | 0.0046 | 1.9759 | 11.2626 | 21 | 522 | chemotaxis |
GO:0051241 | 0.0047 | 2.3366 | 6.3417 | 14 | 296 | negative regulation of multicellular organismal process |
GO:0050432 | 0.0053 | 6.333 | 0.712 | 4 | 33 | catecholamine secretion |
GO:0034368 | 0.0054 | 9.8143 | 0.3668 | 3 | 17 | protein-lipid complex remodeling |
GO:0009880 | 0.0056 | 4.7932 | 1.1435 | 5 | 53 | embryonic pattern specification |
GO:0015844 | 0.0056 | 4.7932 | 1.1435 | 5 | 53 | monoamine transport |
GO:0030855 | 0.0058 | 2.0016 | 10.0328 | 19 | 465 | epithelial cell differentiation |
GO:0035107 | 0.0059 | 9.4262 | 0.3778 | 3 | 18 | appendage morphogenesis |
GO:0035176 | 0.0059 | 6.1214 | 0.7336 | 4 | 34 | social behavior |
GO:0072028 | 0.0059 | 6.1214 | 0.7336 | 4 | 34 | nephron morphogenesis |
GO:0021537 | 0.0062 | 2.6987 | 3.9268 | 10 | 182 | telencephalon development |
GO:0043270 | 0.0062 | 3.1104 | 2.7401 | 8 | 127 | positive regulation of ion transport |
GO:0060349 | 0.0063 | 3.8959 | 1.6613 | 6 | 77 | bone morphogenesis |
GO:0000097 | 0.0064 | 9.1593 | 0.3884 | 3 | 18 | sulfur amino acid biosynthetic process |
GO:0007263 | 0.0064 | 9.1593 | 0.3884 | 3 | 18 | nitric oxide mediated signal transduction |
GO:0035295 | 0.0064 | 1.9122 | 11.6078 | 21 | 538 | tube development |
GO:0007187 | 0.0065 | 3.0843 | 2.7617 | 8 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0018206 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | peptidyl-methionine modification |
GO:0021797 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | forebrain anterior/posterior pattern specification |
GO:0030643 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | cellular phosphate ion homeostasis |
GO:0034370 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | triglyceride-rich lipoprotein particle remodeling |
GO:0042756 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | drinking behavior |
GO:0060017 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | parathyroid gland development |
GO:2001204 | 0.0066 | 22.8339 | 0.1295 | 2 | 6 | regulation of osteoclast development |
GO:0043583 | 0.0066 | 2.6673 | 3.97 | 10 | 184 | ear development |
GO:0010721 | 0.0068 | 3.0585 | 2.7833 | 8 | 129 | negative regulation of cell development |
GO:0021515 | 0.0069 | 5.8184 | 0.7664 | 4 | 36 | cell differentiation in spinal cord |
GO:0035148 | 0.0072 | 3.0332 | 2.8049 | 8 | 130 | tube formation |
GO:0048566 | 0.0073 | 5.7379 | 0.7767 | 4 | 36 | embryonic digestive tract development |
GO:0021895 | 0.0075 | 8.5861 | 0.4099 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0042474 | 0.0075 | 8.5861 | 0.4099 | 3 | 19 | middle ear morphogenesis |
GO:0030902 | 0.0075 | 3.0083 | 2.8264 | 8 | 131 | hindbrain development |
GO:0030509 | 0.0076 | 3.2981 | 2.2655 | 7 | 105 | BMP signaling pathway |
GO:0048863 | 0.0081 | 2.2597 | 6.0628 | 13 | 281 | stem cell differentiation |
GO:0002088 | 0.0081 | 4.3393 | 1.2514 | 5 | 58 | lens development in camera-type eye |
GO:0055074 | 0.0084 | 2.3356 | 5.4156 | 12 | 251 | calcium ion homeostasis |
GO:0010719 | 0.0086 | 8.0804 | 0.4315 | 3 | 20 | negative regulation of epithelial to mesenchymal transition |
GO:0072078 | 0.0086 | 8.0804 | 0.4315 | 3 | 20 | nephron tubule morphogenesis |
GO:0033993 | 0.0086 | 1.8559 | 11.9315 | 21 | 553 | response to lipid |
GO:0046456 | 0.0088 | 5.3995 | 0.8199 | 4 | 38 | icosanoid biosynthetic process |
GO:0032308 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | positive regulation of prostaglandin secretion |
GO:0033504 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | floor plate development |
GO:0034145 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | positive regulation of toll-like receptor 4 signaling pathway |
GO:0034384 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | high-density lipoprotein particle clearance |
GO:0042473 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | outer ear morphogenesis |
GO:0042538 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | hyperosmotic salinity response |
GO:0048318 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | axial mesoderm development |
GO:0060677 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | ureteric bud elongation |
GO:1901522 | 0.0091 | 18.2657 | 0.151 | 2 | 7 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
GO:0007417 | 0.0091 | 1.8477 | 11.997 | 21 | 583 | central nervous system development |
GO:0007267 | 0.0091 | 1.6265 | 21.5328 | 33 | 998 | cell-cell signaling |
GO:0048518 | 0.0092 | 1.3736 | 75.9563 | 94 | 3545 | positive regulation of biological process |
GO:0001654 | 0.0093 | 2.2174 | 6.1707 | 13 | 286 | eye development |
GO:0001756 | 0.0094 | 4.1808 | 1.2946 | 5 | 60 | somitogenesis |
GO:0021545 | 0.0096 | 5.2448 | 0.8415 | 4 | 39 | cranial nerve development |
GO:0072210 | 0.0096 | 5.2448 | 0.8415 | 4 | 39 | metanephric nephron development |
GO:0050880 | 0.0097 | 3.1367 | 2.3734 | 7 | 110 | regulation of blood vessel size |
GO:0070328 | 0.0099 | 7.6309 | 0.4531 | 3 | 21 | triglyceride homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007028 | 1e-04 | 59.8029 | 0.1001 | 3 | 6 | cytoplasm organization |
GO:0002675 | 1e-04 | 21.8375 | 0.2501 | 4 | 15 | positive regulation of acute inflammatory response |
GO:0007186 | 2e-04 | 2.5112 | 10.0222 | 23 | 601 | G-protein coupled receptor signaling pathway |
GO:0007308 | 3e-04 | Inf | 0.0334 | 2 | 2 | oocyte construction |
GO:0007314 | 3e-04 | Inf | 0.0334 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 3e-04 | Inf | 0.0334 | 2 | 2 | P granule organization |
GO:0001806 | 8e-04 | 119.0526 | 0.05 | 2 | 3 | type IV hypersensitivity |
GO:0072164 | 9e-04 | 4.93 | 1.5509 | 7 | 93 | mesonephric tubule development |
GO:0007606 | 9e-04 | 5.8442 | 1.134 | 6 | 68 | sensory perception of chemical stimulus |
GO:0050911 | 0.0012 | 17.9308 | 0.2168 | 3 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0031338 | 0.0015 | 16.2994 | 0.2335 | 3 | 14 | regulation of vesicle fusion |
GO:0033599 | 0.0015 | 16.2994 | 0.2335 | 3 | 14 | regulation of mammary gland epithelial cell proliferation |
GO:0030334 | 0.0022 | 2.3898 | 7.154 | 16 | 429 | regulation of cell migration |
GO:0051270 | 0.0025 | 2.2415 | 8.5881 | 18 | 515 | regulation of cellular component movement |
GO:0045765 | 0.0026 | 3.6197 | 2.368 | 8 | 142 | regulation of angiogenesis |
GO:0071675 | 0.0027 | 39.6778 | 0.0834 | 2 | 5 | regulation of mononuclear cell migration |
GO:0045785 | 0.0028 | 3.5659 | 2.4013 | 8 | 144 | positive regulation of cell adhesion |
GO:0060675 | 0.003 | 5.5681 | 0.9839 | 5 | 59 | ureteric bud morphogenesis |
GO:0034333 | 0.0032 | 5.4665 | 1.0006 | 5 | 60 | adherens junction assembly |
GO:2000026 | 0.0036 | 1.7881 | 18.761 | 31 | 1140 | regulation of multicellular organismal development |
GO:0009838 | 0.004 | 29.756 | 0.1001 | 2 | 6 | abscission |
GO:0034112 | 0.004 | 29.756 | 0.1001 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
GO:1903037 | 0.004 | 29.756 | 0.1001 | 2 | 6 | regulation of leukocyte cell-cell adhesion |
GO:0044700 | 0.0041 | 1.467 | 73.1404 | 92 | 4386 | single organism signaling |
GO:0040012 | 0.0043 | 2.1697 | 8.3379 | 17 | 500 | regulation of locomotion |
GO:0007154 | 0.0044 | 1.4609 | 74.2577 | 93 | 4453 | cell communication |
GO:0050906 | 0.0045 | 5.0089 | 1.0839 | 5 | 65 | detection of stimulus involved in sensory perception |
GO:0061180 | 0.0045 | 5.0089 | 1.0839 | 5 | 65 | mammary gland epithelium development |
GO:0010573 | 0.0049 | 9.9551 | 0.3502 | 3 | 21 | vascular endothelial growth factor production |
GO:0007044 | 0.0055 | 4.7692 | 1.134 | 5 | 68 | cell-substrate junction assembly |
GO:0001765 | 0.0055 | 23.8029 | 0.1167 | 2 | 7 | membrane raft assembly |
GO:0032753 | 0.0055 | 23.8029 | 0.1167 | 2 | 7 | positive regulation of interleukin-4 production |
GO:0010810 | 0.0056 | 3.494 | 2.1345 | 7 | 128 | regulation of cell-substrate adhesion |
GO:2000147 | 0.0057 | 2.7261 | 3.8855 | 10 | 233 | positive regulation of cell motility |
GO:0007162 | 0.0059 | 3.929 | 1.6342 | 6 | 98 | negative regulation of cell adhesion |
GO:0032103 | 0.0061 | 3.4367 | 2.1679 | 7 | 130 | positive regulation of response to external stimulus |
GO:0072073 | 0.0061 | 3.4367 | 2.1679 | 7 | 130 | kidney epithelium development |
GO:0007160 | 0.0062 | 3.1037 | 2.7348 | 8 | 164 | cell-matrix adhesion |
GO:0061217 | 0.0063 | 8.9582 | 0.3835 | 3 | 23 | regulation of mesonephros development |
GO:0002711 | 0.0071 | 8.5309 | 0.4002 | 3 | 24 | positive regulation of T cell mediated immunity |
GO:0050727 | 0.0085 | 2.9323 | 2.8849 | 8 | 173 | regulation of inflammatory response |
GO:0048514 | 0.0085 | 2.1731 | 6.8038 | 14 | 408 | blood vessel morphogenesis |
GO:0007292 | 0.0087 | 4.2291 | 1.2674 | 5 | 76 | female gamete generation |
GO:0002687 | 0.0089 | 5.3235 | 0.8171 | 4 | 49 | positive regulation of leukocyte migration |
GO:2000351 | 0.009 | 7.7878 | 0.4336 | 3 | 26 | regulation of endothelial cell apoptotic process |
GO:0002438 | 0.0092 | 16.9993 | 0.1501 | 2 | 9 | acute inflammatory response to antigenic stimulus |
GO:0003334 | 0.0092 | 16.9993 | 0.1501 | 2 | 9 | keratinocyte development |
GO:0051290 | 0.0092 | 16.9993 | 0.1501 | 2 | 9 | protein heterotetramerization |
GO:1903034 | 0.0097 | 4.1084 | 1.3013 | 5 | 80 | regulation of response to wounding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.4046 | 114.8265 | 176 | 5010 | multicellular organismal process |
GO:0007417 | 0 | 3.6681 | 17.1208 | 52 | 747 | central nervous system development |
GO:0007423 | 0 | 4.0526 | 10.0846 | 35 | 440 | sensory organ development |
GO:2000026 | 0 | 2.9274 | 22.344 | 55 | 1005 | regulation of multicellular organismal development |
GO:0051252 | 0 | 2.2068 | 66.1685 | 113 | 2887 | regulation of RNA metabolic process |
GO:0045944 | 0 | 3.1128 | 17.2354 | 46 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0031326 | 0 | 2.1311 | 74.0299 | 121 | 3230 | regulation of cellular biosynthetic process |
GO:0032774 | 0 | 2.1427 | 67.6353 | 113 | 2951 | RNA biosynthetic process |
GO:0045666 | 0 | 10.0639 | 1.7419 | 14 | 76 | positive regulation of neuron differentiation |
GO:0010556 | 0 | 2.088 | 71.2337 | 116 | 3108 | regulation of macromolecule biosynthetic process |
GO:0045935 | 0 | 2.5732 | 27.4575 | 60 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009891 | 0 | 2.4734 | 28.9473 | 61 | 1263 | positive regulation of biosynthetic process |
GO:1901362 | 0 | 2.011 | 77.1698 | 121 | 3367 | organic cyclic compound biosynthetic process |
GO:0018130 | 0 | 1.998 | 75.13 | 118 | 3278 | heterocycle biosynthetic process |
GO:0019438 | 0 | 1.998 | 75.13 | 118 | 3278 | aromatic compound biosynthetic process |
GO:0044271 | 0 | 1.9877 | 76.2072 | 119 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0050767 | 0 | 3.4255 | 10.6346 | 32 | 464 | regulation of neurogenesis |
GO:0051094 | 0 | 2.9009 | 16.1703 | 41 | 712 | positive regulation of developmental process |
GO:0007275 | 0 | 2.2105 | 44.7793 | 78 | 2363 | multicellular organismal development |
GO:0021516 | 0 | 110.681 | 0.1573 | 5 | 7 | dorsal spinal cord development |
GO:0051171 | 0 | 1.8976 | 82.8768 | 124 | 3616 | regulation of nitrogen compound metabolic process |
GO:0021542 | 0 | 32.6276 | 0.3209 | 6 | 14 | dentate gyrus development |
GO:0048729 | 0 | 3.271 | 9.6123 | 28 | 425 | tissue morphogenesis |
GO:0048699 | 0 | 2.9242 | 12.7673 | 33 | 605 | generation of neurons |
GO:0048562 | 0 | 3.9602 | 5.9591 | 21 | 260 | embryonic organ morphogenesis |
GO:0021527 | 0 | 29 | 0.3438 | 6 | 15 | spinal cord association neuron differentiation |
GO:0021537 | 0 | 4.6035 | 4.1713 | 17 | 182 | telencephalon development |
GO:0042472 | 0 | 6.712 | 2.0857 | 12 | 91 | inner ear morphogenesis |
GO:0061448 | 0 | 4.3119 | 4.4235 | 17 | 193 | connective tissue development |
GO:0009887 | 0 | 3.5542 | 6.5892 | 21 | 322 | organ morphogenesis |
GO:0001501 | 0 | 3.1275 | 8.8698 | 25 | 387 | skeletal system development |
GO:0032940 | 0 | 2.5562 | 15.2414 | 35 | 665 | secretion by cell |
GO:0060537 | 0 | 3.4062 | 6.83 | 21 | 298 | muscle tissue development |
GO:0007548 | 0 | 3.9061 | 4.836 | 17 | 211 | sex differentiation |
GO:0030901 | 0 | 11.7367 | 0.7563 | 7 | 33 | midbrain development |
GO:0009952 | 0 | 4.2337 | 3.9464 | 15 | 175 | anterior/posterior pattern specification |
GO:2000310 | 0 | 24.0819 | 0.3209 | 5 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0072001 | 0 | 3.5065 | 5.6611 | 18 | 247 | renal system development |
GO:0034645 | 0 | 1.6729 | 85.9709 | 119 | 3751 | cellular macromolecule biosynthetic process |
GO:0008284 | 0 | 2.5248 | 13.0798 | 30 | 579 | positive regulation of cell proliferation |
GO:0065007 | 0 | 1.7391 | 187.4583 | 220 | 8179 | biological regulation |
GO:0045665 | 0 | 7.9426 | 1.1918 | 8 | 52 | negative regulation of neuron differentiation |
GO:0022414 | 0 | 2.1779 | 20.8567 | 41 | 910 | reproductive process |
GO:0001709 | 0 | 9.5978 | 0.888 | 7 | 39 | cell fate determination |
GO:0060429 | 0 | 2.3102 | 16.2211 | 34 | 732 | epithelium development |
GO:0048592 | 0 | 4.4413 | 3.0025 | 12 | 131 | eye morphogenesis |
GO:0007517 | 1e-04 | 3.0478 | 6.8071 | 19 | 297 | muscle organ development |
GO:0009953 | 1e-04 | 5.7792 | 1.7666 | 9 | 78 | dorsal/ventral pattern formation |
GO:0048667 | 1e-04 | 2.4242 | 12.6057 | 28 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0048646 | 1e-04 | 2.1227 | 19.6721 | 38 | 864 | anatomical structure formation involved in morphogenesis |
GO:0080090 | 1e-04 | 1.5915 | 104.2377 | 136 | 4548 | regulation of primary metabolic process |
GO:0010467 | 1e-04 | 1.5857 | 93.5802 | 124 | 4083 | gene expression |
GO:0007411 | 1e-04 | 2.8148 | 7.7239 | 20 | 337 | axon guidance |
GO:0001655 | 1e-04 | 9.4153 | 0.7674 | 6 | 35 | urogenital system development |
GO:0050877 | 1e-04 | 2.1959 | 16.4103 | 33 | 716 | neurological system process |
GO:0007565 | 1e-04 | 4.1991 | 2.8879 | 11 | 126 | female pregnancy |
GO:0048598 | 2e-04 | 3.0791 | 5.6435 | 16 | 260 | embryonic morphogenesis |
GO:0048663 | 2e-04 | 8.3621 | 0.8489 | 6 | 38 | neuron fate commitment |
GO:0021915 | 2e-04 | 3.7961 | 3.4608 | 12 | 151 | neural tube development |
GO:0007267 | 2e-04 | 2.7555 | 7.4906 | 19 | 360 | cell-cell signaling |
GO:0009792 | 2e-04 | 2.2831 | 12.812 | 27 | 559 | embryo development ending in birth or egg hatching |
GO:0048812 | 2e-04 | 2.2741 | 12.8578 | 27 | 561 | neuron projection morphogenesis |
GO:0010453 | 2e-04 | 10.8272 | 0.573 | 5 | 25 | regulation of cell fate commitment |
GO:0021533 | 2e-04 | 10.8272 | 0.573 | 5 | 25 | cell differentiation in hindbrain |
GO:0021797 | 2e-04 | 43.0662 | 0.1375 | 3 | 6 | forebrain anterior/posterior pattern specification |
GO:0048852 | 2e-04 | 43.0662 | 0.1375 | 3 | 6 | diencephalon morphogenesis |
GO:0097120 | 2e-04 | 43.0662 | 0.1375 | 3 | 6 | receptor localization to synapse |
GO:0043010 | 2e-04 | 3.0006 | 5.7757 | 16 | 252 | camera-type eye development |
GO:0031018 | 3e-04 | 7.7402 | 0.9078 | 6 | 40 | endocrine pancreas development |
GO:0060173 | 3e-04 | 3.6372 | 3.5984 | 12 | 157 | limb development |
GO:0048608 | 3e-04 | 3.3869 | 4.1707 | 13 | 186 | reproductive structure development |
GO:0061138 | 3e-04 | 3.3661 | 4.1943 | 13 | 183 | morphogenesis of a branching epithelium |
GO:0021983 | 3e-04 | 9.9371 | 0.6131 | 5 | 27 | pituitary gland development |
GO:0048732 | 3e-04 | 2.6972 | 7.1998 | 18 | 322 | gland development |
GO:0048738 | 4e-04 | 3.7655 | 3.1876 | 11 | 140 | cardiac muscle tissue development |
GO:0006355 | 4e-04 | 1.7593 | 35.2276 | 55 | 1767 | regulation of transcription, DNA-templated |
GO:0010604 | 4e-04 | 1.6713 | 43.249 | 65 | 1887 | positive regulation of macromolecule metabolic process |
GO:0003310 | 4e-04 | 32.297 | 0.1604 | 3 | 7 | pancreatic A cell differentiation |
GO:0021796 | 4e-04 | 32.297 | 0.1604 | 3 | 7 | cerebral cortex regionalization |
GO:0007399 | 4e-04 | 2.0113 | 18.5485 | 34 | 939 | nervous system development |
GO:0006935 | 4e-04 | 2.2524 | 11.964 | 25 | 522 | chemotaxis |
GO:0060042 | 4e-04 | 9.1083 | 0.6585 | 5 | 29 | retina morphogenesis in camera-type eye |
GO:0010470 | 5e-04 | 9.0197 | 0.6647 | 5 | 29 | regulation of gastrulation |
GO:0046928 | 5e-04 | 6.8523 | 1.0085 | 6 | 44 | regulation of neurotransmitter secretion |
GO:0009888 | 5e-04 | 3.6288 | 3.2973 | 11 | 168 | tissue development |
GO:0002064 | 5e-04 | 3.3777 | 3.8505 | 12 | 168 | epithelial cell development |
GO:0021514 | 5e-04 | 13.2867 | 0.3896 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0030539 | 5e-04 | 13.2867 | 0.3896 | 4 | 17 | male genitalia development |
GO:0046530 | 5e-04 | 6.6761 | 1.0314 | 6 | 45 | photoreceptor cell differentiation |
GO:0061564 | 5e-04 | 2.2483 | 11.4827 | 24 | 501 | axon development |
GO:0060562 | 5e-04 | 2.6677 | 6.8529 | 17 | 299 | epithelial tube morphogenesis |
GO:0030154 | 6e-04 | 1.7847 | 30.0408 | 48 | 1523 | cell differentiation |
GO:0007215 | 6e-04 | 5.3402 | 1.4668 | 7 | 64 | glutamate receptor signaling pathway |
GO:0021879 | 6e-04 | 6.3934 | 1.0701 | 6 | 47 | forebrain neuron differentiation |
GO:0030902 | 6e-04 | 4.1168 | 2.3923 | 9 | 106 | hindbrain development |
GO:0045595 | 7e-04 | 2.1089 | 13.8257 | 27 | 643 | regulation of cell differentiation |
GO:0048864 | 8e-04 | 2.8797 | 5.2256 | 14 | 228 | stem cell development |
GO:0001502 | 8e-04 | 11.5133 | 0.4355 | 4 | 19 | cartilage condensation |
GO:0090304 | 8e-04 | 1.4836 | 90.509 | 116 | 3949 | nucleic acid metabolic process |
GO:0007610 | 9e-04 | 2.8388 | 5.2975 | 14 | 240 | behavior |
GO:0015671 | 9e-04 | 21.5279 | 0.2063 | 3 | 9 | oxygen transport |
GO:0048839 | 0.001 | 4.932 | 1.5712 | 7 | 71 | inner ear development |
GO:0060850 | 0.001 | 10.7928 | 0.4584 | 4 | 20 | regulation of transcription involved in cell fate commitment |
GO:0072006 | 0.0011 | 4.2487 | 2.0628 | 8 | 90 | nephron development |
GO:0007166 | 0.0011 | 1.5666 | 51.0969 | 72 | 2273 | cell surface receptor signaling pathway |
GO:0002068 | 0.0012 | 10.1571 | 0.4813 | 4 | 21 | glandular epithelial cell development |
GO:0023019 | 0.0012 | 10.1571 | 0.4813 | 4 | 21 | signal transduction involved in regulation of gene expression |
GO:0043403 | 0.0012 | 10.1571 | 0.4813 | 4 | 21 | skeletal muscle tissue regeneration |
GO:2000027 | 0.0012 | 3.4409 | 3.14 | 10 | 137 | regulation of organ morphogenesis |
GO:0007492 | 0.0013 | 4.6799 | 1.6502 | 7 | 72 | endoderm development |
GO:0051963 | 0.0013 | 6.9791 | 0.8251 | 5 | 36 | regulation of synapse assembly |
GO:0035107 | 0.0014 | 3.387 | 3.1858 | 10 | 139 | appendage morphogenesis |
GO:0000902 | 0.0014 | 1.7851 | 22.9424 | 38 | 1001 | cell morphogenesis |
GO:2000179 | 0.0015 | 6.7604 | 0.848 | 5 | 37 | positive regulation of neural precursor cell proliferation |
GO:0021902 | 0.0015 | 85.8472 | 0.0688 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030910 | 0.0015 | 85.8472 | 0.0688 | 2 | 3 | olfactory placode formation |
GO:0042335 | 0.0015 | 85.8472 | 0.0688 | 2 | 3 | cuticle development |
GO:0071698 | 0.0015 | 85.8472 | 0.0688 | 2 | 3 | olfactory placode development |
GO:2000195 | 0.0015 | 85.8472 | 0.0688 | 2 | 3 | negative regulation of female gonad development |
GO:0007268 | 0.0016 | 2.2251 | 9.6011 | 20 | 443 | synaptic transmission |
GO:0048565 | 0.0017 | 3.5677 | 2.7274 | 9 | 119 | digestive tract development |
GO:0030111 | 0.0017 | 2.9052 | 4.4235 | 12 | 193 | regulation of Wnt signaling pathway |
GO:0021521 | 0.0017 | 16.1433 | 0.2521 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0021903 | 0.0017 | 16.1433 | 0.2521 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0097154 | 0.0017 | 16.1433 | 0.2521 | 3 | 11 | GABAergic neuron differentiation |
GO:0030326 | 0.0019 | 3.5034 | 2.7733 | 9 | 121 | embryonic limb morphogenesis |
GO:0048638 | 0.0019 | 3.5034 | 2.7733 | 9 | 121 | regulation of developmental growth |
GO:0030858 | 0.0019 | 6.3617 | 0.8939 | 5 | 39 | positive regulation of epithelial cell differentiation |
GO:0072358 | 0.002 | 2.5893 | 5.7714 | 14 | 261 | cardiovascular system development |
GO:0001764 | 0.0021 | 3.4414 | 2.8191 | 9 | 123 | neuron migration |
GO:0035051 | 0.0021 | 3.7838 | 2.2919 | 8 | 100 | cardiocyte differentiation |
GO:0071383 | 0.0021 | 3.7838 | 2.2919 | 8 | 100 | cellular response to steroid hormone stimulus |
GO:0035987 | 0.0021 | 6.1794 | 0.9168 | 5 | 40 | endodermal cell differentiation |
GO:0050810 | 0.0021 | 6.1794 | 0.9168 | 5 | 40 | regulation of steroid biosynthetic process |
GO:0009653 | 0.0021 | 2.0604 | 12.0357 | 23 | 642 | anatomical structure morphogenesis |
GO:0032946 | 0.0022 | 4.2225 | 1.8106 | 7 | 79 | positive regulation of mononuclear cell proliferation |
GO:0030030 | 0.0022 | 1.745 | 22.759 | 37 | 993 | cell projection organization |
GO:0021513 | 0.0023 | 8.2198 | 0.573 | 4 | 25 | spinal cord dorsal/ventral patterning |
GO:0045165 | 0.0024 | 4.1465 | 1.8351 | 7 | 86 | cell fate commitment |
GO:0044699 | 0.0024 | 1.6232 | 233.4118 | 252 | 10184 | single-organism process |
GO:0050794 | 0.0025 | 1.5284 | 89.3459 | 109 | 4630 | regulation of cellular process |
GO:0007270 | 0.0025 | 8.0446 | 0.5817 | 4 | 26 | neuron-neuron synaptic transmission |
GO:0007611 | 0.0026 | 2.8969 | 4.0567 | 11 | 177 | learning or memory |
GO:0007269 | 0.0026 | 4.7285 | 1.3965 | 6 | 62 | neurotransmitter secretion |
GO:0050803 | 0.0027 | 4.7278 | 1.3981 | 6 | 61 | regulation of synapse structure and activity |
GO:0048665 | 0.0027 | 13.1287 | 0.2932 | 3 | 13 | neuron fate specification |
GO:0021520 | 0.0029 | 12.9125 | 0.298 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0060219 | 0.0029 | 12.9125 | 0.298 | 3 | 13 | camera-type eye photoreceptor cell differentiation |
GO:0001714 | 0.003 | 43.2133 | 0.0911 | 2 | 4 | endodermal cell fate specification |
GO:0003163 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | sinoatrial node development |
GO:0010269 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | response to selenium ion |
GO:0042663 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0042816 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | vitamin B6 metabolic process |
GO:0060018 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | astrocyte fate commitment |
GO:0060214 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | endocardium formation |
GO:0060591 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | chondroblast differentiation |
GO:0060913 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | cardiac cell fate determination |
GO:2000977 | 0.003 | 42.9201 | 0.0917 | 2 | 4 | regulation of forebrain neuron differentiation |
GO:0048666 | 0.0031 | 2.466 | 6.0397 | 14 | 279 | neuron development |
GO:0032729 | 0.0031 | 7.5038 | 0.6188 | 4 | 27 | positive regulation of interferon-gamma production |
GO:0009725 | 0.0032 | 1.8682 | 15.379 | 27 | 671 | response to hormone |
GO:0021517 | 0.0034 | 7.2849 | 0.6337 | 4 | 28 | ventral spinal cord development |
GO:0060079 | 0.0035 | 7.2597 | 0.6359 | 4 | 28 | regulation of excitatory postsynaptic membrane potential |
GO:0003002 | 0.0035 | 5.385 | 1.0284 | 5 | 49 | regionalization |
GO:0090183 | 0.0035 | 5.4048 | 1.0314 | 5 | 45 | regulation of kidney development |
GO:0090090 | 0.0035 | 3.8461 | 1.9711 | 7 | 86 | negative regulation of canonical Wnt signaling pathway |
GO:0021984 | 0.0036 | 11.7377 | 0.3209 | 3 | 14 | adenohypophysis development |
GO:0051968 | 0.0036 | 11.7377 | 0.3209 | 3 | 14 | positive regulation of synaptic transmission, glutamatergic |
GO:0031016 | 0.0037 | 7.1047 | 0.6464 | 4 | 29 | pancreas development |
GO:0032355 | 0.0038 | 3.7977 | 1.994 | 7 | 87 | response to estradiol |
GO:0035019 | 0.0039 | 5.2726 | 1.0543 | 5 | 46 | somatic stem cell maintenance |
GO:0045446 | 0.004 | 4.332 | 1.5127 | 6 | 66 | endothelial cell differentiation |
GO:0009749 | 0.0042 | 3.344 | 2.567 | 8 | 112 | response to glucose |
GO:0001944 | 0.0042 | 1.9886 | 11.1847 | 21 | 488 | vasculature development |
GO:0032502 | 0.0044 | 1.5932 | 36.0293 | 51 | 2068 | developmental process |
GO:0042693 | 0.0044 | 10.7587 | 0.3438 | 3 | 15 | muscle cell fate commitment |
GO:0060581 | 0.0044 | 10.7587 | 0.3438 | 3 | 15 | cell fate commitment involved in pattern specification |
GO:0072112 | 0.0044 | 10.7587 | 0.3438 | 3 | 15 | glomerular visceral epithelial cell differentiation |
GO:2000463 | 0.0044 | 10.7587 | 0.3438 | 3 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0035265 | 0.0046 | 3.6596 | 2.0628 | 7 | 90 | organ growth |
GO:0030900 | 0.0046 | 3.0216 | 3.1762 | 9 | 145 | forebrain development |
GO:0021696 | 0.0046 | 6.6364 | 0.6876 | 4 | 30 | cerebellar cortex morphogenesis |
GO:0060795 | 0.0046 | 6.6364 | 0.6876 | 4 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0040011 | 0.0047 | 1.6095 | 27.9388 | 42 | 1219 | locomotion |
GO:0045596 | 0.0048 | 2.0855 | 9.1307 | 18 | 408 | negative regulation of cell differentiation |
GO:0008406 | 0.0049 | 2.7946 | 3.8046 | 10 | 166 | gonad development |
GO:0032990 | 0.0049 | 1.7833 | 16.6625 | 28 | 727 | cell part morphogenesis |
GO:0001826 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | inner cell mass cell differentiation |
GO:0035881 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | amacrine cell differentiation |
GO:0060290 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | transdifferentiation |
GO:0060297 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | regulation of sarcomere organization |
GO:0060421 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | positive regulation of heart growth |
GO:0090031 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | positive regulation of steroid hormone biosynthetic process |
GO:0097114 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | N-methyl-D-aspartate receptor clustering |
GO:2000727 | 0.005 | 28.6111 | 0.1146 | 2 | 5 | positive regulation of cardiac muscle cell differentiation |
GO:0048854 | 0.0052 | 6.3901 | 0.7105 | 4 | 31 | brain morphogenesis |
GO:0060441 | 0.0052 | 6.3901 | 0.7105 | 4 | 31 | epithelial tube branching involved in lung morphogenesis |
GO:0060512 | 0.0052 | 6.3901 | 0.7105 | 4 | 31 | prostate gland morphogenesis |
GO:0048513 | 0.0053 | 1.7554 | 18.4719 | 30 | 1037 | organ development |
GO:0030072 | 0.0053 | 2.6097 | 4.4693 | 11 | 195 | peptide hormone secretion |
GO:0060999 | 0.0053 | 9.9303 | 0.3667 | 3 | 16 | positive regulation of dendritic spine development |
GO:0072148 | 0.0053 | 9.9303 | 0.3667 | 3 | 16 | epithelial cell fate commitment |
GO:0035295 | 0.0054 | 2.2979 | 6.4444 | 14 | 294 | tube development |
GO:0045445 | 0.0056 | 4.8023 | 1.146 | 5 | 50 | myoblast differentiation |
GO:0051952 | 0.0056 | 4.8023 | 1.146 | 5 | 50 | regulation of amine transport |
GO:0023051 | 0.0056 | 1.4543 | 51.6605 | 69 | 2254 | regulation of signaling |
GO:0021700 | 0.0058 | 2.5812 | 4.5151 | 11 | 197 | developmental maturation |
GO:0050673 | 0.0058 | 2.3606 | 5.8215 | 13 | 254 | epithelial cell proliferation |
GO:0000578 | 0.0059 | 6.1613 | 0.7334 | 4 | 32 | embryonic axis specification |
GO:0007519 | 0.0059 | 2.9011 | 3.3004 | 9 | 144 | skeletal muscle tissue development |
GO:0010646 | 0.006 | 1.4495 | 51.798 | 69 | 2260 | regulation of cell communication |
GO:0007626 | 0.0061 | 2.7067 | 3.9192 | 10 | 171 | locomotory behavior |
GO:0042102 | 0.0061 | 4.6976 | 1.1689 | 5 | 51 | positive regulation of T cell proliferation |
GO:0034284 | 0.0063 | 3.1031 | 2.7503 | 8 | 120 | response to monosaccharide |
GO:0060914 | 0.0064 | 9.2203 | 0.3896 | 3 | 17 | heart formation |
GO:0001678 | 0.0065 | 3.8772 | 1.6731 | 6 | 73 | cellular glucose homeostasis |
GO:0035094 | 0.0066 | 5.9484 | 0.7563 | 4 | 33 | response to nicotine |
GO:0035850 | 0.0066 | 5.9484 | 0.7563 | 4 | 33 | epithelial cell differentiation involved in kidney development |
GO:0051932 | 0.0066 | 5.9484 | 0.7563 | 4 | 33 | synaptic transmission, GABAergic |
GO:0021885 | 0.0066 | 4.5972 | 1.1918 | 5 | 52 | forebrain cell migration |
GO:0060415 | 0.0066 | 4.5972 | 1.1918 | 5 | 52 | muscle tissue morphogenesis |
GO:0009605 | 0.0072 | 1.5184 | 34.5855 | 49 | 1509 | response to external stimulus |
GO:0031128 | 0.0073 | 5.7497 | 0.7793 | 4 | 34 | developmental induction |
GO:0015870 | 0.0074 | 21.4566 | 0.1375 | 2 | 6 | acetylcholine transport |
GO:0051450 | 0.0074 | 21.4566 | 0.1375 | 2 | 6 | myoblast proliferation |
GO:0060527 | 0.0074 | 21.4566 | 0.1375 | 2 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0060534 | 0.0074 | 21.4566 | 0.1375 | 2 | 6 | trachea cartilage development |
GO:0014070 | 0.0075 | 1.8523 | 12.5323 | 22 | 553 | response to organic cyclic compound |
GO:0007271 | 0.0075 | 8.6049 | 0.4126 | 3 | 18 | synaptic transmission, cholinergic |
GO:0072010 | 0.0075 | 8.6049 | 0.4126 | 3 | 18 | glomerular epithelium development |
GO:2000311 | 0.0075 | 8.6049 | 0.4126 | 3 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0021766 | 0.0076 | 5.6793 | 0.7865 | 4 | 35 | hippocampus development |
GO:0007155 | 0.0076 | 1.6611 | 20.4212 | 32 | 891 | cell adhesion |
GO:0035249 | 0.008 | 4.3624 | 1.2489 | 5 | 55 | synaptic transmission, glutamatergic |
GO:0050795 | 0.0081 | 2.9693 | 2.8649 | 8 | 125 | regulation of behavior |
GO:0050805 | 0.0081 | 5.5637 | 0.8022 | 4 | 35 | negative regulation of synaptic transmission |
GO:0045893 | 0.0083 | 2.3409 | 5.4127 | 12 | 264 | positive regulation of transcription, DNA-templated |
GO:0001658 | 0.0083 | 4.3204 | 1.2606 | 5 | 55 | branching involved in ureteric bud morphogenesis |
GO:0021549 | 0.0084 | 3.6576 | 1.7648 | 6 | 77 | cerebellum development |
GO:0022898 | 0.0084 | 2.9439 | 2.8879 | 8 | 126 | regulation of transmembrane transporter activity |
GO:0030534 | 0.0084 | 2.9439 | 2.8879 | 8 | 126 | adult behavior |
GO:0070663 | 0.0084 | 2.9439 | 2.8879 | 8 | 126 | regulation of leukocyte proliferation |
GO:0044057 | 0.0085 | 2.1068 | 7.4947 | 15 | 327 | regulation of system process |
GO:0021871 | 0.0086 | 8.1496 | 0.4312 | 3 | 19 | forebrain regionalization |
GO:0060485 | 0.0086 | 2.5616 | 4.1255 | 10 | 180 | mesenchyme development |
GO:0055012 | 0.0088 | 8.0664 | 0.4355 | 3 | 19 | ventricular cardiac muscle cell differentiation |
GO:0009914 | 0.0088 | 2.3181 | 5.4548 | 12 | 238 | hormone transport |
GO:0000122 | 0.0089 | 1.822 | 12.7203 | 22 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0051046 | 0.009 | 1.9906 | 8.9869 | 17 | 399 | regulation of secretion |
GO:0061351 | 0.0094 | 3.5629 | 1.8068 | 6 | 80 | neural precursor cell proliferation |
GO:0030282 | 0.0095 | 3.5568 | 1.8106 | 6 | 79 | bone mineralization |
GO:0050773 | 0.0095 | 3.5568 | 1.8106 | 6 | 79 | regulation of dendrite development |
GO:0035136 | 0.0098 | 5.2257 | 0.848 | 4 | 37 | forelimb morphogenesis |
GO:0035137 | 0.0098 | 5.2257 | 0.848 | 4 | 37 | hindlimb morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 1e-04 | 3.0146 | 6.8841 | 19 | 314 | G-protein coupled receptor activity |
GO:0043178 | 4e-04 | 5.6979 | 1.3812 | 7 | 63 | alcohol binding |
GO:0005185 | 5e-04 | Inf | 0.0438 | 2 | 2 | neurohypophyseal hormone activity |
GO:0031894 | 5e-04 | Inf | 0.0438 | 2 | 2 | V1A vasopressin receptor binding |
GO:0005104 | 7e-04 | 12.0599 | 0.4166 | 4 | 19 | fibroblast growth factor receptor binding |
GO:0005215 | 7e-04 | 1.8777 | 21.3976 | 37 | 976 | transporter activity |
GO:0001653 | 8e-04 | 4.4544 | 1.9731 | 8 | 90 | peptide receptor activity |
GO:0001664 | 0.0015 | 3.3522 | 3.214 | 10 | 148 | G-protein coupled receptor binding |
GO:0008324 | 0.0015 | 2.151 | 10.94 | 22 | 499 | cation transmembrane transporter activity |
GO:0004871 | 0.0019 | 1.7943 | 21.003 | 35 | 958 | signal transducer activity |
GO:0035198 | 0.002 | 15.0261 | 0.2631 | 3 | 12 | miRNA binding |
GO:0043565 | 0.0028 | 1.9134 | 14.5017 | 26 | 666 | sequence-specific DNA binding |
GO:0008378 | 0.0035 | 7.23 | 0.6358 | 4 | 29 | galactosyltransferase activity |
GO:0005125 | 0.0042 | 3.3435 | 2.5651 | 8 | 117 | cytokine activity |
GO:0004957 | 0.0046 | 29.9554 | 0.1096 | 2 | 5 | prostaglandin E receptor activity |
GO:0008762 | 0.0046 | 29.9554 | 0.1096 | 2 | 5 | UDP-N-acetylmuramate dehydrogenase activity |
GO:0022891 | 0.0048 | 1.8291 | 15.1055 | 26 | 689 | substrate-specific transmembrane transporter activity |
GO:0015077 | 0.0059 | 2.3575 | 5.8317 | 13 | 266 | monovalent inorganic cation transmembrane transporter activity |
GO:0046873 | 0.0062 | 2.1903 | 7.2349 | 15 | 330 | metal ion transmembrane transporter activity |
GO:0008188 | 0.0062 | 6.0225 | 0.7454 | 4 | 34 | neuropeptide receptor activity |
GO:0022804 | 0.0063 | 2.4322 | 5.2179 | 12 | 238 | active transmembrane transporter activity |
GO:0015293 | 0.0067 | 3.3838 | 2.2143 | 7 | 101 | symporter activity |
GO:0004872 | 0.0076 | 1.6909 | 18.8325 | 30 | 859 | receptor activity |
GO:0001205 | 0.0078 | 8.4473 | 0.4166 | 3 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0071855 | 0.009 | 7.9497 | 0.4385 | 3 | 20 | neuropeptide receptor binding |
GO:0003680 | 0.0094 | 17.9703 | 0.1535 | 2 | 7 | AT DNA binding |
GO:0008395 | 0.0094 | 17.9703 | 0.1535 | 2 | 7 | steroid hydroxylase activity |
GO:0015280 | 0.0094 | 17.9703 | 0.1535 | 2 | 7 | ligand-gated sodium channel activity |
GO:0042277 | 0.0097 | 2.8653 | 2.9597 | 8 | 135 | peptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 67.4267 | 0.1693 | 6 | 13 | olfactory receptor activity |
GO:0004930 | 1e-04 | 3.7778 | 4.0898 | 14 | 314 | G-protein coupled receptor activity |
GO:0005232 | 2e-04 | Inf | 0.026 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 2e-04 | Inf | 0.026 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0038023 | 3e-04 | 2.5773 | 9.0132 | 21 | 692 | signaling receptor activity |
GO:0005216 | 3e-04 | 3.3579 | 4.22 | 13 | 324 | ion channel activity |
GO:0022803 | 6e-04 | 3.1206 | 4.5196 | 13 | 347 | passive transmembrane transporter activity |
GO:0046873 | 0.0013 | 3.0092 | 4.2982 | 12 | 330 | metal ion transmembrane transporter activity |
GO:0060089 | 0.0014 | 2.1131 | 12.4778 | 24 | 958 | molecular transducer activity |
GO:0022891 | 0.0016 | 2.3026 | 8.9741 | 19 | 689 | substrate-specific transmembrane transporter activity |
GO:0015347 | 0.0016 | 51.1405 | 0.0651 | 2 | 5 | sodium-independent organic anion transmembrane transporter activity |
GO:0005267 | 0.002 | 4.9324 | 1.3155 | 6 | 101 | potassium channel activity |
GO:0032393 | 0.0024 | 38.3522 | 0.0781 | 2 | 6 | MHC class I receptor activity |
GO:0004972 | 0.0045 | 25.5639 | 0.1042 | 2 | 8 | N-methyl-D-aspartate selective glutamate receptor activity |
GO:0005230 | 0.0068 | 5.7306 | 0.7554 | 4 | 58 | extracellular ligand-gated ion channel activity |
GO:0022836 | 0.0077 | 2.7736 | 3.4386 | 9 | 264 | gated channel activity |
GO:0005262 | 0.008 | 4.3127 | 1.2374 | 5 | 95 | calcium channel activity |
GO:0004993 | 0.0086 | 17.0384 | 0.1433 | 2 | 11 | serotonin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004982 | 3e-04 | Inf | 0.0348 | 2 | 2 | N-formyl peptide receptor activity |
GO:0022892 | 3e-04 | 2.1999 | 13.9495 | 28 | 802 | substrate-specific transporter activity |
GO:0022838 | 7e-04 | 2.8169 | 5.7398 | 15 | 330 | substrate-specific channel activity |
GO:0022836 | 7e-04 | 3.0499 | 4.5919 | 13 | 264 | gated channel activity |
GO:0022803 | 0.0011 | 2.6688 | 6.0355 | 15 | 347 | passive transmembrane transporter activity |
GO:0005261 | 0.0012 | 3.0357 | 4.244 | 12 | 244 | cation channel activity |
GO:0005244 | 0.0017 | 3.5418 | 2.7308 | 9 | 157 | voltage-gated ion channel activity |
GO:0015075 | 0.0019 | 2.1119 | 11.2014 | 22 | 644 | ion transmembrane transporter activity |
GO:0005109 | 0.0022 | 8.2045 | 0.5566 | 4 | 32 | frizzled binding |
GO:0016004 | 0.0029 | 38.0063 | 0.087 | 2 | 5 | phospholipase activator activity |
GO:0022821 | 0.0029 | 38.0063 | 0.087 | 2 | 5 | potassium ion antiporter activity |
GO:0015079 | 0.0034 | 3.8587 | 1.948 | 7 | 113 | potassium ion transmembrane transporter activity |
GO:0022890 | 0.0041 | 2.3035 | 6.9226 | 15 | 398 | inorganic cation transmembrane transporter activity |
GO:0051371 | 0.006 | 22.8 | 0.1218 | 2 | 7 | muscle alpha-actinin binding |
GO:0004872 | 0.0077 | 1.7847 | 14.9409 | 25 | 859 | receptor activity |
GO:0000155 | 0.0079 | 18.9984 | 0.1391 | 2 | 8 | phosphorelay sensor kinase activity |
GO:0005249 | 0.0093 | 4.1674 | 1.2871 | 5 | 74 | voltage-gated potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003840 | 0.0035 | 34.5356 | 0.0955 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0009374 | 0.0035 | 34.5356 | 0.0955 | 2 | 5 | biotin binding |
GO:0019825 | 0.0045 | 10.3948 | 0.3437 | 3 | 18 | oxygen binding |
GO:0004075 | 0.0052 | 25.8996 | 0.1146 | 2 | 6 | biotin carboxylase activity |
GO:0016421 | 0.0052 | 25.8996 | 0.1146 | 2 | 6 | CoA carboxylase activity |
GO:0046703 | 0.0052 | 25.8996 | 0.1146 | 2 | 6 | natural killer cell lectin-like receptor binding |
GO:0016763 | 0.0063 | 5.9557 | 0.7446 | 4 | 39 | transferase activity, transferring pentosyl groups |
GO:0046977 | 0.0072 | 20.7179 | 0.1336 | 2 | 7 | TAP binding |
GO:0046872 | 0.008 | 1.4181 | 63.8829 | 81 | 3346 | metal ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 1e-04 | 3.7519 | 4.1152 | 14 | 314 | G-protein coupled receptor activity |
GO:0004252 | 5e-04 | 5.5765 | 1.3761 | 7 | 105 | serine-type endopeptidase activity |
GO:0004035 | 5e-04 | 152.475 | 0.0393 | 2 | 3 | alkaline phosphatase activity |
GO:0017171 | 0.0013 | 4.6237 | 1.6382 | 7 | 125 | serine hydrolase activity |
GO:0060089 | 0.0016 | 2.0976 | 12.5553 | 24 | 958 | molecular transducer activity |
GO:0038023 | 0.0073 | 2.1085 | 8.1177 | 16 | 632 | signaling receptor activity |
GO:0022839 | 0.0076 | 8.2015 | 0.4063 | 3 | 31 | ion gated channel activity |
GO:0030594 | 0.0078 | 5.4896 | 0.7863 | 4 | 60 | neurotransmitter receptor activity |
GO:0016895 | 0.0087 | 16.9306 | 0.1442 | 2 | 11 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 82.5891 | 0.1883 | 7 | 13 | olfactory receptor activity |
GO:0004872 | 0 | 2.9889 | 12.4392 | 32 | 859 | receptor activity |
GO:0004871 | 0 | 2.8569 | 13.8728 | 34 | 958 | signal transducer activity |
GO:0032393 | 1e-04 | 69.1989 | 0.0869 | 3 | 6 | MHC class I receptor activity |
GO:0004930 | 2e-04 | 3.3606 | 4.547 | 14 | 314 | G-protein coupled receptor activity |
GO:0008392 | 2e-04 | Inf | 0.029 | 2 | 2 | arachidonic acid epoxygenase activity |
GO:0030109 | 2e-04 | Inf | 0.029 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0016907 | 0.002 | 45.8719 | 0.0724 | 2 | 5 | G-protein coupled acetylcholine receptor activity |
GO:0034594 | 0.003 | 34.4011 | 0.0869 | 2 | 6 | phosphatidylinositol trisphosphate phosphatase activity |
GO:0042834 | 0.003 | 34.4011 | 0.0869 | 2 | 6 | peptidoglycan binding |
GO:0046703 | 0.003 | 34.4011 | 0.0869 | 2 | 6 | natural killer cell lectin-like receptor binding |
GO:0004252 | 0.0042 | 4.233 | 1.5205 | 6 | 105 | serine-type endopeptidase activity |
GO:0005344 | 0.0055 | 22.9303 | 0.1158 | 2 | 8 | oxygen transporter activity |
GO:0004888 | 0.006 | 2.7154 | 3.9151 | 10 | 291 | transmembrane signaling receptor activity |
GO:0008157 | 0.007 | 19.6529 | 0.1303 | 2 | 9 | protein phosphatase 1 binding |
GO:0016594 | 0.0087 | 17.1949 | 0.1448 | 2 | 10 | glycine binding |
GO:0017171 | 0.0096 | 3.5157 | 1.8101 | 6 | 125 | serine hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 103.9866 | 0.1514 | 7 | 13 | olfactory receptor activity |
GO:0038023 | 0 | 3.1078 | 8.0615 | 22 | 692 | signaling receptor activity |
GO:0004930 | 1e-04 | 3.9286 | 3.658 | 13 | 314 | G-protein coupled receptor activity |
GO:0060089 | 3e-04 | 2.4161 | 11.1603 | 24 | 958 | molecular transducer activity |
GO:0015075 | 0.0013 | 2.4743 | 7.5023 | 17 | 644 | ion transmembrane transporter activity |
GO:0022838 | 0.0017 | 3.0848 | 3.8443 | 11 | 330 | substrate-specific channel activity |
GO:0003823 | 0.002 | 8.2823 | 0.5359 | 4 | 46 | antigen binding |
GO:0022803 | 0.0024 | 2.9245 | 4.0424 | 11 | 347 | passive transmembrane transporter activity |
GO:0017171 | 0.0034 | 4.4202 | 1.4562 | 6 | 125 | serine hydrolase activity |
GO:0046873 | 0.0052 | 2.7745 | 3.8443 | 10 | 330 | metal ion transmembrane transporter activity |
GO:0022892 | 0.0055 | 2.0833 | 9.3429 | 18 | 802 | substrate-specific transporter activity |
GO:0015293 | 0.0065 | 4.5417 | 1.1766 | 5 | 101 | symporter activity |
GO:0004252 | 0.0076 | 4.3586 | 1.2232 | 5 | 105 | serine-type endopeptidase activity |
GO:0005261 | 0.0077 | 2.9863 | 2.8425 | 8 | 244 | cation channel activity |
GO:0008266 | 0.0082 | 17.193 | 0.1398 | 2 | 12 | poly(U) RNA binding |
GO:0008201 | 0.0086 | 4.2306 | 1.2582 | 5 | 108 | heparin binding |
GO:0043395 | 0.0097 | 15.6287 | 0.1514 | 2 | 13 | heparan sulfate proteoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 7.2582 | 7.8884 | 44 | 360 | sequence-specific DNA binding |
GO:0000975 | 0 | 2.9958 | 10.8134 | 29 | 469 | regulatory region DNA binding |
GO:0000981 | 0 | 3.4637 | 6.4003 | 20 | 285 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0003700 | 0 | 2.6622 | 12.091 | 29 | 567 | sequence-specific DNA binding transcription factor activity |
GO:0000976 | 0 | 3.0781 | 7.1244 | 20 | 309 | transcription regulatory region sequence-specific DNA binding |
GO:0004871 | 1e-04 | 2.0448 | 22.088 | 41 | 958 | signal transducer activity |
GO:0001077 | 1e-04 | 4.103 | 3.2279 | 12 | 140 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0004872 | 2e-04 | 2.0426 | 19.8054 | 37 | 859 | receptor activity |
GO:0000978 | 3e-04 | 3.6168 | 3.6199 | 12 | 157 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0005230 | 4e-04 | 5.937 | 1.3373 | 7 | 58 | extracellular ligand-gated ion channel activity |
GO:0003680 | 4e-04 | 32.1064 | 0.1614 | 3 | 7 | AT DNA binding |
GO:0001012 | 4e-04 | 2.8252 | 6.1099 | 16 | 265 | RNA polymerase II regulatory region DNA binding |
GO:0001159 | 5e-04 | 3.3806 | 3.8504 | 12 | 167 | core promoter proximal region DNA binding |
GO:0003682 | 8e-04 | 2.4144 | 8.4386 | 19 | 366 | chromatin binding |
GO:0050997 | 0.001 | 10.7295 | 0.4611 | 4 | 20 | quaternary ammonium group binding |
GO:0008188 | 0.001 | 7.4181 | 0.7839 | 5 | 34 | neuropeptide receptor activity |
GO:0003705 | 0.0011 | 5.6777 | 1.1881 | 6 | 52 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity |
GO:0046982 | 0.0014 | 2.4236 | 7.4933 | 17 | 325 | protein heterodimerization activity |
GO:0022834 | 0.0015 | 3.6135 | 2.6976 | 9 | 117 | ligand-gated channel activity |
GO:0022824 | 0.0016 | 85.3357 | 0.0692 | 2 | 3 | transmitter-gated ion channel activity |
GO:0036122 | 0.0016 | 85.3357 | 0.0692 | 2 | 3 | BMP binding |
GO:0008083 | 0.0017 | 3.5472 | 2.7437 | 9 | 119 | growth factor activity |
GO:0003676 | 0.0018 | 1.4714 | 73.6652 | 96 | 3195 | nucleic acid binding |
GO:0001047 | 0.0019 | 3.8463 | 2.2595 | 8 | 98 | core promoter binding |
GO:0035198 | 0.0023 | 14.2636 | 0.2767 | 3 | 12 | miRNA binding |
GO:0004930 | 0.0026 | 2.3508 | 7.2397 | 16 | 314 | G-protein coupled receptor activity |
GO:0004888 | 0.0028 | 2.4074 | 6.6318 | 15 | 297 | transmembrane signaling receptor activity |
GO:0070700 | 0.0031 | 42.6643 | 0.0922 | 2 | 4 | BMP receptor binding |
GO:0005216 | 0.0035 | 2.2726 | 7.4703 | 16 | 324 | ion channel activity |
GO:0008762 | 0.0051 | 28.4405 | 0.1153 | 2 | 5 | UDP-N-acetylmuramate dehydrogenase activity |
GO:0015277 | 0.0051 | 28.4405 | 0.1153 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0070888 | 0.0053 | 6.3524 | 0.7147 | 4 | 31 | E-box binding |
GO:0071837 | 0.0054 | 9.8715 | 0.3689 | 3 | 16 | HMG box domain binding |
GO:0005125 | 0.0057 | 3.1708 | 2.6976 | 8 | 117 | cytokine activity |
GO:0005215 | 0.0059 | 1.6566 | 22.503 | 35 | 976 | transporter activity |
GO:0005184 | 0.0065 | 9.1657 | 0.392 | 3 | 17 | neuropeptide hormone activity |
GO:0015267 | 0.0067 | 2.1105 | 8.0006 | 16 | 347 | channel activity |
GO:0048027 | 0.0075 | 21.3286 | 0.1383 | 2 | 6 | mRNA 5'-UTR binding |
GO:0005267 | 0.0088 | 3.2096 | 2.3287 | 7 | 101 | potassium channel activity |
GO:0001205 | 0.0089 | 8.0186 | 0.4381 | 3 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0005104 | 0.0089 | 8.0186 | 0.4381 | 3 | 19 | fibroblast growth factor receptor binding |
GO:0015370 | 0.0091 | 5.3577 | 0.83 | 4 | 36 | solute:sodium symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004982 | 3e-04 | Inf | 0.0371 | 2 | 2 | N-formyl peptide receptor activity |
GO:0004984 | 0.0016 | 16.0912 | 0.2408 | 3 | 13 | olfactory receptor activity |
GO:0038023 | 0.0047 | 1.9131 | 12.82 | 23 | 692 | signaling receptor activity |
GO:0004930 | 0.0057 | 2.3656 | 5.8172 | 13 | 314 | G-protein coupled receptor activity |
GO:0050840 | 0.0068 | 5.8114 | 0.7596 | 4 | 41 | extracellular matrix binding |
GO:0005520 | 0.0085 | 8.0389 | 0.4261 | 3 | 23 | insulin-like growth factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 290.6667 | 0.1578 | 10 | 13 | olfactory receptor activity |
GO:0038023 | 0 | 3.9912 | 8.3974 | 28 | 692 | signaling receptor activity |
GO:0004930 | 0 | 5.4891 | 3.8104 | 18 | 314 | G-protein coupled receptor activity |
GO:0060089 | 0 | 3.0396 | 11.6253 | 30 | 958 | molecular transducer activity |
GO:0032393 | 0 | 83.0476 | 0.0728 | 3 | 6 | MHC class I receptor activity |
GO:0005232 | 1e-04 | Inf | 0.0243 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 1e-04 | Inf | 0.0243 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0004993 | 3e-04 | 31.1301 | 0.1335 | 3 | 11 | serotonin receptor activity |
GO:0047760 | 9e-04 | 82.4932 | 0.0485 | 2 | 4 | butyrate-CoA ligase activity |
GO:0047961 | 9e-04 | 82.4932 | 0.0485 | 2 | 4 | glycine N-acyltransferase activity |
GO:0030246 | 0.0019 | 3.8085 | 2.2571 | 8 | 186 | carbohydrate binding |
GO:0034594 | 0.0021 | 41.2399 | 0.0728 | 2 | 6 | phosphatidylinositol trisphosphate phosphatase activity |
GO:0003810 | 0.0039 | 27.4887 | 0.0971 | 2 | 8 | protein-glutamine gamma-glutamyltransferase activity |
GO:0008157 | 0.005 | 23.5598 | 0.1092 | 2 | 9 | protein phosphatase 1 binding |
GO:0005230 | 0.0053 | 6.1679 | 0.7038 | 4 | 58 | extracellular ligand-gated ion channel activity |
GO:0005216 | 0.0061 | 2.7063 | 3.9317 | 10 | 324 | ion channel activity |
GO:0004745 | 0.0089 | 16.4878 | 0.1456 | 2 | 12 | retinol dehydrogenase activity |
GO:0042288 | 0.0089 | 16.4878 | 0.1456 | 2 | 12 | MHC class I protein binding |
GO:0004252 | 0.009 | 4.1762 | 1.2742 | 5 | 105 | serine-type endopeptidase activity |
GO:0015267 | 0.0097 | 2.5167 | 4.2108 | 10 | 347 | channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 3e-04 | Inf | 0.0345 | 2 | 2 | leukotriene B4 receptor activity |
GO:0071855 | 3e-04 | 14.512 | 0.3446 | 4 | 20 | neuropeptide receptor binding |
GO:0008528 | 9e-04 | 5.0001 | 1.5336 | 7 | 89 | G-protein coupled peptide receptor activity |
GO:0005125 | 9e-04 | 4.3102 | 2.0161 | 8 | 117 | cytokine activity |
GO:0004953 | 0.0013 | 17.34 | 0.224 | 3 | 13 | icosanoid receptor activity |
GO:0016494 | 0.0017 | 57.564 | 0.0689 | 2 | 4 | C-X-C chemokine receptor activity |
GO:0019956 | 0.0017 | 57.564 | 0.0689 | 2 | 4 | chemokine binding |
GO:0031781 | 0.0017 | 57.564 | 0.0689 | 2 | 4 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0017 | 57.564 | 0.0689 | 2 | 4 | type 4 melanocortin receptor binding |
GO:0004871 | 0.0021 | 1.9033 | 16.5079 | 29 | 958 | signal transducer activity |
GO:0005381 | 0.0029 | 38.3728 | 0.0862 | 2 | 5 | iron ion transmembrane transporter activity |
GO:0004888 | 0.0044 | 2.0264 | 10.5285 | 20 | 611 | transmembrane signaling receptor activity |
GO:0005160 | 0.0053 | 9.627 | 0.3619 | 3 | 21 | transforming growth factor beta receptor binding |
GO:0005164 | 0.0053 | 9.627 | 0.3619 | 3 | 21 | tumor necrosis factor receptor binding |
GO:0008179 | 0.0059 | 23.0199 | 0.1206 | 2 | 7 | adenylate cyclase binding |
GO:0005102 | 0.0065 | 1.8168 | 14.7337 | 25 | 880 | receptor binding |
GO:0004872 | 0.0069 | 1.804 | 14.802 | 25 | 859 | receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.8645 | 14.524 | 36 | 859 | receptor activity |
GO:0004871 | 0 | 2.713 | 16.1979 | 38 | 958 | signal transducer activity |
GO:0022836 | 0 | 3.6961 | 4.4637 | 15 | 264 | gated channel activity |
GO:0004930 | 1e-04 | 3.2977 | 5.3091 | 16 | 314 | G-protein coupled receptor activity |
GO:0015464 | 1e-04 | 19.7398 | 0.2705 | 4 | 16 | acetylcholine receptor activity |
GO:0022838 | 2e-04 | 3.1254 | 5.5796 | 16 | 330 | substrate-specific channel activity |
GO:0015276 | 2e-04 | 5.0183 | 1.9782 | 9 | 117 | ligand-gated ion channel activity |
GO:0005261 | 3e-04 | 3.4229 | 4.1256 | 13 | 244 | cation channel activity |
GO:0022803 | 3e-04 | 2.9607 | 5.8671 | 16 | 347 | passive transmembrane transporter activity |
GO:0004888 | 6e-04 | 3.1135 | 4.5148 | 13 | 286 | transmembrane signaling receptor activity |
GO:0004970 | 0.0032 | 11.7835 | 0.3043 | 3 | 18 | ionotropic glutamate receptor activity |
GO:0005234 | 0.0032 | 11.7835 | 0.3043 | 3 | 18 | extracellular-glutamate-gated ion channel activity |
GO:0031681 | 0.0074 | 19.5588 | 0.1353 | 2 | 8 | G-protein beta-subunit binding |
GO:0005231 | 0.008 | 8.1382 | 0.4172 | 3 | 25 | excitatory extracellular ligand-gated ion channel activity |
GO:0019992 | 0.0095 | 16.7633 | 0.1522 | 2 | 9 | diacylglycerol binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 2.7139 | 11.1405 | 27 | 692 | signaling receptor activity |
GO:0060089 | 0 | 2.415 | 15.4229 | 33 | 958 | molecular transducer activity |
GO:0004930 | 2e-04 | 3.2344 | 5.0551 | 15 | 314 | G-protein coupled receptor activity |
GO:0051431 | 8e-04 | 123.4619 | 0.0483 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0016901 | 0.0015 | 61.7259 | 0.0644 | 2 | 4 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0004252 | 0.0015 | 4.4881 | 1.6904 | 7 | 105 | serine-type endopeptidase activity |
GO:0001664 | 0.0016 | 3.5759 | 2.7046 | 9 | 168 | G-protein coupled receptor binding |
GO:0071837 | 0.002 | 14.3042 | 0.2576 | 3 | 16 | HMG box domain binding |
GO:0005184 | 0.0024 | 13.2813 | 0.2737 | 3 | 17 | neuropeptide hormone activity |
GO:0004896 | 0.0027 | 5.6734 | 0.9659 | 5 | 60 | cytokine receptor activity |
GO:0005125 | 0.0028 | 3.9945 | 1.8836 | 7 | 117 | cytokine activity |
GO:0015103 | 0.0035 | 4.4171 | 1.465 | 6 | 91 | inorganic anion transmembrane transporter activity |
GO:0017171 | 0.0041 | 3.7212 | 2.0124 | 7 | 125 | serine hydrolase activity |
GO:0016493 | 0.0051 | 24.6843 | 0.1127 | 2 | 7 | C-C chemokine receptor activity |
GO:0005179 | 0.006 | 6.005 | 0.7304 | 4 | 46 | hormone activity |
GO:0042277 | 0.0062 | 3.4277 | 2.1734 | 7 | 135 | peptide binding |
GO:0005254 | 0.0097 | 5.1769 | 0.8371 | 4 | 52 | chloride channel activity |
GO:0001228 | 0.0099 | 2.8525 | 2.9622 | 8 | 184 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046873 | 2e-04 | 3.1891 | 5.1258 | 15 | 330 | metal ion transmembrane transporter activity |
GO:0015267 | 3e-04 | 3.0215 | 5.3899 | 15 | 347 | channel activity |
GO:0005179 | 4e-04 | 6.8546 | 0.9786 | 6 | 63 | hormone activity |
GO:0005216 | 5e-04 | 3.0088 | 5.0326 | 14 | 324 | ion channel activity |
GO:0015077 | 9e-04 | 3.1273 | 4.1317 | 12 | 266 | monovalent inorganic cation transmembrane transporter activity |
GO:0032395 | 0.0023 | 42.6877 | 0.0777 | 2 | 5 | MHC class II receptor activity |
GO:0008527 | 0.0035 | 32.0132 | 0.0932 | 2 | 6 | taste receptor activity |
GO:0008324 | 0.0048 | 2.1995 | 7.7508 | 16 | 499 | cation transmembrane transporter activity |
GO:0005267 | 0.0049 | 4.0998 | 1.5688 | 6 | 101 | potassium channel activity |
GO:0015293 | 0.0049 | 4.0998 | 1.5688 | 6 | 101 | symporter activity |
GO:0022891 | 0.0052 | 1.9988 | 10.702 | 20 | 689 | substrate-specific transmembrane transporter activity |
GO:0038023 | 0.0055 | 1.9894 | 10.7486 | 20 | 692 | signaling receptor activity |
GO:0003823 | 0.0055 | 6.1434 | 0.7145 | 4 | 46 | antigen binding |
GO:0004252 | 0.0059 | 3.9329 | 1.6309 | 6 | 105 | serine-type endopeptidase activity |
GO:0005031 | 0.0063 | 21.3386 | 0.1243 | 2 | 8 | tumor necrosis factor-activated receptor activity |
GO:0060089 | 0.0072 | 1.8028 | 14.8803 | 25 | 958 | molecular transducer activity |
GO:0005215 | 0.009 | 1.7659 | 15.1599 | 25 | 976 | transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 3.3093 | 14.1014 | 40 | 673 | sequence-specific DNA binding |
GO:0001071 | 1e-04 | 2.1073 | 19.3606 | 37 | 924 | nucleic acid binding transcription factor activity |
GO:0005185 | 4e-04 | Inf | 0.0419 | 2 | 2 | neurohypophyseal hormone activity |
GO:0031894 | 4e-04 | Inf | 0.0419 | 2 | 2 | V1A vasopressin receptor binding |
GO:0000981 | 5e-04 | 2.5995 | 7.4593 | 18 | 356 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0001205 | 6e-04 | 12.64 | 0.3981 | 4 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0001664 | 8e-04 | 3.3746 | 3.5201 | 11 | 168 | G-protein coupled receptor binding |
GO:0004954 | 0.0013 | 17.7158 | 0.2305 | 3 | 11 | prostanoid receptor activity |
GO:0005179 | 0.002 | 5.0114 | 1.32 | 6 | 63 | hormone activity |
GO:0004871 | 0.0032 | 1.7644 | 20.073 | 33 | 958 | signal transducer activity |
GO:0004957 | 0.0042 | 31.3852 | 0.1048 | 2 | 5 | prostaglandin E receptor activity |
GO:0043237 | 0.0042 | 31.3852 | 0.1048 | 2 | 5 | laminin-1 binding |
GO:0035326 | 0.0042 | 4.2599 | 1.5296 | 6 | 73 | enhancer binding |
GO:0004888 | 0.0048 | 1.9084 | 12.8023 | 23 | 611 | transmembrane signaling receptor activity |
GO:0004872 | 0.0074 | 1.7124 | 17.9986 | 29 | 859 | receptor activity |
GO:0046983 | 0.0081 | 1.6992 | 18.1243 | 29 | 865 | protein dimerization activity |
GO:0008395 | 0.0086 | 18.828 | 0.1467 | 2 | 7 | steroid hydroxylase activity |
GO:0045499 | 0.0086 | 18.828 | 0.1467 | 2 | 7 | chemorepellent activity |
GO:0008028 | 0.0091 | 7.8672 | 0.44 | 3 | 21 | monocarboxylic acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 190.2136 | 0.1167 | 8 | 13 | olfactory receptor activity |
GO:0004872 | 0 | 5.595 | 7.7137 | 32 | 859 | receptor activity |
GO:0004930 | 0 | 7.8165 | 2.8197 | 18 | 314 | G-protein coupled receptor activity |
GO:0004871 | 0 | 3.9079 | 8.6027 | 27 | 958 | signal transducer activity |
GO:0005232 | 1e-04 | Inf | 0.018 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 1e-04 | Inf | 0.018 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0004993 | 1e-04 | 42.5069 | 0.0988 | 3 | 11 | serotonin receptor activity |
GO:0003823 | 8e-04 | 10.866 | 0.4131 | 4 | 46 | antigen binding |
GO:0004888 | 0.0021 | 3.7989 | 2.2928 | 8 | 297 | transmembrane signaling receptor activity |
GO:0008157 | 0.0028 | 32.0917 | 0.0808 | 2 | 9 | protein phosphatase 1 binding |
GO:0005044 | 0.0037 | 10.6059 | 0.3143 | 3 | 35 | scavenger receptor activity |
GO:0042288 | 0.005 | 22.4587 | 0.1078 | 2 | 12 | MHC class I protein binding |
GO:0030246 | 0.0066 | 3.8317 | 1.6703 | 6 | 186 | carbohydrate binding |
GO:0030169 | 0.0068 | 18.7125 | 0.1257 | 2 | 14 | low-density lipoprotein particle binding |
GO:0005216 | 0.0087 | 2.9333 | 2.9095 | 8 | 324 | ion channel activity |
GO:0032396 | 0.0088 | Inf | 0.0088 | 1 | 1 | inhibitory MHC class I receptor activity |
GO:0004963 | 0.009 | Inf | 0.009 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0008336 | 0.009 | Inf | 0.009 | 1 | 1 | gamma-butyrobetaine dioxygenase activity |
GO:0018685 | 0.009 | Inf | 0.009 | 1 | 1 | alkane 1-monooxygenase activity |
GO:0019807 | 0.009 | Inf | 0.009 | 1 | 1 | aspartoacylase activity |
GO:0030107 | 0.009 | Inf | 0.009 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
GO:0031721 | 0.009 | Inf | 0.009 | 1 | 1 | hemoglobin alpha binding |
GO:0050051 | 0.009 | Inf | 0.009 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
GO:0052869 | 0.009 | Inf | 0.009 | 1 | 1 | arachidonic acid omega-hydroxylase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004982 | 3e-04 | Inf | 0.0341 | 2 | 2 | N-formyl peptide receptor activity |
GO:0004984 | 0.0012 | 17.5096 | 0.2219 | 3 | 13 | olfactory receptor activity |
GO:0038023 | 0.0017 | 2.0995 | 11.8123 | 23 | 692 | signaling receptor activity |
GO:0060089 | 0.0018 | 1.9246 | 16.3529 | 29 | 958 | molecular transducer activity |
GO:0004930 | 0.0029 | 2.5846 | 5.3599 | 13 | 314 | G-protein coupled receptor activity |
GO:0042605 | 0.0052 | 9.7212 | 0.3585 | 3 | 21 | peptide antigen binding |
GO:0005518 | 0.0077 | 5.5707 | 0.7852 | 4 | 46 | collagen binding |
GO:0043236 | 0.0086 | 7.951 | 0.4267 | 3 | 25 | laminin binding |
GO:0004252 | 0.0092 | 3.5627 | 1.7923 | 6 | 105 | serine-type endopeptidase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044707 | 0 | 1.7084 | 82.9007 | 115 | 2886 | single-multicellular organism process |
GO:0001990 | 0 | 12.132 | 0.6712 | 6 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:0021527 | 0 | 17.9271 | 0.4271 | 5 | 14 | spinal cord association neuron differentiation |
GO:0048663 | 1e-04 | 5.8611 | 1.8 | 9 | 59 | neuron fate commitment |
GO:0001991 | 1e-04 | 25.7412 | 0.2746 | 4 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0021510 | 1e-04 | 4.9419 | 2.3187 | 10 | 76 | spinal cord development |
GO:0002003 | 1e-04 | 96.2541 | 0.122 | 3 | 4 | angiotensin maturation |
GO:0002065 | 1e-04 | 5.3255 | 1.9526 | 9 | 64 | columnar/cuboidal epithelial cell differentiation |
GO:0008284 | 2e-04 | 2.2126 | 14.7968 | 30 | 485 | positive regulation of cell proliferation |
GO:0007399 | 2e-04 | 1.7151 | 42.9564 | 66 | 1408 | nervous system development |
GO:0035883 | 2e-04 | 11.5187 | 0.5797 | 5 | 19 | enteroendocrine cell differentiation |
GO:0060177 | 3e-04 | 48.1221 | 0.1525 | 3 | 5 | regulation of angiotensin metabolic process |
GO:0048839 | 3e-04 | 3.4336 | 4.1797 | 13 | 137 | inner ear development |
GO:0030154 | 3e-04 | 1.6423 | 51.613 | 75 | 1761 | cell differentiation |
GO:0060429 | 4e-04 | 1.9298 | 21.4477 | 38 | 703 | epithelium development |
GO:0048699 | 6e-04 | 1.7852 | 28.1291 | 46 | 922 | generation of neurons |
GO:0006811 | 6e-04 | 1.8171 | 25.7799 | 43 | 845 | ion transport |
GO:0048565 | 8e-04 | 3.6981 | 2.9899 | 10 | 98 | digestive tract development |
GO:0030001 | 9e-04 | 2.1027 | 13.3323 | 26 | 437 | metal ion transport |
GO:0007267 | 9e-04 | 2.4841 | 7.8389 | 18 | 266 | cell-cell signaling |
GO:0031018 | 9e-04 | 6.0561 | 1.1593 | 6 | 38 | endocrine pancreas development |
GO:0003008 | 9e-04 | 1.7666 | 26.4206 | 43 | 866 | system process |
GO:0007517 | 9e-04 | 2.54 | 7.2306 | 17 | 237 | muscle organ development |
GO:0072359 | 0.0018 | 1.8682 | 17.8171 | 31 | 584 | circulatory system development |
GO:0009790 | 0.0019 | 1.7663 | 22.546 | 37 | 739 | embryo development |
GO:0042490 | 0.0026 | 4.841 | 1.4034 | 6 | 46 | mechanoreceptor differentiation |
GO:0033058 | 0.0027 | 63.961 | 0.0915 | 2 | 3 | directional locomotion |
GO:0060018 | 0.0027 | 63.961 | 0.0915 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0027 | 63.961 | 0.0915 | 2 | 3 | transdifferentiation |
GO:0018146 | 0.0028 | 8.0351 | 0.6102 | 4 | 20 | keratan sulfate biosynthetic process |
GO:0030890 | 0.0028 | 8.0351 | 0.6102 | 4 | 20 | positive regulation of B cell proliferation |
GO:0009887 | 0.0028 | 2.0356 | 11.553 | 22 | 388 | organ morphogenesis |
GO:0003073 | 0.0029 | 4.7224 | 1.4339 | 6 | 47 | regulation of systemic arterial blood pressure |
GO:0021521 | 0.0029 | 13.7422 | 0.3051 | 3 | 10 | ventral spinal cord interneuron specification |
GO:0060218 | 0.0029 | 13.7422 | 0.3051 | 3 | 10 | hematopoietic stem cell differentiation |
GO:0065008 | 0.0031 | 1.4664 | 59.2481 | 79 | 1942 | regulation of biological quality |
GO:0007155 | 0.0032 | 1.7748 | 19.2816 | 32 | 632 | cell adhesion |
GO:0048729 | 0.0035 | 1.9966 | 11.7459 | 22 | 385 | tissue morphogenesis |
GO:0007218 | 0.0035 | 3.9007 | 1.9831 | 7 | 65 | neuropeptide signaling pathway |
GO:0048731 | 0.0036 | 1.7097 | 23.5943 | 37 | 884 | system development |
GO:0045597 | 0.0037 | 1.9225 | 13.3018 | 24 | 436 | positive regulation of cell differentiation |
GO:0010922 | 0.0039 | 12.0232 | 0.3356 | 3 | 11 | positive regulation of phosphatase activity |
GO:0001708 | 0.0042 | 3.7699 | 2.0441 | 7 | 67 | cell fate specification |
GO:0007423 | 0.0042 | 1.9962 | 11.1967 | 21 | 367 | sensory organ development |
GO:0050885 | 0.0044 | 5.193 | 1.0983 | 5 | 36 | neuromuscular process controlling balance |
GO:0050896 | 0.0046 | 1.3591 | 140.0049 | 163 | 4589 | response to stimulus |
GO:0021513 | 0.0048 | 6.7644 | 0.7017 | 4 | 23 | spinal cord dorsal/ventral patterning |
GO:0050864 | 0.0048 | 4.207 | 1.5865 | 6 | 52 | regulation of B cell activation |
GO:0021542 | 0.005 | 10.6862 | 0.3661 | 3 | 12 | dentate gyrus development |
GO:0042491 | 0.0056 | 6.4255 | 0.7322 | 4 | 24 | auditory receptor cell differentiation |
GO:0050670 | 0.0057 | 3.1952 | 2.7153 | 8 | 89 | regulation of lymphocyte proliferation |
GO:0018958 | 0.0058 | 4.0308 | 1.6475 | 6 | 54 | phenol-containing compound metabolic process |
GO:0007498 | 0.0061 | 3.1559 | 2.7458 | 8 | 90 | mesoderm development |
GO:0016486 | 0.0062 | 9.7105 | 0.3929 | 3 | 13 | peptide hormone processing |
GO:0055085 | 0.0063 | 1.6368 | 23.4308 | 36 | 768 | transmembrane transport |
GO:0003323 | 0.0064 | 9.6166 | 0.3966 | 3 | 13 | type B pancreatic cell development |
GO:0010043 | 0.0065 | 6.1189 | 0.7627 | 4 | 25 | response to zinc ion |
GO:0006928 | 0.007 | 1.5321 | 32.8275 | 47 | 1076 | cellular component movement |
GO:0070663 | 0.0074 | 3.0436 | 2.8373 | 8 | 93 | regulation of leukocyte proliferation |
GO:0048562 | 0.0075 | 2.2145 | 6.7119 | 14 | 220 | embryonic organ morphogenesis |
GO:0030203 | 0.0076 | 2.8023 | 3.4475 | 9 | 113 | glycosaminoglycan metabolic process |
GO:0044767 | 0.0077 | 1.4283 | 59.1427 | 76 | 2154 | single-organism developmental process |
GO:2000026 | 0.0078 | 1.5655 | 27.9156 | 41 | 915 | regulation of multicellular organismal development |
GO:0010894 | 0.008 | 8.7415 | 0.4271 | 3 | 14 | negative regulation of steroid biosynthetic process |
GO:0016339 | 0.008 | 8.7415 | 0.4271 | 3 | 14 | calcium-dependent cell-cell adhesion |
GO:0042430 | 0.008 | 8.7415 | 0.4271 | 3 | 14 | indole-containing compound metabolic process |
GO:0060581 | 0.008 | 8.7415 | 0.4271 | 3 | 14 | cell fate commitment involved in pattern specification |
GO:0090190 | 0.008 | 8.7415 | 0.4271 | 3 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0007268 | 0.0081 | 1.7706 | 14.9493 | 25 | 490 | synaptic transmission |
GO:0007507 | 0.0084 | 1.9693 | 9.6713 | 18 | 317 | heart development |
GO:0001755 | 0.0086 | 5.5857 | 0.8237 | 4 | 27 | neural crest cell migration |
GO:0021522 | 0.0086 | 5.5857 | 0.8237 | 4 | 27 | spinal cord motor neuron differentiation |
GO:0007166 | 0.0087 | 1.4102 | 55.282 | 72 | 1812 | cell surface receptor signaling pathway |
GO:0001778 | 0.0087 | 21.316 | 0.1525 | 2 | 5 | plasma membrane repair |
GO:0045086 | 0.0087 | 21.316 | 0.1525 | 2 | 5 | positive regulation of interleukin-2 biosynthetic process |
GO:2000675 | 0.0087 | 21.316 | 0.1525 | 2 | 5 | negative regulation of type B pancreatic cell apoptotic process |
GO:0007519 | 0.0089 | 2.7229 | 3.539 | 9 | 116 | skeletal muscle tissue development |
GO:0032943 | 0.0089 | 2.7229 | 3.539 | 9 | 116 | mononuclear cell proliferation |
GO:0007200 | 0.0095 | 4.2334 | 1.3119 | 5 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0007156 | 0.0095 | 3.1823 | 2.3797 | 7 | 78 | homophilic cell adhesion |
GO:0015672 | 0.0098 | 2.0235 | 8.3594 | 16 | 274 | monovalent inorganic cation transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 2e-04 | 33.5592 | 0.1289 | 3 | 10 | keratinization |
GO:0019731 | 0.001 | 77.7364 | 0.0516 | 2 | 4 | antibacterial humoral response |
GO:0048525 | 0.0013 | 9.5414 | 0.477 | 4 | 37 | negative regulation of viral process |
GO:0002227 | 0.0016 | 51.8191 | 0.0645 | 2 | 5 | innate immune response in mucosa |
GO:2000059 | 0.0024 | 38.8605 | 0.0774 | 2 | 6 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0002251 | 0.0044 | 25.9018 | 0.1031 | 2 | 8 | organ or tissue specific immune response |
GO:0006333 | 0.0058 | 4.6986 | 1.1474 | 5 | 89 | chromatin assembly or disassembly |
GO:0043011 | 0.0069 | 19.4225 | 0.1289 | 2 | 10 | myeloid dendritic cell differentiation |
GO:0006334 | 0.0074 | 5.6097 | 0.7735 | 4 | 60 | nucleosome assembly |
GO:0050907 | 0.0084 | 17.2627 | 0.1418 | 2 | 11 | detection of chemical stimulus involved in sensory perception |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048706 | 1e-04 | 4.7358 | 2.3748 | 10 | 95 | embryonic skeletal system development |
GO:0050900 | 2e-04 | 3.6316 | 3.9496 | 13 | 158 | leukocyte migration |
GO:0060231 | 2e-04 | 17.5964 | 0.325 | 4 | 13 | mesenchymal to epithelial transition |
GO:2000026 | 3e-04 | 2.4751 | 9.7286 | 22 | 414 | regulation of multicellular organismal development |
GO:0000904 | 3e-04 | 2.1677 | 14.6236 | 29 | 585 | cell morphogenesis involved in differentiation |
GO:0072001 | 3e-04 | 3.1883 | 4.7995 | 14 | 192 | renal system development |
GO:0007159 | 3e-04 | 9.9267 | 0.6249 | 5 | 25 | leukocyte cell-cell adhesion |
GO:0048870 | 4e-04 | 2.023 | 17.8482 | 33 | 714 | cell motility |
GO:0048646 | 4e-04 | 2.0427 | 17.1233 | 32 | 685 | anatomical structure formation involved in morphogenesis |
GO:0052652 | 5e-04 | 4.7761 | 1.8748 | 8 | 75 | cyclic purine nucleotide metabolic process |
GO:0071637 | 6e-04 | Inf | 0.05 | 2 | 2 | regulation of monocyte chemotactic protein-1 production |
GO:0060562 | 0.0013 | 2.6289 | 6.1494 | 15 | 246 | epithelial tube morphogenesis |
GO:0045597 | 0.0014 | 2.5245 | 6.8286 | 16 | 280 | positive regulation of cell differentiation |
GO:0048729 | 0.0016 | 2.2344 | 9.6241 | 20 | 385 | tissue morphogenesis |
GO:2000027 | 0.0018 | 3.5312 | 2.7747 | 9 | 111 | regulation of organ morphogenesis |
GO:0007190 | 0.002 | 8.7902 | 0.5499 | 4 | 22 | activation of adenylate cyclase activity |
GO:0045165 | 0.002 | 2.8402 | 4.5496 | 12 | 182 | cell fate commitment |
GO:0008217 | 0.0021 | 3.8029 | 2.2998 | 8 | 92 | regulation of blood pressure |
GO:0019371 | 0.0022 | 14.7893 | 0.275 | 3 | 11 | cyclooxygenase pathway |
GO:0045986 | 0.0022 | 14.7893 | 0.275 | 3 | 11 | negative regulation of smooth muscle contraction |
GO:0030819 | 0.0024 | 6.0083 | 0.9499 | 5 | 38 | positive regulation of cAMP biosynthetic process |
GO:0048513 | 0.0025 | 1.5402 | 47.6203 | 66 | 1905 | organ development |
GO:0009792 | 0.0025 | 2.0599 | 11.4489 | 22 | 458 | embryo development ending in birth or egg hatching |
GO:0048699 | 0.0026 | 1.7382 | 23.0477 | 37 | 922 | generation of neurons |
GO:0001676 | 0.0026 | 4.7695 | 1.3999 | 6 | 56 | long-chain fatty acid metabolic process |
GO:0048485 | 0.0029 | 13.1448 | 0.3 | 3 | 12 | sympathetic nervous system development |
GO:0001667 | 0.003 | 2.8481 | 4.1496 | 11 | 166 | ameboidal cell migration |
GO:0006636 | 0.003 | 5.6638 | 0.9999 | 5 | 40 | unsaturated fatty acid biosynthetic process |
GO:0060284 | 0.003 | 2.2531 | 8.0724 | 17 | 331 | regulation of cell development |
GO:0009266 | 0.003 | 3.9826 | 1.9248 | 7 | 77 | response to temperature stimulus |
GO:0014014 | 0.0032 | 7.5322 | 0.6249 | 4 | 25 | negative regulation of gliogenesis |
GO:0044707 | 0.0032 | 1.4537 | 82.4799 | 103 | 3421 | single-multicellular organism process |
GO:0009152 | 0.0034 | 2.9666 | 3.6246 | 10 | 145 | purine ribonucleotide biosynthetic process |
GO:0031622 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | positive regulation of fever generation |
GO:0035860 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | glial cell-derived neurotrophic factor receptor signaling pathway |
GO:0060708 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | spongiotrophoblast differentiation |
GO:0007566 | 0.0037 | 7.1891 | 0.6499 | 4 | 26 | embryo implantation |
GO:0007389 | 0.0039 | 2.1914 | 8.2742 | 17 | 331 | pattern specification process |
GO:0072073 | 0.0042 | 3.3588 | 2.5747 | 8 | 103 | kidney epithelium development |
GO:0007267 | 0.0042 | 1.7606 | 18.8981 | 31 | 756 | cell-cell signaling |
GO:0045664 | 0.0043 | 2.2294 | 7.6492 | 16 | 306 | regulation of neuron differentiation |
GO:0001759 | 0.0046 | 10.7526 | 0.35 | 3 | 14 | organ induction |
GO:0051482 | 0.0046 | 10.7526 | 0.35 | 3 | 14 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0030810 | 0.0046 | 5.0808 | 1.0999 | 5 | 44 | positive regulation of nucleotide biosynthetic process |
GO:0051960 | 0.0047 | 2.0157 | 10.574 | 20 | 423 | regulation of nervous system development |
GO:0043542 | 0.005 | 3.618 | 2.0998 | 7 | 84 | endothelial cell migration |
GO:0007409 | 0.0051 | 2.0382 | 9.924 | 19 | 397 | axonogenesis |
GO:0045596 | 0.0055 | 2.0643 | 9.2741 | 18 | 371 | negative regulation of cell differentiation |
GO:0048705 | 0.0055 | 2.7592 | 3.8746 | 10 | 155 | skeletal system morphogenesis |
GO:0031281 | 0.0055 | 6.3245 | 0.7249 | 4 | 29 | positive regulation of cyclase activity |
GO:0030801 | 0.0056 | 4.832 | 1.1499 | 5 | 46 | positive regulation of cyclic nucleotide metabolic process |
GO:0042119 | 0.0056 | 9.8556 | 0.375 | 3 | 15 | neutrophil activation |
GO:0010720 | 0.0057 | 2.74 | 3.8996 | 10 | 156 | positive regulation of cell development |
GO:0002689 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | negative regulation of leukocyte chemotaxis |
GO:0003180 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | aortic valve morphogenesis |
GO:0034114 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | regulation of heterotypic cell-cell adhesion |
GO:0045636 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | positive regulation of melanocyte differentiation |
GO:0051414 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | response to cortisol |
GO:0001656 | 0.006 | 3.9706 | 1.6498 | 6 | 66 | metanephros development |
GO:0009952 | 0.006 | 2.7211 | 3.9246 | 10 | 157 | anterior/posterior pattern specification |
GO:0023056 | 0.0061 | 1.727 | 18.5732 | 30 | 743 | positive regulation of signaling |
GO:0014033 | 0.0061 | 4.7165 | 1.1749 | 5 | 47 | neural crest cell differentiation |
GO:0046390 | 0.0063 | 2.7024 | 3.9496 | 10 | 158 | ribose phosphate biosynthetic process |
GO:0010647 | 0.0064 | 1.7192 | 18.6482 | 30 | 746 | positive regulation of cell communication |
GO:0048869 | 0.0065 | 1.4593 | 52.3578 | 69 | 2159 | cellular developmental process |
GO:0072522 | 0.0066 | 2.684 | 3.9746 | 10 | 159 | purine-containing compound biosynthetic process |
GO:0051349 | 0.0071 | 5.8548 | 0.7749 | 4 | 31 | positive regulation of lyase activity |
GO:0035295 | 0.0077 | 1.9163 | 11.0739 | 20 | 443 | tube development |
GO:0046456 | 0.0079 | 5.6451 | 0.7999 | 4 | 32 | icosanoid biosynthetic process |
GO:0048701 | 0.0079 | 5.6451 | 0.7999 | 4 | 32 | embryonic cranial skeleton morphogenesis |
GO:0050729 | 0.0079 | 5.6451 | 0.7999 | 4 | 32 | positive regulation of inflammatory response |
GO:0061005 | 0.0079 | 5.6451 | 0.7999 | 4 | 32 | cell differentiation involved in kidney development |
GO:0035336 | 0.0081 | 8.4459 | 0.425 | 3 | 17 | long-chain fatty-acyl-CoA metabolic process |
GO:0090132 | 0.0081 | 2.9785 | 2.8747 | 8 | 115 | epithelium migration |
GO:0007155 | 0.0083 | 1.7502 | 15.7984 | 26 | 632 | cell adhesion |
GO:0007417 | 0.0084 | 1.7685 | 15.0235 | 25 | 601 | central nervous system development |
GO:0031650 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | regulation of heat generation |
GO:0032656 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | regulation of interleukin-13 production |
GO:0042761 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | very long-chain fatty acid biosynthetic process |
GO:0050965 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | detection of temperature stimulus involved in sensory perception of pain |
GO:0003018 | 0.0091 | 3.1988 | 2.3498 | 7 | 94 | vascular process in circulatory system |
GO:0044702 | 0.0098 | 1.7256 | 16.0089 | 26 | 649 | single organism reproductive process |
GO:0090183 | 0.0098 | 5.2677 | 0.8499 | 4 | 34 | regulation of kidney development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050680 | 2e-04 | 6.4457 | 1.2263 | 7 | 70 | negative regulation of epithelial cell proliferation |
GO:0048704 | 2e-04 | 6.3444 | 1.2438 | 7 | 71 | embryonic skeletal system morphogenesis |
GO:1900747 | 3e-04 | Inf | 0.035 | 2 | 2 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0051271 | 7e-04 | 4.5587 | 1.927 | 8 | 110 | negative regulation of cellular component movement |
GO:0055085 | 9e-04 | 2.1303 | 13.4538 | 26 | 768 | transmembrane transport |
GO:2000611 | 9e-04 | 113.4318 | 0.0526 | 2 | 3 | positive regulation of thyroid hormone generation |
GO:0044724 | 0.0014 | 4.6029 | 1.6642 | 7 | 95 | single-organism carbohydrate catabolic process |
GO:0040013 | 0.0014 | 4.0381 | 2.1547 | 8 | 123 | negative regulation of locomotion |
GO:0050715 | 0.0015 | 9.1568 | 0.508 | 4 | 29 | positive regulation of cytokine secretion |
GO:0090288 | 0.0016 | 5.2415 | 1.2613 | 6 | 72 | negative regulation of cellular response to growth factor stimulus |
GO:0048818 | 0.0018 | 56.7102 | 0.0701 | 2 | 4 | positive regulation of hair follicle maturation |
GO:0048015 | 0.0019 | 3.8355 | 2.2598 | 8 | 129 | phosphatidylinositol-mediated signaling |
GO:0030336 | 0.0024 | 4.1291 | 1.8394 | 7 | 105 | negative regulation of cell migration |
GO:0015833 | 0.0032 | 3.2083 | 3.0131 | 9 | 172 | peptide transport |
GO:0071705 | 0.004 | 2.2544 | 7.6203 | 16 | 435 | nitrogen compound transport |
GO:0021546 | 0.0044 | 28.3494 | 0.1051 | 2 | 6 | rhombomere development |
GO:0061085 | 0.0044 | 28.3494 | 0.1051 | 2 | 6 | regulation of histone H3-K27 methylation |
GO:0060828 | 0.0044 | 3.6742 | 2.0496 | 7 | 117 | regulation of canonical Wnt signaling pathway |
GO:0009914 | 0.005 | 2.9847 | 3.2233 | 9 | 184 | hormone transport |
GO:0048638 | 0.0052 | 4.0621 | 1.5941 | 6 | 91 | regulation of developmental growth |
GO:0042060 | 0.0054 | 2.2397 | 7.1648 | 15 | 409 | wound healing |
GO:0060986 | 0.0056 | 9.4905 | 0.3679 | 3 | 21 | endocrine hormone secretion |
GO:0072577 | 0.0056 | 9.4905 | 0.3679 | 3 | 21 | endothelial cell apoptotic process |
GO:0005981 | 0.006 | 22.6773 | 0.1226 | 2 | 7 | regulation of glycogen catabolic process |
GO:0035414 | 0.006 | 22.6773 | 0.1226 | 2 | 7 | negative regulation of catenin import into nucleus |
GO:0060856 | 0.006 | 22.6773 | 0.1226 | 2 | 7 | establishment of blood-brain barrier |
GO:1902547 | 0.006 | 22.6773 | 0.1226 | 2 | 7 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0030072 | 0.0063 | 3.1059 | 2.7503 | 8 | 157 | peptide hormone secretion |
GO:0031952 | 0.0064 | 8.9901 | 0.3854 | 3 | 22 | regulation of protein autophosphorylation |
GO:0045773 | 0.0064 | 8.9901 | 0.3854 | 3 | 22 | positive regulation of axon extension |
GO:0031032 | 0.0066 | 5.8615 | 0.7533 | 4 | 43 | actomyosin structure organization |
GO:0048857 | 0.0072 | 5.7144 | 0.7708 | 4 | 44 | neural nucleus development |
GO:0071695 | 0.0072 | 5.7144 | 0.7708 | 4 | 44 | anatomical structure maturation |
GO:0032350 | 0.0072 | 8.5397 | 0.4029 | 3 | 23 | regulation of hormone metabolic process |
GO:0033240 | 0.008 | 18.8958 | 0.1401 | 2 | 8 | positive regulation of cellular amine metabolic process |
GO:0072182 | 0.008 | 18.8958 | 0.1401 | 2 | 8 | regulation of nephron tubule epithelial cell differentiation |
GO:0051234 | 0.0082 | 1.4913 | 48.0868 | 63 | 2745 | establishment of localization |
GO:0032940 | 0.0093 | 1.9984 | 9.0743 | 17 | 518 | secretion by cell |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 1e-04 | 6.5084 | 1.3971 | 8 | 78 | homophilic cell adhesion |
GO:0046602 | 9e-04 | 110.8667 | 0.0537 | 2 | 3 | regulation of mitotic centrosome separation |
GO:0007200 | 0.001 | 7.39 | 0.7702 | 5 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0050848 | 0.0032 | 11.9294 | 0.3045 | 3 | 17 | regulation of calcium-mediated signaling |
GO:0042178 | 0.0046 | 27.7083 | 0.1075 | 2 | 6 | xenobiotic catabolic process |
GO:0051299 | 0.0046 | 27.7083 | 0.1075 | 2 | 6 | centrosome separation |
GO:0006508 | 0.0056 | 1.8496 | 14.6159 | 25 | 816 | proteolysis |
GO:0001955 | 0.0063 | 22.1644 | 0.1254 | 2 | 7 | blood vessel maturation |
GO:0006307 | 0.0063 | 22.1644 | 0.1254 | 2 | 7 | DNA dealkylation involved in DNA repair |
GO:0043900 | 0.0065 | 2.8645 | 3.3495 | 9 | 187 | regulation of multi-organism process |
GO:0048265 | 0.0068 | 8.7857 | 0.3941 | 3 | 22 | response to pain |
GO:0030574 | 0.0098 | 5.1926 | 0.8418 | 4 | 47 | collagen catabolic process |
GO:0044259 | 0.0098 | 4.1172 | 1.3075 | 5 | 73 | multicellular organismal macromolecule metabolic process |
GO:0050792 | 0.0099 | 3.5096 | 1.827 | 6 | 102 | regulation of viral process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060444 | 0 | 21.5565 | 0.3469 | 5 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0060443 | 1e-04 | 9.9765 | 0.7401 | 6 | 32 | mammary gland morphogenesis |
GO:0003008 | 1e-04 | 2.1541 | 18.6456 | 36 | 820 | system process |
GO:0050911 | 1e-04 | 64.1638 | 0.1156 | 3 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0044700 | 1e-04 | 1.6499 | 78.7728 | 106 | 3406 | single organism signaling |
GO:0022610 | 1e-04 | 2.2626 | 14.6398 | 30 | 633 | biological adhesion |
GO:0007154 | 2e-04 | 1.6314 | 80.2529 | 107 | 3470 | cell communication |
GO:0070830 | 2e-04 | 8.101 | 0.8789 | 6 | 38 | tight junction assembly |
GO:0098602 | 2e-04 | 3.0393 | 5.7588 | 16 | 249 | single organism cell adhesion |
GO:0030903 | 2e-04 | 17.1706 | 0.3238 | 4 | 14 | notochord development |
GO:0007606 | 3e-04 | 7.6229 | 0.9251 | 6 | 40 | sensory perception of chemical stimulus |
GO:0010839 | 4e-04 | 32.0754 | 0.1619 | 3 | 7 | negative regulation of keratinocyte proliferation |
GO:0033598 | 4e-04 | 14.3059 | 0.37 | 4 | 16 | mammary gland epithelial cell proliferation |
GO:0040007 | 5e-04 | 2.1588 | 13.6453 | 27 | 590 | growth |
GO:0010482 | 5e-04 | Inf | 0.0463 | 2 | 2 | regulation of epidermal cell division |
GO:0034329 | 6e-04 | 3.5615 | 3.3766 | 11 | 146 | cell junction assembly |
GO:0060485 | 6e-04 | 3.5615 | 3.3766 | 11 | 146 | mesenchyme development |
GO:0003334 | 6e-04 | 25.6578 | 0.185 | 3 | 8 | keratinocyte development |
GO:0045821 | 6e-04 | 25.6578 | 0.185 | 3 | 8 | positive regulation of glycolytic process |
GO:0010959 | 6e-04 | 3.5088 | 3.4229 | 11 | 148 | regulation of metal ion transport |
GO:0030857 | 7e-04 | 12.2597 | 0.4163 | 4 | 18 | negative regulation of epithelial cell differentiation |
GO:0016477 | 7e-04 | 2.0563 | 15.3799 | 29 | 665 | cell migration |
GO:0072009 | 9e-04 | 6.0219 | 1.1333 | 6 | 49 | nephron epithelium development |
GO:0018212 | 0.0011 | 2.9222 | 4.8106 | 13 | 208 | peptidyl-tyrosine modification |
GO:0007605 | 0.0011 | 4.2308 | 2.0815 | 8 | 90 | sensory perception of sound |
GO:0085029 | 0.0013 | 18.3233 | 0.2313 | 3 | 10 | extracellular matrix assembly |
GO:0030104 | 0.0015 | 9.5315 | 0.5088 | 4 | 22 | water homeostasis |
GO:0048708 | 0.0015 | 6.7215 | 0.8557 | 5 | 37 | astrocyte differentiation |
GO:0071383 | 0.0016 | 4.5177 | 1.7114 | 7 | 74 | cellular response to steroid hormone stimulus |
GO:0072034 | 0.0016 | 85.1931 | 0.0694 | 2 | 3 | renal vesicle induction |
GO:0050678 | 0.0016 | 3.0957 | 3.8392 | 11 | 166 | regulation of epithelial cell proliferation |
GO:0050730 | 0.0016 | 3.5866 | 2.7291 | 9 | 118 | regulation of peptidyl-tyrosine phosphorylation |
GO:0045216 | 0.0017 | 3.2976 | 3.2841 | 10 | 142 | cell-cell junction organization |
GO:0033561 | 0.0018 | 16.0312 | 0.2544 | 3 | 11 | regulation of water loss via skin |
GO:0051674 | 0.0021 | 1.8991 | 16.5131 | 29 | 714 | localization of cell |
GO:0051496 | 0.0024 | 8.1674 | 0.5782 | 4 | 25 | positive regulation of stress fiber assembly |
GO:0032501 | 0.0025 | 1.4661 | 89.5965 | 111 | 3874 | multicellular organismal process |
GO:0002009 | 0.0025 | 2.3686 | 7.239 | 16 | 313 | morphogenesis of an epithelium |
GO:0002064 | 0.0026 | 3.3243 | 2.9248 | 9 | 128 | epithelial cell development |
GO:0032879 | 0.0027 | 1.6657 | 28.9096 | 44 | 1250 | regulation of localization |
GO:0043062 | 0.0027 | 2.6077 | 5.3425 | 13 | 231 | extracellular structure organization |
GO:0001954 | 0.0028 | 7.7954 | 0.6013 | 4 | 26 | positive regulation of cell-matrix adhesion |
GO:0090316 | 0.0028 | 4.0326 | 1.8965 | 7 | 82 | positive regulation of intracellular protein transport |
GO:0033137 | 0.0029 | 12.8224 | 0.3007 | 3 | 13 | negative regulation of peptidyl-serine phosphorylation |
GO:0072202 | 0.0029 | 12.8224 | 0.3007 | 3 | 13 | cell differentiation involved in metanephros development |
GO:0014031 | 0.0029 | 3.5711 | 2.4284 | 8 | 105 | mesenchymal cell development |
GO:0098656 | 0.0029 | 3.5711 | 2.4284 | 8 | 105 | anion transmembrane transport |
GO:0071495 | 0.0032 | 1.8803 | 15.4493 | 27 | 668 | cellular response to endogenous stimulus |
GO:0040011 | 0.0034 | 1.7359 | 21.8325 | 35 | 944 | locomotion |
GO:0006915 | 0.0034 | 1.6667 | 26.7818 | 41 | 1158 | apoptotic process |
GO:0072659 | 0.0035 | 3.4629 | 2.4978 | 8 | 108 | protein localization to plasma membrane |
GO:0007169 | 0.0036 | 1.9976 | 11.7951 | 22 | 510 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:1902476 | 0.0036 | 5.3728 | 1.0407 | 5 | 45 | chloride transmembrane transport |
GO:0009593 | 0.0037 | 7.1443 | 0.6476 | 4 | 28 | detection of chemical stimulus |
GO:0030858 | 0.0037 | 7.1443 | 0.6476 | 4 | 28 | positive regulation of epithelial cell differentiation |
GO:0072091 | 0.0038 | 4.3818 | 1.5033 | 6 | 65 | regulation of stem cell proliferation |
GO:0003014 | 0.004 | 5.2413 | 1.0639 | 5 | 46 | renal system process |
GO:0072210 | 0.0042 | 6.8578 | 0.6707 | 4 | 29 | metanephric nephron development |
GO:0009913 | 0.0045 | 3.6857 | 2.0584 | 7 | 89 | epidermal cell differentiation |
GO:0071392 | 0.0045 | 10.6832 | 0.3469 | 3 | 15 | cellular response to estradiol stimulus |
GO:0009653 | 0.0049 | 1.5476 | 37.5824 | 53 | 1625 | anatomical structure morphogenesis |
GO:0008283 | 0.0053 | 1.6292 | 26.5968 | 40 | 1150 | cell proliferation |
GO:0034109 | 0.0053 | 4.8824 | 1.1333 | 5 | 49 | homotypic cell-cell adhesion |
GO:0032862 | 0.0055 | 9.8604 | 0.37 | 3 | 16 | activation of Rho GTPase activity |
GO:0072170 | 0.0055 | 9.8604 | 0.37 | 3 | 16 | metanephric tubule development |
GO:0008219 | 0.0057 | 1.5813 | 30.9448 | 45 | 1338 | cell death |
GO:0021675 | 0.0058 | 4.7734 | 1.1564 | 5 | 50 | nerve development |
GO:0048731 | 0.006 | 1.447 | 60.4788 | 78 | 2615 | system development |
GO:0046824 | 0.0063 | 4.6692 | 1.1795 | 5 | 51 | positive regulation of nucleocytoplasmic transport |
GO:0001502 | 0.0065 | 9.1552 | 0.3932 | 3 | 17 | cartilage condensation |
GO:0003203 | 0.0065 | 9.1552 | 0.3932 | 3 | 17 | endocardial cushion morphogenesis |
GO:0045684 | 0.0065 | 9.1552 | 0.3932 | 3 | 17 | positive regulation of epidermis development |
GO:0030036 | 0.0065 | 2.1245 | 8.0022 | 16 | 346 | actin cytoskeleton organization |
GO:0090090 | 0.0067 | 3.8554 | 1.6883 | 6 | 73 | negative regulation of canonical Wnt signaling pathway |
GO:0021983 | 0.0067 | 5.9095 | 0.7632 | 4 | 33 | pituitary gland development |
GO:0046661 | 0.0067 | 3.3934 | 2.2203 | 7 | 96 | male sex differentiation |
GO:0051239 | 0.007 | 1.5528 | 32.1706 | 46 | 1391 | regulation of multicellular organismal process |
GO:0048863 | 0.0072 | 2.3963 | 5.3194 | 12 | 230 | stem cell differentiation |
GO:0007166 | 0.0074 | 1.4909 | 41.9073 | 57 | 1812 | cell surface receptor signaling pathway |
GO:0060576 | 0.0075 | 21.2918 | 0.1388 | 2 | 6 | intestinal epithelial cell development |
GO:0032652 | 0.0077 | 8.544 | 0.4163 | 3 | 18 | regulation of interleukin-1 production |
GO:0046825 | 0.0077 | 8.544 | 0.4163 | 3 | 18 | regulation of protein export from nucleus |
GO:0042391 | 0.0079 | 2.3631 | 5.3887 | 12 | 233 | regulation of membrane potential |
GO:0071230 | 0.0083 | 5.5272 | 0.8095 | 4 | 35 | cellular response to amino acid stimulus |
GO:0006928 | 0.0087 | 1.5984 | 24.8853 | 37 | 1076 | cellular component movement |
GO:0007600 | 0.0089 | 2.3231 | 5.4755 | 12 | 242 | sensory perception |
GO:0060487 | 0.009 | 8.0092 | 0.4394 | 3 | 19 | lung epithelial cell differentiation |
GO:1902743 | 0.009 | 8.0092 | 0.4394 | 3 | 19 | regulation of lamellipodium organization |
GO:0042446 | 0.0092 | 5.3539 | 0.8326 | 4 | 36 | hormone biosynthetic process |
GO:0007156 | 0.0092 | 3.5859 | 1.804 | 6 | 78 | homophilic cell adhesion |
GO:0008584 | 0.0092 | 3.5859 | 1.804 | 6 | 78 | male gonad development |
GO:0009968 | 0.0094 | 1.7743 | 14.3854 | 24 | 622 | negative regulation of signal transduction |
GO:0051050 | 0.0097 | 1.9807 | 9.0892 | 17 | 393 | positive regulation of transport |
GO:0008544 | 0.01 | 3.5182 | 1.8347 | 6 | 81 | epidermis development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045165 | 0 | 3.8514 | 4.9615 | 17 | 182 | cell fate commitment |
GO:0003002 | 1e-04 | 2.9592 | 7.0606 | 19 | 259 | regionalization |
GO:0071294 | 1e-04 | 24.1221 | 0.2726 | 4 | 10 | cellular response to zinc ion |
GO:0042403 | 2e-04 | 20.674 | 0.2999 | 4 | 11 | thyroid hormone metabolic process |
GO:0060023 | 2e-04 | 54.0985 | 0.1363 | 3 | 5 | soft palate development |
GO:0009190 | 2e-04 | 4.9205 | 2.0718 | 9 | 76 | cyclic nucleotide biosynthetic process |
GO:0060429 | 4e-04 | 1.9953 | 19.1646 | 35 | 703 | epithelium development |
GO:0003211 | 4e-04 | 36.062 | 0.1636 | 3 | 6 | cardiac ventricle formation |
GO:0001764 | 4e-04 | 4.0757 | 2.7261 | 10 | 100 | neuron migration |
GO:0060562 | 4e-04 | 2.7567 | 6.7062 | 17 | 246 | epithelial tube morphogenesis |
GO:0042753 | 6e-04 | 27.0438 | 0.1908 | 3 | 7 | positive regulation of circadian rhythm |
GO:0030199 | 7e-04 | 8.2403 | 0.736 | 5 | 27 | collagen fibril organization |
GO:0019448 | 7e-04 | Inf | 0.0545 | 2 | 2 | L-cysteine catabolic process |
GO:0002088 | 8e-04 | 6.2303 | 1.1177 | 6 | 41 | lens development in camera-type eye |
GO:0060415 | 8e-04 | 6.2303 | 1.1177 | 6 | 41 | muscle tissue morphogenesis |
GO:0022008 | 0.001 | 1.7692 | 26.525 | 43 | 973 | neurogenesis |
GO:0048870 | 0.001 | 1.8938 | 19.4644 | 34 | 714 | cell motility |
GO:0032501 | 0.001 | 1.4721 | 105.6095 | 131 | 3874 | multicellular organismal process |
GO:0071276 | 0.001 | 21.6328 | 0.2181 | 3 | 8 | cellular response to cadmium ion |
GO:0009887 | 0.0011 | 1.9555 | 16.5747 | 30 | 608 | organ morphogenesis |
GO:0007586 | 0.0013 | 4.7195 | 1.6629 | 7 | 61 | digestion |
GO:0003206 | 0.0013 | 4.1104 | 2.1536 | 8 | 79 | cardiac chamber morphogenesis |
GO:0006171 | 0.0017 | 4.4697 | 1.7447 | 7 | 64 | cAMP biosynthetic process |
GO:0021537 | 0.0017 | 3.0788 | 3.8711 | 11 | 142 | telencephalon development |
GO:0007218 | 0.0019 | 4.3922 | 1.772 | 7 | 65 | neuropeptide signaling pathway |
GO:0007517 | 0.0021 | 2.4917 | 6.4609 | 15 | 237 | muscle organ development |
GO:0051464 | 0.0022 | 71.8764 | 0.0818 | 2 | 3 | positive regulation of cortisol secretion |
GO:0003008 | 0.0022 | 1.739 | 23.6081 | 38 | 866 | system process |
GO:0045666 | 0.0022 | 4.2449 | 1.8265 | 7 | 67 | positive regulation of neuron differentiation |
GO:0035295 | 0.0023 | 2.0404 | 12.0767 | 23 | 443 | tube development |
GO:0003231 | 0.0026 | 4.1072 | 1.881 | 7 | 69 | cardiac ventricle development |
GO:0003214 | 0.0028 | 13.5164 | 0.2999 | 3 | 11 | cardiac left ventricle morphogenesis |
GO:0021692 | 0.0028 | 13.5164 | 0.2999 | 3 | 11 | cerebellar Purkinje cell layer morphogenesis |
GO:0030878 | 0.0028 | 13.5164 | 0.2999 | 3 | 11 | thyroid gland development |
GO:0048712 | 0.0028 | 13.5164 | 0.2999 | 3 | 11 | negative regulation of astrocyte differentiation |
GO:0001756 | 0.003 | 4.6339 | 1.4448 | 6 | 53 | somitogenesis |
GO:0021953 | 0.0033 | 3.5224 | 2.4727 | 8 | 92 | central nervous system neuron differentiation |
GO:0030510 | 0.0033 | 4.5369 | 1.4721 | 6 | 54 | regulation of BMP signaling pathway |
GO:0032502 | 0.0036 | 1.4099 | 93.3693 | 115 | 3425 | developmental process |
GO:0003215 | 0.0037 | 12.0134 | 0.3271 | 3 | 12 | cardiac right ventricle morphogenesis |
GO:0021542 | 0.0037 | 12.0134 | 0.3271 | 3 | 12 | dentate gyrus development |
GO:0043010 | 0.0038 | 2.7543 | 4.2846 | 11 | 160 | camera-type eye development |
GO:0003257 | 0.0043 | 35.9345 | 0.109 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0006534 | 0.0043 | 35.9345 | 0.109 | 2 | 4 | cysteine metabolic process |
GO:0072086 | 0.0043 | 35.9345 | 0.109 | 2 | 4 | specification of loop of Henle identity |
GO:2000848 | 0.0043 | 35.9345 | 0.109 | 2 | 4 | positive regulation of corticosteroid hormone secretion |
GO:0014014 | 0.0044 | 6.8816 | 0.6815 | 4 | 25 | negative regulation of gliogenesis |
GO:0000097 | 0.0047 | 10.8109 | 0.3544 | 3 | 13 | sulfur amino acid biosynthetic process |
GO:0060841 | 0.0047 | 10.8109 | 0.3544 | 3 | 13 | venous blood vessel development |
GO:0021879 | 0.0049 | 5.0286 | 1.1177 | 5 | 41 | forebrain neuron differentiation |
GO:0021761 | 0.0052 | 4.9412 | 1.1341 | 5 | 42 | limbic system development |
GO:0007178 | 0.0053 | 2.3965 | 5.7794 | 13 | 212 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0016331 | 0.0055 | 2.9567 | 3.2713 | 9 | 120 | morphogenesis of embryonic epithelium |
GO:0007423 | 0.0055 | 2.018 | 10.0048 | 19 | 367 | sensory organ development |
GO:0048665 | 0.0058 | 6.2819 | 0.736 | 4 | 27 | neuron fate specification |
GO:0021854 | 0.0058 | 9.8271 | 0.3817 | 3 | 14 | hypothalamus development |
GO:0051412 | 0.0058 | 9.8271 | 0.3817 | 3 | 14 | response to corticosterone |
GO:0001501 | 0.0062 | 2.0817 | 8.669 | 17 | 318 | skeletal system development |
GO:0060485 | 0.0066 | 2.6845 | 3.9801 | 10 | 146 | mesenchyme development |
GO:0055010 | 0.0066 | 6.0195 | 0.7633 | 4 | 28 | ventricular cardiac muscle tissue morphogenesis |
GO:0003278 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | apoptotic process involved in heart morphogenesis |
GO:0015669 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | gas transport |
GO:0015824 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | proline transport |
GO:0035360 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0035881 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | amacrine cell differentiation |
GO:0060017 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | parathyroid gland development |
GO:0072047 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:2000252 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | negative regulation of feeding behavior |
GO:2000609 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000849 | 0.007 | 23.9539 | 0.1363 | 2 | 5 | regulation of glucocorticoid secretion |
GO:0055074 | 0.0071 | 2.5133 | 4.6616 | 11 | 171 | calcium ion homeostasis |
GO:0060284 | 0.0072 | 1.8383 | 13.2762 | 23 | 487 | regulation of cell development |
GO:0021515 | 0.0073 | 4.5239 | 1.2267 | 5 | 45 | cell differentiation in spinal cord |
GO:0048513 | 0.0077 | 1.6062 | 25.5315 | 38 | 1016 | organ development |
GO:0045471 | 0.0084 | 3.6869 | 1.772 | 6 | 65 | response to ethanol |
GO:0072091 | 0.0084 | 3.6869 | 1.772 | 6 | 65 | regulation of stem cell proliferation |
GO:0003151 | 0.0087 | 4.3076 | 1.2813 | 5 | 47 | outflow tract morphogenesis |
GO:0006954 | 0.0092 | 2.0944 | 7.5786 | 15 | 278 | inflammatory response |
GO:2000026 | 0.0095 | 1.5813 | 24.9439 | 37 | 915 | regulation of multicellular organismal development |
GO:0060038 | 0.0095 | 5.3491 | 0.8451 | 4 | 31 | cardiac muscle cell proliferation |
GO:0021549 | 0.0097 | 3.5653 | 1.8265 | 6 | 67 | cerebellum development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042472 | 0 | 8.4257 | 2.418 | 16 | 79 | inner ear morphogenesis |
GO:0022008 | 0 | 3.0105 | 17.1173 | 44 | 596 | neurogenesis |
GO:0007423 | 0 | 3.5719 | 10.7093 | 33 | 354 | sensory organ development |
GO:0007389 | 0 | 3.9996 | 8.1354 | 28 | 274 | pattern specification process |
GO:0001655 | 0 | 4.3738 | 6.6724 | 25 | 218 | urogenital system development |
GO:0006355 | 0 | 1.9603 | 71.4373 | 113 | 2334 | regulation of transcription, DNA-templated |
GO:0021510 | 0 | 7.4417 | 2.3261 | 14 | 76 | spinal cord development |
GO:0000904 | 0 | 2.7554 | 17.9052 | 43 | 585 | cell morphogenesis involved in differentiation |
GO:0021527 | 0 | 32.3783 | 0.4285 | 7 | 14 | spinal cord association neuron differentiation |
GO:0048562 | 0 | 4.9518 | 4.4892 | 19 | 149 | embryonic organ morphogenesis |
GO:0007268 | 0 | 2.8941 | 14.9975 | 38 | 490 | synaptic transmission |
GO:0051252 | 0 | 1.8974 | 73.9471 | 114 | 2416 | regulation of RNA metabolic process |
GO:0031326 | 0 | 1.8391 | 82.058 | 122 | 2681 | regulation of cellular biosynthetic process |
GO:0045944 | 0 | 2.5562 | 18.6398 | 42 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0010628 | 0 | 2.2545 | 27.9138 | 55 | 912 | positive regulation of gene expression |
GO:0045666 | 0 | 7.1475 | 2.0507 | 12 | 67 | positive regulation of neuron differentiation |
GO:0009888 | 0 | 2.3406 | 24.0012 | 49 | 852 | tissue development |
GO:0010556 | 0 | 1.7874 | 79.64 | 117 | 2602 | regulation of macromolecule biosynthetic process |
GO:0050767 | 0 | 2.9238 | 11.5389 | 30 | 377 | regulation of neurogenesis |
GO:0009952 | 0 | 4.3987 | 4.4303 | 17 | 146 | anterior/posterior pattern specification |
GO:0051094 | 0 | 2.5346 | 16.8709 | 38 | 561 | positive regulation of developmental process |
GO:0009790 | 0 | 2.4245 | 18.5657 | 40 | 626 | embryo development |
GO:1902680 | 0 | 2.1458 | 26.8119 | 51 | 876 | positive regulation of RNA biosynthetic process |
GO:0048731 | 0 | 2.013 | 37.0256 | 63 | 1463 | system development |
GO:2000026 | 0 | 2.2267 | 22.2005 | 44 | 758 | regulation of multicellular organismal development |
GO:0007166 | 0 | 1.7991 | 55.4603 | 86 | 1812 | cell surface receptor signaling pathway |
GO:0045935 | 0 | 2.0364 | 30.4542 | 55 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009891 | 0 | 1.999 | 31.556 | 56 | 1031 | positive regulation of biosynthetic process |
GO:0031214 | 0 | 5.6961 | 2.2649 | 11 | 74 | biomineral tissue development |
GO:0051171 | 0 | 1.6507 | 91.9135 | 126 | 3003 | regulation of nitrogen compound metabolic process |
GO:0072358 | 0 | 2.2966 | 17.8746 | 37 | 584 | cardiovascular system development |
GO:0007155 | 0 | 2.2383 | 19.3438 | 39 | 632 | cell adhesion |
GO:0072163 | 0 | 5.4356 | 2.3568 | 11 | 77 | mesonephric epithelium development |
GO:0030901 | 0 | 10.2865 | 0.8876 | 7 | 29 | midbrain development |
GO:0044271 | 0 | 1.6531 | 85.8533 | 119 | 2805 | cellular nitrogen compound biosynthetic process |
GO:0050789 | 0 | 1.6752 | 190.683 | 225 | 6230 | regulation of biological process |
GO:0040007 | 0 | 2.2702 | 18.0583 | 37 | 590 | growth |
GO:0030182 | 0 | 2.234 | 18.9319 | 38 | 670 | neuron differentiation |
GO:0001714 | 0 | 42.7666 | 0.2143 | 4 | 7 | endodermal cell fate specification |
GO:0019438 | 0 | 1.6411 | 84.5984 | 117 | 2764 | aromatic compound biosynthetic process |
GO:0080090 | 0 | 1.6031 | 114.471 | 149 | 3740 | regulation of primary metabolic process |
GO:0018130 | 0 | 1.6361 | 84.782 | 117 | 2770 | heterocycle biosynthetic process |
GO:1901362 | 0 | 1.6247 | 86.8939 | 119 | 2839 | organic cyclic compound biosynthetic process |
GO:0032989 | 1e-04 | 1.9923 | 26.1692 | 47 | 855 | cellular component morphogenesis |
GO:0048592 | 1e-04 | 4.3523 | 3.1219 | 12 | 102 | eye morphogenesis |
GO:0001763 | 1e-04 | 3.5404 | 4.7135 | 15 | 154 | morphogenesis of a branching structure |
GO:0048732 | 1e-04 | 2.8043 | 8.2319 | 21 | 272 | gland development |
GO:0060042 | 1e-04 | 10.2736 | 0.7585 | 6 | 25 | retina morphogenesis in camera-type eye |
GO:2000027 | 1e-04 | 4.1921 | 3.2251 | 12 | 106 | regulation of organ morphogenesis |
GO:0045165 | 1e-04 | 5.5264 | 1.8832 | 9 | 65 | cell fate commitment |
GO:0072172 | 1e-04 | 95.9318 | 0.1224 | 3 | 4 | mesonephric tubule formation |
GO:0048736 | 1e-04 | 3.793 | 3.8259 | 13 | 125 | appendage development |
GO:0007517 | 1e-04 | 2.875 | 7.2539 | 19 | 237 | muscle organ development |
GO:0060548 | 1e-04 | 2.2145 | 15.3036 | 31 | 500 | negative regulation of cell death |
GO:0022414 | 2e-04 | 1.9758 | 22.7718 | 41 | 744 | reproductive process |
GO:0007417 | 2e-04 | 2.1926 | 15.4611 | 31 | 525 | central nervous system development |
GO:0009653 | 2e-04 | 2.8071 | 7.4586 | 19 | 290 | anatomical structure morphogenesis |
GO:0007267 | 2e-04 | 2.7714 | 7.5088 | 19 | 266 | cell-cell signaling |
GO:0034645 | 2e-04 | 1.5345 | 97.4228 | 127 | 3183 | cellular macromolecule biosynthetic process |
GO:0061217 | 2e-04 | 11.4799 | 0.5815 | 5 | 19 | regulation of mesonephros development |
GO:0048858 | 2e-04 | 2.0715 | 17.9052 | 34 | 585 | cell projection morphogenesis |
GO:0050954 | 2e-04 | 4.0214 | 3.0607 | 11 | 100 | sensory perception of mechanical stimulus |
GO:0048839 | 2e-04 | 5.5391 | 1.668 | 8 | 57 | inner ear development |
GO:0001568 | 2e-04 | 2.3974 | 10.8962 | 24 | 356 | blood vessel development |
GO:0050957 | 3e-04 | 47.961 | 0.153 | 3 | 5 | equilibrioception |
GO:0060527 | 3e-04 | 47.961 | 0.153 | 3 | 5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:2000675 | 3e-04 | 47.961 | 0.153 | 3 | 5 | negative regulation of type B pancreatic cell apoptotic process |
GO:0021761 | 3e-04 | 5.3916 | 1.714 | 8 | 56 | limbic system development |
GO:0050885 | 3e-04 | 7.8064 | 0.9401 | 6 | 31 | neuromuscular process controlling balance |
GO:0030855 | 3e-04 | 2.847 | 6.5216 | 17 | 220 | epithelial cell differentiation |
GO:0048663 | 3e-04 | 7.5922 | 0.9599 | 6 | 32 | neuron fate commitment |
GO:0035116 | 4e-04 | 10.0429 | 0.6428 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0050982 | 4e-04 | 10.0429 | 0.6428 | 5 | 21 | detection of mechanical stimulus |
GO:0060560 | 4e-04 | 3.8055 | 3.2138 | 11 | 105 | developmental growth involved in morphogenesis |
GO:0035987 | 4e-04 | 7.433 | 0.9794 | 6 | 32 | endodermal cell differentiation |
GO:0002009 | 4e-04 | 2.5233 | 8.6065 | 20 | 285 | morphogenesis of an epithelium |
GO:0001822 | 4e-04 | 3.2812 | 4.352 | 13 | 144 | kidney development |
GO:0043410 | 4e-04 | 2.6643 | 7.3457 | 18 | 240 | positive regulation of MAPK cascade |
GO:0007610 | 4e-04 | 2.3459 | 10.6334 | 23 | 353 | behavior |
GO:0060079 | 4e-04 | 7.157 | 1.01 | 6 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0048745 | 5e-04 | 14.2468 | 0.3979 | 4 | 13 | smooth muscle tissue development |
GO:0071599 | 5e-04 | 14.2468 | 0.3979 | 4 | 13 | otic vesicle development |
GO:0051216 | 5e-04 | 3.3974 | 3.8871 | 12 | 127 | cartilage development |
GO:0021796 | 5e-04 | 31.9708 | 0.1836 | 3 | 6 | cerebral cortex regionalization |
GO:2000543 | 5e-04 | 31.9708 | 0.1836 | 3 | 6 | positive regulation of gastrulation |
GO:0035115 | 6e-04 | 8.9252 | 0.704 | 5 | 23 | embryonic forelimb morphogenesis |
GO:0048333 | 6e-04 | 8.9252 | 0.704 | 5 | 23 | mesodermal cell differentiation |
GO:0045595 | 6e-04 | 1.8052 | 26.5897 | 44 | 884 | regulation of cell differentiation |
GO:0032835 | 6e-04 | 6.6621 | 1.0713 | 6 | 35 | glomerulus development |
GO:0031175 | 7e-04 | 2.0291 | 15.997 | 30 | 530 | neuron projection development |
GO:0060795 | 7e-04 | 8.4546 | 0.7346 | 5 | 24 | cell fate commitment involved in formation of primary germ layer |
GO:0009887 | 7e-04 | 2.6041 | 7.0727 | 17 | 256 | organ morphogenesis |
GO:0060675 | 8e-04 | 5.2516 | 1.5304 | 7 | 50 | ureteric bud morphogenesis |
GO:0048864 | 8e-04 | 2.7854 | 5.846 | 15 | 191 | stem cell development |
GO:0032502 | 8e-04 | 1.7277 | 35.7812 | 54 | 1495 | developmental process |
GO:0007411 | 8e-04 | 2.4385 | 8.417 | 19 | 275 | axon guidance |
GO:0042391 | 8e-04 | 2.579 | 7.1315 | 17 | 233 | regulation of membrane potential |
GO:0048869 | 8e-04 | 1.6829 | 37.1427 | 56 | 1371 | cellular developmental process |
GO:0007205 | 8e-04 | 8.031 | 0.7652 | 5 | 25 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0009880 | 9e-04 | 11.7792 | 0.4545 | 4 | 15 | embryonic pattern specification |
GO:0033688 | 9e-04 | 11.6541 | 0.4591 | 4 | 15 | regulation of osteoblast proliferation |
GO:0060850 | 9e-04 | 11.6541 | 0.4591 | 4 | 15 | regulation of transcription involved in cell fate commitment |
GO:0035564 | 9e-04 | Inf | 0.0612 | 2 | 2 | regulation of kidney size |
GO:0042706 | 9e-04 | Inf | 0.0612 | 2 | 2 | eye photoreceptor cell fate commitment |
GO:0072166 | 9e-04 | Inf | 0.0612 | 2 | 2 | posterior mesonephric tubule development |
GO:0090185 | 9e-04 | Inf | 0.0612 | 2 | 2 | negative regulation of kidney development |
GO:0031018 | 9e-04 | 6.0357 | 1.1631 | 6 | 38 | endocrine pancreas development |
GO:0035270 | 0.001 | 6.0025 | 1.1653 | 6 | 39 | endocrine system development |
GO:0051093 | 0.001 | 2.0783 | 13.4745 | 26 | 443 | negative regulation of developmental process |
GO:0045937 | 0.001 | 1.9469 | 17.1707 | 31 | 561 | positive regulation of phosphate metabolic process |
GO:0040011 | 0.001 | 2.6103 | 6.6384 | 16 | 228 | locomotion |
GO:0048167 | 0.001 | 3.8841 | 2.571 | 9 | 84 | regulation of synaptic plasticity |
GO:0006029 | 0.0011 | 4.308 | 2.0813 | 8 | 68 | proteoglycan metabolic process |
GO:0035249 | 0.0011 | 4.9076 | 1.6222 | 7 | 53 | synaptic transmission, glutamatergic |
GO:0030902 | 0.0011 | 7.4413 | 0.8114 | 5 | 27 | hindbrain development |
GO:0048070 | 0.0012 | 10.6819 | 0.4897 | 4 | 16 | regulation of developmental pigmentation |
GO:0072078 | 0.0012 | 10.6819 | 0.4897 | 4 | 16 | nephron tubule morphogenesis |
GO:0072028 | 0.0012 | 7.2995 | 0.8264 | 5 | 27 | nephron morphogenesis |
GO:0035108 | 0.0012 | 3.4701 | 3.1642 | 10 | 104 | limb morphogenesis |
GO:0007548 | 0.0013 | 2.7499 | 5.5093 | 14 | 180 | sex differentiation |
GO:0009605 | 0.0013 | 1.6558 | 34.2121 | 52 | 1127 | response to external stimulus |
GO:0001525 | 0.0013 | 2.4512 | 7.4682 | 17 | 244 | angiogenesis |
GO:0010454 | 0.0014 | 19.1786 | 0.2449 | 3 | 8 | negative regulation of cell fate commitment |
GO:0030916 | 0.0014 | 19.1786 | 0.2449 | 3 | 8 | otic vesicle formation |
GO:0048793 | 0.0014 | 19.1786 | 0.2449 | 3 | 8 | pronephros development |
GO:0048665 | 0.0014 | 9.9494 | 0.5158 | 4 | 17 | neuron fate specification |
GO:0021871 | 0.0015 | 9.8592 | 0.5203 | 4 | 17 | forebrain regionalization |
GO:0030325 | 0.0015 | 9.8592 | 0.5203 | 4 | 17 | adrenal gland development |
GO:0034381 | 0.0015 | 9.8592 | 0.5203 | 4 | 17 | plasma lipoprotein particle clearance |
GO:0061448 | 0.0015 | 6.8814 | 0.8642 | 5 | 29 | connective tissue development |
GO:0043066 | 0.0016 | 1.9999 | 13.9504 | 26 | 460 | negative regulation of apoptotic process |
GO:0065008 | 0.0017 | 1.5523 | 48.3872 | 68 | 1646 | regulation of biological quality |
GO:0007492 | 0.0017 | 4.5132 | 1.7446 | 7 | 57 | endoderm development |
GO:0003044 | 0.0017 | 6.6898 | 0.8876 | 5 | 29 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0060563 | 0.0017 | 6.6898 | 0.8876 | 5 | 29 | neuroepithelial cell differentiation |
GO:0001667 | 0.0017 | 2.7649 | 5.0808 | 13 | 166 | ameboidal cell migration |
GO:0048638 | 0.0018 | 3.55 | 2.7853 | 9 | 91 | regulation of developmental growth |
GO:0021707 | 0.0021 | 15.9805 | 0.2755 | 3 | 9 | cerebellar granule cell differentiation |
GO:0050910 | 0.0021 | 15.9805 | 0.2755 | 3 | 9 | detection of mechanical stimulus involved in sensory perception of sound |
GO:0060219 | 0.0021 | 15.9805 | 0.2755 | 3 | 9 | camera-type eye photoreceptor cell differentiation |
GO:0060525 | 0.0021 | 15.9805 | 0.2755 | 3 | 9 | prostate glandular acinus development |
GO:0035239 | 0.0021 | 2.3409 | 7.7874 | 17 | 256 | tube morphogenesis |
GO:0044707 | 0.0021 | 2.0649 | 12.9402 | 24 | 628 | single-multicellular organism process |
GO:0016337 | 0.0022 | 2.4831 | 6.4887 | 15 | 212 | single organismal cell-cell adhesion |
GO:0055074 | 0.0023 | 2.676 | 5.2338 | 13 | 171 | calcium ion homeostasis |
GO:0035113 | 0.0023 | 3.4236 | 2.8771 | 9 | 94 | embryonic appendage morphogenesis |
GO:0001709 | 0.0023 | 6.174 | 0.9488 | 5 | 31 | cell fate determination |
GO:0021697 | 0.0023 | 8.5429 | 0.5815 | 4 | 19 | cerebellar cortex formation |
GO:0048565 | 0.0024 | 4.9323 | 1.3788 | 6 | 46 | digestive tract development |
GO:0007156 | 0.0026 | 3.6888 | 2.3874 | 8 | 78 | homophilic cell adhesion |
GO:0019218 | 0.0026 | 4.8246 | 1.4079 | 6 | 46 | regulation of steroid metabolic process |
GO:0042490 | 0.0026 | 4.8246 | 1.4079 | 6 | 46 | mechanoreceptor differentiation |
GO:0010623 | 0.0027 | 5.9447 | 0.9794 | 5 | 32 | developmental programmed cell death |
GO:0006935 | 0.0027 | 2.1252 | 10.059 | 20 | 334 | chemotaxis |
GO:0003406 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | retinal pigment epithelium development |
GO:0010269 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | response to selenium ion |
GO:0030910 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | olfactory placode formation |
GO:0032455 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | nerve growth factor processing |
GO:0033058 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | detection of glucose |
GO:0060018 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | transdifferentiation |
GO:0060421 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | positive regulation of heart growth |
GO:0061031 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0071698 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | olfactory placode development |
GO:0072180 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | mesonephric duct morphogenesis |
GO:0072197 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | ureter morphogenesis |
GO:1900212 | 0.0027 | 63.7476 | 0.0918 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:0022037 | 0.0028 | 3.6365 | 2.418 | 8 | 79 | metencephalon development |
GO:0009953 | 0.0028 | 4.0729 | 1.9078 | 7 | 63 | dorsal/ventral pattern formation |
GO:0060740 | 0.0028 | 8.0081 | 0.6121 | 4 | 20 | prostate gland epithelium morphogenesis |
GO:0072207 | 0.0028 | 8.0081 | 0.6121 | 4 | 20 | metanephric epithelium development |
GO:0021521 | 0.0029 | 13.6962 | 0.3061 | 3 | 10 | ventral spinal cord interneuron specification |
GO:0021683 | 0.0029 | 13.6962 | 0.3061 | 3 | 10 | cerebellar granular layer morphogenesis |
GO:0021794 | 0.0029 | 13.6962 | 0.3061 | 3 | 10 | thalamus development |
GO:0060602 | 0.0029 | 13.6962 | 0.3061 | 3 | 10 | branch elongation of an epithelium |
GO:0045665 | 0.0029 | 4.7064 | 1.4385 | 6 | 47 | negative regulation of neuron differentiation |
GO:0010720 | 0.003 | 2.7051 | 4.7747 | 12 | 156 | positive regulation of cell development |
GO:0019226 | 0.003 | 3.5856 | 2.4486 | 8 | 80 | transmission of nerve impulse |
GO:0071805 | 0.003 | 3.2684 | 2.9995 | 9 | 98 | potassium ion transmembrane transport |
GO:0021587 | 0.0031 | 5.7318 | 1.01 | 5 | 33 | cerebellum morphogenesis |
GO:0001503 | 0.0031 | 2.3096 | 7.4069 | 16 | 242 | ossification |
GO:0043010 | 0.0033 | 2.6657 | 4.8379 | 12 | 160 | camera-type eye development |
GO:0021846 | 0.0034 | 7.5363 | 0.6428 | 4 | 21 | cell proliferation in forebrain |
GO:0035235 | 0.0034 | 7.5363 | 0.6428 | 4 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0060441 | 0.0034 | 7.5363 | 0.6428 | 4 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0051130 | 0.0035 | 1.9317 | 13.2491 | 24 | 439 | positive regulation of cellular component organization |
GO:0007218 | 0.0036 | 3.8875 | 1.9895 | 7 | 65 | neuropeptide signaling pathway |
GO:0072091 | 0.0036 | 3.8875 | 1.9895 | 7 | 65 | regulation of stem cell proliferation |
GO:0010646 | 0.0036 | 1.4686 | 55.1236 | 74 | 1801 | regulation of cell communication |
GO:0021903 | 0.0039 | 11.983 | 0.3367 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0007369 | 0.0039 | 2.9168 | 3.7002 | 10 | 122 | gastrulation |
GO:0006813 | 0.0039 | 2.9149 | 3.7035 | 10 | 121 | potassium ion transport |
GO:0003407 | 0.0039 | 7.1827 | 0.6675 | 4 | 22 | neural retina development |
GO:0007269 | 0.0041 | 3.3955 | 2.571 | 8 | 84 | neurotransmitter secretion |
GO:0050920 | 0.0042 | 3.7571 | 2.0507 | 7 | 67 | regulation of chemotaxis |
GO:0002064 | 0.0044 | 2.8632 | 3.7631 | 10 | 124 | epithelial cell development |
GO:0007275 | 0.0045 | 2.5787 | 5.0304 | 12 | 230 | multicellular organismal development |
GO:0048754 | 0.0045 | 3.0632 | 3.179 | 9 | 105 | branching morphogenesis of an epithelial tube |
GO:0048645 | 0.0045 | 5.1755 | 1.1019 | 5 | 36 | organ formation |
GO:0007613 | 0.0046 | 3.6952 | 2.0813 | 7 | 68 | memory |
GO:0051240 | 0.0046 | 1.9779 | 11.2916 | 21 | 372 | positive regulation of multicellular organismal process |
GO:0048878 | 0.0046 | 1.8371 | 15.0588 | 26 | 492 | chemical homeostasis |
GO:0021700 | 0.0047 | 2.5436 | 5.0502 | 12 | 165 | developmental maturation |
GO:0048608 | 0.0048 | 2.1449 | 8.4342 | 17 | 278 | reproductive structure development |
GO:0021513 | 0.0048 | 6.7416 | 0.704 | 4 | 23 | spinal cord dorsal/ventral patterning |
GO:0035850 | 0.0048 | 6.7416 | 0.704 | 4 | 23 | epithelial cell differentiation involved in kidney development |
GO:0046777 | 0.0049 | 2.6586 | 4.438 | 11 | 145 | protein autophosphorylation |
GO:0050877 | 0.005 | 2.5253 | 5.0816 | 12 | 178 | neurological system process |
GO:0001708 | 0.005 | 6.6434 | 0.7092 | 4 | 24 | cell fate specification |
GO:0007631 | 0.005 | 3.6352 | 2.1119 | 7 | 69 | feeding behavior |
GO:0071363 | 0.005 | 1.8475 | 14.3854 | 25 | 470 | cellular response to growth factor stimulus |
GO:0010463 | 0.0051 | 5.0133 | 1.1325 | 5 | 37 | mesenchymal cell proliferation |
GO:0050906 | 0.0051 | 5.0133 | 1.1325 | 5 | 37 | detection of stimulus involved in sensory perception |
GO:0021542 | 0.0051 | 10.6504 | 0.3673 | 3 | 12 | dentate gyrus development |
GO:0070307 | 0.0051 | 10.6504 | 0.3673 | 3 | 12 | lens fiber cell development |
GO:0072074 | 0.0051 | 10.6504 | 0.3673 | 3 | 12 | kidney mesenchyme development |
GO:0072234 | 0.0051 | 10.6504 | 0.3673 | 3 | 12 | metanephric nephron tubule development |
GO:0072498 | 0.0051 | 10.6504 | 0.3673 | 3 | 12 | embryonic skeletal joint development |
GO:0098655 | 0.0052 | 1.9539 | 11.4165 | 21 | 373 | cation transmembrane transport |
GO:0072177 | 0.0053 | 32.0749 | 0.1217 | 2 | 4 | mesonephric duct development |
GO:0002318 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | myeloid progenitor cell differentiation |
GO:0007412 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | axon target recognition |
GO:0015671 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | oxygen transport |
GO:0021562 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | vestibulocochlear nerve development |
GO:0060214 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | endocardium formation |
GO:0072040 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
GO:0072162 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | metanephric mesenchymal cell differentiation |
GO:0072179 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | nephric duct formation |
GO:0072289 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | metanephric nephron tubule formation |
GO:0072298 | 0.0054 | 31.8706 | 0.1224 | 2 | 4 | regulation of metanephric glomerulus development |
GO:0060021 | 0.0054 | 3.5771 | 2.1425 | 7 | 70 | palate development |
GO:1900449 | 0.0056 | 6.4039 | 0.7346 | 4 | 24 | regulation of glutamate receptor signaling pathway |
GO:0030500 | 0.0057 | 4.8609 | 1.1631 | 5 | 38 | regulation of bone mineralization |
GO:0023052 | 0.0058 | 1.3956 | 82.315 | 102 | 2916 | signaling |
GO:0048738 | 0.0058 | 2.9353 | 3.3056 | 9 | 108 | cardiac muscle tissue development |
GO:0048704 | 0.0059 | 3.5209 | 2.1731 | 7 | 71 | embryonic skeletal system morphogenesis |
GO:2000177 | 0.0059 | 4.0172 | 1.6528 | 6 | 54 | regulation of neural precursor cell proliferation |
GO:0048546 | 0.0062 | 4.748 | 1.1864 | 5 | 39 | digestive tract morphogenesis |
GO:0035282 | 0.0063 | 3.4663 | 2.2037 | 7 | 72 | segmentation |
GO:0008589 | 0.0064 | 3.9348 | 1.6834 | 6 | 55 | regulation of smoothened signaling pathway |
GO:0045807 | 0.0064 | 3.9348 | 1.6834 | 6 | 55 | positive regulation of endocytosis |
GO:0002092 | 0.0065 | 9.5844 | 0.3979 | 3 | 13 | positive regulation of receptor internalization |
GO:0060571 | 0.0065 | 9.5844 | 0.3979 | 3 | 13 | morphogenesis of an epithelial fold |
GO:2000036 | 0.0065 | 9.5844 | 0.3979 | 3 | 13 | regulation of stem cell maintenance |
GO:0009743 | 0.0065 | 2.8766 | 3.3668 | 9 | 110 | response to carbohydrate |
GO:0017145 | 0.0065 | 6.0983 | 0.7652 | 4 | 25 | stem cell division |
GO:0048870 | 0.0066 | 1.6552 | 21.8536 | 34 | 714 | cell motility |
GO:0032774 | 0.0068 | 1.4762 | 45.1626 | 61 | 1613 | RNA biosynthetic process |
GO:0021915 | 0.0069 | 2.6713 | 4.0095 | 10 | 131 | neural tube development |
GO:0043067 | 0.0069 | 1.5873 | 26.8731 | 40 | 878 | regulation of programmed cell death |
GO:0010976 | 0.007 | 3.8557 | 1.714 | 6 | 56 | positive regulation of neuron projection development |
GO:0048332 | 0.007 | 3.8557 | 1.714 | 6 | 56 | mesoderm morphogenesis |
GO:0021543 | 0.0071 | 3.0696 | 2.8159 | 8 | 92 | pallium development |
GO:0021695 | 0.0071 | 4.5822 | 1.2243 | 5 | 40 | cerebellar cortex development |
GO:0035019 | 0.0071 | 4.5822 | 1.2243 | 5 | 40 | somatic stem cell maintenance |
GO:0008284 | 0.0071 | 1.8958 | 11.7395 | 21 | 390 | positive regulation of cell proliferation |
GO:0051480 | 0.0073 | 2.8201 | 3.428 | 9 | 112 | cytosolic calcium ion homeostasis |
GO:0046903 | 0.0074 | 1.7092 | 17.997 | 29 | 588 | secretion |
GO:0014706 | 0.0077 | 2.7949 | 3.4547 | 9 | 115 | striated muscle tissue development |
GO:0072503 | 0.0078 | 2.3703 | 5.3869 | 12 | 176 | cellular divalent inorganic cation homeostasis |
GO:0000122 | 0.0079 | 1.797 | 14.1405 | 24 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0002088 | 0.0079 | 4.4544 | 1.2549 | 5 | 41 | lens development in camera-type eye |
GO:0021879 | 0.0079 | 4.4544 | 1.2549 | 5 | 41 | forebrain neuron differentiation |
GO:0050807 | 0.0079 | 4.4544 | 1.2549 | 5 | 41 | regulation of synapse organization |
GO:0060415 | 0.0079 | 4.4544 | 1.2549 | 5 | 41 | muscle tissue morphogenesis |
GO:0003018 | 0.008 | 2.9976 | 2.8771 | 8 | 94 | vascular process in circulatory system |
GO:0010894 | 0.008 | 8.7122 | 0.4285 | 3 | 14 | negative regulation of steroid biosynthetic process |
GO:0043403 | 0.008 | 8.7122 | 0.4285 | 3 | 14 | skeletal muscle tissue regeneration |
GO:0060581 | 0.008 | 8.7122 | 0.4285 | 3 | 14 | cell fate commitment involved in pattern specification |
GO:0072087 | 0.008 | 8.7122 | 0.4285 | 3 | 14 | renal vesicle development |
GO:0090190 | 0.008 | 8.7122 | 0.4285 | 3 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0001657 | 0.0081 | 5.6719 | 0.8118 | 4 | 27 | ureteric bud development |
GO:0007600 | 0.0083 | 2.4585 | 4.7654 | 11 | 160 | sensory perception |
GO:0007409 | 0.0084 | 2.7511 | 3.5039 | 9 | 119 | axonogenesis |
GO:0050679 | 0.0085 | 2.9629 | 2.9077 | 8 | 95 | positive regulation of epithelial cell proliferation |
GO:0010453 | 0.0086 | 21.4973 | 0.1513 | 2 | 5 | regulation of cell fate commitment |
GO:0021522 | 0.0087 | 5.5669 | 0.8264 | 4 | 27 | spinal cord motor neuron differentiation |
GO:0060393 | 0.0087 | 5.5669 | 0.8264 | 4 | 27 | regulation of pathway-restricted SMAD protein phosphorylation |
GO:0001826 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | inner cell mass cell differentiation |
GO:0003402 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | planar cell polarity pathway involved in axis elongation |
GO:0030207 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | chondroitin sulfate catabolic process |
GO:0031340 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | positive regulation of vesicle fusion |
GO:0032516 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | positive regulation of phosphoprotein phosphatase activity |
GO:0043374 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | CD8-positive, alpha-beta T cell differentiation |
GO:0048170 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | positive regulation of long-term neuronal synaptic plasticity |
GO:0048852 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | diencephalon morphogenesis |
GO:0060174 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | limb bud formation |
GO:0060374 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | mast cell differentiation |
GO:0060687 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | regulation of branching involved in prostate gland morphogenesis |
GO:0090037 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | positive regulation of protein kinase C signaling |
GO:0097120 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | receptor localization to synapse |
GO:2001012 | 0.0088 | 21.2449 | 0.153 | 2 | 5 | mesenchymal cell differentiation involved in renal system development |
GO:0043009 | 0.0088 | 1.9586 | 9.7232 | 18 | 324 | chordate embryonic development |
GO:0045995 | 0.0091 | 3.2171 | 2.3568 | 7 | 77 | regulation of embryonic development |
GO:0010001 | 0.0091 | 2.7136 | 3.5504 | 9 | 116 | glial cell differentiation |
GO:0023014 | 0.0096 | 1.8126 | 12.8244 | 22 | 419 | signal transduction by phosphorylation |
GO:0060828 | 0.0096 | 2.6882 | 3.581 | 9 | 117 | regulation of canonical Wnt signaling pathway |
GO:0030804 | 0.0097 | 4.2191 | 1.3161 | 5 | 43 | positive regulation of cyclic nucleotide biosynthetic process |
GO:0001964 | 0.0098 | 7.9854 | 0.4591 | 3 | 15 | startle response |
GO:0030539 | 0.0098 | 7.9854 | 0.4591 | 3 | 15 | male genitalia development |
GO:0042659 | 0.0098 | 7.9854 | 0.4591 | 3 | 15 | regulation of cell fate specification |
GO:0000578 | 0.0099 | 5.3344 | 0.857 | 4 | 28 | embryonic axis specification |
GO:0048566 | 0.0099 | 5.3344 | 0.857 | 4 | 28 | embryonic digestive tract development |
GO:0048854 | 0.0099 | 5.3344 | 0.857 | 4 | 28 | brain morphogenesis |
GO:0023057 | 0.0099 | 1.6397 | 20.0171 | 31 | 654 | negative regulation of signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032103 | 1e-04 | 5.2652 | 2.1504 | 10 | 95 | positive regulation of response to external stimulus |
GO:0010641 | 5e-04 | Inf | 0.0453 | 2 | 2 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0010751 | 5e-04 | Inf | 0.0453 | 2 | 2 | negative regulation of nitric oxide mediated signal transduction |
GO:0051897 | 6e-04 | 6.4612 | 1.0639 | 6 | 47 | positive regulation of protein kinase B signaling |
GO:0002685 | 7e-04 | 6.2143 | 1.0998 | 6 | 49 | regulation of leukocyte migration |
GO:0050920 | 8e-04 | 5.1642 | 1.5166 | 7 | 67 | regulation of chemotaxis |
GO:0048520 | 0.0011 | 5.756 | 1.177 | 6 | 52 | positive regulation of behavior |
GO:0051272 | 0.0012 | 3.051 | 4.2555 | 12 | 188 | positive regulation of cellular component movement |
GO:0040017 | 0.0014 | 2.982 | 4.346 | 12 | 192 | positive regulation of locomotion |
GO:0007598 | 0.0015 | 87.1053 | 0.0679 | 2 | 3 | blood coagulation, extrinsic pathway |
GO:0071675 | 0.0015 | 87.1053 | 0.0679 | 2 | 3 | regulation of mononuclear cell migration |
GO:0090237 | 0.0015 | 87.1053 | 0.0679 | 2 | 3 | regulation of arachidonic acid secretion |
GO:0002675 | 0.0017 | 16.3926 | 0.249 | 3 | 11 | positive regulation of acute inflammatory response |
GO:0030194 | 0.0017 | 16.3926 | 0.249 | 3 | 11 | positive regulation of blood coagulation |
GO:0071622 | 0.0017 | 16.3926 | 0.249 | 3 | 11 | regulation of granulocyte chemotaxis |
GO:0060326 | 0.0017 | 3.9403 | 2.2183 | 8 | 98 | cell chemotaxis |
GO:0022603 | 0.0017 | 2.1387 | 11.0914 | 22 | 490 | regulation of anatomical structure morphogenesis |
GO:0002690 | 0.0019 | 8.7708 | 0.5433 | 4 | 24 | positive regulation of leukocyte chemotaxis |
GO:0009611 | 0.0022 | 2.0182 | 12.8117 | 24 | 566 | response to wounding |
GO:0030335 | 0.0023 | 2.9547 | 4.0065 | 11 | 177 | positive regulation of cell migration |
GO:0018108 | 0.0026 | 2.7483 | 4.6856 | 12 | 207 | peptidyl-tyrosine phosphorylation |
GO:0006551 | 0.003 | 43.5482 | 0.0905 | 2 | 4 | leucine metabolic process |
GO:0060708 | 0.003 | 43.5482 | 0.0905 | 2 | 4 | spongiotrophoblast differentiation |
GO:0045744 | 0.003 | 5.6365 | 0.996 | 5 | 44 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:1901342 | 0.0031 | 3.5427 | 2.4446 | 8 | 108 | regulation of vasculature development |
GO:2000026 | 0.0032 | 1.8207 | 17.8209 | 30 | 807 | regulation of multicellular organismal development |
GO:2000811 | 0.0035 | 11.9183 | 0.3169 | 3 | 14 | negative regulation of anoikis |
GO:0045785 | 0.0036 | 3.4385 | 2.5125 | 8 | 111 | positive regulation of cell adhesion |
GO:0031345 | 0.004 | 4.334 | 1.5166 | 6 | 67 | negative regulation of cell projection organization |
GO:0050878 | 0.0042 | 2.1282 | 9.0316 | 18 | 399 | regulation of body fluid levels |
GO:0042119 | 0.0043 | 10.924 | 0.3395 | 3 | 15 | neutrophil activation |
GO:0033273 | 0.0048 | 4.9934 | 1.1091 | 5 | 49 | response to vitamin |
GO:0002689 | 0.0049 | 29.0292 | 0.1132 | 2 | 5 | negative regulation of leukocyte chemotaxis |
GO:0010758 | 0.0049 | 29.0292 | 0.1132 | 2 | 5 | regulation of macrophage chemotaxis |
GO:2000192 | 0.0049 | 29.0292 | 0.1132 | 2 | 5 | negative regulation of fatty acid transport |
GO:0010975 | 0.0062 | 2.5614 | 4.5724 | 11 | 202 | regulation of neuron projection development |
GO:0015711 | 0.0062 | 2.5614 | 4.5724 | 11 | 202 | organic anion transport |
GO:0097530 | 0.0063 | 6.0433 | 0.747 | 4 | 33 | granulocyte migration |
GO:0050817 | 0.007 | 2.1653 | 7.3566 | 15 | 325 | coagulation |
GO:0007171 | 0.0072 | 21.7697 | 0.1358 | 2 | 6 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0060534 | 0.0072 | 21.7697 | 0.1358 | 2 | 6 | trachea cartilage development |
GO:0009266 | 0.0078 | 3.7198 | 1.7429 | 6 | 77 | response to temperature stimulus |
GO:0045766 | 0.0079 | 4.3916 | 1.245 | 5 | 55 | positive regulation of angiogenesis |
GO:0061041 | 0.0079 | 4.3916 | 1.245 | 5 | 55 | regulation of wound healing |
GO:0072593 | 0.0079 | 3.2849 | 2.2862 | 7 | 101 | reactive oxygen species metabolic process |
GO:0065007 | 0.0084 | 1.429 | 147.5613 | 165 | 6519 | biological regulation |
GO:0050927 | 0.0085 | 8.1897 | 0.4301 | 3 | 19 | positive regulation of positive chemotaxis |
GO:0007338 | 0.0085 | 4.305 | 1.2676 | 5 | 56 | single fertilization |
GO:0006811 | 0.0089 | 1.6778 | 19.1271 | 30 | 845 | ion transport |
GO:1900046 | 0.0094 | 5.3087 | 0.8375 | 4 | 37 | regulation of hemostasis |
GO:0098656 | 0.0097 | 3.1496 | 2.3767 | 7 | 105 | anion transmembrane transport |
GO:0001960 | 0.0098 | 7.7072 | 0.4527 | 3 | 20 | negative regulation of cytokine-mediated signaling pathway |
GO:0007339 | 0.0098 | 7.7072 | 0.4527 | 3 | 20 | binding of sperm to zona pellucida |
GO:0034605 | 0.0098 | 7.7072 | 0.4527 | 3 | 20 | cellular response to heat |
GO:0017187 | 0.0099 | 17.414 | 0.1584 | 2 | 7 | peptidyl-glutamic acid carboxylation |
GO:0060192 | 0.0099 | 17.414 | 0.1584 | 2 | 7 | negative regulation of lipase activity |
GO:0061037 | 0.0099 | 17.414 | 0.1584 | 2 | 7 | negative regulation of cartilage development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 94.9177 | 0.0792 | 3 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0061180 | 1e-04 | 9.4027 | 0.7447 | 6 | 47 | mammary gland epithelium development |
GO:0050877 | 1e-04 | 2.7912 | 8.4136 | 21 | 531 | neurological system process |
GO:0060443 | 1e-04 | 11.8388 | 0.507 | 5 | 32 | mammary gland morphogenesis |
GO:0033594 | 2e-04 | Inf | 0.0317 | 2 | 2 | response to hydroxyisoflavone |
GO:0032501 | 6e-04 | 1.6993 | 61.3831 | 82 | 3874 | multicellular organismal process |
GO:0001656 | 6e-04 | 6.4129 | 1.0458 | 6 | 66 | metanephros development |
GO:1902476 | 7e-04 | 7.9808 | 0.713 | 5 | 45 | chloride transmembrane transport |
GO:0043534 | 8e-04 | 7.5992 | 0.7447 | 5 | 47 | blood vessel endothelial cell migration |
GO:0016338 | 0.001 | 18.9684 | 0.206 | 3 | 13 | calcium-independent cell-cell adhesion |
GO:0050714 | 0.0015 | 6.6453 | 0.8398 | 5 | 53 | positive regulation of protein secretion |
GO:0072086 | 0.0015 | 62.8805 | 0.0634 | 2 | 4 | specification of loop of Henle identity |
GO:0060444 | 0.0015 | 15.8038 | 0.2377 | 3 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0071392 | 0.0015 | 15.8038 | 0.2377 | 3 | 15 | cellular response to estradiol stimulus |
GO:0042330 | 0.0017 | 2.5589 | 6.3538 | 15 | 401 | taxis |
GO:0007267 | 0.0018 | 2.1071 | 11.9787 | 23 | 756 | cell-cell signaling |
GO:0030216 | 0.0019 | 6.2525 | 0.8873 | 5 | 56 | keratinocyte differentiation |
GO:0001906 | 0.0024 | 7.9363 | 0.5704 | 4 | 36 | cell killing |
GO:0072047 | 0.0024 | 41.9161 | 0.0792 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0010594 | 0.0027 | 5.6914 | 0.9665 | 5 | 61 | regulation of endothelial cell migration |
GO:0033993 | 0.003 | 2.4031 | 6.7341 | 15 | 425 | response to lipid |
GO:0050927 | 0.0031 | 11.8481 | 0.3011 | 3 | 19 | positive regulation of positive chemotaxis |
GO:0007606 | 0.0036 | 7.0517 | 0.6338 | 4 | 40 | sensory perception of chemical stimulus |
GO:0006929 | 0.0037 | 11.15 | 0.3169 | 3 | 20 | substrate-dependent cell migration |
GO:0014044 | 0.0037 | 11.15 | 0.3169 | 3 | 20 | Schwann cell development |
GO:0050920 | 0.0041 | 5.1375 | 1.0616 | 5 | 67 | regulation of chemotaxis |
GO:0042267 | 0.0042 | 10.5295 | 0.3327 | 3 | 21 | natural killer cell mediated cytotoxicity |
GO:0048469 | 0.0046 | 4.1689 | 1.5528 | 6 | 98 | cell maturation |
GO:0002438 | 0.005 | 25.1447 | 0.1109 | 2 | 7 | acute inflammatory response to antigenic stimulus |
GO:0042730 | 0.005 | 25.1447 | 0.1109 | 2 | 7 | fibrinolysis |
GO:0046541 | 0.005 | 25.1447 | 0.1109 | 2 | 7 | saliva secretion |
GO:0007155 | 0.0052 | 2.049 | 10.014 | 19 | 632 | cell adhesion |
GO:0015698 | 0.0053 | 4.8242 | 1.125 | 5 | 71 | inorganic anion transport |
GO:0042552 | 0.0063 | 4.6131 | 1.1725 | 5 | 74 | myelination |
GO:0030574 | 0.0064 | 5.8996 | 0.7447 | 4 | 47 | collagen catabolic process |
GO:0048731 | 0.0064 | 1.5508 | 41.4344 | 56 | 2615 | system development |
GO:0043627 | 0.0064 | 3.8714 | 1.6637 | 6 | 105 | response to estrogen |
GO:0098656 | 0.0064 | 3.8714 | 1.6637 | 6 | 105 | anion transmembrane transport |
GO:0035878 | 0.0066 | 20.9518 | 0.1268 | 2 | 8 | nail development |
GO:0071305 | 0.0066 | 20.9518 | 0.1268 | 2 | 8 | cellular response to vitamin D |
GO:0072048 | 0.0066 | 20.9518 | 0.1268 | 2 | 8 | renal system pattern specification |
GO:0008544 | 0.0069 | 3.0601 | 2.7887 | 8 | 176 | epidermis development |
GO:0071277 | 0.007 | 8.6116 | 0.3961 | 3 | 25 | cellular response to calcium ion |
GO:0001508 | 0.0073 | 3.7564 | 1.7112 | 6 | 108 | action potential |
GO:0033273 | 0.0074 | 5.6362 | 0.7764 | 4 | 49 | response to vitamin |
GO:0042310 | 0.0074 | 5.6362 | 0.7764 | 4 | 49 | vasoconstriction |
GO:0072009 | 0.0074 | 5.6362 | 0.7764 | 4 | 49 | nephron epithelium development |
GO:0007272 | 0.0074 | 4.4195 | 1.2201 | 5 | 77 | ensheathment of neurons |
GO:0097305 | 0.0078 | 2.9877 | 2.8521 | 8 | 180 | response to alcohol |
GO:0033599 | 0.0083 | 17.9569 | 0.1426 | 2 | 9 | regulation of mammary gland epithelial cell proliferation |
GO:0090022 | 0.0083 | 17.9569 | 0.1426 | 2 | 9 | regulation of neutrophil chemotaxis |
GO:0010977 | 0.0086 | 7.8924 | 0.4278 | 3 | 27 | negative regulation of neuron projection development |
GO:0048678 | 0.0086 | 7.8924 | 0.4278 | 3 | 27 | response to axon injury |
GO:0071407 | 0.0088 | 2.9216 | 2.9128 | 8 | 186 | cellular response to organic cyclic compound |
GO:0048520 | 0.0091 | 5.2824 | 0.8239 | 4 | 52 | positive regulation of behavior |
GO:0051384 | 0.0091 | 4.1852 | 1.2834 | 5 | 81 | response to glucocorticoid |
GO:0003008 | 0.0096 | 2.4123 | 4.8702 | 11 | 335 | system process |
GO:0009593 | 0.0096 | 7.5759 | 0.4437 | 3 | 28 | detection of chemical stimulus |
GO:0042743 | 0.0096 | 7.5759 | 0.4437 | 3 | 28 | hydrogen peroxide metabolic process |
GO:0010631 | 0.0098 | 3.5126 | 1.8222 | 6 | 115 | epithelial cell migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070098 | 4e-04 | 14.1425 | 0.3681 | 4 | 17 | chemokine-mediated signaling pathway |
GO:0051901 | 5e-04 | Inf | 0.0433 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:2000721 | 5e-04 | Inf | 0.0433 | 2 | 2 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0051024 | 0.0014 | 91.1927 | 0.065 | 2 | 3 | positive regulation of immunoglobulin secretion |
GO:0060157 | 0.0014 | 91.1927 | 0.065 | 2 | 3 | urinary bladder development |
GO:1900222 | 0.0014 | 91.1927 | 0.065 | 2 | 3 | negative regulation of beta-amyloid clearance |
GO:0008584 | 0.0015 | 4.5685 | 1.6888 | 7 | 78 | male gonad development |
GO:0042538 | 0.0027 | 45.5917 | 0.0866 | 2 | 4 | hyperosmotic salinity response |
GO:0003254 | 0.0038 | 11.4389 | 0.3248 | 3 | 15 | regulation of membrane depolarization |
GO:0001778 | 0.0045 | 30.3914 | 0.1083 | 2 | 5 | plasma membrane repair |
GO:0003298 | 0.0045 | 30.3914 | 0.1083 | 2 | 5 | physiological muscle hypertrophy |
GO:0060023 | 0.0045 | 30.3914 | 0.1083 | 2 | 5 | soft palate development |
GO:0061049 | 0.0045 | 30.3914 | 0.1083 | 2 | 5 | cell growth involved in cardiac muscle cell development |
GO:2001300 | 0.0045 | 30.3914 | 0.1083 | 2 | 5 | lipoxin metabolic process |
GO:0046661 | 0.0047 | 3.6379 | 2.0785 | 7 | 96 | male sex differentiation |
GO:0006869 | 0.0051 | 2.9861 | 3.2261 | 9 | 149 | lipid transport |
GO:0030511 | 0.0064 | 9.1484 | 0.3897 | 3 | 18 | positive regulation of transforming growth factor beta receptor signaling pathway |
GO:0042178 | 0.0066 | 22.7913 | 0.1299 | 2 | 6 | xenobiotic catabolic process |
GO:0009605 | 0.0077 | 1.6168 | 24.7259 | 37 | 1142 | response to external stimulus |
GO:0006885 | 0.0081 | 5.56 | 0.8011 | 4 | 37 | regulation of pH |
GO:0050906 | 0.0081 | 5.56 | 0.8011 | 4 | 37 | detection of stimulus involved in sensory perception |
GO:0008045 | 0.0087 | 8.0705 | 0.433 | 3 | 20 | motor neuron axon guidance |
GO:0098661 | 0.0095 | 4.1801 | 1.2991 | 5 | 60 | inorganic anion transmembrane transport |
GO:0050982 | 0.01 | 7.6214 | 0.4547 | 3 | 21 | detection of mechanical stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070830 | 0 | 10.8422 | 0.9387 | 8 | 38 | tight junction assembly |
GO:0048514 | 2e-04 | 2.7361 | 7.5836 | 19 | 307 | blood vessel morphogenesis |
GO:0009888 | 3e-04 | 1.8675 | 27.3948 | 46 | 1109 | tissue development |
GO:0048878 | 5e-04 | 2.2794 | 11.4498 | 24 | 470 | chemical homeostasis |
GO:0009609 | 6e-04 | Inf | 0.0494 | 2 | 2 | response to symbiotic bacterium |
GO:0010482 | 6e-04 | Inf | 0.0494 | 2 | 2 | regulation of epidermal cell division |
GO:0032879 | 6e-04 | 1.759 | 30.8779 | 49 | 1250 | regulation of localization |
GO:1902042 | 7e-04 | 12.3289 | 0.4199 | 4 | 17 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0065008 | 7e-04 | 1.6268 | 47.9719 | 69 | 1942 | regulation of biological quality |
GO:0034329 | 0.001 | 3.3187 | 3.6065 | 11 | 146 | cell junction assembly |
GO:0070293 | 0.0011 | 19.9677 | 0.2223 | 3 | 9 | renal absorption |
GO:0006639 | 0.0013 | 4.7097 | 1.6551 | 7 | 67 | acylglycerol metabolic process |
GO:0003008 | 0.0013 | 1.8318 | 21.3922 | 36 | 866 | system process |
GO:0050680 | 0.0016 | 4.4841 | 1.7292 | 7 | 70 | negative regulation of epithelial cell proliferation |
GO:0007605 | 0.0017 | 3.9458 | 2.2232 | 8 | 90 | sensory perception of sound |
GO:0010269 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | response to selenium ion |
GO:0034287 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | detection of glucose |
GO:0071681 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | cellular response to indole-3-methanol |
GO:2000392 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | regulation of lamellipodium morphogenesis |
GO:2001225 | 0.0018 | 79.5904 | 0.0741 | 2 | 3 | regulation of chloride transport |
GO:0030104 | 0.0019 | 8.8997 | 0.5435 | 4 | 22 | water homeostasis |
GO:0002009 | 0.0019 | 2.3596 | 7.7318 | 17 | 313 | morphogenesis of an epithelium |
GO:0031344 | 0.002 | 2.5074 | 6.4226 | 15 | 260 | regulation of cell projection organization |
GO:0033561 | 0.0021 | 14.9728 | 0.2717 | 3 | 11 | regulation of water loss via skin |
GO:0045766 | 0.0023 | 4.9284 | 1.3586 | 6 | 55 | positive regulation of angiogenesis |
GO:0048706 | 0.0024 | 3.7171 | 2.3467 | 8 | 95 | embryonic skeletal system development |
GO:0051130 | 0.0026 | 2.0216 | 12.2029 | 23 | 494 | positive regulation of cellular component organization |
GO:0042127 | 0.0026 | 1.7634 | 21.4663 | 35 | 869 | regulation of cell proliferation |
GO:0042593 | 0.0027 | 3.3133 | 2.9396 | 9 | 119 | glucose homeostasis |
GO:0045216 | 0.0027 | 3.0737 | 3.5077 | 10 | 142 | cell-cell junction organization |
GO:0001944 | 0.0028 | 2.1663 | 9.3869 | 19 | 380 | vasculature development |
GO:0048565 | 0.0029 | 3.5921 | 2.4208 | 8 | 98 | digestive tract development |
GO:0030155 | 0.0034 | 2.5353 | 5.4839 | 13 | 222 | regulation of cell adhesion |
GO:0006642 | 0.0035 | 39.7912 | 0.0988 | 2 | 4 | triglyceride mobilization |
GO:2001256 | 0.0035 | 39.7912 | 0.0988 | 2 | 4 | regulation of store-operated calcium entry |
GO:0030855 | 0.0038 | 2.1483 | 8.9422 | 18 | 362 | epithelial cell differentiation |
GO:0001755 | 0.0041 | 6.9615 | 0.667 | 4 | 27 | neural crest cell migration |
GO:0060193 | 0.0045 | 4.2333 | 1.5562 | 6 | 63 | positive regulation of lipase activity |
GO:0032940 | 0.0046 | 1.9187 | 12.7958 | 23 | 518 | secretion by cell |
GO:0051346 | 0.0046 | 2.674 | 4.397 | 11 | 178 | negative regulation of hydrolase activity |
GO:0000578 | 0.0047 | 6.6707 | 0.6917 | 4 | 28 | embryonic axis specification |
GO:0035094 | 0.0047 | 6.6707 | 0.6917 | 4 | 28 | response to nicotine |
GO:0022603 | 0.0049 | 1.9382 | 12.1041 | 22 | 490 | regulation of anatomical structure morphogenesis |
GO:0071356 | 0.0052 | 4.089 | 1.6056 | 6 | 65 | cellular response to tumor necrosis factor |
GO:0031340 | 0.0058 | 26.5248 | 0.1235 | 2 | 5 | positive regulation of vesicle fusion |
GO:0032753 | 0.0058 | 26.5248 | 0.1235 | 2 | 5 | positive regulation of interleukin-4 production |
GO:0051006 | 0.0058 | 26.5248 | 0.1235 | 2 | 5 | positive regulation of lipoprotein lipase activity |
GO:0003073 | 0.0058 | 4.7755 | 1.161 | 5 | 47 | regulation of systemic arterial blood pressure |
GO:0009743 | 0.0058 | 3.1657 | 2.7173 | 8 | 110 | response to carbohydrate |
GO:0034110 | 0.0066 | 9.2094 | 0.3952 | 3 | 16 | regulation of homotypic cell-cell adhesion |
GO:0048839 | 0.0068 | 2.8421 | 3.3842 | 9 | 137 | inner ear development |
GO:0065009 | 0.007 | 1.496 | 40.8082 | 56 | 1652 | regulation of molecular function |
GO:0048701 | 0.0076 | 5.7154 | 0.7905 | 4 | 32 | embryonic cranial skeleton morphogenesis |
GO:0034381 | 0.0078 | 8.5507 | 0.4199 | 3 | 17 | plasma lipoprotein particle clearance |
GO:0015698 | 0.008 | 3.7093 | 1.7539 | 6 | 71 | inorganic anion transport |
GO:0035270 | 0.0081 | 3.2772 | 2.2973 | 7 | 93 | endocrine system development |
GO:0040017 | 0.0081 | 2.4636 | 4.7428 | 11 | 192 | positive regulation of locomotion |
GO:0060463 | 0.0085 | 19.8916 | 0.1482 | 2 | 6 | lung lobe morphogenesis |
GO:0071379 | 0.0085 | 19.8916 | 0.1482 | 2 | 6 | cellular response to prostaglandin stimulus |
GO:0009410 | 0.0086 | 3.6527 | 1.7786 | 6 | 72 | response to xenobiotic stimulus |
GO:0009790 | 0.0087 | 1.6927 | 18.255 | 29 | 739 | embryo development |
GO:0072359 | 0.0098 | 1.7653 | 14.4261 | 24 | 584 | circulatory system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 0 | 3.0093 | 8.95 | 24 | 431 | G-protein coupled receptor signaling pathway |
GO:0044283 | 4e-04 | 2.8975 | 6.022 | 16 | 290 | small molecule biosynthetic process |
GO:0007207 | 4e-04 | Inf | 0.0415 | 2 | 2 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0035902 | 4e-04 | Inf | 0.0415 | 2 | 2 | response to immobilization stress |
GO:0051901 | 4e-04 | Inf | 0.0415 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:1901570 | 5e-04 | 8.9204 | 0.6645 | 5 | 32 | fatty acid derivative biosynthetic process |
GO:0071345 | 5e-04 | 2.813 | 6.1882 | 16 | 298 | cellular response to cytokine stimulus |
GO:0046457 | 7e-04 | 11.9976 | 0.4153 | 4 | 20 | prostanoid biosynthetic process |
GO:0042445 | 7e-04 | 4.5737 | 1.9312 | 8 | 93 | hormone metabolic process |
GO:0046394 | 8e-04 | 3.1829 | 4.0908 | 12 | 197 | carboxylic acid biosynthetic process |
GO:0030309 | 0.0013 | 95.2057 | 0.0623 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0051464 | 0.0013 | 95.2057 | 0.0623 | 2 | 3 | positive regulation of cortisol secretion |
GO:2001225 | 0.0013 | 95.2057 | 0.0623 | 2 | 3 | regulation of chloride transport |
GO:0019371 | 0.0013 | 17.9243 | 0.2284 | 3 | 11 | cyclooxygenase pathway |
GO:0060333 | 0.0013 | 6.8759 | 0.8306 | 5 | 40 | interferon-gamma-mediated signaling pathway |
GO:0006693 | 0.0014 | 9.5942 | 0.4984 | 4 | 24 | prostaglandin metabolic process |
GO:0007586 | 0.0016 | 5.2656 | 1.2667 | 6 | 61 | digestion |
GO:0006954 | 0.002 | 2.6074 | 5.7729 | 14 | 278 | inflammatory response |
GO:1902476 | 0.0023 | 6.0133 | 0.9345 | 5 | 45 | chloride transmembrane transport |
GO:0050896 | 0.0024 | 1.4951 | 95.2937 | 116 | 4589 | response to stimulus |
GO:0070885 | 0.0025 | 47.5981 | 0.0831 | 2 | 4 | negative regulation of calcineurin-NFAT signaling cascade |
GO:2000848 | 0.0025 | 47.5981 | 0.0831 | 2 | 4 | positive regulation of corticosteroid hormone secretion |
GO:0007626 | 0.0027 | 3.3139 | 2.928 | 9 | 141 | locomotory behavior |
GO:0006805 | 0.0028 | 4.6678 | 1.4121 | 6 | 68 | xenobiotic metabolic process |
GO:0007268 | 0.003 | 2.1121 | 10.1752 | 20 | 490 | synaptic transmission |
GO:0007631 | 0.003 | 4.5933 | 1.4328 | 6 | 69 | feeding behavior |
GO:0015698 | 0.0035 | 4.451 | 1.4744 | 6 | 71 | inorganic anion transport |
GO:0009410 | 0.0037 | 4.3831 | 1.4951 | 6 | 72 | response to xenobiotic stimulus |
GO:0022617 | 0.0037 | 4.3831 | 1.4951 | 6 | 72 | extracellular matrix disassembly |
GO:0002579 | 0.0041 | 31.7289 | 0.1038 | 2 | 5 | positive regulation of antigen processing and presentation |
GO:0045019 | 0.0041 | 31.7289 | 0.1038 | 2 | 5 | negative regulation of nitric oxide biosynthetic process |
GO:0090331 | 0.0041 | 31.7289 | 0.1038 | 2 | 5 | negative regulation of platelet aggregation |
GO:2000849 | 0.0041 | 31.7289 | 0.1038 | 2 | 5 | regulation of glucocorticoid secretion |
GO:2001300 | 0.0041 | 31.7289 | 0.1038 | 2 | 5 | lipoxin metabolic process |
GO:0050848 | 0.0048 | 10.2363 | 0.353 | 3 | 17 | regulation of calcium-mediated signaling |
GO:0060706 | 0.0048 | 10.2363 | 0.353 | 3 | 17 | cell differentiation involved in embryonic placenta development |
GO:0070098 | 0.0048 | 10.2363 | 0.353 | 3 | 17 | chemokine-mediated signaling pathway |
GO:0098656 | 0.0062 | 3.4496 | 2.1804 | 7 | 105 | anion transmembrane transport |
GO:0002687 | 0.0063 | 5.9891 | 0.7476 | 4 | 36 | positive regulation of leukocyte migration |
GO:0034341 | 0.0064 | 4.6201 | 1.1836 | 5 | 57 | response to interferon-gamma |
GO:0051222 | 0.0068 | 3.0726 | 2.7826 | 8 | 134 | positive regulation of protein transport |
GO:0003008 | 0.0068 | 1.7349 | 17.9831 | 29 | 866 | system process |
GO:0050865 | 0.008 | 2.4669 | 4.7346 | 11 | 228 | regulation of cell activation |
GO:0008610 | 0.0082 | 2.0721 | 8.2024 | 16 | 395 | lipid biosynthetic process |
GO:0050801 | 0.0083 | 2.1881 | 6.7904 | 14 | 327 | ion homeostasis |
GO:0022407 | 0.0085 | 4.2883 | 1.2667 | 5 | 61 | regulation of cell-cell adhesion |
GO:0001662 | 0.0089 | 7.9583 | 0.4361 | 3 | 21 | behavioral fear response |
GO:0043436 | 0.0089 | 1.7862 | 14.3491 | 24 | 691 | oxoacid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903046 | 0 | 9.2616 | 1.019 | 8 | 62 | meiotic cell cycle process |
GO:0007126 | 0 | 5.7232 | 1.9722 | 10 | 120 | meiotic nuclear division |
GO:0040029 | 1e-04 | 5.2634 | 1.9065 | 9 | 116 | regulation of gene expression, epigenetic |
GO:0010446 | 3e-04 | Inf | 0.0329 | 2 | 2 | response to alkaline pH |
GO:0006305 | 4e-04 | 9.3163 | 0.6245 | 5 | 38 | DNA alkylation |
GO:0043046 | 5e-04 | 26.0984 | 0.1644 | 3 | 10 | DNA methylation involved in gamete generation |
GO:0044728 | 7e-04 | 7.8783 | 0.7232 | 5 | 44 | DNA methylation or demethylation |
GO:0043414 | 0.0011 | 3.8157 | 2.5639 | 9 | 156 | macromolecule methylation |
GO:0031047 | 0.0011 | 7.1425 | 0.7889 | 5 | 48 | gene silencing by RNA |
GO:0000038 | 0.003 | 12.1695 | 0.2958 | 3 | 18 | very long-chain fatty acid metabolic process |
GO:0060969 | 0.0039 | 30.2727 | 0.0986 | 2 | 6 | negative regulation of gene silencing |
GO:0007129 | 0.0047 | 10.1382 | 0.3451 | 3 | 21 | synapsis |
GO:0002385 | 0.0053 | 24.2158 | 0.115 | 2 | 7 | mucosal immune response |
GO:0003307 | 0.0053 | 24.2158 | 0.115 | 2 | 7 | regulation of Wnt signaling pathway involved in heart development |
GO:0031935 | 0.007 | 20.1778 | 0.1315 | 2 | 8 | regulation of chromatin silencing |
GO:0034587 | 0.007 | 20.1778 | 0.1315 | 2 | 8 | piRNA metabolic process |
GO:0007141 | 0.009 | 17.2935 | 0.1479 | 2 | 9 | male meiosis I |
GO:2000406 | 0.009 | 17.2935 | 0.1479 | 2 | 9 | positive regulation of T cell migration |
GO:0050663 | 0.009 | 5.307 | 0.8218 | 4 | 50 | cytokine secretion |
GO:0046620 | 0.0097 | 5.1936 | 0.8382 | 4 | 51 | regulation of organ growth |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 4.4518 | 7.9851 | 30 | 323 | pattern specification process |
GO:0032501 | 0 | 2.2039 | 96.8405 | 145 | 3874 | multicellular organismal process |
GO:0035107 | 0 | 7.6525 | 2.7247 | 17 | 109 | appendage morphogenesis |
GO:0060173 | 0 | 6.5082 | 3.1247 | 17 | 125 | limb development |
GO:0006355 | 0 | 1.976 | 58.3443 | 93 | 2334 | regulation of transcription, DNA-templated |
GO:0009954 | 0 | 18.6893 | 0.5499 | 7 | 22 | proximal/distal pattern formation |
GO:0045944 | 0 | 2.69 | 15.2235 | 36 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0051252 | 0 | 1.9191 | 60.3941 | 94 | 2416 | regulation of RNA metabolic process |
GO:0001501 | 0 | 3.4119 | 7.9492 | 24 | 318 | skeletal system development |
GO:0000122 | 0 | 2.9374 | 11.5489 | 30 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007275 | 0 | 2.0629 | 41.4246 | 69 | 1911 | multicellular organismal development |
GO:0048665 | 0 | 14.0099 | 0.6749 | 7 | 27 | neuron fate specification |
GO:0060429 | 0 | 2.445 | 17.5733 | 38 | 703 | epithelium development |
GO:0043009 | 0 | 2.9541 | 9.8631 | 26 | 402 | chordate embryonic development |
GO:0035239 | 0 | 3.4574 | 6.4744 | 20 | 259 | tube morphogenesis |
GO:0019438 | 0 | 1.7655 | 69.0932 | 100 | 2764 | aromatic compound biosynthetic process |
GO:1901362 | 0 | 1.7579 | 70.968 | 102 | 2839 | organic cyclic compound biosynthetic process |
GO:0030182 | 0 | 5.9328 | 1.9404 | 10 | 86 | neuron differentiation |
GO:0022008 | 0 | 2.4657 | 14.0715 | 31 | 596 | neurogenesis |
GO:0044271 | 0 | 1.7289 | 70.1181 | 100 | 2805 | cellular nitrogen compound biosynthetic process |
GO:0018130 | 0 | 1.7303 | 69.2432 | 99 | 2770 | heterocycle biosynthetic process |
GO:1902680 | 0 | 2.1553 | 21.8978 | 42 | 876 | positive regulation of RNA biosynthetic process |
GO:0048562 | 0 | 4.3219 | 3.3747 | 13 | 140 | embryonic organ morphogenesis |
GO:0010556 | 0 | 1.7332 | 65.0436 | 94 | 2602 | regulation of macromolecule biosynthetic process |
GO:0010628 | 0 | 2.1195 | 22.7978 | 43 | 912 | positive regulation of gene expression |
GO:0048729 | 0 | 2.7593 | 9.6241 | 24 | 385 | tissue morphogenesis |
GO:0001764 | 0 | 4.9937 | 2.4998 | 11 | 100 | neuron migration |
GO:0001707 | 0 | 7.127 | 1.3249 | 8 | 53 | mesoderm formation |
GO:0072175 | 1e-04 | 4.8294 | 2.5747 | 11 | 103 | epithelial tube formation |
GO:0003231 | 1e-04 | 6.0288 | 1.7248 | 9 | 69 | cardiac ventricle development |
GO:0048646 | 1e-04 | 2.3277 | 15.267 | 32 | 627 | anatomical structure formation involved in morphogenesis |
GO:0030326 | 1e-04 | 5.9437 | 1.7438 | 9 | 71 | embryonic limb morphogenesis |
GO:0031326 | 1e-04 | 1.6915 | 67.0184 | 95 | 2681 | regulation of cellular biosynthetic process |
GO:0048704 | 1e-04 | 5.8331 | 1.7748 | 9 | 71 | embryonic skeletal system morphogenesis |
GO:0050767 | 1e-04 | 2.6869 | 9.4241 | 23 | 377 | regulation of neurogenesis |
GO:0007417 | 1e-04 | 4.1266 | 3.2389 | 12 | 139 | central nervous system development |
GO:0003206 | 1e-04 | 5.1623 | 1.9748 | 9 | 79 | cardiac chamber morphogenesis |
GO:0021542 | 2e-04 | 19.798 | 0.3 | 4 | 12 | dentate gyrus development |
GO:0035115 | 2e-04 | 11.0319 | 0.5749 | 5 | 23 | embryonic forelimb morphogenesis |
GO:0021537 | 2e-04 | 3.7293 | 3.5497 | 12 | 142 | telencephalon development |
GO:0010721 | 3e-04 | 4.2784 | 2.5997 | 10 | 104 | negative regulation of cell development |
GO:0009953 | 3e-04 | 4.6896 | 2.1498 | 9 | 86 | dorsal/ventral pattern formation |
GO:2000026 | 3e-04 | 1.9294 | 22.8727 | 40 | 915 | regulation of multicellular organismal development |
GO:0010629 | 4e-04 | 2.0032 | 19.1731 | 35 | 767 | negative regulation of gene expression |
GO:0003279 | 4e-04 | 5.8209 | 1.3749 | 7 | 55 | cardiac septum development |
GO:0007420 | 4e-04 | 2.3514 | 10.6412 | 23 | 433 | brain development |
GO:0045935 | 5e-04 | 1.8614 | 24.8726 | 42 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:0014706 | 5e-04 | 2.9266 | 5.5745 | 15 | 223 | striated muscle tissue development |
GO:0007517 | 5e-04 | 3.9438 | 2.7951 | 10 | 115 | muscle organ development |
GO:0021522 | 5e-04 | 9.0225 | 0.6749 | 5 | 27 | spinal cord motor neuron differentiation |
GO:0021879 | 5e-04 | 6.824 | 1.0249 | 6 | 41 | forebrain neuron differentiation |
GO:0048598 | 5e-04 | 5.5816 | 1.4162 | 7 | 63 | embryonic morphogenesis |
GO:0009891 | 5e-04 | 1.8397 | 25.7725 | 43 | 1031 | positive regulation of biosynthetic process |
GO:0007155 | 5e-04 | 2.0701 | 15.7984 | 30 | 632 | cell adhesion |
GO:0035137 | 6e-04 | 8.6293 | 0.6999 | 5 | 28 | hindlimb morphogenesis |
GO:0003218 | 6e-04 | Inf | 0.05 | 2 | 2 | cardiac left ventricle formation |
GO:0061056 | 6e-04 | Inf | 0.05 | 2 | 2 | sclerotome development |
GO:0072272 | 6e-04 | Inf | 0.05 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0030901 | 7e-04 | 8.2689 | 0.7249 | 5 | 29 | midbrain development |
GO:0021871 | 7e-04 | 12.1772 | 0.425 | 4 | 17 | forebrain regionalization |
GO:0021895 | 7e-04 | 12.1772 | 0.425 | 4 | 17 | cerebral cortex neuron differentiation |
GO:0060706 | 7e-04 | 12.1772 | 0.425 | 4 | 17 | cell differentiation involved in embryonic placenta development |
GO:0048856 | 7e-04 | 1.7415 | 35.8003 | 54 | 1701 | anatomical structure development |
GO:0060021 | 7e-04 | 5.2095 | 1.5142 | 7 | 61 | palate development |
GO:0042472 | 8e-04 | 4.5052 | 1.9748 | 8 | 79 | inner ear morphogenesis |
GO:0061004 | 8e-04 | 23.6701 | 0.2 | 3 | 8 | pattern specification involved in kidney development |
GO:0007626 | 8e-04 | 3.4045 | 3.5247 | 11 | 141 | locomotory behavior |
GO:0021515 | 8e-04 | 11.5114 | 0.4423 | 4 | 18 | cell differentiation in spinal cord |
GO:1902679 | 9e-04 | 1.97 | 17.0983 | 31 | 684 | negative regulation of RNA biosynthetic process |
GO:0044708 | 9e-04 | 2.6292 | 6.5744 | 16 | 263 | single-organism behavior |
GO:2000179 | 9e-04 | 7.6313 | 0.7749 | 5 | 31 | positive regulation of neural precursor cell proliferation |
GO:0060538 | 9e-04 | 3.5842 | 3.0497 | 10 | 122 | skeletal muscle organ development |
GO:0048663 | 0.001 | 7.5451 | 0.7799 | 5 | 32 | neuron fate commitment |
GO:0009952 | 0.001 | 3.8707 | 2.5516 | 9 | 104 | anterior/posterior pattern specification |
GO:0048869 | 0.0011 | 1.9488 | 18.2165 | 32 | 844 | cellular developmental process |
GO:0010719 | 0.0011 | 10.5515 | 0.475 | 4 | 19 | negative regulation of epithelial to mesenchymal transition |
GO:0051171 | 0.0011 | 1.5142 | 75.0676 | 98 | 3003 | regulation of nitrogen compound metabolic process |
GO:0003214 | 0.0011 | 19.8815 | 0.2233 | 3 | 9 | cardiac left ventricle morphogenesis |
GO:0001841 | 0.0012 | 4.1516 | 2.1248 | 8 | 85 | neural tube formation |
GO:0007369 | 0.0014 | 3.3999 | 3.1997 | 10 | 128 | gastrulation |
GO:0046620 | 0.0016 | 5.3022 | 1.2749 | 6 | 51 | regulation of organ growth |
GO:0007501 | 0.0016 | 16.9038 | 0.25 | 3 | 10 | mesodermal cell fate specification |
GO:0060413 | 0.0016 | 16.9038 | 0.25 | 3 | 10 | atrial septum morphogenesis |
GO:0009890 | 0.0016 | 1.8193 | 20.8729 | 35 | 835 | negative regulation of biosynthetic process |
GO:0009887 | 0.0017 | 2.2797 | 8.977 | 19 | 388 | organ morphogenesis |
GO:0051093 | 0.0018 | 2.1261 | 11.1239 | 22 | 445 | negative regulation of developmental process |
GO:0007498 | 0.0018 | 3.8965 | 2.2498 | 8 | 90 | mesoderm development |
GO:0014707 | 0.0018 | 78.619 | 0.075 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0045934 | 0.0019 | 1.8364 | 19.4481 | 33 | 778 | negative regulation of nucleobase-containing compound metabolic process |
GO:0001756 | 0.002 | 5.0755 | 1.3249 | 6 | 53 | somitogenesis |
GO:0043583 | 0.002 | 3.0055 | 3.9496 | 11 | 158 | ear development |
GO:0030878 | 0.0022 | 14.7893 | 0.275 | 3 | 11 | thyroid gland development |
GO:0007267 | 0.0022 | 1.8283 | 18.8981 | 32 | 756 | cell-cell signaling |
GO:0016331 | 0.0023 | 3.3915 | 2.878 | 9 | 116 | morphogenesis of embryonic epithelium |
GO:0032774 | 0.0026 | 1.6902 | 28.1838 | 43 | 1230 | RNA biosynthetic process |
GO:0048666 | 0.0027 | 1.857 | 16.7983 | 29 | 672 | neuron development |
GO:0003215 | 0.0029 | 13.1448 | 0.3 | 3 | 12 | cardiac right ventricle morphogenesis |
GO:0072079 | 0.0029 | 13.1448 | 0.3 | 3 | 12 | nephron tubule formation |
GO:2000113 | 0.0029 | 1.7961 | 19.1981 | 32 | 768 | negative regulation of cellular macromolecule biosynthetic process |
GO:0050789 | 0.003 | 1.4636 | 155.7347 | 177 | 6230 | regulation of biological process |
GO:0000904 | 0.0031 | 1.907 | 14.6236 | 26 | 585 | cell morphogenesis involved in differentiation |
GO:0060485 | 0.0031 | 3.0138 | 3.572 | 10 | 144 | mesenchyme development |
GO:0014014 | 0.0032 | 7.5322 | 0.6249 | 4 | 25 | negative regulation of gliogenesis |
GO:0007156 | 0.0033 | 3.9261 | 1.9498 | 7 | 78 | homophilic cell adhesion |
GO:0022414 | 0.0033 | 1.7926 | 18.5982 | 31 | 744 | reproductive process |
GO:0003211 | 0.0036 | 39.62 | 0.0992 | 2 | 4 | cardiac ventricle formation |
GO:0050877 | 0.0036 | 1.9347 | 13.2737 | 24 | 531 | neurological system process |
GO:0002072 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | optic cup morphogenesis involved in camera-type eye development |
GO:0003166 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | bundle of His development |
GO:0051891 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | positive regulation of cardioblast differentiation |
GO:0060164 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | regulation of timing of neuron differentiation |
GO:0072086 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | specification of loop of Henle identity |
GO:0072162 | 0.0036 | 39.3056 | 0.1 | 2 | 4 | metanephric mesenchymal cell differentiation |
GO:0003148 | 0.0037 | 11.8291 | 0.325 | 3 | 13 | outflow tract septum morphogenesis |
GO:0009566 | 0.0038 | 3.8178 | 1.9998 | 7 | 80 | fertilization |
GO:0060349 | 0.004 | 4.3337 | 1.5248 | 6 | 61 | bone morphogenesis |
GO:0007628 | 0.0043 | 6.8758 | 0.6749 | 4 | 27 | adult walking behavior |
GO:0048514 | 0.0044 | 2.2215 | 7.6742 | 16 | 307 | blood vessel morphogenesis |
GO:0050953 | 0.0045 | 3.3235 | 2.5997 | 8 | 104 | sensory perception of light stimulus |
GO:0021766 | 0.0046 | 6.6904 | 0.6897 | 4 | 28 | hippocampus development |
GO:0098656 | 0.0047 | 3.2889 | 2.6247 | 8 | 105 | anion transmembrane transport |
GO:0048468 | 0.0048 | 2.0144 | 10.6372 | 20 | 462 | cell development |
GO:1902476 | 0.0051 | 4.9533 | 1.1249 | 5 | 45 | chloride transmembrane transport |
GO:0048863 | 0.0051 | 2.4087 | 5.7494 | 13 | 230 | stem cell differentiation |
GO:0045165 | 0.0052 | 3.5748 | 2.1184 | 7 | 90 | cell fate commitment |
GO:0001708 | 0.0055 | 6.3167 | 0.723 | 4 | 30 | cell fate specification |
GO:0048483 | 0.0055 | 6.3245 | 0.7249 | 4 | 29 | autonomic nervous system development |
GO:0030509 | 0.0056 | 3.5256 | 2.1498 | 7 | 86 | BMP signaling pathway |
GO:0035136 | 0.0057 | 26.6829 | 0.1228 | 2 | 5 | forelimb morphogenesis |
GO:0061448 | 0.0057 | 2.74 | 3.8996 | 10 | 156 | connective tissue development |
GO:0072358 | 0.0059 | 1.8256 | 14.5986 | 25 | 584 | cardiovascular system development |
GO:0060017 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | parathyroid gland development |
GO:0060023 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | soft palate development |
GO:0060174 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | limb bud formation |
GO:2000252 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | negative regulation of feeding behavior |
GO:2001012 | 0.0059 | 26.2011 | 0.125 | 2 | 5 | mesenchymal cell differentiation involved in renal system development |
GO:0045665 | 0.0061 | 4.7165 | 1.1749 | 5 | 47 | negative regulation of neuron differentiation |
GO:0003229 | 0.0063 | 6.0806 | 0.7499 | 4 | 30 | ventricular cardiac muscle tissue development |
GO:0045666 | 0.0064 | 3.9051 | 1.6748 | 6 | 67 | positive regulation of neuron differentiation |
GO:0007605 | 0.0072 | 3.3544 | 2.2498 | 7 | 90 | sensory perception of sound |
GO:2000648 | 0.0073 | 4.5012 | 1.2249 | 5 | 49 | positive regulation of stem cell proliferation |
GO:0022604 | 0.0079 | 2.1991 | 6.7493 | 14 | 270 | regulation of cell morphogenesis |
GO:0032989 | 0.0079 | 1.6503 | 21.3729 | 33 | 855 | cellular component morphogenesis |
GO:0010656 | 0.0081 | 8.4459 | 0.425 | 3 | 17 | negative regulation of muscle cell apoptotic process |
GO:0048557 | 0.0081 | 8.4459 | 0.425 | 3 | 17 | embryonic digestive tract morphogenesis |
GO:0015698 | 0.0085 | 3.6633 | 1.7748 | 6 | 71 | inorganic anion transport |
GO:0001655 | 0.0086 | 2.3352 | 5.4495 | 12 | 218 | urogenital system development |
GO:0021796 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | cerebral cortex regionalization |
GO:0035330 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | regulation of hippo signaling |
GO:0060022 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | hard palate development |
GO:0090009 | 0.0087 | 19.6488 | 0.15 | 2 | 6 | primitive streak formation |
GO:0001843 | 0.0091 | 3.6074 | 1.7998 | 6 | 72 | neural tube closure |
GO:0007399 | 0.0095 | 2.5326 | 4.2041 | 10 | 197 | nervous system development |
GO:0045597 | 0.0095 | 1.9849 | 9.066 | 17 | 369 | positive regulation of cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002003 | 1e-04 | 116.4941 | 0.1016 | 3 | 4 | angiotensin maturation |
GO:0050861 | 1e-04 | 116.4941 | 0.1016 | 3 | 4 | positive regulation of B cell receptor signaling pathway |
GO:0051090 | 1e-04 | 3.1047 | 6.0177 | 17 | 237 | regulation of sequence-specific DNA binding transcription factor activity |
GO:0060177 | 2e-04 | 58.2412 | 0.127 | 3 | 5 | regulation of angiotensin metabolic process |
GO:0050778 | 2e-04 | 2.8959 | 6.8048 | 18 | 268 | positive regulation of immune response |
GO:0009611 | 2e-04 | 2.2087 | 14.3714 | 29 | 566 | response to wounding |
GO:0032410 | 3e-04 | 10.2808 | 0.6094 | 5 | 24 | negative regulation of transporter activity |
GO:0072676 | 4e-04 | 9.7658 | 0.6348 | 5 | 25 | lymphocyte migration |
GO:0050714 | 4e-04 | 5.976 | 1.3457 | 7 | 53 | positive regulation of protein secretion |
GO:0002757 | 4e-04 | 2.9948 | 5.4591 | 15 | 215 | immune response-activating signal transduction |
GO:0015718 | 4e-04 | 4.9981 | 1.8028 | 8 | 71 | monocarboxylic acid transport |
GO:0033209 | 4e-04 | 9.2998 | 0.6602 | 5 | 26 | tumor necrosis factor-mediated signaling pathway |
GO:0044707 | 4e-04 | 1.5465 | 92.0923 | 118 | 3691 | single-multicellular organism process |
GO:0048665 | 5e-04 | 8.8762 | 0.6856 | 5 | 27 | neuron fate specification |
GO:0045597 | 5e-04 | 2.3504 | 10.155 | 22 | 405 | positive regulation of cell differentiation |
GO:0050707 | 5e-04 | 6.7129 | 1.041 | 6 | 41 | regulation of cytokine secretion |
GO:0071637 | 6e-04 | Inf | 0.0508 | 2 | 2 | regulation of monocyte chemotactic protein-1 production |
GO:0006954 | 7e-04 | 2.6059 | 7.0588 | 17 | 278 | inflammatory response |
GO:0050851 | 8e-04 | 4.4951 | 1.9805 | 8 | 78 | antigen receptor-mediated signaling pathway |
GO:0042035 | 9e-04 | 6.022 | 1.1426 | 6 | 45 | regulation of cytokine biosynthetic process |
GO:0048869 | 0.0011 | 1.5476 | 59.4408 | 81 | 2341 | cellular developmental process |
GO:0032844 | 0.0012 | 2.899 | 4.8497 | 13 | 191 | regulation of homeostatic process |
GO:0001991 | 0.0012 | 19.4059 | 0.2285 | 3 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0034104 | 0.0012 | 19.4059 | 0.2285 | 3 | 9 | negative regulation of tissue remodeling |
GO:0071706 | 0.0013 | 5.5901 | 1.2188 | 6 | 48 | tumor necrosis factor superfamily cytokine production |
GO:0048731 | 0.0013 | 1.5755 | 51.9322 | 72 | 2129 | system development |
GO:0051239 | 0.0014 | 1.655 | 35.3192 | 53 | 1391 | regulation of multicellular organismal process |
GO:0030168 | 0.0017 | 3.0833 | 3.8595 | 11 | 152 | platelet activation |
GO:0050482 | 0.0017 | 16.6319 | 0.2539 | 3 | 10 | arachidonic acid secretion |
GO:2000404 | 0.0017 | 16.6319 | 0.2539 | 3 | 10 | regulation of T cell migration |
GO:1902105 | 0.0017 | 3.2873 | 3.3009 | 10 | 130 | regulation of leukocyte differentiation |
GO:0042107 | 0.0017 | 5.2159 | 1.295 | 6 | 51 | cytokine metabolic process |
GO:0043010 | 0.0018 | 2.742 | 5.1036 | 13 | 201 | camera-type eye development |
GO:0002019 | 0.0019 | 77.3594 | 0.0762 | 2 | 3 | regulation of renal output by angiotensin |
GO:0050793 | 0.0019 | 1.6691 | 30.7995 | 47 | 1213 | regulation of developmental process |
GO:0046903 | 0.002 | 1.9464 | 14.93 | 27 | 588 | secretion |
GO:0001990 | 0.0021 | 8.6483 | 0.5586 | 4 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:2000649 | 0.0021 | 8.6483 | 0.5586 | 4 | 22 | regulation of sodium ion transmembrane transporter activity |
GO:0007187 | 0.0021 | 3.786 | 2.3106 | 8 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0045577 | 0.0023 | 14.5515 | 0.2793 | 3 | 11 | regulation of B cell differentiation |
GO:0001819 | 0.0027 | 2.8956 | 4.088 | 11 | 161 | positive regulation of cytokine production |
GO:0007155 | 0.0028 | 1.8743 | 16.0472 | 28 | 632 | cell adhesion |
GO:0015837 | 0.0029 | 5.7365 | 0.9903 | 5 | 39 | amine transport |
GO:0046850 | 0.0029 | 7.7819 | 0.6094 | 4 | 24 | regulation of bone remodeling |
GO:0051092 | 0.0031 | 3.9747 | 1.9297 | 7 | 76 | positive regulation of NF-kappaB transcription factor activity |
GO:0001894 | 0.0032 | 3.5286 | 2.4629 | 8 | 97 | tissue homeostasis |
GO:0002693 | 0.0037 | 38.6758 | 0.1016 | 2 | 4 | positive regulation of cellular extravasation |
GO:0090197 | 0.0037 | 38.6758 | 0.1016 | 2 | 4 | positive regulation of chemokine secretion |
GO:2000977 | 0.0037 | 38.6758 | 0.1016 | 2 | 4 | regulation of forebrain neuron differentiation |
GO:0051354 | 0.0038 | 11.6388 | 0.3301 | 3 | 13 | negative regulation of oxidoreductase activity |
GO:0071715 | 0.0038 | 11.6388 | 0.3301 | 3 | 13 | icosanoid transport |
GO:0001974 | 0.0039 | 7.073 | 0.6602 | 4 | 26 | blood vessel remodeling |
GO:0043271 | 0.004 | 5.2697 | 1.0664 | 5 | 42 | negative regulation of ion transport |
GO:0015672 | 0.0043 | 2.2985 | 6.9572 | 15 | 274 | monovalent inorganic cation transport |
GO:0051674 | 0.0043 | 1.7734 | 18.1293 | 30 | 714 | localization of cell |
GO:0007586 | 0.0044 | 4.2632 | 1.5489 | 6 | 61 | digestion |
GO:0045580 | 0.0044 | 4.2632 | 1.5489 | 6 | 61 | regulation of T cell differentiation |
GO:0050671 | 0.0044 | 4.2632 | 1.5489 | 6 | 61 | positive regulation of lymphocyte proliferation |
GO:0007200 | 0.0044 | 5.1305 | 1.0918 | 5 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002673 | 0.0045 | 6.7648 | 0.6856 | 4 | 27 | regulation of acute inflammatory response |
GO:0030199 | 0.0045 | 6.7648 | 0.6856 | 4 | 27 | collagen fibril organization |
GO:0060216 | 0.0048 | 10.5797 | 0.3555 | 3 | 14 | definitive hemopoiesis |
GO:0090322 | 0.0048 | 10.5797 | 0.3555 | 3 | 14 | regulation of superoxide metabolic process |
GO:0040011 | 0.005 | 1.6605 | 23.9693 | 37 | 944 | locomotion |
GO:0070665 | 0.0051 | 4.1128 | 1.5996 | 6 | 63 | positive regulation of leukocyte proliferation |
GO:0032680 | 0.0054 | 4.873 | 1.1426 | 5 | 45 | regulation of tumor necrosis factor production |
GO:0016477 | 0.0057 | 1.7709 | 16.8851 | 28 | 665 | cell migration |
GO:0071773 | 0.0059 | 9.6971 | 0.3809 | 3 | 15 | cellular response to BMP stimulus |
GO:0001778 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | plasma membrane repair |
GO:0003298 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | physiological muscle hypertrophy |
GO:0045086 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | positive regulation of interleukin-2 biosynthetic process |
GO:0045779 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | negative regulation of bone resorption |
GO:0061049 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | cell growth involved in cardiac muscle cell development |
GO:1901017 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | negative regulation of potassium ion transmembrane transporter activity |
GO:2000778 | 0.0061 | 25.7812 | 0.127 | 2 | 5 | positive regulation of interleukin-6 secretion |
GO:0002520 | 0.0061 | 1.8964 | 12.3401 | 22 | 486 | immune system development |
GO:0009887 | 0.0062 | 1.7948 | 15.4379 | 26 | 608 | organ morphogenesis |
GO:0003073 | 0.0065 | 4.64 | 1.1934 | 5 | 47 | regulation of systemic arterial blood pressure |
GO:0050871 | 0.0066 | 5.9824 | 0.7617 | 4 | 30 | positive regulation of B cell activation |
GO:0002768 | 0.0068 | 2.4159 | 5.2814 | 12 | 208 | immune response-regulating cell surface receptor signaling pathway |
GO:0032088 | 0.0071 | 4.5317 | 1.2188 | 5 | 48 | negative regulation of NF-kappaB transcription factor activity |
GO:0032944 | 0.0074 | 3.3402 | 2.2598 | 7 | 89 | regulation of mononuclear cell proliferation |
GO:0045600 | 0.0075 | 5.7603 | 0.7871 | 4 | 31 | positive regulation of fat cell differentiation |
GO:0030001 | 0.0078 | 1.9116 | 11.096 | 20 | 437 | metal ion transport |
GO:0048663 | 0.0079 | 5.6529 | 0.7989 | 4 | 32 | neuron fate commitment |
GO:0045321 | 0.0079 | 2.0272 | 8.8869 | 17 | 350 | leukocyte activation |
GO:0007631 | 0.008 | 3.7188 | 1.752 | 6 | 69 | feeding behavior |
GO:0051249 | 0.0081 | 2.4613 | 4.7482 | 11 | 187 | regulation of lymphocyte activation |
GO:0009968 | 0.0083 | 1.75 | 15.7933 | 26 | 622 | negative regulation of signal transduction |
GO:0032602 | 0.0083 | 5.554 | 0.8125 | 4 | 32 | chemokine production |
GO:0050848 | 0.0085 | 8.3101 | 0.4317 | 3 | 17 | regulation of calcium-mediated signaling |
GO:0030098 | 0.0086 | 2.5696 | 4.1388 | 10 | 163 | lymphocyte differentiation |
GO:0007599 | 0.0087 | 2.0528 | 8.2521 | 16 | 325 | hemostasis |
GO:0032930 | 0.009 | 19.334 | 0.1523 | 2 | 6 | positive regulation of superoxide anion generation |
GO:0042178 | 0.009 | 19.334 | 0.1523 | 2 | 6 | xenobiotic catabolic process |
GO:0051001 | 0.009 | 19.334 | 0.1523 | 2 | 6 | negative regulation of nitric-oxide synthase activity |
GO:1900746 | 0.009 | 19.334 | 0.1523 | 2 | 6 | regulation of vascular endothelial growth factor signaling pathway |
GO:0042445 | 0.0093 | 3.1835 | 2.3614 | 7 | 93 | hormone metabolic process |
GO:0043524 | 0.0093 | 3.1835 | 2.3614 | 7 | 93 | negative regulation of neuron apoptotic process |
GO:0048538 | 0.0093 | 5.3619 | 0.8379 | 4 | 33 | thymus development |
GO:0097530 | 0.0093 | 5.3619 | 0.8379 | 4 | 33 | granulocyte migration |
GO:0001525 | 0.0094 | 2.2217 | 6.1955 | 13 | 244 | angiogenesis |
GO:0048864 | 0.0095 | 2.4056 | 4.8497 | 11 | 191 | stem cell development |
GO:0048583 | 0.0096 | 1.4311 | 50.3761 | 66 | 1984 | regulation of response to stimulus |
GO:0032652 | 0.01 | 7.7553 | 0.457 | 3 | 18 | regulation of interleukin-1 production |
GO:0002685 | 0.01 | 4.1443 | 1.3203 | 5 | 52 | regulation of leukocyte migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 721.4286 | 0.0295 | 4 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 29.9911 | 0.1653 | 4 | 28 | detection of chemical stimulus |
GO:0050906 | 1e-04 | 21.7922 | 0.2185 | 4 | 37 | detection of stimulus involved in sensory perception |
GO:0007606 | 1e-04 | 19.9702 | 0.2362 | 4 | 40 | sensory perception of chemical stimulus |
GO:0071435 | 7e-04 | 69.6276 | 0.0413 | 2 | 7 | potassium ion export |
GO:0050877 | 0.001 | 3.6775 | 3.1355 | 10 | 531 | neurological system process |
GO:0031424 | 0.0015 | 43.5043 | 0.059 | 2 | 10 | keratinization |
GO:0045332 | 0.0026 | 31.6301 | 0.0768 | 2 | 13 | phospholipid translocation |
GO:0030322 | 0.0059 | Inf | 0.0059 | 1 | 1 | stabilization of membrane potential |
GO:0048681 | 0.0059 | Inf | 0.0059 | 1 | 1 | negative regulation of axon regeneration |
GO:0070512 | 0.0059 | Inf | 0.0059 | 1 | 1 | positive regulation of histone H4-K20 methylation |
GO:2000617 | 0.0059 | Inf | 0.0059 | 1 | 1 | positive regulation of histone H3-K9 acetylation |
GO:2000620 | 0.0059 | Inf | 0.0059 | 1 | 1 | positive regulation of histone H4-K16 acetylation |
GO:0097035 | 0.008 | 16.5517 | 0.1358 | 2 | 23 | regulation of membrane lipid distribution |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0071294 | 0 | 42.3803 | 0.2352 | 5 | 10 | cellular response to zinc ion |
GO:0007389 | 0 | 3.3237 | 7.7856 | 23 | 331 | pattern specification process |
GO:0032501 | 0 | 1.8055 | 91.1215 | 125 | 3874 | multicellular organismal process |
GO:0015850 | 0 | 5.6483 | 2.4462 | 12 | 104 | organic hydroxy compound transport |
GO:0003207 | 0 | 42.2043 | 0.1882 | 4 | 8 | cardiac chamber formation |
GO:0071276 | 0 | 42.2043 | 0.1882 | 4 | 8 | cellular response to cadmium ion |
GO:0060173 | 0 | 4.5888 | 2.9402 | 12 | 125 | limb development |
GO:0098660 | 0 | 2.8659 | 8.4912 | 22 | 361 | inorganic ion transmembrane transport |
GO:0051954 | 1e-04 | 15.1221 | 0.4469 | 5 | 19 | positive regulation of amine transport |
GO:0030326 | 1e-04 | 5.1144 | 2.211 | 10 | 94 | embryonic limb morphogenesis |
GO:0051967 | 1e-04 | 63.0508 | 0.1176 | 3 | 5 | negative regulation of synaptic transmission, glutamatergic |
GO:0032892 | 1e-04 | 21.0936 | 0.2823 | 4 | 12 | positive regulation of organic acid transport |
GO:0048265 | 1e-04 | 12.4497 | 0.5175 | 5 | 22 | response to pain |
GO:0048878 | 2e-04 | 2.5206 | 10.0091 | 23 | 434 | chemical homeostasis |
GO:0098656 | 2e-04 | 4.5171 | 2.4697 | 10 | 105 | anion transmembrane transport |
GO:0044062 | 2e-04 | 18.748 | 0.3058 | 4 | 13 | regulation of excretion |
GO:0007267 | 2e-04 | 2.1134 | 17.7821 | 34 | 756 | cell-cell signaling |
GO:0035107 | 2e-04 | 4.3328 | 2.5638 | 10 | 109 | appendage morphogenesis |
GO:0060261 | 2e-04 | 42.0297 | 0.1411 | 3 | 6 | positive regulation of transcription initiation from RNA polymerase II promoter |
GO:0015698 | 2e-04 | 5.4196 | 1.67 | 8 | 71 | inorganic anion transport |
GO:0021854 | 2e-04 | 16.8715 | 0.3293 | 4 | 14 | hypothalamus development |
GO:0051412 | 2e-04 | 16.8715 | 0.3293 | 4 | 14 | response to corticosterone |
GO:0072359 | 3e-04 | 2.2354 | 13.7364 | 28 | 584 | circulatory system development |
GO:0009790 | 3e-04 | 2.0911 | 17.3822 | 33 | 739 | embryo development |
GO:0048513 | 3e-04 | 1.7964 | 34.8618 | 55 | 1538 | organ development |
GO:0007586 | 3e-04 | 6.1304 | 1.3068 | 7 | 56 | digestion |
GO:0042753 | 4e-04 | 31.5191 | 0.1646 | 3 | 7 | positive regulation of circadian rhythm |
GO:0048663 | 4e-04 | 5.727 | 1.3878 | 7 | 59 | neuron fate commitment |
GO:0007631 | 5e-04 | 8.7707 | 0.6817 | 5 | 30 | feeding behavior |
GO:0003218 | 6e-04 | Inf | 0.047 | 2 | 2 | cardiac left ventricle formation |
GO:0010949 | 6e-04 | Inf | 0.047 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0045796 | 6e-04 | Inf | 0.047 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:1902476 | 6e-04 | 6.5256 | 1.0585 | 6 | 45 | chloride transmembrane transport |
GO:0030001 | 6e-04 | 2.3225 | 10.2788 | 22 | 437 | metal ion transport |
GO:1902358 | 7e-04 | 25.2127 | 0.1882 | 3 | 8 | sulfate transmembrane transport |
GO:0055085 | 7e-04 | 2.4124 | 9.0121 | 20 | 407 | transmembrane transport |
GO:0055078 | 7e-04 | 12.0462 | 0.4234 | 4 | 18 | sodium ion homeostasis |
GO:0071241 | 9e-04 | 5.0439 | 1.5524 | 7 | 66 | cellular response to inorganic substance |
GO:0021983 | 0.001 | 7.5504 | 0.7762 | 5 | 33 | pituitary gland development |
GO:0060079 | 0.001 | 7.5504 | 0.7762 | 5 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0035815 | 0.001 | 21.0085 | 0.2117 | 3 | 9 | positive regulation of renal sodium excretion |
GO:0031960 | 0.001 | 4.315 | 2.0464 | 8 | 87 | response to corticosteroid |
GO:0043009 | 0.0011 | 2.2218 | 10.7022 | 22 | 455 | chordate embryonic development |
GO:0042755 | 0.0011 | 10.5383 | 0.4704 | 4 | 20 | eating behavior |
GO:0001662 | 0.0013 | 9.9174 | 0.4939 | 4 | 21 | behavioral fear response |
GO:0050982 | 0.0013 | 9.9174 | 0.4939 | 4 | 21 | detection of mechanical stimulus |
GO:0072348 | 0.0013 | 9.9174 | 0.4939 | 4 | 21 | sulfur compound transport |
GO:0003013 | 0.0013 | 2.7313 | 5.5275 | 14 | 235 | circulatory system process |
GO:0010628 | 0.0014 | 1.8313 | 21.4514 | 36 | 912 | positive regulation of gene expression |
GO:0014061 | 0.0014 | 18.0054 | 0.2352 | 3 | 10 | regulation of norepinephrine secretion |
GO:0032502 | 0.0014 | 1.5047 | 80.5605 | 103 | 3425 | developmental process |
GO:0055080 | 0.0014 | 2.517 | 6.8447 | 16 | 291 | cation homeostasis |
GO:0043270 | 0.0014 | 4.0561 | 2.164 | 8 | 92 | positive regulation of ion transport |
GO:0010817 | 0.0014 | 2.6014 | 6.2096 | 15 | 264 | regulation of hormone levels |
GO:0042632 | 0.0014 | 6.8176 | 0.8468 | 5 | 36 | cholesterol homeostasis |
GO:0001944 | 0.0016 | 2.2873 | 8.9381 | 19 | 380 | vasculature development |
GO:0002125 | 0.0016 | 83.7215 | 0.0706 | 2 | 3 | maternal aggressive behavior |
GO:0003219 | 0.0016 | 83.7215 | 0.0706 | 2 | 3 | cardiac right ventricle formation |
GO:0045472 | 0.0016 | 83.7215 | 0.0706 | 2 | 3 | response to ether |
GO:0051464 | 0.0016 | 83.7215 | 0.0706 | 2 | 3 | positive regulation of cortisol secretion |
GO:2001199 | 0.0016 | 83.7215 | 0.0706 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0051241 | 0.0017 | 2.7679 | 5.0571 | 13 | 215 | negative regulation of multicellular organismal process |
GO:0008589 | 0.0018 | 5.1886 | 1.2937 | 6 | 55 | regulation of smoothened signaling pathway |
GO:0015812 | 0.0018 | 15.7532 | 0.2587 | 3 | 11 | gamma-aminobutyric acid transport |
GO:0042745 | 0.0018 | 15.7532 | 0.2587 | 3 | 11 | circadian sleep/wake cycle |
GO:0070471 | 0.0018 | 15.7532 | 0.2587 | 3 | 11 | uterine smooth muscle contraction |
GO:0042221 | 0.0019 | 1.5727 | 46.443 | 65 | 2011 | response to chemical |
GO:0048562 | 0.002 | 3.4709 | 2.8127 | 9 | 122 | embryonic organ morphogenesis |
GO:0045777 | 0.0022 | 8.4272 | 0.5645 | 4 | 24 | positive regulation of blood pressure |
GO:0045944 | 0.0023 | 1.9554 | 14.3245 | 26 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0055088 | 0.0023 | 4.8878 | 1.3642 | 6 | 58 | lipid homeostasis |
GO:0015844 | 0.0023 | 6.036 | 0.9409 | 5 | 40 | monoamine transport |
GO:0007156 | 0.0023 | 4.1863 | 1.8347 | 7 | 78 | homophilic cell adhesion |
GO:0055074 | 0.0023 | 2.9436 | 4.0221 | 11 | 171 | calcium ion homeostasis |
GO:0046394 | 0.0024 | 2.7823 | 4.6337 | 12 | 197 | carboxylic acid biosynthetic process |
GO:0050954 | 0.0024 | 3.7004 | 2.3521 | 8 | 100 | sensory perception of mechanical stimulus |
GO:0015874 | 0.0024 | 14.0014 | 0.2823 | 3 | 12 | norepinephrine transport |
GO:0071242 | 0.0024 | 14.0014 | 0.2823 | 3 | 12 | cellular response to ammonium ion |
GO:0048514 | 0.0024 | 2.3746 | 7.221 | 16 | 307 | blood vessel morphogenesis |
GO:0050432 | 0.0026 | 8.0251 | 0.588 | 4 | 25 | catecholamine secretion |
GO:0021879 | 0.0026 | 5.8678 | 0.9644 | 5 | 41 | forebrain neuron differentiation |
GO:0072503 | 0.0029 | 2.8529 | 4.1398 | 11 | 176 | cellular divalent inorganic cation homeostasis |
GO:0042220 | 0.003 | 7.6596 | 0.6116 | 4 | 26 | response to cocaine |
GO:0006875 | 0.0031 | 2.5726 | 5.4099 | 13 | 230 | cellular metal ion homeostasis |
GO:0048863 | 0.0031 | 2.5726 | 5.4099 | 13 | 230 | stem cell differentiation |
GO:0098655 | 0.0031 | 2.195 | 8.7734 | 18 | 373 | cation transmembrane transport |
GO:0000097 | 0.0031 | 12.6 | 0.3058 | 3 | 13 | sulfur amino acid biosynthetic process |
GO:2000142 | 0.0031 | 12.6 | 0.3058 | 3 | 13 | regulation of DNA-templated transcription, initiation |
GO:0003166 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | bundle of His development |
GO:0014054 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0042538 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | hyperosmotic salinity response |
GO:0051386 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | regulation of neurotrophin TRK receptor signaling pathway |
GO:0051891 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | positive regulation of cardioblast differentiation |
GO:0060677 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | ureteric bud elongation |
GO:2000848 | 0.0032 | 41.8565 | 0.0941 | 2 | 4 | positive regulation of corticosteroid hormone secretion |
GO:0003208 | 0.0032 | 5.5578 | 1.0114 | 5 | 43 | cardiac ventricle morphogenesis |
GO:0050886 | 0.0032 | 5.5578 | 1.0114 | 5 | 43 | endocrine process |
GO:0006873 | 0.0032 | 2.4577 | 6.092 | 14 | 259 | cellular ion homeostasis |
GO:0050877 | 0.0034 | 1.9733 | 12.4898 | 23 | 531 | neurological system process |
GO:0032370 | 0.0034 | 7.3258 | 0.6351 | 4 | 27 | positive regulation of lipid transport |
GO:0030431 | 0.0039 | 11.4534 | 0.3293 | 3 | 14 | sleep |
GO:1901615 | 0.0039 | 2.323 | 6.8917 | 15 | 293 | organic hydroxy compound metabolic process |
GO:0021515 | 0.0039 | 5.2788 | 1.0585 | 5 | 45 | cell differentiation in spinal cord |
GO:0035136 | 0.0039 | 7.0199 | 0.6586 | 4 | 28 | forelimb morphogenesis |
GO:0009952 | 0.0039 | 2.9038 | 3.6928 | 10 | 157 | anterior/posterior pattern specification |
GO:0035295 | 0.0039 | 2.0508 | 10.4199 | 20 | 443 | tube development |
GO:0007218 | 0.0041 | 4.3048 | 1.5289 | 6 | 65 | neuropeptide signaling pathway |
GO:0060429 | 0.0042 | 1.8179 | 16.5355 | 28 | 703 | epithelium development |
GO:0048729 | 0.0043 | 2.1205 | 9.0557 | 18 | 385 | tissue morphogenesis |
GO:0003014 | 0.0043 | 5.1496 | 1.082 | 5 | 46 | renal system process |
GO:0010043 | 0.0045 | 10.7197 | 0.3458 | 3 | 15 | response to zinc ion |
GO:1902680 | 0.0045 | 1.7253 | 20.6047 | 33 | 876 | positive regulation of RNA biosynthetic process |
GO:0001967 | 0.0047 | 10.4979 | 0.3528 | 3 | 15 | suckling behavior |
GO:0045666 | 0.0048 | 4.1628 | 1.5759 | 6 | 67 | positive regulation of neuron differentiation |
GO:0008217 | 0.0048 | 4.1583 | 1.5764 | 6 | 68 | regulation of blood pressure |
GO:0051480 | 0.0048 | 3.2694 | 2.6344 | 8 | 112 | cytosolic calcium ion homeostasis |
GO:0050804 | 0.0049 | 2.8068 | 3.8105 | 10 | 162 | regulation of synaptic transmission |
GO:0006805 | 0.0052 | 4.0953 | 1.5994 | 6 | 68 | xenobiotic metabolic process |
GO:0007613 | 0.0052 | 4.0953 | 1.5994 | 6 | 68 | memory |
GO:0044070 | 0.0052 | 4.9091 | 1.129 | 5 | 48 | regulation of anion transport |
GO:0003263 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | cardioblast proliferation |
GO:0003278 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | apoptotic process involved in heart morphogenesis |
GO:0009698 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | phenylpropanoid metabolic process |
GO:0030643 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | cellular phosphate ion homeostasis |
GO:0042756 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | drinking behavior |
GO:0044241 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | lipid digestion |
GO:0050966 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0052803 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | imidazole-containing compound metabolic process |
GO:2000252 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | negative regulation of feeding behavior |
GO:2000849 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | regulation of glucocorticoid secretion |
GO:2001300 | 0.0053 | 27.9015 | 0.1176 | 2 | 5 | lipoxin metabolic process |
GO:0060562 | 0.0054 | 2.392 | 5.7862 | 13 | 246 | epithelial tube morphogenesis |
GO:0033993 | 0.0054 | 2.0242 | 9.9966 | 19 | 425 | response to lipid |
GO:0006816 | 0.0057 | 2.5965 | 4.5161 | 11 | 192 | calcium ion transport |
GO:0007423 | 0.006 | 2.0943 | 8.6323 | 17 | 367 | sensory organ development |
GO:0007626 | 0.006 | 2.9022 | 3.3165 | 9 | 141 | locomotory behavior |
GO:0003205 | 0.0062 | 3.4509 | 2.1875 | 7 | 93 | cardiac chamber development |
GO:0009410 | 0.0068 | 3.8455 | 1.6935 | 6 | 72 | response to xenobiotic stimulus |
GO:0010876 | 0.0068 | 2.6643 | 3.9986 | 10 | 170 | lipid localization |
GO:0007622 | 0.0068 | 8.9964 | 0.3999 | 3 | 17 | rhythmic behavior |
GO:0010656 | 0.0068 | 8.9964 | 0.3999 | 3 | 17 | negative regulation of muscle cell apoptotic process |
GO:0016486 | 0.0068 | 8.9964 | 0.3999 | 3 | 17 | peptide hormone processing |
GO:0070098 | 0.0068 | 8.9964 | 0.3999 | 3 | 17 | chemokine-mediated signaling pathway |
GO:0034765 | 0.0071 | 2.5116 | 4.6572 | 11 | 198 | regulation of ion transmembrane transport |
GO:0035051 | 0.0073 | 3.7877 | 1.7171 | 6 | 73 | cardiocyte differentiation |
GO:0007215 | 0.0073 | 4.4895 | 1.2231 | 5 | 52 | glutamate receptor signaling pathway |
GO:0015833 | 0.0074 | 2.6309 | 4.0457 | 10 | 172 | peptide transport |
GO:0045137 | 0.0075 | 2.7948 | 3.4341 | 9 | 146 | development of primary sexual characteristics |
GO:0007417 | 0.0076 | 1.8079 | 14.1363 | 24 | 601 | central nervous system development |
GO:0003266 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | regulation of secondary heart field cardioblast proliferation |
GO:0014048 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | regulation of glutamate secretion |
GO:0034433 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | steroid esterification |
GO:0034435 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | cholesterol esterification |
GO:0042713 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | sperm ejaculation |
GO:0060456 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | positive regulation of digestive system process |
GO:0060973 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | cell migration involved in heart development |
GO:0090009 | 0.0078 | 20.9241 | 0.1411 | 2 | 6 | primitive streak formation |
GO:0048608 | 0.0079 | 2.1992 | 6.7506 | 14 | 287 | reproductive structure development |
GO:0046717 | 0.0079 | 4.3955 | 1.2466 | 5 | 53 | acid secretion |
GO:0006699 | 0.0081 | 8.3958 | 0.4234 | 3 | 18 | bile acid biosynthetic process |
GO:0030818 | 0.0081 | 8.3958 | 0.4234 | 3 | 18 | negative regulation of cAMP biosynthetic process |
GO:0060081 | 0.0081 | 8.3958 | 0.4234 | 3 | 18 | membrane hyperpolarization |
GO:0001501 | 0.0082 | 2.1258 | 7.4798 | 15 | 318 | skeletal system development |
GO:0042471 | 0.0082 | 3.2596 | 2.3051 | 7 | 98 | ear morphogenesis |
GO:0071805 | 0.0082 | 3.2596 | 2.3051 | 7 | 98 | potassium ion transmembrane transport |
GO:0052652 | 0.0083 | 3.6772 | 1.7641 | 6 | 75 | cyclic purine nucleotide metabolic process |
GO:2000021 | 0.0083 | 3.6772 | 1.7641 | 6 | 75 | regulation of ion homeostasis |
GO:0032787 | 0.0084 | 2.1186 | 7.5033 | 15 | 319 | monocarboxylic acid metabolic process |
GO:0044283 | 0.0086 | 2.1746 | 6.8212 | 14 | 290 | small molecule biosynthetic process |
GO:0022414 | 0.0089 | 1.7062 | 17.4999 | 28 | 744 | reproductive process |
GO:0010719 | 0.0094 | 7.8702 | 0.4469 | 3 | 19 | negative regulation of epithelial to mesenchymal transition |
GO:0045823 | 0.0094 | 7.8702 | 0.4469 | 3 | 19 | positive regulation of heart contraction |
GO:0045923 | 0.0094 | 7.8702 | 0.4469 | 3 | 19 | positive regulation of fatty acid metabolic process |
GO:0048169 | 0.0094 | 7.8702 | 0.4469 | 3 | 19 | regulation of long-term neuronal synaptic plasticity |
GO:0072511 | 0.0094 | 2.4066 | 4.8454 | 11 | 206 | divalent inorganic cation transport |
GO:0032409 | 0.0096 | 3.1546 | 2.3757 | 7 | 101 | regulation of transporter activity |
GO:0003281 | 0.0097 | 5.2606 | 0.8468 | 4 | 36 | ventricular septum development |
GO:0030301 | 0.0097 | 5.2606 | 0.8468 | 4 | 36 | cholesterol transport |
GO:0048645 | 0.0097 | 5.2606 | 0.8468 | 4 | 36 | organ formation |
GO:0008584 | 0.01 | 3.5229 | 1.8347 | 6 | 78 | male gonad development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032103 | 0 | 5.6591 | 2.0101 | 10 | 95 | positive regulation of response to external stimulus |
GO:2000026 | 2e-04 | 2.0746 | 19.3608 | 36 | 915 | regulation of multicellular organismal development |
GO:0010477 | 4e-04 | Inf | 0.0423 | 2 | 2 | response to sulfur dioxide |
GO:0010641 | 4e-04 | Inf | 0.0423 | 2 | 2 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0010751 | 4e-04 | Inf | 0.0423 | 2 | 2 | negative regulation of nitric oxide mediated signal transduction |
GO:0050920 | 5e-04 | 5.545 | 1.4177 | 7 | 67 | regulation of chemotaxis |
GO:0002685 | 5e-04 | 6.6748 | 1.0275 | 6 | 49 | regulation of leukocyte migration |
GO:0033273 | 5e-04 | 6.6116 | 1.0368 | 6 | 49 | response to vitamin |
GO:0048520 | 8e-04 | 6.1785 | 1.1003 | 6 | 52 | positive regulation of behavior |
GO:0009611 | 9e-04 | 2.1802 | 11.9762 | 24 | 566 | response to wounding |
GO:0060326 | 0.0011 | 4.2323 | 2.0736 | 8 | 98 | cell chemotaxis |
GO:0007598 | 0.0013 | 93.3803 | 0.0635 | 2 | 3 | blood coagulation, extrinsic pathway |
GO:0071675 | 0.0013 | 93.3803 | 0.0635 | 2 | 3 | regulation of mononuclear cell migration |
GO:0090237 | 0.0013 | 93.3803 | 0.0635 | 2 | 3 | regulation of arachidonic acid secretion |
GO:0002675 | 0.0014 | 17.579 | 0.2328 | 3 | 11 | positive regulation of acute inflammatory response |
GO:0030194 | 0.0014 | 17.579 | 0.2328 | 3 | 11 | positive regulation of blood coagulation |
GO:0071622 | 0.0014 | 17.579 | 0.2328 | 3 | 11 | regulation of granulocyte chemotaxis |
GO:0002690 | 0.0015 | 9.4085 | 0.5078 | 4 | 24 | positive regulation of leukocyte chemotaxis |
GO:0098656 | 0.0017 | 3.9241 | 2.2217 | 8 | 105 | anion transmembrane transport |
GO:0051272 | 0.0022 | 2.976 | 3.978 | 11 | 188 | positive regulation of cellular component movement |
GO:0045744 | 0.0022 | 6.0482 | 0.931 | 5 | 44 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0045785 | 0.0024 | 3.6933 | 2.3487 | 8 | 111 | positive regulation of cell adhesion |
GO:0040017 | 0.0025 | 2.9091 | 4.0626 | 11 | 192 | positive regulation of locomotion |
GO:0006551 | 0.0026 | 46.6854 | 0.0846 | 2 | 4 | leucine metabolic process |
GO:0060708 | 0.0026 | 46.6854 | 0.0846 | 2 | 4 | spongiotrophoblast differentiation |
GO:0031345 | 0.0029 | 4.6521 | 1.4177 | 6 | 67 | negative regulation of cell projection organization |
GO:0051897 | 0.003 | 5.6145 | 0.9945 | 5 | 47 | positive regulation of protein kinase B signaling |
GO:0042119 | 0.0035 | 11.7146 | 0.3174 | 3 | 15 | neutrophil activation |
GO:0010975 | 0.0038 | 2.754 | 4.2742 | 11 | 202 | regulation of neuron projection development |
GO:0015711 | 0.0038 | 2.754 | 4.2742 | 11 | 202 | organic anion transport |
GO:0050817 | 0.0038 | 2.3313 | 6.8768 | 15 | 325 | coagulation |
GO:0002689 | 0.0043 | 31.1205 | 0.1058 | 2 | 5 | negative regulation of leukocyte chemotaxis |
GO:0010758 | 0.0043 | 31.1205 | 0.1058 | 2 | 5 | regulation of macrophage chemotaxis |
GO:2000192 | 0.0043 | 31.1205 | 0.1058 | 2 | 5 | negative regulation of fatty acid transport |
GO:0030335 | 0.0044 | 2.8564 | 3.7452 | 10 | 177 | positive regulation of cell migration |
GO:0045765 | 0.0047 | 3.6446 | 2.0736 | 7 | 98 | regulation of angiogenesis |
GO:0050878 | 0.0048 | 2.1496 | 8.4426 | 17 | 399 | regulation of body fluid levels |
GO:0097530 | 0.0049 | 6.4828 | 0.6983 | 4 | 33 | granulocyte migration |
GO:0051094 | 0.0056 | 1.9178 | 12.2724 | 22 | 580 | positive regulation of developmental process |
GO:0009266 | 0.0057 | 3.9929 | 1.6293 | 6 | 77 | response to temperature stimulus |
GO:0061041 | 0.006 | 4.7124 | 1.1638 | 5 | 55 | regulation of wound healing |
GO:0002544 | 0.0063 | 23.338 | 0.127 | 2 | 6 | chronic inflammatory response |
GO:0060534 | 0.0063 | 23.338 | 0.127 | 2 | 6 | trachea cartilage development |
GO:0071216 | 0.0064 | 3.8827 | 1.6716 | 6 | 79 | cellular response to biotic stimulus |
GO:0009617 | 0.0066 | 2.6769 | 3.978 | 10 | 188 | response to bacterium |
GO:0050927 | 0.007 | 8.7824 | 0.402 | 3 | 19 | positive regulation of positive chemotaxis |
GO:1900046 | 0.0075 | 5.6947 | 0.7829 | 4 | 37 | regulation of hemostasis |
GO:0001960 | 0.0082 | 8.265 | 0.4232 | 3 | 20 | negative regulation of cytokine-mediated signaling pathway |
GO:0007339 | 0.0082 | 8.265 | 0.4232 | 3 | 20 | binding of sperm to zona pellucida |
GO:0034605 | 0.0082 | 8.265 | 0.4232 | 3 | 20 | cellular response to heat |
GO:0071407 | 0.0082 | 2.588 | 4.1049 | 10 | 194 | cellular response to organic cyclic compound |
GO:0017187 | 0.0087 | 18.6685 | 0.1481 | 2 | 7 | peptidyl-glutamic acid carboxylation |
GO:0048041 | 0.009 | 5.3682 | 0.8252 | 4 | 39 | focal adhesion assembly |
GO:0032890 | 0.0094 | 7.805 | 0.4443 | 3 | 21 | regulation of organic acid transport |
GO:0071222 | 0.0099 | 4.1307 | 1.3119 | 5 | 62 | cellular response to lipopolysaccharide |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022008 | 0 | 3.1451 | 17.3001 | 46 | 596 | neurogenesis |
GO:0042472 | 0 | 8.3673 | 2.4335 | 16 | 79 | inner ear morphogenesis |
GO:0007423 | 0 | 3.5452 | 10.7791 | 33 | 354 | sensory organ development |
GO:0007389 | 0 | 3.9696 | 8.1896 | 28 | 274 | pattern specification process |
GO:0001655 | 0 | 4.3425 | 6.7153 | 25 | 218 | urogenital system development |
GO:0021510 | 0 | 7.3904 | 2.3411 | 14 | 76 | spinal cord development |
GO:0021527 | 0 | 32.1601 | 0.4313 | 7 | 14 | spinal cord association neuron differentiation |
GO:0007275 | 0 | 2.2427 | 39.9717 | 72 | 1576 | multicellular organismal development |
GO:0048562 | 0 | 4.9163 | 4.5187 | 19 | 149 | embryonic organ morphogenesis |
GO:0007268 | 0 | 2.8725 | 15.094 | 38 | 490 | synaptic transmission |
GO:0006355 | 0 | 1.9124 | 71.8967 | 112 | 2334 | regulation of transcription, DNA-templated |
GO:0048663 | 0 | 8.3136 | 1.8174 | 12 | 59 | neuron fate commitment |
GO:0065007 | 0 | 1.9391 | 200.8116 | 242 | 6519 | biological regulation |
GO:0051252 | 0 | 1.851 | 74.4226 | 113 | 2416 | regulation of RNA metabolic process |
GO:0045666 | 0 | 7.0985 | 2.0639 | 12 | 67 | positive regulation of neuron differentiation |
GO:0050877 | 0 | 3.01 | 10.8613 | 29 | 363 | neurological system process |
GO:0001708 | 0 | 7.3795 | 1.8259 | 11 | 60 | cell fate specification |
GO:0031326 | 0 | 1.7691 | 82.5857 | 120 | 2681 | regulation of cellular biosynthetic process |
GO:0010628 | 0 | 2.1846 | 28.0933 | 54 | 912 | positive regulation of gene expression |
GO:0009952 | 0 | 4.3677 | 4.4591 | 17 | 146 | anterior/posterior pattern specification |
GO:0051094 | 0 | 2.5152 | 16.9816 | 38 | 561 | positive regulation of developmental process |
GO:0010556 | 0 | 1.7438 | 80.1522 | 116 | 2602 | regulation of macromolecule biosynthetic process |
GO:0009790 | 0 | 2.4054 | 18.6903 | 40 | 626 | embryo development |
GO:0045944 | 0 | 2.3894 | 18.7597 | 40 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007155 | 0 | 2.361 | 19.4682 | 41 | 632 | cell adhesion |
GO:0050767 | 0 | 2.7876 | 11.6131 | 29 | 377 | regulation of neurogenesis |
GO:2000026 | 0 | 2.2084 | 22.3521 | 44 | 758 | regulation of multicellular organismal development |
GO:0040007 | 0 | 2.3271 | 18.1744 | 38 | 590 | growth |
GO:0007166 | 0 | 1.7828 | 55.8169 | 86 | 1812 | cell surface receptor signaling pathway |
GO:0031214 | 0 | 5.6573 | 2.2795 | 11 | 74 | biomineral tissue development |
GO:0030182 | 0 | 2.2773 | 19.1333 | 39 | 670 | neuron differentiation |
GO:0048667 | 0 | 2.48 | 13.831 | 31 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0030901 | 0 | 10.2172 | 0.8933 | 7 | 29 | midbrain development |
GO:0072163 | 0 | 5.3985 | 2.3719 | 11 | 77 | mesonephric epithelium development |
GO:1902680 | 0 | 2.0246 | 26.9844 | 49 | 876 | positive regulation of RNA biosynthetic process |
GO:0001714 | 0 | 42.4811 | 0.2156 | 4 | 7 | endodermal cell fate specification |
GO:0032502 | 0 | 1.9768 | 32.8293 | 55 | 1347 | developmental process |
GO:0009880 | 0 | 7.354 | 1.3246 | 8 | 43 | embryonic pattern specification |
GO:0030030 | 0 | 2.0283 | 25.1669 | 46 | 817 | cell projection organization |
GO:0019438 | 0 | 1.6239 | 85.1424 | 117 | 2764 | aromatic compound biosynthetic process |
GO:0080090 | 0 | 1.583 | 115.2072 | 149 | 3740 | regulation of primary metabolic process |
GO:0021761 | 0 | 6.1736 | 1.725 | 9 | 56 | limbic system development |
GO:0044271 | 1e-04 | 1.6127 | 86.4054 | 118 | 2805 | cellular nitrogen compound biosynthetic process |
GO:0050954 | 1e-04 | 4.4216 | 3.0804 | 12 | 100 | sensory perception of mechanical stimulus |
GO:1901362 | 1e-04 | 1.6075 | 87.4527 | 119 | 2839 | organic cyclic compound biosynthetic process |
GO:0061564 | 1e-04 | 2.4479 | 12.5681 | 28 | 408 | axon development |
GO:0048729 | 1e-04 | 2.6395 | 9.9953 | 24 | 329 | tissue morphogenesis |
GO:0048592 | 1e-04 | 4.3225 | 3.142 | 12 | 102 | eye morphogenesis |
GO:0048869 | 1e-04 | 1.6874 | 60.5459 | 88 | 2138 | cellular developmental process |
GO:0051171 | 1e-04 | 1.5881 | 92.5046 | 124 | 3003 | regulation of nitrogen compound metabolic process |
GO:0009605 | 1e-04 | 1.8389 | 35.1782 | 58 | 1142 | response to external stimulus |
GO:0018130 | 1e-04 | 1.5961 | 85.3272 | 116 | 2770 | heterocycle biosynthetic process |
GO:0060042 | 1e-04 | 10.2039 | 0.7634 | 6 | 25 | retina morphogenesis in camera-type eye |
GO:0048812 | 1e-04 | 2.3162 | 14.2007 | 30 | 461 | neuron projection morphogenesis |
GO:0048732 | 1e-04 | 2.7842 | 8.2855 | 21 | 272 | gland development |
GO:0045935 | 1e-04 | 1.8814 | 30.65 | 52 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:2000027 | 1e-04 | 4.1632 | 3.246 | 12 | 106 | regulation of organ morphogenesis |
GO:0001568 | 1e-04 | 2.4959 | 10.9662 | 25 | 356 | blood vessel development |
GO:0042391 | 1e-04 | 2.9094 | 7.1773 | 19 | 233 | regulation of membrane potential |
GO:0045165 | 1e-04 | 5.4665 | 1.9026 | 9 | 65 | cell fate commitment |
GO:0072172 | 1e-04 | 95.2935 | 0.1232 | 3 | 4 | mesonephric tubule formation |
GO:0009891 | 1e-04 | 1.8488 | 31.759 | 53 | 1031 | positive regulation of biosynthetic process |
GO:0048736 | 1e-04 | 3.7669 | 3.8505 | 13 | 125 | appendage development |
GO:0031018 | 1e-04 | 7.2443 | 1.1706 | 7 | 38 | endocrine pancreas development |
GO:0043410 | 2e-04 | 2.8152 | 7.393 | 19 | 240 | positive regulation of MAPK cascade |
GO:0060548 | 2e-04 | 2.1983 | 15.402 | 31 | 500 | negative regulation of cell death |
GO:0007267 | 2e-04 | 2.7491 | 7.5639 | 19 | 266 | cell-cell signaling |
GO:0051093 | 2e-04 | 2.2489 | 13.5617 | 28 | 443 | negative regulation of developmental process |
GO:0061217 | 2e-04 | 11.4031 | 0.5853 | 5 | 19 | regulation of mesonephros development |
GO:0048839 | 2e-04 | 5.4996 | 1.6793 | 8 | 57 | inner ear development |
GO:0048864 | 3e-04 | 2.9777 | 5.8836 | 16 | 191 | stem cell development |
GO:0060527 | 3e-04 | 47.6419 | 0.154 | 3 | 5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:2000675 | 3e-04 | 47.6419 | 0.154 | 3 | 5 | negative regulation of type B pancreatic cell apoptotic process |
GO:0035637 | 3e-04 | 3.9054 | 3.142 | 11 | 102 | multicellular organismal signaling |
GO:0007610 | 3e-04 | 3.2261 | 4.771 | 14 | 159 | behavior |
GO:0050885 | 3e-04 | 7.7272 | 0.9493 | 6 | 31 | neuromuscular process controlling balance |
GO:0030855 | 3e-04 | 2.8262 | 6.5655 | 17 | 220 | epithelial cell differentiation |
GO:0045595 | 3e-04 | 1.8412 | 26.7641 | 45 | 884 | regulation of cell differentiation |
GO:0021542 | 4e-04 | 15.9223 | 0.3696 | 4 | 12 | dentate gyrus development |
GO:0035116 | 4e-04 | 9.9756 | 0.6469 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0035235 | 4e-04 | 9.9756 | 0.6469 | 5 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0050982 | 4e-04 | 9.9756 | 0.6469 | 5 | 21 | detection of mechanical stimulus |
GO:0035987 | 4e-04 | 7.3831 | 0.9857 | 6 | 32 | endodermal cell differentiation |
GO:0060560 | 4e-04 | 3.7796 | 3.2344 | 11 | 105 | developmental growth involved in morphogenesis |
GO:0007517 | 4e-04 | 2.6828 | 7.3006 | 18 | 237 | muscle organ development |
GO:0034645 | 4e-04 | 1.4968 | 98.0493 | 126 | 3183 | cellular macromolecule biosynthetic process |
GO:0001822 | 4e-04 | 3.2583 | 4.3804 | 13 | 144 | kidney development |
GO:0060079 | 4e-04 | 7.1089 | 1.0165 | 6 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0048745 | 5e-04 | 14.1517 | 0.4005 | 4 | 13 | smooth muscle tissue development |
GO:0071599 | 5e-04 | 14.1517 | 0.4005 | 4 | 13 | otic vesicle development |
GO:0098655 | 5e-04 | 2.2603 | 11.4899 | 24 | 373 | cation transmembrane transport |
GO:0014706 | 5e-04 | 2.6882 | 6.8693 | 17 | 223 | striated muscle tissue development |
GO:0051216 | 5e-04 | 3.3741 | 3.9121 | 12 | 127 | cartilage development |
GO:0001525 | 5e-04 | 2.5978 | 7.5162 | 18 | 244 | angiogenesis |
GO:0021796 | 5e-04 | 31.7581 | 0.1848 | 3 | 6 | cerebral cortex regionalization |
GO:2000543 | 5e-04 | 31.7581 | 0.1848 | 3 | 6 | positive regulation of gastrulation |
GO:0045937 | 5e-04 | 2.0061 | 17.2811 | 32 | 561 | positive regulation of phosphate metabolic process |
GO:0009653 | 6e-04 | 1.9031 | 21.9598 | 38 | 822 | anatomical structure morphogenesis |
GO:0035115 | 6e-04 | 8.8654 | 0.7085 | 5 | 23 | embryonic forelimb morphogenesis |
GO:0048333 | 6e-04 | 8.8654 | 0.7085 | 5 | 23 | mesodermal cell differentiation |
GO:0044707 | 6e-04 | 2.2589 | 12.5146 | 25 | 610 | single-multicellular organism process |
GO:0032835 | 6e-04 | 6.6173 | 1.0781 | 6 | 35 | glomerulus development |
GO:0060795 | 7e-04 | 8.398 | 0.7393 | 5 | 24 | cell fate commitment involved in formation of primary germ layer |
GO:0008284 | 8e-04 | 2.1924 | 11.817 | 24 | 390 | positive regulation of cell proliferation |
GO:0007507 | 8e-04 | 2.3208 | 9.7649 | 21 | 317 | heart development |
GO:0055074 | 8e-04 | 2.8902 | 5.2675 | 14 | 171 | calcium ion homeostasis |
GO:0071805 | 8e-04 | 3.6604 | 3.0188 | 10 | 98 | potassium ion transmembrane transport |
GO:0007411 | 9e-04 | 2.4214 | 8.4711 | 19 | 275 | axon guidance |
GO:0007205 | 9e-04 | 7.9773 | 0.7701 | 5 | 25 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0032990 | 9e-04 | 1.9256 | 18.5132 | 33 | 601 | cell part morphogenesis |
GO:0033688 | 9e-04 | 11.5763 | 0.4621 | 4 | 15 | regulation of osteoblast proliferation |
GO:0060850 | 9e-04 | 11.5763 | 0.4621 | 4 | 15 | regulation of transcription involved in cell fate commitment |
GO:0035564 | 9e-04 | Inf | 0.0616 | 2 | 2 | regulation of kidney size |
GO:0042706 | 9e-04 | Inf | 0.0616 | 2 | 2 | eye photoreceptor cell fate commitment |
GO:0072166 | 9e-04 | Inf | 0.0616 | 2 | 2 | posterior mesonephric tubule development |
GO:0090185 | 9e-04 | Inf | 0.0616 | 2 | 2 | negative regulation of kidney development |
GO:0035270 | 0.001 | 5.9816 | 1.1692 | 6 | 39 | endocrine system development |
GO:0040011 | 0.0011 | 2.5897 | 6.6867 | 16 | 228 | locomotion |
GO:0006029 | 0.0011 | 4.2789 | 2.0947 | 8 | 68 | proteoglycan metabolic process |
GO:0007613 | 0.0011 | 4.2789 | 2.0947 | 8 | 68 | memory |
GO:0035249 | 0.0011 | 4.8745 | 1.6326 | 7 | 53 | synaptic transmission, glutamatergic |
GO:0001657 | 0.0012 | 7.3615 | 0.8198 | 5 | 27 | ureteric bud development |
GO:0048070 | 0.0012 | 10.6106 | 0.4929 | 4 | 16 | regulation of developmental pigmentation |
GO:0072078 | 0.0012 | 10.6106 | 0.4929 | 4 | 16 | nephron tubule morphogenesis |
GO:0072028 | 0.0012 | 7.2506 | 0.8317 | 5 | 27 | nephron morphogenesis |
GO:0006813 | 0.0012 | 3.2245 | 3.7273 | 11 | 121 | potassium ion transport |
GO:0035108 | 0.0013 | 3.4463 | 3.1847 | 10 | 104 | limb morphogenesis |
GO:0001503 | 0.0013 | 2.4563 | 7.4546 | 17 | 242 | ossification |
GO:0048565 | 0.0014 | 4.6651 | 1.6934 | 7 | 56 | digestive tract development |
GO:0010454 | 0.0014 | 19.051 | 0.2464 | 3 | 8 | negative regulation of cell fate commitment |
GO:0030916 | 0.0014 | 19.051 | 0.2464 | 3 | 8 | otic vesicle formation |
GO:0048793 | 0.0014 | 19.051 | 0.2464 | 3 | 8 | pronephros development |
GO:0009887 | 0.0015 | 2.4209 | 7.5584 | 17 | 271 | organ morphogenesis |
GO:0021871 | 0.0015 | 9.7934 | 0.5237 | 4 | 17 | forebrain regionalization |
GO:0030325 | 0.0015 | 9.7934 | 0.5237 | 4 | 17 | adrenal gland development |
GO:0034381 | 0.0015 | 9.7934 | 0.5237 | 4 | 17 | plasma lipoprotein particle clearance |
GO:0061448 | 0.0015 | 6.8335 | 0.8699 | 5 | 29 | connective tissue development |
GO:0061458 | 0.0016 | 2.2838 | 8.9332 | 19 | 290 | reproductive system development |
GO:0007492 | 0.0017 | 4.4827 | 1.7558 | 7 | 57 | endoderm development |
GO:0003044 | 0.0017 | 6.645 | 0.8933 | 5 | 29 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0060563 | 0.0017 | 6.645 | 0.8933 | 5 | 29 | neuroepithelial cell differentiation |
GO:0043066 | 0.0018 | 1.9854 | 14.041 | 26 | 460 | negative regulation of apoptotic process |
GO:0001667 | 0.0018 | 2.7459 | 5.1135 | 13 | 166 | ameboidal cell migration |
GO:0048638 | 0.0019 | 3.5259 | 2.8032 | 9 | 91 | regulation of developmental growth |
GO:0000904 | 0.002 | 3.0215 | 3.9489 | 11 | 136 | cell morphogenesis involved in differentiation |
GO:0021543 | 0.0021 | 3.4831 | 2.834 | 9 | 92 | pallium development |
GO:0021707 | 0.0021 | 15.8742 | 0.2772 | 3 | 9 | cerebellar granule cell differentiation |
GO:0050910 | 0.0021 | 15.8742 | 0.2772 | 3 | 9 | detection of mechanical stimulus involved in sensory perception of sound |
GO:0060219 | 0.0021 | 15.8742 | 0.2772 | 3 | 9 | camera-type eye photoreceptor cell differentiation |
GO:0060525 | 0.0021 | 15.8742 | 0.2772 | 3 | 9 | prostate glandular acinus development |
GO:0016337 | 0.0023 | 2.4659 | 6.5305 | 15 | 212 | single organismal cell-cell adhesion |
GO:0051240 | 0.0023 | 2.0706 | 11.3649 | 22 | 372 | positive regulation of multicellular organismal process |
GO:0001709 | 0.0024 | 6.1326 | 0.9549 | 5 | 31 | cell fate determination |
GO:0008542 | 0.0024 | 6.1326 | 0.9549 | 5 | 31 | visual learning |
GO:0048806 | 0.0024 | 6.1326 | 0.9549 | 5 | 31 | genitalia development |
GO:0021697 | 0.0024 | 8.4859 | 0.5853 | 4 | 19 | cerebellar cortex formation |
GO:0035883 | 0.0024 | 8.4859 | 0.5853 | 4 | 19 | enteroendocrine cell differentiation |
GO:0035113 | 0.0024 | 3.4004 | 2.8956 | 9 | 94 | embryonic appendage morphogenesis |
GO:0007156 | 0.0027 | 3.6639 | 2.4027 | 8 | 78 | homophilic cell adhesion |
GO:0019218 | 0.0027 | 4.7922 | 1.417 | 6 | 46 | regulation of steroid metabolic process |
GO:0042490 | 0.0027 | 4.7922 | 1.417 | 6 | 46 | mechanoreceptor differentiation |
GO:0010623 | 0.0027 | 5.9049 | 0.9857 | 5 | 32 | developmental programmed cell death |
GO:0042592 | 0.0028 | 1.6972 | 24.674 | 39 | 801 | homeostatic process |
GO:0003406 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | retinal pigment epithelium development |
GO:0010269 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | response to selenium ion |
GO:0030910 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | olfactory placode formation |
GO:0032455 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | nerve growth factor processing |
GO:0033058 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | detection of glucose |
GO:0060018 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | transdifferentiation |
GO:0060421 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | positive regulation of heart growth |
GO:0061031 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0071698 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | olfactory placode development |
GO:0072180 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | mesonephric duct morphogenesis |
GO:0072197 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | ureter morphogenesis |
GO:1900212 | 0.0028 | 63.3248 | 0.0924 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:0010646 | 0.0028 | 1.4829 | 55.4781 | 75 | 1801 | regulation of cell communication |
GO:0006935 | 0.0029 | 2.1099 | 10.1252 | 20 | 334 | chemotaxis |
GO:0022037 | 0.0029 | 3.6119 | 2.4335 | 8 | 79 | metencephalon development |
GO:0060740 | 0.0029 | 7.9547 | 0.6161 | 4 | 20 | prostate gland epithelium morphogenesis |
GO:0072207 | 0.0029 | 7.9547 | 0.6161 | 4 | 20 | metanephric epithelium development |
GO:0009953 | 0.0029 | 4.0451 | 1.9202 | 7 | 63 | dorsal/ventral pattern formation |
GO:0021521 | 0.003 | 13.6051 | 0.308 | 3 | 10 | ventral spinal cord interneuron specification |
GO:0021683 | 0.003 | 13.6051 | 0.308 | 3 | 10 | cerebellar granular layer morphogenesis |
GO:0021794 | 0.003 | 13.6051 | 0.308 | 3 | 10 | thalamus development |
GO:0060602 | 0.003 | 13.6051 | 0.308 | 3 | 10 | branch elongation of an epithelium |
GO:0045665 | 0.003 | 4.6748 | 1.4478 | 6 | 47 | negative regulation of neuron differentiation |
GO:0010001 | 0.003 | 3.0332 | 3.5733 | 10 | 116 | glial cell differentiation |
GO:0072503 | 0.0031 | 2.5747 | 5.4215 | 13 | 176 | cellular divalent inorganic cation homeostasis |
GO:0019228 | 0.0031 | 4 | 1.9407 | 7 | 63 | neuronal action potential |
GO:0061138 | 0.0031 | 2.8366 | 4.1838 | 11 | 137 | morphogenesis of a branching epithelium |
GO:0021587 | 0.0031 | 5.6934 | 1.0165 | 5 | 33 | cerebellum morphogenesis |
GO:0010720 | 0.0032 | 2.6866 | 4.8054 | 12 | 156 | positive regulation of cell development |
GO:0007612 | 0.0034 | 3.5122 | 2.4951 | 8 | 81 | learning |
GO:0021846 | 0.0035 | 7.486 | 0.6469 | 4 | 21 | cell proliferation in forebrain |
GO:0060441 | 0.0035 | 7.486 | 0.6469 | 4 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0023052 | 0.0035 | 1.424 | 82.918 | 104 | 2916 | signaling |
GO:0043010 | 0.0035 | 2.6472 | 4.8696 | 12 | 160 | camera-type eye development |
GO:0007399 | 0.0036 | 2.1173 | 9.621 | 19 | 372 | nervous system development |
GO:0030111 | 0.0037 | 2.631 | 4.8978 | 12 | 159 | regulation of Wnt signaling pathway |
GO:0072091 | 0.0037 | 3.8613 | 2.0023 | 7 | 65 | regulation of stem cell proliferation |
GO:0055082 | 0.0037 | 2.1001 | 9.6417 | 19 | 313 | cellular chemical homeostasis |
GO:0003006 | 0.0038 | 1.9823 | 11.8237 | 22 | 388 | developmental process involved in reproduction |
GO:0055080 | 0.0039 | 2.1401 | 8.964 | 18 | 291 | cation homeostasis |
GO:0098660 | 0.0039 | 2.0112 | 11.1203 | 21 | 361 | inorganic ion transmembrane transport |
GO:0050890 | 0.0039 | 2.6129 | 4.9286 | 12 | 160 | cognition |
GO:0021903 | 0.004 | 11.9032 | 0.3388 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0003407 | 0.004 | 7.1344 | 0.6718 | 4 | 22 | neural retina development |
GO:0007369 | 0.0041 | 2.8967 | 3.7243 | 10 | 122 | gastrulation |
GO:0060675 | 0.0041 | 4.3548 | 1.5402 | 6 | 50 | ureteric bud morphogenesis |
GO:0023051 | 0.0042 | 1.458 | 55.4165 | 74 | 1799 | regulation of signaling |
GO:0007269 | 0.0042 | 3.3726 | 2.5875 | 8 | 84 | neurotransmitter secretion |
GO:0048167 | 0.0042 | 3.3726 | 2.5875 | 8 | 84 | regulation of synaptic plasticity |
GO:0050920 | 0.0044 | 3.7318 | 2.0639 | 7 | 67 | regulation of chemotaxis |
GO:0002064 | 0.0046 | 2.8436 | 3.7876 | 10 | 124 | epithelial cell development |
GO:0048645 | 0.0046 | 5.1409 | 1.1089 | 5 | 36 | organ formation |
GO:0021513 | 0.0049 | 6.6966 | 0.7085 | 4 | 23 | spinal cord dorsal/ventral patterning |
GO:0035850 | 0.0049 | 6.6966 | 0.7085 | 4 | 23 | epithelial cell differentiation involved in kidney development |
GO:0021700 | 0.005 | 2.5262 | 5.0827 | 12 | 165 | developmental maturation |
GO:0046777 | 0.0051 | 2.6405 | 4.4666 | 11 | 145 | protein autophosphorylation |
GO:0070307 | 0.0052 | 10.5796 | 0.3696 | 3 | 12 | lens fiber cell development |
GO:0072074 | 0.0052 | 10.5796 | 0.3696 | 3 | 12 | kidney mesenchyme development |
GO:0072234 | 0.0052 | 10.5796 | 0.3696 | 3 | 12 | metanephric nephron tubule development |
GO:0072498 | 0.0052 | 10.5796 | 0.3696 | 3 | 12 | embryonic skeletal joint development |
GO:0010463 | 0.0052 | 4.9797 | 1.1398 | 5 | 37 | mesenchymal cell proliferation |
GO:0050906 | 0.0052 | 4.9797 | 1.1398 | 5 | 37 | detection of stimulus involved in sensory perception |
GO:0023014 | 0.0052 | 1.893 | 12.9069 | 23 | 419 | signal transduction by phosphorylation |
GO:0072177 | 0.0054 | 31.8608 | 0.1225 | 2 | 4 | mesonephric duct development |
GO:0035239 | 0.0054 | 2.1711 | 7.8378 | 16 | 256 | tube morphogenesis |
GO:0002318 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | myeloid progenitor cell differentiation |
GO:0007412 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | axon target recognition |
GO:0015671 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | oxygen transport |
GO:0021562 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | vestibulocochlear nerve development |
GO:0060214 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | endocardium formation |
GO:0072040 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
GO:0072162 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | metanephric mesenchymal cell differentiation |
GO:0072179 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | nephric duct formation |
GO:0072289 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | metanephric nephron tubule formation |
GO:0072298 | 0.0054 | 31.6592 | 0.1232 | 2 | 4 | regulation of metanephric glomerulus development |
GO:0071363 | 0.0054 | 1.8342 | 14.4779 | 25 | 470 | cellular response to growth factor stimulus |
GO:0060021 | 0.0056 | 3.553 | 2.1563 | 7 | 70 | palate development |
GO:0048863 | 0.0057 | 4.8545 | 1.1618 | 5 | 39 | stem cell differentiation |
GO:1900449 | 0.0058 | 6.3612 | 0.7393 | 4 | 24 | regulation of glutamate receptor signaling pathway |
GO:0030500 | 0.0059 | 4.8283 | 1.1706 | 5 | 38 | regulation of bone mineralization |
GO:0032879 | 0.0059 | 1.5083 | 38.5051 | 54 | 1250 | regulation of localization |
GO:0072358 | 0.0059 | 2.1482 | 7.92 | 16 | 267 | cardiovascular system development |
GO:0048704 | 0.0061 | 3.4971 | 2.1871 | 7 | 71 | embryonic skeletal system morphogenesis |
GO:0018958 | 0.0061 | 3.9902 | 1.6634 | 6 | 54 | phenol-containing compound metabolic process |
GO:2000177 | 0.0061 | 3.9902 | 1.6634 | 6 | 54 | regulation of neural precursor cell proliferation |
GO:0032774 | 0.0063 | 1.4785 | 45.8574 | 62 | 1613 | RNA biosynthetic process |
GO:0048546 | 0.0064 | 4.716 | 1.194 | 5 | 39 | digestive tract morphogenesis |
GO:0010453 | 0.0064 | 9.6088 | 0.3969 | 3 | 13 | regulation of cell fate commitment |
GO:0035282 | 0.0065 | 3.443 | 2.2179 | 7 | 72 | segmentation |
GO:0002092 | 0.0066 | 9.5206 | 0.4005 | 3 | 13 | positive regulation of receptor internalization |
GO:0060571 | 0.0066 | 9.5206 | 0.4005 | 3 | 13 | morphogenesis of an epithelial fold |
GO:2000036 | 0.0066 | 9.5206 | 0.4005 | 3 | 13 | regulation of stem cell maintenance |
GO:0008589 | 0.0066 | 3.9084 | 1.6942 | 6 | 55 | regulation of smoothened signaling pathway |
GO:0045807 | 0.0066 | 3.9084 | 1.6942 | 6 | 55 | positive regulation of endocytosis |
GO:0007420 | 0.0066 | 1.98 | 10.1786 | 19 | 343 | brain development |
GO:0017145 | 0.0067 | 6.0576 | 0.7701 | 4 | 25 | stem cell division |
GO:0009743 | 0.0068 | 2.8571 | 3.3884 | 9 | 110 | response to carbohydrate |
GO:0021915 | 0.0072 | 2.6531 | 4.0353 | 10 | 131 | neural tube development |
GO:0048870 | 0.0072 | 1.643 | 21.9941 | 34 | 714 | cell motility |
GO:0010976 | 0.0072 | 3.8298 | 1.725 | 6 | 56 | positive regulation of neuron projection development |
GO:0048332 | 0.0072 | 3.8298 | 1.725 | 6 | 56 | mesoderm morphogenesis |
GO:0021695 | 0.0073 | 4.5515 | 1.2322 | 5 | 40 | cerebellar cortex development |
GO:0035019 | 0.0073 | 4.5515 | 1.2322 | 5 | 40 | somatic stem cell maintenance |
GO:0008217 | 0.0073 | 3.0489 | 2.834 | 8 | 92 | regulation of blood pressure |
GO:0044708 | 0.0074 | 2.094 | 8.1015 | 16 | 263 | single-organism behavior |
GO:0060429 | 0.0075 | 2.2135 | 6.7192 | 14 | 236 | epithelium development |
GO:0051480 | 0.0076 | 2.801 | 3.4501 | 9 | 112 | cytosolic calcium ion homeostasis |
GO:0043067 | 0.0076 | 1.5754 | 27.046 | 40 | 878 | regulation of programmed cell death |
GO:0051130 | 0.0076 | 1.8267 | 13.3359 | 23 | 439 | positive regulation of cellular component organization |
GO:0002088 | 0.0081 | 4.4246 | 1.263 | 5 | 41 | lens development in camera-type eye |
GO:0021879 | 0.0081 | 4.4246 | 1.263 | 5 | 41 | forebrain neuron differentiation |
GO:0050807 | 0.0081 | 4.4246 | 1.263 | 5 | 41 | regulation of synapse organization |
GO:0010894 | 0.0082 | 8.6543 | 0.4313 | 3 | 14 | negative regulation of steroid biosynthetic process |
GO:0043403 | 0.0082 | 8.6543 | 0.4313 | 3 | 14 | skeletal muscle tissue regeneration |
GO:0060581 | 0.0082 | 8.6543 | 0.4313 | 3 | 14 | cell fate commitment involved in pattern specification |
GO:0072087 | 0.0082 | 8.6543 | 0.4313 | 3 | 14 | renal vesicle development |
GO:0090190 | 0.0082 | 8.6543 | 0.4313 | 3 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0003018 | 0.0083 | 2.9774 | 2.8956 | 8 | 94 | vascular process in circulatory system |
GO:0030902 | 0.0083 | 5.6357 | 0.8168 | 4 | 27 | hindbrain development |
GO:0009888 | 0.0087 | 2.2468 | 6.1474 | 13 | 232 | tissue development |
GO:0050679 | 0.0088 | 2.9428 | 2.9264 | 8 | 95 | positive regulation of epithelial cell proliferation |
GO:0021522 | 0.0089 | 5.5298 | 0.8317 | 4 | 27 | spinal cord motor neuron differentiation |
GO:0060393 | 0.0089 | 5.5298 | 0.8317 | 4 | 27 | regulation of pathway-restricted SMAD protein phosphorylation |
GO:0001826 | 0.0089 | 21.104 | 0.154 | 2 | 5 | inner cell mass cell differentiation |
GO:0001978 | 0.0089 | 21.104 | 0.154 | 2 | 5 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback |
GO:0003402 | 0.0089 | 21.104 | 0.154 | 2 | 5 | planar cell polarity pathway involved in axis elongation |
GO:0030207 | 0.0089 | 21.104 | 0.154 | 2 | 5 | chondroitin sulfate catabolic process |
GO:0031340 | 0.0089 | 21.104 | 0.154 | 2 | 5 | positive regulation of vesicle fusion |
GO:0032516 | 0.0089 | 21.104 | 0.154 | 2 | 5 | positive regulation of phosphoprotein phosphatase activity |
GO:0043374 | 0.0089 | 21.104 | 0.154 | 2 | 5 | CD8-positive, alpha-beta T cell differentiation |
GO:0048170 | 0.0089 | 21.104 | 0.154 | 2 | 5 | positive regulation of long-term neuronal synaptic plasticity |
GO:0048852 | 0.0089 | 21.104 | 0.154 | 2 | 5 | diencephalon morphogenesis |
GO:0050957 | 0.0089 | 21.104 | 0.154 | 2 | 5 | equilibrioception |
GO:0060174 | 0.0089 | 21.104 | 0.154 | 2 | 5 | limb bud formation |
GO:0060374 | 0.0089 | 21.104 | 0.154 | 2 | 5 | mast cell differentiation |
GO:0060687 | 0.0089 | 21.104 | 0.154 | 2 | 5 | regulation of branching involved in prostate gland morphogenesis |
GO:0090037 | 0.0089 | 21.104 | 0.154 | 2 | 5 | positive regulation of protein kinase C signaling |
GO:0097120 | 0.0089 | 21.104 | 0.154 | 2 | 5 | receptor localization to synapse |
GO:2001012 | 0.0089 | 21.104 | 0.154 | 2 | 5 | mesenchymal cell differentiation involved in renal system development |
GO:0050794 | 0.009 | 1.4071 | 98.5953 | 116 | 3710 | regulation of cellular process |
GO:0045995 | 0.0094 | 3.1954 | 2.3719 | 7 | 77 | regulation of embryonic development |
GO:0043009 | 0.0094 | 1.9445 | 9.7878 | 18 | 324 | chordate embryonic development |
GO:0032940 | 0.0096 | 1.7227 | 15.9565 | 26 | 518 | secretion by cell |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 1e-04 | 2.1898 | 16.5448 | 33 | 554 | sequence-specific DNA binding |
GO:0005215 | 1e-04 | 2.0333 | 21.6814 | 40 | 726 | transporter activity |
GO:0046873 | 3e-04 | 2.7267 | 7.1973 | 18 | 241 | metal ion transmembrane transporter activity |
GO:0022891 | 3e-04 | 2.1274 | 15.3502 | 30 | 514 | substrate-specific transmembrane transporter activity |
GO:0005104 | 6e-04 | 13.1577 | 0.4181 | 4 | 14 | fibroblast growth factor receptor binding |
GO:0001653 | 7e-04 | 4.6578 | 1.9412 | 8 | 65 | peptide receptor activity |
GO:0001517 | 9e-04 | Inf | 0.0597 | 2 | 2 | N-acetylglucosamine 6-O-sulfotransferase activity |
GO:0004972 | 0.0013 | 19.6796 | 0.2389 | 3 | 8 | N-methyl-D-aspartate selective glutamate receptor activity |
GO:0005216 | 0.0017 | 2.463 | 6.9882 | 16 | 234 | ion channel activity |
GO:0008188 | 0.0018 | 6.5911 | 0.8959 | 5 | 30 | neuropeptide receptor activity |
GO:0008324 | 0.0018 | 2.2059 | 9.7314 | 20 | 330 | cation transmembrane transporter activity |
GO:0004888 | 0.0021 | 2.022 | 12.7222 | 24 | 426 | transmembrane signaling receptor activity |
GO:0004872 | 0.0029 | 1.8234 | 17.6199 | 30 | 590 | receptor activity |
GO:0015267 | 0.0034 | 2.2907 | 7.4661 | 16 | 250 | channel activity |
GO:0004143 | 0.0047 | 10.9286 | 0.3584 | 3 | 12 | diacylglycerol kinase activity |
GO:0004871 | 0.005 | 1.705 | 20.6661 | 33 | 692 | signal transducer activity |
GO:0008762 | 0.0051 | 32.6983 | 0.1195 | 2 | 4 | UDP-N-acetylmuramate dehydrogenase activity |
GO:0015355 | 0.0051 | 32.6983 | 0.1195 | 2 | 4 | secondary active monocarboxylate transmembrane transporter activity |
GO:0003700 | 0.0054 | 1.8646 | 13.7116 | 24 | 473 | sequence-specific DNA binding transcription factor activity |
GO:0000981 | 0.0054 | 2.1169 | 8.5412 | 17 | 286 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0003951 | 0.006 | 9.8347 | 0.3882 | 3 | 13 | NAD+ kinase activity |
GO:0046943 | 0.0068 | 3.8799 | 1.7023 | 6 | 57 | carboxylic acid transmembrane transporter activity |
GO:0001102 | 0.0069 | 5.9733 | 0.7765 | 4 | 26 | RNA polymerase II activating transcription factor binding |
GO:0015077 | 0.007 | 2.3159 | 5.9729 | 13 | 200 | monovalent inorganic cation transmembrane transporter activity |
GO:0044212 | 0.008 | 1.9068 | 11.1095 | 20 | 372 | transcription regulatory region DNA binding |
GO:0005267 | 0.0085 | 3.2559 | 2.3294 | 7 | 78 | potassium channel activity |
GO:0015293 | 0.0087 | 5.5475 | 0.8257 | 4 | 28 | symporter activity |
GO:0015294 | 0.0087 | 4.3304 | 1.2842 | 5 | 43 | solute:cation symporter activity |
GO:0043178 | 0.0087 | 4.3304 | 1.2842 | 5 | 43 | alcohol binding |
GO:0001067 | 0.0092 | 1.8791 | 11.2588 | 20 | 377 | regulatory region nucleic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0.002 | 3.2166 | 3.3721 | 10 | 262 | protein heterodimerization activity |
GO:0005283 | 0.0033 | 31.1492 | 0.0901 | 2 | 7 | sodium:amino acid symporter activity |
GO:0008270 | 0.0075 | 1.9891 | 10.4253 | 19 | 810 | zinc ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004222 | 2e-04 | 5.4277 | 1.6721 | 8 | 69 | metalloendopeptidase activity |
GO:0004666 | 6e-04 | Inf | 0.0485 | 2 | 2 | prostaglandin-endoperoxide synthase activity |
GO:0003677 | 9e-04 | 1.6494 | 41.5601 | 61 | 1715 | DNA binding |
GO:0003700 | 0.0014 | 1.8906 | 18.3931 | 32 | 759 | sequence-specific DNA binding transcription factor activity |
GO:0016247 | 0.0035 | 4.4792 | 1.4782 | 6 | 61 | channel regulator activity |
GO:0016702 | 0.0042 | 11.1073 | 0.3393 | 3 | 14 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0070888 | 0.0044 | 6.8073 | 0.6785 | 4 | 28 | E-box binding |
GO:0001077 | 0.0049 | 3.2645 | 2.6414 | 8 | 109 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0001968 | 0.0052 | 10.1807 | 0.3635 | 3 | 15 | fibronectin binding |
GO:0004383 | 0.0056 | 27.06 | 0.1212 | 2 | 5 | guanylate cyclase activity |
GO:0001618 | 0.0074 | 8.7245 | 0.412 | 3 | 17 | virus receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015347 | 3e-04 | Inf | 0.034 | 2 | 2 | sodium-independent organic anion transmembrane transporter activity |
GO:0004888 | 9e-04 | 2.5614 | 7.2392 | 17 | 426 | transmembrane signaling receptor activity |
GO:0004872 | 0.001 | 2.296 | 10.0261 | 21 | 590 | receptor activity |
GO:0004871 | 0.0015 | 2.1445 | 11.7595 | 23 | 692 | signal transducer activity |
GO:0015075 | 0.0034 | 2.2395 | 8.1908 | 17 | 482 | ion transmembrane transporter activity |
GO:0022892 | 0.0062 | 2.012 | 10.1621 | 19 | 598 | substrate-specific transporter activity |
GO:0022857 | 0.0067 | 2.0349 | 9.4993 | 18 | 559 | transmembrane transporter activity |
GO:0005126 | 0.0093 | 3.5617 | 1.8013 | 6 | 106 | cytokine receptor binding |
GO:0005452 | 0.0096 | 16.7134 | 0.1529 | 2 | 9 | inorganic anion exchanger activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0.0023 | 2.1584 | 9.9439 | 20 | 402 | calcium ion binding |
GO:0046703 | 0.0058 | 26.4918 | 0.1237 | 2 | 5 | natural killer cell lectin-like receptor binding |
GO:0043548 | 0.0079 | 8.5406 | 0.4205 | 3 | 17 | phosphatidylinositol 3-kinase binding |
GO:0031432 | 0.0086 | 19.8668 | 0.1484 | 2 | 6 | titin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 12.874 | 1.197 | 12 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0 | 10.1285 | 1.4588 | 12 | 78 | serine hydrolase activity |
GO:0070011 | 0 | 3.8119 | 5.9662 | 20 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0005509 | 0 | 3.3109 | 7.5186 | 22 | 402 | calcium ion binding |
GO:0004063 | 3e-04 | Inf | 0.0374 | 2 | 2 | aryldialkylphosphatase activity |
GO:0004064 | 0.002 | 53.0272 | 0.0748 | 2 | 4 | arylesterase activity |
GO:0015288 | 0.002 | 53.0272 | 0.0748 | 2 | 4 | porin activity |
GO:0017080 | 0.003 | 12.29 | 0.2992 | 3 | 16 | sodium channel regulator activity |
GO:0004046 | 0.0034 | 35.3478 | 0.0935 | 2 | 5 | aminoacylase activity |
GO:0004930 | 0.0061 | 2.7156 | 3.9276 | 10 | 210 | G-protein coupled receptor activity |
GO:0016755 | 0.0069 | 21.2043 | 0.1309 | 2 | 7 | transferase activity, transferring amino-acyl groups |
GO:0005092 | 0.009 | 17.6685 | 0.1496 | 2 | 8 | GDP-dissociation inhibitor activity |
GO:0016641 | 0.009 | 17.6685 | 0.1496 | 2 | 8 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 1e-04 | 64.4735 | 0.1151 | 3 | 5 | olfactory receptor activity |
GO:0004872 | 2e-04 | 2.269 | 13.5857 | 28 | 590 | receptor activity |
GO:0004871 | 6e-04 | 2.0618 | 15.9344 | 30 | 692 | signal transducer activity |
GO:0008426 | 0.0016 | 85.5947 | 0.0691 | 2 | 3 | protein kinase C inhibitor activity |
GO:0050839 | 0.0029 | 3.5897 | 2.4178 | 8 | 105 | cell adhesion molecule binding |
GO:0030151 | 0.0031 | 42.793 | 0.0921 | 2 | 4 | molybdenum ion binding |
GO:0004888 | 0.0034 | 2.6593 | 4.837 | 12 | 216 | transmembrane signaling receptor activity |
GO:0004620 | 0.0039 | 5.2673 | 1.0592 | 5 | 46 | phospholipase activity |
GO:0030971 | 0.0041 | 6.8914 | 0.6678 | 4 | 29 | receptor tyrosine kinase binding |
GO:0004435 | 0.0045 | 10.7345 | 0.3454 | 3 | 15 | phosphatidylinositol phospholipase C activity |
GO:0046703 | 0.005 | 28.5257 | 0.1151 | 2 | 5 | natural killer cell lectin-like receptor binding |
GO:0042562 | 0.0053 | 6.3796 | 0.7138 | 4 | 31 | hormone binding |
GO:0005543 | 0.0054 | 2.614 | 4.4902 | 11 | 195 | phospholipid binding |
GO:0070064 | 0.0076 | 8.585 | 0.4145 | 3 | 18 | proline-rich region binding |
GO:0004930 | 0.0093 | 2.4131 | 4.8356 | 11 | 210 | G-protein coupled receptor activity |
GO:0005254 | 0.01 | 5.2164 | 0.852 | 4 | 37 | chloride channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 111.4545 | 0.0679 | 3 | 5 | olfactory receptor activity |
GO:0050220 | 5e-04 | 147.5038 | 0.0407 | 2 | 3 | prostaglandin-E synthase activity |
GO:0005179 | 8e-04 | 7.6617 | 0.733 | 5 | 54 | hormone activity |
GO:0004252 | 0.0017 | 6.3566 | 0.8688 | 5 | 64 | serine-type endopeptidase activity |
GO:0070011 | 0.0041 | 2.7368 | 4.3303 | 11 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0017171 | 0.0041 | 5.1301 | 1.0588 | 5 | 78 | serine hydrolase activity |
GO:0004889 | 0.0049 | 24.5714 | 0.1086 | 2 | 8 | acetylcholine-activated cation-selective channel activity |
GO:0008556 | 0.0049 | 24.5714 | 0.1086 | 2 | 8 | potassium-transporting ATPase activity |
GO:0043295 | 0.0049 | 24.5714 | 0.1086 | 2 | 8 | glutathione binding |
GO:0015464 | 0.0062 | 21.0591 | 0.1222 | 2 | 9 | acetylcholine receptor activity |
GO:0042166 | 0.0062 | 21.0591 | 0.1222 | 2 | 9 | acetylcholine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 7.1197 | 1.4866 | 9 | 64 | serine-type endopeptidase activity |
GO:0017171 | 1e-04 | 5.6669 | 1.8118 | 9 | 78 | serine hydrolase activity |
GO:0001948 | 1e-04 | 7.3727 | 1.1149 | 7 | 48 | glycoprotein binding |
GO:0070053 | 5e-04 | Inf | 0.0465 | 2 | 2 | thrombospondin receptor activity |
GO:0004871 | 7e-04 | 2.0409 | 16.0736 | 30 | 692 | signal transducer activity |
GO:0043236 | 0.001 | 10.6806 | 0.4646 | 4 | 20 | laminin binding |
GO:0004872 | 0.0015 | 2.0567 | 13.1591 | 25 | 573 | receptor activity |
GO:0070011 | 0.0031 | 2.3114 | 7.4097 | 16 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0001968 | 0.0046 | 10.6382 | 0.3484 | 3 | 15 | fibronectin binding |
GO:0004888 | 0.0049 | 2.0494 | 9.895 | 19 | 426 | transmembrane signaling receptor activity |
GO:0005509 | 0.0058 | 2.0533 | 9.3376 | 18 | 402 | calcium ion binding |
GO:0001618 | 0.0066 | 9.1165 | 0.3949 | 3 | 17 | virus receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 97.9 | 0.0769 | 3 | 5 | olfactory receptor activity |
GO:0004252 | 1e-04 | 8.1885 | 0.9846 | 7 | 64 | serine-type endopeptidase activity |
GO:0017171 | 2e-04 | 6.5644 | 1.2 | 7 | 78 | serine hydrolase activity |
GO:0005006 | 2e-04 | Inf | 0.0308 | 2 | 2 | epidermal growth factor-activated receptor activity |
GO:0022824 | 7e-04 | 129.6821 | 0.0462 | 2 | 3 | transmitter-gated ion channel activity |
GO:0001948 | 8e-04 | 7.6595 | 0.7385 | 5 | 48 | glycoprotein binding |
GO:0046703 | 0.0023 | 43.2185 | 0.0769 | 2 | 5 | natural killer cell lectin-like receptor binding |
GO:0005254 | 0.0024 | 7.939 | 0.5692 | 4 | 37 | chloride channel activity |
GO:0038023 | 0.0029 | 2.3425 | 7.4 | 16 | 481 | signaling receptor activity |
GO:0015103 | 0.0032 | 5.4797 | 1 | 5 | 65 | inorganic anion transmembrane transporter activity |
GO:0043236 | 0.0034 | 11.5 | 0.3077 | 3 | 20 | laminin binding |
GO:0004930 | 0.0051 | 2.9823 | 3.2308 | 9 | 210 | G-protein coupled receptor activity |
GO:0008233 | 0.0051 | 2.5191 | 5.1077 | 12 | 332 | peptidase activity |
GO:0002020 | 0.0062 | 5.9475 | 0.7385 | 4 | 48 | protease binding |
GO:0015464 | 0.0079 | 18.5147 | 0.1385 | 2 | 9 | acetylcholine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001637 | 0 | 49.1869 | 0.1625 | 4 | 8 | G-protein coupled chemoattractant receptor activity |
GO:0003846 | 4e-04 | Inf | 0.0406 | 2 | 2 | 2-acylglycerol O-acyltransferase activity |
GO:0004063 | 4e-04 | Inf | 0.0406 | 2 | 2 | aryldialkylphosphatase activity |
GO:0019841 | 6e-04 | 24.4648 | 0.1828 | 3 | 9 | retinol binding |
GO:0004872 | 9e-04 | 2.1861 | 11.9839 | 24 | 590 | receptor activity |
GO:0004144 | 0.0012 | 97.42 | 0.0609 | 2 | 3 | diacylglycerol O-acyltransferase activity |
GO:0016493 | 0.0012 | 97.42 | 0.0609 | 2 | 3 | C-C chemokine receptor activity |
GO:0015026 | 0.0016 | 16.3049 | 0.2437 | 3 | 12 | coreceptor activity |
GO:0008374 | 0.0017 | 8.9265 | 0.5281 | 4 | 26 | O-acyltransferase activity |
GO:0001653 | 0.002 | 5.0246 | 1.3203 | 6 | 65 | peptide receptor activity |
GO:0004064 | 0.0024 | 48.705 | 0.0812 | 2 | 4 | arylesterase activity |
GO:0016494 | 0.0024 | 48.705 | 0.0812 | 2 | 4 | C-X-C chemokine receptor activity |
GO:0004930 | 0.0037 | 2.7621 | 4.2655 | 11 | 210 | G-protein coupled receptor activity |
GO:0030020 | 0.0039 | 32.4667 | 0.1016 | 2 | 5 | extracellular matrix structural constituent conferring tensile strength |
GO:0019840 | 0.0045 | 10.4763 | 0.3453 | 3 | 17 | isoprenoid binding |
GO:0004871 | 0.0069 | 1.8317 | 14.0557 | 24 | 692 | signal transducer activity |
GO:0015295 | 0.0081 | 19.476 | 0.1422 | 2 | 7 | solute:proton symporter activity |
GO:0016918 | 0.0081 | 19.476 | 0.1422 | 2 | 7 | retinal binding |
GO:0004896 | 0.0093 | 5.2995 | 0.8328 | 4 | 41 | cytokine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 6e-04 | Inf | 0.0479 | 2 | 2 | aryldialkylphosphatase activity |
GO:0034190 | 0.0017 | 82.2542 | 0.0718 | 2 | 3 | apolipoprotein receptor binding |
GO:0016247 | 0.0033 | 4.5386 | 1.4598 | 6 | 61 | channel regulator activity |
GO:0004064 | 0.0033 | 41.1229 | 0.0957 | 2 | 4 | arylesterase activity |
GO:0005542 | 0.0033 | 41.1229 | 0.0957 | 2 | 4 | folic acid binding |
GO:0017124 | 0.0044 | 3.6931 | 2.0581 | 7 | 86 | SH3 domain binding |
GO:0004683 | 0.0072 | 8.8386 | 0.4068 | 3 | 17 | calmodulin-dependent protein kinase activity |
GO:0050997 | 0.0072 | 8.8386 | 0.4068 | 3 | 17 | quaternary ammonium group binding |
GO:0005102 | 0.0077 | 1.7125 | 18.1118 | 29 | 763 | receptor binding |
GO:0008146 | 0.0084 | 5.514 | 0.8137 | 4 | 34 | sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.8233 | 4.371 | 15 | 210 | G-protein coupled receptor activity |
GO:0005506 | 1e-04 | 5.6294 | 1.8109 | 9 | 87 | iron ion binding |
GO:0060089 | 2e-04 | 2.23 | 14.4036 | 29 | 692 | molecular transducer activity |
GO:0001653 | 4e-04 | 5.8414 | 1.3529 | 7 | 65 | peptide receptor activity |
GO:0001637 | 5e-04 | 28.6265 | 0.1665 | 3 | 8 | G-protein coupled chemoattractant receptor activity |
GO:0038023 | 8e-04 | 2.4546 | 8.4211 | 19 | 416 | signaling receptor activity |
GO:0005254 | 9e-04 | 7.5077 | 0.7701 | 5 | 37 | chloride channel activity |
GO:0016493 | 0.0013 | 94.9951 | 0.0624 | 2 | 3 | C-C chemokine receptor activity |
GO:0016901 | 0.0013 | 94.9951 | 0.0624 | 2 | 3 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0051431 | 0.0013 | 94.9951 | 0.0624 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0004896 | 0.0015 | 6.6708 | 0.8534 | 5 | 41 | cytokine receptor activity |
GO:0042287 | 0.0022 | 14.3059 | 0.2706 | 3 | 13 | MHC protein binding |
GO:0033218 | 0.0023 | 3.724 | 2.3312 | 8 | 112 | amide binding |
GO:0016702 | 0.0027 | 13.004 | 0.2914 | 3 | 14 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:1901681 | 0.0032 | 3.5187 | 2.4561 | 8 | 118 | sulfur compound binding |
GO:0005184 | 0.0034 | 11.9191 | 0.3122 | 3 | 15 | neuropeptide hormone activity |
GO:0005216 | 0.0036 | 2.6378 | 4.8706 | 12 | 234 | ion channel activity |
GO:0072341 | 0.0037 | 7.087 | 0.6452 | 4 | 31 | modified amino acid binding |
GO:0071855 | 0.0041 | 11.0011 | 0.333 | 3 | 16 | neuropeptide receptor binding |
GO:0004890 | 0.0041 | 31.6585 | 0.1041 | 2 | 5 | GABA-A receptor activity |
GO:0050840 | 0.0042 | 6.8332 | 0.6661 | 4 | 32 | extracellular matrix binding |
GO:0004497 | 0.0052 | 6.3764 | 0.7077 | 4 | 34 | monooxygenase activity |
GO:0015085 | 0.006 | 3.9522 | 1.6443 | 6 | 79 | calcium ion transmembrane transporter activity |
GO:0015267 | 0.006 | 2.4564 | 5.2036 | 12 | 250 | channel activity |
GO:0051219 | 0.007 | 5.7949 | 0.7701 | 4 | 37 | phosphoprotein binding |
GO:0020037 | 0.008 | 4.3578 | 1.2489 | 5 | 60 | heme binding |
GO:0005201 | 0.0085 | 5.4626 | 0.8118 | 4 | 39 | extracellular matrix structural constituent |
GO:0017046 | 0.009 | 7.9412 | 0.4371 | 3 | 21 | peptide hormone binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 4e-04 | 6.8031 | 0.9911 | 6 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0.0013 | 5.4724 | 1.2078 | 6 | 78 | serine hydrolase activity |
GO:0016877 | 0.0018 | 14.9435 | 0.2478 | 3 | 16 | ligase activity, forming carbon-sulfur bonds |
GO:0031957 | 0.0023 | 42.9298 | 0.0774 | 2 | 5 | very long-chain fatty acid-CoA ligase activity |
GO:0005031 | 0.0034 | 32.1941 | 0.0929 | 2 | 6 | tumor necrosis factor-activated receptor activity |
GO:0004467 | 0.0048 | 25.7526 | 0.1084 | 2 | 7 | long-chain fatty acid-CoA ligase activity |
GO:0004888 | 0.0063 | 2.2765 | 6.5967 | 14 | 426 | transmembrane signaling receptor activity |
GO:0004872 | 0.0097 | 1.9962 | 9.1362 | 17 | 590 | receptor activity |
GO:0042605 | 0.0099 | 16.0905 | 0.1549 | 2 | 10 | peptide antigen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 681.5172 | 0.0312 | 4 | 5 | olfactory receptor activity |
GO:0005227 | 0.0038 | 25.3077 | 0.0935 | 2 | 15 | calcium activated cation channel activity |
GO:0004866 | 0.0053 | 9.2552 | 0.3554 | 3 | 57 | endopeptidase inhibitor activity |
GO:0004027 | 0.0062 | Inf | 0.0062 | 1 | 1 | alcohol sulfotransferase activity |
GO:0022851 | 0.0062 | Inf | 0.0062 | 1 | 1 | GABA-gated chloride ion channel activity |
GO:0022894 | 0.0062 | Inf | 0.0062 | 1 | 1 | Intermediate conductance calcium-activated potassium channel activity |
GO:0032396 | 0.0062 | Inf | 0.0062 | 1 | 1 | inhibitory MHC class I receptor activity |
GO:0004930 | 0.0098 | 4.1412 | 1.3092 | 5 | 210 | G-protein coupled receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 7.6474 | 1.39 | 9 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0 | 6.087 | 1.6941 | 9 | 78 | serine hydrolase activity |
GO:0050294 | 5e-04 | Inf | 0.0434 | 2 | 2 | steroid sulfotransferase activity |
GO:0070053 | 5e-04 | Inf | 0.0434 | 2 | 2 | thrombospondin receptor activity |
GO:0001948 | 6e-04 | 6.5898 | 1.0425 | 6 | 48 | glycoprotein binding |
GO:0043236 | 8e-04 | 11.454 | 0.4344 | 4 | 20 | laminin binding |
GO:0004871 | 0.001 | 2.0333 | 15.0299 | 28 | 692 | signal transducer activity |
GO:0004872 | 0.0013 | 2.1201 | 12.2934 | 24 | 573 | receptor activity |
GO:0022824 | 0.0014 | 90.9159 | 0.0652 | 2 | 3 | transmitter-gated ion channel activity |
GO:0008329 | 0.0027 | 45.4533 | 0.0869 | 2 | 4 | signaling pattern recognition receptor activity |
GO:0001968 | 0.0038 | 11.4049 | 0.3258 | 3 | 15 | fibronectin binding |
GO:0070011 | 0.0041 | 2.3137 | 6.9285 | 15 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0001618 | 0.0055 | 9.7736 | 0.3692 | 3 | 17 | virus receptor activity |
GO:0005254 | 0.0082 | 5.5437 | 0.8036 | 4 | 37 | chloride channel activity |
GO:0016917 | 0.0092 | 18.1757 | 0.152 | 2 | 7 | GABA receptor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044707 | 0 | 1.7928 | 218.5645 | 297 | 4789 | single-multicellular organism process |
GO:2000026 | 0 | 2.0241 | 53.1717 | 95 | 1154 | regulation of multicellular organismal development |
GO:0050767 | 0 | 2.5134 | 21.3793 | 48 | 464 | regulation of neurogenesis |
GO:0007267 | 0 | 3.6063 | 7.9531 | 25 | 185 | cell-cell signaling |
GO:0045666 | 0 | 5.199 | 3.5018 | 15 | 76 | positive regulation of neuron differentiation |
GO:0007200 | 0 | 6.3205 | 2.396 | 12 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002125 | 0 | Inf | 0.1843 | 4 | 4 | maternal aggressive behavior |
GO:0031069 | 0 | 9.8643 | 1.1519 | 8 | 25 | hair follicle morphogenesis |
GO:0048731 | 0 | 1.593 | 91.5708 | 129 | 2192 | system development |
GO:0035176 | 0 | 7.5544 | 1.5666 | 9 | 34 | social behavior |
GO:2000310 | 0 | 15.6785 | 0.6451 | 6 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0009952 | 0 | 2.8974 | 8.4384 | 22 | 184 | anterior/posterior pattern specification |
GO:0021510 | 0 | 4.0436 | 4.0086 | 14 | 87 | spinal cord development |
GO:0003014 | 0 | 4.591 | 3.0871 | 12 | 67 | renal system process |
GO:0051094 | 0 | 1.8611 | 32.6223 | 56 | 712 | positive regulation of developmental process |
GO:0007423 | 1e-04 | 2.0862 | 20.2735 | 39 | 440 | sensory organ development |
GO:0032879 | 1e-04 | 1.5562 | 73.6295 | 105 | 1598 | regulation of localization |
GO:0048562 | 1e-04 | 2.8547 | 7.7537 | 20 | 170 | embryonic organ morphogenesis |
GO:0051970 | 1e-04 | Inf | 0.1382 | 3 | 3 | negative regulation of transmission of nerve impulse |
GO:0032892 | 1e-04 | 10.4489 | 0.8294 | 6 | 18 | positive regulation of organic acid transport |
GO:0044062 | 1e-04 | 10.4489 | 0.8294 | 6 | 18 | regulation of excretion |
GO:2000311 | 1e-04 | 10.4489 | 0.8294 | 6 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0034765 | 1e-04 | 2.3735 | 12.3945 | 27 | 269 | regulation of ion transmembrane transport |
GO:0009887 | 1e-04 | 2.0236 | 20.8343 | 39 | 471 | organ morphogenesis |
GO:0009790 | 1e-04 | 1.7148 | 40.9155 | 65 | 888 | embryo development |
GO:0050789 | 2e-04 | 1.4157 | 267.9048 | 306 | 6196 | regulation of biological process |
GO:0045595 | 2e-04 | 1.6281 | 49.7076 | 75 | 1086 | regulation of cell differentiation |
GO:0022008 | 2e-04 | 1.7829 | 32.0412 | 53 | 730 | neurogenesis |
GO:0060429 | 2e-04 | 1.6896 | 40.7773 | 64 | 885 | epithelium development |
GO:0007617 | 2e-04 | 8.9547 | 0.9215 | 6 | 20 | mating behavior |
GO:0050877 | 2e-04 | 1.7591 | 32.9904 | 54 | 716 | neurological system process |
GO:0043589 | 3e-04 | 5.5838 | 1.7509 | 8 | 38 | skin morphogenesis |
GO:0007610 | 3e-04 | 2.1328 | 15.1772 | 30 | 336 | behavior |
GO:0048665 | 3e-04 | 6.3654 | 1.3823 | 7 | 30 | neuron fate specification |
GO:0032849 | 4e-04 | 62.4259 | 0.1843 | 3 | 4 | positive regulation of cellular pH reduction |
GO:0042663 | 4e-04 | 62.4259 | 0.1843 | 3 | 4 | regulation of endodermal cell fate specification |
GO:0050810 | 4e-04 | 5.2339 | 1.843 | 8 | 40 | regulation of steroid biosynthetic process |
GO:0055078 | 4e-04 | 6.0997 | 1.4284 | 7 | 31 | sodium ion homeostasis |
GO:0007270 | 5e-04 | 3.2782 | 4.4391 | 13 | 97 | neuron-neuron synaptic transmission |
GO:0008015 | 5e-04 | 2.0967 | 14.8826 | 29 | 323 | blood circulation |
GO:0048468 | 5e-04 | 1.5216 | 62.3237 | 88 | 1373 | cell development |
GO:0018958 | 5e-04 | 3.7246 | 3.3636 | 11 | 73 | phenol-containing compound metabolic process |
GO:0003073 | 5e-04 | 4.0334 | 2.8567 | 10 | 62 | regulation of systemic arterial blood pressure |
GO:0007218 | 6e-04 | 3.4068 | 3.9625 | 12 | 86 | neuropeptide signaling pathway |
GO:0001990 | 6e-04 | 6.9624 | 1.1058 | 6 | 24 | regulation of systemic arterial blood pressure by hormone |
GO:0007215 | 6e-04 | 3.8834 | 2.9489 | 10 | 64 | glutamate receptor signaling pathway |
GO:0072507 | 6e-04 | 2.1806 | 12.3484 | 25 | 268 | divalent inorganic cation homeostasis |
GO:0060079 | 7e-04 | 4.7841 | 1.9813 | 8 | 43 | regulation of excitatory postsynaptic membrane potential |
GO:0048545 | 7e-04 | 2.0984 | 13.8228 | 27 | 300 | response to steroid hormone |
GO:0048729 | 7e-04 | 1.8473 | 21.9783 | 38 | 477 | tissue morphogenesis |
GO:0035815 | 7e-04 | 13.8906 | 0.4608 | 4 | 10 | positive regulation of renal sodium excretion |
GO:0007268 | 8e-04 | 1.9463 | 17.5901 | 32 | 394 | synaptic transmission |
GO:0009713 | 8e-04 | 8.6923 | 0.7833 | 5 | 17 | catechol-containing compound biosynthetic process |
GO:0071805 | 8e-04 | 2.7944 | 5.8977 | 15 | 128 | potassium ion transmembrane transport |
GO:0051588 | 8e-04 | 4.0985 | 2.5342 | 9 | 55 | regulation of neurotransmitter transport |
GO:0051412 | 0.0011 | 8.023 | 0.8294 | 5 | 18 | response to corticosterone |
GO:0051046 | 0.0011 | 1.8684 | 19.4084 | 34 | 425 | regulation of secretion |
GO:0007165 | 0.0011 | 1.3191 | 178.9091 | 213 | 3910 | signal transduction |
GO:1901362 | 0.0011 | 1.3311 | 155.138 | 188 | 3367 | organic cyclic compound biosynthetic process |
GO:0051093 | 0.0012 | 1.7383 | 25.7104 | 42 | 558 | negative regulation of developmental process |
GO:0010043 | 0.0012 | 5.9663 | 1.2441 | 6 | 27 | response to zinc ion |
GO:0006813 | 0.0012 | 2.4875 | 7.4182 | 17 | 161 | potassium ion transport |
GO:0045944 | 0.0013 | 1.6268 | 34.6492 | 53 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048839 | 0.0013 | 2.4701 | 7.4643 | 17 | 162 | inner ear development |
GO:0021761 | 0.0015 | 3.4358 | 3.2714 | 10 | 71 | limbic system development |
GO:0048663 | 0.0015 | 4.7685 | 1.734 | 7 | 38 | neuron fate commitment |
GO:0019098 | 0.0015 | 5.6947 | 1.2901 | 6 | 28 | reproductive behavior |
GO:0097028 | 0.0015 | 5.6947 | 1.2901 | 6 | 28 | dendritic cell differentiation |
GO:0001568 | 0.0015 | 1.7902 | 21.3793 | 36 | 464 | blood vessel development |
GO:0001991 | 0.0016 | 10.4162 | 0.5529 | 4 | 12 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0061564 | 0.0017 | 1.7479 | 23.0841 | 38 | 501 | axon development |
GO:0003025 | 0.0018 | 20.8052 | 0.2765 | 3 | 6 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0021797 | 0.0018 | 20.8052 | 0.2765 | 3 | 6 | forebrain anterior/posterior pattern specification |
GO:0051954 | 0.0018 | 6.9521 | 0.9215 | 5 | 20 | positive regulation of amine transport |
GO:0045777 | 0.0018 | 5.4466 | 1.3362 | 6 | 29 | positive regulation of blood pressure |
GO:0048806 | 0.0021 | 4.4328 | 1.843 | 7 | 40 | genitalia development |
GO:0001982 | 0.0021 | Inf | 0.0922 | 2 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
GO:0042418 | 0.0021 | Inf | 0.0922 | 2 | 2 | epinephrine biosynthetic process |
GO:0060014 | 0.0021 | Inf | 0.0922 | 2 | 2 | granulosa cell differentiation |
GO:0061017 | 0.0021 | Inf | 0.0922 | 2 | 2 | hepatoblast differentiation |
GO:2000824 | 0.0021 | Inf | 0.0922 | 2 | 2 | negative regulation of androgen receptor activity |
GO:0021955 | 0.0021 | 5.2192 | 1.3823 | 6 | 30 | central nervous system neuron axonogenesis |
GO:0072358 | 0.0022 | 1.9003 | 15.6787 | 28 | 348 | cardiovascular system development |
GO:0001501 | 0.0022 | 2.1204 | 10.5955 | 21 | 234 | skeletal system development |
GO:0023019 | 0.0022 | 6.5171 | 0.9676 | 5 | 21 | signal transduction involved in regulation of gene expression |
GO:0007186 | 0.0023 | 1.7596 | 21.0941 | 35 | 470 | G-protein coupled receptor signaling pathway |
GO:0006355 | 0.0023 | 1.3254 | 128.2296 | 157 | 2783 | regulation of transcription, DNA-templated |
GO:0048935 | 0.0023 | 9.2581 | 0.599 | 4 | 13 | peripheral nervous system neuron development |
GO:0008016 | 0.0023 | 2.5805 | 5.8977 | 14 | 128 | regulation of heart contraction |
GO:0045665 | 0.0024 | 3.8027 | 2.396 | 8 | 52 | negative regulation of neuron differentiation |
GO:0050804 | 0.0024 | 2.312 | 7.9135 | 17 | 173 | regulation of synaptic transmission |
GO:0010628 | 0.0026 | 1.4754 | 51.0522 | 71 | 1108 | positive regulation of gene expression |
GO:0021543 | 0.0026 | 2.6498 | 5.3448 | 13 | 116 | pallium development |
GO:0030182 | 0.0028 | 1.5426 | 38.4561 | 56 | 870 | neuron differentiation |
GO:0009651 | 0.0028 | 6.1332 | 1.0137 | 5 | 22 | response to salt stress |
GO:0016486 | 0.0028 | 6.1332 | 1.0137 | 5 | 22 | peptide hormone processing |
GO:0042755 | 0.0028 | 6.1332 | 1.0137 | 5 | 22 | eating behavior |
GO:0055085 | 0.0028 | 1.4892 | 46.9515 | 66 | 1019 | transmembrane transport |
GO:0007155 | 0.0029 | 1.5209 | 41.0537 | 59 | 891 | cell adhesion |
GO:0003310 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | pancreatic A cell differentiation |
GO:0015816 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | glycine transport |
GO:0021957 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | corticospinal tract morphogenesis |
GO:0033504 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | floor plate development |
GO:0045924 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | regulation of female receptivity |
GO:0048752 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | semicircular canal morphogenesis |
GO:0097119 | 0.003 | 15.6026 | 0.3225 | 3 | 7 | postsynaptic density protein 95 clustering |
GO:0042220 | 0.003 | 4.817 | 1.4744 | 6 | 32 | response to cocaine |
GO:0007625 | 0.0031 | 8.3316 | 0.6451 | 4 | 14 | grooming behavior |
GO:0021542 | 0.0031 | 8.3316 | 0.6451 | 4 | 14 | dentate gyrus development |
GO:0007204 | 0.0031 | 2.3207 | 7.4182 | 16 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0001709 | 0.0032 | 4.0624 | 1.9813 | 7 | 43 | cell fate determination |
GO:0007507 | 0.0034 | 1.7759 | 18.4765 | 31 | 401 | heart development |
GO:0001963 | 0.0034 | 5.792 | 1.0597 | 5 | 23 | synaptic transmission, dopaminergic |
GO:0006874 | 0.0035 | 2.0315 | 11.0122 | 21 | 239 | cellular calcium ion homeostasis |
GO:0050801 | 0.0035 | 1.7083 | 21.6557 | 35 | 470 | ion homeostasis |
GO:0030901 | 0.0036 | 4.6382 | 1.5205 | 6 | 33 | midbrain development |
GO:1902680 | 0.0037 | 1.4661 | 48.3338 | 67 | 1049 | positive regulation of RNA biosynthetic process |
GO:0048812 | 0.0037 | 1.7006 | 21.7456 | 35 | 477 | neuron projection morphogenesis |
GO:0006812 | 0.004 | 1.5361 | 35.7283 | 52 | 779 | cation transport |
GO:0001975 | 0.0042 | 5.4867 | 1.1058 | 5 | 24 | response to amphetamine |
GO:0045686 | 0.0042 | 5.4867 | 1.1058 | 5 | 24 | negative regulation of glial cell differentiation |
GO:0051252 | 0.0043 | 1.2959 | 133.0215 | 160 | 2887 | regulation of RNA metabolic process |
GO:0003015 | 0.0046 | 2.3704 | 6.3585 | 14 | 138 | heart process |
GO:0003139 | 0.0046 | 12.481 | 0.3686 | 3 | 8 | secondary heart field specification |
GO:0032229 | 0.0046 | 12.481 | 0.3686 | 3 | 8 | negative regulation of synaptic transmission, GABAergic |
GO:0046485 | 0.0046 | 12.481 | 0.3686 | 3 | 8 | ether lipid metabolic process |
GO:0070365 | 0.0046 | 12.481 | 0.3686 | 3 | 8 | hepatocyte differentiation |
GO:0071236 | 0.0046 | 12.481 | 0.3686 | 3 | 8 | cellular response to antibiotic |
GO:0048667 | 0.0046 | 1.6886 | 21.2442 | 34 | 466 | cell morphogenesis involved in neuron differentiation |
GO:0015837 | 0.0047 | 4.3499 | 1.6014 | 6 | 35 | amine transport |
GO:0023061 | 0.005 | 1.8189 | 15.1129 | 26 | 328 | signal release |
GO:0010453 | 0.005 | 5.2119 | 1.1519 | 5 | 25 | regulation of cell fate commitment |
GO:0021513 | 0.005 | 5.2119 | 1.1519 | 5 | 25 | spinal cord dorsal/ventral patterning |
GO:0048869 | 0.0051 | 1.4193 | 57.0603 | 76 | 1329 | cellular developmental process |
GO:0048813 | 0.0051 | 2.8291 | 3.8704 | 10 | 84 | dendrite morphogenesis |
GO:0010460 | 0.0052 | 6.9419 | 0.7372 | 4 | 16 | positive regulation of heart rate |
GO:0060999 | 0.0052 | 6.9419 | 0.7372 | 4 | 16 | positive regulation of dendritic spine development |
GO:0031326 | 0.0053 | 1.2766 | 148.8256 | 176 | 3230 | regulation of cellular biosynthetic process |
GO:0031214 | 0.0053 | 2.6488 | 4.5155 | 11 | 98 | biomineral tissue development |
GO:0023052 | 0.0054 | 1.2763 | 162.8345 | 190 | 3748 | signaling |
GO:0007626 | 0.0056 | 2.1692 | 7.879 | 16 | 171 | locomotory behavior |
GO:0009719 | 0.0056 | 1.4212 | 52.711 | 71 | 1144 | response to endogenous stimulus |
GO:0009605 | 0.0056 | 1.3703 | 69.5287 | 90 | 1509 | response to external stimulus |
GO:0042633 | 0.006 | 2.7542 | 3.9625 | 10 | 86 | hair cycle |
GO:0006935 | 0.0061 | 1.6187 | 24.0517 | 37 | 522 | chemotaxis |
GO:0009891 | 0.0061 | 1.3965 | 58.194 | 77 | 1263 | positive regulation of biosynthetic process |
GO:0007422 | 0.0062 | 2.9414 | 3.3636 | 9 | 73 | peripheral nervous system development |
GO:0001997 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
GO:0009635 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | response to herbicide |
GO:0014049 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | positive regulation of glutamate secretion |
GO:0018963 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | phthalate metabolic process |
GO:0021902 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0031394 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0035726 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0060061 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | Spemann organizer formation |
GO:0060112 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | generation of ovulation cycle rhythm |
GO:0061146 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | Peyer's patch morphogenesis |
GO:0097211 | 0.0062 | 41.5456 | 0.1382 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0043010 | 0.0064 | 1.9151 | 11.6112 | 21 | 252 | camera-type eye development |
GO:2000179 | 0.0064 | 4.0384 | 1.7048 | 6 | 37 | positive regulation of neural precursor cell proliferation |
GO:0021514 | 0.0066 | 6.4073 | 0.7833 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0030878 | 0.0066 | 6.4073 | 0.7833 | 4 | 17 | thyroid gland development |
GO:0034367 | 0.0066 | 6.4073 | 0.7833 | 4 | 17 | macromolecular complex remodeling |
GO:0034369 | 0.0066 | 6.4073 | 0.7833 | 4 | 17 | plasma lipoprotein particle remodeling |
GO:0060914 | 0.0066 | 6.4073 | 0.7833 | 4 | 17 | heart formation |
GO:0010935 | 0.0066 | 10.4 | 0.4147 | 3 | 9 | regulation of macrophage cytokine production |
GO:0015671 | 0.0066 | 10.4 | 0.4147 | 3 | 9 | oxygen transport |
GO:0090009 | 0.0066 | 10.4 | 0.4147 | 3 | 9 | primitive streak formation |
GO:0050766 | 0.0071 | 4.7373 | 1.2441 | 5 | 27 | positive regulation of phagocytosis |
GO:0042445 | 0.0072 | 2.4125 | 5.354 | 12 | 117 | hormone metabolic process |
GO:0030902 | 0.0074 | 2.3101 | 6.036 | 13 | 131 | hindbrain development |
GO:0032990 | 0.0074 | 1.5051 | 33.4973 | 48 | 727 | cell part morphogenesis |
GO:0019438 | 0.0075 | 1.2609 | 151.0372 | 177 | 3278 | aromatic compound biosynthetic process |
GO:0045935 | 0.0077 | 1.3926 | 55.1991 | 73 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0007611 | 0.0077 | 2.0873 | 8.1555 | 16 | 177 | learning or memory |
GO:0022404 | 0.008 | 2.809 | 3.5018 | 9 | 76 | molting cycle process |
GO:0007263 | 0.0081 | 5.9492 | 0.8294 | 4 | 18 | nitric oxide mediated signal transduction |
GO:0042127 | 0.0082 | 1.4033 | 50.9601 | 68 | 1106 | regulation of cell proliferation |
GO:0055082 | 0.0083 | 1.6556 | 19.6745 | 31 | 427 | cellular chemical homeostasis |
GO:0048704 | 0.0083 | 2.6156 | 4.1468 | 10 | 90 | embryonic skeletal system morphogenesis |
GO:0051966 | 0.0083 | 3.793 | 1.797 | 6 | 39 | regulation of synaptic transmission, glutamatergic |
GO:0007498 | 0.0083 | 2.4766 | 4.7919 | 11 | 104 | mesoderm development |
GO:0009653 | 0.0083 | 1.5317 | 29.5712 | 43 | 703 | anatomical structure morphogenesis |
GO:1901617 | 0.0084 | 2.1916 | 6.8193 | 14 | 148 | organic hydroxy compound biosynthetic process |
GO:0008202 | 0.0084 | 1.9709 | 9.676 | 18 | 210 | steroid metabolic process |
GO:0002700 | 0.0085 | 3.3216 | 2.3499 | 7 | 51 | regulation of production of molecular mediator of immune response |
GO:0021879 | 0.0085 | 3.3216 | 2.3499 | 7 | 51 | forebrain neuron differentiation |
GO:0051216 | 0.0085 | 2.2653 | 6.141 | 13 | 134 | cartilage development |
GO:0048565 | 0.0087 | 2.3496 | 5.483 | 12 | 119 | digestive tract development |
GO:0043269 | 0.0089 | 2.1722 | 6.8692 | 14 | 153 | regulation of ion transport |
GO:0060485 | 0.009 | 2.0486 | 8.2937 | 16 | 180 | mesenchyme development |
GO:0032305 | 0.0092 | 8.9135 | 0.4608 | 3 | 10 | positive regulation of icosanoid secretion |
GO:0035810 | 0.0092 | 8.9135 | 0.4608 | 3 | 10 | positive regulation of urine volume |
GO:0043084 | 0.0092 | 8.9135 | 0.4608 | 3 | 10 | penile erection |
GO:0048703 | 0.0092 | 8.9135 | 0.4608 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0071379 | 0.0092 | 8.9135 | 0.4608 | 3 | 10 | cellular response to prostaglandin stimulus |
GO:0048864 | 0.0092 | 1.9118 | 10.5053 | 19 | 228 | stem cell development |
GO:0031018 | 0.0092 | 3.6991 | 1.8346 | 6 | 40 | endocrine pancreas development |
GO:0003002 | 0.0096 | 2.3142 | 5.5518 | 12 | 124 | regionalization |
GO:0048646 | 0.0096 | 1.447 | 39.1399 | 54 | 856 | anatomical structure formation involved in morphogenesis |
GO:0015833 | 0.0097 | 1.9401 | 9.8142 | 18 | 213 | peptide transport |
GO:0006775 | 0.0097 | 4.3418 | 1.3362 | 5 | 29 | fat-soluble vitamin metabolic process |
GO:0010470 | 0.0097 | 4.3418 | 1.3362 | 5 | 29 | regulation of gastrulation |
GO:0042417 | 0.0097 | 4.3418 | 1.3362 | 5 | 29 | dopamine metabolic process |
GO:0044060 | 0.0097 | 4.3418 | 1.3362 | 5 | 29 | regulation of endocrine process |
GO:0032502 | 0.0099 | 1.3384 | 77.0301 | 96 | 1925 | developmental process |
GO:0001502 | 0.0099 | 5.5521 | 0.8754 | 4 | 19 | cartilage condensation |
GO:0006972 | 0.0099 | 5.5521 | 0.8754 | 4 | 19 | hyperosmotic response |
GO:0007530 | 0.0099 | 5.5521 | 0.8754 | 4 | 19 | sex determination |
GO:0034122 | 0.0099 | 5.5521 | 0.8754 | 4 | 19 | negative regulation of toll-like receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 3.3705 | 14.0341 | 41 | 344 | pattern specification process |
GO:0048598 | 0 | 2.8525 | 19.5618 | 49 | 481 | embryonic morphogenesis |
GO:2000026 | 0 | 2.1896 | 39.3529 | 76 | 976 | regulation of multicellular organismal development |
GO:0048568 | 0 | 3.0817 | 12.0808 | 33 | 299 | embryonic organ development |
GO:0048729 | 0 | 2.4247 | 19.641 | 43 | 477 | tissue morphogenesis |
GO:0045944 | 0 | 2.0646 | 30.9644 | 58 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0060231 | 0 | 16.5086 | 0.7 | 7 | 17 | mesenchymal to epithelial transition |
GO:0048870 | 0 | 1.9563 | 37.7996 | 67 | 918 | cell motility |
GO:0048704 | 0 | 6.9838 | 1.9853 | 11 | 49 | embryonic skeletal system morphogenesis |
GO:0001763 | 0 | 3.2498 | 7.947 | 23 | 193 | morphogenesis of a branching structure |
GO:0048701 | 0 | 7.639 | 1.6882 | 10 | 41 | embryonic cranial skeleton morphogenesis |
GO:2000679 | 0 | 39.1764 | 0.3294 | 5 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0006355 | 0 | 1.5614 | 114.5928 | 157 | 2783 | regulation of transcription, DNA-templated |
GO:0065007 | 0 | 1.5436 | 336.7786 | 383 | 8179 | biological regulation |
GO:0048485 | 0 | 12.6957 | 0.8235 | 7 | 20 | sympathetic nervous system development |
GO:0007399 | 0 | 1.6546 | 71.8933 | 107 | 1746 | nervous system development |
GO:0031326 | 0 | 1.5164 | 132.9985 | 176 | 3230 | regulation of cellular biosynthetic process |
GO:0061458 | 0 | 2.4723 | 14.6587 | 33 | 356 | reproductive system development |
GO:0060429 | 0 | 1.9548 | 31.9063 | 57 | 787 | epithelium development |
GO:0051252 | 0 | 1.5286 | 118.8751 | 160 | 2887 | regulation of RNA metabolic process |
GO:0009952 | 0 | 4.1474 | 4.1557 | 15 | 103 | anterior/posterior pattern specification |
GO:0009954 | 0 | 8.9936 | 1.1941 | 8 | 29 | proximal/distal pattern formation |
GO:0010556 | 0 | 1.5018 | 127.975 | 169 | 3108 | regulation of macromolecule biosynthetic process |
GO:0022603 | 0 | 2.5983 | 11.8421 | 28 | 294 | regulation of anatomical structure morphogenesis |
GO:0048519 | 0 | 1.5245 | 113.9118 | 153 | 2837 | negative regulation of biological process |
GO:0042127 | 0 | 1.7508 | 45.5407 | 73 | 1106 | regulation of cell proliferation |
GO:0010628 | 0 | 1.7471 | 45.623 | 73 | 1108 | positive regulation of gene expression |
GO:0061308 | 0 | 46.9246 | 0.2471 | 4 | 6 | cardiac neural crest cell development involved in heart development |
GO:0001656 | 0 | 4.2864 | 3.5 | 13 | 85 | metanephros development |
GO:0045597 | 0 | 2.0701 | 22.0292 | 42 | 535 | positive regulation of cell differentiation |
GO:0003253 | 1e-04 | Inf | 0.1235 | 3 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0014033 | 1e-04 | 5.2564 | 2.2647 | 10 | 55 | neural crest cell differentiation |
GO:0045165 | 1e-04 | 3.0259 | 6.5757 | 18 | 162 | cell fate commitment |
GO:0000904 | 1e-04 | 1.8534 | 29.7291 | 51 | 722 | cell morphogenesis involved in differentiation |
GO:0097503 | 1e-04 | 10.0843 | 0.8235 | 6 | 20 | sialylation |
GO:0050767 | 2e-04 | 2.2568 | 13.4172 | 28 | 330 | regulation of neurogenesis |
GO:0060708 | 3e-04 | 70.2568 | 0.1647 | 3 | 4 | spongiotrophoblast differentiation |
GO:0072107 | 3e-04 | 70.2568 | 0.1647 | 3 | 4 | positive regulation of ureteric bud formation |
GO:0045596 | 3e-04 | 2.0723 | 16.6101 | 32 | 408 | negative regulation of cell differentiation |
GO:0009968 | 3e-04 | 1.7548 | 31.8291 | 52 | 773 | negative regulation of signal transduction |
GO:0061005 | 3e-04 | 5.3899 | 1.7706 | 8 | 43 | cell differentiation involved in kidney development |
GO:0034654 | 3e-04 | 1.4035 | 132.5456 | 167 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0021537 | 3e-04 | 3.0498 | 5.4238 | 15 | 133 | telencephalon development |
GO:0051270 | 4e-04 | 1.9223 | 21.2056 | 38 | 515 | regulation of cellular component movement |
GO:0040012 | 4e-04 | 1.9267 | 20.588 | 37 | 500 | regulation of locomotion |
GO:0000122 | 4e-04 | 1.8759 | 22.8527 | 40 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0032989 | 4e-04 | 1.6254 | 43.6466 | 66 | 1060 | cellular component morphogenesis |
GO:0051101 | 4e-04 | 4.0738 | 2.8 | 10 | 68 | regulation of DNA binding |
GO:0048858 | 5e-04 | 1.7611 | 29.1938 | 48 | 709 | cell projection morphogenesis |
GO:0021877 | 5e-04 | 15.6364 | 0.4118 | 4 | 10 | forebrain neuron fate commitment |
GO:0021936 | 5e-04 | 15.6364 | 0.4118 | 4 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0060993 | 5e-04 | 4.9632 | 1.8941 | 8 | 46 | kidney morphogenesis |
GO:0002064 | 6e-04 | 2.6763 | 6.9176 | 17 | 168 | epithelial cell development |
GO:0007420 | 6e-04 | 1.8349 | 23.3056 | 40 | 566 | brain development |
GO:0009888 | 6e-04 | 2.0024 | 16.6111 | 31 | 432 | tissue development |
GO:0001892 | 6e-04 | 5.5417 | 1.5111 | 7 | 37 | embryonic placenta development |
GO:0038107 | 7e-04 | 35.1255 | 0.2059 | 3 | 5 | nodal signaling pathway involved in determination of left/right asymmetry |
GO:0051241 | 7e-04 | 2.1732 | 12.3528 | 25 | 300 | negative regulation of multicellular organismal process |
GO:0048706 | 7e-04 | 6.6476 | 1.1144 | 6 | 28 | embryonic skeletal system development |
GO:0048754 | 7e-04 | 2.7139 | 6.4235 | 16 | 156 | branching morphogenesis of an epithelial tube |
GO:0048666 | 8e-04 | 1.6767 | 33.1325 | 52 | 813 | neuron development |
GO:0048538 | 8e-04 | 5.3161 | 1.5647 | 7 | 38 | thymus development |
GO:0021872 | 8e-04 | 4.0835 | 2.5117 | 9 | 61 | forebrain generation of neurons |
GO:0046189 | 8e-04 | 6.4131 | 1.1529 | 6 | 28 | phenol-containing compound biosynthetic process |
GO:0009890 | 8e-04 | 1.6009 | 41.4231 | 62 | 1006 | negative regulation of biosynthetic process |
GO:0030334 | 9e-04 | 1.9343 | 17.6645 | 32 | 429 | regulation of cell migration |
GO:1902680 | 9e-04 | 1.5848 | 43.1936 | 64 | 1049 | positive regulation of RNA biosynthetic process |
GO:0035148 | 9e-04 | 2.8604 | 5.3529 | 14 | 130 | tube formation |
GO:0001838 | 0.001 | 2.9596 | 4.8176 | 13 | 117 | embryonic epithelial tube formation |
GO:0003156 | 0.0011 | 11.8002 | 0.4911 | 4 | 12 | regulation of organ formation |
GO:0001829 | 0.0011 | 7.8275 | 0.8235 | 5 | 20 | trophectodermal cell differentiation |
GO:0048484 | 0.0011 | 11.7253 | 0.4941 | 4 | 12 | enteric nervous system development |
GO:0009891 | 0.0011 | 1.5236 | 52.0053 | 74 | 1263 | positive regulation of biosynthetic process |
GO:0044707 | 0.0011 | 1.3786 | 134.4775 | 164 | 3707 | single-multicellular organism process |
GO:0006664 | 0.0011 | 3.2907 | 3.7058 | 11 | 90 | glycolipid metabolic process |
GO:0045665 | 0.0012 | 4.2842 | 2.1412 | 8 | 52 | negative regulation of neuron differentiation |
GO:0048665 | 0.0012 | 5.8777 | 1.2353 | 6 | 30 | neuron fate specification |
GO:0035502 | 0.0013 | 23.4151 | 0.2471 | 3 | 6 | metanephric part of ureteric bud development |
GO:0035860 | 0.0013 | 23.4151 | 0.2471 | 3 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
GO:0048731 | 0.0013 | 1.6259 | 36.5379 | 55 | 1003 | system development |
GO:0009948 | 0.0013 | 4.8458 | 1.6882 | 7 | 41 | anterior/posterior axis specification |
GO:1902679 | 0.0013 | 1.6338 | 33.8879 | 52 | 823 | negative regulation of RNA biosynthetic process |
GO:0010629 | 0.0013 | 1.5981 | 38.0055 | 57 | 923 | negative regulation of gene expression |
GO:1901576 | 0.0013 | 1.3206 | 189.8626 | 223 | 4611 | organic substance biosynthetic process |
GO:0008406 | 0.0014 | 2.5309 | 6.8352 | 16 | 166 | gonad development |
GO:0043403 | 0.0014 | 7.3377 | 0.8647 | 5 | 21 | skeletal muscle tissue regeneration |
GO:0045923 | 0.0014 | 7.3377 | 0.8647 | 5 | 21 | positive regulation of fatty acid metabolic process |
GO:0030326 | 0.0014 | 2.8491 | 4.9823 | 13 | 121 | embryonic limb morphogenesis |
GO:0051171 | 0.0014 | 1.3359 | 148.8924 | 180 | 3616 | regulation of nitrogen compound metabolic process |
GO:0080090 | 0.0015 | 1.3179 | 187.2685 | 220 | 4548 | regulation of primary metabolic process |
GO:0048646 | 0.0015 | 1.6948 | 27.6174 | 44 | 689 | anatomical structure formation involved in morphogenesis |
GO:0072164 | 0.0015 | 3.1695 | 3.8294 | 11 | 93 | mesonephric tubule development |
GO:0090288 | 0.0015 | 3.1695 | 3.8294 | 11 | 93 | negative regulation of cellular response to growth factor stimulus |
GO:0048935 | 0.0015 | 10.4217 | 0.5353 | 4 | 13 | peripheral nervous system neuron development |
GO:0072283 | 0.0015 | 10.4217 | 0.5353 | 4 | 13 | metanephric renal vesicle morphogenesis |
GO:0045995 | 0.0016 | 3.1311 | 3.8705 | 11 | 94 | regulation of embryonic development |
GO:0050794 | 0.0017 | 1.3519 | 220.2855 | 250 | 5841 | regulation of cellular process |
GO:0021893 | 0.0017 | Inf | 0.0824 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0060460 | 0.0017 | Inf | 0.0824 | 2 | 2 | left lung morphogenesis |
GO:0001709 | 0.0017 | 4.5759 | 1.7706 | 7 | 43 | cell fate determination |
GO:0051099 | 0.0017 | 3.3243 | 3.3353 | 10 | 81 | positive regulation of binding |
GO:0035107 | 0.0018 | 2.6524 | 5.7235 | 14 | 139 | appendage morphogenesis |
GO:0030856 | 0.0018 | 3.0936 | 3.9117 | 11 | 95 | regulation of epithelial cell differentiation |
GO:0001574 | 0.0021 | 17.5598 | 0.2882 | 3 | 7 | ganglioside biosynthetic process |
GO:0003140 | 0.0021 | 17.5598 | 0.2882 | 3 | 7 | determination of left/right asymmetry in lateral mesoderm |
GO:0032000 | 0.0021 | 17.5598 | 0.2882 | 3 | 7 | positive regulation of fatty acid beta-oxidation |
GO:0045766 | 0.0023 | 3.1888 | 3.4588 | 10 | 84 | positive regulation of angiogenesis |
GO:0060485 | 0.0023 | 2.472 | 6.5353 | 15 | 160 | mesenchyme development |
GO:0043009 | 0.0024 | 1.9093 | 15.0118 | 27 | 384 | chordate embryonic development |
GO:0035282 | 0.0025 | 6.2479 | 0.9777 | 5 | 24 | segmentation |
GO:0021953 | 0.0025 | 2.5466 | 5.9336 | 14 | 145 | central nervous system neuron differentiation |
GO:0007409 | 0.0025 | 1.7788 | 19.6538 | 33 | 479 | axonogenesis |
GO:0014031 | 0.0025 | 2.6508 | 5.3117 | 13 | 129 | mesenchymal cell development |
GO:0060675 | 0.0027 | 3.6941 | 2.4294 | 8 | 59 | ureteric bud morphogenesis |
GO:0021987 | 0.0027 | 3.1043 | 3.5411 | 10 | 86 | cerebral cortex development |
GO:0048518 | 0.0027 | 1.3968 | 80.8087 | 104 | 2071 | positive regulation of biological process |
GO:0007517 | 0.0028 | 1.9988 | 12.2293 | 23 | 297 | muscle organ development |
GO:0009311 | 0.0028 | 4.8623 | 1.4412 | 6 | 35 | oligosaccharide metabolic process |
GO:0007548 | 0.0028 | 2.2137 | 8.6881 | 18 | 211 | sex differentiation |
GO:0022414 | 0.0028 | 1.5595 | 36.0105 | 53 | 881 | reproductive process |
GO:0007267 | 0.0029 | 1.5223 | 41.0937 | 59 | 998 | cell-cell signaling |
GO:0043066 | 0.0029 | 1.6889 | 23.7997 | 38 | 578 | negative regulation of apoptotic process |
GO:0045934 | 0.0029 | 1.538 | 38.5819 | 56 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0001756 | 0.003 | 3.6227 | 2.4706 | 8 | 60 | somitogenesis |
GO:0072001 | 0.0031 | 2.0936 | 10.1705 | 20 | 247 | renal system development |
GO:0048589 | 0.0032 | 2.0463 | 10.9116 | 21 | 265 | developmental growth |
GO:0060563 | 0.0032 | 4.6998 | 1.4823 | 6 | 36 | neuroepithelial cell differentiation |
GO:0021924 | 0.0033 | 14.0467 | 0.3294 | 3 | 8 | cell proliferation in external granule layer |
GO:0060670 | 0.0033 | 14.0467 | 0.3294 | 3 | 8 | branching involved in labyrinthine layer morphogenesis |
GO:1902547 | 0.0033 | 14.0467 | 0.3294 | 3 | 8 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0042310 | 0.0034 | 3.5541 | 2.5117 | 8 | 61 | vasoconstriction |
GO:2000648 | 0.0034 | 3.5541 | 2.5117 | 8 | 61 | positive regulation of stem cell proliferation |
GO:0043067 | 0.0034 | 1.4906 | 44.7995 | 63 | 1088 | regulation of programmed cell death |
GO:0022604 | 0.0035 | 1.897 | 13.9587 | 25 | 339 | regulation of cell morphogenesis |
GO:0019932 | 0.0036 | 2.4357 | 6.1764 | 14 | 150 | second-messenger-mediated signaling |
GO:0060548 | 0.0036 | 1.6444 | 25.6938 | 40 | 624 | negative regulation of cell death |
GO:0035295 | 0.0036 | 1.8925 | 13.9892 | 25 | 348 | tube development |
GO:0021766 | 0.0037 | 3.9202 | 2.0176 | 7 | 49 | hippocampus development |
GO:0022029 | 0.0037 | 3.9202 | 2.0176 | 7 | 49 | telencephalon cell migration |
GO:0010975 | 0.0037 | 2.0567 | 10.3352 | 20 | 251 | regulation of neuron projection development |
GO:2000179 | 0.0037 | 4.5478 | 1.5235 | 6 | 37 | positive regulation of neural precursor cell proliferation |
GO:0006692 | 0.0037 | 5.5883 | 1.0706 | 5 | 26 | prostanoid metabolic process |
GO:0045935 | 0.0038 | 1.4615 | 49.3289 | 68 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0072006 | 0.0038 | 2.9481 | 3.7058 | 10 | 90 | nephron development |
GO:0043583 | 0.0039 | 2.2563 | 7.5764 | 16 | 184 | ear development |
GO:0042475 | 0.0039 | 3.1654 | 3.1294 | 9 | 76 | odontogenesis of dentin-containing tooth |
GO:2000113 | 0.004 | 1.5251 | 37.429 | 54 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0060562 | 0.0041 | 2.4928 | 5.6076 | 13 | 139 | epithelial tube morphogenesis |
GO:0019933 | 0.0043 | 4.4053 | 1.5647 | 6 | 38 | cAMP-mediated signaling |
GO:0060428 | 0.0043 | 4.4053 | 1.5647 | 6 | 38 | lung epithelium development |
GO:0042423 | 0.0044 | 7.2126 | 0.7 | 4 | 17 | catecholamine biosynthetic process |
GO:0072087 | 0.0044 | 7.2126 | 0.7 | 4 | 17 | renal vesicle development |
GO:0051240 | 0.0046 | 1.7183 | 19.6453 | 32 | 480 | positive regulation of multicellular organismal process |
GO:0044767 | 0.0046 | 1.3468 | 100.878 | 124 | 2802 | single-organism developmental process |
GO:0048814 | 0.0046 | 3.7414 | 2.1 | 7 | 51 | regulation of dendrite morphogenesis |
GO:0001764 | 0.0047 | 2.5532 | 5.0646 | 12 | 123 | neuron migration |
GO:0006688 | 0.0048 | 11.7689 | 0.3687 | 3 | 9 | glycosphingolipid biosynthetic process |
GO:0045109 | 0.0048 | 11.7046 | 0.3706 | 3 | 9 | intermediate filament organization |
GO:0014812 | 0.0049 | 4.2715 | 1.6059 | 6 | 39 | muscle cell migration |
GO:0061217 | 0.0049 | 47.0485 | 0.1228 | 2 | 3 | regulation of mesonephros development |
GO:0001705 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | ectoderm formation |
GO:0003358 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | noradrenergic neuron development |
GO:0021550 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | medulla oblongata development |
GO:0021882 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0061056 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | sclerotome development |
GO:0065001 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | specification of axis polarity |
GO:0071603 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | endothelial cell-cell adhesion |
GO:1900175 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:1900748 | 0.0049 | 46.7476 | 0.1235 | 2 | 3 | positive regulation of vascular endothelial growth factor signaling pathway |
GO:0061180 | 0.005 | 3.3036 | 2.6764 | 8 | 65 | mammary gland epithelium development |
GO:0060173 | 0.0054 | 2.3151 | 6.4646 | 14 | 157 | limb development |
GO:0010575 | 0.0055 | 6.6969 | 0.7412 | 4 | 18 | positive regulation vascular endothelial growth factor production |
GO:0042554 | 0.0055 | 6.6969 | 0.7412 | 4 | 18 | superoxide anion generation |
GO:0072074 | 0.0055 | 6.6969 | 0.7412 | 4 | 18 | kidney mesenchyme development |
GO:0060711 | 0.0055 | 4.1455 | 1.647 | 6 | 40 | labyrinthine layer development |
GO:0017015 | 0.0056 | 2.7736 | 3.9117 | 10 | 95 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0023056 | 0.0057 | 1.489 | 38.9525 | 55 | 946 | positive regulation of signaling |
GO:0048584 | 0.0057 | 1.4321 | 50.1936 | 68 | 1219 | positive regulation of response to stimulus |
GO:0009880 | 0.0058 | 3.5782 | 2.1823 | 7 | 53 | embryonic pattern specification |
GO:0007166 | 0.006 | 1.3231 | 96.2283 | 119 | 2337 | cell surface receptor signaling pathway |
GO:2000243 | 0.0061 | 4.8886 | 1.1941 | 5 | 29 | positive regulation of reproductive process |
GO:0016265 | 0.0063 | 1.3702 | 68.1463 | 88 | 1655 | death |
GO:0001944 | 0.0063 | 1.6756 | 20.0939 | 32 | 488 | vasculature development |
GO:0048468 | 0.0064 | 1.8039 | 14.6332 | 25 | 382 | cell development |
GO:0048705 | 0.0064 | 2.715 | 3.9799 | 10 | 100 | skeletal system morphogenesis |
GO:0010647 | 0.0064 | 1.4783 | 39.1996 | 55 | 952 | positive regulation of cell communication |
GO:0032101 | 0.0064 | 1.7038 | 18.5292 | 30 | 450 | regulation of response to external stimulus |
GO:0007519 | 0.0065 | 2.3444 | 5.9293 | 13 | 144 | skeletal muscle tissue development |
GO:0070482 | 0.0066 | 2.0218 | 9.4293 | 18 | 229 | response to oxygen levels |
GO:0001666 | 0.0067 | 2.0648 | 8.7293 | 17 | 212 | response to hypoxia |
GO:0031649 | 0.0067 | 10.0317 | 0.4118 | 3 | 10 | heat generation |
GO:0035358 | 0.0067 | 10.0317 | 0.4118 | 3 | 10 | regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0043084 | 0.0067 | 10.0317 | 0.4118 | 3 | 10 | penile erection |
GO:0007178 | 0.0067 | 1.9369 | 10.9116 | 20 | 265 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0021895 | 0.0067 | 6.2499 | 0.7823 | 4 | 19 | cerebral cortex neuron differentiation |
GO:0042474 | 0.0067 | 6.2499 | 0.7823 | 4 | 19 | middle ear morphogenesis |
GO:0060541 | 0.0068 | 2.1157 | 8.0293 | 16 | 195 | respiratory system development |
GO:0048864 | 0.0068 | 2.691 | 4.0156 | 10 | 99 | stem cell development |
GO:0001755 | 0.0069 | 4.7201 | 1.2285 | 5 | 30 | neural crest cell migration |
GO:0009409 | 0.007 | 4.6926 | 1.2353 | 5 | 30 | response to cold |
GO:0032663 | 0.007 | 4.6926 | 1.2353 | 5 | 30 | regulation of interleukin-2 production |
GO:0060795 | 0.007 | 4.6926 | 1.2353 | 5 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0072088 | 0.007 | 4.6926 | 1.2353 | 5 | 30 | nephron epithelium morphogenesis |
GO:0050896 | 0.0072 | 1.2719 | 185.2966 | 211 | 4677 | response to stimulus |
GO:0001816 | 0.0074 | 1.7191 | 17.1292 | 28 | 416 | cytokine production |
GO:0001654 | 0.0075 | 1.8808 | 11.7763 | 21 | 286 | eye development |
GO:0071495 | 0.0076 | 1.4965 | 34.4231 | 49 | 836 | cellular response to endogenous stimulus |
GO:0007160 | 0.0078 | 2.2058 | 6.7529 | 14 | 164 | cell-matrix adhesion |
GO:0014014 | 0.0081 | 4.5118 | 1.2765 | 5 | 31 | negative regulation of gliogenesis |
GO:0046637 | 0.0081 | 4.5118 | 1.2765 | 5 | 31 | regulation of alpha-beta T cell differentiation |
GO:0007194 | 0.0081 | 5.8588 | 0.8235 | 4 | 20 | negative regulation of adenylate cyclase activity |
GO:0035336 | 0.0081 | 5.8588 | 0.8235 | 4 | 20 | long-chain fatty-acyl-CoA metabolic process |
GO:0051954 | 0.0081 | 5.8588 | 0.8235 | 4 | 20 | positive regulation of amine transport |
GO:0060669 | 0.0081 | 5.8588 | 0.8235 | 4 | 20 | embryonic placenta morphogenesis |
GO:0090189 | 0.0081 | 5.8588 | 0.8235 | 4 | 20 | regulation of branching involved in ureteric bud morphogenesis |
GO:0032844 | 0.0082 | 1.9329 | 10.3764 | 19 | 252 | regulation of homeostatic process |
GO:1903034 | 0.0085 | 1.9245 | 10.4175 | 19 | 253 | regulation of response to wounding |
GO:0006665 | 0.0088 | 2.447 | 4.8176 | 11 | 117 | sphingolipid metabolic process |
GO:0040034 | 0.0089 | 8.777 | 0.4529 | 3 | 11 | regulation of development, heterochronic |
GO:0061029 | 0.0089 | 8.777 | 0.4529 | 3 | 11 | eyelid development in camera-type eye |
GO:0097154 | 0.0089 | 8.777 | 0.4529 | 3 | 11 | GABAergic neuron differentiation |
GO:0050769 | 0.0093 | 2.3208 | 5.5176 | 12 | 134 | positive regulation of neurogenesis |
GO:0003044 | 0.0093 | 4.3443 | 1.3176 | 5 | 32 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0002088 | 0.0094 | 3.226 | 2.3882 | 7 | 58 | lens development in camera-type eye |
GO:0003357 | 0.0095 | 23.4603 | 0.1641 | 2 | 4 | noradrenergic neuron differentiation |
GO:0007412 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | axon target recognition |
GO:0008582 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | regulation of synaptic growth at neuromuscular junction |
GO:0019896 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | axon transport of mitochondrion |
GO:0021569 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | rhombomere 3 development |
GO:0032754 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | positive regulation of interleukin-5 production |
GO:0042738 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | exogenous drug catabolic process |
GO:0048859 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | formation of anatomical boundary |
GO:0060020 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | Bergmann glial cell differentiation |
GO:0060164 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | regulation of timing of neuron differentiation |
GO:0060278 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | regulation of ovulation |
GO:0061325 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0072108 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0097476 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | spinal cord motor neuron migration |
GO:1900246 | 0.0096 | 23.3719 | 0.1647 | 2 | 4 | positive regulation of RIG-I signaling pathway |
GO:0000038 | 0.0097 | 5.5137 | 0.8647 | 4 | 21 | very long-chain fatty acid metabolic process |
GO:0001516 | 0.0097 | 5.5137 | 0.8647 | 4 | 21 | prostaglandin biosynthetic process |
GO:0001759 | 0.0097 | 5.5137 | 0.8647 | 4 | 21 | organ induction |
GO:0048557 | 0.0097 | 5.5137 | 0.8647 | 4 | 21 | embryonic digestive tract morphogenesis |
GO:0021517 | 0.0099 | 3.6125 | 1.8529 | 6 | 45 | ventral spinal cord development |
GO:0048469 | 0.0099 | 2.4013 | 4.8999 | 11 | 119 | cell maturation |
GO:0048565 | 0.0099 | 2.4013 | 4.8999 | 11 | 119 | digestive tract development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044259 | 1e-04 | 3.9854 | 3.6945 | 13 | 98 | multicellular organismal macromolecule metabolic process |
GO:0021602 | 1e-04 | 10.3278 | 0.7917 | 6 | 21 | cranial nerve morphogenesis |
GO:0048704 | 1e-04 | 4.0026 | 3.3929 | 12 | 90 | embryonic skeletal system morphogenesis |
GO:0007155 | 1e-04 | 1.8777 | 27.045 | 47 | 728 | cell adhesion |
GO:0003008 | 1e-04 | 1.6827 | 44.522 | 69 | 1181 | system process |
GO:0071625 | 2e-04 | 20.5852 | 0.3393 | 4 | 9 | vocalization behavior |
GO:0002062 | 2e-04 | 4.0823 | 3.0536 | 11 | 81 | chondrocyte differentiation |
GO:0042391 | 2e-04 | 2.3413 | 11.5358 | 25 | 306 | regulation of membrane potential |
GO:0071805 | 3e-04 | 3.1993 | 4.8254 | 14 | 128 | potassium ion transmembrane transport |
GO:0007600 | 4e-04 | 2.1005 | 15.3433 | 30 | 407 | sensory perception |
GO:0035116 | 6e-04 | 6.7311 | 1.0933 | 6 | 29 | embryonic hindlimb morphogenesis |
GO:0070374 | 7e-04 | 3.4815 | 3.506 | 11 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0035115 | 9e-04 | 6.1916 | 1.1687 | 6 | 31 | embryonic forelimb morphogenesis |
GO:0051965 | 9e-04 | 8.0508 | 0.7917 | 5 | 21 | positive regulation of synapse assembly |
GO:0060021 | 0.001 | 3.5998 | 3.0913 | 10 | 82 | palate development |
GO:0061448 | 0.001 | 2.5198 | 7.2758 | 17 | 193 | connective tissue development |
GO:0007268 | 0.0011 | 1.7722 | 24.0517 | 40 | 638 | synaptic transmission |
GO:0006813 | 0.0011 | 2.6752 | 6.0695 | 15 | 161 | potassium ion transport |
GO:0032501 | 0.0014 | 1.3316 | 188.8698 | 221 | 5010 | multicellular organismal process |
GO:0001101 | 0.0014 | 2.3079 | 8.8215 | 19 | 234 | response to acid chemical |
GO:0071300 | 0.0014 | 4.1368 | 2.1865 | 8 | 58 | cellular response to retinoic acid |
GO:0002528 | 0.0014 | Inf | 0.0754 | 2 | 2 | regulation of vascular permeability involved in acute inflammatory response |
GO:0007521 | 0.0014 | Inf | 0.0754 | 2 | 2 | muscle cell fate determination |
GO:0072610 | 0.0014 | Inf | 0.0754 | 2 | 2 | interleukin-12 secretion |
GO:0021756 | 0.0015 | 10.2884 | 0.5278 | 4 | 14 | striatum development |
GO:0001501 | 0.0016 | 1.9693 | 14.5893 | 27 | 387 | skeletal system development |
GO:0060560 | 0.0016 | 2.7913 | 5.0516 | 13 | 134 | developmental growth involved in morphogenesis |
GO:0061333 | 0.0017 | 6.778 | 0.9048 | 5 | 24 | renal tubule morphogenesis |
GO:0007154 | 0.0021 | 1.3211 | 167.8717 | 198 | 4453 | cell communication |
GO:0032964 | 0.0021 | 6.4386 | 0.9425 | 5 | 25 | collagen biosynthetic process |
GO:0035108 | 0.0023 | 2.6794 | 5.2401 | 13 | 139 | limb morphogenesis |
GO:0048167 | 0.0023 | 2.9703 | 4.0337 | 11 | 107 | regulation of synaptic plasticity |
GO:0044700 | 0.0023 | 1.3175 | 165.3459 | 195 | 4386 | single organism signaling |
GO:1902667 | 0.0025 | 8.5722 | 0.6032 | 4 | 16 | regulation of axon guidance |
GO:0001958 | 0.0025 | 6.1315 | 0.9802 | 5 | 26 | endochondral ossification |
GO:0002920 | 0.0025 | 6.1315 | 0.9802 | 5 | 26 | regulation of humoral immune response |
GO:0021612 | 0.0026 | 15.4063 | 0.3016 | 3 | 8 | facial nerve structural organization |
GO:0048793 | 0.0026 | 15.4063 | 0.3016 | 3 | 8 | pronephros development |
GO:0030574 | 0.0027 | 3.6917 | 2.4127 | 8 | 64 | collagen catabolic process |
GO:0021675 | 0.0032 | 3.5639 | 2.4881 | 8 | 66 | nerve development |
GO:2000353 | 0.0038 | 12.8376 | 0.3393 | 3 | 9 | positive regulation of endothelial cell apoptotic process |
GO:0072358 | 0.0038 | 1.6097 | 28.2362 | 43 | 749 | cardiovascular system development |
GO:0050771 | 0.0041 | 4.4189 | 1.5456 | 6 | 41 | negative regulation of axonogenesis |
GO:0021570 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | rhombomere 4 development |
GO:0021754 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | facial nucleus development |
GO:0036023 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0046598 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | positive regulation of viral entry into host cell |
GO:0071395 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | cellular response to jasmonic acid stimulus |
GO:0097485 | 0.0045 | 1.9138 | 12.7044 | 23 | 337 | neuron projection guidance |
GO:0042330 | 0.0047 | 1.715 | 19.6787 | 32 | 522 | taxis |
GO:0050808 | 0.0047 | 3.0547 | 3.2092 | 9 | 86 | synapse organization |
GO:0048568 | 0.0048 | 1.8471 | 14.2878 | 25 | 379 | embryonic organ development |
GO:0048640 | 0.0049 | 5.1487 | 1.131 | 5 | 30 | negative regulation of developmental growth |
GO:0022617 | 0.0051 | 2.8126 | 3.8453 | 10 | 102 | extracellular matrix disassembly |
GO:0021561 | 0.0052 | 11.0027 | 0.377 | 3 | 10 | facial nerve development |
GO:0001568 | 0.0053 | 1.7472 | 17.4921 | 29 | 464 | blood vessel development |
GO:0050807 | 0.0059 | 3.5409 | 2.1865 | 7 | 58 | regulation of synapse organization |
GO:0035113 | 0.006 | 2.5893 | 4.5615 | 11 | 121 | embryonic appendage morphogenesis |
GO:0042127 | 0.0061 | 1.4698 | 41.6946 | 58 | 1106 | regulation of cell proliferation |
GO:0009887 | 0.0064 | 1.5833 | 26.6005 | 40 | 712 | organ morphogenesis |
GO:0048736 | 0.0064 | 2.341 | 5.9187 | 13 | 157 | appendage development |
GO:0008038 | 0.0065 | 4.7666 | 1.2064 | 5 | 32 | neuron recognition |
GO:0007275 | 0.0065 | 1.2915 | 134.3803 | 159 | 3619 | multicellular organismal development |
GO:0010975 | 0.0069 | 2.0101 | 9.4623 | 18 | 251 | regulation of neuron projection development |
GO:0048871 | 0.007 | 2.1638 | 7.3512 | 15 | 195 | multicellular organismal homeostasis |
GO:0060993 | 0.0072 | 3.865 | 1.7341 | 6 | 46 | kidney morphogenesis |
GO:0050795 | 0.0076 | 2.4976 | 4.7123 | 11 | 125 | regulation of behavior |
GO:0009798 | 0.0077 | 3.0373 | 2.8651 | 8 | 76 | axis specification |
GO:0002883 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | regulation of hypersensitivity |
GO:0003105 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | negative regulation of glomerular filtration |
GO:0021571 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | rhombomere 5 development |
GO:0061590 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | calcium activated phosphatidylcholine scrambling |
GO:0061591 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | calcium activated galactosylceramide scrambling |
GO:0070170 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | regulation of tooth mineralization |
GO:0071205 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | protein localization to juxtaparanode region of axon |
GO:0061564 | 0.0084 | 1.6679 | 18.887 | 30 | 501 | axon development |
GO:0098609 | 0.0087 | 2.2462 | 6.1449 | 13 | 163 | cell-cell adhesion |
GO:0001991 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0021794 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | thalamus development |
GO:0044110 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | growth involved in symbiotic interaction |
GO:0044117 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | growth of symbiont in host |
GO:0032502 | 0.0091 | 1.2609 | 163.3102 | 188 | 4332 | developmental process |
GO:0010721 | 0.0095 | 2.4121 | 4.8631 | 11 | 129 | negative regulation of cell development |
GO:0048667 | 0.0098 | 1.6184 | 20.7342 | 32 | 550 | cell morphogenesis involved in neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 51.4814 | 0.3997 | 8 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 7.0081 | 1.7216 | 10 | 56 | detection of chemical stimulus |
GO:0070830 | 0 | 8.0447 | 1.3835 | 9 | 45 | tight junction assembly |
GO:0006968 | 0 | 8.5627 | 1.1683 | 8 | 38 | cellular defense response |
GO:0007606 | 0 | 5.5527 | 2.0906 | 10 | 68 | sensory perception of chemical stimulus |
GO:0007155 | 0 | 1.955 | 27.3926 | 49 | 891 | cell adhesion |
GO:0007210 | 2e-04 | 18.1922 | 0.3382 | 4 | 11 | serotonin receptor signaling pathway |
GO:0045591 | 3e-04 | 47.6503 | 0.1537 | 3 | 5 | positive regulation of regulatory T cell differentiation |
GO:0050891 | 3e-04 | 7.6693 | 0.9531 | 6 | 31 | multicellular organismal water homeostasis |
GO:0042267 | 4e-04 | 7.1001 | 1.0145 | 6 | 33 | natural killer cell mediated cytotoxicity |
GO:0034115 | 5e-04 | 31.7642 | 0.1845 | 3 | 6 | negative regulation of heterotypic cell-cell adhesion |
GO:0023052 | 8e-04 | 1.4036 | 134.8419 | 165 | 4386 | signaling |
GO:0050906 | 8e-04 | 4.4968 | 1.9983 | 8 | 65 | detection of stimulus involved in sensory perception |
GO:0034329 | 8e-04 | 2.7546 | 5.872 | 15 | 191 | cell junction assembly |
GO:0032689 | 9e-04 | 11.5731 | 0.4612 | 4 | 15 | negative regulation of interferon-gamma production |
GO:0070586 | 9e-04 | 23.8212 | 0.2152 | 3 | 7 | cell-cell adhesion involved in gastrulation |
GO:0050868 | 0.0013 | 4.7632 | 1.6602 | 7 | 54 | negative regulation of T cell activation |
GO:2000352 | 0.0015 | 9.791 | 0.5226 | 4 | 17 | negative regulation of endothelial cell apoptotic process |
GO:0045216 | 0.0018 | 2.6246 | 5.7183 | 14 | 186 | cell-cell junction organization |
GO:0010837 | 0.0019 | 9.0909 | 0.5534 | 4 | 18 | regulation of keratinocyte proliferation |
GO:0001906 | 0.0021 | 4.3035 | 1.8139 | 7 | 59 | cell killing |
GO:0002682 | 0.0024 | 1.6696 | 26.7778 | 42 | 871 | regulation of immune system process |
GO:0050877 | 0.0025 | 1.7373 | 22.0125 | 36 | 716 | neurological system process |
GO:0002718 | 0.0027 | 5.9013 | 0.9838 | 5 | 32 | regulation of cytokine production involved in immune response |
GO:0002774 | 0.0028 | 63.3747 | 0.0922 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007207 | 0.0028 | 63.3747 | 0.0922 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0035880 | 0.0028 | 63.3747 | 0.0922 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0048681 | 0.0028 | 63.3747 | 0.0922 | 2 | 3 | negative regulation of axon regeneration |
GO:0016338 | 0.0029 | 7.9532 | 0.6149 | 4 | 20 | calcium-independent cell-cell adhesion |
GO:0050896 | 0.0034 | 1.3286 | 181.2648 | 208 | 5896 | response to stimulus |
GO:0050663 | 0.0036 | 3.4589 | 2.521 | 8 | 82 | cytokine secretion |
GO:0035637 | 0.0046 | 2.6746 | 4.3963 | 11 | 143 | multicellular organismal signaling |
GO:0007165 | 0.0047 | 1.3307 | 120.8535 | 145 | 3931 | signal transduction |
GO:0032613 | 0.0049 | 6.6958 | 0.7071 | 4 | 23 | interleukin-10 production |
GO:0002765 | 0.0054 | 31.6848 | 0.123 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0046898 | 0.0054 | 31.6848 | 0.123 | 2 | 4 | response to cycloheximide |
GO:2000637 | 0.0054 | 31.6848 | 0.123 | 2 | 4 | positive regulation of gene silencing by miRNA |
GO:0051222 | 0.006 | 2.4546 | 5.1957 | 12 | 169 | positive regulation of protein transport |
GO:0002695 | 0.0064 | 3.1194 | 2.7669 | 8 | 90 | negative regulation of leukocyte activation |
GO:0010737 | 0.0066 | 9.5238 | 0.3997 | 3 | 13 | protein kinase A signaling |
GO:0009611 | 0.0073 | 1.6113 | 23.5497 | 36 | 766 | response to wounding |
GO:0007186 | 0.0076 | 1.6983 | 17.9679 | 29 | 590 | G-protein coupled receptor signaling pathway |
GO:0031623 | 0.0079 | 3.7515 | 1.7524 | 6 | 57 | receptor internalization |
GO:0042219 | 0.0082 | 8.6573 | 0.4304 | 3 | 14 | cellular modified amino acid catabolic process |
GO:0031348 | 0.0083 | 2.9733 | 2.8899 | 8 | 94 | negative regulation of defense response |
GO:0060326 | 0.0083 | 2.5832 | 4.1197 | 10 | 134 | cell chemotaxis |
GO:1902106 | 0.0085 | 3.6791 | 1.7831 | 6 | 58 | negative regulation of leukocyte differentiation |
GO:0019373 | 0.0089 | 21.1214 | 0.1537 | 2 | 5 | epoxygenase P450 pathway |
GO:0035331 | 0.0089 | 21.1214 | 0.1537 | 2 | 5 | negative regulation of hippo signaling |
GO:2001028 | 0.0089 | 21.1214 | 0.1537 | 2 | 5 | positive regulation of endothelial cell chemotaxis |
GO:2001179 | 0.0089 | 21.1214 | 0.1537 | 2 | 5 | regulation of interleukin-10 secretion |
GO:0001775 | 0.0095 | 1.6253 | 20.6905 | 32 | 673 | cell activation |
GO:0009068 | 0.01 | 7.9352 | 0.4612 | 3 | 15 | aspartate family amino acid catabolic process |
GO:0046629 | 0.01 | 7.9352 | 0.4612 | 3 | 15 | gamma-delta T cell activation |
GO:0061436 | 0.01 | 7.9352 | 0.4612 | 3 | 15 | establishment of skin barrier |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.3081 | 221.734 | 332 | 5010 | multicellular organismal process |
GO:0021510 | 0 | 11.9523 | 3.8505 | 30 | 87 | spinal cord development |
GO:0045944 | 0 | 3.3557 | 33.2822 | 91 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006355 | 0 | 2.1313 | 123.1708 | 205 | 2783 | regulation of transcription, DNA-templated |
GO:0007389 | 0 | 5.3208 | 9.6073 | 41 | 228 | pattern specification process |
GO:0010628 | 0 | 2.6173 | 49.0382 | 107 | 1108 | positive regulation of gene expression |
GO:1902680 | 0 | 2.6558 | 46.4269 | 103 | 1049 | positive regulation of RNA biosynthetic process |
GO:0051252 | 0 | 2.0263 | 127.7737 | 205 | 2887 | regulation of RNA metabolic process |
GO:1901362 | 0 | 1.9589 | 149.0176 | 228 | 3367 | organic cyclic compound biosynthetic process |
GO:0009891 | 0 | 2.4055 | 55.8982 | 113 | 1263 | positive regulation of biosynthetic process |
GO:0019438 | 0 | 1.9423 | 145.0786 | 222 | 3278 | aromatic compound biosynthetic process |
GO:0045935 | 0 | 2.412 | 53.0214 | 108 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0018130 | 0 | 1.927 | 145.0786 | 221 | 3278 | heterocycle biosynthetic process |
GO:0044271 | 0 | 1.918 | 147.1588 | 223 | 3325 | cellular nitrogen compound biosynthetic process |
GO:0010556 | 0 | 1.9347 | 137.5547 | 212 | 3108 | regulation of macromolecule biosynthetic process |
GO:0065007 | 0 | 1.9967 | 361.9885 | 437 | 8179 | biological regulation |
GO:0032502 | 0 | 1.9657 | 105.9784 | 165 | 2747 | developmental process |
GO:0051171 | 0 | 1.7783 | 160.0379 | 229 | 3616 | regulation of nitrogen compound metabolic process |
GO:0021513 | 0 | 20.3481 | 1.1065 | 12 | 25 | spinal cord dorsal/ventral patterning |
GO:0009792 | 0 | 2.7305 | 24.7404 | 59 | 559 | embryo development ending in birth or egg hatching |
GO:0007218 | 0 | 6.7492 | 3.8062 | 20 | 86 | neuropeptide signaling pathway |
GO:0022008 | 0 | 2.507 | 30.6038 | 67 | 730 | neurogenesis |
GO:0009954 | 0 | 15.5552 | 1.2835 | 12 | 29 | proximal/distal pattern formation |
GO:0060581 | 0 | 32.9047 | 0.6639 | 9 | 15 | cell fate commitment involved in pattern specification |
GO:0031326 | 0 | 1.8693 | 89.6533 | 141 | 2181 | regulation of cellular biosynthetic process |
GO:0048562 | 0 | 4.3284 | 7.3748 | 27 | 170 | embryonic organ morphogenesis |
GO:0021953 | 0 | 5.3655 | 4.7641 | 21 | 112 | central nervous system neuron differentiation |
GO:0021514 | 0 | 24.6745 | 0.7524 | 9 | 17 | ventral spinal cord interneuron differentiation |
GO:0007423 | 0 | 3.4238 | 11.0662 | 33 | 256 | sensory organ development |
GO:0048468 | 0 | 2.0227 | 52.3232 | 93 | 1226 | cell development |
GO:0007498 | 0 | 5.295 | 4.6029 | 20 | 104 | mesoderm development |
GO:0045666 | 0 | 6.3857 | 3.3636 | 17 | 76 | positive regulation of neuron differentiation |
GO:0048729 | 0 | 2.6135 | 21.1112 | 49 | 477 | tissue morphogenesis |
GO:0001662 | 0 | 14.64 | 1.1065 | 10 | 25 | behavioral fear response |
GO:0021527 | 0 | 25.0228 | 0.6639 | 8 | 15 | spinal cord association neuron differentiation |
GO:0051094 | 0 | 2.2467 | 31.3792 | 63 | 716 | positive regulation of developmental process |
GO:0009887 | 0 | 2.9463 | 14.1777 | 37 | 345 | organ morphogenesis |
GO:0008284 | 0 | 2.3382 | 27.2631 | 57 | 616 | positive regulation of cell proliferation |
GO:0030901 | 0 | 10.9936 | 1.4605 | 11 | 33 | midbrain development |
GO:0021872 | 0 | 6.5717 | 2.6998 | 14 | 61 | forebrain generation of neurons |
GO:0009953 | 0 | 5.8538 | 3.1576 | 15 | 73 | dorsal/ventral pattern formation |
GO:0080090 | 0 | 1.5422 | 201.2867 | 257 | 4548 | regulation of primary metabolic process |
GO:0007417 | 0 | 2.3544 | 22.6366 | 48 | 553 | central nervous system development |
GO:0009799 | 0 | 4.8856 | 4.1603 | 17 | 94 | specification of symmetry |
GO:0009790 | 0 | 2.9476 | 11.795 | 31 | 286 | embryo development |
GO:0021542 | 0 | 21.8553 | 0.6196 | 7 | 14 | dentate gyrus development |
GO:0021797 | 0 | 108.9369 | 0.2655 | 5 | 6 | forebrain anterior/posterior pattern specification |
GO:0033555 | 0 | 6.3629 | 2.567 | 13 | 58 | multicellular organismal response to stress |
GO:0090092 | 0 | 3.554 | 7.3911 | 23 | 167 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0001764 | 0 | 4.0486 | 5.4438 | 19 | 123 | neuron migration |
GO:0030803 | 0 | 10.3798 | 1.2392 | 9 | 28 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0007275 | 0 | 1.7558 | 70.5404 | 107 | 1985 | multicellular organismal development |
GO:0045596 | 0 | 2.4212 | 17.7757 | 39 | 408 | negative regulation of cell differentiation |
GO:0030817 | 0 | 5.1423 | 3.2751 | 14 | 74 | regulation of cAMP biosynthetic process |
GO:1900372 | 0 | 9.3897 | 1.3277 | 9 | 30 | negative regulation of purine nucleotide biosynthetic process |
GO:0002125 | 0 | Inf | 0.177 | 4 | 4 | maternal aggressive behavior |
GO:0021913 | 0 | Inf | 0.177 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0045165 | 0 | 3.7856 | 5.7356 | 19 | 137 | cell fate commitment |
GO:0001707 | 0 | 5.5032 | 2.8768 | 13 | 65 | mesoderm formation |
GO:0014013 | 0 | 5.5032 | 2.8768 | 13 | 65 | regulation of gliogenesis |
GO:0031018 | 0 | 6.7105 | 2.0801 | 11 | 47 | endocrine pancreas development |
GO:0030902 | 0 | 4.6497 | 3.8087 | 15 | 87 | hindbrain development |
GO:0030815 | 0 | 8.9621 | 1.372 | 9 | 31 | negative regulation of cAMP metabolic process |
GO:0001975 | 0 | 10.9393 | 1.0622 | 8 | 24 | response to amphetamine |
GO:0048736 | 0 | 3.4254 | 6.9485 | 21 | 157 | appendage development |
GO:0042220 | 0 | 8.5718 | 1.4163 | 9 | 32 | response to cocaine |
GO:0072507 | 0 | 2.7088 | 11.8612 | 29 | 268 | divalent inorganic cation homeostasis |
GO:0044708 | 0 | 2.6457 | 12.5314 | 30 | 289 | single-organism behavior |
GO:0048665 | 0 | 19.1054 | 0.5638 | 6 | 13 | neuron fate specification |
GO:0007267 | 0 | 3.2049 | 7.7031 | 22 | 185 | cell-cell signaling |
GO:0048935 | 0 | 18.6993 | 0.5754 | 6 | 13 | peripheral nervous system neuron development |
GO:0061564 | 0 | 2.1712 | 22.1734 | 44 | 501 | axon development |
GO:0044705 | 0 | 9.7222 | 1.1507 | 8 | 26 | multi-organism reproductive behavior |
GO:0007586 | 0 | 4.295 | 4.0718 | 15 | 92 | digestion |
GO:1902679 | 0 | 1.8902 | 36.4246 | 63 | 823 | negative regulation of RNA biosynthetic process |
GO:0001947 | 0 | 5.8897 | 2.3014 | 11 | 52 | heart looping |
GO:0045665 | 0 | 5.8897 | 2.3014 | 11 | 52 | negative regulation of neuron differentiation |
GO:0000122 | 0 | 2.0894 | 24.5633 | 47 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007194 | 0 | 11.7624 | 0.8852 | 7 | 20 | negative regulation of adenylate cyclase activity |
GO:0051954 | 0 | 11.7624 | 0.8852 | 7 | 20 | positive regulation of amine transport |
GO:0021871 | 0 | 16.5328 | 0.6135 | 6 | 14 | forebrain regionalization |
GO:0048706 | 0 | 8.9371 | 1.2147 | 8 | 28 | embryonic skeletal system development |
GO:0048664 | 0 | 27.2275 | 0.3983 | 5 | 9 | neuron fate determination |
GO:0090009 | 0 | 27.2275 | 0.3983 | 5 | 9 | primitive streak formation |
GO:0010629 | 0 | 1.8166 | 40.8504 | 68 | 923 | negative regulation of gene expression |
GO:0009719 | 0 | 1.7276 | 50.6315 | 80 | 1144 | response to endogenous stimulus |
GO:0031327 | 0 | 4.9704 | 2.8638 | 12 | 68 | negative regulation of cellular biosynthetic process |
GO:0060429 | 0 | 1.9505 | 29.6016 | 53 | 692 | epithelium development |
GO:0009952 | 0 | 3.7348 | 4.8765 | 16 | 114 | anterior/posterior pattern specification |
GO:0048593 | 0 | 3.9348 | 4.3816 | 15 | 99 | camera-type eye morphogenesis |
GO:0007369 | 0 | 3.2551 | 6.551 | 19 | 149 | gastrulation |
GO:0007204 | 0 | 3.1395 | 7.1256 | 20 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0042755 | 0 | 10.1924 | 0.9737 | 7 | 22 | eating behavior |
GO:0052652 | 0 | 3.8882 | 4.4258 | 15 | 100 | cyclic purine nucleotide metabolic process |
GO:0030808 | 0 | 4.1087 | 3.939 | 14 | 89 | regulation of nucleotide biosynthetic process |
GO:0021520 | 0 | 21.8986 | 0.4403 | 5 | 10 | spinal cord motor neuron cell fate specification |
GO:0045934 | 0 | 1.8031 | 39.2261 | 65 | 898 | negative regulation of nucleobase-containing compound metabolic process |
GO:0034645 | 0 | 1.5002 | 119.5779 | 158 | 2843 | cellular macromolecule biosynthetic process |
GO:0045980 | 0 | 6.5679 | 1.7261 | 9 | 39 | negative regulation of nucleotide metabolic process |
GO:0003215 | 0 | 13.0863 | 0.7081 | 6 | 16 | cardiac right ventricle morphogenesis |
GO:2000113 | 0 | 1.783 | 40.2308 | 66 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0090304 | 0 | 1.4286 | 174.7759 | 218 | 3949 | nucleic acid metabolic process |
GO:0060041 | 0 | 3.5633 | 5.0897 | 16 | 115 | retina development in camera-type eye |
GO:0048667 | 0 | 2.005 | 24.3421 | 45 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0006874 | 1e-04 | 2.5939 | 10.5777 | 25 | 239 | cellular calcium ion homeostasis |
GO:0042711 | 1e-04 | 18.1486 | 0.4868 | 5 | 11 | maternal behavior |
GO:0043583 | 1e-04 | 2.8516 | 8.1435 | 21 | 184 | ear development |
GO:0050768 | 1e-04 | 3.8025 | 4.2045 | 14 | 95 | negative regulation of neurogenesis |
GO:0032924 | 1e-04 | 6.9959 | 1.4605 | 8 | 33 | activin receptor signaling pathway |
GO:0010453 | 1e-04 | 8.4916 | 1.1065 | 7 | 25 | regulation of cell fate commitment |
GO:0021885 | 1e-04 | 5.2169 | 2.3014 | 10 | 52 | forebrain cell migration |
GO:0031960 | 1e-04 | 3.5513 | 4.7799 | 15 | 108 | response to corticosteroid |
GO:0048812 | 1e-04 | 1.9604 | 24.8289 | 45 | 561 | neuron projection morphogenesis |
GO:0023057 | 1e-04 | 1.7906 | 35.6414 | 59 | 808 | negative regulation of signaling |
GO:0021912 | 1e-04 | Inf | 0.1328 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0061056 | 1e-04 | Inf | 0.1328 | 3 | 3 | sclerotome development |
GO:0009880 | 1e-04 | 5.0951 | 2.3457 | 10 | 53 | embryonic pattern specification |
GO:0010648 | 1e-04 | 1.783 | 35.7738 | 59 | 811 | negative regulation of cell communication |
GO:0030799 | 1e-04 | 3.6223 | 4.3816 | 14 | 99 | regulation of cyclic nucleotide metabolic process |
GO:0021521 | 1e-04 | 29.2029 | 0.3077 | 4 | 7 | ventral spinal cord interneuron specification |
GO:0003357 | 1e-04 | 28.9928 | 0.3098 | 4 | 7 | noradrenergic neuron differentiation |
GO:0021796 | 1e-04 | 28.9928 | 0.3098 | 4 | 7 | cerebral cortex regionalization |
GO:2000543 | 1e-04 | 28.9928 | 0.3098 | 4 | 7 | positive regulation of gastrulation |
GO:0021915 | 1e-04 | 2.9864 | 6.683 | 18 | 151 | neural tube development |
GO:0003206 | 1e-04 | 3.5799 | 4.4258 | 14 | 100 | cardiac chamber morphogenesis |
GO:0048585 | 1e-04 | 1.722 | 40.1423 | 64 | 907 | negative regulation of response to stimulus |
GO:0050767 | 1e-04 | 2.2479 | 14.471 | 30 | 335 | regulation of neurogenesis |
GO:0006935 | 1e-04 | 1.9617 | 23.1028 | 42 | 522 | chemotaxis |
GO:0031279 | 1e-04 | 4.8679 | 2.4342 | 10 | 55 | regulation of cyclase activity |
GO:0035050 | 1e-04 | 4.4011 | 2.9113 | 11 | 66 | embryonic heart tube development |
GO:0042493 | 2e-04 | 2.2546 | 13.9414 | 29 | 315 | response to drug |
GO:0044699 | 2e-04 | 1.5889 | 366.4453 | 397 | 9088 | single-organism process |
GO:0007368 | 2e-04 | 3.9508 | 3.4796 | 12 | 79 | determination of left/right symmetry |
GO:0060562 | 2e-04 | 3.0159 | 6.2477 | 17 | 143 | epithelial tube morphogenesis |
GO:0048485 | 2e-04 | 9.3442 | 0.8852 | 6 | 20 | sympathetic nervous system development |
GO:0048870 | 2e-04 | 1.6981 | 40.6291 | 64 | 918 | cell motility |
GO:0007626 | 2e-04 | 3.6533 | 4.0315 | 13 | 92 | locomotory behavior |
GO:0050890 | 2e-04 | 2.6229 | 8.7631 | 21 | 198 | cognition |
GO:0023019 | 2e-04 | 8.7206 | 0.9294 | 6 | 21 | signal transduction involved in regulation of gene expression |
GO:0060485 | 2e-04 | 5.7472 | 1.6957 | 8 | 39 | mesenchyme development |
GO:0060180 | 2e-04 | 21.7428 | 0.3541 | 4 | 8 | female mating behavior |
GO:0051339 | 2e-04 | 4.469 | 2.6112 | 10 | 59 | regulation of lyase activity |
GO:0071542 | 2e-04 | 12.0961 | 0.6196 | 5 | 14 | dopaminergic neuron differentiation |
GO:0048704 | 2e-04 | 4.9616 | 2.1524 | 9 | 49 | embryonic skeletal system morphogenesis |
GO:0043010 | 3e-04 | 3.7038 | 3.6693 | 12 | 85 | camera-type eye development |
GO:0035113 | 3e-04 | 3.1124 | 5.3553 | 15 | 121 | embryonic appendage morphogenesis |
GO:0015850 | 3e-04 | 2.8588 | 6.5502 | 17 | 148 | organic hydroxy compound transport |
GO:0023061 | 3e-04 | 2.1542 | 14.5167 | 29 | 328 | signal release |
GO:0007268 | 3e-04 | 1.8994 | 22.608 | 40 | 518 | synaptic transmission |
GO:0009605 | 3e-04 | 1.5222 | 66.7857 | 94 | 1509 | response to external stimulus |
GO:0055082 | 3e-04 | 1.99 | 18.8983 | 35 | 427 | cellular chemical homeostasis |
GO:0007621 | 3e-04 | 65.1275 | 0.177 | 3 | 4 | negative regulation of female receptivity |
GO:0034287 | 3e-04 | 65.1275 | 0.177 | 3 | 4 | detection of monosaccharide stimulus |
GO:0042660 | 3e-04 | 65.1275 | 0.177 | 3 | 4 | positive regulation of cell fate specification |
GO:0051594 | 3e-04 | 65.1275 | 0.177 | 3 | 4 | detection of glucose |
GO:0060455 | 3e-04 | 65.1275 | 0.177 | 3 | 4 | negative regulation of gastric acid secretion |
GO:0001756 | 3e-04 | 4.719 | 2.2426 | 9 | 51 | somitogenesis |
GO:0007422 | 3e-04 | 3.888 | 3.2309 | 11 | 73 | peripheral nervous system development |
GO:0018958 | 3e-04 | 3.888 | 3.2309 | 11 | 73 | phenol-containing compound metabolic process |
GO:0009914 | 4e-04 | 2.3662 | 10.5335 | 23 | 238 | hormone transport |
GO:0035150 | 4e-04 | 3.171 | 4.9127 | 14 | 111 | regulation of tube size |
GO:0045595 | 4e-04 | 1.8087 | 26.7015 | 45 | 639 | regulation of cell differentiation |
GO:0008406 | 4e-04 | 2.6804 | 7.3469 | 18 | 166 | gonad development |
GO:0009996 | 4e-04 | 17.3928 | 0.3983 | 4 | 9 | negative regulation of cell fate specification |
GO:0032525 | 4e-04 | 17.3928 | 0.3983 | 4 | 9 | somite rostral/caudal axis specification |
GO:0048513 | 4e-04 | 1.6148 | 47.1345 | 70 | 1285 | organ development |
GO:0050877 | 4e-04 | 1.9542 | 19.2128 | 35 | 449 | neurological system process |
GO:0021537 | 5e-04 | 4.0552 | 2.8217 | 10 | 66 | telencephalon development |
GO:0015844 | 5e-04 | 4.4729 | 2.3457 | 9 | 53 | monoamine transport |
GO:0007411 | 5e-04 | 2.0897 | 14.915 | 29 | 337 | axon guidance |
GO:0003018 | 5e-04 | 2.9442 | 5.6208 | 15 | 127 | vascular process in circulatory system |
GO:0050801 | 5e-04 | 1.9051 | 20.8014 | 37 | 470 | ion homeostasis |
GO:0007186 | 5e-04 | 1.941 | 19.322 | 35 | 456 | G-protein coupled receptor signaling pathway |
GO:0045686 | 5e-04 | 7.2653 | 1.0622 | 6 | 24 | negative regulation of glial cell differentiation |
GO:0030030 | 5e-04 | 1.6093 | 43.9485 | 66 | 993 | cell projection organization |
GO:0021549 | 5e-04 | 3.6512 | 3.4079 | 11 | 77 | cerebellum development |
GO:0061458 | 5e-04 | 2.0431 | 15.7559 | 30 | 356 | reproductive system development |
GO:0072089 | 6e-04 | 4.9139 | 1.9251 | 8 | 44 | stem cell proliferation |
GO:0021543 | 6e-04 | 3.9281 | 2.9024 | 10 | 67 | pallium development |
GO:0048869 | 6e-04 | 1.5895 | 48.5634 | 71 | 1280 | cellular developmental process |
GO:0003231 | 6e-04 | 3.3731 | 3.9832 | 12 | 90 | cardiac ventricle development |
GO:0021533 | 6e-04 | 6.8824 | 1.1065 | 6 | 25 | cell differentiation in hindbrain |
GO:0045687 | 6e-04 | 6.8824 | 1.1065 | 6 | 25 | positive regulation of glial cell differentiation |
GO:0016331 | 6e-04 | 2.7493 | 6.3732 | 16 | 144 | morphogenesis of embryonic epithelium |
GO:0003211 | 6e-04 | 14.4928 | 0.4426 | 4 | 10 | cardiac ventricle formation |
GO:0021877 | 6e-04 | 14.4928 | 0.4426 | 4 | 10 | forebrain neuron fate commitment |
GO:0000902 | 6e-04 | 1.5944 | 44.3025 | 66 | 1001 | cell morphogenesis |
GO:0007612 | 7e-04 | 3.1345 | 4.6029 | 13 | 104 | learning |
GO:0021766 | 7e-04 | 5.5211 | 1.5314 | 7 | 35 | hippocampus development |
GO:0030003 | 7e-04 | 2.0354 | 15.2691 | 29 | 345 | cellular cation homeostasis |
GO:0032990 | 7e-04 | 1.6922 | 32.1758 | 51 | 727 | cell part morphogenesis |
GO:0030514 | 7e-04 | 5.4543 | 1.549 | 7 | 35 | negative regulation of BMP signaling pathway |
GO:0019233 | 8e-04 | 3.7727 | 3.0096 | 10 | 68 | sensory perception of pain |
GO:0072358 | 8e-04 | 1.6736 | 33.1495 | 52 | 749 | cardiovascular system development |
GO:0040019 | 8e-04 | 32.6757 | 0.2206 | 3 | 5 | positive regulation of embryonic development |
GO:0003278 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | apoptotic process involved in heart morphogenesis |
GO:0021779 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | glial cell fate specification |
GO:0038107 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | nodal signaling pathway involved in determination of left/right asymmetry |
GO:0042713 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | sperm ejaculation |
GO:0060040 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | retinal bipolar neuron differentiation |
GO:0060406 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | positive regulation of penile erection |
GO:2001199 | 8e-04 | 32.561 | 0.2213 | 3 | 5 | negative regulation of dendritic cell differentiation |
GO:0003151 | 8e-04 | 4.0988 | 2.5227 | 9 | 57 | outflow tract morphogenesis |
GO:0048644 | 8e-04 | 4.0988 | 2.5227 | 9 | 57 | muscle organ morphogenesis |
GO:0055008 | 8e-04 | 4.5976 | 2.0359 | 8 | 46 | cardiac muscle tissue morphogenesis |
GO:0007263 | 9e-04 | 8.3714 | 0.7966 | 5 | 18 | nitric oxide mediated signal transduction |
GO:0032892 | 9e-04 | 8.3714 | 0.7966 | 5 | 18 | positive regulation of organic acid transport |
GO:0007193 | 9e-04 | 4.4957 | 2.073 | 8 | 47 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0001706 | 9e-04 | 12.5216 | 0.4832 | 4 | 11 | endoderm formation |
GO:0048565 | 0.001 | 3.3738 | 3.6444 | 11 | 83 | digestive tract development |
GO:0021903 | 0.001 | 12.4214 | 0.4868 | 4 | 11 | rostrocaudal neural tube patterning |
GO:0055062 | 0.001 | 12.4214 | 0.4868 | 4 | 11 | phosphate ion homeostasis |
GO:0021884 | 0.001 | 6.2259 | 1.195 | 6 | 27 | forebrain neuron development |
GO:0035137 | 0.001 | 5.0899 | 1.6376 | 7 | 37 | hindlimb morphogenesis |
GO:0055065 | 0.0011 | 1.9508 | 16.4198 | 30 | 371 | metal ion homeostasis |
GO:0003006 | 0.0011 | 1.8268 | 20.9919 | 36 | 477 | developmental process involved in reproduction |
GO:0002052 | 0.0012 | 7.7728 | 0.8409 | 5 | 19 | positive regulation of neuroblast proliferation |
GO:0007620 | 0.0012 | 7.7728 | 0.8409 | 5 | 19 | copulation |
GO:0021854 | 0.0012 | 7.7728 | 0.8409 | 5 | 19 | hypothalamus development |
GO:0009892 | 0.0012 | 1.456 | 68.5118 | 93 | 1548 | negative regulation of metabolic process |
GO:0009743 | 0.0012 | 2.6785 | 6.1076 | 15 | 138 | response to carbohydrate |
GO:0048864 | 0.0012 | 2.2372 | 10.0909 | 21 | 228 | stem cell development |
GO:0032774 | 0.0012 | 1.509 | 55.9332 | 78 | 1443 | RNA biosynthetic process |
GO:0061061 | 0.0013 | 1.8303 | 20.3588 | 35 | 460 | muscle structure development |
GO:0014032 | 0.0013 | 4.2602 | 2.1687 | 8 | 49 | neural crest cell development |
GO:0009798 | 0.0013 | 3.4842 | 3.2201 | 10 | 73 | axis specification |
GO:0090087 | 0.0013 | 2.4595 | 7.4796 | 17 | 169 | regulation of peptide transport |
GO:0048762 | 0.0013 | 2.6352 | 6.1962 | 15 | 140 | mesenchymal cell differentiation |
GO:2000026 | 0.0014 | 1.7229 | 25.957 | 42 | 627 | regulation of multicellular organismal development |
GO:0051966 | 0.0014 | 4.771 | 1.7261 | 7 | 39 | regulation of synaptic transmission, glutamatergic |
GO:0000003 | 0.0015 | 1.6453 | 31.6447 | 49 | 715 | reproduction |
GO:0036342 | 0.0015 | 7.2541 | 0.8852 | 5 | 20 | post-anal tail morphogenesis |
GO:0002158 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | osteoclast proliferation |
GO:0008343 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | adult feeding behavior |
GO:0021523 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | somatic motor neuron differentiation |
GO:0042756 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | drinking behavior |
GO:1900107 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | regulation of nodal signaling pathway |
GO:2000252 | 0.0016 | 21.7056 | 0.2655 | 3 | 6 | negative regulation of feeding behavior |
GO:0030178 | 0.0016 | 2.8218 | 5.0454 | 13 | 114 | negative regulation of Wnt signaling pathway |
GO:0048645 | 0.0017 | 4.0613 | 2.2572 | 8 | 51 | organ formation |
GO:0043627 | 0.0017 | 2.5727 | 6.3289 | 15 | 143 | response to estrogen |
GO:0008542 | 0.0017 | 4.626 | 1.7703 | 7 | 40 | visual learning |
GO:0023052 | 0.0017 | 1.3275 | 158.1553 | 189 | 3748 | signaling |
GO:2000241 | 0.0017 | 3.6416 | 2.7883 | 9 | 63 | regulation of reproductive process |
GO:0001825 | 0.0018 | 5.4463 | 1.3277 | 6 | 30 | blastocyst formation |
GO:0003008 | 0.0018 | 2.1571 | 10.4221 | 21 | 253 | system process |
GO:0042886 | 0.0018 | 2.2024 | 9.7368 | 20 | 220 | amide transport |
GO:0009746 | 0.0018 | 2.7665 | 5.134 | 13 | 116 | response to hexose |
GO:0007200 | 0.0019 | 3.9687 | 2.3014 | 8 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0021983 | 0.0019 | 4.4896 | 1.8146 | 7 | 41 | pituitary gland development |
GO:0001546 | 0.002 | Inf | 0.0885 | 2 | 2 | preantral ovarian follicle growth |
GO:0003326 | 0.002 | Inf | 0.0885 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.002 | Inf | 0.0885 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0006540 | 0.002 | Inf | 0.0885 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0007198 | 0.002 | Inf | 0.0885 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0010701 | 0.002 | Inf | 0.0885 | 2 | 2 | positive regulation of norepinephrine secretion |
GO:0021893 | 0.002 | Inf | 0.0885 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0043134 | 0.002 | Inf | 0.0885 | 2 | 2 | regulation of hindgut contraction |
GO:0043503 | 0.002 | Inf | 0.0885 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0048343 | 0.002 | Inf | 0.0885 | 2 | 2 | paraxial mesodermal cell fate commitment |
GO:0060014 | 0.002 | Inf | 0.0885 | 2 | 2 | granulosa cell differentiation |
GO:2000768 | 0.002 | Inf | 0.0885 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0003084 | 0.002 | 9.6595 | 0.5754 | 4 | 13 | positive regulation of systemic arterial blood pressure |
GO:0003214 | 0.002 | 9.6595 | 0.5754 | 4 | 13 | cardiac left ventricle morphogenesis |
GO:0032095 | 0.002 | 9.6595 | 0.5754 | 4 | 13 | regulation of response to food |
GO:0042053 | 0.002 | 9.6595 | 0.5754 | 4 | 13 | regulation of dopamine metabolic process |
GO:2000696 | 0.002 | 9.6595 | 0.5754 | 4 | 13 | regulation of epithelial cell differentiation involved in kidney development |
GO:0021772 | 0.0021 | 5.228 | 1.372 | 6 | 31 | olfactory bulb development |
GO:0035115 | 0.0021 | 5.228 | 1.372 | 6 | 31 | embryonic forelimb morphogenesis |
GO:0042472 | 0.0022 | 3.0087 | 4.0275 | 11 | 91 | inner ear morphogenesis |
GO:0050905 | 0.0022 | 3.0087 | 4.0275 | 11 | 91 | neuromuscular process |
GO:0044058 | 0.0023 | 6.4227 | 0.9704 | 5 | 22 | regulation of digestive system process |
GO:0035883 | 0.0023 | 6.3996 | 0.9737 | 5 | 22 | enteroendocrine cell differentiation |
GO:0048522 | 0.0025 | 1.3565 | 104.8913 | 131 | 2529 | positive regulation of cellular process |
GO:0007270 | 0.0025 | 2.6622 | 5.311 | 13 | 120 | neuron-neuron synaptic transmission |
GO:0072080 | 0.0026 | 4.2395 | 1.9031 | 7 | 43 | nephron tubule development |
GO:0021892 | 0.0026 | 16.3365 | 0.3088 | 3 | 7 | cerebral cortex GABAergic interneuron differentiation |
GO:0003140 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | determination of left/right asymmetry in lateral mesoderm |
GO:0015816 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | glycine transport |
GO:0021798 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0021957 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | corticospinal tract morphogenesis |
GO:0042661 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | regulation of mesodermal cell fate specification |
GO:0071372 | 0.0026 | 16.2778 | 0.3098 | 3 | 7 | cellular response to follicle-stimulating hormone stimulus |
GO:2000177 | 0.0026 | 3.7326 | 2.4231 | 8 | 55 | regulation of neural precursor cell proliferation |
GO:0007512 | 0.0027 | 8.6928 | 0.6196 | 4 | 14 | adult heart development |
GO:0007625 | 0.0027 | 8.6928 | 0.6196 | 4 | 14 | grooming behavior |
GO:0042476 | 0.0027 | 2.7656 | 4.7356 | 12 | 107 | odontogenesis |
GO:0046887 | 0.0027 | 3.1229 | 3.5407 | 10 | 80 | positive regulation of hormone secretion |
GO:0048609 | 0.0027 | 1.6855 | 24.4855 | 39 | 556 | multicellular organismal reproductive process |
GO:0008015 | 0.0028 | 2.2141 | 8.704 | 18 | 199 | blood circulation |
GO:0010862 | 0.0029 | 6.0435 | 1.0179 | 5 | 23 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0048771 | 0.0029 | 2.7365 | 4.7799 | 12 | 108 | tissue remodeling |
GO:0055024 | 0.003 | 4.1245 | 1.9474 | 7 | 44 | regulation of cardiac muscle tissue development |
GO:0048663 | 0.003 | 5.9738 | 1.0202 | 5 | 24 | neuron fate commitment |
GO:0048863 | 0.003 | 4.1078 | 1.9497 | 7 | 45 | stem cell differentiation |
GO:0060021 | 0.0032 | 3.0356 | 3.6292 | 10 | 82 | palate development |
GO:0072091 | 0.0032 | 3.0356 | 3.6292 | 10 | 82 | regulation of stem cell proliferation |
GO:0021522 | 0.0033 | 8.0413 | 0.6529 | 4 | 15 | spinal cord motor neuron differentiation |
GO:0030509 | 0.0033 | 3.2557 | 3.0678 | 9 | 70 | BMP signaling pathway |
GO:0035176 | 0.0034 | 4.6667 | 1.5048 | 6 | 34 | social behavior |
GO:0009888 | 0.0034 | 1.9044 | 13.9319 | 25 | 352 | tissue development |
GO:0001967 | 0.0035 | 7.9019 | 0.6639 | 4 | 15 | suckling behavior |
GO:0051155 | 0.0035 | 5.725 | 1.0622 | 5 | 24 | positive regulation of striated muscle cell differentiation |
GO:0002065 | 0.0035 | 2.9938 | 3.6734 | 10 | 83 | columnar/cuboidal epithelial cell differentiation |
GO:0046717 | 0.0036 | 3.2218 | 3.0981 | 9 | 70 | acid secretion |
GO:0007224 | 0.0037 | 2.653 | 4.9127 | 12 | 111 | smoothened signaling pathway |
GO:0046661 | 0.0037 | 2.653 | 4.9127 | 12 | 111 | male sex differentiation |
GO:0050794 | 0.0037 | 1.4432 | 75.8953 | 96 | 2198 | regulation of cellular process |
GO:0007565 | 0.0038 | 2.5196 | 5.5765 | 13 | 126 | female pregnancy |
GO:0001503 | 0.0041 | 1.903 | 13.366 | 24 | 302 | ossification |
GO:0043270 | 0.0041 | 2.4973 | 5.6208 | 13 | 127 | positive regulation of ion transport |
GO:0001993 | 0.0041 | 13.0212 | 0.3541 | 3 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0010667 | 0.0041 | 13.0212 | 0.3541 | 3 | 8 | negative regulation of cardiac muscle cell apoptotic process |
GO:0032229 | 0.0041 | 13.0212 | 0.3541 | 3 | 8 | negative regulation of synaptic transmission, GABAergic |
GO:0034765 | 0.0041 | 1.9612 | 11.9055 | 22 | 269 | regulation of ion transmembrane transport |
GO:0002793 | 0.0042 | 3.422 | 2.6112 | 8 | 59 | positive regulation of peptide secretion |
GO:0048713 | 0.0042 | 5.4383 | 1.1065 | 5 | 25 | regulation of oligodendrocyte differentiation |
GO:0032879 | 0.0044 | 1.3819 | 70.7247 | 92 | 1598 | regulation of localization |
GO:0030182 | 0.0044 | 1.5782 | 30.1153 | 45 | 751 | neuron differentiation |
GO:0001710 | 0.0045 | 7.269 | 0.7057 | 4 | 16 | mesodermal cell fate commitment |
GO:0010662 | 0.0045 | 7.2428 | 0.7081 | 4 | 16 | regulation of striated muscle cell apoptotic process |
GO:0046390 | 0.0046 | 2.1571 | 8.4091 | 17 | 190 | ribose phosphate biosynthetic process |
GO:0048566 | 0.0046 | 4.3549 | 1.5933 | 6 | 36 | embryonic digestive tract development |
GO:0007165 | 0.0046 | 1.2743 | 171.4804 | 200 | 3910 | signal transduction |
GO:0007519 | 0.0047 | 2.3596 | 6.3732 | 14 | 144 | skeletal muscle tissue development |
GO:0048545 | 0.0047 | 3.0722 | 3.2226 | 9 | 75 | response to steroid hormone |
GO:0060048 | 0.0047 | 3.3559 | 2.6555 | 8 | 60 | cardiac muscle contraction |
GO:0051046 | 0.0048 | 1.7434 | 18.1585 | 30 | 413 | regulation of secretion |
GO:0045471 | 0.005 | 2.8373 | 3.8505 | 10 | 87 | response to ethanol |
GO:0035108 | 0.005 | 2.67 | 4.471 | 11 | 102 | limb morphogenesis |
GO:0060070 | 0.0051 | 2.1321 | 8.4976 | 17 | 192 | canonical Wnt signaling pathway |
GO:0006813 | 0.0052 | 2.2522 | 7.1256 | 15 | 161 | potassium ion transport |
GO:0042310 | 0.0052 | 3.2923 | 2.6998 | 8 | 61 | vasoconstriction |
GO:0009152 | 0.0053 | 2.1798 | 7.8337 | 16 | 177 | purine ribonucleotide biosynthetic process |
GO:0007618 | 0.0056 | 6.738 | 0.7468 | 4 | 17 | mating |
GO:0010720 | 0.0056 | 2.1077 | 8.5861 | 17 | 194 | positive regulation of cell development |
GO:0001705 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | ectoderm formation |
GO:0001997 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
GO:0003285 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | septum secundum development |
GO:0014049 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | positive regulation of glutamate secretion |
GO:0021524 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | visceral motor neuron differentiation |
GO:0021530 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021882 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0031394 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0032100 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | positive regulation of appetite |
GO:0035054 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0051970 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:0055014 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060459 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | left lung development |
GO:0061184 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | positive regulation of dermatome development |
GO:0065001 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | specification of axis polarity |
GO:0090027 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | negative regulation of monocyte chemotaxis |
GO:0097211 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:1900175 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:2000035 | 0.0057 | 43.3405 | 0.1328 | 2 | 3 | regulation of stem cell division |
GO:0010842 | 0.0057 | 6.6851 | 0.7524 | 4 | 17 | retina layer formation |
GO:0030878 | 0.0057 | 6.6851 | 0.7524 | 4 | 17 | thyroid gland development |
GO:0071875 | 0.0057 | 6.6851 | 0.7524 | 4 | 17 | adrenergic receptor signaling pathway |
GO:0072202 | 0.0057 | 6.6851 | 0.7524 | 4 | 17 | cell differentiation involved in metanephros development |
GO:0090276 | 0.0058 | 2.2214 | 7.2141 | 15 | 163 | regulation of peptide hormone secretion |
GO:0045109 | 0.0059 | 10.8501 | 0.3983 | 3 | 9 | intermediate filament organization |
GO:0051890 | 0.0059 | 10.8501 | 0.3983 | 3 | 9 | regulation of cardioblast differentiation |
GO:0015872 | 0.006 | 4.9431 | 1.195 | 5 | 27 | dopamine transport |
GO:0048519 | 0.006 | 1.4622 | 44.3843 | 61 | 1101 | negative regulation of biological process |
GO:0003229 | 0.006 | 4.082 | 1.6818 | 6 | 38 | ventricular cardiac muscle tissue development |
GO:0021795 | 0.006 | 4.082 | 1.6818 | 6 | 38 | cerebral cortex cell migration |
GO:0060425 | 0.0061 | 3.5472 | 2.2129 | 7 | 50 | lung morphogenesis |
GO:0051960 | 0.0063 | 3.5182 | 2.2183 | 7 | 53 | regulation of nervous system development |
GO:1901654 | 0.0068 | 3.1343 | 2.8163 | 8 | 64 | response to ketone |
GO:0060349 | 0.0068 | 2.8885 | 3.4079 | 9 | 77 | bone morphogenesis |
GO:0021545 | 0.0069 | 3.958 | 1.7261 | 6 | 39 | cranial nerve development |
GO:0030858 | 0.0069 | 3.958 | 1.7261 | 6 | 39 | positive regulation of epithelial cell differentiation |
GO:0051412 | 0.0071 | 6.2071 | 0.7966 | 4 | 18 | response to corticosterone |
GO:0048589 | 0.0072 | 1.892 | 11.7284 | 21 | 265 | developmental growth |
GO:0001501 | 0.0073 | 2.2274 | 6.702 | 14 | 158 | skeletal system development |
GO:0042307 | 0.0076 | 3.389 | 2.3014 | 7 | 52 | positive regulation of protein import into nucleus |
GO:0021575 | 0.0078 | 3.8413 | 1.7703 | 6 | 40 | hindbrain morphogenesis |
GO:0035987 | 0.0078 | 3.8413 | 1.7703 | 6 | 40 | endodermal cell differentiation |
GO:0007188 | 0.0078 | 3.3652 | 2.3128 | 7 | 53 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0042593 | 0.0079 | 2.2051 | 6.7715 | 14 | 153 | glucose homeostasis |
GO:0051216 | 0.0079 | 2.2051 | 6.7715 | 14 | 153 | cartilage development |
GO:0008344 | 0.008 | 2.8055 | 3.4964 | 9 | 79 | adult locomotory behavior |
GO:0019228 | 0.008 | 2.8055 | 3.4964 | 9 | 79 | neuronal action potential |
GO:0021936 | 0.0082 | 9.2993 | 0.4426 | 3 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0030002 | 0.0082 | 9.2993 | 0.4426 | 3 | 10 | cellular anion homeostasis |
GO:0030157 | 0.0082 | 9.2993 | 0.4426 | 3 | 10 | pancreatic juice secretion |
GO:0048505 | 0.0082 | 9.2993 | 0.4426 | 3 | 10 | regulation of timing of cell differentiation |
GO:0070472 | 0.0082 | 9.2993 | 0.4426 | 3 | 10 | regulation of uterine smooth muscle contraction |
GO:0006775 | 0.0082 | 4.5304 | 1.2835 | 5 | 29 | fat-soluble vitamin metabolic process |
GO:0032413 | 0.0082 | 4.5304 | 1.2835 | 5 | 29 | negative regulation of ion transmembrane transporter activity |
GO:0045933 | 0.0082 | 4.5304 | 1.2835 | 5 | 29 | positive regulation of muscle contraction |
GO:1902742 | 0.0082 | 4.5304 | 1.2835 | 5 | 29 | apoptotic process involved in development |
GO:0003012 | 0.0084 | 1.8609 | 11.9055 | 21 | 269 | muscle system process |
GO:0040012 | 0.0085 | 1.6128 | 22.1291 | 34 | 500 | regulation of locomotion |
GO:0030073 | 0.0085 | 2.1198 | 7.5239 | 15 | 170 | insulin secretion |
GO:0006972 | 0.0087 | 5.7928 | 0.8409 | 4 | 19 | hyperosmotic response |
GO:0007530 | 0.0087 | 5.7928 | 0.8409 | 4 | 19 | sex determination |
GO:0014706 | 0.0087 | 2.2551 | 6.1544 | 13 | 141 | striated muscle tissue development |
GO:0048646 | 0.0087 | 1.5167 | 30.4533 | 44 | 717 | anatomical structure formation involved in morphogenesis |
GO:0006584 | 0.0088 | 3.7312 | 1.8146 | 6 | 41 | catecholamine metabolic process |
GO:0048701 | 0.0088 | 3.7312 | 1.8146 | 6 | 41 | embryonic cranial skeleton morphogenesis |
GO:1901019 | 0.0088 | 3.7312 | 1.8146 | 6 | 41 | regulation of calcium ion transmembrane transporter activity |
GO:0007154 | 0.0088 | 2.4529 | 4.8265 | 11 | 124 | cell communication |
GO:0008217 | 0.0088 | 2.3425 | 5.488 | 12 | 124 | regulation of blood pressure |
GO:0030900 | 0.0089 | 2.3348 | 5.493 | 12 | 131 | forebrain development |
GO:0048754 | 0.0094 | 2.158 | 6.9043 | 14 | 156 | branching morphogenesis of an epithelial tube |
GO:0050795 | 0.0094 | 2.3216 | 5.5323 | 12 | 125 | regulation of behavior |
GO:0021696 | 0.0095 | 4.3488 | 1.3277 | 5 | 30 | cerebellar cortex morphogenesis |
GO:0021955 | 0.0095 | 4.3488 | 1.3277 | 5 | 30 | central nervous system neuron axonogenesis |
GO:0050433 | 0.0095 | 4.3488 | 1.3277 | 5 | 30 | regulation of catecholamine secretion |
GO:0044702 | 0.0096 | 1.5296 | 28.1116 | 41 | 651 | single organism reproductive process |
GO:0007631 | 0.0099 | 4.2939 | 1.3379 | 5 | 31 | feeding behavior |
GO:0014855 | 0.0099 | 3.6273 | 1.8588 | 6 | 42 | striated muscle cell proliferation |
GO:0097305 | 0.01 | 2.2993 | 5.5772 | 12 | 128 | response to alcohol |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 54.4222 | 0.3791 | 8 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 8.3569 | 1.6331 | 11 | 56 | detection of chemical stimulus |
GO:0050906 | 0 | 6.9589 | 1.8956 | 11 | 65 | detection of stimulus involved in sensory perception |
GO:0007186 | 1e-04 | 2.1695 | 17.527 | 35 | 601 | G-protein coupled receptor signaling pathway |
GO:0045908 | 1e-04 | 100.6803 | 0.1167 | 3 | 4 | negative regulation of vasodilation |
GO:0007606 | 1e-04 | 5.1801 | 1.9831 | 9 | 68 | sensory perception of chemical stimulus |
GO:0044057 | 6e-04 | 2.3621 | 9.5363 | 21 | 327 | regulation of system process |
GO:0006968 | 7e-04 | 6.3285 | 1.1082 | 6 | 38 | cellular defense response |
GO:0032735 | 8e-04 | 12.2271 | 0.4374 | 4 | 15 | positive regulation of interleukin-12 production |
GO:0050896 | 9e-04 | 1.3999 | 171.9453 | 202 | 5896 | response to stimulus |
GO:0050877 | 0.001 | 1.8448 | 20.8807 | 36 | 716 | neurological system process |
GO:0044707 | 0.001 | 1.3965 | 141.8782 | 171 | 4865 | single-multicellular organism process |
GO:0032496 | 0.0013 | 2.8575 | 4.8994 | 13 | 168 | response to lipopolysaccharide |
GO:0044130 | 0.0018 | 16.7732 | 0.2625 | 3 | 9 | negative regulation of growth of symbiont in host |
GO:0044144 | 0.0018 | 16.7732 | 0.2625 | 3 | 9 | modulation of growth of symbiont involved in interaction with host |
GO:0008207 | 0.0019 | 8.9637 | 0.5541 | 4 | 19 | C21-steroid hormone metabolic process |
GO:0006816 | 0.0024 | 2.2966 | 7.874 | 17 | 270 | calcium ion transport |
GO:0002026 | 0.0029 | 7.9078 | 0.6124 | 4 | 21 | regulation of the force of heart contraction |
GO:0045909 | 0.0034 | 7.4679 | 0.6416 | 4 | 22 | positive regulation of vasodilation |
GO:0050795 | 0.0036 | 2.9476 | 3.6454 | 10 | 125 | regulation of behavior |
GO:0042391 | 0.0038 | 2.136 | 8.9239 | 18 | 306 | regulation of membrane potential |
GO:0044110 | 0.0044 | 11.1794 | 0.35 | 3 | 12 | growth involved in symbiotic interaction |
GO:0072511 | 0.0047 | 2.1409 | 8.399 | 17 | 288 | divalent inorganic cation transport |
GO:0021637 | 0.0049 | 33.4659 | 0.1167 | 2 | 4 | trigeminal nerve structural organization |
GO:0050923 | 0.0049 | 33.4659 | 0.1167 | 2 | 4 | regulation of negative chemotaxis |
GO:1902287 | 0.0049 | 33.4659 | 0.1167 | 2 | 4 | semaphorin-plexin signaling pathway involved in axon guidance |
GO:0070542 | 0.0058 | 4.8073 | 1.1665 | 5 | 40 | response to fatty acid |
GO:0010951 | 0.0062 | 2.7095 | 3.937 | 10 | 135 | negative regulation of endopeptidase activity |
GO:0002673 | 0.0065 | 4.6734 | 1.1957 | 5 | 41 | regulation of acute inflammatory response |
GO:0060047 | 0.0068 | 2.6664 | 3.9953 | 10 | 137 | heart contraction |
GO:0002385 | 0.007 | 9.1453 | 0.4083 | 3 | 14 | mucosal immune response |
GO:0007512 | 0.007 | 9.1453 | 0.4083 | 3 | 14 | adult heart development |
GO:0043501 | 0.007 | 9.1453 | 0.4083 | 3 | 14 | skeletal muscle adaptation |
GO:0048841 | 0.007 | 9.1453 | 0.4083 | 3 | 14 | regulation of axon extension involved in axon guidance |
GO:0007155 | 0.0071 | 1.5857 | 25.9843 | 39 | 891 | cell adhesion |
GO:0003013 | 0.0071 | 2.0007 | 9.478 | 18 | 325 | circulatory system process |
GO:0006813 | 0.0076 | 2.4855 | 4.6953 | 11 | 161 | potassium ion transport |
GO:0060079 | 0.008 | 4.4267 | 1.254 | 5 | 43 | regulation of excitatory postsynaptic membrane potential |
GO:0002606 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | positive regulation of dendritic cell antigen processing and presentation |
GO:0002710 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | negative regulation of T cell mediated immunity |
GO:0021785 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | branchiomotor neuron axon guidance |
GO:0021825 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | substrate-dependent cerebral cortex tangential migration |
GO:0032740 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | positive regulation of interleukin-17 production |
GO:0035634 | 0.008 | 22.3088 | 0.1458 | 2 | 5 | response to stilbenoid |
GO:0010811 | 0.0081 | 3.2798 | 2.3039 | 7 | 79 | positive regulation of cell-substrate adhesion |
GO:0050706 | 0.0086 | 8.3825 | 0.4374 | 3 | 15 | regulation of interleukin-1 beta secretion |
GO:0001541 | 0.0088 | 4.3128 | 1.2832 | 5 | 44 | ovarian follicle development |
GO:0032856 | 0.0095 | 5.3738 | 0.8457 | 4 | 29 | activation of Ras GTPase activity |
GO:0098660 | 0.0097 | 1.7564 | 14.3482 | 24 | 492 | inorganic ion transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 5.1557 | 13.3171 | 54 | 283 | pattern specification process |
GO:0045944 | 0 | 3.2223 | 36.4322 | 96 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007423 | 0 | 3.7636 | 21.3167 | 66 | 440 | sensory organ development |
GO:1902680 | 0 | 2.5854 | 50.8209 | 110 | 1049 | positive regulation of RNA biosynthetic process |
GO:0010628 | 0 | 2.4788 | 53.6793 | 112 | 1108 | positive regulation of gene expression |
GO:0044707 | 0 | 1.9736 | 183.4714 | 265 | 4297 | single-multicellular organism process |
GO:0048699 | 0 | 3.0664 | 27.4297 | 71 | 605 | generation of neurons |
GO:0006355 | 0 | 1.9322 | 134.828 | 211 | 2783 | regulation of transcription, DNA-templated |
GO:0045935 | 0 | 2.309 | 58.0395 | 114 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009891 | 0 | 2.2424 | 61.1886 | 117 | 1263 | positive regulation of biosynthetic process |
GO:2000026 | 0 | 2.4099 | 46.4953 | 96 | 991 | regulation of multicellular organismal development |
GO:0051252 | 0 | 1.8367 | 139.8665 | 211 | 2887 | regulation of RNA metabolic process |
GO:0031326 | 0 | 1.7829 | 156.4838 | 228 | 3230 | regulation of cellular biosynthetic process |
GO:0065007 | 0 | 1.7951 | 396.2481 | 467 | 8179 | biological regulation |
GO:0007268 | 0 | 2.8953 | 21.4547 | 54 | 455 | synaptic transmission |
GO:0021510 | 0 | 7.9002 | 3.0825 | 18 | 65 | spinal cord development |
GO:0007399 | 0 | 2.3058 | 40.4263 | 81 | 939 | nervous system development |
GO:0007517 | 0 | 3.2994 | 14.3888 | 41 | 297 | muscle organ development |
GO:0010556 | 0 | 1.708 | 150.5733 | 215 | 3108 | regulation of macromolecule biosynthetic process |
GO:0034654 | 0 | 1.7004 | 155.9509 | 221 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0009792 | 0 | 2.5612 | 27.0819 | 61 | 559 | embryo development ending in birth or egg hatching |
GO:0045666 | 0 | 6.7245 | 3.682 | 19 | 76 | positive regulation of neuron differentiation |
GO:0048667 | 0 | 2.5575 | 26.6459 | 60 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0051171 | 0 | 1.6633 | 175.1844 | 241 | 3616 | regulation of nitrogen compound metabolic process |
GO:0060537 | 0 | 3.1879 | 14.4372 | 40 | 298 | muscle tissue development |
GO:0021527 | 0 | 29.8858 | 0.7267 | 9 | 15 | spinal cord association neuron differentiation |
GO:0007267 | 0 | 4.0379 | 8.1406 | 28 | 185 | cell-cell signaling |
GO:0042472 | 0 | 5.6856 | 4.4087 | 20 | 91 | inner ear morphogenesis |
GO:0048812 | 0 | 2.4478 | 27.1788 | 59 | 561 | neuron projection morphogenesis |
GO:0009952 | 0 | 4.9894 | 5.366 | 22 | 114 | anterior/posterior pattern specification |
GO:0061564 | 0 | 2.5054 | 24.272 | 54 | 501 | axon development |
GO:0007411 | 0 | 2.8439 | 16.3266 | 41 | 337 | axon guidance |
GO:0050767 | 0 | 2.9142 | 15.1747 | 39 | 319 | regulation of neurogenesis |
GO:0001655 | 0 | 3.2398 | 11.297 | 32 | 235 | urogenital system development |
GO:0009887 | 0 | 2.8719 | 14.5227 | 37 | 330 | organ morphogenesis |
GO:0002009 | 0 | 2.6674 | 17.6864 | 42 | 367 | morphogenesis of an epithelium |
GO:0007166 | 0 | 1.6689 | 108.3327 | 158 | 2273 | cell surface receptor signaling pathway |
GO:0035239 | 0 | 2.8064 | 15.2608 | 38 | 315 | tube morphogenesis |
GO:0021983 | 0 | 11.7971 | 1.301 | 10 | 27 | pituitary gland development |
GO:0000122 | 0 | 2.2749 | 26.8881 | 55 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048738 | 0 | 3.84 | 6.9764 | 23 | 144 | cardiac muscle tissue development |
GO:0009653 | 0 | 2.6221 | 17.1178 | 40 | 413 | anatomical structure morphogenesis |
GO:0021514 | 0 | 17.6764 | 0.8236 | 8 | 17 | ventral spinal cord interneuron differentiation |
GO:0048704 | 0 | 4.6759 | 4.3602 | 17 | 90 | embryonic skeletal system morphogenesis |
GO:0006935 | 0 | 2.229 | 25.2893 | 51 | 522 | chemotaxis |
GO:0048663 | 0 | 9.2741 | 1.5167 | 10 | 32 | neuron fate commitment |
GO:0021513 | 0 | 11.1978 | 1.2112 | 9 | 25 | spinal cord dorsal/ventral patterning |
GO:0021797 | 0 | 99.0049 | 0.2907 | 5 | 6 | forebrain anterior/posterior pattern specification |
GO:0061458 | 0 | 2.5127 | 17.2471 | 39 | 356 | reproductive system development |
GO:0014033 | 0 | 6.1894 | 2.6646 | 13 | 55 | neural crest cell differentiation |
GO:0043010 | 0 | 2.8486 | 12.2086 | 31 | 252 | camera-type eye development |
GO:0060485 | 0 | 3.7309 | 6.5039 | 21 | 136 | mesenchyme development |
GO:0048736 | 0 | 3.4637 | 7.6062 | 23 | 157 | appendage development |
GO:0001763 | 0 | 3.149 | 9.3503 | 26 | 193 | morphogenesis of a branching structure |
GO:0030901 | 0 | 8.6646 | 1.5988 | 10 | 33 | midbrain development |
GO:0021781 | 0 | 17.3729 | 0.7267 | 7 | 15 | glial cell fate commitment |
GO:0060581 | 0 | 17.3729 | 0.7267 | 7 | 15 | cell fate commitment involved in pattern specification |
GO:0050794 | 0 | 1.53 | 278.4273 | 328 | 6326 | regulation of cellular process |
GO:0022414 | 0 | 1.8707 | 44.0868 | 75 | 910 | reproductive process |
GO:0023019 | 0 | 12.2334 | 1.0174 | 8 | 21 | signal transduction involved in regulation of gene expression |
GO:0021915 | 0 | 3.4371 | 7.3155 | 22 | 151 | neural tube development |
GO:0030030 | 0 | 1.8292 | 48.1079 | 80 | 993 | cell projection organization |
GO:0014031 | 0 | 3.6917 | 6.2497 | 20 | 129 | mesenchymal cell development |
GO:0048592 | 0 | 3.6246 | 6.3466 | 20 | 131 | eye morphogenesis |
GO:0021516 | 0 | 50.217 | 0.3345 | 5 | 7 | dorsal spinal cord development |
GO:0035113 | 0 | 3.7437 | 5.8621 | 19 | 121 | embryonic appendage morphogenesis |
GO:0021913 | 0 | Inf | 0.1938 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0021761 | 0 | 4.9135 | 3.4397 | 14 | 71 | limbic system development |
GO:0001764 | 0 | 3.6711 | 5.959 | 19 | 123 | neuron migration |
GO:0001657 | 0 | 4.219 | 4.4571 | 16 | 92 | ureteric bud development |
GO:0007417 | 0 | 2.2018 | 21.9233 | 44 | 486 | central nervous system development |
GO:0032990 | 0 | 1.9247 | 35.221 | 62 | 727 | cell part morphogenesis |
GO:0072163 | 0 | 4.1638 | 4.5056 | 16 | 93 | mesonephric epithelium development |
GO:1902679 | 0 | 1.8649 | 39.8719 | 68 | 823 | negative regulation of RNA biosynthetic process |
GO:0050877 | 0 | 2.5089 | 14.5341 | 33 | 309 | neurological system process |
GO:0080090 | 0 | 1.4382 | 220.337 | 271 | 4548 | regulation of primary metabolic process |
GO:0009890 | 0 | 1.7735 | 48.7377 | 79 | 1006 | negative regulation of biosynthetic process |
GO:0035115 | 0 | 8.1398 | 1.5019 | 9 | 31 | embryonic forelimb morphogenesis |
GO:0007269 | 0 | 3.8302 | 5.1354 | 17 | 106 | neurotransmitter secretion |
GO:0001714 | 0 | 32.9962 | 0.3876 | 5 | 8 | endodermal cell fate specification |
GO:0031018 | 0 | 6.67 | 1.9295 | 10 | 40 | endocrine pancreas development |
GO:0010453 | 0 | 9.3519 | 1.2112 | 8 | 25 | regulation of cell fate commitment |
GO:0030900 | 0 | 2.64 | 11.7357 | 28 | 247 | forebrain development |
GO:0034765 | 0 | 2.5408 | 13.0322 | 30 | 269 | regulation of ion transmembrane transport |
GO:0003206 | 0 | 3.8146 | 4.8447 | 16 | 100 | cardiac chamber morphogenesis |
GO:0001944 | 0 | 2.074 | 23.6421 | 45 | 488 | vasculature development |
GO:0021879 | 0 | 5.4817 | 2.4708 | 11 | 51 | forebrain neuron differentiation |
GO:0021542 | 0 | 14.8666 | 0.6783 | 6 | 14 | dentate gyrus development |
GO:2000310 | 0 | 14.8666 | 0.6783 | 6 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0060415 | 0 | 5.3476 | 2.5192 | 11 | 52 | muscle tissue morphogenesis |
GO:0045934 | 0 | 1.7486 | 45.3948 | 73 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007492 | 0 | 4.3998 | 3.4882 | 13 | 72 | endoderm development |
GO:2000113 | 0 | 1.7511 | 44.0383 | 71 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0010092 | 0 | 7.9471 | 1.3565 | 8 | 28 | specification of organ identity |
GO:0021543 | 0 | 3.4404 | 5.6199 | 17 | 116 | pallium development |
GO:1902476 | 0 | 4.6031 | 3.1006 | 12 | 64 | chloride transmembrane transport |
GO:0021522 | 1e-04 | 7.2468 | 1.449 | 8 | 30 | spinal cord motor neuron differentiation |
GO:0061448 | 1e-04 | 5.9466 | 1.8848 | 9 | 40 | connective tissue development |
GO:0003231 | 1e-04 | 3.6793 | 4.3602 | 14 | 90 | cardiac ventricle development |
GO:0035265 | 1e-04 | 3.6793 | 4.3602 | 14 | 90 | organ growth |
GO:0048589 | 1e-04 | 2.4982 | 10.9699 | 25 | 228 | developmental growth |
GO:0032879 | 1e-04 | 1.5325 | 77.4183 | 109 | 1598 | regulation of localization |
GO:0002793 | 1e-04 | 4.5651 | 2.8584 | 11 | 59 | positive regulation of peptide secretion |
GO:2000027 | 1e-04 | 3.0305 | 6.6372 | 18 | 137 | regulation of organ morphogenesis |
GO:0021912 | 1e-04 | Inf | 0.1453 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0001755 | 1e-04 | 6.355 | 1.5988 | 8 | 33 | neural crest cell migration |
GO:0007263 | 1e-04 | 9.9077 | 0.872 | 6 | 18 | nitric oxide mediated signal transduction |
GO:0009746 | 1e-04 | 3.2 | 5.6199 | 16 | 116 | response to hexose |
GO:0009953 | 2e-04 | 3.9878 | 3.4814 | 12 | 73 | dorsal/ventral pattern formation |
GO:0001709 | 2e-04 | 6.1375 | 1.6403 | 8 | 34 | cell fate determination |
GO:1901576 | 2e-04 | 1.3576 | 223.3892 | 266 | 4611 | organic substance biosynthetic process |
GO:0021796 | 2e-04 | 26.3536 | 0.3391 | 4 | 7 | cerebral cortex regionalization |
GO:0071420 | 2e-04 | 26.3536 | 0.3391 | 4 | 7 | cellular response to histamine |
GO:2000543 | 2e-04 | 26.3536 | 0.3391 | 4 | 7 | positive regulation of gastrulation |
GO:0031128 | 2e-04 | 6.1101 | 1.6472 | 8 | 34 | developmental induction |
GO:0055010 | 2e-04 | 6.1101 | 1.6472 | 8 | 34 | ventricular cardiac muscle tissue morphogenesis |
GO:0010629 | 2e-04 | 1.6614 | 44.7166 | 69 | 923 | negative regulation of gene expression |
GO:0048665 | 2e-04 | 9.2485 | 0.9108 | 6 | 19 | neuron fate specification |
GO:0042391 | 2e-04 | 2.1933 | 14.8248 | 30 | 306 | regulation of membrane potential |
GO:0007155 | 2e-04 | 1.6703 | 43.1663 | 67 | 891 | cell adhesion |
GO:0007214 | 2e-04 | 9.1448 | 0.9205 | 6 | 19 | gamma-aminobutyric acid signaling pathway |
GO:0030154 | 2e-04 | 1.8382 | 28.3564 | 48 | 712 | cell differentiation |
GO:0030902 | 2e-04 | 3.5528 | 4.1606 | 13 | 87 | hindbrain development |
GO:0060219 | 2e-04 | 12.3684 | 0.6298 | 5 | 13 | camera-type eye photoreceptor cell differentiation |
GO:0007270 | 2e-04 | 3.531 | 4.1845 | 13 | 87 | neuron-neuron synaptic transmission |
GO:0098660 | 3e-04 | 1.8945 | 23.8359 | 42 | 492 | inorganic ion transmembrane transport |
GO:0016358 | 3e-04 | 2.9067 | 6.4919 | 17 | 134 | dendrite development |
GO:0023052 | 3e-04 | 1.3845 | 166.5778 | 204 | 3748 | signaling |
GO:0036342 | 3e-04 | 8.4909 | 0.9689 | 6 | 20 | post-anal tail morphogenesis |
GO:0044057 | 3e-04 | 2.1133 | 15.8422 | 31 | 327 | regulation of system process |
GO:0051094 | 3e-04 | 2.6875 | 7.7612 | 19 | 171 | positive regulation of developmental process |
GO:0048565 | 3e-04 | 3.2839 | 4.7966 | 14 | 100 | digestive tract development |
GO:0006813 | 3e-04 | 2.6801 | 7.8 | 19 | 161 | potassium ion transport |
GO:0045446 | 3e-04 | 3.9817 | 3.1975 | 11 | 66 | endothelial cell differentiation |
GO:0045596 | 3e-04 | 1.9806 | 19.5565 | 36 | 408 | negative regulation of cell differentiation |
GO:0035051 | 3e-04 | 3.2487 | 4.8447 | 14 | 100 | cardiocyte differentiation |
GO:0048585 | 3e-04 | 1.6361 | 43.9414 | 67 | 907 | negative regulation of response to stimulus |
GO:0000904 | 3e-04 | 2.6504 | 7.8589 | 19 | 172 | cell morphogenesis involved in differentiation |
GO:0048793 | 3e-04 | 19.7635 | 0.3876 | 4 | 8 | pronephros development |
GO:0045165 | 3e-04 | 3.8996 | 3.2324 | 11 | 71 | cell fate commitment |
GO:0051216 | 3e-04 | 2.8179 | 6.6646 | 17 | 139 | cartilage development |
GO:0015698 | 4e-04 | 3.2111 | 4.8931 | 14 | 101 | inorganic anion transport |
GO:0060042 | 4e-04 | 6.3583 | 1.3949 | 7 | 29 | retina morphogenesis in camera-type eye |
GO:0048562 | 4e-04 | 3.8739 | 3.2526 | 11 | 71 | embryonic organ morphogenesis |
GO:0072189 | 4e-04 | 10.9932 | 0.6783 | 5 | 14 | ureter development |
GO:0060384 | 4e-04 | 7.9242 | 1.0174 | 6 | 21 | innervation |
GO:0009954 | 4e-04 | 6.3101 | 1.405 | 7 | 29 | proximal/distal pattern formation |
GO:0035116 | 4e-04 | 6.3101 | 1.405 | 7 | 29 | embryonic hindlimb morphogenesis |
GO:0048332 | 4e-04 | 3.8414 | 3.2944 | 11 | 68 | mesoderm morphogenesis |
GO:0007631 | 4e-04 | 3.5681 | 3.8273 | 12 | 79 | feeding behavior |
GO:0040011 | 4e-04 | 2.1483 | 14.0817 | 28 | 301 | locomotion |
GO:0098656 | 4e-04 | 2.7635 | 6.7826 | 17 | 140 | anion transmembrane transport |
GO:0008406 | 4e-04 | 2.5879 | 8.0422 | 19 | 166 | gonad development |
GO:0055082 | 4e-04 | 1.9188 | 20.6869 | 37 | 427 | cellular chemical homeostasis |
GO:0034287 | 4e-04 | 59.2082 | 0.1938 | 3 | 4 | detection of monosaccharide stimulus |
GO:0042660 | 4e-04 | 59.2082 | 0.1938 | 3 | 4 | positive regulation of cell fate specification |
GO:0048619 | 4e-04 | 59.2082 | 0.1938 | 3 | 4 | embryonic hindgut morphogenesis |
GO:0051594 | 4e-04 | 59.2082 | 0.1938 | 3 | 4 | detection of glucose |
GO:0060591 | 4e-04 | 59.2082 | 0.1938 | 3 | 4 | chondroblast differentiation |
GO:0051046 | 4e-04 | 1.8986 | 21.462 | 38 | 443 | regulation of secretion |
GO:0071805 | 5e-04 | 2.8543 | 6.2012 | 16 | 128 | potassium ion transmembrane transport |
GO:0001658 | 5e-04 | 5.1514 | 1.8795 | 8 | 39 | branching involved in ureteric bud morphogenesis |
GO:0048333 | 5e-04 | 6.0352 | 1.4534 | 7 | 30 | mesodermal cell differentiation |
GO:0060795 | 5e-04 | 6.0352 | 1.4534 | 7 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0042733 | 5e-04 | 4.0583 | 2.8584 | 10 | 59 | embryonic digit morphogenesis |
GO:0072358 | 5e-04 | 2.2164 | 12.1864 | 25 | 261 | cardiovascular system development |
GO:2000036 | 5e-04 | 9.8931 | 0.7267 | 5 | 15 | regulation of stem cell maintenance |
GO:0007548 | 5e-04 | 2.5381 | 8.1751 | 19 | 171 | sex differentiation |
GO:0021575 | 6e-04 | 4.962 | 1.9379 | 8 | 40 | hindbrain morphogenesis |
GO:0035987 | 6e-04 | 4.962 | 1.9379 | 8 | 40 | endodermal cell differentiation |
GO:0050810 | 6e-04 | 4.962 | 1.9379 | 8 | 40 | regulation of steroid biosynthetic process |
GO:0009799 | 6e-04 | 3.1989 | 4.554 | 13 | 94 | specification of symmetry |
GO:0048806 | 6e-04 | 7.0296 | 1.1085 | 6 | 23 | genitalia development |
GO:0061217 | 6e-04 | 6.9908 | 1.1143 | 6 | 23 | regulation of mesonephros development |
GO:0007215 | 6e-04 | 4.844 | 1.9737 | 8 | 41 | glutamate receptor signaling pathway |
GO:0055021 | 7e-04 | 5.5515 | 1.5503 | 7 | 32 | regulation of cardiac muscle tissue growth |
GO:0090102 | 7e-04 | 5.5515 | 1.5503 | 7 | 32 | cochlea development |
GO:0003215 | 7e-04 | 8.993 | 0.7752 | 5 | 16 | cardiac right ventricle morphogenesis |
GO:0042136 | 7e-04 | 8.993 | 0.7752 | 5 | 16 | neurotransmitter biosynthetic process |
GO:0045665 | 8e-04 | 4.1573 | 2.5192 | 9 | 52 | negative regulation of neuron differentiation |
GO:0014855 | 8e-04 | 4.6693 | 2.0348 | 8 | 42 | striated muscle cell proliferation |
GO:0070887 | 8e-04 | 1.4196 | 87.9798 | 116 | 1816 | cellular response to chemical stimulus |
GO:0050880 | 8e-04 | 2.9079 | 5.3292 | 14 | 110 | regulation of blood vessel size |
GO:0007218 | 9e-04 | 3.2287 | 4.1664 | 12 | 86 | neuropeptide signaling pathway |
GO:0035094 | 9e-04 | 5.3375 | 1.5988 | 7 | 33 | response to nicotine |
GO:0009605 | 9e-04 | 1.4521 | 73.1065 | 99 | 1509 | response to external stimulus |
GO:0003299 | 9e-04 | 13.1735 | 0.4845 | 4 | 10 | muscle hypertrophy in response to stress |
GO:0060536 | 9e-04 | 13.1735 | 0.4845 | 4 | 10 | cartilage morphogenesis |
GO:0007611 | 0.001 | 2.4055 | 8.5751 | 19 | 177 | learning or memory |
GO:0045471 | 0.001 | 3.1854 | 4.2149 | 12 | 87 | response to ethanol |
GO:0007600 | 0.001 | 1.8821 | 19.2946 | 34 | 400 | sensory perception |
GO:0021533 | 0.001 | 6.2539 | 1.2112 | 6 | 25 | cell differentiation in hindbrain |
GO:0060420 | 0.001 | 29.8831 | 0.2401 | 3 | 5 | regulation of heart growth |
GO:0021778 | 0.0011 | 29.6016 | 0.2422 | 3 | 5 | oligodendrocyte cell fate specification |
GO:0060290 | 0.0011 | 29.6016 | 0.2422 | 3 | 5 | transdifferentiation |
GO:0072172 | 0.0011 | 29.6016 | 0.2422 | 3 | 5 | mesonephric tubule formation |
GO:0014013 | 0.0011 | 3.6137 | 3.1491 | 10 | 65 | regulation of gliogenesis |
GO:0021549 | 0.0011 | 3.3151 | 3.7304 | 11 | 77 | cerebellum development |
GO:0060349 | 0.0011 | 3.3151 | 3.7304 | 11 | 77 | bone morphogenesis |
GO:0051050 | 0.0011 | 1.7529 | 24.9018 | 41 | 514 | positive regulation of transport |
GO:0042471 | 0.0012 | 7.8205 | 0.8497 | 5 | 18 | ear morphogenesis |
GO:0051588 | 0.0012 | 3.8852 | 2.6646 | 9 | 55 | regulation of neurotransmitter transport |
GO:0014070 | 0.0012 | 1.7228 | 26.5545 | 43 | 553 | response to organic cyclic compound |
GO:0050805 | 0.0012 | 4.9554 | 1.6956 | 7 | 35 | negative regulation of synaptic transmission |
GO:0032024 | 0.0013 | 4.2897 | 2.1801 | 8 | 45 | positive regulation of insulin secretion |
GO:0046530 | 0.0013 | 4.2897 | 2.1801 | 8 | 45 | photoreceptor cell differentiation |
GO:0072507 | 0.0013 | 2.0641 | 12.9838 | 25 | 268 | divalent inorganic cation homeostasis |
GO:0001704 | 0.0013 | 3.2486 | 3.7926 | 11 | 79 | formation of primary germ layer |
GO:0007187 | 0.0013 | 2.6475 | 6.2012 | 15 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0060045 | 0.0013 | 7.6082 | 0.872 | 5 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:2000311 | 0.0013 | 7.6082 | 0.872 | 5 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0071495 | 0.0013 | 1.5749 | 40.5017 | 60 | 836 | cellular response to endogenous stimulus |
GO:0007494 | 0.0014 | 11.2906 | 0.5329 | 4 | 11 | midgut development |
GO:0014887 | 0.0014 | 11.2906 | 0.5329 | 4 | 11 | cardiac muscle adaptation |
GO:0060379 | 0.0014 | 11.2906 | 0.5329 | 4 | 11 | cardiac muscle cell myoblast differentiation |
GO:0097154 | 0.0014 | 11.2906 | 0.5329 | 4 | 11 | GABAergic neuron differentiation |
GO:0048598 | 0.0014 | 2.3146 | 8.8475 | 19 | 198 | embryonic morphogenesis |
GO:0008344 | 0.0014 | 3.217 | 3.8273 | 11 | 79 | adult locomotory behavior |
GO:0051963 | 0.0015 | 4.7842 | 1.7441 | 7 | 36 | regulation of synapse assembly |
GO:0048709 | 0.0015 | 3.426 | 3.2944 | 10 | 68 | oligodendrocyte differentiation |
GO:0048646 | 0.0015 | 1.861 | 18.3231 | 32 | 395 | anatomical structure formation involved in morphogenesis |
GO:0046887 | 0.0016 | 3.1701 | 3.8758 | 11 | 80 | positive regulation of hormone secretion |
GO:0007519 | 0.0016 | 2.4941 | 6.9764 | 16 | 144 | skeletal muscle tissue development |
GO:0030509 | 0.0016 | 2.8138 | 5.0869 | 13 | 105 | BMP signaling pathway |
GO:0010463 | 0.0017 | 4.069 | 2.277 | 8 | 47 | mesenchymal cell proliferation |
GO:0048708 | 0.0017 | 4.069 | 2.277 | 8 | 47 | astrocyte differentiation |
GO:0044763 | 0.0017 | 1.3531 | 375.9341 | 406 | 8224 | single-organism cellular process |
GO:2000179 | 0.0017 | 4.6243 | 1.7925 | 7 | 37 | positive regulation of neural precursor cell proliferation |
GO:0060429 | 0.0018 | 1.7758 | 21.5508 | 36 | 471 | epithelium development |
GO:0060079 | 0.0019 | 5.4306 | 1.3493 | 6 | 28 | regulation of excitatory postsynaptic membrane potential |
GO:0048870 | 0.0019 | 1.5269 | 44.4744 | 64 | 918 | cell motility |
GO:0060021 | 0.0019 | 3.0803 | 3.9727 | 11 | 82 | palate development |
GO:0050679 | 0.002 | 2.6314 | 5.8136 | 14 | 120 | positive regulation of epithelial cell proliferation |
GO:0021794 | 0.002 | 9.8785 | 0.5814 | 4 | 12 | thalamus development |
GO:0003025 | 0.002 | 19.7328 | 0.2907 | 3 | 6 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0048852 | 0.002 | 19.7328 | 0.2907 | 3 | 6 | diencephalon morphogenesis |
GO:0097120 | 0.002 | 19.7328 | 0.2907 | 3 | 6 | receptor localization to synapse |
GO:1902338 | 0.002 | 19.7328 | 0.2907 | 3 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:2000177 | 0.0021 | 6.66 | 0.9597 | 5 | 20 | regulation of neural precursor cell proliferation |
GO:0007156 | 0.0021 | 2.6066 | 5.8621 | 14 | 121 | homophilic cell adhesion |
GO:0008306 | 0.0022 | 3.5028 | 2.9068 | 9 | 60 | associative learning |
GO:0003013 | 0.0023 | 1.8925 | 15.7453 | 28 | 325 | circulatory system process |
GO:0002244 | 0.0023 | 2.5822 | 5.9105 | 14 | 122 | hematopoietic progenitor cell differentiation |
GO:0021903 | 0.0023 | Inf | 0.0965 | 2 | 2 | rostrocaudal neural tube patterning |
GO:0001982 | 0.0023 | Inf | 0.0969 | 2 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
GO:0006540 | 0.0023 | Inf | 0.0969 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0070858 | 0.0023 | Inf | 0.0969 | 2 | 2 | negative regulation of bile acid biosynthetic process |
GO:0072166 | 0.0023 | Inf | 0.0969 | 2 | 2 | posterior mesonephric tubule development |
GO:1903242 | 0.0023 | Inf | 0.0969 | 2 | 2 | regulation of cardiac muscle hypertrophy in response to stress |
GO:0048731 | 0.0024 | 1.6574 | 28.4594 | 44 | 788 | system development |
GO:0030858 | 0.0024 | 4.3346 | 1.8894 | 7 | 39 | positive regulation of epithelial cell differentiation |
GO:0051966 | 0.0024 | 4.3346 | 1.8894 | 7 | 39 | regulation of synaptic transmission, glutamatergic |
GO:0002064 | 0.0024 | 2.47 | 6.5884 | 15 | 137 | epithelial cell development |
GO:0010817 | 0.0025 | 1.8374 | 17.344 | 30 | 358 | regulation of hormone levels |
GO:0060070 | 0.0025 | 2.1941 | 9.3018 | 19 | 192 | canonical Wnt signaling pathway |
GO:0098655 | 0.0025 | 1.6951 | 24.3688 | 39 | 503 | cation transmembrane transport |
GO:0060359 | 0.0025 | 3.4352 | 2.9553 | 9 | 61 | response to ammonium ion |
GO:2000648 | 0.0025 | 3.4352 | 2.9553 | 9 | 61 | positive regulation of stem cell proliferation |
GO:0033993 | 0.0025 | 1.6595 | 26.7912 | 42 | 553 | response to lipid |
GO:0009725 | 0.0026 | 1.5948 | 32.5079 | 49 | 671 | response to hormone |
GO:0001501 | 0.0027 | 2.3597 | 7.3125 | 16 | 158 | skeletal system development |
GO:0048368 | 0.0027 | 8.7801 | 0.6298 | 4 | 13 | lateral mesoderm development |
GO:0048935 | 0.0027 | 8.7801 | 0.6298 | 4 | 13 | peripheral nervous system neuron development |
GO:0060413 | 0.0027 | 8.7801 | 0.6298 | 4 | 13 | atrial septum morphogenesis |
GO:0001825 | 0.0028 | 4.9489 | 1.4534 | 6 | 30 | blastocyst formation |
GO:0021696 | 0.0028 | 4.9489 | 1.4534 | 6 | 30 | cerebellar cortex morphogenesis |
GO:0048557 | 0.0028 | 6.1801 | 1.0174 | 5 | 21 | embryonic digestive tract morphogenesis |
GO:0072132 | 0.0028 | 6.1801 | 1.0174 | 5 | 21 | mesenchyme morphogenesis |
GO:0007368 | 0.0028 | 2.9151 | 4.1664 | 11 | 86 | determination of left/right symmetry |
GO:0001525 | 0.0028 | 1.8603 | 15.9875 | 28 | 330 | angiogenesis |
GO:0001756 | 0.0028 | 3.7058 | 2.4605 | 8 | 51 | somitogenesis |
GO:0042493 | 0.0029 | 1.8801 | 15.2608 | 27 | 315 | response to drug |
GO:0006874 | 0.0029 | 2.0282 | 11.5788 | 22 | 239 | cellular calcium ion homeostasis |
GO:0048863 | 0.003 | 3.654 | 2.4826 | 8 | 53 | stem cell differentiation |
GO:0022898 | 0.0031 | 2.4891 | 6.1043 | 14 | 126 | regulation of transmembrane transporter activity |
GO:0002065 | 0.0032 | 3.6336 | 2.5007 | 8 | 52 | columnar/cuboidal epithelial cell differentiation |
GO:0050896 | 0.0032 | 1.3073 | 167.5892 | 196 | 3757 | response to stimulus |
GO:0021545 | 0.0032 | 4.7722 | 1.4955 | 6 | 31 | cranial nerve development |
GO:0002066 | 0.0033 | 4.7506 | 1.5019 | 6 | 31 | columnar/cuboidal epithelial cell development |
GO:0048854 | 0.0033 | 4.7506 | 1.5019 | 6 | 31 | brain morphogenesis |
GO:0001947 | 0.0033 | 3.6051 | 2.5192 | 8 | 52 | heart looping |
GO:0007200 | 0.0033 | 3.6051 | 2.5192 | 8 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0021521 | 0.0034 | 14.896 | 0.337 | 3 | 7 | ventral spinal cord interneuron specification |
GO:0003310 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | pancreatic A cell differentiation |
GO:0015816 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | glycine transport |
GO:0021798 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0022601 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | menstrual cycle phase |
GO:0031017 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | exocrine pancreas development |
GO:0046549 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | retinal cone cell development |
GO:0050957 | 0.0034 | 14.7984 | 0.3391 | 3 | 7 | equilibrioception |
GO:0090087 | 0.0034 | 2.2308 | 8.1875 | 17 | 169 | regulation of peptide transport |
GO:0016339 | 0.0035 | 5.8161 | 1.0658 | 5 | 22 | calcium-dependent cell-cell adhesion |
GO:0045909 | 0.0035 | 5.8161 | 1.0658 | 5 | 22 | positive regulation of vasodilation |
GO:0048666 | 0.0035 | 1.9604 | 12.4793 | 23 | 274 | neuron development |
GO:0048514 | 0.0037 | 2.9847 | 3.7028 | 10 | 78 | blood vessel morphogenesis |
GO:0021984 | 0.0037 | 7.9015 | 0.6783 | 4 | 14 | adenohypophysis development |
GO:0031338 | 0.0037 | 7.9015 | 0.6783 | 4 | 14 | regulation of vesicle fusion |
GO:0072160 | 0.0037 | 7.9015 | 0.6783 | 4 | 14 | nephron tubule epithelial cell differentiation |
GO:0008284 | 0.0038 | 1.7273 | 20.2008 | 33 | 429 | positive regulation of cell proliferation |
GO:0042063 | 0.004 | 2.6248 | 4.9819 | 12 | 104 | gliogenesis |
GO:0021953 | 0.0041 | 3.1607 | 3.1625 | 9 | 68 | central nervous system neuron differentiation |
GO:0046903 | 0.0042 | 1.8462 | 14.9283 | 26 | 317 | secretion |
GO:0043069 | 0.0042 | 1.5973 | 28.3899 | 43 | 586 | negative regulation of programmed cell death |
GO:0061005 | 0.0043 | 3.8517 | 2.0832 | 7 | 43 | cell differentiation involved in kidney development |
GO:0035235 | 0.0043 | 5.4925 | 1.1143 | 5 | 23 | ionotropic glutamate receptor signaling pathway |
GO:0072273 | 0.0043 | 5.4925 | 1.1143 | 5 | 23 | metanephric nephron morphogenesis |
GO:0001838 | 0.0043 | 2.4867 | 5.6683 | 13 | 117 | embryonic epithelial tube formation |
GO:0050801 | 0.0044 | 1.6685 | 22.7701 | 36 | 470 | ion homeostasis |
GO:0022603 | 0.0044 | 1.6558 | 23.5794 | 37 | 496 | regulation of anatomical structure morphogenesis |
GO:0009743 | 0.0045 | 3.1087 | 3.2163 | 9 | 67 | response to carbohydrate |
GO:0051932 | 0.0046 | 4.3979 | 1.5988 | 6 | 33 | synaptic transmission, GABAergic |
GO:0009888 | 0.0046 | 2.2824 | 7.0409 | 15 | 166 | tissue development |
GO:0030282 | 0.0047 | 2.8772 | 3.8273 | 10 | 79 | bone mineralization |
GO:0045595 | 0.0047 | 1.9746 | 11.303 | 21 | 252 | regulation of cell differentiation |
GO:0060322 | 0.0047 | 3.3742 | 2.6646 | 8 | 55 | head development |
GO:0045597 | 0.0048 | 1.7139 | 19.7087 | 32 | 421 | positive regulation of cell differentiation |
GO:0035883 | 0.0048 | 7.2157 | 0.7235 | 4 | 15 | enteroendocrine cell differentiation |
GO:0042693 | 0.0049 | 7.1826 | 0.7267 | 4 | 15 | muscle cell fate commitment |
GO:0060438 | 0.0049 | 7.1826 | 0.7267 | 4 | 15 | trachea development |
GO:0072112 | 0.0049 | 7.1826 | 0.7267 | 4 | 15 | glomerular visceral epithelial cell differentiation |
GO:2000463 | 0.0049 | 7.1826 | 0.7267 | 4 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0097285 | 0.0049 | 1.7816 | 16.6173 | 28 | 343 | cell-type specific apoptotic process |
GO:0009889 | 0.0049 | 47.0809 | 0.1228 | 2 | 3 | regulation of biosynthetic process |
GO:0007204 | 0.005 | 2.1986 | 7.8 | 16 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0044767 | 0.0051 | 1.3556 | 89.9714 | 112 | 2404 | single-organism developmental process |
GO:0042886 | 0.0051 | 1.9966 | 10.6583 | 20 | 220 | amide transport |
GO:0035137 | 0.0051 | 11.9532 | 0.384 | 3 | 8 | hindlimb morphogenesis |
GO:0030325 | 0.0052 | 5.203 | 1.1627 | 5 | 24 | adrenal gland development |
GO:0045686 | 0.0052 | 5.203 | 1.1627 | 5 | 24 | negative regulation of glial cell differentiation |
GO:0061333 | 0.0052 | 5.203 | 1.1627 | 5 | 24 | renal tubule morphogenesis |
GO:0044708 | 0.0052 | 2.2543 | 7.1417 | 15 | 150 | single-organism behavior |
GO:0010975 | 0.0053 | 1.9199 | 12.1602 | 22 | 251 | regulation of neuron projection development |
GO:0003139 | 0.0053 | 11.8377 | 0.3876 | 3 | 8 | secondary heart field specification |
GO:0015824 | 0.0053 | 11.8377 | 0.3876 | 3 | 8 | proline transport |
GO:0021559 | 0.0053 | 11.8377 | 0.3876 | 3 | 8 | trigeminal nerve development |
GO:0040019 | 0.0053 | 11.8377 | 0.3876 | 3 | 8 | positive regulation of embryonic development |
GO:0046485 | 0.0053 | 11.8377 | 0.3876 | 3 | 8 | ether lipid metabolic process |
GO:0001708 | 0.0053 | 4.226 | 1.6457 | 6 | 35 | cell fate specification |
GO:0010243 | 0.0055 | 1.5618 | 29.6496 | 44 | 612 | response to organonitrogen compound |
GO:0090276 | 0.0057 | 2.1683 | 7.8969 | 16 | 163 | regulation of peptide hormone secretion |
GO:0031016 | 0.0057 | 5.0434 | 1.1883 | 5 | 25 | pancreas development |
GO:0003151 | 0.0059 | 3.2359 | 2.7615 | 8 | 57 | outflow tract morphogenesis |
GO:0048839 | 0.006 | 4.1072 | 1.684 | 6 | 36 | inner ear development |
GO:0016337 | 0.006 | 1.8389 | 13.8074 | 24 | 285 | single organismal cell-cell adhesion |
GO:0043410 | 0.0061 | 1.8122 | 14.5825 | 25 | 301 | positive regulation of MAPK cascade |
GO:0050768 | 0.0061 | 2.6008 | 4.6025 | 11 | 95 | negative regulation of neurogenesis |
GO:0021846 | 0.0062 | 4.9424 | 1.2112 | 5 | 25 | cell proliferation in forebrain |
GO:0031069 | 0.0062 | 4.9424 | 1.2112 | 5 | 25 | hair follicle morphogenesis |
GO:0003323 | 0.0062 | 6.5835 | 0.7752 | 4 | 16 | type B pancreatic cell development |
GO:0072077 | 0.0062 | 6.5835 | 0.7752 | 4 | 16 | renal vesicle morphogenesis |
GO:0072148 | 0.0062 | 6.5835 | 0.7752 | 4 | 16 | epithelial cell fate commitment |
GO:0072224 | 0.0062 | 6.5835 | 0.7752 | 4 | 16 | metanephric glomerulus development |
GO:0090190 | 0.0062 | 6.5835 | 0.7752 | 4 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0035019 | 0.0062 | 3.5545 | 2.2286 | 7 | 46 | somatic stem cell maintenance |
GO:0010648 | 0.0063 | 1.4899 | 37.4127 | 53 | 779 | negative regulation of cell communication |
GO:0001656 | 0.0063 | 3.1915 | 2.793 | 8 | 58 | metanephros development |
GO:0007605 | 0.0066 | 2.3498 | 5.959 | 13 | 123 | sensory perception of sound |
GO:0015820 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | leucine transport |
GO:0015891 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | siderophore transport |
GO:0021524 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | visceral motor neuron differentiation |
GO:0021902 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030910 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | olfactory placode formation |
GO:0035054 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0035564 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | regulation of kidney size |
GO:0035726 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0036023 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0042335 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | cuticle development |
GO:0048807 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | female genitalia morphogenesis |
GO:0060112 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | generation of ovulation cycle rhythm |
GO:0071698 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | olfactory placode development |
GO:0072093 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | metanephric renal vesicle formation |
GO:0072180 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | mesonephric duct morphogenesis |
GO:0097211 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0097477 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | lateral motor column neuron migration |
GO:1900212 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000195 | 0.0068 | 39.4075 | 0.1453 | 2 | 3 | negative regulation of female gonad development |
GO:0030850 | 0.007 | 3.4653 | 2.277 | 7 | 47 | prostate gland development |
GO:0048864 | 0.007 | 2.5436 | 4.6876 | 11 | 99 | stem cell development |
GO:0071322 | 0.0071 | 2.8787 | 3.4397 | 9 | 71 | cellular response to carbohydrate stimulus |
GO:0051606 | 0.0073 | 1.9634 | 10.2708 | 19 | 212 | detection of stimulus |
GO:0055065 | 0.0076 | 1.6985 | 17.9738 | 29 | 371 | metal ion homeostasis |
GO:0014051 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | gamma-aminobutyric acid secretion |
GO:0015671 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | oxygen transport |
GO:0030917 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | midbrain-hindbrain boundary development |
GO:0032525 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | somite rostral/caudal axis specification |
GO:0046113 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | nucleobase catabolic process |
GO:0048664 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | neuron fate determination |
GO:0060872 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | semicircular canal development |
GO:0061004 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | pattern specification involved in kidney development |
GO:0061525 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | hindgut development |
GO:0090009 | 0.0076 | 9.8639 | 0.436 | 3 | 9 | primitive streak formation |
GO:0072009 | 0.0077 | 3.399 | 2.3136 | 7 | 48 | nephron epithelium development |
GO:0030539 | 0.0078 | 6.0765 | 0.8236 | 4 | 17 | male genitalia development |
GO:0030878 | 0.0078 | 6.0765 | 0.8236 | 4 | 17 | thyroid gland development |
GO:0060231 | 0.0078 | 6.0765 | 0.8236 | 4 | 17 | mesenchymal to epithelial transition |
GO:0060914 | 0.0078 | 6.0765 | 0.8236 | 4 | 17 | heart formation |
GO:0007565 | 0.008 | 2.2869 | 6.1043 | 13 | 126 | female pregnancy |
GO:0051146 | 0.008 | 1.9821 | 9.641 | 18 | 199 | striated muscle cell differentiation |
GO:0042246 | 0.0081 | 3.8292 | 1.7925 | 6 | 37 | tissue regeneration |
GO:0061383 | 0.0081 | 3.8292 | 1.7925 | 6 | 37 | trabecula morphogenesis |
GO:0009611 | 0.0083 | 1.4703 | 37.1104 | 52 | 766 | response to wounding |
GO:0016202 | 0.0083 | 2.4817 | 4.7963 | 11 | 99 | regulation of striated muscle tissue development |
GO:0030802 | 0.0085 | 2.6106 | 4.1664 | 10 | 86 | regulation of cyclic nucleotide biosynthetic process |
GO:0050851 | 0.0085 | 2.3602 | 5.4745 | 12 | 113 | antigen receptor-mediated signaling pathway |
GO:0048754 | 0.0086 | 2.4666 | 4.8183 | 11 | 101 | branching morphogenesis of an epithelial tube |
GO:0072207 | 0.0087 | 4.4924 | 1.3081 | 5 | 27 | metanephric epithelium development |
GO:1902692 | 0.0087 | 4.4924 | 1.3081 | 5 | 27 | regulation of neuroblast proliferation |
GO:0006811 | 0.0088 | 1.516 | 30.4727 | 44 | 649 | ion transport |
GO:0050803 | 0.0088 | 2.9907 | 2.9553 | 8 | 61 | regulation of synapse structure and activity |
GO:0071333 | 0.0088 | 2.9907 | 2.9553 | 8 | 61 | cellular response to glucose stimulus |
GO:0060113 | 0.0088 | 3.2998 | 2.3739 | 7 | 49 | inner ear receptor cell differentiation |
GO:0071383 | 0.0089 | 2.4536 | 4.8447 | 11 | 100 | cellular response to steroid hormone stimulus |
GO:0023057 | 0.009 | 1.4634 | 37.2687 | 52 | 776 | negative regulation of signaling |
GO:0030178 | 0.0091 | 2.3369 | 5.523 | 12 | 114 | negative regulation of Wnt signaling pathway |
GO:0035108 | 0.0094 | 2.4343 | 4.8752 | 11 | 102 | limb morphogenesis |
GO:0048706 | 0.0094 | 4.3934 | 1.3283 | 5 | 28 | embryonic skeletal system development |
GO:0023061 | 0.0095 | 1.9057 | 10.5453 | 19 | 222 | signal release |
GO:0071363 | 0.0096 | 1.5294 | 28.0993 | 41 | 580 | cellular response to growth factor stimulus |
GO:0006182 | 0.0097 | 5.642 | 0.872 | 4 | 18 | cGMP biosynthetic process |
GO:0072010 | 0.0097 | 5.642 | 0.872 | 4 | 18 | glomerular epithelium development |
GO:0072074 | 0.0097 | 5.642 | 0.872 | 4 | 18 | kidney mesenchyme development |
GO:0048468 | 0.0097 | 1.6649 | 18.3165 | 29 | 431 | cell development |
GO:0043524 | 0.0097 | 2.314 | 5.5714 | 12 | 115 | negative regulation of neuron apoptotic process |
GO:0051952 | 0.0099 | 3.2228 | 2.4224 | 7 | 50 | regulation of amine transport |
GO:0071695 | 0.0099 | 3.2228 | 2.4224 | 7 | 50 | anatomical structure maturation |
GO:0001101 | 0.0099 | 1.8638 | 11.3366 | 20 | 234 | response to acid chemical |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060750 | 2e-04 | 77.057 | 0.1508 | 3 | 4 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:0003334 | 2e-04 | 20.5852 | 0.3393 | 4 | 9 | keratinocyte development |
GO:0019373 | 5e-04 | 38.5253 | 0.1885 | 3 | 5 | epoxygenase P450 pathway |
GO:1900028 | 5e-04 | 38.5253 | 0.1885 | 3 | 5 | negative regulation of ruffle assembly |
GO:0030879 | 6e-04 | 3.1307 | 4.5615 | 13 | 121 | mammary gland development |
GO:0030855 | 8e-04 | 1.9502 | 17.5298 | 32 | 465 | epithelial cell differentiation |
GO:1901342 | 8e-04 | 2.7713 | 5.881 | 15 | 156 | regulation of vasculature development |
GO:0007028 | 0.001 | 25.6814 | 0.2262 | 3 | 6 | cytoplasm organization |
GO:0001676 | 0.0012 | 3.8194 | 2.6389 | 9 | 70 | long-chain fatty acid metabolic process |
GO:0022603 | 0.0013 | 1.7959 | 21.9304 | 37 | 587 | regulation of anatomical structure morphogenesis |
GO:0043588 | 0.0013 | 2.215 | 10.1409 | 21 | 269 | skin development |
GO:0001101 | 0.0014 | 2.3079 | 8.8215 | 19 | 234 | response to acid chemical |
GO:0007308 | 0.0014 | Inf | 0.0754 | 2 | 2 | oocyte construction |
GO:0007314 | 0.0014 | Inf | 0.0754 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0014 | Inf | 0.0754 | 2 | 2 | P granule organization |
GO:0097168 | 0.0014 | Inf | 0.0754 | 2 | 2 | mesenchymal stem cell proliferation |
GO:0045606 | 0.0015 | 10.2884 | 0.5278 | 4 | 14 | positive regulation of epidermal cell differentiation |
GO:0046330 | 0.0015 | 4.635 | 1.7341 | 7 | 46 | positive regulation of JNK cascade |
GO:0030334 | 0.0017 | 1.9057 | 16.1727 | 29 | 429 | regulation of cell migration |
GO:0051270 | 0.0021 | 1.8032 | 19.4148 | 33 | 515 | regulation of cellular component movement |
GO:1903036 | 0.0022 | 3.8291 | 2.3373 | 8 | 62 | positive regulation of response to wounding |
GO:0050727 | 0.0023 | 2.4696 | 6.5219 | 15 | 173 | regulation of inflammatory response |
GO:0043410 | 0.0024 | 2.0618 | 11.3473 | 22 | 301 | positive regulation of MAPK cascade |
GO:0048589 | 0.0025 | 2.1312 | 9.9901 | 20 | 265 | developmental growth |
GO:0009888 | 0.0028 | 1.4673 | 53.0796 | 73 | 1408 | tissue development |
GO:0034330 | 0.0031 | 2.2472 | 8.0675 | 17 | 214 | cell junction organization |
GO:1902041 | 0.0032 | 4.6875 | 1.4702 | 6 | 39 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:2000352 | 0.0032 | 7.9122 | 0.6409 | 4 | 17 | negative regulation of endothelial cell apoptotic process |
GO:0070555 | 0.0036 | 3.9274 | 1.998 | 7 | 53 | response to interleukin-1 |
GO:0007044 | 0.0039 | 3.4445 | 2.5635 | 8 | 68 | cell-substrate junction assembly |
GO:0007186 | 0.004 | 1.6776 | 22.6568 | 36 | 601 | G-protein coupled receptor signaling pathway |
GO:0001806 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | type IV hypersensitivity |
GO:0002578 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | negative regulation of antigen processing and presentation |
GO:0010482 | 0.0041 | 51.2632 | 0.1131 | 2 | 3 | regulation of epidermal cell division |
GO:0045766 | 0.0043 | 3.1028 | 3.1667 | 9 | 84 | positive regulation of angiogenesis |
GO:0060491 | 0.0043 | 3.1028 | 3.1667 | 9 | 84 | regulation of cell projection assembly |
GO:0070304 | 0.0049 | 3.686 | 2.1111 | 7 | 56 | positive regulation of stress-activated protein kinase signaling cascade |
GO:0060602 | 0.0049 | 6.8561 | 0.7163 | 4 | 19 | branch elongation of an epithelium |
GO:0071356 | 0.005 | 3.0217 | 3.2421 | 9 | 86 | cellular response to tumor necrosis factor |
GO:0031649 | 0.0052 | 11.0027 | 0.377 | 3 | 10 | heat generation |
GO:0045026 | 0.0052 | 11.0027 | 0.377 | 3 | 10 | plasma membrane fusion |
GO:0060192 | 0.0052 | 11.0027 | 0.377 | 3 | 10 | negative regulation of lipase activity |
GO:0031529 | 0.0056 | 4.9503 | 1.1687 | 5 | 31 | ruffle organization |
GO:0030155 | 0.0062 | 1.952 | 10.8195 | 20 | 287 | regulation of cell adhesion |
GO:2000146 | 0.0066 | 2.429 | 5.2778 | 12 | 140 | negative regulation of cell motility |
GO:0002675 | 0.0069 | 9.6658 | 0.4131 | 3 | 11 | positive regulation of acute inflammatory response |
GO:0042060 | 0.007 | 1.6494 | 21.0358 | 33 | 558 | wound healing |
GO:0051239 | 0.0071 | 1.3724 | 65.866 | 85 | 1763 | regulation of multicellular organismal process |
GO:0034333 | 0.0071 | 3.4067 | 2.2619 | 7 | 60 | adherens junction assembly |
GO:0045682 | 0.0072 | 3.865 | 1.7341 | 6 | 46 | regulation of epidermis development |
GO:0060688 | 0.0072 | 3.865 | 1.7341 | 6 | 46 | regulation of morphogenesis of a branching structure |
GO:0002291 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0007598 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | blood coagulation, extrinsic pathway |
GO:0008582 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | regulation of synaptic growth at neuromuscular junction |
GO:0031622 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | positive regulation of fever generation |
GO:0072107 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0097267 | 0.0081 | 25.6295 | 0.1508 | 2 | 4 | omega-hydroxylase P450 pathway |
GO:0040012 | 0.0081 | 1.6716 | 18.8493 | 30 | 500 | regulation of locomotion |
GO:0050678 | 0.0088 | 2.047 | 8.256 | 16 | 219 | regulation of epithelial cell proliferation |
GO:0045995 | 0.0089 | 2.7355 | 3.5437 | 9 | 94 | regulation of embryonic development |
GO:0019371 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | cyclooxygenase pathway |
GO:0040037 | 0.0091 | 8.5563 | 0.4524 | 3 | 12 | negative regulation of fibroblast growth factor receptor signaling pathway |
GO:0009967 | 0.0091 | 1.4871 | 33.9287 | 48 | 900 | positive regulation of signal transduction |
GO:0010812 | 0.0095 | 4.2888 | 1.3194 | 5 | 35 | negative regulation of cell-substrate adhesion |
GO:0030104 | 0.0095 | 4.2888 | 1.3194 | 5 | 35 | water homeostasis |
GO:0060603 | 0.0095 | 4.2888 | 1.3194 | 5 | 35 | mammary gland duct morphogenesis |
GO:0001568 | 0.0097 | 1.6792 | 17.4921 | 28 | 464 | blood vessel development |
GO:0032501 | 0.0097 | 1.2521 | 188.8698 | 214 | 5010 | multicellular organismal process |
GO:0002687 | 0.0098 | 3.5944 | 1.8472 | 6 | 49 | positive regulation of leukocyte migration |
GO:0010595 | 0.0098 | 3.5944 | 1.8472 | 6 | 49 | positive regulation of endothelial cell migration |
GO:0061217 | 0.01 | 5.4109 | 0.8671 | 4 | 23 | regulation of mesonephros development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 121.3215 | 0.3575 | 10 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 8.2561 | 1.7877 | 12 | 65 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 8.8928 | 1.5402 | 11 | 56 | detection of chemical stimulus |
GO:0007606 | 0 | 6.2472 | 1.8702 | 10 | 68 | sensory perception of chemical stimulus |
GO:0007028 | 4e-04 | 35.658 | 0.165 | 3 | 6 | cytoplasm organization |
GO:0007308 | 8e-04 | Inf | 0.055 | 2 | 2 | oocyte construction |
GO:0007314 | 8e-04 | Inf | 0.055 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 8e-04 | Inf | 0.055 | 2 | 2 | P granule organization |
GO:2000352 | 0.001 | 10.9946 | 0.4676 | 4 | 17 | negative regulation of endothelial cell apoptotic process |
GO:0007155 | 0.0015 | 1.748 | 24.5055 | 40 | 891 | cell adhesion |
GO:0002774 | 0.0022 | 71.1214 | 0.0825 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0001568 | 0.0023 | 1.9975 | 12.7616 | 24 | 464 | blood vessel development |
GO:0007210 | 0.0029 | 13.3663 | 0.3025 | 3 | 11 | serotonin receptor signaling pathway |
GO:0010631 | 0.0035 | 2.7761 | 4.2355 | 11 | 154 | epithelial cell migration |
GO:0006968 | 0.0036 | 5.421 | 1.0451 | 5 | 38 | cellular defense response |
GO:0006955 | 0.0037 | 1.6373 | 26.6508 | 41 | 969 | immune response |
GO:0002765 | 0.0044 | 35.5578 | 0.11 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0006533 | 0.0044 | 35.5578 | 0.11 | 2 | 4 | aspartate catabolic process |
GO:0007598 | 0.0044 | 35.5578 | 0.11 | 2 | 4 | blood coagulation, extrinsic pathway |
GO:0034116 | 0.0044 | 35.5578 | 0.11 | 2 | 4 | positive regulation of heterotypic cell-cell adhesion |
GO:0042373 | 0.0044 | 35.5578 | 0.11 | 2 | 4 | vitamin K metabolic process |
GO:0090130 | 0.0045 | 2.6812 | 4.373 | 11 | 159 | tissue migration |
GO:0001525 | 0.0045 | 2.0967 | 9.0761 | 18 | 330 | angiogenesis |
GO:0010594 | 0.0052 | 3.588 | 2.1178 | 7 | 77 | regulation of endothelial cell migration |
GO:0001906 | 0.0055 | 4.0556 | 1.6227 | 6 | 59 | cell killing |
GO:0006805 | 0.0059 | 3.1581 | 2.7228 | 8 | 99 | xenobiotic metabolic process |
GO:0043616 | 0.006 | 6.2093 | 0.7426 | 4 | 27 | keratinocyte proliferation |
GO:0007350 | 0.006 | 9.7186 | 0.385 | 3 | 14 | blastoderm segmentation |
GO:0008595 | 0.006 | 9.7186 | 0.385 | 3 | 14 | anterior/posterior axis specification, embryo |
GO:0007186 | 0.006 | 1.7696 | 16.1011 | 27 | 590 | G-protein coupled receptor signaling pathway |
GO:0044699 | 0.007 | 1.4583 | 280.0942 | 298 | 10184 | single-organism process |
GO:0032689 | 0.0073 | 8.908 | 0.4126 | 3 | 15 | negative regulation of interferon-gamma production |
GO:0061436 | 0.0073 | 8.908 | 0.4126 | 3 | 15 | establishment of skin barrier |
GO:0070830 | 0.0076 | 4.4698 | 1.2377 | 5 | 45 | tight junction assembly |
GO:0009410 | 0.0083 | 2.9613 | 2.8879 | 8 | 105 | response to xenobiotic stimulus |
GO:2000725 | 0.0089 | 8.2221 | 0.4401 | 3 | 16 | regulation of cardiac muscle cell differentiation |
GO:0050896 | 0.0097 | 1.32 | 129.4581 | 150 | 4927 | response to stimulus |
GO:0003008 | 0.0098 | 1.499 | 32.4815 | 46 | 1181 | system process |
GO:0050891 | 0.0098 | 5.2877 | 0.8526 | 4 | 31 | multicellular organismal water homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070830 | 0 | 7.9954 | 1.5826 | 10 | 45 | tight junction assembly |
GO:0098655 | 0 | 2.4313 | 17.6903 | 39 | 503 | cation transmembrane transport |
GO:0035725 | 0 | 5.1175 | 3.2004 | 14 | 91 | sodium ion transmembrane transport |
GO:0044707 | 0 | 1.5921 | 141.5634 | 185 | 4201 | single-multicellular organism process |
GO:0007186 | 0 | 2.3011 | 19.0828 | 40 | 549 | G-protein coupled receptor signaling pathway |
GO:0007268 | 0 | 2.1454 | 22.4382 | 44 | 638 | synaptic transmission |
GO:0050896 | 0 | 1.5148 | 181.1295 | 222 | 5371 | response to stimulus |
GO:0098660 | 0 | 2.2684 | 17.3034 | 36 | 492 | inorganic ion transmembrane transport |
GO:0030001 | 0 | 2.3808 | 13.715 | 30 | 397 | metal ion transport |
GO:0042391 | 1e-04 | 2.5265 | 10.7619 | 25 | 306 | regulation of membrane potential |
GO:0006816 | 1e-04 | 2.6393 | 9.4958 | 23 | 270 | calcium ion transport |
GO:0003013 | 1e-04 | 2.4715 | 11.4301 | 26 | 325 | circulatory system process |
GO:0086010 | 1e-04 | 7.7882 | 1.1254 | 7 | 32 | membrane depolarization during action potential |
GO:0007165 | 1e-04 | 1.4637 | 133.7769 | 170 | 3848 | signal transduction |
GO:0007155 | 1e-04 | 1.8345 | 31.336 | 53 | 891 | cell adhesion |
GO:0035235 | 1e-04 | 9.8012 | 0.8089 | 6 | 23 | ionotropic glutamate receptor signaling pathway |
GO:0008217 | 1e-04 | 3.5725 | 4.361 | 14 | 124 | regulation of blood pressure |
GO:0044700 | 1e-04 | 2.2965 | 13.9286 | 29 | 455 | single organism signaling |
GO:0072511 | 2e-04 | 2.4563 | 10.1288 | 23 | 288 | divalent inorganic cation transport |
GO:0044057 | 2e-04 | 2.3467 | 11.5004 | 25 | 327 | regulation of system process |
GO:0002687 | 3e-04 | 5.4326 | 1.7233 | 8 | 49 | positive regulation of leukocyte migration |
GO:0007612 | 3e-04 | 3.6498 | 3.6576 | 12 | 104 | learning |
GO:0045591 | 4e-04 | 41.4231 | 0.1758 | 3 | 5 | positive regulation of regulatory T cell differentiation |
GO:0051712 | 4e-04 | 41.4231 | 0.1758 | 3 | 5 | positive regulation of killing of cells of other organism |
GO:0046068 | 4e-04 | 7.2408 | 1.0199 | 6 | 29 | cGMP metabolic process |
GO:0034765 | 5e-04 | 2.3885 | 9.4606 | 21 | 269 | regulation of ion transmembrane transport |
GO:0050808 | 5e-04 | 3.0179 | 5.0644 | 14 | 144 | synapse organization |
GO:0007158 | 6e-04 | 13.8322 | 0.422 | 4 | 12 | neuron cell-cell adhesion |
GO:0015672 | 7e-04 | 2.1274 | 13.0831 | 26 | 372 | monovalent inorganic cation transport |
GO:0070293 | 8e-04 | 12.2943 | 0.4572 | 4 | 13 | renal absorption |
GO:0048731 | 8e-04 | 1.3975 | 116.3056 | 146 | 3307 | system development |
GO:0016339 | 8e-04 | 8.1491 | 0.7737 | 5 | 22 | calcium-dependent cell-cell adhesion |
GO:0035176 | 0.0011 | 5.9453 | 1.1958 | 6 | 34 | social behavior |
GO:0032782 | 0.0012 | Inf | 0.0703 | 2 | 2 | bile acid secretion |
GO:0030104 | 0.0012 | 5.7398 | 1.2309 | 6 | 35 | water homeostasis |
GO:0050890 | 0.0017 | 2.4644 | 6.9636 | 16 | 198 | cognition |
GO:0086069 | 0.0021 | 16.5652 | 0.2814 | 3 | 8 | bundle of His cell to Purkinje myocyte communication |
GO:0007200 | 0.0022 | 4.3197 | 1.8288 | 7 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002376 | 0.0023 | 1.4546 | 60.5971 | 82 | 1723 | immune system process |
GO:0007606 | 0.0026 | 3.7065 | 2.3915 | 8 | 68 | sensory perception of chemical stimulus |
GO:0019233 | 0.0026 | 3.7065 | 2.3915 | 8 | 68 | sensory perception of pain |
GO:0045071 | 0.0026 | 6.0203 | 0.9847 | 5 | 28 | negative regulation of viral genome replication |
GO:0050877 | 0.0027 | 1.9137 | 14.408 | 26 | 423 | neurological system process |
GO:0042592 | 0.0027 | 1.5535 | 37.6666 | 55 | 1071 | homeostatic process |
GO:0035249 | 0.0028 | 3.6454 | 2.4267 | 8 | 69 | synaptic transmission, glutamatergic |
GO:0007626 | 0.0029 | 2.4933 | 6.014 | 14 | 171 | locomotory behavior |
GO:0014068 | 0.0029 | 4.7535 | 1.442 | 6 | 41 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0009581 | 0.003 | 2.7007 | 4.7831 | 12 | 136 | detection of external stimulus |
GO:0071625 | 0.0031 | 13.8032 | 0.3165 | 3 | 9 | vocalization behavior |
GO:0033561 | 0.0031 | 7.9002 | 0.6331 | 4 | 18 | regulation of water loss via skin |
GO:0071356 | 0.0032 | 3.2521 | 3.0246 | 9 | 86 | cellular response to tumor necrosis factor |
GO:0009593 | 0.0033 | 3.9658 | 1.9695 | 7 | 56 | detection of chemical stimulus |
GO:0055074 | 0.0034 | 2.1665 | 8.8276 | 18 | 251 | calcium ion homeostasis |
GO:0019226 | 0.0036 | 2.9626 | 3.6576 | 10 | 104 | transmission of nerve impulse |
GO:0015891 | 0.0036 | 55.1106 | 0.1055 | 2 | 3 | siderophore transport |
GO:0042420 | 0.0036 | 55.1106 | 0.1055 | 2 | 3 | dopamine catabolic process |
GO:0050915 | 0.0036 | 55.1106 | 0.1055 | 2 | 3 | sensory perception of sour taste |
GO:0070268 | 0.0036 | 55.1106 | 0.1055 | 2 | 3 | cornification |
GO:0090240 | 0.0036 | 55.1106 | 0.1055 | 2 | 3 | positive regulation of histone H4 acetylation |
GO:2000147 | 0.0036 | 2.2052 | 8.1945 | 17 | 233 | positive regulation of cell motility |
GO:0009582 | 0.0036 | 2.6363 | 4.8886 | 12 | 139 | detection of abiotic stimulus |
GO:0007605 | 0.004 | 2.7373 | 4.3259 | 11 | 123 | sensory perception of sound |
GO:0007269 | 0.0041 | 2.9004 | 3.728 | 10 | 106 | neurotransmitter secretion |
GO:0021707 | 0.0043 | 11.8303 | 0.3517 | 3 | 10 | cerebellar granule cell differentiation |
GO:0032695 | 0.0043 | 11.8303 | 0.3517 | 3 | 10 | negative regulation of interleukin-12 production |
GO:0050801 | 0.0046 | 1.7874 | 16.5297 | 28 | 470 | ion homeostasis |
GO:0051049 | 0.0047 | 1.4883 | 42.0628 | 59 | 1196 | regulation of transport |
GO:0061028 | 0.0047 | 6.9116 | 0.7034 | 4 | 20 | establishment of endothelial barrier |
GO:0030534 | 0.0048 | 2.6653 | 4.4314 | 11 | 126 | adult behavior |
GO:0050878 | 0.0056 | 1.707 | 19.1322 | 31 | 544 | regulation of body fluid levels |
GO:0051965 | 0.0056 | 6.5045 | 0.7386 | 4 | 21 | positive regulation of synapse assembly |
GO:0007610 | 0.0057 | 1.8987 | 12.2235 | 22 | 354 | behavior |
GO:0021683 | 0.0058 | 10.3507 | 0.3869 | 3 | 11 | cerebellar granular layer morphogenesis |
GO:0044364 | 0.0058 | 10.3507 | 0.3869 | 3 | 11 | disruption of cells of other organism |
GO:0031018 | 0.0058 | 4.0559 | 1.653 | 6 | 47 | endocrine pancreas development |
GO:0010959 | 0.0062 | 2.1948 | 7.2449 | 15 | 206 | regulation of metal ion transport |
GO:0007154 | 0.0063 | 1.8407 | 13.9243 | 24 | 464 | cell communication |
GO:0030216 | 0.0065 | 3.1294 | 2.7784 | 8 | 79 | keratinocyte differentiation |
GO:0002001 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | renin secretion into blood stream |
GO:0002925 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0008228 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | opsonization |
GO:0019614 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | catechol-containing compound catabolic process |
GO:0032455 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | nerve growth factor processing |
GO:0042663 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0070886 | 0.0071 | 27.553 | 0.1407 | 2 | 4 | positive regulation of calcineurin-NFAT signaling cascade |
GO:2000756 | 0.0071 | 4.6129 | 1.2309 | 5 | 35 | regulation of peptidyl-lysine acetylation |
GO:0016337 | 0.0074 | 1.9933 | 9.524 | 18 | 273 | single organismal cell-cell adhesion |
GO:0044765 | 0.0074 | 1.3163 | 100.0221 | 122 | 2844 | single-organism transport |
GO:0030855 | 0.0074 | 1.7358 | 16.3538 | 27 | 465 | epithelial cell differentiation |
GO:0034329 | 0.0076 | 2.2079 | 6.7174 | 14 | 191 | cell junction assembly |
GO:0050906 | 0.0076 | 3.3479 | 2.286 | 7 | 65 | detection of stimulus involved in sensory perception |
GO:0008544 | 0.0077 | 2.0804 | 8.1242 | 16 | 231 | epidermis development |
GO:0050776 | 0.0086 | 1.6361 | 20.539 | 32 | 584 | regulation of immune response |
GO:0050885 | 0.0086 | 3.6942 | 1.7936 | 6 | 51 | neuromuscular process controlling balance |
GO:0007602 | 0.0087 | 2.9615 | 2.9191 | 8 | 83 | phototransduction |
GO:0007613 | 0.0087 | 2.9615 | 2.9191 | 8 | 83 | memory |
GO:0060047 | 0.009 | 2.4304 | 4.8182 | 11 | 137 | heart contraction |
GO:0071248 | 0.0093 | 2.9223 | 2.9542 | 8 | 84 | cellular response to metal ion |
GO:0042177 | 0.0095 | 3.6135 | 1.8288 | 6 | 52 | negative regulation of protein catabolic process |
GO:0050911 | 0.0095 | 8.2792 | 0.4572 | 3 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007188 | 0.0097 | 2.689 | 3.5873 | 9 | 102 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042246 | 0 | 7.9207 | 1.465 | 9 | 37 | tissue regeneration |
GO:0007186 | 1e-04 | 2.139 | 18.7639 | 37 | 484 | G-protein coupled receptor signaling pathway |
GO:0050877 | 1e-04 | 1.912 | 28.3503 | 50 | 716 | neurological system process |
GO:0007586 | 1e-04 | 4.0711 | 3.6428 | 13 | 92 | digestion |
GO:0060429 | 1e-04 | 1.7929 | 35.0419 | 58 | 885 | epithelium development |
GO:0043588 | 2e-04 | 2.4453 | 10.6511 | 24 | 269 | skin development |
GO:0042693 | 2e-04 | 12.2399 | 0.5939 | 5 | 15 | muscle cell fate commitment |
GO:0040007 | 2e-04 | 1.9207 | 22.9743 | 41 | 589 | growth |
GO:0048545 | 3e-04 | 2.3455 | 11.0541 | 24 | 281 | response to steroid hormone |
GO:0044057 | 4e-04 | 2.2635 | 11.9002 | 25 | 303 | regulation of system process |
GO:0046661 | 4e-04 | 3.2766 | 4.3951 | 13 | 111 | male sex differentiation |
GO:0034765 | 4e-04 | 2.3288 | 10.6511 | 23 | 269 | regulation of ion transmembrane transport |
GO:0030155 | 5e-04 | 2.2745 | 11.3639 | 24 | 287 | regulation of cell adhesion |
GO:0065007 | 6e-04 | 1.3864 | 323.8504 | 358 | 8179 | biological regulation |
GO:0043415 | 6e-04 | 36.5964 | 0.198 | 3 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0060040 | 6e-04 | 36.5964 | 0.198 | 3 | 5 | retinal bipolar neuron differentiation |
GO:0032103 | 6e-04 | 2.9828 | 5.1474 | 14 | 130 | positive regulation of response to external stimulus |
GO:0009617 | 9e-04 | 2.2983 | 9.8196 | 21 | 248 | response to bacterium |
GO:0009719 | 0.0011 | 1.5586 | 45.2971 | 66 | 1144 | response to endogenous stimulus |
GO:0098660 | 0.0011 | 1.8589 | 19.4809 | 34 | 492 | inorganic ion transmembrane transport |
GO:0007267 | 0.0012 | 1.594 | 39.5162 | 59 | 998 | cell-cell signaling |
GO:0044707 | 0.0012 | 1.3527 | 158.9295 | 190 | 4209 | single-multicellular organism process |
GO:0001558 | 0.0012 | 2.1866 | 10.7699 | 22 | 272 | regulation of cell growth |
GO:0032095 | 0.0013 | 10.8589 | 0.5147 | 4 | 13 | regulation of response to food |
GO:0051240 | 0.0015 | 1.8217 | 19.8373 | 34 | 501 | positive regulation of multicellular organismal process |
GO:0043270 | 0.0016 | 2.813 | 5.0286 | 13 | 127 | positive regulation of ion transport |
GO:0043503 | 0.0016 | Inf | 0.0792 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0061041 | 0.0016 | 3.37 | 3.2864 | 10 | 83 | regulation of wound healing |
GO:0032879 | 0.0017 | 1.4583 | 63.2734 | 86 | 1598 | regulation of localization |
GO:0050927 | 0.0018 | 6.7955 | 0.9107 | 5 | 23 | positive regulation of positive chemotaxis |
GO:0009611 | 0.0018 | 1.6462 | 30.33 | 47 | 766 | response to wounding |
GO:0030335 | 0.0018 | 2.2525 | 9.0277 | 19 | 228 | positive regulation of cell migration |
GO:0007204 | 0.0018 | 2.5381 | 6.3749 | 15 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0051047 | 0.0018 | 2.3092 | 8.3546 | 18 | 211 | positive regulation of secretion |
GO:0040017 | 0.0019 | 2.1942 | 9.7405 | 20 | 246 | positive regulation of locomotion |
GO:0051051 | 0.002 | 2.0552 | 11.9182 | 23 | 301 | negative regulation of transport |
GO:0048878 | 0.002 | 1.6722 | 27.2812 | 43 | 689 | chemical homeostasis |
GO:0007218 | 0.0021 | 3.2361 | 3.4052 | 10 | 86 | neuropeptide signaling pathway |
GO:0044058 | 0.0022 | 6.4373 | 0.9503 | 5 | 24 | regulation of digestive system process |
GO:0002675 | 0.0023 | 8.8831 | 0.5939 | 4 | 15 | positive regulation of acute inflammatory response |
GO:0006590 | 0.0023 | 8.8831 | 0.5939 | 4 | 15 | thyroid hormone generation |
GO:0008584 | 0.0027 | 3.1125 | 3.524 | 10 | 89 | male gonad development |
GO:0006937 | 0.0028 | 2.7367 | 4.7514 | 12 | 120 | regulation of muscle contraction |
GO:0045137 | 0.0029 | 2.4046 | 6.6916 | 15 | 169 | development of primary sexual characteristics |
GO:0002579 | 0.003 | 14.6349 | 0.3168 | 3 | 8 | positive regulation of antigen processing and presentation |
GO:0035414 | 0.003 | 14.6349 | 0.3168 | 3 | 8 | negative regulation of catenin import into nucleus |
GO:0001942 | 0.003 | 3.2995 | 3.0092 | 9 | 76 | hair follicle development |
GO:0022404 | 0.003 | 3.2995 | 3.0092 | 9 | 76 | molting cycle process |
GO:0035813 | 0.003 | 8.1422 | 0.6335 | 4 | 16 | regulation of renal sodium excretion |
GO:0023052 | 0.0031 | 1.2978 | 173.6652 | 203 | 4386 | signaling |
GO:0032755 | 0.0031 | 5.8233 | 1.0295 | 5 | 26 | positive regulation of interleukin-6 production |
GO:0051272 | 0.0032 | 2.1281 | 9.5029 | 19 | 240 | positive regulation of cellular component movement |
GO:0055080 | 0.0033 | 1.8338 | 16.1549 | 28 | 408 | cation homeostasis |
GO:0022408 | 0.0035 | 4.5909 | 1.5046 | 6 | 38 | negative regulation of cell-cell adhesion |
GO:1902476 | 0.0036 | 3.5051 | 2.5341 | 8 | 64 | chloride transmembrane transport |
GO:0008217 | 0.0037 | 2.638 | 4.9098 | 12 | 124 | regulation of blood pressure |
GO:0010043 | 0.0037 | 5.5581 | 1.0691 | 5 | 27 | response to zinc ion |
GO:0032729 | 0.0037 | 5.5581 | 1.0691 | 5 | 27 | positive regulation of interferon-gamma production |
GO:0071622 | 0.0038 | 7.5152 | 0.6731 | 4 | 17 | regulation of granulocyte chemotaxis |
GO:0050896 | 0.0039 | 1.3042 | 179.609 | 207 | 4752 | response to stimulus |
GO:0030858 | 0.004 | 4.4514 | 1.5442 | 6 | 39 | positive regulation of epithelial cell differentiation |
GO:0045927 | 0.0042 | 2.4828 | 5.6225 | 13 | 142 | positive regulation of growth |
GO:2000145 | 0.0042 | 1.7618 | 17.9763 | 30 | 454 | regulation of cell motility |
GO:0015671 | 0.0043 | 12.1948 | 0.3564 | 3 | 9 | oxygen transport |
GO:2000484 | 0.0043 | 12.1948 | 0.3564 | 3 | 9 | positive regulation of interleukin-8 secretion |
GO:0048731 | 0.0045 | 1.3043 | 130.9418 | 157 | 3307 | system development |
GO:0001806 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | type IV hypersensitivity |
GO:0002830 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | positive regulation of type 2 immune response |
GO:0006651 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | diacylglycerol biosynthetic process |
GO:0007207 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0014717 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0030309 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0035589 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | G-protein coupled purinergic nucleotide receptor signaling pathway |
GO:0060729 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | intestinal epithelial structure maintenance |
GO:0072592 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | oxygen metabolic process |
GO:1900424 | 0.0046 | 48.7014 | 0.1188 | 2 | 3 | regulation of defense response to bacterium |
GO:2001257 | 0.0047 | 3.7292 | 2.0986 | 7 | 53 | regulation of cation channel activity |
GO:0033561 | 0.0048 | 6.9779 | 0.7127 | 4 | 18 | regulation of water loss via skin |
GO:0060740 | 0.0052 | 5.0941 | 1.1483 | 5 | 29 | prostate gland epithelium morphogenesis |
GO:2000243 | 0.0052 | 5.0941 | 1.1483 | 5 | 29 | positive regulation of reproductive process |
GO:0003012 | 0.0052 | 1.9877 | 10.6511 | 20 | 269 | muscle system process |
GO:0019233 | 0.0052 | 3.2703 | 2.6925 | 8 | 68 | sensory perception of pain |
GO:0030001 | 0.0054 | 1.6323 | 23.876 | 37 | 603 | metal ion transport |
GO:0032104 | 0.0058 | 4.0795 | 1.663 | 6 | 42 | regulation of response to extracellular stimulus |
GO:0033574 | 0.0059 | 6.5121 | 0.7523 | 4 | 19 | response to testosterone |
GO:1901700 | 0.0059 | 1.5284 | 33.1168 | 48 | 849 | response to oxygen-containing compound |
GO:0030238 | 0.006 | 10.4518 | 0.396 | 3 | 10 | male sex determination |
GO:0043084 | 0.006 | 10.4518 | 0.396 | 3 | 10 | penile erection |
GO:0070472 | 0.006 | 10.4518 | 0.396 | 3 | 10 | regulation of uterine smooth muscle contraction |
GO:0090280 | 0.006 | 10.4518 | 0.396 | 3 | 10 | positive regulation of calcium ion import |
GO:0050865 | 0.0062 | 1.8864 | 12.3074 | 22 | 312 | regulation of cell activation |
GO:0006874 | 0.0068 | 2.0119 | 9.4633 | 18 | 239 | cellular calcium ion homeostasis |
GO:0042633 | 0.0068 | 2.8686 | 3.4052 | 9 | 86 | hair cycle |
GO:0048608 | 0.0069 | 1.8138 | 13.9376 | 24 | 352 | reproductive structure development |
GO:0060326 | 0.0069 | 2.4198 | 5.3058 | 12 | 134 | cell chemotaxis |
GO:0060986 | 0.0069 | 4.7015 | 1.2275 | 5 | 31 | endocrine hormone secretion |
GO:0002064 | 0.0069 | 2.2397 | 6.652 | 14 | 168 | epithelial cell development |
GO:0032496 | 0.0069 | 2.2397 | 6.652 | 14 | 168 | response to lipopolysaccharide |
GO:0001829 | 0.0071 | 6.1046 | 0.7919 | 4 | 20 | trophectodermal cell differentiation |
GO:0032355 | 0.0074 | 2.8316 | 3.4448 | 9 | 87 | response to estradiol |
GO:0002696 | 0.0075 | 2.1497 | 7.4043 | 15 | 187 | positive regulation of leukocyte activation |
GO:0043207 | 0.0075 | 1.6995 | 17.9367 | 29 | 453 | response to external biotic stimulus |
GO:0071396 | 0.0076 | 1.9482 | 10.2948 | 19 | 260 | cellular response to lipid |
GO:0033555 | 0.0077 | 3.3622 | 2.2965 | 7 | 58 | multicellular organismal response to stress |
GO:0006954 | 0.0077 | 2.0295 | 8.8581 | 17 | 227 | inflammatory response |
GO:0007205 | 0.0079 | 4.527 | 1.2671 | 5 | 32 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0090102 | 0.0079 | 4.527 | 1.2671 | 5 | 32 | cochlea development |
GO:0055062 | 0.008 | 9.1446 | 0.4355 | 3 | 11 | phosphate ion homeostasis |
GO:0006873 | 0.0081 | 1.7858 | 14.1355 | 24 | 357 | cellular ion homeostasis |
GO:0010817 | 0.0084 | 1.7803 | 14.1751 | 24 | 358 | regulation of hormone levels |
GO:0048520 | 0.0087 | 2.9715 | 2.9301 | 8 | 74 | positive regulation of behavior |
GO:0050727 | 0.0089 | 2.1684 | 6.85 | 14 | 173 | regulation of inflammatory response |
GO:0007621 | 0.0089 | 24.3487 | 0.1584 | 2 | 4 | negative regulation of female receptivity |
GO:0015705 | 0.0089 | 24.3487 | 0.1584 | 2 | 4 | iodide transport |
GO:0060278 | 0.0089 | 24.3487 | 0.1584 | 2 | 4 | regulation of ovulation |
GO:0060688 | 0.0091 | 3.6703 | 1.8214 | 6 | 46 | regulation of morphogenesis of a branching structure |
GO:0008306 | 0.0092 | 3.2348 | 2.3757 | 7 | 60 | associative learning |
GO:0002685 | 0.0094 | 2.9269 | 2.9697 | 8 | 75 | regulation of leukocyte migration |
GO:0007605 | 0.0096 | 2.4133 | 4.8702 | 11 | 123 | sensory perception of sound |
GO:0055074 | 0.0099 | 8.2792 | 0.4669 | 3 | 12 | calcium ion homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007131 | 6e-04 | 6.7784 | 1.0788 | 6 | 30 | reciprocal meiotic recombination |
GO:0009071 | 9e-04 | 12.0118 | 0.4675 | 4 | 13 | serine family amino acid catabolic process |
GO:0045132 | 9e-04 | 7.9614 | 0.7911 | 5 | 22 | meiotic chromosome segregation |
GO:0043062 | 0.0011 | 2.1632 | 11.3633 | 23 | 316 | extracellular structure organization |
GO:0032501 | 0.0012 | 1.3456 | 180.1589 | 212 | 5010 | multicellular organismal process |
GO:0036309 | 0.0013 | Inf | 0.0719 | 2 | 2 | protein localization to M-band |
GO:0002675 | 0.0016 | 9.8262 | 0.5394 | 4 | 15 | positive regulation of acute inflammatory response |
GO:0030204 | 0.0019 | 4.4168 | 1.798 | 7 | 50 | chondroitin sulfate metabolic process |
GO:0007129 | 0.0025 | 6.1495 | 0.9709 | 5 | 27 | synapsis |
GO:0051321 | 0.0033 | 2.8244 | 4.2083 | 11 | 118 | meiotic cell cycle |
GO:0060263 | 0.0033 | 13.4867 | 0.3236 | 3 | 9 | regulation of respiratory burst |
GO:0098660 | 0.0034 | 1.7931 | 17.6922 | 30 | 492 | inorganic ion transmembrane transport |
GO:0007143 | 0.0034 | 7.7187 | 0.6473 | 4 | 18 | female meiotic division |
GO:0051180 | 0.0034 | 7.7187 | 0.6473 | 4 | 18 | vitamin transport |
GO:0022617 | 0.0036 | 2.957 | 3.6679 | 10 | 102 | extracellular matrix disassembly |
GO:0046642 | 0.0038 | 53.8499 | 0.1079 | 2 | 3 | negative regulation of alpha-beta T cell proliferation |
GO:0009566 | 0.0039 | 2.925 | 3.7039 | 10 | 103 | fertilization |
GO:0017121 | 0.0046 | 11.5591 | 0.3596 | 3 | 10 | phospholipid scrambling |
GO:0038083 | 0.0046 | 11.5591 | 0.3596 | 3 | 10 | peptidyl-tyrosine autophosphorylation |
GO:0001541 | 0.0046 | 4.2762 | 1.5822 | 6 | 44 | ovarian follicle development |
GO:0007292 | 0.0058 | 3.1925 | 2.7329 | 8 | 76 | female gamete generation |
GO:0007320 | 0.0061 | 10.1134 | 0.3956 | 3 | 11 | insemination |
GO:0007597 | 0.0061 | 10.1134 | 0.3956 | 3 | 11 | blood coagulation, intrinsic pathway |
GO:0030277 | 0.0061 | 10.1134 | 0.3956 | 3 | 11 | maintenance of gastrointestinal epithelium |
GO:0071805 | 0.0064 | 2.5582 | 4.6029 | 11 | 128 | potassium ion transmembrane transport |
GO:0007600 | 0.0065 | 1.7984 | 14.6357 | 25 | 407 | sensory perception |
GO:0061370 | 0.0074 | 26.9227 | 0.1438 | 2 | 4 | testosterone biosynthetic process |
GO:0051445 | 0.0078 | 4.5067 | 1.2586 | 5 | 35 | regulation of meiotic cell cycle |
GO:0061564 | 0.0079 | 1.6912 | 18.0159 | 29 | 501 | axon development |
GO:0021794 | 0.008 | 8.9889 | 0.4315 | 3 | 12 | thalamus development |
GO:0003008 | 0.0087 | 1.4408 | 42.4686 | 58 | 1181 | system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006355 | 0 | 2.8274 | 121.8511 | 238 | 2783 | regulation of transcription, DNA-templated |
GO:0051252 | 0 | 2.708 | 126.4046 | 239 | 2887 | regulation of RNA metabolic process |
GO:0045944 | 0 | 4.0292 | 32.9256 | 103 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0031326 | 0 | 2.5755 | 141.4226 | 253 | 3230 | regulation of cellular biosynthetic process |
GO:1901362 | 0 | 2.5398 | 147.421 | 259 | 3367 | organic cyclic compound biosynthetic process |
GO:0019438 | 0 | 2.5019 | 143.5242 | 252 | 3278 | aromatic compound biosynthetic process |
GO:0018130 | 0 | 2.4827 | 143.5242 | 251 | 3278 | heterocycle biosynthetic process |
GO:0010556 | 0 | 2.4988 | 136.0809 | 242 | 3108 | regulation of macromolecule biosynthetic process |
GO:0044271 | 0 | 2.4699 | 145.5821 | 253 | 3325 | cellular nitrogen compound biosynthetic process |
GO:1902680 | 0 | 3.1314 | 45.9295 | 115 | 1049 | positive regulation of RNA biosynthetic process |
GO:0007423 | 0 | 4.4974 | 19.265 | 69 | 440 | sensory organ development |
GO:0007389 | 0 | 6.4413 | 9.7541 | 48 | 232 | pattern specification process |
GO:0010628 | 0 | 3.0369 | 48.5128 | 118 | 1108 | positive regulation of gene expression |
GO:0032501 | 0 | 2.2112 | 219.3583 | 323 | 5010 | multicellular organismal process |
GO:0051171 | 0 | 2.2172 | 158.3232 | 255 | 3616 | regulation of nitrogen compound metabolic process |
GO:0009891 | 0 | 2.7749 | 55.2993 | 124 | 1263 | positive regulation of biosynthetic process |
GO:0045935 | 0 | 2.7939 | 52.4533 | 119 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0032502 | 0 | 2.2156 | 160.9246 | 253 | 3836 | developmental process |
GO:0035107 | 0 | 7.1664 | 6.086 | 33 | 139 | appendage morphogenesis |
GO:0045165 | 0 | 6.7141 | 6.3688 | 33 | 150 | cell fate commitment |
GO:0060173 | 0 | 6.1169 | 6.8741 | 33 | 157 | limb development |
GO:0000122 | 0 | 3.2111 | 24.3002 | 66 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0010629 | 0 | 2.6616 | 40.4127 | 91 | 923 | negative regulation of gene expression |
GO:0080090 | 0 | 1.9037 | 199.13 | 282 | 4548 | regulation of primary metabolic process |
GO:1902679 | 0 | 2.7474 | 36.0343 | 84 | 823 | negative regulation of RNA biosynthetic process |
GO:0090304 | 0 | 1.911 | 172.9033 | 253 | 3949 | nucleic acid metabolic process |
GO:0043009 | 0 | 5.4028 | 7.7973 | 34 | 186 | chordate embryonic development |
GO:0045934 | 0 | 2.5767 | 41.0257 | 90 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 0 | 2.4716 | 44.0468 | 93 | 1006 | negative regulation of biosynthetic process |
GO:0065007 | 0 | 1.9892 | 358.11 | 432 | 8179 | biological regulation |
GO:2000113 | 0 | 2.4799 | 39.7997 | 85 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:2000026 | 0 | 2.3444 | 45.5769 | 92 | 1060 | regulation of multicellular organismal development |
GO:0060562 | 0 | 4.9608 | 6.0761 | 25 | 143 | epithelial tube morphogenesis |
GO:0042472 | 0 | 6.3449 | 3.9844 | 20 | 91 | inner ear morphogenesis |
GO:0009952 | 0 | 5.3681 | 5.2348 | 23 | 122 | anterior/posterior pattern specification |
GO:0003151 | 0 | 10.8833 | 1.8678 | 14 | 43 | outflow tract morphogenesis |
GO:0072359 | 0 | 2.3891 | 32.7943 | 69 | 749 | circulatory system development |
GO:0035115 | 0 | 14.0765 | 1.3573 | 12 | 31 | embryonic forelimb morphogenesis |
GO:0009888 | 0 | 2.241 | 40.87 | 80 | 1021 | tissue development |
GO:0021517 | 0 | 10.0927 | 1.9703 | 14 | 45 | ventral spinal cord development |
GO:0032774 | 0 | 2.0933 | 53.2143 | 95 | 1443 | RNA biosynthetic process |
GO:0060485 | 0 | 4.3682 | 7.039 | 26 | 162 | mesenchyme development |
GO:0035148 | 0 | 4.8545 | 5.6919 | 23 | 130 | tube formation |
GO:0048665 | 0 | 25.1729 | 0.7384 | 9 | 17 | neuron fate specification |
GO:0034645 | 0 | 1.7771 | 113.5264 | 167 | 2843 | cellular macromolecule biosynthetic process |
GO:0061061 | 0 | 2.6909 | 20.1407 | 48 | 460 | muscle structure development |
GO:0009953 | 0 | 5.5742 | 4.1828 | 19 | 96 | dorsal/ventral pattern formation |
GO:0021515 | 0 | 10.3679 | 1.6507 | 12 | 38 | cell differentiation in spinal cord |
GO:0009887 | 0 | 3.0893 | 13.2009 | 36 | 343 | organ morphogenesis |
GO:0001501 | 0 | 3.432 | 9.9965 | 30 | 234 | skeletal system development |
GO:0060021 | 0 | 5.861 | 3.5903 | 17 | 82 | palate development |
GO:0001764 | 0 | 4.6341 | 5.3854 | 21 | 123 | neuron migration |
GO:0048598 | 0 | 4.7219 | 4.993 | 20 | 127 | embryonic morphogenesis |
GO:0048562 | 0 | 6.5206 | 2.871 | 15 | 71 | embryonic organ morphogenesis |
GO:0003215 | 0 | 22.1447 | 0.7005 | 8 | 16 | cardiac right ventricle morphogenesis |
GO:0045666 | 0 | 5.9673 | 3.3276 | 16 | 76 | positive regulation of neuron differentiation |
GO:0021953 | 0 | 5.3413 | 3.8483 | 17 | 91 | central nervous system neuron differentiation |
GO:0030878 | 0 | 19.6825 | 0.7443 | 8 | 17 | thyroid gland development |
GO:0009954 | 0 | 11.6873 | 1.2697 | 10 | 29 | proximal/distal pattern formation |
GO:0045665 | 0 | 7.4307 | 2.2768 | 13 | 52 | negative regulation of neuron differentiation |
GO:0003231 | 0 | 7.9504 | 1.9919 | 12 | 46 | cardiac ventricle development |
GO:0050767 | 0 | 2.7914 | 14.4443 | 36 | 335 | regulation of neurogenesis |
GO:0060541 | 0 | 3.5224 | 8.1055 | 25 | 186 | respiratory system development |
GO:0060041 | 0 | 4.4404 | 5.0352 | 19 | 115 | retina development in camera-type eye |
GO:0021871 | 0 | 22.2989 | 0.608 | 7 | 14 | forebrain regionalization |
GO:0048704 | 0 | 7.3634 | 2.1058 | 12 | 49 | embryonic skeletal system morphogenesis |
GO:0030901 | 0 | 9.6515 | 1.4449 | 10 | 33 | midbrain development |
GO:0045596 | 0 | 2.5367 | 17.5167 | 40 | 408 | negative regulation of cell differentiation |
GO:0001841 | 0 | 4.697 | 4.2908 | 17 | 98 | neural tube formation |
GO:0010092 | 0 | 10.4993 | 1.226 | 9 | 28 | specification of organ identity |
GO:0001947 | 0 | 6.6747 | 2.2768 | 12 | 52 | heart looping |
GO:0048518 | 0 | 1.5372 | 155.4335 | 205 | 3550 | positive regulation of biological process |
GO:0001655 | 0 | 2.7979 | 12.3471 | 31 | 282 | urogenital system development |
GO:0097154 | 0 | 26.4832 | 0.4816 | 6 | 11 | GABAergic neuron differentiation |
GO:0061326 | 0 | 7.1885 | 1.9703 | 11 | 45 | renal tubule development |
GO:0021796 | 0 | 55.0865 | 0.3065 | 5 | 7 | cerebral cortex regionalization |
GO:0050794 | 0 | 1.6453 | 157.3806 | 199 | 4284 | regulation of cellular process |
GO:0060538 | 0 | 3.6654 | 6.2317 | 20 | 143 | skeletal muscle organ development |
GO:0060914 | 0 | 15.4704 | 0.7443 | 7 | 17 | heart formation |
GO:0001944 | 0 | 2.2647 | 21.3666 | 44 | 488 | vasculature development |
GO:0007368 | 0 | 4.7145 | 3.7654 | 15 | 86 | determination of left/right symmetry |
GO:0031018 | 0 | 6.7881 | 2.0579 | 11 | 47 | endocrine pancreas development |
GO:0048701 | 0 | 9.1102 | 1.351 | 9 | 31 | embryonic cranial skeleton morphogenesis |
GO:0072210 | 0 | 7.6509 | 1.7076 | 10 | 39 | metanephric nephron development |
GO:0061458 | 0 | 2.4744 | 15.5871 | 35 | 356 | reproductive system development |
GO:0042733 | 0 | 5.6773 | 2.5833 | 12 | 59 | embryonic digit morphogenesis |
GO:0048935 | 0 | 18.9135 | 0.5692 | 6 | 13 | peripheral nervous system neuron development |
GO:0021895 | 0 | 12.8899 | 0.8319 | 7 | 19 | cerebral cortex neuron differentiation |
GO:0001843 | 0 | 4.6558 | 3.5465 | 14 | 81 | neural tube closure |
GO:0000904 | 0 | 1.9719 | 31.6121 | 57 | 722 | cell morphogenesis involved in differentiation |
GO:0048596 | 0 | 9.8339 | 1.1384 | 8 | 26 | embryonic camera-type eye morphogenesis |
GO:0072028 | 0 | 7.9755 | 1.4887 | 9 | 34 | nephron morphogenesis |
GO:0072163 | 0 | 4.2889 | 4.0719 | 15 | 93 | mesonephric epithelium development |
GO:0030902 | 0 | 3.9988 | 4.6083 | 16 | 106 | hindbrain development |
GO:0009799 | 0 | 4.2343 | 4.1157 | 15 | 94 | specification of symmetry |
GO:0021542 | 0 | 16.5479 | 0.613 | 6 | 14 | dentate gyrus development |
GO:0090009 | 0 | 27.5387 | 0.3941 | 5 | 9 | primitive streak formation |
GO:0009790 | 0 | 2.5826 | 12.3387 | 29 | 325 | embryo development |
GO:0030323 | 0 | 3.1501 | 7.4618 | 21 | 171 | respiratory tube development |
GO:0051891 | 0 | 87.9855 | 0.2189 | 4 | 5 | positive regulation of cardioblast differentiation |
GO:0072172 | 0 | 87.9855 | 0.2189 | 4 | 5 | mesonephric tubule formation |
GO:0001763 | 0 | 3.3611 | 6.3665 | 19 | 147 | morphogenesis of a branching structure |
GO:0048557 | 0 | 11.0466 | 0.9195 | 7 | 21 | embryonic digestive tract morphogenesis |
GO:0009725 | 0 | 1.9653 | 29.3791 | 53 | 671 | response to hormone |
GO:0007600 | 0 | 2.2687 | 17.8201 | 37 | 407 | sensory perception |
GO:0033993 | 0 | 2.0704 | 24.2126 | 46 | 553 | response to lipid |
GO:0035116 | 0 | 8.427 | 1.2697 | 8 | 29 | embryonic hindlimb morphogenesis |
GO:0060579 | 0 | 14.708 | 0.6568 | 6 | 15 | ventral spinal cord interneuron fate commitment |
GO:0016202 | 0 | 3.9806 | 4.3346 | 15 | 99 | regulation of striated muscle tissue development |
GO:0060349 | 0 | 4.5187 | 3.3714 | 13 | 77 | bone morphogenesis |
GO:0035051 | 0 | 3.9334 | 4.3784 | 15 | 100 | cardiocyte differentiation |
GO:0060536 | 0 | 22.0291 | 0.4378 | 5 | 10 | cartilage morphogenesis |
GO:0061217 | 0 | 9.6642 | 1.007 | 7 | 23 | regulation of mesonephros development |
GO:0014706 | 0 | 2.9532 | 7.8866 | 21 | 184 | striated muscle tissue development |
GO:0048793 | 1e-04 | 44.1496 | 0.2618 | 4 | 6 | pronephros development |
GO:0021797 | 1e-04 | 43.9891 | 0.2627 | 4 | 6 | forebrain anterior/posterior pattern specification |
GO:0003006 | 1e-04 | 2.0904 | 20.7654 | 40 | 477 | developmental process involved in reproduction |
GO:0055021 | 1e-04 | 7.3718 | 1.4011 | 8 | 32 | regulation of cardiac muscle tissue growth |
GO:0045686 | 1e-04 | 9.095 | 1.0508 | 7 | 24 | negative regulation of glial cell differentiation |
GO:0021983 | 1e-04 | 6.2272 | 1.7951 | 9 | 41 | pituitary gland development |
GO:0045995 | 1e-04 | 3.895 | 4.1157 | 14 | 94 | regulation of embryonic development |
GO:0060573 | 1e-04 | 18.3561 | 0.4816 | 5 | 11 | cell fate specification involved in pattern specification |
GO:0030326 | 1e-04 | 7.0511 | 1.4394 | 8 | 34 | embryonic limb morphogenesis |
GO:0035850 | 1e-04 | 7.0763 | 1.4449 | 8 | 33 | epithelial cell differentiation involved in kidney development |
GO:0048593 | 1e-04 | 5.2656 | 2.2744 | 10 | 53 | camera-type eye morphogenesis |
GO:0048638 | 1e-04 | 3.3971 | 5.2979 | 16 | 121 | regulation of developmental growth |
GO:0007507 | 1e-04 | 2.6563 | 9.4979 | 23 | 224 | heart development |
GO:0060045 | 1e-04 | 11.0283 | 0.7881 | 6 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:0003253 | 1e-04 | Inf | 0.1314 | 3 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0014707 | 1e-04 | Inf | 0.1314 | 3 | 3 | branchiomeric skeletal muscle development |
GO:0021524 | 1e-04 | Inf | 0.1314 | 3 | 3 | visceral motor neuron differentiation |
GO:0072069 | 1e-04 | Inf | 0.1314 | 3 | 3 | DCT cell differentiation |
GO:1900211 | 1e-04 | Inf | 0.1314 | 3 | 3 | regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:0007218 | 1e-04 | 3.9586 | 3.7654 | 13 | 86 | neuropeptide signaling pathway |
GO:0003206 | 1e-04 | 3.9089 | 3.801 | 13 | 88 | cardiac chamber morphogenesis |
GO:0001838 | 1e-04 | 10.4346 | 0.8127 | 6 | 19 | embryonic epithelial tube formation |
GO:0009798 | 1e-04 | 4.1634 | 3.3276 | 12 | 76 | axis specification |
GO:0046620 | 1e-04 | 4.5186 | 2.846 | 11 | 65 | regulation of organ growth |
GO:0002072 | 1e-04 | 29.3236 | 0.3065 | 4 | 7 | optic cup morphogenesis involved in camera-type eye development |
GO:0061303 | 1e-04 | 29.3236 | 0.3065 | 4 | 7 | cornea development in camera-type eye |
GO:2000543 | 1e-04 | 29.3236 | 0.3065 | 4 | 7 | positive regulation of gastrulation |
GO:0014033 | 1e-04 | 4.924 | 2.4081 | 10 | 55 | neural crest cell differentiation |
GO:0035050 | 1e-04 | 4.4521 | 2.88 | 11 | 66 | embryonic heart tube development |
GO:0021511 | 1e-04 | 7.7288 | 1.1822 | 7 | 27 | spinal cord patterning |
GO:2000736 | 1e-04 | 3.8014 | 3.8968 | 13 | 89 | regulation of stem cell differentiation |
GO:0007187 | 1e-04 | 3.183 | 5.6044 | 16 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0060413 | 2e-04 | 13.7648 | 0.5692 | 5 | 13 | atrial septum morphogenesis |
GO:0048485 | 2e-04 | 9.4513 | 0.8757 | 6 | 20 | sympathetic nervous system development |
GO:0072078 | 2e-04 | 9.4513 | 0.8757 | 6 | 20 | nephron tubule morphogenesis |
GO:0014031 | 2e-04 | 3.1545 | 5.6481 | 16 | 129 | mesenchymal cell development |
GO:0048644 | 2e-04 | 4.7137 | 2.4957 | 10 | 57 | muscle organ morphogenesis |
GO:0030154 | 2e-04 | 1.635 | 52.3901 | 78 | 1401 | cell differentiation |
GO:0007267 | 2e-04 | 1.837 | 28.757 | 49 | 670 | cell-cell signaling |
GO:0071495 | 2e-04 | 1.7368 | 36.6035 | 59 | 836 | cellular response to endogenous stimulus |
GO:0032989 | 2e-04 | 1.6513 | 46.4111 | 71 | 1060 | cellular component morphogenesis |
GO:0003229 | 2e-04 | 5.8945 | 1.6638 | 8 | 38 | ventricular cardiac muscle tissue development |
GO:0060425 | 2e-04 | 5.1254 | 2.0944 | 9 | 48 | lung morphogenesis |
GO:0003230 | 2e-04 | 7.025 | 1.2697 | 7 | 29 | cardiac atrium development |
GO:0003211 | 2e-04 | 22.0712 | 0.3491 | 4 | 8 | cardiac ventricle formation |
GO:0002118 | 2e-04 | 21.9909 | 0.3503 | 4 | 8 | aggressive behavior |
GO:0003264 | 2e-04 | 21.9909 | 0.3503 | 4 | 8 | regulation of cardioblast proliferation |
GO:0072009 | 2e-04 | 5.0196 | 2.1289 | 9 | 49 | nephron epithelium development |
GO:0003148 | 2e-04 | 12.2344 | 0.613 | 5 | 14 | outflow tract septum morphogenesis |
GO:0061323 | 2e-04 | 12.2344 | 0.613 | 5 | 14 | cell proliferation involved in heart morphogenesis |
GO:0050768 | 2e-04 | 3.5215 | 4.1595 | 13 | 95 | negative regulation of neurogenesis |
GO:0002065 | 2e-04 | 3.7507 | 3.6341 | 12 | 83 | columnar/cuboidal epithelial cell differentiation |
GO:0021545 | 3e-04 | 6.4714 | 1.3508 | 7 | 31 | cranial nerve development |
GO:0021772 | 3e-04 | 6.4385 | 1.3573 | 7 | 31 | olfactory bulb development |
GO:0003166 | 3e-04 | 65.8693 | 0.1751 | 3 | 4 | bundle of His development |
GO:0021913 | 3e-04 | 65.8693 | 0.1751 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0048880 | 3e-04 | 65.8693 | 0.1751 | 3 | 4 | sensory system development |
GO:0072039 | 3e-04 | 65.8693 | 0.1751 | 3 | 4 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
GO:1902455 | 3e-04 | 65.8693 | 0.1751 | 3 | 4 | negative regulation of stem cell maintenance |
GO:0014070 | 3e-04 | 1.8396 | 25.6575 | 44 | 586 | response to organic cyclic compound |
GO:0060419 | 3e-04 | 4.7406 | 2.233 | 9 | 51 | heart growth |
GO:0021527 | 3e-04 | 11.01 | 0.6568 | 5 | 15 | spinal cord association neuron differentiation |
GO:0071371 | 3e-04 | 11.01 | 0.6568 | 5 | 15 | cellular response to gonadotropin stimulus |
GO:0001657 | 3e-04 | 3.6169 | 3.7468 | 12 | 86 | ureteric bud development |
GO:0030900 | 4e-04 | 3.0311 | 5.4614 | 15 | 131 | forebrain development |
GO:0048664 | 4e-04 | 17.5913 | 0.3941 | 4 | 9 | neuron fate determination |
GO:0061004 | 4e-04 | 17.5913 | 0.3941 | 4 | 9 | pattern specification involved in kidney development |
GO:0014855 | 4e-04 | 5.1993 | 1.8389 | 8 | 42 | striated muscle cell proliferation |
GO:0007399 | 4e-04 | 1.6918 | 36.3446 | 57 | 956 | nervous system development |
GO:0048546 | 4e-04 | 6.0123 | 1.429 | 7 | 33 | digestive tract morphogenesis |
GO:0090190 | 5e-04 | 10.0083 | 0.7005 | 5 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0035295 | 5e-04 | 2.7169 | 6.8221 | 17 | 170 | tube development |
GO:0014013 | 5e-04 | 4.0254 | 2.846 | 10 | 65 | regulation of gliogenesis |
GO:0007626 | 5e-04 | 2.622 | 7.4871 | 18 | 171 | locomotory behavior |
GO:0048863 | 5e-04 | 5.7442 | 1.4754 | 7 | 35 | stem cell differentiation |
GO:0003281 | 6e-04 | 4.9096 | 1.9265 | 8 | 44 | ventricular septum development |
GO:0031128 | 6e-04 | 5.7217 | 1.4887 | 7 | 34 | developmental induction |
GO:0010453 | 6e-04 | 6.9612 | 1.0946 | 6 | 25 | regulation of cell fate commitment |
GO:2000826 | 6e-04 | 6.9612 | 1.0946 | 6 | 25 | regulation of heart morphogenesis |
GO:0002009 | 6e-04 | 3.5845 | 3.4405 | 11 | 84 | morphogenesis of an epithelium |
GO:0014898 | 6e-04 | 14.6582 | 0.4378 | 4 | 10 | cardiac muscle hypertrophy in response to stress |
GO:0071379 | 6e-04 | 14.6582 | 0.4378 | 4 | 10 | cellular response to prostaglandin stimulus |
GO:0010842 | 6e-04 | 9.1735 | 0.7443 | 5 | 17 | retina layer formation |
GO:0060231 | 6e-04 | 9.1735 | 0.7443 | 5 | 17 | mesenchymal to epithelial transition |
GO:0071875 | 6e-04 | 9.1735 | 0.7443 | 5 | 17 | adrenergic receptor signaling pathway |
GO:0072087 | 6e-04 | 9.1735 | 0.7443 | 5 | 17 | renal vesicle development |
GO:0021766 | 6e-04 | 5.5744 | 1.5175 | 7 | 35 | hippocampus development |
GO:0042471 | 7e-04 | 34.204 | 0.2112 | 3 | 5 | ear morphogenesis |
GO:0007369 | 8e-04 | 2.6951 | 6.4803 | 16 | 149 | gastrulation |
GO:0051145 | 8e-04 | 4.6505 | 2.0141 | 8 | 46 | smooth muscle cell differentiation |
GO:0060688 | 8e-04 | 4.6505 | 2.0141 | 8 | 46 | regulation of morphogenesis of a branching structure |
GO:0001826 | 8e-04 | 32.9319 | 0.2189 | 3 | 5 | inner cell mass cell differentiation |
GO:0060040 | 8e-04 | 32.9319 | 0.2189 | 3 | 5 | retinal bipolar neuron differentiation |
GO:0072162 | 8e-04 | 32.9319 | 0.2189 | 3 | 5 | metanephric mesenchymal cell differentiation |
GO:0072221 | 8e-04 | 32.9319 | 0.2189 | 3 | 5 | metanephric distal convoluted tubule development |
GO:0042476 | 8e-04 | 3.0689 | 4.6849 | 13 | 107 | odontogenesis |
GO:0021537 | 8e-04 | 4.1121 | 2.505 | 9 | 59 | telencephalon development |
GO:0003171 | 8e-04 | 8.4671 | 0.7881 | 5 | 18 | atrioventricular valve development |
GO:0072074 | 8e-04 | 8.4671 | 0.7881 | 5 | 18 | kidney mesenchyme development |
GO:0048699 | 9e-04 | 1.781 | 24.587 | 41 | 605 | generation of neurons |
GO:0001706 | 9e-04 | 12.666 | 0.4779 | 4 | 11 | endoderm formation |
GO:0021884 | 9e-04 | 6.2972 | 1.1822 | 6 | 27 | forebrain neuron development |
GO:0060479 | 9e-04 | 6.2972 | 1.1822 | 6 | 27 | lung cell differentiation |
GO:0003161 | 9e-04 | 12.5631 | 0.4816 | 4 | 11 | cardiac conduction system development |
GO:0061029 | 9e-04 | 12.5631 | 0.4816 | 4 | 11 | eyelid development in camera-type eye |
GO:0061140 | 9e-04 | 12.5631 | 0.4816 | 4 | 11 | lung secretory cell differentiation |
GO:0072176 | 9e-04 | 12.5631 | 0.4816 | 4 | 11 | nephric duct development |
GO:0007605 | 0.001 | 2.8519 | 5.3854 | 14 | 123 | sensory perception of sound |
GO:0001656 | 0.001 | 5.0688 | 1.6368 | 7 | 38 | metanephros development |
GO:0042474 | 0.0011 | 7.8617 | 0.8319 | 5 | 19 | middle ear morphogenesis |
GO:0046661 | 0.0011 | 2.9426 | 4.86 | 13 | 111 | male sex differentiation |
GO:0007193 | 0.0012 | 4.3091 | 2.1454 | 8 | 49 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0032835 | 0.0012 | 4.3091 | 2.1454 | 8 | 49 | glomerulus development |
GO:0001701 | 0.0012 | 2.1452 | 11.4897 | 23 | 265 | in utero embryonic development |
GO:0007422 | 0.0012 | 3.5119 | 3.1962 | 10 | 73 | peripheral nervous system development |
GO:0048754 | 0.0013 | 3.0384 | 4.3533 | 12 | 101 | branching morphogenesis of an epithelial tube |
GO:0048731 | 0.0013 | 1.7511 | 25.238 | 41 | 747 | system development |
GO:0001525 | 0.0013 | 1.9946 | 14.4487 | 27 | 330 | angiogenesis |
GO:0040007 | 0.0014 | 1.7014 | 27.5013 | 44 | 641 | growth |
GO:0045445 | 0.0014 | 4.2062 | 2.1892 | 8 | 50 | myoblast differentiation |
GO:0046541 | 0.0014 | 10.9918 | 0.5254 | 4 | 12 | saliva secretion |
GO:0072017 | 0.0014 | 10.9918 | 0.5254 | 4 | 12 | distal tubule development |
GO:1902742 | 0.0014 | 5.7487 | 1.2697 | 6 | 29 | apoptotic process involved in development |
GO:0051216 | 0.0014 | 2.626 | 6.2095 | 15 | 143 | cartilage development |
GO:0007420 | 0.0014 | 2.6209 | 6.2023 | 15 | 154 | brain development |
GO:0007617 | 0.0014 | 7.337 | 0.8757 | 5 | 20 | mating behavior |
GO:0010656 | 0.0014 | 7.337 | 0.8757 | 5 | 20 | negative regulation of muscle cell apoptotic process |
GO:0031290 | 0.0014 | 7.337 | 0.8757 | 5 | 20 | retinal ganglion cell axon guidance |
GO:0036342 | 0.0014 | 7.337 | 0.8757 | 5 | 20 | post-anal tail morphogenesis |
GO:0003025 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0014050 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | negative regulation of glutamate secretion |
GO:0035502 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | metanephric part of ureteric bud development |
GO:0061308 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | cardiac neural crest cell development involved in heart development |
GO:0072284 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | metanephric S-shaped body morphogenesis |
GO:1902338 | 0.0015 | 21.9528 | 0.2627 | 3 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:0007601 | 0.0015 | 2.5042 | 6.9179 | 16 | 158 | visual perception |
GO:0001709 | 0.0015 | 5.588 | 1.2959 | 6 | 30 | cell fate determination |
GO:0021510 | 0.0016 | 7.0827 | 0.8943 | 5 | 21 | spinal cord development |
GO:0060795 | 0.0017 | 5.5087 | 1.3135 | 6 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0007492 | 0.0017 | 6.9817 | 0.9065 | 5 | 21 | endoderm development |
GO:0008584 | 0.0017 | 3.122 | 3.8968 | 11 | 89 | male gonad development |
GO:0022603 | 0.0017 | 1.7122 | 25.4225 | 41 | 587 | regulation of anatomical structure morphogenesis |
GO:0048858 | 0.0017 | 1.6415 | 31.0429 | 48 | 709 | cell projection morphogenesis |
GO:0035914 | 0.0018 | 4.0143 | 2.2768 | 8 | 52 | skeletal muscle cell differentiation |
GO:1902476 | 0.0018 | 3.6162 | 2.8022 | 9 | 64 | chloride transmembrane transport |
GO:0072089 | 0.0018 | 3.6095 | 2.803 | 9 | 65 | stem cell proliferation |
GO:0023019 | 0.0018 | 6.8778 | 0.9195 | 5 | 21 | signal transduction involved in regulation of gene expression |
GO:0003207 | 0.0019 | Inf | 0.0867 | 2 | 2 | cardiac chamber formation |
GO:0007501 | 0.0019 | 9.7697 | 0.5692 | 4 | 13 | mesodermal cell fate specification |
GO:0060219 | 0.0019 | 9.7697 | 0.5692 | 4 | 13 | camera-type eye photoreceptor cell differentiation |
GO:0072283 | 0.0019 | 9.7697 | 0.5692 | 4 | 13 | metanephric renal vesicle morphogenesis |
GO:2000380 | 0.0019 | 9.7697 | 0.5692 | 4 | 13 | regulation of mesoderm development |
GO:0001983 | 0.0019 | Inf | 0.0876 | 2 | 2 | baroreceptor response to increased systemic arterial blood pressure |
GO:0001994 | 0.0019 | Inf | 0.0876 | 2 | 2 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0003218 | 0.0019 | Inf | 0.0876 | 2 | 2 | cardiac left ventricle formation |
GO:0003326 | 0.0019 | Inf | 0.0876 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0019 | Inf | 0.0876 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0007493 | 0.0019 | Inf | 0.0876 | 2 | 2 | endodermal cell fate determination |
GO:0007521 | 0.0019 | Inf | 0.0876 | 2 | 2 | muscle cell fate determination |
GO:0021893 | 0.0019 | Inf | 0.0876 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0032912 | 0.0019 | Inf | 0.0876 | 2 | 2 | negative regulation of transforming growth factor beta2 production |
GO:0033595 | 0.0019 | Inf | 0.0876 | 2 | 2 | response to genistein |
GO:0039003 | 0.0019 | Inf | 0.0876 | 2 | 2 | pronephric field specification |
GO:0060014 | 0.0019 | Inf | 0.0876 | 2 | 2 | granulosa cell differentiation |
GO:0060460 | 0.0019 | Inf | 0.0876 | 2 | 2 | left lung morphogenesis |
GO:0060465 | 0.0019 | Inf | 0.0876 | 2 | 2 | pharynx development |
GO:0060577 | 0.0019 | Inf | 0.0876 | 2 | 2 | pulmonary vein morphogenesis |
GO:0060932 | 0.0019 | Inf | 0.0876 | 2 | 2 | His-Purkinje system cell differentiation |
GO:0061017 | 0.0019 | Inf | 0.0876 | 2 | 2 | hepatoblast differentiation |
GO:0061032 | 0.0019 | Inf | 0.0876 | 2 | 2 | visceral serous pericardium development |
GO:0061379 | 0.0019 | Inf | 0.0876 | 2 | 2 | inferior colliculus development |
GO:0072139 | 0.0019 | Inf | 0.0876 | 2 | 2 | glomerular parietal epithelial cell differentiation |
GO:0072166 | 0.0019 | Inf | 0.0876 | 2 | 2 | posterior mesonephric tubule development |
GO:0072305 | 0.0019 | Inf | 0.0876 | 2 | 2 | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis |
GO:1900215 | 0.0019 | Inf | 0.0876 | 2 | 2 | negative regulation of apoptotic process involved in metanephric collecting duct development |
GO:1900218 | 0.0019 | Inf | 0.0876 | 2 | 2 | negative regulation of apoptotic process involved in metanephric nephron tubule development |
GO:2000594 | 0.0019 | Inf | 0.0876 | 2 | 2 | positive regulation of metanephric DCT cell differentiation |
GO:2000768 | 0.0019 | Inf | 0.0876 | 2 | 2 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0030219 | 0.002 | 5.2879 | 1.3573 | 6 | 31 | megakaryocyte differentiation |
GO:2000648 | 0.002 | 4.4379 | 1.8284 | 7 | 42 | positive regulation of stem cell proliferation |
GO:0021761 | 0.0021 | 6.61 | 0.9443 | 5 | 22 | limbic system development |
GO:0007166 | 0.0021 | 1.3597 | 102.3234 | 129 | 2337 | cell surface receptor signaling pathway |
GO:0002089 | 0.0022 | 6.4727 | 0.9632 | 5 | 22 | lens morphogenesis in camera-type eye |
GO:0035883 | 0.0022 | 6.4727 | 0.9632 | 5 | 22 | enteroendocrine cell differentiation |
GO:0042755 | 0.0022 | 6.4727 | 0.9632 | 5 | 22 | eating behavior |
GO:0007270 | 0.0023 | 2.6931 | 5.2541 | 13 | 120 | neuron-neuron synaptic transmission |
GO:0034284 | 0.0023 | 2.6931 | 5.2541 | 13 | 120 | response to monosaccharide |
GO:0050679 | 0.0023 | 2.6931 | 5.2541 | 13 | 120 | positive regulation of epithelial cell proliferation |
GO:0008284 | 0.0023 | 1.8277 | 17.9983 | 31 | 429 | positive regulation of cell proliferation |
GO:0035265 | 0.0024 | 8.9232 | 0.6044 | 4 | 14 | organ growth |
GO:0007156 | 0.0024 | 2.668 | 5.2979 | 13 | 121 | homophilic cell adhesion |
GO:0042127 | 0.0025 | 2.9468 | 4.0804 | 11 | 102 | regulation of cell proliferation |
GO:0009058 | 0.0025 | 1.3765 | 103.0046 | 128 | 2824 | biosynthetic process |
GO:0060284 | 0.0025 | 2.7829 | 4.693 | 12 | 114 | regulation of cell development |
GO:0021877 | 0.0025 | 16.5219 | 0.3055 | 3 | 7 | forebrain neuron fate commitment |
GO:0015837 | 0.0025 | 3.7572 | 2.4081 | 8 | 55 | amine transport |
GO:0003357 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | noradrenergic neuron differentiation |
GO:0021798 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0021957 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | corticospinal tract morphogenesis |
GO:0033504 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | floor plate development |
GO:0046549 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | retinal cone cell development |
GO:0060677 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | ureteric bud elongation |
GO:0060923 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | cardiac muscle cell fate commitment |
GO:0061072 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | iris morphogenesis |
GO:2001012 | 0.0026 | 16.4632 | 0.3065 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
GO:0007350 | 0.0026 | 8.792 | 0.613 | 4 | 14 | blastoderm segmentation |
GO:0007512 | 0.0026 | 8.792 | 0.613 | 4 | 14 | adult heart development |
GO:0008595 | 0.0026 | 8.792 | 0.613 | 4 | 14 | anterior/posterior axis specification, embryo |
GO:0071542 | 0.0026 | 8.792 | 0.613 | 4 | 14 | dopaminergic neuron differentiation |
GO:0072189 | 0.0026 | 8.792 | 0.613 | 4 | 14 | ureter development |
GO:0007409 | 0.0026 | 1.7746 | 19.7019 | 33 | 453 | axonogenesis |
GO:0007498 | 0.0026 | 4.9612 | 1.4268 | 6 | 33 | mesoderm development |
GO:0003279 | 0.0026 | 6.1845 | 0.996 | 5 | 23 | cardiac septum development |
GO:0031960 | 0.0027 | 2.7682 | 4.7287 | 12 | 108 | response to corticosteroid |
GO:0048332 | 0.0027 | 3.3699 | 2.9773 | 9 | 68 | mesoderm morphogenesis |
GO:0048709 | 0.0027 | 3.3699 | 2.9773 | 9 | 68 | oligodendrocyte differentiation |
GO:0051101 | 0.0027 | 3.3699 | 2.9773 | 9 | 68 | regulation of DNA binding |
GO:0003015 | 0.0029 | 2.5037 | 6.0422 | 14 | 138 | heart process |
GO:0007275 | 0.003 | 2.154 | 9.4532 | 19 | 297 | multicellular organismal development |
GO:0061515 | 0.0032 | 4.0617 | 1.9703 | 7 | 45 | myeloid cell development |
GO:0021879 | 0.0032 | 8.1383 | 0.6456 | 4 | 15 | forebrain neuron differentiation |
GO:0001570 | 0.0033 | 3.2589 | 3.0649 | 9 | 70 | vasculogenesis |
GO:0003179 | 0.0034 | 5.7904 | 1.0508 | 5 | 24 | heart valve morphogenesis |
GO:0046660 | 0.0034 | 2.8297 | 4.2471 | 11 | 97 | female sex differentiation |
GO:0051955 | 0.0034 | 7.9921 | 0.6568 | 4 | 15 | regulation of amino acid transport |
GO:0072498 | 0.0034 | 7.9921 | 0.6568 | 4 | 15 | embryonic skeletal joint development |
GO:0048864 | 0.0034 | 2.8221 | 4.2528 | 11 | 99 | stem cell development |
GO:0001503 | 0.0036 | 1.9255 | 13.2228 | 24 | 302 | ossification |
GO:0033555 | 0.0036 | 3.5308 | 2.5395 | 8 | 58 | multicellular organismal response to stress |
GO:0055008 | 0.0036 | 3.9572 | 2.0141 | 7 | 46 | cardiac muscle tissue morphogenesis |
GO:0043010 | 0.0036 | 3.2021 | 3.1024 | 9 | 74 | camera-type eye development |
GO:0031175 | 0.0037 | 1.5788 | 31.437 | 47 | 718 | neuron projection development |
GO:0007417 | 0.0037 | 2.9608 | 3.6809 | 10 | 95 | central nervous system development |
GO:0097485 | 0.0037 | 1.8665 | 14.7552 | 26 | 337 | neuron projection guidance |
GO:0035137 | 0.0038 | 13.3403 | 0.346 | 3 | 8 | hindlimb morphogenesis |
GO:2000177 | 0.0038 | 5.5778 | 1.0802 | 5 | 25 | regulation of neural precursor cell proliferation |
GO:0001993 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0003139 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | secondary heart field specification |
GO:0010667 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | negative regulation of cardiac muscle cell apoptotic process |
GO:0021559 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | trigeminal nerve development |
GO:0032229 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | negative regulation of synaptic transmission, GABAergic |
GO:2000679 | 0.004 | 13.1695 | 0.3503 | 3 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0001662 | 0.0041 | 5.5005 | 1.0946 | 5 | 25 | behavioral fear response |
GO:0008045 | 0.0041 | 5.5005 | 1.0946 | 5 | 25 | motor neuron axon guidance |
GO:0014888 | 0.0041 | 5.5005 | 1.0946 | 5 | 25 | striated muscle adaptation |
GO:0021533 | 0.0041 | 5.5005 | 1.0946 | 5 | 25 | cell differentiation in hindbrain |
GO:0048645 | 0.0041 | 7.4746 | 0.6873 | 4 | 16 | organ formation |
GO:0071383 | 0.0043 | 2.7337 | 4.3784 | 11 | 100 | cellular response to steroid hormone stimulus |
GO:0048514 | 0.0044 | 4.3906 | 1.5756 | 6 | 37 | blood vessel morphogenesis |
GO:0001756 | 0.0044 | 3.3945 | 2.627 | 8 | 60 | somitogenesis |
GO:0001824 | 0.0044 | 3.3945 | 2.627 | 8 | 60 | blastocyst development |
GO:0060048 | 0.0044 | 3.3945 | 2.627 | 8 | 60 | cardiac muscle contraction |
GO:0015698 | 0.0046 | 2.7031 | 4.4222 | 11 | 101 | inorganic anion transport |
GO:0044057 | 0.0049 | 1.8461 | 14.3174 | 25 | 327 | regulation of system process |
GO:0040011 | 0.005 | 1.4263 | 53.3728 | 72 | 1219 | locomotion |
GO:0023061 | 0.0051 | 1.8398 | 14.3612 | 25 | 328 | signal release |
GO:0048565 | 0.0051 | 3.2944 | 2.6906 | 8 | 63 | digestive tract development |
GO:0022029 | 0.0052 | 3.6737 | 2.1454 | 7 | 49 | telencephalon cell migration |
GO:0048523 | 0.0054 | 1.3533 | 82.382 | 104 | 2031 | negative regulation of cellular process |
GO:0030855 | 0.0055 | 1.8531 | 13.6832 | 24 | 323 | epithelial cell differentiation |
GO:0003203 | 0.0055 | 6.7614 | 0.7443 | 4 | 17 | endocardial cushion morphogenesis |
GO:0071310 | 0.0055 | 1.3839 | 65.0631 | 85 | 1486 | cellular response to organic substance |
GO:0001997 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
GO:0002074 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | extraocular skeletal muscle development |
GO:0003285 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | septum secundum development |
GO:0003350 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | pulmonary myocardium development |
GO:0021882 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021902 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035054 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0035564 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | regulation of kidney size |
GO:0035726 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0036023 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0060166 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | olfactory pit development |
GO:0060435 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | bronchiole development |
GO:0061010 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | gall bladder development |
GO:0072003 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | kidney rudiment formation |
GO:0072180 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | mesonephric duct morphogenesis |
GO:0072513 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
GO:0097211 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:2000035 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | regulation of stem cell division |
GO:2000041 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2000111 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | positive regulation of macrophage apoptotic process |
GO:2000729 | 0.0056 | 43.8333 | 0.1314 | 2 | 3 | positive regulation of mesenchymal cell proliferation involved in ureter development |
GO:0030818 | 0.0057 | 4.9996 | 1.1822 | 5 | 27 | negative regulation of cAMP biosynthetic process |
GO:0032729 | 0.0057 | 4.9996 | 1.1822 | 5 | 27 | positive regulation of interferon-gamma production |
GO:0072207 | 0.0057 | 4.9996 | 1.1822 | 5 | 27 | metanephric epithelium development |
GO:0060428 | 0.0057 | 4.1288 | 1.6638 | 6 | 38 | lung epithelium development |
GO:0009996 | 0.0058 | 10.9737 | 0.3941 | 3 | 9 | negative regulation of cell fate specification |
GO:0060539 | 0.0058 | 10.9737 | 0.3941 | 3 | 9 | diaphragm development |
GO:0060592 | 0.0058 | 10.9737 | 0.3941 | 3 | 9 | mammary gland formation |
GO:0072239 | 0.0058 | 10.9737 | 0.3941 | 3 | 9 | metanephric glomerulus vasculature development |
GO:2001054 | 0.0058 | 10.9737 | 0.3941 | 3 | 9 | negative regulation of mesenchymal cell apoptotic process |
GO:0015833 | 0.0058 | 2.0501 | 9.326 | 18 | 213 | peptide transport |
GO:0042493 | 0.006 | 1.8375 | 13.792 | 24 | 315 | response to drug |
GO:0030111 | 0.006 | 3.553 | 2.2053 | 7 | 51 | regulation of Wnt signaling pathway |
GO:0050877 | 0.006 | 1.8628 | 13.0453 | 23 | 309 | neurological system process |
GO:0030509 | 0.0062 | 2.5872 | 4.5973 | 11 | 105 | BMP signaling pathway |
GO:0001658 | 0.0063 | 4.0365 | 1.6943 | 6 | 39 | branching involved in ureteric bud morphogenesis |
GO:0021549 | 0.0063 | 2.9217 | 3.3714 | 9 | 77 | cerebellum development |
GO:0009880 | 0.0063 | 4.0294 | 1.6971 | 6 | 39 | embryonic pattern specification |
GO:0030858 | 0.0065 | 4.0033 | 1.7076 | 6 | 39 | positive regulation of epithelial cell differentiation |
GO:0051966 | 0.0065 | 4.0033 | 1.7076 | 6 | 39 | regulation of synaptic transmission, glutamatergic |
GO:2000179 | 0.0067 | 6.3161 | 0.7836 | 4 | 18 | positive regulation of neural precursor cell proliferation |
GO:0030879 | 0.0067 | 2.4354 | 5.2979 | 12 | 121 | mammary gland development |
GO:0019098 | 0.0067 | 4.7818 | 1.226 | 5 | 28 | reproductive behavior |
GO:0007263 | 0.0068 | 6.2779 | 0.7881 | 4 | 18 | nitric oxide mediated signal transduction |
GO:0051412 | 0.0068 | 6.2779 | 0.7881 | 4 | 18 | response to corticosterone |
GO:0045597 | 0.0069 | 1.711 | 17.8357 | 29 | 422 | positive regulation of cell differentiation |
GO:0008285 | 0.007 | 1.6359 | 21.8483 | 34 | 499 | negative regulation of cell proliferation |
GO:0055074 | 0.0072 | 1.9242 | 10.9898 | 20 | 251 | calcium ion homeostasis |
GO:0035987 | 0.0074 | 3.8853 | 1.7514 | 6 | 40 | endodermal cell differentiation |
GO:0048806 | 0.0074 | 3.8853 | 1.7514 | 6 | 40 | genitalia development |
GO:0021543 | 0.0077 | 3.0538 | 2.8758 | 8 | 67 | pallium development |
GO:0008406 | 0.0078 | 5.969 | 0.8174 | 4 | 19 | gonad development |
GO:0006775 | 0.0078 | 4.5822 | 1.2697 | 5 | 29 | fat-soluble vitamin metabolic process |
GO:0048742 | 0.0078 | 4.5822 | 1.2697 | 5 | 29 | regulation of skeletal muscle fiber development |
GO:0072182 | 0.0079 | 9.4395 | 0.4363 | 3 | 10 | regulation of nephron tubule epithelial cell differentiation |
GO:0021520 | 0.0079 | 9.4387 | 0.4364 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0021936 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0030002 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | cellular anion homeostasis |
GO:0032354 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | response to follicle-stimulating hormone |
GO:0033147 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | negative regulation of intracellular estrogen receptor signaling pathway |
GO:0043249 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | erythrocyte maturation |
GO:0048505 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | regulation of timing of cell differentiation |
GO:0048643 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | positive regulation of skeletal muscle tissue development |
GO:0048703 | 0.008 | 9.4052 | 0.4378 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0046887 | 0.0081 | 2.7976 | 3.5027 | 9 | 80 | positive regulation of hormone secretion |
GO:0008015 | 0.0081 | 1.7871 | 14.1423 | 24 | 323 | blood circulation |
GO:0002052 | 0.0083 | 5.8589 | 0.8319 | 4 | 19 | positive regulation of neuroblast proliferation |
GO:0007530 | 0.0083 | 5.8589 | 0.8319 | 4 | 19 | sex determination |
GO:0048286 | 0.0084 | 3.7739 | 1.7951 | 6 | 41 | lung alveolus development |
GO:0098656 | 0.0084 | 2.2652 | 6.1298 | 13 | 140 | anion transmembrane transport |
GO:0009914 | 0.0085 | 1.9265 | 10.4206 | 19 | 238 | hormone transport |
GO:0009968 | 0.0088 | 1.4882 | 33.8451 | 48 | 773 | negative regulation of signal transduction |
GO:0003401 | 0.0091 | 4.3985 | 1.3135 | 5 | 30 | axis elongation |
GO:0021955 | 0.0091 | 4.3985 | 1.3135 | 5 | 30 | central nervous system neuron axonogenesis |
GO:0030501 | 0.0091 | 4.3985 | 1.3135 | 5 | 30 | positive regulation of bone mineralization |
GO:0030809 | 0.0091 | 4.3985 | 1.3135 | 5 | 30 | negative regulation of nucleotide biosynthetic process |
GO:0048333 | 0.0091 | 4.3985 | 1.3135 | 5 | 30 | mesodermal cell differentiation |
GO:0042221 | 0.0093 | 1.2939 | 102.194 | 124 | 2379 | response to chemical |
GO:0060324 | 0.0094 | 3.6688 | 1.8389 | 6 | 42 | face development |
GO:0060828 | 0.0094 | 2.2297 | 6.2173 | 13 | 142 | regulation of canonical Wnt signaling pathway |
GO:0008585 | 0.0095 | 2.7205 | 3.5903 | 9 | 82 | female gonad development |
GO:0009749 | 0.0099 | 2.4065 | 4.9038 | 11 | 112 | response to glucose |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.6929 | 216.1906 | 284 | 5010 | multicellular organismal process |
GO:0007156 | 0 | 5.0925 | 5.2214 | 22 | 121 | homophilic cell adhesion |
GO:0007155 | 0 | 2.1299 | 38.4483 | 73 | 891 | cell adhesion |
GO:0007389 | 0 | 2.5172 | 17.1744 | 39 | 398 | pattern specification process |
GO:0045165 | 0 | 3.113 | 9.7523 | 27 | 226 | cell fate commitment |
GO:0050865 | 0 | 4.0447 | 5.1376 | 18 | 121 | regulation of cell activation |
GO:0032502 | 0 | 1.4889 | 186.9337 | 236 | 4332 | developmental process |
GO:2000026 | 0 | 1.7913 | 49.7972 | 81 | 1154 | regulation of multicellular organismal development |
GO:0050776 | 0 | 2.0807 | 25.2007 | 48 | 584 | regulation of immune response |
GO:0051954 | 0 | 12.0819 | 0.863 | 7 | 20 | positive regulation of amine transport |
GO:0060406 | 0 | 89.3432 | 0.2158 | 4 | 5 | positive regulation of penile erection |
GO:0051048 | 0 | 3.6733 | 5.2645 | 17 | 122 | negative regulation of secretion |
GO:0009952 | 0 | 2.9837 | 8.1988 | 22 | 190 | anterior/posterior pattern specification |
GO:0002697 | 0 | 2.9658 | 8.242 | 22 | 191 | regulation of immune effector process |
GO:0002695 | 0 | 4.1659 | 3.8837 | 14 | 90 | negative regulation of leukocyte activation |
GO:0048598 | 0 | 2.3293 | 15.4664 | 33 | 364 | embryonic morphogenesis |
GO:0021537 | 0 | 2.968 | 7.8536 | 21 | 182 | telencephalon development |
GO:0009887 | 0 | 1.9065 | 30.183 | 53 | 707 | organ morphogenesis |
GO:0002684 | 1e-04 | 2.0497 | 22.2232 | 42 | 515 | positive regulation of immune system process |
GO:0051970 | 1e-04 | Inf | 0.1295 | 3 | 3 | negative regulation of transmission of nerve impulse |
GO:0007620 | 1e-04 | 10.3368 | 0.8199 | 6 | 19 | copulation |
GO:0065007 | 2e-04 | 1.4121 | 352.9387 | 392 | 8179 | biological regulation |
GO:0007423 | 2e-04 | 2.0448 | 18.9868 | 36 | 440 | sensory organ development |
GO:0003013 | 2e-04 | 2.2382 | 14.0243 | 29 | 325 | circulatory system process |
GO:0050670 | 2e-04 | 3.2289 | 5.1782 | 15 | 120 | regulation of lymphocyte proliferation |
GO:0007204 | 2e-04 | 2.8522 | 6.9474 | 18 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0072507 | 2e-04 | 2.3428 | 11.5647 | 25 | 268 | divalent inorganic cation homeostasis |
GO:0033993 | 3e-04 | 1.8911 | 23.863 | 42 | 553 | response to lipid |
GO:0042755 | 3e-04 | 8.3965 | 0.9493 | 6 | 22 | eating behavior |
GO:0006874 | 3e-04 | 2.421 | 10.3133 | 23 | 239 | cellular calcium ion homeostasis |
GO:0043207 | 3e-04 | 1.9788 | 19.5478 | 36 | 453 | response to external biotic stimulus |
GO:0002125 | 3e-04 | 66.884 | 0.1726 | 3 | 4 | maternal aggressive behavior |
GO:0060020 | 3e-04 | 66.884 | 0.1726 | 3 | 4 | Bergmann glial cell differentiation |
GO:0060457 | 4e-04 | 17.8627 | 0.3884 | 4 | 9 | negative regulation of digestive system process |
GO:0048568 | 4e-04 | 2.126 | 14.6802 | 29 | 343 | embryonic organ development |
GO:0048729 | 4e-04 | 1.9275 | 20.5834 | 37 | 477 | tissue morphogenesis |
GO:0045596 | 4e-04 | 1.945 | 19.8498 | 36 | 460 | negative regulation of cell differentiation |
GO:0051155 | 4e-04 | 7.4623 | 1.0356 | 6 | 24 | positive regulation of striated muscle cell differentiation |
GO:0050863 | 5e-04 | 2.5621 | 8.0694 | 19 | 187 | regulation of T cell activation |
GO:0007498 | 5e-04 | 3.4447 | 3.9021 | 12 | 91 | mesoderm development |
GO:0032946 | 5e-04 | 3.6402 | 3.409 | 11 | 79 | positive regulation of mononuclear cell proliferation |
GO:0043010 | 6e-04 | 2.281 | 10.8743 | 23 | 252 | camera-type eye development |
GO:0019800 | 7e-04 | 33.4392 | 0.2158 | 3 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0042713 | 7e-04 | 33.4392 | 0.2158 | 3 | 5 | sperm ejaculation |
GO:0060023 | 7e-04 | 33.4392 | 0.2158 | 3 | 5 | soft palate development |
GO:0044062 | 8e-04 | 8.598 | 0.7767 | 5 | 18 | regulation of excretion |
GO:0061053 | 8e-04 | 3.746 | 3.0206 | 10 | 70 | somite development |
GO:0030890 | 9e-04 | 6.3947 | 1.1651 | 6 | 27 | positive regulation of B cell proliferation |
GO:0042711 | 9e-04 | 12.757 | 0.4747 | 4 | 11 | maternal behavior |
GO:1902358 | 9e-04 | 12.757 | 0.4747 | 4 | 11 | sulfate transmembrane transport |
GO:0051216 | 9e-04 | 2.6377 | 6.6022 | 16 | 153 | cartilage development |
GO:0019098 | 0.0011 | 6.1035 | 1.2083 | 6 | 28 | reproductive behavior |
GO:0030803 | 0.0011 | 6.1035 | 1.2083 | 6 | 28 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0008217 | 0.0012 | 3.8521 | 2.6492 | 9 | 62 | regulation of blood pressure |
GO:0007617 | 0.0013 | 7.4504 | 0.863 | 5 | 20 | mating behavior |
GO:0048645 | 0.0014 | 4.1719 | 2.2007 | 8 | 51 | organ formation |
GO:0007399 | 0.0015 | 1.425 | 75.3431 | 100 | 1746 | nervous system development |
GO:1900372 | 0.0015 | 5.594 | 1.2946 | 6 | 30 | negative regulation of purine nucleotide biosynthetic process |
GO:0018958 | 0.0016 | 7.0632 | 0.8966 | 5 | 21 | phenol-containing compound metabolic process |
GO:0007200 | 0.0016 | 4.0767 | 2.2439 | 8 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0048534 | 0.0017 | 1.7092 | 25.4596 | 41 | 590 | hematopoietic or lymphoid organ development |
GO:2000380 | 0.0018 | 9.9205 | 0.561 | 4 | 13 | regulation of mesoderm development |
GO:0001707 | 0.0018 | 3.6066 | 2.8049 | 9 | 65 | mesoderm formation |
GO:0030815 | 0.0018 | 5.3698 | 1.3377 | 6 | 31 | negative regulation of cAMP metabolic process |
GO:0010701 | 0.0019 | Inf | 0.0863 | 2 | 2 | positive regulation of norepinephrine secretion |
GO:0010901 | 0.0019 | Inf | 0.0863 | 2 | 2 | regulation of very-low-density lipoprotein particle remodeling |
GO:0048697 | 0.0019 | Inf | 0.0863 | 2 | 2 | positive regulation of collateral sprouting in absence of injury |
GO:0060014 | 0.0019 | Inf | 0.0863 | 2 | 2 | granulosa cell differentiation |
GO:0050767 | 0.0019 | 1.9706 | 14.0498 | 26 | 330 | regulation of neurogenesis |
GO:0002521 | 0.0019 | 1.9678 | 14.0675 | 26 | 326 | leukocyte differentiation |
GO:0007586 | 0.002 | 3.0526 | 3.97 | 11 | 92 | digestion |
GO:0048869 | 0.002 | 1.352 | 113.4308 | 141 | 2716 | cellular developmental process |
GO:0032101 | 0.0021 | 1.8033 | 19.4183 | 33 | 450 | regulation of response to external stimulus |
GO:0050900 | 0.0021 | 2.1752 | 9.8386 | 20 | 228 | leukocyte migration |
GO:0003014 | 0.0022 | 3.4817 | 2.8912 | 9 | 67 | renal system process |
GO:0050864 | 0.0022 | 3.4817 | 2.8912 | 9 | 67 | regulation of B cell activation |
GO:0006954 | 0.0023 | 1.8443 | 17.2607 | 30 | 400 | inflammatory response |
GO:0021542 | 0.0024 | 8.9277 | 0.6041 | 4 | 14 | dentate gyrus development |
GO:0045924 | 0.0025 | 16.7169 | 0.3021 | 3 | 7 | regulation of female receptivity |
GO:0051001 | 0.0025 | 16.7169 | 0.3021 | 3 | 7 | negative regulation of nitric-oxide synthase activity |
GO:0009617 | 0.0025 | 2.0934 | 10.7017 | 21 | 248 | response to bacterium |
GO:0042471 | 0.0026 | 2.7823 | 4.7035 | 12 | 109 | ear morphogenesis |
GO:0050710 | 0.0026 | 6.2071 | 0.9925 | 5 | 23 | negative regulation of cytokine secretion |
GO:0002253 | 0.0026 | 1.9484 | 13.636 | 25 | 316 | activation of immune response |
GO:0045089 | 0.0026 | 2.3587 | 7.2927 | 16 | 169 | positive regulation of innate immune response |
GO:0019953 | 0.0027 | 1.7125 | 22.8705 | 37 | 530 | sexual reproduction |
GO:1901654 | 0.0027 | 3.1185 | 3.5384 | 10 | 82 | response to ketone |
GO:0042445 | 0.0027 | 2.5225 | 5.9981 | 14 | 139 | hormone metabolic process |
GO:0010975 | 0.0029 | 2.0656 | 10.8311 | 21 | 251 | regulation of neuron projection development |
GO:0031644 | 0.003 | 4.7933 | 1.4672 | 6 | 34 | regulation of neurological system process |
GO:0035176 | 0.003 | 4.7933 | 1.4672 | 6 | 34 | social behavior |
GO:0070663 | 0.003 | 3.0589 | 3.5969 | 10 | 84 | regulation of leukocyte proliferation |
GO:0007369 | 0.0031 | 2.3973 | 6.7317 | 15 | 156 | gastrulation |
GO:0001990 | 0.0032 | 5.8799 | 1.0356 | 5 | 24 | regulation of systemic arterial blood pressure by hormone |
GO:0006590 | 0.0032 | 8.1154 | 0.6473 | 4 | 15 | thyroid hormone generation |
GO:0033555 | 0.0033 | 3.5857 | 2.5028 | 8 | 58 | multicellular organismal response to stress |
GO:0021766 | 0.0034 | 4.6583 | 1.5009 | 6 | 35 | hippocampus development |
GO:0007267 | 0.0034 | 1.4993 | 43.0655 | 61 | 998 | cell-cell signaling |
GO:0035295 | 0.0034 | 1.6839 | 23.2157 | 37 | 538 | tube development |
GO:0051249 | 0.0035 | 13.7919 | 0.3352 | 3 | 8 | regulation of lymphocyte activation |
GO:0055123 | 0.0035 | 2.5434 | 5.5234 | 13 | 128 | digestive system development |
GO:0051251 | 0.0035 | 2.2831 | 7.5084 | 16 | 174 | positive regulation of lymphocyte activation |
GO:0008284 | 0.0038 | 1.6283 | 26.5815 | 41 | 616 | positive regulation of cell proliferation |
GO:0003139 | 0.0038 | 13.3724 | 0.3452 | 3 | 8 | secondary heart field specification |
GO:0045723 | 0.0038 | 13.3724 | 0.3452 | 3 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0070365 | 0.0038 | 13.3724 | 0.3452 | 3 | 8 | hepatocyte differentiation |
GO:0001662 | 0.0038 | 5.5855 | 1.0788 | 5 | 25 | behavioral fear response |
GO:0007186 | 0.004 | 1.6661 | 23.4396 | 37 | 549 | G-protein coupled receptor signaling pathway |
GO:0048566 | 0.0041 | 4.473 | 1.5535 | 6 | 36 | embryonic digestive tract development |
GO:0050801 | 0.0041 | 1.7179 | 20.2814 | 33 | 470 | ion homeostasis |
GO:0043267 | 0.0041 | 7.4385 | 0.6904 | 4 | 16 | negative regulation of potassium ion transport |
GO:0051354 | 0.0041 | 7.4385 | 0.6904 | 4 | 16 | negative regulation of oxidoreductase activity |
GO:0008593 | 0.0042 | 3.822 | 2.0713 | 7 | 48 | regulation of Notch signaling pathway |
GO:0045597 | 0.0044 | 1.7234 | 19.5979 | 32 | 459 | positive regulation of cell differentiation |
GO:0050867 | 0.0044 | 2.166 | 8.3715 | 17 | 194 | positive regulation of cell activation |
GO:0007188 | 0.0045 | 2.7149 | 4.4015 | 11 | 102 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0032680 | 0.0045 | 3.3819 | 2.6323 | 8 | 61 | regulation of tumor necrosis factor production |
GO:0014032 | 0.0048 | 3.7307 | 2.1144 | 7 | 49 | neural crest cell development |
GO:0060759 | 0.0048 | 3.0576 | 3.2364 | 9 | 75 | regulation of response to cytokine stimulus |
GO:0051241 | 0.0049 | 2.2684 | 7.0695 | 15 | 167 | negative regulation of multicellular organismal process |
GO:0060485 | 0.0049 | 2.1984 | 7.7673 | 16 | 180 | mesenchyme development |
GO:0003073 | 0.005 | 3.319 | 2.6754 | 8 | 62 | regulation of systemic arterial blood pressure |
GO:0030198 | 0.005 | 1.8669 | 13.5928 | 24 | 315 | extracellular matrix organization |
GO:0048863 | 0.0052 | 1.9206 | 12.1257 | 22 | 281 | stem cell differentiation |
GO:0048870 | 0.0052 | 1.4909 | 39.6134 | 56 | 918 | cell motility |
GO:0050769 | 0.0052 | 2.416 | 5.7823 | 13 | 134 | positive regulation of neurogenesis |
GO:0045666 | 0.0053 | 3.0118 | 3.2795 | 9 | 76 | positive regulation of neuron differentiation |
GO:0048704 | 0.0053 | 2.8048 | 3.8837 | 10 | 90 | embryonic skeletal system morphogenesis |
GO:0002260 | 0.0053 | 3.6436 | 2.1576 | 7 | 50 | lymphocyte homeostasis |
GO:0014049 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | positive regulation of glutamate secretion |
GO:0031394 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0032827 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | negative regulation of natural killer cell differentiation involved in immune response |
GO:0035726 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0042414 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | epinephrine metabolic process |
GO:0060061 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | Spemann organizer formation |
GO:0061184 | 0.0054 | 44.5074 | 0.1295 | 2 | 3 | positive regulation of dermatome development |
GO:0045620 | 0.0054 | 11.2124 | 0.3861 | 3 | 9 | negative regulation of lymphocyte differentiation |
GO:0002634 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | regulation of germinal center formation |
GO:0009996 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | negative regulation of cell fate specification |
GO:0010935 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | regulation of macrophage cytokine production |
GO:0032375 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | negative regulation of cholesterol transport |
GO:0045109 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | intermediate filament organization |
GO:0048664 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | neuron fate determination |
GO:0061162 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | establishment of monopolar cell polarity |
GO:0071294 | 0.0055 | 11.1427 | 0.3884 | 3 | 9 | cellular response to zinc ion |
GO:0048609 | 0.0058 | 1.6355 | 23.1697 | 36 | 540 | multicellular organismal reproductive process |
GO:0071706 | 0.006 | 3.1999 | 2.7617 | 8 | 64 | tumor necrosis factor superfamily cytokine production |
GO:0048706 | 0.006 | 4.9144 | 1.1946 | 5 | 28 | embryonic skeletal system development |
GO:0032768 | 0.0061 | 4.0653 | 1.6829 | 6 | 39 | regulation of monooxygenase activity |
GO:0045980 | 0.0061 | 4.0653 | 1.6829 | 6 | 39 | negative regulation of nucleotide metabolic process |
GO:0045321 | 0.0061 | 1.746 | 16.8963 | 28 | 399 | leukocyte activation |
GO:0001960 | 0.0063 | 4.8557 | 1.2083 | 5 | 28 | negative regulation of cytokine-mediated signaling pathway |
GO:0046189 | 0.0063 | 4.8557 | 1.2083 | 5 | 28 | phenol-containing compound biosynthetic process |
GO:0048167 | 0.0064 | 2.5724 | 4.6172 | 11 | 107 | regulation of synaptic plasticity |
GO:0032844 | 0.0064 | 1.9462 | 10.8743 | 20 | 252 | regulation of homeostatic process |
GO:0001710 | 0.0065 | 6.3748 | 0.7767 | 4 | 18 | mesodermal cell fate commitment |
GO:0007263 | 0.0065 | 6.3748 | 0.7767 | 4 | 18 | nitric oxide mediated signal transduction |
GO:0032892 | 0.0065 | 6.3748 | 0.7767 | 4 | 18 | positive regulation of organic acid transport |
GO:0045581 | 0.0065 | 6.3748 | 0.7767 | 4 | 18 | negative regulation of T cell differentiation |
GO:0002683 | 0.0065 | 2.8988 | 3.3877 | 9 | 80 | negative regulation of immune system process |
GO:0030182 | 0.0066 | 1.4663 | 40.9464 | 57 | 959 | neuron differentiation |
GO:1903034 | 0.0067 | 1.9377 | 10.9174 | 20 | 253 | regulation of response to wounding |
GO:0071222 | 0.0068 | 2.882 | 3.409 | 9 | 79 | cellular response to lipopolysaccharide |
GO:0050896 | 0.007 | 1.2449 | 254.4231 | 283 | 5896 | response to stimulus |
GO:0009615 | 0.007 | 2.0092 | 9.4934 | 18 | 220 | response to virus |
GO:0031348 | 0.0072 | 2.6704 | 4.0563 | 10 | 94 | negative regulation of defense response |
GO:0001818 | 0.0073 | 2.4067 | 5.3508 | 12 | 124 | negative regulation of cytokine production |
GO:0050794 | 0.0074 | 1.2595 | 294.9702 | 322 | 7122 | regulation of cellular process |
GO:0009954 | 0.0074 | 4.653 | 1.2514 | 5 | 29 | proximal/distal pattern formation |
GO:0003211 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | cardiac ventricle formation |
GO:0030157 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | pancreatic juice secretion |
GO:0031649 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | heat generation |
GO:0035815 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | positive regulation of renal sodium excretion |
GO:0045060 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | negative thymic T cell selection |
GO:0051967 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:0060174 | 0.0076 | 9.5501 | 0.4315 | 3 | 10 | limb bud formation |
GO:0007420 | 0.0077 | 1.591 | 24.4239 | 37 | 566 | brain development |
GO:0048731 | 0.0077 | 1.4474 | 44.056 | 60 | 1113 | system development |
GO:0002673 | 0.0078 | 3.8324 | 1.7692 | 6 | 41 | regulation of acute inflammatory response |
GO:0009712 | 0.0078 | 3.8324 | 1.7692 | 6 | 41 | catechol-containing compound metabolic process |
GO:0007530 | 0.0079 | 5.9493 | 0.8199 | 4 | 19 | sex determination |
GO:0033057 | 0.0079 | 5.9493 | 0.8199 | 4 | 19 | multicellular organismal reproductive behavior |
GO:0043368 | 0.0079 | 5.9493 | 0.8199 | 4 | 19 | positive T cell selection |
GO:0030003 | 0.0079 | 1.7675 | 14.8874 | 25 | 345 | cellular cation homeostasis |
GO:0060173 | 0.008 | 2.2017 | 6.7748 | 14 | 157 | limb development |
GO:0007275 | 0.0081 | 1.7498 | 15.7485 | 26 | 417 | multicellular organismal development |
GO:0032940 | 0.0084 | 1.5361 | 28.696 | 42 | 665 | secretion by cell |
GO:0048665 | 0.0086 | 4.4665 | 1.2946 | 5 | 30 | neuron fate specification |
GO:0006171 | 0.0086 | 2.7628 | 3.5384 | 9 | 82 | cAMP biosynthetic process |
GO:0098542 | 0.0087 | 1.9598 | 9.7092 | 18 | 225 | defense response to other organism |
GO:0070664 | 0.0088 | 3.7256 | 1.8124 | 6 | 42 | negative regulation of leukocyte proliferation |
GO:0046903 | 0.0091 | 2.7383 | 3.5624 | 9 | 85 | secretion |
GO:0001779 | 0.0096 | 5.577 | 0.863 | 4 | 20 | natural killer cell differentiation |
GO:0007194 | 0.0096 | 5.577 | 0.863 | 4 | 20 | negative regulation of adenylate cyclase activity |
GO:0072358 | 0.0097 | 1.4924 | 32.3207 | 46 | 749 | cardiovascular system development |
GO:0014014 | 0.0098 | 4.2944 | 1.3377 | 5 | 31 | negative regulation of gliogenesis |
GO:0019748 | 0.0098 | 4.2944 | 1.3377 | 5 | 31 | secondary metabolic process |
GO:0055078 | 0.0098 | 4.2944 | 1.3377 | 5 | 31 | sodium ion homeostasis |
GO:0031347 | 0.0099 | 1.8017 | 12.8462 | 22 | 301 | regulation of defense response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 7.8191 | 5.1353 | 30 | 121 | homophilic cell adhesion |
GO:0045944 | 0 | 2.9328 | 31.9153 | 79 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007389 | 0 | 4.2283 | 11.5841 | 41 | 282 | pattern specification process |
GO:0048568 | 0 | 3.4045 | 16.085 | 47 | 379 | embryonic organ development |
GO:0009887 | 0 | 2.8446 | 25.2195 | 62 | 610 | organ morphogenesis |
GO:0010628 | 0 | 2.2267 | 47.0241 | 91 | 1108 | positive regulation of gene expression |
GO:1902680 | 0 | 2.2084 | 44.5201 | 86 | 1049 | positive regulation of RNA biosynthetic process |
GO:0007423 | 0 | 2.9358 | 18.6738 | 48 | 440 | sensory organ development |
GO:0009952 | 0 | 4.4367 | 7.2013 | 27 | 172 | anterior/posterior pattern specification |
GO:0009891 | 0 | 2.0424 | 53.6024 | 96 | 1263 | positive regulation of biosynthetic process |
GO:0001501 | 0 | 2.8949 | 16.4245 | 42 | 387 | skeletal system development |
GO:0045935 | 0 | 2.0003 | 50.8438 | 90 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0048736 | 0 | 4.2151 | 6.6632 | 24 | 157 | appendage development |
GO:0006355 | 0 | 1.6542 | 118.112 | 168 | 2783 | regulation of transcription, DNA-templated |
GO:2000026 | 0 | 1.9143 | 48.9764 | 84 | 1154 | regulation of multicellular organismal development |
GO:0021797 | 0 | 113.8628 | 0.2546 | 5 | 6 | forebrain anterior/posterior pattern specification |
GO:0048598 | 0 | 3.2188 | 9.0883 | 26 | 226 | embryonic morphogenesis |
GO:0009954 | 0 | 10.3091 | 1.2308 | 9 | 29 | proximal/distal pattern formation |
GO:0051252 | 0 | 1.5735 | 122.5258 | 168 | 2887 | regulation of RNA metabolic process |
GO:0007399 | 0 | 1.7237 | 66.7241 | 103 | 1595 | nervous system development |
GO:0002125 | 0 | Inf | 0.1698 | 4 | 4 | maternal aggressive behavior |
GO:0035113 | 0 | 4.045 | 5.1353 | 18 | 121 | embryonic appendage morphogenesis |
GO:0035115 | 0 | 9.3704 | 1.3157 | 9 | 31 | embryonic forelimb morphogenesis |
GO:0048704 | 0 | 6.7176 | 2.0592 | 11 | 49 | embryonic skeletal system morphogenesis |
GO:0034654 | 0 | 1.5326 | 136.6161 | 182 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0021513 | 0 | 10.763 | 1.061 | 8 | 25 | spinal cord dorsal/ventral patterning |
GO:0043009 | 0 | 2.4156 | 16.8588 | 37 | 403 | chordate embryonic development |
GO:0045165 | 0 | 3.4571 | 6.5284 | 20 | 158 | cell fate commitment |
GO:0031326 | 0 | 1.5205 | 131.75 | 175 | 3141 | regulation of cellular biosynthetic process |
GO:0007186 | 0 | 2.4498 | 15.2502 | 34 | 373 | G-protein coupled receptor signaling pathway |
GO:0009880 | 0 | 6.0119 | 2.2493 | 11 | 53 | embryonic pattern specification |
GO:0021953 | 0 | 3.4653 | 6.189 | 19 | 147 | central nervous system neuron differentiation |
GO:0071294 | 0 | 28.4586 | 0.382 | 5 | 9 | cellular response to zinc ion |
GO:0090009 | 0 | 28.4586 | 0.382 | 5 | 9 | primitive streak formation |
GO:0045666 | 0 | 4.7464 | 3.2255 | 13 | 76 | positive regulation of neuron differentiation |
GO:0007267 | 0 | 1.8071 | 42.3556 | 70 | 998 | cell-cell signaling |
GO:0009953 | 0 | 4.6643 | 3.2675 | 13 | 78 | dorsal/ventral pattern formation |
GO:0061053 | 0 | 4.7519 | 2.9708 | 12 | 70 | somite development |
GO:0043010 | 1e-04 | 2.9039 | 7.9937 | 21 | 191 | camera-type eye development |
GO:0030901 | 1e-04 | 7.314 | 1.4005 | 8 | 33 | midbrain development |
GO:0007200 | 1e-04 | 5.455 | 2.2069 | 10 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0045665 | 1e-04 | 5.455 | 2.2069 | 10 | 52 | negative regulation of neuron differentiation |
GO:0010556 | 1e-04 | 1.4602 | 131.9052 | 171 | 3108 | regulation of macromolecule biosynthetic process |
GO:0001662 | 1e-04 | 8.8769 | 1.061 | 7 | 25 | behavioral fear response |
GO:0007218 | 1e-04 | 4.0928 | 3.6499 | 13 | 86 | neuropeptide signaling pathway |
GO:0048729 | 1e-04 | 2.088 | 20.2441 | 39 | 477 | tissue morphogenesis |
GO:0006579 | 1e-04 | Inf | 0.1273 | 3 | 3 | amino-acid betaine catabolic process |
GO:0050767 | 1e-04 | 2.0897 | 19.6924 | 38 | 464 | regulation of neurogenesis |
GO:0007187 | 1e-04 | 3.2915 | 5.4324 | 16 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0061303 | 1e-04 | 30.3014 | 0.2971 | 4 | 7 | cornea development in camera-type eye |
GO:0007626 | 1e-04 | 2.8871 | 7.2573 | 19 | 171 | locomotory behavior |
GO:0007586 | 1e-04 | 3.7801 | 3.9045 | 13 | 92 | digestion |
GO:0007155 | 1e-04 | 1.7425 | 37.8145 | 61 | 891 | cell adhesion |
GO:0007193 | 1e-04 | 5.4384 | 1.9876 | 9 | 47 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0008284 | 1e-04 | 1.8977 | 26.1434 | 46 | 616 | positive regulation of cell proliferation |
GO:0001523 | 1e-04 | 4.7707 | 2.4616 | 10 | 58 | retinoid metabolic process |
GO:0033555 | 1e-04 | 4.7707 | 2.4616 | 10 | 58 | multicellular organismal response to stress |
GO:0007420 | 1e-04 | 2.1107 | 17.4014 | 34 | 421 | brain development |
GO:0035137 | 2e-04 | 22.8939 | 0.3371 | 4 | 8 | hindlimb morphogenesis |
GO:0045723 | 2e-04 | 22.7242 | 0.3395 | 4 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0071542 | 2e-04 | 12.6431 | 0.5942 | 5 | 14 | dopaminergic neuron differentiation |
GO:0060425 | 2e-04 | 5.0201 | 2.122 | 9 | 50 | lung morphogenesis |
GO:0030902 | 3e-04 | 5.6179 | 1.7166 | 8 | 41 | hindbrain development |
GO:0032502 | 3e-04 | 1.4342 | 124.4687 | 158 | 3124 | developmental process |
GO:0060581 | 3e-04 | 11.3778 | 0.6366 | 5 | 15 | cell fate commitment involved in pattern specification |
GO:0008589 | 3e-04 | 4.3189 | 2.6738 | 10 | 63 | regulation of smoothened signaling pathway |
GO:0052652 | 3e-04 | 3.4302 | 4.2441 | 13 | 100 | cyclic purine nucleotide metabolic process |
GO:0009798 | 3e-04 | 3.8772 | 3.2255 | 11 | 76 | axis specification |
GO:0051171 | 4e-04 | 1.377 | 153.4649 | 189 | 3616 | regulation of nitrogen compound metabolic process |
GO:0042472 | 4e-04 | 3.4827 | 3.8621 | 12 | 91 | inner ear morphogenesis |
GO:0001657 | 5e-04 | 3.4389 | 3.9045 | 12 | 92 | ureteric bud development |
GO:0015850 | 5e-04 | 2.7881 | 6.2812 | 16 | 148 | organic hydroxy compound transport |
GO:0072163 | 5e-04 | 3.3961 | 3.947 | 12 | 93 | mesonephric epithelium development |
GO:0021514 | 5e-04 | 9.4799 | 0.7215 | 5 | 17 | ventral spinal cord interneuron differentiation |
GO:0003211 | 5e-04 | 15.147 | 0.4244 | 4 | 10 | cardiac ventricle formation |
GO:0021936 | 5e-04 | 15.147 | 0.4244 | 4 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0035815 | 5e-04 | 15.147 | 0.4244 | 4 | 10 | positive regulation of renal sodium excretion |
GO:0006721 | 6e-04 | 3.9449 | 2.886 | 10 | 68 | terpenoid metabolic process |
GO:0002088 | 7e-04 | 4.1977 | 2.4616 | 9 | 58 | lens development in camera-type eye |
GO:0009605 | 7e-04 | 1.4964 | 64.0428 | 89 | 1509 | response to external stimulus |
GO:0021779 | 7e-04 | 34.0281 | 0.2122 | 3 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 7e-04 | 34.0281 | 0.2122 | 3 | 5 | glial cell fate specification |
GO:0042713 | 7e-04 | 34.0281 | 0.2122 | 3 | 5 | sperm ejaculation |
GO:0060431 | 7e-04 | 34.0281 | 0.2122 | 3 | 5 | primary lung bud formation |
GO:2001199 | 7e-04 | 34.0281 | 0.2122 | 3 | 5 | negative regulation of dendritic cell differentiation |
GO:0031018 | 7e-04 | 4.683 | 1.9947 | 8 | 47 | endocrine pancreas development |
GO:0044062 | 7e-04 | 8.75 | 0.7639 | 5 | 18 | regulation of excretion |
GO:0021521 | 8e-04 | 12.982 | 0.4668 | 4 | 11 | ventral spinal cord interneuron specification |
GO:0042711 | 8e-04 | 12.982 | 0.4668 | 4 | 11 | maternal behavior |
GO:0055062 | 8e-04 | 12.982 | 0.4668 | 4 | 11 | phosphate ion homeostasis |
GO:0048665 | 9e-04 | 8.1811 | 0.8011 | 5 | 19 | neuron fate specification |
GO:0010092 | 0.001 | 6.2116 | 1.1883 | 6 | 28 | specification of organ identity |
GO:0030803 | 0.001 | 6.2116 | 1.1883 | 6 | 28 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0060429 | 0.001 | 1.7132 | 28.6346 | 46 | 690 | epithelium development |
GO:0042310 | 0.001 | 3.9545 | 2.5889 | 9 | 61 | vasoconstriction |
GO:0030817 | 0.0011 | 3.5733 | 3.1406 | 10 | 74 | regulation of cAMP biosynthetic process |
GO:0048646 | 0.0012 | 1.6646 | 31.35 | 49 | 753 | anatomical structure formation involved in morphogenesis |
GO:0007617 | 0.0012 | 7.5821 | 0.8488 | 5 | 20 | mating behavior |
GO:0035136 | 0.0013 | 23.0305 | 0.251 | 3 | 6 | forelimb morphogenesis |
GO:0000122 | 0.0014 | 1.7605 | 23.5545 | 39 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0002158 | 0.0014 | 22.6835 | 0.2546 | 3 | 6 | osteoclast proliferation |
GO:0042756 | 0.0014 | 22.6835 | 0.2546 | 3 | 6 | drinking behavior |
GO:0072088 | 0.0014 | 5.693 | 1.2732 | 6 | 30 | nephron epithelium morphogenesis |
GO:1900372 | 0.0014 | 5.693 | 1.2732 | 6 | 30 | negative regulation of purine nucleotide biosynthetic process |
GO:0022037 | 0.0014 | 3.1864 | 3.8196 | 11 | 90 | metencephalon development |
GO:1902679 | 0.0015 | 1.6136 | 34.9286 | 53 | 823 | negative regulation of RNA biosynthetic process |
GO:0048701 | 0.0015 | 4.6933 | 1.7401 | 7 | 41 | embryonic cranial skeleton morphogenesis |
GO:0048557 | 0.0016 | 7.1076 | 0.8913 | 5 | 21 | embryonic digestive tract morphogenesis |
GO:0015844 | 0.0016 | 4.0566 | 2.2493 | 8 | 53 | monoamine transport |
GO:0003084 | 0.0017 | 10.0955 | 0.5517 | 4 | 13 | positive regulation of systemic arterial blood pressure |
GO:0003214 | 0.0017 | 10.0955 | 0.5517 | 4 | 13 | cardiac left ventricle morphogenesis |
GO:0042053 | 0.0017 | 10.0955 | 0.5517 | 4 | 13 | regulation of dopamine metabolic process |
GO:0030815 | 0.0017 | 5.4649 | 1.3157 | 6 | 31 | negative regulation of cAMP metabolic process |
GO:0055078 | 0.0017 | 5.4649 | 1.3157 | 6 | 31 | sodium ion homeostasis |
GO:0007198 | 0.0018 | Inf | 0.0849 | 2 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0009440 | 0.0018 | Inf | 0.0849 | 2 | 2 | cyanate catabolic process |
GO:0010901 | 0.0018 | Inf | 0.0849 | 2 | 2 | regulation of very-low-density lipoprotein particle remodeling |
GO:0061017 | 0.0018 | Inf | 0.0849 | 2 | 2 | hepatoblast differentiation |
GO:0048699 | 0.0018 | 1.6837 | 27.1423 | 43 | 663 | generation of neurons |
GO:0048663 | 0.0018 | 5.3543 | 1.3341 | 6 | 32 | neuron fate commitment |
GO:0048468 | 0.0019 | 1.6047 | 34.5084 | 52 | 841 | cell development |
GO:0009855 | 0.0019 | 3.069 | 3.947 | 11 | 93 | determination of bilateral symmetry |
GO:0010002 | 0.002 | 6.689 | 0.9337 | 5 | 22 | cardioblast differentiation |
GO:0051705 | 0.002 | 3.5437 | 2.8435 | 9 | 67 | multi-organism behavior |
GO:0042220 | 0.002 | 5.2542 | 1.3581 | 6 | 32 | response to cocaine |
GO:0061138 | 0.002 | 2.3535 | 7.7666 | 17 | 183 | morphogenesis of a branching epithelium |
GO:0072080 | 0.002 | 4.4319 | 1.8249 | 7 | 43 | nephron tubule development |
GO:0007379 | 0.0023 | 9.0852 | 0.5942 | 4 | 14 | segment specification |
GO:0007625 | 0.0023 | 9.0852 | 0.5942 | 4 | 14 | grooming behavior |
GO:0021542 | 0.0023 | 9.0852 | 0.5942 | 4 | 14 | dentate gyrus development |
GO:0072079 | 0.0023 | 9.0852 | 0.5942 | 4 | 14 | nephron tubule formation |
GO:0008217 | 0.0023 | 2.6832 | 5.2626 | 13 | 124 | regulation of blood pressure |
GO:0003140 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | determination of left/right asymmetry in lateral mesoderm |
GO:0003357 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | noradrenergic neuron differentiation |
GO:0042538 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | hyperosmotic salinity response |
GO:0045924 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | regulation of female receptivity |
GO:0061072 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | iris morphogenesis |
GO:2000543 | 0.0023 | 17.0112 | 0.2971 | 3 | 7 | positive regulation of gastrulation |
GO:0048536 | 0.0024 | 5.0592 | 1.4005 | 6 | 33 | spleen development |
GO:0035282 | 0.0026 | 3.3915 | 2.952 | 9 | 70 | segmentation |
GO:0021761 | 0.003 | 3.314 | 3.0133 | 9 | 71 | limbic system development |
GO:0003013 | 0.003 | 1.9232 | 13.7932 | 25 | 325 | circulatory system process |
GO:0050729 | 0.003 | 4.0899 | 1.9523 | 7 | 46 | positive regulation of inflammatory response |
GO:0065007 | 0.0031 | 1.3029 | 347.1211 | 377 | 8179 | biological regulation |
GO:0001658 | 0.0031 | 4.739 | 1.4767 | 6 | 35 | branching involved in ureteric bud morphogenesis |
GO:0050877 | 0.0032 | 1.6005 | 30.3874 | 46 | 716 | neurological system process |
GO:0044707 | 0.0033 | 1.3181 | 151.6077 | 179 | 4080 | single-multicellular organism process |
GO:0007492 | 0.0033 | 3.2611 | 3.0557 | 9 | 72 | endoderm development |
GO:0048732 | 0.0034 | 1.8561 | 15.4059 | 27 | 363 | gland development |
GO:0003206 | 0.0034 | 2.826 | 4.2441 | 11 | 100 | cardiac chamber morphogenesis |
GO:0048708 | 0.0034 | 3.9874 | 1.9947 | 7 | 47 | astrocyte differentiation |
GO:0007631 | 0.0035 | 3.2274 | 3.0823 | 9 | 73 | feeding behavior |
GO:0048518 | 0.0035 | 1.2971 | 150.6639 | 179 | 3550 | positive regulation of biological process |
GO:0030111 | 0.0035 | 2.2179 | 8.191 | 17 | 193 | regulation of Wnt signaling pathway |
GO:0021515 | 0.0036 | 4.5909 | 1.5157 | 6 | 36 | cell differentiation in spinal cord |
GO:0021924 | 0.0036 | 13.6079 | 0.3395 | 3 | 8 | cell proliferation in external granule layer |
GO:0040019 | 0.0036 | 13.6079 | 0.3395 | 3 | 8 | positive regulation of embryonic development |
GO:0035270 | 0.0037 | 3.1985 | 3.1053 | 9 | 74 | endocrine system development |
GO:0021543 | 0.0037 | 2.64 | 4.9231 | 12 | 116 | pallium development |
GO:0060541 | 0.0039 | 2.1926 | 8.2759 | 17 | 195 | respiratory system development |
GO:0060537 | 0.0042 | 1.9267 | 12.6473 | 23 | 298 | muscle tissue development |
GO:0072175 | 0.0043 | 2.5898 | 5.008 | 12 | 118 | epithelial tube formation |
GO:0009890 | 0.0043 | 1.4852 | 42.6952 | 60 | 1006 | negative regulation of biosynthetic process |
GO:0045685 | 0.0044 | 3.7969 | 2.0796 | 7 | 49 | regulation of glial cell differentiation |
GO:0030808 | 0.0044 | 2.8912 | 3.7772 | 10 | 89 | regulation of nucleotide biosynthetic process |
GO:0007178 | 0.0045 | 1.9802 | 11.2467 | 21 | 265 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0051241 | 0.0045 | 1.9125 | 12.7322 | 23 | 300 | negative regulation of multicellular organismal process |
GO:0007498 | 0.0046 | 2.7036 | 4.4138 | 11 | 104 | mesoderm development |
GO:0003231 | 0.0047 | 2.8548 | 3.8196 | 10 | 90 | cardiac ventricle development |
GO:0072202 | 0.0049 | 6.9869 | 0.7215 | 4 | 17 | cell differentiation involved in metanephros development |
GO:0021536 | 0.0049 | 2.6746 | 4.4563 | 11 | 105 | diencephalon development |
GO:0007270 | 0.0049 | 2.5414 | 5.0929 | 12 | 120 | neuron-neuron synaptic transmission |
GO:0021915 | 0.0049 | 2.3406 | 6.4085 | 14 | 151 | neural tube development |
GO:0006935 | 0.005 | 1.6649 | 22.154 | 35 | 522 | chemotaxis |
GO:0055074 | 0.0052 | 1.9903 | 10.6526 | 20 | 251 | calcium ion homeostasis |
GO:0000432 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO:0014049 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | positive regulation of glutamate secretion |
GO:0014707 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0019482 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | beta-alanine metabolic process |
GO:0021530 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0031394 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0033505 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | floor plate morphogenesis |
GO:0042631 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | cellular response to water deprivation |
GO:0051970 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:0060061 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | Spemann organizer formation |
GO:0060166 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | olfactory pit development |
GO:0060423 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | foregut regionalization |
GO:0060492 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | lung induction |
GO:0072093 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | metanephric renal vesicle formation |
GO:0072180 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | mesonephric duct morphogenesis |
GO:1900157 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | regulation of bone mineralization involved in bone maturation |
GO:1901382 | 0.0052 | 45.2897 | 0.1273 | 2 | 3 | regulation of chorionic trophoblast cell proliferation |
GO:0021892 | 0.0053 | 11.339 | 0.382 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0032525 | 0.0053 | 11.339 | 0.382 | 3 | 9 | somite rostral/caudal axis specification |
GO:0048664 | 0.0053 | 11.339 | 0.382 | 3 | 9 | neuron fate determination |
GO:0060456 | 0.0053 | 11.339 | 0.382 | 3 | 9 | positive regulation of digestive system process |
GO:0016053 | 0.0054 | 1.9816 | 10.695 | 20 | 252 | organic acid biosynthetic process |
GO:1902476 | 0.0055 | 3.2568 | 2.7162 | 8 | 64 | chloride transmembrane transport |
GO:1990267 | 0.0055 | 3.2568 | 2.7162 | 8 | 64 | response to transition metal nanoparticle |
GO:0021545 | 0.0056 | 4.1373 | 1.6552 | 6 | 39 | cranial nerve development |
GO:0045980 | 0.0056 | 4.1373 | 1.6552 | 6 | 39 | negative regulation of nucleotide metabolic process |
GO:0072210 | 0.0056 | 4.1373 | 1.6552 | 6 | 39 | metanephric nephron development |
GO:0042476 | 0.0057 | 2.6184 | 4.5411 | 11 | 107 | odontogenesis |
GO:0042471 | 0.0058 | 6.5934 | 0.7523 | 4 | 18 | ear morphogenesis |
GO:0048565 | 0.0059 | 2.6043 | 4.5619 | 11 | 108 | digestive tract development |
GO:0019098 | 0.0059 | 4.9416 | 1.1883 | 5 | 28 | reproductive behavior |
GO:0016331 | 0.0059 | 2.374 | 5.8686 | 13 | 139 | morphogenesis of embryonic epithelium |
GO:0060485 | 0.006 | 4.0728 | 1.6751 | 6 | 40 | mesenchyme development |
GO:0030510 | 0.006 | 3.1994 | 2.7586 | 8 | 65 | regulation of BMP signaling pathway |
GO:0032892 | 0.0061 | 6.4873 | 0.7639 | 4 | 18 | positive regulation of organic acid transport |
GO:0001704 | 0.0065 | 2.5646 | 4.626 | 11 | 109 | formation of primary germ layer |
GO:0048762 | 0.0066 | 2.342 | 5.9417 | 13 | 140 | mesenchymal cell differentiation |
GO:0035116 | 0.0069 | 4.7353 | 1.2308 | 5 | 29 | embryonic hindlimb morphogenesis |
GO:0003014 | 0.0072 | 3.0904 | 2.8435 | 8 | 67 | renal system process |
GO:0006584 | 0.0072 | 3.9002 | 1.7401 | 6 | 41 | catecholamine metabolic process |
GO:0072358 | 0.0072 | 1.521 | 31.788 | 46 | 749 | cardiovascular system development |
GO:0072089 | 0.0073 | 2.4064 | 5.3475 | 12 | 126 | stem cell proliferation |
GO:0030002 | 0.0073 | 9.7183 | 0.4244 | 3 | 10 | cellular anion homeostasis |
GO:0043084 | 0.0073 | 9.7183 | 0.4244 | 3 | 10 | penile erection |
GO:0048505 | 0.0073 | 9.7183 | 0.4244 | 3 | 10 | regulation of timing of cell differentiation |
GO:0051967 | 0.0073 | 9.7183 | 0.4244 | 3 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:0070472 | 0.0073 | 9.7183 | 0.4244 | 3 | 10 | regulation of uterine smooth muscle contraction |
GO:0035150 | 0.0074 | 2.5129 | 4.7109 | 11 | 111 | regulation of tube size |
GO:0007530 | 0.0075 | 6.0543 | 0.8064 | 4 | 19 | sex determination |
GO:0033057 | 0.0075 | 6.0543 | 0.8064 | 4 | 19 | multicellular organismal reproductive behavior |
GO:0045934 | 0.0075 | 1.4746 | 37.8023 | 53 | 898 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007603 | 0.0079 | 3.0387 | 2.886 | 8 | 68 | phototransduction, visible light |
GO:0051093 | 0.0081 | 1.596 | 23.6818 | 36 | 558 | negative regulation of developmental process |
GO:0072330 | 0.0082 | 2.1947 | 6.7905 | 14 | 160 | monocarboxylic acid biosynthetic process |
GO:0031279 | 0.0083 | 3.3206 | 2.3342 | 7 | 55 | regulation of cyclase activity |
GO:0010721 | 0.0087 | 2.3441 | 5.4748 | 12 | 129 | negative regulation of cell development |
GO:0001655 | 0.009 | 1.8485 | 11.9682 | 21 | 282 | urogenital system development |
GO:0048545 | 0.009 | 1.8191 | 12.7322 | 22 | 300 | response to steroid hormone |
GO:0061351 | 0.009 | 2.4391 | 4.8382 | 11 | 114 | neural precursor cell proliferation |
GO:0007194 | 0.009 | 5.6754 | 0.8488 | 4 | 20 | negative regulation of adenylate cyclase activity |
GO:0045823 | 0.009 | 5.6754 | 0.8488 | 4 | 20 | positive regulation of heart contraction |
GO:0048485 | 0.009 | 5.6754 | 0.8488 | 4 | 20 | sympathetic nervous system development |
GO:0051954 | 0.009 | 5.6754 | 0.8488 | 4 | 20 | positive regulation of amine transport |
GO:0090189 | 0.009 | 5.6754 | 0.8488 | 4 | 20 | regulation of branching involved in ureteric bud morphogenesis |
GO:0031128 | 0.0091 | 4.3864 | 1.3111 | 5 | 31 | developmental induction |
GO:0060562 | 0.0091 | 2.0985 | 7.5808 | 15 | 181 | epithelial tube morphogenesis |
GO:0030799 | 0.0092 | 2.5642 | 4.2016 | 10 | 99 | regulation of cyclic nucleotide metabolic process |
GO:0014014 | 0.0092 | 4.3703 | 1.3157 | 5 | 31 | negative regulation of gliogenesis |
GO:0021772 | 0.0092 | 4.3703 | 1.3157 | 5 | 31 | olfactory bulb development |
GO:0048048 | 0.0092 | 4.3703 | 1.3157 | 5 | 31 | embryonic eye morphogenesis |
GO:0050891 | 0.0092 | 4.3703 | 1.3157 | 5 | 31 | multicellular organismal water homeostasis |
GO:0035108 | 0.0093 | 2.7233 | 3.5765 | 9 | 86 | limb morphogenesis |
GO:0000904 | 0.0097 | 1.5057 | 30.6421 | 44 | 722 | cell morphogenesis involved in differentiation |
GO:0007494 | 0.0097 | 8.5028 | 0.4668 | 3 | 11 | midgut development |
GO:0014061 | 0.0097 | 8.5028 | 0.4668 | 3 | 11 | regulation of norepinephrine secretion |
GO:0021903 | 0.0097 | 8.5028 | 0.4668 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0071276 | 0.0097 | 8.5028 | 0.4668 | 3 | 11 | cellular response to cadmium ion |
GO:0045597 | 0.0099 | 1.6455 | 19.1235 | 30 | 459 | positive regulation of cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 1e-04 | 17.4528 | 0.4541 | 5 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007186 | 1e-04 | 2.0059 | 20.9944 | 39 | 601 | G-protein coupled receptor signaling pathway |
GO:0060750 | 2e-04 | 83.4396 | 0.1397 | 3 | 4 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:0007028 | 8e-04 | 27.8087 | 0.2096 | 3 | 6 | cytoplasm organization |
GO:1900027 | 0.0011 | 11.1425 | 0.4891 | 4 | 14 | regulation of ruffle assembly |
GO:1901342 | 0.0011 | 2.7801 | 5.4495 | 14 | 156 | regulation of vasculature development |
GO:0030104 | 0.0012 | 5.7808 | 1.2226 | 6 | 35 | water homeostasis |
GO:0007308 | 0.0012 | Inf | 0.0699 | 2 | 2 | oocyte construction |
GO:0007314 | 0.0012 | Inf | 0.0699 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0012 | Inf | 0.0699 | 2 | 2 | P granule organization |
GO:0097168 | 0.0012 | Inf | 0.0699 | 2 | 2 | mesenchymal stem cell proliferation |
GO:0051923 | 0.0013 | 20.8548 | 0.2445 | 3 | 7 | sulfation |
GO:0002675 | 0.0015 | 10.1287 | 0.524 | 4 | 15 | positive regulation of acute inflammatory response |
GO:0065007 | 0.0016 | 1.371 | 285.7123 | 315 | 8179 | biological regulation |
GO:1902041 | 0.0022 | 5.0784 | 1.3624 | 6 | 39 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0007606 | 0.0025 | 3.733 | 2.3754 | 8 | 68 | sensory perception of chemical stimulus |
GO:0050727 | 0.003 | 2.4794 | 6.0433 | 14 | 173 | regulation of inflammatory response |
GO:0003334 | 0.003 | 13.9009 | 0.3144 | 3 | 9 | keratinocyte development |
GO:0033561 | 0.003 | 7.9563 | 0.6288 | 4 | 18 | regulation of water loss via skin |
GO:0009593 | 0.0032 | 3.9941 | 1.9562 | 7 | 56 | detection of chemical stimulus |
GO:0001101 | 0.0035 | 2.2109 | 8.1742 | 17 | 234 | response to acid chemical |
GO:0001806 | 0.0036 | 55.5 | 0.1048 | 2 | 3 | type IV hypersensitivity |
GO:0002578 | 0.0036 | 55.5 | 0.1048 | 2 | 3 | negative regulation of antigen processing and presentation |
GO:0007207 | 0.0036 | 55.5 | 0.1048 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0010482 | 0.0036 | 55.5 | 0.1048 | 2 | 3 | regulation of epidermal cell division |
GO:0034110 | 0.0038 | 7.4253 | 0.6637 | 4 | 19 | regulation of homotypic cell-cell adhesion |
GO:0022603 | 0.0048 | 1.67 | 22.1122 | 35 | 633 | regulation of anatomical structure morphogenesis |
GO:0046330 | 0.005 | 4.1873 | 1.6069 | 6 | 46 | positive regulation of JNK cascade |
GO:1903036 | 0.0057 | 3.5566 | 2.1658 | 7 | 62 | positive regulation of response to wounding |
GO:0030155 | 0.0058 | 2.0017 | 10.0256 | 19 | 287 | regulation of cell adhesion |
GO:0002687 | 0.0069 | 3.8942 | 1.7117 | 6 | 49 | positive regulation of leukocyte migration |
GO:0010595 | 0.0069 | 3.8942 | 1.7117 | 6 | 49 | positive regulation of endothelial cell migration |
GO:0002291 | 0.007 | 27.7477 | 0.1397 | 2 | 4 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0060480 | 0.007 | 27.7477 | 0.1397 | 2 | 4 | lung goblet cell differentiation |
GO:0097267 | 0.007 | 27.7477 | 0.1397 | 2 | 4 | omega-hydroxylase P450 pathway |
GO:0034097 | 0.007 | 1.7446 | 16.2785 | 27 | 466 | response to cytokine |
GO:0008544 | 0.0072 | 2.0956 | 8.0694 | 16 | 231 | epidermis development |
GO:0042127 | 0.0072 | 1.4763 | 38.6353 | 54 | 1106 | regulation of cell proliferation |
GO:0042060 | 0.0073 | 1.6722 | 19.4923 | 31 | 558 | wound healing |
GO:0050906 | 0.0073 | 3.3718 | 2.2706 | 7 | 65 | detection of stimulus involved in sensory perception |
GO:0061180 | 0.0073 | 3.3718 | 2.2706 | 7 | 65 | mammary gland epithelium development |
GO:0040037 | 0.0074 | 9.265 | 0.4192 | 3 | 12 | negative regulation of fibroblast growth factor receptor signaling pathway |
GO:0034330 | 0.0082 | 2.1204 | 7.4755 | 15 | 214 | cell junction organization |
GO:0006952 | 0.0086 | 1.4768 | 36.3996 | 51 | 1042 | defense response |
GO:0030334 | 0.0087 | 1.7521 | 14.986 | 25 | 429 | regulation of cell migration |
GO:0045766 | 0.0089 | 2.9432 | 2.9343 | 8 | 84 | positive regulation of angiogenesis |
GO:0060444 | 0.009 | 5.5667 | 0.8384 | 4 | 24 | branching involved in mammary gland duct morphogenesis |
GO:0070528 | 0.009 | 5.5667 | 0.8384 | 4 | 24 | protein kinase C signaling |
GO:0040015 | 0.0093 | 8.3378 | 0.4541 | 3 | 13 | negative regulation of multicellular organism growth |
GO:0007044 | 0.0094 | 3.2052 | 2.3754 | 7 | 68 | cell-substrate junction assembly |
GO:0043410 | 0.0095 | 1.9001 | 10.5147 | 19 | 301 | positive regulation of MAPK cascade |
GO:0051239 | 0.0099 | 1.3612 | 63.1928 | 81 | 1809 | regulation of multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045944 | 0 | 2.9301 | 35.8378 | 88 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007423 | 0 | 3.6123 | 20.9689 | 63 | 440 | sensory organ development |
GO:0007389 | 0 | 4.2682 | 13.9785 | 49 | 300 | pattern specification process |
GO:0048699 | 0 | 3.0016 | 27.0806 | 69 | 605 | generation of neurons |
GO:1902680 | 0 | 2.387 | 49.9919 | 102 | 1049 | positive regulation of RNA biosynthetic process |
GO:0010628 | 0 | 2.293 | 52.8036 | 104 | 1108 | positive regulation of gene expression |
GO:0045935 | 0 | 2.1938 | 57.0927 | 108 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0006355 | 0 | 1.8335 | 132.6285 | 201 | 2783 | regulation of transcription, DNA-templated |
GO:0007268 | 0 | 2.9068 | 23.4752 | 59 | 505 | synaptic transmission |
GO:0007275 | 0 | 1.9776 | 93.893 | 151 | 2334 | multicellular organismal development |
GO:0009891 | 0 | 2.1087 | 60.1904 | 110 | 1263 | positive regulation of biosynthetic process |
GO:0045666 | 0 | 7.3475 | 3.6219 | 20 | 76 | positive regulation of neuron differentiation |
GO:0065007 | 0 | 1.7878 | 389.784 | 459 | 8179 | biological regulation |
GO:0045595 | 0 | 2.1751 | 51.1696 | 97 | 1086 | regulation of cell differentiation |
GO:0051094 | 0 | 2.4687 | 32.8458 | 71 | 698 | positive regulation of developmental process |
GO:0051252 | 0 | 1.757 | 137.5848 | 202 | 2887 | regulation of RNA metabolic process |
GO:0048863 | 0 | 3.374 | 13.3915 | 39 | 281 | stem cell differentiation |
GO:0021983 | 0 | 10.5843 | 1.9539 | 14 | 41 | pituitary gland development |
GO:0021527 | 0 | 30.4141 | 0.7149 | 9 | 15 | spinal cord association neuron differentiation |
GO:0050767 | 0 | 3.0567 | 15.7282 | 42 | 335 | regulation of neurogenesis |
GO:0031326 | 0 | 1.6693 | 148 | 208 | 3141 | regulation of cellular biosynthetic process |
GO:0051171 | 0 | 1.6253 | 172.3266 | 234 | 3616 | regulation of nitrogen compound metabolic process |
GO:0007267 | 0 | 3.9527 | 7.9688 | 27 | 185 | cell-cell signaling |
GO:0007399 | 0 | 2.446 | 26.3921 | 57 | 636 | nervous system development |
GO:0051093 | 0 | 2.4303 | 26.368 | 57 | 555 | negative regulation of developmental process |
GO:0007166 | 0 | 1.725 | 106.5271 | 159 | 2273 | cell surface receptor signaling pathway |
GO:0048667 | 0 | 2.3949 | 26.2112 | 56 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0034654 | 0 | 1.618 | 153.4069 | 211 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0010556 | 0 | 1.6229 | 148.117 | 205 | 3108 | regulation of macromolecule biosynthetic process |
GO:0007517 | 0 | 2.9643 | 14.154 | 37 | 297 | muscle organ development |
GO:0009792 | 0 | 2.3502 | 26.6401 | 56 | 559 | embryo development ending in birth or egg hatching |
GO:0072358 | 0 | 2.1219 | 35.6949 | 68 | 749 | cardiovascular system development |
GO:0048812 | 0 | 2.2897 | 26.7354 | 55 | 561 | neuron projection morphogenesis |
GO:0060537 | 0 | 2.8567 | 14.2017 | 36 | 298 | muscle tissue development |
GO:0007417 | 0 | 2.3748 | 22.9635 | 49 | 511 | central nervous system development |
GO:0021514 | 0 | 17.9884 | 0.8102 | 8 | 17 | ventral spinal cord interneuron differentiation |
GO:0061564 | 0 | 2.3254 | 23.876 | 50 | 501 | axon development |
GO:0001655 | 0 | 3.0522 | 11.1106 | 30 | 235 | urogenital system development |
GO:0009887 | 0 | 2.6435 | 15.6062 | 37 | 354 | organ morphogenesis |
GO:0048729 | 0 | 2.562 | 16.948 | 39 | 362 | tissue morphogenesis |
GO:0042472 | 0 | 4.695 | 4.3368 | 17 | 91 | inner ear morphogenesis |
GO:0021797 | 0 | 100.7441 | 0.2859 | 5 | 6 | forebrain anterior/posterior pattern specification |
GO:0007411 | 0 | 2.5604 | 16.0603 | 37 | 337 | axon guidance |
GO:0030901 | 0 | 8.8181 | 1.5727 | 10 | 33 | midbrain development |
GO:0021781 | 0 | 17.6791 | 0.7149 | 7 | 15 | glial cell fate commitment |
GO:0060581 | 0 | 17.6791 | 0.7149 | 7 | 15 | cell fate commitment involved in pattern specification |
GO:0023019 | 0 | 12.4494 | 1.0008 | 8 | 21 | signal transduction involved in regulation of gene expression |
GO:0043010 | 0 | 2.7895 | 12.0095 | 30 | 252 | camera-type eye development |
GO:0021516 | 0 | 51.1121 | 0.329 | 5 | 7 | dorsal spinal cord development |
GO:0048738 | 0 | 3.4988 | 6.8626 | 21 | 144 | cardiac muscle tissue development |
GO:0030900 | 0 | 2.8036 | 11.5391 | 29 | 247 | forebrain development |
GO:0034765 | 0 | 2.6898 | 12.8196 | 31 | 269 | regulation of ion transmembrane transport |
GO:0021913 | 0 | Inf | 0.1906 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0060173 | 0 | 3.342 | 7.4821 | 22 | 157 | limb development |
GO:0021761 | 0 | 5.0011 | 3.3836 | 14 | 71 | limbic system development |
GO:0009952 | 0 | 3.8217 | 5.4315 | 18 | 117 | anterior/posterior pattern specification |
GO:0060485 | 0 | 3.2398 | 7.6801 | 22 | 162 | mesenchyme development |
GO:0014033 | 0 | 5.6697 | 2.6211 | 12 | 55 | neural crest cell differentiation |
GO:0006935 | 0 | 2.1122 | 24.8768 | 48 | 522 | chemotaxis |
GO:0021915 | 0 | 3.3085 | 7.1962 | 21 | 151 | neural tube development |
GO:0080090 | 0 | 1.4421 | 216.7426 | 267 | 4548 | regulation of primary metabolic process |
GO:0048663 | 0 | 8.114 | 1.4913 | 9 | 32 | neuron fate commitment |
GO:0014031 | 0 | 3.5314 | 6.1477 | 19 | 129 | mesenchymal cell development |
GO:0001714 | 0 | 33.5758 | 0.3813 | 5 | 8 | endodermal cell fate specification |
GO:0030030 | 0 | 1.7793 | 47.3231 | 77 | 993 | cell projection organization |
GO:0022414 | 0 | 1.8142 | 43.3676 | 72 | 910 | reproductive process |
GO:0010453 | 0 | 9.517 | 1.1914 | 8 | 25 | regulation of cell fate commitment |
GO:0021513 | 0 | 9.517 | 1.1914 | 8 | 25 | spinal cord dorsal/ventral patterning |
GO:0048592 | 0 | 3.4678 | 6.243 | 19 | 131 | eye morphogenesis |
GO:0035113 | 0 | 3.5689 | 5.7665 | 18 | 121 | embryonic appendage morphogenesis |
GO:0050880 | 0 | 3.7298 | 5.2422 | 17 | 110 | regulation of blood vessel size |
GO:0050877 | 0 | 2.4621 | 14.307 | 32 | 309 | neurological system process |
GO:0000122 | 0 | 2.0179 | 26.4495 | 49 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0021879 | 0 | 5.579 | 2.4305 | 11 | 51 | forebrain neuron differentiation |
GO:0021542 | 0 | 15.1281 | 0.6672 | 6 | 14 | dentate gyrus development |
GO:2000310 | 0 | 15.1281 | 0.6672 | 6 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0042391 | 0 | 2.4086 | 14.5829 | 32 | 306 | regulation of membrane potential |
GO:0048513 | 0 | 1.73 | 51.0642 | 80 | 1255 | organ development |
GO:0001657 | 0 | 3.9667 | 4.3844 | 15 | 92 | ureteric bud development |
GO:0007610 | 0 | 2.1311 | 20.9628 | 41 | 446 | behavior |
GO:0032502 | 0 | 1.6299 | 74.5876 | 107 | 1925 | developmental process |
GO:0072163 | 0 | 3.9155 | 4.4321 | 15 | 93 | mesonephric epithelium development |
GO:0000904 | 0 | 3.0154 | 7.7736 | 21 | 172 | cell morphogenesis involved in differentiation |
GO:0021543 | 0 | 3.502 | 5.5282 | 17 | 116 | pallium development |
GO:0007155 | 0 | 1.765 | 42.4621 | 69 | 891 | cell adhesion |
GO:0009653 | 0 | 1.9738 | 27.1272 | 49 | 656 | anatomical structure morphogenesis |
GO:0007269 | 0 | 3.6222 | 5.0516 | 16 | 106 | neurotransmitter secretion |
GO:0002064 | 0 | 2.9217 | 8.0063 | 21 | 168 | epithelial cell development |
GO:0061138 | 1e-04 | 2.7962 | 8.7212 | 22 | 183 | morphogenesis of a branching epithelium |
GO:0023052 | 1e-04 | 1.4342 | 163.1464 | 204 | 3748 | signaling |
GO:0016358 | 1e-04 | 3.1655 | 6.386 | 18 | 134 | dendrite development |
GO:0061448 | 1e-04 | 6.0338 | 1.8592 | 9 | 40 | connective tissue development |
GO:0032990 | 1e-04 | 1.8104 | 34.6464 | 58 | 727 | cell part morphogenesis |
GO:0035115 | 1e-04 | 7.0308 | 1.4774 | 8 | 31 | embryonic forelimb morphogenesis |
GO:0051216 | 1e-04 | 2.9983 | 7.0678 | 19 | 149 | cartilage development |
GO:0031018 | 1e-04 | 5.9022 | 1.8978 | 9 | 40 | endocrine pancreas development |
GO:0035265 | 1e-04 | 3.7449 | 4.2891 | 14 | 90 | organ growth |
GO:0048704 | 1e-04 | 3.7449 | 4.2891 | 14 | 90 | embryonic skeletal system morphogenesis |
GO:0060562 | 1e-04 | 2.293 | 14.2493 | 30 | 299 | epithelial tube morphogenesis |
GO:0021912 | 1e-04 | Inf | 0.143 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0071805 | 1e-04 | 3.1203 | 6.1001 | 17 | 128 | potassium ion transmembrane transport |
GO:0007263 | 1e-04 | 10.0821 | 0.8578 | 6 | 18 | nitric oxide mediated signal transduction |
GO:0007492 | 1e-04 | 4.0575 | 3.4313 | 12 | 72 | endoderm development |
GO:0045165 | 1e-04 | 3.7502 | 3.9517 | 13 | 88 | cell fate commitment |
GO:0001709 | 1e-04 | 6.2464 | 1.6134 | 8 | 34 | cell fate determination |
GO:0050794 | 2e-04 | 1.5497 | 100.899 | 131 | 2566 | regulation of cellular process |
GO:0021796 | 2e-04 | 26.8158 | 0.3336 | 4 | 7 | cerebral cortex regionalization |
GO:0071420 | 2e-04 | 26.8158 | 0.3336 | 4 | 7 | cellular response to histamine |
GO:2000543 | 2e-04 | 26.8158 | 0.3336 | 4 | 7 | positive regulation of gastrulation |
GO:0009890 | 2e-04 | 1.6412 | 47.9426 | 73 | 1006 | negative regulation of biosynthetic process |
GO:0034284 | 2e-04 | 3.1309 | 5.7188 | 16 | 120 | response to monosaccharide |
GO:0010646 | 2e-04 | 1.4444 | 107.7041 | 142 | 2260 | regulation of cell communication |
GO:0003013 | 2e-04 | 2.1671 | 15.4884 | 31 | 325 | circulatory system process |
GO:0060429 | 2e-04 | 1.7841 | 31.9778 | 53 | 693 | epithelium development |
GO:0007218 | 2e-04 | 3.6151 | 4.0985 | 13 | 86 | neuropeptide signaling pathway |
GO:0032879 | 2e-04 | 1.5093 | 76.1554 | 106 | 1598 | regulation of localization |
GO:1902679 | 2e-04 | 1.7001 | 39.2214 | 62 | 823 | negative regulation of RNA biosynthetic process |
GO:0007270 | 2e-04 | 3.5944 | 4.1156 | 13 | 87 | neuron-neuron synaptic transmission |
GO:0060219 | 2e-04 | 12.5857 | 0.6195 | 5 | 13 | camera-type eye photoreceptor cell differentiation |
GO:0001658 | 2e-04 | 4.4988 | 2.6211 | 10 | 55 | branching involved in ureteric bud morphogenesis |
GO:0023051 | 2e-04 | 1.4353 | 107.4182 | 141 | 2254 | regulation of signaling |
GO:0006813 | 2e-04 | 2.7283 | 7.6727 | 19 | 161 | potassium ion transport |
GO:0001764 | 2e-04 | 3.0424 | 5.8618 | 16 | 123 | neuron migration |
GO:0021517 | 2e-04 | 6.8141 | 1.3185 | 7 | 28 | ventral spinal cord development |
GO:0043410 | 2e-04 | 2.1877 | 14.3447 | 29 | 301 | positive regulation of MAPK cascade |
GO:0036342 | 2e-04 | 8.6403 | 0.9531 | 6 | 20 | post-anal tail morphogenesis |
GO:2000027 | 3e-04 | 2.8841 | 6.529 | 17 | 137 | regulation of organ morphogenesis |
GO:0015824 | 3e-04 | 20.1102 | 0.3813 | 4 | 8 | proline transport |
GO:0048793 | 3e-04 | 20.1102 | 0.3813 | 4 | 8 | pronephros development |
GO:0072177 | 3e-04 | 20.1102 | 0.3813 | 4 | 8 | mesonephric duct development |
GO:0072178 | 3e-04 | 20.1102 | 0.3813 | 4 | 8 | nephric duct morphogenesis |
GO:0060384 | 3e-04 | 8.0637 | 1.0008 | 6 | 21 | innervation |
GO:0035116 | 3e-04 | 6.4213 | 1.382 | 7 | 29 | embryonic hindlimb morphogenesis |
GO:0007631 | 3e-04 | 3.6315 | 3.7649 | 12 | 79 | feeding behavior |
GO:0001568 | 4e-04 | 1.8914 | 22.1127 | 39 | 464 | blood vessel development |
GO:0042660 | 4e-04 | 60.245 | 0.1906 | 3 | 4 | positive regulation of cell fate specification |
GO:0048619 | 4e-04 | 60.245 | 0.1906 | 3 | 4 | embryonic hindgut morphogenesis |
GO:0060591 | 4e-04 | 60.245 | 0.1906 | 3 | 4 | chondroblast differentiation |
GO:0060795 | 4e-04 | 6.1416 | 1.4297 | 7 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:0002793 | 4e-04 | 4.1302 | 2.8117 | 10 | 59 | positive regulation of peptide secretion |
GO:0045137 | 4e-04 | 2.5811 | 8.054 | 19 | 169 | development of primary sexual characteristics |
GO:0016339 | 4e-04 | 7.559 | 1.0484 | 6 | 22 | calcium-dependent cell-cell adhesion |
GO:0045909 | 4e-04 | 7.559 | 1.0484 | 6 | 22 | positive regulation of vasodilation |
GO:0044057 | 5e-04 | 2.4377 | 9.3741 | 21 | 199 | regulation of system process |
GO:0060021 | 5e-04 | 3.475 | 3.9078 | 12 | 82 | palate development |
GO:0014070 | 5e-04 | 1.7998 | 26.1601 | 44 | 553 | response to organic cyclic compound |
GO:0045934 | 5e-04 | 1.6063 | 44.6543 | 67 | 937 | negative regulation of nucleobase-containing compound metabolic process |
GO:0035987 | 5e-04 | 5.0496 | 1.9063 | 8 | 40 | endodermal cell differentiation |
GO:0050810 | 5e-04 | 5.0496 | 1.9063 | 8 | 40 | regulation of steroid biosynthetic process |
GO:0009605 | 5e-04 | 1.4823 | 71.9139 | 99 | 1509 | response to external stimulus |
GO:0002065 | 5e-04 | 3.4258 | 3.9555 | 12 | 83 | columnar/cuboidal epithelial cell differentiation |
GO:0048806 | 6e-04 | 7.1667 | 1.0885 | 6 | 23 | genitalia development |
GO:0007215 | 6e-04 | 4.9303 | 1.9413 | 8 | 41 | glutamate receptor signaling pathway |
GO:2000113 | 6e-04 | 1.6041 | 43.3199 | 65 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0090102 | 6e-04 | 5.6493 | 1.525 | 7 | 32 | cochlea development |
GO:0098660 | 7e-04 | 1.823 | 23.4471 | 40 | 492 | inorganic ion transmembrane transport |
GO:0042136 | 7e-04 | 9.151 | 0.7625 | 5 | 16 | neurotransmitter biosynthetic process |
GO:0007369 | 7e-04 | 2.6366 | 7.0576 | 17 | 149 | gastrulation |
GO:0045665 | 7e-04 | 4.2308 | 2.4781 | 9 | 52 | negative regulation of neuron differentiation |
GO:0060415 | 7e-04 | 4.2308 | 2.4781 | 9 | 52 | muscle tissue morphogenesis |
GO:0001755 | 8e-04 | 5.4316 | 1.5727 | 7 | 33 | neural crest cell migration |
GO:1902476 | 8e-04 | 3.7462 | 3.05 | 10 | 64 | chloride transmembrane transport |
GO:0021953 | 8e-04 | 3.2348 | 4.1426 | 12 | 90 | central nervous system neuron differentiation |
GO:0003299 | 9e-04 | 13.4046 | 0.4766 | 4 | 10 | muscle hypertrophy in response to stress |
GO:1902337 | 9e-04 | 13.4046 | 0.4766 | 4 | 10 | regulation of apoptotic process involved in morphogenesis |
GO:0071495 | 9e-04 | 1.6053 | 39.841 | 60 | 836 | cellular response to endogenous stimulus |
GO:0010629 | 9e-04 | 1.576 | 43.9871 | 65 | 923 | negative regulation of gene expression |
GO:0035051 | 9e-04 | 3.0298 | 4.7657 | 13 | 100 | cardiocyte differentiation |
GO:0001501 | 9e-04 | 2.5586 | 7.2362 | 17 | 158 | skeletal system development |
GO:0030539 | 9e-04 | 8.3877 | 0.8102 | 5 | 17 | male genitalia development |
GO:0021533 | 9e-04 | 6.3639 | 1.1914 | 6 | 25 | cell differentiation in hindbrain |
GO:0014013 | 9e-04 | 3.6778 | 3.0977 | 10 | 65 | regulation of gliogenesis |
GO:0031128 | 9e-04 | 5.23 | 1.6203 | 7 | 34 | developmental induction |
GO:0055010 | 9e-04 | 5.23 | 1.6203 | 7 | 34 | ventricular cardiac muscle tissue morphogenesis |
GO:0072089 | 0.001 | 2.7438 | 6.0047 | 15 | 126 | stem cell proliferation |
GO:0060420 | 0.001 | 30.3586 | 0.2365 | 3 | 5 | regulation of heart growth |
GO:0021778 | 0.001 | 30.12 | 0.2383 | 3 | 5 | oligodendrocyte cell fate specification |
GO:0072507 | 0.001 | 2.1016 | 12.772 | 25 | 268 | divalent inorganic cation homeostasis |
GO:0045446 | 0.0011 | 3.6118 | 3.1453 | 10 | 66 | endothelial cell differentiation |
GO:0051588 | 0.0011 | 3.9539 | 2.6211 | 9 | 55 | regulation of neurotransmitter transport |
GO:0048468 | 0.0011 | 1.7998 | 22.5494 | 38 | 532 | cell development |
GO:0022037 | 0.0011 | 3.1165 | 4.2891 | 12 | 90 | metencephalon development |
GO:0042471 | 0.0011 | 7.9194 | 0.8397 | 5 | 18 | ear morphogenesis |
GO:0050805 | 0.0011 | 5.0428 | 1.668 | 7 | 35 | negative regulation of synaptic transmission |
GO:0046530 | 0.0011 | 4.3654 | 2.1446 | 8 | 45 | photoreceptor cell differentiation |
GO:0090183 | 0.0011 | 4.3654 | 2.1446 | 8 | 45 | regulation of kidney development |
GO:0042063 | 0.0012 | 2.932 | 4.8993 | 13 | 104 | gliogenesis |
GO:0051046 | 0.0012 | 1.8163 | 21.1119 | 36 | 443 | regulation of secretion |
GO:2000311 | 0.0012 | 7.7418 | 0.8578 | 5 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0055082 | 0.0012 | 1.8326 | 20.3494 | 35 | 427 | cellular chemical homeostasis |
GO:0048870 | 0.0013 | 1.5567 | 43.7488 | 64 | 918 | cell motility |
GO:0014887 | 0.0013 | 11.4887 | 0.5242 | 4 | 11 | cardiac muscle adaptation |
GO:0060379 | 0.0013 | 11.4887 | 0.5242 | 4 | 11 | cardiac muscle cell myoblast differentiation |
GO:0097154 | 0.0013 | 11.4887 | 0.5242 | 4 | 11 | GABAergic neuron differentiation |
GO:0048562 | 0.0013 | 3.2343 | 3.7921 | 11 | 83 | embryonic organ morphogenesis |
GO:0048709 | 0.0013 | 3.4867 | 3.2407 | 10 | 68 | oligodendrocyte differentiation |
GO:0021587 | 0.0013 | 4.8685 | 1.7156 | 7 | 36 | cerebellum morphogenesis |
GO:0007600 | 0.0014 | 1.8521 | 18.9783 | 33 | 400 | sensory perception |
GO:0030509 | 0.0014 | 2.8639 | 5.004 | 13 | 105 | BMP signaling pathway |
GO:0072207 | 0.0014 | 5.7569 | 1.2867 | 6 | 27 | metanephric epithelium development |
GO:0030902 | 0.0015 | 4.7869 | 1.7352 | 7 | 37 | hindbrain development |
GO:0040011 | 0.0015 | 2.0127 | 13.8252 | 26 | 301 | locomotion |
GO:0048708 | 0.0015 | 4.1408 | 2.2399 | 8 | 47 | astrocyte differentiation |
GO:0050807 | 0.0016 | 3.7109 | 2.7641 | 9 | 58 | regulation of synapse organization |
GO:0007214 | 0.0016 | 7.1882 | 0.9055 | 5 | 19 | gamma-aminobutyric acid signaling pathway |
GO:0022603 | 0.0017 | 1.7522 | 23.0428 | 38 | 492 | regulation of anatomical structure morphogenesis |
GO:2000177 | 0.0017 | 5.5362 | 1.325 | 6 | 28 | regulation of neural precursor cell proliferation |
GO:0060079 | 0.0017 | 5.5268 | 1.3271 | 6 | 28 | regulation of excitatory postsynaptic membrane potential |
GO:0048522 | 0.0017 | 1.3573 | 112.9058 | 141 | 2511 | positive regulation of cellular process |
GO:0042733 | 0.0018 | 3.6364 | 2.8117 | 9 | 59 | embryonic digit morphogenesis |
GO:1901576 | 0.0018 | 1.285 | 219.745 | 254 | 4611 | organic substance biosynthetic process |
GO:0001946 | 0.0019 | 10.0518 | 0.5719 | 4 | 12 | lymphangiogenesis |
GO:0098655 | 0.0019 | 1.7266 | 23.9713 | 39 | 503 | cation transmembrane transport |
GO:0003025 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0018119 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | peptidyl-cysteine S-nitrosylation |
GO:0031284 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | positive regulation of guanylate cyclase activity |
GO:0048852 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | diencephalon morphogenesis |
GO:0072038 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
GO:0097120 | 0.0019 | 20.0783 | 0.2859 | 3 | 6 | receptor localization to synapse |
GO:0007611 | 0.002 | 2.3011 | 8.4352 | 18 | 177 | learning or memory |
GO:0090066 | 0.002 | 1.9652 | 14.1104 | 26 | 297 | regulation of anatomical structure size |
GO:0008306 | 0.002 | 3.5648 | 2.8594 | 9 | 60 | associative learning |
GO:0060042 | 0.002 | 5.2963 | 1.372 | 6 | 29 | retina morphogenesis in camera-type eye |
GO:0060070 | 0.0021 | 2.2336 | 9.1501 | 19 | 192 | canonical Wnt signaling pathway |
GO:0072078 | 0.0021 | 6.7085 | 0.9531 | 5 | 20 | nephron tubule morphogenesis |
GO:0009953 | 0.0021 | 3.2582 | 3.4294 | 10 | 73 | dorsal/ventral pattern formation |
GO:0009954 | 0.0021 | 5.2554 | 1.382 | 6 | 29 | proximal/distal pattern formation |
GO:0030858 | 0.0022 | 4.411 | 1.8586 | 7 | 39 | positive regulation of epithelial cell differentiation |
GO:0051966 | 0.0022 | 4.411 | 1.8586 | 7 | 39 | regulation of synaptic transmission, glutamatergic |
GO:0021903 | 0.0022 | Inf | 0.0949 | 2 | 2 | rostrocaudal neural tube patterning |
GO:0060359 | 0.0023 | 3.4959 | 2.9071 | 9 | 61 | response to ammonium ion |
GO:0001982 | 0.0023 | Inf | 0.0953 | 2 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
GO:0006540 | 0.0023 | Inf | 0.0953 | 2 | 2 | glutamate decarboxylation to succinate |
GO:0070858 | 0.0023 | Inf | 0.0953 | 2 | 2 | negative regulation of bile acid biosynthetic process |
GO:0072166 | 0.0023 | Inf | 0.0953 | 2 | 2 | posterior mesonephric tubule development |
GO:0072181 | 0.0023 | Inf | 0.0953 | 2 | 2 | mesonephric duct formation |
GO:1902257 | 0.0023 | Inf | 0.0953 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:1903242 | 0.0023 | Inf | 0.0953 | 2 | 2 | regulation of cardiac muscle hypertrophy in response to stress |
GO:0006874 | 0.0024 | 2.0648 | 11.3899 | 22 | 239 | cellular calcium ion homeostasis |
GO:0016337 | 0.0024 | 1.9613 | 13.5822 | 25 | 285 | single organismal cell-cell adhesion |
GO:0048665 | 0.0025 | 9.0644 | 0.6111 | 4 | 13 | neuron fate specification |
GO:0009749 | 0.0025 | 3.7888 | 2.4099 | 8 | 51 | response to glucose |
GO:0048333 | 0.0025 | 5.036 | 1.4297 | 6 | 30 | mesodermal cell differentiation |
GO:0030799 | 0.0026 | 2.792 | 4.718 | 12 | 99 | regulation of cyclic nucleotide metabolic process |
GO:0001756 | 0.0026 | 3.7715 | 2.4201 | 8 | 51 | somitogenesis |
GO:0030826 | 0.0026 | 8.9341 | 0.6195 | 4 | 13 | regulation of cGMP biosynthetic process |
GO:0048935 | 0.0026 | 8.9341 | 0.6195 | 4 | 13 | peripheral nervous system neuron development |
GO:0001945 | 0.0026 | 6.2887 | 1.0008 | 5 | 21 | lymph vessel development |
GO:0002068 | 0.0026 | 6.2887 | 1.0008 | 5 | 21 | glandular epithelial cell development |
GO:0051965 | 0.0026 | 6.2887 | 1.0008 | 5 | 21 | positive regulation of synapse assembly |
GO:0048523 | 0.0027 | 1.3466 | 104.7934 | 131 | 2251 | negative regulation of cellular process |
GO:0022898 | 0.0027 | 2.5335 | 6.0047 | 14 | 126 | regulation of transmembrane transporter activity |
GO:0048589 | 0.0027 | 2.0804 | 10.7892 | 21 | 228 | developmental growth |
GO:0045471 | 0.0027 | 2.9275 | 4.1461 | 11 | 87 | response to ethanol |
GO:0023014 | 0.0028 | 1.6726 | 25.3057 | 40 | 531 | signal transduction by phosphorylation |
GO:0003206 | 0.0028 | 2.76 | 4.7657 | 12 | 100 | cardiac chamber morphogenesis |
GO:0032526 | 0.0028 | 2.76 | 4.7657 | 12 | 100 | response to retinoic acid |
GO:0052652 | 0.0028 | 2.76 | 4.7657 | 12 | 100 | cyclic purine nucleotide metabolic process |
GO:0090087 | 0.0029 | 2.2708 | 8.054 | 17 | 169 | regulation of peptide transport |
GO:0007200 | 0.003 | 3.6688 | 2.4781 | 8 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0048666 | 0.0031 | 1.984 | 12.3434 | 23 | 274 | neuron development |
GO:0009725 | 0.0031 | 1.5863 | 31.9776 | 48 | 671 | response to hormone |
GO:0007187 | 0.0031 | 2.4887 | 6.1001 | 14 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048598 | 0.0031 | 2.8612 | 4.2108 | 11 | 95 | embryonic morphogenesis |
GO:0021521 | 0.0032 | 15.1586 | 0.3315 | 3 | 7 | ventral spinal cord interneuron specification |
GO:0003310 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | pancreatic A cell differentiation |
GO:0015816 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | glycine transport |
GO:0021798 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0022601 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | menstrual cycle phase |
GO:0046549 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | retinal cone cell development |
GO:0050957 | 0.0033 | 15.0575 | 0.3336 | 3 | 7 | equilibrioception |
GO:0030808 | 0.0033 | 2.852 | 4.2414 | 11 | 89 | regulation of nucleotide biosynthetic process |
GO:0060349 | 0.0034 | 3.016 | 3.6696 | 10 | 77 | bone morphogenesis |
GO:0072160 | 0.0035 | 8.0401 | 0.6672 | 4 | 14 | nephron tubule epithelial cell differentiation |
GO:0072189 | 0.0035 | 8.0401 | 0.6672 | 4 | 14 | ureter development |
GO:0003231 | 0.0036 | 2.8156 | 4.2891 | 11 | 90 | cardiac ventricle development |
GO:0055021 | 0.0036 | 4.6479 | 1.525 | 6 | 32 | regulation of cardiac muscle tissue growth |
GO:0051960 | 0.0037 | 3.5184 | 2.5533 | 8 | 57 | regulation of nervous system development |
GO:0048585 | 0.0037 | 1.4905 | 43.2246 | 61 | 907 | negative regulation of response to stimulus |
GO:0001838 | 0.0038 | 2.5309 | 5.5758 | 13 | 117 | embryonic epithelial tube formation |
GO:0048546 | 0.0038 | 3.5087 | 2.5735 | 8 | 54 | digestive tract morphogenesis |
GO:0061005 | 0.0039 | 3.9196 | 2.0492 | 7 | 43 | cell differentiation involved in kidney development |
GO:0035235 | 0.004 | 5.589 | 1.0961 | 5 | 23 | ionotropic glutamate receptor signaling pathway |
GO:0072273 | 0.004 | 5.589 | 1.0961 | 5 | 23 | metanephric nephron morphogenesis |
GO:0010243 | 0.0041 | 1.5911 | 29.1659 | 44 | 612 | response to organonitrogen compound |
GO:0008344 | 0.0042 | 2.9281 | 3.7649 | 10 | 79 | adult locomotory behavior |
GO:0030282 | 0.0042 | 2.9281 | 3.7649 | 10 | 79 | bone mineralization |
GO:0008284 | 0.0042 | 1.7012 | 21.1086 | 34 | 453 | positive regulation of cell proliferation |
GO:0043066 | 0.0042 | 1.6082 | 27.5456 | 42 | 578 | negative regulation of apoptotic process |
GO:0035094 | 0.0042 | 4.4753 | 1.5727 | 6 | 33 | response to nicotine |
GO:0051932 | 0.0042 | 4.4753 | 1.5727 | 6 | 33 | synaptic transmission, GABAergic |
GO:0042886 | 0.0043 | 2.0326 | 10.4845 | 20 | 220 | amide transport |
GO:0060322 | 0.0043 | 3.4337 | 2.6211 | 8 | 55 | head development |
GO:0007204 | 0.0043 | 2.2379 | 7.6727 | 16 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0010975 | 0.0043 | 1.9546 | 11.9618 | 22 | 251 | regulation of neuron projection development |
GO:0001525 | 0.0044 | 1.8173 | 15.7267 | 27 | 330 | angiogenesis |
GO:0071363 | 0.0044 | 1.602 | 27.6409 | 42 | 580 | cellular response to growth factor stimulus |
GO:0046887 | 0.0046 | 2.8861 | 3.8125 | 10 | 80 | positive regulation of hormone secretion |
GO:1901699 | 0.0046 | 1.7038 | 20.4447 | 33 | 429 | cellular response to nitrogen compound |
GO:0072112 | 0.0046 | 7.3085 | 0.7149 | 4 | 15 | glomerular visceral epithelial cell differentiation |
GO:2000036 | 0.0046 | 7.3085 | 0.7149 | 4 | 15 | regulation of stem cell maintenance |
GO:2000463 | 0.0046 | 7.3085 | 0.7149 | 4 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0050679 | 0.0047 | 2.4594 | 5.7188 | 13 | 120 | positive regulation of epithelial cell proliferation |
GO:2000026 | 0.0047 | 1.6737 | 22.0781 | 35 | 514 | regulation of multicellular organismal development |
GO:0070887 | 0.0047 | 1.3934 | 64.6752 | 85 | 1387 | cellular response to chemical stimulus |
GO:0048608 | 0.0047 | 1.9069 | 12.7903 | 23 | 274 | reproductive structure development |
GO:0051050 | 0.0048 | 1.6354 | 24.4955 | 38 | 514 | positive regulation of transport |
GO:0048332 | 0.0048 | 3.0794 | 3.2407 | 9 | 68 | mesoderm morphogenesis |
GO:0030325 | 0.0048 | 5.2944 | 1.1438 | 5 | 24 | adrenal gland development |
GO:0045686 | 0.0048 | 5.2944 | 1.1438 | 5 | 24 | negative regulation of glial cell differentiation |
GO:0090276 | 0.0048 | 2.2071 | 7.768 | 16 | 163 | regulation of peptide hormone secretion |
GO:0009889 | 0.0049 | 47.2094 | 0.1225 | 2 | 3 | regulation of biosynthetic process |
GO:0035137 | 0.0049 | 12.1649 | 0.3777 | 3 | 8 | hindlimb morphogenesis |
GO:0007156 | 0.005 | 2.4364 | 5.7665 | 13 | 121 | homophilic cell adhesion |
GO:0006527 | 0.005 | 12.045 | 0.3813 | 3 | 8 | arginine catabolic process |
GO:0021559 | 0.005 | 12.045 | 0.3813 | 3 | 8 | trigeminal nerve development |
GO:0040019 | 0.005 | 12.045 | 0.3813 | 3 | 8 | positive regulation of embryonic development |
GO:0046485 | 0.005 | 12.045 | 0.3813 | 3 | 8 | ether lipid metabolic process |
GO:0032024 | 0.005 | 3.7126 | 2.1446 | 7 | 45 | positive regulation of insulin secretion |
GO:0061326 | 0.005 | 3.7126 | 2.1446 | 7 | 45 | renal tubule development |
GO:0048771 | 0.0053 | 2.5283 | 5.1469 | 12 | 108 | tissue remodeling |
GO:0002244 | 0.0054 | 2.4138 | 5.8141 | 13 | 122 | hematopoietic progenitor cell differentiation |
GO:0050768 | 0.0054 | 2.6469 | 4.5274 | 11 | 95 | negative regulation of neurogenesis |
GO:0048839 | 0.0055 | 3.2626 | 2.7314 | 8 | 59 | inner ear development |
GO:0019827 | 0.0056 | 2.6309 | 4.5501 | 11 | 96 | stem cell maintenance |
GO:0007605 | 0.0057 | 2.3917 | 5.8618 | 13 | 123 | sensory perception of sound |
GO:0021846 | 0.0058 | 5.0293 | 1.1914 | 5 | 25 | cell proliferation in forebrain |
GO:0072077 | 0.0059 | 6.6989 | 0.7625 | 4 | 16 | renal vesicle morphogenesis |
GO:0072148 | 0.0059 | 6.6989 | 0.7625 | 4 | 16 | epithelial cell fate commitment |
GO:0072224 | 0.0059 | 6.6989 | 0.7625 | 4 | 16 | metanephric glomerulus development |
GO:0009611 | 0.0061 | 1.4984 | 36.505 | 52 | 766 | response to wounding |
GO:0055065 | 0.0061 | 1.7296 | 17.6806 | 29 | 371 | metal ion homeostasis |
GO:0030154 | 0.0063 | 1.5721 | 28.2892 | 42 | 712 | cell differentiation |
GO:0048511 | 0.0063 | 1.9531 | 10.8657 | 20 | 228 | rhythmic process |
GO:0007254 | 0.0063 | 2.202 | 7.2915 | 15 | 153 | JNK cascade |
GO:0071322 | 0.0064 | 2.9296 | 3.3836 | 9 | 71 | cellular response to carbohydrate stimulus |
GO:0030850 | 0.0064 | 3.5264 | 2.2399 | 7 | 47 | prostate gland development |
GO:0072172 | 0.0065 | 40.2304 | 0.1425 | 2 | 3 | mesonephric tubule formation |
GO:0048566 | 0.0066 | 4.0268 | 1.7156 | 6 | 36 | embryonic digestive tract development |
GO:0015820 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | leucine transport |
GO:0015891 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | siderophore transport |
GO:0021902 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030910 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | olfactory placode formation |
GO:0035564 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | regulation of kidney size |
GO:0035726 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0036023 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0042335 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | cuticle development |
GO:0048807 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | female genitalia morphogenesis |
GO:0060112 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | generation of ovulation cycle rhythm |
GO:0071698 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | olfactory placode development |
GO:0072003 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | kidney rudiment formation |
GO:0097211 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0097477 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | lateral motor column neuron migration |
GO:1900212 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000195 | 0.0066 | 40.0965 | 0.143 | 2 | 3 | negative regulation of female gonad development |
GO:0046903 | 0.0068 | 1.793 | 14.7206 | 25 | 317 | secretion |
GO:0006811 | 0.0069 | 1.5404 | 30.0458 | 44 | 649 | ion transport |
GO:0044707 | 0.0069 | 1.5189 | 35.4331 | 50 | 1055 | single-multicellular organism process |
GO:0007565 | 0.007 | 2.3276 | 6.0047 | 13 | 126 | female pregnancy |
GO:0072009 | 0.007 | 3.4593 | 2.2756 | 7 | 48 | nephron epithelium development |
GO:0014051 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | gamma-aminobutyric acid secretion |
GO:0015671 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | oxygen transport |
GO:0030917 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | midbrain-hindbrain boundary development |
GO:0032525 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | somite rostral/caudal axis specification |
GO:0046113 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | nucleobase catabolic process |
GO:0048664 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | neuron fate determination |
GO:0061004 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | pattern specification involved in kidney development |
GO:0061525 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | hindgut development |
GO:0090009 | 0.0073 | 10.0367 | 0.4289 | 3 | 9 | primitive streak formation |
GO:0030878 | 0.0074 | 6.1831 | 0.8102 | 4 | 17 | thyroid gland development |
GO:0060231 | 0.0074 | 6.1831 | 0.8102 | 4 | 17 | mesenchymal to epithelial transition |
GO:0009967 | 0.0074 | 1.4455 | 42.891 | 59 | 900 | positive regulation of signal transduction |
GO:0042246 | 0.0075 | 3.8966 | 1.7633 | 6 | 37 | tissue regeneration |
GO:2000179 | 0.0075 | 3.8966 | 1.7633 | 6 | 37 | positive regulation of neural precursor cell proliferation |
GO:0007422 | 0.0076 | 2.8376 | 3.4789 | 9 | 73 | peripheral nervous system development |
GO:0071383 | 0.0079 | 2.4972 | 4.7657 | 11 | 100 | cellular response to steroid hormone stimulus |
GO:0008016 | 0.008 | 2.2867 | 6.1001 | 13 | 128 | regulation of heart contraction |
GO:0071333 | 0.008 | 3.0435 | 2.9071 | 8 | 61 | cellular response to glucose stimulus |
GO:0030178 | 0.0081 | 2.3784 | 5.4329 | 12 | 114 | negative regulation of Wnt signaling pathway |
GO:0023061 | 0.0082 | 1.9373 | 10.3861 | 19 | 222 | signal release |
GO:0015698 | 0.0085 | 2.4692 | 4.8133 | 11 | 101 | inorganic anion transport |
GO:0007519 | 0.0088 | 2.1794 | 6.8626 | 14 | 144 | skeletal muscle tissue development |
GO:0048706 | 0.0089 | 4.4487 | 1.3127 | 5 | 28 | embryonic skeletal system development |
GO:0060038 | 0.009 | 5.7729 | 0.8533 | 4 | 18 | cardiac muscle cell proliferation |
GO:0051952 | 0.0091 | 3.2796 | 2.3828 | 7 | 50 | regulation of amine transport |
GO:0071695 | 0.0091 | 3.2796 | 2.3828 | 7 | 50 | anatomical structure maturation |
GO:0035148 | 0.0091 | 2.2473 | 6.1954 | 13 | 130 | tube formation |
GO:0010575 | 0.0092 | 5.741 | 0.8578 | 4 | 18 | positive regulation vascular endothelial growth factor production |
GO:0060045 | 0.0092 | 5.741 | 0.8578 | 4 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:0072010 | 0.0092 | 5.741 | 0.8578 | 4 | 18 | glomerular epithelium development |
GO:0072074 | 0.0092 | 5.741 | 0.8578 | 4 | 18 | kidney mesenchyme development |
GO:0060548 | 0.0094 | 1.5158 | 29.7378 | 43 | 624 | negative regulation of cell death |
GO:0048565 | 0.0094 | 3.2495 | 2.399 | 7 | 51 | digestive tract development |
GO:0010092 | 0.0095 | 4.3722 | 1.3344 | 5 | 28 | specification of organ identity |
GO:0008584 | 0.0096 | 2.5553 | 4.2414 | 10 | 89 | male gonad development |
GO:0009798 | 0.0099 | 2.7099 | 3.6219 | 9 | 76 | axis specification |
GO:0021520 | 0.0099 | 8.6454 | 0.4743 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0009914 | 0.01 | 1.8619 | 11.3423 | 20 | 238 | hormone transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 2.5508 | 30.0816 | 67 | 666 | sequence-specific DNA binding |
GO:0060089 | 0 | 1.8764 | 43.4785 | 74 | 958 | molecular transducer activity |
GO:0001071 | 0 | 1.8596 | 41.9354 | 71 | 924 | nucleic acid binding transcription factor activity |
GO:0038023 | 0 | 2.0448 | 28.412 | 53 | 632 | signaling receptor activity |
GO:0005179 | 1e-04 | 4.5185 | 2.8592 | 11 | 63 | hormone activity |
GO:0001205 | 1e-04 | 9.8021 | 0.8623 | 6 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0005267 | 2e-04 | 3.4458 | 4.5839 | 14 | 101 | potassium channel activity |
GO:0071855 | 2e-04 | 9.1012 | 0.9077 | 6 | 20 | neuropeptide receptor binding |
GO:0000981 | 4e-04 | 2.7091 | 7.2873 | 18 | 163 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0008201 | 4e-04 | 3.1873 | 4.9015 | 14 | 108 | heparin binding |
GO:0022836 | 4e-04 | 2.2562 | 11.9816 | 25 | 264 | gated channel activity |
GO:0019841 | 4e-04 | 16.9408 | 0.4085 | 4 | 9 | retinol binding |
GO:0022838 | 5e-04 | 2.0825 | 14.9769 | 29 | 330 | substrate-specific channel activity |
GO:0046873 | 5e-04 | 2.0825 | 14.9769 | 29 | 330 | metal ion transmembrane transporter activity |
GO:0008324 | 6e-04 | 1.8418 | 22.647 | 39 | 499 | cation transmembrane transporter activity |
GO:0008528 | 7e-04 | 3.3278 | 4.0392 | 12 | 89 | G-protein coupled peptide receptor activity |
GO:0016918 | 7e-04 | 14.1161 | 0.4538 | 4 | 10 | retinal binding |
GO:0005244 | 8e-04 | 2.6027 | 7.1254 | 17 | 157 | voltage-gated ion channel activity |
GO:0008083 | 0.001 | 2.8507 | 5.4008 | 14 | 119 | growth factor activity |
GO:0005540 | 0.001 | 8.1537 | 0.8169 | 5 | 18 | hyaluronic acid binding |
GO:0019825 | 0.001 | 8.1537 | 0.8169 | 5 | 18 | oxygen binding |
GO:0015077 | 0.0011 | 2.1345 | 12.0723 | 24 | 266 | monovalent inorganic cation transmembrane transporter activity |
GO:0001540 | 0.0011 | 6.0638 | 1.2254 | 6 | 27 | beta-amyloid binding |
GO:0022803 | 0.0011 | 1.9682 | 15.7485 | 29 | 347 | passive transmembrane transporter activity |
GO:0005104 | 0.0013 | 7.5707 | 0.8623 | 5 | 19 | fibroblast growth factor receptor binding |
GO:0022892 | 0.0016 | 1.6006 | 35.8659 | 54 | 794 | substrate-specific transporter activity |
GO:0015293 | 0.002 | 2.8762 | 4.5839 | 12 | 101 | symporter activity |
GO:0004991 | 0.0021 | Inf | 0.0908 | 2 | 2 | parathyroid hormone receptor activity |
GO:0005185 | 0.0021 | Inf | 0.0908 | 2 | 2 | neurohypophyseal hormone activity |
GO:0005275 | 0.0021 | Inf | 0.0908 | 2 | 2 | amine transmembrane transporter activity |
GO:0031894 | 0.0021 | Inf | 0.0908 | 2 | 2 | V1A vasopressin receptor binding |
GO:0034987 | 0.0021 | Inf | 0.0908 | 2 | 2 | immunoglobulin receptor binding |
GO:0004953 | 0.0022 | 9.4083 | 0.59 | 4 | 13 | icosanoid receptor activity |
GO:0003680 | 0.0028 | 15.8548 | 0.3177 | 3 | 7 | AT DNA binding |
GO:0008395 | 0.0028 | 15.8548 | 0.3177 | 3 | 7 | steroid hydroxylase activity |
GO:0005344 | 0.0044 | 12.6828 | 0.3631 | 3 | 8 | oxygen transporter activity |
GO:0031681 | 0.0044 | 12.6828 | 0.3631 | 3 | 8 | G-protein beta-subunit binding |
GO:0071837 | 0.0049 | 7.0545 | 0.7262 | 4 | 16 | HMG box domain binding |
GO:0030594 | 0.0055 | 3.2683 | 2.7231 | 8 | 60 | neurotransmitter receptor activity |
GO:0035326 | 0.0056 | 2.9898 | 3.3131 | 9 | 73 | enhancer binding |
GO:0019840 | 0.0056 | 5.0441 | 1.18 | 5 | 26 | isoprenoid binding |
GO:0004930 | 0.0057 | 2.0575 | 9.3033 | 18 | 210 | G-protein coupled receptor activity |
GO:0001847 | 0.006 | 42.2147 | 0.1362 | 2 | 3 | opsonin receptor activity |
GO:0004937 | 0.006 | 42.2147 | 0.1362 | 2 | 3 | alpha1-adrenergic receptor activity |
GO:0016167 | 0.006 | 42.2147 | 0.1362 | 2 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0070996 | 0.006 | 42.2147 | 0.1362 | 2 | 3 | type 1 melanocortin receptor binding |
GO:0005125 | 0.0068 | 2.4346 | 5.31 | 12 | 117 | cytokine activity |
GO:0000982 | 0.0068 | 2.0639 | 8.7592 | 17 | 193 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity |
GO:0005102 | 0.0078 | 1.5073 | 32.7923 | 47 | 751 | receptor binding |
GO:0000977 | 0.0086 | 1.8573 | 11.9362 | 21 | 263 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0004955 | 0.0088 | 9.0576 | 0.4538 | 3 | 10 | prostaglandin receptor activity |
GO:0005251 | 0.0091 | 4.4125 | 1.3162 | 5 | 29 | delayed rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 27.5182 | 0.3986 | 6 | 13 | olfactory receptor activity |
GO:0005232 | 9e-04 | Inf | 0.0613 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 9e-04 | Inf | 0.0613 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0003774 | 0.0023 | 3.1564 | 3.434 | 10 | 112 | motor activity |
GO:0038023 | 0.0024 | 1.7538 | 21.2174 | 35 | 692 | signaling receptor activity |
GO:0031433 | 0.0028 | 63.5597 | 0.092 | 2 | 3 | telethonin binding |
GO:0005506 | 0.0048 | 2.8213 | 3.802 | 10 | 124 | iron ion binding |
GO:0003779 | 0.0051 | 2.0274 | 9.9035 | 19 | 323 | actin binding |
GO:0034618 | 0.0054 | 31.7772 | 0.1226 | 2 | 4 | arginine binding |
GO:0047760 | 0.0054 | 31.7772 | 0.1226 | 2 | 4 | butyrate-CoA ligase activity |
GO:0022838 | 0.0064 | 1.9806 | 10.1181 | 19 | 330 | substrate-specific channel activity |
GO:0004930 | 0.0082 | 1.9685 | 9.6275 | 18 | 314 | G-protein coupled receptor activity |
GO:0015216 | 0.0088 | 21.183 | 0.1533 | 2 | 5 | purine nucleotide transmembrane transporter activity |
GO:0015347 | 0.0088 | 21.183 | 0.1533 | 2 | 5 | sodium-independent organic anion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 2.0112 | 25.472 | 47 | 692 | signaling receptor activity |
GO:0022836 | 3e-04 | 2.4489 | 9.7177 | 22 | 264 | gated channel activity |
GO:0060089 | 4e-04 | 1.7122 | 35.2633 | 56 | 958 | molecular transducer activity |
GO:0022838 | 5e-04 | 2.2114 | 12.1471 | 25 | 330 | substrate-specific channel activity |
GO:0004930 | 6e-04 | 2.2305 | 11.5581 | 24 | 314 | G-protein coupled receptor activity |
GO:0015077 | 8e-04 | 2.303 | 9.7913 | 21 | 266 | monovalent inorganic cation transmembrane transporter activity |
GO:0022803 | 0.0011 | 2.0916 | 12.7728 | 25 | 347 | passive transmembrane transporter activity |
GO:0046873 | 0.0012 | 2.1109 | 12.1471 | 24 | 330 | metal ion transmembrane transporter activity |
GO:0004982 | 0.0014 | Inf | 0.0736 | 2 | 2 | N-formyl peptide receptor activity |
GO:0030109 | 0.0014 | Inf | 0.0736 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0008324 | 0.0016 | 1.853 | 18.3679 | 32 | 499 | cation transmembrane transporter activity |
GO:0022892 | 0.0018 | 1.6588 | 29.5211 | 46 | 802 | substrate-specific transporter activity |
GO:0005244 | 0.002 | 2.6114 | 5.7791 | 14 | 157 | voltage-gated ion channel activity |
GO:0003777 | 0.0037 | 3.4753 | 2.5398 | 8 | 69 | microtubule motor activity |
GO:0004958 | 0.004 | 52.5607 | 0.1104 | 2 | 3 | prostaglandin F receptor activity |
GO:0018636 | 0.004 | 52.5607 | 0.1104 | 2 | 3 | phenanthrene 9,10-monooxygenase activity |
GO:0047086 | 0.004 | 52.5607 | 0.1104 | 2 | 3 | ketosteroid monooxygenase activity |
GO:0030898 | 0.0049 | 11.2822 | 0.3681 | 3 | 10 | actin-dependent ATPase activity |
GO:0048407 | 0.0049 | 11.2822 | 0.3681 | 3 | 10 | platelet-derived growth factor binding |
GO:0005267 | 0.0052 | 3.0009 | 3.2576 | 9 | 89 | potassium channel activity |
GO:0047115 | 0.0077 | 26.2781 | 0.1472 | 2 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
GO:0015269 | 0.0085 | 8.7736 | 0.4417 | 3 | 12 | calcium-activated potassium channel activity |
GO:0008060 | 0.0092 | 5.5488 | 0.8466 | 4 | 23 | ARF GTPase activator activity |
GO:0004867 | 0.0097 | 3.6026 | 1.8405 | 6 | 50 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015026 | 1e-04 | 11.5302 | 0.7558 | 6 | 18 | coreceptor activity |
GO:0043425 | 5e-04 | 7.2779 | 1.0497 | 6 | 25 | bHLH transcription factor binding |
GO:0005085 | 0.0012 | 2.4883 | 7.3897 | 17 | 176 | guanyl-nucleotide exchange factor activity |
GO:0004075 | 0.0013 | 22.9438 | 0.2519 | 3 | 6 | biotin carboxylase activity |
GO:0046977 | 0.0023 | 17.2064 | 0.2939 | 3 | 7 | TAP binding |
GO:0005089 | 0.0023 | 3.4653 | 2.8971 | 9 | 69 | Rho guanyl-nucleotide exchange factor activity |
GO:0004896 | 0.0034 | 3.5496 | 2.5192 | 8 | 60 | cytokine receptor activity |
GO:0019842 | 0.0034 | 3.5496 | 2.5192 | 8 | 60 | vitamin binding |
GO:0070402 | 0.0051 | 11.469 | 0.3779 | 3 | 9 | NADPH binding |
GO:0031826 | 0.0051 | 45.8066 | 0.126 | 2 | 3 | type 2A serotonin receptor binding |
GO:0016763 | 0.0053 | 4.1854 | 1.6375 | 6 | 39 | transferase activity, transferring pentosyl groups |
GO:0004872 | 0.0074 | 1.4881 | 36.0667 | 51 | 859 | receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 2.4888 | 18.4183 | 41 | 692 | signaling receptor activity |
GO:0060089 | 0 | 2.0346 | 25.4981 | 47 | 958 | molecular transducer activity |
GO:0004930 | 1e-04 | 3.1786 | 5.8487 | 17 | 225 | G-protein coupled receptor activity |
GO:0004252 | 5e-04 | 3.939 | 2.7947 | 10 | 105 | serine-type endopeptidase activity |
GO:0001632 | 7e-04 | Inf | 0.0532 | 2 | 2 | leukotriene B4 receptor activity |
GO:0004982 | 7e-04 | Inf | 0.0532 | 2 | 2 | N-formyl peptide receptor activity |
GO:0005232 | 7e-04 | Inf | 0.0532 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0019865 | 0.0014 | 18.4448 | 0.2395 | 3 | 9 | immunoglobulin binding |
GO:0017171 | 0.0018 | 3.2485 | 3.327 | 10 | 125 | serine hydrolase activity |
GO:0004035 | 0.0021 | 73.5841 | 0.0798 | 2 | 3 | alkaline phosphatase activity |
GO:0015226 | 0.0021 | 73.5841 | 0.0798 | 2 | 3 | carnitine transmembrane transporter activity |
GO:0019957 | 0.0021 | 73.5841 | 0.0798 | 2 | 3 | C-C chemokine binding |
GO:0032396 | 0.0021 | 73.5841 | 0.0798 | 2 | 3 | inhibitory MHC class I receptor activity |
GO:0047374 | 0.0021 | 73.5841 | 0.0798 | 2 | 3 | methylumbelliferyl-acetate deacetylase activity |
GO:0008528 | 0.0021 | 3.7945 | 2.3019 | 8 | 87 | G-protein coupled peptide receptor activity |
GO:0005416 | 0.0034 | 12.2935 | 0.3194 | 3 | 12 | cation:amino acid symporter activity |
GO:0015467 | 0.0041 | 36.789 | 0.1065 | 2 | 4 | G-protein activated inward rectifier potassium channel activity |
GO:0004984 | 0.0044 | 11.0632 | 0.346 | 3 | 13 | olfactory receptor activity |
GO:0015187 | 0.0067 | 24.524 | 0.1331 | 2 | 5 | glycine transmembrane transporter activity |
GO:0003823 | 0.0073 | 4.5133 | 1.2243 | 5 | 46 | antigen binding |
GO:0004601 | 0.0078 | 5.6833 | 0.7985 | 4 | 30 | peroxidase activity |
GO:0033764 | 0.0081 | 8.508 | 0.4259 | 3 | 16 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GO:0008172 | 0.0099 | 18.3914 | 0.1597 | 2 | 6 | S-methyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 54.3683 | 0.3797 | 8 | 13 | olfactory receptor activity |
GO:0004871 | 0 | 2.6231 | 27.9782 | 63 | 958 | signal transducer activity |
GO:0004872 | 0 | 2.6763 | 25.0869 | 58 | 859 | receptor activity |
GO:0004930 | 0 | 3.0151 | 9.1703 | 25 | 314 | G-protein coupled receptor activity |
GO:0004888 | 1e-04 | 2.8514 | 8.0478 | 21 | 291 | transmembrane signaling receptor activity |
GO:0004993 | 2e-04 | 19.1965 | 0.3213 | 4 | 11 | serotonin receptor activity |
GO:0032393 | 5e-04 | 33.5112 | 0.1752 | 3 | 6 | MHC class I receptor activity |
GO:0005232 | 9e-04 | Inf | 0.0584 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0008392 | 9e-04 | Inf | 0.0584 | 2 | 2 | arachidonic acid epoxygenase activity |
GO:0030109 | 9e-04 | Inf | 0.0584 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0008157 | 0.0018 | 16.7514 | 0.2628 | 3 | 9 | protein phosphatase 1 binding |
GO:0004252 | 0.0036 | 3.1705 | 3.0665 | 9 | 105 | serine-type endopeptidase activity |
GO:0004745 | 0.0045 | 11.1648 | 0.3505 | 3 | 12 | retinol dehydrogenase activity |
GO:0016151 | 0.0049 | 33.4206 | 0.1168 | 2 | 4 | nickel cation binding |
GO:0005230 | 0.0067 | 3.8834 | 1.6939 | 6 | 58 | extracellular ligand-gated ion channel activity |
GO:0003840 | 0.008 | 22.2786 | 0.146 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0016892 | 0.008 | 22.2786 | 0.146 | 2 | 5 | endoribonuclease activity, producing 3'-phosphomonoesters |
GO:0016907 | 0.008 | 22.2786 | 0.146 | 2 | 5 | G-protein coupled acetylcholine receptor activity |
GO:0051378 | 0.008 | 22.2786 | 0.146 | 2 | 5 | serotonin binding |
GO:0030246 | 0.0085 | 2.3369 | 5.4321 | 12 | 186 | carbohydrate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 57.0255 | 0.3628 | 8 | 13 | olfactory receptor activity |
GO:0004872 | 0 | 2.4651 | 23.975 | 52 | 859 | receptor activity |
GO:0004871 | 0 | 2.1247 | 26.7381 | 51 | 958 | signal transducer activity |
GO:0004930 | 0 | 3.0231 | 8.7639 | 24 | 314 | G-protein coupled receptor activity |
GO:0022838 | 1e-04 | 2.7243 | 9.2104 | 23 | 330 | substrate-specific channel activity |
GO:0005229 | 1e-04 | 23.48 | 0.2791 | 4 | 10 | intracellular calcium activated chloride channel activity |
GO:0022803 | 1e-04 | 2.5776 | 9.6849 | 23 | 347 | passive transmembrane transporter activity |
GO:0022836 | 2e-04 | 2.8002 | 7.3683 | 19 | 264 | gated channel activity |
GO:0005261 | 5e-04 | 2.6917 | 6.8101 | 17 | 244 | cation channel activity |
GO:0015075 | 5e-04 | 1.9743 | 17.9743 | 33 | 644 | ion transmembrane transporter activity |
GO:0046873 | 0.001 | 2.3238 | 9.2104 | 20 | 330 | metal ion transmembrane transporter activity |
GO:0004888 | 0.0026 | 2.286 | 7.9138 | 17 | 297 | transmembrane signaling receptor activity |
GO:0004175 | 0.0026 | 2.2807 | 7.9265 | 17 | 284 | endopeptidase activity |
GO:0022892 | 0.0032 | 1.7111 | 22.3841 | 36 | 802 | substrate-specific transporter activity |
GO:0004866 | 0.0039 | 3.413 | 2.5398 | 8 | 91 | endopeptidase inhibitor activity |
GO:0043395 | 0.005 | 10.5316 | 0.3628 | 3 | 13 | heparan sulfate proteoglycan binding |
GO:0008236 | 0.0075 | 2.7965 | 3.433 | 9 | 123 | serine-type peptidase activity |
GO:0005516 | 0.0086 | 2.5693 | 4.1307 | 10 | 148 | calmodulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004062 | 0.0014 | Inf | 0.0748 | 2 | 2 | aryl sulfotransferase activity |
GO:0004909 | 0.0014 | Inf | 0.0748 | 2 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0004982 | 0.0014 | Inf | 0.0748 | 2 | 2 | N-formyl peptide receptor activity |
GO:0008392 | 0.0014 | Inf | 0.0748 | 2 | 2 | arachidonic acid epoxygenase activity |
GO:0004871 | 0.0015 | 1.6098 | 35.8058 | 54 | 958 | signal transducer activity |
GO:0008009 | 0.0025 | 8.6514 | 0.598 | 4 | 16 | chemokine activity |
GO:0004888 | 0.0026 | 1.7177 | 22.8365 | 37 | 611 | transmembrane signaling receptor activity |
GO:0019834 | 0.0041 | 51.7304 | 0.1121 | 2 | 3 | phospholipase A2 inhibitor activity |
GO:0004872 | 0.0053 | 1.5463 | 32.1057 | 47 | 859 | receptor activity |
GO:0004252 | 0.0058 | 2.749 | 3.9244 | 10 | 105 | serine-type endopeptidase activity |
GO:0004090 | 0.008 | 25.863 | 0.1495 | 2 | 4 | carbonyl reductase (NADPH) activity |
GO:1990050 | 0.008 | 25.863 | 0.1495 | 2 | 4 | phosphatidic acid transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 122.5382 | 0.3544 | 10 | 13 | olfactory receptor activity |
GO:0004930 | 0 | 2.8061 | 8.5606 | 22 | 314 | G-protein coupled receptor activity |
GO:0047760 | 1e-04 | 107.991 | 0.1091 | 3 | 4 | butyrate-CoA ligase activity |
GO:0038023 | 1e-04 | 2.0726 | 18.8661 | 36 | 692 | signaling receptor activity |
GO:0060089 | 2e-04 | 1.8755 | 26.1181 | 45 | 958 | molecular transducer activity |
GO:0032393 | 4e-04 | 35.991 | 0.1636 | 3 | 6 | MHC class I receptor activity |
GO:0005232 | 7e-04 | Inf | 0.0545 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 7e-04 | Inf | 0.0545 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0005216 | 0.0014 | 2.2957 | 8.8333 | 19 | 324 | ion channel activity |
GO:0004252 | 0.0023 | 3.4093 | 2.8626 | 9 | 105 | serine-type endopeptidase activity |
GO:0004993 | 0.0028 | 13.491 | 0.2999 | 3 | 11 | serotonin receptor activity |
GO:0015267 | 0.0031 | 2.1305 | 9.4603 | 19 | 347 | channel activity |
GO:0004090 | 0.0043 | 35.8866 | 0.1091 | 2 | 4 | carbonyl reductase (NADPH) activity |
GO:0047961 | 0.0043 | 35.8866 | 0.1091 | 2 | 4 | glycine N-acyltransferase activity |
GO:0005230 | 0.0048 | 4.1734 | 1.5813 | 6 | 58 | extracellular ligand-gated ion channel activity |
GO:0030246 | 0.005 | 2.5146 | 5.0709 | 12 | 186 | carbohydrate binding |
GO:0003840 | 0.007 | 23.9224 | 0.1363 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0004046 | 0.007 | 23.9224 | 0.1363 | 2 | 5 | aminoacylase activity |
GO:0017171 | 0.0072 | 2.8168 | 3.4079 | 9 | 125 | serine hydrolase activity |
GO:0003823 | 0.008 | 4.4016 | 1.2541 | 5 | 46 | antigen binding |
GO:0008009 | 0.0086 | 8.2987 | 0.4362 | 3 | 16 | chemokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004871 | 0 | 2.206 | 37.5109 | 73 | 958 | signal transducer activity |
GO:0004888 | 0 | 2.3239 | 23.924 | 50 | 611 | transmembrane signaling receptor activity |
GO:0004872 | 0 | 2.0425 | 33.6345 | 62 | 859 | receptor activity |
GO:0001664 | 2e-04 | 3.064 | 5.7564 | 16 | 148 | G-protein coupled receptor binding |
GO:0008528 | 4e-04 | 3.7922 | 3.2632 | 11 | 84 | G-protein coupled peptide receptor activity |
GO:0004957 | 6e-04 | 37.0322 | 0.1958 | 3 | 5 | prostaglandin E receptor activity |
GO:0005160 | 0.0011 | 7.7381 | 0.8223 | 5 | 21 | transforming growth factor beta receptor binding |
GO:0004953 | 0.0015 | Inf | 0.0779 | 2 | 2 | icosanoid receptor activity |
GO:0001632 | 0.0015 | Inf | 0.0783 | 2 | 2 | leukotriene B4 receptor activity |
GO:0004982 | 0.0015 | Inf | 0.0783 | 2 | 2 | N-formyl peptide receptor activity |
GO:0005185 | 0.0015 | Inf | 0.0783 | 2 | 2 | neurohypophyseal hormone activity |
GO:0004252 | 0.0027 | 2.9151 | 4.1113 | 11 | 105 | serine-type endopeptidase activity |
GO:0017171 | 0.0036 | 2.6468 | 4.8944 | 12 | 125 | serine hydrolase activity |
GO:0004939 | 0.0045 | 49.278 | 0.1175 | 2 | 3 | beta-adrenergic receptor activity |
GO:0004967 | 0.0045 | 49.278 | 0.1175 | 2 | 3 | glucagon receptor activity |
GO:0019957 | 0.0045 | 49.278 | 0.1175 | 2 | 3 | C-C chemokine binding |
GO:0034584 | 0.0045 | 49.278 | 0.1175 | 2 | 3 | piRNA binding |
GO:0071855 | 0.0068 | 6.1776 | 0.7831 | 4 | 20 | neuropeptide receptor binding |
GO:0004954 | 0.0078 | 9.2534 | 0.4307 | 3 | 11 | prostanoid receptor activity |
GO:0005164 | 0.0082 | 5.8137 | 0.8223 | 4 | 21 | tumor necrosis factor receptor binding |
GO:0015220 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | choline transmembrane transporter activity |
GO:0016019 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | peptidoglycan receptor activity |
GO:0016494 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | C-X-C chemokine receptor activity |
GO:0016901 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0031781 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | type 4 melanocortin receptor binding |
GO:0051380 | 0.0087 | 24.6369 | 0.1566 | 2 | 4 | norepinephrine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022838 | 0 | 4.0009 | 11.1326 | 38 | 330 | substrate-specific channel activity |
GO:0022803 | 0 | 3.7753 | 11.7061 | 38 | 347 | passive transmembrane transporter activity |
GO:0022836 | 0 | 4.196 | 8.9061 | 32 | 264 | gated channel activity |
GO:0004871 | 0 | 2.5116 | 32.3183 | 70 | 958 | signal transducer activity |
GO:0004872 | 0 | 2.5426 | 28.9785 | 64 | 859 | receptor activity |
GO:0005261 | 0 | 4.0116 | 7.7449 | 27 | 231 | cation channel activity |
GO:0015075 | 0 | 2.5397 | 21.7254 | 49 | 644 | ion transmembrane transporter activity |
GO:0005244 | 0 | 4.0841 | 5.2964 | 19 | 157 | voltage-gated ion channel activity |
GO:0022892 | 0 | 2.1763 | 27.0556 | 53 | 802 | substrate-specific transporter activity |
GO:0022890 | 0 | 2.5334 | 13.4266 | 31 | 398 | inorganic cation transmembrane transporter activity |
GO:0004970 | 0 | 14.5158 | 0.6072 | 6 | 18 | ionotropic glutamate receptor activity |
GO:0005234 | 0 | 14.5158 | 0.6072 | 6 | 18 | extracellular-glutamate-gated ion channel activity |
GO:0004930 | 1e-04 | 2.9394 | 7.4621 | 20 | 225 | G-protein coupled receptor activity |
GO:0015276 | 1e-04 | 3.9581 | 3.6863 | 13 | 110 | ligand-gated ion channel activity |
GO:0005248 | 1e-04 | 14.483 | 0.506 | 5 | 15 | voltage-gated sodium channel activity |
GO:0004888 | 1e-04 | 2.629 | 9.1009 | 22 | 286 | transmembrane signaling receptor activity |
GO:0015464 | 1e-04 | 13.1653 | 0.5398 | 5 | 16 | acetylcholine receptor activity |
GO:0015085 | 3e-04 | 3.5816 | 3.7109 | 12 | 110 | calcium ion transmembrane transporter activity |
GO:0030506 | 6e-04 | 9.0473 | 0.7084 | 5 | 21 | ankyrin binding |
GO:0008528 | 8e-04 | 3.6902 | 3.0024 | 10 | 89 | G-protein coupled peptide receptor activity |
GO:0015280 | 0.0012 | 21.6304 | 0.2361 | 3 | 7 | ligand-gated sodium channel activity |
GO:0030246 | 0.0016 | 2.569 | 6.2747 | 15 | 186 | carbohydrate binding |
GO:0031681 | 0.0019 | 17.3029 | 0.2699 | 3 | 8 | G-protein beta-subunit binding |
GO:0005509 | 0.0026 | 1.7935 | 18.9254 | 32 | 561 | calcium ion binding |
GO:0016247 | 0.0028 | 3.313 | 2.9687 | 9 | 88 | channel regulator activity |
GO:0097109 | 0.0033 | 57.5566 | 0.1012 | 2 | 3 | neuroligin family protein binding |
GO:0015081 | 0.0037 | 3.1673 | 3.0897 | 9 | 92 | sodium ion transmembrane transporter activity |
GO:0042166 | 0.0038 | 12.3571 | 0.3374 | 3 | 10 | acetylcholine binding |
GO:0005539 | 0.0039 | 2.6114 | 4.9253 | 12 | 146 | glycosaminoglycan binding |
GO:0004497 | 0.0043 | 3.7593 | 2.0578 | 7 | 61 | monooxygenase activity |
GO:0008273 | 0.0065 | 28.7759 | 0.1349 | 2 | 4 | calcium, potassium:sodium antiporter activity |
GO:0030151 | 0.0065 | 28.7759 | 0.1349 | 2 | 4 | molybdenum ion binding |
GO:0034617 | 0.0065 | 28.7759 | 0.1349 | 2 | 4 | tetrahydrobiopterin binding |
GO:0015079 | 0.0065 | 2.6927 | 3.9807 | 10 | 118 | potassium ion transmembrane transporter activity |
GO:0004889 | 0.0085 | 8.6478 | 0.4386 | 3 | 13 | acetylcholine-activated cation-selective channel activity |
GO:0004984 | 0.0085 | 8.6478 | 0.4386 | 3 | 13 | olfactory receptor activity |
GO:0030165 | 0.009 | 2.9377 | 2.935 | 8 | 87 | PDZ domain binding |
GO:0005245 | 0.0096 | 4.2511 | 1.3157 | 5 | 39 | voltage-gated calcium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.0126 | 12.3202 | 33 | 314 | G-protein coupled receptor activity |
GO:0060089 | 0 | 1.9034 | 37.5884 | 65 | 958 | molecular transducer activity |
GO:0038023 | 0 | 2.1167 | 23.2539 | 45 | 602 | signaling receptor activity |
GO:0005184 | 4e-04 | 10.2986 | 0.667 | 5 | 17 | neuropeptide hormone activity |
GO:0019825 | 5e-04 | 9.5056 | 0.7063 | 5 | 18 | oxygen binding |
GO:0001664 | 7e-04 | 2.7145 | 6.4103 | 16 | 164 | G-protein coupled receptor binding |
GO:0001653 | 8e-04 | 3.4654 | 3.5313 | 11 | 90 | peptide receptor activity |
GO:0004252 | 8e-04 | 3.2143 | 4.1198 | 12 | 105 | serine-type endopeptidase activity |
GO:0022838 | 0.0013 | 2.0618 | 12.948 | 25 | 330 | substrate-specific channel activity |
GO:0015111 | 0.0015 | Inf | 0.0785 | 2 | 2 | iodide transmembrane transporter activity |
GO:0034987 | 0.0015 | Inf | 0.0785 | 2 | 2 | immunoglobulin receptor binding |
GO:0022836 | 0.0017 | 2.1666 | 10.3584 | 21 | 264 | gated channel activity |
GO:0008188 | 0.0019 | 5.3003 | 1.334 | 6 | 34 | neuropeptide receptor activity |
GO:0005249 | 0.0023 | 3.4356 | 2.9035 | 9 | 74 | voltage-gated potassium channel activity |
GO:0022803 | 0.0026 | 1.9501 | 13.615 | 25 | 347 | passive transmembrane transporter activity |
GO:0005344 | 0.0029 | 14.7772 | 0.3139 | 3 | 8 | oxygen transporter activity |
GO:0008009 | 0.0029 | 8.2218 | 0.6278 | 4 | 16 | chemokine activity |
GO:0017171 | 0.0037 | 2.6409 | 4.9045 | 12 | 125 | serine hydrolase activity |
GO:0005254 | 0.004 | 3.8502 | 2.0403 | 7 | 52 | chloride channel activity |
GO:0008146 | 0.0044 | 4.3628 | 1.5695 | 6 | 40 | sulfotransferase activity |
GO:0045028 | 0.0045 | 49.1718 | 0.1177 | 2 | 3 | G-protein coupled purinergic nucleotide receptor activity |
GO:0051431 | 0.0045 | 49.1718 | 0.1177 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0016502 | 0.0059 | 10.5533 | 0.3924 | 3 | 10 | nucleotide receptor activity |
GO:0070888 | 0.0067 | 4.7476 | 1.2163 | 5 | 31 | E-box binding |
GO:0015075 | 0.0078 | 1.581 | 25.2682 | 38 | 644 | ion transmembrane transporter activity |
GO:0001733 | 0.0087 | 24.5839 | 0.1569 | 2 | 4 | galactosylceramide sulfotransferase activity |
GO:0016901 | 0.0087 | 24.5839 | 0.1569 | 2 | 4 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0031685 | 0.0087 | 24.5839 | 0.1569 | 2 | 4 | adenosine receptor binding |
GO:0005244 | 0.0089 | 2.2439 | 6.1601 | 13 | 157 | voltage-gated ion channel activity |
GO:0008201 | 0.0098 | 2.5302 | 4.2375 | 10 | 108 | heparin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 4.5948 | 3.7715 | 15 | 105 | serine-type endopeptidase activity |
GO:0017171 | 0 | 3.753 | 4.4899 | 15 | 125 | serine hydrolase activity |
GO:0015293 | 0.001 | 3.3384 | 3.6279 | 11 | 101 | symporter activity |
GO:0038023 | 0.0011 | 1.7606 | 24.8562 | 41 | 692 | signaling receptor activity |
GO:0005216 | 0.0015 | 2.1083 | 11.6379 | 23 | 324 | ion channel activity |
GO:0005215 | 0.0015 | 1.6146 | 35.0574 | 53 | 976 | transporter activity |
GO:0015267 | 0.0017 | 2.0511 | 12.464 | 24 | 347 | channel activity |
GO:0005179 | 0.0018 | 3.9573 | 2.2629 | 8 | 63 | hormone activity |
GO:0022891 | 0.0032 | 1.6692 | 24.7485 | 39 | 689 | substrate-specific transmembrane transporter activity |
GO:0004966 | 0.0038 | 53.9186 | 0.1078 | 2 | 3 | galanin receptor activity |
GO:0046873 | 0.004 | 1.965 | 11.8534 | 22 | 330 | metal ion transmembrane transporter activity |
GO:0016702 | 0.0041 | 7.2133 | 0.6825 | 4 | 19 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0060089 | 0.0047 | 1.5386 | 34.4108 | 50 | 958 | molecular transducer activity |
GO:0008289 | 0.0053 | 1.7682 | 16.7025 | 28 | 465 | lipid binding |
GO:0015145 | 0.0061 | 10.1267 | 0.3951 | 3 | 11 | monosaccharide transmembrane transporter activity |
GO:0005509 | 0.0066 | 1.672 | 20.1508 | 32 | 561 | calcium ion binding |
GO:0015321 | 0.0074 | 26.957 | 0.1437 | 2 | 4 | sodium-dependent phosphate transmembrane transporter activity |
GO:0004622 | 0.0079 | 9.0008 | 0.431 | 3 | 12 | lysophospholipase activity |
GO:0004930 | 0.0096 | 1.8648 | 11.2787 | 20 | 314 | G-protein coupled receptor activity |
GO:0015296 | 0.0099 | 4.2301 | 1.329 | 5 | 37 | anion:cation symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 130.05 | 0.2303 | 9 | 13 | olfactory receptor activity |
GO:0004930 | 0 | 5.03 | 5.5631 | 24 | 314 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.5771 | 11.8719 | 36 | 682 | signaling receptor activity |
GO:0060089 | 0 | 2.8196 | 16.9729 | 41 | 958 | molecular transducer activity |
GO:0003823 | 0 | 10.2469 | 0.815 | 7 | 46 | antigen binding |
GO:0008329 | 0 | 37.631 | 0.1772 | 4 | 10 | signaling pattern recognition receptor activity |
GO:0032393 | 1e-04 | 56.1991 | 0.1063 | 3 | 6 | MHC class I receptor activity |
GO:0030246 | 1e-04 | 3.9873 | 3.2954 | 12 | 186 | carbohydrate binding |
GO:0005232 | 3e-04 | Inf | 0.0354 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 3e-04 | Inf | 0.0354 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0004993 | 8e-04 | 21.066 | 0.1949 | 3 | 11 | serotonin receptor activity |
GO:0030169 | 0.0017 | 15.3169 | 0.248 | 3 | 14 | low-density lipoprotein particle binding |
GO:0000146 | 0.0037 | 11.2287 | 0.3189 | 3 | 18 | microfilament motor activity |
GO:0005216 | 0.0051 | 2.4007 | 5.7403 | 13 | 324 | ion channel activity |
GO:0004866 | 0.0055 | 3.9957 | 1.6122 | 6 | 91 | endopeptidase inhibitor activity |
GO:0071814 | 0.0066 | 8.8618 | 0.3898 | 3 | 22 | protein-lipid complex binding |
GO:0061134 | 0.0071 | 3.336 | 2.2323 | 7 | 126 | peptidase regulator activity |
GO:0005344 | 0.0082 | 18.6421 | 0.1417 | 2 | 8 | oxygen transporter activity |
GO:0015267 | 0.0089 | 2.231 | 6.1478 | 13 | 347 | channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0 | 1.8543 | 34.1783 | 58 | 958 | molecular transducer activity |
GO:0004984 | 1e-04 | 17.0757 | 0.4638 | 5 | 13 | olfactory receptor activity |
GO:0038023 | 1e-04 | 1.9799 | 24.6883 | 45 | 692 | signaling receptor activity |
GO:0004930 | 9e-04 | 2.1989 | 11.2025 | 23 | 314 | G-protein coupled receptor activity |
GO:0004062 | 0.0013 | Inf | 0.0714 | 2 | 2 | aryl sulfotransferase activity |
GO:0004982 | 0.0013 | Inf | 0.0714 | 2 | 2 | N-formyl peptide receptor activity |
GO:0008009 | 0.0021 | 9.0831 | 0.5708 | 4 | 16 | chemokine activity |
GO:0019834 | 0.0037 | 54.3007 | 0.107 | 2 | 3 | phospholipase A2 inhibitor activity |
GO:0004896 | 0.0053 | 3.6114 | 2.1406 | 7 | 60 | cytokine receptor activity |
GO:0004090 | 0.0073 | 27.1481 | 0.1427 | 2 | 4 | carbonyl reductase (NADPH) activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032502 | 0 | 1.6167 | 157.0822 | 211 | 2845 | developmental process |
GO:0044707 | 0 | 1.6077 | 139.0957 | 187 | 2615 | single-multicellular organism process |
GO:0048562 | 0 | 3.0989 | 8.5058 | 23 | 149 | embryonic organ morphogenesis |
GO:0048665 | 0 | 8.2816 | 1.5571 | 9 | 27 | neuron fate specification |
GO:0007423 | 0 | 2.2404 | 20.3023 | 41 | 354 | sensory organ development |
GO:0009605 | 0 | 1.6629 | 65.8608 | 99 | 1142 | response to external stimulus |
GO:0072359 | 0 | 1.8898 | 33.6801 | 58 | 584 | circulatory system development |
GO:0007399 | 0 | 1.5927 | 76.3894 | 110 | 1341 | nervous system development |
GO:0048565 | 0 | 3.5019 | 5.6518 | 17 | 98 | digestive tract development |
GO:2000026 | 1e-04 | 1.6811 | 52.7694 | 81 | 915 | regulation of multicellular organismal development |
GO:0021511 | 1e-04 | 7.7818 | 1.4418 | 8 | 25 | spinal cord patterning |
GO:0021527 | 1e-04 | 12.3711 | 0.8074 | 6 | 14 | spinal cord association neuron differentiation |
GO:0035270 | 1e-04 | 3.4625 | 5.3634 | 16 | 93 | endocrine system development |
GO:0008284 | 1e-04 | 1.9126 | 27.9707 | 49 | 485 | positive regulation of cell proliferation |
GO:0003008 | 1e-04 | 1.6571 | 49.9435 | 76 | 866 | system process |
GO:0040011 | 1e-04 | 1.6317 | 54.0996 | 81 | 941 | locomotion |
GO:0007166 | 1e-04 | 1.4688 | 104.5007 | 139 | 1812 | cell surface receptor signaling pathway |
GO:0048732 | 1e-04 | 2.1723 | 16.6671 | 33 | 289 | gland development |
GO:0007200 | 1e-04 | 5.02 | 2.4799 | 10 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0001655 | 1e-04 | 2.373 | 12.5724 | 27 | 218 | urogenital system development |
GO:0042472 | 1e-04 | 3.581 | 4.556 | 14 | 79 | inner ear morphogenesis |
GO:0009790 | 2e-04 | 1.7213 | 39.7596 | 63 | 696 | embryo development |
GO:0060537 | 2e-04 | 2.305 | 13.3798 | 28 | 232 | muscle tissue development |
GO:0001501 | 2e-04 | 2.0856 | 18.3395 | 35 | 318 | skeletal system development |
GO:0048699 | 2e-04 | 1.8159 | 30.5253 | 51 | 545 | generation of neurons |
GO:0007268 | 3e-04 | 1.9372 | 22.4304 | 40 | 394 | synaptic transmission |
GO:0051094 | 3e-04 | 1.7679 | 32.464 | 53 | 566 | positive regulation of developmental process |
GO:0003007 | 3e-04 | 2.6288 | 8.4777 | 20 | 147 | heart morphogenesis |
GO:0001944 | 3e-04 | 1.9307 | 21.9152 | 39 | 380 | vasculature development |
GO:0048812 | 3e-04 | 1.8313 | 26.5866 | 45 | 461 | neuron projection morphogenesis |
GO:0048667 | 4e-04 | 1.8381 | 25.8945 | 44 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0060415 | 4e-04 | 4.6516 | 2.3645 | 9 | 41 | muscle tissue morphogenesis |
GO:0002067 | 4e-04 | 5.2872 | 1.9032 | 8 | 33 | glandular epithelial cell differentiation |
GO:0021510 | 5e-04 | 4.0867 | 2.9082 | 10 | 51 | spinal cord development |
GO:0050767 | 5e-04 | 1.8892 | 21.7422 | 38 | 377 | regulation of neurogenesis |
GO:0002009 | 6e-04 | 1.981 | 18.0512 | 33 | 313 | morphogenesis of an epithelium |
GO:0007498 | 6e-04 | 3.0591 | 5.1904 | 14 | 90 | mesoderm development |
GO:0007389 | 6e-04 | 2.0444 | 15.9248 | 30 | 280 | pattern specification process |
GO:0061564 | 7e-04 | 1.8329 | 23.53 | 40 | 408 | axon development |
GO:0030154 | 7e-04 | 1.7812 | 26.7767 | 44 | 505 | cell differentiation |
GO:0002003 | 7e-04 | 49.2659 | 0.2307 | 3 | 4 | angiotensin maturation |
GO:0015816 | 7e-04 | 49.2659 | 0.2307 | 3 | 4 | glycine transport |
GO:2000977 | 7e-04 | 49.2659 | 0.2307 | 3 | 4 | regulation of forebrain neuron differentiation |
GO:0007517 | 8e-04 | 2.7283 | 6.541 | 16 | 115 | muscle organ development |
GO:0030855 | 8e-04 | 1.8914 | 19.9602 | 35 | 348 | epithelial cell differentiation |
GO:0044259 | 9e-04 | 3.2606 | 4.21 | 12 | 73 | multicellular organismal macromolecule metabolic process |
GO:0035235 | 9e-04 | 6.5931 | 1.2111 | 6 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0006935 | 0.001 | 1.8682 | 20.1754 | 35 | 353 | chemotaxis |
GO:0048839 | 0.0011 | 3.6601 | 3.1778 | 10 | 56 | inner ear development |
GO:0042490 | 0.0011 | 4.0209 | 2.6529 | 9 | 46 | mechanoreceptor differentiation |
GO:0001991 | 0.0011 | 13.1546 | 0.519 | 4 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0007411 | 0.0012 | 1.9744 | 15.8597 | 29 | 275 | axon guidance |
GO:0001990 | 0.0012 | 6.1804 | 1.2688 | 6 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:0030574 | 0.0013 | 3.9147 | 2.7106 | 9 | 47 | collagen catabolic process |
GO:0007155 | 0.0013 | 1.6152 | 36.4484 | 55 | 632 | cell adhesion |
GO:0048731 | 0.0013 | 1.6538 | 33.3629 | 51 | 672 | system development |
GO:0072163 | 0.0014 | 3.0587 | 4.4407 | 12 | 77 | mesonephric epithelium development |
GO:0045666 | 0.0014 | 3.2518 | 3.864 | 11 | 67 | positive regulation of neuron differentiation |
GO:0045944 | 0.0016 | 1.613 | 35.1219 | 53 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001709 | 0.0016 | 4.8112 | 1.7878 | 7 | 31 | cell fate determination |
GO:0048863 | 0.0017 | 2.0369 | 13.2644 | 25 | 230 | stem cell differentiation |
GO:0009952 | 0.0017 | 2.2915 | 9.0544 | 19 | 157 | anterior/posterior pattern specification |
GO:0048468 | 0.0017 | 1.427 | 73.0009 | 97 | 1273 | cell development |
GO:0060573 | 0.0017 | 10.9611 | 0.5767 | 4 | 10 | cell fate specification involved in pattern specification |
GO:0060177 | 0.0017 | 24.6304 | 0.2884 | 3 | 5 | regulation of angiotensin metabolic process |
GO:0060527 | 0.0017 | 24.6304 | 0.2884 | 3 | 5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0060485 | 0.0018 | 2.3389 | 8.42 | 18 | 146 | mesenchyme development |
GO:0045595 | 0.0018 | 1.4953 | 52.1927 | 73 | 905 | regulation of cell differentiation |
GO:0031016 | 0.0018 | 3.3751 | 3.4026 | 10 | 59 | pancreas development |
GO:0055074 | 0.002 | 2.2053 | 9.8618 | 20 | 171 | calcium ion homeostasis |
GO:0060675 | 0.002 | 3.6271 | 2.8836 | 9 | 50 | ureteric bud morphogenesis |
GO:0007154 | 0.002 | 1.2924 | 200.1201 | 233 | 3470 | cell communication |
GO:0006355 | 0.0021 | 1.3262 | 134.6053 | 164 | 2334 | regulation of transcription, DNA-templated |
GO:0003309 | 0.0022 | 6.8581 | 0.9804 | 5 | 17 | type B pancreatic cell differentiation |
GO:0031069 | 0.0022 | 6.8581 | 0.9804 | 5 | 17 | hair follicle morphogenesis |
GO:0048754 | 0.0024 | 2.4153 | 7.2666 | 16 | 126 | branching morphogenesis of an epithelial tube |
GO:0010043 | 0.0025 | 5.2029 | 1.4418 | 6 | 25 | response to zinc ion |
GO:0022617 | 0.0026 | 2.9837 | 4.1523 | 11 | 72 | extracellular matrix disassembly |
GO:0044700 | 0.0028 | 1.282 | 196.4291 | 228 | 3406 | single organism signaling |
GO:0009880 | 0.0028 | 3.7726 | 2.4799 | 8 | 43 | embryonic pattern specification |
GO:0030335 | 0.003 | 2.1197 | 10.2079 | 20 | 177 | positive regulation of cell migration |
GO:0010157 | 0.0033 | Inf | 0.1153 | 2 | 2 | response to chlorate |
GO:0035990 | 0.0033 | Inf | 0.1153 | 2 | 2 | tendon cell differentiation |
GO:0070858 | 0.0033 | Inf | 0.1153 | 2 | 2 | negative regulation of bile acid biosynthetic process |
GO:0072166 | 0.0033 | Inf | 0.1153 | 2 | 2 | posterior mesonephric tubule development |
GO:0007270 | 0.0033 | 2.5946 | 5.5365 | 13 | 96 | neuron-neuron synaptic transmission |
GO:0021575 | 0.0033 | 4.1222 | 2.0185 | 7 | 35 | hindbrain morphogenesis |
GO:0060688 | 0.0033 | 4.1222 | 2.0185 | 7 | 35 | regulation of morphogenesis of a branching structure |
GO:0042178 | 0.0033 | 16.4185 | 0.346 | 3 | 6 | xenobiotic catabolic process |
GO:0010628 | 0.0034 | 1.4566 | 52.5964 | 72 | 912 | positive regulation of gene expression |
GO:0018958 | 0.0034 | 3.3033 | 3.1143 | 9 | 54 | phenol-containing compound metabolic process |
GO:0007600 | 0.0034 | 1.8414 | 16.2634 | 28 | 282 | sensory perception |
GO:0048738 | 0.0036 | 2.4686 | 6.2285 | 14 | 108 | cardiac muscle tissue development |
GO:0006811 | 0.0036 | 1.5782 | 32.3415 | 48 | 571 | ion transport |
GO:0009953 | 0.0037 | 2.6842 | 4.9597 | 12 | 86 | dorsal/ventral pattern formation |
GO:0061217 | 0.0037 | 5.8772 | 1.0958 | 5 | 19 | regulation of mesonephros development |
GO:0021542 | 0.0037 | 8.2191 | 0.6921 | 4 | 12 | dentate gyrus development |
GO:0070307 | 0.0037 | 8.2191 | 0.6921 | 4 | 12 | lens fiber cell development |
GO:0072079 | 0.0037 | 8.2191 | 0.6921 | 4 | 12 | nephron tubule formation |
GO:0072224 | 0.0037 | 8.2191 | 0.6921 | 4 | 12 | metanephric glomerulus development |
GO:0072243 | 0.0037 | 8.2191 | 0.6921 | 4 | 12 | metanephric nephron epithelium development |
GO:0021522 | 0.0037 | 4.7064 | 1.5571 | 6 | 27 | spinal cord motor neuron differentiation |
GO:0021696 | 0.0037 | 4.7064 | 1.5571 | 6 | 27 | cerebellar cortex morphogenesis |
GO:0072028 | 0.0037 | 4.7064 | 1.5571 | 6 | 27 | nephron morphogenesis |
GO:0061448 | 0.0038 | 2.1671 | 8.9968 | 18 | 156 | connective tissue development |
GO:0051252 | 0.0038 | 1.2983 | 139.3343 | 167 | 2416 | regulation of RNA metabolic process |
GO:0050885 | 0.0039 | 3.9796 | 2.0762 | 7 | 36 | neuromuscular process controlling balance |
GO:0071805 | 0.004 | 2.533 | 5.6518 | 13 | 98 | potassium ion transmembrane transport |
GO:0060538 | 0.0043 | 2.3245 | 7.0359 | 15 | 122 | skeletal muscle organ development |
GO:0002244 | 0.0044 | 2.5033 | 5.7095 | 13 | 99 | hematopoietic progenitor cell differentiation |
GO:0043010 | 0.0045 | 2.1237 | 9.1542 | 18 | 160 | camera-type eye development |
GO:0042509 | 0.0045 | 4.492 | 1.6148 | 6 | 28 | regulation of tyrosine phosphorylation of STAT protein |
GO:0043589 | 0.0045 | 4.492 | 1.6148 | 6 | 28 | skin morphogenesis |
GO:0055010 | 0.0045 | 4.492 | 1.6148 | 6 | 28 | ventricular cardiac muscle tissue morphogenesis |
GO:0030890 | 0.0047 | 5.4848 | 1.1534 | 5 | 20 | positive regulation of B cell proliferation |
GO:0043009 | 0.0049 | 1.617 | 26.2405 | 40 | 455 | chordate embryonic development |
GO:0051480 | 0.005 | 2.3669 | 6.4592 | 14 | 112 | cytosolic calcium ion homeostasis |
GO:0009887 | 0.0051 | 1.826 | 15.1816 | 26 | 279 | organ morphogenesis |
GO:0071599 | 0.0052 | 7.3051 | 0.7497 | 4 | 13 | otic vesicle development |
GO:0007605 | 0.0054 | 2.5454 | 5.1904 | 12 | 90 | sensory perception of sound |
GO:0030901 | 0.0055 | 4.2963 | 1.6725 | 6 | 29 | midbrain development |
GO:0048483 | 0.0055 | 4.2963 | 1.6725 | 6 | 29 | autonomic nervous system development |
GO:0003310 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | pancreatic A cell differentiation |
GO:0006600 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | creatine metabolic process |
GO:0033504 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | floor plate development |
GO:0042523 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | positive regulation of tyrosine phosphorylation of Stat5 protein |
GO:0072177 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | mesonephric duct development |
GO:0072203 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | cell proliferation involved in metanephros development |
GO:0072282 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | metanephric nephron tubule morphogenesis |
GO:2000251 | 0.0056 | 12.3126 | 0.4037 | 3 | 7 | positive regulation of actin cytoskeleton reorganization |
GO:0050921 | 0.0057 | 3.2993 | 2.7682 | 8 | 48 | positive regulation of chemotaxis |
GO:0051272 | 0.0059 | 1.9786 | 10.8422 | 20 | 188 | positive regulation of cellular component movement |
GO:0003231 | 0.0059 | 2.8001 | 3.9793 | 10 | 69 | cardiac ventricle development |
GO:0003338 | 0.0059 | 5.1415 | 1.2111 | 5 | 21 | metanephros morphogenesis |
GO:0021533 | 0.0059 | 5.1415 | 1.2111 | 5 | 21 | cell differentiation in hindbrain |
GO:0035116 | 0.0059 | 5.1415 | 1.2111 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0060512 | 0.0059 | 5.1415 | 1.2111 | 5 | 21 | prostate gland morphogenesis |
GO:0060429 | 0.0061 | 2.2257 | 7.2941 | 15 | 133 | epithelium development |
GO:0048663 | 0.0061 | 4.1729 | 1.7084 | 6 | 30 | neuron fate commitment |
GO:0072503 | 0.0061 | 2.0102 | 10.1502 | 19 | 176 | cellular divalent inorganic cation homeostasis |
GO:0019725 | 0.0062 | 1.6449 | 22.5496 | 35 | 391 | cellular homeostasis |
GO:0065008 | 0.0063 | 1.3001 | 111.998 | 136 | 1942 | regulation of biological quality |
GO:0048534 | 0.0063 | 1.589 | 26.6442 | 40 | 462 | hematopoietic or lymphoid organ development |
GO:1902680 | 0.0065 | 1.4244 | 50.5202 | 68 | 876 | positive regulation of RNA biosynthetic process |
GO:0060021 | 0.0065 | 2.7532 | 4.037 | 10 | 70 | palate development |
GO:0035239 | 0.0065 | 1.8089 | 14.7179 | 25 | 256 | tube morphogenesis |
GO:0048878 | 0.0066 | 1.5656 | 28.3744 | 42 | 492 | chemical homeostasis |
GO:0034105 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | positive regulation of tissue remodeling |
GO:0045939 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | negative regulation of steroid metabolic process |
GO:0060579 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | ventral spinal cord interneuron fate commitment |
GO:0060644 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | mammary gland epithelial cell differentiation |
GO:0072087 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | renal vesicle development |
GO:0090190 | 0.0069 | 6.5739 | 0.8074 | 4 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0030001 | 0.0072 | 1.5947 | 25.2024 | 38 | 437 | metal ion transport |
GO:0032879 | 0.0072 | 1.3537 | 72.0894 | 92 | 1250 | regulation of localization |
GO:0048704 | 0.0072 | 2.7078 | 4.0947 | 10 | 71 | embryonic skeletal system morphogenesis |
GO:0001525 | 0.0073 | 1.8159 | 14.0718 | 24 | 244 | angiogenesis |
GO:0021675 | 0.0073 | 3.1415 | 2.8836 | 8 | 50 | nerve development |
GO:0043062 | 0.0073 | 1.8397 | 13.3221 | 23 | 231 | extracellular structure organization |
GO:0002088 | 0.0083 | 3.3926 | 2.3645 | 7 | 41 | lens development in camera-type eye |
GO:0006820 | 0.0084 | 1.7461 | 15.802 | 26 | 274 | anion transport |
GO:0021781 | 0.0085 | 9.8819 | 0.4599 | 3 | 8 | glial cell fate commitment |
GO:0030916 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | otic vesicle formation |
GO:0032769 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | negative regulation of monooxygenase activity |
GO:0035855 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | megakaryocyte development |
GO:0042362 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | fat-soluble vitamin biosynthetic process |
GO:0042537 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | benzene-containing compound metabolic process |
GO:0060872 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | semicircular canal development |
GO:0061004 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | pattern specification involved in kidney development |
GO:0097050 | 0.0086 | 9.8491 | 0.4614 | 3 | 8 | type B pancreatic cell apoptotic process |
GO:0048514 | 0.0086 | 2.8032 | 3.5702 | 9 | 63 | blood vessel morphogenesis |
GO:0046427 | 0.009 | 3.7993 | 1.8455 | 6 | 32 | positive regulation of JAK-STAT cascade |
GO:0055085 | 0.0091 | 1.4286 | 44.2917 | 60 | 768 | transmembrane transport |
GO:0050864 | 0.0093 | 2.9981 | 2.9989 | 8 | 52 | regulation of B cell activation |
GO:0010556 | 0.0093 | 1.254 | 150.0612 | 175 | 2602 | regulation of macromolecule biosynthetic process |
GO:0040007 | 0.0094 | 1.4869 | 34.0262 | 48 | 590 | growth |
GO:0060411 | 0.0095 | 3.2953 | 2.4222 | 7 | 42 | cardiac septum morphogenesis |
GO:0010269 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | response to selenium ion |
GO:0010455 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | positive regulation of cell fate commitment |
GO:0021902 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0021913 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0030240 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0033058 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | detection of glucose |
GO:0060018 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | transdifferentiation |
GO:0060421 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | positive regulation of heart growth |
GO:0072197 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | ureter morphogenesis |
GO:2000318 | 0.0096 | 32.7877 | 0.173 | 2 | 3 | positive regulation of T-helper 17 type immune response |
GO:0001822 | 0.0098 | 1.9479 | 9.8765 | 18 | 172 | kidney development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000026 | 0 | 2.1674 | 44.6649 | 84 | 915 | regulation of multicellular organismal development |
GO:0045165 | 0 | 4.259 | 7.6053 | 27 | 157 | cell fate commitment |
GO:0051674 | 0 | 2.1358 | 34.8533 | 66 | 714 | localization of cell |
GO:0001501 | 0 | 3.4126 | 9.1369 | 27 | 191 | skeletal system development |
GO:0007389 | 0 | 2.7525 | 14.3705 | 35 | 297 | pattern specification process |
GO:0009954 | 0 | 11.3009 | 1.0739 | 8 | 22 | proximal/distal pattern formation |
GO:0048729 | 0 | 2.2985 | 18.7934 | 39 | 385 | tissue morphogenesis |
GO:0044707 | 0 | 1.5234 | 139.1444 | 179 | 3098 | single-multicellular organism process |
GO:2000145 | 0 | 2.2929 | 17.329 | 36 | 355 | regulation of cell motility |
GO:0009952 | 0 | 3.0977 | 7.6638 | 21 | 157 | anterior/posterior pattern specification |
GO:0009887 | 0 | 2.0318 | 25.9859 | 48 | 542 | organ morphogenesis |
GO:0060562 | 0 | 2.5927 | 12.0083 | 28 | 246 | epithelial tube morphogenesis |
GO:0060485 | 0 | 3.1809 | 7.1269 | 20 | 146 | mesenchyme development |
GO:0050767 | 0 | 2.2108 | 18.4029 | 37 | 377 | regulation of neurogenesis |
GO:0048598 | 1e-04 | 2.1109 | 20.2364 | 39 | 418 | embryonic morphogenesis |
GO:0007155 | 1e-04 | 1.8774 | 30.8505 | 53 | 632 | cell adhesion |
GO:0048731 | 1e-04 | 1.5814 | 76.2796 | 107 | 1730 | system development |
GO:0048701 | 1e-04 | 6.5854 | 1.5621 | 8 | 32 | embryonic cranial skeleton morphogenesis |
GO:0023051 | 1e-04 | 1.518 | 87.8166 | 120 | 1799 | regulation of signaling |
GO:0010646 | 1e-04 | 1.5158 | 87.9142 | 120 | 1801 | regulation of cell communication |
GO:0042330 | 1e-04 | 2.0598 | 19.5745 | 37 | 401 | taxis |
GO:0022029 | 2e-04 | 6.0776 | 1.6597 | 8 | 34 | telencephalon cell migration |
GO:0007409 | 2e-04 | 2.017 | 19.3792 | 36 | 397 | axonogenesis |
GO:0035295 | 2e-04 | 1.9563 | 21.6246 | 39 | 443 | tube development |
GO:0072359 | 2e-04 | 1.8248 | 28.5074 | 48 | 584 | circulatory system development |
GO:0022603 | 2e-04 | 1.9033 | 23.9189 | 42 | 490 | regulation of anatomical structure morphogenesis |
GO:0052652 | 3e-04 | 3.7788 | 3.6611 | 12 | 75 | cyclic purine nucleotide metabolic process |
GO:0035107 | 3e-04 | 3.1752 | 5.3207 | 15 | 109 | appendage morphogenesis |
GO:0048568 | 3e-04 | 2.1499 | 15.1812 | 30 | 311 | embryonic organ development |
GO:0035136 | 3e-04 | 6.574 | 1.3668 | 7 | 28 | forelimb morphogenesis |
GO:0001656 | 3e-04 | 3.9629 | 3.2217 | 11 | 66 | metanephros development |
GO:0097529 | 3e-04 | 4.3026 | 2.7336 | 10 | 56 | myeloid leukocyte migration |
GO:0048665 | 4e-04 | 11.005 | 0.6788 | 5 | 14 | neuron fate specification |
GO:0014033 | 4e-04 | 4.6819 | 2.2943 | 9 | 47 | neural crest cell differentiation |
GO:0048646 | 4e-04 | 1.829 | 26.0056 | 44 | 544 | anatomical structure formation involved in morphogenesis |
GO:0043009 | 4e-04 | 1.8974 | 22.2104 | 39 | 455 | chordate embryonic development |
GO:0072001 | 4e-04 | 2.4546 | 9.3723 | 21 | 192 | renal system development |
GO:0051216 | 4e-04 | 2.8691 | 6.1994 | 16 | 127 | cartilage development |
GO:0006551 | 4e-04 | 58.8073 | 0.1953 | 3 | 4 | leucine metabolic process |
GO:0048704 | 4e-04 | 5.1667 | 1.879 | 8 | 39 | embryonic skeletal system morphogenesis |
GO:0090132 | 5e-04 | 2.9828 | 5.6136 | 15 | 115 | epithelium migration |
GO:0021953 | 5e-04 | 2.9737 | 5.6262 | 15 | 116 | central nervous system neuron differentiation |
GO:0031175 | 5e-04 | 1.7723 | 28.6051 | 47 | 586 | neuron projection development |
GO:0014031 | 6e-04 | 3.0559 | 5.1255 | 14 | 105 | mesenchymal cell development |
GO:0032989 | 6e-04 | 1.63 | 41.736 | 63 | 855 | cellular component morphogenesis |
GO:0010720 | 6e-04 | 2.5997 | 7.615 | 18 | 156 | positive regulation of cell development |
GO:0021766 | 6e-04 | 4.9349 | 1.9526 | 8 | 40 | hippocampus development |
GO:0010632 | 7e-04 | 3.3503 | 4.0516 | 12 | 83 | regulation of epithelial cell migration |
GO:0048468 | 7e-04 | 1.7303 | 29.9549 | 48 | 650 | cell development |
GO:0061138 | 8e-04 | 2.6031 | 7.1757 | 17 | 147 | morphogenesis of a branching epithelium |
GO:0051093 | 0.001 | 1.8289 | 21.7223 | 37 | 445 | negative regulation of developmental process |
GO:0002689 | 0.0011 | 29.4006 | 0.2441 | 3 | 5 | negative regulation of leukocyte chemotaxis |
GO:0051967 | 0.0011 | 29.4006 | 0.2441 | 3 | 5 | negative regulation of synaptic transmission, glutamatergic |
GO:0060173 | 0.0011 | 2.7088 | 6.1018 | 15 | 125 | limb development |
GO:0001667 | 0.0011 | 2.6071 | 6.7347 | 16 | 139 | ameboidal cell migration |
GO:0040017 | 0.0011 | 2.319 | 9.3723 | 20 | 192 | positive regulation of locomotion |
GO:0044702 | 0.0011 | 1.6605 | 32.9495 | 51 | 675 | single organism reproductive process |
GO:0006355 | 0.0011 | 1.3819 | 113.9321 | 143 | 2334 | regulation of transcription, DNA-templated |
GO:0051240 | 0.0011 | 1.9059 | 18.0373 | 32 | 372 | positive regulation of multicellular organismal process |
GO:0051252 | 0.0012 | 1.3729 | 117.9348 | 147 | 2416 | regulation of RNA metabolic process |
GO:0045766 | 0.0012 | 3.8644 | 2.6848 | 9 | 55 | positive regulation of angiogenesis |
GO:0050877 | 0.0013 | 1.736 | 25.9203 | 42 | 531 | neurological system process |
GO:0003382 | 0.0013 | 4.9269 | 1.7085 | 7 | 35 | epithelial cell morphogenesis |
GO:0030182 | 0.0014 | 1.6517 | 32.4608 | 50 | 686 | neuron differentiation |
GO:0030818 | 0.0014 | 7.5607 | 0.8787 | 5 | 18 | negative regulation of cAMP biosynthetic process |
GO:0019371 | 0.0014 | 11.2172 | 0.537 | 4 | 11 | cyclooxygenase pathway |
GO:0033630 | 0.0014 | 11.2172 | 0.537 | 4 | 11 | positive regulation of cell adhesion mediated by integrin |
GO:0045986 | 0.0014 | 11.2172 | 0.537 | 4 | 11 | negative regulation of smooth muscle contraction |
GO:0072073 | 0.0015 | 2.8635 | 5.0279 | 13 | 103 | kidney epithelium development |
GO:0048645 | 0.0015 | 4.7565 | 1.7573 | 7 | 36 | organ formation |
GO:0090288 | 0.0017 | 3.3636 | 3.3556 | 10 | 69 | negative regulation of cellular response to growth factor stimulus |
GO:0045665 | 0.0018 | 4.0462 | 2.2943 | 8 | 47 | negative regulation of neuron differentiation |
GO:0021799 | 0.0018 | 7.0199 | 0.9275 | 5 | 19 | cerebral cortex radially oriented cell migration |
GO:0042474 | 0.0018 | 7.0199 | 0.9275 | 5 | 19 | middle ear morphogenesis |
GO:0046189 | 0.0018 | 7.0199 | 0.9275 | 5 | 19 | phenol-containing compound biosynthetic process |
GO:0001944 | 0.0018 | 1.8464 | 18.5494 | 32 | 380 | vasculature development |
GO:0045597 | 0.0019 | 2.0067 | 13.3773 | 25 | 280 | positive regulation of cell differentiation |
GO:0048863 | 0.0019 | 2.1103 | 11.2272 | 22 | 230 | stem cell differentiation |
GO:0046637 | 0.002 | 5.3672 | 1.3668 | 6 | 28 | regulation of alpha-beta T cell differentiation |
GO:0030326 | 0.002 | 2.8975 | 4.5885 | 12 | 94 | embryonic limb morphogenesis |
GO:0007420 | 0.002 | 1.7526 | 22.5521 | 37 | 462 | brain development |
GO:0097485 | 0.002 | 1.9989 | 13.4239 | 25 | 275 | neuron projection guidance |
GO:0048485 | 0.002 | 9.814 | 0.5858 | 4 | 12 | sympathetic nervous system development |
GO:1900746 | 0.0021 | 19.5984 | 0.2929 | 3 | 6 | regulation of vascular endothelial growth factor signaling pathway |
GO:0051272 | 0.0021 | 2.2382 | 9.177 | 19 | 188 | positive regulation of cellular component movement |
GO:0048514 | 0.0022 | 1.9296 | 14.9859 | 27 | 307 | blood vessel morphogenesis |
GO:0008015 | 0.0022 | 2.4209 | 7.1861 | 16 | 149 | blood circulation |
GO:0001666 | 0.0022 | 2.3466 | 7.8591 | 17 | 161 | response to hypoxia |
GO:0065007 | 0.0022 | 1.3313 | 318.2191 | 348 | 6519 | biological regulation |
GO:0030800 | 0.0023 | 6.5513 | 0.9763 | 5 | 20 | negative regulation of cyclic nucleotide metabolic process |
GO:0030809 | 0.0023 | 6.5513 | 0.9763 | 5 | 20 | negative regulation of nucleotide biosynthetic process |
GO:0046457 | 0.0023 | 6.5513 | 0.9763 | 5 | 20 | prostanoid biosynthetic process |
GO:0007267 | 0.0023 | 2.0771 | 11.3888 | 22 | 242 | cell-cell signaling |
GO:0021569 | 0.0024 | Inf | 0.0976 | 2 | 2 | rhombomere 3 development |
GO:0032227 | 0.0024 | Inf | 0.0976 | 2 | 2 | negative regulation of synaptic transmission, dopaminergic |
GO:0071637 | 0.0024 | Inf | 0.0976 | 2 | 2 | regulation of monocyte chemotactic protein-1 production |
GO:0072272 | 0.0024 | Inf | 0.0976 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:1901492 | 0.0024 | Inf | 0.0976 | 2 | 2 | positive regulation of lymphangiogenesis |
GO:0016477 | 0.0025 | 1.9366 | 14.3745 | 26 | 307 | cell migration |
GO:0030335 | 0.0025 | 2.2514 | 8.6401 | 18 | 177 | positive regulation of cell migration |
GO:0048583 | 0.0026 | 1.367 | 96.8472 | 122 | 1984 | regulation of response to stimulus |
GO:0021520 | 0.0028 | 8.7227 | 0.6346 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0042423 | 0.0028 | 8.7227 | 0.6346 | 4 | 13 | catecholamine biosynthetic process |
GO:0021846 | 0.0029 | 6.1412 | 1.0251 | 5 | 21 | cell proliferation in forebrain |
GO:0034113 | 0.0029 | 6.1412 | 1.0251 | 5 | 21 | heterotypic cell-cell adhesion |
GO:0045058 | 0.0029 | 6.1412 | 1.0251 | 5 | 21 | T cell selection |
GO:0048521 | 0.0029 | 6.1412 | 1.0251 | 5 | 21 | negative regulation of behavior |
GO:0007268 | 0.003 | 1.6911 | 23.9189 | 38 | 490 | synaptic transmission |
GO:0032774 | 0.0031 | 1.3313 | 121.4495 | 148 | 2488 | RNA biosynthetic process |
GO:0031326 | 0.0031 | 1.3233 | 130.8706 | 158 | 2681 | regulation of cellular biosynthetic process |
GO:0030802 | 0.0033 | 3.2892 | 3.0753 | 9 | 63 | regulation of cyclic nucleotide biosynthetic process |
GO:0045944 | 0.0033 | 1.6101 | 29.7278 | 45 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0002685 | 0.0034 | 3.5846 | 2.5383 | 8 | 52 | regulation of leukocyte migration |
GO:0005513 | 0.0035 | 14.6973 | 0.3417 | 3 | 7 | detection of calcium ion |
GO:0030814 | 0.0037 | 3.229 | 3.1241 | 9 | 64 | regulation of cAMP metabolic process |
GO:0001759 | 0.0038 | 7.8496 | 0.6834 | 4 | 14 | organ induction |
GO:0002052 | 0.0038 | 7.8496 | 0.6834 | 4 | 14 | positive regulation of neuroblast proliferation |
GO:0051482 | 0.0038 | 7.8496 | 0.6834 | 4 | 14 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0045595 | 0.0038 | 1.7051 | 21.8465 | 35 | 469 | regulation of cell differentiation |
GO:0019233 | 0.0039 | 3.5046 | 2.5871 | 8 | 53 | sensory perception of pain |
GO:0030595 | 0.0039 | 3.19 | 3.1553 | 9 | 65 | leukocyte chemotaxis |
GO:0061005 | 0.004 | 4.5396 | 1.5621 | 6 | 32 | cell differentiation involved in kidney development |
GO:1901570 | 0.004 | 4.5396 | 1.5621 | 6 | 32 | fatty acid derivative biosynthetic process |
GO:0010769 | 0.004 | 2.1417 | 9.0306 | 18 | 185 | regulation of cell morphogenesis involved in differentiation |
GO:0010556 | 0.0041 | 1.3143 | 127.0143 | 153 | 2602 | regulation of macromolecule biosynthetic process |
GO:1900371 | 0.0041 | 3.1711 | 3.1729 | 9 | 65 | regulation of purine nucleotide biosynthetic process |
GO:0055074 | 0.0041 | 2.1919 | 8.3472 | 17 | 171 | calcium ion homeostasis |
GO:0043583 | 0.0044 | 2.2354 | 7.7126 | 16 | 158 | ear development |
GO:0044057 | 0.0047 | 1.9809 | 11.3249 | 21 | 232 | regulation of system process |
GO:0070482 | 0.0049 | 2.1493 | 8.4937 | 17 | 174 | response to oxygen levels |
GO:0001504 | 0.005 | 7.1353 | 0.7322 | 4 | 15 | neurotransmitter uptake |
GO:0007620 | 0.005 | 7.1353 | 0.7322 | 4 | 15 | copulation |
GO:0042554 | 0.005 | 7.1353 | 0.7322 | 4 | 15 | superoxide anion generation |
GO:0044767 | 0.005 | 1.3658 | 87.3939 | 109 | 2008 | single-organism developmental process |
GO:0007160 | 0.0052 | 2.4272 | 5.8089 | 13 | 119 | cell-matrix adhesion |
GO:0051047 | 0.0053 | 2.1885 | 7.8591 | 16 | 161 | positive regulation of secretion |
GO:0006693 | 0.0053 | 5.1699 | 1.1715 | 5 | 24 | prostaglandin metabolic process |
GO:0072088 | 0.0053 | 5.1699 | 1.1715 | 5 | 24 | nephron epithelium morphogenesis |
GO:1900543 | 0.0053 | 5.1699 | 1.1715 | 5 | 24 | negative regulation of purine nucleotide metabolic process |
GO:0003337 | 0.0054 | 11.7566 | 0.3905 | 3 | 8 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:2000679 | 0.0054 | 11.7566 | 0.3905 | 3 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0001569 | 0.0055 | 4.2144 | 1.6597 | 6 | 34 | patterning of blood vessels |
GO:0072503 | 0.0055 | 2.1218 | 8.5913 | 17 | 176 | cellular divalent inorganic cation homeostasis |
GO:0019438 | 0.0058 | 1.2956 | 132.8924 | 158 | 2745 | aromatic compound biosynthetic process |
GO:0050727 | 0.006 | 2.3817 | 5.9065 | 13 | 121 | regulation of inflammatory response |
GO:0007631 | 0.0061 | 2.9584 | 3.3682 | 9 | 69 | feeding behavior |
GO:0000904 | 0.0062 | 1.7339 | 17.7333 | 29 | 373 | cell morphogenesis involved in differentiation |
GO:0006928 | 0.0062 | 1.5581 | 29.9434 | 44 | 640 | cellular component movement |
GO:0044271 | 0.0063 | 1.2886 | 136.9235 | 162 | 2805 | cellular nitrogen compound biosynthetic process |
GO:2001257 | 0.0064 | 4.0687 | 1.7085 | 6 | 35 | regulation of cation channel activity |
GO:0007159 | 0.0064 | 4.9109 | 1.2204 | 5 | 25 | leukocyte cell-cell adhesion |
GO:0014014 | 0.0064 | 4.9109 | 1.2204 | 5 | 25 | negative regulation of gliogenesis |
GO:0045168 | 0.0064 | 4.9109 | 1.2204 | 5 | 25 | cell-cell signaling involved in cell fate commitment |
GO:0072676 | 0.0064 | 4.9109 | 1.2204 | 5 | 25 | lymphocyte migration |
GO:0007507 | 0.0066 | 1.782 | 15.4741 | 26 | 317 | heart development |
GO:0018130 | 0.0066 | 1.2872 | 135.215 | 160 | 2770 | heterocycle biosynthetic process |
GO:0007188 | 0.0067 | 2.9096 | 3.417 | 9 | 70 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0021987 | 0.0067 | 2.9096 | 3.417 | 9 | 70 | cerebral cortex development |
GO:0007186 | 0.0068 | 1.6595 | 21.0389 | 33 | 431 | G-protein coupled receptor signaling pathway |
GO:0060298 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | positive regulation of sarcomere organization |
GO:0060594 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | mammary gland specification |
GO:0070100 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | negative regulation of chemokine-mediated signaling pathway |
GO:0070235 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | regulation of activation-induced cell death of T cells |
GO:0072107 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | positive regulation of ureteric bud formation |
GO:1902548 | 0.0069 | 39.1255 | 0.1464 | 2 | 3 | negative regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0003073 | 0.0073 | 3.4445 | 2.2943 | 7 | 47 | regulation of systemic arterial blood pressure |
GO:0048066 | 0.0073 | 3.9327 | 1.7573 | 6 | 36 | developmental pigmentation |
GO:0060425 | 0.0073 | 3.9327 | 1.7573 | 6 | 36 | lung morphogenesis |
GO:0050880 | 0.0075 | 2.6668 | 4.1004 | 10 | 84 | regulation of blood vessel size |
GO:0031649 | 0.0078 | 9.7961 | 0.4393 | 3 | 9 | heat generation |
GO:0050884 | 0.0078 | 9.7961 | 0.4393 | 3 | 9 | neuromuscular process controlling posture |
GO:0072070 | 0.0078 | 9.7961 | 0.4393 | 3 | 9 | loop of Henle development |
GO:0090022 | 0.0078 | 9.7961 | 0.4393 | 3 | 9 | regulation of neutrophil chemotaxis |
GO:0035148 | 0.0078 | 2.3957 | 5.4184 | 12 | 111 | tube formation |
GO:0009968 | 0.008 | 1.5304 | 30.3624 | 44 | 622 | negative regulation of signal transduction |
GO:0021895 | 0.008 | 6.0363 | 0.8298 | 4 | 17 | cerebral cortex neuron differentiation |
GO:0035336 | 0.008 | 6.0363 | 0.8298 | 4 | 17 | long-chain fatty-acyl-CoA metabolic process |
GO:0048557 | 0.008 | 6.0363 | 0.8298 | 4 | 17 | embryonic digestive tract morphogenesis |
GO:0035282 | 0.0081 | 2.8167 | 3.5146 | 9 | 72 | segmentation |
GO:0021872 | 0.0082 | 3.3602 | 2.3431 | 7 | 48 | forebrain generation of neurons |
GO:0051480 | 0.0083 | 2.3715 | 5.4672 | 12 | 112 | cytosolic calcium ion homeostasis |
GO:0010595 | 0.0084 | 3.8054 | 1.8061 | 6 | 37 | positive regulation of endothelial cell migration |
GO:0022008 | 0.0084 | 1.5499 | 27.9603 | 41 | 596 | neurogenesis |
GO:0001755 | 0.009 | 4.4635 | 1.318 | 5 | 27 | neural crest cell migration |
GO:1990266 | 0.009 | 4.4635 | 1.318 | 5 | 27 | neutrophil migration |
GO:0080090 | 0.009 | 1.2541 | 182.5647 | 208 | 3740 | regulation of primary metabolic process |
GO:0019722 | 0.0092 | 2.9731 | 2.9777 | 8 | 61 | calcium-mediated signaling |
GO:0022407 | 0.0092 | 2.9731 | 2.9777 | 8 | 61 | regulation of cell-cell adhesion |
GO:0001764 | 0.0094 | 2.4403 | 4.8814 | 11 | 100 | neuron migration |
GO:1901362 | 0.0096 | 1.2704 | 136.5234 | 160 | 2820 | organic cyclic compound biosynthetic process |
GO:0044708 | 0.0096 | 1.8149 | 12.8381 | 22 | 263 | single-organism behavior |
GO:0000038 | 0.0099 | 5.6045 | 0.8787 | 4 | 18 | very long-chain fatty acid metabolic process |
GO:0031290 | 0.0099 | 5.6045 | 0.8787 | 4 | 18 | retinal ganglion cell axon guidance |
GO:0045123 | 0.0099 | 5.6045 | 0.8787 | 4 | 18 | cellular extravasation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050892 | 2e-04 | 19.355 | 0.3366 | 4 | 10 | intestinal absorption |
GO:0044241 | 4e-04 | 43.4381 | 0.1683 | 3 | 5 | lipid digestion |
GO:0010949 | 0.0011 | Inf | 0.0673 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0035873 | 0.0011 | Inf | 0.0673 | 2 | 2 | lactate transmembrane transport |
GO:0045796 | 0.0011 | Inf | 0.0673 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:1900747 | 0.0011 | Inf | 0.0673 | 2 | 2 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0055085 | 0.0021 | 1.7035 | 25.8494 | 41 | 768 | transmembrane transport |
GO:0048704 | 0.0025 | 3.7092 | 2.3897 | 8 | 71 | embryonic skeletal system morphogenesis |
GO:2000114 | 0.0027 | 14.4735 | 0.3029 | 3 | 9 | regulation of establishment of cell polarity |
GO:0031427 | 0.0033 | 57.7529 | 0.101 | 2 | 3 | response to methotrexate |
GO:2000611 | 0.0033 | 57.7529 | 0.101 | 2 | 3 | positive regulation of thyroid hormone generation |
GO:0051271 | 0.0039 | 2.9274 | 3.7024 | 10 | 110 | negative regulation of cellular component movement |
GO:0048015 | 0.0041 | 2.7321 | 4.3419 | 11 | 129 | phosphatidylinositol-mediated signaling |
GO:0044724 | 0.0046 | 3.0588 | 3.1975 | 9 | 95 | single-organism carbohydrate catabolic process |
GO:0048818 | 0.0065 | 28.8735 | 0.1346 | 2 | 4 | positive regulation of hair follicle maturation |
GO:0030195 | 0.0066 | 9.646 | 0.4039 | 3 | 12 | negative regulation of blood coagulation |
GO:0015850 | 0.0083 | 2.7664 | 3.5004 | 9 | 104 | organic hydroxy compound transport |
GO:0016338 | 0.0084 | 8.6805 | 0.4376 | 3 | 13 | calcium-independent cell-cell adhesion |
GO:0071599 | 0.0084 | 8.6805 | 0.4376 | 3 | 13 | otic vesicle development |
GO:0040013 | 0.0085 | 2.5872 | 4.1399 | 10 | 123 | negative regulation of locomotion |
GO:0030336 | 0.0088 | 2.7373 | 3.5341 | 9 | 105 | negative regulation of cell migration |
GO:0050680 | 0.009 | 3.2358 | 2.3561 | 7 | 70 | negative regulation of epithelial cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003009 | 1e-04 | 11.4251 | 0.7213 | 6 | 21 | skeletal muscle contraction |
GO:0007600 | 1e-04 | 2.6023 | 9.6859 | 23 | 282 | sensory perception |
GO:1902476 | 1e-04 | 6.198 | 1.5456 | 8 | 45 | chloride transmembrane transport |
GO:0050907 | 4e-04 | 16.2402 | 0.3778 | 4 | 11 | detection of chemical stimulus involved in sensory perception |
GO:0050879 | 4e-04 | 7.4451 | 0.9961 | 6 | 29 | multicellular organismal movement |
GO:0003008 | 4e-04 | 1.9007 | 22.3002 | 39 | 665 | system process |
GO:0071621 | 5e-04 | 7.1341 | 1.0304 | 6 | 30 | granulocyte chemotaxis |
GO:0015698 | 7e-04 | 4.1627 | 2.4386 | 9 | 71 | inorganic anion transport |
GO:0098656 | 9e-04 | 3.3645 | 3.6064 | 11 | 105 | anion transmembrane transport |
GO:0007308 | 0.0012 | Inf | 0.0687 | 2 | 2 | oocyte construction |
GO:0007314 | 0.0012 | Inf | 0.0687 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0014722 | 0.0012 | Inf | 0.0687 | 2 | 2 | regulation of skeletal muscle contraction by calcium ion signaling |
GO:0030719 | 0.0012 | Inf | 0.0687 | 2 | 2 | P granule organization |
GO:0048850 | 0.0012 | Inf | 0.0687 | 2 | 2 | hypophysis morphogenesis |
GO:2000360 | 0.0012 | Inf | 0.0687 | 2 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:0001955 | 0.0013 | 21.2601 | 0.2404 | 3 | 7 | blood vessel maturation |
GO:0006307 | 0.0013 | 21.2601 | 0.2404 | 3 | 7 | DNA dealkylation involved in DNA repair |
GO:0007156 | 0.0014 | 3.7377 | 2.6791 | 9 | 78 | homophilic cell adhesion |
GO:0009605 | 0.0014 | 1.6048 | 39.2243 | 58 | 1142 | response to external stimulus |
GO:0030049 | 0.0029 | 8.1143 | 0.6182 | 4 | 18 | muscle filament sliding |
GO:0014070 | 0.003 | 1.8772 | 15.338 | 27 | 449 | response to organic cyclic compound |
GO:0007186 | 0.0032 | 1.9452 | 13.1532 | 24 | 388 | G-protein coupled receptor signaling pathway |
GO:0007200 | 0.0033 | 4.6214 | 1.4769 | 6 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0031427 | 0.0034 | 56.5476 | 0.103 | 2 | 3 | response to methotrexate |
GO:0032571 | 0.0034 | 56.5476 | 0.103 | 2 | 3 | response to vitamin K |
GO:0033239 | 0.0034 | 56.5476 | 0.103 | 2 | 3 | negative regulation of cellular amine metabolic process |
GO:0046598 | 0.0034 | 56.5476 | 0.103 | 2 | 3 | positive regulation of viral entry into host cell |
GO:0046602 | 0.0034 | 56.5476 | 0.103 | 2 | 3 | regulation of mitotic centrosome separation |
GO:0009611 | 0.0037 | 1.7539 | 19.4404 | 32 | 566 | response to wounding |
GO:0003012 | 0.0039 | 2.3242 | 6.9037 | 15 | 201 | muscle system process |
GO:0008210 | 0.004 | 12.1449 | 0.3435 | 3 | 10 | estrogen metabolic process |
GO:0031424 | 0.004 | 12.1449 | 0.3435 | 3 | 10 | keratinization |
GO:0051606 | 0.0045 | 2.6967 | 4.3964 | 11 | 128 | detection of stimulus |
GO:0042445 | 0.0046 | 3.0655 | 3.1943 | 9 | 93 | hormone metabolic process |
GO:0007586 | 0.0047 | 3.6986 | 2.0952 | 7 | 61 | digestion |
GO:0043900 | 0.0051 | 2.3285 | 6.4229 | 14 | 187 | regulation of multi-organism process |
GO:0044319 | 0.0054 | 10.6257 | 0.3778 | 3 | 11 | wound healing, spreading of cells |
GO:0006952 | 0.0056 | 1.6153 | 25.6916 | 39 | 748 | defense response |
GO:0006811 | 0.0057 | 1.5787 | 29.0232 | 43 | 845 | ion transport |
GO:0040012 | 0.006 | 1.8685 | 13.0519 | 23 | 380 | regulation of locomotion |
GO:0048265 | 0.0061 | 6.3085 | 0.7556 | 4 | 22 | response to pain |
GO:0051707 | 0.0063 | 1.9177 | 11.6093 | 21 | 338 | response to other organism |
GO:0060326 | 0.0064 | 2.8918 | 3.366 | 9 | 98 | cell chemotaxis |
GO:0042398 | 0.0065 | 4.7393 | 1.2021 | 5 | 35 | cellular modified amino acid biosynthetic process |
GO:0009607 | 0.0066 | 1.88 | 12.3993 | 22 | 361 | response to biotic stimulus |
GO:0018119 | 0.0067 | 28.2709 | 0.1374 | 2 | 4 | peptidyl-cysteine S-nitrosylation |
GO:0071360 | 0.0067 | 28.2709 | 0.1374 | 2 | 4 | cellular response to exogenous dsRNA |
GO:2000345 | 0.0067 | 28.2709 | 0.1374 | 2 | 4 | regulation of hepatocyte proliferation |
GO:0048246 | 0.007 | 9.4441 | 0.4122 | 3 | 12 | macrophage chemotaxis |
GO:0090504 | 0.007 | 9.4441 | 0.4122 | 3 | 12 | epiboly |
GO:0002687 | 0.0073 | 4.586 | 1.2365 | 5 | 36 | positive regulation of leukocyte migration |
GO:0007601 | 0.0078 | 2.7967 | 3.469 | 9 | 101 | visual perception |
GO:0050792 | 0.0083 | 2.7663 | 3.5034 | 9 | 102 | regulation of viral process |
GO:0006805 | 0.0085 | 3.2718 | 2.3356 | 7 | 68 | xenobiotic metabolic process |
GO:0050727 | 0.0087 | 2.5781 | 4.156 | 10 | 121 | regulation of inflammatory response |
GO:0001937 | 0.0089 | 8.4988 | 0.4465 | 3 | 13 | negative regulation of endothelial cell proliferation |
GO:0032963 | 0.0099 | 3.1673 | 2.4043 | 7 | 70 | collagen metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0023052 | 0 | 1.6476 | 154.1935 | 206 | 3406 | signaling |
GO:0060444 | 0 | 14.232 | 0.6791 | 6 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0070830 | 0 | 6.6556 | 1.7203 | 9 | 38 | tight junction assembly |
GO:0072009 | 1e-04 | 5.5054 | 2.2183 | 10 | 49 | nephron epithelium development |
GO:0002064 | 1e-04 | 3.3363 | 5.7614 | 17 | 128 | epithelial cell development |
GO:0048729 | 1e-04 | 2.2002 | 17.4294 | 35 | 385 | tissue morphogenesis |
GO:0060443 | 1e-04 | 7.1364 | 1.4487 | 8 | 32 | mammary gland morphogenesis |
GO:0007166 | 1e-04 | 1.5529 | 82.0313 | 114 | 1812 | cell surface receptor signaling pathway |
GO:0016337 | 1e-04 | 2.6488 | 9.5975 | 23 | 212 | single organismal cell-cell adhesion |
GO:0003104 | 1e-04 | Inf | 0.1358 | 3 | 3 | positive regulation of glomerular filtration |
GO:0034329 | 1e-04 | 3.0457 | 6.6096 | 18 | 146 | cell junction assembly |
GO:0051674 | 1e-04 | 1.822 | 32.3236 | 54 | 714 | localization of cell |
GO:0040011 | 1e-04 | 1.7153 | 42.736 | 67 | 944 | locomotion |
GO:0007155 | 1e-04 | 2.2479 | 14.5869 | 30 | 333 | cell adhesion |
GO:0035329 | 2e-04 | 7.4798 | 1.2223 | 7 | 27 | hippo signaling |
GO:0050896 | 2e-04 | 1.4182 | 207.7492 | 246 | 4589 | response to stimulus |
GO:0060429 | 2e-04 | 1.8521 | 28.7929 | 49 | 645 | epithelium development |
GO:0072202 | 2e-04 | 13.3146 | 0.5885 | 5 | 13 | cell differentiation involved in metanephros development |
GO:0044699 | 3e-04 | 1.6154 | 301.3617 | 329 | 6963 | single-organism process |
GO:0030903 | 3e-04 | 11.8339 | 0.6338 | 5 | 14 | notochord development |
GO:0051239 | 3e-04 | 1.5475 | 62.9721 | 89 | 1391 | regulation of multicellular organismal process |
GO:0007606 | 4e-04 | 5.3479 | 1.8108 | 8 | 40 | sensory perception of chemical stimulus |
GO:0072359 | 6e-04 | 1.7944 | 26.4383 | 44 | 584 | circulatory system development |
GO:0001763 | 6e-04 | 2.6789 | 6.9718 | 17 | 154 | morphogenesis of a branching structure |
GO:0045216 | 7e-04 | 2.7385 | 6.4285 | 16 | 142 | cell-cell junction organization |
GO:0032331 | 7e-04 | 14.174 | 0.4527 | 4 | 10 | negative regulation of chondrocyte differentiation |
GO:0097205 | 7e-04 | 14.174 | 0.4527 | 4 | 10 | renal filtration |
GO:0007156 | 7e-04 | 3.5227 | 3.5311 | 11 | 78 | homophilic cell adhesion |
GO:0007622 | 7e-04 | 8.8727 | 0.7696 | 5 | 17 | rhythmic behavior |
GO:0060562 | 8e-04 | 2.237 | 11.1367 | 23 | 246 | epithelial tube morphogenesis |
GO:0032922 | 8e-04 | 5.3383 | 1.5845 | 7 | 35 | circadian regulation of gene expression |
GO:0050911 | 9e-04 | 31.8348 | 0.2264 | 3 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0032501 | 9e-04 | 1.3588 | 175.3804 | 208 | 3874 | multicellular organismal process |
GO:0048646 | 9e-04 | 1.6993 | 31.0107 | 49 | 685 | anatomical structure formation involved in morphogenesis |
GO:0060485 | 9e-04 | 2.6531 | 6.6096 | 16 | 146 | mesenchyme development |
GO:0003014 | 9e-04 | 5.1964 | 1.6172 | 7 | 36 | renal system process |
GO:0016477 | 0.001 | 1.8368 | 21.653 | 37 | 488 | cell migration |
GO:0030857 | 0.001 | 8.1893 | 0.8149 | 5 | 18 | negative regulation of epithelial cell differentiation |
GO:0050877 | 0.001 | 1.7864 | 24.039 | 40 | 531 | neurological system process |
GO:0001944 | 0.0011 | 1.9363 | 17.203 | 31 | 380 | vasculature development |
GO:0030155 | 0.0011 | 2.2609 | 10.0502 | 21 | 222 | regulation of cell adhesion |
GO:0018212 | 0.0012 | 2.3 | 9.4164 | 20 | 208 | peptidyl-tyrosine modification |
GO:1902531 | 0.0012 | 1.5708 | 43.8677 | 64 | 969 | regulation of intracellular signal transduction |
GO:0007165 | 0.0014 | 1.5712 | 45.3112 | 65 | 1092 | signal transduction |
GO:0048699 | 0.0015 | 1.5697 | 41.74 | 61 | 922 | generation of neurons |
GO:0007169 | 0.0016 | 1.7607 | 23.0883 | 38 | 510 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0001977 | 0.0017 | 21.221 | 0.2716 | 3 | 6 | renal system process involved in regulation of blood volume |
GO:0045475 | 0.0017 | 21.221 | 0.2716 | 3 | 6 | locomotor rhythm |
GO:0060534 | 0.0017 | 21.221 | 0.2716 | 3 | 6 | trachea cartilage development |
GO:0060576 | 0.0017 | 21.221 | 0.2716 | 3 | 6 | intestinal epithelial cell development |
GO:0003415 | 0.002 | Inf | 0.0905 | 2 | 2 | chondrocyte hypertrophy |
GO:0010482 | 0.002 | Inf | 0.0905 | 2 | 2 | regulation of epidermal cell division |
GO:0030200 | 0.002 | Inf | 0.0905 | 2 | 2 | heparan sulfate proteoglycan catabolic process |
GO:0051639 | 0.002 | Inf | 0.0905 | 2 | 2 | actin filament network formation |
GO:0061370 | 0.002 | Inf | 0.0905 | 2 | 2 | testosterone biosynthetic process |
GO:2000669 | 0.002 | Inf | 0.0905 | 2 | 2 | negative regulation of dendritic cell apoptotic process |
GO:0007416 | 0.0022 | 3.8846 | 2.3541 | 8 | 52 | synapse assembly |
GO:0030198 | 0.0022 | 2.1725 | 9.9044 | 20 | 220 | extracellular matrix organization |
GO:0007399 | 0.0022 | 1.4694 | 57.9685 | 79 | 1311 | nervous system development |
GO:0045669 | 0.0022 | 4.3935 | 1.8561 | 7 | 41 | positive regulation of osteoblast differentiation |
GO:0042063 | 0.0022 | 2.5937 | 5.8852 | 14 | 130 | gliogenesis |
GO:0009887 | 0.0023 | 1.6674 | 27.5248 | 43 | 608 | organ morphogenesis |
GO:0001909 | 0.0023 | 5.1151 | 1.4034 | 6 | 31 | leukocyte mediated cytotoxicity |
GO:0007605 | 0.0024 | 2.9839 | 4.0744 | 11 | 90 | sensory perception of sound |
GO:0050795 | 0.0024 | 2.9839 | 4.0744 | 11 | 90 | regulation of behavior |
GO:0001501 | 0.0025 | 1.9304 | 14.3962 | 26 | 318 | skeletal system development |
GO:0030335 | 0.0027 | 2.2883 | 8.013 | 17 | 177 | positive regulation of cell migration |
GO:0006928 | 0.0027 | 1.5458 | 39.4449 | 57 | 888 | cellular component movement |
GO:0007528 | 0.0028 | 4.9178 | 1.4487 | 6 | 32 | neuromuscular junction development |
GO:0033598 | 0.0028 | 16.0094 | 0.3151 | 3 | 7 | mammary gland epithelial cell proliferation |
GO:0030900 | 0.0028 | 2.0062 | 12.2685 | 23 | 271 | forebrain development |
GO:0043588 | 0.0028 | 2.1683 | 9.4164 | 19 | 208 | skin development |
GO:0010839 | 0.0028 | 15.9141 | 0.3169 | 3 | 7 | negative regulation of keratinocyte proliferation |
GO:0015721 | 0.0028 | 15.9141 | 0.3169 | 3 | 7 | bile acid and bile salt transport |
GO:2000145 | 0.003 | 1.858 | 16.0713 | 28 | 355 | regulation of cell motility |
GO:0016331 | 0.003 | 2.6077 | 5.4325 | 13 | 120 | morphogenesis of embryonic epithelium |
GO:0035850 | 0.0032 | 5.9115 | 1.0412 | 5 | 23 | epithelial cell differentiation involved in kidney development |
GO:0061326 | 0.0033 | 4.7352 | 1.4939 | 6 | 33 | renal tubule development |
GO:0001508 | 0.0035 | 2.68 | 4.8893 | 12 | 108 | action potential |
GO:0007267 | 0.0035 | 1.5684 | 33.951 | 50 | 753 | cell-cell signaling |
GO:0022612 | 0.0035 | 3.9901 | 2.0081 | 7 | 45 | gland morphogenesis |
GO:1902476 | 0.0038 | 3.9294 | 2.0372 | 7 | 45 | chloride transmembrane transport |
GO:0010591 | 0.0038 | 7.7273 | 0.6791 | 4 | 15 | regulation of lamellipodium assembly |
GO:0090183 | 0.0038 | 4.5656 | 1.5392 | 6 | 34 | regulation of kidney development |
GO:0003334 | 0.0044 | 12.73 | 0.3622 | 3 | 8 | keratinocyte development |
GO:0045821 | 0.0044 | 12.73 | 0.3622 | 3 | 8 | positive regulation of glycolytic process |
GO:0043401 | 0.0044 | 4.4077 | 1.5845 | 6 | 35 | steroid hormone mediated signaling pathway |
GO:0048869 | 0.0045 | 1.3345 | 105.9797 | 130 | 2341 | cellular developmental process |
GO:0006935 | 0.0046 | 1.8147 | 15.8122 | 27 | 353 | chemotaxis |
GO:0048565 | 0.0046 | 2.7073 | 4.4366 | 11 | 98 | digestive tract development |
GO:0014037 | 0.0047 | 5.3192 | 1.1318 | 5 | 25 | Schwann cell differentiation |
GO:0042982 | 0.0047 | 5.3192 | 1.1318 | 5 | 25 | amyloid precursor protein metabolic process |
GO:0061448 | 0.0047 | 2.2854 | 7.0623 | 15 | 156 | connective tissue development |
GO:0008219 | 0.0048 | 1.4129 | 60.5728 | 80 | 1338 | cell death |
GO:0045665 | 0.0049 | 3.7322 | 2.1277 | 7 | 47 | negative regulation of neuron differentiation |
GO:0060445 | 0.0049 | 7.0826 | 0.7243 | 4 | 16 | branching involved in salivary gland morphogenesis |
GO:0072170 | 0.0049 | 7.0826 | 0.7243 | 4 | 16 | metanephric tubule development |
GO:0048856 | 0.005 | 1.3249 | 116.9402 | 141 | 2691 | anatomical structure development |
GO:0030203 | 0.005 | 2.546 | 5.1156 | 12 | 113 | glycosaminoglycan metabolic process |
GO:0051272 | 0.0051 | 2.1387 | 8.511 | 17 | 188 | positive regulation of cellular component movement |
GO:0050806 | 0.0055 | 3.6408 | 2.173 | 7 | 48 | positive regulation of synaptic transmission |
GO:0050921 | 0.0055 | 3.6408 | 2.173 | 7 | 48 | positive regulation of chemotaxis |
GO:0008283 | 0.0056 | 1.4327 | 52.0618 | 70 | 1150 | cell proliferation |
GO:0046578 | 0.0056 | 1.8814 | 12.9928 | 23 | 287 | regulation of Ras protein signal transduction |
GO:0007275 | 0.0058 | 1.2988 | 135.0891 | 160 | 2984 | multicellular organismal development |
GO:0009968 | 0.0058 | 1.5801 | 28.1586 | 42 | 622 | negative regulation of signal transduction |
GO:0030193 | 0.0059 | 4.1225 | 1.675 | 6 | 37 | regulation of blood coagulation |
GO:0048708 | 0.0059 | 4.1225 | 1.675 | 6 | 37 | astrocyte differentiation |
GO:0044087 | 0.0059 | 1.8197 | 14.5773 | 25 | 322 | regulation of cellular component biogenesis |
GO:0000103 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | sulfate assimilation |
GO:0014832 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | urinary bladder smooth muscle contraction |
GO:0035880 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0042271 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | susceptibility to natural killer cell mediated cytotoxicity |
GO:0048669 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | collateral sprouting in absence of injury |
GO:0051852 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | disruption by host of symbiont cells |
GO:0060638 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | mesenchymal-epithelial cell signaling |
GO:0070943 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | neutrophil mediated killing of symbiont cell |
GO:0072034 | 0.006 | 42.3581 | 0.1358 | 2 | 3 | renal vesicle induction |
GO:0003203 | 0.0062 | 6.5371 | 0.7696 | 4 | 17 | endocardial cushion morphogenesis |
GO:0040036 | 0.0062 | 6.5371 | 0.7696 | 4 | 17 | regulation of fibroblast growth factor receptor signaling pathway |
GO:0045684 | 0.0062 | 6.5371 | 0.7696 | 4 | 17 | positive regulation of epidermis development |
GO:0033599 | 0.0063 | 10.6072 | 0.4074 | 3 | 9 | regulation of mammary gland epithelial cell proliferation |
GO:0072070 | 0.0063 | 10.6072 | 0.4074 | 3 | 9 | loop of Henle development |
GO:0048514 | 0.0064 | 1.8319 | 13.8982 | 24 | 307 | blood vessel morphogenesis |
GO:0060428 | 0.0066 | 4.8347 | 1.2223 | 5 | 27 | lung epithelium development |
GO:0072028 | 0.0066 | 4.8347 | 1.2223 | 5 | 27 | nephron morphogenesis |
GO:0040007 | 0.0066 | 1.5846 | 26.71 | 40 | 590 | growth |
GO:0051924 | 0.0068 | 2.7066 | 4.0291 | 10 | 89 | regulation of calcium ion transport |
GO:0021675 | 0.0069 | 3.4707 | 2.2636 | 7 | 50 | nerve development |
GO:1900542 | 0.007 | 1.6688 | 20.2815 | 32 | 448 | regulation of purine nucleotide metabolic process |
GO:0050730 | 0.0071 | 2.4246 | 5.342 | 12 | 118 | regulation of peptidyl-tyrosine phosphorylation |
GO:0061035 | 0.0076 | 3.8718 | 1.7656 | 6 | 39 | regulation of cartilage development |
GO:0031290 | 0.0076 | 6.0695 | 0.8149 | 4 | 18 | retinal ganglion cell axon guidance |
GO:0050891 | 0.0076 | 6.0695 | 0.8149 | 4 | 18 | multicellular organismal water homeostasis |
GO:0030036 | 0.0077 | 1.7562 | 15.6638 | 26 | 346 | actin cytoskeleton organization |
GO:0007431 | 0.0077 | 4.624 | 1.2676 | 5 | 28 | salivary gland development |
GO:0009593 | 0.0077 | 4.624 | 1.2676 | 5 | 28 | detection of chemical stimulus |
GO:0060560 | 0.0078 | 2.5038 | 4.7535 | 11 | 105 | developmental growth involved in morphogenesis |
GO:0009118 | 0.0083 | 1.7064 | 17.3388 | 28 | 383 | regulation of nucleoside metabolic process |
GO:0031589 | 0.0084 | 2.0699 | 8.2393 | 16 | 182 | cell-substrate adhesion |
GO:0001889 | 0.0084 | 2.7857 | 3.5311 | 9 | 78 | liver development |
GO:0008584 | 0.0084 | 2.7857 | 3.5311 | 9 | 78 | male gonad development |
GO:0043270 | 0.0085 | 2.6068 | 4.1649 | 10 | 92 | positive regulation of ion transport |
GO:0072091 | 0.0087 | 2.9946 | 2.9426 | 8 | 65 | regulation of stem cell proliferation |
GO:0006911 | 0.0087 | 9.091 | 0.4527 | 3 | 10 | phagocytosis, engulfment |
GO:0035767 | 0.0087 | 9.091 | 0.4527 | 3 | 10 | endothelial cell chemotaxis |
GO:0085029 | 0.0087 | 9.091 | 0.4527 | 3 | 10 | extracellular matrix assembly |
GO:0043087 | 0.0089 | 1.7338 | 15.8449 | 26 | 350 | regulation of GTPase activity |
GO:0048661 | 0.009 | 4.4309 | 1.3129 | 5 | 29 | positive regulation of smooth muscle cell proliferation |
GO:0072210 | 0.009 | 4.4309 | 1.3129 | 5 | 29 | metanephric nephron development |
GO:0035270 | 0.0092 | 2.5751 | 4.2102 | 10 | 93 | endocrine system development |
GO:0007157 | 0.0093 | 5.6643 | 0.8602 | 4 | 19 | heterophilic cell-cell adhesion |
GO:0008015 | 0.0094 | 1.91 | 10.5482 | 19 | 233 | blood circulation |
GO:0000904 | 0.0095 | 1.5533 | 26.4836 | 39 | 585 | cell morphogenesis involved in differentiation |
GO:0045595 | 0.0095 | 1.4452 | 40.9704 | 56 | 905 | regulation of cell differentiation |
GO:0070374 | 0.0095 | 2.9426 | 2.9879 | 8 | 66 | positive regulation of ERK1 and ERK2 cascade |
GO:0031175 | 0.0097 | 1.5503 | 26.5289 | 39 | 586 | neuron projection development |
GO:0070167 | 0.0097 | 3.6498 | 1.8561 | 6 | 41 | regulation of biomineral tissue development |
GO:0065008 | 0.0099 | 1.3161 | 87.9165 | 108 | 1942 | regulation of biological quality |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044707 | 0 | 1.7391 | 170.3177 | 233 | 3291 | single-multicellular organism process |
GO:0021510 | 0 | 5.9737 | 4.1287 | 19 | 76 | spinal cord development |
GO:0007586 | 0 | 6.3443 | 3.3138 | 16 | 61 | digestion |
GO:0007218 | 0 | 5.3402 | 3.5311 | 15 | 65 | neuropeptide signaling pathway |
GO:0001654 | 0 | 2.7992 | 12.5492 | 31 | 231 | eye development |
GO:0006590 | 0 | 21.1077 | 0.5976 | 6 | 11 | thyroid hormone generation |
GO:0007268 | 0 | 2.1397 | 23.7761 | 46 | 442 | synaptic transmission |
GO:0032502 | 0 | 1.5692 | 110.0105 | 149 | 2186 | developmental process |
GO:0045944 | 0 | 1.9454 | 32.8625 | 58 | 607 | positive regulation of transcription from RNA polymerase II promoter |
GO:0022008 | 0 | 1.9632 | 31.4935 | 56 | 596 | neurogenesis |
GO:0001764 | 0 | 3.6469 | 5.4325 | 17 | 100 | neuron migration |
GO:0007155 | 0 | 1.8872 | 34.3336 | 59 | 632 | cell adhesion |
GO:0060562 | 0 | 2.4992 | 13.364 | 30 | 246 | epithelial tube morphogenesis |
GO:2000026 | 0 | 1.7246 | 49.7077 | 78 | 915 | regulation of multicellular organismal development |
GO:0021983 | 0 | 6.6195 | 1.7927 | 9 | 33 | pituitary gland development |
GO:0021879 | 1e-04 | 5.7005 | 2.2273 | 10 | 41 | forebrain neuron differentiation |
GO:0001501 | 1e-04 | 2.2309 | 17.2755 | 35 | 318 | skeletal system development |
GO:0021527 | 1e-04 | 13.1882 | 0.7606 | 6 | 14 | spinal cord association neuron differentiation |
GO:0048593 | 1e-04 | 3.943 | 4.1831 | 14 | 77 | camera-type eye morphogenesis |
GO:0021522 | 1e-04 | 7.4226 | 1.4668 | 8 | 27 | spinal cord motor neuron differentiation |
GO:0048870 | 1e-04 | 1.7728 | 38.7883 | 63 | 714 | cell motility |
GO:0007187 | 1e-04 | 3.5037 | 4.9436 | 15 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048468 | 1e-04 | 1.6238 | 55.9259 | 83 | 1056 | cell development |
GO:0007517 | 1e-04 | 3.1308 | 6.163 | 17 | 115 | muscle organ development |
GO:0060173 | 1e-04 | 2.9934 | 6.7907 | 18 | 125 | limb development |
GO:0048665 | 2e-04 | 9.672 | 0.9161 | 6 | 17 | neuron fate specification |
GO:0060429 | 2e-04 | 1.811 | 30.5675 | 51 | 572 | epithelium development |
GO:0048729 | 2e-04 | 2.0622 | 18.4917 | 35 | 344 | tissue morphogenesis |
GO:0006355 | 2e-04 | 1.4223 | 126.7954 | 162 | 2334 | regulation of transcription, DNA-templated |
GO:0035137 | 3e-04 | 23.5482 | 0.3776 | 4 | 7 | hindlimb morphogenesis |
GO:0060900 | 3e-04 | 23.3723 | 0.3803 | 4 | 7 | embryonic camera-type eye formation |
GO:0007156 | 3e-04 | 3.5414 | 4.2374 | 13 | 78 | homophilic cell adhesion |
GO:0002088 | 3e-04 | 4.9605 | 2.2273 | 9 | 41 | lens development in camera-type eye |
GO:0001655 | 3e-04 | 2.3144 | 11.8429 | 25 | 218 | urogenital system development |
GO:0050877 | 4e-04 | 1.7954 | 28.28 | 47 | 523 | neurological system process |
GO:0060041 | 4e-04 | 3.1797 | 4.9979 | 14 | 92 | retina development in camera-type eye |
GO:0048839 | 4e-04 | 2.6881 | 7.4426 | 18 | 137 | inner ear development |
GO:0022617 | 5e-04 | 3.5367 | 3.9114 | 12 | 72 | extracellular matrix disassembly |
GO:0042127 | 5e-04 | 1.6013 | 47.2087 | 70 | 869 | regulation of cell proliferation |
GO:0072359 | 5e-04 | 1.7334 | 31.726 | 51 | 584 | circulatory system development |
GO:0072048 | 5e-04 | 17.5274 | 0.4346 | 4 | 8 | renal system pattern specification |
GO:0035113 | 5e-04 | 3.0996 | 5.1066 | 14 | 94 | embryonic appendage morphogenesis |
GO:0018958 | 6e-04 | 4.0108 | 2.9336 | 10 | 54 | phenol-containing compound metabolic process |
GO:0030858 | 6e-04 | 5.8642 | 1.5211 | 7 | 28 | positive regulation of epithelial cell differentiation |
GO:0051252 | 6e-04 | 1.3808 | 131.2501 | 164 | 2416 | regulation of RNA metabolic process |
GO:0003257 | 6e-04 | 52.5027 | 0.2173 | 3 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0021854 | 6e-04 | 9.7502 | 0.7606 | 5 | 14 | hypothalamus development |
GO:0051412 | 6e-04 | 9.7502 | 0.7606 | 5 | 14 | response to corticosterone |
GO:0060581 | 6e-04 | 9.7502 | 0.7606 | 5 | 14 | cell fate commitment involved in pattern specification |
GO:0035295 | 6e-04 | 2.0126 | 16.6732 | 31 | 312 | tube development |
GO:0009887 | 6e-04 | 1.9039 | 20.4128 | 36 | 388 | organ morphogenesis |
GO:0001662 | 7e-04 | 7.0286 | 1.1408 | 6 | 21 | behavioral fear response |
GO:0007420 | 7e-04 | 1.8018 | 25.0983 | 42 | 462 | brain development |
GO:0045665 | 8e-04 | 4.1746 | 2.5533 | 9 | 47 | negative regulation of neuron differentiation |
GO:0003002 | 9e-04 | 3.2512 | 4.1871 | 12 | 79 | regionalization |
GO:0006812 | 9e-04 | 1.6893 | 31.7803 | 50 | 585 | cation transport |
GO:0045666 | 9e-04 | 3.4685 | 3.6398 | 11 | 67 | positive regulation of neuron differentiation |
GO:0009954 | 9e-04 | 6.5886 | 1.1952 | 6 | 22 | proximal/distal pattern formation |
GO:0045595 | 9e-04 | 1.5531 | 49.1645 | 71 | 905 | regulation of cell differentiation |
GO:0001568 | 9e-04 | 1.8931 | 19.3398 | 34 | 356 | blood vessel development |
GO:0035148 | 9e-04 | 2.768 | 6.0301 | 15 | 111 | tube formation |
GO:0055085 | 9e-04 | 1.5956 | 41.7219 | 62 | 768 | transmembrane transport |
GO:0014706 | 0.001 | 2.1494 | 12.1146 | 24 | 223 | striated muscle tissue development |
GO:0048731 | 0.0011 | 1.4484 | 79.5252 | 105 | 1651 | system development |
GO:0045165 | 0.0011 | 2.8469 | 5.4769 | 14 | 104 | cell fate commitment |
GO:0072009 | 0.0011 | 3.9651 | 2.6619 | 9 | 49 | nephron epithelium development |
GO:2000179 | 0.0011 | 5.1296 | 1.6841 | 7 | 31 | positive regulation of neural precursor cell proliferation |
GO:0003231 | 0.0011 | 3.3482 | 3.7484 | 11 | 69 | cardiac ventricle development |
GO:0007631 | 0.0011 | 3.3482 | 3.7484 | 11 | 69 | feeding behavior |
GO:0021513 | 0.0011 | 6.2004 | 1.2495 | 6 | 23 | spinal cord dorsal/ventral patterning |
GO:0035115 | 0.0011 | 6.2004 | 1.2495 | 6 | 23 | embryonic forelimb morphogenesis |
GO:0001838 | 0.0012 | 2.8154 | 5.5412 | 14 | 102 | embryonic epithelial tube formation |
GO:0021514 | 0.0012 | 7.9757 | 0.8692 | 5 | 16 | ventral spinal cord interneuron differentiation |
GO:0048663 | 0.0012 | 5.0169 | 1.7083 | 7 | 32 | neuron fate commitment |
GO:0050767 | 0.0013 | 1.8344 | 20.4807 | 35 | 377 | regulation of neurogenesis |
GO:0061318 | 0.0014 | 11.6825 | 0.5433 | 4 | 10 | renal filtration cell differentiation |
GO:0071294 | 0.0014 | 11.6825 | 0.5433 | 4 | 10 | cellular response to zinc ion |
GO:0060415 | 0.0014 | 4.2674 | 2.2273 | 8 | 41 | muscle tissue morphogenesis |
GO:0035136 | 0.0014 | 26.4917 | 0.2693 | 3 | 5 | forelimb morphogenesis |
GO:0035933 | 0.0015 | 26.2486 | 0.2716 | 3 | 5 | glucocorticoid secretion |
GO:0060023 | 0.0015 | 26.2486 | 0.2716 | 3 | 5 | soft palate development |
GO:0060040 | 0.0015 | 26.2486 | 0.2716 | 3 | 5 | retinal bipolar neuron differentiation |
GO:0072081 | 0.0015 | 26.2486 | 0.2716 | 3 | 5 | specification of nephron tubule identity |
GO:0006821 | 0.0015 | 3.7755 | 2.7706 | 9 | 51 | chloride transport |
GO:0035270 | 0.0016 | 3.7517 | 2.7798 | 9 | 52 | endocrine system development |
GO:0021761 | 0.0016 | 4.1759 | 2.2641 | 8 | 42 | limbic system development |
GO:0021871 | 0.0017 | 7.3103 | 0.9235 | 5 | 17 | forebrain regionalization |
GO:0043062 | 0.0017 | 2.0646 | 12.5492 | 24 | 231 | extracellular structure organization |
GO:0010628 | 0.0017 | 1.5121 | 49.5447 | 70 | 912 | positive regulation of gene expression |
GO:0051093 | 0.0018 | 1.7389 | 23.9837 | 39 | 443 | negative regulation of developmental process |
GO:0050679 | 0.0018 | 2.8022 | 5.1609 | 13 | 95 | positive regulation of epithelial cell proliferation |
GO:0043269 | 0.0018 | 1.887 | 17.0582 | 30 | 314 | regulation of ion transport |
GO:0048048 | 0.0018 | 5.5466 | 1.3581 | 6 | 25 | embryonic eye morphogenesis |
GO:0021915 | 0.0019 | 2.4644 | 7.1166 | 16 | 131 | neural tube development |
GO:0007423 | 0.002 | 2.4525 | 7.1355 | 16 | 136 | sensory organ development |
GO:0007189 | 0.002 | 4.5582 | 1.8471 | 7 | 34 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0001707 | 0.002 | 3.6031 | 2.8792 | 9 | 53 | mesoderm formation |
GO:0015812 | 0.0021 | 10.0125 | 0.5976 | 4 | 11 | gamma-aminobutyric acid transport |
GO:0022010 | 0.0021 | 10.0125 | 0.5976 | 4 | 11 | central nervous system myelination |
GO:0030878 | 0.0021 | 10.0125 | 0.5976 | 4 | 11 | thyroid gland development |
GO:0048712 | 0.0021 | 10.0125 | 0.5976 | 4 | 11 | negative regulation of astrocyte differentiation |
GO:0072311 | 0.0021 | 10.0125 | 0.5976 | 4 | 11 | glomerular epithelial cell differentiation |
GO:0009952 | 0.0021 | 2.2965 | 8.5291 | 18 | 157 | anterior/posterior pattern specification |
GO:0014014 | 0.0022 | 6.7817 | 0.9732 | 5 | 18 | negative regulation of gliogenesis |
GO:0048812 | 0.0022 | 1.705 | 25.044 | 40 | 461 | neuron projection morphogenesis |
GO:1902680 | 0.0024 | 1.5027 | 47.589 | 67 | 876 | positive regulation of RNA biosynthetic process |
GO:0032835 | 0.0024 | 4.395 | 1.9014 | 7 | 35 | glomerulus development |
GO:0031960 | 0.0025 | 2.8249 | 4.7263 | 12 | 87 | response to corticosteroid |
GO:0009190 | 0.0025 | 2.9855 | 4.1287 | 11 | 76 | cyclic nucleotide biosynthetic process |
GO:0045766 | 0.0026 | 3.4457 | 2.9879 | 9 | 55 | positive regulation of angiogenesis |
GO:0061564 | 0.0027 | 1.7324 | 22.1647 | 36 | 408 | axon development |
GO:0044708 | 0.0028 | 1.9774 | 13.0308 | 24 | 242 | single-organism behavior |
GO:0003211 | 0.0028 | 17.4973 | 0.326 | 3 | 6 | cardiac ventricle formation |
GO:0021796 | 0.0028 | 17.4973 | 0.326 | 3 | 6 | cerebral cortex regionalization |
GO:2000846 | 0.0028 | 17.4973 | 0.326 | 3 | 6 | regulation of corticosteroid hormone secretion |
GO:0019448 | 0.0029 | Inf | 0.1087 | 2 | 2 | L-cysteine catabolic process |
GO:0051901 | 0.0029 | Inf | 0.1087 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:0055005 | 0.0029 | Inf | 0.1087 | 2 | 2 | ventricular cardiac myofibril assembly |
GO:0055009 | 0.0029 | Inf | 0.1087 | 2 | 2 | atrial cardiac muscle tissue morphogenesis |
GO:1900155 | 0.0029 | Inf | 0.1087 | 2 | 2 | negative regulation of bone trabecula formation |
GO:2000721 | 0.0029 | Inf | 0.1087 | 2 | 2 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:2000852 | 0.0029 | Inf | 0.1087 | 2 | 2 | regulation of corticosterone secretion |
GO:0048709 | 0.003 | 3.372 | 3.0422 | 9 | 56 | oligodendrocyte differentiation |
GO:0001946 | 0.003 | 8.76 | 0.6519 | 4 | 12 | lymphangiogenesis |
GO:0021542 | 0.003 | 8.76 | 0.6519 | 4 | 12 | dentate gyrus development |
GO:0032892 | 0.003 | 8.76 | 0.6519 | 4 | 12 | positive regulation of organic acid transport |
GO:0071242 | 0.003 | 8.76 | 0.6519 | 4 | 12 | cellular response to ammonium ion |
GO:0033555 | 0.003 | 3.7039 | 2.499 | 8 | 46 | multicellular organismal response to stress |
GO:0006836 | 0.0032 | 2.4997 | 6.1388 | 14 | 113 | neurotransmitter transport |
GO:0007204 | 0.0034 | 2.5799 | 5.5412 | 13 | 102 | positive regulation of cytosolic calcium ion concentration |
GO:0072089 | 0.0034 | 2.5799 | 5.5412 | 13 | 102 | stem cell proliferation |
GO:0051094 | 0.0036 | 1.6203 | 28.2085 | 43 | 525 | positive regulation of developmental process |
GO:0006935 | 0.0036 | 1.7097 | 21.7845 | 35 | 401 | chemotaxis |
GO:0006874 | 0.0037 | 2.1697 | 8.9637 | 18 | 165 | cellular calcium ion homeostasis |
GO:0050806 | 0.004 | 3.518 | 2.6076 | 8 | 48 | positive regulation of synaptic transmission |
GO:0008217 | 0.004 | 2.6469 | 4.9979 | 12 | 92 | regulation of blood pressure |
GO:0021543 | 0.004 | 2.6469 | 4.9979 | 12 | 92 | pallium development |
GO:0010721 | 0.004 | 2.5227 | 5.6498 | 13 | 104 | negative regulation of cell development |
GO:0072210 | 0.0041 | 4.58 | 1.5754 | 6 | 29 | metanephric nephron development |
GO:0007411 | 0.0041 | 1.8581 | 14.9395 | 26 | 275 | axon guidance |
GO:0048667 | 0.0042 | 1.6545 | 24.3921 | 38 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0031326 | 0.0043 | 1.2924 | 145.6463 | 173 | 2681 | regulation of cellular biosynthetic process |
GO:0003013 | 0.0044 | 1.9272 | 12.7665 | 23 | 235 | circulatory system process |
GO:0015837 | 0.0045 | 3.844 | 2.1187 | 7 | 39 | amine transport |
GO:0045685 | 0.0045 | 3.844 | 2.1187 | 7 | 39 | regulation of glial cell differentiation |
GO:0035116 | 0.0046 | 5.4805 | 1.1408 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0021521 | 0.0047 | 13.1682 | 0.379 | 3 | 7 | ventral spinal cord interneuron specification |
GO:0030182 | 0.0047 | 1.5264 | 36.1538 | 52 | 700 | neuron differentiation |
GO:0003310 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | pancreatic A cell differentiation |
GO:0042753 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | positive regulation of circadian rhythm |
GO:0046851 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | negative regulation of bone remodeling |
GO:0060253 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | negative regulation of glial cell proliferation |
GO:0071711 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | basement membrane organization |
GO:0072015 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | glomerular visceral epithelial cell development |
GO:1902547 | 0.0047 | 13.1216 | 0.3803 | 3 | 7 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0048704 | 0.0048 | 2.8879 | 3.8571 | 10 | 71 | embryonic skeletal system morphogenesis |
GO:0090092 | 0.0049 | 2.2859 | 7.1166 | 15 | 131 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0010556 | 0.0049 | 1.2897 | 141.3546 | 168 | 2602 | regulation of macromolecule biosynthetic process |
GO:0007267 | 0.0053 | 1.8686 | 13.6974 | 24 | 266 | cell-cell signaling |
GO:0035282 | 0.0053 | 2.841 | 3.9114 | 10 | 72 | segmentation |
GO:0048646 | 0.0054 | 1.5626 | 30.5127 | 45 | 572 | anatomical structure formation involved in morphogenesis |
GO:0050789 | 0.0056 | 1.2675 | 338.447 | 367 | 6230 | regulation of biological process |
GO:0043542 | 0.0056 | 2.6561 | 4.5633 | 11 | 84 | endothelial cell migration |
GO:0072507 | 0.0056 | 2.0278 | 10.0502 | 19 | 185 | divalent inorganic cation homeostasis |
GO:0001709 | 0.0058 | 4.2127 | 1.6841 | 6 | 31 | cell fate determination |
GO:0009792 | 0.0059 | 1.6175 | 24.881 | 38 | 458 | embryo development ending in birth or egg hatching |
GO:0006813 | 0.0059 | 2.3109 | 6.5734 | 14 | 121 | potassium ion transport |
GO:0034654 | 0.0059 | 1.2777 | 147.7107 | 174 | 2719 | nucleobase-containing compound biosynthetic process |
GO:0060538 | 0.0063 | 2.2892 | 6.6277 | 14 | 122 | skeletal muscle organ development |
GO:0051240 | 0.0064 | 1.6672 | 20.9696 | 33 | 386 | positive regulation of multicellular organismal process |
GO:0048562 | 0.0064 | 3.2014 | 2.816 | 8 | 53 | embryonic organ morphogenesis |
GO:0030509 | 0.0066 | 2.5847 | 4.672 | 11 | 86 | BMP signaling pathway |
GO:0042471 | 0.0066 | 2.4607 | 5.3239 | 12 | 98 | ear morphogenesis |
GO:0071805 | 0.0066 | 2.4607 | 5.3239 | 12 | 98 | potassium ion transmembrane transport |
GO:0061005 | 0.0068 | 4.0503 | 1.7384 | 6 | 32 | cell differentiation involved in kidney development |
GO:0002064 | 0.0069 | 2.1903 | 7.3882 | 15 | 136 | epithelial cell development |
GO:0007588 | 0.0069 | 3.5134 | 2.2817 | 7 | 42 | excretion |
GO:0009891 | 0.0071 | 1.3996 | 56.0094 | 74 | 1031 | positive regulation of biosynthetic process |
GO:2000021 | 0.0071 | 2.7091 | 4.0744 | 10 | 75 | regulation of ion homeostasis |
GO:0031645 | 0.0073 | 10.4962 | 0.4346 | 3 | 8 | negative regulation of neurological system process |
GO:0042362 | 0.0073 | 10.4962 | 0.4346 | 3 | 8 | fat-soluble vitamin biosynthetic process |
GO:0048845 | 0.0073 | 10.4962 | 0.4346 | 3 | 8 | venous blood vessel morphogenesis |
GO:0060180 | 0.0073 | 10.4962 | 0.4346 | 3 | 8 | female mating behavior |
GO:0071276 | 0.0073 | 10.4962 | 0.4346 | 3 | 8 | cellular response to cadmium ion |
GO:0006171 | 0.0073 | 2.8792 | 3.4768 | 9 | 64 | cAMP biosynthetic process |
GO:0046717 | 0.0074 | 3.1255 | 2.8792 | 8 | 53 | acid secretion |
GO:0022414 | 0.0074 | 1.464 | 40.4181 | 56 | 744 | reproductive process |
GO:0007507 | 0.0075 | 1.7232 | 17.2211 | 28 | 317 | heart development |
GO:0006820 | 0.0076 | 1.7832 | 14.8851 | 25 | 274 | anion transport |
GO:0007200 | 0.0079 | 3.4154 | 2.336 | 7 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0045471 | 0.0081 | 2.8274 | 3.5311 | 9 | 65 | response to ethanol |
GO:0002125 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | maternal aggressive behavior |
GO:0007621 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | negative regulation of female receptivity |
GO:0014816 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | skeletal muscle satellite cell differentiation |
GO:0021912 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0021913 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0021960 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | anterior commissure morphogenesis |
GO:0030240 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0032849 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | positive regulation of cellular pH reduction |
GO:0042335 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | cuticle development |
GO:0045472 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | response to ether |
GO:0051122 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | hepoxilin biosynthetic process |
GO:0051464 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | positive regulation of cortisol secretion |
GO:2000637 | 0.0085 | 34.9382 | 0.163 | 2 | 3 | positive regulation of gene silencing by miRNA |
GO:0002040 | 0.0089 | 3.3228 | 2.3903 | 7 | 44 | sprouting angiogenesis |
GO:0007166 | 0.0091 | 1.2997 | 98.4376 | 120 | 1812 | cell surface receptor signaling pathway |
GO:0003279 | 0.0092 | 2.9919 | 2.9879 | 8 | 55 | cardiac septum development |
GO:0072078 | 0.0093 | 5.8376 | 0.8692 | 4 | 16 | nephron tubule morphogenesis |
GO:0007498 | 0.0093 | 2.4528 | 4.8893 | 11 | 90 | mesoderm development |
GO:0009605 | 0.0094 | 1.3641 | 62.0396 | 80 | 1142 | response to external stimulus |
GO:0045935 | 0.0095 | 1.3874 | 54.0537 | 71 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:0007626 | 0.0095 | 2.1023 | 7.6599 | 15 | 141 | locomotory behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032502 | 0 | 2.0937 | 141.6292 | 222 | 2562 | developmental process |
GO:0022008 | 0 | 2.7744 | 33.5646 | 78 | 596 | neurogenesis |
GO:0043583 | 0 | 4.5975 | 9.2831 | 34 | 158 | ear development |
GO:0007155 | 0 | 2.4036 | 37.1326 | 77 | 632 | cell adhesion |
GO:0007389 | 0 | 3.215 | 15.7555 | 43 | 274 | pattern specification process |
GO:0007268 | 0 | 3.0203 | 17.4072 | 45 | 303 | synaptic transmission |
GO:0007166 | 0 | 1.7535 | 106.4624 | 160 | 1812 | cell surface receptor signaling pathway |
GO:0048562 | 0 | 4.0486 | 8.0686 | 27 | 140 | embryonic organ morphogenesis |
GO:0042472 | 0 | 5.2069 | 4.6416 | 19 | 79 | inner ear morphogenesis |
GO:0007218 | 0 | 5.8108 | 3.819 | 17 | 65 | neuropeptide signaling pathway |
GO:0048667 | 0 | 2.3618 | 26.3806 | 55 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0061564 | 0 | 2.4089 | 23.9717 | 51 | 408 | axon development |
GO:0021527 | 0 | 21.6367 | 0.8226 | 8 | 14 | spinal cord association neuron differentiation |
GO:0045944 | 0 | 2.1043 | 35.7812 | 67 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0043010 | 0 | 3.3948 | 9.3123 | 27 | 160 | camera-type eye development |
GO:0065007 | 0 | 1.5808 | 366.1998 | 420 | 6357 | biological regulation |
GO:0007600 | 0 | 2.666 | 16.2011 | 38 | 277 | sensory perception |
GO:0048812 | 0 | 2.2374 | 27.0856 | 54 | 461 | neuron projection morphogenesis |
GO:0048565 | 0 | 4.4157 | 5.2654 | 19 | 90 | digestive tract development |
GO:0007517 | 0 | 2.7848 | 13.9247 | 34 | 237 | muscle organ development |
GO:0060485 | 0 | 3.4109 | 8.5781 | 25 | 146 | mesenchyme development |
GO:0021514 | 0 | 16.2241 | 0.9401 | 8 | 16 | ventral spinal cord interneuron differentiation |
GO:0009792 | 0 | 2.2033 | 26.9094 | 53 | 458 | embryo development ending in birth or egg hatching |
GO:0010628 | 0 | 1.8338 | 53.5837 | 88 | 912 | positive regulation of gene expression |
GO:0048592 | 0 | 4.0081 | 5.9929 | 20 | 102 | eye morphogenesis |
GO:0007411 | 0 | 2.589 | 16.1574 | 37 | 275 | axon guidance |
GO:0060042 | 0 | 11.3128 | 1.2854 | 9 | 22 | retina morphogenesis in camera-type eye |
GO:0040007 | 0 | 2.0231 | 34.6649 | 63 | 590 | growth |
GO:0030182 | 0 | 2.0218 | 34.1531 | 62 | 620 | neuron differentiation |
GO:0021513 | 0 | 10.441 | 1.3513 | 9 | 23 | spinal cord dorsal/ventral patterning |
GO:0048863 | 0 | 2.7631 | 12.3163 | 30 | 211 | stem cell differentiation |
GO:0060581 | 0 | 16.1983 | 0.8226 | 7 | 14 | cell fate commitment involved in pattern specification |
GO:0007423 | 0 | 2.7938 | 11.7632 | 29 | 209 | sensory organ development |
GO:0045666 | 0 | 4.7145 | 3.9365 | 15 | 67 | positive regulation of neuron differentiation |
GO:0031018 | 0 | 7.778 | 1.8135 | 10 | 31 | endocrine pancreas development |
GO:1902680 | 0 | 1.786 | 51.4686 | 83 | 876 | positive regulation of RNA biosynthetic process |
GO:0048663 | 0 | 7.5591 | 1.8409 | 10 | 32 | neuron fate commitment |
GO:0072163 | 0 | 4.2902 | 4.5241 | 16 | 77 | mesonephric epithelium development |
GO:0007267 | 0 | 3.3667 | 7.2064 | 21 | 134 | cell-cell signaling |
GO:0060079 | 0 | 7.0669 | 1.9389 | 10 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0071805 | 0 | 3.6855 | 5.7579 | 18 | 98 | potassium ion transmembrane transport |
GO:0042391 | 0 | 2.5384 | 13.6897 | 31 | 233 | regulation of membrane potential |
GO:0045935 | 0 | 1.6985 | 58.4603 | 90 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:0021879 | 0 | 5.9655 | 2.4089 | 11 | 41 | forebrain neuron differentiation |
GO:0023019 | 0 | 12.596 | 0.9401 | 7 | 16 | signal transduction involved in regulation of gene expression |
GO:0030030 | 0 | 1.7657 | 48.0021 | 77 | 817 | cell projection organization |
GO:0007548 | 0 | 2.7823 | 10.5757 | 26 | 180 | sex differentiation |
GO:0009790 | 0 | 2.5501 | 13.1708 | 30 | 236 | embryo development |
GO:0006935 | 0 | 2.1086 | 23.5604 | 45 | 401 | chemotaxis |
GO:0021915 | 0 | 3.1334 | 7.6968 | 21 | 131 | neural tube development |
GO:0006355 | 0 | 1.4723 | 137.132 | 179 | 2334 | regulation of transcription, DNA-templated |
GO:0009581 | 0 | 3.735 | 5.0528 | 16 | 86 | detection of external stimulus |
GO:0098655 | 0 | 2.1109 | 21.9153 | 42 | 373 | cation transmembrane transport |
GO:0001708 | 0 | 8.3544 | 1.371 | 8 | 24 | cell fate specification |
GO:0048736 | 0 | 3.1226 | 7.3443 | 20 | 125 | appendage development |
GO:0009891 | 0 | 1.65 | 60.5754 | 91 | 1031 | positive regulation of biosynthetic process |
GO:0035239 | 0 | 2.3697 | 14.9951 | 32 | 256 | tube morphogenesis |
GO:0051094 | 0 | 1.8824 | 32.5803 | 56 | 561 | positive regulation of developmental process |
GO:0003007 | 0 | 2.8892 | 8.6368 | 22 | 147 | heart morphogenesis |
GO:0051216 | 0 | 3.0635 | 7.4618 | 20 | 127 | cartilage development |
GO:2000026 | 0 | 1.7703 | 41.4379 | 67 | 729 | regulation of multicellular organismal development |
GO:0001944 | 1e-04 | 2.0656 | 22.3265 | 42 | 380 | vasculature development |
GO:0021559 | 1e-04 | 64.5059 | 0.2938 | 4 | 5 | trigeminal nerve development |
GO:0060527 | 1e-04 | 64.5059 | 0.2938 | 4 | 5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0035108 | 1e-04 | 3.2362 | 6.4042 | 18 | 109 | limb morphogenesis |
GO:0051252 | 1e-04 | 1.4389 | 141.9498 | 182 | 2416 | regulation of RNA metabolic process |
GO:0060537 | 1e-04 | 2.4296 | 12.7973 | 28 | 219 | muscle tissue development |
GO:0006813 | 1e-04 | 3.0494 | 7.1092 | 19 | 121 | potassium ion transport |
GO:0050877 | 1e-04 | 3.1532 | 6.518 | 18 | 117 | neurological system process |
GO:0061458 | 1e-04 | 2.1958 | 17.0387 | 34 | 290 | reproductive system development |
GO:0034765 | 1e-04 | 2.4864 | 11.6333 | 26 | 198 | regulation of ion transmembrane transport |
GO:0007631 | 1e-04 | 4.7387 | 2.8605 | 11 | 49 | feeding behavior |
GO:0051093 | 1e-04 | 1.9347 | 25.946 | 46 | 443 | negative regulation of developmental process |
GO:0032990 | 1e-04 | 1.7877 | 35.3112 | 58 | 601 | cell part morphogenesis |
GO:0001755 | 1e-04 | 6.8233 | 1.5864 | 8 | 27 | neural crest cell migration |
GO:0031326 | 1e-04 | 1.4037 | 157.5196 | 197 | 2681 | regulation of cellular biosynthetic process |
GO:0050767 | 1e-04 | 2.2294 | 15.2914 | 31 | 264 | regulation of neurogenesis |
GO:0035116 | 1e-04 | 8.0932 | 1.2338 | 7 | 21 | embryonic hindlimb morphogenesis |
GO:0035235 | 1e-04 | 8.0932 | 1.2338 | 7 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0007270 | 1e-04 | 3.2647 | 5.6404 | 16 | 96 | neuron-neuron synaptic transmission |
GO:0021796 | 2e-04 | 32.2496 | 0.3525 | 4 | 6 | cerebral cortex regionalization |
GO:2000543 | 2e-04 | 32.2496 | 0.3525 | 4 | 6 | positive regulation of gastrulation |
GO:0009582 | 2e-04 | 3.3509 | 5.1704 | 15 | 88 | detection of abiotic stimulus |
GO:0021517 | 2e-04 | 7.6503 | 1.2773 | 7 | 22 | ventral spinal cord development |
GO:0044708 | 2e-04 | 2.2575 | 14.1286 | 29 | 242 | single-organism behavior |
GO:0001822 | 2e-04 | 2.6316 | 8.9076 | 21 | 153 | kidney development |
GO:0022414 | 2e-04 | 9.3325 | 0.9478 | 6 | 17 | reproductive process |
GO:0048704 | 2e-04 | 3.6484 | 4.1715 | 13 | 71 | embryonic skeletal system morphogenesis |
GO:0009187 | 2e-04 | 3.1079 | 5.8754 | 16 | 100 | cyclic nucleotide metabolic process |
GO:0048665 | 2e-04 | 13.6521 | 0.6376 | 5 | 11 | neuron fate specification |
GO:0035115 | 2e-04 | 7.0801 | 1.3513 | 7 | 23 | embryonic forelimb morphogenesis |
GO:0051171 | 3e-04 | 1.3679 | 176.4384 | 215 | 3003 | regulation of nitrogen compound metabolic process |
GO:0048557 | 3e-04 | 8.8168 | 0.9988 | 6 | 17 | embryonic digestive tract morphogenesis |
GO:0098660 | 3e-04 | 1.9449 | 21.2102 | 38 | 361 | inorganic ion transmembrane transport |
GO:0009888 | 3e-04 | 2.5239 | 9.1985 | 21 | 175 | tissue development |
GO:0035113 | 4e-04 | 3.0944 | 5.5229 | 15 | 94 | embryonic appendage morphogenesis |
GO:0021521 | 4e-04 | 21.568 | 0.41 | 4 | 7 | ventral spinal cord interneuron specification |
GO:0001714 | 4e-04 | 21.4975 | 0.4113 | 4 | 7 | endodermal cell fate specification |
GO:0050794 | 4e-04 | 1.3706 | 281.7589 | 319 | 5064 | regulation of cellular process |
GO:0072498 | 4e-04 | 11.5311 | 0.705 | 5 | 12 | embryonic skeletal joint development |
GO:0040011 | 5e-04 | 2.2066 | 12.8906 | 26 | 228 | locomotion |
GO:0044057 | 5e-04 | 2.1625 | 13.6309 | 27 | 232 | regulation of system process |
GO:0050804 | 5e-04 | 2.4365 | 9.5182 | 21 | 162 | regulation of synaptic transmission |
GO:0010556 | 5e-04 | 1.3615 | 152.8781 | 188 | 2602 | regulation of macromolecule biosynthetic process |
GO:0072358 | 5e-04 | 2.2714 | 11.5755 | 24 | 204 | cardiovascular system development |
GO:0003407 | 5e-04 | 7.5033 | 1.1102 | 6 | 19 | neural retina development |
GO:0060675 | 6e-04 | 4.0562 | 2.9377 | 10 | 50 | ureteric bud morphogenesis |
GO:0061217 | 6e-04 | 7.4588 | 1.1163 | 6 | 19 | regulation of mesonephros development |
GO:0002009 | 7e-04 | 2.0837 | 14.6024 | 28 | 253 | morphogenesis of an epithelium |
GO:0048793 | 7e-04 | 16.1214 | 0.47 | 4 | 8 | pronephros development |
GO:0001764 | 7e-04 | 2.8742 | 5.8754 | 15 | 100 | neuron migration |
GO:0007498 | 7e-04 | 2.9979 | 5.2879 | 14 | 90 | mesoderm development |
GO:0009605 | 7e-04 | 1.5131 | 59.8624 | 84 | 1042 | response to external stimulus |
GO:0009880 | 7e-04 | 4.2902 | 2.5264 | 9 | 43 | embryonic pattern specification |
GO:0021696 | 7e-04 | 5.6617 | 1.5864 | 7 | 27 | cerebellar cortex morphogenesis |
GO:0045595 | 7e-04 | 1.5506 | 51.3487 | 74 | 884 | regulation of cell differentiation |
GO:0045880 | 8e-04 | 6.9253 | 1.1751 | 6 | 20 | positive regulation of smoothened signaling pathway |
GO:0007412 | 8e-04 | 48.298 | 0.235 | 3 | 4 | axon target recognition |
GO:0014054 | 8e-04 | 48.298 | 0.235 | 3 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0015816 | 8e-04 | 48.298 | 0.235 | 3 | 4 | glycine transport |
GO:0072172 | 8e-04 | 48.298 | 0.235 | 3 | 4 | mesonephric tubule formation |
GO:0048514 | 8e-04 | 3.5174 | 3.6211 | 11 | 63 | blood vessel morphogenesis |
GO:0009887 | 8e-04 | 2.3831 | 9.1971 | 20 | 171 | organ morphogenesis |
GO:0014031 | 9e-04 | 4.6765 | 2.0939 | 8 | 36 | mesenchymal cell development |
GO:0001756 | 9e-04 | 3.772 | 3.114 | 10 | 53 | somitogenesis |
GO:0009952 | 9e-04 | 2.9018 | 5.427 | 14 | 94 | anterior/posterior pattern specification |
GO:0048645 | 9e-04 | 4.6258 | 2.1151 | 8 | 36 | organ formation |
GO:0023052 | 0.001 | 1.3465 | 159.2026 | 192 | 2916 | signaling |
GO:0080090 | 0.001 | 1.3101 | 219.7402 | 256 | 3740 | regulation of primary metabolic process |
GO:0021983 | 0.001 | 6.5015 | 1.227 | 6 | 21 | pituitary gland development |
GO:0003401 | 0.001 | 6.4629 | 1.2338 | 6 | 21 | axis elongation |
GO:0021533 | 0.001 | 6.4629 | 1.2338 | 6 | 21 | cell differentiation in hindbrain |
GO:0060441 | 0.001 | 6.4629 | 1.2338 | 6 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0051240 | 0.001 | 1.8313 | 21.74 | 37 | 372 | positive regulation of multicellular organismal process |
GO:0018958 | 0.001 | 3.6859 | 3.1727 | 10 | 54 | phenol-containing compound metabolic process |
GO:0034654 | 0.0011 | 1.331 | 159.7523 | 193 | 2719 | nucleobase-containing compound biosynthetic process |
GO:0001525 | 0.0011 | 2.0403 | 14.336 | 27 | 244 | angiogenesis |
GO:0007269 | 0.0012 | 2.9763 | 4.9353 | 13 | 84 | neurotransmitter secretion |
GO:0030901 | 0.0012 | 5.1459 | 1.7039 | 7 | 29 | midbrain development |
GO:0060525 | 0.0012 | 12.8958 | 0.5288 | 4 | 9 | prostate glandular acinus development |
GO:0072176 | 0.0012 | 12.8958 | 0.5288 | 4 | 9 | nephric duct development |
GO:0045165 | 0.0012 | 3.3212 | 3.7834 | 11 | 68 | cell fate commitment |
GO:2000027 | 0.0012 | 2.6963 | 6.1997 | 15 | 106 | regulation of organ morphogenesis |
GO:0030900 | 0.0013 | 2.6872 | 6.2112 | 15 | 108 | forebrain development |
GO:0048468 | 0.0013 | 1.6208 | 36.4374 | 55 | 673 | cell development |
GO:0030539 | 0.0013 | 8.0693 | 0.8813 | 5 | 15 | male genitalia development |
GO:0046903 | 0.0013 | 2.0113 | 14.5173 | 27 | 252 | secretion |
GO:0007275 | 0.0014 | 2.2333 | 10.2471 | 21 | 230 | multicellular organismal development |
GO:0006811 | 0.0014 | 1.7089 | 27.6078 | 44 | 484 | ion transport |
GO:0021761 | 0.0014 | 3.5249 | 3.2902 | 10 | 56 | limbic system development |
GO:0008344 | 0.0015 | 3.2454 | 3.8778 | 11 | 66 | adult locomotory behavior |
GO:0016337 | 0.0015 | 2.0889 | 12.4559 | 24 | 212 | single organismal cell-cell adhesion |
GO:0022612 | 0.0017 | 2.9977 | 4.5241 | 12 | 77 | gland morphogenesis |
GO:0045995 | 0.0017 | 2.9977 | 4.5241 | 12 | 77 | regulation of embryonic development |
GO:0048333 | 0.0017 | 5.7014 | 1.3513 | 6 | 23 | mesodermal cell differentiation |
GO:0050974 | 0.0017 | 7.3349 | 0.9401 | 5 | 16 | detection of mechanical stimulus involved in sensory perception |
GO:0071705 | 0.0018 | 1.7163 | 25.558 | 41 | 435 | nitrogen compound transport |
GO:0048870 | 0.0018 | 1.553 | 41.9504 | 61 | 714 | cell motility |
GO:0021520 | 0.0018 | 10.7806 | 0.5857 | 4 | 10 | spinal cord motor neuron cell fate specification |
GO:0001826 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | inner cell mass cell differentiation |
GO:0003025 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0015824 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | proline transport |
GO:0043374 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | CD8-positive, alpha-beta T cell differentiation |
GO:0050957 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | equilibrioception |
GO:0051967 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | negative regulation of synaptic transmission, glutamatergic |
GO:0060687 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | regulation of branching involved in prostate gland morphogenesis |
GO:0090037 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | positive regulation of protein kinase C signaling |
GO:2000675 | 0.0018 | 24.1465 | 0.2938 | 3 | 5 | negative regulation of type B pancreatic cell apoptotic process |
GO:0007156 | 0.0019 | 2.952 | 4.5828 | 12 | 78 | homophilic cell adhesion |
GO:0021794 | 0.0019 | 10.7454 | 0.5875 | 4 | 10 | thalamus development |
GO:0042136 | 0.0019 | 10.7454 | 0.5875 | 4 | 10 | neurotransmitter biosynthetic process |
GO:0021953 | 0.0019 | 3.1285 | 3.9859 | 11 | 70 | central nervous system neuron differentiation |
GO:0006029 | 0.0019 | 3.1309 | 3.9953 | 11 | 68 | proteoglycan metabolic process |
GO:0045937 | 0.0019 | 1.6194 | 32.961 | 50 | 561 | positive regulation of phosphate metabolic process |
GO:0072009 | 0.0019 | 3.6444 | 2.8789 | 9 | 49 | nephron epithelium development |
GO:0007399 | 0.002 | 2.3785 | 7.7977 | 17 | 154 | nervous system development |
GO:0097305 | 0.002 | 2.1565 | 10.5757 | 21 | 180 | response to alcohol |
GO:0030198 | 0.0021 | 1.9954 | 13.5134 | 25 | 230 | extracellular matrix organization |
GO:1900449 | 0.0022 | 5.3841 | 1.4101 | 6 | 24 | regulation of glutamate receptor signaling pathway |
GO:0001704 | 0.0022 | 2.7426 | 5.2879 | 13 | 90 | formation of primary germ layer |
GO:0007605 | 0.0022 | 2.7426 | 5.2879 | 13 | 90 | sensory perception of sound |
GO:0048585 | 0.0022 | 1.5353 | 42.3617 | 61 | 721 | negative regulation of response to stimulus |
GO:0007601 | 0.0022 | 2.6158 | 5.9342 | 14 | 101 | visual perception |
GO:0002088 | 0.0023 | 3.9228 | 2.4089 | 8 | 41 | lens development in camera-type eye |
GO:0060415 | 0.0023 | 3.9228 | 2.4089 | 8 | 41 | muscle tissue morphogenesis |
GO:0021871 | 0.0024 | 6.723 | 0.9988 | 5 | 17 | forebrain regionalization |
GO:0030325 | 0.0024 | 6.723 | 0.9988 | 5 | 17 | adrenal gland development |
GO:0060021 | 0.0024 | 3.0241 | 4.1128 | 11 | 70 | palate development |
GO:0007187 | 0.0024 | 2.7072 | 5.3466 | 13 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048638 | 0.0024 | 2.7072 | 5.3466 | 13 | 91 | regulation of developmental growth |
GO:0030111 | 0.0024 | 2.2128 | 9.3419 | 19 | 159 | regulation of Wnt signaling pathway |
GO:0055074 | 0.0025 | 2.1608 | 10.0469 | 20 | 171 | calcium ion homeostasis |
GO:0035637 | 0.0025 | 2.5858 | 5.9929 | 14 | 102 | multicellular organismal signaling |
GO:0044707 | 0.0025 | 1.6983 | 26.2502 | 41 | 626 | single-multicellular organism process |
GO:0031214 | 0.0025 | 4.389 | 1.9239 | 7 | 33 | biomineral tissue development |
GO:0023057 | 0.0026 | 1.552 | 38.4252 | 56 | 654 | negative regulation of signaling |
GO:0060350 | 0.0026 | 4.3524 | 1.9389 | 7 | 33 | endochondral bone morphogenesis |
GO:0009914 | 0.0026 | 2.1027 | 10.8107 | 21 | 184 | hormone transport |
GO:0015833 | 0.0026 | 2.1463 | 10.1057 | 20 | 172 | peptide transport |
GO:0048731 | 0.0026 | 1.6012 | 33.6237 | 50 | 718 | system development |
GO:0060548 | 0.0027 | 1.632 | 29.377 | 45 | 500 | negative regulation of cell death |
GO:0046887 | 0.0027 | 3.1777 | 3.584 | 10 | 61 | positive regulation of hormone secretion |
GO:0015812 | 0.0028 | 9.2093 | 0.6463 | 4 | 11 | gamma-aminobutyric acid transport |
GO:0021903 | 0.0028 | 9.2093 | 0.6463 | 4 | 11 | rostrocaudal neural tube patterning |
GO:0048935 | 0.0028 | 9.2093 | 0.6463 | 4 | 11 | peripheral nervous system neuron development |
GO:0060395 | 0.0028 | 9.2093 | 0.6463 | 4 | 11 | SMAD protein signal transduction |
GO:0071697 | 0.0028 | 9.2093 | 0.6463 | 4 | 11 | ectodermal placode morphogenesis |
GO:0001655 | 0.0028 | 5.0361 | 1.4736 | 6 | 26 | urogenital system development |
GO:0021515 | 0.0028 | 6.3585 | 1.0337 | 5 | 18 | cell differentiation in spinal cord |
GO:0042592 | 0.0028 | 1.493 | 47.062 | 66 | 801 | homeostatic process |
GO:0003013 | 0.0029 | 1.9468 | 13.8072 | 25 | 235 | circulatory system process |
GO:0010648 | 0.0029 | 1.5437 | 38.6014 | 56 | 657 | negative regulation of cell communication |
GO:0003205 | 0.003 | 2.639 | 5.4641 | 13 | 93 | cardiac chamber development |
GO:0097285 | 0.003 | 1.8639 | 16.0986 | 28 | 274 | cell-type specific apoptotic process |
GO:0007417 | 0.003 | 1.6591 | 26.3215 | 41 | 468 | central nervous system development |
GO:0048754 | 0.003 | 2.5218 | 6.1198 | 14 | 105 | branching morphogenesis of an epithelial tube |
GO:0060384 | 0.0031 | 6.2052 | 1.0576 | 5 | 18 | innervation |
GO:0072273 | 0.0031 | 6.2052 | 1.0576 | 5 | 18 | metanephric nephron morphogenesis |
GO:0007189 | 0.0031 | 4.1908 | 1.9976 | 7 | 34 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0034103 | 0.0031 | 4.1908 | 1.9976 | 7 | 34 | regulation of tissue remodeling |
GO:0009953 | 0.0031 | 3.1002 | 3.654 | 10 | 63 | dorsal/ventral pattern formation |
GO:0003208 | 0.0032 | 3.6979 | 2.5264 | 8 | 43 | cardiac ventricle morphogenesis |
GO:0007519 | 0.0032 | 2.4148 | 6.8155 | 15 | 116 | skeletal muscle tissue development |
GO:0060560 | 0.0033 | 2.728 | 4.8959 | 12 | 84 | developmental growth involved in morphogenesis |
GO:0090090 | 0.0034 | 2.8769 | 4.289 | 11 | 73 | negative regulation of canonical Wnt signaling pathway |
GO:0044702 | 0.0034 | 1.608 | 29.7672 | 45 | 516 | single organism reproductive process |
GO:0021516 | 0.0034 | 16.3055 | 0.3483 | 3 | 6 | dorsal spinal cord development |
GO:0014034 | 0.0034 | Inf | 0.1175 | 2 | 2 | neural crest cell fate commitment |
GO:0032725 | 0.0034 | Inf | 0.1175 | 2 | 2 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0035564 | 0.0034 | Inf | 0.1175 | 2 | 2 | regulation of kidney size |
GO:0036023 | 0.0034 | Inf | 0.1175 | 2 | 2 | embryonic skeletal limb joint morphogenesis |
GO:0042706 | 0.0034 | Inf | 0.1175 | 2 | 2 | eye photoreceptor cell fate commitment |
GO:0048880 | 0.0034 | Inf | 0.1175 | 2 | 2 | sensory system development |
GO:0061032 | 0.0034 | Inf | 0.1175 | 2 | 2 | visceral serous pericardium development |
GO:0072166 | 0.0034 | Inf | 0.1175 | 2 | 2 | posterior mesonephric tubule development |
GO:0090185 | 0.0034 | Inf | 0.1175 | 2 | 2 | negative regulation of kidney development |
GO:0019228 | 0.0034 | 3.0571 | 3.7015 | 10 | 63 | neuronal action potential |
GO:0030802 | 0.0034 | 3.0571 | 3.7015 | 10 | 63 | regulation of cyclic nucleotide biosynthetic process |
GO:0010463 | 0.0035 | 16.2177 | 0.35 | 3 | 6 | mesenchymal cell proliferation |
GO:0000904 | 0.0035 | 2.8477 | 4.3064 | 11 | 78 | cell morphogenesis involved in differentiation |
GO:0032229 | 0.0035 | 16.096 | 0.3525 | 3 | 6 | negative regulation of synaptic transmission, GABAergic |
GO:0071379 | 0.0035 | 16.096 | 0.3525 | 3 | 6 | cellular response to prostaglandin stimulus |
GO:0090009 | 0.0035 | 16.096 | 0.3525 | 3 | 6 | primitive streak formation |
GO:0050679 | 0.0036 | 2.574 | 5.5816 | 13 | 95 | positive regulation of epithelial cell proliferation |
GO:0072001 | 0.0036 | 8.3221 | 0.6841 | 4 | 12 | renal system development |
GO:0001763 | 0.0036 | 2.3746 | 6.9101 | 15 | 119 | morphogenesis of a branching structure |
GO:0002793 | 0.0037 | 3.5948 | 2.5852 | 8 | 44 | positive regulation of peptide secretion |
GO:0021575 | 0.0037 | 4.0407 | 2.0564 | 7 | 35 | hindbrain morphogenesis |
GO:0009855 | 0.0037 | 2.8309 | 4.3478 | 11 | 74 | determination of bilateral symmetry |
GO:0001657 | 0.0039 | 4.6732 | 1.5675 | 6 | 27 | ureteric bud development |
GO:0006171 | 0.0039 | 3.0002 | 3.7603 | 10 | 64 | cAMP biosynthetic process |
GO:0030814 | 0.0039 | 3.0002 | 3.7603 | 10 | 64 | regulation of cAMP metabolic process |
GO:0009719 | 0.0039 | 1.447 | 52.8787 | 72 | 900 | response to endogenous stimulus |
GO:0048545 | 0.0039 | 1.9218 | 13.3959 | 24 | 228 | response to steroid hormone |
GO:0035883 | 0.0039 | 8.0949 | 0.702 | 4 | 12 | enteroendocrine cell differentiation |
GO:0001649 | 0.004 | 2.2133 | 8.3431 | 17 | 142 | osteoblast differentiation |
GO:0021537 | 0.004 | 2.2133 | 8.3431 | 17 | 142 | telencephalon development |
GO:0006700 | 0.004 | 8.0573 | 0.705 | 4 | 12 | C21-steroid hormone biosynthetic process |
GO:0010842 | 0.004 | 8.0573 | 0.705 | 4 | 12 | retina layer formation |
GO:0021542 | 0.004 | 8.0573 | 0.705 | 4 | 12 | dentate gyrus development |
GO:0021984 | 0.004 | 8.0573 | 0.705 | 4 | 12 | adenohypophysis development |
GO:0070307 | 0.004 | 8.0573 | 0.705 | 4 | 12 | lens fiber cell development |
GO:0072224 | 0.004 | 8.0573 | 0.705 | 4 | 12 | metanephric glomerulus development |
GO:0010002 | 0.004 | 5.7613 | 1.1163 | 5 | 19 | cardioblast differentiation |
GO:0051954 | 0.004 | 5.7613 | 1.1163 | 5 | 19 | positive regulation of amine transport |
GO:1902692 | 0.004 | 5.7613 | 1.1163 | 5 | 19 | regulation of neuroblast proliferation |
GO:0014033 | 0.0042 | 3.5092 | 2.6356 | 8 | 45 | neural crest cell differentiation |
GO:0048738 | 0.0042 | 2.4193 | 6.3454 | 14 | 108 | cardiac muscle tissue development |
GO:1900371 | 0.0043 | 2.9453 | 3.819 | 10 | 65 | regulation of purine nucleotide biosynthetic process |
GO:0023061 | 0.0044 | 2.0805 | 9.8521 | 19 | 170 | signal release |
GO:0050769 | 0.0046 | 2.3935 | 6.4042 | 14 | 109 | positive regulation of neurogenesis |
GO:0030855 | 0.0046 | 1.82 | 15.834 | 27 | 276 | epithelial cell differentiation |
GO:0006928 | 0.0046 | 1.7113 | 20.539 | 33 | 362 | cellular component movement |
GO:0060349 | 0.0048 | 4.444 | 1.6311 | 6 | 28 | bone morphogenesis |
GO:0001709 | 0.0049 | 4.4178 | 1.6401 | 6 | 28 | cell fate determination |
GO:0009743 | 0.005 | 2.3684 | 6.4629 | 14 | 110 | response to carbohydrate |
GO:0090102 | 0.005 | 4.4033 | 1.6451 | 6 | 28 | cochlea development |
GO:0042755 | 0.0051 | 5.3767 | 1.1751 | 5 | 20 | eating behavior |
GO:0060740 | 0.0051 | 5.3767 | 1.1751 | 5 | 20 | prostate gland epithelium morphogenesis |
GO:0072207 | 0.0051 | 5.3767 | 1.1751 | 5 | 20 | metanephric epithelium development |
GO:0003323 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | type B pancreatic cell development |
GO:0009713 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | catechol-containing compound biosynthetic process |
GO:0048745 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | smooth muscle tissue development |
GO:0071599 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | otic vesicle development |
GO:0072077 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | renal vesicle morphogenesis |
GO:2000036 | 0.0055 | 7.1613 | 0.7638 | 4 | 13 | regulation of stem cell maintenance |
GO:0045665 | 0.0056 | 3.3172 | 2.7614 | 8 | 47 | negative regulation of neuron differentiation |
GO:0050801 | 0.0056 | 1.7149 | 19.2126 | 31 | 327 | ion homeostasis |
GO:0055085 | 0.0056 | 1.6457 | 23.2156 | 36 | 407 | transmembrane transport |
GO:0051480 | 0.0058 | 2.3195 | 6.5805 | 14 | 112 | cytosolic calcium ion homeostasis |
GO:0031016 | 0.0059 | 5.1398 | 1.2115 | 5 | 21 | pancreas development |
GO:0002862 | 0.0059 | 12.0707 | 0.4113 | 3 | 7 | negative regulation of inflammatory response to antigenic stimulus |
GO:0003310 | 0.0059 | 12.0707 | 0.4113 | 3 | 7 | pancreatic A cell differentiation |
GO:0033689 | 0.0059 | 12.0707 | 0.4113 | 3 | 7 | negative regulation of osteoblast proliferation |
GO:0042523 | 0.0059 | 12.0707 | 0.4113 | 3 | 7 | positive regulation of tyrosine phosphorylation of Stat5 protein |
GO:0046851 | 0.0059 | 12.0707 | 0.4113 | 3 | 7 | negative regulation of bone remodeling |
GO:0050890 | 0.006 | 2.0628 | 9.4006 | 18 | 160 | cognition |
GO:0048483 | 0.006 | 4.2114 | 1.7039 | 6 | 29 | autonomic nervous system development |
GO:0060563 | 0.006 | 4.2114 | 1.7039 | 6 | 29 | neuroepithelial cell differentiation |
GO:0010817 | 0.006 | 2.6331 | 4.6186 | 11 | 80 | regulation of hormone levels |
GO:0030073 | 0.006 | 2.1673 | 7.9906 | 16 | 136 | insulin secretion |
GO:0007613 | 0.006 | 2.7921 | 3.9953 | 10 | 68 | memory |
GO:0060429 | 0.0062 | 2.3861 | 5.9385 | 13 | 108 | epithelium development |
GO:0009611 | 0.0062 | 1.5268 | 33.2548 | 48 | 566 | response to wounding |
GO:0061351 | 0.0064 | 2.7664 | 4.0244 | 10 | 69 | neural precursor cell proliferation |
GO:0001662 | 0.0064 | 5.0401 | 1.2338 | 5 | 21 | behavioral fear response |
GO:0048596 | 0.0064 | 5.0401 | 1.2338 | 5 | 21 | embryonic camera-type eye morphogenesis |
GO:0001838 | 0.0066 | 2.3698 | 5.9929 | 13 | 102 | embryonic epithelial tube formation |
GO:0001837 | 0.0067 | 2.7445 | 4.054 | 10 | 69 | epithelial to mesenchymal transition |
GO:0007610 | 0.0068 | 2.2714 | 6.6876 | 14 | 119 | behavior |
GO:0060688 | 0.0069 | 4.0553 | 1.7546 | 6 | 30 | regulation of morphogenesis of a branching structure |
GO:0002065 | 0.0071 | 6.5276 | 0.8128 | 4 | 14 | columnar/cuboidal epithelial cell differentiation |
GO:0001738 | 0.0071 | 4.0355 | 1.7626 | 6 | 30 | morphogenesis of a polarized epithelium |
GO:0042733 | 0.0072 | 3.1547 | 2.8789 | 8 | 49 | embryonic digit morphogenesis |
GO:2000648 | 0.0072 | 3.1547 | 2.8789 | 8 | 49 | positive regulation of stem cell proliferation |
GO:0016486 | 0.0073 | 6.4657 | 0.82 | 4 | 14 | peptide hormone processing |
GO:0048706 | 0.0073 | 4.828 | 1.2714 | 5 | 22 | embryonic skeletal system development |
GO:0090190 | 0.0074 | 6.4445 | 0.8226 | 4 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0008217 | 0.0074 | 2.4318 | 5.4054 | 12 | 92 | regulation of blood pressure |
GO:0043066 | 0.0074 | 1.5716 | 26.9043 | 40 | 460 | negative regulation of apoptotic process |
GO:0043410 | 0.0074 | 1.8127 | 14.101 | 24 | 240 | positive regulation of MAPK cascade |
GO:0072503 | 0.0074 | 1.9696 | 10.3407 | 19 | 176 | cellular divalent inorganic cation homeostasis |
GO:0051384 | 0.0075 | 2.5459 | 4.7591 | 11 | 81 | response to glucocorticoid |
GO:0002066 | 0.0079 | 4.7431 | 1.2926 | 5 | 22 | columnar/cuboidal epithelial cell development |
GO:0007190 | 0.0079 | 4.7431 | 1.2926 | 5 | 22 | activation of adenylate cyclase activity |
GO:0045773 | 0.0079 | 4.7431 | 1.2926 | 5 | 22 | positive regulation of axon extension |
GO:0030204 | 0.008 | 3.4267 | 2.3502 | 7 | 40 | chondroitin sulfate metabolic process |
GO:0035019 | 0.008 | 3.4267 | 2.3502 | 7 | 40 | somatic stem cell maintenance |
GO:0045761 | 0.008 | 3.4267 | 2.3502 | 7 | 40 | regulation of adenylate cyclase activity |
GO:0050885 | 0.0082 | 3.8927 | 1.8131 | 6 | 31 | neuromuscular process controlling balance |
GO:0042476 | 0.0082 | 2.5098 | 4.8178 | 11 | 82 | odontogenesis |
GO:0051046 | 0.0083 | 1.6627 | 19.7414 | 31 | 336 | regulation of secretion |
GO:0008284 | 0.0083 | 1.6614 | 19.7536 | 31 | 343 | positive regulation of cell proliferation |
GO:0010464 | 0.0084 | 3.8737 | 1.8214 | 6 | 31 | regulation of mesenchymal cell proliferation |
GO:2000179 | 0.0084 | 3.8737 | 1.8214 | 6 | 31 | positive regulation of neural precursor cell proliferation |
GO:0000122 | 0.0086 | 1.5557 | 27.1444 | 40 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0051049 | 0.0086 | 1.4962 | 33.8736 | 48 | 588 | regulation of transport |
GO:0007586 | 0.0088 | 2.7998 | 3.584 | 9 | 61 | digestion |
GO:0044703 | 0.0089 | 1.5191 | 30.5521 | 44 | 520 | multi-organism reproductive process |
GO:0032989 | 0.0089 | 1.7812 | 14.3207 | 24 | 254 | cellular component morphogenesis |
GO:0021781 | 0.009 | 9.6872 | 0.4686 | 3 | 8 | glial cell fate commitment |
GO:0001993 | 0.009 | 9.6556 | 0.47 | 3 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0002347 | 0.009 | 9.6556 | 0.47 | 3 | 8 | response to tumor cell |
GO:0003337 | 0.009 | 9.6556 | 0.47 | 3 | 8 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0007494 | 0.009 | 9.6556 | 0.47 | 3 | 8 | midgut development |
GO:0010454 | 0.009 | 9.6556 | 0.47 | 3 | 8 | negative regulation of cell fate commitment |
GO:0030916 | 0.009 | 9.6556 | 0.47 | 3 | 8 | otic vesicle formation |
GO:0060872 | 0.009 | 9.6556 | 0.47 | 3 | 8 | semicircular canal development |
GO:0006940 | 0.0091 | 3.3255 | 2.4089 | 7 | 41 | regulation of smooth muscle contraction |
GO:0070167 | 0.0091 | 3.3255 | 2.4089 | 7 | 41 | regulation of biomineral tissue development |
GO:0021675 | 0.0095 | 3.751 | 1.8677 | 6 | 32 | nerve development |
GO:0030501 | 0.0096 | 4.4792 | 1.3513 | 5 | 23 | positive regulation of bone mineralization |
GO:0035850 | 0.0096 | 4.4792 | 1.3513 | 5 | 23 | epithelial cell differentiation involved in kidney development |
GO:0001964 | 0.0096 | 5.858 | 0.8813 | 4 | 15 | startle response |
GO:0031102 | 0.0096 | 5.858 | 0.8813 | 4 | 15 | neuron projection regeneration |
GO:0042659 | 0.0096 | 5.858 | 0.8813 | 4 | 15 | regulation of cell fate specification |
GO:0048853 | 0.0096 | 5.858 | 0.8813 | 4 | 15 | forebrain morphogenesis |
GO:0008406 | 0.0097 | 2.0463 | 8.4018 | 16 | 143 | gonad development |
GO:0051130 | 0.0097 | 1.5256 | 29.0245 | 42 | 494 | positive regulation of cellular component organization |
GO:0050808 | 0.0098 | 2.2426 | 6.2867 | 13 | 107 | synapse organization |
GO:0010453 | 0.0098 | 32.4312 | 0.1748 | 2 | 3 | regulation of cell fate commitment |
GO:0010623 | 0.0098 | 3.7243 | 1.8801 | 6 | 32 | developmental programmed cell death |
GO:0035987 | 0.0098 | 3.7243 | 1.8801 | 6 | 32 | endodermal cell differentiation |
GO:0042593 | 0.0099 | 2.1633 | 6.9917 | 14 | 119 | glucose homeostasis |
GO:0001983 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | baroreceptor response to increased systemic arterial blood pressure |
GO:0001994 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0003406 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | retinal pigment epithelium development |
GO:0010269 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | response to selenium ion |
GO:0010455 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | positive regulation of cell fate commitment |
GO:0021855 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | hypothalamus cell migration |
GO:0021902 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0021913 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0030240 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0030910 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | olfactory placode formation |
GO:0032455 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | nerve growth factor processing |
GO:0033058 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | detection of monosaccharide stimulus |
GO:0042421 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | norepinephrine biosynthetic process |
GO:0051594 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | detection of glucose |
GO:0055091 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | phospholipid homeostasis |
GO:0060018 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | transdifferentiation |
GO:0060300 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | regulation of cytokine activity |
GO:0060421 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | positive regulation of heart growth |
GO:0060594 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | mammary gland specification |
GO:0060913 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0071698 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | olfactory placode development |
GO:0072093 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | metanephric renal vesicle formation |
GO:0072180 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | mesonephric duct morphogenesis |
GO:0072197 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | ureter morphogenesis |
GO:1900212 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000041 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2000318 | 0.0099 | 32.1445 | 0.1763 | 2 | 3 | positive regulation of T-helper 17 type immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032103 | 0 | 5.1509 | 4.254 | 18 | 95 | positive regulation of response to external stimulus |
GO:0048520 | 0 | 7.2903 | 2.3285 | 13 | 52 | positive regulation of behavior |
GO:0050920 | 0 | 5.782 | 3.0002 | 14 | 67 | regulation of chemotaxis |
GO:0040017 | 0 | 2.85 | 8.5976 | 22 | 192 | positive regulation of locomotion |
GO:1901342 | 1e-04 | 3.5238 | 4.8361 | 15 | 108 | regulation of vasculature development |
GO:0007598 | 1e-04 | Inf | 0.1343 | 3 | 3 | blood coagulation, extrinsic pathway |
GO:0032571 | 1e-04 | Inf | 0.1343 | 3 | 3 | response to vitamin K |
GO:0060326 | 1e-04 | 3.6364 | 4.3883 | 14 | 98 | cell chemotaxis |
GO:0017187 | 1e-04 | 28.6859 | 0.3135 | 4 | 7 | peptidyl-glutamic acid carboxylation |
GO:0051272 | 3e-04 | 2.6103 | 8.4185 | 20 | 188 | positive regulation of cellular component movement |
GO:0051674 | 3e-04 | 1.7628 | 31.9722 | 52 | 714 | localization of cell |
GO:0002690 | 5e-04 | 7.1923 | 1.0747 | 6 | 24 | positive regulation of leukocyte chemotaxis |
GO:0045766 | 7e-04 | 4.2377 | 2.4628 | 9 | 55 | positive regulation of angiogenesis |
GO:0030335 | 0.001 | 2.4732 | 7.9259 | 18 | 177 | positive regulation of cell migration |
GO:0050930 | 0.001 | 12.2889 | 0.4926 | 4 | 11 | induction of positive chemotaxis |
GO:2000352 | 0.001 | 12.2889 | 0.4926 | 4 | 11 | negative regulation of endothelial cell apoptotic process |
GO:0051897 | 0.001 | 4.4362 | 2.1046 | 8 | 47 | positive regulation of protein kinase B signaling |
GO:0010595 | 0.0011 | 5.0396 | 1.6568 | 7 | 37 | positive regulation of endothelial cell migration |
GO:2000145 | 0.0013 | 1.9587 | 15.8966 | 29 | 355 | regulation of cell motility |
GO:0002685 | 0.0013 | 4.2374 | 2.1852 | 8 | 49 | regulation of leukocyte migration |
GO:0007599 | 0.0014 | 1.9916 | 14.5532 | 27 | 325 | hemostasis |
GO:0050817 | 0.0014 | 1.9916 | 14.5532 | 27 | 325 | coagulation |
GO:0042534 | 0.0016 | 21.4668 | 0.2687 | 3 | 6 | regulation of tumor necrosis factor biosynthetic process |
GO:0007207 | 0.002 | Inf | 0.0896 | 2 | 2 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0010477 | 0.002 | Inf | 0.0896 | 2 | 2 | response to sulfur dioxide |
GO:0010641 | 0.002 | Inf | 0.0896 | 2 | 2 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0010751 | 0.002 | Inf | 0.0896 | 2 | 2 | negative regulation of nitric oxide mediated signal transduction |
GO:0021569 | 0.002 | Inf | 0.0896 | 2 | 2 | rhombomere 3 development |
GO:1901492 | 0.002 | Inf | 0.0896 | 2 | 2 | positive regulation of lymphangiogenesis |
GO:0051894 | 0.0021 | 9.556 | 0.5821 | 4 | 13 | positive regulation of focal adhesion assembly |
GO:0042060 | 0.0024 | 1.8277 | 18.1057 | 31 | 406 | wound healing |
GO:0090109 | 0.0025 | 6.3327 | 0.9851 | 5 | 22 | regulation of cell-substrate junction assembly |
GO:0060192 | 0.0027 | 16.0985 | 0.3135 | 3 | 7 | negative regulation of lipase activity |
GO:1903391 | 0.003 | 5.9802 | 1.0299 | 5 | 23 | regulation of adherens junction organization |
GO:0002576 | 0.0031 | 4.0832 | 1.9703 | 7 | 44 | platelet degranulation |
GO:0045744 | 0.0031 | 4.0832 | 1.9703 | 7 | 44 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0030168 | 0.0033 | 2.3811 | 6.8064 | 15 | 152 | platelet activation |
GO:1902476 | 0.0036 | 3.9753 | 2.0151 | 7 | 45 | chloride transmembrane transport |
GO:0010632 | 0.0038 | 2.9654 | 3.7167 | 10 | 83 | regulation of epithelial cell migration |
GO:0022603 | 0.0041 | 1.6943 | 21.9417 | 35 | 490 | regulation of anatomical structure morphogenesis |
GO:0050927 | 0.0041 | 12.983 | 0.3555 | 3 | 8 | positive regulation of positive chemotaxis |
GO:0015711 | 0.0042 | 2.1316 | 9.0454 | 18 | 202 | organic anion transport |
GO:0051187 | 0.0042 | 12.8774 | 0.3582 | 3 | 8 | cofactor catabolic process |
GO:0071305 | 0.0042 | 12.8774 | 0.3582 | 3 | 8 | cellular response to vitamin D |
GO:0010811 | 0.0045 | 3.3882 | 2.642 | 8 | 59 | positive regulation of cell-substrate adhesion |
GO:0043534 | 0.0046 | 3.7758 | 2.1046 | 7 | 47 | blood vessel endothelial cell migration |
GO:0030155 | 0.0051 | 2.04 | 9.941 | 19 | 222 | regulation of cell adhesion |
GO:0044070 | 0.0052 | 3.6833 | 2.1494 | 7 | 48 | regulation of anion transport |
GO:0090132 | 0.0053 | 2.5255 | 5.1496 | 12 | 115 | epithelium migration |
GO:0018108 | 0.0054 | 2.0741 | 9.2693 | 18 | 207 | peptidyl-tyrosine phosphorylation |
GO:0007584 | 0.0054 | 2.647 | 4.5227 | 11 | 101 | response to nutrient |
GO:0009812 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | flavonoid metabolic process |
GO:0019276 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | UDP-N-acetylgalactosamine metabolic process |
GO:0046813 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:0060638 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | mesenchymal-epithelial cell signaling |
GO:0061045 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | negative regulation of wound healing |
GO:0071675 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | regulation of mononuclear cell migration |
GO:0090237 | 0.0058 | 42.8477 | 0.1343 | 2 | 3 | regulation of arachidonic acid secretion |
GO:2001240 | 0.0059 | 6.613 | 0.7612 | 4 | 17 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0006670 | 0.0061 | 10.7301 | 0.403 | 3 | 9 | sphingosine metabolic process |
GO:0031581 | 0.0061 | 10.7301 | 0.403 | 3 | 9 | hemidesmosome assembly |
GO:0060712 | 0.0061 | 10.7301 | 0.403 | 3 | 9 | spongiotrophoblast layer development |
GO:0006954 | 0.0068 | 1.8755 | 12.4486 | 22 | 278 | inflammatory response |
GO:0098656 | 0.0069 | 2.8857 | 3.4195 | 9 | 77 | anion transmembrane transport |
GO:0001952 | 0.0072 | 3.4311 | 2.2837 | 7 | 51 | regulation of cell-matrix adhesion |
GO:0007045 | 0.0072 | 3.917 | 1.7464 | 6 | 39 | cell-substrate adherens junction assembly |
GO:0006811 | 0.0073 | 1.4839 | 37.8383 | 53 | 845 | ion transport |
GO:0006953 | 0.0074 | 6.14 | 0.806 | 4 | 18 | acute-phase response |
GO:0003333 | 0.0074 | 4.6778 | 1.2538 | 5 | 28 | amino acid transmembrane transport |
GO:0071229 | 0.0077 | 2.5064 | 4.7466 | 11 | 106 | cellular response to acid chemical |
GO:0030879 | 0.0079 | 2.6374 | 4.1197 | 10 | 92 | mammary gland development |
GO:0010092 | 0.009 | 5.7301 | 0.8508 | 4 | 19 | specification of organ identity |
GO:0015804 | 0.009 | 5.7301 | 0.8508 | 4 | 19 | neutral amino acid transport |
GO:0042474 | 0.009 | 5.7301 | 0.8508 | 4 | 19 | middle ear morphogenesis |
GO:0051707 | 0.0094 | 1.7447 | 15.1353 | 25 | 338 | response to other organism |
GO:0048706 | 0.0099 | 2.5436 | 4.254 | 10 | 95 | embryonic skeletal system development |
GO:0071621 | 0.0099 | 4.3027 | 1.3434 | 5 | 30 | granulocyte chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 107.2986 | 0.1816 | 4 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0044259 | 0 | 5.3622 | 2.651 | 12 | 73 | multicellular organismal macromolecule metabolic process |
GO:0003008 | 0 | 1.984 | 31.4491 | 56 | 866 | system process |
GO:0030574 | 0 | 6.4171 | 1.7068 | 9 | 47 | collagen catabolic process |
GO:0060443 | 1e-04 | 7.5546 | 1.1621 | 7 | 32 | mammary gland morphogenesis |
GO:0001656 | 1e-04 | 4.8428 | 2.3968 | 10 | 66 | metanephros development |
GO:1902476 | 2e-04 | 5.8426 | 1.6342 | 8 | 45 | chloride transmembrane transport |
GO:0007155 | 2e-04 | 1.9461 | 22.9513 | 41 | 632 | cell adhesion |
GO:0072073 | 3e-04 | 3.5833 | 3.7405 | 12 | 103 | kidney epithelium development |
GO:0098656 | 4e-04 | 3.5056 | 3.8131 | 12 | 105 | anion transmembrane transport |
GO:0009593 | 4e-04 | 7.3403 | 1.0168 | 6 | 28 | detection of chemical stimulus |
GO:0061180 | 7e-04 | 6.5214 | 1.1153 | 6 | 31 | mammary gland epithelium development |
GO:0072080 | 8e-04 | 6.4575 | 1.1258 | 6 | 31 | nephron tubule development |
GO:0030216 | 9e-04 | 4.4986 | 2.0337 | 8 | 56 | keratinocyte differentiation |
GO:0071479 | 0.0011 | 5.978 | 1.1984 | 6 | 33 | cellular response to ionizing radiation |
GO:0007600 | 0.0011 | 2.3616 | 8.6796 | 19 | 242 | sensory perception |
GO:0035850 | 0.0012 | 7.4588 | 0.8353 | 5 | 23 | epithelial cell differentiation involved in kidney development |
GO:0048870 | 0.0012 | 1.7431 | 25.9291 | 42 | 714 | cell motility |
GO:0032501 | 0.0013 | 1.3883 | 140.6856 | 169 | 3874 | multicellular organismal process |
GO:0033594 | 0.0013 | Inf | 0.0726 | 2 | 2 | response to hydroxyisoflavone |
GO:0051045 | 0.0013 | Inf | 0.0726 | 2 | 2 | negative regulation of membrane protein ectodomain proteolysis |
GO:0010839 | 0.0015 | 20.0574 | 0.2542 | 3 | 7 | negative regulation of keratinocyte proliferation |
GO:0006935 | 0.0016 | 2.9433 | 4.4481 | 12 | 126 | chemotaxis |
GO:0060444 | 0.0017 | 9.7445 | 0.5447 | 4 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0007268 | 0.0018 | 1.8649 | 17.7945 | 31 | 490 | synaptic transmission |
GO:0016337 | 0.0018 | 2.3769 | 7.6988 | 17 | 212 | single organismal cell-cell adhesion |
GO:0033598 | 0.0022 | 8.9315 | 0.581 | 4 | 16 | mammary gland epithelial cell proliferation |
GO:0032689 | 0.0023 | 16.0443 | 0.2905 | 3 | 8 | negative regulation of interferon-gamma production |
GO:0071305 | 0.0023 | 16.0443 | 0.2905 | 3 | 8 | cellular response to vitamin D |
GO:0072182 | 0.0023 | 16.0443 | 0.2905 | 3 | 8 | regulation of nephron tubule epithelial cell differentiation |
GO:0097485 | 0.0025 | 2.1433 | 9.9867 | 20 | 275 | neuron projection guidance |
GO:0048598 | 0.0025 | 1.8837 | 15.8698 | 28 | 437 | embryonic morphogenesis |
GO:0009887 | 0.0025 | 1.7426 | 22.0797 | 36 | 608 | organ morphogenesis |
GO:0061138 | 0.0027 | 2.6319 | 5.3384 | 13 | 147 | morphogenesis of a branching epithelium |
GO:1901701 | 0.0028 | 1.7728 | 19.8645 | 33 | 547 | cellular response to oxygen-containing compound |
GO:0015711 | 0.0028 | 2.3409 | 7.3357 | 16 | 202 | organic anion transport |
GO:0072006 | 0.0028 | 3.6558 | 2.4331 | 8 | 67 | nephron development |
GO:0071407 | 0.003 | 2.4032 | 6.705 | 15 | 186 | cellular response to organic cyclic compound |
GO:0007606 | 0.003 | 4.7438 | 1.4526 | 6 | 40 | sensory perception of chemical stimulus |
GO:0045669 | 0.0034 | 4.6078 | 1.4889 | 6 | 41 | positive regulation of osteoblast differentiation |
GO:0051222 | 0.0034 | 2.6643 | 4.8663 | 12 | 134 | positive regulation of protein transport |
GO:0031290 | 0.0035 | 7.654 | 0.6537 | 4 | 18 | retinal ganglion cell axon guidance |
GO:0071364 | 0.0035 | 7.654 | 0.6537 | 4 | 18 | cellular response to epidermal growth factor stimulus |
GO:0007601 | 0.0036 | 2.9695 | 3.6678 | 10 | 101 | visual perception |
GO:0060562 | 0.0037 | 2.1511 | 8.9336 | 18 | 246 | epithelial tube morphogenesis |
GO:0000255 | 0.0039 | 53.3569 | 0.1089 | 2 | 3 | allantoin metabolic process |
GO:0003273 | 0.0039 | 53.3569 | 0.1089 | 2 | 3 | cell migration involved in endocardial cushion formation |
GO:0022009 | 0.0039 | 53.3569 | 0.1089 | 2 | 3 | central nervous system vasculogenesis |
GO:0032571 | 0.0039 | 53.3569 | 0.1089 | 2 | 3 | response to vitamin K |
GO:0015698 | 0.004 | 3.4222 | 2.5784 | 8 | 71 | inorganic anion transport |
GO:0048704 | 0.004 | 3.4222 | 2.5784 | 8 | 71 | embryonic skeletal system morphogenesis |
GO:0072001 | 0.0043 | 2.3018 | 6.9725 | 15 | 192 | renal system development |
GO:0030198 | 0.0044 | 2.4689 | 5.6535 | 13 | 158 | extracellular matrix organization |
GO:0022617 | 0.0044 | 3.3684 | 2.6147 | 8 | 72 | extracellular matrix disassembly |
GO:0022008 | 0.0045 | 1.5429 | 35.3348 | 51 | 973 | neurogenesis |
GO:0048568 | 0.0046 | 1.9772 | 11.2941 | 21 | 311 | embryonic organ development |
GO:0048468 | 0.0048 | 1.473 | 46.6652 | 64 | 1285 | cell development |
GO:0008544 | 0.0049 | 2.3443 | 6.3915 | 14 | 176 | epidermis development |
GO:0030334 | 0.0051 | 1.9264 | 12.1293 | 22 | 334 | regulation of cell migration |
GO:0006929 | 0.0052 | 6.6959 | 0.7263 | 4 | 20 | substrate-dependent cell migration |
GO:0031670 | 0.0052 | 6.6959 | 0.7263 | 4 | 20 | cellular response to nutrient |
GO:0007605 | 0.0053 | 2.9972 | 3.2684 | 9 | 90 | sensory perception of sound |
GO:0007610 | 0.0059 | 1.7986 | 15.3251 | 26 | 422 | behavior |
GO:0033273 | 0.0059 | 4.0517 | 1.6619 | 6 | 46 | response to vitamin |
GO:0040012 | 0.0059 | 1.8439 | 13.7998 | 24 | 380 | regulation of locomotion |
GO:0042267 | 0.0063 | 6.3014 | 0.7626 | 4 | 21 | natural killer cell mediated cytotoxicity |
GO:0097094 | 0.0063 | 10.0246 | 0.3995 | 3 | 11 | craniofacial suture morphogenesis |
GO:0060350 | 0.0063 | 4.79 | 1.1984 | 5 | 33 | endochondral bone morphogenesis |
GO:0030182 | 0.0065 | 1.5485 | 30.9043 | 45 | 851 | neuron differentiation |
GO:0007156 | 0.0072 | 3.0778 | 2.8326 | 8 | 78 | homophilic cell adhesion |
GO:0050678 | 0.0074 | 2.3006 | 6.0283 | 13 | 166 | regulation of epithelial cell proliferation |
GO:0006775 | 0.0074 | 5.9507 | 0.7989 | 4 | 22 | fat-soluble vitamin metabolic process |
GO:0009954 | 0.0074 | 5.9507 | 0.7989 | 4 | 22 | proximal/distal pattern formation |
GO:0019731 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | antibacterial humoral response |
GO:0031536 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | positive regulation of exit from mitosis |
GO:0035457 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | cellular response to interferon-alpha |
GO:0060364 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | frontal suture morphogenesis |
GO:0060482 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | lobar bronchus development |
GO:0060535 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | trachea cartilage morphogenesis |
GO:0072086 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | specification of loop of Henle identity |
GO:0072602 | 0.0075 | 26.6757 | 0.1453 | 2 | 4 | interleukin-4 secretion |
GO:0009605 | 0.0075 | 1.4661 | 41.4721 | 57 | 1142 | response to external stimulus |
GO:0031175 | 0.0079 | 1.6409 | 21.2808 | 33 | 586 | neuron projection development |
GO:0048731 | 0.008 | 1.3463 | 86.0409 | 106 | 2423 | system development |
GO:0097035 | 0.0088 | 5.6369 | 0.8353 | 4 | 23 | regulation of membrane lipid distribution |
GO:2000107 | 0.0088 | 5.6369 | 0.8353 | 4 | 23 | negative regulation of leukocyte apoptotic process |
GO:0048545 | 0.0089 | 2.0482 | 8.2799 | 16 | 228 | response to steroid hormone |
GO:0072091 | 0.009 | 3.2453 | 2.3605 | 7 | 65 | regulation of stem cell proliferation |
GO:0060348 | 0.0091 | 2.7256 | 3.5589 | 9 | 98 | bone development |
GO:0001906 | 0.0092 | 4.3252 | 1.3074 | 5 | 36 | cell killing |
GO:0071396 | 0.0096 | 2.1471 | 6.9213 | 14 | 192 | cellular response to lipid |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009410 | 3e-04 | 3.9265 | 3.217 | 11 | 72 | response to xenobiotic stimulus |
GO:0006198 | 7e-04 | 14.3719 | 0.4468 | 4 | 10 | cAMP catabolic process |
GO:0070098 | 7e-04 | 8.9968 | 0.7596 | 5 | 17 | chemokine-mediated signaling pathway |
GO:0002275 | 8e-04 | 6.4868 | 1.1617 | 6 | 26 | myeloid cell activation involved in immune response |
GO:0009605 | 9e-04 | 1.5482 | 51.0253 | 73 | 1142 | response to external stimulus |
GO:0031281 | 0.0015 | 5.639 | 1.2957 | 6 | 29 | positive regulation of cyclase activity |
GO:0042178 | 0.0016 | 21.5166 | 0.2681 | 3 | 6 | xenobiotic catabolic process |
GO:0042573 | 0.0016 | 21.5166 | 0.2681 | 3 | 6 | retinoic acid metabolic process |
GO:0051901 | 0.002 | Inf | 0.0894 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:2000721 | 0.002 | Inf | 0.0894 | 2 | 2 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0051349 | 0.0022 | 5.1868 | 1.3851 | 6 | 31 | positive regulation of lyase activity |
GO:0006775 | 0.0024 | 6.3474 | 0.983 | 5 | 22 | fat-soluble vitamin metabolic process |
GO:0007190 | 0.0024 | 6.3474 | 0.983 | 5 | 22 | activation of adenylate cyclase activity |
GO:0042593 | 0.0025 | 2.67 | 5.317 | 13 | 119 | glucose homeostasis |
GO:0006820 | 0.0027 | 2.0104 | 12.2425 | 23 | 274 | anion transport |
GO:0050702 | 0.0027 | 16.1358 | 0.3128 | 3 | 7 | interleukin-1 beta secretion |
GO:0044255 | 0.0027 | 1.6689 | 26.1829 | 41 | 586 | cellular lipid metabolic process |
GO:0003008 | 0.0029 | 1.5455 | 38.6934 | 56 | 866 | system process |
GO:0016101 | 0.0041 | 4.4695 | 1.5638 | 6 | 35 | diterpenoid metabolic process |
GO:0009187 | 0.0049 | 2.6834 | 4.4681 | 11 | 100 | cyclic nucleotide metabolic process |
GO:0098661 | 0.005 | 3.3305 | 2.6808 | 8 | 60 | inorganic anion transmembrane transport |
GO:0030593 | 0.0053 | 5.1363 | 1.1617 | 5 | 26 | neutrophil chemotaxis |
GO:0050906 | 0.0055 | 4.1803 | 1.6532 | 6 | 37 | detection of stimulus involved in sensory perception |
GO:0001992 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | regulation of systemic arterial blood pressure by vasopressin |
GO:0009804 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | coumarin metabolic process |
GO:0009812 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | flavonoid metabolic process |
GO:0051024 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | positive regulation of immunoglobulin secretion |
GO:0060157 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | urinary bladder development |
GO:0071670 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | smooth muscle cell chemotaxis |
GO:1900222 | 0.0058 | 42.9469 | 0.134 | 2 | 3 | negative regulation of beta-amyloid clearance |
GO:0006805 | 0.0058 | 3.2272 | 2.7535 | 8 | 62 | xenobiotic metabolic process |
GO:0008272 | 0.0061 | 10.755 | 0.4021 | 3 | 9 | sulfate transport |
GO:0035588 | 0.0061 | 10.755 | 0.4021 | 3 | 9 | G-protein coupled purinergic receptor signaling pathway |
GO:0070542 | 0.0062 | 4.9023 | 1.2064 | 5 | 27 | response to fatty acid |
GO:0030819 | 0.0063 | 4.0492 | 1.6979 | 6 | 38 | positive regulation of cAMP biosynthetic process |
GO:0006954 | 0.0066 | 1.8801 | 12.4212 | 22 | 278 | inflammatory response |
GO:0014075 | 0.0073 | 4.6887 | 1.2511 | 5 | 28 | response to amine |
GO:0048878 | 0.0074 | 1.6348 | 21.9829 | 34 | 492 | chemical homeostasis |
GO:0042445 | 0.0084 | 2.6115 | 4.1553 | 10 | 93 | hormone metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.537 | 182.2431 | 230 | 3874 | multicellular organismal process |
GO:0051006 | 0 | 81.7046 | 0.2352 | 4 | 5 | positive regulation of lipoprotein lipase activity |
GO:0042632 | 0 | 6.8628 | 1.6935 | 9 | 36 | cholesterol homeostasis |
GO:0055088 | 1e-04 | 4.8292 | 2.7285 | 11 | 58 | lipid homeostasis |
GO:0065008 | 1e-04 | 1.533 | 91.3568 | 125 | 1942 | regulation of biological quality |
GO:0060429 | 1e-04 | 1.8129 | 33.071 | 55 | 703 | epithelium development |
GO:0048706 | 1e-04 | 3.5767 | 4.469 | 14 | 95 | embryonic skeletal system development |
GO:0003008 | 2e-04 | 1.7325 | 38.354 | 61 | 824 | system process |
GO:0007155 | 2e-04 | 1.8268 | 29.7309 | 50 | 632 | cell adhesion |
GO:0048878 | 2e-04 | 2.0025 | 20.0612 | 37 | 434 | chemical homeostasis |
GO:0007605 | 3e-04 | 3.4877 | 4.2338 | 13 | 90 | sensory perception of sound |
GO:0033344 | 3e-04 | 8.1932 | 0.9879 | 6 | 21 | cholesterol efflux |
GO:0070830 | 3e-04 | 5.4769 | 1.7876 | 8 | 38 | tight junction assembly |
GO:0015833 | 5e-04 | 2.5784 | 8.0913 | 19 | 172 | peptide transport |
GO:0007600 | 5e-04 | 2.2861 | 11.4224 | 24 | 245 | sensory perception |
GO:0007603 | 5e-04 | 4.9774 | 1.9287 | 8 | 41 | phototransduction, visible light |
GO:0060193 | 7e-04 | 3.8824 | 2.9637 | 10 | 63 | positive regulation of lipase activity |
GO:0031424 | 8e-04 | 13.6104 | 0.4704 | 4 | 10 | keratinization |
GO:0032879 | 9e-04 | 1.5096 | 58.8033 | 82 | 1250 | regulation of localization |
GO:0009583 | 0.001 | 4.0203 | 2.5873 | 9 | 55 | detection of light stimulus |
GO:0044241 | 0.001 | 30.5716 | 0.2352 | 3 | 5 | lipid digestion |
GO:0007156 | 0.001 | 3.3806 | 3.6693 | 11 | 78 | homophilic cell adhesion |
GO:0006639 | 0.0011 | 3.6085 | 3.1519 | 10 | 67 | acylglycerol metabolic process |
GO:0030072 | 0.0011 | 2.5137 | 7.3857 | 17 | 157 | peptide hormone secretion |
GO:0007275 | 0.0011 | 1.3603 | 140.3752 | 171 | 2984 | multicellular organismal development |
GO:0032355 | 0.0012 | 3.5459 | 3.1989 | 10 | 68 | response to estradiol |
GO:0048729 | 0.0012 | 1.8964 | 18.1114 | 32 | 385 | tissue morphogenesis |
GO:0070328 | 0.0012 | 11.6649 | 0.5175 | 4 | 11 | triglyceride homeostasis |
GO:0035094 | 0.0016 | 5.5822 | 1.3172 | 6 | 28 | response to nicotine |
GO:0018108 | 0.0018 | 2.2175 | 9.7378 | 20 | 207 | peptidyl-tyrosine phosphorylation |
GO:0048513 | 0.0018 | 1.3969 | 89.6162 | 115 | 1905 | organ development |
GO:0009609 | 0.0022 | Inf | 0.0941 | 2 | 2 | response to symbiotic bacterium |
GO:0010482 | 0.0022 | Inf | 0.0941 | 2 | 2 | regulation of epidermal cell division |
GO:0010898 | 0.0022 | Inf | 0.0941 | 2 | 2 | positive regulation of triglyceride catabolic process |
GO:0010949 | 0.0022 | Inf | 0.0941 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0034382 | 0.0022 | Inf | 0.0941 | 2 | 2 | chylomicron remnant clearance |
GO:0045796 | 0.0022 | Inf | 0.0941 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:0097195 | 0.0022 | Inf | 0.0941 | 2 | 2 | pilomotor reflex |
GO:0051046 | 0.0023 | 1.8939 | 15.8063 | 28 | 336 | regulation of secretion |
GO:0032374 | 0.0025 | 6.3868 | 0.9879 | 5 | 21 | regulation of cholesterol transport |
GO:0055081 | 0.0025 | 6.3868 | 0.9879 | 5 | 21 | anion homeostasis |
GO:0060441 | 0.0025 | 6.3868 | 0.9879 | 5 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0009914 | 0.0026 | 2.2434 | 8.6558 | 18 | 184 | hormone transport |
GO:0044763 | 0.0028 | 1.3651 | 346.61 | 373 | 7368 | single-organism cellular process |
GO:0015721 | 0.0031 | 15.2826 | 0.3293 | 3 | 7 | bile acid and bile salt transport |
GO:0007588 | 0.0031 | 4.0968 | 1.9758 | 7 | 42 | excretion |
GO:0034308 | 0.0033 | 8.1629 | 0.6586 | 4 | 14 | primary alcohol metabolic process |
GO:0090207 | 0.0033 | 8.1629 | 0.6586 | 4 | 14 | regulation of triglyceride metabolic process |
GO:0007200 | 0.0036 | 3.9826 | 2.0228 | 7 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0009880 | 0.0036 | 3.9826 | 2.0228 | 7 | 43 | embryonic pattern specification |
GO:0048562 | 0.0036 | 2.0705 | 10.3494 | 20 | 220 | embryonic organ morphogenesis |
GO:0042472 | 0.0038 | 2.9772 | 3.7164 | 10 | 79 | inner ear morphogenesis |
GO:0023061 | 0.0042 | 1.9654 | 11.9488 | 22 | 254 | signal release |
GO:0023052 | 0.0046 | 1.3141 | 133.5734 | 159 | 2916 | signaling |
GO:0019932 | 0.0047 | 2.5716 | 5.0806 | 12 | 108 | second-messenger-mediated signaling |
GO:0045723 | 0.0049 | 12.2248 | 0.3763 | 3 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0048565 | 0.005 | 3.0523 | 3.2675 | 9 | 70 | digestive tract development |
GO:0016337 | 0.0052 | 2.0354 | 9.973 | 19 | 212 | single organismal cell-cell adhesion |
GO:0050680 | 0.0053 | 3.0269 | 3.293 | 9 | 70 | negative regulation of epithelial cell proliferation |
GO:0016101 | 0.0053 | 4.2317 | 1.6465 | 6 | 35 | diterpenoid metabolic process |
GO:0009653 | 0.0057 | 1.4168 | 56.5712 | 75 | 1240 | anatomical structure morphogenesis |
GO:0009725 | 0.0061 | 1.6133 | 24.9326 | 38 | 530 | response to hormone |
GO:0015918 | 0.0061 | 4.0903 | 1.6935 | 6 | 36 | sterol transport |
GO:0006069 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | ethanol oxidation |
GO:0010269 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | response to selenium ion |
GO:0033058 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | detection of monosaccharide stimulus |
GO:0042126 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | nitrate metabolic process |
GO:0051410 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | detoxification of nitrogen compound |
GO:0051594 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | detection of glucose |
GO:0071681 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | cellular response to indole-3-methanol |
GO:2000392 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | regulation of lamellipodium morphogenesis |
GO:2001225 | 0.0064 | 40.6807 | 0.1411 | 2 | 3 | regulation of chloride transport |
GO:0007165 | 0.0065 | 1.2856 | 143.9034 | 169 | 3059 | signal transduction |
GO:0098661 | 0.0067 | 3.1525 | 2.8226 | 8 | 60 | inorganic anion transmembrane transport |
GO:0048762 | 0.0067 | 2.443 | 5.3158 | 12 | 113 | mesenchymal cell differentiation |
GO:0070208 | 0.007 | 10.1863 | 0.4234 | 3 | 9 | protein heterotrimerization |
GO:0070293 | 0.007 | 10.1863 | 0.4234 | 3 | 9 | renal absorption |
GO:0050906 | 0.007 | 3.9579 | 1.7406 | 6 | 37 | detection of stimulus involved in sensory perception |
GO:0034381 | 0.0071 | 6.2772 | 0.7997 | 4 | 17 | plasma lipoprotein particle clearance |
GO:0042133 | 0.0071 | 6.2772 | 0.7997 | 4 | 17 | neurotransmitter metabolic process |
GO:0072525 | 0.0071 | 6.2772 | 0.7997 | 4 | 17 | pyridine-containing compound biosynthetic process |
GO:1902042 | 0.0071 | 6.2772 | 0.7997 | 4 | 17 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0007267 | 0.0072 | 2.3215 | 6.0264 | 13 | 134 | cell-cell signaling |
GO:0043583 | 0.0075 | 2.1613 | 7.4327 | 15 | 158 | ear development |
GO:0001755 | 0.0077 | 4.642 | 1.2702 | 5 | 27 | neural crest cell migration |
GO:0007584 | 0.0077 | 2.5107 | 4.7513 | 11 | 101 | response to nutrient |
GO:0050891 | 0.0087 | 5.8282 | 0.8468 | 4 | 18 | multicellular organismal water homeostasis |
GO:0007268 | 0.0088 | 1.6024 | 23.0509 | 35 | 490 | synaptic transmission |
GO:0034329 | 0.0088 | 2.1832 | 6.8682 | 14 | 146 | cell junction assembly |
GO:0050796 | 0.0088 | 2.349 | 5.504 | 12 | 117 | regulation of insulin secretion |
GO:0040017 | 0.009 | 2.0035 | 9.0322 | 17 | 192 | positive regulation of locomotion |
GO:0042743 | 0.009 | 4.4397 | 1.3172 | 5 | 28 | hydrogen peroxide metabolic process |
GO:0048566 | 0.009 | 4.4397 | 1.3172 | 5 | 28 | embryonic digestive tract development |
GO:0030335 | 0.0092 | 2.0482 | 8.3265 | 16 | 177 | positive regulation of cell migration |
GO:0030182 | 0.0092 | 1.4517 | 40.0333 | 55 | 851 | neuron differentiation |
GO:0061138 | 0.0093 | 2.1665 | 6.9153 | 14 | 147 | morphogenesis of a branching epithelium |
GO:0071346 | 0.0094 | 3.2558 | 2.3992 | 7 | 51 | cellular response to interferon-gamma |
GO:0051606 | 0.0096 | 2.5576 | 4.2426 | 10 | 91 | detection of stimulus |
GO:0050892 | 0.0097 | 8.7302 | 0.4704 | 3 | 10 | intestinal absorption |
GO:0090330 | 0.0097 | 8.7302 | 0.4704 | 3 | 10 | regulation of platelet aggregation |
GO:0002065 | 0.0099 | 2.9261 | 3.0107 | 8 | 64 | columnar/cuboidal epithelial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.4699 | 187.1995 | 231 | 3874 | multicellular organismal process |
GO:0033555 | 1e-04 | 5.5636 | 2.2228 | 10 | 46 | multicellular organismal response to stress |
GO:0007600 | 1e-04 | 2.3364 | 13.6268 | 29 | 282 | sensory perception |
GO:0098656 | 1e-04 | 3.3543 | 5.0738 | 15 | 105 | anion transmembrane transport |
GO:0048513 | 2e-04 | 1.4966 | 92.0534 | 124 | 1905 | organ development |
GO:0007186 | 2e-04 | 2.1252 | 16.9174 | 33 | 357 | G-protein coupled receptor signaling pathway |
GO:1902476 | 2e-04 | 4.9969 | 2.1745 | 9 | 45 | chloride transmembrane transport |
GO:0098660 | 3e-04 | 2.0522 | 17.4442 | 33 | 361 | inorganic ion transmembrane transport |
GO:0007268 | 4e-04 | 2.09 | 15.5617 | 30 | 329 | synaptic transmission |
GO:0007626 | 4e-04 | 2.761 | 6.8134 | 17 | 141 | locomotory behavior |
GO:0008217 | 4e-04 | 3.3018 | 4.4456 | 13 | 92 | regulation of blood pressure |
GO:0015698 | 6e-04 | 3.6705 | 3.4309 | 11 | 71 | inorganic anion transport |
GO:0048266 | 6e-04 | 15.8768 | 0.4349 | 4 | 9 | behavioral response to pain |
GO:0050804 | 8e-04 | 2.5174 | 7.8282 | 18 | 162 | regulation of synaptic transmission |
GO:0008544 | 8e-04 | 2.4391 | 8.5047 | 19 | 176 | epidermis development |
GO:0018958 | 0.001 | 3.9938 | 2.6094 | 9 | 54 | phenol-containing compound metabolic process |
GO:0007218 | 0.001 | 3.6345 | 3.1409 | 10 | 65 | neuropeptide signaling pathway |
GO:0060017 | 0.001 | 29.7172 | 0.2416 | 3 | 5 | parathyroid gland development |
GO:0007155 | 0.0011 | 1.6858 | 30.5395 | 48 | 632 | cell adhesion |
GO:0007275 | 0.0012 | 1.3527 | 144.1929 | 175 | 2984 | multicellular organismal development |
GO:0007605 | 0.0012 | 3.0808 | 4.349 | 12 | 90 | sensory perception of sound |
GO:0007631 | 0.0017 | 3.3867 | 3.3342 | 10 | 69 | feeding behavior |
GO:0001654 | 0.0018 | 2.1234 | 11.1624 | 22 | 231 | eye development |
GO:0007207 | 0.0023 | Inf | 0.0966 | 2 | 2 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0035902 | 0.0023 | Inf | 0.0966 | 2 | 2 | response to immobilization stress |
GO:0051901 | 0.0023 | Inf | 0.0966 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:0071805 | 0.0026 | 2.7919 | 4.7356 | 12 | 98 | potassium ion transmembrane transport |
GO:0007154 | 0.0027 | 1.3096 | 167.6774 | 197 | 3470 | cell communication |
GO:0030855 | 0.0027 | 1.8304 | 17.4926 | 30 | 362 | epithelial cell differentiation |
GO:0060333 | 0.0027 | 4.2236 | 1.9329 | 7 | 40 | interferon-gamma-mediated signaling pathway |
GO:0001662 | 0.0028 | 6.2076 | 1.0148 | 5 | 21 | behavioral fear response |
GO:0050877 | 0.0031 | 2.0242 | 11.6447 | 22 | 249 | neurological system process |
GO:0006836 | 0.0031 | 2.6027 | 5.4604 | 13 | 113 | neurotransmitter transport |
GO:0046394 | 0.0031 | 2.1466 | 9.5194 | 19 | 197 | carboxylic acid biosynthetic process |
GO:0044700 | 0.0034 | 1.3016 | 164.5848 | 193 | 3406 | single organism signaling |
GO:0070884 | 0.0034 | 14.8555 | 0.3383 | 3 | 7 | regulation of calcineurin-NFAT signaling cascade |
GO:1902547 | 0.0034 | 14.8555 | 0.3383 | 3 | 7 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0007204 | 0.0036 | 2.6667 | 4.9288 | 12 | 102 | positive regulation of cytosolic calcium ion concentration |
GO:0006954 | 0.0042 | 1.9051 | 13.4335 | 24 | 278 | inflammatory response |
GO:0042472 | 0.0046 | 2.8928 | 3.8174 | 10 | 79 | inner ear morphogenesis |
GO:0060041 | 0.0047 | 2.7129 | 4.4456 | 11 | 92 | retina development in camera-type eye |
GO:0072503 | 0.005 | 2.1454 | 8.5047 | 17 | 176 | cellular divalent inorganic cation homeostasis |
GO:0042445 | 0.0051 | 2.6796 | 4.4939 | 11 | 93 | hormone metabolic process |
GO:0006837 | 0.0052 | 11.8832 | 0.3866 | 3 | 8 | serotonin transport |
GO:1902358 | 0.0052 | 11.8832 | 0.3866 | 3 | 8 | sulfate transmembrane transport |
GO:0006813 | 0.0056 | 2.4079 | 5.847 | 13 | 121 | potassium ion transport |
GO:0097305 | 0.0062 | 2.0918 | 8.698 | 17 | 180 | response to alcohol |
GO:0007188 | 0.0063 | 2.9413 | 3.3825 | 9 | 70 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0050896 | 0.0065 | 1.2636 | 221.7497 | 249 | 4589 | response to stimulus |
GO:0014062 | 0.0068 | 39.546 | 0.145 | 2 | 3 | regulation of serotonin secretion |
GO:0014707 | 0.0068 | 39.546 | 0.145 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0014719 | 0.0068 | 39.546 | 0.145 | 2 | 3 | skeletal muscle satellite cell activation |
GO:0021960 | 0.0068 | 39.546 | 0.145 | 2 | 3 | anterior commissure morphogenesis |
GO:0030240 | 0.0068 | 39.546 | 0.145 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0030309 | 0.0068 | 39.546 | 0.145 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0031133 | 0.0068 | 39.546 | 0.145 | 2 | 3 | regulation of axon diameter |
GO:0051464 | 0.0068 | 39.546 | 0.145 | 2 | 3 | positive regulation of cortisol secretion |
GO:0061146 | 0.0068 | 39.546 | 0.145 | 2 | 3 | Peyer's patch morphogenesis |
GO:2001225 | 0.0068 | 39.546 | 0.145 | 2 | 3 | regulation of chloride transport |
GO:0045665 | 0.0069 | 3.4819 | 2.2711 | 7 | 47 | negative regulation of neuron differentiation |
GO:0002687 | 0.007 | 3.9753 | 1.7396 | 6 | 36 | positive regulation of leukocyte migration |
GO:0050885 | 0.007 | 3.9753 | 1.7396 | 6 | 36 | neuromuscular process controlling balance |
GO:0044283 | 0.007 | 1.8169 | 14.0134 | 24 | 290 | small molecule biosynthetic process |
GO:0055080 | 0.0073 | 1.8099 | 14.0617 | 24 | 291 | cation homeostasis |
GO:0022617 | 0.0076 | 2.8474 | 3.4792 | 9 | 72 | extracellular matrix disassembly |
GO:0021707 | 0.0076 | 9.9016 | 0.4349 | 3 | 9 | cerebellar granule cell differentiation |
GO:0045745 | 0.0076 | 9.9016 | 0.4349 | 3 | 9 | positive regulation of G-protein coupled receptor protein signaling pathway |
GO:1901160 | 0.0076 | 9.9016 | 0.4349 | 3 | 9 | primary amino compound metabolic process |
GO:0048016 | 0.0078 | 6.1014 | 0.8215 | 4 | 17 | inositol phosphate-mediated signaling |
GO:0044708 | 0.0082 | 1.9045 | 11.155 | 20 | 234 | single-organism behavior |
GO:0043269 | 0.0082 | 1.7677 | 14.9714 | 25 | 311 | regulation of ion transport |
GO:0007586 | 0.0087 | 3.0054 | 2.9476 | 8 | 61 | digestion |
GO:0009187 | 0.0087 | 2.467 | 4.8322 | 11 | 100 | cyclic nucleotide metabolic process |
GO:0006865 | 0.009 | 2.5901 | 4.204 | 10 | 87 | amino acid transport |
GO:0042552 | 0.009 | 2.7592 | 3.5758 | 9 | 74 | myelination |
GO:0006811 | 0.0093 | 1.7286 | 15.9089 | 26 | 343 | ion transport |
GO:0052652 | 0.0098 | 2.7171 | 3.6242 | 9 | 75 | cyclic purine nucleotide metabolic process |
GO:2000021 | 0.0098 | 2.7171 | 3.6242 | 9 | 75 | regulation of ion homeostasis |
GO:0003013 | 0.0099 | 1.8674 | 11.3557 | 20 | 235 | circulatory system process |
GO:0032502 | 0.0099 | 1.2556 | 165.5029 | 190 | 3425 | developmental process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007140 | 2e-04 | 8.8487 | 0.8834 | 6 | 24 | male meiosis |
GO:1903046 | 4e-04 | 4.5286 | 2.2821 | 9 | 62 | meiotic cell cycle process |
GO:0050900 | 7e-04 | 2.8179 | 5.8156 | 15 | 158 | leukocyte migration |
GO:0007283 | 7e-04 | 2.2901 | 10.3797 | 22 | 282 | spermatogenesis |
GO:0044703 | 8e-04 | 1.9138 | 19.1398 | 34 | 520 | multi-organism reproductive process |
GO:0001780 | 0.0014 | Inf | 0.0736 | 2 | 2 | neutrophil homeostasis |
GO:0010446 | 0.0014 | Inf | 0.0736 | 2 | 2 | response to alkaline pH |
GO:0030574 | 0.0015 | 4.6478 | 1.7299 | 7 | 47 | collagen catabolic process |
GO:0001525 | 0.0017 | 2.2745 | 8.981 | 19 | 244 | angiogenesis |
GO:0048845 | 0.0024 | 15.8199 | 0.2945 | 3 | 8 | venous blood vessel morphogenesis |
GO:0007126 | 0.0025 | 3.1451 | 3.4851 | 10 | 96 | meiotic nuclear division |
GO:0006012 | 0.0035 | 13.1819 | 0.3313 | 3 | 9 | galactose metabolic process |
GO:0040029 | 0.0036 | 2.7942 | 4.2697 | 11 | 116 | regulation of gene expression, epigenetic |
GO:0035194 | 0.0038 | 5.5121 | 1.0674 | 5 | 29 | posttranscriptional gene silencing by RNA |
GO:0007597 | 0.004 | 52.6129 | 0.1104 | 2 | 3 | blood coagulation, intrinsic pathway |
GO:0046877 | 0.004 | 52.6129 | 0.1104 | 2 | 3 | regulation of saliva secretion |
GO:0051445 | 0.0044 | 5.2911 | 1.1042 | 5 | 30 | regulation of meiotic cell cycle |
GO:0007276 | 0.0047 | 1.9106 | 12.7918 | 23 | 350 | gamete generation |
GO:0043046 | 0.0049 | 11.2977 | 0.3681 | 3 | 10 | DNA methylation involved in gamete generation |
GO:0001709 | 0.0051 | 5.087 | 1.141 | 5 | 31 | cell fate determination |
GO:0044259 | 0.0052 | 3.2693 | 2.6869 | 8 | 73 | multicellular organismal macromolecule metabolic process |
GO:0006968 | 0.0055 | 6.602 | 0.7361 | 4 | 20 | cellular defense response |
GO:0007193 | 0.0058 | 4.8981 | 1.1778 | 5 | 32 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0007129 | 0.0066 | 6.213 | 0.773 | 4 | 21 | synapsis |
GO:0022412 | 0.0068 | 2.3294 | 5.9628 | 13 | 162 | cellular process involved in reproduction in multicellular organism |
GO:0022898 | 0.0071 | 2.8482 | 3.4231 | 9 | 93 | regulation of transmembrane transporter activity |
GO:0016458 | 0.0072 | 3.0785 | 2.8342 | 8 | 77 | gene silencing |
GO:0098660 | 0.0074 | 1.8318 | 13.2875 | 23 | 361 | inorganic ion transmembrane transport |
GO:0032504 | 0.0075 | 1.9178 | 11.0477 | 20 | 306 | multicellular organism reproduction |
GO:0043950 | 0.0077 | 26.3038 | 0.1472 | 2 | 4 | positive regulation of cAMP-mediated signaling |
GO:0072602 | 0.0077 | 26.3038 | 0.1472 | 2 | 4 | interleukin-4 secretion |
GO:1901723 | 0.0077 | 26.3038 | 0.1472 | 2 | 4 | negative regulation of cell proliferation involved in kidney development |
GO:0003272 | 0.0085 | 8.7853 | 0.4417 | 3 | 12 | endocardial cushion formation |
GO:0007275 | 0.0091 | 1.3102 | 109.8333 | 131 | 2984 | multicellular organismal development |
GO:1900371 | 0.0096 | 3.1994 | 2.3925 | 7 | 65 | regulation of purine nucleotide biosynthetic process |
GO:0048468 | 0.0098 | 1.4198 | 47.2975 | 63 | 1285 | cell development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.236 | 209.3127 | 312 | 3874 | multicellular organismal process |
GO:0022008 | 0 | 2.7715 | 30.8234 | 72 | 596 | neurogenesis |
GO:0045944 | 0 | 2.6432 | 32.9043 | 74 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0021510 | 0 | 7.389 | 4.1063 | 22 | 76 | spinal cord development |
GO:0048729 | 0 | 3.0588 | 20.8016 | 54 | 385 | tissue morphogenesis |
GO:0007275 | 0 | 2.145 | 67.3326 | 117 | 1507 | multicellular organismal development |
GO:0007389 | 0 | 3.4139 | 14.5565 | 42 | 276 | pattern specification process |
GO:0006355 | 0 | 1.8118 | 126.1063 | 188 | 2334 | regulation of transcription, DNA-templated |
GO:0051252 | 0 | 1.7561 | 130.5368 | 190 | 2416 | regulation of RNA metabolic process |
GO:0043583 | 0 | 4.0997 | 8.5368 | 29 | 158 | ear development |
GO:0010628 | 0 | 2.0968 | 49.2755 | 90 | 912 | positive regulation of gene expression |
GO:1902680 | 0 | 2.1058 | 47.3304 | 87 | 876 | positive regulation of RNA biosynthetic process |
GO:0060562 | 0 | 3.2513 | 13.2914 | 37 | 246 | epithelial tube morphogenesis |
GO:0035107 | 0 | 4.8434 | 5.8893 | 23 | 109 | appendage morphogenesis |
GO:0060537 | 0 | 3.2543 | 12.535 | 35 | 232 | muscle tissue development |
GO:0072359 | 0 | 2.3072 | 31.5536 | 64 | 584 | circulatory system development |
GO:1901362 | 0 | 1.6454 | 153.3915 | 210 | 2839 | organic cyclic compound biosynthetic process |
GO:0001764 | 0 | 4.7994 | 5.403 | 21 | 100 | neuron migration |
GO:0019438 | 0 | 1.6425 | 149.3392 | 205 | 2764 | aromatic compound biosynthetic process |
GO:0001501 | 0 | 3.4528 | 10.1648 | 30 | 191 | skeletal system development |
GO:0009891 | 0 | 1.9396 | 55.705 | 95 | 1031 | positive regulation of biosynthetic process |
GO:0031326 | 0 | 1.6333 | 144.8547 | 199 | 2681 | regulation of cellular biosynthetic process |
GO:0045935 | 0 | 1.9416 | 53.76 | 92 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:0060173 | 0 | 4.0768 | 6.7538 | 23 | 125 | limb development |
GO:0048562 | 0 | 4.0543 | 6.7639 | 23 | 129 | embryonic organ morphogenesis |
GO:0018130 | 0 | 1.6102 | 149.6634 | 203 | 2770 | heterocycle biosynthetic process |
GO:0044271 | 0 | 1.6072 | 151.5545 | 205 | 2805 | cellular nitrogen compound biosynthetic process |
GO:0007155 | 0 | 2.1424 | 34.147 | 65 | 632 | cell adhesion |
GO:0048665 | 0 | 31.4607 | 0.5866 | 7 | 11 | neuron fate specification |
GO:0010556 | 0 | 1.6072 | 140.5864 | 192 | 2602 | regulation of macromolecule biosynthetic process |
GO:0001707 | 0 | 6.4233 | 2.8636 | 14 | 53 | mesoderm formation |
GO:0009887 | 0 | 2.5428 | 18.1818 | 41 | 359 | organ morphogenesis |
GO:0009954 | 0 | 12.3064 | 1.1887 | 9 | 22 | proximal/distal pattern formation |
GO:2000026 | 0 | 1.9084 | 47.5808 | 81 | 888 | regulation of multicellular organismal development |
GO:0050767 | 0 | 2.3606 | 20.3694 | 43 | 377 | regulation of neurogenesis |
GO:0000122 | 0 | 2.1828 | 24.9619 | 49 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0035148 | 0 | 3.7096 | 5.9973 | 19 | 111 | tube formation |
GO:0007517 | 0 | 2.9444 | 10.0172 | 26 | 189 | muscle organ development |
GO:0065007 | 0 | 1.5285 | 337.5905 | 384 | 6357 | biological regulation |
GO:0061564 | 0 | 2.2136 | 22.0443 | 44 | 408 | axon development |
GO:0030878 | 0 | 21.2309 | 0.5943 | 6 | 11 | thyroid gland development |
GO:0048514 | 0 | 2.424 | 16.0794 | 35 | 299 | blood vessel morphogenesis |
GO:0007268 | 0 | 2.3489 | 17.5028 | 37 | 329 | synaptic transmission |
GO:0007420 | 0 | 2.1428 | 23.2056 | 45 | 433 | brain development |
GO:0042472 | 0 | 4.1907 | 4.2684 | 15 | 79 | inner ear morphogenesis |
GO:0048704 | 0 | 4.7665 | 3.3284 | 13 | 62 | embryonic skeletal system morphogenesis |
GO:0048644 | 0 | 5.7598 | 2.4314 | 11 | 45 | muscle organ morphogenesis |
GO:0003207 | 0 | 29.4393 | 0.4322 | 5 | 8 | cardiac chamber formation |
GO:0051171 | 0 | 1.4633 | 162.2524 | 206 | 3003 | regulation of nitrogen compound metabolic process |
GO:0007498 | 0 | 4.0223 | 4.4097 | 15 | 82 | mesoderm development |
GO:0001710 | 0 | 15.1618 | 0.7024 | 6 | 13 | mesodermal cell fate commitment |
GO:0003205 | 0 | 4.1991 | 3.9692 | 14 | 74 | cardiac chamber development |
GO:0007411 | 0 | 2.3864 | 14.8583 | 32 | 275 | axon guidance |
GO:0061005 | 0 | 6.9486 | 1.729 | 9 | 32 | cell differentiation involved in kidney development |
GO:0021761 | 0 | 4.8593 | 3.0257 | 12 | 56 | limbic system development |
GO:0060017 | 0 | 70.5394 | 0.2702 | 4 | 5 | parathyroid gland development |
GO:0060023 | 0 | 70.5394 | 0.2702 | 4 | 5 | soft palate development |
GO:0048667 | 0 | 2.035 | 24.2595 | 45 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0001656 | 0 | 4.3744 | 3.566 | 13 | 66 | metanephros development |
GO:0072009 | 0 | 5.1513 | 2.6475 | 11 | 49 | nephron epithelium development |
GO:0045666 | 0 | 4.2929 | 3.62 | 13 | 67 | positive regulation of neuron differentiation |
GO:0021527 | 1e-04 | 13.2652 | 0.7564 | 6 | 14 | spinal cord association neuron differentiation |
GO:0060581 | 1e-04 | 13.2652 | 0.7564 | 6 | 14 | cell fate commitment involved in pattern specification |
GO:0000904 | 1e-04 | 3.044 | 7.0577 | 19 | 136 | cell morphogenesis involved in differentiation |
GO:0044708 | 1e-04 | 2.3268 | 14.2099 | 30 | 263 | single-organism behavior |
GO:0048869 | 1e-04 | 1.7801 | 39.1607 | 63 | 844 | cellular developmental process |
GO:0048646 | 1e-04 | 1.9154 | 27.3498 | 48 | 525 | anatomical structure formation involved in morphogenesis |
GO:0021521 | 1e-04 | 17.6599 | 0.5403 | 5 | 10 | ventral spinal cord interneuron specification |
GO:0048864 | 1e-04 | 2.5855 | 10.3198 | 24 | 191 | stem cell development |
GO:0001944 | 1e-04 | 2.0954 | 19.3117 | 37 | 360 | vasculature development |
GO:0060041 | 1e-04 | 3.4784 | 4.9708 | 15 | 92 | retina development in camera-type eye |
GO:0021796 | 1e-04 | 35.2661 | 0.3242 | 4 | 6 | cerebral cortex regionalization |
GO:0009952 | 1e-04 | 3.456 | 4.9895 | 15 | 94 | anterior/posterior pattern specification |
GO:0021915 | 1e-04 | 5.009 | 2.4516 | 10 | 46 | neural tube development |
GO:0021514 | 1e-04 | 10.6099 | 0.8645 | 6 | 16 | ventral spinal cord interneuron differentiation |
GO:0003008 | 1e-04 | 1.6763 | 46.7901 | 72 | 866 | system process |
GO:0007600 | 1e-04 | 2.2319 | 15.2365 | 31 | 282 | sensory perception |
GO:0001709 | 1e-04 | 7.7849 | 1.2369 | 7 | 23 | cell fate determination |
GO:0035115 | 1e-04 | 7.7458 | 1.2427 | 7 | 23 | embryonic forelimb morphogenesis |
GO:0045665 | 2e-04 | 4.8012 | 2.5394 | 10 | 47 | negative regulation of neuron differentiation |
GO:0021871 | 2e-04 | 9.6444 | 0.9185 | 6 | 17 | forebrain regionalization |
GO:2000179 | 2e-04 | 6.1651 | 1.6749 | 8 | 31 | positive regulation of neural precursor cell proliferation |
GO:1902679 | 2e-04 | 1.7314 | 36.9566 | 59 | 684 | negative regulation of RNA biosynthetic process |
GO:0048598 | 2e-04 | 3.2387 | 5.2487 | 15 | 104 | embryonic morphogenesis |
GO:0007423 | 2e-04 | 2.4319 | 10.8647 | 24 | 209 | sensory organ development |
GO:0003208 | 2e-04 | 5.9707 | 1.7119 | 8 | 32 | cardiac ventricle morphogenesis |
GO:0048593 | 2e-04 | 3.6184 | 4.1603 | 13 | 77 | camera-type eye morphogenesis |
GO:0030182 | 2e-04 | 3.5969 | 4.1437 | 13 | 85 | neuron differentiation |
GO:0007267 | 2e-04 | 2.2517 | 13.6149 | 28 | 266 | cell-cell signaling |
GO:0045934 | 2e-04 | 1.6762 | 42.0354 | 65 | 778 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006935 | 2e-04 | 1.954 | 21.6661 | 39 | 401 | chemotaxis |
GO:0007156 | 3e-04 | 3.5623 | 4.2143 | 13 | 78 | homophilic cell adhesion |
GO:0035137 | 3e-04 | 23.6864 | 0.3755 | 4 | 7 | hindlimb morphogenesis |
GO:0060900 | 3e-04 | 23.5083 | 0.3782 | 4 | 7 | embryonic camera-type eye formation |
GO:0021542 | 3e-04 | 12.6116 | 0.6484 | 5 | 12 | dentate gyrus development |
GO:0048812 | 3e-04 | 1.9471 | 21.7342 | 39 | 406 | neuron projection morphogenesis |
GO:0021879 | 3e-04 | 4.9896 | 2.2152 | 9 | 41 | forebrain neuron differentiation |
GO:0010629 | 3e-04 | 1.6723 | 41.4411 | 64 | 767 | negative regulation of gene expression |
GO:0048856 | 3e-04 | 1.6312 | 51.176 | 75 | 1210 | anatomical structure development |
GO:0021545 | 3e-04 | 6.5208 | 1.4048 | 7 | 26 | cranial nerve development |
GO:0021543 | 4e-04 | 3.1986 | 4.9708 | 14 | 92 | pallium development |
GO:0043269 | 4e-04 | 2.0478 | 16.9655 | 32 | 314 | regulation of ion transport |
GO:0003148 | 4e-04 | 11.034 | 0.7024 | 5 | 13 | outflow tract septum morphogenesis |
GO:0021520 | 4e-04 | 11.034 | 0.7024 | 5 | 13 | spinal cord motor neuron cell fate specification |
GO:0071599 | 4e-04 | 11.034 | 0.7024 | 5 | 13 | otic vesicle development |
GO:0014855 | 4e-04 | 5.2495 | 1.8911 | 8 | 35 | striated muscle cell proliferation |
GO:0030800 | 5e-04 | 7.5754 | 1.0806 | 6 | 20 | negative regulation of cyclic nucleotide metabolic process |
GO:0072048 | 5e-04 | 17.6294 | 0.4322 | 4 | 8 | renal system pattern specification |
GO:0003281 | 5e-04 | 5.0615 | 1.9451 | 8 | 36 | ventricular septum development |
GO:0007626 | 6e-04 | 2.6151 | 7.6182 | 18 | 141 | locomotory behavior |
GO:0009890 | 6e-04 | 1.6007 | 45.1151 | 67 | 835 | negative regulation of biosynthetic process |
GO:0021779 | 6e-04 | 52.8077 | 0.2161 | 3 | 4 | oligodendrocyte cell fate commitment |
GO:0021780 | 6e-04 | 52.8077 | 0.2161 | 3 | 4 | glial cell fate specification |
GO:0072162 | 6e-04 | 52.8077 | 0.2161 | 3 | 4 | metanephric mesenchymal cell differentiation |
GO:0048870 | 6e-04 | 1.6466 | 38.5775 | 59 | 714 | cell motility |
GO:0052652 | 6e-04 | 3.3871 | 4.0523 | 12 | 75 | cyclic purine nucleotide metabolic process |
GO:0048762 | 6e-04 | 2.8908 | 5.8062 | 15 | 108 | mesenchymal cell differentiation |
GO:0035295 | 7e-04 | 2.4902 | 8.3801 | 19 | 163 | tube development |
GO:0043009 | 7e-04 | 2.0771 | 14.6029 | 28 | 281 | chordate embryonic development |
GO:0043062 | 7e-04 | 2.1784 | 12.481 | 25 | 231 | extracellular structure organization |
GO:0048565 | 8e-04 | 2.9682 | 5.295 | 14 | 98 | digestive tract development |
GO:0007519 | 8e-04 | 2.8347 | 5.9035 | 15 | 110 | skeletal muscle tissue development |
GO:0032990 | 8e-04 | 1.6873 | 32.4721 | 51 | 601 | cell part morphogenesis |
GO:0003214 | 8e-04 | 14.154 | 0.4846 | 4 | 9 | cardiac left ventricle morphogenesis |
GO:0060272 | 9e-04 | 14.102 | 0.4863 | 4 | 9 | embryonic skeletal joint morphogenesis |
GO:0060850 | 9e-04 | 8.8254 | 0.8105 | 5 | 15 | regulation of transcription involved in cell fate commitment |
GO:0007399 | 9e-04 | 1.9679 | 17.022 | 31 | 367 | nervous system development |
GO:0003229 | 9e-04 | 5.3845 | 1.6209 | 7 | 30 | ventricular cardiac muscle tissue development |
GO:0044699 | 0.001 | 1.4572 | 411.6135 | 439 | 7850 | single-organism process |
GO:0007605 | 0.001 | 3.0034 | 4.8627 | 13 | 90 | sensory perception of sound |
GO:0021513 | 0.0011 | 6.2366 | 1.2427 | 6 | 23 | spinal cord dorsal/ventral patterning |
GO:0044273 | 0.0011 | 6.2366 | 1.2427 | 6 | 23 | sulfur compound catabolic process |
GO:0045165 | 0.0011 | 3.3354 | 3.7401 | 11 | 73 | cell fate commitment |
GO:0016202 | 0.0011 | 3.1364 | 4.3224 | 12 | 80 | regulation of striated muscle tissue development |
GO:0080090 | 0.0013 | 1.3143 | 202.0726 | 236 | 3740 | regulation of primary metabolic process |
GO:0048589 | 0.0013 | 2.1875 | 10.9141 | 22 | 202 | developmental growth |
GO:0048519 | 0.0013 | 1.3456 | 136.372 | 167 | 2524 | negative regulation of biological process |
GO:2000113 | 0.0014 | 1.5744 | 41.4951 | 61 | 768 | negative regulation of cellular macromolecule biosynthetic process |
GO:0061318 | 0.0014 | 11.7505 | 0.5403 | 4 | 10 | renal filtration cell differentiation |
GO:0035136 | 0.0014 | 26.6994 | 0.2673 | 3 | 5 | forelimb morphogenesis |
GO:1900543 | 0.0014 | 5.8895 | 1.2967 | 6 | 24 | negative regulation of purine nucleotide metabolic process |
GO:0003180 | 0.0014 | 26.4011 | 0.2702 | 3 | 5 | aortic valve morphogenesis |
GO:0051967 | 0.0014 | 26.4011 | 0.2702 | 3 | 5 | negative regulation of synaptic transmission, glutamatergic |
GO:0060040 | 0.0014 | 26.4011 | 0.2702 | 3 | 5 | retinal bipolar neuron differentiation |
GO:0072081 | 0.0014 | 26.4011 | 0.2702 | 3 | 5 | specification of nephron tubule identity |
GO:2001012 | 0.0014 | 26.4011 | 0.2702 | 3 | 5 | mesenchymal cell differentiation involved in renal system development |
GO:0060349 | 0.0015 | 3.4781 | 3.2958 | 10 | 61 | bone morphogenesis |
GO:0001838 | 0.0015 | 7.4616 | 0.906 | 5 | 17 | embryonic epithelial tube formation |
GO:0048483 | 0.0016 | 7.4012 | 0.9129 | 5 | 17 | autonomic nervous system development |
GO:0055008 | 0.0016 | 4.7793 | 1.7768 | 7 | 33 | cardiac muscle tissue morphogenesis |
GO:0032989 | 0.0016 | 2.0387 | 13.2314 | 25 | 254 | cellular component morphogenesis |
GO:0021983 | 0.0016 | 4.7617 | 1.783 | 7 | 33 | pituitary gland development |
GO:0061326 | 0.0016 | 4.7617 | 1.783 | 7 | 33 | renal tubule development |
GO:0035265 | 0.0017 | 3.1494 | 3.9442 | 11 | 73 | organ growth |
GO:0009953 | 0.0018 | 3.3778 | 3.3743 | 10 | 63 | dorsal/ventral pattern formation |
GO:0048048 | 0.0018 | 5.5789 | 1.3508 | 6 | 25 | embryonic eye morphogenesis |
GO:0032774 | 0.0019 | 1.47 | 61.203 | 83 | 1230 | RNA biosynthetic process |
GO:0003151 | 0.0019 | 4.6237 | 1.8226 | 7 | 34 | outflow tract morphogenesis |
GO:0006835 | 0.0019 | 4.0463 | 2.3233 | 8 | 43 | dicarboxylic acid transport |
GO:0042127 | 0.0019 | 1.5274 | 45.4943 | 65 | 848 | regulation of cell proliferation |
GO:0001756 | 0.0019 | 3.6242 | 2.8636 | 9 | 53 | somitogenesis |
GO:0001841 | 0.0019 | 2.92 | 4.5926 | 12 | 85 | neural tube formation |
GO:0030326 | 0.002 | 5.4091 | 1.3782 | 6 | 26 | embryonic limb morphogenesis |
GO:0021903 | 0.0021 | 10.0708 | 0.5943 | 4 | 11 | rostrocaudal neural tube patterning |
GO:0072311 | 0.0021 | 10.0708 | 0.5943 | 4 | 11 | glomerular epithelial cell differentiation |
GO:0009790 | 0.0021 | 1.9394 | 14.9385 | 27 | 302 | embryo development |
GO:0030855 | 0.0021 | 2.0636 | 12.0158 | 23 | 226 | epithelial cell differentiation |
GO:0030818 | 0.0022 | 6.7866 | 0.9725 | 5 | 18 | negative regulation of cAMP biosynthetic process |
GO:0022603 | 0.0022 | 1.7038 | 25.059 | 40 | 467 | regulation of anatomical structure morphogenesis |
GO:0030030 | 0.0023 | 1.5229 | 44.1426 | 63 | 817 | cell projection organization |
GO:0048663 | 0.0024 | 5.1911 | 1.4208 | 6 | 27 | neuron fate commitment |
GO:0007218 | 0.0024 | 3.2238 | 3.512 | 10 | 65 | neuropeptide signaling pathway |
GO:0061138 | 0.0024 | 2.3307 | 7.9424 | 17 | 147 | morphogenesis of a branching epithelium |
GO:0050793 | 0.0025 | 2.2026 | 9.3346 | 19 | 187 | regulation of developmental process |
GO:0045766 | 0.0025 | 3.4659 | 2.9717 | 9 | 55 | positive regulation of angiogenesis |
GO:1902476 | 0.0025 | 3.8267 | 2.4314 | 8 | 45 | chloride transmembrane transport |
GO:0060429 | 0.0025 | 2.0623 | 11.482 | 22 | 226 | epithelium development |
GO:0002064 | 0.0027 | 2.3745 | 7.3481 | 16 | 136 | epithelial cell development |
GO:0030199 | 0.0027 | 5.0466 | 1.4588 | 6 | 27 | collagen fibril organization |
GO:0060420 | 0.0027 | 5.0466 | 1.4588 | 6 | 27 | regulation of heart growth |
GO:0014048 | 0.0028 | 17.5989 | 0.3242 | 3 | 6 | regulation of glutamate secretion |
GO:0051957 | 0.0028 | 17.5989 | 0.3242 | 3 | 6 | positive regulation of amino acid transport |
GO:0003230 | 0.0028 | 6.3012 | 1.0266 | 5 | 19 | cardiac atrium development |
GO:0010092 | 0.0028 | 6.3012 | 1.0266 | 5 | 19 | specification of organ identity |
GO:0010719 | 0.0028 | 6.3012 | 1.0266 | 5 | 19 | negative regulation of epithelial to mesenchymal transition |
GO:0045214 | 0.0028 | 6.3012 | 1.0266 | 5 | 19 | sarcomere organization |
GO:0050804 | 0.0028 | 2.2288 | 8.7529 | 18 | 162 | regulation of synaptic transmission |
GO:0003218 | 0.0029 | Inf | 0.1081 | 2 | 2 | cardiac left ventricle formation |
GO:0003221 | 0.0029 | Inf | 0.1081 | 2 | 2 | right ventricular cardiac muscle tissue morphogenesis |
GO:0003326 | 0.0029 | Inf | 0.1081 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0029 | Inf | 0.1081 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0019448 | 0.0029 | Inf | 0.1081 | 2 | 2 | L-cysteine catabolic process |
GO:0048677 | 0.0029 | Inf | 0.1081 | 2 | 2 | axon extension involved in regeneration |
GO:0055005 | 0.0029 | Inf | 0.1081 | 2 | 2 | ventricular cardiac myofibril assembly |
GO:0055009 | 0.0029 | Inf | 0.1081 | 2 | 2 | atrial cardiac muscle tissue morphogenesis |
GO:0060435 | 0.0029 | Inf | 0.1081 | 2 | 2 | bronchiole development |
GO:0061056 | 0.0029 | Inf | 0.1081 | 2 | 2 | sclerotome development |
GO:0072272 | 0.0029 | Inf | 0.1081 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0072513 | 0.0029 | Inf | 0.1081 | 2 | 2 | positive regulation of secondary heart field cardioblast proliferation |
GO:2000035 | 0.0029 | Inf | 0.1081 | 2 | 2 | regulation of stem cell division |
GO:0001946 | 0.0029 | 8.811 | 0.6484 | 4 | 12 | lymphangiogenesis |
GO:0048485 | 0.0029 | 8.811 | 0.6484 | 4 | 12 | sympathetic nervous system development |
GO:0060037 | 0.0029 | 8.811 | 0.6484 | 4 | 12 | pharyngeal system development |
GO:0072224 | 0.0029 | 8.811 | 0.6484 | 4 | 12 | metanephric glomerulus development |
GO:0007601 | 0.003 | 2.6249 | 5.457 | 13 | 101 | visual perception |
GO:0048708 | 0.0032 | 4.1251 | 1.9991 | 7 | 37 | astrocyte differentiation |
GO:0055017 | 0.0032 | 4.1251 | 1.9991 | 7 | 37 | cardiac muscle tissue growth |
GO:0022408 | 0.0033 | 4.8167 | 1.5128 | 6 | 28 | negative regulation of cell-cell adhesion |
GO:0090102 | 0.0033 | 4.8167 | 1.5128 | 6 | 28 | cochlea development |
GO:0051216 | 0.0035 | 2.3826 | 6.8618 | 15 | 127 | cartilage development |
GO:0007187 | 0.0035 | 2.6966 | 4.9167 | 12 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0007507 | 0.0035 | 2.0016 | 11.7918 | 22 | 224 | heart development |
GO:0001945 | 0.0036 | 5.8805 | 1.0806 | 5 | 20 | lymph vessel development |
GO:0030809 | 0.0036 | 5.8805 | 1.0806 | 5 | 20 | negative regulation of nucleotide biosynthetic process |
GO:0071300 | 0.0038 | 3.5386 | 2.5934 | 8 | 48 | cellular response to retinoic acid |
GO:0010721 | 0.0039 | 2.5376 | 5.6191 | 13 | 104 | negative regulation of cell development |
GO:0021522 | 0.0039 | 7.9118 | 0.6957 | 4 | 13 | spinal cord motor neuron differentiation |
GO:0007369 | 0.004 | 2.5286 | 5.6342 | 13 | 105 | gastrulation |
GO:0030901 | 0.004 | 4.6068 | 1.5669 | 6 | 29 | midbrain development |
GO:0040011 | 0.004 | 1.9773 | 11.9297 | 22 | 230 | locomotion |
GO:0000097 | 0.0041 | 7.8312 | 0.7024 | 4 | 13 | sulfur amino acid biosynthetic process |
GO:0009713 | 0.0041 | 7.8312 | 0.7024 | 4 | 13 | catechol-containing compound biosynthetic process |
GO:0045597 | 0.0042 | 1.7373 | 19.5942 | 32 | 369 | positive regulation of cell differentiation |
GO:0045596 | 0.0043 | 1.9636 | 11.994 | 22 | 228 | negative regulation of cell differentiation |
GO:0042733 | 0.0044 | 3.452 | 2.6475 | 8 | 49 | embryonic digit morphogenesis |
GO:2000648 | 0.0044 | 3.452 | 2.6475 | 8 | 49 | positive regulation of stem cell proliferation |
GO:0015837 | 0.0044 | 3.8665 | 2.1072 | 7 | 39 | amine transport |
GO:0035116 | 0.0045 | 5.5124 | 1.1346 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0060043 | 0.0045 | 5.5124 | 1.1346 | 5 | 21 | regulation of cardiac muscle cell proliferation |
GO:0060441 | 0.0045 | 5.5124 | 1.1346 | 5 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0051146 | 0.0045 | 2.1778 | 8.4287 | 17 | 156 | striated muscle cell differentiation |
GO:0015698 | 0.0046 | 2.9049 | 3.8361 | 10 | 71 | inorganic anion transport |
GO:0030002 | 0.0047 | 13.1978 | 0.3782 | 3 | 7 | cellular anion homeostasis |
GO:0042473 | 0.0047 | 13.1978 | 0.3782 | 3 | 7 | outer ear morphogenesis |
GO:0071711 | 0.0047 | 13.1978 | 0.3782 | 3 | 7 | basement membrane organization |
GO:0072015 | 0.0047 | 13.1978 | 0.3782 | 3 | 7 | glomerular visceral epithelial cell development |
GO:0072178 | 0.0047 | 13.1978 | 0.3782 | 3 | 7 | nephric duct morphogenesis |
GO:0001843 | 0.0051 | 2.8577 | 3.8902 | 10 | 72 | neural tube closure |
GO:0043010 | 0.0051 | 3.7376 | 2.1605 | 7 | 41 | camera-type eye development |
GO:0007269 | 0.0053 | 2.6717 | 4.5385 | 11 | 84 | neurotransmitter secretion |
GO:0015849 | 0.0054 | 2.1895 | 7.8884 | 16 | 146 | organic acid transport |
GO:0051412 | 0.0055 | 7.0473 | 0.7564 | 4 | 14 | response to corticosterone |
GO:0031076 | 0.0056 | 4.2373 | 1.6749 | 6 | 31 | embryonic camera-type eye development |
GO:0048468 | 0.0058 | 1.9087 | 12.2971 | 22 | 257 | cell development |
GO:0002088 | 0.0059 | 3.6383 | 2.2152 | 7 | 41 | lens development in camera-type eye |
GO:0014032 | 0.0059 | 3.6383 | 2.2152 | 7 | 41 | neural crest cell development |
GO:0048666 | 0.0059 | 1.9384 | 11.5725 | 21 | 223 | neuron development |
GO:1901617 | 0.0062 | 2.3791 | 5.9433 | 13 | 110 | organic hydroxy compound biosynthetic process |
GO:0055001 | 0.0064 | 2.4753 | 5.295 | 12 | 98 | muscle cell development |
GO:0072001 | 0.0065 | 2.5906 | 4.6551 | 11 | 88 | renal system development |
GO:0072089 | 0.0067 | 3.1773 | 2.8355 | 8 | 53 | stem cell proliferation |
GO:0003156 | 0.0068 | 4.8989 | 1.2427 | 5 | 23 | regulation of organ formation |
GO:0010470 | 0.0068 | 4.8989 | 1.2427 | 5 | 23 | regulation of gastrulation |
GO:2000736 | 0.0068 | 2.725 | 4.0523 | 10 | 75 | regulation of stem cell differentiation |
GO:0050794 | 0.0071 | 1.2734 | 249.9488 | 276 | 4918 | regulation of cellular process |
GO:0030814 | 0.0071 | 2.8961 | 3.4579 | 9 | 64 | regulation of cAMP metabolic process |
GO:0042659 | 0.0071 | 6.406 | 0.8105 | 4 | 15 | regulation of cell fate specification |
GO:0071773 | 0.0071 | 6.406 | 0.8105 | 4 | 15 | cellular response to BMP stimulus |
GO:0010454 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | negative regulation of cell fate commitment |
GO:0048664 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | neuron fate determination |
GO:0048845 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | venous blood vessel morphogenesis |
GO:0072182 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | regulation of nephron tubule epithelial cell differentiation |
GO:2000380 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | regulation of mesoderm development |
GO:2000679 | 0.0072 | 10.5571 | 0.4322 | 3 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0060021 | 0.0075 | 2.865 | 3.4881 | 9 | 65 | palate development |
GO:0002067 | 0.0077 | 3.9227 | 1.783 | 6 | 33 | glandular epithelial cell differentiation |
GO:0060079 | 0.0077 | 3.9227 | 1.783 | 6 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0006874 | 0.0078 | 2.0434 | 8.915 | 17 | 165 | cellular calcium ion homeostasis |
GO:0034645 | 0.008 | 1.2872 | 125.5065 | 149 | 2416 | cellular macromolecule biosynthetic process |
GO:0018958 | 0.008 | 3.0751 | 2.9176 | 8 | 54 | phenol-containing compound metabolic process |
GO:0003006 | 0.008 | 1.6262 | 22.0983 | 34 | 409 | developmental process involved in reproduction |
GO:0031128 | 0.0082 | 4.6406 | 1.2967 | 5 | 24 | developmental induction |
GO:0060561 | 0.0082 | 4.6406 | 1.2967 | 5 | 24 | apoptotic process involved in morphogenesis |
GO:0001657 | 0.0082 | 2.6431 | 4.1603 | 10 | 77 | ureteric bud development |
GO:0072163 | 0.0082 | 2.6431 | 4.1603 | 10 | 77 | mesonephric epithelium development |
GO:0001672 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | regulation of chromatin assembly or disassembly |
GO:0014707 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0014816 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | skeletal muscle satellite cell differentiation |
GO:0021524 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | visceral motor neuron differentiation |
GO:0021530 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021960 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | anterior commissure morphogenesis |
GO:0030240 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0032849 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | positive regulation of cellular pH reduction |
GO:0035799 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | ureter maturation |
GO:0042421 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | norepinephrine biosynthetic process |
GO:0042662 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | negative regulation of mesodermal cell fate specification |
GO:0061146 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | Peyer's patch morphogenesis |
GO:0072025 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | distal convoluted tubule development |
GO:0072240 | 0.0084 | 35.1408 | 0.1621 | 2 | 3 | metanephric DCT cell differentiation |
GO:0001708 | 0.0086 | 4.5567 | 1.3094 | 5 | 25 | cell fate specification |
GO:0002040 | 0.0087 | 3.3422 | 2.3773 | 7 | 44 | sprouting angiogenesis |
GO:1990138 | 0.0089 | 3.0094 | 2.9717 | 8 | 55 | neuron projection extension |
GO:0009719 | 0.0089 | 1.4117 | 48.6271 | 65 | 900 | response to endogenous stimulus |
GO:0001569 | 0.0089 | 3.7822 | 1.837 | 6 | 34 | patterning of blood vessels |
GO:0008584 | 0.009 | 2.604 | 4.2143 | 10 | 78 | male gonad development |
GO:0023019 | 0.0091 | 5.8716 | 0.8645 | 4 | 16 | signal transduction involved in regulation of gene expression |
GO:0034199 | 0.0091 | 5.8716 | 0.8645 | 4 | 16 | activation of protein kinase A activity |
GO:0072078 | 0.0091 | 5.8716 | 0.8645 | 4 | 16 | nephron tubule morphogenesis |
GO:0034762 | 0.0092 | 1.885 | 11.2923 | 20 | 209 | regulation of transmembrane transport |
GO:0045927 | 0.0097 | 2.2391 | 6.2675 | 13 | 116 | positive regulation of growth |
GO:0014014 | 0.0098 | 4.4081 | 1.3508 | 5 | 25 | negative regulation of gliogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.9072 | 198.6373 | 277 | 3874 | multicellular organismal process |
GO:0032502 | 0 | 1.6889 | 175.6151 | 237 | 3425 | developmental process |
GO:0007275 | 0 | 1.8361 | 77.3327 | 120 | 1634 | multicellular organismal development |
GO:0048665 | 0 | 9.3965 | 1.3844 | 9 | 27 | neuron fate specification |
GO:0002003 | 0 | Inf | 0.2051 | 4 | 4 | angiotensin maturation |
GO:0050727 | 0 | 3.5392 | 6.2042 | 19 | 121 | regulation of inflammatory response |
GO:0060177 | 0 | 74.5764 | 0.2564 | 4 | 5 | regulation of angiotensin metabolic process |
GO:0050778 | 0 | 2.4137 | 13.7416 | 30 | 268 | positive regulation of immune response |
GO:0048562 | 1e-04 | 2.5575 | 11.2804 | 26 | 220 | embryonic organ morphogenesis |
GO:0007155 | 1e-04 | 1.8538 | 32.4055 | 55 | 632 | cell adhesion |
GO:0007263 | 1e-04 | 18.6725 | 0.5127 | 5 | 10 | nitric oxide mediated signal transduction |
GO:0006590 | 1e-04 | 15.5588 | 0.564 | 5 | 11 | thyroid hormone generation |
GO:0002019 | 1e-04 | Inf | 0.1538 | 3 | 3 | regulation of renal output by angiotensin |
GO:0001955 | 2e-04 | 24.8536 | 0.3589 | 4 | 7 | blood vessel maturation |
GO:0042445 | 3e-04 | 3.3419 | 4.7685 | 14 | 93 | hormone metabolic process |
GO:0001990 | 3e-04 | 8.6604 | 0.9708 | 6 | 19 | regulation of systemic arterial blood pressure by hormone |
GO:0007423 | 3e-04 | 2.0191 | 18.8177 | 35 | 367 | sensory organ development |
GO:0006954 | 3e-04 | 2.6795 | 7.85 | 19 | 157 | inflammatory response |
GO:0002520 | 3e-04 | 1.8676 | 24.9194 | 43 | 486 | immune system development |
GO:0009611 | 3e-04 | 1.8401 | 26.4653 | 45 | 523 | response to wounding |
GO:1903036 | 3e-04 | 4.8239 | 2.2561 | 9 | 44 | positive regulation of response to wounding |
GO:1902105 | 3e-04 | 2.8438 | 6.6657 | 17 | 130 | regulation of leukocyte differentiation |
GO:0018958 | 4e-04 | 4.2679 | 2.7688 | 10 | 54 | phenol-containing compound metabolic process |
GO:0021515 | 4e-04 | 4.6895 | 2.3074 | 9 | 45 | cell differentiation in spinal cord |
GO:0030097 | 4e-04 | 1.8888 | 22.3044 | 39 | 435 | hemopoiesis |
GO:0072678 | 5e-04 | 10.3693 | 0.7178 | 5 | 14 | T cell migration |
GO:0050861 | 5e-04 | 55.8243 | 0.2051 | 3 | 4 | positive regulation of B cell receptor signaling pathway |
GO:0003073 | 5e-04 | 4.4417 | 2.4099 | 9 | 47 | regulation of systemic arterial blood pressure |
GO:0021517 | 6e-04 | 4.9955 | 1.9484 | 8 | 38 | ventral spinal cord development |
GO:0032944 | 6e-04 | 3.2204 | 4.5634 | 13 | 89 | regulation of mononuclear cell proliferation |
GO:0030098 | 7e-04 | 2.4959 | 8.3577 | 19 | 163 | lymphocyte differentiation |
GO:0001991 | 7e-04 | 14.9091 | 0.4615 | 4 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0050884 | 7e-04 | 14.9091 | 0.4615 | 4 | 9 | neuromuscular process controlling posture |
GO:0007631 | 7e-04 | 3.5633 | 3.5379 | 11 | 69 | feeding behavior |
GO:0007399 | 7e-04 | 1.4732 | 72.1945 | 98 | 1408 | nervous system development |
GO:0048513 | 8e-04 | 1.5652 | 49.9807 | 72 | 1058 | organ development |
GO:0030154 | 8e-04 | 1.6853 | 33.4453 | 52 | 698 | cell differentiation |
GO:0046903 | 9e-04 | 1.7101 | 30.1494 | 48 | 588 | secretion |
GO:0015718 | 9e-04 | 3.4438 | 3.6405 | 11 | 71 | monocarboxylic acid transport |
GO:0009887 | 9e-04 | 1.8942 | 19.32 | 34 | 388 | organ morphogenesis |
GO:0009605 | 0.001 | 1.53 | 52.8389 | 75 | 1047 | response to external stimulus |
GO:0002694 | 0.0011 | 2.2287 | 10.7164 | 22 | 209 | regulation of leukocyte activation |
GO:0032103 | 0.0011 | 2.9829 | 4.8711 | 13 | 95 | positive regulation of response to external stimulus |
GO:0050482 | 0.0011 | 12.423 | 0.5127 | 4 | 10 | arachidonic acid secretion |
GO:0021953 | 0.0012 | 2.5788 | 6.8195 | 16 | 133 | central nervous system neuron differentiation |
GO:0007200 | 0.0013 | 4.2796 | 2.2048 | 8 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0065008 | 0.0013 | 1.3897 | 99.575 | 127 | 1942 | regulation of biological quality |
GO:0007159 | 0.0014 | 5.8994 | 1.2819 | 6 | 25 | leukocyte cell-cell adhesion |
GO:0010043 | 0.0014 | 5.8994 | 1.2819 | 6 | 25 | response to zinc ion |
GO:0031349 | 0.0014 | 2.3936 | 8.2039 | 18 | 160 | positive regulation of defense response |
GO:0071805 | 0.0014 | 2.8767 | 5.0249 | 13 | 98 | potassium ion transmembrane transport |
GO:0042108 | 0.0017 | 5.6039 | 1.3331 | 6 | 26 | positive regulation of cytokine biosynthetic process |
GO:0045577 | 0.0017 | 10.6471 | 0.564 | 4 | 11 | regulation of B cell differentiation |
GO:0031348 | 0.0018 | 3.3492 | 3.3841 | 10 | 66 | negative regulation of defense response |
GO:0001775 | 0.0019 | 1.8794 | 17.1041 | 30 | 339 | cell activation |
GO:0045666 | 0.002 | 3.2901 | 3.4354 | 10 | 67 | positive regulation of neuron differentiation |
GO:0007187 | 0.0023 | 2.8532 | 4.666 | 12 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0051001 | 0.0024 | 18.6042 | 0.3076 | 3 | 6 | negative regulation of nitric-oxide synthase activity |
GO:0007517 | 0.0024 | 2.0343 | 12.1521 | 23 | 237 | muscle organ development |
GO:0010535 | 0.0026 | Inf | 0.1025 | 2 | 2 | positive regulation of activation of JAK2 kinase activity |
GO:0019448 | 0.0026 | Inf | 0.1025 | 2 | 2 | L-cysteine catabolic process |
GO:0060478 | 0.0026 | Inf | 0.1025 | 2 | 2 | acrosomal vesicle exocytosis |
GO:0060741 | 0.0026 | Inf | 0.1025 | 2 | 2 | prostate gland stromal morphogenesis |
GO:0071637 | 0.0026 | Inf | 0.1025 | 2 | 2 | regulation of monocyte chemotactic protein-1 production |
GO:0086023 | 0.0026 | Inf | 0.1025 | 2 | 2 | adrenergic receptor signaling pathway involved in heart process |
GO:0097324 | 0.0026 | Inf | 0.1025 | 2 | 2 | melanocyte migration |
GO:0006575 | 0.0028 | 2.5319 | 6.0504 | 14 | 118 | cellular modified amino acid metabolic process |
GO:0045124 | 0.0028 | 6.2177 | 1.0255 | 5 | 20 | regulation of bone resorption |
GO:0042593 | 0.003 | 2.5076 | 6.1017 | 14 | 119 | glucose homeostasis |
GO:0009790 | 0.0031 | 1.5454 | 37.8918 | 55 | 739 | embryo development |
GO:0048706 | 0.0033 | 2.7146 | 4.8711 | 12 | 95 | embryonic skeletal system development |
GO:0015849 | 0.0033 | 2.3177 | 7.4861 | 16 | 146 | organic acid transport |
GO:0051354 | 0.0034 | 8.2794 | 0.6666 | 4 | 13 | negative regulation of oxidoreductase activity |
GO:0071715 | 0.0034 | 8.2794 | 0.6666 | 4 | 13 | icosanoid transport |
GO:0002757 | 0.0034 | 2.045 | 11.024 | 21 | 215 | immune response-activating signal transduction |
GO:0001525 | 0.0035 | 1.9684 | 12.511 | 23 | 244 | angiogenesis |
GO:0006813 | 0.0035 | 2.4602 | 6.2042 | 14 | 121 | potassium ion transport |
GO:0045058 | 0.0036 | 5.8285 | 1.0768 | 5 | 21 | T cell selection |
GO:0001819 | 0.0036 | 2.2243 | 8.2552 | 17 | 161 | positive regulation of cytokine production |
GO:0050871 | 0.0037 | 4.668 | 1.5382 | 6 | 30 | positive regulation of B cell activation |
GO:0050671 | 0.0037 | 3.2411 | 3.1277 | 9 | 61 | positive regulation of lymphocyte proliferation |
GO:0045597 | 0.0038 | 1.7665 | 18.6803 | 31 | 369 | positive regulation of cell differentiation |
GO:0002698 | 0.0038 | 3.9647 | 2.051 | 7 | 40 | negative regulation of immune effector process |
GO:0006636 | 0.0038 | 3.9647 | 2.051 | 7 | 40 | unsaturated fatty acid biosynthetic process |
GO:0045582 | 0.0038 | 3.9647 | 2.051 | 7 | 40 | positive regulation of T cell differentiation |
GO:0016477 | 0.0038 | 1.5578 | 34.0975 | 50 | 665 | cell migration |
GO:0006812 | 0.0039 | 1.5931 | 29.9956 | 45 | 585 | cation transport |
GO:0042107 | 0.0041 | 3.4805 | 2.615 | 8 | 51 | cytokine metabolic process |
GO:0048583 | 0.0042 | 1.336 | 101.7286 | 126 | 1984 | regulation of response to stimulus |
GO:0044700 | 0.0043 | 1.2829 | 174.6409 | 203 | 3406 | single organism signaling |
GO:0050707 | 0.0044 | 3.8477 | 2.1023 | 7 | 41 | regulation of cytokine secretion |
GO:0051412 | 0.0045 | 7.4507 | 0.7178 | 4 | 14 | response to corticosterone |
GO:0070665 | 0.0046 | 3.1204 | 3.2303 | 9 | 63 | positive regulation of leukocyte proliferation |
GO:0048699 | 0.0047 | 1.4609 | 47.2751 | 65 | 922 | generation of neurons |
GO:0048663 | 0.0048 | 4.3764 | 1.6167 | 6 | 32 | neuron fate commitment |
GO:0007154 | 0.0048 | 1.2775 | 177.9224 | 206 | 3470 | cell communication |
GO:0006928 | 0.0048 | 1.4272 | 55.1713 | 74 | 1076 | cellular component movement |
GO:0030168 | 0.0049 | 2.2141 | 7.7937 | 16 | 152 | platelet activation |
GO:0048468 | 0.005 | 1.3918 | 65.8877 | 86 | 1285 | cell development |
GO:0046456 | 0.0051 | 4.308 | 1.6408 | 6 | 32 | icosanoid biosynthetic process |
GO:1901568 | 0.0052 | 3.3251 | 2.7175 | 8 | 53 | fatty acid derivative metabolic process |
GO:0046006 | 0.0059 | 6.7726 | 0.7691 | 4 | 15 | regulation of activated T cell proliferation |
GO:0006801 | 0.006 | 4.148 | 1.6921 | 6 | 33 | superoxide metabolic process |
GO:0032649 | 0.006 | 4.148 | 1.6921 | 6 | 33 | regulation of interferon-gamma production |
GO:0097530 | 0.006 | 4.148 | 1.6921 | 6 | 33 | granulocyte migration |
GO:0051674 | 0.0061 | 1.5037 | 36.61 | 52 | 714 | localization of cell |
GO:0007498 | 0.0061 | 2.6103 | 4.6147 | 11 | 90 | mesoderm development |
GO:0002675 | 0.0061 | 11.2023 | 0.4087 | 3 | 8 | positive regulation of acute inflammatory response |
GO:0002691 | 0.0062 | 11.1602 | 0.4102 | 3 | 8 | regulation of cellular extravasation |
GO:0010661 | 0.0062 | 11.1602 | 0.4102 | 3 | 8 | positive regulation of muscle cell apoptotic process |
GO:0031645 | 0.0062 | 11.1602 | 0.4102 | 3 | 8 | negative regulation of neurological system process |
GO:0035855 | 0.0062 | 11.1602 | 0.4102 | 3 | 8 | megakaryocyte development |
GO:0034765 | 0.0063 | 2.0005 | 10.1523 | 19 | 198 | regulation of ion transmembrane transport |
GO:0072358 | 0.0063 | 1.5545 | 29.9443 | 44 | 584 | cardiovascular system development |
GO:0050877 | 0.0065 | 1.5856 | 26.6831 | 40 | 523 | neurological system process |
GO:0032410 | 0.0066 | 4.9067 | 1.2306 | 5 | 24 | negative regulation of transporter activity |
GO:0002819 | 0.0066 | 3.1829 | 2.8201 | 8 | 55 | regulation of adaptive immune response |
GO:0055074 | 0.0067 | 2.0777 | 8.7679 | 17 | 171 | calcium ion homeostasis |
GO:0042127 | 0.0068 | 1.4495 | 44.5575 | 61 | 869 | regulation of cell proliferation |
GO:0007268 | 0.0069 | 1.5993 | 25.1245 | 38 | 490 | synaptic transmission |
GO:0042472 | 0.0069 | 2.7145 | 4.0507 | 10 | 79 | inner ear morphogenesis |
GO:2000026 | 0.0069 | 1.4761 | 39.4417 | 55 | 785 | regulation of multicellular organismal development |
GO:0006820 | 0.0072 | 1.8138 | 14.0492 | 24 | 274 | anion transport |
GO:0002703 | 0.0073 | 3.1163 | 2.8714 | 8 | 56 | regulation of leukocyte mediated immunity |
GO:0007338 | 0.0073 | 3.1163 | 2.8714 | 8 | 56 | single fertilization |
GO:0043010 | 0.0073 | 1.9669 | 10.3062 | 19 | 201 | camera-type eye development |
GO:0015837 | 0.0075 | 37.462 | 0.1526 | 2 | 3 | amine transport |
GO:0042098 | 0.0075 | 2.6754 | 4.102 | 10 | 80 | T cell proliferation |
GO:0050974 | 0.0076 | 6.2076 | 0.8204 | 4 | 16 | detection of mechanical stimulus involved in sensory perception |
GO:0001992 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | regulation of systemic arterial blood pressure by vasopressin |
GO:0002866 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | positive regulation of acute inflammatory response to antigenic stimulus |
GO:0010533 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | regulation of activation of Janus kinase activity |
GO:0010666 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | positive regulation of cardiac muscle cell apoptotic process |
GO:0021524 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | visceral motor neuron differentiation |
GO:0030223 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | neutrophil differentiation |
GO:0032645 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:0042335 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | cuticle development |
GO:0072540 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | T-helper 17 cell lineage commitment |
GO:2001199 | 0.0076 | 37.1445 | 0.1538 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0002376 | 0.0083 | 1.4623 | 39.821 | 55 | 806 | immune system process |
GO:0007186 | 0.0083 | 1.7458 | 15.77 | 26 | 313 | G-protein coupled receptor signaling pathway |
GO:0033555 | 0.0084 | 3.3526 | 2.3586 | 7 | 46 | multicellular organismal response to stress |
GO:0048839 | 0.0085 | 3.0285 | 2.9397 | 8 | 58 | inner ear development |
GO:0008015 | 0.0085 | 1.8678 | 11.947 | 21 | 233 | blood circulation |
GO:0022414 | 0.0086 | 1.4666 | 38.1482 | 53 | 744 | reproductive process |
GO:0003008 | 0.0088 | 1.719 | 16.6282 | 27 | 335 | system process |
GO:0045596 | 0.0089 | 1.6662 | 19.0228 | 30 | 371 | negative regulation of cell differentiation |
GO:0032928 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | regulation of superoxide anion generation |
GO:0034104 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | negative regulation of tissue remodeling |
GO:0035358 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0042508 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | tyrosine phosphorylation of Stat1 protein |
GO:0043651 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | linoleic acid metabolic process |
GO:0097154 | 0.0089 | 9.2992 | 0.4615 | 3 | 9 | GABAergic neuron differentiation |
GO:0007599 | 0.009 | 1.7134 | 16.6642 | 27 | 325 | hemostasis |
GO:0002687 | 0.0092 | 3.732 | 1.8459 | 6 | 36 | positive regulation of leukocyte migration |
GO:0051952 | 0.0092 | 3.732 | 1.8459 | 6 | 36 | regulation of amine transport |
GO:0050863 | 0.0093 | 2.1723 | 6.9221 | 14 | 135 | regulation of T cell activation |
GO:0033209 | 0.0093 | 4.4384 | 1.3331 | 5 | 26 | tumor necrosis factor-mediated signaling pathway |
GO:0050848 | 0.0095 | 5.7295 | 0.8717 | 4 | 17 | regulation of calcium-mediated signaling |
GO:0040017 | 0.0097 | 1.9468 | 9.8447 | 18 | 192 | positive regulation of locomotion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 261.5163 | 0.0773 | 4 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 11.6517 | 0.618 | 6 | 40 | sensory perception of chemical stimulus |
GO:0050906 | 2e-04 | 10.2508 | 0.5717 | 5 | 37 | detection of stimulus involved in sensory perception |
GO:0031424 | 4e-04 | 27.821 | 0.1545 | 3 | 10 | keratinization |
GO:0009593 | 8e-04 | 10.8715 | 0.4326 | 4 | 28 | detection of chemical stimulus |
GO:0045591 | 0.0014 | 64.529 | 0.0618 | 2 | 4 | positive regulation of regulatory T cell differentiation |
GO:0008544 | 0.0016 | 3.582 | 2.7194 | 9 | 176 | epidermis development |
GO:0051006 | 0.0023 | 43.0151 | 0.0773 | 2 | 5 | positive regulation of lipoprotein lipase activity |
GO:2000252 | 0.0023 | 43.0151 | 0.0773 | 2 | 5 | negative regulation of feeding behavior |
GO:0045104 | 0.0029 | 12.1607 | 0.2936 | 3 | 19 | intermediate filament cytoskeleton organization |
GO:0010951 | 0.0033 | 4.4774 | 1.4524 | 6 | 94 | negative regulation of endopeptidase activity |
GO:0071435 | 0.0047 | 25.8039 | 0.1082 | 2 | 7 | potassium ion export |
GO:1902476 | 0.005 | 6.3529 | 0.6953 | 4 | 45 | chloride transmembrane transport |
GO:0030216 | 0.0051 | 6.3206 | 0.6979 | 4 | 46 | keratinocyte differentiation |
GO:0009584 | 0.0058 | 6.0562 | 0.7262 | 4 | 47 | detection of visible light |
GO:1902358 | 0.0062 | 21.5011 | 0.1236 | 2 | 8 | sulfate transmembrane transport |
GO:0050994 | 0.0065 | 8.8388 | 0.3863 | 3 | 25 | regulation of lipid catabolic process |
GO:0050877 | 0.0079 | 2.0908 | 8.2046 | 16 | 531 | neurological system process |
GO:0006869 | 0.0083 | 3.241 | 2.3022 | 7 | 149 | lipid transport |
GO:0097006 | 0.0099 | 7.476 | 0.4481 | 3 | 29 | regulation of plasma lipoprotein particle levels |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 3.0784 | 17.037 | 45 | 331 | pattern specification process |
GO:0032501 | 0 | 1.6491 | 190.1396 | 249 | 3749 | multicellular organismal process |
GO:0060173 | 0 | 3.8349 | 6.4339 | 21 | 125 | limb development |
GO:0035107 | 0 | 3.9994 | 5.6104 | 19 | 109 | appendage morphogenesis |
GO:0001501 | 0 | 2.5351 | 16.3679 | 37 | 318 | skeletal system development |
GO:0051952 | 0 | 7.2065 | 1.853 | 10 | 36 | regulation of amine transport |
GO:0048562 | 0 | 3.1644 | 7.546 | 21 | 149 | embryonic organ morphogenesis |
GO:0035295 | 0 | 2.127 | 22.8018 | 44 | 443 | tube development |
GO:0048663 | 0 | 7.3901 | 1.6325 | 9 | 32 | neuron fate commitment |
GO:0021879 | 0 | 7.3582 | 1.6391 | 9 | 32 | forebrain neuron differentiation |
GO:0009605 | 0 | 1.6719 | 58.7802 | 89 | 1142 | response to external stimulus |
GO:0010817 | 0 | 2.4455 | 13.5884 | 30 | 264 | regulation of hormone levels |
GO:0007586 | 0 | 10.1883 | 1.0158 | 7 | 20 | digestion |
GO:0043009 | 0 | 2.0622 | 23.4194 | 44 | 455 | chordate embryonic development |
GO:0042755 | 0 | 10.044 | 1.0294 | 7 | 20 | eating behavior |
GO:0009952 | 1e-04 | 2.9228 | 8.081 | 21 | 157 | anterior/posterior pattern specification |
GO:0048878 | 1e-04 | 1.9875 | 25.3239 | 46 | 492 | chemical homeostasis |
GO:0030001 | 1e-04 | 2.0432 | 22.493 | 42 | 437 | metal ion transport |
GO:0071294 | 1e-04 | 18.5965 | 0.5147 | 5 | 10 | cellular response to zinc ion |
GO:0009954 | 1e-04 | 8.703 | 1.1324 | 7 | 22 | proximal/distal pattern formation |
GO:0060261 | 1e-04 | 37.1329 | 0.3088 | 4 | 6 | positive regulation of transcription initiation from RNA polymerase II promoter |
GO:0007218 | 1e-04 | 4.2469 | 3.3456 | 12 | 65 | neuropeptide signaling pathway |
GO:0098660 | 1e-04 | 2.1183 | 18.5811 | 36 | 361 | inorganic ion transmembrane transport |
GO:0032502 | 1e-04 | 1.4382 | 148.4479 | 186 | 2980 | developmental process |
GO:0048484 | 1e-04 | 15.4955 | 0.5662 | 5 | 11 | enteric nervous system development |
GO:0045666 | 1e-04 | 4.0917 | 3.4486 | 12 | 67 | positive regulation of neuron differentiation |
GO:0007417 | 1e-04 | 1.8278 | 30.9343 | 52 | 601 | central nervous system development |
GO:0007156 | 2e-04 | 3.7541 | 4.0148 | 13 | 78 | homophilic cell adhesion |
GO:0014032 | 2e-04 | 5.2562 | 2.1103 | 9 | 41 | neural crest cell development |
GO:0022600 | 2e-04 | 5.2562 | 2.1103 | 9 | 41 | digestive system process |
GO:1990267 | 2e-04 | 4.6774 | 2.5736 | 10 | 50 | response to transition metal nanoparticle |
GO:0048485 | 2e-04 | 13.2805 | 0.6177 | 5 | 12 | sympathetic nervous system development |
GO:0007517 | 2e-04 | 2.3373 | 12.1987 | 26 | 237 | muscle organ development |
GO:0030326 | 2e-04 | 3.8431 | 3.6277 | 12 | 71 | embryonic limb morphogenesis |
GO:0050804 | 2e-04 | 2.659 | 8.3384 | 20 | 162 | regulation of synaptic transmission |
GO:0048704 | 2e-04 | 3.8127 | 3.6545 | 12 | 71 | embryonic skeletal system morphogenesis |
GO:0007267 | 3e-04 | 2.264 | 13.0373 | 27 | 266 | cell-cell signaling |
GO:0006730 | 3e-04 | 8.5925 | 0.978 | 6 | 19 | one-carbon metabolic process |
GO:0007519 | 3e-04 | 3.01 | 5.9707 | 16 | 116 | skeletal muscle tissue development |
GO:0050880 | 3e-04 | 3.4347 | 4.3236 | 13 | 84 | regulation of blood vessel size |
GO:0044708 | 3e-04 | 2.3027 | 11.8673 | 25 | 233 | single-organism behavior |
GO:0050877 | 3e-04 | 1.8437 | 25.8106 | 44 | 505 | neurological system process |
GO:0045944 | 4e-04 | 1.7582 | 31.346 | 51 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006837 | 4e-04 | 18.5626 | 0.4118 | 4 | 8 | serotonin transport |
GO:0071276 | 4e-04 | 18.5626 | 0.4118 | 4 | 8 | cellular response to cadmium ion |
GO:0007631 | 4e-04 | 4.6178 | 2.3322 | 9 | 46 | feeding behavior |
GO:0009887 | 4e-04 | 2.1125 | 14.8987 | 29 | 308 | organ morphogenesis |
GO:0003013 | 4e-04 | 2.2538 | 12.0958 | 25 | 235 | circulatory system process |
GO:0021527 | 5e-04 | 10.3271 | 0.7206 | 5 | 14 | spinal cord association neuron differentiation |
GO:0021854 | 5e-04 | 10.3271 | 0.7206 | 5 | 14 | hypothalamus development |
GO:0032890 | 5e-04 | 7.4453 | 1.0809 | 6 | 21 | regulation of organic acid transport |
GO:0035235 | 5e-04 | 7.4453 | 1.0809 | 6 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0008343 | 5e-04 | 55.5981 | 0.2059 | 3 | 4 | adult feeding behavior |
GO:0035148 | 5e-04 | 2.9349 | 5.7133 | 15 | 111 | tube formation |
GO:0045665 | 6e-04 | 4.4235 | 2.4192 | 9 | 47 | negative regulation of neuron differentiation |
GO:0050789 | 6e-04 | 1.366 | 320.6663 | 356 | 6230 | regulation of biological process |
GO:0007423 | 6e-04 | 1.9429 | 18.89 | 34 | 367 | sensory organ development |
GO:0007613 | 6e-04 | 3.6113 | 3.5 | 11 | 68 | memory |
GO:0044070 | 7e-04 | 4.3096 | 2.4706 | 9 | 48 | regulation of anion transport |
GO:0051241 | 7e-04 | 2.2631 | 11.0663 | 23 | 215 | negative regulation of multicellular organismal process |
GO:0003214 | 7e-04 | 14.906 | 0.4616 | 4 | 9 | cardiac left ventricle morphogenesis |
GO:0051093 | 8e-04 | 1.8323 | 22.9047 | 39 | 445 | negative regulation of developmental process |
GO:0001709 | 8e-04 | 5.4343 | 1.5956 | 7 | 31 | cell fate determination |
GO:0007155 | 8e-04 | 1.6844 | 32.5299 | 51 | 632 | cell adhesion |
GO:0060537 | 9e-04 | 2.1805 | 11.9413 | 24 | 232 | muscle tissue development |
GO:0015698 | 9e-04 | 3.4296 | 3.6545 | 11 | 71 | inorganic anion transport |
GO:0098656 | 9e-04 | 2.8856 | 5.4045 | 14 | 105 | anion transmembrane transport |
GO:0006811 | 0.001 | 1.7875 | 24.0518 | 40 | 484 | ion transport |
GO:0048598 | 0.001 | 2.2313 | 10.6961 | 22 | 217 | embryonic morphogenesis |
GO:0072088 | 0.0011 | 6.2025 | 1.2353 | 6 | 24 | nephron epithelium morphogenesis |
GO:1901615 | 0.0012 | 2.0007 | 15.0811 | 28 | 293 | organic hydroxy compound metabolic process |
GO:0007270 | 0.0012 | 2.9344 | 4.9412 | 13 | 96 | neuron-neuron synaptic transmission |
GO:0035136 | 0.0012 | 28.0136 | 0.2555 | 3 | 5 | forelimb morphogenesis |
GO:0044241 | 0.0013 | 27.7962 | 0.2574 | 3 | 5 | lipid digestion |
GO:0051956 | 0.0013 | 27.7962 | 0.2574 | 3 | 5 | negative regulation of amino acid transport |
GO:0051967 | 0.0013 | 27.7962 | 0.2574 | 3 | 5 | negative regulation of synaptic transmission, glutamatergic |
GO:0060017 | 0.0013 | 27.7962 | 0.2574 | 3 | 5 | parathyroid gland development |
GO:0007268 | 0.0014 | 1.9756 | 15.2503 | 28 | 303 | synaptic transmission |
GO:0007200 | 0.0014 | 4.2621 | 2.2133 | 8 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0007202 | 0.0014 | 4.2621 | 2.2133 | 8 | 43 | activation of phospholipase C activity |
GO:0019229 | 0.0015 | 4.829 | 1.75 | 7 | 34 | regulation of vasoconstriction |
GO:0098655 | 0.0016 | 1.8417 | 19.1988 | 33 | 373 | cation transmembrane transport |
GO:0009190 | 0.0017 | 3.1642 | 3.9118 | 11 | 76 | cyclic nucleotide biosynthetic process |
GO:0010628 | 0.0017 | 1.5289 | 46.9418 | 67 | 912 | positive regulation of gene expression |
GO:0035640 | 0.0017 | 10.6039 | 0.5662 | 4 | 11 | exploration behavior |
GO:0042403 | 0.0017 | 10.6039 | 0.5662 | 4 | 11 | thyroid hormone metabolic process |
GO:0001764 | 0.0018 | 2.7984 | 5.1471 | 13 | 100 | neuron migration |
GO:0008589 | 0.0018 | 3.6512 | 2.8309 | 9 | 55 | regulation of smoothened signaling pathway |
GO:2000026 | 0.0018 | 1.523 | 47.0963 | 67 | 915 | regulation of multicellular organismal development |
GO:0001656 | 0.0019 | 3.3354 | 3.3971 | 10 | 66 | metanephros development |
GO:0015672 | 0.0019 | 1.9808 | 14.1031 | 26 | 274 | monovalent inorganic cation transport |
GO:0048762 | 0.0019 | 2.6502 | 5.8163 | 14 | 113 | mesenchymal cell differentiation |
GO:0050767 | 0.0019 | 1.8195 | 19.4047 | 33 | 377 | regulation of neurogenesis |
GO:0048864 | 0.002 | 2.2013 | 9.831 | 20 | 191 | stem cell development |
GO:0007584 | 0.002 | 2.7663 | 5.1986 | 13 | 101 | response to nutrient |
GO:0048754 | 0.002 | 2.5343 | 6.4854 | 15 | 126 | branching morphogenesis of an epithelial tube |
GO:0072001 | 0.0021 | 2.1883 | 9.8825 | 20 | 192 | renal system development |
GO:0003281 | 0.0021 | 4.495 | 1.853 | 7 | 36 | ventricular septum development |
GO:0048665 | 0.0021 | 5.3147 | 1.3897 | 6 | 27 | neuron fate specification |
GO:0008217 | 0.0022 | 3.245 | 3.4748 | 10 | 68 | regulation of blood pressure |
GO:0010719 | 0.0023 | 6.6354 | 0.978 | 5 | 19 | negative regulation of epithelial to mesenchymal transition |
GO:0003206 | 0.0023 | 3.0236 | 4.0662 | 11 | 79 | cardiac chamber morphogenesis |
GO:0042472 | 0.0023 | 3.0236 | 4.0662 | 11 | 79 | inner ear morphogenesis |
GO:0043279 | 0.0023 | 3.0236 | 4.0662 | 11 | 79 | response to alkaloid |
GO:0001763 | 0.0024 | 2.33 | 7.9266 | 17 | 154 | morphogenesis of a branching structure |
GO:0014048 | 0.0024 | 18.5288 | 0.3088 | 3 | 6 | regulation of glutamate secretion |
GO:0042713 | 0.0024 | 18.5288 | 0.3088 | 3 | 6 | sperm ejaculation |
GO:0051450 | 0.0024 | 18.5288 | 0.3088 | 3 | 6 | myoblast proliferation |
GO:0051957 | 0.0024 | 18.5288 | 0.3088 | 3 | 6 | positive regulation of amino acid transport |
GO:0090009 | 0.0024 | 18.5288 | 0.3088 | 3 | 6 | primitive streak formation |
GO:0010662 | 0.0025 | 9.2775 | 0.6177 | 4 | 12 | regulation of striated muscle cell apoptotic process |
GO:0071242 | 0.0025 | 9.2775 | 0.6177 | 4 | 12 | cellular response to ammonium ion |
GO:0072079 | 0.0025 | 9.2775 | 0.6177 | 4 | 12 | nephron tubule formation |
GO:0035137 | 0.0026 | 5.0726 | 1.4412 | 6 | 28 | hindlimb morphogenesis |
GO:0007275 | 0.0026 | 1.4089 | 79.0949 | 102 | 1695 | multicellular organismal development |
GO:0003211 | 0.0026 | Inf | 0.1024 | 2 | 2 | cardiac ventricle formation |
GO:0003218 | 0.0026 | Inf | 0.1029 | 2 | 2 | cardiac left ventricle formation |
GO:0010949 | 0.0026 | Inf | 0.1029 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0015889 | 0.0026 | Inf | 0.1029 | 2 | 2 | cobalamin transport |
GO:0032100 | 0.0026 | Inf | 0.1029 | 2 | 2 | positive regulation of appetite |
GO:0043134 | 0.0026 | Inf | 0.1029 | 2 | 2 | regulation of hindgut contraction |
GO:0045796 | 0.0026 | Inf | 0.1029 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:0055005 | 0.0026 | Inf | 0.1029 | 2 | 2 | ventricular cardiac myofibril assembly |
GO:0061056 | 0.0026 | Inf | 0.1029 | 2 | 2 | sclerotome development |
GO:0070093 | 0.0026 | Inf | 0.1029 | 2 | 2 | negative regulation of glucagon secretion |
GO:0072272 | 0.0026 | Inf | 0.1029 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0097195 | 0.0026 | Inf | 0.1029 | 2 | 2 | pilomotor reflex |
GO:0000122 | 0.0028 | 1.7026 | 23.7797 | 38 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0046395 | 0.0028 | 2.3634 | 7.3604 | 16 | 143 | carboxylic acid catabolic process |
GO:0046903 | 0.0028 | 1.6184 | 30.2651 | 46 | 588 | secretion |
GO:0006935 | 0.0028 | 1.7564 | 20.64 | 34 | 401 | chemotaxis |
GO:0007422 | 0.003 | 3.3577 | 3.0368 | 9 | 59 | peripheral nervous system development |
GO:0007588 | 0.003 | 4.8848 | 1.4831 | 6 | 29 | excretion |
GO:0030902 | 0.003 | 2.6162 | 5.456 | 13 | 106 | hindbrain development |
GO:0048545 | 0.0033 | 2.0106 | 11.7355 | 22 | 228 | response to steroid hormone |
GO:0045137 | 0.0034 | 2.3081 | 7.5148 | 16 | 146 | development of primary sexual characteristics |
GO:0009651 | 0.0034 | 8.2458 | 0.6691 | 4 | 13 | response to salt stress |
GO:0044062 | 0.0034 | 8.2458 | 0.6691 | 4 | 13 | regulation of excretion |
GO:2000142 | 0.0034 | 8.2458 | 0.6691 | 4 | 13 | regulation of DNA-templated transcription, initiation |
GO:0002009 | 0.0035 | 1.884 | 14.7394 | 26 | 289 | morphogenesis of an epithelium |
GO:0048608 | 0.0036 | 1.8795 | 14.7723 | 26 | 287 | reproductive structure development |
GO:0009410 | 0.0036 | 3.0108 | 3.7059 | 10 | 72 | response to xenobiotic stimulus |
GO:0001662 | 0.0036 | 5.8048 | 1.0809 | 5 | 21 | behavioral fear response |
GO:0048521 | 0.0036 | 5.8048 | 1.0809 | 5 | 21 | negative regulation of behavior |
GO:0055085 | 0.0037 | 1.7373 | 20.2254 | 33 | 407 | transmembrane transport |
GO:0001708 | 0.0037 | 3.9862 | 2.0407 | 7 | 40 | cell fate specification |
GO:1902680 | 0.0038 | 1.4866 | 45.0889 | 63 | 876 | positive regulation of RNA biosynthetic process |
GO:0010667 | 0.0041 | 13.8952 | 0.3603 | 3 | 7 | negative regulation of cardiac muscle cell apoptotic process |
GO:0042753 | 0.0041 | 13.8952 | 0.3603 | 3 | 7 | positive regulation of circadian rhythm |
GO:0046500 | 0.0041 | 13.8952 | 0.3603 | 3 | 7 | S-adenosylmethionine metabolic process |
GO:0055062 | 0.0041 | 13.8952 | 0.3603 | 3 | 7 | phosphate ion homeostasis |
GO:0072358 | 0.0041 | 1.5892 | 30.0592 | 45 | 584 | cardiovascular system development |
GO:1900274 | 0.0042 | 3.4662 | 2.625 | 8 | 51 | regulation of phospholipase C activity |
GO:0021515 | 0.0042 | 4.5019 | 1.5825 | 6 | 31 | cell differentiation in spinal cord |
GO:0071805 | 0.0044 | 2.6083 | 5.0442 | 12 | 98 | potassium ion transmembrane transport |
GO:2000179 | 0.0044 | 4.4625 | 1.5956 | 6 | 31 | positive regulation of neural precursor cell proliferation |
GO:0002088 | 0.0045 | 3.832 | 2.1103 | 7 | 41 | lens development in camera-type eye |
GO:0006775 | 0.0045 | 5.4628 | 1.1324 | 5 | 22 | fat-soluble vitamin metabolic process |
GO:0045987 | 0.0045 | 5.4628 | 1.1324 | 5 | 22 | positive regulation of smooth muscle contraction |
GO:0048265 | 0.0045 | 5.4628 | 1.1324 | 5 | 22 | response to pain |
GO:0030431 | 0.0046 | 7.4204 | 0.7206 | 4 | 14 | sleep |
GO:0042430 | 0.0046 | 7.4204 | 0.7206 | 4 | 14 | indole-containing compound metabolic process |
GO:0051412 | 0.0046 | 7.4204 | 0.7206 | 4 | 14 | response to corticosterone |
GO:0072511 | 0.0047 | 2.0206 | 10.6031 | 20 | 206 | divalent inorganic cation transport |
GO:0006816 | 0.0047 | 2.0625 | 9.8825 | 19 | 192 | calcium ion transport |
GO:0042127 | 0.0048 | 1.4717 | 44.7286 | 62 | 869 | regulation of cell proliferation |
GO:2000021 | 0.0049 | 2.8709 | 3.8603 | 10 | 75 | regulation of ion homeostasis |
GO:0044706 | 0.0049 | 2.3607 | 6.4339 | 14 | 125 | multi-multicellular organism process |
GO:0006171 | 0.0052 | 3.0508 | 3.2942 | 9 | 64 | cAMP biosynthetic process |
GO:0009888 | 0.0053 | 1.4702 | 44.0752 | 61 | 877 | tissue development |
GO:0019233 | 0.0053 | 3.3115 | 2.728 | 8 | 53 | sensory perception of pain |
GO:0048659 | 0.0053 | 3.3115 | 2.728 | 8 | 53 | smooth muscle cell proliferation |
GO:0043436 | 0.0055 | 1.5191 | 35.5667 | 51 | 691 | oxoacid metabolic process |
GO:0010470 | 0.0055 | 5.1587 | 1.1838 | 5 | 23 | regulation of gastrulation |
GO:0035115 | 0.0055 | 5.1587 | 1.1838 | 5 | 23 | embryonic forelimb morphogenesis |
GO:0003231 | 0.0058 | 4.1752 | 1.6818 | 6 | 33 | cardiac ventricle development |
GO:0006835 | 0.0059 | 3.6183 | 2.2133 | 7 | 43 | dicarboxylic acid transport |
GO:0050886 | 0.0059 | 3.6183 | 2.2133 | 7 | 43 | endocrine process |
GO:0001838 | 0.006 | 2.6179 | 4.6024 | 11 | 90 | embryonic epithelial tube formation |
GO:0006972 | 0.006 | 6.7451 | 0.7721 | 4 | 15 | hyperosmotic response |
GO:0007620 | 0.006 | 6.7451 | 0.7721 | 4 | 15 | copulation |
GO:0010460 | 0.006 | 6.7451 | 0.7721 | 4 | 15 | positive regulation of heart rate |
GO:0022414 | 0.006 | 1.4931 | 38.2947 | 54 | 744 | reproductive process |
GO:0007204 | 0.006 | 2.4913 | 5.2501 | 12 | 102 | positive regulation of cytosolic calcium ion concentration |
GO:0021983 | 0.0061 | 4.1311 | 1.6986 | 6 | 33 | pituitary gland development |
GO:0060079 | 0.0061 | 4.1311 | 1.6986 | 6 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0060993 | 0.0061 | 4.1311 | 1.6986 | 6 | 33 | kidney morphogenesis |
GO:0046394 | 0.0062 | 2.0035 | 10.1398 | 19 | 197 | carboxylic acid biosynthetic process |
GO:0014051 | 0.0063 | 11.115 | 0.4118 | 3 | 8 | gamma-aminobutyric acid secretion |
GO:0021936 | 0.0063 | 11.115 | 0.4118 | 3 | 8 | regulation of cerebellar granule cell precursor proliferation |
GO:0060180 | 0.0063 | 11.115 | 0.4118 | 3 | 8 | female mating behavior |
GO:1902358 | 0.0063 | 11.115 | 0.4118 | 3 | 8 | sulfate transmembrane transport |
GO:0001704 | 0.0063 | 2.5996 | 4.6324 | 11 | 90 | formation of primary germ layer |
GO:0008344 | 0.0064 | 2.9432 | 3.3971 | 9 | 66 | adult locomotory behavior |
GO:0071241 | 0.0064 | 2.9432 | 3.3971 | 9 | 66 | cellular response to inorganic substance |
GO:0008584 | 0.0064 | 2.7434 | 4.0148 | 10 | 78 | male gonad development |
GO:0034765 | 0.0065 | 1.9921 | 10.1913 | 19 | 198 | regulation of ion transmembrane transport |
GO:0045927 | 0.0065 | 2.3597 | 5.9707 | 13 | 116 | positive regulation of growth |
GO:0046879 | 0.0066 | 2.0338 | 9.4707 | 18 | 184 | hormone secretion |
GO:0048511 | 0.0066 | 2.0338 | 9.4707 | 18 | 184 | rhythmic process |
GO:0008206 | 0.0067 | 4.8867 | 1.2353 | 5 | 24 | bile acid metabolic process |
GO:0031128 | 0.0067 | 4.8867 | 1.2353 | 5 | 24 | developmental induction |
GO:0045777 | 0.0067 | 4.8867 | 1.2353 | 5 | 24 | positive regulation of blood pressure |
GO:0055074 | 0.0069 | 2.069 | 8.8016 | 17 | 171 | calcium ion homeostasis |
GO:0010721 | 0.007 | 2.4367 | 5.353 | 12 | 104 | negative regulation of cell development |
GO:0006584 | 0.0071 | 3.9831 | 1.75 | 6 | 34 | catecholamine metabolic process |
GO:0015833 | 0.0074 | 2.0555 | 8.8531 | 17 | 172 | peptide transport |
GO:0002125 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | maternal aggressive behavior |
GO:0003219 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | cardiac right ventricle formation |
GO:0014062 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | regulation of serotonin secretion |
GO:0016115 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | terpenoid catabolic process |
GO:0016199 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | axon midline choice point recognition |
GO:0021902 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030240 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0032849 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | positive regulation of cellular pH reduction |
GO:0034653 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | retinoic acid catabolic process |
GO:0042421 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | norepinephrine biosynthetic process |
GO:0045472 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | response to ether |
GO:0051464 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | positive regulation of cortisol secretion |
GO:0072107 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | positive regulation of ureteric bud formation |
GO:2000611 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | positive regulation of thyroid hormone generation |
GO:2001199 | 0.0077 | 36.9942 | 0.1544 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0048512 | 0.0077 | 6.1824 | 0.8235 | 4 | 16 | circadian behavior |
GO:0050974 | 0.0077 | 6.1824 | 0.8235 | 4 | 16 | detection of mechanical stimulus involved in sensory perception |
GO:0045595 | 0.0077 | 1.4307 | 46.5815 | 63 | 905 | regulation of cell differentiation |
GO:0006805 | 0.0078 | 2.8428 | 3.5 | 9 | 68 | xenobiotic metabolic process |
GO:0006355 | 0.0081 | 1.2878 | 118.7031 | 142 | 2321 | regulation of transcription, DNA-templated |
GO:0051252 | 0.0081 | 1.2825 | 124.3547 | 148 | 2416 | regulation of RNA metabolic process |
GO:0051937 | 0.0082 | 3.8454 | 1.8015 | 6 | 35 | catecholamine transport |
GO:0055080 | 0.0082 | 1.7687 | 14.9782 | 25 | 291 | cation homeostasis |
GO:0010518 | 0.0083 | 3.0399 | 2.9339 | 8 | 57 | positive regulation of phospholipase activity |
GO:0003014 | 0.0086 | 3.3389 | 2.3677 | 7 | 46 | renal system process |
GO:0071705 | 0.0086 | 1.6166 | 22.2062 | 34 | 433 | nitrogen compound transport |
GO:0010951 | 0.0087 | 2.4733 | 4.8383 | 11 | 94 | negative regulation of endopeptidase activity |
GO:0001655 | 0.0087 | 4.5157 | 1.3119 | 5 | 26 | urogenital system development |
GO:0021889 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | olfactory bulb interneuron differentiation |
GO:0033605 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | positive regulation of catecholamine secretion |
GO:0035815 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | positive regulation of renal sodium excretion |
GO:0048486 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | parasympathetic nervous system development |
GO:0060536 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | cartilage morphogenesis |
GO:0060977 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | coronary vasculature morphogenesis |
GO:0097154 | 0.009 | 9.2615 | 0.4632 | 3 | 9 | GABAergic neuron differentiation |
GO:0031326 | 0.009 | 1.2682 | 137.9946 | 162 | 2681 | regulation of cellular biosynthetic process |
GO:0042476 | 0.0091 | 2.5899 | 4.2206 | 10 | 82 | odontogenesis |
GO:0007188 | 0.0094 | 2.749 | 3.603 | 9 | 70 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0060021 | 0.0094 | 2.749 | 3.603 | 9 | 70 | palate development |
GO:0021545 | 0.0095 | 4.4204 | 1.3383 | 5 | 26 | cranial nerve development |
GO:0031644 | 0.0095 | 4.4204 | 1.3383 | 5 | 26 | regulation of neurological system process |
GO:0010656 | 0.0097 | 5.7062 | 0.875 | 4 | 17 | negative regulation of muscle cell apoptotic process |
GO:0021871 | 0.0097 | 5.7062 | 0.875 | 4 | 17 | forebrain regionalization |
GO:0090189 | 0.0097 | 5.7062 | 0.875 | 4 | 17 | regulation of branching involved in ureteric bud morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048520 | 0 | 6.819 | 2.2415 | 12 | 52 | positive regulation of behavior |
GO:0032103 | 0 | 4.6285 | 4.0951 | 16 | 95 | positive regulation of response to external stimulus |
GO:0050920 | 0 | 5.477 | 2.8881 | 13 | 67 | regulation of chemotaxis |
GO:1901342 | 1e-04 | 3.6719 | 4.6554 | 15 | 108 | regulation of vasculature development |
GO:0007598 | 1e-04 | Inf | 0.1293 | 3 | 3 | blood coagulation, extrinsic pathway |
GO:0032571 | 1e-04 | Inf | 0.1293 | 3 | 3 | response to vitamin K |
GO:0050927 | 1e-04 | 10.3739 | 0.819 | 6 | 19 | positive regulation of positive chemotaxis |
GO:0017187 | 1e-04 | 29.8618 | 0.3017 | 4 | 7 | peptidyl-glutamic acid carboxylation |
GO:0040017 | 2e-04 | 2.6569 | 8.2764 | 20 | 192 | positive regulation of locomotion |
GO:0060326 | 3e-04 | 3.4683 | 4.2244 | 13 | 98 | cell chemotaxis |
GO:0009611 | 4e-04 | 1.8619 | 24.398 | 42 | 566 | response to wounding |
GO:0002690 | 4e-04 | 7.4884 | 1.0345 | 6 | 24 | positive regulation of leukocyte chemotaxis |
GO:0051272 | 5e-04 | 2.5635 | 8.1039 | 19 | 188 | positive regulation of cellular component movement |
GO:0045766 | 5e-04 | 4.4133 | 2.3708 | 9 | 55 | positive regulation of angiogenesis |
GO:0051897 | 8e-04 | 4.6197 | 2.026 | 8 | 47 | positive regulation of protein kinase B signaling |
GO:0010595 | 9e-04 | 5.2476 | 1.5949 | 7 | 37 | positive regulation of endothelial cell migration |
GO:2000352 | 9e-04 | 12.7926 | 0.4742 | 4 | 11 | negative regulation of endothelial cell apoptotic process |
GO:0002685 | 0.001 | 4.4135 | 2.1032 | 8 | 49 | regulation of leukocyte migration |
GO:0050878 | 0.0011 | 1.9363 | 17.1993 | 31 | 399 | regulation of body fluid levels |
GO:0051674 | 0.0013 | 1.6737 | 30.7777 | 48 | 714 | localization of cell |
GO:0042534 | 0.0014 | 22.3448 | 0.2586 | 3 | 6 | regulation of tumor necrosis factor biosynthetic process |
GO:2000145 | 0.0015 | 1.9623 | 15.3026 | 28 | 355 | regulation of cell motility |
GO:0030335 | 0.0016 | 2.4135 | 7.6298 | 17 | 177 | positive regulation of cell migration |
GO:0051894 | 0.0018 | 9.9478 | 0.5604 | 4 | 13 | positive regulation of focal adhesion assembly |
GO:0007207 | 0.0019 | Inf | 0.0862 | 2 | 2 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0010477 | 0.0019 | Inf | 0.0862 | 2 | 2 | response to sulfur dioxide |
GO:0010641 | 0.0019 | Inf | 0.0862 | 2 | 2 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0010751 | 0.0019 | Inf | 0.0862 | 2 | 2 | negative regulation of nitric oxide mediated signal transduction |
GO:1901492 | 0.0019 | Inf | 0.0862 | 2 | 2 | positive regulation of lymphangiogenesis |
GO:2000360 | 0.0019 | Inf | 0.0862 | 2 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:0090109 | 0.0021 | 6.5929 | 0.9483 | 5 | 22 | regulation of cell-substrate junction assembly |
GO:0060192 | 0.0024 | 16.7569 | 0.3017 | 3 | 7 | negative regulation of lipase activity |
GO:0045744 | 0.0025 | 4.2517 | 1.8967 | 7 | 44 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:1903391 | 0.0026 | 6.2259 | 0.9914 | 5 | 23 | regulation of adherens junction organization |
GO:0015711 | 0.0028 | 2.2218 | 8.7074 | 18 | 202 | organic anion transport |
GO:1902476 | 0.0029 | 4.1394 | 1.9398 | 7 | 45 | chloride transmembrane transport |
GO:0010632 | 0.0029 | 3.0886 | 3.5778 | 10 | 83 | regulation of epithelial cell migration |
GO:0007596 | 0.0032 | 1.9211 | 13.8801 | 25 | 322 | blood coagulation |
GO:0010811 | 0.0036 | 3.5283 | 2.5433 | 8 | 59 | positive regulation of cell-substrate adhesion |
GO:0018108 | 0.0036 | 2.1619 | 8.9229 | 18 | 207 | peptidyl-tyrosine phosphorylation |
GO:0043534 | 0.0037 | 3.9316 | 2.026 | 7 | 47 | blood vessel endothelial cell migration |
GO:0051187 | 0.0038 | 13.4041 | 0.3448 | 3 | 8 | cofactor catabolic process |
GO:0071305 | 0.0038 | 13.4041 | 0.3448 | 3 | 8 | cellular response to vitamin D |
GO:0090132 | 0.0039 | 2.6309 | 4.9572 | 12 | 115 | epithelium migration |
GO:0022603 | 0.004 | 1.7103 | 21.1219 | 34 | 490 | regulation of anatomical structure morphogenesis |
GO:0044070 | 0.0042 | 3.8353 | 2.0691 | 7 | 48 | regulation of anion transport |
GO:0009988 | 0.0045 | 5.3349 | 1.1208 | 5 | 26 | cell-cell recognition |
GO:0032319 | 0.0048 | 2.5557 | 5.0865 | 12 | 118 | regulation of Rho GTPase activity |
GO:0098656 | 0.0054 | 3.0067 | 3.2903 | 9 | 77 | anion transmembrane transport |
GO:0006811 | 0.0054 | 1.517 | 36.4246 | 52 | 845 | ion transport |
GO:0009812 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | flavonoid metabolic process |
GO:0046813 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | receptor-mediated virion attachment to host cell |
GO:0060638 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | mesenchymal-epithelial cell signaling |
GO:0061045 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | negative regulation of wound healing |
GO:0071675 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | regulation of mononuclear cell migration |
GO:0090237 | 0.0054 | 44.5963 | 0.1293 | 2 | 3 | regulation of arachidonic acid secretion |
GO:0006670 | 0.0055 | 11.169 | 0.388 | 3 | 9 | sphingosine metabolic process |
GO:0031581 | 0.0055 | 11.169 | 0.388 | 3 | 9 | hemidesmosome assembly |
GO:0060712 | 0.0055 | 11.169 | 0.388 | 3 | 9 | spongiotrophoblast layer development |
GO:0055085 | 0.0056 | 1.539 | 33.1054 | 48 | 768 | transmembrane transport |
GO:0051707 | 0.0059 | 1.8198 | 14.5698 | 25 | 338 | response to other organism |
GO:0007045 | 0.006 | 4.0783 | 1.6811 | 6 | 39 | cell-substrate adherens junction assembly |
GO:0003333 | 0.0063 | 4.87 | 1.207 | 5 | 28 | amino acid transmembrane transport |
GO:0006953 | 0.0064 | 6.3917 | 0.7759 | 4 | 18 | acute-phase response |
GO:0048514 | 0.007 | 1.842 | 13.2335 | 23 | 307 | blood vessel morphogenesis |
GO:0015804 | 0.0079 | 5.965 | 0.819 | 4 | 19 | neutral amino acid transport |
GO:0071621 | 0.0085 | 4.4794 | 1.2932 | 5 | 30 | granulocyte chemotaxis |
GO:0001894 | 0.0088 | 2.5878 | 4.1813 | 10 | 97 | tissue homeostasis |
GO:0006954 | 0.0089 | 1.8549 | 11.9835 | 21 | 278 | inflammatory response |
GO:0001945 | 0.0095 | 5.5916 | 0.8621 | 4 | 20 | lymph vessel development |
GO:0001960 | 0.0095 | 5.5916 | 0.8621 | 4 | 20 | negative regulation of cytokine-mediated signaling pathway |
GO:0031670 | 0.0095 | 5.5916 | 0.8621 | 4 | 20 | cellular response to nutrient |
GO:0023057 | 0.0096 | 1.5348 | 28.1913 | 41 | 654 | negative regulation of signaling |
GO:0097529 | 0.0098 | 3.2065 | 2.4139 | 7 | 56 | myeloid leukocyte migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.3957 | 226.8507 | 347 | 3874 | multicellular organismal process |
GO:0007275 | 0 | 2.1988 | 80.6635 | 141 | 1576 | multicellular organismal development |
GO:0048699 | 0 | 2.826 | 27.613 | 66 | 495 | generation of neurons |
GO:0043583 | 0 | 4.6149 | 9.252 | 34 | 158 | ear development |
GO:0003008 | 0 | 2.5029 | 36.4828 | 78 | 638 | system process |
GO:0000904 | 0 | 2.6093 | 29.9108 | 67 | 516 | cell morphogenesis involved in differentiation |
GO:0007155 | 0 | 2.4135 | 37.0082 | 77 | 632 | cell adhesion |
GO:0007399 | 0 | 2.3634 | 39.5133 | 80 | 732 | nervous system development |
GO:0007389 | 0 | 3.1267 | 15.7284 | 42 | 274 | pattern specification process |
GO:0007268 | 0 | 2.8467 | 17.4375 | 43 | 303 | synaptic transmission |
GO:0042472 | 0 | 5.2261 | 4.626 | 19 | 79 | inner ear morphogenesis |
GO:0007166 | 0 | 1.6974 | 106.1057 | 156 | 1812 | cell surface receptor signaling pathway |
GO:0007218 | 0 | 5.8321 | 3.8062 | 17 | 65 | neuropeptide signaling pathway |
GO:0072359 | 0 | 2.1793 | 34.1974 | 66 | 584 | circulatory system development |
GO:0031175 | 0 | 2.1704 | 34.3145 | 66 | 586 | neuron projection development |
GO:0007600 | 0 | 2.7635 | 16.1465 | 39 | 277 | sensory perception |
GO:0021527 | 0 | 21.7149 | 0.8198 | 8 | 14 | spinal cord association neuron differentiation |
GO:0048562 | 0 | 3.6835 | 8.0409 | 25 | 140 | embryonic organ morphogenesis |
GO:0007517 | 0 | 2.8973 | 13.8781 | 35 | 237 | muscle organ development |
GO:0043010 | 0 | 3.4076 | 9.2806 | 27 | 160 | camera-type eye development |
GO:0048729 | 0 | 2.4939 | 19.9534 | 44 | 344 | tissue morphogenesis |
GO:0045944 | 0 | 2.0732 | 35.6614 | 66 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048565 | 0 | 4.4321 | 5.2477 | 19 | 90 | digestive tract development |
GO:0021514 | 0 | 16.2828 | 0.9369 | 8 | 16 | ventral spinal cord interneuron differentiation |
GO:0032989 | 0 | 1.8752 | 50.0664 | 84 | 855 | cellular component morphogenesis |
GO:0048592 | 0 | 4.0229 | 5.9728 | 20 | 102 | eye morphogenesis |
GO:0007411 | 0 | 2.5988 | 16.1032 | 37 | 275 | axon guidance |
GO:0060042 | 0 | 11.3541 | 1.2811 | 9 | 22 | retina morphogenesis in camera-type eye |
GO:0021513 | 0 | 10.4788 | 1.3468 | 9 | 23 | spinal cord dorsal/ventral patterning |
GO:0060485 | 0 | 3.2537 | 8.5494 | 24 | 146 | mesenchyme development |
GO:0010628 | 0 | 1.7878 | 53.4042 | 86 | 912 | positive regulation of gene expression |
GO:0060429 | 0 | 2.0268 | 31.7552 | 58 | 558 | epithelium development |
GO:0032502 | 0 | 1.7184 | 72.6522 | 108 | 1495 | developmental process |
GO:0030154 | 0 | 1.7474 | 61.2226 | 95 | 1145 | cell differentiation |
GO:0060581 | 0 | 16.2568 | 0.8198 | 7 | 14 | cell fate commitment involved in pattern specification |
GO:0045666 | 0 | 4.7318 | 3.9233 | 15 | 67 | positive regulation of neuron differentiation |
GO:0031018 | 0 | 7.8064 | 1.8074 | 10 | 31 | endocrine pancreas development |
GO:0048663 | 0 | 7.5872 | 1.8346 | 10 | 32 | neuron fate commitment |
GO:0009790 | 0 | 2.648 | 13.1953 | 31 | 236 | embryo development |
GO:0072163 | 0 | 4.3059 | 4.5089 | 16 | 77 | mesonephric epithelium development |
GO:0007267 | 0 | 3.3451 | 7.2486 | 21 | 134 | cell-cell signaling |
GO:0009887 | 0 | 2.4947 | 14.7858 | 33 | 271 | organ morphogenesis |
GO:0048858 | 0 | 1.9313 | 34.256 | 60 | 585 | cell projection morphogenesis |
GO:0009792 | 0 | 2.0593 | 26.8192 | 50 | 458 | embryo development ending in birth or egg hatching |
GO:0007423 | 0 | 2.6879 | 11.7214 | 28 | 209 | sensory organ development |
GO:0021879 | 0 | 5.9872 | 2.4008 | 11 | 41 | forebrain neuron differentiation |
GO:0007548 | 0 | 2.7927 | 10.5403 | 26 | 180 | sex differentiation |
GO:0006935 | 0 | 2.1167 | 23.4814 | 45 | 401 | chemotaxis |
GO:1902680 | 0 | 1.7386 | 51.2961 | 81 | 876 | positive regulation of RNA biosynthetic process |
GO:0060537 | 0 | 2.544 | 12.7541 | 29 | 219 | muscle tissue development |
GO:0006355 | 0 | 1.4671 | 136.6726 | 178 | 2334 | regulation of transcription, DNA-templated |
GO:0009891 | 0 | 1.6569 | 60.3725 | 91 | 1031 | positive regulation of biosynthetic process |
GO:0001708 | 0 | 8.3856 | 1.3663 | 8 | 24 | cell fate specification |
GO:0051094 | 0 | 1.89 | 32.4696 | 56 | 561 | positive regulation of developmental process |
GO:0045935 | 0 | 1.657 | 58.2644 | 88 | 995 | positive regulation of nucleobase-containing compound metabolic process |
GO:2000026 | 0 | 1.7741 | 41.3648 | 67 | 729 | regulation of multicellular organismal development |
GO:0071805 | 0 | 3.4441 | 5.7386 | 17 | 98 | potassium ion transmembrane transport |
GO:0021559 | 1e-04 | 64.7377 | 0.2928 | 4 | 5 | trigeminal nerve development |
GO:0060527 | 1e-04 | 64.7377 | 0.2928 | 4 | 5 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0040007 | 1e-04 | 2.1767 | 18.2095 | 36 | 317 | growth |
GO:0021915 | 1e-04 | 2.9628 | 7.671 | 20 | 131 | neural tube development |
GO:0006813 | 1e-04 | 3.0606 | 7.0854 | 19 | 121 | potassium ion transport |
GO:0051252 | 1e-04 | 1.434 | 141.4743 | 181 | 2416 | regulation of RNA metabolic process |
GO:0001822 | 1e-04 | 2.84 | 8.3484 | 21 | 144 | kidney development |
GO:0061458 | 1e-04 | 2.2041 | 16.9816 | 34 | 290 | reproductive system development |
GO:0051093 | 1e-04 | 1.9422 | 25.8587 | 46 | 443 | negative regulation of developmental process |
GO:0007269 | 1e-04 | 3.5596 | 4.9188 | 15 | 84 | neurotransmitter secretion |
GO:0001944 | 1e-04 | 2.0143 | 22.2517 | 41 | 380 | vasculature development |
GO:0031326 | 1e-04 | 1.4112 | 156.9919 | 197 | 2681 | regulation of cellular biosynthetic process |
GO:0048736 | 1e-04 | 2.9439 | 7.3197 | 19 | 125 | appendage development |
GO:0009581 | 1e-04 | 3.4586 | 5.0359 | 15 | 86 | detection of external stimulus |
GO:0050767 | 1e-04 | 2.2381 | 15.2389 | 31 | 264 | regulation of neurogenesis |
GO:0035116 | 1e-04 | 8.1224 | 1.2297 | 7 | 21 | embryonic hindlimb morphogenesis |
GO:0051216 | 1e-04 | 2.8887 | 7.4368 | 19 | 127 | cartilage development |
GO:0098655 | 1e-04 | 1.9983 | 21.8418 | 40 | 373 | cation transmembrane transport |
GO:0065007 | 1e-04 | 1.4498 | 243.1208 | 280 | 4567 | biological regulation |
GO:0032879 | 2e-04 | 1.5366 | 73.1965 | 103 | 1250 | regulation of localization |
GO:0021796 | 2e-04 | 32.3655 | 0.3513 | 4 | 6 | cerebral cortex regionalization |
GO:2000543 | 2e-04 | 32.3655 | 0.3513 | 4 | 6 | positive regulation of gastrulation |
GO:0021517 | 2e-04 | 7.6783 | 1.2729 | 7 | 22 | ventral spinal cord development |
GO:0007507 | 2e-04 | 2.3779 | 12.0789 | 26 | 209 | heart development |
GO:0035108 | 2e-04 | 3.0288 | 6.3827 | 17 | 109 | limb morphogenesis |
GO:0023019 | 2e-04 | 9.7345 | 0.9369 | 6 | 16 | signal transduction involved in regulation of gene expression |
GO:0035239 | 2e-04 | 2.2019 | 14.9447 | 30 | 256 | tube morphogenesis |
GO:0065008 | 2e-04 | 1.4661 | 97.603 | 130 | 1709 | regulation of biological quality |
GO:0048704 | 2e-04 | 3.6617 | 4.1576 | 13 | 71 | embryonic skeletal system morphogenesis |
GO:0048665 | 2e-04 | 13.702 | 0.6354 | 5 | 11 | neuron fate specification |
GO:0042391 | 2e-04 | 2.255 | 13.6438 | 28 | 233 | regulation of membrane potential |
GO:0035115 | 2e-04 | 7.1057 | 1.3468 | 7 | 23 | embryonic forelimb morphogenesis |
GO:0048333 | 2e-04 | 7.1057 | 1.3468 | 7 | 23 | mesodermal cell differentiation |
GO:0046903 | 3e-04 | 2.1969 | 14.466 | 29 | 252 | secretion |
GO:0048557 | 3e-04 | 8.8486 | 0.9955 | 6 | 17 | embryonic digestive tract morphogenesis |
GO:0009888 | 3e-04 | 2.552 | 9.1093 | 21 | 174 | tissue development |
GO:0044708 | 3e-04 | 2.1269 | 15.4006 | 30 | 263 | single-organism behavior |
GO:0021521 | 3e-04 | 21.6457 | 0.4086 | 4 | 7 | ventral spinal cord interneuron specification |
GO:0001714 | 4e-04 | 21.5747 | 0.4099 | 4 | 7 | endodermal cell fate specification |
GO:0072498 | 4e-04 | 11.5726 | 0.7027 | 5 | 12 | embryonic skeletal joint development |
GO:0022414 | 4e-04 | 3.602 | 3.8697 | 12 | 69 | reproductive process |
GO:0051171 | 4e-04 | 1.3542 | 175.8474 | 213 | 3003 | regulation of nitrogen compound metabolic process |
GO:0010556 | 4e-04 | 1.3685 | 152.3659 | 188 | 2602 | regulation of macromolecule biosynthetic process |
GO:0072009 | 5e-04 | 4.1758 | 2.8693 | 10 | 49 | nephron epithelium development |
GO:0040011 | 5e-04 | 2.2112 | 12.8665 | 26 | 228 | locomotion |
GO:0001525 | 5e-04 | 2.1376 | 14.288 | 28 | 244 | angiogenesis |
GO:0044057 | 5e-04 | 2.1706 | 13.5853 | 27 | 232 | regulation of system process |
GO:0060079 | 5e-04 | 5.2012 | 1.9324 | 8 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0060675 | 5e-04 | 4.0709 | 2.9279 | 10 | 50 | ureteric bud morphogenesis |
GO:0003407 | 5e-04 | 7.5306 | 1.1064 | 6 | 19 | neural retina development |
GO:0007156 | 5e-04 | 3.2649 | 4.5675 | 13 | 78 | homophilic cell adhesion |
GO:0034765 | 5e-04 | 2.2687 | 11.5943 | 24 | 198 | regulation of ion transmembrane transport |
GO:0009582 | 5e-04 | 3.0908 | 5.153 | 14 | 88 | detection of abiotic stimulus |
GO:0061217 | 6e-04 | 7.4857 | 1.1126 | 6 | 19 | regulation of mesonephros development |
GO:0034103 | 6e-04 | 5.0007 | 1.9909 | 8 | 34 | regulation of tissue remodeling |
GO:0034654 | 7e-04 | 1.3491 | 159.2171 | 194 | 2719 | nucleobase-containing compound biosynthetic process |
GO:0009187 | 7e-04 | 2.8847 | 5.8557 | 15 | 100 | cyclic nucleotide metabolic process |
GO:0048793 | 7e-04 | 16.1794 | 0.4685 | 4 | 8 | pronephros development |
GO:0007498 | 7e-04 | 3.0089 | 5.2702 | 14 | 90 | mesoderm development |
GO:0001755 | 7e-04 | 5.6821 | 1.581 | 7 | 27 | neural crest cell migration |
GO:0021696 | 7e-04 | 5.6821 | 1.581 | 7 | 27 | cerebellar cortex morphogenesis |
GO:0045880 | 8e-04 | 6.9503 | 1.1711 | 6 | 20 | positive regulation of smoothened signaling pathway |
GO:0007412 | 8e-04 | 48.4713 | 0.2342 | 3 | 4 | axon target recognition |
GO:0015671 | 8e-04 | 48.4713 | 0.2342 | 3 | 4 | oxygen transport |
GO:0015816 | 8e-04 | 48.4713 | 0.2342 | 3 | 4 | glycine transport |
GO:0072172 | 8e-04 | 48.4713 | 0.2342 | 3 | 4 | mesonephric tubule formation |
GO:0048666 | 8e-04 | 3.0968 | 4.7513 | 13 | 86 | neuron development |
GO:0007417 | 9e-04 | 1.7625 | 26.2282 | 43 | 468 | central nervous system development |
GO:0009952 | 9e-04 | 2.9072 | 5.4177 | 14 | 94 | anterior/posterior pattern specification |
GO:0023052 | 9e-04 | 1.3456 | 160.1071 | 193 | 2916 | signaling |
GO:0021983 | 0.001 | 6.5251 | 1.2229 | 6 | 21 | pituitary gland development |
GO:0003401 | 0.001 | 6.4862 | 1.2297 | 6 | 21 | axis elongation |
GO:0021533 | 0.001 | 6.4862 | 1.2297 | 6 | 21 | cell differentiation in hindbrain |
GO:0060441 | 0.001 | 6.4862 | 1.2297 | 6 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0045595 | 0.0011 | 1.5309 | 51.1744 | 73 | 884 | regulation of cell differentiation |
GO:0035113 | 0.0011 | 2.8572 | 5.5044 | 14 | 94 | embryonic appendage morphogenesis |
GO:0007519 | 0.0011 | 2.6158 | 6.7926 | 16 | 116 | skeletal muscle tissue development |
GO:0030901 | 0.0011 | 5.1645 | 1.6982 | 7 | 29 | midbrain development |
GO:0060525 | 0.0012 | 12.9421 | 0.527 | 4 | 9 | prostate glandular acinus development |
GO:0072176 | 0.0012 | 12.9421 | 0.527 | 4 | 9 | nephric duct development |
GO:0045165 | 0.0012 | 3.3341 | 3.7699 | 11 | 68 | cell fate commitment |
GO:0050679 | 0.0012 | 2.8217 | 5.5629 | 14 | 95 | positive regulation of epithelial cell proliferation |
GO:0030900 | 0.0012 | 2.6974 | 6.1896 | 15 | 108 | forebrain development |
GO:0030539 | 0.0012 | 8.0983 | 0.8784 | 5 | 15 | male genitalia development |
GO:0021761 | 0.0014 | 3.5377 | 3.2792 | 10 | 56 | limbic system development |
GO:0080090 | 0.0014 | 1.2991 | 219.004 | 254 | 3740 | regulation of primary metabolic process |
GO:0016337 | 0.0014 | 2.0967 | 12.4141 | 24 | 212 | single organismal cell-cell adhesion |
GO:0050794 | 0.0016 | 1.3195 | 281.2118 | 314 | 5064 | regulation of cellular process |
GO:0022612 | 0.0016 | 3.0086 | 4.5089 | 12 | 77 | gland morphogenesis |
GO:0045995 | 0.0016 | 3.0086 | 4.5089 | 12 | 77 | regulation of embryonic development |
GO:0060348 | 0.0016 | 2.72 | 5.7386 | 14 | 98 | bone development |
GO:0050974 | 0.0017 | 7.3613 | 0.9369 | 5 | 16 | detection of mechanical stimulus involved in sensory perception |
GO:0051240 | 0.0018 | 1.7799 | 21.6667 | 36 | 372 | positive regulation of multicellular organismal process |
GO:0021953 | 0.0018 | 3.1403 | 3.9721 | 11 | 70 | central nervous system neuron differentiation |
GO:0007631 | 0.0018 | 3.6833 | 2.8508 | 9 | 49 | feeding behavior |
GO:0021520 | 0.0018 | 10.8195 | 0.5838 | 4 | 10 | spinal cord motor neuron cell fate specification |
GO:0048878 | 0.0018 | 1.6691 | 28.8102 | 45 | 492 | chemical homeostasis |
GO:0001826 | 0.0018 | 24.2331 | 0.2928 | 3 | 5 | inner cell mass cell differentiation |
GO:0043374 | 0.0018 | 24.2331 | 0.2928 | 3 | 5 | CD8-positive, alpha-beta T cell differentiation |
GO:0050957 | 0.0018 | 24.2331 | 0.2928 | 3 | 5 | equilibrioception |
GO:0060687 | 0.0018 | 24.2331 | 0.2928 | 3 | 5 | regulation of branching involved in prostate gland morphogenesis |
GO:2000675 | 0.0018 | 24.2331 | 0.2928 | 3 | 5 | negative regulation of type B pancreatic cell apoptotic process |
GO:0006029 | 0.0018 | 3.1422 | 3.9819 | 11 | 68 | proteoglycan metabolic process |
GO:0007263 | 0.0018 | 10.784 | 0.5856 | 4 | 10 | nitric oxide mediated signal transduction |
GO:0021794 | 0.0018 | 10.784 | 0.5856 | 4 | 10 | thalamus development |
GO:0042136 | 0.0018 | 10.784 | 0.5856 | 4 | 10 | neurotransmitter biosynthetic process |
GO:0061318 | 0.0018 | 10.784 | 0.5856 | 4 | 10 | renal filtration cell differentiation |
GO:0097305 | 0.0019 | 2.1645 | 10.5403 | 21 | 180 | response to alcohol |
GO:0001704 | 0.0021 | 2.7526 | 5.2702 | 13 | 90 | formation of primary germ layer |
GO:0007605 | 0.0021 | 2.7526 | 5.2702 | 13 | 90 | sensory perception of sound |
GO:0007601 | 0.0022 | 2.6254 | 5.9143 | 14 | 101 | visual perception |
GO:0098660 | 0.0022 | 1.7715 | 21.1392 | 35 | 361 | inorganic ion transmembrane transport |
GO:0002088 | 0.0023 | 3.937 | 2.4008 | 8 | 41 | lens development in camera-type eye |
GO:0060415 | 0.0023 | 3.937 | 2.4008 | 8 | 41 | muscle tissue morphogenesis |
GO:0044699 | 0.0023 | 1.7881 | 30.7567 | 45 | 698 | single-organism process |
GO:0021871 | 0.0023 | 6.7472 | 0.9955 | 5 | 17 | forebrain regionalization |
GO:0030325 | 0.0023 | 6.7472 | 0.9955 | 5 | 17 | adrenal gland development |
GO:0030111 | 0.0023 | 2.2209 | 9.3106 | 19 | 159 | regulation of Wnt signaling pathway |
GO:0048638 | 0.0024 | 2.7171 | 5.3287 | 13 | 91 | regulation of developmental growth |
GO:0008015 | 0.0024 | 1.9733 | 13.6438 | 25 | 233 | blood circulation |
GO:0031214 | 0.0024 | 4.405 | 1.9174 | 7 | 33 | biomineral tissue development |
GO:0009605 | 0.0025 | 1.4483 | 59.7589 | 81 | 1042 | response to external stimulus |
GO:0009914 | 0.0025 | 2.1105 | 10.7745 | 21 | 184 | hormone transport |
GO:0030198 | 0.0025 | 1.9981 | 12.9444 | 24 | 222 | extracellular matrix organization |
GO:0015833 | 0.0025 | 2.1542 | 10.0718 | 20 | 172 | peptide transport |
GO:0060350 | 0.0026 | 4.3681 | 1.9324 | 7 | 33 | endochondral bone morphogenesis |
GO:0048870 | 0.0026 | 1.5283 | 41.8099 | 60 | 714 | cell motility |
GO:0046887 | 0.0026 | 3.1892 | 3.572 | 10 | 61 | positive regulation of hormone secretion |
GO:0001655 | 0.0027 | 5.0649 | 1.4657 | 6 | 26 | urogenital system development |
GO:0021903 | 0.0028 | 9.2424 | 0.6441 | 4 | 11 | rostrocaudal neural tube patterning |
GO:0071697 | 0.0028 | 9.2424 | 0.6441 | 4 | 11 | ectodermal placode morphogenesis |
GO:0072311 | 0.0028 | 9.2424 | 0.6441 | 4 | 11 | glomerular epithelial cell differentiation |
GO:0044763 | 0.0028 | 1.3433 | 335.2676 | 363 | 6131 | single-organism cellular process |
GO:0021515 | 0.0028 | 6.3819 | 1.0302 | 5 | 18 | cell differentiation in spinal cord |
GO:0048514 | 0.0028 | 3.1493 | 3.602 | 10 | 63 | blood vessel morphogenesis |
GO:0048754 | 0.0029 | 2.5311 | 6.0991 | 14 | 105 | branching morphogenesis of an epithelial tube |
GO:0071705 | 0.0029 | 1.6733 | 25.4724 | 40 | 435 | nitrogen compound transport |
GO:0045937 | 0.003 | 1.587 | 32.8506 | 49 | 561 | positive regulation of phosphate metabolic process |
GO:0060384 | 0.0031 | 6.2275 | 1.054 | 5 | 18 | innervation |
GO:0072273 | 0.0031 | 6.2275 | 1.054 | 5 | 18 | metanephric nephron morphogenesis |
GO:0007189 | 0.0031 | 4.2059 | 1.9909 | 7 | 34 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0009953 | 0.0031 | 3.1116 | 3.6415 | 10 | 63 | dorsal/ventral pattern formation |
GO:0009653 | 0.0031 | 2.3364 | 7.4457 | 16 | 149 | anatomical structure morphogenesis |
GO:0009880 | 0.0031 | 3.7113 | 2.518 | 8 | 43 | embryonic pattern specification |
GO:0060560 | 0.0032 | 2.738 | 4.8793 | 12 | 84 | developmental growth involved in morphogenesis |
GO:0090090 | 0.0033 | 2.8873 | 4.2747 | 11 | 73 | negative regulation of canonical Wnt signaling pathway |
GO:0048585 | 0.0033 | 1.5109 | 42.2198 | 60 | 721 | negative regulation of response to stimulus |
GO:2000027 | 0.0033 | 2.4938 | 6.1788 | 14 | 106 | regulation of organ morphogenesis |
GO:0001756 | 0.0033 | 3.3237 | 3.1035 | 9 | 53 | somitogenesis |
GO:0030802 | 0.0034 | 3.0682 | 3.6891 | 10 | 63 | regulation of cyclic nucleotide biosynthetic process |
GO:0051130 | 0.0034 | 1.6177 | 28.9273 | 44 | 494 | positive regulation of cellular component organization |
GO:0021516 | 0.0034 | 16.3647 | 0.3471 | 3 | 6 | dorsal spinal cord development |
GO:0014034 | 0.0034 | Inf | 0.1171 | 2 | 2 | neural crest cell fate commitment |
GO:0032725 | 0.0034 | Inf | 0.1171 | 2 | 2 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0035564 | 0.0034 | Inf | 0.1171 | 2 | 2 | regulation of kidney size |
GO:0036023 | 0.0034 | Inf | 0.1171 | 2 | 2 | embryonic skeletal limb joint morphogenesis |
GO:0038162 | 0.0034 | Inf | 0.1171 | 2 | 2 | erythropoietin-mediated signaling pathway |
GO:0042706 | 0.0034 | Inf | 0.1171 | 2 | 2 | eye photoreceptor cell fate commitment |
GO:0048880 | 0.0034 | Inf | 0.1171 | 2 | 2 | sensory system development |
GO:0072166 | 0.0034 | Inf | 0.1171 | 2 | 2 | posterior mesonephric tubule development |
GO:0090185 | 0.0034 | Inf | 0.1171 | 2 | 2 | negative regulation of kidney development |
GO:0019934 | 0.0035 | 16.1537 | 0.3513 | 3 | 6 | cGMP-mediated signaling |
GO:0071379 | 0.0035 | 16.1537 | 0.3513 | 3 | 6 | cellular response to prostaglandin stimulus |
GO:0072001 | 0.0035 | 8.3692 | 0.6805 | 4 | 12 | renal system development |
GO:0001763 | 0.0035 | 2.3835 | 6.8866 | 15 | 119 | morphogenesis of a branching structure |
GO:0002793 | 0.0036 | 3.6078 | 2.5765 | 8 | 44 | positive regulation of peptide secretion |
GO:0021575 | 0.0036 | 4.0553 | 2.0495 | 7 | 35 | hindbrain morphogenesis |
GO:0006171 | 0.0038 | 3.0111 | 3.7477 | 10 | 64 | cAMP biosynthetic process |
GO:0007270 | 0.0038 | 2.552 | 5.6215 | 13 | 96 | neuron-neuron synaptic transmission |
GO:0001657 | 0.0038 | 4.6904 | 1.5622 | 6 | 27 | ureteric bud development |
GO:0021537 | 0.0038 | 2.2214 | 8.3151 | 17 | 142 | telencephalon development |
GO:0035883 | 0.0039 | 8.1241 | 0.6996 | 4 | 12 | enteroendocrine cell differentiation |
GO:0006700 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | C21-steroid hormone biosynthetic process |
GO:0010842 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | retina layer formation |
GO:0021542 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | dentate gyrus development |
GO:0021984 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | adenohypophysis development |
GO:0070307 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | lens fiber cell development |
GO:0072224 | 0.0039 | 8.0863 | 0.7027 | 4 | 12 | metanephric glomerulus development |
GO:1902692 | 0.004 | 5.7821 | 1.1126 | 5 | 19 | regulation of neuroblast proliferation |
GO:0001501 | 0.004 | 2.2735 | 7.6556 | 16 | 134 | skeletal system development |
GO:0043069 | 0.0041 | 1.6176 | 27.5805 | 42 | 471 | negative regulation of programmed cell death |
GO:0014031 | 0.0041 | 3.9581 | 2.0868 | 7 | 36 | mesenchymal cell development |
GO:0048738 | 0.0041 | 2.4281 | 6.3242 | 14 | 108 | cardiac muscle tissue development |
GO:0006811 | 0.0042 | 1.6139 | 27.6571 | 42 | 484 | ion transport |
GO:1900371 | 0.0042 | 2.956 | 3.8062 | 10 | 65 | regulation of purine nucleotide biosynthetic process |
GO:0016331 | 0.0043 | 2.3303 | 7.0269 | 15 | 120 | morphogenesis of embryonic epithelium |
GO:0048645 | 0.0043 | 3.915 | 2.1081 | 7 | 36 | organ formation |
GO:0050769 | 0.0044 | 2.4023 | 6.3827 | 14 | 109 | positive regulation of neurogenesis |
GO:0006928 | 0.0045 | 1.715 | 20.5007 | 33 | 362 | cellular component movement |
GO:1901137 | 0.0047 | 1.5929 | 28.6345 | 43 | 489 | carbohydrate derivative biosynthetic process |
GO:0008344 | 0.0048 | 2.9029 | 3.8648 | 10 | 66 | adult locomotory behavior |
GO:0001709 | 0.0048 | 4.4338 | 1.6346 | 6 | 28 | cell fate determination |
GO:0090102 | 0.0049 | 4.4192 | 1.6396 | 6 | 28 | cochlea development |
GO:0051050 | 0.0049 | 1.6612 | 23.013 | 36 | 393 | positive regulation of transport |
GO:0042755 | 0.005 | 5.396 | 1.1711 | 5 | 20 | eating behavior |
GO:0060740 | 0.005 | 5.396 | 1.1711 | 5 | 20 | prostate gland epithelium morphogenesis |
GO:0072207 | 0.005 | 5.396 | 1.1711 | 5 | 20 | metanephric epithelium development |
GO:0016049 | 0.0052 | 1.8009 | 15.9861 | 27 | 273 | cell growth |
GO:0001764 | 0.0054 | 2.4337 | 5.8557 | 13 | 100 | neuron migration |
GO:0003323 | 0.0054 | 7.1871 | 0.7612 | 4 | 13 | type B pancreatic cell development |
GO:0048745 | 0.0054 | 7.1871 | 0.7612 | 4 | 13 | smooth muscle tissue development |
GO:0071599 | 0.0054 | 7.1871 | 0.7612 | 4 | 13 | otic vesicle development |
GO:0072077 | 0.0054 | 7.1871 | 0.7612 | 4 | 13 | renal vesicle morphogenesis |
GO:2000036 | 0.0054 | 7.1871 | 0.7612 | 4 | 13 | regulation of stem cell maintenance |
GO:0045665 | 0.0055 | 3.3292 | 2.7522 | 8 | 47 | negative regulation of neuron differentiation |
GO:0002064 | 0.0058 | 2.4095 | 5.9022 | 13 | 102 | epithelial cell development |
GO:0031016 | 0.0058 | 5.1587 | 1.2073 | 5 | 21 | pancreas development |
GO:0030073 | 0.0058 | 2.1752 | 7.9638 | 16 | 136 | insulin secretion |
GO:0002862 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | negative regulation of inflammatory response to antigenic stimulus |
GO:0003310 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | pancreatic A cell differentiation |
GO:0033689 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | negative regulation of osteoblast proliferation |
GO:0042523 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | positive regulation of tyrosine phosphorylation of Stat5 protein |
GO:0046851 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | negative regulation of bone remodeling |
GO:0072015 | 0.0059 | 12.114 | 0.4099 | 3 | 7 | glomerular visceral epithelial cell development |
GO:0060563 | 0.0059 | 4.2266 | 1.6982 | 6 | 29 | neuroepithelial cell differentiation |
GO:0007613 | 0.0059 | 2.8022 | 3.9819 | 10 | 68 | memory |
GO:0003206 | 0.0061 | 2.6309 | 4.626 | 11 | 79 | cardiac chamber morphogenesis |
GO:0023057 | 0.0061 | 1.4916 | 38.2964 | 54 | 654 | negative regulation of signaling |
GO:0061351 | 0.0062 | 2.7766 | 4.0108 | 10 | 69 | neural precursor cell proliferation |
GO:0035235 | 0.0063 | 5.0583 | 1.2297 | 5 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0048596 | 0.0063 | 5.0583 | 1.2297 | 5 | 21 | embryonic camera-type eye morphogenesis |
GO:0050804 | 0.0065 | 2.0412 | 9.4863 | 18 | 162 | regulation of synaptic transmission |
GO:0001837 | 0.0065 | 2.7545 | 4.0404 | 10 | 69 | epithelial to mesenchymal transition |
GO:0007187 | 0.0066 | 2.4718 | 5.3287 | 12 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0010648 | 0.0066 | 1.4837 | 38.4721 | 54 | 657 | negative regulation of cell communication |
GO:0019226 | 0.0067 | 2.5925 | 4.6846 | 11 | 80 | transmission of nerve impulse |
GO:0007409 | 0.0068 | 2.2686 | 6.6947 | 14 | 119 | axonogenesis |
GO:0060688 | 0.0068 | 4.07 | 1.7487 | 6 | 30 | regulation of morphogenesis of a branching structure |
GO:0002065 | 0.007 | 6.5515 | 0.81 | 4 | 14 | columnar/cuboidal epithelial cell differentiation |
GO:0001738 | 0.007 | 4.0501 | 1.7567 | 6 | 30 | morphogenesis of a polarized epithelium |
GO:2000648 | 0.0071 | 3.1662 | 2.8693 | 8 | 49 | positive regulation of stem cell proliferation |
GO:0016486 | 0.0072 | 6.489 | 0.8173 | 4 | 14 | peptide hormone processing |
GO:0060021 | 0.0072 | 2.7083 | 4.099 | 10 | 70 | palate development |
GO:0090190 | 0.0073 | 6.4677 | 0.8198 | 4 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0048545 | 0.0075 | 1.8361 | 13.351 | 23 | 228 | response to steroid hormone |
GO:0002066 | 0.0078 | 4.7602 | 1.2883 | 5 | 22 | columnar/cuboidal epithelial cell development |
GO:0007190 | 0.0078 | 4.7602 | 1.2883 | 5 | 22 | activation of adenylate cyclase activity |
GO:0045773 | 0.0078 | 4.7602 | 1.2883 | 5 | 22 | positive regulation of axon extension |
GO:0008284 | 0.0078 | 1.6712 | 19.6509 | 31 | 343 | positive regulation of cell proliferation |
GO:0035019 | 0.0078 | 3.439 | 2.3423 | 7 | 40 | somatic stem cell maintenance |
GO:0045761 | 0.0078 | 3.439 | 2.3423 | 7 | 40 | regulation of adenylate cyclase activity |
GO:0051046 | 0.0079 | 1.6689 | 19.6752 | 31 | 336 | regulation of secretion |
GO:0050885 | 0.0081 | 3.9068 | 1.807 | 6 | 31 | neuromuscular process controlling balance |
GO:0010464 | 0.0082 | 3.8877 | 1.8153 | 6 | 31 | regulation of mesenchymal cell proliferation |
GO:2000179 | 0.0082 | 3.8877 | 1.8153 | 6 | 31 | positive regulation of neural precursor cell proliferation |
GO:0044702 | 0.0086 | 1.5301 | 29.6641 | 43 | 516 | single organism reproductive process |
GO:0001649 | 0.0088 | 2.0703 | 8.3151 | 16 | 142 | osteoblast differentiation |
GO:0021781 | 0.0089 | 9.722 | 0.467 | 3 | 8 | glial cell fate commitment |
GO:0070848 | 0.0089 | 1.5423 | 28.0489 | 41 | 479 | response to growth factor |
GO:0023061 | 0.009 | 1.9691 | 9.7847 | 18 | 170 | signal release |
GO:0002347 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | response to tumor cell |
GO:0003337 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0007494 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | midgut development |
GO:0010454 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | negative regulation of cell fate commitment |
GO:0030916 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | otic vesicle formation |
GO:0032836 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | glomerular basement membrane development |
GO:0060872 | 0.009 | 9.6902 | 0.4685 | 3 | 8 | semicircular canal development |
GO:0070167 | 0.009 | 3.3375 | 2.4008 | 7 | 41 | regulation of biomineral tissue development |
GO:0009611 | 0.0092 | 1.495 | 33.1434 | 47 | 566 | response to wounding |
GO:0021675 | 0.0094 | 3.7646 | 1.8614 | 6 | 32 | nerve development |
GO:0008406 | 0.0094 | 2.0538 | 8.3737 | 16 | 143 | gonad development |
GO:0030501 | 0.0094 | 4.4953 | 1.3468 | 5 | 23 | positive regulation of bone mineralization |
GO:0001964 | 0.0095 | 5.8791 | 0.8784 | 4 | 15 | startle response |
GO:0042659 | 0.0095 | 5.8791 | 0.8784 | 4 | 15 | regulation of cell fate specification |
GO:0048853 | 0.0095 | 5.8791 | 0.8784 | 4 | 15 | forebrain morphogenesis |
GO:0042593 | 0.0096 | 2.1712 | 6.9683 | 14 | 119 | glucose homeostasis |
GO:0035987 | 0.0097 | 3.7378 | 1.8738 | 6 | 32 | endodermal cell differentiation |
GO:0061005 | 0.0097 | 3.7378 | 1.8738 | 6 | 32 | cell differentiation involved in kidney development |
GO:1902041 | 0.0097 | 3.7378 | 1.8738 | 6 | 32 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0010453 | 0.0097 | 32.5486 | 0.1742 | 2 | 3 | regulation of cell fate commitment |
GO:0003406 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | retinal pigment epithelium development |
GO:0010269 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | response to selenium ion |
GO:0010455 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | positive regulation of cell fate commitment |
GO:0021855 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | hypothalamus cell migration |
GO:0021902 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0021913 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0030240 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | skeletal muscle thin filament assembly |
GO:0030910 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | olfactory placode formation |
GO:0032455 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | nerve growth factor processing |
GO:0033058 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | detection of glucose |
GO:0055091 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | phospholipid homeostasis |
GO:0060018 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | transdifferentiation |
GO:0060300 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | regulation of cytokine activity |
GO:0060421 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | positive regulation of heart growth |
GO:0060594 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | mammary gland specification |
GO:0060913 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0071698 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | olfactory placode development |
GO:0072093 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | metanephric renal vesicle formation |
GO:0072180 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | mesonephric duct morphogenesis |
GO:0072197 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | ureter morphogenesis |
GO:1900212 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000041 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2000318 | 0.0099 | 32.2597 | 0.1757 | 2 | 3 | positive regulation of T-helper 17 type immune response |
GO:0048864 | 0.01 | 2.4323 | 4.9431 | 11 | 86 | stem cell development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 2e-04 | 57.2008 | 0.1292 | 3 | 5 | olfactory receptor activity |
GO:0030280 | 7e-04 | Inf | 0.0517 | 2 | 2 | structural constituent of epidermis |
GO:0005328 | 0.004 | 11.4307 | 0.3359 | 3 | 13 | neurotransmitter:sodium symporter activity |
GO:0035255 | 0.005 | 10.3905 | 0.3618 | 3 | 14 | ionotropic glutamate receptor binding |
GO:0050661 | 0.0055 | 6.3663 | 0.7236 | 4 | 28 | NADP binding |
GO:0015081 | 0.0065 | 3.9013 | 1.6797 | 6 | 65 | sodium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015347 | 0.0011 | Inf | 0.0668 | 2 | 2 | sodium-independent organic anion transmembrane transporter activity |
GO:0030280 | 0.0011 | Inf | 0.0668 | 2 | 2 | structural constituent of epidermis |
GO:0022892 | 0.0016 | 1.8306 | 19.9634 | 34 | 598 | substrate-specific transporter activity |
GO:0005452 | 0.0027 | 14.6003 | 0.3005 | 3 | 9 | inorganic anion exchanger activity |
GO:0015297 | 0.0044 | 5.2343 | 1.1017 | 5 | 33 | antiporter activity |
GO:0015075 | 0.0058 | 1.7818 | 16.0909 | 27 | 482 | ion transmembrane transporter activity |
GO:0022804 | 0.006 | 2.3626 | 5.8755 | 13 | 176 | active transmembrane transporter activity |
GO:0015355 | 0.0064 | 29.1242 | 0.1335 | 2 | 4 | secondary active monocarboxylate transmembrane transporter activity |
GO:0031013 | 0.0064 | 29.1242 | 0.1335 | 2 | 4 | troponin I binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002039 | 3e-04 | 4.7744 | 2.2785 | 9 | 44 | p53 binding |
GO:0005536 | 0.0025 | 18.4121 | 0.3107 | 3 | 6 | glucose binding |
GO:0004658 | 0.0027 | Inf | 0.1036 | 2 | 2 | propionyl-CoA carboxylase activity |
GO:0035254 | 0.0068 | 4.856 | 1.2428 | 5 | 24 | glutamate receptor binding |
GO:0019239 | 0.0079 | 6.1435 | 0.8286 | 4 | 16 | deaminase activity |
GO:0019842 | 0.0089 | 3.318 | 2.3821 | 7 | 46 | vitamin binding |
GO:0003684 | 0.0097 | 3.6935 | 1.8643 | 6 | 36 | damaged DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 8.8047 | 2.2331 | 15 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0 | 6.8381 | 2.7216 | 15 | 78 | serine hydrolase activity |
GO:0005509 | 0 | 2.5336 | 14.0265 | 32 | 402 | calcium ion binding |
GO:0005254 | 0 | 7.7868 | 1.291 | 8 | 37 | chloride channel activity |
GO:0070011 | 1e-04 | 2.457 | 11.1305 | 25 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0015103 | 4e-04 | 4.5371 | 2.268 | 9 | 65 | inorganic anion transmembrane transporter activity |
GO:0005031 | 8e-04 | 27.8924 | 0.2094 | 3 | 6 | tumor necrosis factor-activated receptor activity |
GO:0004930 | 0.0011 | 2.5104 | 7.3273 | 17 | 210 | G-protein coupled receptor activity |
GO:0004063 | 0.0012 | Inf | 0.0698 | 2 | 2 | aryldialkylphosphatase activity |
GO:0015347 | 0.0012 | Inf | 0.0698 | 2 | 2 | sodium-independent organic anion transmembrane transporter activity |
GO:0030172 | 0.0012 | Inf | 0.0698 | 2 | 2 | troponin C binding |
GO:0038023 | 0.0014 | 1.9194 | 16.783 | 30 | 481 | signaling receptor activity |
GO:0015267 | 0.0029 | 2.2087 | 8.723 | 18 | 250 | channel activity |
GO:0005452 | 0.003 | 13.9419 | 0.314 | 3 | 9 | inorganic anion exchanger activity |
GO:0031014 | 0.0036 | 55.6348 | 0.1047 | 2 | 3 | troponin T binding |
GO:0047374 | 0.0036 | 55.6348 | 0.1047 | 2 | 3 | methylumbelliferyl-acetate deacetylase activity |
GO:0005215 | 0.0044 | 1.6424 | 25.3315 | 39 | 726 | transporter activity |
GO:0048306 | 0.0047 | 5.1825 | 1.1165 | 5 | 32 | calcium-dependent protein binding |
GO:0050840 | 0.0047 | 5.1825 | 1.1165 | 5 | 32 | extracellular matrix binding |
GO:0060089 | 0.006 | 1.6296 | 24.1452 | 37 | 692 | molecular transducer activity |
GO:0004064 | 0.007 | 27.8145 | 0.1396 | 2 | 4 | arylesterase activity |
GO:0015288 | 0.007 | 27.8145 | 0.1396 | 2 | 4 | porin activity |
GO:0022891 | 0.0071 | 1.7135 | 17.9344 | 29 | 514 | substrate-specific transmembrane transporter activity |
GO:0005216 | 0.0079 | 2.0799 | 8.1647 | 16 | 234 | ion channel activity |
GO:0008233 | 0.0083 | 8.7404 | 0.4349 | 3 | 13 | peptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.3725 | 26.8155 | 56 | 590 | receptor activity |
GO:0004871 | 0 | 2.146 | 31.4514 | 60 | 692 | signal transducer activity |
GO:0019199 | 2e-04 | 4.2803 | 2.9997 | 11 | 66 | transmembrane receptor protein kinase activity |
GO:0008201 | 3e-04 | 3.9884 | 3.1815 | 11 | 70 | heparin binding |
GO:0004984 | 9e-04 | 31.7071 | 0.2272 | 3 | 5 | olfactory receptor activity |
GO:0005543 | 0.0014 | 2.3229 | 8.8627 | 19 | 195 | phospholipid binding |
GO:0004930 | 0.0014 | 2.2668 | 9.5445 | 20 | 210 | G-protein coupled receptor activity |
GO:0030971 | 0.0017 | 5.5391 | 1.318 | 6 | 29 | receptor tyrosine kinase binding |
GO:0005006 | 0.0021 | Inf | 0.0909 | 2 | 2 | epidermal growth factor-activated receptor activity |
GO:0005003 | 0.0022 | 9.4087 | 0.5908 | 4 | 13 | ephrin receptor activity |
GO:0050839 | 0.0028 | 2.7566 | 4.7722 | 12 | 105 | cell adhesion molecule binding |
GO:0015108 | 0.0044 | 3.8132 | 2.0907 | 7 | 46 | chloride transmembrane transporter activity |
GO:0016597 | 0.0044 | 3.4029 | 2.6361 | 8 | 58 | amino acid binding |
GO:0008426 | 0.006 | 42.1867 | 0.1363 | 2 | 3 | protein kinase C inhibitor activity |
GO:0004888 | 0.0061 | 2.2878 | 6.574 | 14 | 151 | transmembrane signaling receptor activity |
GO:0030247 | 0.0064 | 10.5646 | 0.409 | 3 | 9 | polysaccharide binding |
GO:0045295 | 0.0064 | 10.5646 | 0.409 | 3 | 9 | gamma-catenin binding |
GO:0070064 | 0.0078 | 6.0453 | 0.8181 | 4 | 18 | proline-rich region binding |
GO:0004252 | 0.0081 | 3.0364 | 2.9088 | 8 | 64 | serine-type endopeptidase activity |
GO:0004713 | 0.0086 | 2.4675 | 4.8177 | 11 | 106 | protein tyrosine kinase activity |
GO:0015269 | 0.0088 | 9.0544 | 0.4545 | 3 | 10 | calcium-activated potassium channel activity |
GO:0005520 | 0.0095 | 5.6417 | 0.8635 | 4 | 19 | insulin-like growth factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 134.5366 | 0.1463 | 4 | 5 | olfactory receptor activity |
GO:0030280 | 9e-04 | Inf | 0.0585 | 2 | 2 | structural constituent of epidermis |
GO:0046943 | 0.0013 | 4.7344 | 1.6679 | 7 | 57 | carboxylic acid transmembrane transporter activity |
GO:0022891 | 0.0023 | 1.9251 | 15.0401 | 27 | 514 | substrate-specific transmembrane transporter activity |
GO:0019865 | 0.0025 | 66.8028 | 0.0878 | 2 | 3 | immunoglobulin binding |
GO:0050220 | 0.0025 | 66.8028 | 0.0878 | 2 | 3 | prostaglandin-E synthase activity |
GO:0005216 | 0.0037 | 2.3414 | 6.8471 | 15 | 234 | ion channel activity |
GO:0046873 | 0.0048 | 2.2672 | 7.0519 | 15 | 241 | metal ion transmembrane transporter activity |
GO:0008527 | 0.0049 | 33.3979 | 0.117 | 2 | 4 | taste receptor activity |
GO:0015355 | 0.0049 | 33.3979 | 0.117 | 2 | 4 | secondary active monocarboxylate transmembrane transporter activity |
GO:0015175 | 0.0057 | 10.0458 | 0.3804 | 3 | 13 | neutral amino acid transmembrane transporter activity |
GO:0015267 | 0.0067 | 2.1783 | 7.3152 | 15 | 250 | channel activity |
GO:0048406 | 0.008 | 22.263 | 0.1463 | 2 | 5 | nerve growth factor binding |
GO:0005245 | 0.0096 | 5.3681 | 0.8486 | 4 | 29 | voltage-gated calcium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 1e-04 | 4.4853 | 2.8831 | 11 | 64 | serine-type endopeptidase activity |
GO:0017171 | 2e-04 | 3.9329 | 3.5137 | 12 | 78 | serine hydrolase activity |
GO:0005254 | 0.0011 | 5.009 | 1.6668 | 7 | 37 | chloride channel activity |
GO:0001948 | 0.0012 | 4.2986 | 2.1623 | 8 | 48 | glycoprotein binding |
GO:0050294 | 0.002 | Inf | 0.0901 | 2 | 2 | steroid sulfotransferase activity |
GO:0070053 | 0.002 | Inf | 0.0901 | 2 | 2 | thrombospondin receptor activity |
GO:0070576 | 0.002 | Inf | 0.0901 | 2 | 2 | vitamin D 24-hydroxylase activity |
GO:0015175 | 0.0021 | 9.4975 | 0.5856 | 4 | 13 | neutral amino acid transmembrane transporter activity |
GO:0016289 | 0.0021 | 9.4975 | 0.5856 | 4 | 13 | CoA hydrolase activity |
GO:0001786 | 0.0028 | 8.5468 | 0.6307 | 4 | 14 | phosphatidylserine binding |
GO:0015459 | 0.0038 | 5.6303 | 1.0811 | 5 | 24 | potassium channel regulator activity |
GO:0004953 | 0.0043 | 12.7982 | 0.3604 | 3 | 8 | icosanoid receptor activity |
GO:0016290 | 0.0043 | 12.7982 | 0.3604 | 3 | 8 | palmitoyl-CoA hydrolase activity |
GO:0004871 | 0.0048 | 1.5678 | 31.1731 | 46 | 692 | signal transducer activity |
GO:0004872 | 0.0056 | 1.614 | 25.6257 | 39 | 573 | receptor activity |
GO:0004090 | 0.0059 | 42.583 | 0.1351 | 2 | 3 | carbonyl reductase (NADPH) activity |
GO:0008426 | 0.0059 | 42.583 | 0.1351 | 2 | 3 | protein kinase C inhibitor activity |
GO:0022824 | 0.0059 | 42.583 | 0.1351 | 2 | 3 | transmitter-gated ion channel activity |
GO:0001618 | 0.0061 | 6.5724 | 0.7658 | 4 | 17 | virus receptor activity |
GO:0015103 | 0.0084 | 3.0112 | 2.9281 | 8 | 65 | inorganic anion transmembrane transporter activity |
GO:0048018 | 0.0086 | 9.1396 | 0.4505 | 3 | 10 | receptor agonist activity |
GO:0015267 | 0.0091 | 1.8828 | 11.2619 | 20 | 250 | channel activity |
GO:0004888 | 0.01 | 1.6494 | 19.1903 | 30 | 426 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 108.9545 | 0.179 | 4 | 5 | olfactory receptor activity |
GO:0015108 | 2e-04 | 5.778 | 1.6467 | 8 | 46 | chloride transmembrane transporter activity |
GO:0004252 | 4e-04 | 4.496 | 2.291 | 9 | 64 | serine-type endopeptidase activity |
GO:0005509 | 0.0012 | 2.0164 | 14.3903 | 27 | 402 | calcium ion binding |
GO:0005006 | 0.0013 | Inf | 0.0716 | 2 | 2 | epidermal growth factor-activated receptor activity |
GO:0016934 | 0.0013 | Inf | 0.0716 | 2 | 2 | extracellular-glycine-gated chloride channel activity |
GO:0008509 | 0.0017 | 2.7794 | 5.0832 | 13 | 142 | anion transmembrane transporter activity |
GO:0017171 | 0.0018 | 3.5785 | 2.7922 | 9 | 78 | serine hydrolase activity |
GO:0004090 | 0.0037 | 54.1695 | 0.1074 | 2 | 3 | carbonyl reductase (NADPH) activity |
GO:0022824 | 0.0037 | 54.1695 | 0.1074 | 2 | 3 | transmitter-gated ion channel activity |
GO:0038023 | 0.0041 | 1.7927 | 17.2183 | 29 | 481 | signaling receptor activity |
GO:0043236 | 0.005 | 6.799 | 0.7159 | 4 | 20 | laminin binding |
GO:0003840 | 0.0073 | 27.0819 | 0.1432 | 2 | 4 | gamma-glutamyltransferase activity |
GO:0045499 | 0.0073 | 27.0819 | 0.1432 | 2 | 4 | chemorepellent activity |
GO:0008233 | 0.0082 | 1.8701 | 11.8846 | 21 | 332 | peptidase activity |
GO:0005102 | 0.0098 | 1.5453 | 27.4204 | 40 | 766 | receptor binding |
GO:0019903 | 0.0098 | 3.1854 | 2.3984 | 7 | 67 | protein phosphatase binding |
GO:0005328 | 0.01 | 8.1408 | 0.4654 | 3 | 13 | neurotransmitter:sodium symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004115 | 1e-04 | 30.0664 | 0.2998 | 4 | 7 | 3',5'-cyclic-AMP phosphodiesterase activity |
GO:0001637 | 2e-04 | 22.5474 | 0.3427 | 4 | 8 | G-protein coupled chemoattractant receptor activity |
GO:0004930 | 3e-04 | 2.5597 | 8.9955 | 21 | 210 | G-protein coupled receptor activity |
GO:0043014 | 3e-04 | 11.2933 | 0.6425 | 5 | 15 | alpha-tubulin binding |
GO:0019841 | 4e-04 | 18.036 | 0.3855 | 4 | 9 | retinol binding |
GO:0019840 | 6e-04 | 9.4091 | 0.7282 | 5 | 17 | isoprenoid binding |
GO:0060089 | 6e-04 | 1.75 | 29.6422 | 48 | 692 | molecular transducer activity |
GO:0038023 | 8e-04 | 1.9598 | 17.6 | 32 | 416 | signaling receptor activity |
GO:0004252 | 0.0015 | 3.7138 | 2.7415 | 9 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0.0017 | 3.341 | 3.3412 | 10 | 78 | serine hydrolase activity |
GO:0003846 | 0.0018 | Inf | 0.0857 | 2 | 2 | 2-acylglycerol O-acyltransferase activity |
GO:0004063 | 0.0018 | Inf | 0.0857 | 2 | 2 | aryldialkylphosphatase activity |
GO:0004967 | 0.0018 | Inf | 0.0857 | 2 | 2 | glucagon receptor activity |
GO:0004112 | 0.0024 | 9.0133 | 0.5997 | 4 | 14 | cyclic-nucleotide phosphodiesterase activity |
GO:0016918 | 0.0024 | 16.8706 | 0.2998 | 3 | 7 | retinal binding |
GO:0035586 | 0.0037 | 13.495 | 0.3427 | 3 | 8 | purinergic receptor activity |
GO:0008233 | 0.0043 | 1.8707 | 14.2214 | 25 | 332 | peptidase activity |
GO:0004144 | 0.0053 | 44.8962 | 0.1285 | 2 | 3 | diacylglycerol O-acyltransferase activity |
GO:0016493 | 0.0053 | 44.8962 | 0.1285 | 2 | 3 | C-C chemokine receptor activity |
GO:0022857 | 0.0054 | 1.6394 | 23.9451 | 37 | 559 | transmembrane transporter activity |
GO:0001653 | 0.0063 | 3.177 | 2.7843 | 8 | 65 | peptide receptor activity |
GO:0015103 | 0.0063 | 3.177 | 2.7843 | 8 | 65 | inorganic anion transmembrane transporter activity |
GO:0004896 | 0.0075 | 3.871 | 1.7563 | 6 | 41 | cytokine receptor activity |
GO:0052689 | 0.0086 | 3.2964 | 2.356 | 7 | 55 | carboxylic ester hydrolase activity |
GO:0008201 | 0.0098 | 2.9193 | 2.9985 | 8 | 70 | heparin binding |
GO:0008009 | 0.01 | 8.4317 | 0.4712 | 3 | 11 | chemokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017127 | 1e-04 | 41.6879 | 0.2769 | 4 | 6 | cholesterol transporter activity |
GO:0004872 | 1e-04 | 1.9272 | 27.2308 | 48 | 590 | receptor activity |
GO:0005215 | 3e-04 | 1.7488 | 33.5077 | 54 | 726 | transporter activity |
GO:0005319 | 5e-04 | 4.3921 | 2.4 | 9 | 52 | lipid transporter activity |
GO:0004252 | 6e-04 | 3.8901 | 2.9538 | 10 | 64 | serine-type endopeptidase activity |
GO:0008201 | 0.0013 | 3.4989 | 3.2308 | 10 | 70 | heparin binding |
GO:0004063 | 0.0021 | Inf | 0.0923 | 2 | 2 | aryldialkylphosphatase activity |
GO:0008940 | 0.0021 | Inf | 0.0923 | 2 | 2 | nitrate reductase activity |
GO:0016492 | 0.0021 | Inf | 0.0923 | 2 | 2 | G-protein coupled neurotensin receptor activity |
GO:0017171 | 0.003 | 3.0846 | 3.6 | 10 | 78 | serine hydrolase activity |
GO:0005179 | 0.0031 | 3.6402 | 2.4923 | 8 | 54 | hormone activity |
GO:0004888 | 0.0037 | 1.7679 | 18.6621 | 31 | 409 | transmembrane signaling receptor activity |
GO:0004889 | 0.0046 | 12.475 | 0.3692 | 3 | 8 | acetylcholine-activated cation-selective channel activity |
GO:0005035 | 0.0046 | 12.475 | 0.3692 | 3 | 8 | death receptor activity |
GO:0022803 | 0.0058 | 1.9381 | 11.5385 | 21 | 250 | passive transmembrane transporter activity |
GO:0000309 | 0.0062 | 41.5098 | 0.1385 | 2 | 3 | nicotinamide-nucleotide adenylyltransferase activity |
GO:0034190 | 0.0062 | 41.5098 | 0.1385 | 2 | 3 | apolipoprotein receptor binding |
GO:0005509 | 0.0063 | 1.7133 | 18.5538 | 30 | 402 | calcium ion binding |
GO:0005230 | 0.0064 | 4.0397 | 1.7077 | 6 | 37 | extracellular ligand-gated ion channel activity |
GO:0004683 | 0.0066 | 6.4061 | 0.7846 | 4 | 17 | calmodulin-dependent protein kinase activity |
GO:0015464 | 0.0067 | 10.3947 | 0.4154 | 3 | 9 | acetylcholine receptor activity |
GO:0042166 | 0.0067 | 10.3947 | 0.4154 | 3 | 9 | acetylcholine binding |
GO:0022838 | 0.007 | 1.9368 | 10.9846 | 20 | 238 | substrate-specific channel activity |
GO:0005201 | 0.0084 | 3.7941 | 1.8 | 6 | 39 | extracellular matrix structural constituent |
GO:0004714 | 0.0085 | 3.3233 | 2.3538 | 7 | 51 | transmembrane receptor protein tyrosine kinase activity |
GO:0022834 | 0.0087 | 2.77 | 3.5538 | 9 | 77 | ligand-gated channel activity |
GO:0015103 | 0.0097 | 2.9343 | 3 | 8 | 65 | inorganic anion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022891 | 0 | 2.12 | 25.0669 | 48 | 514 | substrate-specific transmembrane transporter activity |
GO:0038023 | 0 | 2.2182 | 20.9612 | 42 | 435 | signaling receptor activity |
GO:0015267 | 0 | 2.5496 | 12.1921 | 28 | 250 | channel activity |
GO:0004252 | 1e-04 | 4.59 | 3.1212 | 12 | 64 | serine-type endopeptidase activity |
GO:0005215 | 1e-04 | 1.8258 | 35.4057 | 59 | 726 | transporter activity |
GO:0005201 | 1e-04 | 5.9433 | 1.902 | 9 | 39 | extracellular matrix structural constituent |
GO:0017171 | 1e-04 | 3.9809 | 3.8039 | 13 | 78 | serine hydrolase activity |
GO:0060089 | 1e-04 | 1.8111 | 33.7476 | 56 | 692 | molecular transducer activity |
GO:0046870 | 1e-04 | Inf | 0.1463 | 3 | 3 | cadmium ion binding |
GO:0008528 | 3e-04 | 4.3335 | 2.7163 | 10 | 56 | G-protein coupled peptide receptor activity |
GO:0005254 | 3e-04 | 5.4542 | 1.8044 | 8 | 37 | chloride channel activity |
GO:0004890 | 0.0011 | 29.4336 | 0.2438 | 3 | 5 | GABA-A receptor activity |
GO:0022890 | 0.0014 | 1.9989 | 14.5329 | 27 | 298 | inorganic cation transmembrane transporter activity |
GO:0008509 | 0.0015 | 2.5272 | 6.9251 | 16 | 142 | anion transmembrane transporter activity |
GO:0030594 | 0.0015 | 4.1584 | 2.2433 | 8 | 46 | neurotransmitter receptor activity |
GO:0004930 | 0.0016 | 2.5045 | 6.9742 | 16 | 146 | G-protein coupled receptor activity |
GO:0015079 | 0.0016 | 2.9746 | 4.4867 | 12 | 92 | potassium ion transmembrane transporter activity |
GO:0070011 | 0.0018 | 1.9305 | 15.5571 | 28 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0005261 | 0.0019 | 2.3139 | 8.4369 | 18 | 173 | cation channel activity |
GO:0005216 | 0.0023 | 3.4967 | 2.9152 | 9 | 61 | ion channel activity |
GO:0003846 | 0.0024 | Inf | 0.0975 | 2 | 2 | 2-acylglycerol O-acyltransferase activity |
GO:0004966 | 0.0024 | Inf | 0.0975 | 2 | 2 | galanin receptor activity |
GO:0016151 | 0.0024 | Inf | 0.0975 | 2 | 2 | nickel cation binding |
GO:0050294 | 0.0024 | Inf | 0.0975 | 2 | 2 | steroid sulfotransferase activity |
GO:0005328 | 0.0028 | 8.7327 | 0.634 | 4 | 13 | neurotransmitter:sodium symporter activity |
GO:0042287 | 0.0028 | 8.7327 | 0.634 | 4 | 13 | MHC protein binding |
GO:0017046 | 0.0029 | 6.1484 | 1.0241 | 5 | 21 | peptide hormone binding |
GO:0005506 | 0.0032 | 2.8654 | 4.2428 | 11 | 87 | iron ion binding |
GO:0022834 | 0.004 | 2.9515 | 3.7552 | 10 | 77 | ligand-gated channel activity |
GO:0015081 | 0.0041 | 3.1751 | 3.1699 | 9 | 65 | sodium ion transmembrane transporter activity |
GO:0005509 | 0.0042 | 1.7355 | 19.6048 | 32 | 402 | calcium ion binding |
GO:0005125 | 0.0049 | 2.8653 | 3.8527 | 10 | 79 | cytokine activity |
GO:0005184 | 0.005 | 7.1435 | 0.7315 | 4 | 15 | neuropeptide hormone activity |
GO:0001637 | 0.0054 | 11.7697 | 0.3901 | 3 | 8 | G-protein coupled chemoattractant receptor activity |
GO:0015116 | 0.0054 | 11.7697 | 0.3901 | 3 | 8 | sulfate transmembrane transporter activity |
GO:0050998 | 0.0054 | 11.7697 | 0.3901 | 3 | 8 | nitric-oxide synthase binding |
GO:0022804 | 0.0055 | 2.1249 | 8.5832 | 17 | 176 | active transmembrane transporter activity |
GO:0004222 | 0.0061 | 2.9622 | 3.365 | 9 | 69 | metalloendopeptidase activity |
GO:0071855 | 0.0064 | 6.5475 | 0.7803 | 4 | 16 | neuropeptide receptor binding |
GO:0005249 | 0.0068 | 3.1564 | 2.8286 | 8 | 58 | voltage-gated potassium channel activity |
GO:0016597 | 0.0068 | 3.1564 | 2.8286 | 8 | 58 | amino acid binding |
GO:0004111 | 0.0069 | 39.1677 | 0.1463 | 2 | 3 | creatine kinase activity |
GO:0004144 | 0.0069 | 39.1677 | 0.1463 | 2 | 3 | diacylglycerol O-acyltransferase activity |
GO:0016493 | 0.0069 | 39.1677 | 0.1463 | 2 | 3 | C-C chemokine receptor activity |
GO:0016901 | 0.0069 | 39.1677 | 0.1463 | 2 | 3 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0051431 | 0.0069 | 39.1677 | 0.1463 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0015293 | 0.0073 | 2.866 | 3.4625 | 9 | 71 | symporter activity |
GO:0005230 | 0.0084 | 3.81 | 1.8044 | 6 | 37 | extracellular ligand-gated ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0.0014 | 1.825 | 20.6045 | 35 | 573 | receptor activity |
GO:0004252 | 0.0021 | 3.8559 | 2.3232 | 8 | 64 | serine-type endopeptidase activity |
GO:0015645 | 0.0023 | 16.0542 | 0.2904 | 3 | 8 | fatty acid ligase activity |
GO:0001618 | 0.0028 | 8.2491 | 0.6171 | 4 | 17 | virus receptor activity |
GO:0004888 | 0.0034 | 1.8609 | 15.4637 | 27 | 426 | transmembrane signaling receptor activity |
GO:0017171 | 0.0071 | 3.0802 | 2.8314 | 8 | 78 | serine hydrolase activity |
GO:0030551 | 0.0087 | 5.6406 | 0.8349 | 4 | 23 | cyclic nucleotide binding |
GO:0005244 | 0.01 | 2.5234 | 4.2471 | 10 | 117 | voltage-gated ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 244.5 | 0.0825 | 4 | 5 | olfactory receptor activity |
GO:0030280 | 3e-04 | Inf | 0.033 | 2 | 2 | structural constituent of epidermis |
GO:0004252 | 6e-04 | 6.366 | 1.0554 | 6 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0.0018 | 5.1208 | 1.2863 | 6 | 78 | serine hydrolase activity |
GO:0004866 | 0.0024 | 5.8835 | 0.94 | 5 | 57 | endopeptidase inhibitor activity |
GO:0008271 | 0.0039 | 30.1759 | 0.0989 | 2 | 6 | secondary active sulfate transmembrane transporter activity |
GO:0031210 | 0.0039 | 30.1759 | 0.0989 | 2 | 6 | phosphatidylcholine binding |
GO:0022857 | 0.0049 | 2.1057 | 9.2183 | 18 | 559 | transmembrane transporter activity |
GO:0015075 | 0.0059 | 2.161 | 7.9485 | 16 | 482 | ion transmembrane transporter activity |
GO:0070011 | 0.0065 | 2.4363 | 5.2605 | 12 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0015108 | 0.0068 | 5.797 | 0.7586 | 4 | 46 | chloride transmembrane transporter activity |
GO:0015370 | 0.0087 | 7.9055 | 0.4288 | 3 | 26 | solute:sodium symporter activity |
GO:0005212 | 0.009 | 17.2381 | 0.1484 | 2 | 9 | structural constituent of eye lens |
GO:0061134 | 0.0092 | 4.182 | 1.2863 | 5 | 78 | peptidase regulator activity |
GO:0022892 | 0.0096 | 1.9558 | 9.8614 | 18 | 598 | substrate-specific transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004252 | 0 | 5.2243 | 2.7672 | 12 | 64 | serine-type endopeptidase activity |
GO:0017171 | 0 | 4.5324 | 3.3725 | 13 | 78 | serine hydrolase activity |
GO:0005254 | 9e-04 | 5.2321 | 1.5998 | 7 | 37 | chloride channel activity |
GO:0001948 | 9e-04 | 4.4905 | 2.0754 | 8 | 48 | glycoprotein binding |
GO:0005215 | 0.0011 | 1.6789 | 31.3906 | 49 | 726 | transporter activity |
GO:0015175 | 0.0018 | 9.9176 | 0.5621 | 4 | 13 | neutral amino acid transmembrane transporter activity |
GO:0050294 | 0.0019 | Inf | 0.0865 | 2 | 2 | steroid sulfotransferase activity |
GO:0070053 | 0.0019 | Inf | 0.0865 | 2 | 2 | thrombospondin receptor activity |
GO:0070576 | 0.0019 | Inf | 0.0865 | 2 | 2 | vitamin D 24-hydroxylase activity |
GO:0001786 | 0.0024 | 8.9249 | 0.6053 | 4 | 14 | phosphatidylserine binding |
GO:0005509 | 0.0025 | 1.8433 | 17.3816 | 30 | 402 | calcium ion binding |
GO:0015267 | 0.0027 | 2.082 | 10.8095 | 21 | 250 | channel activity |
GO:0070011 | 0.0029 | 1.936 | 13.7929 | 25 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0060089 | 0.0037 | 1.602 | 29.9206 | 45 | 692 | molecular transducer activity |
GO:0001618 | 0.0052 | 6.8631 | 0.735 | 4 | 17 | virus receptor activity |
GO:0004090 | 0.0054 | 44.4579 | 0.1297 | 2 | 3 | carbonyl reductase (NADPH) activity |
GO:0008426 | 0.0054 | 44.4579 | 0.1297 | 2 | 3 | protein kinase C inhibitor activity |
GO:0022824 | 0.0054 | 44.4579 | 0.1297 | 2 | 3 | transmitter-gated ion channel activity |
GO:0005216 | 0.0062 | 1.9997 | 10.1176 | 19 | 234 | ion channel activity |
GO:0015103 | 0.0067 | 3.1456 | 2.8105 | 8 | 65 | inorganic anion transmembrane transporter activity |
GO:0047617 | 0.0077 | 9.543 | 0.4324 | 3 | 10 | acyl-CoA hydrolase activity |
GO:0022891 | 0.0087 | 1.6161 | 22.2242 | 34 | 514 | substrate-specific transmembrane transporter activity |
GO:0038023 | 0.0088 | 1.6393 | 20.6187 | 32 | 479 | signaling receptor activity |
GO:0043236 | 0.0096 | 5.5745 | 0.8648 | 4 | 20 | laminin binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.8465 | 213.023 | 291 | 5010 | multicellular organismal process |
GO:0007399 | 0 | 1.8708 | 70.3511 | 115 | 1673 | nervous system development |
GO:2000026 | 0 | 1.9974 | 49.0676 | 87 | 1154 | regulation of multicellular organismal development |
GO:0007267 | 0 | 3.7464 | 7.3438 | 24 | 185 | cell-cell signaling |
GO:0050767 | 0 | 2.4801 | 19.7291 | 44 | 464 | regulation of neurogenesis |
GO:0007275 | 0 | 1.752 | 78.2616 | 118 | 2057 | multicellular organismal development |
GO:0007200 | 0 | 6.8869 | 2.211 | 12 | 52 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002125 | 0 | Inf | 0.1701 | 4 | 4 | maternal aggressive behavior |
GO:0031069 | 0 | 10.7418 | 1.063 | 8 | 25 | hair follicle morphogenesis |
GO:0035176 | 0 | 8.2276 | 1.4457 | 9 | 34 | social behavior |
GO:2000310 | 0 | 17.0681 | 0.5953 | 6 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0009952 | 0 | 3.1765 | 7.3944 | 21 | 175 | anterior/posterior pattern specification |
GO:0045666 | 0 | 4.737 | 3.2315 | 13 | 76 | positive regulation of neuron differentiation |
GO:0048468 | 0 | 1.6144 | 68.0738 | 100 | 1601 | cell development |
GO:0044699 | 0 | 2.179 | 32.9275 | 53 | 967 | single-organism process |
GO:0072359 | 0 | 1.874 | 31.8472 | 55 | 749 | circulatory system development |
GO:0060429 | 1e-04 | 1.7871 | 37.6298 | 62 | 885 | epithelium development |
GO:0009790 | 1e-04 | 1.7802 | 37.7574 | 62 | 888 | embryo development |
GO:2000311 | 1e-04 | 11.375 | 0.7654 | 6 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0021510 | 1e-04 | 4.0292 | 3.6992 | 13 | 87 | spinal cord development |
GO:0051970 | 1e-04 | Inf | 0.1276 | 3 | 3 | negative regulation of transmission of nerve impulse |
GO:0048562 | 1e-04 | 2.9378 | 7.1448 | 19 | 170 | embryonic organ morphogenesis |
GO:0003014 | 1e-04 | 4.4947 | 2.8488 | 11 | 67 | renal system process |
GO:0007423 | 1e-04 | 2.0788 | 18.7086 | 36 | 440 | sensory organ development |
GO:0007617 | 1e-04 | 9.7484 | 0.8504 | 6 | 20 | mating behavior |
GO:0051094 | 1e-04 | 1.8278 | 30.0869 | 51 | 712 | positive regulation of developmental process |
GO:0043589 | 2e-04 | 6.0805 | 1.6157 | 8 | 38 | skin morphogenesis |
GO:0072507 | 2e-04 | 2.3809 | 11.3952 | 25 | 268 | divalent inorganic cation homeostasis |
GO:0009887 | 2e-04 | 2.0252 | 19.1584 | 36 | 471 | organ morphogenesis |
GO:0021953 | 2e-04 | 2.8378 | 6.9732 | 18 | 164 | central nervous system neuron differentiation |
GO:0045595 | 2e-04 | 1.6486 | 45.8377 | 70 | 1086 | regulation of cell differentiation |
GO:0018958 | 2e-04 | 4.0578 | 3.1039 | 11 | 73 | phenol-containing compound metabolic process |
GO:0050789 | 3e-04 | 1.42 | 248.2884 | 284 | 6196 | regulation of biological process |
GO:0007218 | 3e-04 | 3.7122 | 3.6567 | 12 | 86 | neuropeptide signaling pathway |
GO:0006584 | 3e-04 | 5.5264 | 1.7433 | 8 | 41 | catecholamine metabolic process |
GO:0032849 | 3e-04 | 67.929 | 0.1701 | 3 | 4 | positive regulation of cellular pH reduction |
GO:0042663 | 3e-04 | 67.929 | 0.1701 | 3 | 4 | regulation of endodermal cell fate specification |
GO:0007215 | 3e-04 | 4.2301 | 2.7213 | 10 | 64 | glutamate receptor signaling pathway |
GO:0031016 | 3e-04 | 3.8695 | 3.2315 | 11 | 76 | pancreas development |
GO:0032879 | 4e-04 | 1.5141 | 67.9463 | 95 | 1598 | regulation of localization |
GO:0060079 | 4e-04 | 5.2097 | 1.8283 | 8 | 43 | regulation of excitatory postsynaptic membrane potential |
GO:0001990 | 4e-04 | 7.5796 | 1.0205 | 6 | 24 | regulation of systemic arterial blood pressure by hormone |
GO:0051588 | 5e-04 | 4.4638 | 2.3386 | 9 | 55 | regulation of neurotransmitter transport |
GO:0034765 | 5e-04 | 2.2622 | 11.4378 | 24 | 269 | regulation of ion transmembrane transport |
GO:0009713 | 6e-04 | 9.4614 | 0.7228 | 5 | 17 | catechol-containing compound biosynthetic process |
GO:0048729 | 6e-04 | 1.8984 | 20.2818 | 36 | 477 | tissue morphogenesis |
GO:0045944 | 6e-04 | 1.7051 | 31.9747 | 51 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0033993 | 7e-04 | 1.8165 | 23.5133 | 40 | 553 | response to lipid |
GO:0044062 | 7e-04 | 8.7329 | 0.7654 | 5 | 18 | regulation of excretion |
GO:0009605 | 8e-04 | 1.4929 | 64.162 | 89 | 1509 | response to external stimulus |
GO:0007270 | 8e-04 | 3.2549 | 4.0935 | 12 | 97 | neuron-neuron synaptic transmission |
GO:0010043 | 8e-04 | 6.4952 | 1.148 | 6 | 27 | response to zinc ion |
GO:0048699 | 8e-04 | 1.7496 | 26.8703 | 44 | 663 | generation of neurons |
GO:0007507 | 0.001 | 1.9409 | 17.0503 | 31 | 401 | heart development |
GO:0019098 | 0.001 | 6.1994 | 1.1905 | 6 | 28 | reproductive behavior |
GO:0008016 | 0.0011 | 2.8126 | 5.4425 | 14 | 128 | regulation of heart contraction |
GO:0051046 | 0.0011 | 1.903 | 17.9284 | 32 | 425 | regulation of secretion |
GO:0001991 | 0.0012 | 11.3361 | 0.5102 | 4 | 12 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0048806 | 0.0013 | 4.8265 | 1.7008 | 7 | 40 | genitalia development |
GO:0006874 | 0.0013 | 2.2167 | 10.1622 | 21 | 239 | cellular calcium ion homeostasis |
GO:0007204 | 0.0014 | 2.5303 | 6.8456 | 16 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0003025 | 0.0014 | 22.6393 | 0.2551 | 3 | 6 | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO:0021797 | 0.0014 | 22.6393 | 0.2551 | 3 | 6 | forebrain anterior/posterior pattern specification |
GO:0021955 | 0.0014 | 5.6819 | 1.2756 | 6 | 30 | central nervous system neuron axonogenesis |
GO:0061564 | 0.0014 | 1.7967 | 21.3023 | 36 | 501 | axon development |
GO:0007165 | 0.0015 | 1.3242 | 164.9802 | 197 | 3910 | signal transduction |
GO:0045665 | 0.0015 | 4.141 | 2.211 | 8 | 52 | negative regulation of neuron differentiation |
GO:0006811 | 0.0015 | 1.9822 | 14.5386 | 27 | 355 | ion transport |
GO:1901362 | 0.0015 | 1.3357 | 143.1634 | 174 | 3367 | organic cyclic compound biosynthetic process |
GO:0051093 | 0.0016 | 1.7462 | 23.7259 | 39 | 558 | negative regulation of developmental process |
GO:0055085 | 0.0016 | 1.5482 | 43.3274 | 63 | 1019 | transmembrane transport |
GO:0023019 | 0.0016 | 7.0937 | 0.8929 | 5 | 21 | signal transduction involved in regulation of gene expression |
GO:0048935 | 0.0017 | 10.0757 | 0.5528 | 4 | 13 | peripheral nervous system neuron development |
GO:0055078 | 0.0017 | 5.4541 | 1.3181 | 6 | 31 | sodium ion homeostasis |
GO:0050801 | 0.0017 | 1.807 | 19.9842 | 34 | 470 | ion homeostasis |
GO:0001982 | 0.0018 | Inf | 0.085 | 2 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
GO:0042418 | 0.0018 | Inf | 0.085 | 2 | 2 | epinephrine biosynthetic process |
GO:0060014 | 0.0018 | Inf | 0.085 | 2 | 2 | granulosa cell differentiation |
GO:0061017 | 0.0018 | Inf | 0.085 | 2 | 2 | hepatoblast differentiation |
GO:2000824 | 0.0018 | Inf | 0.085 | 2 | 2 | negative regulation of androgen receptor activity |
GO:0007631 | 0.0018 | 3.3064 | 3.359 | 10 | 79 | feeding behavior |
GO:0001501 | 0.0019 | 2.1947 | 9.7531 | 20 | 234 | skeletal system development |
GO:0009651 | 0.002 | 6.6759 | 0.9354 | 5 | 22 | response to salt stress |
GO:0016486 | 0.002 | 6.6759 | 0.9354 | 5 | 22 | peptide hormone processing |
GO:0042220 | 0.002 | 5.2439 | 1.3606 | 6 | 32 | response to cocaine |
GO:0003015 | 0.0022 | 2.5836 | 5.8677 | 14 | 138 | heart process |
GO:0007625 | 0.0023 | 9.0674 | 0.5953 | 4 | 14 | grooming behavior |
GO:0021542 | 0.0023 | 9.0674 | 0.5953 | 4 | 14 | dentate gyrus development |
GO:0008217 | 0.0023 | 2.6779 | 5.2724 | 13 | 124 | regulation of blood pressure |
GO:0003310 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | pancreatic A cell differentiation |
GO:0015816 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | glycine transport |
GO:0021957 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | corticospinal tract morphogenesis |
GO:0033504 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | floor plate development |
GO:0045924 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | regulation of female receptivity |
GO:0048752 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | semicircular canal morphogenesis |
GO:0097119 | 0.0024 | 16.978 | 0.2976 | 3 | 7 | postsynaptic density protein 95 clustering |
GO:0030901 | 0.0024 | 5.0493 | 1.4031 | 6 | 33 | midbrain development |
GO:0001963 | 0.0024 | 6.3045 | 0.9779 | 5 | 23 | synaptic transmission, dopaminergic |
GO:0007610 | 0.0024 | 2.0572 | 11.3925 | 22 | 276 | behavior |
GO:0007268 | 0.0025 | 1.8767 | 15.8347 | 28 | 385 | synaptic transmission |
GO:0050877 | 0.0025 | 1.9841 | 12.8687 | 24 | 309 | neurological system process |
GO:0055082 | 0.0026 | 1.8095 | 18.1559 | 31 | 427 | cellular chemical homeostasis |
GO:0009725 | 0.0028 | 1.6319 | 28.5306 | 44 | 671 | response to hormone |
GO:0042127 | 0.0029 | 1.4891 | 47.0266 | 66 | 1106 | regulation of cell proliferation |
GO:0048813 | 0.0029 | 3.0817 | 3.5716 | 10 | 84 | dendrite morphogenesis |
GO:0006935 | 0.0029 | 1.716 | 22.1952 | 36 | 522 | chemotaxis |
GO:0001975 | 0.003 | 5.9722 | 1.0205 | 5 | 24 | response to amphetamine |
GO:0045686 | 0.003 | 5.9722 | 1.0205 | 5 | 24 | negative regulation of glial cell differentiation |
GO:0010628 | 0.003 | 1.4859 | 47.1117 | 66 | 1108 | positive regulation of gene expression |
GO:0021761 | 0.003 | 3.3074 | 3.0189 | 9 | 71 | limbic system development |
GO:0015837 | 0.0032 | 4.7296 | 1.4795 | 6 | 35 | amine transport |
GO:0006355 | 0.0032 | 1.3255 | 118.3319 | 145 | 2783 | regulation of transcription, DNA-templated |
GO:0006812 | 0.0034 | 1.5719 | 32.9563 | 49 | 779 | cation transport |
GO:0042633 | 0.0034 | 3.0001 | 3.6567 | 10 | 86 | hair cycle |
GO:0023061 | 0.0035 | 1.8998 | 13.9464 | 25 | 328 | signal release |
GO:0010453 | 0.0036 | 5.6731 | 1.063 | 5 | 25 | regulation of cell fate commitment |
GO:0021513 | 0.0036 | 5.6731 | 1.063 | 5 | 25 | spinal cord dorsal/ventral patterning |
GO:0003139 | 0.0036 | 13.5813 | 0.3402 | 3 | 8 | secondary heart field specification |
GO:0032229 | 0.0036 | 13.5813 | 0.3402 | 3 | 8 | negative regulation of synaptic transmission, GABAergic |
GO:0046485 | 0.0036 | 13.5813 | 0.3402 | 3 | 8 | ether lipid metabolic process |
GO:0070365 | 0.0036 | 13.5813 | 0.3402 | 3 | 8 | hepatocyte differentiation |
GO:0071236 | 0.0036 | 13.5813 | 0.3402 | 3 | 8 | cellular response to antibiotic |
GO:0007422 | 0.0037 | 3.2035 | 3.1039 | 9 | 73 | peripheral nervous system development |
GO:0008202 | 0.0037 | 2.1496 | 8.9291 | 18 | 210 | steroid metabolic process |
GO:0021543 | 0.0038 | 2.6348 | 4.9323 | 12 | 116 | pallium development |
GO:0048839 | 0.0038 | 2.335 | 6.8882 | 15 | 162 | inner ear development |
GO:0042445 | 0.0038 | 2.6308 | 4.9371 | 12 | 117 | hormone metabolic process |
GO:0010460 | 0.0039 | 7.5549 | 0.6803 | 4 | 16 | positive regulation of heart rate |
GO:0060999 | 0.0039 | 7.5549 | 0.6803 | 4 | 16 | positive regulation of dendritic spine development |
GO:0048667 | 0.0043 | 1.7254 | 19.5758 | 32 | 466 | cell morphogenesis involved in neuron differentiation |
GO:2000179 | 0.0043 | 4.3963 | 1.5732 | 6 | 37 | positive regulation of neural precursor cell proliferation |
GO:0051216 | 0.0044 | 2.4702 | 5.6638 | 13 | 134 | cartilage development |
GO:0035270 | 0.0044 | 2.7159 | 4.3951 | 11 | 104 | endocrine system development |
GO:0007498 | 0.0046 | 2.6982 | 4.422 | 11 | 104 | mesoderm development |
GO:0051241 | 0.0046 | 1.9086 | 12.7559 | 23 | 300 | negative regulation of multicellular organismal process |
GO:0048565 | 0.0047 | 2.5603 | 5.0598 | 12 | 119 | digestive tract development |
GO:0048663 | 0.0047 | 4.3071 | 1.5985 | 6 | 38 | neuron fate commitment |
GO:0023052 | 0.0048 | 1.2939 | 150.3567 | 177 | 3748 | signaling |
GO:1902680 | 0.0048 | 1.4685 | 44.603 | 62 | 1049 | positive regulation of RNA biosynthetic process |
GO:0048704 | 0.0048 | 2.8492 | 3.8268 | 10 | 90 | embryonic skeletal system morphogenesis |
GO:0022404 | 0.0048 | 3.0593 | 3.2315 | 9 | 76 | molting cycle process |
GO:0001568 | 0.0049 | 1.7103 | 19.7291 | 32 | 464 | blood vessel development |
GO:0030878 | 0.0049 | 6.9732 | 0.7228 | 4 | 17 | thyroid gland development |
GO:0034367 | 0.0049 | 6.9732 | 0.7228 | 4 | 17 | macromolecular complex remodeling |
GO:0034369 | 0.0049 | 6.9732 | 0.7228 | 4 | 17 | plasma lipoprotein particle remodeling |
GO:0060914 | 0.0049 | 6.9732 | 0.7228 | 4 | 17 | heart formation |
GO:0003002 | 0.005 | 2.5317 | 5.1041 | 12 | 124 | regionalization |
GO:0001997 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
GO:0009635 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | response to herbicide |
GO:0014049 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | positive regulation of glutamate secretion |
GO:0018963 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | phthalate metabolic process |
GO:0031394 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0035726 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | common myeloid progenitor cell proliferation |
GO:0060061 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | Spemann organizer formation |
GO:0060112 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | generation of ovulation cycle rhythm |
GO:0061146 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | Peyer's patch morphogenesis |
GO:0097211 | 0.0053 | 45.2015 | 0.1276 | 2 | 3 | cellular response to gonadotropin-releasing hormone |
GO:0010935 | 0.0053 | 11.3168 | 0.3827 | 3 | 9 | regulation of macrophage cytokine production |
GO:0015671 | 0.0053 | 11.3168 | 0.3827 | 3 | 9 | oxygen transport |
GO:0090009 | 0.0053 | 11.3168 | 0.3827 | 3 | 9 | primitive streak formation |
GO:0043010 | 0.0055 | 1.9776 | 10.7149 | 20 | 252 | camera-type eye development |
GO:0002700 | 0.0055 | 3.6165 | 2.1685 | 7 | 51 | regulation of production of molecular mediator of immune response |
GO:0009653 | 0.0057 | 1.4638 | 44.1834 | 61 | 1125 | anatomical structure morphogenesis |
GO:0051966 | 0.0057 | 4.1292 | 1.6583 | 6 | 39 | regulation of synaptic transmission, glutamatergic |
GO:0009891 | 0.0058 | 1.4172 | 53.7022 | 72 | 1263 | positive regulation of biosynthetic process |
GO:0032502 | 0.0059 | 1.384 | 71.2058 | 91 | 1925 | developmental process |
GO:0097028 | 0.006 | 4.9319 | 1.1905 | 5 | 28 | dendritic cell differentiation |
GO:0042221 | 0.006 | 1.334 | 89.8808 | 112 | 2172 | response to chemical |
GO:0070374 | 0.006 | 2.7455 | 3.9543 | 10 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0048812 | 0.0061 | 1.6812 | 20.0379 | 32 | 477 | neuron projection morphogenesis |
GO:0031326 | 0.0061 | 1.2823 | 137.3382 | 163 | 3230 | regulation of cellular biosynthetic process |
GO:0007263 | 0.0061 | 6.4746 | 0.7654 | 4 | 18 | nitric oxide mediated signal transduction |
GO:0032892 | 0.0061 | 6.4746 | 0.7654 | 4 | 18 | positive regulation of organic acid transport |
GO:0051412 | 0.0061 | 6.4746 | 0.7654 | 4 | 18 | response to corticosterone |
GO:0050773 | 0.0062 | 2.9275 | 3.359 | 9 | 79 | regulation of dendrite development |
GO:0007626 | 0.0063 | 2.1987 | 7.2708 | 15 | 171 | locomotory behavior |
GO:0030003 | 0.0066 | 1.7963 | 14.6692 | 25 | 345 | cellular cation homeostasis |
GO:0050810 | 0.0068 | 4.7496 | 1.2273 | 5 | 29 | regulation of steroid biosynthetic process |
GO:0007186 | 0.0068 | 1.6805 | 19.405 | 31 | 470 | G-protein coupled receptor signaling pathway |
GO:0006775 | 0.0069 | 4.726 | 1.2331 | 5 | 29 | fat-soluble vitamin metabolic process |
GO:0010470 | 0.0069 | 4.726 | 1.2331 | 5 | 29 | regulation of gastrulation |
GO:0044060 | 0.0069 | 4.726 | 1.2331 | 5 | 29 | regulation of endocrine process |
GO:0032990 | 0.0071 | 1.5302 | 30.9117 | 45 | 727 | cell part morphogenesis |
GO:0051252 | 0.0071 | 1.2864 | 122.754 | 147 | 2887 | regulation of RNA metabolic process |
GO:0014068 | 0.0073 | 3.8926 | 1.7433 | 6 | 41 | positive regulation of phosphatidylinositol 3-kinase signaling |
GO:0035815 | 0.0073 | 9.6993 | 0.4252 | 3 | 10 | positive regulation of renal sodium excretion |
GO:0043084 | 0.0073 | 9.6993 | 0.4252 | 3 | 10 | penile erection |
GO:0048703 | 0.0073 | 9.6993 | 0.4252 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0071379 | 0.0073 | 9.6993 | 0.4252 | 3 | 10 | cellular response to prostaglandin stimulus |
GO:0048665 | 0.0074 | 6.0726 | 0.8041 | 4 | 19 | neuron fate specification |
GO:0001502 | 0.0075 | 6.0424 | 0.8079 | 4 | 19 | cartilage condensation |
GO:0006972 | 0.0075 | 6.0424 | 0.8079 | 4 | 19 | hyperosmotic response |
GO:0007530 | 0.0075 | 6.0424 | 0.8079 | 4 | 19 | sex determination |
GO:0034122 | 0.0075 | 6.0424 | 0.8079 | 4 | 19 | negative regulation of toll-like receptor signaling pathway |
GO:0046661 | 0.0075 | 2.5079 | 4.7197 | 11 | 111 | male sex differentiation |
GO:0048863 | 0.0078 | 1.874 | 11.8207 | 21 | 279 | stem cell differentiation |
GO:0030154 | 0.0079 | 1.5192 | 32.0364 | 46 | 829 | cell differentiation |
GO:0007155 | 0.0079 | 1.4706 | 37.8849 | 53 | 891 | cell adhesion |
GO:0043627 | 0.0079 | 2.2829 | 6.0803 | 13 | 143 | response to estrogen |
GO:0045935 | 0.008 | 1.4065 | 50.9384 | 68 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0040011 | 0.0081 | 1.4028 | 51.8313 | 69 | 1219 | locomotion |
GO:0071805 | 0.0083 | 2.3598 | 5.4425 | 12 | 128 | potassium ion transmembrane transport |
GO:0007600 | 0.0084 | 1.7001 | 17.3055 | 28 | 407 | sensory perception |
GO:0022414 | 0.0084 | 1.4701 | 37.1663 | 52 | 882 | reproductive process |
GO:0007611 | 0.0085 | 2.1162 | 7.526 | 15 | 177 | learning or memory |
GO:0031214 | 0.0087 | 2.5885 | 4.1669 | 10 | 98 | biomineral tissue development |
GO:0006813 | 0.0087 | 2.1752 | 6.8456 | 14 | 161 | potassium ion transport |
GO:0044763 | 0.0088 | 1.2954 | 334.7129 | 358 | 8198 | single-organism cellular process |
GO:0051091 | 0.009 | 2.103 | 7.5685 | 15 | 178 | positive regulation of sequence-specific DNA binding transcription factor activity |
GO:0003309 | 0.0091 | 5.6643 | 0.8504 | 4 | 20 | type B pancreatic cell differentiation |
GO:0036342 | 0.0091 | 5.6643 | 0.8504 | 4 | 20 | post-anal tail morphogenesis |
GO:0051954 | 0.0091 | 5.6643 | 0.8504 | 4 | 20 | positive regulation of amine transport |
GO:0001709 | 0.0092 | 3.6816 | 1.8283 | 6 | 43 | cell fate determination |
GO:0050806 | 0.0092 | 3.2462 | 2.3811 | 7 | 56 | positive regulation of synaptic transmission |
GO:0021772 | 0.0093 | 4.3617 | 1.3181 | 5 | 31 | olfactory bulb development |
GO:0001505 | 0.0094 | 2.2308 | 6.2079 | 13 | 146 | regulation of neurotransmitter levels |
GO:0007411 | 0.0095 | 1.7606 | 14.3291 | 24 | 337 | axon guidance |
GO:0015833 | 0.0095 | 1.9842 | 9.0567 | 17 | 213 | peptide transport |
GO:0003084 | 0.0097 | 8.5181 | 0.4661 | 3 | 11 | positive regulation of systemic arterial blood pressure |
GO:0061458 | 0.0097 | 1.735 | 15.137 | 25 | 356 | reproductive system development |
GO:0021521 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0021903 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0032769 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | negative regulation of monooxygenase activity |
GO:0042416 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | dopamine biosynthetic process |
GO:0042711 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | maternal behavior |
GO:0060068 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | vagina development |
GO:0090030 | 0.0098 | 8.4862 | 0.4677 | 3 | 11 | regulation of steroid hormone biosynthetic process |
GO:0060485 | 0.0099 | 2.0772 | 7.6535 | 15 | 180 | mesenchyme development |
GO:0030902 | 0.0099 | 2.2998 | 5.5701 | 12 | 131 | hindbrain development |
GO:0043408 | 0.0099 | 1.6444 | 19.1338 | 30 | 450 | regulation of MAPK cascade |
GO:0003206 | 0.01 | 2.5305 | 4.252 | 10 | 100 | cardiac chamber morphogenesis |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048568 | 0 | 8.3484 | 1.947 | 13 | 379 | embryonic organ development |
GO:0048704 | 0 | 15.138 | 0.4623 | 6 | 90 | embryonic skeletal system morphogenesis |
GO:0061029 | 0 | 76.0887 | 0.0565 | 3 | 11 | eyelid development in camera-type eye |
GO:0001501 | 0 | 5.8891 | 1.9881 | 10 | 387 | skeletal system development |
GO:0048729 | 0 | 5.2989 | 2.4504 | 11 | 477 | tissue morphogenesis |
GO:0007389 | 0 | 5.717 | 2.0446 | 10 | 398 | pattern specification process |
GO:0032501 | 0 | 2.8009 | 25.737 | 42 | 5010 | multicellular organismal process |
GO:0009952 | 1e-04 | 8.1812 | 0.9761 | 7 | 190 | anterior/posterior pattern specification |
GO:0035108 | 1e-04 | 9.5234 | 0.7141 | 6 | 139 | limb morphogenesis |
GO:0050794 | 1e-04 | 3.1127 | 38.2048 | 53 | 7437 | regulation of cellular process |
GO:0043009 | 1e-04 | 7.305 | 1.096 | 7 | 229 | chordate embryonic development |
GO:0048485 | 1e-04 | 35.7808 | 0.1027 | 3 | 20 | sympathetic nervous system development |
GO:0060669 | 1e-04 | 35.7808 | 0.1027 | 3 | 20 | embryonic placenta morphogenesis |
GO:0048736 | 1e-04 | 8.376 | 0.8065 | 6 | 157 | appendage development |
GO:0021569 | 2e-04 | 199.7778 | 0.0205 | 2 | 4 | rhombomere 3 development |
GO:0002088 | 2e-04 | 15.2204 | 0.298 | 4 | 58 | lens development in camera-type eye |
GO:0042471 | 2e-04 | 10.0032 | 0.5599 | 5 | 109 | ear morphogenesis |
GO:0003180 | 3e-04 | 133.1746 | 0.0257 | 2 | 5 | aortic valve morphogenesis |
GO:0071637 | 3e-04 | 133.1746 | 0.0257 | 2 | 5 | regulation of monocyte chemotactic protein-1 production |
GO:0065007 | 3e-04 | 3.0222 | 42.0165 | 55 | 8179 | biological regulation |
GO:0072175 | 3e-04 | 9.1999 | 0.6062 | 5 | 118 | epithelial tube formation |
GO:0045597 | 4e-04 | 4.1777 | 2.7484 | 10 | 535 | positive regulation of cell differentiation |
GO:0035113 | 4e-04 | 8.9598 | 0.6216 | 5 | 121 | embryonic appendage morphogenesis |
GO:0060429 | 5e-04 | 3.3589 | 4.5464 | 13 | 885 | epithelium development |
GO:0001654 | 6e-04 | 5.3246 | 1.4692 | 7 | 286 | eye development |
GO:0060670 | 7e-04 | 66.5714 | 0.0411 | 2 | 8 | branching involved in labyrinthine layer morphogenesis |
GO:2000679 | 7e-04 | 66.5714 | 0.0411 | 2 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0002011 | 8e-04 | 18.9859 | 0.1798 | 3 | 35 | morphogenesis of an epithelial sheet |
GO:0009887 | 8e-04 | 3.7639 | 3.0544 | 10 | 627 | organ morphogenesis |
GO:0090066 | 8e-04 | 5.0644 | 1.5411 | 7 | 300 | regulation of anatomical structure size |
GO:0016331 | 8e-04 | 7.4634 | 0.7397 | 5 | 144 | morphogenesis of embryonic epithelium |
GO:0060711 | 0.0011 | 16.4137 | 0.2055 | 3 | 40 | labyrinthine layer development |
GO:0035239 | 0.0011 | 4.8119 | 1.6182 | 7 | 315 | tube morphogenesis |
GO:0060712 | 0.0011 | 49.9206 | 0.0514 | 2 | 10 | spongiotrophoblast layer development |
GO:0050793 | 0.0014 | 2.6121 | 7.8084 | 17 | 1520 | regulation of developmental process |
GO:0001709 | 0.0014 | 15.179 | 0.2209 | 3 | 43 | cell fate determination |
GO:0048518 | 0.0014 | 2.2081 | 18.2368 | 30 | 3550 | positive regulation of biological process |
GO:0043518 | 0.0014 | 44.3704 | 0.0565 | 2 | 11 | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0048670 | 0.0014 | 44.3704 | 0.0565 | 2 | 11 | regulation of collateral sprouting |
GO:0060900 | 0.0014 | 44.3704 | 0.0565 | 2 | 11 | embryonic camera-type eye formation |
GO:0019229 | 0.0016 | 14.4539 | 0.2312 | 3 | 45 | regulation of vasoconstriction |
GO:0001841 | 0.0016 | 8.7157 | 0.5034 | 4 | 98 | neural tube formation |
GO:0001649 | 0.002 | 6.1238 | 0.8939 | 5 | 174 | osteoblast differentiation |
GO:0010595 | 0.002 | 13.1928 | 0.2517 | 3 | 49 | positive regulation of endothelial cell migration |
GO:0048812 | 0.0022 | 3.5043 | 2.8819 | 9 | 561 | neuron projection morphogenesis |
GO:0080090 | 0.0023 | 2.0875 | 23.3636 | 35 | 4548 | regulation of primary metabolic process |
GO:0048589 | 0.0023 | 4.8409 | 1.3613 | 6 | 265 | developmental growth |
GO:0050880 | 0.0024 | 7.7216 | 0.5651 | 4 | 110 | regulation of blood vessel size |
GO:0003071 | 0.0026 | 30.7082 | 0.0771 | 2 | 15 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0045664 | 0.0028 | 4.0761 | 1.8956 | 7 | 369 | regulation of neuron differentiation |
GO:0001764 | 0.0033 | 7.0452 | 0.6171 | 4 | 122 | neuron migration |
GO:0060231 | 0.0034 | 26.6095 | 0.0873 | 2 | 17 | mesenchymal to epithelial transition |
GO:0042733 | 0.0034 | 10.8283 | 0.3031 | 3 | 59 | embryonic digit morphogenesis |
GO:0008284 | 0.004 | 3.1722 | 3.1645 | 9 | 616 | positive regulation of cell proliferation |
GO:0031113 | 0.0042 | 23.4753 | 0.0976 | 2 | 19 | regulation of microtubule polymerization |
GO:0051241 | 0.0043 | 4.2525 | 1.5411 | 6 | 300 | negative regulation of multicellular organismal process |
GO:0000902 | 0.0045 | 2.6554 | 5.1423 | 12 | 1001 | cell morphogenesis |
GO:0016055 | 0.0048 | 4.1654 | 1.572 | 6 | 306 | Wnt signaling pathway |
GO:0051960 | 0.005 | 3.3036 | 2.6764 | 8 | 521 | regulation of nervous system development |
GO:0051101 | 0.0051 | 9.3223 | 0.3493 | 3 | 68 | regulation of DNA binding |
GO:0003294 | 0.0051 | Inf | 0.0051 | 1 | 1 | atrial ventricular junction remodeling |
GO:0003365 | 0.0051 | Inf | 0.0051 | 1 | 1 | establishment of cell polarity involved in ameboidal cell migration |
GO:0010232 | 0.0051 | Inf | 0.0051 | 1 | 1 | vascular transport |
GO:0010652 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of cell communication by chemical coupling |
GO:0018009 | 0.0051 | Inf | 0.0051 | 1 | 1 | N-terminal peptidyl-L-cysteine N-palmitoylation |
GO:0021852 | 0.0051 | Inf | 0.0051 | 1 | 1 | pyramidal neuron migration |
GO:0035332 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of hippo signaling |
GO:0035732 | 0.0051 | Inf | 0.0051 | 1 | 1 | nitric oxide storage |
GO:0035898 | 0.0051 | Inf | 0.0051 | 1 | 1 | parathyroid hormone secretion |
GO:0048698 | 0.0051 | Inf | 0.0051 | 1 | 1 | negative regulation of collateral sprouting in absence of injury |
GO:0060156 | 0.0051 | Inf | 0.0051 | 1 | 1 | milk ejection |
GO:0086097 | 0.0051 | Inf | 0.0051 | 1 | 1 | phospholipase C-activating angiotensin-activated signaling pathway |
GO:2000607 | 0.0051 | Inf | 0.0051 | 1 | 1 | negative regulation of cell proliferation involved in mesonephros development |
GO:2000703 | 0.0051 | Inf | 0.0051 | 1 | 1 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
GO:2000734 | 0.0051 | Inf | 0.0051 | 1 | 1 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
GO:2000802 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:2001111 | 0.0051 | Inf | 0.0051 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
GO:2000027 | 0.0053 | 6.1408 | 0.7038 | 4 | 137 | regulation of organ morphogenesis |
GO:0018345 | 0.0056 | 19.9492 | 0.113 | 2 | 22 | protein palmitoylation |
GO:0045909 | 0.0056 | 19.9492 | 0.113 | 2 | 22 | positive regulation of vasodilation |
GO:0046320 | 0.0056 | 19.9492 | 0.113 | 2 | 22 | regulation of fatty acid oxidation |
GO:0010468 | 0.0058 | 1.9835 | 17.1939 | 27 | 3347 | regulation of gene expression |
GO:0001701 | 0.0063 | 3.9113 | 1.6696 | 6 | 325 | in utero embryonic development |
GO:0003013 | 0.0063 | 3.9113 | 1.6696 | 6 | 325 | circulatory system process |
GO:0051674 | 0.0066 | 2.6234 | 4.7159 | 11 | 918 | localization of cell |
GO:0001822 | 0.0067 | 4.5378 | 1.1918 | 5 | 232 | kidney development |
GO:0006357 | 0.0068 | 2.3493 | 6.8375 | 14 | 1331 | regulation of transcription from RNA polymerase II promoter |
GO:2000147 | 0.0068 | 4.5175 | 1.1969 | 5 | 233 | positive regulation of cell motility |
GO:0045444 | 0.0068 | 5.7068 | 0.7552 | 4 | 147 | fat cell differentiation |
GO:0048667 | 0.0069 | 3.1193 | 2.8254 | 8 | 550 | cell morphogenesis involved in neuron differentiation |
GO:0022008 | 0.0069 | 2.4147 | 6.1337 | 13 | 1194 | neurogenesis |
GO:0001933 | 0.007 | 4.4975 | 1.2021 | 5 | 234 | negative regulation of protein phosphorylation |
GO:0051252 | 0.007 | 1.9884 | 14.8309 | 24 | 2887 | regulation of RNA metabolic process |
GO:0032720 | 0.0072 | 17.343 | 0.1284 | 2 | 25 | negative regulation of tumor necrosis factor production |
GO:0031326 | 0.0072 | 1.9526 | 16.5929 | 26 | 3230 | regulation of cellular biosynthetic process |
GO:0019932 | 0.0073 | 5.5881 | 0.7706 | 4 | 150 | second-messenger-mediated signaling |
GO:0042060 | 0.0075 | 3.0719 | 2.8665 | 8 | 558 | wound healing |
GO:0043434 | 0.0077 | 3.7426 | 1.7415 | 6 | 339 | response to peptide hormone |
GO:0003170 | 0.0078 | 16.619 | 0.1336 | 2 | 26 | heart valve development |
GO:0031111 | 0.0078 | 16.619 | 0.1336 | 2 | 26 | negative regulation of microtubule polymerization or depolymerization |
GO:0001843 | 0.0083 | 7.7605 | 0.4161 | 3 | 81 | neural tube closure |
GO:0010556 | 0.0089 | 1.9269 | 15.9662 | 25 | 3108 | regulation of macromolecule biosynthetic process |
GO:0035282 | 0.0092 | 7.4713 | 0.4315 | 3 | 84 | segmentation |
GO:0045766 | 0.0092 | 7.4713 | 0.4315 | 3 | 84 | positive regulation of angiogenesis |
GO:0045834 | 0.0092 | 7.4713 | 0.4315 | 3 | 84 | positive regulation of lipid metabolic process |
GO:0032502 | 0.0093 | 2.1209 | 12.1272 | 20 | 2813 | developmental process |
GO:0007140 | 0.0096 | 14.769 | 0.149 | 2 | 29 | male meiosis |
GO:0009954 | 0.0096 | 14.769 | 0.149 | 2 | 29 | proximal/distal pattern formation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001501 | 0 | 3.6303 | 5.8419 | 19 | 387 | skeletal system development |
GO:0048704 | 0 | 7.5586 | 1.3586 | 9 | 90 | embryonic skeletal system morphogenesis |
GO:0035115 | 1e-04 | 12.8577 | 0.468 | 5 | 31 | embryonic forelimb morphogenesis |
GO:0002062 | 2e-04 | 6.3687 | 1.2227 | 7 | 81 | chondrocyte differentiation |
GO:0001101 | 2e-04 | 3.6962 | 3.5323 | 12 | 234 | response to acid chemical |
GO:0007267 | 5e-04 | 2.1232 | 15.065 | 29 | 998 | cell-cell signaling |
GO:0035113 | 5e-04 | 4.7774 | 1.8265 | 8 | 121 | embryonic appendage morphogenesis |
GO:0061448 | 7e-04 | 3.7071 | 2.9134 | 10 | 193 | connective tissue development |
GO:0035116 | 9e-04 | 10.6413 | 0.4378 | 4 | 29 | embryonic hindlimb morphogenesis |
GO:0035108 | 0.0012 | 4.115 | 2.0982 | 8 | 139 | limb morphogenesis |
GO:0008038 | 0.0013 | 9.4989 | 0.483 | 4 | 32 | neuron recognition |
GO:1902667 | 0.0016 | 15.2811 | 0.2415 | 3 | 16 | regulation of axon guidance |
GO:0071300 | 0.0018 | 6.2939 | 0.8755 | 5 | 58 | cellular response to retinoic acid |
GO:0048568 | 0.0018 | 2.6214 | 5.7211 | 14 | 379 | embryonic organ development |
GO:0021825 | 0.0022 | 43.9471 | 0.0755 | 2 | 5 | substrate-dependent cerebral cortex tangential migration |
GO:1902284 | 0.0023 | 13.2415 | 0.2717 | 3 | 18 | neuron projection extension involved in neuron projection guidance |
GO:0042391 | 0.0024 | 2.7746 | 4.6191 | 12 | 306 | regulation of membrane potential |
GO:0009952 | 0.0024 | 3.3553 | 2.8681 | 9 | 190 | anterior/posterior pattern specification |
GO:0048736 | 0.0026 | 3.6126 | 2.37 | 8 | 157 | appendage development |
GO:0071230 | 0.0027 | 7.5948 | 0.5887 | 4 | 39 | cellular response to amino acid stimulus |
GO:0050795 | 0.0029 | 3.9797 | 1.8869 | 7 | 125 | regulation of behavior |
GO:0007389 | 0.0029 | 2.4878 | 6.0079 | 14 | 398 | pattern specification process |
GO:0055085 | 0.0029 | 1.9036 | 15.382 | 27 | 1019 | transmembrane transport |
GO:0006813 | 0.0031 | 3.517 | 2.4303 | 8 | 161 | potassium ion transport |
GO:0071805 | 0.0033 | 3.8801 | 1.9322 | 7 | 128 | potassium ion transmembrane transport |
GO:0003376 | 0.0033 | 32.9577 | 0.0906 | 2 | 6 | sphingosine-1-phosphate signaling pathway |
GO:0050771 | 0.0033 | 7.1831 | 0.6189 | 4 | 41 | negative regulation of axonogenesis |
GO:0021602 | 0.0037 | 11.0319 | 0.317 | 3 | 21 | cranial nerve morphogenesis |
GO:0061303 | 0.0045 | 26.364 | 0.1057 | 2 | 7 | cornea development in camera-type eye |
GO:0009887 | 0.0052 | 1.9652 | 11.4422 | 21 | 758 | organ morphogenesis |
GO:0061333 | 0.0054 | 9.4536 | 0.3623 | 3 | 24 | renal tubule morphogenesis |
GO:0021546 | 0.006 | 21.9683 | 0.1208 | 2 | 8 | rhombomere development |
GO:0021612 | 0.006 | 21.9683 | 0.1208 | 2 | 8 | facial nerve structural organization |
GO:0048843 | 0.006 | 21.9683 | 0.1208 | 2 | 8 | negative regulation of axon extension involved in axon guidance |
GO:0051917 | 0.006 | 21.9683 | 0.1208 | 2 | 8 | regulation of fibrinolysis |
GO:0001958 | 0.0068 | 8.6302 | 0.3925 | 3 | 26 | endochondral ossification |
GO:0002920 | 0.0068 | 8.6302 | 0.3925 | 3 | 26 | regulation of humoral immune response |
GO:0030195 | 0.0076 | 8.2699 | 0.4076 | 3 | 27 | negative regulation of blood coagulation |
GO:0097320 | 0.0076 | 18.8284 | 0.1359 | 2 | 9 | membrane tubulation |
GO:0060021 | 0.0079 | 4.3238 | 1.2378 | 5 | 82 | palate development |
GO:0010769 | 0.008 | 2.7517 | 3.4568 | 9 | 229 | regulation of cell morphogenesis involved in differentiation |
GO:0046676 | 0.0084 | 7.9385 | 0.4227 | 3 | 28 | negative regulation of insulin secretion |
GO:0060070 | 0.0087 | 2.9171 | 2.8983 | 8 | 192 | canonical Wnt signaling pathway |
GO:2000243 | 0.0093 | 7.6326 | 0.4378 | 3 | 29 | positive regulation of reproductive process |
GO:0072358 | 0.0093 | 1.8824 | 11.3063 | 20 | 749 | cardiovascular system development |
GO:0021561 | 0.0094 | 16.4735 | 0.151 | 2 | 10 | facial nerve development |
GO:0031639 | 0.0094 | 16.4735 | 0.151 | 2 | 10 | plasminogen activation |
GO:0060322 | 0.0094 | 5.2054 | 0.8302 | 4 | 55 | head development |
GO:0032501 | 0.0094 | 1.4255 | 75.6271 | 92 | 5010 | multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032514 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of protein phosphatase type 2B activity |
GO:0042697 | 0.0032 | Inf | 0.0032 | 1 | 1 | menopause |
GO:1990166 | 0.0032 | Inf | 0.0032 | 1 | 1 | protein localization to site of double-strand break |
GO:0007308 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | P granule organization |
GO:0034970 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | histone H3-R2 methylation |
GO:0051533 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | positive regulation of NFAT protein import into nucleus |
GO:0061051 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:1902261 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | positive regulation of delayed rectifier potassium channel activity |
GO:0006584 | 0.0074 | 16.969 | 0.1296 | 2 | 41 | catecholamine metabolic process |
GO:0018242 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | protein O-linked glycosylation via serine |
GO:0051106 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | positive regulation of DNA ligation |
GO:0055025 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | positive regulation of cardiac muscle tissue development |
GO:0006259 | 0.01 | 3.2716 | 2.45 | 7 | 775 | DNA metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 74.0714 | 0.2086 | 7 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0070830 | 0 | 11.6654 | 0.722 | 7 | 45 | tight junction assembly |
GO:0009593 | 0 | 9.0386 | 0.8984 | 7 | 56 | detection of chemical stimulus |
GO:0023052 | 0 | 1.7766 | 70.3673 | 98 | 4386 | signaling |
GO:0045591 | 0 | 93.36 | 0.0802 | 3 | 5 | positive regulation of regulatory T cell differentiation |
GO:0032689 | 1e-04 | 22.73 | 0.2407 | 4 | 15 | negative regulation of interferon-gamma production |
GO:0050906 | 1e-04 | 7.6305 | 1.0428 | 7 | 65 | detection of stimulus involved in sensory perception |
GO:0007606 | 1e-04 | 7.2535 | 1.091 | 7 | 68 | sensory perception of chemical stimulus |
GO:0007165 | 1e-04 | 1.7138 | 63.0675 | 88 | 3931 | signal transduction |
GO:0002718 | 1e-04 | 11.619 | 0.5134 | 5 | 32 | regulation of cytokine production involved in immune response |
GO:0050868 | 2e-04 | 7.8693 | 0.8664 | 6 | 54 | negative regulation of T cell activation |
GO:0034329 | 3e-04 | 3.9054 | 3.0643 | 11 | 191 | cell junction assembly |
GO:0006968 | 3e-04 | 9.5018 | 0.6097 | 5 | 38 | cellular defense response |
GO:0032613 | 4e-04 | 13.151 | 0.369 | 4 | 23 | interleukin-10 production |
GO:0002695 | 6e-04 | 5.3214 | 1.4439 | 7 | 90 | negative regulation of leukocyte activation |
GO:0002682 | 7e-04 | 2.1096 | 13.974 | 27 | 871 | regulation of immune system process |
GO:0002774 | 8e-04 | 123.8706 | 0.0481 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007207 | 8e-04 | 123.8706 | 0.0481 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0050877 | 0.0012 | 2.1678 | 11.4872 | 23 | 716 | neurological system process |
GO:0050896 | 0.0013 | 1.603 | 73.7954 | 94 | 4927 | response to stimulus |
GO:0002765 | 0.0015 | 61.9303 | 0.0642 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0002443 | 0.0016 | 3.5862 | 2.6953 | 9 | 168 | leukocyte mediated immunity |
GO:0007186 | 0.0016 | 2.2326 | 9.6422 | 20 | 601 | G-protein coupled receptor signaling pathway |
GO:0044707 | 0.0016 | 1.5347 | 78.0522 | 99 | 4865 | single-multicellular organism process |
GO:0006955 | 0.0017 | 1.9569 | 15.5463 | 28 | 969 | immune response |
GO:0042267 | 0.0018 | 8.6093 | 0.5294 | 4 | 33 | natural killer cell mediated cytotoxicity |
GO:0009595 | 0.002 | 14.3504 | 0.2567 | 3 | 16 | detection of biotic stimulus |
GO:0002440 | 0.0023 | 4.8309 | 1.3477 | 6 | 84 | production of molecular mediator of immune response |
GO:0030104 | 0.0023 | 8.0525 | 0.5615 | 4 | 35 | water homeostasis |
GO:1902106 | 0.0023 | 5.9067 | 0.9305 | 5 | 58 | negative regulation of leukocyte differentiation |
GO:0019373 | 0.0025 | 41.2836 | 0.0802 | 2 | 5 | epoxygenase P450 pathway |
GO:2001179 | 0.0025 | 41.2836 | 0.0802 | 2 | 5 | regulation of interleukin-10 secretion |
GO:0001906 | 0.0025 | 5.7969 | 0.9466 | 5 | 59 | cell killing |
GO:0010837 | 0.0028 | 12.435 | 0.2888 | 3 | 18 | regulation of keratinocyte proliferation |
GO:0033561 | 0.0028 | 12.435 | 0.2888 | 3 | 18 | regulation of water loss via skin |
GO:0045216 | 0.0031 | 3.2168 | 2.9841 | 9 | 186 | cell-cell junction organization |
GO:0002664 | 0.0037 | 30.9602 | 0.0963 | 2 | 6 | regulation of T cell tolerance induction |
GO:2000668 | 0.0037 | 30.9602 | 0.0963 | 2 | 6 | regulation of dendritic cell apoptotic process |
GO:0071887 | 0.005 | 4.8872 | 1.107 | 5 | 69 | leukocyte apoptotic process |
GO:0046645 | 0.0051 | 24.7662 | 0.1123 | 2 | 7 | positive regulation of gamma-delta T cell activation |
GO:2001198 | 0.0051 | 24.7662 | 0.1123 | 2 | 7 | regulation of dendritic cell differentiation |
GO:0050663 | 0.0064 | 4.5752 | 1.1763 | 5 | 74 | cytokine secretion |
GO:0030857 | 0.0064 | 8.8779 | 0.385 | 3 | 24 | negative regulation of epithelial cell differentiation |
GO:0072643 | 0.0067 | 20.6368 | 0.1283 | 2 | 8 | interferon-gamma secretion |
GO:0002573 | 0.0068 | 3.3585 | 2.214 | 7 | 138 | myeloid leukocyte differentiation |
GO:0051239 | 0.0078 | 1.5772 | 29.0229 | 42 | 1809 | regulation of multicellular organismal process |
GO:0015671 | 0.0086 | 17.6873 | 0.1444 | 2 | 9 | oxygen transport |
GO:0043116 | 0.0086 | 17.6873 | 0.1444 | 2 | 9 | negative regulation of vascular permeability |
GO:0060576 | 0.0086 | 17.6873 | 0.1444 | 2 | 9 | intestinal epithelial cell development |
GO:0019228 | 0.0087 | 4.2233 | 1.2674 | 5 | 79 | neuronal action potential |
GO:0042098 | 0.0093 | 3.5468 | 1.7969 | 6 | 112 | T cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.0484 | 814.8724 | 1118 | 5010 | multicellular organismal process |
GO:0032502 | 0 | 1.8455 | 593.7926 | 818 | 3774 | developmental process |
GO:0007389 | 0 | 4.5615 | 36.9644 | 105 | 231 | pattern specification process |
GO:0045944 | 0 | 2.3946 | 122.3122 | 228 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0022008 | 0 | 2.2745 | 115.4082 | 209 | 730 | neurogenesis |
GO:0010628 | 0 | 1.9293 | 180.2153 | 287 | 1108 | positive regulation of gene expression |
GO:0065007 | 0 | 1.5449 | 1330.3076 | 1493 | 8179 | biological regulation |
GO:2000026 | 0 | 2.0058 | 124.5261 | 207 | 787 | regulation of multicellular organismal development |
GO:0007156 | 0 | 4.5315 | 19.6806 | 56 | 121 | homophilic cell adhesion |
GO:0048729 | 0 | 2.5599 | 57.0278 | 114 | 355 | tissue morphogenesis |
GO:0009891 | 0 | 1.7328 | 205.4259 | 303 | 1263 | positive regulation of biosynthetic process |
GO:0045935 | 0 | 1.7317 | 194.8537 | 288 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009792 | 0 | 2.114 | 90.9209 | 158 | 559 | embryo development ending in birth or egg hatching |
GO:1902680 | 0 | 1.7765 | 170.619 | 258 | 1049 | positive regulation of RNA biosynthetic process |
GO:0009952 | 0 | 5.0917 | 14.4467 | 44 | 90 | anterior/posterior pattern specification |
GO:0009887 | 0 | 2.612 | 46.3988 | 95 | 301 | organ morphogenesis |
GO:0007423 | 0 | 2.7493 | 40.7333 | 86 | 256 | sensory organ development |
GO:0048666 | 0 | 1.8153 | 131.6292 | 204 | 813 | neuron development |
GO:0007517 | 0 | 2.4914 | 47.7605 | 94 | 294 | muscle organ development |
GO:0060173 | 0 | 3.2501 | 25.5359 | 60 | 157 | limb development |
GO:0035107 | 0 | 3.4359 | 22.6082 | 55 | 139 | appendage morphogenesis |
GO:0007267 | 0 | 3.0972 | 26.8639 | 62 | 175 | cell-cell signaling |
GO:0030900 | 0 | 2.3191 | 54.4875 | 102 | 335 | forebrain development |
GO:0042472 | 0 | 4.287 | 14.8011 | 41 | 91 | inner ear morphogenesis |
GO:0021527 | 0 | 72.5616 | 2.4397 | 14 | 15 | spinal cord association neuron differentiation |
GO:0048665 | 0 | 39.045 | 2.7558 | 15 | 17 | neuron fate specification |
GO:0009953 | 0 | 4.0761 | 15.585 | 42 | 96 | dorsal/ventral pattern formation |
GO:0006355 | 0 | 1.4207 | 452.6527 | 563 | 2783 | regulation of transcription, DNA-templated |
GO:0021517 | 0 | 7.1223 | 7.3192 | 26 | 45 | ventral spinal cord development |
GO:0050767 | 0 | 2.4914 | 40.4949 | 80 | 251 | regulation of neurogenesis |
GO:0007187 | 0 | 3.3574 | 20.8191 | 50 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0034765 | 0 | 2.4731 | 40.7242 | 80 | 251 | regulation of ion transmembrane transport |
GO:0060537 | 0 | 2.3712 | 45.09 | 86 | 278 | muscle tissue development |
GO:0048562 | 0 | 3.2439 | 21.1403 | 50 | 133 | embryonic organ morphogenesis |
GO:0045666 | 0 | 4.4535 | 12.3613 | 35 | 76 | positive regulation of neuron differentiation |
GO:0000904 | 0 | 1.7702 | 110.3593 | 169 | 682 | cell morphogenesis involved in differentiation |
GO:0050794 | 0 | 1.3982 | 680.5941 | 785 | 4480 | regulation of cellular process |
GO:0007155 | 0 | 2.1371 | 56.4293 | 100 | 352 | cell adhesion |
GO:0048870 | 0 | 1.6526 | 149.3119 | 216 | 918 | cell motility |
GO:0048704 | 0 | 5.9386 | 7.9064 | 26 | 49 | embryonic skeletal system morphogenesis |
GO:0007218 | 0 | 3.9403 | 13.9878 | 37 | 86 | neuropeptide signaling pathway |
GO:0007268 | 0 | 2.0586 | 58.4497 | 101 | 367 | synaptic transmission |
GO:0051252 | 0 | 1.3686 | 469.5682 | 570 | 2887 | regulation of RNA metabolic process |
GO:0048565 | 0 | 3.3319 | 17.5301 | 42 | 108 | digestive tract development |
GO:0030802 | 0 | 4.8847 | 9.3903 | 28 | 58 | regulation of cyclic nucleotide biosynthetic process |
GO:0021953 | 0 | 3.6345 | 14.5976 | 37 | 91 | central nervous system neuron differentiation |
GO:0001655 | 0 | 2.1955 | 45.8671 | 83 | 282 | urogenital system development |
GO:0061217 | 0 | 11.8517 | 3.7409 | 16 | 23 | regulation of mesonephros development |
GO:1900371 | 0 | 4.7258 | 9.5537 | 28 | 59 | regulation of purine nucleotide biosynthetic process |
GO:0007399 | 0 | 2.4551 | 32.1954 | 64 | 218 | nervous system development |
GO:0030810 | 0 | 4.8436 | 9.1084 | 27 | 56 | positive regulation of nucleotide biosynthetic process |
GO:0001568 | 0 | 1.8671 | 75.4692 | 121 | 464 | blood vessel development |
GO:0060349 | 0 | 3.9078 | 12.524 | 33 | 77 | bone morphogenesis |
GO:0001657 | 0 | 3.5084 | 14.9637 | 37 | 92 | ureteric bud development |
GO:0001764 | 0 | 3.0705 | 19.3237 | 44 | 119 | neuron migration |
GO:0009954 | 0 | 8.4898 | 4.7168 | 18 | 29 | proximal/distal pattern formation |
GO:0021515 | 0 | 6.4586 | 6.1459 | 21 | 38 | cell differentiation in spinal cord |
GO:0050877 | 0 | 2.3058 | 37.1652 | 70 | 235 | neurological system process |
GO:0072163 | 0 | 3.4455 | 15.1264 | 37 | 93 | mesonephric epithelium development |
GO:0001763 | 0 | 2.7185 | 23.7401 | 50 | 147 | morphogenesis of a branching structure |
GO:0045165 | 0 | 3.9457 | 11.2141 | 30 | 71 | cell fate commitment |
GO:0030801 | 0 | 4.3882 | 9.5963 | 27 | 59 | positive regulation of cyclic nucleotide metabolic process |
GO:0060429 | 0 | 2.1367 | 43.135 | 77 | 275 | epithelium development |
GO:0007586 | 0 | 3.3507 | 14.9637 | 36 | 92 | digestion |
GO:0006937 | 0 | 2.915 | 19.5179 | 43 | 120 | regulation of muscle contraction |
GO:0035115 | 0 | 7.1824 | 5.0421 | 18 | 31 | embryonic forelimb morphogenesis |
GO:0006813 | 0 | 2.6761 | 23.5222 | 49 | 145 | potassium ion transport |
GO:0003015 | 0 | 2.6977 | 22.4456 | 47 | 138 | heart process |
GO:0006874 | 0 | 2.1723 | 38.8732 | 70 | 239 | cellular calcium ion homeostasis |
GO:0007204 | 0 | 2.595 | 24.0032 | 49 | 148 | positive regulation of cytosolic calcium ion concentration |
GO:0048593 | 0 | 3.1103 | 16.1023 | 37 | 99 | camera-type eye morphogenesis |
GO:0048557 | 0 | 10.3601 | 3.4156 | 14 | 21 | embryonic digestive tract morphogenesis |
GO:0051049 | 0 | 1.5075 | 165.6 | 224 | 1027 | regulation of transport |
GO:0008217 | 0 | 2.77 | 20.1685 | 43 | 124 | regulation of blood pressure |
GO:0003012 | 0 | 2.0667 | 43.7526 | 76 | 269 | muscle system process |
GO:0048663 | 0 | 6.8678 | 4.8276 | 17 | 30 | neuron fate commitment |
GO:0010556 | 0 | 1.308 | 505.5136 | 595 | 3108 | regulation of macromolecule biosynthetic process |
GO:0040007 | 0 | 1.5972 | 118.8965 | 169 | 731 | growth |
GO:0006935 | 0 | 1.7171 | 84.9029 | 128 | 522 | chemotaxis |
GO:0033555 | 0 | 6.8138 | 4.8594 | 17 | 30 | multicellular organismal response to stress |
GO:0021511 | 0 | 7.5391 | 4.3915 | 16 | 27 | spinal cord patterning |
GO:0031327 | 0 | 3.7246 | 10.858 | 28 | 68 | negative regulation of cellular biosynthetic process |
GO:0008284 | 0 | 1.7803 | 71.4326 | 111 | 447 | positive regulation of cell proliferation |
GO:0023061 | 0 | 1.9273 | 53.3489 | 88 | 328 | signal release |
GO:0050801 | 0 | 1.7489 | 76.4451 | 117 | 470 | ion homeostasis |
GO:0042755 | 0 | 9.0642 | 3.5783 | 14 | 22 | eating behavior |
GO:0001709 | 0 | 5.8496 | 5.5179 | 18 | 34 | cell fate determination |
GO:0030878 | 0 | 12.4223 | 2.765 | 12 | 17 | thyroid gland development |
GO:0048701 | 0 | 6.3113 | 5.0314 | 17 | 31 | embryonic cranial skeleton morphogenesis |
GO:0001501 | 0 | 2.4419 | 24.8751 | 49 | 158 | skeletal system development |
GO:0045596 | 0 | 1.7936 | 65.89 | 103 | 408 | negative regulation of cell differentiation |
GO:0051716 | 0 | 1.2621 | 778.1136 | 874 | 4784 | cellular response to stimulus |
GO:0072078 | 0 | 9.6154 | 3.253 | 13 | 20 | nephron tubule morphogenesis |
GO:0042693 | 0 | 14.2283 | 2.4397 | 11 | 15 | muscle cell fate commitment |
GO:0031326 | 0 | 1.3353 | 354.2235 | 428 | 2239 | regulation of cellular biosynthetic process |
GO:0045665 | 0 | 4.1179 | 8.4578 | 23 | 52 | negative regulation of neuron differentiation |
GO:0032990 | 0 | 1.5561 | 118.2459 | 165 | 727 | cell part morphogenesis |
GO:0034654 | 0 | 1.2921 | 478.4043 | 560 | 2972 | nucleobase-containing compound biosynthetic process |
GO:0001503 | 0 | 2.5673 | 20.6786 | 42 | 128 | ossification |
GO:0098660 | 0 | 1.6819 | 80.0234 | 119 | 492 | inorganic ion transmembrane transport |
GO:0030819 | 0 | 4.3588 | 7.4819 | 21 | 46 | positive regulation of cAMP biosynthetic process |
GO:0030198 | 0 | 1.8772 | 51.2345 | 83 | 315 | extracellular matrix organization |
GO:0021516 | 0 | Inf | 1.1321 | 7 | 7 | dorsal spinal cord development |
GO:0023019 | 0 | 8.4127 | 3.4156 | 13 | 21 | signal transduction involved in regulation of gene expression |
GO:0050679 | 0 | 2.6053 | 19.5179 | 40 | 120 | positive regulation of epithelial cell proliferation |
GO:0007626 | 0 | 2.9314 | 14.8748 | 33 | 92 | locomotory behavior |
GO:0043010 | 0 | 5.0193 | 5.9108 | 18 | 37 | camera-type eye development |
GO:0071805 | 0 | 2.5788 | 19.6436 | 40 | 121 | potassium ion transmembrane transport |
GO:0072077 | 0 | 11.3815 | 2.6024 | 11 | 16 | renal vesicle morphogenesis |
GO:0090190 | 0 | 11.3815 | 2.6024 | 11 | 16 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0001838 | 0 | 2.6045 | 19.03 | 39 | 117 | embryonic epithelial tube formation |
GO:0060021 | 0 | 3.1464 | 12.5046 | 29 | 77 | palate development |
GO:0009914 | 0 | 2.0078 | 38.7105 | 66 | 238 | hormone transport |
GO:0008406 | 0 | 8.9889 | 3.0568 | 12 | 19 | gonad development |
GO:0007186 | 0 | 1.8092 | 55.0475 | 87 | 349 | G-protein coupled receptor signaling pathway |
GO:0060419 | 0 | 3.9369 | 8.2951 | 22 | 51 | heart growth |
GO:0042474 | 0 | 8.8714 | 3.0903 | 12 | 19 | middle ear morphogenesis |
GO:0009719 | 0 | 1.8595 | 49.0006 | 79 | 308 | response to endogenous stimulus |
GO:1900544 | 0 | 3.1631 | 12.036 | 28 | 74 | positive regulation of purine nucleotide metabolic process |
GO:0021983 | 0 | 4.4783 | 6.6686 | 19 | 41 | pituitary gland development |
GO:0007190 | 0 | 6.5903 | 4.0662 | 14 | 25 | activation of adenylate cyclase activity |
GO:0045597 | 0 | 1.7241 | 65.0794 | 99 | 408 | positive regulation of cell differentiation |
GO:0007631 | 0 | 3.8337 | 8.4058 | 22 | 52 | feeding behavior |
GO:0051171 | 0 | 1.2567 | 588.1394 | 671 | 3616 | regulation of nitrogen compound metabolic process |
GO:0030030 | 0 | 1.4431 | 161.5106 | 212 | 993 | cell projection organization |
GO:0000122 | 0 | 1.5963 | 90.2703 | 129 | 555 | negative regulation of transcription from RNA polymerase II promoter |
GO:0055021 | 0 | 5.1807 | 5.2048 | 16 | 32 | regulation of cardiac muscle tissue growth |
GO:0050908 | 0 | 15.5081 | 1.9518 | 9 | 12 | detection of light stimulus involved in visual perception |
GO:0007492 | 0 | 3.1167 | 11.7107 | 27 | 72 | endoderm development |
GO:0035148 | 0 | 2.3995 | 21.1444 | 41 | 130 | tube formation |
GO:0007200 | 0 | 4.4582 | 6.3252 | 18 | 39 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0030858 | 0 | 4.4429 | 6.3433 | 18 | 39 | positive regulation of epithelial cell differentiation |
GO:0031076 | 0 | 4.4429 | 6.3433 | 18 | 39 | embryonic camera-type eye development |
GO:0042445 | 0 | 2.3338 | 22.6082 | 43 | 139 | hormone metabolic process |
GO:0022898 | 0 | 2.4222 | 20.4938 | 40 | 126 | regulation of transmembrane transporter activity |
GO:0007600 | 0 | 1.7734 | 54.6548 | 85 | 339 | sensory perception |
GO:0048468 | 0 | 1.7787 | 53.0055 | 83 | 351 | cell development |
GO:0044708 | 0 | 2.3439 | 21.9631 | 42 | 137 | single-organism behavior |
GO:0007422 | 0 | 3.0486 | 11.8734 | 27 | 73 | peripheral nervous system development |
GO:0042481 | 0 | 20.7182 | 1.6233 | 8 | 10 | regulation of odontogenesis |
GO:0007270 | 0 | 3.1885 | 10.6708 | 25 | 66 | neuron-neuron synaptic transmission |
GO:0060579 | 0 | 10.3418 | 2.4397 | 10 | 15 | ventral spinal cord interneuron fate commitment |
GO:0071371 | 0 | 10.3418 | 2.4397 | 10 | 15 | cellular response to gonadotropin stimulus |
GO:0009799 | 0 | 2.6833 | 15.289 | 32 | 94 | specification of symmetry |
GO:0022037 | 0 | 2.7311 | 14.6384 | 31 | 90 | metencephalon development |
GO:0048333 | 0 | 5.1787 | 4.8795 | 15 | 30 | mesodermal cell differentiation |
GO:0072089 | 0 | 3.9695 | 7.1122 | 19 | 44 | stem cell proliferation |
GO:0001658 | 0 | 4.4302 | 5.9885 | 17 | 37 | branching involved in ureteric bud morphogenesis |
GO:0021915 | 0 | 2.2121 | 24.56 | 45 | 151 | neural tube development |
GO:0001662 | 0 | 6.9122 | 3.4101 | 12 | 21 | behavioral fear response |
GO:0051155 | 0 | 6.1166 | 3.9036 | 13 | 24 | positive regulation of striated muscle cell differentiation |
GO:0055082 | 0 | 1.6479 | 69.4512 | 102 | 427 | cellular chemical homeostasis |
GO:0055117 | 0 | 3.315 | 9.5963 | 23 | 59 | regulation of cardiac muscle contraction |
GO:0072522 | 0 | 2.027 | 31.3913 | 54 | 193 | purine-containing compound biosynthetic process |
GO:0060688 | 0 | 4.0633 | 6.6583 | 18 | 41 | regulation of morphogenesis of a branching structure |
GO:0019233 | 0 | 3.5243 | 8.4355 | 21 | 52 | sensory perception of pain |
GO:0007275 | 0 | 1.71 | 55.6653 | 85 | 419 | multicellular organismal development |
GO:0048706 | 0 | 5.2832 | 4.4776 | 14 | 28 | embryonic skeletal system development |
GO:0048935 | 0 | 11.6299 | 2.1144 | 9 | 13 | peripheral nervous system neuron development |
GO:0030815 | 0 | 4.8545 | 5.0421 | 15 | 31 | negative regulation of cAMP metabolic process |
GO:0007417 | 0 | 2.7151 | 13.6028 | 29 | 88 | central nervous system development |
GO:0030003 | 0 | 1.7125 | 56.114 | 85 | 345 | cellular cation homeostasis |
GO:0048332 | 0 | 3.0177 | 11.0601 | 25 | 68 | mesoderm morphogenesis |
GO:0030803 | 0 | 5.1766 | 4.5542 | 14 | 28 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0031018 | 0 | 5.6275 | 4.0535 | 13 | 25 | endocrine pancreas development |
GO:0009880 | 0 | 3.403 | 8.6204 | 21 | 53 | embryonic pattern specification |
GO:0035813 | 0 | 8.6174 | 2.6024 | 10 | 16 | regulation of renal sodium excretion |
GO:0031069 | 0 | 5.6063 | 4.0662 | 13 | 25 | hair follicle morphogenesis |
GO:0045880 | 0 | 5.6063 | 4.0662 | 13 | 25 | positive regulation of smoothened signaling pathway |
GO:0048731 | 0 | 1.4678 | 117.2572 | 157 | 853 | system development |
GO:0007620 | 0 | 7.1114 | 3.0903 | 11 | 19 | copulation |
GO:0060041 | 0 | 2.37 | 18.7047 | 36 | 115 | retina development in camera-type eye |
GO:0014013 | 0 | 3.0373 | 10.5722 | 24 | 65 | regulation of gliogenesis |
GO:0046661 | 0 | 2.5661 | 15.2426 | 31 | 94 | male sex differentiation |
GO:0048762 | 0 | 13.9674 | 1.7689 | 8 | 11 | mesenchymal cell differentiation |
GO:0060573 | 1e-04 | 13.7782 | 1.7891 | 8 | 11 | cell fate specification involved in pattern specification |
GO:0030814 | 1e-04 | 3.319 | 8.7405 | 21 | 54 | regulation of cAMP metabolic process |
GO:0071300 | 1e-04 | 3.1693 | 9.4337 | 22 | 58 | cellular response to retinoic acid |
GO:0045761 | 1e-04 | 4.8502 | 4.7013 | 14 | 29 | regulation of adenylate cyclase activity |
GO:0009260 | 1e-04 | 1.9788 | 30.7407 | 52 | 189 | ribonucleotide biosynthetic process |
GO:0035116 | 1e-04 | 4.8311 | 4.7168 | 14 | 29 | embryonic hindlimb morphogenesis |
GO:1902679 | 1e-04 | 1.4266 | 133.8603 | 175 | 823 | negative regulation of RNA biosynthetic process |
GO:0019953 | 1e-04 | 1.5382 | 86.2041 | 120 | 530 | sexual reproduction |
GO:0048598 | 1e-04 | 2.029 | 27.7027 | 48 | 178 | embryonic morphogenesis |
GO:1901700 | 1e-04 | 1.4194 | 137.4881 | 179 | 853 | response to oxygen-containing compound |
GO:0021587 | 1e-04 | 4.143 | 5.8554 | 16 | 36 | cerebellum morphogenesis |
GO:0060541 | 1e-04 | 1.9459 | 31.7166 | 53 | 195 | respiratory system development |
GO:0021542 | 1e-04 | 9.3031 | 2.2771 | 9 | 14 | dentate gyrus development |
GO:0051216 | 1e-04 | 3.6368 | 7.0749 | 18 | 44 | cartilage development |
GO:0003382 | 1e-04 | 3.8286 | 6.506 | 17 | 40 | epithelial cell morphogenesis |
GO:0030901 | 1e-04 | 4.3143 | 5.3674 | 15 | 33 | midbrain development |
GO:0021892 | 1e-04 | 18.0768 | 1.4638 | 7 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0030828 | 1e-04 | 18.0768 | 1.4638 | 7 | 9 | positive regulation of cGMP biosynthetic process |
GO:0072048 | 1e-04 | 18.0768 | 1.4638 | 7 | 9 | renal system pattern specification |
GO:0071875 | 1e-04 | 7.3856 | 2.765 | 10 | 17 | adrenergic receptor signaling pathway |
GO:0048485 | 1e-04 | 6.3207 | 3.253 | 11 | 20 | sympathetic nervous system development |
GO:0048609 | 1e-04 | 1.5113 | 90.2929 | 124 | 556 | multicellular organismal reproductive process |
GO:0016202 | 1e-04 | 2.6028 | 13.6322 | 28 | 84 | regulation of striated muscle tissue development |
GO:0009605 | 1e-04 | 1.4084 | 138.3182 | 179 | 872 | response to external stimulus |
GO:1900372 | 1e-04 | 4.5287 | 4.8795 | 14 | 30 | negative regulation of purine nucleotide biosynthetic process |
GO:0007548 | 1e-04 | 4.154 | 5.4559 | 15 | 34 | sex differentiation |
GO:0048638 | 1e-04 | 2.3033 | 17.9981 | 34 | 111 | regulation of developmental growth |
GO:0050896 | 1e-04 | 1.4832 | 100.7157 | 135 | 690 | response to stimulus |
GO:0031281 | 1e-04 | 4.8158 | 4.3829 | 13 | 27 | positive regulation of cyclase activity |
GO:0061303 | 1e-04 | 30.9766 | 1.1385 | 6 | 7 | cornea development in camera-type eye |
GO:0072207 | 1e-04 | 4.8045 | 4.3915 | 13 | 27 | metanephric epithelium development |
GO:0021779 | 1e-04 | Inf | 0.8132 | 5 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 1e-04 | Inf | 0.8132 | 5 | 5 | glial cell fate specification |
GO:0051122 | 1e-04 | Inf | 0.8132 | 5 | 5 | hepoxilin biosynthetic process |
GO:0051891 | 1e-04 | Inf | 0.8132 | 5 | 5 | positive regulation of cardioblast differentiation |
GO:0060406 | 1e-04 | Inf | 0.8132 | 5 | 5 | positive regulation of penile erection |
GO:0072172 | 1e-04 | Inf | 0.8132 | 5 | 5 | mesonephric tubule formation |
GO:0001704 | 1e-04 | 2.6607 | 12.4642 | 26 | 77 | formation of primary germ layer |
GO:0007411 | 1e-04 | 1.6892 | 50.5999 | 76 | 312 | axon guidance |
GO:0031214 | 1e-04 | 2.4031 | 15.9396 | 31 | 98 | biomineral tissue development |
GO:0072358 | 1e-04 | 1.651 | 55.5289 | 82 | 348 | cardiovascular system development |
GO:0032844 | 1e-04 | 1.7767 | 40.9876 | 64 | 252 | regulation of homeostatic process |
GO:0007193 | 1e-04 | 3.2816 | 7.9698 | 19 | 49 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0048484 | 1e-04 | 10.3327 | 1.9518 | 8 | 12 | enteric nervous system development |
GO:2001053 | 1e-04 | 10.3327 | 1.9518 | 8 | 12 | regulation of mesenchymal cell apoptotic process |
GO:0001975 | 1e-04 | 5.1725 | 3.9036 | 12 | 24 | response to amphetamine |
GO:0030325 | 1e-04 | 5.1725 | 3.9036 | 12 | 24 | adrenal gland development |
GO:0046620 | 1e-04 | 2.8398 | 10.5722 | 23 | 65 | regulation of organ growth |
GO:0035282 | 1e-04 | 5.7445 | 3.3877 | 11 | 21 | segmentation |
GO:0098655 | 1e-04 | 1.5202 | 81.8125 | 113 | 503 | cation transmembrane transport |
GO:0052652 | 1e-04 | 6.5488 | 2.8952 | 10 | 18 | cyclic purine nucleotide metabolic process |
GO:0060512 | 1e-04 | 4.2619 | 5.0421 | 14 | 31 | prostate gland morphogenesis |
GO:0001759 | 1e-04 | 5.6881 | 3.4156 | 11 | 21 | organ induction |
GO:0008285 | 2e-04 | 1.5181 | 81.1619 | 112 | 499 | negative regulation of cell proliferation |
GO:0014855 | 2e-04 | 3.5216 | 6.8313 | 17 | 42 | striated muscle cell proliferation |
GO:0051241 | 2e-04 | 1.7088 | 46.162 | 70 | 285 | negative regulation of multicellular organismal process |
GO:0007263 | 2e-04 | 6.4618 | 2.9277 | 10 | 18 | nitric oxide mediated signal transduction |
GO:0009266 | 2e-04 | 2.3084 | 16.9155 | 32 | 104 | response to temperature stimulus |
GO:0051047 | 2e-04 | 1.8375 | 34.319 | 55 | 211 | positive regulation of secretion |
GO:0048545 | 2e-04 | 2.2001 | 19.1018 | 35 | 119 | response to steroid hormone |
GO:0060425 | 2e-04 | 3.1754 | 8.1325 | 19 | 50 | lung morphogenesis |
GO:0048265 | 2e-04 | 4.4838 | 4.5542 | 13 | 28 | response to pain |
GO:0009187 | 2e-04 | 2.6204 | 12.095 | 25 | 75 | cyclic nucleotide metabolic process |
GO:0070838 | 2e-04 | 1.6919 | 46.5177 | 70 | 286 | divalent metal ion transport |
GO:0030111 | 2e-04 | 1.8706 | 31.3913 | 51 | 193 | regulation of Wnt signaling pathway |
GO:0010453 | 2e-04 | 4.7742 | 4.0662 | 12 | 25 | regulation of cell fate commitment |
GO:2000826 | 2e-04 | 4.7742 | 4.0662 | 12 | 25 | regulation of heart morphogenesis |
GO:0003211 | 2e-04 | 12.0501 | 1.6265 | 7 | 10 | cardiac ventricle formation |
GO:0021936 | 2e-04 | 12.0501 | 1.6265 | 7 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:0042391 | 2e-04 | 1.6812 | 46.7273 | 70 | 288 | regulation of membrane potential |
GO:0001756 | 2e-04 | 3.0823 | 8.2808 | 19 | 51 | somitogenesis |
GO:0043270 | 2e-04 | 2.1883 | 18.6496 | 34 | 115 | positive regulation of ion transport |
GO:0046660 | 2e-04 | 2.3245 | 15.777 | 30 | 97 | female sex differentiation |
GO:0006171 | 2e-04 | 3.7265 | 5.8168 | 15 | 36 | cAMP biosynthetic process |
GO:0045909 | 3e-04 | 5.1705 | 3.5783 | 11 | 22 | positive regulation of vasodilation |
GO:0070374 | 3e-04 | 2.3518 | 15.1264 | 29 | 93 | positive regulation of ERK1 and ERK2 cascade |
GO:0044060 | 3e-04 | 4.2031 | 4.7168 | 13 | 29 | regulation of endocrine process |
GO:0060562 | 3e-04 | 2.0313 | 22.5239 | 39 | 141 | epithelial tube morphogenesis |
GO:0035987 | 3e-04 | 3.4512 | 6.506 | 16 | 40 | endodermal cell differentiation |
GO:0007530 | 3e-04 | 5.7433 | 3.0903 | 10 | 19 | sex determination |
GO:0007611 | 3e-04 | 2.3286 | 15.218 | 29 | 94 | learning or memory |
GO:0051482 | 3e-04 | 8.2654 | 2.1144 | 8 | 13 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0060219 | 3e-04 | 8.2654 | 2.1144 | 8 | 13 | camera-type eye photoreceptor cell differentiation |
GO:0071599 | 3e-04 | 8.2654 | 2.1144 | 8 | 13 | otic vesicle development |
GO:0072210 | 3e-04 | 6.6799 | 2.5907 | 9 | 16 | metanephric nephron development |
GO:0030823 | 3e-04 | 6.6438 | 2.6024 | 9 | 16 | regulation of cGMP metabolic process |
GO:0007215 | 3e-04 | 2.715 | 10.4095 | 22 | 64 | glutamate receptor signaling pathway |
GO:0040011 | 3e-04 | 1.6647 | 46.3036 | 69 | 295 | locomotion |
GO:0001947 | 3e-04 | 2.9824 | 8.4578 | 19 | 52 | heart looping |
GO:0006812 | 3e-04 | 1.6908 | 43.135 | 65 | 270 | cation transport |
GO:0035850 | 3e-04 | 3.8125 | 5.3674 | 14 | 33 | epithelial cell differentiation involved in kidney development |
GO:0006836 | 3e-04 | 1.9738 | 24.2347 | 41 | 149 | neurotransmitter transport |
GO:0071495 | 3e-04 | 1.3743 | 132.8056 | 169 | 819 | cellular response to endogenous stimulus |
GO:0030182 | 3e-04 | 2.7409 | 9.7408 | 21 | 64 | neuron differentiation |
GO:0042462 | 3e-04 | 4.4328 | 4.2289 | 12 | 26 | eye photoreceptor cell development |
GO:0007565 | 3e-04 | 2.0781 | 20.4938 | 36 | 126 | female pregnancy |
GO:0048518 | 3e-04 | 1.2536 | 310.0801 | 361 | 2002 | positive regulation of biological process |
GO:0007368 | 4e-04 | 2.374 | 13.9878 | 27 | 86 | determination of left/right symmetry |
GO:0021546 | 4e-04 | 15.4868 | 1.3012 | 6 | 8 | rhombomere development |
GO:0048793 | 4e-04 | 15.4868 | 1.3012 | 6 | 8 | pronephros development |
GO:1901293 | 4e-04 | 1.7094 | 40.1743 | 61 | 247 | nucleoside phosphate biosynthetic process |
GO:0051145 | 4e-04 | 3.319 | 6.6583 | 16 | 41 | smooth muscle cell differentiation |
GO:0008585 | 4e-04 | 2.408 | 13.3372 | 26 | 82 | female gonad development |
GO:0072091 | 4e-04 | 2.408 | 13.3372 | 26 | 82 | regulation of stem cell proliferation |
GO:0090087 | 4e-04 | 1.8877 | 27.4877 | 45 | 169 | regulation of peptide transport |
GO:0009712 | 4e-04 | 3.3128 | 6.6686 | 16 | 41 | catechol-containing compound metabolic process |
GO:0030323 | 4e-04 | 1.8696 | 28.301 | 46 | 174 | respiratory tube development |
GO:0051349 | 4e-04 | 3.9649 | 4.8699 | 13 | 30 | positive regulation of lyase activity |
GO:0046530 | 4e-04 | 3.1434 | 7.3192 | 17 | 45 | photoreceptor cell differentiation |
GO:0060795 | 4e-04 | 3.9555 | 4.8795 | 13 | 30 | cell fate commitment involved in formation of primary germ layer |
GO:2000736 | 4e-04 | 2.4967 | 12.0035 | 24 | 74 | regulation of stem cell differentiation |
GO:0022414 | 4e-04 | 2.541 | 11.2982 | 23 | 72 | reproductive process |
GO:0001822 | 4e-04 | 1.8053 | 31.5623 | 50 | 195 | kidney development |
GO:0048708 | 5e-04 | 3.632 | 5.5169 | 14 | 34 | astrocyte differentiation |
GO:0021879 | 5e-04 | 5.1987 | 3.2372 | 10 | 20 | forebrain neuron differentiation |
GO:0001570 | 5e-04 | 2.5365 | 11.3854 | 23 | 70 | vasculogenesis |
GO:0007194 | 5e-04 | 5.1685 | 3.253 | 10 | 20 | negative regulation of adenylate cyclase activity |
GO:0045823 | 5e-04 | 5.1685 | 3.253 | 10 | 20 | positive regulation of heart contraction |
GO:0030326 | 5e-04 | 2.462 | 12.1064 | 24 | 75 | embryonic limb morphogenesis |
GO:0042493 | 5e-04 | 1.6024 | 51.2345 | 74 | 315 | response to drug |
GO:0023056 | 5e-04 | 1.3465 | 143.7763 | 180 | 890 | positive regulation of signaling |
GO:0060070 | 5e-04 | 2.1594 | 17.1479 | 31 | 106 | canonical Wnt signaling pathway |
GO:0010629 | 5e-04 | 1.3388 | 150.1252 | 187 | 923 | negative regulation of gene expression |
GO:0015698 | 5e-04 | 2.1927 | 16.4276 | 30 | 101 | inorganic anion transport |
GO:0043589 | 5e-04 | 3.3748 | 6.1807 | 15 | 38 | skin morphogenesis |
GO:0048538 | 5e-04 | 3.3748 | 6.1807 | 15 | 38 | thymus development |
GO:0008344 | 5e-04 | 2.4004 | 12.8493 | 25 | 79 | adult locomotory behavior |
GO:0045620 | 5e-04 | 4.1369 | 4.3915 | 12 | 27 | negative regulation of lymphocyte differentiation |
GO:0003206 | 5e-04 | 2.448 | 12.1634 | 24 | 75 | cardiac chamber morphogenesis |
GO:0042886 | 5e-04 | 1.7357 | 35.7828 | 55 | 220 | amide transport |
GO:0002027 | 5e-04 | 2.8181 | 8.7659 | 19 | 54 | regulation of heart rate |
GO:0072273 | 5e-04 | 5.823 | 2.761 | 9 | 17 | metanephric nephron morphogenesis |
GO:0030539 | 5e-04 | 5.8128 | 2.765 | 9 | 17 | male genitalia development |
GO:0032332 | 5e-04 | 5.8128 | 2.765 | 9 | 17 | positive regulation of chondrocyte differentiation |
GO:0060914 | 5e-04 | 5.8128 | 2.765 | 9 | 17 | heart formation |
GO:0071773 | 5e-04 | 5.8128 | 2.765 | 9 | 17 | cellular response to BMP stimulus |
GO:0061035 | 6e-04 | 2.9126 | 8.1325 | 18 | 50 | regulation of cartilage development |
GO:0021543 | 6e-04 | 2.5529 | 10.8282 | 22 | 67 | pallium development |
GO:0090092 | 6e-04 | 1.86 | 27.1624 | 44 | 167 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0051968 | 6e-04 | 6.8872 | 2.2771 | 8 | 14 | positive regulation of synaptic transmission, glutamatergic |
GO:0071542 | 6e-04 | 6.8872 | 2.2771 | 8 | 14 | dopaminergic neuron differentiation |
GO:0008015 | 6e-04 | 1.981 | 21.7539 | 37 | 136 | blood circulation |
GO:0010459 | 6e-04 | 25.8013 | 0.9759 | 5 | 6 | negative regulation of heart rate |
GO:0021797 | 6e-04 | 25.8013 | 0.9759 | 5 | 6 | forebrain anterior/posterior pattern specification |
GO:0031284 | 6e-04 | 25.8013 | 0.9759 | 5 | 6 | positive regulation of guanylate cyclase activity |
GO:0072038 | 6e-04 | 25.8013 | 0.9759 | 5 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
GO:0045766 | 6e-04 | 2.3245 | 13.6625 | 26 | 84 | positive regulation of angiogenesis |
GO:0061351 | 6e-04 | 2.367 | 12.9646 | 25 | 80 | neural precursor cell proliferation |
GO:0080090 | 6e-04 | 1.1761 | 739.7284 | 805 | 4548 | regulation of primary metabolic process |
GO:0048048 | 6e-04 | 3.7354 | 5.0421 | 13 | 31 | embryonic eye morphogenesis |
GO:0060986 | 6e-04 | 3.7354 | 5.0421 | 13 | 31 | endocrine hormone secretion |
GO:0050795 | 6e-04 | 2.0194 | 20.3311 | 35 | 125 | regulation of behavior |
GO:0003014 | 6e-04 | 2.5333 | 10.8975 | 22 | 67 | renal system process |
GO:0007409 | 6e-04 | 1.9303 | 23.3771 | 39 | 146 | axonogenesis |
GO:0030855 | 6e-04 | 1.6056 | 48.3103 | 70 | 302 | epithelial cell differentiation |
GO:0045686 | 6e-04 | 4.3742 | 3.9036 | 11 | 24 | negative regulation of glial cell differentiation |
GO:0044057 | 7e-04 | 2.0038 | 20.3912 | 35 | 128 | regulation of system process |
GO:0002125 | 7e-04 | Inf | 0.6506 | 4 | 4 | maternal aggressive behavior |
GO:0021913 | 7e-04 | Inf | 0.6506 | 4 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0034287 | 7e-04 | Inf | 0.6506 | 4 | 4 | detection of monosaccharide stimulus |
GO:0042660 | 7e-04 | Inf | 0.6506 | 4 | 4 | positive regulation of cell fate specification |
GO:0051594 | 7e-04 | Inf | 0.6506 | 4 | 4 | detection of glucose |
GO:0072095 | 7e-04 | Inf | 0.6506 | 4 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:0072197 | 7e-04 | Inf | 0.6506 | 4 | 4 | ureter morphogenesis |
GO:0072289 | 7e-04 | Inf | 0.6506 | 4 | 4 | metanephric nephron tubule formation |
GO:0097475 | 7e-04 | Inf | 0.6506 | 4 | 4 | motor neuron migration |
GO:1903365 | 7e-04 | Inf | 0.6506 | 4 | 4 | regulation of fear response |
GO:2000987 | 7e-04 | Inf | 0.6506 | 4 | 4 | positive regulation of behavioral fear response |
GO:0060322 | 7e-04 | 2.7331 | 8.9457 | 19 | 55 | head development |
GO:0045980 | 7e-04 | 3.2339 | 6.3433 | 15 | 39 | negative regulation of nucleotide metabolic process |
GO:0003151 | 7e-04 | 3.0754 | 6.9778 | 16 | 43 | outflow tract morphogenesis |
GO:0060485 | 7e-04 | 3.6108 | 5.118 | 13 | 32 | mesenchyme development |
GO:0018958 | 8e-04 | 4.7301 | 3.3964 | 10 | 21 | phenol-containing compound metabolic process |
GO:0035637 | 8e-04 | 2.1578 | 16.0485 | 29 | 99 | multicellular organismal signaling |
GO:0031960 | 8e-04 | 2.0891 | 17.5661 | 31 | 108 | response to corticosteroid |
GO:0021602 | 8e-04 | 4.6982 | 3.4156 | 10 | 21 | cranial nerve morphogenesis |
GO:0042475 | 8e-04 | 2.5359 | 10.3891 | 21 | 64 | odontogenesis of dentin-containing tooth |
GO:0060560 | 8e-04 | 1.9797 | 20.6177 | 35 | 127 | developmental growth involved in morphogenesis |
GO:0071310 | 8e-04 | 1.2573 | 241.6967 | 285 | 1486 | cellular response to organic substance |
GO:0019932 | 8e-04 | 1.9553 | 21.3958 | 36 | 132 | second-messenger-mediated signaling |
GO:0045995 | 9e-04 | 2.2515 | 13.9627 | 26 | 86 | regulation of embryonic development |
GO:0002053 | 9e-04 | 3.5437 | 5.1984 | 13 | 32 | positive regulation of mesenchymal cell proliferation |
GO:0090102 | 9e-04 | 3.5385 | 5.2048 | 13 | 32 | cochlea development |
GO:0008306 | 9e-04 | 2.5895 | 9.759 | 20 | 60 | associative learning |
GO:0045934 | 9e-04 | 1.3259 | 145.4427 | 180 | 898 | negative regulation of nucleobase-containing compound metabolic process |
GO:0070848 | 9e-04 | 1.4024 | 96.2883 | 125 | 592 | response to growth factor |
GO:0051953 | 9e-04 | 5.1664 | 2.9277 | 9 | 18 | negative regulation of amine transport |
GO:0060045 | 9e-04 | 5.1664 | 2.9277 | 9 | 18 | positive regulation of cardiac muscle cell proliferation |
GO:1903115 | 9e-04 | 3.2917 | 5.8554 | 14 | 36 | regulation of actin filament-based movement |
GO:0007605 | 9e-04 | 1.983 | 20.0058 | 34 | 123 | sensory perception of sound |
GO:0035914 | 9e-04 | 2.7407 | 8.4578 | 18 | 52 | skeletal muscle cell differentiation |
GO:0060415 | 9e-04 | 2.7407 | 8.4578 | 18 | 52 | muscle tissue morphogenesis |
GO:0010647 | 0.001 | 1.3243 | 144.7456 | 179 | 896 | positive regulation of cell communication |
GO:0072028 | 0.001 | 10.3837 | 1.4568 | 6 | 9 | nephron morphogenesis |
GO:0051966 | 0.001 | 4.075 | 4.0549 | 11 | 25 | regulation of synaptic transmission, glutamatergic |
GO:0071695 | 0.001 | 2.9623 | 7.146 | 16 | 44 | anatomical structure maturation |
GO:0048844 | 0.001 | 2.8384 | 7.8072 | 17 | 48 | artery morphogenesis |
GO:0035050 | 0.001 | 2.425 | 11.2228 | 22 | 69 | embryonic heart tube development |
GO:0007189 | 0.001 | 2.957 | 7.1566 | 16 | 44 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0009996 | 0.001 | 10.3236 | 1.4638 | 6 | 9 | negative regulation of cell fate specification |
GO:0048664 | 0.001 | 10.3236 | 1.4638 | 6 | 9 | neuron fate determination |
GO:0048469 | 0.001 | 2.0808 | 17.0389 | 30 | 105 | cell maturation |
GO:0051924 | 0.001 | 1.9269 | 21.6323 | 36 | 133 | regulation of calcium ion transport |
GO:0006590 | 0.0011 | 5.9027 | 2.4397 | 8 | 15 | thyroid hormone generation |
GO:0060008 | 0.0011 | 5.9027 | 2.4397 | 8 | 15 | Sertoli cell differentiation |
GO:2000036 | 0.0011 | 5.9027 | 2.4397 | 8 | 15 | regulation of stem cell maintenance |
GO:0007166 | 0.0011 | 1.2432 | 260.5604 | 304 | 1689 | cell surface receptor signaling pathway |
GO:0043583 | 0.0011 | 4.404 | 3.512 | 10 | 22 | ear development |
GO:0032879 | 0.0011 | 1.4945 | 62.7719 | 86 | 402 | regulation of localization |
GO:0072182 | 0.0011 | 7.2287 | 1.9518 | 7 | 12 | regulation of nephron tubule epithelial cell differentiation |
GO:0019218 | 0.0011 | 2.5261 | 9.9216 | 20 | 61 | regulation of steroid metabolic process |
GO:1902742 | 0.0011 | 3.6495 | 4.7168 | 12 | 29 | apoptotic process involved in development |
GO:0050880 | 0.0012 | 2.7691 | 7.9228 | 17 | 49 | regulation of blood vessel size |
GO:0090276 | 0.0012 | 1.8034 | 26.5118 | 42 | 163 | regulation of peptide hormone secretion |
GO:0007154 | 0.0012 | 1.2039 | 408.1601 | 458 | 2737 | cell communication |
GO:0048536 | 0.0012 | 3.3612 | 5.3674 | 13 | 33 | spleen development |
GO:0043069 | 0.0012 | 1.391 | 95.3124 | 123 | 586 | negative regulation of programmed cell death |
GO:0021697 | 0.0012 | 4.3062 | 3.5783 | 10 | 22 | cerebellar cortex formation |
GO:0022029 | 0.0013 | 2.7494 | 7.9698 | 17 | 49 | telencephalon cell migration |
GO:0014902 | 0.0013 | 2.1738 | 14.3131 | 26 | 88 | myotube differentiation |
GO:2000179 | 0.0013 | 3.1483 | 6.018 | 14 | 37 | positive regulation of neural precursor cell proliferation |
GO:0051093 | 0.0013 | 2.1265 | 15.041 | 27 | 95 | negative regulation of developmental process |
GO:0002067 | 0.0013 | 2.9846 | 6.6686 | 15 | 41 | glandular epithelial cell differentiation |
GO:0051048 | 0.0013 | 2.2075 | 13.6038 | 25 | 84 | negative regulation of secretion |
GO:0007420 | 0.0014 | 1.8308 | 24.2555 | 39 | 154 | brain development |
GO:0030879 | 0.0014 | 1.9457 | 19.6806 | 33 | 121 | mammary gland development |
GO:0051147 | 0.0014 | 2.0207 | 17.4035 | 30 | 107 | regulation of muscle cell differentiation |
GO:0003008 | 0.0014 | 2.0358 | 16.5933 | 29 | 109 | system process |
GO:2000113 | 0.0014 | 1.307 | 147.8481 | 181 | 909 | negative regulation of cellular macromolecule biosynthetic process |
GO:0044705 | 0.0015 | 3.7903 | 4.2289 | 11 | 26 | multi-organism reproductive behavior |
GO:0002088 | 0.0015 | 2.5222 | 9.4337 | 19 | 58 | lens development in camera-type eye |
GO:0007214 | 0.0015 | 4.6493 | 3.0903 | 9 | 19 | gamma-aminobutyric acid signaling pathway |
GO:0009581 | 0.0016 | 1.8685 | 22.1203 | 36 | 136 | detection of external stimulus |
GO:0030073 | 0.0016 | 1.7589 | 27.6504 | 43 | 170 | insulin secretion |
GO:0050433 | 0.0016 | 3.4464 | 4.8795 | 12 | 30 | regulation of catecholamine secretion |
GO:0022404 | 0.0017 | 2.2481 | 12.3613 | 23 | 76 | molting cycle process |
GO:0009612 | 0.0017 | 1.8267 | 23.7468 | 38 | 146 | response to mechanical stimulus |
GO:0050806 | 0.0017 | 2.8834 | 6.8122 | 15 | 42 | positive regulation of synaptic transmission |
GO:0023014 | 0.0017 | 1.3978 | 86.3667 | 112 | 531 | signal transduction by phosphorylation |
GO:0048741 | 0.0017 | 2.7594 | 7.4819 | 16 | 46 | skeletal muscle fiber development |
GO:0035176 | 0.0017 | 3.2009 | 5.5301 | 13 | 34 | social behavior |
GO:2000241 | 0.0017 | 2.4082 | 10.2469 | 20 | 63 | regulation of reproductive process |
GO:0009968 | 0.0017 | 1.3264 | 125.7278 | 156 | 773 | negative regulation of signal transduction |
GO:0040017 | 0.0017 | 1.6053 | 40.0117 | 58 | 246 | positive regulation of locomotion |
GO:0044058 | 0.0018 | 12.9464 | 1.1351 | 5 | 7 | regulation of digestive system process |
GO:0014032 | 0.0018 | 5.1906 | 2.5914 | 8 | 16 | neural crest cell development |
GO:0072009 | 0.0018 | 4.0098 | 3.7136 | 10 | 23 | nephron epithelium development |
GO:0003310 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | pancreatic A cell differentiation |
GO:0021796 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | cerebral cortex regionalization |
GO:0021798 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | forebrain dorsal/ventral pattern formation |
GO:0022601 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | menstrual cycle phase |
GO:0030916 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | otic vesicle formation |
GO:0051957 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | positive regulation of amino acid transport |
GO:0060677 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | ureteric bud elongation |
GO:0060684 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | epithelial-mesenchymal cell signaling |
GO:0071435 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | potassium ion export |
GO:0072161 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | mesenchymal cell differentiation involved in kidney development |
GO:2000543 | 0.0018 | 12.8994 | 1.1385 | 5 | 7 | positive regulation of gastrulation |
GO:0048584 | 0.0018 | 1.2763 | 174.21 | 209 | 1078 | positive regulation of response to stimulus |
GO:0006688 | 0.0018 | 5.1644 | 2.6024 | 8 | 16 | glycosphingolipid biosynthetic process |
GO:0043267 | 0.0018 | 5.1644 | 2.6024 | 8 | 16 | negative regulation of potassium ion transport |
GO:0051930 | 0.0018 | 5.1644 | 2.6024 | 8 | 16 | regulation of sensory perception of pain |
GO:0016331 | 0.0019 | 3.5953 | 4.3485 | 11 | 27 | morphogenesis of embryonic epithelium |
GO:0010001 | 0.002 | 2.7021 | 7.5693 | 16 | 47 | glial cell differentiation |
GO:0032989 | 0.002 | 1.5077 | 52.8567 | 73 | 333 | cellular component morphogenesis |
GO:0090090 | 0.002 | 2.1236 | 13.9878 | 25 | 86 | negative regulation of canonical Wnt signaling pathway |
GO:0021533 | 0.002 | 6.0376 | 2.1103 | 7 | 13 | cell differentiation in hindbrain |
GO:0051954 | 0.002 | 6.0369 | 2.1105 | 7 | 13 | positive regulation of amine transport |
GO:0003084 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | positive regulation of systemic arterial blood pressure |
GO:0003214 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | cardiac left ventricle morphogenesis |
GO:0007501 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | mesodermal cell fate specification |
GO:0014002 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | astrocyte development |
GO:0048368 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | lateral mesoderm development |
GO:2000380 | 0.0021 | 6.0233 | 2.1144 | 7 | 13 | regulation of mesoderm development |
GO:0031128 | 0.0021 | 7.7878 | 1.6185 | 6 | 10 | developmental induction |
GO:0003158 | 0.0021 | 7.7842 | 1.6191 | 6 | 10 | endothelium development |
GO:0009743 | 0.0021 | 1.8316 | 22.4456 | 36 | 138 | response to carbohydrate |
GO:0021781 | 0.0021 | 7.7609 | 1.6232 | 6 | 10 | glial cell fate commitment |
GO:0021884 | 0.0021 | 3.553 | 4.3915 | 11 | 27 | forebrain neuron development |
GO:0021520 | 0.0021 | 7.7533 | 1.6245 | 6 | 10 | spinal cord motor neuron cell fate specification |
GO:0031649 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | heat generation |
GO:0048703 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | embryonic viscerocranium morphogenesis |
GO:0060080 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | regulation of inhibitory postsynaptic membrane potential |
GO:0060536 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | cartilage morphogenesis |
GO:0070472 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | regulation of uterine smooth muscle contraction |
GO:0072173 | 0.0021 | 7.742 | 1.6265 | 6 | 10 | metanephric tubule morphogenesis |
GO:1902476 | 0.0021 | 2.3532 | 10.4095 | 20 | 64 | chloride transmembrane transport |
GO:0055002 | 0.0021 | 1.9077 | 19.3553 | 32 | 119 | striated muscle cell development |
GO:0002790 | 0.0022 | 1.737 | 27.2479 | 42 | 168 | peptide secretion |
GO:0030335 | 0.0022 | 1.6138 | 37.084 | 54 | 228 | positive regulation of cell migration |
GO:0007507 | 0.0022 | 1.6459 | 33.7867 | 50 | 210 | heart development |
GO:0055078 | 0.0023 | 3.2647 | 5.0421 | 12 | 31 | sodium ion homeostasis |
GO:0060079 | 0.0023 | 2.7709 | 6.9939 | 15 | 43 | regulation of excitatory postsynaptic membrane potential |
GO:0001569 | 0.0023 | 2.8959 | 6.3433 | 14 | 39 | patterning of blood vessels |
GO:0003309 | 0.0024 | 4.2263 | 3.253 | 9 | 20 | type B pancreatic cell differentiation |
GO:0036342 | 0.0024 | 4.2263 | 3.253 | 9 | 20 | post-anal tail morphogenesis |
GO:0048745 | 0.0024 | 4.2263 | 3.253 | 9 | 20 | smooth muscle tissue development |
GO:0009582 | 0.0024 | 1.8136 | 22.6082 | 36 | 139 | detection of abiotic stimulus |
GO:0001101 | 0.0024 | 1.5978 | 38.0599 | 55 | 234 | response to acid chemical |
GO:0042476 | 0.0026 | 3.7309 | 3.8683 | 10 | 24 | odontogenesis |
GO:0008584 | 0.0026 | 2.198 | 12.0035 | 22 | 74 | male gonad development |
GO:0030334 | 0.0027 | 1.6469 | 32.4188 | 48 | 201 | regulation of cell migration |
GO:0009746 | 0.0028 | 1.891 | 18.8673 | 31 | 116 | response to hexose |
GO:0046717 | 0.0028 | 2.3462 | 9.9045 | 19 | 61 | acid secretion |
GO:0032355 | 0.0028 | 2.2257 | 11.3564 | 21 | 70 | response to estradiol |
GO:0046883 | 0.0029 | 2.9491 | 5.8107 | 13 | 36 | regulation of hormone secretion |
GO:0002683 | 0.0029 | 1.7036 | 27.6504 | 42 | 170 | negative regulation of immune system process |
GO:0003203 | 0.0029 | 4.5901 | 2.765 | 8 | 17 | endocardial cushion morphogenesis |
GO:0071392 | 0.0029 | 4.5901 | 2.765 | 8 | 17 | cellular response to estradiol stimulus |
GO:0072234 | 0.0029 | 4.5901 | 2.765 | 8 | 17 | metanephric nephron tubule development |
GO:0046189 | 0.003 | 3.3437 | 4.5542 | 11 | 28 | phenol-containing compound biosynthetic process |
GO:0021978 | 0.003 | 20.6774 | 0.8117 | 4 | 5 | telencephalon regionalization |
GO:0003337 | 0.003 | 20.6673 | 0.8121 | 4 | 5 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0001993 | 0.003 | 20.6611 | 0.8123 | 4 | 5 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0001996 | 0.003 | 20.631 | 0.8132 | 4 | 5 | positive regulation of heart rate by epinephrine-norepinephrine |
GO:0019800 | 0.003 | 20.631 | 0.8132 | 4 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0035934 | 0.003 | 20.631 | 0.8132 | 4 | 5 | corticosterone secretion |
GO:0042713 | 0.003 | 20.631 | 0.8132 | 4 | 5 | sperm ejaculation |
GO:0060023 | 0.003 | 20.631 | 0.8132 | 4 | 5 | soft palate development |
GO:0060040 | 0.003 | 20.631 | 0.8132 | 4 | 5 | retinal bipolar neuron differentiation |
GO:0060290 | 0.003 | 20.631 | 0.8132 | 4 | 5 | transdifferentiation |
GO:0061046 | 0.003 | 20.631 | 0.8132 | 4 | 5 | regulation of branching involved in lung morphogenesis |
GO:0072081 | 0.003 | 20.631 | 0.8132 | 4 | 5 | specification of nephron tubule identity |
GO:0072179 | 0.003 | 20.631 | 0.8132 | 4 | 5 | nephric duct formation |
GO:0072193 | 0.003 | 20.631 | 0.8132 | 4 | 5 | ureter smooth muscle cell differentiation |
GO:2000288 | 0.003 | 20.631 | 0.8132 | 4 | 5 | positive regulation of myoblast proliferation |
GO:2000851 | 0.003 | 20.631 | 0.8132 | 4 | 5 | positive regulation of glucocorticoid secretion |
GO:0001974 | 0.0031 | 3.1012 | 5.2048 | 12 | 32 | blood vessel remodeling |
GO:0045446 | 0.0032 | 2.2505 | 10.7348 | 20 | 66 | endothelial cell differentiation |
GO:0048738 | 0.0032 | 2.3039 | 10.0218 | 19 | 62 | cardiac muscle tissue development |
GO:0045937 | 0.0033 | 1.3157 | 114.993 | 142 | 707 | positive regulation of phosphate metabolic process |
GO:0060284 | 0.0034 | 1.8527 | 19.0885 | 31 | 121 | regulation of cell development |
GO:0031589 | 0.0035 | 1.5517 | 40.337 | 57 | 248 | cell-substrate adhesion |
GO:0051240 | 0.0035 | 1.4368 | 60.8933 | 81 | 382 | positive regulation of multicellular organismal process |
GO:0032835 | 0.0035 | 2.5078 | 7.9698 | 16 | 49 | glomerulus development |
GO:0002070 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | epithelial cell maturation |
GO:0003148 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | outflow tract septum morphogenesis |
GO:0015874 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | norepinephrine transport |
GO:0060442 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | branching involved in prostate gland morphogenesis |
GO:0061323 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | cell proliferation involved in heart morphogenesis |
GO:2000310 | 0.0035 | 5.1624 | 2.2771 | 7 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0030154 | 0.0038 | 1.3845 | 75.0012 | 97 | 528 | cell differentiation |
GO:0010863 | 0.0038 | 2.3283 | 9.4337 | 18 | 58 | positive regulation of phospholipase C activity |
GO:0015844 | 0.0038 | 2.6872 | 6.6555 | 14 | 41 | monoamine transport |
GO:0031016 | 0.0039 | 3.1863 | 4.6815 | 11 | 29 | pancreas development |
GO:0003279 | 0.0039 | 2.2024 | 10.8975 | 20 | 67 | cardiac septum development |
GO:0003209 | 0.0039 | 3.444 | 4.0662 | 10 | 25 | cardiac atrium morphogenesis |
GO:0008045 | 0.0039 | 3.444 | 4.0662 | 10 | 25 | motor neuron axon guidance |
GO:0060343 | 0.0039 | 3.444 | 4.0662 | 10 | 25 | trabecula formation |
GO:0060571 | 0.0039 | 3.444 | 4.0662 | 10 | 25 | morphogenesis of an epithelial fold |
GO:0003231 | 0.0039 | 1.9921 | 14.6384 | 25 | 90 | cardiac ventricle development |
GO:0035137 | 0.004 | 8.6456 | 1.2953 | 5 | 8 | hindlimb morphogenesis |
GO:0003161 | 0.004 | 6.193 | 1.7891 | 6 | 11 | cardiac conduction system development |
GO:0007494 | 0.004 | 6.193 | 1.7891 | 6 | 11 | midgut development |
GO:0019372 | 0.004 | 6.193 | 1.7891 | 6 | 11 | lipoxygenase pathway |
GO:0021903 | 0.004 | 6.193 | 1.7891 | 6 | 11 | rostrocaudal neural tube patterning |
GO:0032769 | 0.004 | 6.193 | 1.7891 | 6 | 11 | negative regulation of monooxygenase activity |
GO:0043568 | 0.004 | 6.193 | 1.7891 | 6 | 11 | positive regulation of insulin-like growth factor receptor signaling pathway |
GO:0045986 | 0.004 | 6.193 | 1.7891 | 6 | 11 | negative regulation of smooth muscle contraction |
GO:0060900 | 0.004 | 6.193 | 1.7891 | 6 | 11 | embryonic camera-type eye formation |
GO:0061029 | 0.004 | 6.193 | 1.7891 | 6 | 11 | eyelid development in camera-type eye |
GO:0072176 | 0.004 | 6.193 | 1.7891 | 6 | 11 | nephric duct development |
GO:2000833 | 0.004 | 6.193 | 1.7891 | 6 | 11 | positive regulation of steroid hormone secretion |
GO:2000846 | 0.004 | 6.193 | 1.7891 | 6 | 11 | regulation of corticosteroid hormone secretion |
GO:0042246 | 0.0041 | 2.8 | 6.018 | 13 | 37 | tissue regeneration |
GO:0009991 | 0.0041 | 1.4691 | 51.7224 | 70 | 318 | response to extracellular stimulus |
GO:0042417 | 0.0041 | 3.1577 | 4.7168 | 11 | 29 | dopamine metabolic process |
GO:0021924 | 0.0041 | 8.5988 | 1.3012 | 5 | 8 | cell proliferation in external granule layer |
GO:0040019 | 0.0041 | 8.5988 | 1.3012 | 5 | 8 | positive regulation of embryonic development |
GO:0060180 | 0.0041 | 8.5988 | 1.3012 | 5 | 8 | female mating behavior |
GO:2000679 | 0.0041 | 8.5988 | 1.3012 | 5 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0051932 | 0.0041 | 2.9532 | 5.3674 | 12 | 33 | synaptic transmission, GABAergic |
GO:0001705 | 0.0043 | Inf | 0.4879 | 3 | 3 | ectoderm formation |
GO:0001997 | 0.0043 | Inf | 0.4879 | 3 | 3 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
GO:0002025 | 0.0043 | Inf | 0.4879 | 3 | 3 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure |
GO:0003253 | 0.0043 | Inf | 0.4879 | 3 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0003358 | 0.0043 | Inf | 0.4879 | 3 | 3 | noradrenergic neuron development |
GO:0006579 | 0.0043 | Inf | 0.4879 | 3 | 3 | amino-acid betaine catabolic process |
GO:0014707 | 0.0043 | Inf | 0.4879 | 3 | 3 | branchiomeric skeletal muscle development |
GO:0021530 | 0.0043 | Inf | 0.4879 | 3 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021550 | 0.0043 | Inf | 0.4879 | 3 | 3 | medulla oblongata development |
GO:0021902 | 0.0043 | Inf | 0.4879 | 3 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0043 | Inf | 0.4879 | 3 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035284 | 0.0043 | Inf | 0.4879 | 3 | 3 | brain segmentation |
GO:0035726 | 0.0043 | Inf | 0.4879 | 3 | 3 | common myeloid progenitor cell proliferation |
GO:0035811 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of urine volume |
GO:0035990 | 0.0043 | Inf | 0.4879 | 3 | 3 | tendon cell differentiation |
GO:0042335 | 0.0043 | Inf | 0.4879 | 3 | 3 | cuticle development |
GO:0042414 | 0.0043 | Inf | 0.4879 | 3 | 3 | epinephrine metabolic process |
GO:0051799 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of hair follicle development |
GO:0051970 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of transmission of nerve impulse |
GO:0060061 | 0.0043 | Inf | 0.4879 | 3 | 3 | Spemann organizer formation |
GO:0060166 | 0.0043 | Inf | 0.4879 | 3 | 3 | olfactory pit development |
GO:0060459 | 0.0043 | Inf | 0.4879 | 3 | 3 | left lung development |
GO:0060729 | 0.0043 | Inf | 0.4879 | 3 | 3 | intestinal epithelial structure maintenance |
GO:0061056 | 0.0043 | Inf | 0.4879 | 3 | 3 | sclerotome development |
GO:0072003 | 0.0043 | Inf | 0.4879 | 3 | 3 | kidney rudiment formation |
GO:0072180 | 0.0043 | Inf | 0.4879 | 3 | 3 | mesonephric duct morphogenesis |
GO:0072190 | 0.0043 | Inf | 0.4879 | 3 | 3 | ureter urothelium development |
GO:0072240 | 0.0043 | Inf | 0.4879 | 3 | 3 | metanephric DCT cell differentiation |
GO:0072513 | 0.0043 | Inf | 0.4879 | 3 | 3 | positive regulation of secondary heart field cardioblast proliferation |
GO:0090027 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of monocyte chemotaxis |
GO:0090191 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0097477 | 0.0043 | Inf | 0.4879 | 3 | 3 | lateral motor column neuron migration |
GO:1900212 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000041 | 0.0043 | Inf | 0.4879 | 3 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2000729 | 0.0043 | Inf | 0.4879 | 3 | 3 | positive regulation of mesenchymal cell proliferation involved in ureter development |
GO:0051272 | 0.0043 | 1.5451 | 39.0358 | 55 | 240 | positive regulation of cellular component movement |
GO:0030155 | 0.0043 | 1.4928 | 46.6803 | 64 | 287 | regulation of cell adhesion |
GO:0021545 | 0.0045 | 4.1467 | 2.9183 | 8 | 18 | cranial nerve development |
GO:0001649 | 0.0045 | 1.6514 | 28.301 | 42 | 174 | osteoblast differentiation |
GO:0007274 | 0.0045 | 4.1307 | 2.9277 | 8 | 18 | neuromuscular synaptic transmission |
GO:0051412 | 0.0045 | 4.1307 | 2.9277 | 8 | 18 | response to corticosterone |
GO:0060306 | 0.0045 | 4.1307 | 2.9277 | 8 | 18 | regulation of membrane repolarization |
GO:2000311 | 0.0045 | 4.1307 | 2.9277 | 8 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0050905 | 0.0046 | 1.9618 | 14.8011 | 25 | 91 | neuromuscular process |
GO:0007588 | 0.0046 | 2.2713 | 9.5963 | 18 | 59 | excretion |
GO:0010959 | 0.0046 | 2.1082 | 11.7896 | 21 | 73 | regulation of metal ion transport |
GO:0043524 | 0.0047 | 1.8291 | 18.7047 | 30 | 115 | negative regulation of neuron apoptotic process |
GO:0007568 | 0.0049 | 1.6029 | 31.7166 | 46 | 195 | aging |
GO:0001708 | 0.0049 | 3.2819 | 4.1714 | 10 | 26 | cell fate specification |
GO:0032103 | 0.0049 | 1.7637 | 21.1444 | 33 | 130 | positive regulation of response to external stimulus |
GO:0002062 | 0.005 | 2.1926 | 10.378 | 19 | 64 | chondrocyte differentiation |
GO:0034103 | 0.005 | 2.5849 | 6.8313 | 14 | 42 | regulation of tissue remodeling |
GO:0008016 | 0.005 | 2.8501 | 5.4794 | 12 | 34 | regulation of heart contraction |
GO:0043408 | 0.0051 | 1.3766 | 73.1921 | 94 | 450 | regulation of MAPK cascade |
GO:0045907 | 0.0052 | 3.5754 | 3.5783 | 9 | 22 | positive regulation of vasoconstriction |
GO:0045987 | 0.0052 | 3.5754 | 3.5783 | 9 | 22 | positive regulation of smooth muscle contraction |
GO:0019933 | 0.0053 | 2.6877 | 6.1807 | 13 | 38 | cAMP-mediated signaling |
GO:0071383 | 0.0053 | 2.3739 | 8.2667 | 16 | 51 | cellular response to steroid hormone stimulus |
GO:0009948 | 0.0054 | 3.2371 | 4.2195 | 10 | 26 | anterior/posterior axis specification |
GO:0010623 | 0.0055 | 2.8187 | 5.5301 | 12 | 34 | developmental programmed cell death |
GO:0031644 | 0.0055 | 2.8187 | 5.5301 | 12 | 34 | regulation of neurological system process |
GO:0001958 | 0.0055 | 3.2285 | 4.2289 | 10 | 26 | endochondral ossification |
GO:0007622 | 0.0055 | 3.2285 | 4.2289 | 10 | 26 | rhythmic behavior |
GO:0060487 | 0.0055 | 3.2285 | 4.2289 | 10 | 26 | lung epithelial cell differentiation |
GO:0086002 | 0.0055 | 3.2285 | 4.2289 | 10 | 26 | cardiac muscle cell action potential involved in contraction |
GO:0001755 | 0.0055 | 2.9956 | 4.8735 | 11 | 30 | neural crest cell migration |
GO:0030501 | 0.0055 | 2.9912 | 4.8795 | 11 | 30 | positive regulation of bone mineralization |
GO:0072080 | 0.0056 | 4.5443 | 2.4273 | 7 | 15 | nephron tubule development |
GO:0033273 | 0.0056 | 2.217 | 9.759 | 18 | 60 | response to vitamin |
GO:0046849 | 0.0056 | 2.217 | 9.759 | 18 | 60 | bone remodeling |
GO:0001505 | 0.0057 | 1.6971 | 23.7468 | 36 | 146 | regulation of neurotransmitter levels |
GO:0007613 | 0.0057 | 1.9845 | 13.4999 | 23 | 83 | memory |
GO:0032098 | 0.0057 | 4.5166 | 2.4397 | 7 | 15 | regulation of appetite |
GO:0045844 | 0.0057 | 4.5166 | 2.4397 | 7 | 15 | positive regulation of striated muscle tissue development |
GO:0060065 | 0.0057 | 4.5166 | 2.4397 | 7 | 15 | uterus development |
GO:0072075 | 0.0057 | 4.5166 | 2.4397 | 7 | 15 | metanephric mesenchyme development |
GO:0044702 | 0.0057 | 1.3159 | 98.5428 | 122 | 619 | single organism reproductive process |
GO:2000027 | 0.0058 | 1.9778 | 13.5133 | 23 | 84 | regulation of organ morphogenesis |
GO:0060193 | 0.006 | 2.0506 | 12.036 | 21 | 74 | positive regulation of lipase activity |
GO:0014074 | 0.006 | 1.8102 | 18.2167 | 29 | 112 | response to purine-containing compound |
GO:0070509 | 0.0063 | 2.4955 | 6.9939 | 14 | 43 | calcium ion import |
GO:0019228 | 0.0064 | 1.9977 | 12.8493 | 22 | 79 | neuronal action potential |
GO:0048754 | 0.0064 | 2.1255 | 10.5911 | 19 | 66 | branching morphogenesis of an epithelial tube |
GO:0030509 | 0.0064 | 2.0774 | 11.3505 | 20 | 70 | BMP signaling pathway |
GO:0055074 | 0.0065 | 5.2573 | 1.9217 | 6 | 12 | calcium ion homeostasis |
GO:0048839 | 0.0065 | 2.2373 | 9.1351 | 17 | 57 | inner ear development |
GO:0042310 | 0.0066 | 2.5923 | 6.3266 | 13 | 39 | vasoconstriction |
GO:0022602 | 0.0067 | 2.0697 | 11.3854 | 20 | 70 | ovulation cycle process |
GO:0007519 | 0.0067 | 2.3771 | 7.7331 | 15 | 48 | skeletal muscle tissue development |
GO:0001502 | 0.0067 | 3.7549 | 3.0903 | 8 | 19 | cartilage condensation |
GO:0021854 | 0.0067 | 3.7549 | 3.0903 | 8 | 19 | hypothalamus development |
GO:0060602 | 0.0067 | 3.7549 | 3.0903 | 8 | 19 | branch elongation of an epithelium |
GO:0032414 | 0.0067 | 2.5841 | 6.3433 | 13 | 39 | positive regulation of ion transmembrane transporter activity |
GO:0071320 | 0.0067 | 2.5841 | 6.3433 | 13 | 39 | cellular response to cAMP |
GO:0010092 | 0.0069 | 5.1827 | 1.9448 | 6 | 12 | specification of organ identity |
GO:0014031 | 0.0069 | 1.9794 | 12.9229 | 22 | 80 | mesenchymal cell development |
GO:0021766 | 0.0069 | 2.7065 | 5.6741 | 12 | 35 | hippocampus development |
GO:0044700 | 0.0069 | 1.1673 | 385.3015 | 425 | 2603 | single organism signaling |
GO:0050727 | 0.0069 | 1.6112 | 28.1383 | 41 | 173 | regulation of inflammatory response |
GO:0006941 | 0.007 | 1.9115 | 14.4758 | 24 | 89 | striated muscle contraction |
GO:0001946 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | lymphangiogenesis |
GO:0006837 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | serotonin transport |
GO:0021702 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | cerebellar Purkinje cell differentiation |
GO:0021794 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | thalamus development |
GO:0042487 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | regulation of odontogenesis of dentin-containing tooth |
GO:0046541 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | saliva secretion |
GO:0051580 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | regulation of neurotransmitter uptake |
GO:0060766 | 0.007 | 5.1603 | 1.9518 | 6 | 12 | negative regulation of androgen receptor signaling pathway |
GO:0030514 | 0.0071 | 2.6959 | 5.6927 | 12 | 35 | negative regulation of BMP signaling pathway |
GO:0050805 | 0.0071 | 2.6959 | 5.6927 | 12 | 35 | negative regulation of synaptic transmission |
GO:0030500 | 0.0071 | 3.3316 | 3.7298 | 9 | 23 | regulation of bone mineralization |
GO:0001963 | 0.0073 | 3.3197 | 3.7409 | 9 | 23 | synaptic transmission, dopaminergic |
GO:0030431 | 0.0073 | 3.3197 | 3.7409 | 9 | 23 | sleep |
GO:0045684 | 0.0073 | 3.3197 | 3.7409 | 9 | 23 | positive regulation of epidermis development |
GO:0061448 | 0.0074 | 2.5393 | 6.3968 | 13 | 40 | connective tissue development |
GO:0046683 | 0.0074 | 1.8443 | 16.1023 | 26 | 99 | response to organophosphorus |
GO:0050866 | 0.0074 | 1.8443 | 16.1023 | 26 | 99 | negative regulation of cell activation |
GO:0021799 | 0.0074 | 3.0383 | 4.3915 | 10 | 27 | cerebral cortex radially oriented cell migration |
GO:0051341 | 0.0075 | 2.1979 | 9.271 | 17 | 57 | regulation of oxidoreductase activity |
GO:1901699 | 0.0076 | 1.3633 | 69.7765 | 89 | 429 | cellular response to nitrogen compound |
GO:0035136 | 0.0078 | 10.3929 | 0.9697 | 4 | 6 | forelimb morphogenesis |
GO:0022603 | 0.0078 | 1.3384 | 78.7625 | 99 | 492 | regulation of anatomical structure morphogenesis |
GO:0002024 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | diet induced thermogenesis |
GO:0003057 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | regulation of the force of heart contraction by chemical signal |
GO:0003339 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010700 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | negative regulation of norepinephrine secretion |
GO:0014050 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | negative regulation of glutamate secretion |
GO:0015870 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | acetylcholine transport |
GO:0021523 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | somatic motor neuron differentiation |
GO:0021578 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | hindbrain maturation |
GO:0021937 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0032811 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | negative regulation of epinephrine secretion |
GO:0033603 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | positive regulation of dopamine secretion |
GO:0042363 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | fat-soluble vitamin catabolic process |
GO:0042637 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | catagen |
GO:0043416 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | regulation of skeletal muscle tissue regeneration |
GO:0072049 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | comma-shaped body morphogenesis |
GO:0072284 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | metanephric S-shaped body morphogenesis |
GO:1902338 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:1903037 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | regulation of leukocyte cell-cell adhesion |
GO:2000252 | 0.0079 | 10.3145 | 0.9759 | 4 | 6 | negative regulation of feeding behavior |
GO:0061337 | 0.0079 | 2.4121 | 7.1566 | 14 | 44 | cardiac conduction |
GO:0072189 | 0.0079 | 6.4642 | 1.4609 | 5 | 9 | ureter development |
GO:0055007 | 0.008 | 2.1213 | 10.0627 | 18 | 62 | cardiac muscle cell differentiation |
GO:0014051 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | gamma-aminobutyric acid secretion |
GO:0015671 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | oxygen transport |
GO:0032525 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | somite rostral/caudal axis specification |
GO:0035988 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | chondrocyte proliferation |
GO:0045109 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | intermediate filament organization |
GO:0048845 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | venous blood vessel morphogenesis |
GO:0060456 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | positive regulation of digestive system process |
GO:0060457 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | negative regulation of digestive system process |
GO:0060872 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | semicircular canal development |
GO:0071294 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | cellular response to zinc ion |
GO:0072239 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | metanephric glomerulus vasculature development |
GO:0090009 | 0.008 | 6.4485 | 1.4638 | 5 | 9 | primitive streak formation |
GO:0050769 | 0.008 | 1.6932 | 21.795 | 33 | 134 | positive regulation of neurogenesis |
GO:1903036 | 0.0082 | 2.1158 | 10.0842 | 18 | 62 | positive regulation of response to wounding |
GO:0050768 | 0.0083 | 1.849 | 15.4517 | 25 | 95 | negative regulation of neurogenesis |
GO:0007292 | 0.0083 | 1.9756 | 12.3613 | 21 | 76 | female gamete generation |
GO:0043279 | 0.0085 | 2.0545 | 10.8667 | 19 | 67 | response to alkaloid |
GO:0033993 | 0.0085 | 1.4801 | 40.2858 | 55 | 253 | response to lipid |
GO:0048523 | 0.0086 | 1.1725 | 312.8762 | 349 | 2002 | negative regulation of cellular process |
GO:0048608 | 0.0086 | 1.5838 | 28.4709 | 41 | 178 | reproductive structure development |
GO:0048812 | 0.0087 | 1.9616 | 12.389 | 21 | 78 | neuron projection morphogenesis |
GO:0098602 | 0.0087 | 1.4108 | 53.3489 | 70 | 328 | single organism cell adhesion |
GO:0021783 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | preganglionic parasympathetic nervous system development |
GO:0042136 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | neurotransmitter biosynthetic process |
GO:0060004 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | reflex |
GO:0072148 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | epithelial cell fate commitment |
GO:2000725 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | regulation of cardiac muscle cell differentiation |
GO:2001258 | 0.0088 | 4.0144 | 2.6024 | 7 | 16 | negative regulation of cation channel activity |
GO:0030902 | 0.0088 | 2.7427 | 5.1464 | 11 | 32 | hindbrain development |
GO:0042592 | 0.009 | 1.2543 | 131.9902 | 157 | 821 | homeostatic process |
GO:0043401 | 0.009 | 2.2806 | 7.9698 | 15 | 49 | steroid hormone mediated signaling pathway |
GO:0042633 | 0.009 | 1.8894 | 13.9878 | 23 | 86 | hair cycle |
GO:0051963 | 0.0091 | 2.5833 | 5.8554 | 12 | 36 | regulation of synapse assembly |
GO:0015837 | 0.0093 | 3.4686 | 3.2319 | 8 | 20 | amine transport |
GO:0001525 | 0.0093 | 1.5169 | 34.4974 | 48 | 214 | angiogenesis |
GO:0007601 | 0.0095 | 1.6409 | 23.6654 | 35 | 146 | visual perception |
GO:0048709 | 0.0096 | 2.0737 | 10.226 | 18 | 63 | oligodendrocyte differentiation |
GO:0002792 | 0.0096 | 2.7058 | 5.2048 | 11 | 32 | negative regulation of peptide secretion |
GO:0042220 | 0.0096 | 2.7058 | 5.2048 | 11 | 32 | response to cocaine |
GO:0010719 | 0.0097 | 3.4416 | 3.253 | 8 | 20 | negative regulation of epithelial to mesenchymal transition |
GO:0021544 | 0.0097 | 3.4416 | 3.253 | 8 | 20 | subpallium development |
GO:0097503 | 0.0097 | 3.4416 | 3.253 | 8 | 20 | sialylation |
GO:0016101 | 0.0098 | 2.0686 | 10.2469 | 18 | 63 | diterpenoid metabolic process |
GO:1901342 | 0.0098 | 1.6117 | 25.3733 | 37 | 156 | regulation of vasculature development |
GO:0021695 | 0.0098 | 2.3341 | 7.3192 | 14 | 45 | cerebellar cortex development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002542 | 0.001 | Inf | 0.001 | 1 | 1 | Factor XII activation |
GO:0006583 | 0.001 | Inf | 0.001 | 1 | 1 | melanin biosynthetic process from tyrosine |
GO:0002254 | 0.0021 | 1053.25 | 0.0021 | 1 | 2 | kinin cascade |
GO:0070236 | 0.0021 | 1053.25 | 0.0021 | 1 | 2 | negative regulation of activation-induced cell death of T cells |
GO:0021847 | 0.0031 | 526.5833 | 0.0031 | 1 | 3 | ventricular zone neuroblast division |
GO:0051919 | 0.0031 | 526.5833 | 0.0031 | 1 | 3 | positive regulation of fibrinolysis |
GO:0048539 | 0.0041 | 351.0278 | 0.0041 | 1 | 4 | bone marrow development |
GO:0010756 | 0.0051 | 263.25 | 0.0051 | 1 | 5 | positive regulation of plasminogen activation |
GO:0070970 | 0.0061 | 210.5833 | 0.0062 | 1 | 6 | interleukin-2 secretion |
GO:0072089 | 0.0071 | 18.3519 | 0.1295 | 2 | 126 | stem cell proliferation |
GO:0051788 | 0.0072 | 175.4722 | 0.0072 | 1 | 7 | response to misfolded protein |
GO:0035264 | 0.0077 | 17.6335 | 0.1346 | 2 | 131 | multicellular organism growth |
GO:0055091 | 0.0092 | 131.5833 | 0.0092 | 1 | 9 | phospholipid homeostasis |
GO:0090399 | 0.0092 | 131.5833 | 0.0092 | 1 | 9 | replicative senescence |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1902905 | 3e-04 | Inf | 3e-04 | 1 | 1 | positive regulation of fibril organization |
GO:0009609 | 6e-04 | 4216 | 6e-04 | 1 | 2 | response to symbiotic bacterium |
GO:0006982 | 9e-04 | 2107.8333 | 9e-04 | 1 | 3 | response to lipid hydroperoxide |
GO:0010269 | 0.0013 | 1405.1111 | 0.0013 | 1 | 4 | response to selenium ion |
GO:0018158 | 0.0016 | 1053.75 | 0.0016 | 1 | 5 | protein oxidation |
GO:0021540 | 0.0016 | 1053.75 | 0.0016 | 1 | 5 | corpus callosum morphogenesis |
GO:0060040 | 0.0016 | 1053.75 | 0.0016 | 1 | 5 | retinal bipolar neuron differentiation |
GO:0021960 | 0.0019 | 842.9333 | 0.0019 | 1 | 6 | anterior commissure morphogenesis |
GO:0051450 | 0.0019 | 842.9333 | 0.0019 | 1 | 6 | myoblast proliferation |
GO:0002862 | 0.0022 | 702.3889 | 0.0022 | 1 | 7 | negative regulation of inflammatory response to antigenic stimulus |
GO:0021796 | 0.0022 | 702.3889 | 0.0022 | 1 | 7 | cerebral cortex regionalization |
GO:0021957 | 0.0022 | 702.3889 | 0.0022 | 1 | 7 | corticospinal tract morphogenesis |
GO:0015671 | 0.0028 | 526.7083 | 0.0028 | 1 | 9 | oxygen transport |
GO:0051593 | 0.0028 | 526.7083 | 0.0028 | 1 | 9 | response to folic acid |
GO:0009650 | 0.0035 | 421.3 | 0.0035 | 1 | 11 | UV protection |
GO:0019372 | 0.0035 | 421.3 | 0.0035 | 1 | 11 | lipoxygenase pathway |
GO:0090201 | 0.0038 | 382.9697 | 0.0038 | 1 | 12 | negative regulation of release of cytochrome c from mitochondria |
GO:1902176 | 0.0038 | 382.9697 | 0.0038 | 1 | 12 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO:0060055 | 0.0041 | 351.0278 | 0.0041 | 1 | 13 | angiogenesis involved in wound healing |
GO:0033599 | 0.0044 | 324 | 0.0044 | 1 | 14 | regulation of mammary gland epithelial cell proliferation |
GO:1902883 | 0.0054 | 263.1875 | 0.0054 | 1 | 17 | negative regulation of response to oxidative stress |
GO:0042744 | 0.006 | 233.9074 | 0.006 | 1 | 19 | hydrogen peroxide catabolic process |
GO:0043403 | 0.0066 | 210.4833 | 0.0066 | 1 | 21 | skeletal muscle tissue regeneration |
GO:1902042 | 0.0066 | 210.4833 | 0.0066 | 1 | 21 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0051702 | 0.0076 | 182.9855 | 0.0076 | 1 | 24 | interaction with symbiont |
GO:1903201 | 0.0076 | 182.9855 | 0.0076 | 1 | 24 | regulation of oxidative stress-induced cell death |
GO:0021871 | 0.0079 | 175.3472 | 0.0079 | 1 | 25 | forebrain regionalization |
GO:0001659 | 0.0085 | 161.8333 | 0.0085 | 1 | 27 | temperature homeostasis |
GO:0021955 | 0.0095 | 145.0575 | 0.0095 | 1 | 30 | central nervous system neuron axonogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 2e-04 | Inf | 2e-04 | 1 | 2 | oocyte construction |
GO:0007314 | 2e-04 | Inf | 2e-04 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 2e-04 | Inf | 2e-04 | 1 | 2 | P granule organization |
GO:0007028 | 5e-04 | Inf | 5e-04 | 1 | 6 | cytoplasm organization |
GO:0034587 | 9e-04 | Inf | 9e-04 | 1 | 11 | piRNA metabolic process |
GO:0006655 | 9e-04 | Inf | 9e-04 | 1 | 12 | phosphatidylglycerol biosynthetic process |
GO:0007350 | 0.0011 | Inf | 0.0011 | 1 | 14 | blastoderm segmentation |
GO:0008595 | 0.0011 | Inf | 0.0011 | 1 | 14 | anterior/posterior axis specification, embryo |
GO:0043046 | 0.0012 | Inf | 0.0012 | 1 | 15 | DNA methylation involved in gamete generation |
GO:0008053 | 0.0014 | Inf | 0.0014 | 1 | 18 | mitochondrial fusion |
GO:0009994 | 0.0027 | Inf | 0.0027 | 1 | 34 | oocyte differentiation |
GO:0006305 | 0.0036 | Inf | 0.0036 | 1 | 45 | DNA alkylation |
GO:0044728 | 0.0043 | Inf | 0.0043 | 1 | 54 | DNA methylation or demethylation |
GO:0007292 | 0.006 | Inf | 0.006 | 1 | 76 | female gamete generation |
GO:0009798 | 0.006 | Inf | 0.006 | 1 | 76 | axis specification |
GO:0007286 | 0.0063 | Inf | 0.0063 | 1 | 80 | spermatid development |
GO:0061025 | 0.0078 | Inf | 0.0078 | 1 | 99 | membrane fusion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 136.6445 | 0.3195 | 10 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 9.3057 | 1.5976 | 12 | 65 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 8.8805 | 1.3764 | 10 | 56 | detection of chemical stimulus |
GO:0007606 | 0 | 7.0363 | 1.6714 | 10 | 68 | sensory perception of chemical stimulus |
GO:0007028 | 3e-04 | 40.0617 | 0.1475 | 3 | 6 | cytoplasm organization |
GO:0007308 | 6e-04 | Inf | 0.0492 | 2 | 2 | oocyte construction |
GO:0007314 | 6e-04 | Inf | 0.0492 | 2 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 6e-04 | Inf | 0.0492 | 2 | 2 | P granule organization |
GO:2000352 | 7e-04 | 12.3568 | 0.4178 | 4 | 17 | negative regulation of endothelial cell apoptotic process |
GO:0050896 | 8e-04 | 1.4499 | 144.9187 | 173 | 5896 | response to stimulus |
GO:0048514 | 0.0012 | 2.237 | 10.0283 | 21 | 408 | blood vessel morphogenesis |
GO:0007155 | 0.0012 | 1.8165 | 21.9 | 37 | 891 | cell adhesion |
GO:0090132 | 0.0015 | 3.1279 | 3.7852 | 11 | 154 | epithelium migration |
GO:0002774 | 0.0018 | 79.877 | 0.0737 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0007210 | 0.0021 | 15.017 | 0.2704 | 3 | 11 | serotonin receptor signaling pathway |
GO:0001944 | 0.0022 | 2.0398 | 11.9946 | 23 | 488 | vasculature development |
GO:0006968 | 0.0022 | 6.0948 | 0.934 | 5 | 38 | cellular defense response |
GO:0010594 | 0.0028 | 4.0368 | 1.8926 | 7 | 77 | regulation of endothelial cell migration |
GO:0001906 | 0.0032 | 4.5613 | 1.4502 | 6 | 59 | cell killing |
GO:0002765 | 0.0035 | 39.9353 | 0.0983 | 2 | 4 | immune response-inhibiting signal transduction |
GO:0006533 | 0.0035 | 39.9353 | 0.0983 | 2 | 4 | aspartate catabolic process |
GO:0007598 | 0.0035 | 39.9353 | 0.0983 | 2 | 4 | blood coagulation, extrinsic pathway |
GO:0042373 | 0.0035 | 39.9353 | 0.0983 | 2 | 4 | vitamin K metabolic process |
GO:0007350 | 0.0044 | 10.9188 | 0.3441 | 3 | 14 | blastoderm segmentation |
GO:0008595 | 0.0044 | 10.9188 | 0.3441 | 3 | 14 | anterior/posterior axis specification, embryo |
GO:0070830 | 0.0047 | 5.0253 | 1.1061 | 5 | 45 | tight junction assembly |
GO:0032689 | 0.0054 | 10.0081 | 0.3687 | 3 | 15 | negative regulation of interferon-gamma production |
GO:0061436 | 0.0054 | 10.0081 | 0.3687 | 3 | 15 | establishment of skin barrier |
GO:0050877 | 0.0056 | 1.7446 | 17.5987 | 29 | 716 | neurological system process |
GO:0034113 | 0.0059 | 6.1719 | 0.7374 | 4 | 30 | heterotypic cell-cell adhesion |
GO:2000725 | 0.0065 | 9.2375 | 0.3933 | 3 | 16 | regulation of cardiac muscle cell differentiation |
GO:0050891 | 0.0067 | 5.9428 | 0.762 | 4 | 31 | multicellular organismal water homeostasis |
GO:0044700 | 0.0067 | 1.3462 | 107.8042 | 129 | 4386 | single organism signaling |
GO:0050714 | 0.0069 | 3.8342 | 1.696 | 6 | 69 | positive regulation of protein secretion |
GO:0035329 | 0.0075 | 5.7301 | 0.7865 | 4 | 32 | hippo signaling |
GO:0042403 | 0.0077 | 8.577 | 0.4178 | 3 | 17 | thyroid hormone metabolic process |
GO:0051926 | 0.0077 | 8.577 | 0.4178 | 3 | 17 | negative regulation of calcium ion transport |
GO:0032101 | 0.0078 | 1.9039 | 11.0606 | 20 | 450 | regulation of response to external stimulus |
GO:0043542 | 0.0079 | 5.6294 | 0.7976 | 4 | 33 | endothelial cell migration |
GO:0042267 | 0.0084 | 5.5321 | 0.8111 | 4 | 33 | natural killer cell mediated cytotoxicity |
GO:0002664 | 0.0085 | 19.9644 | 0.1475 | 2 | 6 | regulation of T cell tolerance induction |
GO:0007154 | 0.0085 | 1.3323 | 109.451 | 130 | 4453 | cell communication |
GO:0010837 | 0.0091 | 8.0045 | 0.4424 | 3 | 18 | regulation of keratinocyte proliferation |
GO:0032731 | 0.0091 | 8.0045 | 0.4424 | 3 | 18 | positive regulation of interleukin-1 beta production |
GO:0002040 | 0.0095 | 4.185 | 1.3027 | 5 | 53 | sprouting angiogenesis |
GO:0050776 | 0.0096 | 1.7594 | 14.3542 | 24 | 584 | regulation of immune response |
GO:0007186 | 0.0097 | 1.757 | 14.3743 | 24 | 590 | G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1901585 | 6e-04 | Inf | 6e-04 | 1 | 1 | regulation of acid-sensing ion channel activity |
GO:0036018 | 0.0022 | 702.3889 | 0.0022 | 1 | 4 | cellular response to erythropoietin |
GO:0071294 | 0.005 | 263.2917 | 0.005 | 1 | 9 | cellular response to zinc ion |
GO:0071276 | 0.0061 | 210.6 | 0.0061 | 1 | 11 | cellular response to cadmium ion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042246 | 2e-04 | 11.1728 | 0.5234 | 5 | 37 | tissue regeneration |
GO:0033993 | 3e-04 | 2.6552 | 7.8232 | 19 | 553 | response to lipid |
GO:0040008 | 5e-04 | 2.6861 | 6.8754 | 17 | 486 | regulation of growth |
GO:0007207 | 6e-04 | 140.9379 | 0.0424 | 2 | 3 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0014717 | 6e-04 | 140.9379 | 0.0424 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0030309 | 6e-04 | 140.9379 | 0.0424 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0032095 | 7e-04 | 21.2455 | 0.1839 | 3 | 13 | regulation of response to food |
GO:0046661 | 0.001 | 4.8407 | 1.5703 | 7 | 111 | male sex differentiation |
GO:0007205 | 0.001 | 10.16 | 0.4527 | 4 | 32 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0061436 | 0.0011 | 17.7017 | 0.2122 | 3 | 15 | establishment of skin barrier |
GO:0051049 | 0.0014 | 1.9526 | 16.9196 | 30 | 1196 | regulation of transport |
GO:0010812 | 0.0014 | 9.1746 | 0.4951 | 4 | 35 | negative regulation of cell-substrate adhesion |
GO:0045597 | 0.0015 | 2.4221 | 7.5686 | 17 | 535 | positive regulation of cell differentiation |
GO:0008584 | 0.0016 | 5.1777 | 1.2591 | 6 | 89 | male gonad development |
GO:0008627 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | intrinsic apoptotic signaling pathway in response to osmotic stress |
GO:0014719 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | skeletal muscle satellite cell activation |
GO:0043415 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0046884 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | follicle-stimulating hormone secretion |
GO:0051901 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | positive regulation of mitochondrial depolarization |
GO:0060040 | 0.0019 | 46.9718 | 0.0707 | 2 | 5 | retinal bipolar neuron differentiation |
GO:0007565 | 0.0021 | 4.2254 | 1.7825 | 7 | 126 | female pregnancy |
GO:0032501 | 0.0023 | 1.5526 | 70.8757 | 90 | 5010 | multicellular organismal process |
GO:0044057 | 0.0024 | 2.7737 | 4.626 | 12 | 327 | regulation of system process |
GO:0007044 | 0.0027 | 5.6609 | 0.962 | 5 | 68 | cell-substrate junction assembly |
GO:0045137 | 0.0028 | 3.5779 | 2.3908 | 8 | 169 | development of primary sexual characteristics |
GO:0030643 | 0.0029 | 35.226 | 0.0849 | 2 | 6 | cellular phosphate ion homeostasis |
GO:1903034 | 0.0032 | 2.9783 | 3.5792 | 10 | 253 | regulation of response to wounding |
GO:0030857 | 0.0045 | 10.108 | 0.3395 | 3 | 24 | negative regulation of epithelial cell differentiation |
GO:0022414 | 0.0047 | 1.926 | 12.8736 | 23 | 910 | reproductive process |
GO:0032099 | 0.0053 | 23.4802 | 0.1132 | 2 | 8 | negative regulation of appetite |
GO:0045603 | 0.0053 | 23.4802 | 0.1132 | 2 | 8 | positive regulation of endothelial cell differentiation |
GO:0098661 | 0.0064 | 4.5668 | 1.1742 | 5 | 83 | inorganic anion transmembrane transport |
GO:2001257 | 0.0066 | 5.7959 | 0.7498 | 4 | 53 | regulation of cation channel activity |
GO:0042541 | 0.0067 | 20.1243 | 0.1273 | 2 | 9 | hemoglobin biosynthetic process |
GO:0051960 | 0.0071 | 2.1633 | 7.3705 | 15 | 521 | regulation of nervous system development |
GO:0030307 | 0.0074 | 4.3966 | 1.2166 | 5 | 86 | positive regulation of cell growth |
GO:0032649 | 0.0075 | 5.5677 | 0.7781 | 4 | 55 | regulation of interferon-gamma production |
GO:0030155 | 0.0077 | 2.6055 | 4.0601 | 10 | 287 | regulation of cell adhesion |
GO:0051048 | 0.0077 | 3.6948 | 1.7259 | 6 | 122 | negative regulation of secretion |
GO:0007204 | 0.0079 | 3.2558 | 2.2776 | 7 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0030002 | 0.0083 | 17.6073 | 0.1415 | 2 | 10 | cellular anion homeostasis |
GO:0051895 | 0.0083 | 17.6073 | 0.1415 | 2 | 10 | negative regulation of focal adhesion assembly |
GO:0090280 | 0.0083 | 17.6073 | 0.1415 | 2 | 10 | positive regulation of calcium ion import |
GO:0048878 | 0.0088 | 1.9666 | 9.7472 | 18 | 689 | chemical homeostasis |
GO:0051239 | 0.0088 | 1.6821 | 20.079 | 31 | 1482 | regulation of multicellular organismal process |
GO:0065007 | 0.0089 | 1.5009 | 115.707 | 131 | 8179 | biological regulation |
GO:0010959 | 0.009 | 2.9006 | 2.9142 | 8 | 206 | regulation of metal ion transport |
GO:0071300 | 0.0091 | 5.2571 | 0.8205 | 4 | 58 | cellular response to retinoic acid |
GO:0050891 | 0.0094 | 7.5767 | 0.4386 | 3 | 31 | multicellular organismal water homeostasis |
GO:0060986 | 0.0094 | 7.5767 | 0.4386 | 3 | 31 | endocrine hormone secretion |
GO:0007187 | 0.0097 | 3.5114 | 1.8108 | 6 | 128 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0043010 | 0.0097 | 2.6647 | 3.565 | 9 | 252 | camera-type eye development |
GO:0007586 | 0.0098 | 4.0914 | 1.3015 | 5 | 92 | digestion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042843 | 0.0021 | Inf | 0.0021 | 1 | 1 | D-xylose catabolic process |
GO:2000266 | 0.0021 | Inf | 0.0021 | 1 | 1 | regulation of blood coagulation, intrinsic pathway |
GO:0006968 | 0.0027 | 29.1458 | 0.0781 | 2 | 38 | cellular defense response |
GO:0010845 | 0.0041 | 505.04 | 0.0041 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
GO:0030150 | 0.0041 | 505.04 | 0.0041 | 1 | 2 | protein import into mitochondrial matrix |
GO:0045918 | 0.0041 | 505.04 | 0.0041 | 1 | 2 | negative regulation of cytolysis |
GO:0043414 | 0.0055 | 9.3351 | 0.3637 | 3 | 177 | macromolecule methylation |
GO:0006311 | 0.0062 | 252.5 | 0.0062 | 1 | 3 | meiotic gene conversion |
GO:0045347 | 0.0082 | 168.32 | 0.0082 | 1 | 4 | negative regulation of MHC class II biosynthetic process |
GO:0051024 | 0.0082 | 168.32 | 0.0082 | 1 | 4 | positive regulation of immunoglobulin secretion |
GO:0060903 | 0.0082 | 168.32 | 0.0082 | 1 | 4 | positive regulation of meiosis I |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003002 | 0 | 10.0547 | 0.9926 | 8 | 314 | regionalization |
GO:0045665 | 0 | 29.0856 | 0.1644 | 4 | 52 | negative regulation of neuron differentiation |
GO:0002089 | 0 | 53.744 | 0.0695 | 3 | 22 | lens morphogenesis in camera-type eye |
GO:0044707 | 1e-04 | 3.7511 | 15.3798 | 28 | 4865 | single-multicellular organism process |
GO:0045944 | 1e-04 | 5.3329 | 2.3773 | 10 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0008284 | 1e-04 | 5.7424 | 1.9474 | 9 | 616 | positive regulation of cell proliferation |
GO:0043010 | 1e-04 | 8.8716 | 0.7966 | 6 | 252 | camera-type eye development |
GO:0051239 | 2e-04 | 3.6184 | 5.7188 | 15 | 1809 | regulation of multicellular organismal process |
GO:0002118 | 3e-04 | 110.5877 | 0.0253 | 2 | 8 | aggressive behavior |
GO:0007420 | 3e-04 | 5.401 | 1.7893 | 8 | 566 | brain development |
GO:0007423 | 4e-04 | 5.9668 | 1.391 | 7 | 440 | sensory organ development |
GO:0010628 | 5e-04 | 3.9819 | 3.5027 | 11 | 1108 | positive regulation of gene expression |
GO:0001525 | 5e-04 | 6.6934 | 1.0432 | 6 | 330 | angiogenesis |
GO:0023057 | 6e-04 | 4.435 | 2.4911 | 9 | 808 | negative regulation of signaling |
GO:0010648 | 6e-04 | 4.4173 | 2.5003 | 9 | 811 | negative regulation of cell communication |
GO:0021872 | 9e-04 | 17.5513 | 0.1928 | 3 | 61 | forebrain generation of neurons |
GO:0060581 | 0.001 | 51.0121 | 0.0474 | 2 | 15 | cell fate commitment involved in pattern specification |
GO:0048731 | 0.001 | 2.8372 | 10.4544 | 20 | 3307 | system development |
GO:0065007 | 0.0011 | 3.8412 | 25.8563 | 35 | 8179 | biological regulation |
GO:0014013 | 0.0011 | 16.4137 | 0.2055 | 3 | 65 | regulation of gliogenesis |
GO:0021954 | 0.0012 | 15.8982 | 0.2118 | 3 | 67 | central nervous system neuron development |
GO:1902680 | 0.0012 | 3.7132 | 3.3162 | 10 | 1049 | positive regulation of RNA biosynthetic process |
GO:0021514 | 0.0013 | 44.2035 | 0.0537 | 2 | 17 | ventral spinal cord interneuron differentiation |
GO:0009891 | 0.0014 | 3.442 | 3.9927 | 11 | 1263 | positive regulation of biosynthetic process |
GO:0071346 | 0.0014 | 14.9583 | 0.2245 | 3 | 71 | cellular response to interferon-gamma |
GO:0071310 | 0.0016 | 3.2387 | 4.6977 | 12 | 1486 | cellular response to organic substance |
GO:0021895 | 0.0016 | 38.9969 | 0.0601 | 2 | 19 | cerebral cortex neuron differentiation |
GO:0051093 | 0.0016 | 4.6436 | 1.764 | 7 | 558 | negative regulation of developmental process |
GO:0010594 | 0.0018 | 13.7389 | 0.2434 | 3 | 77 | regulation of endothelial cell migration |
GO:0045595 | 0.0019 | 3.4853 | 3.5122 | 10 | 1111 | regulation of cell differentiation |
GO:0009887 | 0.0021 | 4.4653 | 1.8527 | 7 | 627 | organ morphogenesis |
GO:0042129 | 0.0025 | 12.2403 | 0.2719 | 3 | 86 | regulation of T cell proliferation |
GO:0021537 | 0.0025 | 7.7622 | 0.5754 | 4 | 182 | telencephalon development |
GO:0045686 | 0.0026 | 30.122 | 0.0759 | 2 | 24 | negative regulation of glial cell differentiation |
GO:0021510 | 0.0026 | 12.0936 | 0.275 | 3 | 87 | spinal cord development |
GO:0021513 | 0.0028 | 28.8101 | 0.079 | 2 | 25 | spinal cord dorsal/ventral patterning |
GO:0048713 | 0.0028 | 28.8101 | 0.079 | 2 | 25 | regulation of oligodendrocyte differentiation |
GO:0090288 | 0.0031 | 11.282 | 0.294 | 3 | 93 | negative regulation of cellular response to growth factor stimulus |
GO:0001568 | 0.0031 | 4.6834 | 1.4668 | 6 | 464 | blood vessel development |
GO:0001827 | 0.0032 | Inf | 0.0032 | 1 | 1 | inner cell mass cell fate commitment |
GO:0002646 | 0.0032 | Inf | 0.0032 | 1 | 1 | regulation of central tolerance induction |
GO:0002897 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of central B cell tolerance induction |
GO:0003327 | 0.0032 | Inf | 0.0032 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0021723 | 0.0032 | Inf | 0.0032 | 1 | 1 | medullary reticular formation development |
GO:0021764 | 0.0032 | Inf | 0.0032 | 1 | 1 | amygdala development |
GO:0034972 | 0.0032 | Inf | 0.0032 | 1 | 1 | histone H3-R26 methylation |
GO:0035922 | 0.0032 | Inf | 0.0032 | 1 | 1 | foramen ovale closure |
GO:0036306 | 0.0032 | Inf | 0.0032 | 1 | 1 | embryonic heart tube elongation |
GO:0048894 | 0.0032 | Inf | 0.0032 | 1 | 1 | efferent axon development in a lateral line nerve |
GO:0048925 | 0.0032 | Inf | 0.0032 | 1 | 1 | lateral line system development |
GO:0051308 | 0.0032 | Inf | 0.0032 | 1 | 1 | male meiosis chromosome separation |
GO:0060580 | 0.0032 | Inf | 0.0032 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0061452 | 0.0032 | Inf | 0.0032 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
GO:0072016 | 0.0032 | Inf | 0.0032 | 1 | 1 | glomerular parietal epithelial cell development |
GO:1901003 | 0.0032 | Inf | 0.0032 | 1 | 1 | negative regulation of fermentation |
GO:1901248 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
GO:1901751 | 0.0032 | Inf | 0.0032 | 1 | 1 | leukotriene A4 metabolic process |
GO:2001306 | 0.0032 | Inf | 0.0032 | 1 | 1 | lipoxin B4 biosynthetic process |
GO:0002042 | 0.0033 | 26.5011 | 0.0854 | 2 | 27 | cell migration involved in sprouting angiogenesis |
GO:0032729 | 0.0033 | 26.5011 | 0.0854 | 2 | 27 | positive regulation of interferon-gamma production |
GO:0045087 | 0.0033 | 4.0687 | 1.9979 | 7 | 632 | innate immune response |
GO:0045935 | 0.0034 | 3.2057 | 3.7872 | 10 | 1198 | positive regulation of nucleobase-containing compound metabolic process |
GO:0090101 | 0.0035 | 10.7984 | 0.3066 | 3 | 97 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0060191 | 0.0038 | 10.462 | 0.3161 | 3 | 100 | regulation of lipase activity |
GO:0048665 | 0.004 | 23.656 | 0.0948 | 2 | 30 | neuron fate specification |
GO:0001667 | 0.0051 | 6.3472 | 0.6986 | 4 | 221 | ameboidal cell migration |
GO:0035176 | 0.0051 | 20.6924 | 0.1075 | 2 | 34 | social behavior |
GO:0048869 | 0.0053 | 2.4481 | 9.3006 | 17 | 2942 | cellular developmental process |
GO:0051960 | 0.0055 | 4.1455 | 1.647 | 6 | 521 | regulation of nervous system development |
GO:0034654 | 0.0056 | 2.4057 | 10.1762 | 18 | 3219 | nucleobase-containing compound biosynthetic process |
GO:0001992 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | regulation of systemic arterial blood pressure by vasopressin |
GO:0002635 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | negative regulation of germinal center formation |
GO:0002661 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | regulation of B cell tolerance induction |
GO:0002713 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | negative regulation of B cell mediated immunity |
GO:0002924 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
GO:0003193 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | pulmonary valve formation |
GO:0003326 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | pancreatic PP cell fate commitment |
GO:0021893 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0021934 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | hindbrain tangential cell migration |
GO:0030150 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | protein import into mitochondrial matrix |
GO:0033693 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | neurofilament bundle assembly |
GO:0060577 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | pulmonary vein morphogenesis |
GO:2001303 | 0.0063 | 323.3846 | 0.0063 | 1 | 2 | lipoxin A4 biosynthetic process |
GO:0046456 | 0.0064 | 18.3874 | 0.1201 | 2 | 38 | icosanoid biosynthetic process |
GO:0032944 | 0.0065 | 8.5857 | 0.3825 | 3 | 121 | regulation of mononuclear cell proliferation |
GO:0021545 | 0.0067 | 17.889 | 0.1233 | 2 | 39 | cranial nerve development |
GO:0001764 | 0.0068 | 8.4412 | 0.3888 | 3 | 123 | neuron migration |
GO:0051094 | 0.0072 | 3.4987 | 2.3014 | 7 | 728 | positive regulation of developmental process |
GO:0006355 | 0.0077 | 2.3722 | 8.7979 | 16 | 2783 | regulation of transcription, DNA-templated |
GO:0048592 | 0.0081 | 7.9086 | 0.4141 | 3 | 131 | eye morphogenesis |
GO:0009719 | 0.0082 | 2.936 | 3.6165 | 9 | 1144 | response to endogenous stimulus |
GO:0048585 | 0.0087 | 3.3875 | 2.3979 | 7 | 814 | negative regulation of response to stimulus |
GO:0010171 | 0.0089 | 15.3856 | 0.1423 | 2 | 45 | body morphogenesis |
GO:0032502 | 0.0089 | 2.5667 | 8.4281 | 15 | 3251 | developmental process |
GO:0009743 | 0.0093 | 7.4943 | 0.4363 | 3 | 138 | response to carbohydrate |
GO:0003175 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | tricuspid valve development |
GO:0003358 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | noradrenergic neuron development |
GO:0014049 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | positive regulation of glutamate secretion |
GO:0021524 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | visceral motor neuron differentiation |
GO:0021530 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021882 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0031133 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | regulation of axon diameter |
GO:0031394 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0032513 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | negative regulation of protein phosphatase type 2B activity |
GO:0042631 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | cellular response to water deprivation |
GO:0051970 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | negative regulation of transmission of nerve impulse |
GO:0072709 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | cellular response to sorbitol |
GO:1901166 | 0.0095 | 161.6795 | 0.0095 | 1 | 3 | neural crest cell migration involved in autonomic nervous system development |
GO:0006636 | 0.0096 | 14.6994 | 0.1486 | 2 | 47 | unsaturated fatty acid biosynthetic process |
GO:0031018 | 0.0096 | 14.6994 | 0.1486 | 2 | 47 | endocrine pancreas development |
GO:0031295 | 0.0096 | 14.6994 | 0.1486 | 2 | 47 | T cell costimulation |
GO:0048708 | 0.0096 | 14.6994 | 0.1486 | 2 | 47 | astrocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.772 | 96.9675 | 133 | 4437 | multicellular organismal process |
GO:0007389 | 0 | 2.9147 | 9.059 | 24 | 398 | pattern specification process |
GO:0007618 | 0 | 10.5966 | 0.8194 | 7 | 36 | mating |
GO:0050670 | 0 | 4.9344 | 2.7314 | 12 | 120 | regulation of lymphocyte proliferation |
GO:0002125 | 0 | 130.1474 | 0.091 | 3 | 4 | maternal aggressive behavior |
GO:0048598 | 1e-04 | 2.4912 | 11.8359 | 27 | 520 | embryonic morphogenesis |
GO:0051954 | 1e-04 | 14.5465 | 0.4552 | 5 | 20 | positive regulation of amine transport |
GO:0032946 | 1e-04 | 5.6659 | 1.7982 | 9 | 79 | positive regulation of mononuclear cell proliferation |
GO:0050793 | 1e-04 | 1.8377 | 33.979 | 56 | 1507 | regulation of developmental process |
GO:0060406 | 1e-04 | 65.0684 | 0.1138 | 3 | 5 | positive regulation of penile erection |
GO:0009952 | 1e-04 | 3.5386 | 4.3247 | 14 | 190 | anterior/posterior pattern specification |
GO:0050710 | 1e-04 | 12.1192 | 0.5235 | 5 | 23 | negative regulation of cytokine secretion |
GO:0051960 | 1e-04 | 2.3797 | 11.8587 | 26 | 521 | regulation of nervous system development |
GO:0051241 | 2e-04 | 2.8565 | 6.8284 | 18 | 300 | negative regulation of multicellular organismal process |
GO:0021761 | 2e-04 | 5.5791 | 1.6161 | 8 | 71 | limbic system development |
GO:0021542 | 2e-04 | 17.4014 | 0.3187 | 4 | 14 | dentate gyrus development |
GO:0044705 | 3e-04 | 10.3853 | 0.5918 | 5 | 26 | multi-organism reproductive behavior |
GO:0060759 | 3e-04 | 5.2443 | 1.7071 | 8 | 75 | regulation of response to cytokine stimulus |
GO:0045664 | 3e-04 | 2.5694 | 8.399 | 20 | 369 | regulation of neuron differentiation |
GO:0009712 | 3e-04 | 7.4954 | 0.9332 | 6 | 41 | catechol-containing compound metabolic process |
GO:0001960 | 4e-04 | 9.4807 | 0.6373 | 5 | 28 | negative regulation of cytokine-mediated signaling pathway |
GO:0007275 | 4e-04 | 1.5679 | 72.7696 | 98 | 3378 | multicellular organismal development |
GO:0071222 | 4e-04 | 4.9473 | 1.7982 | 8 | 79 | cellular response to lipopolysaccharide |
GO:0051048 | 5e-04 | 3.9353 | 2.7769 | 10 | 122 | negative regulation of secretion |
GO:0003013 | 5e-04 | 2.6185 | 7.3975 | 18 | 325 | circulatory system process |
GO:0048870 | 5e-04 | 1.9215 | 20.895 | 37 | 918 | cell motility |
GO:0042403 | 5e-04 | 13.3824 | 0.3869 | 4 | 17 | thyroid hormone metabolic process |
GO:0010901 | 5e-04 | Inf | 0.0455 | 2 | 2 | regulation of very-low-density lipoprotein particle remodeling |
GO:0008217 | 5e-04 | 3.8656 | 2.8224 | 10 | 124 | regulation of blood pressure |
GO:0001501 | 6e-04 | 2.4397 | 8.8087 | 20 | 387 | skeletal system development |
GO:0070663 | 6e-04 | 4.6898 | 1.885 | 8 | 84 | regulation of leukocyte proliferation |
GO:0003139 | 6e-04 | 26.0211 | 0.1821 | 3 | 8 | secondary heart field specification |
GO:0045723 | 6e-04 | 26.0211 | 0.1821 | 3 | 8 | positive regulation of fatty acid biosynthetic process |
GO:0060180 | 6e-04 | 26.0211 | 0.1821 | 3 | 8 | female mating behavior |
GO:0071706 | 6e-04 | 5.379 | 1.4567 | 7 | 64 | tumor necrosis factor superfamily cytokine production |
GO:0032892 | 6e-04 | 12.4256 | 0.4097 | 4 | 18 | positive regulation of organic acid transport |
GO:0044062 | 6e-04 | 12.4256 | 0.4097 | 4 | 18 | regulation of excretion |
GO:0045597 | 8e-04 | 2.2177 | 11.128 | 23 | 496 | positive regulation of cell differentiation |
GO:0002237 | 8e-04 | 3.1757 | 4.0743 | 12 | 179 | response to molecule of bacterial origin |
GO:0045596 | 8e-04 | 2.2522 | 10.4702 | 22 | 460 | negative regulation of cell differentiation |
GO:0048664 | 9e-04 | 21.6825 | 0.2049 | 3 | 9 | neuron fate determination |
GO:0050714 | 0.001 | 4.9432 | 1.5705 | 7 | 69 | positive regulation of protein secretion |
GO:0035176 | 0.001 | 7.5155 | 0.7739 | 5 | 34 | social behavior |
GO:0002520 | 0.001 | 2.05 | 14.1348 | 27 | 621 | immune system development |
GO:0002694 | 0.001 | 2.6055 | 6.578 | 16 | 289 | regulation of leukocyte activation |
GO:0065007 | 0.001 | 1.5122 | 186.1655 | 211 | 8179 | biological regulation |
GO:0050900 | 0.0011 | 2.9188 | 4.7812 | 13 | 212 | leukocyte migration |
GO:0009887 | 0.0011 | 1.931 | 17.2531 | 31 | 758 | organ morphogenesis |
GO:0060284 | 0.0012 | 2.0497 | 13.5886 | 26 | 597 | regulation of cell development |
GO:0050863 | 0.0012 | 3.0286 | 4.2564 | 12 | 187 | regulation of T cell activation |
GO:0035815 | 0.0012 | 18.5835 | 0.2276 | 3 | 10 | positive regulation of renal sodium excretion |
GO:0045060 | 0.0012 | 18.5835 | 0.2276 | 3 | 10 | negative thymic T cell selection |
GO:0021543 | 0.0013 | 3.6955 | 2.6403 | 9 | 116 | pallium development |
GO:0021953 | 0.0013 | 3.1696 | 3.7329 | 11 | 164 | central nervous system neuron differentiation |
GO:0033993 | 0.0015 | 2.6781 | 5.5913 | 14 | 253 | response to lipid |
GO:0014049 | 0.0015 | 86.4615 | 0.0683 | 2 | 3 | positive regulation of glutamate secretion |
GO:0031394 | 0.0015 | 86.4615 | 0.0683 | 2 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0042414 | 0.0015 | 86.4615 | 0.0683 | 2 | 3 | epinephrine metabolic process |
GO:0051970 | 0.0015 | 86.4615 | 0.0683 | 2 | 3 | negative regulation of transmission of nerve impulse |
GO:1901700 | 0.0016 | 1.7678 | 23.1483 | 38 | 1017 | response to oxygen-containing compound |
GO:0042711 | 0.0017 | 16.2592 | 0.2504 | 3 | 11 | maternal behavior |
GO:0001708 | 0.0017 | 4.4392 | 1.7299 | 7 | 76 | cell fate specification |
GO:0071216 | 0.0018 | 3.8968 | 2.2306 | 8 | 98 | cellular response to biotic stimulus |
GO:0030858 | 0.0018 | 6.4077 | 0.8877 | 5 | 39 | positive regulation of epithelial cell differentiation |
GO:0006805 | 0.0019 | 3.8537 | 2.2534 | 8 | 99 | xenobiotic metabolic process |
GO:0051155 | 0.0019 | 8.6937 | 0.5463 | 4 | 24 | positive regulation of striated muscle cell differentiation |
GO:0048663 | 0.0021 | 4.9933 | 1.3299 | 6 | 59 | neuron fate commitment |
GO:0051251 | 0.0021 | 2.9727 | 3.9605 | 11 | 174 | positive regulation of lymphocyte activation |
GO:0032720 | 0.0023 | 8.279 | 0.569 | 4 | 25 | negative regulation of tumor necrosis factor production |
GO:0006355 | 0.0024 | 1.4747 | 63.345 | 84 | 2783 | regulation of transcription, DNA-templated |
GO:0070664 | 0.0025 | 5.8867 | 0.956 | 5 | 42 | negative regulation of leukocyte proliferation |
GO:0048646 | 0.0025 | 1.787 | 19.7569 | 33 | 868 | anatomical structure formation involved in morphogenesis |
GO:0032940 | 0.0026 | 1.9015 | 15.1363 | 27 | 665 | secretion by cell |
GO:0050798 | 0.0026 | 7.902 | 0.5918 | 4 | 26 | activated T cell proliferation |
GO:0051239 | 0.0026 | 1.6774 | 27.1243 | 42 | 1274 | regulation of multicellular organismal process |
GO:0048568 | 0.0027 | 2.2168 | 8.6266 | 18 | 379 | embryonic organ development |
GO:0009410 | 0.0027 | 3.6135 | 2.3899 | 8 | 105 | response to xenobiotic stimulus |
GO:0048368 | 0.0028 | 13.0053 | 0.2959 | 3 | 13 | lateral mesoderm development |
GO:2000380 | 0.0028 | 13.0053 | 0.2959 | 3 | 13 | regulation of mesoderm development |
GO:0032504 | 0.003 | 1.9566 | 13.0423 | 24 | 573 | multicellular organism reproduction |
GO:0007621 | 0.003 | 43.2273 | 0.091 | 2 | 4 | negative regulation of female receptivity |
GO:0010936 | 0.003 | 43.2273 | 0.091 | 2 | 4 | negative regulation of macrophage cytokine production |
GO:0032849 | 0.003 | 43.2273 | 0.091 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0042738 | 0.003 | 43.2273 | 0.091 | 2 | 4 | exogenous drug catabolic process |
GO:0070235 | 0.003 | 43.2273 | 0.091 | 2 | 4 | regulation of activation-induced cell death of T cells |
GO:2001279 | 0.003 | 43.2273 | 0.091 | 2 | 4 | regulation of unsaturated fatty acid biosynthetic process |
GO:0048729 | 0.003 | 2.0541 | 10.8572 | 21 | 477 | tissue morphogenesis |
GO:0033077 | 0.003 | 4.5943 | 1.434 | 6 | 63 | T cell differentiation in thymus |
GO:0030890 | 0.0031 | 7.5579 | 0.6146 | 4 | 27 | positive regulation of B cell proliferation |
GO:0051252 | 0.0031 | 1.4537 | 65.7122 | 86 | 2887 | regulation of RNA metabolic process |
GO:0050776 | 0.0033 | 1.967 | 12.4212 | 23 | 552 | regulation of immune response |
GO:0071356 | 0.0034 | 3.8741 | 1.9575 | 7 | 86 | cellular response to tumor necrosis factor |
GO:0010092 | 0.0035 | 7.2424 | 0.6373 | 4 | 28 | specification of organ identity |
GO:0046189 | 0.0035 | 7.2424 | 0.6373 | 4 | 28 | phenol-containing compound biosynthetic process |
GO:0007625 | 0.0035 | 11.822 | 0.3187 | 3 | 14 | grooming behavior |
GO:0010803 | 0.0035 | 11.822 | 0.3187 | 3 | 14 | regulation of tumor necrosis factor-mediated signaling pathway |
GO:0048545 | 0.0037 | 2.3289 | 6.8284 | 15 | 300 | response to steroid hormone |
GO:0045944 | 0.0038 | 1.803 | 17.1166 | 29 | 752 | positive regulation of transcription from RNA polymerase II promoter |
GO:0030098 | 0.0038 | 2.6048 | 4.8937 | 12 | 215 | lymphocyte differentiation |
GO:0042417 | 0.004 | 6.9521 | 0.6601 | 4 | 29 | dopamine metabolic process |
GO:0043009 | 0.004 | 1.9343 | 12.6098 | 23 | 554 | chordate embryonic development |
GO:0010628 | 0.0041 | 1.6551 | 25.2196 | 39 | 1108 | positive regulation of gene expression |
GO:0030097 | 0.0041 | 1.9305 | 12.6326 | 23 | 555 | hemopoiesis |
GO:0031347 | 0.0041 | 2.1199 | 8.9908 | 18 | 395 | regulation of defense response |
GO:0051955 | 0.0043 | 10.836 | 0.3414 | 3 | 15 | regulation of amino acid transport |
GO:0061082 | 0.0043 | 10.836 | 0.3414 | 3 | 15 | myeloid leukocyte cytokine production |
GO:0002697 | 0.0043 | 2.6882 | 4.3474 | 11 | 191 | regulation of immune effector process |
GO:0048704 | 0.0044 | 3.6862 | 2.0485 | 7 | 90 | embryonic skeletal system morphogenesis |
GO:0009891 | 0.0047 | 1.6033 | 28.7476 | 43 | 1263 | positive regulation of biosynthetic process |
GO:0001667 | 0.0047 | 2.5288 | 5.0303 | 12 | 221 | ameboidal cell migration |
GO:0050794 | 0.0047 | 1.3911 | 169.2765 | 191 | 7437 | regulation of cellular process |
GO:0001817 | 0.0048 | 2.1927 | 7.7182 | 16 | 343 | regulation of cytokine production |
GO:0043084 | 0.0048 | 29.1166 | 0.1127 | 2 | 5 | penile erection |
GO:0050867 | 0.0049 | 2.6435 | 4.4157 | 11 | 194 | positive regulation of cell activation |
GO:0042713 | 0.0049 | 28.8159 | 0.1138 | 2 | 5 | sperm ejaculation |
GO:0071374 | 0.0049 | 28.8159 | 0.1138 | 2 | 5 | cellular response to parathyroid hormone stimulus |
GO:1900094 | 0.0049 | 28.8159 | 0.1138 | 2 | 5 | regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry |
GO:1900164 | 0.0049 | 28.8159 | 0.1138 | 2 | 5 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:2000609 | 0.0049 | 28.8159 | 0.1138 | 2 | 5 | regulation of thyroid hormone generation |
GO:0045165 | 0.005 | 3.2407 | 2.6397 | 8 | 120 | cell fate commitment |
GO:0019748 | 0.0051 | 6.4361 | 0.7056 | 4 | 31 | secondary metabolic process |
GO:0055078 | 0.0051 | 6.4361 | 0.7056 | 4 | 31 | sodium ion homeostasis |
GO:0046717 | 0.0051 | 4.0894 | 1.5933 | 6 | 70 | acid secretion |
GO:0061053 | 0.0051 | 4.0894 | 1.5933 | 6 | 70 | somite development |
GO:0002686 | 0.0052 | 10.0016 | 0.3642 | 3 | 16 | negative regulation of leukocyte migration |
GO:0045089 | 0.0053 | 2.7614 | 3.8467 | 10 | 169 | positive regulation of innate immune response |
GO:0048699 | 0.0054 | 1.6234 | 25.6521 | 39 | 1127 | generation of neurons |
GO:0002260 | 0.0054 | 4.8371 | 1.1381 | 5 | 50 | lymphocyte homeostasis |
GO:0010556 | 0.0055 | 1.4078 | 70.7424 | 90 | 3108 | regulation of macromolecule biosynthetic process |
GO:0045995 | 0.0056 | 3.5156 | 2.1396 | 7 | 94 | regulation of embryonic development |
GO:0001974 | 0.0057 | 6.2057 | 0.7284 | 4 | 32 | blood vessel remodeling |
GO:0002718 | 0.0057 | 6.2057 | 0.7284 | 4 | 32 | regulation of cytokine production involved in immune response |
GO:0042130 | 0.0057 | 6.2057 | 0.7284 | 4 | 32 | negative regulation of T cell proliferation |
GO:0002684 | 0.0059 | 1.928 | 11.5106 | 21 | 509 | positive regulation of immune system process |
GO:0042102 | 0.0059 | 4.7315 | 1.1608 | 5 | 51 | positive regulation of T cell proliferation |
GO:0031327 | 0.0061 | 1.651 | 22.5565 | 35 | 991 | negative regulation of cellular biosynthetic process |
GO:0042113 | 0.0062 | 2.8792 | 3.3232 | 9 | 146 | B cell activation |
GO:0042423 | 0.0063 | 9.2865 | 0.3869 | 3 | 17 | catecholamine biosynthetic process |
GO:0060914 | 0.0063 | 9.2865 | 0.3869 | 3 | 17 | heart formation |
GO:0051172 | 0.0063 | 1.6594 | 21.7827 | 34 | 957 | negative regulation of nitrogen compound metabolic process |
GO:0032924 | 0.0064 | 5.9913 | 0.7511 | 4 | 33 | activin receptor signaling pathway |
GO:0048536 | 0.0064 | 5.9913 | 0.7511 | 4 | 33 | spleen development |
GO:0015850 | 0.0068 | 2.8373 | 3.3687 | 9 | 148 | organic hydroxy compound transport |
GO:1901362 | 0.007 | 1.3868 | 75.111 | 94 | 3339 | organic cyclic compound biosynthetic process |
GO:0031644 | 0.0071 | 5.7911 | 0.7739 | 4 | 34 | regulation of neurological system process |
GO:0033238 | 0.0071 | 3.7916 | 1.7071 | 6 | 75 | regulation of cellular amine metabolic process |
GO:0008284 | 0.0072 | 1.8079 | 14.021 | 24 | 616 | positive regulation of cell proliferation |
GO:0015711 | 0.0073 | 2.2134 | 6.6691 | 14 | 293 | organic anion transport |
GO:0002645 | 0.0073 | 21.6101 | 0.1366 | 2 | 6 | positive regulation of tolerance induction |
GO:0034370 | 0.0073 | 21.6101 | 0.1366 | 2 | 6 | triglyceride-rich lipoprotein particle remodeling |
GO:0044597 | 0.0073 | 21.6101 | 0.1366 | 2 | 6 | daunorubicin metabolic process |
GO:0044598 | 0.0073 | 21.6101 | 0.1366 | 2 | 6 | doxorubicin metabolic process |
GO:0090197 | 0.0073 | 21.6101 | 0.1366 | 2 | 6 | positive regulation of chemokine secretion |
GO:0015718 | 0.0074 | 3.3232 | 2.2534 | 7 | 99 | monocarboxylic acid transport |
GO:0045581 | 0.0074 | 8.6667 | 0.4097 | 3 | 18 | negative regulation of T cell differentiation |
GO:0051412 | 0.0074 | 8.6667 | 0.4097 | 3 | 18 | response to corticosterone |
GO:0003158 | 0.0076 | 3.7371 | 1.7299 | 6 | 76 | endothelium development |
GO:0051707 | 0.0078 | 1.9417 | 10.3109 | 19 | 453 | response to other organism |
GO:0071347 | 0.0079 | 5.6038 | 0.7966 | 4 | 35 | cellular response to interleukin-1 |
GO:0010817 | 0.008 | 2.0679 | 8.1486 | 16 | 358 | regulation of hormone levels |
GO:0048856 | 0.008 | 1.3742 | 81.2202 | 100 | 3697 | anatomical structure development |
GO:0014033 | 0.0081 | 4.3516 | 1.2519 | 5 | 55 | neural crest cell differentiation |
GO:0032774 | 0.0084 | 1.3878 | 67.1689 | 85 | 2951 | RNA biosynthetic process |
GO:0006972 | 0.0086 | 8.1243 | 0.4325 | 3 | 19 | hyperosmotic response |
GO:0043368 | 0.0086 | 8.1243 | 0.4325 | 3 | 19 | positive T cell selection |
GO:0048585 | 0.0088 | 1.6414 | 20.6446 | 32 | 907 | negative regulation of response to stimulus |
GO:0031325 | 0.0094 | 1.4441 | 44.7489 | 60 | 1966 | positive regulation of cellular metabolic process |
GO:0003208 | 0.0094 | 4.1835 | 1.2974 | 5 | 57 | cardiac ventricle morphogenesis |
GO:1901615 | 0.0095 | 1.9785 | 9.0363 | 17 | 397 | organic hydroxy compound metabolic process |
GO:0009605 | 0.01 | 1.4927 | 34.347 | 48 | 1509 | response to external stimulus |
GO:0002931 | 0.01 | 7.6458 | 0.4552 | 3 | 20 | response to ischemia |
GO:0007194 | 0.01 | 7.6458 | 0.4552 | 3 | 20 | negative regulation of adenylate cyclase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 108 | 1.311 | 12 | 13 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 5.8529 | 5.6474 | 22 | 56 | detection of chemical stimulus |
GO:0007606 | 0 | 4.6224 | 6.8575 | 23 | 68 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 4.6242 | 6.555 | 22 | 65 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 1.846 | 60.6082 | 100 | 601 | G-protein coupled receptor signaling pathway |
GO:0051606 | 0 | 3.1773 | 11.6273 | 30 | 117 | detection of stimulus |
GO:0003008 | 0 | 1.539 | 119.0987 | 167 | 1181 | system process |
GO:0007601 | 0 | 2.5805 | 15.9336 | 35 | 158 | visual perception |
GO:0009583 | 0 | 3.188 | 9.2778 | 24 | 92 | detection of light stimulus |
GO:0002920 | 0 | 6.5867 | 2.622 | 11 | 26 | regulation of humoral immune response |
GO:0098655 | 0 | 1.7322 | 50.7254 | 80 | 503 | cation transmembrane transport |
GO:0007603 | 0 | 3.4944 | 6.8575 | 19 | 68 | phototransduction, visible light |
GO:0006968 | 1e-04 | 4.6738 | 3.8321 | 13 | 38 | cellular defense response |
GO:0010951 | 1e-04 | 2.4728 | 13.6142 | 29 | 135 | negative regulation of endopeptidase activity |
GO:0098660 | 1e-04 | 1.6687 | 49.6161 | 76 | 492 | inorganic ion transmembrane transport |
GO:2000257 | 1e-04 | 7.9692 | 1.7144 | 8 | 17 | regulation of protein activation cascade |
GO:0007204 | 1e-04 | 2.2429 | 16.2361 | 32 | 161 | positive regulation of cytosolic calcium ion concentration |
GO:0006954 | 2e-04 | 1.7014 | 40.3383 | 63 | 400 | inflammatory response |
GO:0007600 | 2e-04 | 1.8242 | 30.1093 | 50 | 303 | sensory perception |
GO:0006874 | 2e-04 | 1.9316 | 24.1021 | 42 | 239 | cellular calcium ion homeostasis |
GO:0061436 | 3e-04 | 7.8391 | 1.5127 | 7 | 15 | establishment of skin barrier |
GO:0001895 | 4e-04 | 3.6492 | 4.5381 | 13 | 45 | retina homeostasis |
GO:0015672 | 5e-04 | 1.6777 | 37.5146 | 58 | 372 | monovalent inorganic cation transport |
GO:0002673 | 5e-04 | 3.715 | 4.1347 | 12 | 41 | regulation of acute inflammatory response |
GO:0098542 | 5e-04 | 1.8969 | 22.6903 | 39 | 225 | defense response to other organism |
GO:0031424 | 6e-04 | 5.5152 | 2.1178 | 8 | 21 | keratinization |
GO:0050891 | 6e-04 | 4.2714 | 3.1262 | 10 | 31 | multicellular organismal water homeostasis |
GO:0006958 | 8e-04 | 6.2702 | 1.7144 | 7 | 17 | complement activation, classical pathway |
GO:0071395 | 0.001 | Inf | 0.3025 | 3 | 3 | cellular response to jasmonic acid stimulus |
GO:0001867 | 0.0013 | 17.8852 | 0.6051 | 4 | 6 | complement activation, lectin pathway |
GO:0072507 | 0.0014 | 1.7285 | 27.0266 | 43 | 268 | divalent inorganic cation homeostasis |
GO:0007155 | 0.0015 | 1.3829 | 89.8535 | 117 | 891 | cell adhesion |
GO:0060401 | 0.0015 | 2.4522 | 8.471 | 18 | 84 | cytosolic calcium ion transport |
GO:0070838 | 0.0017 | 1.6891 | 28.8419 | 45 | 286 | divalent metal ion transport |
GO:0070098 | 0.0018 | 4.4799 | 2.4203 | 8 | 24 | chemokine-mediated signaling pathway |
GO:0071805 | 0.002 | 2.0778 | 12.9082 | 24 | 128 | potassium ion transmembrane transport |
GO:0003341 | 0.0021 | 3.8412 | 3.0254 | 9 | 30 | cilium movement |
GO:0034113 | 0.0021 | 3.8412 | 3.0254 | 9 | 30 | heterotypic cell-cell adhesion |
GO:0031664 | 0.0023 | 5.9675 | 1.5127 | 6 | 15 | regulation of lipopolysaccharide-mediated signaling pathway |
GO:0002684 | 0.0025 | 1.476 | 51.9355 | 72 | 515 | positive regulation of immune system process |
GO:0018298 | 0.0028 | 11.9224 | 0.7059 | 4 | 7 | protein-chromophore linkage |
GO:0030647 | 0.0028 | 11.9224 | 0.7059 | 4 | 7 | aminoglycoside antibiotic metabolic process |
GO:0009988 | 0.0029 | 3.3205 | 3.7313 | 10 | 37 | cell-cell recognition |
GO:0050708 | 0.003 | 2.1223 | 11.093 | 21 | 110 | regulation of protein secretion |
GO:0042592 | 0.0031 | 1.3198 | 108.0057 | 135 | 1071 | homeostatic process |
GO:0050795 | 0.0032 | 2.0291 | 12.6057 | 23 | 125 | regulation of behavior |
GO:0050922 | 0.0034 | 4.4771 | 2.1178 | 7 | 21 | negative regulation of chemotaxis |
GO:0035743 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | CD4-positive, alpha-beta T cell cytokine production |
GO:0045345 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | positive regulation of MHC class I biosynthetic process |
GO:0048304 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | positive regulation of isotype switching to IgG isotypes |
GO:0050923 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | regulation of negative chemotaxis |
GO:0071221 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | cellular response to bacterial lipopeptide |
GO:0071280 | 0.0038 | 26.8091 | 0.4034 | 3 | 4 | cellular response to copper ion |
GO:0001523 | 0.0044 | 2.592 | 5.849 | 13 | 58 | retinoid metabolic process |
GO:0044110 | 0.0045 | 6.3898 | 1.2101 | 5 | 12 | growth involved in symbiotic interaction |
GO:0009072 | 0.0046 | 4.1783 | 2.2186 | 7 | 22 | aromatic amino acid family metabolic process |
GO:0070588 | 0.0048 | 1.8906 | 14.5218 | 25 | 144 | calcium ion transmembrane transport |
GO:0001539 | 0.0048 | 4.8816 | 1.7144 | 6 | 17 | cilium or flagellum-dependent cell motility |
GO:0051209 | 0.0051 | 2.5354 | 5.9499 | 13 | 59 | release of sequestered calcium ion into cytosol |
GO:0030049 | 0.0052 | 3.5826 | 2.8237 | 8 | 28 | muscle filament sliding |
GO:0002697 | 0.0052 | 1.7456 | 19.2615 | 31 | 191 | regulation of immune effector process |
GO:0032103 | 0.0052 | 1.9334 | 13.1099 | 23 | 130 | positive regulation of response to external stimulus |
GO:0030001 | 0.0057 | 1.5563 | 31.5539 | 46 | 317 | metal ion transport |
GO:0051282 | 0.006 | 2.4813 | 6.0507 | 13 | 60 | regulation of sequestering of calcium ion |
GO:0006586 | 0.0067 | 5.5906 | 1.311 | 5 | 13 | indolalkylamine metabolic process |
GO:0036149 | 0.0067 | 5.5906 | 1.311 | 5 | 13 | phosphatidylinositol acyl-chain remodeling |
GO:0006959 | 0.0068 | 2.6849 | 4.8087 | 11 | 48 | humoral immune response |
GO:0006721 | 0.0071 | 2.3261 | 6.8575 | 14 | 68 | terpenoid metabolic process |
GO:0050801 | 0.0076 | 1.4269 | 47.3975 | 64 | 470 | ion homeostasis |
GO:0032501 | 0.0077 | 1.1583 | 505.2367 | 546 | 5010 | multicellular organismal process |
GO:0050715 | 0.0079 | 2.9942 | 3.6216 | 9 | 36 | positive regulation of cytokine secretion |
GO:0042116 | 0.008 | 2.9861 | 3.6304 | 9 | 36 | macrophage activation |
GO:0050830 | 0.0081 | 3.2564 | 3.0254 | 8 | 30 | defense response to Gram-positive bacterium |
GO:0010466 | 0.0085 | 13.588 | 0.4981 | 3 | 5 | negative regulation of peptidase activity |
GO:0030299 | 0.0086 | 7.1522 | 0.9076 | 4 | 9 | intestinal cholesterol absorption |
GO:0044130 | 0.0086 | 7.1522 | 0.9076 | 4 | 9 | negative regulation of growth of symbiont in host |
GO:0044144 | 0.0086 | 7.1522 | 0.9076 | 4 | 9 | modulation of growth of symbiont involved in interaction with host |
GO:2000484 | 0.0086 | 7.1522 | 0.9076 | 4 | 9 | positive regulation of interleukin-8 secretion |
GO:0019441 | 0.0088 | 13.4034 | 0.5042 | 3 | 5 | tryptophan catabolic process to kynurenine |
GO:0032493 | 0.0088 | 13.4034 | 0.5042 | 3 | 5 | response to bacterial lipoprotein |
GO:0042723 | 0.0088 | 13.4034 | 0.5042 | 3 | 5 | thiamine-containing compound metabolic process |
GO:0045591 | 0.0088 | 13.4034 | 0.5042 | 3 | 5 | positive regulation of regulatory T cell differentiation |
GO:0045916 | 0.0088 | 13.4034 | 0.5042 | 3 | 5 | negative regulation of complement activation |
GO:0010522 | 0.0089 | 2.4453 | 5.6474 | 12 | 56 | regulation of calcium ion transport into cytosol |
GO:0008207 | 0.0089 | 4.1299 | 1.9161 | 6 | 19 | C21-steroid hormone metabolic process |
GO:0070252 | 0.0091 | 2.7153 | 4.3364 | 10 | 43 | actin-mediated cell contraction |
GO:0001819 | 0.0094 | 1.633 | 21.6818 | 33 | 215 | positive regulation of cytokine production |
GO:0048841 | 0.0095 | 4.969 | 1.4118 | 5 | 14 | regulation of axon extension involved in axon guidance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 2e-04 | Inf | 2e-04 | 1 | 2 | oocyte construction |
GO:0007314 | 2e-04 | Inf | 2e-04 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 2e-04 | Inf | 2e-04 | 1 | 2 | P granule organization |
GO:0007028 | 5e-04 | Inf | 5e-04 | 1 | 6 | cytoplasm organization |
GO:0034587 | 9e-04 | Inf | 9e-04 | 1 | 11 | piRNA metabolic process |
GO:0006655 | 9e-04 | Inf | 9e-04 | 1 | 12 | phosphatidylglycerol biosynthetic process |
GO:0007350 | 0.0011 | Inf | 0.0011 | 1 | 14 | blastoderm segmentation |
GO:0008595 | 0.0011 | Inf | 0.0011 | 1 | 14 | anterior/posterior axis specification, embryo |
GO:0043046 | 0.0012 | Inf | 0.0012 | 1 | 15 | DNA methylation involved in gamete generation |
GO:0008053 | 0.0014 | Inf | 0.0014 | 1 | 18 | mitochondrial fusion |
GO:0009994 | 0.0027 | Inf | 0.0027 | 1 | 34 | oocyte differentiation |
GO:0006305 | 0.0036 | Inf | 0.0036 | 1 | 45 | DNA alkylation |
GO:0044728 | 0.0043 | Inf | 0.0043 | 1 | 54 | DNA methylation or demethylation |
GO:0007292 | 0.006 | Inf | 0.006 | 1 | 76 | female gamete generation |
GO:0009798 | 0.006 | Inf | 0.006 | 1 | 76 | axis specification |
GO:0007286 | 0.0063 | Inf | 0.0063 | 1 | 80 | spermatid development |
GO:0061025 | 0.0078 | Inf | 0.0078 | 1 | 99 | membrane fusion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021540 | 8e-04 | 3161.75 | 8e-04 | 1 | 5 | corpus callosum morphogenesis |
GO:0060040 | 8e-04 | 3161.75 | 8e-04 | 1 | 5 | retinal bipolar neuron differentiation |
GO:0021960 | 9e-04 | 2529.2 | 9e-04 | 1 | 6 | anterior commissure morphogenesis |
GO:0021796 | 0.0011 | 2107.5 | 0.0011 | 1 | 7 | cerebral cortex regionalization |
GO:0021957 | 0.0011 | 2107.5 | 0.0011 | 1 | 7 | corticospinal tract morphogenesis |
GO:0015671 | 0.0014 | 1580.375 | 0.0014 | 1 | 9 | oxygen transport |
GO:0021871 | 0.0039 | 526.125 | 0.004 | 1 | 25 | forebrain regionalization |
GO:0021955 | 0.0047 | 435.2414 | 0.0047 | 1 | 30 | central nervous system neuron axonogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 2.6611 | 27.6557 | 64 | 666 | sequence-specific DNA binding |
GO:0060089 | 0 | 1.9024 | 39.9909 | 69 | 958 | molecular transducer activity |
GO:0001071 | 0 | 1.9132 | 38.5716 | 67 | 924 | nucleic acid binding transcription factor activity |
GO:0000981 | 0 | 2.4372 | 14.8609 | 33 | 356 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0038023 | 0 | 2.0028 | 26.1 | 48 | 632 | signaling receptor activity |
GO:0001205 | 1e-04 | 10.7077 | 0.7931 | 6 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0071855 | 1e-04 | 9.942 | 0.8349 | 6 | 20 | neuropeptide receptor binding |
GO:0008528 | 3e-04 | 3.6388 | 3.7152 | 12 | 89 | G-protein coupled peptide receptor activity |
GO:0019841 | 3e-04 | 18.5 | 0.3757 | 4 | 9 | retinol binding |
GO:0008324 | 5e-04 | 1.9032 | 20.8304 | 37 | 499 | cation transmembrane transporter activity |
GO:0016918 | 5e-04 | 15.4154 | 0.4174 | 4 | 10 | retinal binding |
GO:0008201 | 5e-04 | 3.1966 | 4.5084 | 13 | 108 | heparin binding |
GO:0022838 | 7e-04 | 2.1033 | 13.7756 | 27 | 330 | substrate-specific channel activity |
GO:0046873 | 7e-04 | 2.1033 | 13.7756 | 27 | 330 | metal ion transmembrane transporter activity |
GO:0019825 | 7e-04 | 8.9056 | 0.7514 | 5 | 18 | oxygen binding |
GO:0022836 | 7e-04 | 2.2463 | 11.0205 | 23 | 264 | gated channel activity |
GO:0001540 | 7e-04 | 6.6241 | 1.1271 | 6 | 27 | beta-amyloid binding |
GO:0005104 | 9e-04 | 8.2688 | 0.7931 | 5 | 19 | fibroblast growth factor receptor binding |
GO:0005267 | 0.001 | 3.145 | 4.2162 | 12 | 101 | potassium channel activity |
GO:0015293 | 0.001 | 3.145 | 4.2162 | 12 | 101 | symporter activity |
GO:0022892 | 0.0012 | 1.6487 | 32.9735 | 51 | 794 | substrate-specific transporter activity |
GO:0008083 | 0.0014 | 2.8622 | 4.9676 | 13 | 119 | growth factor activity |
GO:0022803 | 0.0014 | 1.9886 | 14.4852 | 27 | 347 | passive transmembrane transporter activity |
GO:0004953 | 0.0016 | 10.2743 | 0.5427 | 4 | 13 | icosanoid receptor activity |
GO:0005102 | 0.0017 | 1.6293 | 32.6691 | 50 | 803 | receptor binding |
GO:0005185 | 0.0017 | Inf | 0.0835 | 2 | 2 | neurohypophyseal hormone activity |
GO:0005275 | 0.0017 | Inf | 0.0835 | 2 | 2 | amine transmembrane transporter activity |
GO:0031894 | 0.0017 | Inf | 0.0835 | 2 | 2 | V1A vasopressin receptor binding |
GO:0034987 | 0.0017 | Inf | 0.0835 | 2 | 2 | immunoglobulin receptor binding |
GO:0015077 | 0.0018 | 2.1174 | 11.104 | 22 | 266 | monovalent inorganic cation transmembrane transporter activity |
GO:0003680 | 0.0022 | 17.3114 | 0.2922 | 3 | 7 | AT DNA binding |
GO:0008395 | 0.0022 | 17.3114 | 0.2922 | 3 | 7 | steroid hydroxylase activity |
GO:0005244 | 0.0024 | 2.4675 | 6.5538 | 15 | 157 | voltage-gated ion channel activity |
GO:0030594 | 0.0033 | 3.5715 | 2.5047 | 8 | 60 | neurotransmitter receptor activity |
GO:0005344 | 0.0035 | 13.848 | 0.334 | 3 | 8 | oxygen transporter activity |
GO:0031681 | 0.0035 | 13.848 | 0.334 | 3 | 8 | G-protein beta-subunit binding |
GO:0071837 | 0.0037 | 7.7038 | 0.6679 | 4 | 16 | HMG box domain binding |
GO:0019840 | 0.0039 | 5.5093 | 1.0853 | 5 | 26 | isoprenoid binding |
GO:0001847 | 0.0051 | 46.0856 | 0.1252 | 2 | 3 | opsonin receptor activity |
GO:0004937 | 0.0051 | 46.0856 | 0.1252 | 2 | 3 | alpha1-adrenergic receptor activity |
GO:0016167 | 0.0051 | 46.0856 | 0.1252 | 2 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0070996 | 0.0051 | 46.0856 | 0.1252 | 2 | 3 | type 1 melanocortin receptor binding |
GO:0033218 | 0.0057 | 2.3847 | 5.8442 | 13 | 140 | amide binding |
GO:0005540 | 0.0058 | 6.6021 | 0.7514 | 4 | 18 | hyaluronic acid binding |
GO:0004930 | 0.0061 | 2.0873 | 8.6467 | 17 | 212 | G-protein coupled receptor activity |
GO:0005251 | 0.0064 | 4.8194 | 1.2106 | 5 | 29 | delayed rectifier potassium channel activity |
GO:0004955 | 0.007 | 9.8897 | 0.4174 | 3 | 10 | prostaglandin receptor activity |
GO:0050997 | 0.0085 | 5.7759 | 0.8349 | 4 | 20 | quaternary ammonium group binding |
GO:0005125 | 0.0097 | 2.4123 | 4.8841 | 11 | 117 | cytokine activity |
GO:0031781 | 0.0099 | 23.0409 | 0.167 | 2 | 4 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0099 | 23.0409 | 0.167 | 2 | 4 | type 4 melanocortin receptor binding |
GO:0070700 | 0.0099 | 23.0409 | 0.167 | 2 | 4 | BMP receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | Inf | 0.0789 | 3 | 325 | protein heterodimerization activity |
GO:0003677 | 0.0042 | Inf | 0.4839 | 3 | 1994 | DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003700 | 0.0012 | 3.0116 | 5.0029 | 13 | 923 | sequence-specific DNA binding transcription factor activity |
GO:0043565 | 0.0032 | 3.0777 | 3.6478 | 10 | 673 | sequence-specific DNA binding |
GO:0001596 | 0.0054 | Inf | 0.0054 | 1 | 1 | angiotensin type I receptor activity |
GO:0005324 | 0.0054 | Inf | 0.0054 | 1 | 1 | long-chain fatty acid transporter activity |
GO:0015068 | 0.0054 | Inf | 0.0054 | 1 | 1 | glycine amidinotransferase activity |
GO:0031700 | 0.0054 | Inf | 0.0054 | 1 | 1 | adrenomedullin receptor binding |
GO:0035594 | 0.0054 | Inf | 0.0054 | 1 | 1 | ganglioside binding |
GO:0035730 | 0.0054 | Inf | 0.0054 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0054 | Inf | 0.0054 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0070026 | 0.0054 | Inf | 0.0054 | 1 | 1 | nitric oxide binding |
GO:0048487 | 0.01 | 14.5183 | 0.1518 | 2 | 28 | beta-tubulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022892 | 2e-04 | 2.372 | 12.1328 | 26 | 802 | substrate-specific transporter activity |
GO:0004982 | 2e-04 | Inf | 0.0303 | 2 | 2 | N-formyl peptide receptor activity |
GO:0022838 | 5e-04 | 3.0367 | 4.9923 | 14 | 330 | substrate-specific channel activity |
GO:0005244 | 6e-04 | 4.1085 | 2.3751 | 9 | 157 | voltage-gated ion channel activity |
GO:0022836 | 7e-04 | 3.2441 | 3.9939 | 12 | 264 | gated channel activity |
GO:0022803 | 8e-04 | 2.8776 | 5.2495 | 14 | 347 | passive transmembrane transporter activity |
GO:0005261 | 0.0012 | 3.2031 | 3.6913 | 11 | 244 | cation channel activity |
GO:0005109 | 0.0013 | 9.4817 | 0.4841 | 4 | 32 | frizzled binding |
GO:0015075 | 0.0018 | 2.2167 | 9.7426 | 20 | 644 | ion transmembrane transporter activity |
GO:0016004 | 0.0022 | 43.8595 | 0.0756 | 2 | 5 | phospholipase activator activity |
GO:0022821 | 0.0022 | 43.8595 | 0.0756 | 2 | 5 | potassium ion antiporter activity |
GO:0004872 | 0.0026 | 1.9995 | 12.9951 | 24 | 859 | receptor activity |
GO:0051371 | 0.0045 | 26.3114 | 0.1059 | 2 | 7 | muscle alpha-actinin binding |
GO:0005249 | 0.0052 | 4.8196 | 1.1195 | 5 | 74 | voltage-gated potassium channel activity |
GO:0000155 | 0.006 | 21.9243 | 0.121 | 2 | 8 | phosphorelay sensor kinase activity |
GO:0015079 | 0.007 | 3.7793 | 1.6919 | 6 | 113 | potassium ion transmembrane transporter activity |
GO:0022890 | 0.0075 | 2.2878 | 6.021 | 13 | 398 | inorganic cation transmembrane transporter activity |
GO:0048407 | 0.0095 | 16.4405 | 0.1513 | 2 | 10 | platelet-derived growth factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003840 | 1e-04 | 241.6078 | 0.0146 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0008761 | 0.0029 | Inf | 0.0029 | 1 | 1 | UDP-N-acetylglucosamine 2-epimerase activity |
GO:0009384 | 0.0029 | Inf | 0.0029 | 1 | 1 | N-acylmannosamine kinase activity |
GO:0018455 | 0.0029 | Inf | 0.0029 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0001785 | 0.0058 | 352.1143 | 0.0058 | 1 | 2 | prostaglandin J receptor activity |
GO:0004956 | 0.0058 | 352.1143 | 0.0058 | 1 | 2 | prostaglandin D receptor activity |
GO:0000253 | 0.0087 | 176.0429 | 0.0087 | 1 | 3 | 3-keto sterol reductase activity |
GO:0036374 | 0.0087 | 176.0429 | 0.0087 | 1 | 3 | glutathione hydrolase activity |
GO:0043734 | 0.0087 | 176.0429 | 0.0087 | 1 | 3 | DNA-N1-methyladenine dioxygenase activity |
GO:0047223 | 0.0087 | 176.0429 | 0.0087 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004096 | 0.0032 | Inf | 0.0032 | 1 | 1 | catalase activity |
GO:0035755 | 0.0032 | Inf | 0.0032 | 1 | 1 | cardiolipin hydrolase activity |
GO:0047894 | 0.0032 | Inf | 0.0032 | 1 | 1 | flavonol 3-sulfotransferase activity |
GO:0070611 | 0.0032 | Inf | 0.0032 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0032 | Inf | 0.0032 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GO:0022839 | 0.0045 | 22.3085 | 0.1003 | 2 | 31 | ion gated channel activity |
GO:0003854 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0004062 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | aryl sulfotransferase activity |
GO:0004609 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | phosphatidylserine decarboxylase activity |
GO:0005153 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | interleukin-8 receptor binding |
GO:0050294 | 0.0065 | 315.8974 | 0.0065 | 1 | 2 | steroid sulfotransferase activity |
GO:0042803 | 0.0077 | 3.85 | 1.7668 | 6 | 546 | protein homodimerization activity |
GO:0004995 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | tachykinin receptor activity |
GO:0008853 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | exodeoxyribonuclease III activity |
GO:0016167 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0035241 | 0.0097 | 157.9359 | 0.0097 | 1 | 3 | protein-arginine omega-N monomethyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 76.7036 | 0.2019 | 7 | 13 | olfactory receptor activity |
GO:0004872 | 0 | 2.9589 | 13.3426 | 34 | 859 | receptor activity |
GO:0004871 | 0 | 2.815 | 14.8803 | 36 | 958 | signal transducer activity |
GO:0004930 | 0 | 3.6214 | 4.8773 | 16 | 314 | G-protein coupled receptor activity |
GO:0032393 | 1e-04 | 64.3704 | 0.0932 | 3 | 6 | MHC class I receptor activity |
GO:0008392 | 2e-04 | Inf | 0.0311 | 2 | 2 | arachidonic acid epoxygenase activity |
GO:0030109 | 2e-04 | Inf | 0.0311 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0016907 | 0.0023 | 42.6877 | 0.0777 | 2 | 5 | G-protein coupled acetylcholine receptor activity |
GO:0034594 | 0.0035 | 32.0132 | 0.0932 | 2 | 6 | phosphatidylinositol trisphosphate phosphatase activity |
GO:0042834 | 0.0035 | 32.0132 | 0.0932 | 2 | 6 | peptidoglycan binding |
GO:0046703 | 0.0035 | 32.0132 | 0.0932 | 2 | 6 | natural killer cell lectin-like receptor binding |
GO:0004252 | 0.0059 | 3.9329 | 1.6309 | 6 | 105 | serine-type endopeptidase activity |
GO:0005344 | 0.0063 | 21.3386 | 0.1243 | 2 | 8 | oxygen transporter activity |
GO:0008157 | 0.008 | 18.2887 | 0.1398 | 2 | 9 | protein phosphatase 1 binding |
GO:0030246 | 0.0086 | 2.9289 | 2.8891 | 8 | 186 | carbohydrate binding |
GO:0004888 | 0.0093 | 2.5297 | 4.181 | 10 | 291 | transmembrane signaling receptor activity |
GO:0016594 | 0.01 | 16.0013 | 0.1553 | 2 | 10 | glycine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004167 | 0.0019 | 1122.5455 | 0.0019 | 1 | 2 | dopachrome isomerase activity |
GO:0004998 | 0.0019 | 1122.5455 | 0.0019 | 1 | 2 | transferrin receptor activity |
GO:0070009 | 0.0019 | 1122.5455 | 0.0019 | 1 | 2 | serine-type aminopeptidase activity |
GO:0004366 | 0.0039 | 374.1212 | 0.0039 | 1 | 4 | glycerol-3-phosphate O-acyltransferase activity |
GO:0051787 | 0.0068 | 187.0152 | 0.0068 | 1 | 7 | misfolded protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047066 | 6e-04 | 4118.6667 | 6e-04 | 1 | 2 | phospholipid-hydroperoxide glutathione peroxidase activity |
GO:0005344 | 0.0026 | 588.0952 | 0.0026 | 1 | 8 | oxygen transporter activity |
GO:0043295 | 0.0032 | 457.3333 | 0.0032 | 1 | 10 | glutathione binding |
GO:0004602 | 0.0039 | 374.1212 | 0.0039 | 1 | 12 | glutathione peroxidase activity |
GO:0008430 | 0.0039 | 374.1212 | 0.0039 | 1 | 12 | selenium binding |
GO:0019825 | 0.0058 | 241.9608 | 0.0058 | 1 | 18 | oxygen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035755 | 1e-04 | Inf | 1e-04 | 1 | 1 | cardiolipin hydrolase activity |
GO:0004519 | 0.0068 | Inf | 0.0068 | 1 | 84 | endonuclease activity |
GO:0016298 | 0.0068 | Inf | 0.0068 | 1 | 84 | lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 139.0888 | 0.3145 | 10 | 13 | olfactory receptor activity |
GO:0047760 | 1e-04 | 122.2399 | 0.0968 | 3 | 4 | butyrate-CoA ligase activity |
GO:0004930 | 1e-04 | 2.8693 | 7.5953 | 20 | 314 | G-protein coupled receptor activity |
GO:0060089 | 1e-04 | 1.9886 | 23.173 | 42 | 958 | molecular transducer activity |
GO:0038023 | 1e-04 | 2.1467 | 16.7388 | 33 | 692 | signaling receptor activity |
GO:0032393 | 3e-04 | 40.7399 | 0.1451 | 3 | 6 | MHC class I receptor activity |
GO:0005232 | 6e-04 | Inf | 0.0484 | 2 | 2 | serotonin-activated cation-selective channel activity |
GO:0030109 | 6e-04 | Inf | 0.0484 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0004252 | 0.001 | 3.8683 | 2.5398 | 9 | 105 | serine-type endopeptidase activity |
GO:0030246 | 0.0019 | 2.8567 | 4.4992 | 12 | 186 | carbohydrate binding |
GO:0004993 | 0.002 | 15.2711 | 0.2661 | 3 | 11 | serotonin receptor activity |
GO:0005230 | 0.0027 | 4.7296 | 1.403 | 6 | 58 | extracellular ligand-gated ion channel activity |
GO:0017171 | 0.0033 | 3.196 | 3.0236 | 9 | 125 | serine hydrolase activity |
GO:0004090 | 0.0034 | 40.6061 | 0.0968 | 2 | 4 | carbonyl reductase (NADPH) activity |
GO:0047961 | 0.0034 | 40.6061 | 0.0968 | 2 | 4 | glycine N-acyltransferase activity |
GO:0003823 | 0.0049 | 4.9863 | 1.1127 | 5 | 46 | antigen binding |
GO:0003840 | 0.0056 | 27.0685 | 0.1209 | 2 | 5 | gamma-glutamyltransferase activity |
GO:0004046 | 0.0056 | 27.0685 | 0.1209 | 2 | 5 | aminoacylase activity |
GO:0008009 | 0.0062 | 9.3937 | 0.387 | 3 | 16 | chemokine activity |
GO:0022834 | 0.0075 | 3.0147 | 2.8301 | 8 | 117 | ligand-gated channel activity |
GO:0034594 | 0.0082 | 20.2997 | 0.1451 | 2 | 6 | phosphatidylinositol trisphosphate phosphatase activity |
GO:0046703 | 0.0082 | 20.2997 | 0.1451 | 2 | 6 | natural killer cell lectin-like receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008239 | 0.0057 | 228.6111 | 0.0057 | 1 | 10 | dipeptidyl-peptidase activity |
GO:0008430 | 0.0068 | 187.0152 | 0.0068 | 1 | 12 | selenium binding |
GO:0016805 | 0.0068 | 187.0152 | 0.0068 | 1 | 12 | dipeptidase activity |
GO:0032794 | 0.0068 | 187.0152 | 0.0068 | 1 | 12 | GTPase activating protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004888 | 0.0023 | 3.4983 | 2.9163 | 9 | 611 | transmembrane signaling receptor activity |
GO:0004411 | 0.0048 | Inf | 0.0048 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0008613 | 0.0048 | Inf | 0.0048 | 1 | 1 | diuretic hormone activity |
GO:0008892 | 0.0048 | Inf | 0.0048 | 1 | 1 | guanine deaminase activity |
GO:0017064 | 0.0048 | Inf | 0.0048 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0017174 | 0.0048 | Inf | 0.0048 | 1 | 1 | glycine N-methyltransferase activity |
GO:0031721 | 0.0048 | Inf | 0.0048 | 1 | 1 | hemoglobin alpha binding |
GO:0070524 | 0.0048 | Inf | 0.0048 | 1 | 1 | 11-beta-hydroxysteroid dehydrogenase (NADP+) activity |
GO:0005272 | 0.0073 | 17.2309 | 0.1289 | 2 | 27 | sodium channel activity |
GO:0003845 | 0.0095 | 212.0862 | 0.0095 | 1 | 2 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity |
GO:0004951 | 0.0095 | 212.0862 | 0.0095 | 1 | 2 | cholecystokinin receptor activity |
GO:0008502 | 0.0095 | 212.0862 | 0.0095 | 1 | 2 | melatonin receptor activity |
GO:0034485 | 0.0095 | 212.0862 | 0.0095 | 1 | 2 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 2e-04 | 2.5561 | 9.517 | 22 | 692 | signaling receptor activity |
GO:0005179 | 2e-04 | 7.7882 | 0.8664 | 6 | 63 | hormone activity |
GO:0051431 | 6e-04 | 145.119 | 0.0413 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0060089 | 6e-04 | 2.1812 | 13.1753 | 26 | 958 | molecular transducer activity |
GO:0001664 | 0.0022 | 3.7133 | 2.3105 | 8 | 168 | G-protein coupled receptor binding |
GO:0042277 | 0.0026 | 4.0472 | 1.8566 | 7 | 135 | peptide binding |
GO:0004930 | 0.0052 | 2.7741 | 3.833 | 10 | 283 | G-protein coupled receptor activity |
GO:0004872 | 0.0054 | 3.5251 | 2.1181 | 7 | 167 | receptor activity |
GO:0043295 | 0.0079 | 18.1295 | 0.1375 | 2 | 10 | glutathione binding |
GO:0015103 | 0.0083 | 4.2653 | 1.2515 | 5 | 91 | inorganic anion transmembrane transporter activity |
GO:0008227 | 0.0087 | 7.8035 | 0.4263 | 3 | 31 | G-protein coupled amine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010844 | 0.0019 | Inf | 0.0019 | 1 | 1 | recombination hotspot binding |
GO:0047837 | 0.0019 | Inf | 0.0019 | 1 | 1 | D-xylose 1-dehydrogenase (NADP+) activity |
GO:0008017 | 0.0025 | 12.7021 | 0.2735 | 3 | 147 | microtubule binding |
GO:0001632 | 0.0037 | 560.7727 | 0.0037 | 1 | 2 | leukotriene B4 receptor activity |
GO:0008746 | 0.0037 | 560.7727 | 0.0037 | 1 | 2 | NAD(P)+ transhydrogenase activity |
GO:0047006 | 0.0037 | 560.7727 | 0.0037 | 1 | 2 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
GO:0048248 | 0.0037 | 560.7727 | 0.0037 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0004867 | 0.0038 | 24.3849 | 0.093 | 2 | 50 | serine-type endopeptidase inhibitor activity |
GO:0032795 | 0.0056 | 280.3636 | 0.0056 | 1 | 3 | heterotrimeric G-protein binding |
GO:0047035 | 0.0074 | 186.8939 | 0.0074 | 1 | 4 | testosterone dehydrogenase (NAD+) activity |
GO:0047115 | 0.0074 | 186.8939 | 0.0074 | 1 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 3.1203 | 14.8092 | 40 | 673 | sequence-specific DNA binding |
GO:0001071 | 1e-04 | 2.119 | 20.3323 | 39 | 924 | nucleic acid binding transcription factor activity |
GO:0000981 | 3e-04 | 2.6189 | 7.8337 | 19 | 356 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0005179 | 4e-04 | 5.6759 | 1.3863 | 7 | 63 | hormone activity |
GO:0005185 | 5e-04 | Inf | 0.044 | 2 | 2 | neurohypophyseal hormone activity |
GO:0031894 | 5e-04 | Inf | 0.044 | 2 | 2 | V1A vasopressin receptor binding |
GO:0001205 | 7e-04 | 12.0139 | 0.4181 | 4 | 19 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0001664 | 0.0012 | 3.2031 | 3.6968 | 11 | 168 | G-protein coupled receptor binding |
GO:0004954 | 0.0015 | 16.8415 | 0.2421 | 3 | 11 | prostanoid receptor activity |
GO:0004871 | 0.002 | 1.7866 | 21.0805 | 35 | 958 | signal transducer activity |
GO:0004888 | 0.0021 | 1.9868 | 13.4449 | 25 | 611 | transmembrane signaling receptor activity |
GO:0004872 | 0.0044 | 1.7494 | 18.902 | 31 | 859 | receptor activity |
GO:0004957 | 0.0046 | 29.842 | 0.11 | 2 | 5 | prostaglandin E receptor activity |
GO:0043237 | 0.0046 | 29.842 | 0.11 | 2 | 5 | laminin-1 binding |
GO:0035326 | 0.0053 | 4.0474 | 1.6063 | 6 | 73 | enhancer binding |
GO:0008395 | 0.0094 | 17.9022 | 0.154 | 2 | 7 | steroid hydroxylase activity |
GO:0045499 | 0.0094 | 17.9022 | 0.154 | 2 | 7 | chemorepellent activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 108.0778 | 1.3104 | 12 | 13 | olfactory receptor activity |
GO:0004872 | 0 | 1.9366 | 80.9969 | 137 | 808 | receptor activity |
GO:0022838 | 0 | 2.1637 | 33.2643 | 63 | 330 | substrate-specific channel activity |
GO:0022803 | 0 | 2.1143 | 34.9779 | 65 | 347 | passive transmembrane transporter activity |
GO:0004930 | 0 | 2.1655 | 28.3918 | 54 | 283 | G-protein coupled receptor activity |
GO:0005261 | 0 | 2.6049 | 14.8927 | 33 | 149 | cation channel activity |
GO:0061134 | 0 | 2.7067 | 12.7009 | 29 | 126 | peptidase regulator activity |
GO:0030246 | 0 | 2.331 | 18.749 | 38 | 186 | carbohydrate binding |
GO:0017171 | 0 | 2.6112 | 12.6001 | 28 | 125 | serine hydrolase activity |
GO:0004871 | 0 | 1.505 | 96.5673 | 134 | 958 | signal transducer activity |
GO:0004867 | 1e-04 | 3.8575 | 5.04 | 15 | 50 | serine-type endopeptidase inhibitor activity |
GO:0015075 | 1e-04 | 1.5885 | 64.9158 | 95 | 644 | ion transmembrane transporter activity |
GO:0022892 | 2e-04 | 1.4922 | 80.8423 | 112 | 802 | substrate-specific transporter activity |
GO:0004950 | 2e-04 | 8.9653 | 1.4112 | 7 | 14 | chemokine receptor activity |
GO:0004252 | 3e-04 | 2.5304 | 10.5841 | 23 | 105 | serine-type endopeptidase activity |
GO:0022836 | 5e-04 | 1.8855 | 23.3945 | 40 | 233 | gated channel activity |
GO:0005198 | 5e-04 | 1.5945 | 47.3764 | 70 | 470 | structural molecule activity |
GO:0008009 | 5e-04 | 6.9718 | 1.6128 | 7 | 16 | chemokine activity |
GO:0015079 | 6e-04 | 2.3027 | 11.8945 | 24 | 118 | potassium ion transmembrane transporter activity |
GO:0005244 | 9e-04 | 2.0454 | 15.8257 | 29 | 157 | voltage-gated ion channel activity |
GO:0018636 | 0.001 | Inf | 0.3024 | 3 | 3 | phenanthrene 9,10-monooxygenase activity |
GO:0032396 | 0.001 | Inf | 0.3024 | 3 | 3 | inhibitory MHC class I receptor activity |
GO:0047086 | 0.001 | Inf | 0.3024 | 3 | 3 | ketosteroid monooxygenase activity |
GO:0005262 | 0.0011 | 2.4013 | 9.5761 | 20 | 95 | calcium channel activity |
GO:0004623 | 0.0018 | 4.4826 | 2.4192 | 8 | 24 | phospholipase A2 activity |
GO:0004866 | 0.0018 | 3.321 | 4.0997 | 11 | 41 | endopeptidase inhibitor activity |
GO:0005509 | 0.0019 | 1.47 | 56.5493 | 78 | 561 | calcium ion binding |
GO:0046873 | 0.002 | 1.8065 | 21.1602 | 35 | 212 | metal ion transmembrane transporter activity |
GO:0008227 | 0.0027 | 3.6686 | 3.1248 | 9 | 31 | G-protein coupled amine receptor activity |
GO:0005231 | 0.0029 | 3.0848 | 4.3344 | 11 | 43 | excitatory extracellular ligand-gated ion channel activity |
GO:0072509 | 0.0034 | 1.9831 | 13.4065 | 24 | 133 | divalent inorganic cation transmembrane transporter activity |
GO:0004888 | 0.0036 | 1.6202 | 29.165 | 44 | 297 | transmembrane signaling receptor activity |
GO:0008273 | 0.0038 | 26.8238 | 0.4032 | 3 | 4 | calcium, potassium:sodium antiporter activity |
GO:0047115 | 0.0038 | 26.8238 | 0.4032 | 3 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
GO:0047760 | 0.0038 | 26.8238 | 0.4032 | 3 | 4 | butyrate-CoA ligase activity |
GO:0038024 | 0.004 | 2.7618 | 5.1408 | 12 | 51 | cargo receptor activity |
GO:0003810 | 0.0052 | 8.9461 | 0.8064 | 4 | 8 | protein-glutamine gamma-glutamyltransferase activity |
GO:0005249 | 0.0063 | 2.2834 | 7.4593 | 15 | 74 | voltage-gated potassium channel activity |
GO:0000146 | 0.0066 | 4.477 | 1.8144 | 6 | 18 | microfilament motor activity |
GO:0043395 | 0.0067 | 5.5938 | 1.3104 | 5 | 13 | heparan sulfate proteoglycan binding |
GO:0004497 | 0.0069 | 2.4309 | 6.1489 | 13 | 61 | monooxygenase activity |
GO:0016811 | 0.0071 | 2.6668 | 4.8384 | 11 | 48 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
GO:0015291 | 0.0074 | 1.8148 | 15.0193 | 25 | 149 | secondary active transmembrane transporter activity |
GO:0005041 | 0.0085 | 7.1562 | 0.9072 | 4 | 9 | low-density lipoprotein receptor activity |
GO:0004181 | 0.0089 | 4.1323 | 1.9152 | 6 | 19 | metallocarboxypeptidase activity |
GO:0015491 | 0.0089 | 4.1323 | 1.9152 | 6 | 19 | cation:cation antiporter activity |
GO:0030169 | 0.0095 | 4.9718 | 1.4112 | 5 | 14 | low-density lipoprotein particle binding |
GO:0022839 | 0.01 | 3.1164 | 3.1248 | 8 | 31 | ion gated channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003837 | 0.0012 | Inf | 0.0012 | 1 | 1 | beta-ureidopropionase activity |
GO:0070891 | 0.0024 | 881.7857 | 0.0024 | 1 | 2 | lipoteichoic acid binding |
GO:0001601 | 0.0036 | 440.8571 | 0.0036 | 1 | 3 | peptide YY receptor activity |
GO:0043565 | 0.0073 | 6.3471 | 0.8167 | 4 | 673 | sequence-specific DNA binding |
GO:0003810 | 0.0097 | 125.9082 | 0.0097 | 1 | 8 | protein-glutamine gamma-glutamyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035755 | 1e-04 | Inf | 1e-04 | 1 | 1 | cardiolipin hydrolase activity |
GO:0004519 | 0.0068 | Inf | 0.0068 | 1 | 84 | endonuclease activity |
GO:0016298 | 0.0068 | Inf | 0.0068 | 1 | 84 | lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005344 | 0.0013 | 1764.5714 | 0.0013 | 1 | 8 | oxygen transporter activity |
GO:0019825 | 0.0029 | 726 | 0.0029 | 1 | 18 | oxygen binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044707 | 0 | 1.7188 | 142.5147 | 197 | 2886 | single-multicellular organism process |
GO:0048731 | 0 | 1.8535 | 72.1113 | 114 | 1512 | system development |
GO:0007423 | 0 | 2.4538 | 19.215 | 42 | 367 | sensory organ development |
GO:0021510 | 0 | 4.9452 | 3.9791 | 16 | 76 | spinal cord development |
GO:0048665 | 0 | 9.1883 | 1.4136 | 9 | 27 | neuron fate specification |
GO:0060429 | 0 | 2.0318 | 27.1285 | 50 | 527 | epithelium development |
GO:0007268 | 0 | 2.0613 | 25.655 | 48 | 490 | synaptic transmission |
GO:0009605 | 0 | 1.6842 | 59.7918 | 91 | 1142 | response to external stimulus |
GO:0003008 | 0 | 1.7721 | 45.3412 | 73 | 866 | system process |
GO:2000026 | 0 | 1.7461 | 47.9067 | 76 | 915 | regulation of multicellular organismal development |
GO:0008284 | 0 | 2.0335 | 25.3932 | 47 | 485 | positive regulation of cell proliferation |
GO:0048562 | 0 | 2.614 | 11.5186 | 27 | 220 | embryonic organ morphogenesis |
GO:0022008 | 1e-04 | 1.887 | 30.1533 | 52 | 596 | neurogenesis |
GO:0048812 | 1e-04 | 1.9918 | 24.1366 | 44 | 461 | neuron projection morphogenesis |
GO:0051094 | 1e-04 | 1.8901 | 29.4519 | 51 | 566 | positive regulation of developmental process |
GO:0007166 | 1e-04 | 1.5113 | 94.871 | 129 | 1812 | cell surface receptor signaling pathway |
GO:0048667 | 1e-04 | 1.9976 | 23.5083 | 43 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0048468 | 1e-04 | 1.5844 | 67.2788 | 97 | 1285 | cell development |
GO:0002065 | 1e-04 | 4.2501 | 3.3509 | 12 | 64 | columnar/cuboidal epithelial cell differentiation |
GO:0048729 | 1e-04 | 2.0576 | 20.1575 | 38 | 385 | tissue morphogenesis |
GO:0030182 | 1e-04 | 1.7539 | 37.8941 | 61 | 741 | neuron differentiation |
GO:0045165 | 1e-04 | 2.8866 | 7.3746 | 19 | 143 | cell fate commitment |
GO:0050767 | 2e-04 | 2.0421 | 19.7386 | 37 | 377 | regulation of neurogenesis |
GO:0009887 | 2e-04 | 2.281 | 13.4473 | 28 | 269 | organ morphogenesis |
GO:0061564 | 2e-04 | 1.9852 | 21.3617 | 39 | 408 | axon development |
GO:0003002 | 2e-04 | 3.2421 | 5.2509 | 15 | 102 | regionalization |
GO:0007498 | 2e-04 | 3.3972 | 4.7121 | 14 | 90 | mesoderm development |
GO:0001568 | 2e-04 | 2.042 | 18.6391 | 35 | 356 | blood vessel development |
GO:0045595 | 3e-04 | 1.6242 | 47.3831 | 71 | 905 | regulation of cell differentiation |
GO:0007200 | 3e-04 | 4.8563 | 2.2514 | 9 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0040011 | 3e-04 | 1.6121 | 49.0973 | 73 | 941 | locomotion |
GO:0035270 | 3e-04 | 3.2672 | 4.8692 | 14 | 93 | endocrine system development |
GO:0043010 | 3e-04 | 2.3992 | 10.5238 | 23 | 201 | camera-type eye development |
GO:0021527 | 5e-04 | 10.1413 | 0.733 | 5 | 14 | spinal cord association neuron differentiation |
GO:0042490 | 5e-04 | 4.4612 | 2.4084 | 9 | 46 | mechanoreceptor differentiation |
GO:0002003 | 5e-04 | 54.6011 | 0.2094 | 3 | 4 | angiotensin maturation |
GO:0015816 | 5e-04 | 54.6011 | 0.2094 | 3 | 4 | glycine transport |
GO:0035235 | 6e-04 | 7.311 | 1.0995 | 6 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0007411 | 6e-04 | 2.1102 | 14.3982 | 28 | 275 | axon guidance |
GO:0048839 | 6e-04 | 3.9691 | 2.9402 | 10 | 57 | inner ear development |
GO:0006935 | 7e-04 | 1.9468 | 18.2905 | 33 | 353 | chemotaxis |
GO:0001990 | 7e-04 | 6.8534 | 1.1519 | 6 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:0001991 | 8e-04 | 14.5818 | 0.4712 | 4 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0042472 | 8e-04 | 3.2935 | 4.1362 | 12 | 79 | inner ear morphogenesis |
GO:0007154 | 8e-04 | 1.3392 | 181.679 | 216 | 3470 | cell communication |
GO:0050789 | 0.001 | 1.3403 | 326.1844 | 360 | 6230 | regulation of biological process |
GO:0044767 | 0.0011 | 1.4304 | 91.7154 | 118 | 1988 | single-organism developmental process |
GO:0060573 | 0.0012 | 12.1503 | 0.5236 | 4 | 10 | cell fate specification involved in pattern specification |
GO:0007155 | 0.0012 | 1.6512 | 33.0897 | 51 | 632 | cell adhesion |
GO:0060177 | 0.0013 | 27.2977 | 0.2618 | 3 | 5 | regulation of angiotensin metabolic process |
GO:0044700 | 0.0013 | 1.3237 | 178.3281 | 211 | 3406 | single organism signaling |
GO:0044259 | 0.0014 | 3.2579 | 3.8221 | 11 | 73 | multicellular organismal macromolecule metabolic process |
GO:0003309 | 0.0014 | 7.6036 | 0.8901 | 5 | 17 | type B pancreatic cell differentiation |
GO:0031069 | 0.0014 | 7.6036 | 0.8901 | 5 | 17 | hair follicle morphogenesis |
GO:0014706 | 0.0014 | 2.1303 | 11.6756 | 23 | 223 | striated muscle tissue development |
GO:0010043 | 0.0015 | 5.7695 | 1.3089 | 6 | 25 | response to zinc ion |
GO:0009880 | 0.0015 | 4.185 | 2.2514 | 8 | 43 | embryonic pattern specification |
GO:0055074 | 0.0015 | 2.3092 | 8.9531 | 19 | 171 | calcium ion homeostasis |
GO:0048565 | 0.0017 | 2.8125 | 5.131 | 13 | 98 | digestive tract development |
GO:0007600 | 0.0017 | 1.9654 | 14.7647 | 27 | 282 | sensory perception |
GO:0002244 | 0.0019 | 2.7795 | 5.1833 | 13 | 99 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0.0021 | 2.0568 | 12.0421 | 23 | 230 | stem cell differentiation |
GO:0065008 | 0.0022 | 1.365 | 101.6774 | 128 | 1942 | regulation of biological quality |
GO:0007517 | 0.0023 | 2.1688 | 9.9644 | 20 | 192 | muscle organ development |
GO:0006355 | 0.0023 | 1.3386 | 122.2014 | 150 | 2334 | regulation of transcription, DNA-templated |
GO:0021522 | 0.0023 | 5.2189 | 1.4136 | 6 | 27 | spinal cord motor neuron differentiation |
GO:0001655 | 0.0024 | 2.0761 | 11.4138 | 22 | 218 | urogenital system development |
GO:0048754 | 0.0024 | 2.4878 | 6.597 | 15 | 126 | branching morphogenesis of an epithelial tube |
GO:0045666 | 0.0024 | 3.217 | 3.5079 | 10 | 67 | positive regulation of neuron differentiation |
GO:0007507 | 0.0024 | 1.87 | 16.5972 | 29 | 317 | heart development |
GO:0061217 | 0.0024 | 6.516 | 0.9948 | 5 | 19 | regulation of mesonephros development |
GO:0072358 | 0.0025 | 1.9665 | 13.6429 | 25 | 267 | cardiovascular system development |
GO:0042178 | 0.0025 | 18.1966 | 0.3141 | 3 | 6 | xenobiotic catabolic process |
GO:0072079 | 0.0026 | 9.1108 | 0.6283 | 4 | 12 | nephron tubule formation |
GO:0072224 | 0.0026 | 9.1108 | 0.6283 | 4 | 12 | metanephric glomerulus development |
GO:0072243 | 0.0026 | 9.1108 | 0.6283 | 4 | 12 | metanephric nephron epithelium development |
GO:0010157 | 0.0027 | Inf | 0.1047 | 2 | 2 | response to chlorate |
GO:0035990 | 0.0027 | Inf | 0.1047 | 2 | 2 | tendon cell differentiation |
GO:0072166 | 0.0027 | Inf | 0.1047 | 2 | 2 | posterior mesonephric tubule development |
GO:0045944 | 0.0028 | 1.603 | 31.8854 | 48 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0030574 | 0.0028 | 3.7542 | 2.4608 | 8 | 47 | collagen catabolic process |
GO:0042509 | 0.0028 | 4.9812 | 1.466 | 6 | 28 | regulation of tyrosine phosphorylation of STAT protein |
GO:0043589 | 0.0028 | 4.9812 | 1.466 | 6 | 28 | skin morphogenesis |
GO:0002520 | 0.0029 | 1.674 | 25.4455 | 40 | 486 | immune system development |
GO:0050905 | 0.003 | 3.1073 | 3.6126 | 10 | 69 | neuromuscular process |
GO:0030890 | 0.0031 | 6.081 | 1.0471 | 5 | 20 | positive regulation of B cell proliferation |
GO:0050921 | 0.0032 | 3.6599 | 2.5131 | 8 | 48 | positive regulation of chemotaxis |
GO:0061448 | 0.0033 | 2.2537 | 8.1677 | 17 | 156 | connective tissue development |
GO:0031016 | 0.0033 | 3.2968 | 3.0891 | 9 | 59 | pancreas development |
GO:0030901 | 0.0034 | 4.7641 | 1.5184 | 6 | 29 | midbrain development |
GO:0009952 | 0.0035 | 2.2374 | 8.2201 | 17 | 157 | anterior/posterior pattern specification |
GO:0032990 | 0.0035 | 1.5874 | 31.4666 | 47 | 601 | cell part morphogenesis |
GO:0048878 | 0.0036 | 1.6507 | 25.7597 | 40 | 492 | chemical homeostasis |
GO:0048706 | 0.0039 | 2.6541 | 4.9739 | 12 | 95 | embryonic skeletal system development |
GO:0003338 | 0.0039 | 5.7003 | 1.0995 | 5 | 21 | metanephros morphogenesis |
GO:0035116 | 0.0039 | 5.7003 | 1.0995 | 5 | 21 | embryonic hindlimb morphogenesis |
GO:0010628 | 0.0039 | 1.4704 | 47.7496 | 66 | 912 | positive regulation of gene expression |
GO:0060485 | 0.004 | 2.2657 | 7.6441 | 16 | 146 | mesenchyme development |
GO:0022617 | 0.0041 | 2.9561 | 3.7697 | 10 | 72 | extracellular matrix disassembly |
GO:0021675 | 0.0041 | 3.4849 | 2.6179 | 8 | 50 | nerve development |
GO:0009790 | 0.0041 | 1.909 | 13.4371 | 24 | 264 | embryo development |
GO:0003310 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | pancreatic A cell differentiation |
GO:0006600 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | creatine metabolic process |
GO:0033504 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | floor plate development |
GO:0042523 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | positive regulation of tyrosine phosphorylation of Stat5 protein |
GO:0072203 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | cell proliferation involved in metanephros development |
GO:0072282 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | metanephric nephron tubule morphogenesis |
GO:2000251 | 0.0043 | 13.646 | 0.3665 | 3 | 7 | positive regulation of actin cytoskeleton reorganization |
GO:0030030 | 0.0043 | 1.4898 | 42.7757 | 60 | 817 | cell projection organization |
GO:0006811 | 0.0043 | 1.5928 | 29.3383 | 44 | 571 | ion transport |
GO:0001525 | 0.0045 | 1.9236 | 12.7751 | 23 | 244 | angiogenesis |
GO:0001709 | 0.0048 | 4.3821 | 1.6231 | 6 | 31 | cell fate determination |
GO:0060579 | 0.0049 | 7.2871 | 0.733 | 4 | 14 | ventral spinal cord interneuron fate commitment |
GO:0060644 | 0.0049 | 7.2871 | 0.733 | 4 | 14 | mammary gland epithelial cell differentiation |
GO:0072087 | 0.0049 | 7.2871 | 0.733 | 4 | 14 | renal vesicle development |
GO:0090190 | 0.0049 | 7.2871 | 0.733 | 4 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0008544 | 0.0049 | 2.0992 | 9.2148 | 18 | 176 | epidermis development |
GO:0072503 | 0.0049 | 2.0992 | 9.2148 | 18 | 176 | cellular divalent inorganic cation homeostasis |
GO:0071805 | 0.005 | 2.5607 | 5.131 | 12 | 98 | potassium ion transmembrane transport |
GO:0051252 | 0.005 | 1.3012 | 126.4946 | 152 | 2416 | regulation of RNA metabolic process |
GO:0030335 | 0.0052 | 2.0857 | 9.2672 | 18 | 177 | positive regulation of cell migration |
GO:0050864 | 0.0053 | 3.3258 | 2.7226 | 8 | 52 | regulation of B cell activation |
GO:0009792 | 0.0055 | 1.6349 | 23.9795 | 37 | 458 | embryo development ending in birth or egg hatching |
GO:0051480 | 0.0056 | 2.4112 | 5.864 | 13 | 112 | cytosolic calcium ion homeostasis |
GO:0046427 | 0.0057 | 4.2131 | 1.6754 | 6 | 32 | positive regulation of JAK-STAT cascade |
GO:0035249 | 0.0059 | 3.2516 | 2.7749 | 8 | 53 | synaptic transmission, glutamatergic |
GO:0030203 | 0.006 | 2.3868 | 5.9163 | 13 | 113 | glycosaminoglycan metabolic process |
GO:0003208 | 0.0065 | 3.553 | 2.2514 | 7 | 43 | cardiac ventricle morphogenesis |
GO:0021781 | 0.0065 | 10.956 | 0.4174 | 3 | 8 | glial cell fate commitment |
GO:0050670 | 0.0066 | 2.5853 | 4.6598 | 11 | 89 | regulation of lymphocyte proliferation |
GO:0032769 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | negative regulation of monooxygenase activity |
GO:0035855 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | megakaryocyte development |
GO:0042362 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | fat-soluble vitamin biosynthetic process |
GO:0042537 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | benzene-containing compound metabolic process |
GO:0060872 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | semicircular canal development |
GO:0061004 | 0.0066 | 10.9157 | 0.4189 | 3 | 8 | pattern specification involved in kidney development |
GO:0001657 | 0.0066 | 2.734 | 4.0315 | 10 | 77 | ureteric bud development |
GO:0072163 | 0.0066 | 2.734 | 4.0315 | 10 | 77 | mesonephric epithelium development |
GO:0048538 | 0.0066 | 4.0566 | 1.7278 | 6 | 33 | thymus development |
GO:0060079 | 0.0066 | 4.0566 | 1.7278 | 6 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0030154 | 0.0071 | 1.6342 | 22.7786 | 35 | 486 | cell differentiation |
GO:0001704 | 0.0071 | 2.5523 | 4.7121 | 11 | 90 | formation of primary germ layer |
GO:0007605 | 0.0071 | 2.5523 | 4.7121 | 11 | 90 | sensory perception of sound |
GO:0048705 | 0.0071 | 2.117 | 8.1153 | 16 | 155 | skeletal system morphogenesis |
GO:0051057 | 0.0072 | 4.7988 | 1.2566 | 5 | 24 | positive regulation of small GTPase mediated signal transduction |
GO:0072088 | 0.0072 | 4.7988 | 1.2566 | 5 | 24 | nephron epithelium morphogenesis |
GO:0032943 | 0.0075 | 2.3166 | 6.0734 | 13 | 116 | mononuclear cell proliferation |
GO:0034103 | 0.0077 | 3.9113 | 1.7801 | 6 | 34 | regulation of tissue remodeling |
GO:0072006 | 0.0078 | 2.8397 | 3.5079 | 9 | 67 | nephron development |
GO:0010455 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | positive regulation of cell fate commitment |
GO:0021902 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0021912 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0021913 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0033058 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | directional locomotion |
GO:0034287 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | detection of monosaccharide stimulus |
GO:0051594 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | detection of glucose |
GO:0060018 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | astrocyte fate commitment |
GO:0060290 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | transdifferentiation |
GO:0072197 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | ureter morphogenesis |
GO:2000318 | 0.0079 | 36.3321 | 0.1571 | 2 | 3 | positive regulation of T-helper 17 type immune response |
GO:0019725 | 0.0079 | 1.6526 | 20.4716 | 32 | 391 | cellular homeostasis |
GO:0002068 | 0.0082 | 6.0713 | 0.8377 | 4 | 16 | glandular epithelial cell development |
GO:0023019 | 0.0082 | 6.0713 | 0.8377 | 4 | 16 | signal transduction involved in regulation of gene expression |
GO:0050974 | 0.0082 | 6.0713 | 0.8377 | 4 | 16 | detection of mechanical stimulus involved in sensory perception |
GO:0072170 | 0.0082 | 6.0713 | 0.8377 | 4 | 16 | metanephric tubule development |
GO:0000902 | 0.0082 | 1.4465 | 42.3569 | 58 | 809 | cell morphogenesis |
GO:0048644 | 0.0083 | 3.3653 | 2.3561 | 7 | 45 | muscle organ morphogenesis |
GO:1902680 | 0.0083 | 1.4285 | 45.8648 | 62 | 876 | positive regulation of RNA biosynthetic process |
GO:0048646 | 0.0088 | 1.6685 | 19.0117 | 30 | 373 | anatomical structure formation involved in morphogenesis |
GO:0002700 | 0.0089 | 3.7761 | 1.8325 | 6 | 35 | regulation of production of molecular mediator of immune response |
GO:0021575 | 0.0089 | 3.7761 | 1.8325 | 6 | 35 | hindbrain morphogenesis |
GO:0055008 | 0.0089 | 3.7761 | 1.8325 | 6 | 35 | cardiac muscle tissue morphogenesis |
GO:0060688 | 0.0089 | 3.7761 | 1.8325 | 6 | 35 | regulation of morphogenesis of a branching structure |
GO:0070663 | 0.0091 | 2.4581 | 4.8692 | 11 | 93 | regulation of leukocyte proliferation |
GO:0006873 | 0.0091 | 1.7985 | 13.5605 | 23 | 259 | cellular ion homeostasis |
GO:0006820 | 0.0092 | 1.7724 | 14.3458 | 24 | 274 | anion transport |
GO:0021513 | 0.0093 | 9.1552 | 0.4683 | 3 | 9 | spinal cord dorsal/ventral patterning |
GO:0007631 | 0.0095 | 2.7445 | 3.6126 | 9 | 69 | feeding behavior |
GO:0010556 | 0.0096 | 1.2658 | 136.233 | 160 | 2602 | regulation of macromolecule biosynthetic process |
GO:0051272 | 0.0096 | 1.9485 | 9.8431 | 18 | 188 | positive regulation of cellular component movement |
GO:0043062 | 0.0097 | 1.8432 | 12.0945 | 21 | 231 | extracellular structure organization |
GO:0043406 | 0.0097 | 2.1599 | 6.9635 | 14 | 133 | positive regulation of MAP kinase activity |
GO:0016331 | 0.0099 | 2.2291 | 6.2828 | 13 | 120 | morphogenesis of embryonic epithelium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019731 | 0.0024 | 676.8 | 0.0024 | 1 | 4 | antibacterial humoral response |
GO:0002227 | 0.0029 | 507.55 | 0.003 | 1 | 5 | innate immune response in mucosa |
GO:0002251 | 0.0047 | 289.9429 | 0.0047 | 1 | 8 | organ or tissue specific immune response |
GO:0060628 | 0.0059 | 225.4667 | 0.0059 | 1 | 10 | regulation of ER to Golgi vesicle-mediated transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 10.5021 | 0.7756 | 7 | 71 | embryonic skeletal system morphogenesis |
GO:1900747 | 1e-04 | Inf | 0.0218 | 2 | 2 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0001501 | 2e-04 | 3.8598 | 3.4739 | 12 | 318 | skeletal system development |
GO:0048015 | 5e-04 | 5.4773 | 1.4092 | 7 | 129 | phosphatidylinositol-mediated signaling |
GO:0007389 | 0.001 | 3.3447 | 3.6159 | 11 | 331 | pattern specification process |
GO:2000146 | 0.0012 | 5.5731 | 1.1798 | 6 | 108 | negative regulation of cell motility |
GO:0045773 | 0.0017 | 14.6652 | 0.2403 | 3 | 22 | positive regulation of axon extension |
GO:0021546 | 0.0017 | 46.0826 | 0.0655 | 2 | 6 | rhombomere development |
GO:0060828 | 0.0017 | 5.1166 | 1.2781 | 6 | 117 | regulation of canonical Wnt signaling pathway |
GO:0035414 | 0.0024 | 36.8624 | 0.0765 | 2 | 7 | negative regulation of catenin import into nucleus |
GO:0060856 | 0.0024 | 36.8624 | 0.0765 | 2 | 7 | establishment of blood-brain barrier |
GO:1902547 | 0.0024 | 36.8624 | 0.0765 | 2 | 7 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0043551 | 0.0027 | 12.1099 | 0.284 | 3 | 26 | regulation of phosphatidylinositol 3-kinase activity |
GO:0042886 | 0.003 | 3.9591 | 1.9117 | 7 | 175 | amide transport |
GO:0048638 | 0.0031 | 5.4651 | 0.9941 | 5 | 91 | regulation of developmental growth |
GO:0050680 | 0.0032 | 7.1777 | 0.6122 | 4 | 57 | negative regulation of epithelial cell proliferation |
GO:0030239 | 0.0034 | 11.1389 | 0.3059 | 3 | 28 | myofibril assembly |
GO:0010518 | 0.0034 | 7.0513 | 0.6227 | 4 | 57 | positive regulation of phospholipase activity |
GO:0030334 | 0.0035 | 2.9721 | 3.6487 | 10 | 334 | regulation of cell migration |
GO:0050715 | 0.0038 | 10.7094 | 0.3168 | 3 | 29 | positive regulation of cytokine secretion |
GO:0071310 | 0.0039 | 2.0069 | 12.9014 | 23 | 1181 | cellular response to organic substance |
GO:0009967 | 0.004 | 2.2882 | 7.7015 | 16 | 705 | positive regulation of signal transduction |
GO:0002686 | 0.004 | 26.325 | 0.0983 | 2 | 9 | negative regulation of leukocyte migration |
GO:0071425 | 0.004 | 26.325 | 0.0983 | 2 | 9 | hematopoietic stem cell proliferation |
GO:0048864 | 0.0049 | 3.609 | 2.0865 | 7 | 191 | stem cell development |
GO:0042060 | 0.005 | 2.6676 | 4.468 | 11 | 409 | wound healing |
GO:0007166 | 0.0055 | 1.7991 | 19.7945 | 31 | 1812 | cell surface receptor signaling pathway |
GO:0070371 | 0.0055 | 4.7413 | 1.1361 | 5 | 104 | ERK1 and ERK2 cascade |
GO:0008361 | 0.0058 | 6.0223 | 0.721 | 4 | 66 | regulation of cell size |
GO:0030878 | 0.0061 | 20.4709 | 0.1202 | 2 | 11 | thyroid gland development |
GO:0048712 | 0.0061 | 20.4709 | 0.1202 | 2 | 11 | negative regulation of astrocyte differentiation |
GO:0048568 | 0.0069 | 2.8481 | 3.3974 | 9 | 311 | embryonic organ development |
GO:0021602 | 0.0073 | 18.422 | 0.1311 | 2 | 12 | cranial nerve morphogenesis |
GO:0030195 | 0.0073 | 18.422 | 0.1311 | 2 | 12 | negative regulation of blood coagulation |
GO:0031954 | 0.0073 | 18.422 | 0.1311 | 2 | 12 | positive regulation of protein autophosphorylation |
GO:0009952 | 0.0074 | 3.7461 | 1.7151 | 6 | 157 | anterior/posterior pattern specification |
GO:0090288 | 0.0079 | 5.4876 | 0.7865 | 4 | 72 | negative regulation of cellular response to growth factor stimulus |
GO:0048598 | 0.0081 | 2.4851 | 4.7738 | 11 | 437 | embryonic morphogenesis |
GO:0001937 | 0.0085 | 16.7456 | 0.142 | 2 | 13 | negative regulation of endothelial cell proliferation |
GO:0051354 | 0.0085 | 16.7456 | 0.142 | 2 | 13 | negative regulation of oxidoreductase activity |
GO:0040012 | 0.0085 | 2.5903 | 4.1512 | 10 | 380 | regulation of locomotion |
GO:0045927 | 0.0087 | 4.2236 | 1.2672 | 5 | 116 | positive regulation of growth |
GO:2000736 | 0.009 | 5.2542 | 0.8193 | 4 | 75 | regulation of stem cell differentiation |
GO:0001558 | 0.0091 | 3.1848 | 2.3487 | 7 | 215 | regulation of cell growth |
GO:0023051 | 0.0093 | 1.7338 | 19.6525 | 30 | 1799 | regulation of signaling |
GO:0035019 | 0.0093 | 7.5173 | 0.437 | 3 | 40 | somatic stem cell maintenance |
GO:0010646 | 0.0094 | 1.7314 | 19.6743 | 30 | 1801 | regulation of cell communication |
GO:0007169 | 0.0096 | 2.3249 | 5.5713 | 12 | 510 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0051224 | 0.0099 | 5.1092 | 0.8412 | 4 | 77 | negative regulation of protein transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061138 | 0 | 3.2497 | 8.9551 | 25 | 147 | morphogenesis of a branching epithelium |
GO:0072202 | 0 | 18.1786 | 0.7919 | 7 | 13 | cell differentiation involved in metanephros development |
GO:0051674 | 0 | 1.8566 | 43.4963 | 73 | 714 | localization of cell |
GO:2000145 | 0 | 2.2085 | 21.6263 | 43 | 355 | regulation of cell motility |
GO:0051716 | 0 | 1.4327 | 228.6907 | 279 | 3754 | cellular response to stimulus |
GO:0007166 | 0 | 1.5309 | 110.3856 | 151 | 1812 | cell surface receptor signaling pathway |
GO:0035329 | 0 | 7.8066 | 1.6448 | 9 | 27 | hippo signaling |
GO:0034329 | 0 | 2.9552 | 8.8942 | 23 | 146 | cell junction assembly |
GO:0072359 | 0 | 1.8472 | 35.5768 | 60 | 584 | circulatory system development |
GO:0050920 | 0 | 4.143 | 4.0816 | 14 | 67 | regulation of chemotaxis |
GO:0032501 | 0 | 1.3958 | 236.001 | 283 | 3874 | multicellular organismal process |
GO:0007267 | 0 | 1.7342 | 46.0549 | 73 | 756 | cell-cell signaling |
GO:0048520 | 1e-04 | 4.6962 | 3.1678 | 12 | 52 | positive regulation of behavior |
GO:0007435 | 1e-04 | 7.7954 | 1.4621 | 8 | 24 | salivary gland morphogenesis |
GO:0030335 | 1e-04 | 2.6 | 10.7827 | 25 | 177 | positive regulation of cell migration |
GO:0009968 | 1e-04 | 1.7853 | 37.8917 | 62 | 622 | negative regulation of signal transduction |
GO:0032879 | 1e-04 | 1.5546 | 76.149 | 108 | 1250 | regulation of localization |
GO:0016337 | 1e-04 | 2.4095 | 12.9149 | 28 | 212 | single organismal cell-cell adhesion |
GO:0072001 | 1e-04 | 2.4764 | 11.6965 | 26 | 192 | renal system development |
GO:0072207 | 1e-04 | 8.384 | 1.2184 | 7 | 20 | metanephric epithelium development |
GO:0060444 | 2e-04 | 10.3676 | 0.9138 | 6 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0032331 | 2e-04 | 15.5326 | 0.6092 | 5 | 10 | negative regulation of chondrocyte differentiation |
GO:0007155 | 2e-04 | 1.9314 | 24.256 | 43 | 410 | cell adhesion |
GO:0051272 | 2e-04 | 2.4217 | 11.4528 | 25 | 188 | positive regulation of cellular component movement |
GO:0009888 | 2e-04 | 1.6516 | 46.6901 | 71 | 791 | tissue development |
GO:0002064 | 2e-04 | 2.7131 | 8.285 | 20 | 136 | epithelial cell development |
GO:0048583 | 2e-04 | 1.4218 | 120.8637 | 156 | 1984 | regulation of response to stimulus |
GO:0010001 | 2e-04 | 2.8862 | 7.0666 | 18 | 116 | glial cell differentiation |
GO:0003008 | 2e-04 | 1.6274 | 49.2892 | 74 | 820 | system process |
GO:0003104 | 2e-04 | Inf | 0.1828 | 3 | 3 | positive regulation of glomerular filtration |
GO:0033598 | 2e-04 | 9.3299 | 0.9747 | 6 | 16 | mammary gland epithelial cell proliferation |
GO:0035295 | 2e-04 | 1.8493 | 26.9872 | 46 | 443 | tube development |
GO:0007154 | 3e-04 | 1.5231 | 77.4534 | 106 | 1410 | cell communication |
GO:0040017 | 3e-04 | 2.3627 | 11.6965 | 25 | 192 | positive regulation of locomotion |
GO:0060326 | 3e-04 | 3.0611 | 5.9701 | 16 | 98 | cell chemotaxis |
GO:0007417 | 3e-04 | 1.7134 | 36.6124 | 58 | 601 | central nervous system development |
GO:0035272 | 3e-04 | 5.0132 | 2.254 | 9 | 37 | exocrine system development |
GO:0060491 | 3e-04 | 3.753 | 3.777 | 12 | 62 | regulation of cell projection assembly |
GO:0007411 | 3e-04 | 2.0861 | 16.7528 | 32 | 275 | axon guidance |
GO:0030155 | 3e-04 | 2.8761 | 6.6821 | 17 | 111 | regulation of cell adhesion |
GO:0048468 | 3e-04 | 1.5176 | 68.6535 | 96 | 1149 | cell development |
GO:0070830 | 4e-04 | 5.4434 | 1.8806 | 8 | 31 | tight junction assembly |
GO:0010646 | 4e-04 | 1.4145 | 109.7155 | 142 | 1801 | regulation of cell communication |
GO:0030903 | 4e-04 | 20.8096 | 0.424 | 4 | 7 | notochord development |
GO:0010839 | 4e-04 | 20.6808 | 0.4264 | 4 | 7 | negative regulation of keratinocyte proliferation |
GO:0048570 | 4e-04 | 20.6808 | 0.4264 | 4 | 7 | notochord morphogenesis |
GO:0008544 | 4e-04 | 2.3682 | 10.7218 | 23 | 176 | epidermis development |
GO:0008283 | 4e-04 | 1.4981 | 70.0571 | 97 | 1150 | cell proliferation |
GO:0050678 | 5e-04 | 2.405 | 10.1126 | 22 | 166 | regulation of epithelial cell proliferation |
GO:0001944 | 5e-04 | 1.8698 | 23.1493 | 40 | 380 | vasculature development |
GO:0030900 | 5e-04 | 2.0434 | 16.5091 | 31 | 271 | forebrain development |
GO:0060443 | 5e-04 | 5.1926 | 1.9494 | 8 | 32 | mammary gland morphogenesis |
GO:0007169 | 5e-04 | 1.7349 | 31.0688 | 50 | 510 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0060562 | 6e-04 | 2.1453 | 13.7427 | 27 | 227 | epithelial tube morphogenesis |
GO:0032103 | 6e-04 | 2.9373 | 5.7873 | 15 | 95 | positive regulation of response to external stimulus |
GO:0044700 | 6e-04 | 1.5011 | 71.2407 | 97 | 1305 | single organism signaling |
GO:0033273 | 6e-04 | 4.0011 | 2.985 | 10 | 49 | response to vitamin |
GO:0046661 | 7e-04 | 2.9007 | 5.8482 | 15 | 96 | male sex differentiation |
GO:0022008 | 7e-04 | 1.6708 | 35.453 | 55 | 596 | neurogenesis |
GO:0050927 | 7e-04 | 7.1746 | 1.1575 | 6 | 19 | positive regulation of positive chemotaxis |
GO:0030855 | 7e-04 | 2.188 | 12.4838 | 25 | 210 | epithelial cell differentiation |
GO:0009653 | 7e-04 | 1.7219 | 30.7376 | 49 | 533 | anatomical structure morphogenesis |
GO:0021675 | 7e-04 | 3.9007 | 3.046 | 10 | 50 | nerve development |
GO:0030198 | 8e-04 | 2.0982 | 14.0114 | 27 | 230 | extracellular matrix organization |
GO:0023051 | 8e-04 | 1.3888 | 109.5936 | 140 | 1799 | regulation of signaling |
GO:0016331 | 9e-04 | 2.5879 | 7.3103 | 17 | 120 | morphogenesis of embryonic epithelium |
GO:0051093 | 9e-04 | 1.7444 | 27.109 | 44 | 445 | negative regulation of developmental process |
GO:0043401 | 0.001 | 4.6142 | 2.1322 | 8 | 35 | steroid hormone mediated signaling pathway |
GO:0007605 | 0.001 | 2.8822 | 5.4827 | 14 | 90 | sensory perception of sound |
GO:0008219 | 0.001 | 1.4282 | 81.5099 | 108 | 1338 | cell death |
GO:0030030 | 0.0011 | 1.5639 | 45.2497 | 66 | 750 | cell projection organization |
GO:0048762 | 0.0013 | 2.5836 | 6.8839 | 16 | 113 | mesenchymal cell differentiation |
GO:0060536 | 0.0013 | 12.4059 | 0.5483 | 4 | 9 | cartilage morphogenesis |
GO:0090090 | 0.0014 | 3.0727 | 4.4471 | 12 | 73 | negative regulation of canonical Wnt signaling pathway |
GO:0045595 | 0.0014 | 1.4951 | 55.1319 | 77 | 905 | regulation of cell differentiation |
GO:0030278 | 0.0014 | 2.557 | 6.9448 | 16 | 114 | regulation of ossification |
GO:0006935 | 0.0015 | 1.9194 | 16.8492 | 30 | 282 | chemotaxis |
GO:2000242 | 0.0015 | 7.7622 | 0.9138 | 5 | 15 | negative regulation of reproductive process |
GO:0030111 | 0.0016 | 2.2587 | 9.6862 | 20 | 159 | regulation of Wnt signaling pathway |
GO:0001658 | 0.0016 | 3.7902 | 2.8023 | 9 | 46 | branching involved in ureteric bud morphogenesis |
GO:0030182 | 0.0016 | 1.5216 | 48.4912 | 69 | 804 | neuron differentiation |
GO:0072091 | 0.0017 | 3.1788 | 3.9597 | 11 | 65 | regulation of stem cell proliferation |
GO:0030216 | 0.0018 | 3.3897 | 3.4115 | 10 | 56 | keratinocyte differentiation |
GO:0001501 | 0.0018 | 1.8291 | 19.3723 | 33 | 318 | skeletal system development |
GO:0045665 | 0.0018 | 3.6901 | 2.8632 | 9 | 47 | negative regulation of neuron differentiation |
GO:0018212 | 0.0019 | 2.0514 | 12.6712 | 24 | 208 | peptidyl-tyrosine modification |
GO:0048514 | 0.002 | 1.837 | 18.7022 | 32 | 307 | blood vessel morphogenesis |
GO:0008015 | 0.002 | 1.9773 | 14.1942 | 26 | 233 | blood circulation |
GO:0050911 | 0.0021 | 23.2305 | 0.3046 | 3 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:1901678 | 0.0021 | 23.2305 | 0.3046 | 3 | 5 | iron coordination entity transport |
GO:2001028 | 0.0021 | 23.2305 | 0.3046 | 3 | 5 | positive regulation of endothelial cell chemotaxis |
GO:0050730 | 0.0021 | 2.4557 | 7.1885 | 16 | 118 | regulation of peptidyl-tyrosine phosphorylation |
GO:0061035 | 0.0021 | 4.0171 | 2.3758 | 8 | 39 | regulation of cartilage development |
GO:0051094 | 0.0021 | 1.5957 | 34.7615 | 52 | 573 | positive regulation of developmental process |
GO:0006911 | 0.0021 | 10.3371 | 0.6092 | 4 | 10 | phagocytosis, engulfment |
GO:0097205 | 0.0021 | 10.3371 | 0.6092 | 4 | 10 | renal filtration |
GO:0009887 | 0.0022 | 1.5993 | 34.0088 | 51 | 567 | organ morphogenesis |
GO:0001508 | 0.0022 | 2.5232 | 6.5793 | 15 | 108 | action potential |
GO:1903034 | 0.0023 | 2.1267 | 10.7218 | 21 | 176 | regulation of response to wounding |
GO:2000026 | 0.0024 | 1.498 | 48.4131 | 68 | 813 | regulation of multicellular organismal development |
GO:0000902 | 0.0024 | 1.4922 | 49.2836 | 69 | 809 | cell morphogenesis |
GO:0007606 | 0.0025 | 3.8912 | 2.4368 | 8 | 40 | sensory perception of chemical stimulus |
GO:0048732 | 0.0025 | 2.1121 | 10.7799 | 21 | 180 | gland development |
GO:0007156 | 0.0025 | 2.8384 | 4.7517 | 12 | 78 | homophilic cell adhesion |
GO:0008584 | 0.0025 | 2.8384 | 4.7517 | 12 | 78 | male gonad development |
GO:0048608 | 0.0026 | 1.8402 | 17.4838 | 30 | 287 | reproductive structure development |
GO:0002690 | 0.0026 | 5.1789 | 1.4621 | 6 | 24 | positive regulation of leukocyte chemotaxis |
GO:0072088 | 0.0026 | 5.1789 | 1.4621 | 6 | 24 | nephron epithelium morphogenesis |
GO:0007528 | 0.0027 | 4.3542 | 1.9494 | 7 | 32 | neuromuscular junction development |
GO:0050767 | 0.0027 | 1.7206 | 22.9665 | 37 | 377 | regulation of neurogenesis |
GO:0003203 | 0.0028 | 6.4672 | 1.0356 | 5 | 17 | endocardial cushion morphogenesis |
GO:0007622 | 0.0028 | 6.4672 | 1.0356 | 5 | 17 | rhythmic behavior |
GO:0040036 | 0.0028 | 6.4672 | 1.0356 | 5 | 17 | regulation of fibroblast growth factor receptor signaling pathway |
GO:0006915 | 0.0028 | 1.4073 | 70.5444 | 93 | 1158 | apoptotic process |
GO:0045669 | 0.0029 | 3.7729 | 2.4977 | 8 | 41 | positive regulation of osteoblast differentiation |
GO:0070167 | 0.0029 | 3.7729 | 2.4977 | 8 | 41 | regulation of biomineral tissue development |
GO:0061448 | 0.0029 | 2.1739 | 9.5034 | 19 | 156 | connective tissue development |
GO:0051222 | 0.0031 | 2.2748 | 8.1632 | 17 | 134 | positive regulation of protein transport |
GO:0072009 | 0.0031 | 4.9449 | 1.5118 | 6 | 25 | nephron epithelium development |
GO:0002009 | 0.0032 | 4.1811 | 2.0024 | 7 | 34 | morphogenesis of an epithelium |
GO:0040013 | 0.0032 | 2.3397 | 7.4931 | 16 | 123 | negative regulation of locomotion |
GO:0050427 | 0.0032 | 8.8595 | 0.6701 | 4 | 11 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process |
GO:0070328 | 0.0032 | 8.8595 | 0.6701 | 4 | 11 | triglyceride homeostasis |
GO:0021983 | 0.0032 | 4.1863 | 2.0103 | 7 | 33 | pituitary gland development |
GO:0034332 | 0.0035 | 2.8592 | 4.3253 | 11 | 71 | adherens junction organization |
GO:0030857 | 0.0036 | 5.9691 | 1.0965 | 5 | 18 | negative regulation of epithelial cell differentiation |
GO:0003415 | 0.0037 | Inf | 0.1218 | 2 | 2 | chondrocyte hypertrophy |
GO:0010482 | 0.0037 | Inf | 0.1218 | 2 | 2 | regulation of epidermal cell division |
GO:0010641 | 0.0037 | Inf | 0.1218 | 2 | 2 | positive regulation of platelet-derived growth factor receptor signaling pathway |
GO:0030200 | 0.0037 | Inf | 0.1218 | 2 | 2 | heparan sulfate proteoglycan catabolic process |
GO:0048312 | 0.0037 | Inf | 0.1218 | 2 | 2 | intracellular distribution of mitochondria |
GO:0051639 | 0.0037 | Inf | 0.1218 | 2 | 2 | actin filament network formation |
GO:0060435 | 0.0037 | Inf | 0.1218 | 2 | 2 | bronchiole development |
GO:0061370 | 0.0037 | Inf | 0.1218 | 2 | 2 | testosterone biosynthetic process |
GO:2000669 | 0.0037 | Inf | 0.1218 | 2 | 2 | negative regulation of dendritic cell apoptotic process |
GO:0007416 | 0.0038 | 3.2593 | 3.1678 | 9 | 52 | synapse assembly |
GO:0001977 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | renal system process involved in regulation of blood volume |
GO:0021546 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | rhombomere development |
GO:0045475 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | locomotor rhythm |
GO:0060534 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | trachea cartilage development |
GO:0060576 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | intestinal epithelial cell development |
GO:0086069 | 0.0039 | 15.4854 | 0.3655 | 3 | 6 | bundle of His cell to Purkinje myocyte communication |
GO:0015748 | 0.0039 | 3.5565 | 2.6195 | 8 | 43 | organophosphate ester transport |
GO:0048646 | 0.004 | 1.5393 | 35.8619 | 52 | 595 | anatomical structure formation involved in morphogenesis |
GO:0010632 | 0.0043 | 2.6371 | 5.0563 | 12 | 83 | regulation of epithelial cell migration |
GO:0060993 | 0.0045 | 7.8016 | 0.7266 | 4 | 12 | kidney morphogenesis |
GO:0030336 | 0.0045 | 2.4033 | 6.3965 | 14 | 105 | negative regulation of cell migration |
GO:0032922 | 0.0045 | 3.8864 | 2.1322 | 7 | 35 | circadian regulation of gene expression |
GO:0072012 | 0.0046 | 7.7512 | 0.731 | 4 | 12 | glomerulus vasculature development |
GO:0072079 | 0.0046 | 7.7512 | 0.731 | 4 | 12 | nephron tubule formation |
GO:0072224 | 0.0046 | 7.7512 | 0.731 | 4 | 12 | metanephric glomerulus development |
GO:0072234 | 0.0046 | 7.7512 | 0.731 | 4 | 12 | metanephric nephron tubule development |
GO:0065008 | 0.0046 | 1.3057 | 118.3051 | 144 | 1942 | regulation of biological quality |
GO:0061333 | 0.0047 | 5.5421 | 1.1575 | 5 | 19 | renal tubule morphogenesis |
GO:1902743 | 0.0047 | 5.5421 | 1.1575 | 5 | 19 | regulation of lamellipodium organization |
GO:0090183 | 0.0048 | 4.4576 | 1.638 | 6 | 27 | regulation of kidney development |
GO:0003014 | 0.0052 | 3.7743 | 2.1811 | 7 | 36 | renal system process |
GO:0035556 | 0.0052 | 1.3401 | 87.461 | 110 | 1453 | intracellular signal transduction |
GO:0048812 | 0.0055 | 1.5849 | 28.0838 | 42 | 461 | neuron projection morphogenesis |
GO:0006928 | 0.0056 | 1.4519 | 46.7226 | 64 | 793 | cellular component movement |
GO:0040011 | 0.0056 | 1.4991 | 38.164 | 54 | 648 | locomotion |
GO:0008016 | 0.0057 | 2.5294 | 5.2391 | 12 | 86 | regulation of heart contraction |
GO:0015711 | 0.0057 | 1.9167 | 12.3057 | 22 | 202 | organic anion transport |
GO:0003015 | 0.0058 | 2.4154 | 5.9092 | 13 | 97 | heart process |
GO:0060688 | 0.0058 | 4.2545 | 1.6986 | 6 | 28 | regulation of morphogenesis of a branching structure |
GO:0001667 | 0.0058 | 2.0239 | 10.1126 | 19 | 166 | ameboidal cell migration |
GO:0007600 | 0.0059 | 1.827 | 14.6094 | 25 | 242 | sensory perception |
GO:0048710 | 0.0059 | 5.1721 | 1.2184 | 5 | 20 | regulation of astrocyte differentiation |
GO:0060740 | 0.0059 | 5.1721 | 1.2184 | 5 | 20 | prostate gland epithelium morphogenesis |
GO:0032990 | 0.0061 | 1.5023 | 36.6124 | 52 | 601 | cell part morphogenesis |
GO:0030193 | 0.0062 | 3.6266 | 2.254 | 7 | 37 | regulation of blood coagulation |
GO:0001976 | 0.0063 | 6.8893 | 0.7919 | 4 | 13 | neurological system process involved in regulation of systemic arterial blood pressure |
GO:0045332 | 0.0063 | 6.8893 | 0.7919 | 4 | 13 | phospholipid translocation |
GO:0048332 | 0.0063 | 2.9806 | 3.4115 | 9 | 56 | mesoderm morphogenesis |
GO:0015721 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | bile acid and bile salt transport |
GO:0016081 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | synaptic vesicle docking involved in exocytosis |
GO:0060693 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | regulation of branching involved in salivary gland morphogenesis |
GO:0090192 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | regulation of glomerulus development |
GO:1900006 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | positive regulation of dendrite development |
GO:2000810 | 0.0065 | 11.6128 | 0.4264 | 3 | 7 | regulation of tight junction assembly |
GO:0030029 | 0.0067 | 1.637 | 22.6619 | 35 | 372 | actin filament-based process |
GO:0051271 | 0.0068 | 2.2769 | 6.7011 | 14 | 110 | negative regulation of cellular component movement |
GO:0051056 | 0.0069 | 1.6736 | 20.2861 | 32 | 333 | regulation of small GTPase mediated signal transduction |
GO:0051897 | 0.0069 | 3.1904 | 2.8632 | 8 | 47 | positive regulation of protein kinase B signaling |
GO:0031345 | 0.007 | 2.7324 | 4.0816 | 10 | 67 | negative regulation of cell projection organization |
GO:0048661 | 0.0071 | 4.0509 | 1.7667 | 6 | 29 | positive regulation of smooth muscle cell proliferation |
GO:0071407 | 0.0073 | 1.9018 | 11.8183 | 21 | 194 | cellular response to organic cyclic compound |
GO:0045785 | 0.0073 | 2.2532 | 6.762 | 14 | 111 | positive regulation of cell adhesion |
GO:0001889 | 0.0073 | 2.5585 | 4.7517 | 11 | 78 | liver development |
GO:0003338 | 0.0074 | 4.8483 | 1.2793 | 5 | 21 | metanephros morphogenesis |
GO:0010876 | 0.0075 | 1.9694 | 10.3563 | 19 | 170 | lipid localization |
GO:0006805 | 0.0077 | 2.685 | 4.1425 | 10 | 68 | xenobiotic metabolic process |
GO:0019220 | 0.008 | 1.3445 | 73.2249 | 93 | 1202 | regulation of phosphate metabolic process |
GO:0043087 | 0.0081 | 1.6388 | 21.3217 | 33 | 350 | regulation of GTPase activity |
GO:0001704 | 0.0082 | 2.3987 | 5.4827 | 12 | 90 | formation of primary germ layer |
GO:0007274 | 0.0084 | 6.1997 | 0.8529 | 4 | 14 | neuromuscular synaptic transmission |
GO:0010575 | 0.0084 | 6.1997 | 0.8529 | 4 | 14 | positive regulation vascular endothelial growth factor production |
GO:0050435 | 0.0084 | 6.1997 | 0.8529 | 4 | 14 | beta-amyloid metabolic process |
GO:0001837 | 0.0086 | 2.6392 | 4.2034 | 10 | 69 | epithelial to mesenchymal transition |
GO:0048598 | 0.0086 | 1.6725 | 19.0055 | 30 | 317 | embryonic morphogenesis |
GO:0035637 | 0.0088 | 2.2785 | 6.2138 | 13 | 102 | multicellular organismal signaling |
GO:0034446 | 0.0089 | 3.0341 | 2.985 | 8 | 49 | substrate adhesion-dependent cell spreading |
GO:0009605 | 0.0091 | 1.3621 | 62.8242 | 81 | 1047 | response to external stimulus |
GO:1900542 | 0.0093 | 1.5466 | 27.2918 | 40 | 448 | regulation of purine nucleotide metabolic process |
GO:0061564 | 0.0096 | 1.5715 | 24.855 | 37 | 408 | axon development |
GO:0048667 | 0.0097 | 1.5427 | 27.3527 | 40 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0035019 | 0.0097 | 3.2959 | 2.4368 | 7 | 40 | somatic stem cell maintenance |
GO:0045216 | 0.0097 | 2.5827 | 4.2783 | 10 | 71 | cell-cell junction organization |
GO:0001909 | 0.0099 | 3.7261 | 1.8885 | 6 | 31 | leukocyte mediated cytotoxicity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.9544 | 558.1671 | 763 | 3874 | multicellular organismal process |
GO:0003008 | 0 | 2.1585 | 77.4511 | 138 | 551 | system process |
GO:0007268 | 0 | 2.4639 | 46.8643 | 93 | 332 | synaptic transmission |
GO:0007423 | 0 | 2.3487 | 52.8775 | 101 | 367 | sensory organ development |
GO:0007218 | 0 | 5.8669 | 9.3652 | 32 | 65 | neuropeptide signaling pathway |
GO:2000026 | 0 | 1.8904 | 104.6107 | 168 | 737 | regulation of multicellular organismal development |
GO:0060485 | 0 | 3.3705 | 21.0357 | 52 | 146 | mesenchyme development |
GO:0007586 | 0 | 5.8483 | 8.7889 | 30 | 61 | digestion |
GO:0007389 | 0 | 2.7032 | 33.3413 | 71 | 235 | pattern specification process |
GO:0048468 | 0 | 1.684 | 153.7605 | 224 | 1089 | cell development |
GO:0007155 | 0 | 2.0049 | 74.3397 | 126 | 521 | cell adhesion |
GO:0048870 | 0 | 1.8035 | 102.8733 | 160 | 714 | cell motility |
GO:0007156 | 0 | 4.4338 | 11.2383 | 33 | 78 | homophilic cell adhesion |
GO:0007517 | 0 | 2.9796 | 22.3167 | 51 | 156 | muscle organ development |
GO:0009887 | 0 | 2.2563 | 43.7642 | 82 | 315 | organ morphogenesis |
GO:0042472 | 0 | 4.1127 | 11.3823 | 32 | 79 | inner ear morphogenesis |
GO:0065007 | 0 | 1.4028 | 939.2595 | 1033 | 6519 | biological regulation |
GO:0014033 | 0 | 5.768 | 6.7718 | 23 | 47 | neural crest cell differentiation |
GO:0055074 | 0 | 2.7309 | 24.6377 | 53 | 171 | calcium ion homeostasis |
GO:0098660 | 0 | 2.0686 | 52.013 | 91 | 361 | inorganic ion transmembrane transport |
GO:0022008 | 0 | 1.8159 | 83.15 | 131 | 596 | neurogenesis |
GO:0048665 | 0 | 60.1801 | 1.5765 | 10 | 11 | neuron fate specification |
GO:0034765 | 0 | 2.5214 | 28.5279 | 58 | 198 | regulation of ion transmembrane transport |
GO:0048729 | 0 | 2.1729 | 41.6992 | 76 | 293 | tissue morphogenesis |
GO:0014031 | 0 | 3.2903 | 15.1284 | 37 | 105 | mesenchymal cell development |
GO:0050767 | 0 | 2.2229 | 38.2857 | 71 | 268 | regulation of neurogenesis |
GO:0072503 | 0 | 2.5461 | 25.3581 | 52 | 176 | cellular divalent inorganic cation homeostasis |
GO:0051093 | 0 | 1.897 | 61.0196 | 100 | 425 | negative regulation of developmental process |
GO:0061564 | 0 | 1.9134 | 58.7848 | 97 | 408 | axon development |
GO:0042755 | 0 | 11.1224 | 2.8816 | 13 | 20 | eating behavior |
GO:0071805 | 0 | 3.2072 | 14.1199 | 34 | 98 | potassium ion transmembrane transport |
GO:0048562 | 0 | 2.7294 | 19.8869 | 43 | 140 | embryonic organ morphogenesis |
GO:0098655 | 0 | 1.9174 | 53.742 | 89 | 373 | cation transmembrane transport |
GO:0007420 | 0 | 1.9381 | 50.842 | 85 | 356 | brain development |
GO:0003206 | 0 | 3.495 | 11.3823 | 29 | 79 | cardiac chamber morphogenesis |
GO:0001755 | 0 | 7.4922 | 3.8902 | 15 | 27 | neural crest cell migration |
GO:0009792 | 0 | 1.8022 | 65.9888 | 104 | 458 | embryo development ending in birth or egg hatching |
GO:0006935 | 0 | 1.9205 | 50.5782 | 84 | 353 | chemotaxis |
GO:0032355 | 0 | 3.7259 | 9.7975 | 26 | 68 | response to estradiol |
GO:0048565 | 0 | 3.0625 | 14.1199 | 33 | 98 | digestive tract development |
GO:0046717 | 0 | 4.265 | 7.6363 | 22 | 53 | acid secretion |
GO:0048265 | 0 | 8.6487 | 3.1698 | 13 | 22 | response to pain |
GO:0048667 | 0 | 1.7778 | 64.6921 | 101 | 449 | cell morphogenesis involved in neuron differentiation |
GO:0048863 | 0 | 2.5258 | 21.0042 | 43 | 147 | stem cell differentiation |
GO:0032502 | 0 | 1.4373 | 211.9411 | 270 | 1658 | developmental process |
GO:0001568 | 0 | 1.8922 | 49.2801 | 81 | 343 | blood vessel development |
GO:0048704 | 0 | 3.4763 | 10.2297 | 26 | 71 | embryonic skeletal system morphogenesis |
GO:0060173 | 0 | 2.6372 | 18.01 | 38 | 125 | limb development |
GO:0000902 | 0 | 1.5481 | 116.561 | 162 | 809 | cell morphogenesis |
GO:0021510 | 0 | 3.9195 | 8.0126 | 22 | 56 | spinal cord development |
GO:0006813 | 0 | 2.6586 | 17.4337 | 37 | 121 | potassium ion transport |
GO:0007267 | 0 | 2.7857 | 14.8786 | 33 | 110 | cell-cell signaling |
GO:0045944 | 0 | 1.6189 | 87.7449 | 127 | 609 | positive regulation of transcription from RNA polymerase II promoter |
GO:0035107 | 0 | 2.7333 | 15.7048 | 34 | 109 | appendage morphogenesis |
GO:0007186 | 0 | 2.0009 | 36.5207 | 63 | 261 | G-protein coupled receptor signaling pathway |
GO:0001662 | 0 | 7.978 | 3.0257 | 12 | 21 | behavioral fear response |
GO:0032101 | 0 | 1.8706 | 45.9616 | 75 | 319 | regulation of response to external stimulus |
GO:0007507 | 0 | 1.9473 | 39.1542 | 66 | 273 | heart development |
GO:0001763 | 0 | 2.3407 | 22.1884 | 43 | 154 | morphogenesis of a branching structure |
GO:0045666 | 0 | 3.3543 | 9.6534 | 24 | 67 | positive regulation of neuron differentiation |
GO:0045665 | 0 | 4.071 | 6.7718 | 19 | 47 | negative regulation of neuron differentiation |
GO:0035150 | 0 | 2.9556 | 12.2468 | 28 | 85 | regulation of tube size |
GO:0003018 | 0 | 2.822 | 13.5435 | 30 | 94 | vascular process in circulatory system |
GO:0008217 | 0 | 4.8409 | 5.1444 | 16 | 36 | regulation of blood pressure |
GO:0006937 | 0 | 2.8611 | 12.9672 | 29 | 90 | regulation of muscle contraction |
GO:0007200 | 0 | 5.6155 | 4.1612 | 14 | 29 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0010721 | 0 | 2.6769 | 14.9844 | 32 | 104 | negative regulation of cell development |
GO:0015844 | 0 | 4.4307 | 5.7632 | 17 | 40 | monoamine transport |
GO:0022603 | 0 | 1.6723 | 67.0236 | 100 | 467 | regulation of anatomical structure morphogenesis |
GO:0008284 | 0 | 1.7372 | 55.8305 | 86 | 390 | positive regulation of cell proliferation |
GO:0048878 | 0 | 1.6376 | 70.8875 | 104 | 492 | chemical homeostasis |
GO:0007204 | 0 | 2.8206 | 12.6272 | 28 | 88 | positive regulation of cytosolic calcium ion concentration |
GO:0072009 | 0 | 3.7987 | 7.0599 | 19 | 49 | nephron epithelium development |
GO:0003012 | 0 | 2.0566 | 28.9601 | 51 | 201 | muscle system process |
GO:0007600 | 0 | 1.9802 | 32.7143 | 56 | 229 | sensory perception |
GO:0021527 | 0 | 10.753 | 2.0171 | 9 | 14 | spinal cord association neuron differentiation |
GO:0030855 | 0 | 1.7624 | 50.0034 | 78 | 348 | epithelial cell differentiation |
GO:0009952 | 0 | 2.7171 | 13.4046 | 29 | 94 | anterior/posterior pattern specification |
GO:0001508 | 0 | 2.5348 | 15.5607 | 32 | 108 | action potential |
GO:0006875 | 0 | 1.9482 | 33.1385 | 56 | 230 | cellular metal ion homeostasis |
GO:0007399 | 0 | 1.7784 | 44.9898 | 71 | 336 | nervous system development |
GO:0048521 | 0 | 6.5765 | 3.0257 | 11 | 21 | negative regulation of behavior |
GO:0006873 | 0 | 1.8663 | 37.3168 | 61 | 259 | cellular ion homeostasis |
GO:0009888 | 1e-04 | 1.8193 | 40.4408 | 65 | 297 | tissue development |
GO:0009653 | 1e-04 | 1.6121 | 68.109 | 99 | 515 | anatomical structure morphogenesis |
GO:0014706 | 1e-04 | 2.4917 | 15.2218 | 31 | 107 | striated muscle tissue development |
GO:0048545 | 1e-04 | 1.9233 | 32.8503 | 55 | 228 | response to steroid hormone |
GO:0003231 | 1e-04 | 3.0017 | 9.9415 | 23 | 69 | cardiac ventricle development |
GO:0007620 | 1e-04 | 8.9598 | 2.1612 | 9 | 15 | copulation |
GO:0043270 | 1e-04 | 2.6302 | 13.2554 | 28 | 92 | positive regulation of ion transport |
GO:1903034 | 1e-04 | 2.0737 | 25.3581 | 45 | 176 | regulation of response to wounding |
GO:0044699 | 1e-04 | 1.3417 | 995.6544 | 1048 | 7222 | single-organism process |
GO:0021915 | 1e-04 | 2.2827 | 18.8745 | 36 | 131 | neural tube development |
GO:0045597 | 1e-04 | 1.696 | 52.1199 | 79 | 366 | positive regulation of cell differentiation |
GO:0009954 | 1e-04 | 5.978 | 3.1698 | 11 | 22 | proximal/distal pattern formation |
GO:0001656 | 1e-04 | 3.0003 | 9.5093 | 22 | 66 | metanephros development |
GO:0055080 | 1e-04 | 1.7776 | 41.9274 | 66 | 291 | cation homeostasis |
GO:0052652 | 1e-04 | 2.8255 | 10.806 | 24 | 75 | cyclic purine nucleotide metabolic process |
GO:0021983 | 1e-04 | 4.4099 | 4.7547 | 14 | 33 | pituitary gland development |
GO:0048638 | 1e-04 | 2.888 | 10.1939 | 23 | 71 | regulation of developmental growth |
GO:0060415 | 1e-04 | 3.8329 | 5.9073 | 16 | 41 | muscle tissue morphogenesis |
GO:0070588 | 1e-04 | 2.4906 | 14.264 | 29 | 99 | calcium ion transmembrane transport |
GO:0010002 | 1e-04 | 6.6392 | 2.7375 | 10 | 19 | cardioblast differentiation |
GO:0007263 | 1e-04 | 13.9231 | 1.4408 | 7 | 10 | nitric oxide mediated signal transduction |
GO:0007605 | 1e-04 | 2.575 | 12.9672 | 27 | 90 | sensory perception of sound |
GO:0072358 | 1e-04 | 1.8052 | 37.5655 | 60 | 267 | cardiovascular system development |
GO:0007187 | 1e-04 | 2.5345 | 13.1113 | 27 | 91 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0040012 | 1e-04 | 1.645 | 54.7505 | 81 | 380 | regulation of locomotion |
GO:0072164 | 1e-04 | 2.7182 | 11.0942 | 24 | 77 | mesonephric tubule development |
GO:0001709 | 1e-04 | 5.4962 | 3.3051 | 11 | 23 | cell fate determination |
GO:0048333 | 1e-04 | 5.4792 | 3.3138 | 11 | 23 | mesodermal cell differentiation |
GO:0048663 | 1e-04 | 4.8515 | 3.8438 | 12 | 27 | neuron fate commitment |
GO:1990138 | 1e-04 | 3.1634 | 7.9244 | 19 | 55 | neuron projection extension |
GO:0070838 | 2e-04 | 1.9084 | 29.3924 | 49 | 204 | divalent metal ion transport |
GO:0030574 | 2e-04 | 3.3941 | 6.7718 | 17 | 47 | collagen catabolic process |
GO:0009605 | 2e-04 | 1.4251 | 116.1499 | 152 | 823 | response to external stimulus |
GO:0045880 | 2e-04 | 5.9746 | 2.8816 | 10 | 20 | positive regulation of smoothened signaling pathway |
GO:0061387 | 2e-04 | 3.5482 | 6.1955 | 16 | 43 | regulation of extent of cell growth |
GO:0048598 | 2e-04 | 1.8749 | 30.3202 | 50 | 217 | embryonic morphogenesis |
GO:0071276 | 2e-04 | 17.8909 | 1.1526 | 6 | 8 | cellular response to cadmium ion |
GO:0042445 | 2e-04 | 2.4571 | 13.3995 | 27 | 93 | hormone metabolic process |
GO:0001823 | 2e-04 | 2.6188 | 11.3823 | 24 | 79 | mesonephros development |
GO:0035295 | 2e-04 | 2.0262 | 22.8309 | 40 | 163 | tube development |
GO:0007411 | 2e-04 | 1.7955 | 35.2053 | 56 | 246 | axon guidance |
GO:0043010 | 2e-04 | 1.893 | 28.9601 | 48 | 201 | camera-type eye development |
GO:0048557 | 2e-04 | 6.7183 | 2.4494 | 9 | 17 | embryonic digestive tract morphogenesis |
GO:0048812 | 2e-04 | 1.5984 | 58.0517 | 84 | 406 | neuron projection morphogenesis |
GO:0050806 | 2e-04 | 3.2843 | 6.9159 | 17 | 48 | positive regulation of synaptic transmission |
GO:0023052 | 2e-04 | 1.2507 | 397.7049 | 453 | 2916 | signaling |
GO:0018958 | 2e-04 | 8.012 | 2.0057 | 8 | 14 | phenol-containing compound metabolic process |
GO:0051482 | 2e-04 | 7.9588 | 2.0171 | 8 | 14 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0003214 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | cardiac left ventricle morphogenesis |
GO:0015812 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | gamma-aminobutyric acid transport |
GO:0021781 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | glial cell fate commitment |
GO:0030878 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | thyroid gland development |
GO:0032098 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | regulation of appetite |
GO:0048484 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | enteric nervous system development |
GO:1902667 | 2e-04 | 10.4411 | 1.5849 | 7 | 11 | regulation of axon guidance |
GO:0060429 | 3e-04 | 1.9008 | 27.5797 | 46 | 198 | epithelium development |
GO:0019226 | 3e-04 | 2.5717 | 11.5264 | 24 | 80 | transmission of nerve impulse |
GO:0050885 | 3e-04 | 3.8072 | 5.1869 | 14 | 36 | neuromuscular process controlling balance |
GO:0044702 | 3e-04 | 1.4496 | 96.1173 | 128 | 669 | single organism reproductive process |
GO:0001756 | 3e-04 | 3.0807 | 7.6363 | 18 | 53 | somitogenesis |
GO:0060562 | 3e-04 | 2.2293 | 16.4789 | 31 | 116 | epithelial tube morphogenesis |
GO:0001525 | 3e-04 | 1.9963 | 23.1291 | 40 | 162 | angiogenesis |
GO:0030182 | 3e-04 | 1.4745 | 85.7261 | 116 | 620 | neuron differentiation |
GO:0035235 | 3e-04 | 5.4308 | 3.0257 | 10 | 21 | ionotropic glutamate receptor signaling pathway |
GO:0051049 | 3e-04 | 1.4113 | 113.0338 | 147 | 791 | regulation of transport |
GO:0048608 | 3e-04 | 1.701 | 41.351 | 63 | 287 | reproductive structure development |
GO:0003211 | 3e-04 | 29.8012 | 0.8645 | 5 | 6 | cardiac ventricle formation |
GO:0021796 | 3e-04 | 29.8012 | 0.8645 | 5 | 6 | cerebral cortex regionalization |
GO:0042713 | 3e-04 | 29.8012 | 0.8645 | 5 | 6 | sperm ejaculation |
GO:0060453 | 3e-04 | 29.8012 | 0.8645 | 5 | 6 | regulation of gastric acid secretion |
GO:0022617 | 3e-04 | 2.6385 | 10.3738 | 22 | 72 | extracellular matrix disassembly |
GO:0006355 | 3e-04 | 1.251 | 336.2834 | 388 | 2334 | regulation of transcription, DNA-templated |
GO:0045927 | 3e-04 | 2.269 | 15.2353 | 29 | 106 | positive regulation of growth |
GO:0045785 | 4e-04 | 2.2253 | 15.9929 | 30 | 111 | positive regulation of cell adhesion |
GO:0010628 | 4e-04 | 1.3743 | 131.4012 | 167 | 912 | positive regulation of gene expression |
GO:0060079 | 4e-04 | 3.887 | 4.7547 | 13 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0044259 | 4e-04 | 2.5864 | 10.5179 | 22 | 73 | multicellular organismal macromolecule metabolic process |
GO:0002003 | 4e-04 | Inf | 0.5763 | 4 | 4 | angiotensin maturation |
GO:0014054 | 4e-04 | Inf | 0.5763 | 4 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0001504 | 5e-04 | 6.821 | 2.1612 | 8 | 15 | neurotransmitter uptake |
GO:0001990 | 5e-04 | 4.9776 | 3.1698 | 10 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:0045987 | 5e-04 | 4.9776 | 3.1698 | 10 | 22 | positive regulation of smooth muscle contraction |
GO:0030030 | 5e-04 | 1.3868 | 117.7136 | 151 | 817 | cell projection organization |
GO:0022898 | 5e-04 | 2.3289 | 13.3995 | 26 | 93 | regulation of transmembrane transporter activity |
GO:0042220 | 5e-04 | 4.3818 | 3.7461 | 11 | 26 | response to cocaine |
GO:0032892 | 5e-04 | 8.352 | 1.729 | 7 | 12 | positive regulation of organic acid transport |
GO:0051240 | 5e-04 | 1.626 | 46.2079 | 68 | 325 | positive regulation of multicellular organismal process |
GO:0009712 | 5e-04 | 3.7015 | 4.8987 | 13 | 34 | catechol-containing compound metabolic process |
GO:0048167 | 6e-04 | 2.3992 | 12.1027 | 24 | 84 | regulation of synaptic plasticity |
GO:0048332 | 6e-04 | 2.8365 | 8.0685 | 18 | 56 | mesoderm morphogenesis |
GO:0015850 | 6e-04 | 2.2118 | 14.9844 | 28 | 104 | organic hydroxy compound transport |
GO:0032990 | 6e-04 | 1.4403 | 86.5923 | 115 | 601 | cell part morphogenesis |
GO:2000021 | 6e-04 | 2.4883 | 10.806 | 22 | 75 | regulation of ion homeostasis |
GO:0046942 | 7e-04 | 1.968 | 21.0357 | 36 | 146 | carboxylic acid transport |
GO:0051048 | 7e-04 | 2.3596 | 12.2468 | 24 | 85 | negative regulation of secretion |
GO:0001764 | 7e-04 | 2.2197 | 14.408 | 27 | 100 | neuron migration |
GO:0021513 | 7e-04 | 4.5942 | 3.3138 | 10 | 23 | spinal cord dorsal/ventral patterning |
GO:0035115 | 7e-04 | 4.5942 | 3.3138 | 10 | 23 | embryonic forelimb morphogenesis |
GO:0055024 | 7e-04 | 3.5328 | 5.0428 | 13 | 35 | regulation of cardiac muscle tissue development |
GO:0021514 | 8e-04 | 5.9677 | 2.3053 | 8 | 16 | ventral spinal cord interneuron differentiation |
GO:0072078 | 8e-04 | 5.9677 | 2.3053 | 8 | 16 | nephron tubule morphogenesis |
GO:0010769 | 8e-04 | 1.8231 | 26.6549 | 43 | 185 | regulation of cell morphogenesis involved in differentiation |
GO:0035148 | 8e-04 | 2.1232 | 15.9929 | 29 | 111 | tube formation |
GO:0030902 | 8e-04 | 2.1546 | 15.2725 | 28 | 106 | hindbrain development |
GO:0051216 | 9e-04 | 2.0234 | 18.2982 | 32 | 127 | cartilage development |
GO:0019725 | 9e-04 | 1.5329 | 56.3354 | 79 | 391 | cellular homeostasis |
GO:0051252 | 9e-04 | 1.2256 | 348.098 | 396 | 2416 | regulation of RNA metabolic process |
GO:0009953 | 0.001 | 2.5999 | 9.0355 | 19 | 63 | dorsal/ventral pattern formation |
GO:0001838 | 0.001 | 2.16 | 14.6962 | 27 | 102 | embryonic epithelial tube formation |
GO:0015872 | 0.001 | 4.8843 | 2.8816 | 9 | 20 | dopamine transport |
GO:0032729 | 0.001 | 4.8843 | 2.8816 | 9 | 20 | positive regulation of interferon-gamma production |
GO:0003148 | 0.001 | 6.9592 | 1.873 | 7 | 13 | outflow tract septum morphogenesis |
GO:0021520 | 0.001 | 6.9592 | 1.873 | 7 | 13 | spinal cord motor neuron cell fate specification |
GO:0042423 | 0.001 | 6.9592 | 1.873 | 7 | 13 | catecholamine biosynthetic process |
GO:0044062 | 0.001 | 6.9592 | 1.873 | 7 | 13 | regulation of excretion |
GO:0021543 | 0.001 | 2.2378 | 13.2554 | 25 | 92 | pallium development |
GO:0035137 | 0.001 | 14.9586 | 1.0051 | 5 | 7 | hindlimb morphogenesis |
GO:0046427 | 0.0011 | 3.5855 | 4.6106 | 12 | 32 | positive regulation of JAK-STAT cascade |
GO:0050729 | 0.0011 | 3.5855 | 4.6106 | 12 | 32 | positive regulation of inflammatory response |
GO:0007519 | 0.0011 | 2.3687 | 11.1803 | 22 | 78 | skeletal muscle tissue development |
GO:0045777 | 0.0011 | 4.2656 | 3.4579 | 10 | 24 | positive regulation of blood pressure |
GO:0060795 | 0.0011 | 4.2656 | 3.4579 | 10 | 24 | cell fate commitment involved in formation of primary germ layer |
GO:0007613 | 0.0011 | 2.4957 | 9.7975 | 20 | 68 | memory |
GO:0055010 | 0.0011 | 3.8654 | 4.0342 | 11 | 28 | ventricular cardiac muscle tissue morphogenesis |
GO:0007501 | 0.0011 | 8.9434 | 1.4408 | 6 | 10 | mesodermal cell fate specification |
GO:0010665 | 0.0011 | 8.9434 | 1.4408 | 6 | 10 | regulation of cardiac muscle cell apoptotic process |
GO:0021521 | 0.0011 | 8.9434 | 1.4408 | 6 | 10 | ventral spinal cord interneuron specification |
GO:0001501 | 0.0011 | 2.0062 | 17.796 | 31 | 126 | skeletal system development |
GO:0007422 | 0.0012 | 2.6281 | 8.5007 | 18 | 59 | peripheral nervous system development |
GO:0019233 | 0.0012 | 3.1111 | 5.89 | 14 | 41 | sensory perception of pain |
GO:0001101 | 0.0012 | 1.7923 | 26.3667 | 42 | 183 | response to acid chemical |
GO:0060675 | 0.0012 | 2.8154 | 7.204 | 16 | 50 | ureteric bud morphogenesis |
GO:0030814 | 0.0012 | 2.5281 | 9.2211 | 19 | 64 | regulation of cAMP metabolic process |
GO:0050769 | 0.0013 | 2.0741 | 15.7048 | 28 | 109 | positive regulation of neurogenesis |
GO:0021871 | 0.0013 | 5.304 | 2.4494 | 8 | 17 | forebrain regionalization |
GO:0036342 | 0.0013 | 5.304 | 2.4494 | 8 | 17 | post-anal tail morphogenesis |
GO:0048708 | 0.0013 | 3.2377 | 5.331 | 13 | 37 | astrocyte differentiation |
GO:0009855 | 0.0013 | 2.3735 | 10.6619 | 21 | 74 | determination of bilateral symmetry |
GO:0045137 | 0.0013 | 1.8945 | 21.0357 | 35 | 146 | development of primary sexual characteristics |
GO:0045766 | 0.0014 | 2.6771 | 7.9244 | 17 | 55 | positive regulation of angiogenesis |
GO:0007626 | 0.0014 | 1.9088 | 20.3153 | 34 | 141 | locomotory behavior |
GO:0008038 | 0.0015 | 4.4768 | 3.0257 | 9 | 21 | neuron recognition |
GO:0008015 | 0.0015 | 2.4728 | 9.338 | 19 | 66 | blood circulation |
GO:0050805 | 0.0015 | 3.6503 | 4.1783 | 11 | 29 | negative regulation of synaptic transmission |
GO:0045471 | 0.0015 | 2.4728 | 9.3652 | 19 | 65 | response to ethanol |
GO:0021761 | 0.0015 | 3.0014 | 6.0307 | 14 | 42 | limbic system development |
GO:0045168 | 0.0015 | 3.9807 | 3.602 | 10 | 25 | cell-cell signaling involved in cell fate commitment |
GO:1901861 | 0.0016 | 2.2724 | 11.5264 | 22 | 80 | regulation of muscle tissue development |
GO:0001759 | 0.0017 | 5.9643 | 2.0171 | 7 | 14 | organ induction |
GO:0021854 | 0.0017 | 5.9643 | 2.0171 | 7 | 14 | hypothalamus development |
GO:0045907 | 0.0017 | 5.9643 | 2.0171 | 7 | 14 | positive regulation of vasoconstriction |
GO:0060581 | 0.0017 | 5.9643 | 2.0171 | 7 | 14 | cell fate commitment involved in pattern specification |
GO:0035914 | 0.0018 | 3.1078 | 5.4751 | 13 | 38 | skeletal muscle cell differentiation |
GO:0003158 | 0.0018 | 2.5053 | 8.7889 | 18 | 61 | endothelium development |
GO:0046887 | 0.0018 | 2.5053 | 8.7889 | 18 | 61 | positive regulation of hormone secretion |
GO:0003073 | 0.0018 | 2.8031 | 6.7718 | 15 | 47 | regulation of systemic arterial blood pressure |
GO:0032941 | 0.0018 | 2.8031 | 6.7718 | 15 | 47 | secretion by tissue |
GO:0007601 | 0.0019 | 2.0786 | 14.5521 | 26 | 101 | visual perception |
GO:0007270 | 0.0019 | 2.9127 | 6.1471 | 14 | 43 | neuron-neuron synaptic transmission |
GO:0003263 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | cardioblast proliferation |
GO:0021559 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | trigeminal nerve development |
GO:0031620 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | regulation of fever generation |
GO:0042756 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | drinking behavior |
GO:0042977 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | activation of JAK2 kinase activity |
GO:0048843 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | negative regulation of axon extension involved in axon guidance |
GO:0051956 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | negative regulation of amino acid transport |
GO:0060023 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | soft palate development |
GO:0060177 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | regulation of angiotensin metabolic process |
GO:0060406 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | positive regulation of penile erection |
GO:0072081 | 0.0019 | 23.8247 | 0.7204 | 4 | 5 | specification of nephron tubule identity |
GO:0015698 | 0.0019 | 2.3481 | 10.2297 | 20 | 71 | inorganic anion transport |
GO:0001569 | 0.0019 | 3.2588 | 4.8987 | 12 | 34 | patterning of blood vessels |
GO:0032411 | 0.0019 | 3.2588 | 4.8987 | 12 | 34 | positive regulation of transporter activity |
GO:0033002 | 0.0019 | 2.1874 | 12.3909 | 23 | 86 | muscle cell proliferation |
GO:0048634 | 0.0019 | 2.2337 | 11.6705 | 22 | 81 | regulation of muscle organ development |
GO:0048747 | 0.002 | 2.6584 | 7.4922 | 16 | 52 | muscle fiber development |
GO:0050803 | 0.002 | 2.8859 | 6.1955 | 14 | 43 | regulation of synapse structure and activity |
GO:0050794 | 0.002 | 1.2125 | 487.2251 | 531 | 3610 | regulation of cellular process |
GO:0072273 | 0.0021 | 4.7731 | 2.5934 | 8 | 18 | metanephric nephron morphogenesis |
GO:0007631 | 0.0021 | 3.0213 | 5.5665 | 13 | 39 | feeding behavior |
GO:0006590 | 0.0021 | 7.1539 | 1.5849 | 6 | 11 | thyroid hormone generation |
GO:0021903 | 0.0021 | 7.1539 | 1.5849 | 6 | 11 | rostrocaudal neural tube patterning |
GO:0032095 | 0.0021 | 7.1539 | 1.5849 | 6 | 11 | regulation of response to food |
GO:0035640 | 0.0021 | 7.1539 | 1.5849 | 6 | 11 | exploration behavior |
GO:0048935 | 0.0021 | 7.1539 | 1.5849 | 6 | 11 | peripheral nervous system neuron development |
GO:0021879 | 0.0021 | 4.1495 | 3.1584 | 9 | 22 | forebrain neuron differentiation |
GO:0044057 | 0.0021 | 1.7517 | 25.5183 | 40 | 179 | regulation of system process |
GO:0072089 | 0.0022 | 2.051 | 14.6962 | 26 | 102 | stem cell proliferation |
GO:0001974 | 0.0022 | 3.7315 | 3.7461 | 10 | 26 | blood vessel remodeling |
GO:0034220 | 0.0022 | 2.5117 | 8.2419 | 17 | 59 | ion transmembrane transport |
GO:0051241 | 0.0022 | 1.6865 | 29.6054 | 45 | 206 | negative regulation of multicellular organismal process |
GO:0097285 | 0.0022 | 1.5831 | 39.478 | 57 | 274 | cell-type specific apoptotic process |
GO:0050921 | 0.0023 | 2.7179 | 6.9159 | 15 | 48 | positive regulation of chemotaxis |
GO:0071300 | 0.0023 | 2.7179 | 6.9159 | 15 | 48 | cellular response to retinoic acid |
GO:0050731 | 0.0023 | 2.1962 | 11.8146 | 22 | 82 | positive regulation of peptidyl-tyrosine phosphorylation |
GO:0030198 | 0.0023 | 1.8573 | 20.1029 | 33 | 141 | extracellular matrix organization |
GO:0003337 | 0.0024 | 9.9315 | 1.1526 | 5 | 8 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010454 | 0.0024 | 9.9315 | 1.1526 | 5 | 8 | negative regulation of cell fate commitment |
GO:0048664 | 0.0024 | 9.9315 | 1.1526 | 5 | 8 | neuron fate determination |
GO:0072048 | 0.0024 | 9.9315 | 1.1526 | 5 | 8 | renal system pattern specification |
GO:0048732 | 0.0024 | 1.6135 | 35.4356 | 52 | 248 | gland development |
GO:1901342 | 0.0024 | 1.9986 | 15.5607 | 27 | 108 | regulation of vasculature development |
GO:0009914 | 0.0025 | 1.7235 | 26.5108 | 41 | 184 | hormone transport |
GO:0031326 | 0.0025 | 1.1955 | 386.2793 | 431 | 2681 | regulation of cellular biosynthetic process |
GO:0042310 | 0.0025 | 3.1294 | 5.0256 | 12 | 35 | vasoconstriction |
GO:0055001 | 0.0026 | 2.0524 | 14.1199 | 25 | 98 | muscle cell development |
GO:0043524 | 0.0026 | 2.0841 | 13.3995 | 24 | 93 | negative regulation of neuron apoptotic process |
GO:0030802 | 0.0027 | 2.3934 | 9.0771 | 18 | 63 | regulation of cyclic nucleotide biosynthetic process |
GO:0070887 | 0.0029 | 1.2454 | 205.0263 | 240 | 1423 | cellular response to chemical stimulus |
GO:0045761 | 0.003 | 2.8769 | 5.7632 | 13 | 40 | regulation of adenylate cyclase activity |
GO:0090189 | 0.003 | Inf | 0.4311 | 3 | 3 | regulation of branching involved in ureteric bud morphogenesis |
GO:0002118 | 0.003 | Inf | 0.4315 | 3 | 3 | aggressive behavior |
GO:0002125 | 0.003 | Inf | 0.4322 | 3 | 3 | maternal aggressive behavior |
GO:0010455 | 0.003 | Inf | 0.4322 | 3 | 3 | positive regulation of cell fate commitment |
GO:0031133 | 0.003 | Inf | 0.4322 | 3 | 3 | regulation of axon diameter |
GO:0033058 | 0.003 | Inf | 0.4322 | 3 | 3 | directional locomotion |
GO:0033563 | 0.003 | Inf | 0.4322 | 3 | 3 | dorsal/ventral axon guidance |
GO:0034374 | 0.003 | Inf | 0.4322 | 3 | 3 | low-density lipoprotein particle remodeling |
GO:0043301 | 0.003 | Inf | 0.4322 | 3 | 3 | negative regulation of leukocyte degranulation |
GO:0061364 | 0.003 | Inf | 0.4322 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0071670 | 0.003 | Inf | 0.4322 | 3 | 3 | smooth muscle cell chemotaxis |
GO:0072540 | 0.003 | Inf | 0.4322 | 3 | 3 | T-helper 17 cell lineage commitment |
GO:2000041 | 0.003 | Inf | 0.4322 | 3 | 3 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:0035282 | 0.003 | 4.3753 | 2.718 | 8 | 19 | segmentation |
GO:0030199 | 0.003 | 3.5116 | 3.8902 | 10 | 27 | collagen fibril organization |
GO:0051966 | 0.003 | 3.5116 | 3.8902 | 10 | 27 | regulation of synaptic transmission, glutamatergic |
GO:0090132 | 0.0031 | 1.9297 | 16.5692 | 28 | 115 | epithelium migration |
GO:0042886 | 0.0031 | 1.7228 | 25.2141 | 39 | 175 | amide transport |
GO:0010719 | 0.0031 | 4.3387 | 2.7375 | 8 | 19 | negative regulation of epithelial to mesenchymal transition |
GO:0021697 | 0.0031 | 4.3387 | 2.7375 | 8 | 19 | cerebellar cortex formation |
GO:0021884 | 0.0031 | 4.3387 | 2.7375 | 8 | 19 | forebrain neuron development |
GO:0046189 | 0.0031 | 4.3387 | 2.7375 | 8 | 19 | phenol-containing compound biosynthetic process |
GO:0060343 | 0.0031 | 4.3387 | 2.7375 | 8 | 19 | trabecula formation |
GO:0051924 | 0.0031 | 2.0873 | 12.8231 | 23 | 89 | regulation of calcium ion transport |
GO:0010470 | 0.0032 | 3.8364 | 3.3138 | 9 | 23 | regulation of gastrulation |
GO:0043542 | 0.0032 | 2.1248 | 12.1027 | 22 | 84 | endothelial cell migration |
GO:0021953 | 0.0034 | 2.6762 | 6.4977 | 14 | 46 | central nervous system neuron differentiation |
GO:0048869 | 0.0034 | 1.2898 | 138.1578 | 167 | 1038 | cellular developmental process |
GO:0021675 | 0.0035 | 2.562 | 7.204 | 15 | 50 | nerve development |
GO:0050728 | 0.0035 | 2.562 | 7.204 | 15 | 50 | negative regulation of inflammatory response |
GO:1902680 | 0.0036 | 1.2985 | 126.2143 | 154 | 876 | positive regulation of RNA biosynthetic process |
GO:0009187 | 0.0036 | 2.1396 | 11.486 | 21 | 80 | cyclic nucleotide metabolic process |
GO:0001946 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | lymphangiogenesis |
GO:0003215 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | cardiac right ventricle morphogenesis |
GO:0021542 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | dentate gyrus development |
GO:0048485 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | sympathetic nervous system development |
GO:0051930 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | regulation of sensory perception of pain |
GO:0060037 | 0.0037 | 5.9609 | 1.729 | 6 | 12 | pharyngeal system development |
GO:0030335 | 0.0038 | 1.6974 | 25.5022 | 39 | 177 | positive regulation of cell migration |
GO:2000736 | 0.0038 | 2.1763 | 10.806 | 20 | 75 | regulation of stem cell differentiation |
GO:1900371 | 0.0038 | 2.291 | 9.3652 | 18 | 65 | regulation of purine nucleotide biosynthetic process |
GO:0033993 | 0.0039 | 1.6589 | 27.9445 | 42 | 197 | response to lipid |
GO:0090087 | 0.0039 | 1.8229 | 19.1627 | 31 | 133 | regulation of peptide transport |
GO:0006939 | 0.0039 | 2.6289 | 6.5967 | 14 | 46 | smooth muscle contraction |
GO:0009891 | 0.0039 | 1.2728 | 148.5468 | 178 | 1031 | positive regulation of biosynthetic process |
GO:0072593 | 0.004 | 1.9707 | 14.5521 | 25 | 101 | reactive oxygen species metabolic process |
GO:0045595 | 0.0041 | 1.4241 | 61.132 | 81 | 438 | regulation of cell differentiation |
GO:0019218 | 0.0041 | 2.6144 | 6.6277 | 14 | 46 | regulation of steroid metabolic process |
GO:0048706 | 0.0041 | 3.6265 | 3.4204 | 9 | 24 | embryonic skeletal system development |
GO:0042509 | 0.0041 | 3.3161 | 4.0342 | 10 | 28 | regulation of tyrosine phosphorylation of STAT protein |
GO:0048754 | 0.0042 | 2.2077 | 10.1449 | 19 | 71 | branching morphogenesis of an epithelial tube |
GO:0033555 | 0.0042 | 3.6087 | 3.4347 | 9 | 24 | multicellular organismal response to stress |
GO:0055017 | 0.0043 | 2.8668 | 5.331 | 12 | 37 | cardiac muscle tissue growth |
GO:0030326 | 0.0043 | 2.3241 | 8.7453 | 17 | 61 | embryonic limb morphogenesis |
GO:0038084 | 0.0044 | 4.6378 | 2.3053 | 7 | 16 | vascular endothelial growth factor signaling pathway |
GO:0042517 | 0.0044 | 4.6378 | 2.3053 | 7 | 16 | positive regulation of tyrosine phosphorylation of Stat3 protein |
GO:0015837 | 0.0044 | 4 | 2.8673 | 8 | 20 | amine transport |
GO:0002042 | 0.0044 | 3.5802 | 3.4579 | 9 | 24 | cell migration involved in sprouting angiogenesis |
GO:0051963 | 0.0044 | 3.5802 | 3.4579 | 9 | 24 | regulation of synapse assembly |
GO:0007612 | 0.0044 | 2.0949 | 11.6705 | 21 | 81 | learning |
GO:0061053 | 0.0045 | 7.5104 | 1.2875 | 5 | 9 | somite development |
GO:0001945 | 0.0046 | 3.9766 | 2.8816 | 8 | 20 | lymph vessel development |
GO:0030800 | 0.0046 | 3.9766 | 2.8816 | 8 | 20 | negative regulation of cyclic nucleotide metabolic process |
GO:0048640 | 0.0046 | 3.9766 | 2.8816 | 8 | 20 | negative regulation of developmental growth |
GO:2000826 | 0.0046 | 3.9766 | 2.8816 | 8 | 20 | regulation of heart morphogenesis |
GO:0072028 | 0.0046 | 7.4802 | 1.2919 | 5 | 9 | nephron morphogenesis |
GO:0003156 | 0.0046 | 7.4776 | 1.2923 | 5 | 9 | regulation of organ formation |
GO:0090276 | 0.0046 | 1.8169 | 18.5864 | 30 | 129 | regulation of peptide hormone secretion |
GO:0048846 | 0.0046 | 7.4674 | 1.2938 | 5 | 9 | axon extension involved in axon guidance |
GO:0050905 | 0.0047 | 3.0066 | 4.7259 | 11 | 33 | neuromuscular process |
GO:0021707 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | cerebellar granule cell differentiation |
GO:0031649 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | heat generation |
GO:0033605 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | positive regulation of catecholamine secretion |
GO:0034104 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | negative regulation of tissue remodeling |
GO:0035815 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | positive regulation of renal sodium excretion |
GO:0043651 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | linoleic acid metabolic process |
GO:0048486 | 0.0047 | 7.4477 | 1.2967 | 5 | 9 | parasympathetic nervous system development |
GO:0007275 | 0.0047 | 1.5249 | 39.0175 | 55 | 326 | multicellular organismal development |
GO:0021587 | 0.0049 | 2.9852 | 4.7547 | 11 | 33 | cerebellum morphogenesis |
GO:0061326 | 0.0049 | 2.9852 | 4.7547 | 11 | 33 | renal tubule development |
GO:0018212 | 0.0049 | 1.6122 | 29.9687 | 44 | 208 | peptidyl-tyrosine modification |
GO:0021516 | 0.005 | 11.9779 | 0.8604 | 4 | 6 | dorsal spinal cord development |
GO:0044708 | 0.005 | 1.7826 | 19.4681 | 31 | 137 | single-organism behavior |
GO:0002016 | 0.005 | 11.911 | 0.8645 | 4 | 6 | regulation of blood volume by renin-angiotensin |
GO:0003266 | 0.005 | 11.911 | 0.8645 | 4 | 6 | regulation of secondary heart field cardioblast proliferation |
GO:0014048 | 0.005 | 11.911 | 0.8645 | 4 | 6 | regulation of glutamate secretion |
GO:0022601 | 0.005 | 11.911 | 0.8645 | 4 | 6 | menstrual cycle phase |
GO:0042178 | 0.005 | 11.911 | 0.8645 | 4 | 6 | xenobiotic catabolic process |
GO:0060456 | 0.005 | 11.911 | 0.8645 | 4 | 6 | positive regulation of digestive system process |
GO:2000047 | 0.005 | 11.911 | 0.8645 | 4 | 6 | regulation of cell-cell adhesion mediated by cadherin |
GO:0010646 | 0.0052 | 1.205 | 259.4886 | 295 | 1801 | regulation of cell communication |
GO:0023061 | 0.0053 | 1.682 | 24.3436 | 37 | 170 | signal release |
GO:0007589 | 0.0053 | 2.4229 | 7.4922 | 15 | 52 | body fluid secretion |
GO:0007272 | 0.0053 | 2.0994 | 11.0942 | 20 | 77 | ensheathment of neurons |
GO:0007492 | 0.0054 | 2.3328 | 8.2126 | 16 | 57 | endoderm development |
GO:0030819 | 0.0055 | 2.7562 | 5.4751 | 12 | 38 | positive regulation of cAMP biosynthetic process |
GO:0006954 | 0.0056 | 1.6161 | 28.5233 | 42 | 200 | inflammatory response |
GO:0048839 | 0.0056 | 2.3158 | 8.238 | 16 | 58 | inner ear development |
GO:0022414 | 0.0057 | 2.1784 | 9.6815 | 18 | 69 | reproductive process |
GO:0009880 | 0.0059 | 2.5884 | 6.1955 | 13 | 43 | embryonic pattern specification |
GO:0007498 | 0.006 | 2.8782 | 4.8653 | 11 | 34 | mesoderm development |
GO:0014014 | 0.006 | 3.3561 | 3.602 | 9 | 25 | negative regulation of gliogenesis |
GO:0032228 | 0.006 | 3.3561 | 3.602 | 9 | 25 | regulation of synaptic transmission, GABAergic |
GO:0023051 | 0.006 | 1.2008 | 259.2005 | 294 | 1799 | regulation of signaling |
GO:0007166 | 0.0061 | 1.2345 | 181.8873 | 212 | 1339 | cell surface receptor signaling pathway |
GO:0010658 | 0.0061 | 5.1088 | 1.873 | 6 | 13 | striated muscle cell apoptotic process |
GO:0042693 | 0.0061 | 5.1088 | 1.873 | 6 | 13 | muscle cell fate commitment |
GO:0060841 | 0.0061 | 5.1088 | 1.873 | 6 | 13 | venous blood vessel development |
GO:0072077 | 0.0061 | 5.1088 | 1.873 | 6 | 13 | renal vesicle morphogenesis |
GO:0006836 | 0.0062 | 4.2186 | 2.4271 | 7 | 17 | neurotransmitter transport |
GO:0048731 | 0.0063 | 1.3359 | 85.3182 | 107 | 694 | system development |
GO:0007189 | 0.0063 | 2.8551 | 4.8987 | 11 | 34 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0060042 | 0.0063 | 2.8551 | 4.8987 | 11 | 34 | retina morphogenesis in camera-type eye |
GO:0051272 | 0.0064 | 1.6226 | 27.0871 | 40 | 188 | positive regulation of cellular component movement |
GO:0021846 | 0.0065 | 3.6703 | 3.0257 | 8 | 21 | cell proliferation in forebrain |
GO:0035116 | 0.0065 | 3.6703 | 3.0257 | 8 | 21 | embryonic hindlimb morphogenesis |
GO:0060441 | 0.0065 | 3.6703 | 3.0257 | 8 | 21 | epithelial tube branching involved in lung morphogenesis |
GO:0007565 | 0.0065 | 1.9392 | 13.5435 | 23 | 94 | female pregnancy |
GO:0001708 | 0.0065 | 3.0343 | 4.2612 | 10 | 30 | cell fate specification |
GO:2000178 | 0.0066 | 4.1736 | 2.4494 | 7 | 17 | negative regulation of neural precursor cell proliferation |
GO:0001822 | 0.0066 | 2.093 | 10.5462 | 19 | 74 | kidney development |
GO:0050890 | 0.0066 | 1.6796 | 23.0528 | 35 | 160 | cognition |
GO:0001667 | 0.0069 | 1.7362 | 19.8748 | 31 | 139 | ameboidal cell migration |
GO:0007269 | 0.007 | 1.9945 | 12.1027 | 21 | 84 | neurotransmitter secretion |
GO:0016337 | 0.007 | 1.5731 | 30.545 | 44 | 212 | single organismal cell-cell adhesion |
GO:0051270 | 0.0071 | 1.5889 | 28.9011 | 42 | 203 | regulation of cellular component movement |
GO:0055013 | 0.0072 | 2.9838 | 4.3224 | 10 | 30 | cardiac muscle cell development |
GO:0040011 | 0.0072 | 1.5861 | 28.8925 | 42 | 210 | locomotion |
GO:0002793 | 0.0073 | 2.5046 | 6.3395 | 13 | 44 | positive regulation of peptide secretion |
GO:0031623 | 0.0073 | 2.5046 | 6.3395 | 13 | 44 | receptor internalization |
GO:0061371 | 0.0073 | 2.5046 | 6.3395 | 13 | 44 | determination of heart left/right asymmetry |
GO:0050679 | 0.0074 | 1.912 | 13.6876 | 23 | 95 | positive regulation of epithelial cell proliferation |
GO:0042552 | 0.0074 | 2.066 | 10.6619 | 19 | 74 | myelination |
GO:0043069 | 0.0074 | 1.3678 | 67.8618 | 87 | 471 | negative regulation of programmed cell death |
GO:0030334 | 0.0075 | 1.6764 | 22.4084 | 34 | 157 | regulation of cell migration |
GO:1901654 | 0.0076 | 2.1103 | 9.9415 | 18 | 69 | response to ketone |
GO:0072001 | 0.0077 | 6.0803 | 1.416 | 5 | 10 | renal system development |
GO:0008585 | 0.0077 | 2.1622 | 9.2211 | 17 | 64 | female gonad development |
GO:0031016 | 0.0077 | 2.2238 | 8.5007 | 16 | 59 | pancreas development |
GO:0051480 | 0.0078 | 6.0618 | 1.4196 | 5 | 10 | cytosolic calcium ion homeostasis |
GO:0051606 | 0.0078 | 1.7551 | 18.4423 | 29 | 128 | detection of stimulus |
GO:0035249 | 0.0079 | 3.1739 | 3.7304 | 9 | 26 | synaptic transmission, glutamatergic |
GO:0010975 | 0.008 | 1.5759 | 29.1042 | 42 | 202 | regulation of neuron projection development |
GO:0030534 | 0.008 | 1.8658 | 14.5521 | 24 | 101 | adult behavior |
GO:0003382 | 0.008 | 2.7358 | 5.0428 | 11 | 35 | epithelial cell morphogenesis |
GO:0010660 | 0.0081 | 3.1583 | 3.7461 | 9 | 26 | regulation of muscle cell apoptotic process |
GO:0031644 | 0.0081 | 3.1583 | 3.7461 | 9 | 26 | regulation of neurological system process |
GO:0044058 | 0.0081 | 5.9842 | 1.4353 | 5 | 10 | regulation of digestive system process |
GO:0051954 | 0.0082 | 5.9752 | 1.4372 | 5 | 10 | positive regulation of amine transport |
GO:1901700 | 0.0082 | 1.2946 | 101.4588 | 124 | 710 | response to oxygen-containing compound |
GO:0021683 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | cerebellar granular layer morphogenesis |
GO:0021794 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | thalamus development |
GO:0042136 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | neurotransmitter biosynthetic process |
GO:0046622 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | positive regulation of organ growth |
GO:0060259 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | regulation of feeding behavior |
GO:0060413 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | atrial septum morphogenesis |
GO:0071294 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | cellular response to zinc ion |
GO:0072112 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | glomerular visceral epithelial cell differentiation |
GO:2000310 | 0.0083 | 5.9575 | 1.4408 | 5 | 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0015672 | 0.0083 | 1.6754 | 21.7461 | 33 | 153 | monovalent inorganic cation transport |
GO:0060047 | 0.0084 | 1.8856 | 13.8317 | 23 | 96 | heart contraction |
GO:0021695 | 0.0086 | 2.5587 | 5.7632 | 12 | 40 | cerebellar cortex development |
GO:0042391 | 0.0088 | 1.7525 | 17.8056 | 28 | 125 | regulation of membrane potential |
GO:0060021 | 0.0089 | 2.1225 | 9.3442 | 17 | 65 | palate development |
GO:0007190 | 0.0089 | 3.4078 | 3.1698 | 8 | 22 | activation of adenylate cyclase activity |
GO:0045773 | 0.0089 | 3.4078 | 3.1698 | 8 | 22 | positive regulation of axon extension |
GO:0086004 | 0.0089 | 3.4078 | 3.1698 | 8 | 22 | regulation of cardiac muscle cell contraction |
GO:0000122 | 0.0089 | 1.3603 | 66.5651 | 85 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007215 | 0.009 | 2.8575 | 4.4452 | 10 | 31 | glutamate receptor signaling pathway |
GO:0002027 | 0.009 | 2.426 | 6.4836 | 13 | 45 | regulation of heart rate |
GO:1902476 | 0.009 | 2.426 | 6.4836 | 13 | 45 | chloride transmembrane transport |
GO:0048592 | 0.0091 | 1.8417 | 14.6962 | 24 | 102 | eye morphogenesis |
GO:0003279 | 0.0092 | 2.2404 | 7.9244 | 15 | 55 | cardiac septum development |
GO:0045807 | 0.0092 | 2.2404 | 7.9244 | 15 | 55 | positive regulation of endocytosis |
GO:0021522 | 0.0093 | 4.4881 | 2.0101 | 6 | 14 | spinal cord motor neuron differentiation |
GO:0010556 | 0.0093 | 1.1636 | 374.897 | 412 | 2602 | regulation of macromolecule biosynthetic process |
GO:0042744 | 0.0094 | 4.4697 | 2.0171 | 6 | 14 | hydrogen peroxide catabolic process |
GO:0072148 | 0.0094 | 4.4697 | 2.0171 | 6 | 14 | epithelial cell fate commitment |
GO:0090190 | 0.0094 | 4.4697 | 2.0171 | 6 | 14 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0030818 | 0.0094 | 3.7937 | 2.5934 | 7 | 18 | negative regulation of cAMP biosynthetic process |
GO:0031290 | 0.0094 | 3.7937 | 2.5934 | 7 | 18 | retinal ganglion cell axon guidance |
GO:0055078 | 0.0094 | 3.7937 | 2.5934 | 7 | 18 | sodium ion homeostasis |
GO:0051384 | 0.0096 | 1.9609 | 11.6705 | 20 | 81 | response to glucocorticoid |
GO:0042593 | 0.0098 | 1.7574 | 17.1456 | 27 | 119 | glucose homeostasis |
GO:0009719 | 0.01 | 1.2529 | 129.6723 | 154 | 900 | response to endogenous stimulus |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030574 | 0 | 7.5153 | 1.4709 | 9 | 47 | collagen catabolic process |
GO:0060443 | 0 | 8.8394 | 1.0015 | 7 | 32 | mammary gland morphogenesis |
GO:0006935 | 1e-04 | 2.4513 | 12.5497 | 28 | 401 | chemotaxis |
GO:1902476 | 1e-04 | 6.8394 | 1.4083 | 8 | 45 | chloride transmembrane transport |
GO:0044259 | 1e-04 | 5.0402 | 2.2846 | 10 | 73 | multicellular organismal macromolecule metabolic process |
GO:0098656 | 1e-04 | 4.1113 | 3.2861 | 12 | 105 | anion transmembrane transport |
GO:0001656 | 2e-04 | 5.0005 | 2.0655 | 9 | 66 | metanephros development |
GO:0050877 | 3e-04 | 2.0952 | 16.6182 | 32 | 531 | neurological system process |
GO:0050911 | 3e-04 | 46.8619 | 0.1565 | 3 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0030216 | 3e-04 | 5.2661 | 1.7526 | 8 | 56 | keratinocyte differentiation |
GO:0007155 | 3e-04 | 1.9807 | 19.7792 | 36 | 632 | cell adhesion |
GO:0072073 | 4e-04 | 3.7977 | 3.2235 | 11 | 103 | kidney epithelium development |
GO:0007399 | 4e-04 | 1.6591 | 44.065 | 66 | 1408 | nervous system development |
GO:0044707 | 4e-04 | 1.4928 | 110.3813 | 139 | 3598 | single-multicellular organism process |
GO:0035850 | 6e-04 | 8.7194 | 0.7198 | 5 | 23 | epithelial cell differentiation involved in kidney development |
GO:0007268 | 7e-04 | 2.0422 | 15.3351 | 29 | 490 | synaptic transmission |
GO:0048870 | 9e-04 | 1.8404 | 22.3454 | 38 | 714 | cell motility |
GO:0033594 | 0.001 | Inf | 0.0626 | 2 | 2 | response to hydroxyisoflavone |
GO:0051045 | 0.001 | Inf | 0.0626 | 2 | 2 | negative regulation of membrane protein ectodomain proteolysis |
GO:0060444 | 0.001 | 11.3862 | 0.4694 | 4 | 15 | branching involved in mammary gland duct morphogenesis |
GO:0007584 | 0.0012 | 3.4794 | 3.1609 | 10 | 101 | response to nutrient |
GO:0008544 | 0.0012 | 2.7521 | 5.5081 | 14 | 176 | epidermis development |
GO:0033598 | 0.0013 | 10.4363 | 0.5007 | 4 | 16 | mammary gland epithelial cell proliferation |
GO:0048856 | 0.0015 | 1.4345 | 96.1417 | 121 | 3072 | anatomical structure development |
GO:0032689 | 0.0015 | 18.739 | 0.2504 | 3 | 8 | negative regulation of interferon-gamma production |
GO:0072182 | 0.0015 | 18.739 | 0.2504 | 3 | 8 | regulation of nephron tubule epithelial cell differentiation |
GO:0015698 | 0.0016 | 4.0061 | 2.222 | 8 | 71 | inorganic anion transport |
GO:0048704 | 0.0016 | 4.0061 | 2.222 | 8 | 71 | embryonic skeletal system morphogenesis |
GO:0015711 | 0.0017 | 2.5563 | 6.3218 | 15 | 202 | organic anion transport |
GO:0071407 | 0.0023 | 2.5603 | 5.8807 | 14 | 189 | cellular response to organic cyclic compound |
GO:0001501 | 0.0024 | 2.1497 | 9.9522 | 20 | 318 | skeletal system development |
GO:0007411 | 0.0025 | 2.238 | 8.6064 | 18 | 275 | axon guidance |
GO:0072080 | 0.0025 | 6.0316 | 0.9702 | 5 | 31 | nephron tubule development |
GO:0048598 | 0.0026 | 1.9531 | 13.6764 | 25 | 437 | embryonic morphogenesis |
GO:0009887 | 0.0026 | 1.8001 | 19.028 | 32 | 608 | organ morphogenesis |
GO:0032571 | 0.0029 | 62.2911 | 0.0939 | 2 | 3 | response to vitamin K |
GO:0048699 | 0.003 | 1.6397 | 28.855 | 44 | 922 | generation of neurons |
GO:0071479 | 0.0034 | 5.5996 | 1.0328 | 5 | 33 | cellular response to ionizing radiation |
GO:0030198 | 0.0035 | 2.6477 | 4.8705 | 12 | 158 | extracellular matrix organization |
GO:0042267 | 0.0037 | 7.3631 | 0.6572 | 4 | 21 | natural killer cell mediated cytotoxicity |
GO:0050730 | 0.0038 | 2.9266 | 3.6929 | 10 | 118 | regulation of peptidyl-tyrosine phosphorylation |
GO:0040012 | 0.004 | 1.9692 | 11.8925 | 22 | 380 | regulation of locomotion |
GO:0030334 | 0.0041 | 2.0367 | 10.4529 | 20 | 334 | regulation of cell migration |
GO:0048568 | 0.0041 | 2.0785 | 9.7331 | 19 | 311 | embryonic organ development |
GO:0071295 | 0.0042 | 11.7083 | 0.3443 | 3 | 11 | cellular response to vitamin |
GO:0097094 | 0.0042 | 11.7083 | 0.3443 | 3 | 11 | craniofacial suture morphogenesis |
GO:0043542 | 0.0047 | 3.3165 | 2.6289 | 8 | 84 | endothelial cell migration |
GO:0042060 | 0.0047 | 1.9102 | 12.8001 | 23 | 409 | wound healing |
GO:0097306 | 0.0049 | 4.1872 | 1.5961 | 6 | 51 | cellular response to alcohol |
GO:0001906 | 0.0049 | 5.0562 | 1.1267 | 5 | 36 | cell killing |
GO:0097035 | 0.0052 | 6.5867 | 0.7198 | 4 | 23 | regulation of membrane lipid distribution |
GO:2000107 | 0.0052 | 6.5867 | 0.7198 | 4 | 23 | negative regulation of leukocyte apoptotic process |
GO:0050953 | 0.0052 | 2.9887 | 3.2548 | 9 | 104 | sensory perception of light stimulus |
GO:0048812 | 0.0052 | 1.8409 | 14.4275 | 25 | 461 | neuron projection morphogenesis |
GO:0010837 | 0.0054 | 10.4063 | 0.3756 | 3 | 12 | regulation of keratinocyte proliferation |
GO:0035457 | 0.0056 | 31.1424 | 0.1252 | 2 | 4 | cellular response to interferon-alpha |
GO:0060364 | 0.0056 | 31.1424 | 0.1252 | 2 | 4 | frontal suture morphogenesis |
GO:0072086 | 0.0056 | 31.1424 | 0.1252 | 2 | 4 | specification of loop of Henle identity |
GO:0072602 | 0.0056 | 31.1424 | 0.1252 | 2 | 4 | interleukin-4 secretion |
GO:0030154 | 0.0057 | 1.4022 | 68.7889 | 88 | 2198 | cell differentiation |
GO:0050714 | 0.006 | 4.0082 | 1.6587 | 6 | 53 | positive regulation of protein secretion |
GO:0042391 | 0.0065 | 2.1857 | 7.292 | 15 | 233 | regulation of membrane potential |
GO:0048666 | 0.0065 | 1.6678 | 21.031 | 33 | 672 | neuron development |
GO:0016337 | 0.0068 | 2.2433 | 6.6348 | 14 | 212 | single organismal cell-cell adhesion |
GO:0007610 | 0.0068 | 1.8454 | 13.207 | 23 | 422 | behavior |
GO:0016338 | 0.0069 | 9.3648 | 0.4068 | 3 | 13 | calcium-independent cell-cell adhesion |
GO:0045332 | 0.0069 | 9.3648 | 0.4068 | 3 | 13 | phospholipid translocation |
GO:0022617 | 0.0071 | 3.3859 | 2.2533 | 7 | 72 | extracellular matrix disassembly |
GO:0030856 | 0.0071 | 3.3859 | 2.2533 | 7 | 72 | regulation of epithelial cell differentiation |
GO:0072001 | 0.0073 | 2.3012 | 6.0089 | 13 | 192 | renal system development |
GO:0035239 | 0.0074 | 2.093 | 8.1057 | 16 | 259 | tube morphogenesis |
GO:0010633 | 0.0082 | 5.6867 | 0.8137 | 4 | 26 | negative regulation of epithelial cell migration |
GO:0001944 | 0.0082 | 1.8679 | 11.8925 | 21 | 380 | vasculature development |
GO:0051239 | 0.0083 | 1.4556 | 43.5329 | 59 | 1391 | regulation of multicellular organismal process |
GO:0060644 | 0.0086 | 8.5126 | 0.4381 | 3 | 14 | mammary gland epithelial cell differentiation |
GO:0001706 | 0.0087 | 4.3517 | 1.2831 | 5 | 41 | endoderm formation |
GO:0045669 | 0.0087 | 4.3517 | 1.2831 | 5 | 41 | positive regulation of osteoblast differentiation |
GO:0050707 | 0.0087 | 4.3517 | 1.2831 | 5 | 41 | regulation of cytokine secretion |
GO:0001763 | 0.009 | 2.4305 | 4.8196 | 11 | 154 | morphogenesis of a branching structure |
GO:0061564 | 0.0091 | 1.8209 | 12.7688 | 22 | 408 | axon development |
GO:0071321 | 0.0092 | 20.7595 | 0.1565 | 2 | 5 | cellular response to cGMP |
GO:0072047 | 0.0092 | 20.7595 | 0.1565 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0021795 | 0.0094 | 5.4389 | 0.845 | 4 | 27 | cerebral cortex cell migration |
GO:0002009 | 0.0095 | 1.942 | 9.7957 | 18 | 313 | morphogenesis of an epithelium |
GO:0090132 | 0.0099 | 2.6755 | 3.5991 | 9 | 115 | epithelium migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 0.001 | 2538.75 | 0.001 | 1 | 2 | oocyte construction |
GO:0007314 | 0.001 | 2538.75 | 0.001 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.001 | 2538.75 | 0.001 | 1 | 2 | P granule organization |
GO:2000852 | 0.001 | 2538.75 | 0.001 | 1 | 2 | regulation of corticosterone secretion |
GO:0035933 | 0.0025 | 634.5 | 0.0025 | 1 | 5 | glucocorticoid secretion |
GO:2000846 | 0.0029 | 507.55 | 0.003 | 1 | 6 | regulation of corticosteroid hormone secretion |
GO:0007028 | 0.0034 | 422.9167 | 0.0034 | 1 | 7 | cytoplasm organization |
GO:0031507 | 0.0034 | 422.9167 | 0.0034 | 1 | 7 | heterochromatin assembly |
GO:0006655 | 0.0039 | 362.4643 | 0.0039 | 1 | 8 | phosphatidylglycerol biosynthetic process |
GO:0034587 | 0.0039 | 362.4643 | 0.0039 | 1 | 8 | piRNA metabolic process |
GO:0043046 | 0.0049 | 281.8611 | 0.0049 | 1 | 10 | DNA methylation involved in gamete generation |
GO:0007350 | 0.0054 | 253.65 | 0.0054 | 1 | 11 | blastoderm segmentation |
GO:0008595 | 0.0054 | 253.65 | 0.0054 | 1 | 11 | anterior/posterior axis specification, embryo |
GO:0032098 | 0.0054 | 253.65 | 0.0054 | 1 | 11 | regulation of appetite |
GO:0035929 | 0.0054 | 253.65 | 0.0054 | 1 | 11 | steroid hormone secretion |
GO:0008053 | 0.0083 | 158.4375 | 0.0084 | 1 | 17 | mitochondrial fusion |
GO:0016486 | 0.0083 | 158.4375 | 0.0084 | 1 | 17 | peptide hormone processing |
GO:0032720 | 0.0093 | 140.8056 | 0.0093 | 1 | 19 | negative regulation of tumor necrosis factor production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007266 | 1e-04 | 22.6847 | 0.2098 | 4 | 52 | Rho protein signal transduction |
GO:0009410 | 2e-04 | 15.9809 | 0.2905 | 4 | 72 | response to xenobiotic stimulus |
GO:0044282 | 7e-04 | 7.939 | 0.7223 | 5 | 179 | small molecule catabolic process |
GO:0032879 | 9e-04 | 3.3341 | 5.0438 | 13 | 1250 | regulation of localization |
GO:0040017 | 0.001 | 7.3775 | 0.7747 | 5 | 192 | positive regulation of locomotion |
GO:0006641 | 0.002 | 13.4625 | 0.2502 | 3 | 62 | triglyceride metabolic process |
GO:0006638 | 0.0024 | 12.4046 | 0.2703 | 3 | 67 | neutral lipid metabolic process |
GO:0046395 | 0.0025 | 7.7628 | 0.577 | 4 | 143 | carboxylic acid catabolic process |
GO:0006805 | 0.0025 | 12.2126 | 0.2744 | 3 | 68 | xenobiotic metabolic process |
GO:0010823 | 0.0032 | 27.2632 | 0.0847 | 2 | 21 | negative regulation of mitochondrion organization |
GO:0010124 | 0.004 | Inf | 0.004 | 1 | 1 | phenylacetate catabolic process |
GO:0010730 | 0.004 | Inf | 0.004 | 1 | 1 | negative regulation of hydrogen peroxide biosynthetic process |
GO:0035623 | 0.004 | Inf | 0.004 | 1 | 1 | renal glucose absorption |
GO:0046226 | 0.004 | Inf | 0.004 | 1 | 1 | coumarin catabolic process |
GO:0060468 | 0.004 | Inf | 0.004 | 1 | 1 | prevention of polyspermy |
GO:0070593 | 0.004 | Inf | 0.004 | 1 | 1 | dendrite self-avoidance |
GO:0071673 | 0.004 | Inf | 0.004 | 1 | 1 | positive regulation of smooth muscle cell chemotaxis |
GO:1900128 | 0.004 | Inf | 0.004 | 1 | 1 | regulation of G-protein activated inward rectifier potassium channel activity |
GO:1902905 | 0.004 | Inf | 0.004 | 1 | 1 | positive regulation of fibril organization |
GO:0006796 | 0.0048 | 2.4317 | 10.015 | 18 | 2482 | phosphate-containing compound metabolic process |
GO:0051128 | 0.0051 | 2.8572 | 4.6887 | 11 | 1162 | regulation of cellular component organization |
GO:0030335 | 0.0055 | 6.2159 | 0.7142 | 4 | 177 | positive regulation of cell migration |
GO:0042743 | 0.0056 | 19.9093 | 0.113 | 2 | 28 | hydrogen peroxide metabolic process |
GO:0043436 | 0.0057 | 3.3496 | 2.7882 | 8 | 691 | oxoacid metabolic process |
GO:0001885 | 0.0064 | 18.4835 | 0.1211 | 2 | 30 | endothelial cell development |
GO:0051272 | 0.0067 | 5.8378 | 0.7586 | 4 | 188 | positive regulation of cellular component movement |
GO:0009609 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | response to symbiotic bacterium |
GO:0032803 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | regulation of low-density lipoprotein particle receptor catabolic process |
GO:1903426 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | regulation of reactive oxygen species biosynthetic process |
GO:2000360 | 0.0081 | 252.975 | 0.0081 | 1 | 2 | negative regulation of binding of sperm to zona pellucida |
GO:0016358 | 0.0084 | 7.8314 | 0.4196 | 3 | 104 | dendrite development |
GO:0042632 | 0.0092 | 15.2127 | 0.1453 | 2 | 36 | cholesterol homeostasis |
GO:0046486 | 0.0097 | 5.2287 | 0.8433 | 4 | 209 | glycerolipid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007207 | 2e-04 | Inf | 0.0262 | 2 | 2 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway |
GO:0035902 | 2e-04 | Inf | 0.0262 | 2 | 2 | response to immobilization stress |
GO:0051901 | 2e-04 | Inf | 0.0262 | 2 | 2 | positive regulation of mitochondrial depolarization |
GO:0030309 | 5e-04 | 153.084 | 0.0393 | 2 | 3 | poly-N-acetyllactosamine metabolic process |
GO:0051223 | 7e-04 | 3.7284 | 2.932 | 10 | 224 | regulation of protein transport |
GO:1901570 | 8e-04 | 11.0742 | 0.4189 | 4 | 32 | fatty acid derivative biosynthetic process |
GO:0050865 | 8e-04 | 3.6585 | 2.9844 | 10 | 228 | regulation of cell activation |
GO:0070885 | 0.001 | 76.5344 | 0.0524 | 2 | 4 | negative regulation of calcineurin-NFAT signaling cascade |
GO:0032880 | 0.0015 | 2.9703 | 4.398 | 12 | 336 | regulation of protein localization |
GO:0050870 | 0.0015 | 5.2759 | 1.2435 | 6 | 95 | positive regulation of T cell activation |
GO:0002579 | 0.0017 | 51.0178 | 0.0654 | 2 | 5 | positive regulation of antigen processing and presentation |
GO:2001300 | 0.0017 | 51.0178 | 0.0654 | 2 | 5 | lipoxin metabolic process |
GO:0060333 | 0.0018 | 8.6064 | 0.5236 | 4 | 40 | interferon-gamma-mediated signaling pathway |
GO:0071345 | 0.0018 | 3.0602 | 3.9006 | 11 | 298 | cellular response to cytokine stimulus |
GO:0046457 | 0.0021 | 13.5896 | 0.2618 | 3 | 20 | prostanoid biosynthetic process |
GO:0019752 | 0.0024 | 2.3359 | 7.9714 | 17 | 609 | carboxylic acid metabolic process |
GO:0022617 | 0.0025 | 5.8075 | 0.9424 | 5 | 72 | extracellular matrix disassembly |
GO:0051249 | 0.0031 | 3.5214 | 2.4477 | 8 | 187 | regulation of lymphocyte activation |
GO:0050896 | 0.0035 | 1.6294 | 60.0666 | 76 | 4589 | response to stimulus |
GO:0071706 | 0.0035 | 7.0359 | 0.6283 | 4 | 48 | tumor necrosis factor superfamily cytokine production |
GO:0006954 | 0.0035 | 2.9608 | 3.6388 | 10 | 278 | inflammatory response |
GO:0006693 | 0.0036 | 10.9967 | 0.3141 | 3 | 24 | prostaglandin metabolic process |
GO:0002792 | 0.0041 | 10.4958 | 0.3272 | 3 | 25 | negative regulation of peptide secretion |
GO:0007205 | 0.0041 | 10.4958 | 0.3272 | 3 | 25 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0006082 | 0.0042 | 2.1517 | 9.1363 | 18 | 698 | organic acid metabolic process |
GO:0090316 | 0.0043 | 5.0482 | 1.0733 | 5 | 82 | positive regulation of intracellular protein transport |
GO:0060341 | 0.0045 | 2.2441 | 7.7488 | 16 | 592 | regulation of cellular localization |
GO:0061436 | 0.0045 | 25.5013 | 0.1047 | 2 | 8 | establishment of skin barrier |
GO:0071257 | 0.0045 | 25.5013 | 0.1047 | 2 | 8 | cellular response to electrical stimulus |
GO:0006694 | 0.0053 | 4.797 | 1.1257 | 5 | 86 | steroid biosynthetic process |
GO:0051050 | 0.0054 | 2.5111 | 5.1441 | 12 | 393 | positive regulation of transport |
GO:0071900 | 0.0054 | 2.7693 | 3.8744 | 10 | 296 | regulation of protein serine/threonine kinase activity |
GO:0019883 | 0.0058 | 21.8561 | 0.1178 | 2 | 9 | antigen processing and presentation of endogenous antigen |
GO:0031581 | 0.0058 | 21.8561 | 0.1178 | 2 | 9 | hemidesmosome assembly |
GO:0060707 | 0.0058 | 21.8561 | 0.1178 | 2 | 9 | trophoblast giant cell differentiation |
GO:2000406 | 0.0058 | 21.8561 | 0.1178 | 2 | 9 | positive regulation of T cell migration |
GO:0007186 | 0.0059 | 2.4809 | 5.2072 | 12 | 406 | G-protein coupled receptor signaling pathway |
GO:0072330 | 0.0059 | 3.934 | 1.6362 | 6 | 125 | monocarboxylic acid biosynthetic process |
GO:0034341 | 0.0065 | 5.8359 | 0.7461 | 4 | 57 | response to interferon-gamma |
GO:0051241 | 0.0072 | 3.0364 | 2.8142 | 8 | 215 | negative regulation of multicellular organismal process |
GO:0042445 | 0.0074 | 4.4123 | 1.2173 | 5 | 93 | hormone metabolic process |
GO:0044708 | 0.0076 | 2.7929 | 3.4425 | 9 | 263 | single-organism behavior |
GO:0032103 | 0.0081 | 4.3134 | 1.2435 | 5 | 95 | positive regulation of response to external stimulus |
GO:0007586 | 0.0082 | 5.4242 | 0.7984 | 4 | 61 | digestion |
GO:0050671 | 0.0082 | 5.4242 | 0.7984 | 4 | 61 | positive regulation of lymphocyte proliferation |
GO:0002696 | 0.0082 | 3.654 | 1.754 | 6 | 134 | positive regulation of leukocyte activation |
GO:0008544 | 0.0083 | 3.241 | 2.3037 | 7 | 176 | epidermis development |
GO:0006590 | 0.0087 | 16.9958 | 0.144 | 2 | 11 | thyroid hormone generation |
GO:0019371 | 0.0087 | 16.9958 | 0.144 | 2 | 11 | cyclooxygenase pathway |
GO:0032095 | 0.0087 | 16.9958 | 0.144 | 2 | 11 | regulation of response to food |
GO:0032098 | 0.0087 | 16.9958 | 0.144 | 2 | 11 | regulation of appetite |
GO:0070665 | 0.0092 | 5.2393 | 0.8246 | 4 | 63 | positive regulation of leukocyte proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001207 | 0.0021 | Inf | 0.0021 | 1 | 1 | histone displacement |
GO:0051039 | 0.0021 | Inf | 0.0021 | 1 | 1 | positive regulation of transcription during meiosis |
GO:0010845 | 0.0041 | 506.95 | 0.0041 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
GO:0006311 | 0.0062 | 253.45 | 0.0062 | 1 | 3 | meiotic gene conversion |
GO:0007597 | 0.0062 | 253.45 | 0.0062 | 1 | 3 | blood coagulation, intrinsic pathway |
GO:0046951 | 0.0062 | 253.45 | 0.0062 | 1 | 3 | ketone body biosynthetic process |
GO:0051024 | 0.0062 | 253.45 | 0.0062 | 1 | 3 | positive regulation of immunoglobulin secretion |
GO:0071670 | 0.0062 | 253.45 | 0.0062 | 1 | 3 | smooth muscle cell chemotaxis |
GO:0006642 | 0.0082 | 168.95 | 0.0083 | 1 | 4 | triglyceride mobilization |
GO:0060903 | 0.0082 | 168.95 | 0.0083 | 1 | 4 | positive regulation of meiosis I |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.587 | 37.3636 | 60 | 3874 | multicellular organismal process |
GO:0007389 | 0 | 4.6868 | 3.1924 | 13 | 331 | pattern specification process |
GO:0030326 | 0 | 8.8205 | 0.9066 | 7 | 94 | embryonic limb morphogenesis |
GO:0045165 | 1e-04 | 5.8813 | 1.7281 | 9 | 181 | cell fate commitment |
GO:0035107 | 1e-04 | 7.5121 | 1.0513 | 7 | 109 | appendage morphogenesis |
GO:0048665 | 1e-04 | 18.5754 | 0.2604 | 4 | 27 | neuron fate specification |
GO:0030878 | 1e-04 | 39.6908 | 0.1061 | 3 | 11 | thyroid gland development |
GO:0060173 | 2e-04 | 6.4831 | 1.2056 | 7 | 125 | limb development |
GO:0048562 | 3e-04 | 4.7217 | 2.1218 | 9 | 220 | embryonic organ morphogenesis |
GO:0051252 | 3e-04 | 2.1374 | 23.3016 | 39 | 2416 | regulation of RNA metabolic process |
GO:0001764 | 4e-04 | 6.9165 | 0.9645 | 6 | 100 | neuron migration |
GO:1901362 | 5e-04 | 2.032 | 27.3814 | 43 | 2839 | organic cyclic compound biosynthetic process |
GO:0010656 | 5e-04 | 22.6669 | 0.164 | 3 | 17 | negative regulation of muscle cell apoptotic process |
GO:0021871 | 5e-04 | 22.6669 | 0.164 | 3 | 17 | forebrain regionalization |
GO:0048705 | 7e-04 | 5.1533 | 1.4949 | 7 | 155 | skeletal system morphogenesis |
GO:0060284 | 8e-04 | 3.094 | 4.697 | 13 | 487 | regulation of cell development |
GO:0044271 | 8e-04 | 1.9815 | 27.0534 | 42 | 2805 | cellular nitrogen compound biosynthetic process |
GO:0048598 | 8e-04 | 5.9777 | 1.1087 | 6 | 127 | embryonic morphogenesis |
GO:0045597 | 0.001 | 3.1721 | 4.2051 | 12 | 436 | positive regulation of cell differentiation |
GO:0050793 | 0.001 | 2.2866 | 11.699 | 23 | 1213 | regulation of developmental process |
GO:0035295 | 0.0011 | 3.1183 | 4.2726 | 12 | 443 | tube development |
GO:0032774 | 0.0011 | 1.968 | 23.9961 | 38 | 2488 | RNA biosynthetic process |
GO:0019438 | 0.0012 | 1.9389 | 26.658 | 41 | 2764 | aromatic compound biosynthetic process |
GO:0018130 | 0.0012 | 1.9331 | 26.7159 | 41 | 2770 | heterocycle biosynthetic process |
GO:0007275 | 0.0013 | 2.1047 | 19.4796 | 32 | 2389 | multicellular organismal development |
GO:0046620 | 0.0014 | 9.0684 | 0.4919 | 4 | 51 | regulation of organ growth |
GO:0060561 | 0.0015 | 15.1008 | 0.2315 | 3 | 24 | apoptotic process involved in morphogenesis |
GO:0000122 | 0.0016 | 2.9808 | 4.4559 | 12 | 462 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007420 | 0.0016 | 2.9808 | 4.4559 | 12 | 462 | brain development |
GO:0010667 | 0.0019 | 41.9083 | 0.0675 | 2 | 7 | negative regulation of cardiac muscle cell apoptotic process |
GO:0032502 | 0.0024 | 2.0434 | 18.5468 | 30 | 2213 | developmental process |
GO:0051960 | 0.0025 | 2.9618 | 4.0797 | 11 | 423 | regulation of nervous system development |
GO:0010556 | 0.0027 | 1.8523 | 25.0956 | 38 | 2602 | regulation of macromolecule biosynthetic process |
GO:0048514 | 0.0028 | 3.3137 | 2.9609 | 9 | 307 | blood vessel morphogenesis |
GO:0048513 | 0.003 | 2.1064 | 12.7949 | 23 | 1443 | organ development |
GO:0001701 | 0.0036 | 3.4607 | 2.5076 | 8 | 260 | in utero embryonic development |
GO:0007501 | 0.0039 | 26.1849 | 0.0964 | 2 | 10 | mesodermal cell fate specification |
GO:0035148 | 0.0043 | 5.0502 | 1.0706 | 5 | 111 | tube formation |
GO:0030307 | 0.0046 | 6.4455 | 0.6751 | 4 | 70 | positive regulation of cell growth |
GO:0031327 | 0.0051 | 2.241 | 7.928 | 16 | 822 | negative regulation of cellular biosynthetic process |
GO:0010662 | 0.0057 | 20.9438 | 0.1157 | 2 | 12 | regulation of striated muscle cell apoptotic process |
GO:2000736 | 0.0059 | 5.9886 | 0.7234 | 4 | 75 | regulation of stem cell differentiation |
GO:0010629 | 0.0064 | 2.2376 | 7.3975 | 15 | 767 | negative regulation of gene expression |
GO:0045893 | 0.0066 | 2.1734 | 8.1498 | 16 | 845 | positive regulation of transcription, DNA-templated |
GO:0003148 | 0.0067 | 19.0379 | 0.1254 | 2 | 13 | outflow tract septum morphogenesis |
GO:0090101 | 0.0067 | 5.7441 | 0.7523 | 4 | 78 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0008284 | 0.0069 | 2.5578 | 4.6777 | 11 | 485 | positive regulation of cell proliferation |
GO:0042472 | 0.007 | 5.667 | 0.7619 | 4 | 79 | inner ear morphogenesis |
GO:0021879 | 0.0071 | 8.331 | 0.3954 | 3 | 41 | forebrain neuron differentiation |
GO:0007417 | 0.0077 | 4.3666 | 1.2325 | 5 | 139 | central nervous system development |
GO:0002052 | 0.0078 | 17.4497 | 0.135 | 2 | 14 | positive regulation of neuroblast proliferation |
GO:0007369 | 0.0078 | 4.3448 | 1.2345 | 5 | 128 | gastrulation |
GO:0051321 | 0.0078 | 4.3448 | 1.2345 | 5 | 128 | meiotic cell cycle |
GO:0007167 | 0.0079 | 2.2431 | 6.8478 | 14 | 710 | enzyme linked receptor protein signaling pathway |
GO:0006355 | 0.0082 | 1.9413 | 13.1063 | 22 | 1489 | regulation of transcription, DNA-templated |
GO:0043009 | 0.0086 | 3.6364 | 1.7725 | 6 | 195 | chordate embryonic development |
GO:0051172 | 0.0086 | 2.1598 | 7.6386 | 15 | 792 | negative regulation of nitrogen compound metabolic process |
GO:0001841 | 0.0091 | 5.244 | 0.8198 | 4 | 85 | neural tube formation |
GO:0009953 | 0.0095 | 5.1796 | 0.8294 | 4 | 86 | dorsal/ventral pattern formation |
GO:0001827 | 0.0096 | Inf | 0.0096 | 1 | 1 | inner cell mass cell fate commitment |
GO:0003168 | 0.0096 | Inf | 0.0096 | 1 | 1 | Purkinje myocyte differentiation |
GO:0003342 | 0.0096 | Inf | 0.0096 | 1 | 1 | proepicardium development |
GO:0003350 | 0.0096 | Inf | 0.0096 | 1 | 1 | pulmonary myocardium development |
GO:0021633 | 0.0096 | Inf | 0.0096 | 1 | 1 | optic nerve structural organization |
GO:0021759 | 0.0096 | Inf | 0.0096 | 1 | 1 | globus pallidus development |
GO:0034972 | 0.0096 | Inf | 0.0096 | 1 | 1 | histone H3-R26 methylation |
GO:0035566 | 0.0096 | Inf | 0.0096 | 1 | 1 | regulation of metanephros size |
GO:0042696 | 0.0096 | Inf | 0.0096 | 1 | 1 | menarche |
GO:0051308 | 0.0096 | Inf | 0.0096 | 1 | 1 | male meiosis chromosome separation |
GO:0055014 | 0.0096 | Inf | 0.0096 | 1 | 1 | atrial cardiac muscle cell development |
GO:0060929 | 0.0096 | Inf | 0.0096 | 1 | 1 | atrioventricular node cell fate commitment |
GO:0061185 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of dermatome development |
GO:0061360 | 0.0096 | Inf | 0.0096 | 1 | 1 | optic chiasma development |
GO:1901751 | 0.0096 | Inf | 0.0096 | 1 | 1 | leukotriene A4 metabolic process |
GO:2000597 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of optic nerve formation |
GO:2001303 | 0.0096 | Inf | 0.0096 | 1 | 1 | lipoxin A4 biosynthetic process |
GO:2001306 | 0.0096 | Inf | 0.0096 | 1 | 1 | lipoxin B4 biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 1.8705 | 268.4082 | 369 | 3874 | multicellular organismal process |
GO:0007275 | 0 | 1.7617 | 99.8539 | 150 | 1585 | multicellular organismal development |
GO:0050727 | 0 | 3.2254 | 8.3834 | 23 | 121 | regulation of inflammatory response |
GO:0043583 | 0 | 2.8392 | 10.947 | 27 | 158 | ear development |
GO:0018958 | 0 | 4.7767 | 3.7414 | 14 | 54 | phenol-containing compound metabolic process |
GO:0007155 | 0 | 1.81 | 43.7878 | 72 | 632 | cell adhesion |
GO:2000026 | 0 | 1.7267 | 53.5281 | 84 | 785 | regulation of multicellular organismal development |
GO:0009790 | 0 | 1.7386 | 51.2013 | 81 | 739 | embryo development |
GO:0030154 | 0 | 1.5117 | 112.9885 | 153 | 1717 | cell differentiation |
GO:0002003 | 0 | Inf | 0.2771 | 4 | 4 | angiotensin maturation |
GO:0048513 | 0 | 1.696 | 56.6925 | 87 | 876 | organ development |
GO:0048562 | 0 | 2.7987 | 10.2336 | 25 | 149 | embryonic organ morphogenesis |
GO:0007399 | 0 | 1.5253 | 97.5526 | 135 | 1408 | nervous system development |
GO:0009605 | 0 | 1.7283 | 49.563 | 78 | 742 | response to external stimulus |
GO:0045596 | 0 | 2.0165 | 25.7046 | 47 | 371 | negative regulation of cell differentiation |
GO:0006954 | 1e-04 | 2.6639 | 10.6491 | 25 | 157 | inflammatory response |
GO:0070663 | 1e-04 | 3.2823 | 6.4435 | 18 | 93 | regulation of leukocyte proliferation |
GO:0001990 | 1e-04 | 7.7529 | 1.5243 | 8 | 22 | regulation of systemic arterial blood pressure by hormone |
GO:0050778 | 1e-04 | 2.1429 | 18.5683 | 36 | 268 | positive regulation of immune response |
GO:0060177 | 1e-04 | 54.0343 | 0.3464 | 4 | 5 | regulation of angiotensin metabolic process |
GO:2000609 | 1e-04 | 54.0343 | 0.3464 | 4 | 5 | regulation of thyroid hormone generation |
GO:0050670 | 1e-04 | 3.2255 | 6.1663 | 17 | 89 | regulation of lymphocyte proliferation |
GO:0051094 | 1e-04 | 1.7328 | 40.185 | 64 | 580 | positive regulation of developmental process |
GO:0006935 | 1e-04 | 1.8871 | 27.7831 | 48 | 401 | chemotaxis |
GO:1903036 | 2e-04 | 4.5329 | 3.0485 | 11 | 44 | positive regulation of response to wounding |
GO:0009611 | 2e-04 | 1.76 | 35.8212 | 58 | 523 | response to wounding |
GO:0048699 | 2e-04 | 1.5625 | 63.8803 | 92 | 922 | generation of neurons |
GO:0032502 | 2e-04 | 1.4794 | 98.6692 | 131 | 1608 | developmental process |
GO:0023052 | 2e-04 | 1.3374 | 235.9831 | 280 | 3406 | signaling |
GO:0042445 | 2e-04 | 3.0544 | 6.4435 | 17 | 93 | hormone metabolic process |
GO:0048665 | 2e-04 | 10.2017 | 0.9657 | 6 | 14 | neuron fate specification |
GO:0021527 | 2e-04 | 10.1529 | 0.97 | 6 | 14 | spinal cord association neuron differentiation |
GO:0032946 | 2e-04 | 3.6878 | 4.2264 | 13 | 61 | positive regulation of mononuclear cell proliferation |
GO:0030097 | 3e-04 | 1.8015 | 30.1388 | 50 | 435 | hemopoiesis |
GO:0032729 | 3e-04 | 7.2959 | 1.3857 | 7 | 20 | positive regulation of interferon-gamma production |
GO:0007263 | 3e-04 | 13.5222 | 0.6928 | 5 | 10 | nitric oxide mediated signal transduction |
GO:0050789 | 3e-04 | 1.3355 | 396.2665 | 438 | 5840 | regulation of biological process |
GO:0002019 | 3e-04 | Inf | 0.2079 | 3 | 3 | regulation of renal output by angiotensin |
GO:1900211 | 3e-04 | Inf | 0.2079 | 3 | 3 | regulation of mesenchymal cell apoptotic process involved in metanephros development |
GO:2000318 | 3e-04 | Inf | 0.2079 | 3 | 3 | positive regulation of T-helper 17 type immune response |
GO:0002520 | 3e-04 | 1.7356 | 33.6723 | 54 | 486 | immune system development |
GO:0032846 | 4e-04 | 4.3813 | 2.8407 | 10 | 41 | positive regulation of homeostatic process |
GO:0034103 | 4e-04 | 4.8856 | 2.3557 | 9 | 34 | regulation of tissue remodeling |
GO:0009887 | 4e-04 | 1.8303 | 26.0722 | 44 | 388 | organ morphogenesis |
GO:0007218 | 4e-04 | 3.4027 | 4.5035 | 13 | 65 | neuropeptide signaling pathway |
GO:0030878 | 5e-04 | 11.2673 | 0.7621 | 5 | 11 | thyroid gland development |
GO:0002694 | 6e-04 | 2.1227 | 14.4805 | 28 | 209 | regulation of leukocyte activation |
GO:0007200 | 6e-04 | 4.1149 | 2.9792 | 10 | 43 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:1902105 | 6e-04 | 2.4846 | 9.007 | 20 | 130 | regulation of leukocyte differentiation |
GO:0007165 | 6e-04 | 1.312 | 211.9413 | 251 | 3059 | signal transduction |
GO:0042107 | 6e-04 | 3.7369 | 3.5335 | 11 | 51 | cytokine metabolic process |
GO:0001955 | 7e-04 | 18.0076 | 0.485 | 4 | 7 | blood vessel maturation |
GO:0072359 | 7e-04 | 1.6206 | 40.4622 | 61 | 584 | circulatory system development |
GO:0007389 | 7e-04 | 1.8407 | 22.9332 | 39 | 331 | pattern specification process |
GO:0032103 | 8e-04 | 2.7607 | 6.582 | 16 | 95 | positive regulation of response to external stimulus |
GO:0007631 | 8e-04 | 3.1583 | 4.7806 | 13 | 69 | feeding behavior |
GO:0007186 | 8e-04 | 1.8457 | 22.2732 | 38 | 328 | G-protein coupled receptor signaling pathway |
GO:0042035 | 8e-04 | 3.879 | 3.1178 | 10 | 45 | regulation of cytokine biosynthetic process |
GO:0030098 | 8e-04 | 2.2477 | 11.2934 | 23 | 163 | lymphocyte differentiation |
GO:0007267 | 8e-04 | 1.5366 | 52.3791 | 75 | 756 | cell-cell signaling |
GO:0021517 | 9e-04 | 4.21 | 2.6328 | 9 | 38 | ventral spinal cord development |
GO:0042472 | 9e-04 | 2.9317 | 5.4735 | 14 | 79 | inner ear morphogenesis |
GO:0043269 | 0.001 | 1.8384 | 21.7553 | 37 | 314 | regulation of ion transport |
GO:0043207 | 0.0011 | 1.7963 | 23.4182 | 39 | 338 | response to external biotic stimulus |
GO:0040011 | 0.0011 | 2.0196 | 15.108 | 28 | 225 | locomotion |
GO:0009952 | 0.0012 | 2.2275 | 10.8777 | 22 | 157 | anterior/posterior pattern specification |
GO:0002295 | 0.0013 | 40.4679 | 0.2771 | 3 | 4 | T-helper cell lineage commitment |
GO:0031622 | 0.0013 | 40.4679 | 0.2771 | 3 | 4 | positive regulation of fever generation |
GO:0050861 | 0.0013 | 40.4679 | 0.2771 | 3 | 4 | positive regulation of B cell receptor signaling pathway |
GO:0072039 | 0.0013 | 40.4679 | 0.2771 | 3 | 4 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
GO:1902455 | 0.0013 | 40.4679 | 0.2771 | 3 | 4 | negative regulation of stem cell maintenance |
GO:0001501 | 0.0013 | 1.8114 | 22.0325 | 37 | 318 | skeletal system development |
GO:0071715 | 0.0013 | 8.4487 | 0.9007 | 5 | 13 | icosanoid transport |
GO:2000514 | 0.0013 | 6.2447 | 1.3164 | 6 | 19 | regulation of CD4-positive, alpha-beta T cell activation |
GO:0042102 | 0.0014 | 3.9375 | 2.7714 | 9 | 40 | positive regulation of T cell proliferation |
GO:0051251 | 0.0014 | 2.3569 | 8.9377 | 19 | 129 | positive regulation of lymphocyte activation |
GO:0002822 | 0.0014 | 3.5716 | 3.3257 | 10 | 48 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0042113 | 0.0014 | 2.4916 | 7.6213 | 17 | 110 | B cell activation |
GO:0072593 | 0.0015 | 2.5642 | 6.9977 | 16 | 101 | reactive oxygen species metabolic process |
GO:0097530 | 0.0015 | 4.3366 | 2.2864 | 8 | 33 | granulocyte migration |
GO:0050867 | 0.0015 | 2.2751 | 9.6998 | 20 | 140 | positive regulation of cell activation |
GO:0055074 | 0.0016 | 2.1243 | 11.8477 | 23 | 171 | calcium ion homeostasis |
GO:1901700 | 0.0017 | 1.4813 | 55.4969 | 77 | 801 | response to oxygen-containing compound |
GO:0060429 | 0.0018 | 1.5122 | 48.707 | 69 | 703 | epithelium development |
GO:0030890 | 0.0018 | 5.798 | 1.3857 | 6 | 20 | positive regulation of B cell proliferation |
GO:0045124 | 0.0018 | 5.798 | 1.3857 | 6 | 20 | regulation of bone resorption |
GO:0072678 | 0.0019 | 7.5091 | 0.97 | 5 | 14 | T cell migration |
GO:0045666 | 0.002 | 2.9644 | 4.6421 | 12 | 67 | positive regulation of neuron differentiation |
GO:0007588 | 0.002 | 3.6981 | 2.9099 | 9 | 42 | excretion |
GO:0050877 | 0.0021 | 1.5964 | 34.7795 | 52 | 505 | neurological system process |
GO:0001991 | 0.0022 | 10.8023 | 0.6236 | 4 | 9 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0021877 | 0.0022 | 10.8023 | 0.6236 | 4 | 9 | forebrain neuron fate commitment |
GO:0050884 | 0.0022 | 10.8023 | 0.6236 | 4 | 9 | neuromuscular process controlling posture |
GO:0046903 | 0.0023 | 1.5438 | 40.7393 | 59 | 588 | secretion |
GO:0050863 | 0.0024 | 2.2336 | 9.3534 | 19 | 135 | regulation of T cell activation |
GO:0001662 | 0.0024 | 5.4109 | 1.455 | 6 | 21 | behavioral fear response |
GO:0045058 | 0.0024 | 5.4109 | 1.455 | 6 | 21 | T cell selection |
GO:0050878 | 0.0024 | 1.6631 | 27.6445 | 43 | 399 | regulation of body fluid levels |
GO:0007620 | 0.0026 | 6.7575 | 1.0393 | 5 | 15 | copulation |
GO:0042554 | 0.0026 | 6.7575 | 1.0393 | 5 | 15 | superoxide anion generation |
GO:0046006 | 0.0026 | 6.7575 | 1.0393 | 5 | 15 | regulation of activated T cell proliferation |
GO:0048870 | 0.0026 | 1.4845 | 49.4691 | 69 | 714 | cell motility |
GO:0007586 | 0.0028 | 2.9863 | 4.2264 | 11 | 61 | digestion |
GO:0008284 | 0.0028 | 1.5856 | 33.603 | 50 | 485 | positive regulation of cell proliferation |
GO:0001778 | 0.003 | 20.2318 | 0.3464 | 3 | 5 | plasma membrane repair |
GO:0002363 | 0.003 | 20.2318 | 0.3464 | 3 | 5 | alpha-beta T cell lineage commitment |
GO:0043369 | 0.003 | 20.2318 | 0.3464 | 3 | 5 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
GO:0045086 | 0.003 | 20.2318 | 0.3464 | 3 | 5 | positive regulation of interleukin-2 biosynthetic process |
GO:0006575 | 0.0031 | 2.2922 | 8.1756 | 17 | 118 | cellular modified amino acid metabolic process |
GO:1901568 | 0.0031 | 3.1546 | 3.6721 | 10 | 53 | fatty acid derivative metabolic process |
GO:0021953 | 0.0031 | 2.2876 | 8.1859 | 17 | 119 | central nervous system neuron differentiation |
GO:0015718 | 0.0032 | 2.7622 | 4.9192 | 12 | 71 | monocarboxylic acid transport |
GO:0042593 | 0.0033 | 2.2695 | 8.2449 | 17 | 119 | glucose homeostasis |
GO:0031349 | 0.0034 | 2.0611 | 11.0855 | 21 | 160 | positive regulation of defense response |
GO:0050482 | 0.0034 | 9.001 | 0.6928 | 4 | 10 | arachidonic acid secretion |
GO:0001819 | 0.0035 | 2.1413 | 9.6911 | 19 | 141 | positive regulation of cytokine production |
GO:0002250 | 0.0035 | 2.4004 | 6.9285 | 15 | 100 | adaptive immune response |
GO:0061564 | 0.0037 | 1.6204 | 28.2681 | 43 | 408 | axon development |
GO:0048729 | 0.0037 | 1.6382 | 26.6745 | 41 | 385 | tissue morphogenesis |
GO:0033555 | 0.0038 | 3.2969 | 3.1871 | 9 | 46 | multicellular organismal response to stress |
GO:0030168 | 0.0041 | 2.0656 | 10.5312 | 20 | 152 | platelet activation |
GO:0009889 | 0.0042 | 1.2578 | 187.3453 | 218 | 2704 | regulation of biosynthetic process |
GO:0080134 | 0.0042 | 1.5003 | 41.0164 | 58 | 592 | regulation of response to stress |
GO:0021515 | 0.0043 | 3.9782 | 2.1325 | 7 | 31 | cell differentiation in spinal cord |
GO:0051480 | 0.0043 | 2.2677 | 7.7599 | 16 | 112 | cytosolic calcium ion homeostasis |
GO:0003073 | 0.0044 | 3.2098 | 3.2564 | 9 | 47 | regulation of systemic arterial blood pressure |
GO:0001709 | 0.0045 | 3.9473 | 2.1478 | 7 | 31 | cell fate determination |
GO:0045600 | 0.0045 | 3.9473 | 2.1478 | 7 | 31 | positive regulation of fat cell differentiation |
GO:0009653 | 0.0046 | 1.4206 | 57.6436 | 77 | 886 | anatomical structure morphogenesis |
GO:0007338 | 0.0046 | 2.9479 | 3.8799 | 10 | 56 | single fertilization |
GO:0040008 | 0.0047 | 1.6139 | 27.021 | 41 | 390 | regulation of growth |
GO:0002351 | 0.0048 | Inf | 0.1386 | 2 | 2 | serotonin production involved in inflammatory response |
GO:0002554 | 0.0048 | Inf | 0.1386 | 2 | 2 | serotonin secretion by platelet |
GO:0010535 | 0.0048 | Inf | 0.1386 | 2 | 2 | positive regulation of activation of JAK2 kinase activity |
GO:0019448 | 0.0048 | Inf | 0.1386 | 2 | 2 | L-cysteine catabolic process |
GO:0035564 | 0.0048 | Inf | 0.1386 | 2 | 2 | regulation of kidney size |
GO:0035990 | 0.0048 | Inf | 0.1386 | 2 | 2 | tendon cell differentiation |
GO:0039003 | 0.0048 | Inf | 0.1386 | 2 | 2 | pronephric field specification |
GO:0060478 | 0.0048 | Inf | 0.1386 | 2 | 2 | acrosomal vesicle exocytosis |
GO:0060741 | 0.0048 | Inf | 0.1386 | 2 | 2 | prostate gland stromal morphogenesis |
GO:0071637 | 0.0048 | Inf | 0.1386 | 2 | 2 | regulation of monocyte chemotactic protein-1 production |
GO:0072305 | 0.0048 | Inf | 0.1386 | 2 | 2 | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis |
GO:0086023 | 0.0048 | Inf | 0.1386 | 2 | 2 | adrenergic receptor signaling pathway involved in heart process |
GO:0097324 | 0.0048 | Inf | 0.1386 | 2 | 2 | melanocyte migration |
GO:1900215 | 0.0048 | Inf | 0.1386 | 2 | 2 | negative regulation of apoptotic process involved in metanephric collecting duct development |
GO:1900218 | 0.0048 | Inf | 0.1386 | 2 | 2 | negative regulation of apoptotic process involved in metanephric nephron tubule development |
GO:2000319 | 0.0048 | Inf | 0.1386 | 2 | 2 | regulation of T-helper 17 cell differentiation |
GO:2000330 | 0.0048 | Inf | 0.1386 | 2 | 2 | positive regulation of T-helper 17 cell lineage commitment |
GO:2000594 | 0.0048 | Inf | 0.1386 | 2 | 2 | positive regulation of metanephric DCT cell differentiation |
GO:0050848 | 0.0048 | 5.6301 | 1.1778 | 5 | 17 | regulation of calcium-mediated signaling |
GO:0090189 | 0.0048 | 5.6301 | 1.1778 | 5 | 17 | regulation of branching involved in ureteric bud morphogenesis |
GO:0007411 | 0.0049 | 1.7392 | 19.0532 | 31 | 275 | axon guidance |
GO:0006693 | 0.005 | 4.5076 | 1.6628 | 6 | 24 | prostaglandin metabolic process |
GO:0072503 | 0.005 | 1.9487 | 12.1941 | 22 | 176 | cellular divalent inorganic cation homeostasis |
GO:0060284 | 0.005 | 1.5404 | 33.7416 | 49 | 487 | regulation of cell development |
GO:0021781 | 0.0051 | 7.7143 | 0.7621 | 4 | 11 | glial cell fate commitment |
GO:0035813 | 0.0051 | 7.7143 | 0.7621 | 4 | 11 | regulation of renal sodium excretion |
GO:0045577 | 0.0051 | 7.7143 | 0.7621 | 4 | 11 | regulation of B cell differentiation |
GO:0000904 | 0.0051 | 1.4898 | 40.5314 | 57 | 585 | cell morphogenesis involved in differentiation |
GO:0006636 | 0.0054 | 3.3854 | 2.7714 | 8 | 40 | unsaturated fatty acid biosynthetic process |
GO:0015844 | 0.0054 | 3.3854 | 2.7714 | 8 | 40 | monoamine transport |
GO:0045582 | 0.0054 | 3.3854 | 2.7714 | 8 | 40 | positive regulation of T cell differentiation |
GO:0046456 | 0.0054 | 3.789 | 2.2171 | 7 | 32 | icosanoid biosynthetic process |
GO:0006590 | 0.0056 | 13.5624 | 0.4135 | 3 | 6 | thyroid hormone generation |
GO:0002118 | 0.0057 | 13.4864 | 0.4157 | 3 | 6 | aggressive behavior |
GO:0031650 | 0.0057 | 13.4864 | 0.4157 | 3 | 6 | regulation of heat generation |
GO:0042178 | 0.0057 | 13.4864 | 0.4157 | 3 | 6 | xenobiotic catabolic process |
GO:0051001 | 0.0057 | 13.4864 | 0.4157 | 3 | 6 | negative regulation of nitric-oxide synthase activity |
GO:1902338 | 0.0057 | 13.4864 | 0.4157 | 3 | 6 | negative regulation of apoptotic process involved in morphogenesis |
GO:0001525 | 0.0057 | 1.7721 | 16.9054 | 28 | 244 | angiogenesis |
GO:0015849 | 0.0057 | 2.0377 | 10.1155 | 19 | 146 | organic acid transport |
GO:0048663 | 0.0057 | 4.3413 | 1.7058 | 6 | 25 | neuron fate commitment |
GO:0048878 | 0.0061 | 1.5222 | 34.088 | 49 | 492 | chemical homeostasis |
GO:0019221 | 0.0061 | 1.8026 | 15.4504 | 26 | 223 | cytokine-mediated signaling pathway |
GO:0007159 | 0.0061 | 4.2699 | 1.7321 | 6 | 25 | leukocyte cell-cell adhesion |
GO:0010043 | 0.0061 | 4.2699 | 1.7321 | 6 | 25 | response to zinc ion |
GO:0019233 | 0.0061 | 3.2987 | 2.8279 | 8 | 41 | sensory perception of pain |
GO:0050900 | 0.0063 | 1.9745 | 10.947 | 20 | 158 | leukocyte migration |
GO:0060079 | 0.0065 | 3.6429 | 2.2864 | 7 | 33 | regulation of excitatory postsynaptic membrane potential |
GO:0048864 | 0.0066 | 1.8674 | 13.2333 | 23 | 191 | stem cell development |
GO:0021536 | 0.0066 | 2.3855 | 6.0278 | 13 | 87 | diencephalon development |
GO:0035239 | 0.0069 | 1.7236 | 17.9447 | 29 | 259 | tube morphogenesis |
GO:0040017 | 0.007 | 1.8562 | 13.3026 | 23 | 192 | positive regulation of locomotion |
GO:0071310 | 0.007 | 1.3321 | 81.825 | 103 | 1181 | cellular response to organic substance |
GO:0007156 | 0.0071 | 2.4674 | 5.4042 | 12 | 78 | homophilic cell adhesion |
GO:0007517 | 0.0072 | 1.7561 | 16.4204 | 27 | 237 | muscle organ development |
GO:0021542 | 0.0072 | 6.7493 | 0.8314 | 4 | 12 | dentate gyrus development |
GO:0051930 | 0.0072 | 6.7493 | 0.8314 | 4 | 12 | regulation of sensory perception of pain |
GO:0061082 | 0.0072 | 6.7493 | 0.8314 | 4 | 12 | myeloid leukocyte cytokine production |
GO:0072079 | 0.0072 | 6.7493 | 0.8314 | 4 | 12 | nephron tubule formation |
GO:0002757 | 0.0074 | 1.7958 | 14.8962 | 25 | 215 | immune response-activating signal transduction |
GO:0071805 | 0.0074 | 2.264 | 6.7899 | 14 | 98 | potassium ion transmembrane transport |
GO:0030593 | 0.0075 | 4.056 | 1.8014 | 6 | 26 | neutrophil chemotaxis |
GO:0031644 | 0.0075 | 4.056 | 1.8014 | 6 | 26 | regulation of neurological system process |
GO:0044702 | 0.0076 | 1.4299 | 46.5052 | 63 | 673 | single organism reproductive process |
GO:0019229 | 0.0077 | 3.5076 | 2.3557 | 7 | 34 | regulation of vasoconstriction |
GO:0007420 | 0.0078 | 1.5193 | 32.0094 | 46 | 462 | brain development |
GO:0045165 | 0.0078 | 2.243 | 6.8335 | 14 | 101 | cell fate commitment |
GO:0006812 | 0.0079 | 1.4585 | 40.5314 | 56 | 585 | cation transport |
GO:0001775 | 0.008 | 1.7816 | 14.9915 | 25 | 222 | cell activation |
GO:0051954 | 0.0081 | 4.8247 | 1.3164 | 5 | 19 | positive regulation of amine transport |
GO:0001944 | 0.0085 | 1.5678 | 26.3281 | 39 | 380 | vasculature development |
GO:0002699 | 0.0087 | 2.8351 | 3.6028 | 9 | 52 | positive regulation of immune effector process |
GO:0001704 | 0.0088 | 2.2918 | 6.2356 | 13 | 90 | formation of primary germ layer |
GO:0007498 | 0.0088 | 2.2918 | 6.2356 | 13 | 90 | mesoderm development |
GO:0009615 | 0.0088 | 1.9045 | 11.2934 | 20 | 163 | response to virus |
GO:0006355 | 0.009 | 1.2412 | 161.7101 | 188 | 2334 | regulation of transcription, DNA-templated |
GO:0002700 | 0.0091 | 3.382 | 2.425 | 7 | 35 | regulation of production of molecular mediator of immune response |
GO:0048704 | 0.0092 | 2.486 | 4.9192 | 11 | 71 | embryonic skeletal system morphogenesis |
GO:0002675 | 0.0093 | 10.1562 | 0.4831 | 3 | 7 | positive regulation of acute inflammatory response |
GO:0003310 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | pancreatic A cell differentiation |
GO:0010935 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | regulation of macrophage cytokine production |
GO:0021892 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | cerebral cortex GABAergic interneuron differentiation |
GO:0042832 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | defense response to protozoan |
GO:0060405 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | regulation of penile erection |
GO:0071711 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | basement membrane organization |
GO:0072282 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | metanephric nephron tubule morphogenesis |
GO:1902547 | 0.0094 | 10.1138 | 0.485 | 3 | 7 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0043009 | 0.0095 | 1.5068 | 31.5245 | 45 | 455 | chordate embryonic development |
GO:0002376 | 0.0096 | 1.4169 | 46.1768 | 62 | 692 | immune system process |
GO:0021520 | 0.0099 | 5.9987 | 0.9007 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0051354 | 0.0099 | 5.9987 | 0.9007 | 4 | 13 | negative regulation of oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009167 | 1e-04 | 1.7955 | 34.3366 | 56 | 351 | purine ribonucleoside monophosphate metabolic process |
GO:0007067 | 2e-04 | 1.8713 | 28.3693 | 48 | 290 | mitotic nuclear division |
GO:0009123 | 2e-04 | 1.7587 | 36.1953 | 58 | 370 | nucleoside monophosphate metabolic process |
GO:0006200 | 3e-04 | 1.8917 | 25.141 | 43 | 257 | ATP catabolic process |
GO:0009158 | 4e-04 | 1.8737 | 25.3367 | 43 | 259 | ribonucleoside monophosphate catabolic process |
GO:0032984 | 4e-04 | 2.2228 | 14.2825 | 28 | 146 | macromolecular complex disassembly |
GO:0048285 | 4e-04 | 1.6709 | 40.4017 | 62 | 413 | organelle fission |
GO:0009128 | 4e-04 | 1.8649 | 25.4345 | 43 | 260 | purine nucleoside monophosphate catabolic process |
GO:0044241 | 4e-04 | 37.0343 | 0.4891 | 4 | 5 | lipid digestion |
GO:0050911 | 4e-04 | 37.0343 | 0.4891 | 4 | 5 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0.0012 | 3.5261 | 3.913 | 11 | 40 | sensory perception of chemical stimulus |
GO:0006744 | 0.0015 | 9.2639 | 0.9783 | 5 | 10 | ubiquinone biosynthetic process |
GO:0000226 | 0.0015 | 1.7626 | 24.7497 | 40 | 253 | microtubule cytoskeleton organization |
GO:0051297 | 0.0016 | 2.8326 | 5.8695 | 14 | 60 | centrosome organization |
GO:0019083 | 0.002 | 2.1614 | 11.4455 | 22 | 117 | viral transcription |
GO:1900026 | 0.002 | 6.1795 | 1.4674 | 6 | 15 | positive regulation of substrate adhesion-dependent cell spreading |
GO:0000956 | 0.0021 | 2.0308 | 13.6955 | 25 | 140 | nuclear-transcribed mRNA catabolic process |
GO:0048208 | 0.0025 | 7.7191 | 1.0761 | 5 | 11 | COPII vesicle coating |
GO:0034501 | 0.0025 | 12.3421 | 0.6848 | 4 | 7 | protein localization to kinetochore |
GO:0048524 | 0.0026 | 2.6583 | 6.163 | 14 | 63 | positive regulation of viral process |
GO:0044033 | 0.0032 | 2.0248 | 12.6194 | 23 | 129 | multi-organism metabolic process |
GO:0010606 | 0.0035 | 27.7477 | 0.3913 | 3 | 4 | positive regulation of cytoplasmic mRNA processing body assembly |
GO:0045357 | 0.0035 | 27.7477 | 0.3913 | 3 | 4 | regulation of interferon-beta biosynthetic process |
GO:0006414 | 0.0041 | 2.2613 | 8.5108 | 17 | 87 | translational elongation |
GO:0043624 | 0.0042 | 2.0115 | 12.1303 | 22 | 124 | cellular protein complex disassembly |
GO:0071824 | 0.0048 | 2.1072 | 10.076 | 19 | 103 | protein-DNA complex subunit organization |
GO:0006333 | 0.0052 | 2.198 | 8.7064 | 17 | 89 | chromatin assembly or disassembly |
GO:0006733 | 0.0057 | 2.7613 | 4.6956 | 11 | 48 | oxidoreduction coenzyme metabolic process |
GO:0019439 | 0.0057 | 1.3044 | 103.7923 | 128 | 1061 | aromatic compound catabolic process |
GO:0071222 | 0.0062 | 2.4659 | 6.0652 | 13 | 62 | cellular response to lipopolysaccharide |
GO:0043903 | 0.0063 | 2.0035 | 11.0542 | 20 | 113 | regulation of symbiosis, encompassing mutualism through parasitism |
GO:0006397 | 0.0068 | 1.5559 | 30.2279 | 44 | 309 | mRNA processing |
GO:0019076 | 0.0077 | 4.2762 | 1.8587 | 6 | 19 | viral release from host cell |
GO:0045047 | 0.0079 | 2.2141 | 7.6304 | 15 | 78 | protein targeting to ER |
GO:0006281 | 0.0079 | 1.5333 | 31.304 | 45 | 320 | DNA repair |
GO:0050906 | 0.0079 | 2.9823 | 3.6195 | 9 | 37 | detection of stimulus involved in sensory perception |
GO:0065003 | 0.0079 | 1.3186 | 84.8143 | 106 | 867 | macromolecular complex assembly |
GO:0019058 | 0.0083 | 1.6956 | 19.0937 | 30 | 196 | viral life cycle |
GO:0001895 | 0.0083 | 3.6048 | 2.4456 | 7 | 25 | retina homeostasis |
GO:0000718 | 0.0084 | 5.1444 | 1.3696 | 5 | 14 | nucleotide-excision repair, DNA damage removal |
GO:0071216 | 0.0088 | 2.1793 | 7.7282 | 15 | 79 | cellular response to biotic stimulus |
GO:0044270 | 0.0093 | 1.2826 | 103.4989 | 126 | 1058 | cellular nitrogen compound catabolic process |
GO:0006612 | 0.0095 | 1.8808 | 12.2281 | 21 | 125 | protein targeting to membrane |
GO:0006420 | 0.0096 | Inf | 0.1957 | 2 | 2 | arginyl-tRNA aminoacylation |
GO:0009992 | 0.0096 | Inf | 0.1957 | 2 | 2 | cellular water homeostasis |
GO:0010070 | 0.0096 | Inf | 0.1957 | 2 | 2 | zygote asymmetric cell division |
GO:0010949 | 0.0096 | Inf | 0.1957 | 2 | 2 | negative regulation of intestinal phytosterol absorption |
GO:0045796 | 0.0096 | Inf | 0.1957 | 2 | 2 | negative regulation of intestinal cholesterol absorption |
GO:0045908 | 0.0096 | Inf | 0.1957 | 2 | 2 | negative regulation of vasodilation |
GO:0070995 | 0.0096 | Inf | 0.1957 | 2 | 2 | NADPH oxidation |
GO:0071335 | 0.0096 | Inf | 0.1957 | 2 | 2 | hair follicle cell proliferation |
GO:2000118 | 0.0096 | Inf | 0.1957 | 2 | 2 | regulation of sodium-dependent phosphate transport |
GO:2000301 | 0.0096 | Inf | 0.1957 | 2 | 2 | negative regulation of synaptic vesicle exocytosis |
GO:1901361 | 0.0099 | 1.2769 | 105.5532 | 128 | 1079 | organic cyclic compound catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007308 | 0.0012 | 2030.8 | 0.0012 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0012 | 2030.8 | 0.0012 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0012 | 2030.8 | 0.0012 | 1 | 2 | P granule organization |
GO:0045091 | 0.0024 | 676.8 | 0.0024 | 1 | 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO:0090023 | 0.0035 | 406 | 0.0035 | 1 | 6 | positive regulation of neutrophil chemotaxis |
GO:0005981 | 0.0041 | 338.3 | 0.0041 | 1 | 7 | regulation of glycogen catabolic process |
GO:0007028 | 0.0041 | 338.3 | 0.0041 | 1 | 7 | cytoplasm organization |
GO:0039694 | 0.0047 | 289.9429 | 0.0047 | 1 | 8 | viral RNA genome replication |
GO:0043046 | 0.0059 | 225.4667 | 0.0059 | 1 | 10 | DNA methylation involved in gamete generation |
GO:1902622 | 0.0059 | 225.4667 | 0.0059 | 1 | 10 | regulation of neutrophil migration |
GO:0007350 | 0.0065 | 202.9 | 0.0065 | 1 | 11 | blastoderm segmentation |
GO:0008595 | 0.0065 | 202.9 | 0.0065 | 1 | 11 | anterior/posterior axis specification, embryo |
GO:0050930 | 0.0065 | 202.9 | 0.0065 | 1 | 11 | induction of positive chemotaxis |
GO:0071622 | 0.0065 | 202.9 | 0.0065 | 1 | 11 | regulation of granulocyte chemotaxis |
GO:0042119 | 0.0088 | 144.8714 | 0.0089 | 1 | 15 | neutrophil activation |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0034450 | 0.0042 | 331.1 | 0.0042 | 1 | 7 | ubiquitin-ubiquitin ligase activity |
GO:0004842 | 0.0068 | 22.5069 | 0.1315 | 2 | 218 | ubiquitin-protein transferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046983 | 0.0012 | 4.0511 | 2.7137 | 9 | 692 | protein dimerization activity |
GO:0001596 | 0.0039 | Inf | 0.0039 | 1 | 1 | angiotensin type I receptor activity |
GO:0004485 | 0.0039 | Inf | 0.0039 | 1 | 1 | methylcrotonoyl-CoA carboxylase activity |
GO:0004945 | 0.0039 | Inf | 0.0039 | 1 | 1 | angiotensin type II receptor activity |
GO:0005152 | 0.0039 | Inf | 0.0039 | 1 | 1 | interleukin-1 receptor antagonist activity |
GO:0015130 | 0.0039 | Inf | 0.0039 | 1 | 1 | mevalonate transmembrane transporter activity |
GO:0035730 | 0.0039 | Inf | 0.0039 | 1 | 1 | S-nitrosoglutathione binding |
GO:0035731 | 0.0039 | Inf | 0.0039 | 1 | 1 | dinitrosyl-iron complex binding |
GO:0047915 | 0.0039 | Inf | 0.0039 | 1 | 1 | ganglioside galactosyltransferase activity |
GO:0070026 | 0.0039 | Inf | 0.0039 | 1 | 1 | nitric oxide binding |
GO:0070888 | 0.0053 | 20.5405 | 0.1098 | 2 | 28 | E-box binding |
GO:0005052 | 0.0078 | 260.6579 | 0.0078 | 1 | 2 | peroxisome matrix targeting signal-1 binding |
GO:0005134 | 0.0078 | 260.6579 | 0.0078 | 1 | 2 | interleukin-2 receptor binding |
GO:0031711 | 0.0078 | 260.6579 | 0.0078 | 1 | 2 | bradykinin receptor binding |
GO:0033872 | 0.0078 | 260.6579 | 0.0078 | 1 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0.0011 | 2.5641 | 7.4453 | 17 | 692 | molecular transducer activity |
GO:0038023 | 0.0019 | 2.7689 | 5.1752 | 13 | 481 | signaling receptor activity |
GO:0005123 | 0.0049 | 23.4048 | 0.1076 | 2 | 10 | death receptor binding |
GO:0019199 | 0.0055 | 6.1234 | 0.7101 | 4 | 66 | transmembrane receptor protein kinase activity |
GO:0005126 | 0.0056 | 4.7258 | 1.1405 | 5 | 106 | cytokine receptor binding |
GO:0005159 | 0.0071 | 18.72 | 0.1291 | 2 | 12 | insulin-like growth factor receptor binding |
GO:0035591 | 0.0084 | 7.8542 | 0.4196 | 3 | 39 | signaling adaptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046872 | 0 | 3.9234 | 10.1122 | 22 | 2718 | metal ion binding |
GO:0043167 | 7e-04 | 3.1122 | 14.8744 | 25 | 3998 | ion binding |
GO:0035257 | 0.0032 | 11.2655 | 0.2976 | 3 | 80 | nuclear hormone receptor binding |
GO:0097110 | 0.0035 | 25.6779 | 0.0893 | 2 | 24 | scaffold protein binding |
GO:0004473 | 0.0037 | Inf | 0.0037 | 1 | 1 | malate dehydrogenase (decarboxylating) (NADP+) activity |
GO:0004613 | 0.0037 | Inf | 0.0037 | 1 | 1 | phosphoenolpyruvate carboxykinase (GTP) activity |
GO:0016532 | 0.0037 | Inf | 0.0037 | 1 | 1 | superoxide dismutase copper chaperone activity |
GO:0018455 | 0.0037 | Inf | 0.0037 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0019172 | 0.0037 | Inf | 0.0037 | 1 | 1 | glyoxalase III activity |
GO:0036470 | 0.0037 | Inf | 0.0037 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
GO:0036478 | 0.0037 | Inf | 0.0037 | 1 | 1 | L-dopa decarboxylase activator activity |
GO:0044388 | 0.0037 | Inf | 0.0037 | 1 | 1 | small protein activating enzyme binding |
GO:1903135 | 0.0037 | Inf | 0.0037 | 1 | 1 | cupric ion binding |
GO:1903136 | 0.0037 | Inf | 0.0037 | 1 | 1 | cuprous ion binding |
GO:1990422 | 0.0037 | Inf | 0.0037 | 1 | 1 | glyoxalase (glycolic acid-forming) activity |
GO:0050681 | 0.0045 | 22.5897 | 0.1005 | 2 | 27 | androgen receptor binding |
GO:0031406 | 0.0063 | 8.7424 | 0.3795 | 3 | 102 | carboxylic acid binding |
GO:0016830 | 0.0066 | 18.2065 | 0.1228 | 2 | 33 | carbon-carbon lyase activity |
GO:0004471 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | malate dehydrogenase (decarboxylating) (NAD+) activity |
GO:0004658 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | propionyl-CoA carboxylase activity |
GO:0008948 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | oxaloacetate decarboxylase activity |
GO:0016530 | 0.0074 | 275.1944 | 0.0074 | 1 | 2 | metallochaperone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 1e-04 | Inf | 0.0175 | 2 | 2 | aryldialkylphosphatase activity |
GO:0004252 | 2e-04 | 10.1271 | 0.5599 | 5 | 64 | serine-type endopeptidase activity |
GO:0004064 | 4e-04 | 115.9529 | 0.035 | 2 | 4 | arylesterase activity |
GO:0015288 | 4e-04 | 115.9529 | 0.035 | 2 | 4 | porin activity |
GO:0017171 | 6e-04 | 8.1732 | 0.6824 | 5 | 78 | serine hydrolase activity |
GO:0005509 | 0.0026 | 3.1361 | 3.5167 | 10 | 402 | calcium ion binding |
GO:0015464 | 0.0026 | 33.1126 | 0.0787 | 2 | 9 | acetylcholine receptor activity |
GO:0048306 | 0.0027 | 12.1047 | 0.2799 | 3 | 32 | calcium-dependent protein binding |
GO:0070011 | 0.0061 | 3.159 | 2.7502 | 8 | 318 | peptidase activity, acting on L-amino acid peptides |
GO:0001632 | 0.0087 | Inf | 0.0087 | 1 | 1 | leukotriene B4 receptor activity |
GO:0003868 | 0.0087 | Inf | 0.0087 | 1 | 1 | 4-hydroxyphenylpyruvate dioxygenase activity |
GO:0003908 | 0.0087 | Inf | 0.0087 | 1 | 1 | methylated-DNA-[protein]-cysteine S-methyltransferase activity |
GO:0004096 | 0.0087 | Inf | 0.0087 | 1 | 1 | catalase activity |
GO:0008725 | 0.0087 | Inf | 0.0087 | 1 | 1 | DNA-3-methyladenine glycosylase activity |
GO:0018733 | 0.0087 | Inf | 0.0087 | 1 | 1 | 3,4-dihydrocoumarin hydrolase activity |
GO:0033041 | 0.0087 | Inf | 0.0087 | 1 | 1 | sweet taste receptor activity |
GO:0043916 | 0.0087 | Inf | 0.0087 | 1 | 1 | DNA-7-methylguanine glycosylase activity |
GO:0047856 | 0.0087 | Inf | 0.0087 | 1 | 1 | dihydrocoumarin hydrolase activity |
GO:0052821 | 0.0087 | Inf | 0.0087 | 1 | 1 | DNA-7-methyladenine glycosylase activity |
GO:0052822 | 0.0087 | Inf | 0.0087 | 1 | 1 | DNA-3-methylguanine glycosylase activity |
GO:0070002 | 0.0087 | Inf | 0.0087 | 1 | 1 | glutamic-type peptidase activity |
GO:0070611 | 0.0087 | Inf | 0.0087 | 1 | 1 | histone methyltransferase activity (H3-R2 specific) |
GO:0070612 | 0.0087 | Inf | 0.0087 | 1 | 1 | histone methyltransferase activity (H2A-R3 specific) |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.2105 | 36.0111 | 70 | 590 | receptor activity |
GO:0004871 | 0 | 1.959 | 42.2367 | 74 | 692 | signal transducer activity |
GO:0000146 | 1e-04 | 13.3078 | 0.7935 | 6 | 13 | microfilament motor activity |
GO:0004888 | 2e-04 | 2.001 | 21.2842 | 39 | 355 | transmembrane signaling receptor activity |
GO:0019199 | 6e-04 | 3.4674 | 4.0284 | 12 | 66 | transmembrane receptor protein kinase activity |
GO:0045545 | 9e-04 | 46.3758 | 0.2441 | 3 | 4 | syndecan binding |
GO:0070330 | 9e-04 | 46.3758 | 0.2441 | 3 | 4 | aromatase activity |
GO:0008201 | 0.001 | 3.2269 | 4.2725 | 12 | 70 | heparin binding |
GO:0030247 | 0.0014 | 12.3821 | 0.5493 | 4 | 9 | polysaccharide binding |
GO:0050839 | 0.0017 | 4.1883 | 2.2966 | 8 | 38 | cell adhesion molecule binding |
GO:0005543 | 0.0018 | 2.0988 | 11.902 | 23 | 195 | phospholipid binding |
GO:0004879 | 0.0018 | 4.725 | 1.8311 | 7 | 30 | ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0004984 | 0.0021 | 23.1854 | 0.3052 | 3 | 5 | olfactory receptor activity |
GO:0003707 | 0.0032 | 4.1785 | 2.0142 | 7 | 33 | steroid hormone receptor activity |
GO:0008092 | 0.0034 | 1.5907 | 31.4334 | 47 | 515 | cytoskeletal protein binding |
GO:0051015 | 0.0036 | 2.854 | 4.3335 | 11 | 71 | actin filament binding |
GO:0005006 | 0.0037 | Inf | 0.1221 | 2 | 2 | epidermal growth factor-activated receptor activity |
GO:0031849 | 0.0037 | Inf | 0.1221 | 2 | 2 | olfactory receptor binding |
GO:0005520 | 0.0047 | 5.5316 | 1.1597 | 5 | 19 | insulin-like growth factor binding |
GO:0004252 | 0.0051 | 2.8798 | 3.9063 | 10 | 64 | serine-type endopeptidase activity |
GO:0005003 | 0.0063 | 6.876 | 0.7935 | 4 | 13 | ephrin receptor activity |
GO:0005178 | 0.0071 | 2.7274 | 4.0894 | 10 | 67 | integrin binding |
GO:0030971 | 0.0072 | 4.0433 | 1.77 | 6 | 29 | receptor tyrosine kinase binding |
GO:1901681 | 0.0074 | 3.1482 | 2.8922 | 8 | 48 | sulfur compound binding |
GO:0005547 | 0.0075 | 4.8391 | 1.2817 | 5 | 21 | phosphatidylinositol-3,4,5-trisphosphate binding |
GO:0001948 | 0.0079 | 3.1045 | 2.9297 | 8 | 48 | glycoprotein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005534 | 0.0033 | 496.6 | 0.0033 | 1 | 3 | galactose binding |
GO:0042043 | 0.0055 | 248.25 | 0.0055 | 1 | 5 | neurexin family protein binding |
GO:0005114 | 0.0066 | 198.58 | 0.0066 | 1 | 6 | type II transforming growth factor beta receptor binding |
GO:0004703 | 0.0077 | 165.4667 | 0.0077 | 1 | 7 | G-protein coupled receptor kinase activity |
GO:0005072 | 0.0077 | 165.4667 | 0.0077 | 1 | 7 | transforming growth factor beta receptor, cytoplasmic mediator activity |
GO:0004889 | 0.0088 | 141.8143 | 0.0088 | 1 | 8 | acetylcholine-activated cation-selective channel activity |
GO:0034713 | 0.0088 | 141.8143 | 0.0088 | 1 | 8 | type I transforming growth factor beta receptor binding |
GO:0070530 | 0.0088 | 141.8143 | 0.0088 | 1 | 8 | K63-linked polyubiquitin binding |
GO:0015464 | 0.0099 | 124.075 | 0.01 | 1 | 9 | acetylcholine receptor activity |
GO:0042166 | 0.0099 | 124.075 | 0.01 | 1 | 9 | acetylcholine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0020037 | 0.001 | 56.7759 | 0.0483 | 2 | 60 | heme binding |
GO:0000248 | 0.0016 | 1419.4286 | 0.0016 | 1 | 2 | C-5 sterol desaturase activity |
GO:0047066 | 0.0016 | 1419.4286 | 0.0016 | 1 | 2 | phospholipid-hydroperoxide glutathione peroxidase activity |
GO:0005506 | 0.002 | 38.6353 | 0.07 | 2 | 87 | iron ion binding |
GO:0005344 | 0.0024 | 709.6429 | 0.0024 | 1 | 3 | oxygen transporter activity |
GO:0045569 | 0.0032 | 473.0476 | 0.0032 | 1 | 4 | TRAIL binding |
GO:0043295 | 0.0064 | 202.6531 | 0.0064 | 1 | 8 | glutathione binding |
GO:0008430 | 0.008 | 157.5873 | 0.008 | 1 | 10 | selenium binding |
GO:0019825 | 0.008 | 157.5873 | 0.008 | 1 | 10 | oxygen binding |
GO:0004602 | 0.0096 | 128.9091 | 0.0097 | 1 | 12 | glutathione peroxidase activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015108 | 1e-04 | 6.8063 | 1.4108 | 8 | 46 | chloride transmembrane transporter activity |
GO:0004984 | 3e-04 | 47.8709 | 0.1533 | 3 | 5 | olfactory receptor activity |
GO:0005509 | 6e-04 | 2.1938 | 12.3288 | 25 | 402 | calcium ion binding |
GO:0004252 | 7e-04 | 4.6099 | 1.9628 | 8 | 64 | serine-type endopeptidase activity |
GO:0005006 | 9e-04 | Inf | 0.0613 | 2 | 2 | epidermal growth factor-activated receptor activity |
GO:0016934 | 9e-04 | Inf | 0.0613 | 2 | 2 | extracellular-glycine-gated chloride channel activity |
GO:0017171 | 0.0026 | 3.6825 | 2.3922 | 8 | 78 | serine hydrolase activity |
GO:0022824 | 0.0028 | 63.6238 | 0.092 | 2 | 3 | transmitter-gated ion channel activity |
GO:0019903 | 0.0043 | 3.7506 | 2.0548 | 7 | 67 | protein phosphatase binding |
GO:0003840 | 0.0054 | 31.8086 | 0.1227 | 2 | 4 | gamma-glutamyltransferase activity |
GO:0045499 | 0.0054 | 31.8086 | 0.1227 | 2 | 4 | chemorepellent activity |
GO:0005328 | 0.0065 | 9.5662 | 0.3987 | 3 | 13 | neurotransmitter:sodium symporter activity |
GO:0038023 | 0.0068 | 1.7982 | 14.7516 | 25 | 481 | signaling receptor activity |
GO:0070851 | 0.008 | 3.3066 | 2.3002 | 7 | 75 | growth factor receptor binding |
GO:0016597 | 0.0084 | 3.7 | 1.7788 | 6 | 58 | amino acid binding |
GO:0046703 | 0.0088 | 21.2035 | 0.1533 | 2 | 5 | natural killer cell lectin-like receptor binding |
GO:0070011 | 0.0094 | 1.9459 | 9.7833 | 18 | 319 | peptidase activity, acting on L-amino acid peptides |
GO:0005253 | 0.0097 | 4.2114 | 1.3188 | 5 | 43 | anion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035755 | 4e-04 | Inf | 4e-04 | 1 | 1 | cardiolipin hydrolase activity |
GO:0031781 | 8e-04 | 3313.3333 | 8e-04 | 1 | 2 | type 3 melanocortin receptor binding |
GO:0031782 | 8e-04 | 3313.3333 | 8e-04 | 1 | 2 | type 4 melanocortin receptor binding |
GO:0070996 | 8e-04 | 3313.3333 | 8e-04 | 1 | 2 | type 1 melanocortin receptor binding |
GO:0071855 | 0.0064 | 220.5778 | 0.0064 | 1 | 16 | neuropeptide receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 0 | Inf | 0.0084 | 2 | 2 | aryldialkylphosphatase activity |
GO:0004064 | 1e-04 | 247.525 | 0.0169 | 2 | 4 | arylesterase activity |
GO:0008430 | 8e-04 | 61.8438 | 0.0422 | 2 | 10 | selenium binding |
GO:0004411 | 0.0042 | Inf | 0.0042 | 1 | 1 | homogentisate 1,2-dioxygenase activity |
GO:0009032 | 0.0042 | Inf | 0.0042 | 1 | 1 | thymidine phosphorylase activity |
GO:0016154 | 0.0042 | Inf | 0.0042 | 1 | 1 | pyrimidine-nucleoside phosphorylase activity |
GO:0017064 | 0.0042 | Inf | 0.0042 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0017174 | 0.0042 | Inf | 0.0042 | 1 | 1 | glycine N-methyltransferase activity |
GO:0018733 | 0.0042 | Inf | 0.0042 | 1 | 1 | 3,4-dihydrocoumarin hydrolase activity |
GO:0047747 | 0.0042 | Inf | 0.0042 | 1 | 1 | cholate-CoA ligase activity |
GO:0047856 | 0.0042 | Inf | 0.0042 | 1 | 1 | dihydrocoumarin hydrolase activity |
GO:0070002 | 0.0042 | Inf | 0.0042 | 1 | 1 | glutamic-type peptidase activity |
GO:0008083 | 0.007 | 8.3872 | 0.3928 | 3 | 93 | growth factor activity |
GO:0072341 | 0.0075 | 17.0241 | 0.1309 | 2 | 31 | modified amino acid binding |
GO:0004030 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | aldehyde dehydrogenase [NAD(P)+] activity |
GO:0008502 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | melatonin receptor activity |
GO:0032051 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | clathrin light chain binding |
GO:0034189 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | very-low-density lipoprotein particle binding |
GO:0047066 | 0.0084 | 241.5122 | 0.0084 | 1 | 2 | phospholipid-hydroperoxide glutathione peroxidase activity |
GO:0042803 | 0.0089 | 3.7169 | 1.8202 | 6 | 431 | protein homodimerization activity |
GO:0005543 | 0.009 | 5.3524 | 0.8235 | 4 | 195 | phospholipid binding |
GO:0031406 | 0.009 | 7.6177 | 0.4308 | 3 | 102 | carboxylic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016493 | 5e-04 | 154.5669 | 0.0389 | 2 | 3 | C-C chemokine receptor activity |
GO:0016901 | 5e-04 | 154.5669 | 0.0389 | 2 | 3 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0051431 | 5e-04 | 154.5669 | 0.0389 | 2 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0050840 | 7e-04 | 11.1863 | 0.4151 | 4 | 32 | extracellular matrix binding |
GO:0005184 | 9e-04 | 19.4524 | 0.1946 | 3 | 15 | neuropeptide hormone activity |
GO:0071855 | 0.0011 | 17.9542 | 0.2075 | 3 | 16 | neuropeptide receptor binding |
GO:0004896 | 0.0019 | 8.4575 | 0.5318 | 4 | 41 | cytokine receptor activity |
GO:0033218 | 0.0033 | 4.4685 | 1.4528 | 6 | 112 | amide binding |
GO:0038023 | 0.0038 | 2.4371 | 6.2392 | 14 | 481 | signaling receptor activity |
GO:0001637 | 0.0044 | 25.748 | 0.1038 | 2 | 8 | G-protein coupled chemoattractant receptor activity |
GO:0005092 | 0.0044 | 25.748 | 0.1038 | 2 | 8 | GDP-dissociation inhibitor activity |
GO:0043295 | 0.0044 | 25.748 | 0.1038 | 2 | 8 | glutathione binding |
GO:0050998 | 0.0044 | 25.748 | 0.1038 | 2 | 8 | nitric-oxide synthase binding |
GO:0004930 | 0.0059 | 3.1467 | 2.724 | 8 | 210 | G-protein coupled receptor activity |
GO:0042288 | 0.007 | 19.3071 | 0.1297 | 2 | 10 | MHC class I protein binding |
GO:0042605 | 0.007 | 19.3071 | 0.1297 | 2 | 10 | peptide antigen binding |
GO:0060089 | 0.0079 | 2.0555 | 8.9762 | 17 | 692 | molecular transducer activity |
GO:0033764 | 0.0085 | 17.1601 | 0.1427 | 2 | 11 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010844 | 0.0018 | Inf | 0.0018 | 1 | 1 | recombination hotspot binding |
GO:0047747 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholate-CoA ligase activity |
GO:0001733 | 0.0054 | 291.9118 | 0.0054 | 1 | 3 | galactosylceramide sulfotransferase activity |
GO:0015245 | 0.0054 | 291.9118 | 0.0054 | 1 | 3 | fatty acid transporter activity |
GO:0031957 | 0.009 | 145.9265 | 0.009 | 1 | 5 | very long-chain fatty acid-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016887 | 0 | 1.9908 | 27.6025 | 49 | 277 | ATPase activity |
GO:0017025 | 1e-04 | 13.6294 | 0.9965 | 6 | 10 | TBP-class protein binding |
GO:0044822 | 4e-04 | 1.4502 | 86.2952 | 116 | 866 | poly(A) RNA binding |
GO:0004984 | 5e-04 | 36.2837 | 0.4982 | 4 | 5 | olfactory receptor activity |
GO:0004386 | 7e-04 | 2.3401 | 11.2602 | 23 | 113 | helicase activity |
GO:0016817 | 0.0011 | 1.5173 | 54.6071 | 77 | 548 | hydrolase activity, acting on acid anhydrides |
GO:0004252 | 0.0013 | 2.7931 | 6.3775 | 15 | 64 | serine-type endopeptidase activity |
GO:0016462 | 0.0021 | 1.4813 | 54.2085 | 75 | 544 | pyrophosphatase activity |
GO:0016655 | 0.0026 | 3.3703 | 3.687 | 10 | 37 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
GO:0043024 | 0.0027 | 12.0919 | 0.6975 | 4 | 7 | ribosomal small subunit binding |
GO:0017171 | 0.0038 | 2.3535 | 7.7725 | 16 | 78 | serine hydrolase activity |
GO:0008565 | 0.0043 | 2.7316 | 5.1817 | 12 | 52 | protein transporter activity |
GO:0008026 | 0.0048 | 2.4531 | 6.5768 | 14 | 66 | ATP-dependent helicase activity |
GO:0031072 | 0.0065 | 2.7051 | 4.7831 | 11 | 48 | heat shock protein binding |
GO:0003857 | 0.0085 | 13.5911 | 0.4982 | 3 | 5 | 3-hydroxyacyl-CoA dehydrogenase activity |
GO:0003735 | 0.0098 | 1.947 | 10.762 | 19 | 108 | structural constituent of ribosome |
GO:0004609 | 0.0099 | Inf | 0.1993 | 2 | 2 | phosphatidylserine decarboxylase activity |
GO:0004814 | 0.0099 | Inf | 0.1993 | 2 | 2 | arginine-tRNA ligase activity |
GO:0004886 | 0.0099 | Inf | 0.1993 | 2 | 2 | 9-cis retinoic acid receptor activity |
GO:0015266 | 0.0099 | Inf | 0.1993 | 2 | 2 | protein channel activity |
GO:0016508 | 0.0099 | Inf | 0.1993 | 2 | 2 | long-chain-enoyl-CoA hydratase activity |
GO:0030280 | 0.0099 | Inf | 0.1993 | 2 | 2 | structural constituent of epidermis |
GO:0033038 | 0.0099 | Inf | 0.1993 | 2 | 2 | bitter taste receptor activity |
GO:0042500 | 0.0099 | Inf | 0.1993 | 2 | 2 | aspartic endopeptidase activity, intramembrane cleaving |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002058 | 0.0017 | Inf | 0.0017 | 1 | 1 | uracil binding |
GO:0002059 | 0.0017 | Inf | 0.0017 | 1 | 1 | thymine binding |
GO:0005185 | 0.0017 | Inf | 0.0017 | 1 | 1 | neurohypophyseal hormone activity |
GO:0031855 | 0.0017 | Inf | 0.0017 | 1 | 1 | oxytocin receptor binding |
GO:0003847 | 0.0034 | 620.4375 | 0.0034 | 1 | 2 | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO:0004067 | 0.0034 | 620.4375 | 0.0034 | 1 | 2 | asparaginase activity |
GO:0004157 | 0.0034 | 620.4375 | 0.0034 | 1 | 2 | dihydropyrimidinase activity |
GO:0050682 | 0.0034 | 620.4375 | 0.0034 | 1 | 2 | AF-2 domain binding |
GO:0005179 | 0.0037 | 25.3231 | 0.0923 | 2 | 54 | hormone activity |
GO:0016810 | 0.0066 | 18.7771 | 0.1231 | 2 | 72 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
GO:0002054 | 0.0068 | 206.7708 | 0.0068 | 1 | 4 | nucleobase binding |
GO:0003700 | 0.0073 | 5.0696 | 1.2974 | 5 | 759 | sequence-specific DNA binding transcription factor activity |
GO:0003708 | 0.0085 | 155.0625 | 0.0085 | 1 | 5 | retinoic acid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005153 | 8e-04 | 3313.3333 | 8e-04 | 1 | 2 | interleukin-8 receptor binding |
GO:0016290 | 0.0032 | 473.0476 | 0.0032 | 1 | 8 | palmitoyl-CoA hydrolase activity |
GO:0008009 | 0.0044 | 331.0333 | 0.0044 | 1 | 11 | chemokine activity |
GO:0016289 | 0.0052 | 275.8056 | 0.0052 | 1 | 13 | CoA hydrolase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |